data_6tir_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6tir _Structure_validation_residue.Date_analyzed 2019-11-29 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.824 0.345 . . . . 52.03 111.12 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.1 t 60.47 82.58 0.22 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.649 0.737 . . . . 74.34 111.148 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 167.76 23.49 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.684 2.256 . . . . 75.31 112.323 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 116.48 4.59 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.653 2.236 . . . . 75.3 112.324 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.8 t -107.85 -39.44 5.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 74.44 111.172 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -67.96 -35.17 77.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 74.45 110.896 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -73.17 -23.32 60.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.113 -0.494 . . . . 74.35 111.103 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -90.02 13.95 13.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 72.51 110.855 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 45.2 mt -73.77 -34.27 64.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.2 -0.455 . . . . 74.43 110.954 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 172.62 40.94 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.699 -0.762 . . . . 71.41 112.437 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 44.4 tptt -68.6 -46.02 70.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.823 0.344 . . . . 74.13 110.917 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.1 t -64.79 -39.44 93.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 72.21 110.865 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.14 -49.97 52.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 55.14 111.083 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -66.72 -32.79 74.32 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.223 -0.444 . . . . 75.52 110.87 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -58.89 -48.17 82.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.147 -0.478 . . . . 73.45 110.837 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.8 p -81.54 -31.44 11.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 73.24 111.148 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -65.92 -41.35 91.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 74.32 110.905 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 69.0 p -73.81 76.92 1.6 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 73.55 111.187 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.95 124.68 18.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 72.33 110.882 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -53.49 120.11 12.76 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.761 -0.733 . . . . 73.21 112.456 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -59.89 97.96 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.936 0.398 . . . . 74.2 110.914 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -77.74 88.78 1.05 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.749 -0.739 . . . . 74.11 112.529 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -101.12 13.39 35.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.914 0.388 . . . . 73.53 110.888 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.85 13.31 80.77 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.709 -0.758 . . . . 71.42 112.481 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.7 pp -101.91 174.81 5.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.836 0.351 . . . . 74.53 110.881 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 1.7 mp -116.94 123.89 72.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 74.42 111.142 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 71.6 mttt -101.69 154.56 18.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 73.45 110.909 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -146.05 136.34 23.85 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.23 -0.441 . . . . 73.25 110.88 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -153.81 124.64 7.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.456 . . . . 73.13 110.93 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -137.2 128.12 27.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.196 -0.456 . . . . 74.4 110.919 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 10.8 pttp -120.7 134.67 55.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 74.04 110.936 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -137.95 120.65 16.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 65.31 111.147 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -126.12 146.99 49.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.234 -0.439 . . . . 75.12 110.892 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -139.06 166.99 23.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 64.41 110.878 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -89.42 49.46 1.76 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.118 -0.492 . . . . 62.32 110.878 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -136.37 4.84 2.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.476 . . . . 73.22 110.875 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.513 ' HA2' ' O ' ' A' ' 63' ' ' ARG . . . 89.13 -7.16 82.76 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.741 -0.742 . . . . 74.33 112.482 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.415 ' O ' HD21 ' A' ' 39' ' ' LEU . 1.6 pt? -98.76 129.83 45.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.779 0.323 . . . . 75.43 110.926 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -142.08 117.86 10.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.444 . . . . 70.12 110.895 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.51 122.29 43.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 71.42 110.872 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.11 115.32 19.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 70.42 111.12 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.7 p -115.68 134.43 55.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.249 -0.432 . . . . 73.15 110.888 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 74.8 m -149.26 126.64 11.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 64.43 110.827 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -173.62 167.53 40.17 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.734 -0.746 . . . . 70.24 112.524 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.4 p -137.58 158.05 45.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.885 0.374 . . . . 73.54 110.865 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.428 ' HA ' ' HA ' ' A' ' 54' ' ' VAL . . . -140.42 129.66 23.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 74.01 111.085 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -98.06 127.34 43.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 74.54 110.874 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 28.6 p -90.68 -52.93 4.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 74.31 111.113 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -51.51 -38.28 53.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 73.12 110.896 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 43.9 p -133.91 161.79 33.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 73.24 111.134 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.2 p -75.7 78.1 2.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.227 -0.442 . . . . 72.2 111.111 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 10.9 ttpt -142.7 78.83 1.63 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 74.45 110.906 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.428 ' HA ' ' HA ' ' A' ' 47' ' ' ALA . 1.3 p -127.79 121.24 56.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 74.14 111.104 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 6.3 m -137.22 126.72 25.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.202 -0.454 . . . . 73.13 111.107 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -111.87 154.28 16.86 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.751 -0.738 . . . . 64.33 112.487 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.5 m -136.98 143.87 43.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.889 0.376 . . . . 61.21 110.865 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -121.08 126.28 49.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 72.21 110.911 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -121.69 126.46 49.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 72.13 110.878 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -104.11 120.12 40.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.143 -0.481 . . . . 73.01 111.119 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -119.76 158.75 25.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.181 -0.463 . . . . 74.42 110.855 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.418 ' HB2' ' HB2' ' A' ' 71' ' ' PHE . 21.7 m-85 -133.16 140.89 47.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.145 -0.479 . . . . 74.04 110.898 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.513 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 21.4 tpp180 -131.25 103.32 6.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.107 -0.497 . . . . 73.14 110.86 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 17.8 m95 -116.15 121.26 41.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.461 . . . . 72.44 110.961 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.7 m 66.34 136.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.251 -0.431 . . . . 73.05 111.148 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -63.82 106.07 0.94 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.241 -0.436 . . . . 74.42 110.858 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 23.2 t80 66.51 59.08 0.63 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.154 -0.475 . . . . 73.53 110.886 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -140.62 -65.78 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.743 -0.741 . . . . 71.42 112.482 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -130.62 129.03 42.18 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.891 0.377 . . . . 74.14 110.907 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 5.1 m -137.92 133.26 33.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.177 -0.465 . . . . 62.34 111.124 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.418 ' HB2' ' HB2' ' A' ' 62' ' ' TYR . 19.9 m-85 -123.27 134.79 54.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.444 . . . . 74.13 110.886 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.8 p -127.28 118.52 24.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.466 . . . . 72.5 111.19 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -121.82 130.06 53.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.259 -0.428 . . . . 74.44 110.849 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -122.24 104.98 9.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.48 . . . . 73.23 110.857 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 8.6 t90 -122.35 125.71 46.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.251 -0.431 . . . . 75.23 110.909 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -102.81 137.11 41.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 70.22 110.926 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 24.0 m -66.85 -34.4 77.72 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.206 -0.452 . . . . 73.32 111.136 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -110.81 -34.08 6.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.258 -0.428 . . . . 64.24 110.891 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -81.25 -160.55 0.34 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 72.25 110.901 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 66.6 p -80.95 154.05 27.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 74.53 111.154 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -111.44 137.31 49.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 74.24 110.896 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -159.77 162.94 33.37 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.73 -0.748 . . . . 54.11 112.466 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.5 t -138.46 163.54 31.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.721 0.296 . . . . 74.22 111.137 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.33 145.48 25.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.456 . . . . 74.21 110.868 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.56 138.08 55.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.475 . . . . 74.52 111.146 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 20.3 m -127.03 129.15 47.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.18 -0.463 . . . . 73.44 111.156 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.4 p -128.61 137.34 57.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 74.14 111.16 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -102.62 118.47 36.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 71.54 110.878 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -50.49 128.07 19.2 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.156 -0.474 . . . . 74.33 110.867 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -79.43 -56.71 4.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.185 -0.461 . . . . 71.43 110.935 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 15.3 mt -72.26 -41.29 66.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 74.42 110.928 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -93.78 71.6 4.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 74.24 111.121 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 11.5 tpt180 -50.98 135.32 24.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 74.31 110.883 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 101.75 -23.61 34.27 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.762 -0.733 . . . . 71.41 112.507 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.8 119.41 22.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.914 0.388 . . . . 75.33 110.905 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -121.42 125.74 47.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 74.44 110.871 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -118.62 126.71 52.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.445 . . . . 75.4 110.943 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 97.2 m -131.33 119.83 22.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 72.12 111.139 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -115.11 121.73 43.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 75.21 110.895 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -119.29 150.0 40.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.163 -0.471 . . . . 73.32 110.851 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 7.1 t -142.22 124.81 15.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 73.42 110.84 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 4.9 m -99.77 146.52 26.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.108 -0.496 . . . . 75.24 110.898 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -143.12 138.55 29.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.458 . . . . 74.41 110.923 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 17.7 m -99.0 137.41 20.48 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.647 0.737 . . . . 72.32 110.882 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.83 125.57 12.26 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.719 2.279 . . . . 62.32 112.332 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 51.01 48.86 22.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 71.14 110.928 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 25.9 m -136.96 -41.53 0.59 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.143 -0.481 . . . . 71.43 111.103 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 92.28 -18.01 55.55 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.763 -0.732 . . . . 72.42 112.525 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 8.5 tttm -65.94 116.61 7.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.855 0.36 . . . . 75.41 110.931 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 15.0 ptmt -115.81 131.0 57.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 74.13 110.912 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -120.98 123.87 43.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.208 -0.451 . . . . 73.23 110.907 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -110.55 136.2 50.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.454 . . . . 72.43 111.113 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 11.2 mttt -138.25 137.78 37.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 74.51 110.888 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 5.7 tp -120.34 130.73 74.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.437 . . . . 65.33 111.127 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.6 tptp -120.35 119.69 33.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 74.03 110.879 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 58.7 m -129.61 121.48 27.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 74.33 111.145 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -150.56 170.68 30.43 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.769 -0.729 . . . . 74.24 112.497 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -127.98 135.84 50.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.973 0.416 . . . . 75.02 110.934 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.9 tttt -110.86 118.02 34.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.12 -0.491 . . . . 75.51 110.87 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 23.1 ttm-85 -111.42 143.73 41.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 71.44 110.883 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -52.35 -29.36 23.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 74.42 110.899 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -86.31 -41.16 14.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 74.54 110.883 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.3 pp -148.25 153.53 11.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.224 -0.444 . . . . 74.51 111.111 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -127.24 115.06 18.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 75.5 110.905 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.616 ' CD2' ' C ' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -133.39 142.79 48.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 72.42 110.927 179.959 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -148.02 141.97 9.67 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.723 -0.751 . . . . 71.2 112.47 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 2.0 t -113.32 131.0 56.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.81 0.338 . . . . 74.42 110.883 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -119.68 150.41 40.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.232 -0.44 . . . . 75.34 110.888 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 8.1 ttt -138.03 119.76 15.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.446 . . . . 75.21 110.886 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -102.33 120.95 41.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.202 -0.454 . . . . 73.31 110.871 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -95.34 116.34 28.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 75.04 110.868 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -109.94 173.66 6.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 62.21 110.87 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 2.8 mp -93.34 -33.59 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 72.44 111.154 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -92.69 -19.77 21.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 75.42 111.075 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 168.9 106.63 0.19 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.76 -0.733 . . . . 71.45 112.484 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 144.56 54.25 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.639 2.226 . . . . 75.14 112.328 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 9.4 t -128.77 152.35 48.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.444 . . . . 73.24 110.841 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 1.7 mp -112.34 135.48 51.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.131 -0.486 . . . . 73.14 111.09 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 8.5 ttm180 -121.48 112.32 18.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.458 . . . . 73.4 110.871 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -111.65 136.38 13.51 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.775 -0.726 . . . . 70.21 112.525 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -138.54 116.26 11.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.799 0.333 . . . . 74.43 111.125 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.1 tp -123.86 124.51 42.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.252 -0.431 . . . . 74.41 110.901 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 44.5 t -114.25 129.85 69.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 74.2 111.081 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -106.14 138.85 41.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 74.51 110.899 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -116.27 136.6 13.0 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.781 -0.723 . . . . 73.1 112.487 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -140.46 146.43 38.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.876 0.37 . . . . 75.01 110.909 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 74.5 mt-10 -50.31 96.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.136 -0.483 . . . . 75.42 110.907 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 90.16 -26.08 10.89 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.745 -0.741 . . . . 55.55 112.541 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 7.1 m0 -105.15 135.64 46.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.803 0.335 . . . . 75.54 110.886 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -126.53 140.07 52.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.265 -0.425 . . . . 75.44 110.876 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -139.76 145.2 37.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 73.24 111.083 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -146.97 132.97 4.58 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.71 -0.757 . . . . 62.21 112.516 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -135.43 120.17 18.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.842 0.354 . . . . 75.54 110.899 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -134.05 122.45 23.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.137 -0.483 . . . . 72.23 110.95 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 4.3 ptt? -145.96 155.39 42.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 73.33 110.892 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -112.72 129.92 56.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 74.24 110.846 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.405 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 62.1 t80 -90.44 133.16 35.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.48 . . . . 75.13 110.861 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -77.82 101.94 6.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.473 . . . . 74.4 110.914 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.97 -47.4 77.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.127 -0.488 . . . . 74.12 111.117 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -48.6 -26.07 2.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 71.3 111.097 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 4.1 tptt -126.11 -167.51 1.72 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 65.11 110.919 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 11.7 t -112.03 40.83 2.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.446 . . . . 75.42 110.814 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -154.47 176.09 12.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 75.34 110.869 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 2.0 t -82.55 141.51 14.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.446 . . . . 74.15 111.125 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 15.2 t -91.01 -34.19 15.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.192 -0.458 . . . . 73.24 111.154 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -152.45 138.18 17.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 74.24 110.897 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 3.5 m -124.7 131.14 53.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 72.41 110.879 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -132.09 135.16 46.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 71.53 110.843 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -130.06 148.51 51.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.103 -0.499 . . . . 72.32 110.887 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -153.42 138.13 16.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 74.14 111.117 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 61.8 t -120.64 134.7 63.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.252 -0.431 . . . . 72.11 111.09 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -116.01 131.29 9.53 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.737 -0.744 . . . . 65.03 112.497 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -130.03 120.66 25.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.961 0.41 . . . . 74.22 110.926 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.14 132.28 54.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.079 -0.509 . . . . 73.3 110.888 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.47 166.49 21.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 74.42 111.136 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -39.79 -73.82 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.22 -0.446 . . . . 61.03 110.885 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -117.05 14.81 15.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.459 . . . . 55.34 110.951 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -126.15 142.3 51.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.115 -0.493 . . . . 70.01 110.897 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 53.8 mm-40 -136.6 125.29 23.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.111 -0.495 . . . . 71.23 110.9 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -123.31 129.01 50.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.462 . . . . 72.45 110.929 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 25.7 m80 -129.85 117.78 20.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 73.13 110.89 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 9.2 m -109.31 155.77 20.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 73.4 111.175 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -162.47 139.42 7.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.24 -0.436 . . . . 73.25 110.909 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.546 ' HB ' ' HA ' ' A' ' 190' ' ' PHE . 2.0 m -133.62 138.61 50.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 70.41 111.139 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -97.7 88.77 4.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 75.35 110.891 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 72.4 -176.4 0.18 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.195 -0.457 . . . . 74.33 110.888 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -79.45 3.08 69.12 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.73 -0.748 . . . . 71.21 112.479 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 3.9 t -107.54 -22.29 12.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.801 0.334 . . . . 73.41 111.172 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -120.83 124.32 44.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.47 . . . . 74.42 110.894 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' PHE . . . . . 0.546 ' HA ' ' HB ' ' A' ' 184' ' ' VAL . 0.4 OUTLIER -137.76 125.38 22.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.183 -0.462 . . . . 74.21 110.882 -179.906 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -146.3 170.91 27.31 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.752 -0.737 . . . . 73.05 112.467 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -150.5 164.14 29.74 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.73 -0.748 . . . . 54.02 112.458 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -139.56 141.98 37.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.863 0.363 . . . . 71.44 110.836 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 5.3 mp -131.65 116.89 32.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 75.41 111.107 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -108.83 122.31 46.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.134 -0.485 . . . . 71.32 110.915 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 22.4 tp60 -124.3 122.6 38.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.089 -0.505 . . . . 72.55 110.922 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.94 127.29 47.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 75.15 110.925 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 9.3 t -82.64 155.99 3.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.228 -0.442 . . . . 75.15 111.089 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -50.45 -50.2 52.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 73.31 110.919 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 13.7 mmtp -69.63 -170.42 0.3 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 74.11 110.885 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 23.3 mtpp -81.45 55.58 2.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 73.23 110.912 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -135.61 116.25 13.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 75.41 110.922 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -107.25 139.35 41.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 75.04 110.913 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 6.1 m -124.0 138.83 54.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 74.43 111.106 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -137.6 143.34 41.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 74.41 111.087 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 10.6 t -132.43 137.94 53.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.46 . . . . 74.32 111.124 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -149.22 125.89 11.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 74.0 110.902 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -147.08 150.58 35.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.162 -0.472 . . . . 74.02 110.929 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -134.44 149.28 50.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 75.44 111.075 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 17.3 t90 -130.42 132.02 45.53 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.214 -0.448 . . . . 75.51 110.926 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 1.7 m -95.69 107.89 20.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 75.42 111.153 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -51.88 146.76 7.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 64.31 111.075 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 104.35 -38.54 3.21 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.732 -0.747 . . . . 71.11 112.442 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 31.8 m120 -121.23 166.94 13.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.877 0.37 . . . . 74.5 110.86 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 39.3 m -97.38 36.93 1.4 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 72.22 110.833 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 16.9 t30 -101.83 111.52 23.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.107 -0.497 . . . . 74.11 110.937 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 35.0 p -115.33 138.66 50.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.45 . . . . 71.31 111.139 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -126.77 123.97 38.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 71.03 110.896 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -132.69 156.11 47.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 74.22 110.842 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -149.33 147.88 18.68 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.729 -0.748 . . . . 60.12 112.482 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 3.7 mp -120.67 132.15 70.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.87 0.367 . . . . 75.31 111.106 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -138.06 130.81 29.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 63.21 111.101 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -123.97 158.41 32.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 73.44 111.098 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 19.4 ttmm -124.09 137.48 54.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.431 . . . . 73.25 110.936 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -132.34 117.61 18.36 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.206 -0.452 . . . . 75.01 110.944 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -89.95 130.48 36.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.131 -0.486 . . . . 73.32 110.915 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 62.7 mt -81.83 -57.67 4.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 74.41 111.085 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . 0.546 ' N ' ' HD2' ' A' ' 229' ' ' PRO . 0.6 OUTLIER 170.7 -56.89 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.673 0.749 . . . . 73.04 110.877 179.938 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 228' ' ' ASP . 53.4 Cg_endo -69.81 -156.42 0.04 OUTLIER 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.68 2.253 . . . . 73.43 112.359 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -85.49 17.27 3.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.225 -0.443 . . . . 74.02 110.862 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -119.52 122.12 40.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 44.41 111.097 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 32.5 t -120.6 142.68 49.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.451 . . . . 73.22 110.886 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -108.88 128.18 54.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 75.11 110.855 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -122.12 154.07 37.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 72.24 110.853 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -133.03 149.78 52.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.122 -0.49 . . . . 72.5 111.169 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 34.0 mttp -145.74 164.06 33.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.23 -0.441 . . . . 73.25 110.94 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 6.0 p -156.19 143.17 10.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.266 -0.424 . . . . 73.23 111.171 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -106.2 147.97 28.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 73.54 110.879 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' ASN . . . . . 0.412 ' C ' ' H ' ' A' ' 241' ' ' SER . 4.3 t30 -52.55 -22.77 5.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 73.05 110.854 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 32.2 t -81.2 26.15 0.46 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.46 . . . . 72.1 110.84 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' SER . . . . . 0.412 ' H ' ' C ' ' A' ' 239' ' ' ASN . 5.0 t 58.08 38.98 26.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.475 . . . . 73.21 110.902 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 3.6 mp -98.7 129.54 45.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.093 -0.503 . . . . 75.3 110.888 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 4.0 mp -93.02 117.78 37.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.458 . . . . 74.52 111.12 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -117.53 144.3 18.22 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.766 -0.731 . . . . 55.25 112.468 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.3 128.56 16.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.828 0.347 . . . . 75.15 110.953 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -130.35 122.06 3.51 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.733 -0.746 . . . . 74.51 112.466 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -110.27 115.97 30.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.907 0.384 . . . . 75.24 110.949 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.58 114.88 28.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 74.34 111.143 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -143.4 138.64 29.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 74.13 110.924 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' THR . . . . . 0.445 ' HA ' ' HA ' ' A' ' 256' ' ' LYS . 16.3 p -77.95 147.51 34.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 74.25 111.137 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 13.8 tp -111.36 -74.71 0.63 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 75.43 110.954 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' LYS . . . . . 0.562 ' HB3' ' HD2' ' A' ' 253' ' ' PRO . 12.7 mmmt -97.43 163.15 20.36 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.564 0.697 . . . . 74.45 110.918 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' PRO . . . . . 0.562 ' HD2' ' HB3' ' A' ' 252' ' ' LYS . 53.7 Cg_endo -69.75 67.08 1.75 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.718 2.278 . . . . 73.22 112.335 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . 0.617 ' O ' ' HB3' ' A' ' 281' ' ' PHE . . . 157.67 -17.94 0.35 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.767 -0.73 . . . . 74.14 112.495 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.435 ' HA ' ' CB ' ' A' ' 281' ' ' PHE . 15.9 pt -129.36 141.5 46.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.928 0.394 . . . . 75.22 111.121 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 250' ' ' THR . 48.7 tttt -117.69 138.33 52.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 75.02 110.895 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.09 128.56 43.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 74.35 110.92 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 4.4 m -119.81 122.62 41.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.465 . . . . 75.12 111.16 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -110.29 138.94 45.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.218 -0.446 . . . . 75.51 110.912 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 70.6 m -136.67 140.55 42.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 71.13 110.857 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -146.57 129.07 15.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.099 -0.5 . . . . 55.54 111.14 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -121.94 130.05 53.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.27 -0.423 . . . . 72.11 110.924 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -124.24 110.55 14.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.469 . . . . 72.32 110.919 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . 0.554 ' O ' ' HB ' ' A' ' 268' ' ' VAL . 0.7 OUTLIER -86.8 98.33 11.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.155 -0.475 . . . . 75.4 110.846 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -53.02 -11.95 1.62 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.762 -0.732 . . . . 74.2 112.454 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -64.41 -25.46 68.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.78 0.324 . . . . 74.02 110.896 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -168.44 19.91 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 72.04 110.873 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . 0.554 ' HB ' ' O ' ' A' ' 264' ' ' ASP . 1.7 p -68.52 -27.0 34.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 71.32 111.16 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -77.8 -44.83 26.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 75.13 110.922 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -95.93 12.41 30.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 64.43 111.11 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -129.62 -104.22 1.1 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.708 -0.758 . . . . 71.13 112.47 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -164.67 172.26 40.35 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.708 -0.758 . . . . 73.4 112.489 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 2.4 p-80 -105.25 146.66 29.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.839 0.352 . . . . 74.21 110.909 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -95.66 136.34 36.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 74.21 110.884 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -134.36 139.07 45.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.243 -0.435 . . . . 74.23 110.917 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -140.04 130.29 4.61 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.685 -0.769 . . . . 63.02 112.462 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -115.93 138.67 50.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.859 0.361 . . . . 73.22 110.904 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -162.04 129.06 2.0 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.74 -0.743 . . . . 73.52 112.474 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.69 127.99 54.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.784 0.326 . . . . 73.53 110.896 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . 0.436 ' O ' ' HB2' ' A' ' 281' ' ' PHE . 1.8 pm0 -140.92 147.06 38.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.162 -0.472 . . . . 71.11 110.888 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . 0.617 ' HB3' ' O ' ' A' ' 254' ' ' GLY . 0.0 OUTLIER 168.73 -157.99 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.134 -0.484 . . . . 73.13 110.842 -179.945 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -136.22 143.15 44.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.145 -0.48 . . . . 63.12 110.984 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -91.17 112.43 24.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 74.02 111.131 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -136.99 179.18 6.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.23 -0.441 . . . . 71.05 110.944 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.214 -0.448 . . . . 74.11 110.898 179.962 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.097 0 CA-C-O 120.861 0.362 . . . . 72.15 111.1 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 24.8 t -139.7 82.16 18.52 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.601 0.715 . . . . 73.21 111.127 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 168.28 21.98 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.712 2.275 . . . . 74.11 112.319 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 95.55 0.56 Allowed 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.636 2.224 . . . . 72.22 112.349 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -79.64 -48.6 13.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.247 -0.433 . . . . 72.11 111.088 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -52.79 -40.52 63.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.21 -0.45 . . . . 73.14 110.931 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.99 -19.86 58.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.134 -0.485 . . . . 71.12 111.109 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -88.62 10.47 20.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.168 -0.469 . . . . 75.3 110.833 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.59 -34.15 77.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.456 . . . . 72.32 110.935 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -152.09 63.57 0.38 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.748 -0.739 . . . . 74.33 112.499 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.34 -54.51 14.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.833 0.349 . . . . 75.41 110.879 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 m -64.02 -39.49 94.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 64.15 110.83 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.51 -37.7 73.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 73.13 111.11 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 63.2 mtt-85 -61.85 -36.85 82.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.451 . . . . 74.3 110.874 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.91 -37.97 82.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.218 -0.446 . . . . 71.44 110.855 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 97.6 t -75.24 -35.88 35.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.143 -0.48 . . . . 74.33 111.139 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -60.92 -41.0 95.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 73.31 110.853 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.0 m 51.9 78.34 0.12 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 73.42 111.137 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.84 119.74 11.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.44 . . . . 75.41 110.862 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.46 96.74 1.28 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.733 -0.746 . . . . 73.3 112.507 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -86.55 -175.83 5.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.928 0.394 . . . . 74.51 110.932 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.84 114.5 5.34 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.728 -0.748 . . . . 64.2 112.478 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -103.9 12.85 33.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.956 0.408 . . . . 75.22 110.924 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.61 14.18 77.79 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.685 -0.769 . . . . 73.35 112.498 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.2 pp -114.81 179.81 3.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.794 0.331 . . . . 74.05 110.932 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 32.6 mm -109.87 125.84 67.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 75.01 111.125 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.9 mttt -102.84 149.85 24.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.182 -0.463 . . . . 73.24 110.878 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -147.1 130.3 16.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 62.3 110.911 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -146.71 126.3 13.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.207 -0.452 . . . . 74.14 110.897 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -134.78 125.54 27.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 74.31 110.922 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.86 147.23 45.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.218 -0.446 . . . . 75.15 110.898 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.9 p -137.2 120.48 16.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.44 . . . . 74.01 111.15 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 40.1 mtpt -115.32 129.99 56.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.245 -0.434 . . . . 74.14 110.917 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -125.44 138.13 54.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 74.32 110.822 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -76.85 60.29 1.73 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.476 . . . . 73.32 110.868 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -159.28 23.12 0.19 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 73.34 110.895 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.578 ' HA2' ' O ' ' A' ' 63' ' ' ARG . . . 79.59 -3.73 67.34 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.781 -0.723 . . . . 51.52 112.437 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -97.39 124.3 41.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.802 0.334 . . . . 74.33 110.899 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -145.26 117.98 8.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.134 -0.484 . . . . 73.2 110.893 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -111.71 123.58 50.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.481 . . . . 72.23 110.902 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.65 120.97 30.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 74.13 111.168 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.9 p -121.37 142.36 50.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 71.04 110.87 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 21.0 m -147.99 136.05 21.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.147 -0.479 . . . . 61.31 110.861 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -172.87 158.85 29.08 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.759 -0.734 . . . . 74.34 112.492 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -138.32 150.69 46.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.911 0.386 . . . . 74.52 110.872 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -121.17 130.74 53.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.475 . . . . 75.51 111.055 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -72.07 118.94 15.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 75.3 110.91 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 33.8 m -58.73 149.68 25.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.47 . . . . 74.43 111.186 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 39.9 40.13 0.67 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 74.13 110.92 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 98.8 m -161.26 126.69 3.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.154 -0.475 . . . . 74.32 111.126 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 71.5 p -76.24 66.8 2.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.251 -0.432 . . . . 75.31 111.153 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.6 ttmt -156.27 104.04 2.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 74.43 110.886 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.2 m -126.47 148.29 31.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.182 -0.463 . . . . 65.03 111.146 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 91.5 m -116.26 126.61 53.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 72.42 111.164 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -127.73 150.8 18.38 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.742 -0.742 . . . . 71.04 112.478 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 78.0 p -146.29 142.23 28.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.918 0.39 . . . . 73.12 110.869 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -121.88 125.27 46.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.124 -0.489 . . . . 74.32 110.935 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -124.77 129.47 50.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 75.42 110.902 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.9 t -99.63 128.85 45.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.135 -0.484 . . . . 54.15 111.129 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.401 ' HA ' ' O ' ' A' ' 71' ' ' PHE . 26.7 ttmt -126.98 154.36 44.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 72.01 110.906 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.429 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 9.4 m-85 -130.38 140.08 50.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.443 . . . . 72.43 110.887 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.578 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 21.7 tpp85 -118.0 103.99 10.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.062 -0.517 . . . . 73.12 110.879 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -106.4 114.66 28.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 74.25 110.895 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 6.0 t -94.41 -167.55 1.68 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.209 -0.45 . . . . 74.1 111.108 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 59.41 30.42 20.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 71.32 110.857 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 179.58 -53.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 65.41 110.949 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 110.51 64.77 0.53 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.732 -0.747 . . . . 65.5 112.505 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.0 mp -134.44 132.33 39.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.88 0.371 . . . . 72.42 110.933 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 44.2 p -136.29 135.1 38.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 63.11 111.167 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.402 ' HB3' ' HB2' ' A' ' 62' ' ' TYR . 23.7 t80 -117.46 131.14 56.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.241 -0.436 . . . . 74.33 110.899 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.8 t -128.56 121.09 27.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 72.22 111.107 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -126.62 130.21 50.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 75.2 110.883 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 5.4 ttpm? -113.0 110.82 21.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.479 . . . . 73.23 110.883 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.421 ' CD1' ' CB ' ' A' ' 81' ' ' LEU . 2.6 t90 -115.67 126.92 54.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 72.43 110.908 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -120.74 136.11 54.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.25 -0.432 . . . . 74.13 110.904 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 9.5 t -70.5 -36.08 73.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 74.24 111.177 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -111.6 -35.37 5.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.207 -0.451 . . . . 72.05 110.886 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -78.88 -154.0 0.07 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 72.51 110.904 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.1 t -78.97 149.39 32.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 74.31 111.135 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.421 ' CB ' ' CD1' ' A' ' 75' ' ' TRP . 0.1 OUTLIER -124.04 117.64 25.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 73.05 110.897 179.962 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.83 170.16 39.03 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.743 -0.742 . . . . 73.43 112.489 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -131.52 159.63 37.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.776 0.322 . . . . 72.44 111.119 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -142.42 144.54 33.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 74.11 110.899 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.5 pp -121.61 138.87 50.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 71.51 111.146 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.46 127.73 43.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 71.35 111.123 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.9 m -128.39 138.36 54.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 75.24 111.099 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -118.47 128.48 54.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.139 -0.482 . . . . 73.22 110.922 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 56.98 39.85 29.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.184 -0.462 . . . . 74.21 110.88 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -66.81 -35.32 79.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.452 . . . . 75.43 110.872 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.3 tt -122.31 -37.12 2.85 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.24 -0.436 . . . . 64.41 110.904 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -146.67 138.4 24.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 72.51 111.112 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -59.73 134.45 57.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.25 -0.432 . . . . 73.01 110.853 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 100.37 -23.45 35.8 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.717 -0.754 . . . . 62.11 112.473 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 4.7 tp -95.62 129.4 42.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.879 0.371 . . . . 63.34 110.898 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 8.8 tttm -122.66 131.48 53.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 72.04 110.904 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.82 127.31 54.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.235 -0.439 . . . . 73.15 110.934 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.8 m -129.76 123.53 31.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.203 -0.453 . . . . 73.43 111.127 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -110.38 121.97 46.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.459 . . . . 75.54 110.874 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -110.36 124.49 51.8 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.163 -0.472 . . . . 74.34 110.877 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.0 t -124.14 121.45 35.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 73.33 110.865 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 75.7 m -114.88 145.86 41.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 75.13 110.852 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -135.12 137.41 42.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.147 -0.479 . . . . 73.35 110.895 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.7 t -128.41 138.94 34.12 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.681 0.753 . . . . 75.42 110.847 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.79 -23.91 30.13 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.646 2.231 . . . . 74.51 112.319 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -56.2 99.06 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.431 . . . . 75.42 110.877 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 53.2 26.92 5.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 75.31 111.171 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 67.15 24.5 73.35 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.71 -0.757 . . . . 62.43 112.515 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 58.3 tttt -65.43 118.02 8.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.881 0.372 . . . . 74.23 110.87 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 17.6 pttm -122.59 151.09 41.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 74.23 110.893 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -127.2 136.59 52.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 74.4 110.862 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -116.04 131.03 57.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 72.42 111.092 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -138.28 138.68 38.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 74.43 110.865 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 5.4 tp -134.07 127.32 51.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 73.31 111.135 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 7.2 mmtp -119.53 118.86 32.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 73.33 110.885 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.1 t -129.74 119.67 23.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.216 -0.447 . . . . 71.3 111.099 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.459 ' HA3' ' HA2' ' A' ' 126' ' ' GLY . . . -153.29 168.76 32.06 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.693 -0.765 . . . . 72.33 112.476 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -133.16 132.05 41.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.971 0.415 . . . . 73.12 110.95 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 18.0 mtmm -108.18 119.47 39.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 72.54 110.95 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 43.3 ttt180 -110.14 143.53 40.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.279 -0.419 . . . . 72.51 110.878 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -51.48 -28.01 12.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 74.44 110.901 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 70.7 m80 -89.17 -40.12 13.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 65.35 110.861 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 2.3 tp -149.23 138.3 15.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 74.12 111.077 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.498 ' HB3' HG22 ' A' ' 143' ' ' VAL . 0.3 OUTLIER -105.03 118.66 37.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 65.12 110.851 179.947 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -116.51 140.52 49.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 75.25 110.91 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.459 ' HA2' ' HA3' ' A' ' 117' ' ' GLY . . . -143.29 121.52 1.71 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.749 -0.739 . . . . 51.11 112.476 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -112.47 107.71 16.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.8 0.333 . . . . 74.34 110.881 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -104.92 145.18 30.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.223 -0.444 . . . . 73.32 110.836 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 96.8 mtp -138.68 136.1 35.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 73.14 110.892 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -128.27 135.69 49.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 75.51 110.854 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -95.8 102.38 14.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 64.42 110.9 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.4 149.87 21.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.134 -0.485 . . . . 72.21 110.847 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.2 tp -52.71 -44.06 45.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 63.31 111.14 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -73.77 -18.93 60.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 54.54 111.084 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 155.24 150.34 5.54 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.797 -0.716 . . . . 72.4 112.504 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 112.37 3.05 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.749 2.3 . . . . 61.3 112.322 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.5 m -81.89 147.55 29.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.442 . . . . 64.51 110.847 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.1 mp -107.28 118.83 55.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 74.51 111.126 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 -106.95 121.85 45.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 72.31 110.83 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -110.99 133.83 11.79 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.778 -0.725 . . . . 74.11 112.503 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -131.38 122.54 26.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.798 0.332 . . . . 74.04 111.082 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -140.39 122.35 15.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.242 -0.436 . . . . 74.2 110.89 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.523 ' HA ' ' HA2' ' A' ' 152' ' ' GLY . 0.7 OUTLIER -133.76 144.93 34.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 62.23 111.1 179.866 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -107.84 139.96 41.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.184 -0.462 . . . . 74.03 110.902 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -110.7 118.7 5.03 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.771 -0.728 . . . . 72.14 112.471 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -122.91 146.38 47.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.901 0.381 . . . . 74.42 110.902 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -50.44 96.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.118 -0.492 . . . . 64.41 110.931 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 93.94 -29.41 8.69 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.783 -0.722 . . . . 73.25 112.475 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 36.6 m95 -102.15 141.7 34.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.833 0.349 . . . . 75.22 110.903 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.98 136.61 42.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.436 . . . . 73.13 110.91 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -142.77 143.88 32.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.448 . . . . 75.43 111.082 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.523 ' HA2' ' HA ' ' A' ' 143' ' ' VAL . . . -153.48 144.09 10.94 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.72 -0.752 . . . . 72.4 112.473 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -145.12 119.21 9.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.849 0.356 . . . . 74.24 110.923 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -118.95 123.79 45.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.145 -0.48 . . . . 74.34 110.89 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.7 134.68 52.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 73.32 110.894 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -112.29 123.07 49.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.253 -0.43 . . . . 71.32 110.876 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.44 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 15.0 t80 -94.4 125.88 39.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 73.33 110.888 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.43 ' HG2' ' HB ' ' A' ' 165' ' ' THR . 0.1 OUTLIER -79.33 103.16 9.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.136 -0.484 . . . . 72.15 110.904 -179.912 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 75.5 m -65.53 -48.18 73.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 65.14 111.171 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -48.35 -26.12 1.9 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 74.21 111.103 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 12.1 mmtp -125.79 -168.76 1.89 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 72.44 110.874 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 2.4 m -110.63 40.2 2.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 75.22 110.875 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 2.4 tpp180 -156.67 175.25 14.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.131 -0.486 . . . . 75.53 110.904 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.44 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 0.9 OUTLIER -74.52 142.5 14.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 73.5 111.124 179.966 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' THR . . . . . 0.43 ' HB ' ' HG2' ' A' ' 158' ' ' GLU . 2.5 t -90.63 -34.6 15.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.459 . . . . 75.24 111.14 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -153.99 136.14 14.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.244 -0.434 . . . . 73.01 110.897 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -123.06 127.34 48.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.446 . . . . 72.32 110.858 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -135.68 142.75 45.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 74.04 110.926 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -149.03 140.13 23.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 75.02 110.878 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -148.49 129.12 14.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 74.23 111.107 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 7.3 t -148.1 139.59 17.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.451 . . . . 71.42 111.112 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -165.25 163.83 36.78 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.723 -0.751 . . . . 75.24 112.504 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -118.95 125.09 48.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.946 0.403 . . . . 74.25 110.919 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 39.9 mtpt -101.84 126.14 48.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.132 -0.485 . . . . 71.23 110.926 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.431 ' HB ' ' H ' ' A' ' 178' ' ' PHE . 1.2 m -131.26 165.02 24.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.444 . . . . 70.25 111.112 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -78.14 -7.76 57.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 52.13 110.86 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -118.13 -31.65 4.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.211 -0.45 . . . . 71.05 110.873 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.431 ' H ' ' HB ' ' A' ' 175' ' ' THR . 18.4 p90 -144.54 150.14 37.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 75.4 110.891 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -136.51 123.05 20.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 71.43 110.913 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -124.15 128.26 49.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.211 -0.45 . . . . 65.12 110.943 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 15.7 m170 -131.36 115.01 15.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 73.32 110.865 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.05 135.55 42.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 64.04 111.144 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -128.0 139.25 52.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.441 . . . . 73.31 110.92 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 2.8 t -134.33 110.04 13.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 73.1 111.147 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -101.08 89.46 3.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 75.04 110.898 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 65.77 179.46 0.2 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 73.03 110.865 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -73.1 -3.49 60.85 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.684 -0.77 . . . . 75.12 112.466 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 5.7 m -95.96 -25.54 15.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.804 0.335 . . . . 72.32 111.174 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -121.95 112.49 18.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.192 -0.458 . . . . 72.42 110.903 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -138.85 123.41 18.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.135 -0.484 . . . . 75.31 110.883 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 174.17 -154.86 20.35 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.715 -0.755 . . . . 43.13 112.456 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -176.56 -163.2 28.55 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.743 -0.741 . . . . 75.04 112.471 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 11.4 p -148.39 155.47 41.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.857 0.361 . . . . 73.42 110.868 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 3.5 mp -131.62 120.27 44.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.122 -0.49 . . . . 63.34 111.104 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -108.87 121.05 44.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.188 -0.46 . . . . 74.2 110.922 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -125.52 131.52 52.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.476 . . . . 62.31 110.891 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 1.8 tppp? -96.04 127.66 42.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 72.21 110.863 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 34.5 t -85.73 117.36 30.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.44 . . . . 74.24 111.135 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -49.82 132.96 22.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 74.43 110.867 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp 51.05 33.82 9.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 75.21 110.893 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 4.8 mmtp -153.83 -167.31 2.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 75.43 110.861 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 1.4 pp -79.19 -168.49 1.51 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.45 . . . . 74.03 110.936 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -115.11 136.15 53.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 64.21 110.884 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 11.5 t -123.96 138.78 54.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.12 -0.491 . . . . 73.41 111.143 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -145.01 163.49 34.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.434 . . . . 75.34 111.117 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 1.7 m -133.58 149.08 30.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.255 -0.429 . . . . 62.41 111.094 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -113.91 131.52 56.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 73.11 110.89 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -119.71 129.93 54.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 63.04 110.955 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -138.42 130.77 28.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.446 . . . . 73.51 111.1 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 11.7 t90 -130.09 123.21 29.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 74.45 110.9 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 94.5 m -112.22 110.51 20.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.264 -0.425 . . . . 73.12 111.173 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -51.4 128.09 21.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.263 -0.426 . . . . 74.1 111.095 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 163.78 -73.66 0.18 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.749 -0.738 . . . . 64.5 112.514 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 65.9 m-80 -125.61 33.79 5.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.804 0.335 . . . . 75.14 110.861 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 43.4 m 51.43 52.77 14.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.452 . . . . 74.43 110.858 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -94.69 112.0 23.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.122 -0.49 . . . . 64.2 110.938 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 2.5 p -94.29 135.63 35.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 74.14 111.121 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 17.7 tpp85 -117.41 119.18 34.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 75.12 110.845 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 21.4 t80 -122.83 137.6 54.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 74.01 110.893 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -145.69 159.17 27.87 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.767 -0.73 . . . . 63.2 112.52 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 4.7 mp -137.29 130.46 43.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.828 0.347 . . . . 71.44 111.133 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -124.89 141.52 52.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 73.21 111.117 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -116.08 134.84 54.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.243 -0.435 . . . . 64.41 111.1 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 11.1 mttt -120.64 115.44 23.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 73.23 110.905 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -130.75 128.66 41.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.232 -0.44 . . . . 73.45 110.899 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -111.92 115.99 29.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.158 -0.474 . . . . 71.42 110.941 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 8.1 tp -103.05 -35.21 3.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 71.42 111.128 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -130.24 160.6 64.82 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.64 0.733 . . . . 74.41 110.857 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.72 -32.58 18.45 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.684 2.256 . . . . 74.1 112.312 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -107.19 10.27 30.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 74.44 110.838 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -141.41 127.18 19.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 73.54 111.123 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 42.4 t -134.47 141.97 46.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.255 -0.429 . . . . 64.45 110.924 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -112.25 130.24 56.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 74.11 110.873 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 84.2 p -129.51 140.62 51.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.464 . . . . 71.24 110.885 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -127.01 159.29 34.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 73.44 111.126 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.77 147.81 21.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.217 -0.447 . . . . 74.0 110.917 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 5.4 p -144.86 142.69 22.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.444 . . . . 55.43 111.15 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -106.54 147.64 29.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 75.44 110.92 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' ASN . . . . . 0.405 ' C ' ' H ' ' A' ' 241' ' ' SER . 7.1 t-20 -54.71 -21.01 9.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.185 -0.461 . . . . 70.21 110.9 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 3.7 m -81.7 26.28 0.5 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.459 . . . . 64.51 110.874 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' SER . . . . . 0.405 ' H ' ' C ' ' A' ' 239' ' ' ASN . 6.8 t 59.98 39.33 20.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.081 -0.509 . . . . 75.35 110.854 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 18.4 mt -98.91 124.9 44.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.12 -0.491 . . . . 71.43 110.903 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 3.0 mp -99.83 118.73 46.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 75.25 111.09 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -129.49 138.75 10.45 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.714 -0.755 . . . . 73.33 112.471 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.424 ' N ' ' CD1' ' A' ' 245' ' ' LEU . 0.0 OUTLIER -145.92 158.93 43.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.865 0.364 . . . . 75.51 110.865 -179.885 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -162.57 144.27 9.49 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.719 -0.753 . . . . 55.14 112.443 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -128.31 131.84 48.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.99 0.424 . . . . 74.12 110.894 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 27.6 p -115.5 117.77 31.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.076 -0.511 . . . . 73.13 111.124 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -129.38 131.48 46.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 74.42 110.899 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 3.7 m -59.74 148.43 34.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 75.23 111.167 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 46.0 tp -78.58 -73.33 0.33 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 75.21 110.904 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' LYS . . . . . 0.462 ' N ' ' HD2' ' A' ' 253' ' ' PRO . 0.1 OUTLIER 179.29 -60.66 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.558 0.694 . . . . 71.51 110.882 179.848 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' A' ' 252' ' ' LYS . 54.0 Cg_endo -69.77 -86.4 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.679 2.253 . . . . 71.54 112.395 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . 0.566 ' O ' ' HB3' ' A' ' 281' ' ' PHE . . . -146.7 33.9 1.38 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.746 -0.74 . . . . 61.1 112.499 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 3.6 mp -131.01 145.3 35.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.893 0.377 . . . . 71.4 111.093 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 279' ' ' LEU . 19.7 ttpp -113.12 135.41 53.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 73.43 110.882 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 5.1 tp -96.74 124.35 40.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 75.45 110.879 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 2.8 p -124.29 122.34 37.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.161 -0.472 . . . . 72.42 111.115 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -116.58 126.53 53.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 74.22 110.92 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 27.7 p -124.92 145.84 49.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 62.1 110.878 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -147.99 135.25 20.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 75.21 111.112 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -125.41 122.22 36.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.453 . . . . 71.11 110.877 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.03 109.86 15.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 74.01 110.929 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -82.72 116.95 22.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.184 -0.462 . . . . 75.44 110.831 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -54.41 -21.15 19.09 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.744 -0.741 . . . . 72.25 112.464 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.77 -26.56 20.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.839 0.352 . . . . 74.43 110.912 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 13.8 m-20 -95.42 -57.86 2.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.194 -0.457 . . . . 74.11 110.926 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 11.7 m -51.6 -29.34 9.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.469 . . . . 73.53 111.104 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -53.02 -36.43 60.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 74.25 110.89 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -103.65 -17.69 15.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 75.24 111.144 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 124.73 100.75 1.34 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.691 -0.766 . . . . 74.23 112.45 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 168.16 92.74 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.722 -0.752 . . . . 73.14 112.493 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 19.2 p80 -111.9 144.64 40.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.899 0.38 . . . . 75.24 110.83 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -102.26 137.34 40.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 74.33 110.935 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -135.94 144.11 45.28 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.253 -0.43 . . . . 74.22 110.927 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -147.52 133.65 4.81 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.694 -0.765 . . . . 74.01 112.492 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -125.81 135.23 51.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.819 0.342 . . . . 75.04 110.913 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -161.59 140.08 6.4 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.694 -0.765 . . . . 45.12 112.488 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . 0.411 ' HA ' ' O ' ' A' ' 256' ' ' LYS . 0.0 OUTLIER -119.59 129.86 54.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.809 0.337 . . . . 73.14 110.899 -179.938 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . 0.502 ' O ' ' HB2' ' A' ' 281' ' ' PHE . 2.5 pp20? -141.94 146.41 35.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.47 . . . . 71.12 110.899 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . 0.566 ' HB3' ' O ' ' A' ' 254' ' ' GLY . 0.3 OUTLIER 172.08 -150.75 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.155 -0.475 . . . . 65.21 110.894 -179.88 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -138.55 144.68 40.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 75.52 110.891 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -113.09 112.6 24.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.45 . . . . 72.41 111.128 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 12.7 mt -130.41 178.63 6.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 74.42 110.878 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 71.41 110.909 179.943 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.834 0.35 . . . . 72.01 111.111 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.1 t 61.18 75.62 0.44 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.668 0.747 . . . . 70.01 111.083 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 167.91 23.06 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.667 2.244 . . . . 70.31 112.362 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 108.97 2.2 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.734 2.289 . . . . 75.1 112.326 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 12.3 t -107.15 -28.47 9.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 75.53 111.138 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 32.9 p90 -55.53 -30.59 61.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.25 -0.432 . . . . 74.44 110.92 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -72.26 -19.4 61.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.108 -0.497 . . . . 64.5 111.114 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -95.03 11.9 30.4 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.243 -0.435 . . . . 74.21 110.878 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.56 -33.05 72.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.211 -0.45 . . . . 74.21 110.87 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -136.17 31.28 2.63 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.758 -0.734 . . . . 72.45 112.488 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.3 mmtt -69.58 -54.5 13.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.78 0.324 . . . . 65.14 110.88 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.9 t -60.25 -39.72 87.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.252 -0.431 . . . . 73.15 110.873 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.56 -37.62 76.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 74.0 111.113 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -61.05 -32.66 72.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 75.42 110.859 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -58.38 -48.45 80.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 72.15 110.866 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.5 t -80.43 -36.91 16.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 64.41 111.128 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -63.33 -34.98 78.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 74.03 110.888 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.2 m 65.06 80.51 0.23 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 70.15 111.159 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -57.77 -34.61 69.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.251 -0.431 . . . . 74.24 110.855 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -51.5 106.82 0.34 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.72 -0.753 . . . . 54.31 112.462 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -58.43 151.69 19.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.886 0.374 . . . . 74.25 110.942 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -133.8 69.26 0.53 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.727 -0.749 . . . . 73.24 112.531 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -91.95 13.71 17.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.906 0.384 . . . . 73.42 110.915 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.07 14.6 64.2 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.713 -0.756 . . . . 74.23 112.498 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.2 pp -118.98 -179.1 3.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.762 0.315 . . . . 73.11 110.918 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.446 HG13 ' HB3' ' A' ' 277' ' ' LEU . 1.6 mp -109.99 131.8 59.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 73.12 111.132 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.406 ' HG2' ' HA2' ' A' ' 278' ' ' GLY . 6.4 ptmm? -115.91 138.22 51.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 73.12 110.904 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -123.67 136.45 54.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.235 -0.439 . . . . 72.43 110.891 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -126.76 127.78 45.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.469 . . . . 71.22 110.871 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.75 125.1 52.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 72.34 110.902 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.3 tptp -123.57 125.09 44.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 72.4 110.866 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.9 m -135.42 120.67 18.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 71.12 111.14 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -134.22 125.6 28.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 72.52 110.875 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 38.4 t -127.24 143.7 51.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 71.44 110.859 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -76.59 58.72 1.41 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 73.03 110.885 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -147.67 16.96 1.13 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.146 -0.479 . . . . 73.55 110.865 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.552 ' HA2' ' O ' ' A' ' 63' ' ' ARG . . . 82.94 -5.3 76.55 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.729 -0.748 . . . . 65.31 112.489 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -101.14 126.22 47.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.8 0.333 . . . . 75.1 110.904 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -139.46 117.68 11.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.168 -0.469 . . . . 74.31 110.885 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -107.07 121.48 44.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.122 -0.49 . . . . 70.12 110.887 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 3.9 m -127.96 115.15 18.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.141 -0.481 . . . . 73.34 111.183 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -122.05 141.7 51.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 72.51 110.864 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.4 p -151.01 126.41 10.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.464 . . . . 63.41 110.892 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -166.41 165.5 38.32 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.722 -0.751 . . . . 73.54 112.48 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 82.8 p -137.25 168.96 18.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.896 0.379 . . . . 70.42 110.876 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -158.63 140.57 13.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 60.23 111.118 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 46.0 t-20 -101.26 141.9 33.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.242 -0.435 . . . . 74.12 110.832 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.5 t -92.7 -35.24 13.58 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.168 -0.469 . . . . 73.44 111.165 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.85 -63.48 1.15 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.227 -0.442 . . . . 75.11 110.89 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.18 149.91 33.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.125 -0.489 . . . . 74.33 111.108 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.3 t -59.09 110.69 1.1 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.172 -0.467 . . . . 64.54 111.155 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.6 mtpm? -166.53 99.9 0.59 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.242 -0.436 . . . . 74.24 110.949 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 24.2 t -122.5 133.49 68.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.245 -0.434 . . . . 65.51 111.125 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.0 m -136.04 134.56 38.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.165 -0.47 . . . . 72.13 111.132 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -142.8 140.48 9.84 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.699 -0.762 . . . . 73.35 112.441 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.6 p -133.18 144.52 49.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.903 0.383 . . . . 72.11 110.839 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -120.92 134.51 55.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.108 -0.496 . . . . 73.35 110.903 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -134.33 123.05 23.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 74.21 110.888 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 23.1 p -107.0 134.0 50.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 52.31 111.095 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 47.6 mttt -133.41 159.68 39.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 74.24 110.931 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.512 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 9.2 t80 -121.06 129.67 53.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 74.44 110.892 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.552 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 3.9 ttt85 -112.9 103.43 11.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 74.52 110.865 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -112.73 98.65 7.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.188 -0.46 . . . . 63.05 110.933 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 60.68 163.43 0.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 62.5 111.156 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -78.78 145.16 34.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.248 -0.433 . . . . 73.13 110.877 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 26.0 p90 37.81 43.35 0.49 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.177 -0.465 . . . . 64.42 110.872 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -123.75 -78.93 0.41 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.743 -0.742 . . . . 70.33 112.445 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -134.59 129.06 34.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.914 0.387 . . . . 64.32 110.883 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.8 m -138.61 114.89 10.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.157 -0.474 . . . . 73.41 111.136 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -99.39 132.89 44.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 71.03 110.894 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.73 119.87 31.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.122 -0.49 . . . . 74.41 111.181 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -131.52 122.56 26.36 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.196 -0.456 . . . . 74.33 110.902 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -106.38 137.49 44.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.153 -0.476 . . . . 72.53 110.908 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 9.8 t90 -134.53 128.75 33.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.456 . . . . 73.22 110.887 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 28.9 t30 -117.13 155.41 29.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 63.25 110.908 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 12.3 m -60.36 -18.12 48.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 73.45 111.127 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.417 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 9.0 m-20 -74.63 0.37 15.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 71.43 110.863 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.417 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 4.1 m120 77.16 38.55 0.23 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.198 -0.455 . . . . 63.0 110.885 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 28.3 m -114.83 125.63 53.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.455 . . . . 74.31 111.157 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.6 mp -114.14 127.35 55.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.294 -0.412 . . . . 74.34 110.939 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -113.42 107.71 1.98 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.788 -0.72 . . . . 72.22 112.489 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.1 m -87.52 131.45 34.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.713 0.292 . . . . 73.25 111.16 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -159.99 96.68 1.23 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 74.1 110.893 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.1 pp -111.6 138.65 39.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 74.04 111.172 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.6 m -118.11 139.57 51.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 72.12 111.119 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.2 m -129.39 139.62 51.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 74.25 111.155 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 -97.8 129.18 44.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 73.35 110.926 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -50.56 168.61 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.199 -0.455 . . . . 74.12 110.893 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -123.45 -35.58 2.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 63.31 110.911 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 92.5 mt -96.79 -70.12 0.73 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.245 -0.434 . . . . 75.1 110.945 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.86 78.03 1.15 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 72.25 111.07 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 9.2 ptp85 -49.29 135.32 17.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.467 . . . . 73.32 110.889 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 101.59 9.29 44.11 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.715 -0.755 . . . . 65.52 112.531 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.7 tp -114.93 129.15 56.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.898 0.38 . . . . 75.24 110.891 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 31.5 pttt -124.56 136.19 53.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 75.21 110.897 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -124.8 126.72 46.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 74.21 110.877 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.6 m -125.61 139.41 53.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.462 . . . . 74.32 111.131 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -116.02 123.01 46.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.252 -0.431 . . . . 64.21 110.841 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -113.97 130.29 56.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.112 -0.494 . . . . 73.1 110.855 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.5 m -142.41 134.07 26.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.475 . . . . 72.54 110.851 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.6 t -95.81 126.17 40.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.115 -0.493 . . . . 74.52 110.857 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -118.34 119.65 35.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.097 -0.502 . . . . 75.22 110.869 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.409 ' HA ' ' HD2' ' A' ' 105' ' ' PRO . 1.7 t -128.83 101.39 20.28 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.61 0.719 . . . . 72.5 110.919 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 104' ' ' SER . 53.4 Cg_endo -69.79 -32.89 17.56 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.681 2.254 . . . . 75.24 112.301 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 16.9 t30 -51.56 -74.25 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.269 -0.423 . . . . 73.0 110.916 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 6.0 m -77.02 -33.57 57.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 74.32 111.139 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.61 23.92 14.94 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.773 -0.727 . . . . 61.11 112.51 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -94.48 147.02 23.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.853 0.359 . . . . 74.41 110.907 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 27.6 ttpt -133.42 140.88 47.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.218 -0.446 . . . . 73.34 110.938 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -120.94 136.22 55.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 75.21 110.938 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -110.57 125.28 53.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 70.41 111.094 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 17.4 mtmt -138.87 138.23 37.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 73.12 110.888 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 5.7 tp -121.99 139.86 47.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.212 -0.449 . . . . 74.3 111.092 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 19.8 ttpt -130.06 118.87 22.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.166 -0.47 . . . . 73.23 110.899 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 4.8 t -130.9 118.6 20.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.446 . . . . 73.11 111.13 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.432 ' HA3' ' HA2' ' A' ' 126' ' ' GLY . . . -152.99 159.14 28.32 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.695 -0.764 . . . . 41.41 112.476 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -129.34 138.34 51.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.982 0.42 . . . . 74.53 110.912 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 36.2 pttt -109.82 121.15 44.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.115 -0.493 . . . . 74.43 110.891 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 6.8 tpt180 -109.53 143.88 38.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 74.52 110.885 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -50.73 -28.31 8.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 72.25 110.881 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 59.2 m-70 -88.45 -41.97 12.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 75.34 110.897 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 2.2 tt -151.67 145.03 16.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 73.11 111.198 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -113.73 116.02 28.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 74.53 110.822 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.418 ' HG ' HD22 ' A' ' 142' ' ' LEU . 2.0 mt -119.24 141.45 48.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.472 . . . . 75.14 110.895 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.432 ' HA2' ' HA3' ' A' ' 117' ' ' GLY . . . -145.96 125.91 2.4 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.721 -0.752 . . . . 74.35 112.457 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 8.3 t -114.51 119.46 36.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.816 0.341 . . . . 64.31 110.883 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -118.9 146.58 44.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.466 . . . . 72.12 110.867 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 7.8 ttt -136.62 136.27 39.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.203 -0.453 . . . . 75.44 110.869 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -110.86 124.99 53.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.173 -0.467 . . . . 71.12 110.883 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -95.53 98.2 10.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 74.22 110.886 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -103.92 169.65 8.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.139 -0.482 . . . . 65.24 110.898 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 2.5 pp -74.91 -35.61 36.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 75.24 111.121 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -77.06 -20.27 56.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 74.12 111.07 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 154.16 149.64 5.28 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.705 -0.759 . . . . 62.13 112.467 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 114.5 3.73 Favored 'Trans proline' 0 C--O 1.231 0.146 0 C-N-CA 122.69 2.26 . . . . 74.52 112.315 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.64 148.76 30.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.211 -0.449 . . . . 75.03 110.915 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 5.3 mp -106.3 122.84 60.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.19 -0.459 . . . . 72.24 111.145 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 3.9 ttm105 -121.56 114.55 21.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 74.51 110.874 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -110.63 133.96 11.89 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.732 -0.747 . . . . 74.34 112.478 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -132.91 116.31 16.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.815 0.341 . . . . 62.04 111.109 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.421 HD23 HD21 ' A' ' 144' ' ' LEU . 0.2 OUTLIER -121.97 125.23 45.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.161 -0.472 . . . . 61.32 110.878 -179.939 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 40.7 t -131.19 123.17 52.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 73.31 111.151 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.421 HD21 HD23 ' A' ' 142' ' ' LEU . 0.3 OUTLIER -116.85 156.32 27.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 75.21 110.934 179.996 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -106.71 133.05 11.44 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.746 -0.74 . . . . 72.24 112.465 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.413 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 0.2 OUTLIER -128.58 147.88 50.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.823 0.344 . . . . 74.54 110.874 -179.765 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 48.7 tt0 -57.35 97.99 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.077 -0.511 . . . . 74.51 110.826 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.527 ' O ' ' HB3' ' A' ' 173' ' ' TYR . . . 86.04 -15.9 45.93 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.74 -0.743 . . . . 73.23 112.505 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.413 ' O ' ' CB ' ' A' ' 146' ' ' TYR . 5.1 m95 -123.61 146.68 47.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.78 0.324 . . . . 71.13 110.929 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.69 ' N ' ' HB2' ' A' ' 173' ' ' TYR . 13.0 tp -108.75 156.45 19.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.264 -0.426 . . . . 72.13 110.899 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.406 ' HB1' ' HG ' ' A' ' 144' ' ' LEU . . . -127.64 131.31 49.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.191 -0.459 . . . . 73.15 111.127 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -155.64 133.24 3.66 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.748 -0.739 . . . . 41.22 112.474 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -145.81 118.81 8.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.81 0.338 . . . . 73.11 110.941 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -122.43 123.13 40.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.096 -0.502 . . . . 74.04 110.883 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 97.8 mtp -133.57 134.89 43.89 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.172 -0.467 . . . . 75.33 110.873 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.473 ' O ' ' HB ' ' A' ' 164' ' ' VAL . 4.9 m120 -112.36 117.48 32.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 71.31 110.899 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.474 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 0.2 OUTLIER -87.23 125.69 34.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 74.23 110.882 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.39 108.15 15.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.13 -0.486 . . . . 75.22 110.943 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 6.0 t -66.14 -47.14 75.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.476 . . . . 74.24 111.152 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -50.71 -26.17 5.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 74.22 111.063 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 10.6 mmtt -120.93 -167.72 1.54 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.244 -0.434 . . . . 74.51 110.889 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 50.1 m -112.92 39.29 2.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 74.54 110.885 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.66 174.88 9.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 74.33 110.853 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.474 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 1.0 OUTLIER -78.63 146.0 8.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 75.25 111.167 179.925 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 15.3 t -88.32 -34.11 17.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 74.13 111.109 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -152.7 132.74 13.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 73.12 110.945 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 3.8 m -126.06 125.78 43.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 74.42 110.858 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 15.1 p-10 -135.72 137.02 41.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 74.35 110.891 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -131.64 150.26 52.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.459 . . . . 75.05 110.88 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -150.33 129.46 12.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.485 . . . . 61.15 111.068 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -145.69 138.5 20.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.157 -0.474 . . . . 74.32 111.123 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . 0.432 ' O ' ' HB3' ' A' ' 150' ' ' LEU . . . 136.69 146.25 5.14 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.747 -0.74 . . . . 52.45 112.478 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . 0.69 ' HB2' ' N ' ' A' ' 150' ' ' LEU . 5.0 t80 -151.04 177.56 10.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.008 0.433 . . . . 75.44 110.88 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -97.1 136.08 38.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.105 -0.498 . . . . 71.33 110.895 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.651 ' O ' ' C ' ' A' ' 176' ' ' ASP . 0.2 OUTLIER -122.86 165.54 16.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.224 -0.443 . . . . 73.33 111.156 179.979 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.651 ' C ' ' O ' ' A' ' 175' ' ' THR . 2.0 m-20 -9.5 -86.72 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.25 -0.432 . . . . 73.3 110.869 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -120.35 12.95 11.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 64.3 110.884 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -130.2 116.58 18.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 74.12 110.889 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -114.13 124.2 51.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.135 -0.484 . . . . 73.13 110.91 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -122.07 120.99 35.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 74.42 110.936 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -123.71 145.75 48.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 73.41 110.869 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.89 136.72 23.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 74.32 111.102 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 22.1 m120 -132.65 140.04 48.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 73.24 110.853 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 2.5 t -132.74 110.38 15.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 75.53 111.117 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -99.0 90.07 4.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 75.22 110.893 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 66.2 176.86 0.22 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.177 -0.465 . . . . 64.34 110.86 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -73.22 -2.2 58.44 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.737 -0.744 . . . . 63.53 112.52 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 7.7 t -98.4 -25.35 14.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.742 0.306 . . . . 71.44 111.12 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -121.94 115.27 22.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 74.53 110.926 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -140.81 124.47 16.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 75.44 110.883 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -175.55 -161.6 25.25 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.756 -0.735 . . . . 33.14 112.503 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -175.33 -172.05 39.87 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.767 -0.73 . . . . 74.22 112.529 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 34.3 m -147.63 148.42 31.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.796 0.331 . . . . 75.21 110.877 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 4.7 mp -119.63 130.96 73.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.12 -0.491 . . . . 75.04 111.168 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -119.24 126.05 50.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.198 -0.455 . . . . 75.41 110.942 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 3.7 tm0? -124.75 131.13 53.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.095 -0.502 . . . . 72.14 110.881 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 36.0 mttt -100.64 127.23 47.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 72.11 110.873 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 16.4 t -80.33 152.63 4.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.27 -0.423 . . . . 75.42 111.174 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -51.15 -37.9 48.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 75.44 110.908 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.75 -170.4 2.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 63.3 110.92 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 1.6 ptmt -76.71 64.67 2.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 75.04 110.926 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 6.3 mp -145.62 128.45 16.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.236 -0.438 . . . . 64.11 110.915 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -120.61 130.07 54.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.15 -0.477 . . . . 72.21 110.889 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 2.3 t -132.23 138.31 47.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 74.53 111.091 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -149.69 156.7 42.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 74.24 111.111 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 1.3 m -126.08 147.21 30.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 75.34 111.173 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -117.92 127.96 54.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.454 . . . . 72.3 110.923 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 2.2 mp -125.7 147.03 49.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 73.02 110.877 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -157.24 131.55 8.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 72.13 111.105 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 21.5 t90 -129.91 133.56 46.93 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.26 -0.427 . . . . 74.3 110.927 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -101.09 103.68 14.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.25 -0.432 . . . . 61.14 111.152 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -53.26 140.88 25.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.26 -0.427 . . . . 73.23 111.111 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 134.74 -72.76 0.46 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.689 -0.767 . . . . 63.44 112.481 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -171.79 36.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.793 0.33 . . . . 51.44 110.882 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 32.8 t -111.85 165.33 12.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 63.33 110.852 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -88.16 162.59 16.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 74.43 110.866 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 2.9 m -78.11 137.96 38.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 74.42 111.172 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 33.4 ttp180 -102.95 129.06 49.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 75.35 110.872 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -134.0 133.25 41.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 65.21 110.86 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -143.53 145.46 15.26 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.72 -0.752 . . . . 50.2 112.5 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.14 138.32 52.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.863 0.363 . . . . 73.51 111.173 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -138.12 153.22 49.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.451 . . . . 73.11 111.13 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -145.49 157.72 43.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.239 -0.437 . . . . 73.34 111.097 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 3.1 tttm -142.94 124.41 14.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.441 . . . . 73.42 110.861 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -133.6 133.93 42.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 63.41 110.938 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 7.9 mm-40 -79.15 130.71 35.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.139 -0.482 . . . . 72.02 110.894 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . 0.416 ' CG2' ' HD2' ' A' ' 229' ' ' PRO . 1.3 tp -77.41 -38.34 26.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.469 . . . . 74.14 111.108 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . 0.469 ' N ' ' HD2' ' A' ' 229' ' ' PRO . 0.3 OUTLIER 172.12 -60.91 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.6 0.714 . . . . 72.4 110.863 179.884 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' A' ' 228' ' ' ASP . 53.8 Cg_endo -69.76 -157.52 0.04 OUTLIER 'Trans proline' 0 C--O 1.231 0.148 0 C-N-CA 122.722 2.281 . . . . 72.24 112.315 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -85.37 15.23 4.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 72.44 110.906 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -120.59 122.0 39.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 75.54 111.078 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 13.0 p -112.79 144.56 42.12 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.444 . . . . 73.21 110.864 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -97.2 127.64 43.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 74.23 110.888 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 1.2 t -117.54 137.15 52.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.126 -0.488 . . . . 64.51 110.807 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -130.67 141.27 50.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 60.5 111.094 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 7.7 pttm -144.45 165.06 29.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 73.4 110.884 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 8.7 p -154.93 146.23 13.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 73.25 111.124 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -104.82 147.69 27.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 70.44 110.848 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -53.46 -22.83 8.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.111 -0.495 . . . . 64.51 110.851 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 2.6 t -82.03 26.86 0.5 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 73.11 110.901 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 59.14 37.77 23.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.078 -0.51 . . . . 54.15 110.881 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -98.39 121.14 39.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.103 -0.499 . . . . 74.32 110.901 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 5.4 mp -86.82 123.06 39.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 70.12 111.128 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -115.81 133.8 11.09 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.74 -0.743 . . . . 74.44 112.492 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 11.0 mp -130.58 129.81 43.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.878 0.37 . . . . 75.2 110.942 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -140.29 121.74 2.04 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.729 -0.748 . . . . 70.0 112.465 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -111.76 121.68 45.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.936 0.398 . . . . 75.43 110.964 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -109.75 120.8 43.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.476 . . . . 62.13 111.112 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -128.32 122.68 32.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 72.24 110.931 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 96.0 m -110.31 111.51 22.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 71.53 111.137 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -106.37 88.57 2.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 73.34 110.904 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 6.2 mtmt 62.44 161.46 0.12 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.549 0.69 . . . . 73.22 110.925 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 76.84 1.13 Allowed 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.679 2.253 . . . . 75.3 112.306 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 169.34 -32.16 0.17 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.751 -0.738 . . . . 62.44 112.467 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 4.4 mp -118.19 122.47 69.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.831 0.348 . . . . 73.51 111.119 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 25.7 mmtt -131.6 132.83 44.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.229 -0.442 . . . . 72.14 110.877 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 1.5 tt -114.11 127.05 55.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.223 -0.444 . . . . 74.25 110.878 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 13.9 p -126.45 117.11 22.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 72.24 111.12 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.98 130.6 55.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 70.31 110.91 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 15.8 p -127.25 140.6 52.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 70.31 110.87 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -151.99 128.79 10.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.127 -0.488 . . . . 61.53 111.105 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -125.21 115.8 20.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 75.54 110.868 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.63 109.62 19.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 74.42 110.928 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.01 116.45 22.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.204 -0.453 . . . . 72.53 110.853 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -57.19 -16.58 20.24 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.716 -0.754 . . . . 64.14 112.513 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -86.11 -22.15 27.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.844 0.354 . . . . 75.55 110.945 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -108.57 -53.6 2.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 73.34 110.889 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 17.4 m -50.88 -30.29 8.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 74.4 111.138 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -52.98 -41.02 64.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 70.21 110.864 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -103.73 -17.62 15.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.14 -0.482 . . . . 73.1 111.124 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 128.49 94.39 0.79 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.762 -0.732 . . . . 71.3 112.482 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 175.53 78.67 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.762 -0.732 . . . . 72.41 112.491 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 13.0 p80 -104.91 144.19 32.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.853 0.359 . . . . 70.2 110.871 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 1.6 mtpt -99.43 136.19 39.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.268 -0.424 . . . . 74.12 110.887 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -136.58 144.91 44.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 73.11 110.88 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -154.19 130.63 2.96 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.729 -0.748 . . . . 55.52 112.487 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.446 ' HB3' HG13 ' A' ' 27' ' ' ILE . 0.1 OUTLIER -113.7 140.21 48.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.824 0.345 . . . . 74.32 110.928 -179.923 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . 0.406 ' HA2' ' HG2' ' A' ' 28' ' ' LYS . . . -147.16 126.79 2.5 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.781 -0.723 . . . . 73.43 112.502 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -121.67 133.25 54.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.762 0.315 . . . . 64.04 110.952 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -114.98 133.35 56.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 73.44 110.925 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -126.29 120.2 29.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 75.44 110.867 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -113.74 117.34 31.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.133 -0.485 . . . . 75.14 110.9 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -99.59 112.41 24.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 74.24 111.09 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 10.9 mt -144.87 -170.4 3.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.203 -0.453 . . . . 71.15 110.863 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 74.44 110.946 179.917 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.864 0.364 . . . . 75.04 111.112 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 17.8 t -141.1 75.33 23.9 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.675 0.75 . . . . 73.23 111.13 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 168.01 22.76 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.678 2.252 . . . . 73.4 112.372 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 101.23 0.88 Allowed 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.638 2.226 . . . . 71.54 112.374 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -80.0 -34.49 38.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.456 . . . . 71.43 111.157 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -53.7 -30.98 46.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 62.32 110.929 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -80.55 -26.02 38.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.147 -0.479 . . . . 75.35 111.057 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -74.31 -9.94 59.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.227 -0.442 . . . . 73.51 110.888 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.4 mp -56.72 -34.25 67.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 62.41 110.953 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 152.24 64.38 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.759 -0.734 . . . . 75.15 112.517 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 24.5 ttpp -62.81 -52.44 63.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.771 0.319 . . . . 74.23 110.913 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 75.5 m -62.87 -49.39 75.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.448 . . . . 54.31 110.855 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.94 -37.38 79.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 75.14 111.13 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 45.7 ttt180 -66.01 -34.03 77.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 71.55 110.909 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -60.29 -46.28 90.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 72.11 110.857 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.3 p -80.98 -33.74 13.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 74.14 111.133 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -66.9 -41.18 87.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.485 . . . . 54.3 110.89 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.26 -173.93 2.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 71.11 111.16 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.8 mtmt -95.56 -168.48 1.79 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 75.33 110.915 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.56 48.95 1.46 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.741 -0.742 . . . . 53.44 112.493 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 12.9 p90 -122.63 -35.77 3.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.937 0.399 . . . . 74.12 110.933 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -144.98 139.29 8.31 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.754 -0.736 . . . . 73.0 112.528 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -104.24 -6.35 21.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.926 0.393 . . . . 71.34 110.899 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.27 12.42 57.39 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.772 -0.728 . . . . 73.52 112.488 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.518 ' CD1' ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -150.88 -173.48 4.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.819 0.343 . . . . 65.41 110.937 -179.934 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.404 ' HA ' ' O ' ' A' ' 277' ' ' LEU . 21.2 mm -92.34 133.46 33.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 74.45 111.124 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.5 mtpp -113.06 154.66 26.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 75.42 110.885 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -147.79 136.84 22.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.229 -0.442 . . . . 72.54 110.944 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -152.22 124.21 8.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 74.5 110.863 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -125.5 129.13 49.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 72.31 110.907 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.17 128.24 56.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 70.54 110.88 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 93.8 m -137.21 121.12 17.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.44 . . . . 75.14 111.154 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.9 ptmm? -140.89 141.93 34.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 72.44 110.888 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 17.9 t -139.23 152.49 47.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.207 -0.451 . . . . 71.22 110.864 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -75.97 61.45 1.51 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 71.24 110.907 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -153.27 20.67 0.56 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.132 -0.486 . . . . 73.2 110.876 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.538 ' HA2' ' O ' ' A' ' 63' ' ' ARG . . . 75.72 -3.53 49.23 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.721 -0.752 . . . . 72.23 112.524 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.2 mp -98.94 124.16 43.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.771 0.319 . . . . 74.1 110.897 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.82 118.28 10.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.162 -0.472 . . . . 72.2 110.825 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -110.1 123.58 49.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 73.02 110.905 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 83.9 m -127.39 116.62 20.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.47 . . . . 73.53 111.18 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.5 t -115.44 135.81 53.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.435 . . . . 74.23 110.861 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.27 143.91 25.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 61.42 110.871 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 164.95 168.49 27.18 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.712 -0.756 . . . . 70.21 112.463 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -137.3 169.45 17.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.866 0.365 . . . . 75.24 110.872 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -147.11 127.43 13.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 75.04 111.089 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.423 ' HA ' ' HB2' ' A' ' 26' ' ' LEU . 2.5 m120 -95.45 142.55 27.68 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.198 -0.456 . . . . 74.53 110.852 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 61.1 p -94.12 56.45 2.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 75.01 111.174 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -126.19 -74.89 0.59 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 64.1 110.889 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.4 ' O ' ' C ' ' A' ' 52' ' ' THR . 2.2 m -130.33 65.65 1.52 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 65.24 111.133 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.4 ' C ' ' O ' ' A' ' 51' ' ' THR . 10.1 t 37.05 43.88 0.34 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 65.41 111.16 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -105.2 95.02 5.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 75.41 110.885 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -126.81 148.23 31.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 74.22 111.144 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.7 p -113.27 126.59 55.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 75.22 111.138 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -118.94 147.27 18.43 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.797 -0.716 . . . . 60.13 112.52 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.4 p -146.06 133.55 20.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.918 0.389 . . . . 75.15 110.871 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.458 ' O ' ' HB3' ' A' ' 74' ' ' LYS . 0.3 OUTLIER -123.09 130.08 52.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.465 . . . . 71.11 110.892 -179.968 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.513 ' HA ' ' CB ' ' A' ' 74' ' ' LYS . 0.9 OUTLIER -134.84 120.82 19.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.21 -0.45 . . . . 62.02 110.86 179.923 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.479 ' H ' ' HB2' ' A' ' 74' ' ' LYS . 20.3 m -105.43 117.81 34.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.126 -0.488 . . . . 72.44 111.149 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 71' ' ' PHE . 8.2 mttp -106.58 157.95 17.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 75.13 110.867 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.509 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 10.3 t80 -122.16 121.16 36.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 62.23 110.899 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.538 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -88.45 101.31 13.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.082 -0.508 . . . . 75.42 110.908 179.963 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 42.5 t-105 -116.21 136.35 53.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.209 -0.451 . . . . 73.51 110.895 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 24.0 p -80.98 -169.85 2.42 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.211 -0.45 . . . . 75.31 111.182 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 66.29 101.89 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.235 -0.438 . . . . 74.14 110.859 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 65.04 13.98 9.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.158 -0.474 . . . . 74.12 110.946 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 49.95 91.19 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.717 -0.754 . . . . 73.22 112.51 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -118.05 141.04 48.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.834 0.349 . . . . 71.13 110.941 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 62' ' ' TYR . 83.4 m -135.68 121.74 20.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 73.3 111.161 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.409 ' O ' ' HA ' ' A' ' 61' ' ' LYS . 14.2 t80 -100.26 119.73 38.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 73.43 110.902 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.403 ' O ' ' HA ' ' A' ' 83' ' ' THR . 3.1 t -111.37 116.06 30.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 74.31 111.154 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.59 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 8.5 tt0 -139.66 126.94 21.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 73.44 110.895 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.59 ' HB2' ' O ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER 165.63 -156.78 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 74.22 110.934 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.414 ' CD1' ' HB3' ' A' ' 81' ' ' LEU . 12.2 t90 -133.93 136.38 44.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.268 -0.424 . . . . 75.0 110.896 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -107.88 155.64 20.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.281 -0.418 . . . . 71.33 110.909 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 15.2 t -68.79 -8.42 43.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.172 -0.467 . . . . 72.21 111.128 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.472 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 5.1 m-20 -73.8 3.43 6.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.237 -0.438 . . . . 74.53 110.839 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.472 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 3.9 m-20 81.03 15.33 0.6 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 73.32 110.842 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -116.0 116.25 27.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 65.24 111.126 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.414 ' HB3' ' CD1' ' A' ' 75' ' ' TRP . 0.1 OUTLIER -122.97 128.21 49.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 74.25 110.914 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 177.58 -133.19 2.15 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.776 -0.726 . . . . 72.22 112.536 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.445 ' OG1' ' N ' ' A' ' 84' ' ' GLU . 4.3 t -178.92 -178.35 0.54 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.812 0.339 . . . . 74.34 111.109 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.65 ' HB3' ' O ' ' A' ' 99' ' ' PHE . 0.6 OUTLIER 170.93 -166.58 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.202 -0.454 . . . . 73.51 110.932 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.8 pp -136.78 145.69 29.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.203 -0.453 . . . . 73.35 111.135 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 98.6 m -128.96 123.27 32.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.465 . . . . 72.51 111.196 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.2 p -112.54 138.66 40.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 73.43 111.157 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -123.86 118.69 27.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 70.34 110.887 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 43.1 t0 64.42 76.88 0.33 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.143 -0.48 . . . . 63.34 110.878 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -109.01 -68.87 0.89 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 73.32 110.882 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -65.33 -74.28 0.11 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 73.23 110.86 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -121.41 142.38 50.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.174 -0.466 . . . . 63.23 111.117 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 19.5 ttm180 -50.64 133.99 24.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 70.45 110.9 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 100.88 -22.31 40.08 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.732 -0.747 . . . . 72.25 112.49 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.98 125.04 34.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.923 0.392 . . . . 73.2 110.917 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 28.8 tttp -124.02 129.83 51.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.466 . . . . 74.2 110.903 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -122.2 123.04 40.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.45 . . . . 73.42 110.92 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 87.6 m -123.79 118.68 27.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.209 -0.451 . . . . 72.04 111.108 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.65 ' O ' ' HB3' ' A' ' 84' ' ' GLU . 0.7 OUTLIER -115.3 117.33 30.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.455 . . . . 74.32 110.857 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.558 ' HA ' ' CB ' ' A' ' 84' ' ' GLU . 8.4 t70 -121.62 139.47 53.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.103 -0.499 . . . . 72.23 110.901 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 37.7 t -130.55 121.26 25.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 72.11 110.87 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 15.8 m -116.6 153.41 32.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.096 -0.502 . . . . 71.52 110.878 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -123.72 138.41 54.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 75.42 110.895 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 4.2 t -116.83 106.69 47.47 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.634 0.73 . . . . 71.12 110.881 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.68 -32.61 18.55 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.683 2.255 . . . . 75.2 112.389 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -57.3 -35.9 70.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.469 . . . . 73.03 110.903 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 10.0 m -99.09 -32.4 11.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 61.1 111.12 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.66 -18.58 57.24 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.762 -0.732 . . . . 71.52 112.532 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 29.6 tptt -94.44 147.47 23.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.817 0.342 . . . . 74.23 110.915 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -92.95 150.84 20.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.279 -0.419 . . . . 74.22 110.924 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.1 m120 -121.08 126.32 49.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.436 . . . . 60.34 110.913 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -113.68 139.3 49.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 65.44 111.066 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 27.9 mttm -138.3 137.91 37.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 64.11 110.889 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 4.1 tp -134.66 133.68 54.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 64.42 111.152 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 40.0 mttp -125.42 120.83 32.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 72.33 110.894 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.7 p -127.81 118.33 23.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 74.42 111.167 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -152.19 156.08 26.5 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.753 -0.737 . . . . 74.22 112.495 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -132.41 130.49 40.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.973 0.416 . . . . 73.52 110.896 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 37.7 mttp -107.05 118.5 36.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.103 -0.499 . . . . 75.54 110.893 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.26 142.94 42.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 74.43 110.851 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -52.42 -27.32 15.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.134 -0.485 . . . . 75.35 110.887 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 27.9 m80 -90.38 -38.3 13.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 75.14 110.895 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 9.3 tp -147.67 140.65 19.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.445 . . . . 74.53 111.098 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -111.25 115.94 30.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 72.34 110.87 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -122.96 139.91 53.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.175 -0.466 . . . . 75.21 110.935 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -146.74 121.5 1.44 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.741 -0.743 . . . . 64.22 112.437 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 18.5 m -113.19 134.02 54.78 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.791 0.329 . . . . 72.1 110.916 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -126.62 146.97 49.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 71.11 110.905 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 8.7 mtm -139.04 127.23 22.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 72.24 110.869 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -117.81 121.3 40.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 75.22 110.88 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -95.26 119.71 34.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.465 . . . . 75.33 110.887 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -128.2 121.15 28.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 75.11 110.855 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.1 tp -52.41 -43.75 41.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 73.41 111.166 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -74.39 -18.29 60.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.481 . . . . 65.53 111.121 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.402 ' HA2' ' HD2' ' A' ' 136' ' ' PRO . . . 161.47 103.59 0.18 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.725 -0.75 . . . . 72.42 112.454 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.402 ' HD2' ' HA2' ' A' ' 135' ' ' GLY . 53.8 Cg_endo -69.72 147.99 64.34 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.656 2.237 . . . . 74.13 112.382 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 28.4 t -128.73 150.49 50.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 75.14 110.875 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 1.4 mp -107.89 132.99 54.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.12 -0.491 . . . . 73.35 111.136 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 18.9 mtp180 -112.37 131.25 55.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 73.43 110.869 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -126.72 134.01 8.3 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.705 -0.76 . . . . 70.41 112.485 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -139.17 116.94 11.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.832 0.349 . . . . 72.01 111.125 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.3 tp -127.01 124.59 39.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.242 -0.436 . . . . 62.45 110.954 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 46.6 t -123.34 134.8 65.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 64.44 111.092 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -109.38 143.36 39.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.106 -0.497 . . . . 75.12 110.889 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -121.36 120.25 4.37 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.774 -0.727 . . . . 74.02 112.513 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.417 ' HB3' ' HB2' ' A' ' 149' ' ' TRP . 38.5 t80 -128.85 145.5 51.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.825 0.345 . . . . 73.45 110.893 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -50.95 96.89 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.126 -0.488 . . . . 64.32 110.876 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 92.88 -30.7 6.78 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.707 -0.759 . . . . 63.35 112.464 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.417 ' HB2' ' HB3' ' A' ' 146' ' ' TYR . 25.0 m95 -104.77 141.09 37.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.828 0.347 . . . . 74.33 110.863 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -130.71 140.6 50.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.446 . . . . 74.04 110.943 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -131.44 148.12 52.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 73.54 111.086 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -150.95 137.06 5.86 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.752 -0.737 . . . . 74.42 112.484 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -144.11 119.78 10.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.877 0.37 . . . . 74.31 110.923 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -126.94 122.44 34.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.117 -0.492 . . . . 74.3 110.892 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 15.6 ptt? -146.82 150.17 34.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 71.33 110.846 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 48.9 m-20 -112.12 138.56 48.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 73.12 110.891 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -92.24 132.49 36.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 63.43 110.868 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -77.86 99.64 6.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.141 -0.482 . . . . 71.43 110.865 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.21 -47.0 78.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.139 -0.482 . . . . 75.32 111.165 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -48.29 -26.11 1.85 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 75.55 111.119 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 43.9 mttt -127.33 -166.64 1.63 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.459 . . . . 63.11 110.935 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 39.6 m -111.18 40.29 2.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.44 . . . . 73.33 110.795 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 11.0 mmm180 -153.3 176.21 12.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 73.25 110.889 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 1.5 t -78.01 141.42 15.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 74.11 111.119 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 15.2 t -90.61 -33.73 15.74 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.158 -0.474 . . . . 62.15 111.131 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -150.97 134.84 16.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.445 . . . . 74.42 110.9 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 89.5 p -124.81 119.01 27.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 73.31 110.893 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -130.47 142.56 50.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 75.23 110.89 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -138.2 158.14 44.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.126 -0.488 . . . . 71.32 110.866 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -154.07 138.96 17.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 64.21 111.114 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 46.2 t -120.63 134.87 62.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 74.12 111.113 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -117.59 112.56 2.48 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.706 -0.759 . . . . 73.11 112.491 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -114.18 121.58 44.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.994 0.426 . . . . 73.32 110.901 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 26.0 ttmt -104.36 134.77 47.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.113 -0.494 . . . . 75.1 110.916 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.97 165.11 22.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 74.35 111.128 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -40.93 -74.82 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.175 -0.466 . . . . 54.22 110.892 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -116.07 15.15 16.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 72.21 110.913 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -127.09 149.57 49.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 75.41 110.868 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 6.6 mm-40 -135.22 123.87 23.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.123 -0.49 . . . . 74.23 110.881 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -124.23 122.32 37.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.132 -0.485 . . . . 75.4 110.873 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -130.47 115.94 17.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 72.23 110.9 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.77 153.12 17.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.217 -0.447 . . . . 75.34 111.1 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -146.76 138.56 24.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 73.31 110.896 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 2.3 t -134.72 111.3 13.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.473 . . . . 71.52 111.143 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -100.09 89.28 3.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 72.3 110.9 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 65.28 179.14 0.19 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.179 -0.464 . . . . 71.22 110.821 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -73.47 -4.17 64.2 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.69 -0.767 . . . . 75.4 112.506 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 29.3 p -95.38 -25.87 16.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.765 0.317 . . . . 62.14 111.15 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -122.83 114.17 20.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 75.43 110.915 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -139.72 124.13 18.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 73.11 110.813 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 178.8 -150.88 9.87 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.678 -0.772 . . . . 44.43 112.47 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -176.42 170.43 43.24 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.726 -0.749 . . . . 74.35 112.485 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 65.3 m -121.21 147.19 45.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.872 0.368 . . . . 63.22 110.798 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 4.0 mp -119.79 123.45 70.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.104 -0.498 . . . . 73.22 111.073 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -108.48 121.91 45.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 75.45 110.929 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 53.9 tp60 -124.47 130.2 52.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 74.52 110.914 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 21.2 mtpp -106.25 127.19 53.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 74.53 110.874 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 14.7 t -79.21 153.33 4.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 73.51 111.159 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' ASN . . . . . 0.406 ' O ' ' C ' ' A' ' 200' ' ' LYS . 47.0 t30 -59.62 97.94 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 73.35 110.9 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . 0.406 ' C ' ' O ' ' A' ' 199' ' ' ASN . 16.6 ptpt 37.3 63.12 0.76 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 75.11 110.897 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 25.3 mttm -145.46 -56.46 0.31 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 75.53 110.917 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -173.76 172.42 3.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 74.01 110.936 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -116.58 144.9 43.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 72.24 110.876 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 7.3 m -146.53 138.77 24.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 74.02 111.105 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -145.3 136.64 25.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.441 . . . . 72.14 111.141 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 1.1 m -113.79 149.97 15.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 73.23 111.095 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -113.58 137.19 51.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.485 . . . . 72.43 110.865 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -120.61 129.72 53.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.17 -0.468 . . . . 73.51 110.897 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -129.77 130.07 44.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.119 -0.492 . . . . 73.24 111.08 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 2.9 t-105 -129.67 128.1 41.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 71.4 110.941 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 2.7 p -99.14 109.02 21.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.225 -0.443 . . . . 75.33 111.159 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -54.91 149.84 10.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 72.14 111.063 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 95.59 -36.49 3.8 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.71 -0.757 . . . . 72.41 112.474 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -121.54 -179.46 4.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.782 0.325 . . . . 74.12 110.879 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 3.0 t -112.11 38.37 2.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 71.12 110.882 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -102.17 112.21 24.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 75.55 110.905 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 18.6 m -114.65 138.45 50.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.459 . . . . 74.33 111.132 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 18.4 ttt85 -108.55 131.99 54.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.441 . . . . 75.43 110.848 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -117.45 136.7 53.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 74.41 110.89 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -137.46 140.63 11.48 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.737 -0.744 . . . . 71.32 112.511 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 4.8 mp -123.85 130.73 73.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.854 0.359 . . . . 70.45 111.104 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -127.61 152.21 47.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 65.41 111.1 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -137.37 129.34 29.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.246 -0.434 . . . . 75.22 111.084 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 7.3 ttmt -115.21 128.48 56.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 73.32 110.894 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -132.25 131.54 42.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.252 -0.431 . . . . 73.24 110.913 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 58.7 mm-40 -102.71 112.28 24.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 75.35 110.875 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 71.4 mt -102.68 -40.1 6.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 73.33 111.109 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -124.17 160.7 51.19 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.579 0.704 . . . . 62.32 110.882 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -32.34 18.82 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.725 2.283 . . . . 73.44 112.317 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -109.2 10.49 25.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.435 . . . . 72.43 110.882 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -136.1 140.42 43.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.179 -0.464 . . . . 64.12 111.086 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 21.8 m -138.74 136.49 35.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.213 -0.449 . . . . 62.25 110.903 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -110.42 132.77 53.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 73.3 110.924 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 58.2 p -137.08 149.71 47.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 72.44 110.826 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -136.47 155.59 49.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.096 -0.502 . . . . 73.44 111.089 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.51 145.91 29.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 74.41 110.861 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 1.7 p -143.04 143.88 24.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 73.32 111.143 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -112.31 148.08 34.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 73.03 110.886 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' ASN . . . . . 0.415 ' C ' ' H ' ' A' ' 241' ' ' SER . 2.4 t-20 -57.1 -18.53 15.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 63.55 110.89 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 29.9 t -80.93 25.89 0.44 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 73.31 110.814 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' SER . . . . . 0.415 ' H ' ' C ' ' A' ' 239' ' ' ASN . 0.8 OUTLIER 62.22 35.19 15.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.123 -0.49 . . . . 73.32 110.875 -179.838 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 4.9 mp -99.25 118.5 36.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.132 -0.486 . . . . 74.01 110.916 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -107.42 117.88 54.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 74.35 111.154 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -137.12 149.62 20.33 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.701 -0.762 . . . . 71.3 112.467 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.425 ' CD1' ' N ' ' A' ' 245' ' ' LEU . 0.0 OUTLIER -145.83 158.48 43.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.869 0.366 . . . . 64.44 110.887 -179.895 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -163.01 136.83 4.48 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.687 -0.768 . . . . 71.42 112.465 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -128.42 132.59 48.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.902 0.382 . . . . 75.4 110.932 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 7.8 t -111.99 125.83 54.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.487 . . . . 62.41 111.177 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -143.43 148.82 36.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.235 -0.438 . . . . 75.11 110.961 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 5.5 m -88.93 145.24 25.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.262 -0.426 . . . . 72.03 111.127 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 47.4 mt -93.94 -176.05 3.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 71.45 110.889 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' LYS . . . . . 0.472 ' CB ' ' CD ' ' A' ' 253' ' ' PRO . 0.1 OUTLIER -51.16 -61.07 4.46 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.545 0.688 . . . . 73.4 110.87 179.845 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' PRO . . . . . 0.472 ' CD ' ' CB ' ' A' ' 252' ' ' LYS . 53.8 Cg_endo -69.73 -170.26 0.38 Allowed 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.687 2.258 . . . . 64.35 112.306 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . 0.538 ' O ' ' HB3' ' A' ' 281' ' ' PHE . . . -85.1 51.55 4.56 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.737 -0.744 . . . . 73.42 112.465 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.435 ' HA ' ' CB ' ' A' ' 281' ' ' PHE . 6.2 pt -129.27 135.1 62.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.893 0.377 . . . . 65.31 111.152 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . 0.425 ' H ' ' HB2' ' A' ' 281' ' ' PHE . 0.1 OUTLIER -98.39 132.1 44.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.447 . . . . 74.1 110.888 179.858 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 5.2 tp -100.07 125.45 46.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 75.22 110.921 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 21.9 m -116.39 111.75 20.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 73.11 111.152 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.33 130.02 55.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.253 -0.431 . . . . 75.41 110.868 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 1.7 t -144.16 155.8 44.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.167 -0.469 . . . . 73.25 110.898 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -158.88 128.38 5.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 62.24 111.06 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -118.48 122.98 44.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 71.32 110.921 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -118.93 110.56 17.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.159 -0.473 . . . . 73.4 110.88 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . 0.55 ' O ' ' HB ' ' A' ' 268' ' ' VAL . 1.7 m-20 -88.62 99.87 12.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 73.31 110.844 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -52.86 -11.48 1.35 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.737 -0.744 . . . . 74.45 112.464 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . 0.407 ' H ' ' C ' ' A' ' 264' ' ' ASP . 7.4 ttmm -63.86 -25.66 68.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.825 0.345 . . . . 70.13 110.915 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -166.82 16.91 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 72.05 110.881 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . 0.55 ' HB ' ' O ' ' A' ' 264' ' ' ASP . 1.4 p -68.05 -28.51 41.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 64.54 111.119 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -74.48 -37.44 63.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 74.25 110.914 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -85.83 -17.64 35.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.142 -0.481 . . . . 62.41 111.103 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 131.21 95.26 0.68 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.768 -0.729 . . . . 72.51 112.515 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 178.86 53.74 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.774 -0.727 . . . . 74.14 112.537 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 14.8 p80 -112.17 144.21 41.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.887 0.375 . . . . 72.3 110.84 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -123.71 149.32 45.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 72.11 110.889 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 2.4 tp -128.41 148.55 50.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 72.3 110.898 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -131.34 97.53 0.36 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.784 -0.722 . . . . 75.45 112.501 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.404 ' O ' ' HA ' ' A' ' 27' ' ' ILE . 3.2 tm? -119.28 129.65 55.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.845 0.355 . . . . 74.45 110.886 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -164.48 145.61 10.51 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.752 -0.737 . . . . 72.53 112.533 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . 0.415 ' CD2' ' N ' ' A' ' 279' ' ' LEU . 0.0 OUTLIER -118.47 130.03 55.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.745 0.307 . . . . 72.44 110.971 -179.969 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . 0.526 ' O ' ' HB2' ' A' ' 281' ' ' PHE . 0.0 OUTLIER -140.37 143.58 35.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.449 . . . . 73.2 110.924 179.961 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . 0.538 ' HB3' ' O ' ' A' ' 254' ' ' GLY . 0.2 OUTLIER 172.63 -144.39 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 73.34 110.856 -179.949 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -137.47 148.82 46.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 72.04 110.933 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -101.11 111.45 23.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 71.31 111.106 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -151.31 178.44 9.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.235 -0.439 . . . . 75.11 110.904 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 73.15 110.893 179.919 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.845 0.355 . . . . 75.52 111.104 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.1 t -114.43 78.48 4.8 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.668 0.746 . . . . 71.11 111.14 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 167.7 23.68 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.681 2.254 . . . . 72.14 112.351 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 119.57 6.49 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.654 2.236 . . . . 61.03 112.335 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 34.7 p -106.99 -49.61 3.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 70.21 111.154 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -56.39 -30.69 63.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.26 -0.427 . . . . 74.54 110.924 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -79.75 -23.08 42.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.082 -0.508 . . . . 74.03 111.117 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -90.66 13.28 16.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 74.33 110.846 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.39 -33.83 71.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.21 -0.45 . . . . 64.44 110.907 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 161.31 49.8 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.764 -0.731 . . . . 72.12 112.511 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.29 -48.51 81.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.775 0.321 . . . . 74.43 110.921 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.6 m -61.25 -49.14 78.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 71.11 110.839 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.22 -38.21 88.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 75.32 111.083 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.0 ttt-85 -60.73 -33.51 73.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 75.22 110.873 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -58.05 -46.02 86.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 74.23 110.893 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 92.8 t -65.19 -41.92 92.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 73.04 111.127 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -62.67 -41.01 98.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 71.44 110.911 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.0 t -94.11 43.13 1.1 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.145 -0.48 . . . . 64.21 111.165 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -129.5 174.1 9.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 75.41 110.866 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 77.55 -72.53 2.17 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.764 -0.732 . . . . 61.14 112.459 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -68.1 87.76 0.28 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.966 0.412 . . . . 73.21 110.942 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -61.29 -176.05 1.83 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.751 -0.738 . . . . 74.11 112.445 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -97.68 -4.49 37.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.944 0.402 . . . . 74.31 110.894 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.61 13.15 77.97 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.738 -0.744 . . . . 72.54 112.457 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.2 pp -149.54 -176.7 5.5 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.749 0.309 . . . . 74.33 110.952 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 1.6 mp -118.33 120.91 65.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.206 -0.452 . . . . 72.24 111.171 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.43 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 0.0 OUTLIER -125.81 117.13 22.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 74.44 110.915 179.844 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.69 137.91 50.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.44 . . . . 75.52 110.926 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.548 ' C ' ' HB3' ' A' ' 281' ' ' PHE . 0.7 OUTLIER -147.51 132.54 18.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.238 -0.437 . . . . 74.33 110.864 179.88 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.762 ' HA ' ' HA ' ' A' ' 281' ' ' PHE . 4.2 tt -129.55 124.58 34.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.196 -0.456 . . . . 75.43 110.952 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.595 ' N ' ' HB2' ' A' ' 281' ' ' PHE . 0.3 OUTLIER -120.36 125.29 47.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 72.23 110.891 179.873 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 46.2 m -122.2 121.11 36.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 74.14 111.124 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 5.9 ptmt -121.01 148.03 44.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 71.35 110.89 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 75.6 m -139.07 169.3 18.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 65.33 110.873 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -83.17 52.49 2.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.105 -0.498 . . . . 74.22 110.874 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -140.65 8.59 2.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.139 -0.482 . . . . 74.32 110.908 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' A' ' 63' ' ' ARG . . . 79.27 -5.09 60.71 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.727 -0.749 . . . . 72.02 112.511 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -99.08 128.53 45.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.726 0.298 . . . . 61.02 110.94 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.401 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -139.82 118.49 12.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 72.32 110.86 179.934 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -102.97 126.59 50.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 74.3 110.872 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 54.3 m -127.08 117.42 22.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.108 -0.496 . . . . 75.52 111.173 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 36.5 p -104.31 134.27 47.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 73.25 110.9 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 35.6 t -127.0 127.15 44.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 71.52 110.835 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -141.86 129.79 4.09 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.7 -0.762 . . . . 51.53 112.453 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 48.6 m -128.97 135.74 49.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.87 0.367 . . . . 72.21 110.866 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.401 ' HA ' ' HA ' ' A' ' 54' ' ' VAL . . . -134.66 129.7 35.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.128 -0.487 . . . . 74.11 111.106 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -92.18 136.42 33.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 75.21 110.866 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -96.23 -55.89 2.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 72.12 111.168 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -50.49 -34.91 26.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.221 -0.445 . . . . 73.51 110.9 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -139.3 165.21 27.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 72.41 111.117 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 22.0 p -78.72 84.6 4.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.462 . . . . 73.35 111.112 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 10.9 tptp -145.61 82.27 1.63 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 74.41 110.885 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.401 ' HA ' ' HA ' ' A' ' 47' ' ' ALA . 0.7 OUTLIER -126.68 120.07 55.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 75.22 111.128 179.845 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 82.7 p -137.93 160.82 38.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.198 -0.455 . . . . 72.34 111.117 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -129.74 158.57 22.28 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.733 -0.746 . . . . 71.41 112.502 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.2 p -146.51 161.21 40.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.913 0.387 . . . . 73.22 110.869 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -119.95 131.04 55.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.115 -0.493 . . . . 75.31 110.929 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -115.84 124.41 50.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 73.43 110.88 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.57 125.8 51.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 72.41 111.161 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.401 ' HB2' ' HB3' ' A' ' 40' ' ' GLU . 3.6 mttp -134.57 159.16 42.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 75.41 110.905 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -131.92 140.77 49.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 74.51 110.936 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.492 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 2.9 tmm_? -130.33 103.27 6.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 75.43 110.855 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 16.9 m95 -116.06 120.21 38.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 74.43 110.917 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.6 m 64.74 118.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 64.23 111.146 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -51.02 115.07 1.36 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.441 . . . . 75.35 110.85 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 65.59 56.93 0.9 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.113 -0.494 . . . . 75.15 110.948 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -144.35 -70.52 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.711 -0.757 . . . . 72.14 112.493 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -125.12 128.88 49.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.869 0.366 . . . . 60.31 110.928 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -137.67 128.82 27.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.26 -0.427 . . . . 71.54 111.156 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -114.47 133.35 55.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 75.52 110.848 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 49.8 p -126.32 115.0 19.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.127 -0.488 . . . . 73.41 111.171 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -132.06 136.16 47.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.231 -0.44 . . . . 64.43 110.857 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 13.6 pttp -123.15 94.72 4.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.47 . . . . 74.03 110.903 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.479 ' CD1' ' HB3' ' A' ' 81' ' ' LEU . 5.8 t90 -95.37 125.88 40.29 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.232 -0.44 . . . . 72.33 110.896 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -94.25 137.12 33.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.267 -0.424 . . . . 75.23 110.873 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 8.0 t -65.57 -36.66 84.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.153 -0.476 . . . . 75.35 111.162 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -112.1 -37.19 5.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.182 -0.463 . . . . 63.23 110.931 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -77.71 -162.19 0.3 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 74.52 110.898 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 20.7 p -81.09 157.35 25.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.161 -0.472 . . . . 74.02 111.156 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.479 ' HB3' ' CD1' ' A' ' 75' ' ' TRP . 0.2 OUTLIER -96.38 119.15 34.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 71.53 110.909 179.961 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.19 144.11 15.74 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.752 -0.737 . . . . 54.51 112.51 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.9 t -144.98 124.9 13.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.73 0.3 . . . . 75.44 111.169 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 50.9 tt0 -134.73 151.4 50.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 73.44 110.89 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.1 tt -129.12 139.02 52.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 72.55 111.117 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 7.6 p -129.11 121.24 27.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.16 -0.473 . . . . 73.55 111.155 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.0 p -118.62 134.39 62.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 75.02 111.168 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -106.75 128.12 53.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 64.43 110.874 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 61.34 56.03 2.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.185 -0.461 . . . . 74.35 110.849 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -64.34 -67.52 0.43 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 73.4 110.892 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 56.5 tp -106.6 -53.99 2.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.18 -0.464 . . . . 64.03 110.919 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -106.44 124.44 49.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 74.02 111.109 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 -51.71 133.64 30.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.242 -0.435 . . . . 74.4 110.923 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 99.97 -23.59 35.42 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.734 -0.746 . . . . 74.24 112.479 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.24 134.6 34.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.844 0.354 . . . . 75.2 110.937 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.7 tttp -122.29 131.15 53.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 74.2 110.883 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -116.75 130.72 56.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.205 -0.452 . . . . 75.22 110.924 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 51.6 m -129.64 125.0 35.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 64.33 111.106 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -115.42 116.47 28.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.232 -0.44 . . . . 73.53 110.875 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -109.33 133.15 53.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.17 -0.468 . . . . 72.24 110.844 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.4 t -142.87 128.38 19.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 71.21 110.857 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.1 m -108.11 151.02 26.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.131 -0.486 . . . . 72.12 110.866 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -133.23 132.44 41.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 70.54 110.868 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 9.6 t -128.18 109.67 19.73 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.627 0.727 . . . . 74.52 110.9 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 -16.35 37.67 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.623 2.216 . . . . 73.41 112.36 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -48.97 -70.7 0.08 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 63.32 110.839 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.6 m -129.13 31.47 4.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 73.03 111.145 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 67.76 24.22 74.14 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.726 -0.75 . . . . 75.12 112.472 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.55 116.53 13.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.837 0.351 . . . . 74.53 110.891 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 37.0 mtmt -116.01 147.98 40.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.172 -0.467 . . . . 73.34 110.911 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -120.5 132.54 55.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 73.43 110.889 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -114.65 121.48 43.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 64.42 111.129 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 16.5 ttmt -138.03 138.21 38.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.253 -0.431 . . . . 75.35 110.926 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 6.1 tp -134.11 123.23 43.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.434 . . . . 71.41 111.144 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 68.7 tttt -119.13 121.0 38.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 74.42 110.922 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.0 t -128.23 125.4 38.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.44 . . . . 73.11 111.136 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -150.7 157.47 27.21 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.78 -0.724 . . . . 71.42 112.494 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 16.3 p90 -132.21 130.78 41.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.939 0.399 . . . . 75.55 110.953 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 29.7 tttp -107.64 118.23 36.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.481 . . . . 75.34 110.884 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 12.4 mmt85 -110.85 142.91 42.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.247 -0.433 . . . . 74.42 110.857 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -52.79 -27.41 17.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 64.11 110.88 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 74.6 t60 -88.08 -39.61 14.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 75.24 110.859 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 8.6 tp -148.41 144.65 18.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 72.42 111.149 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -109.47 119.11 38.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 75.51 110.913 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -123.62 139.59 53.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 74.32 110.952 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -145.34 121.77 1.58 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.711 -0.757 . . . . 73.01 112.462 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -112.41 134.44 53.94 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.808 0.337 . . . . 75.32 110.857 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -129.67 133.82 47.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.164 -0.471 . . . . 72.32 110.898 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 2.1 mmt -127.99 129.17 46.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.457 . . . . 72.4 110.855 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -123.23 120.2 32.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 73.53 110.866 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -94.98 127.92 41.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 74.31 110.901 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -134.77 122.71 22.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.112 -0.494 . . . . 64.32 110.858 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -55.31 -25.25 16.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 74.12 111.133 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -91.79 -20.03 21.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 70.53 111.095 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 164.04 98.97 0.13 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.711 -0.757 . . . . 62.22 112.452 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.82 138.44 37.63 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.692 2.261 . . . . 65.21 112.328 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.1 m -127.77 159.52 34.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 71.42 110.844 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.4 mp -123.63 140.83 45.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.105 -0.498 . . . . 75.21 111.121 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 43.7 ttt180 -121.36 120.44 35.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 74.22 110.819 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -112.08 134.0 11.78 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.757 -0.735 . . . . 41.3 112.431 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -134.28 120.71 20.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.762 0.315 . . . . 75.52 111.135 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.0 tp -131.62 125.74 32.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.229 -0.441 . . . . 73.24 110.92 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 78.5 t -127.93 133.92 66.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.45 . . . . 75.24 111.134 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.6 mp -110.04 138.68 46.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 75.45 110.898 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -111.96 124.72 6.89 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.751 -0.738 . . . . 72.0 112.498 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -134.2 145.07 48.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.825 0.345 . . . . 73.24 110.968 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -50.45 96.47 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.125 -0.489 . . . . 62.41 110.903 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 90.02 -26.77 9.18 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.724 -0.75 . . . . 74.5 112.462 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 8.4 m0 -104.91 135.89 45.41 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.819 0.342 . . . . 72.42 110.913 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -129.91 137.56 50.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 74.24 110.903 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -129.98 137.4 50.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 62.12 111.136 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -138.72 136.08 7.8 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.739 -0.743 . . . . 72.53 112.48 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -139.33 119.38 13.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.831 0.348 . . . . 74.24 110.911 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 38.0 tt0 -132.59 122.44 24.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.484 . . . . 70.24 110.895 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 10.7 ptt? -146.12 157.76 43.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 75.5 110.843 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.42 ' O ' ' HB ' ' A' ' 164' ' ' VAL . 5.0 m120 -112.86 121.5 44.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.435 . . . . 74.03 110.868 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.515 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 49.0 t80 -84.29 128.63 34.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.121 -0.49 . . . . 70.05 110.854 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.416 ' H ' ' HA ' ' A' ' 164' ' ' VAL . 5.0 tp10 -85.51 107.88 17.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.491 . . . . 71.14 110.899 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.92 -48.31 71.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.137 -0.483 . . . . 74.2 111.156 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -50.24 -26.25 4.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.453 . . . . 75.11 111.066 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 43.6 mttm -117.02 -166.59 1.19 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 74.14 110.872 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 18.8 t -114.26 37.28 3.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 75.12 110.891 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 7.5 ptp85 -168.32 175.01 6.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.112 -0.494 . . . . 73.11 110.867 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.515 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 1.7 m -80.45 142.18 14.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 72.41 111.131 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 7.9 t -91.13 -25.81 19.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.196 -0.456 . . . . 75.55 111.156 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 5.3 tp60 -139.31 133.25 30.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 72.23 110.968 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -125.23 130.54 52.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.178 -0.465 . . . . 71.15 110.878 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -136.07 138.2 41.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 73.15 110.891 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -133.26 144.58 49.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 72.14 110.857 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -149.97 137.04 19.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 73.35 111.119 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 21.7 t -121.11 140.53 44.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 72.12 111.127 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -115.24 126.36 7.14 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.736 -0.745 . . . . 71.02 112.51 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -128.43 121.59 29.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.924 0.392 . . . . 73.32 110.928 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 22.3 mtmm -103.39 133.33 48.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.112 -0.494 . . . . 62.23 110.917 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -127.05 165.26 19.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 73.43 111.121 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -38.96 -76.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 70.5 110.828 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -117.13 14.22 14.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 74.43 110.879 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -125.39 150.14 47.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.48 . . . . 74.43 110.889 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 46.2 mm-40 -129.34 124.88 35.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 74.35 110.863 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -122.71 124.49 43.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 75.21 110.893 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 76.4 m-70 -130.72 116.35 17.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.21 -0.45 . . . . 73.12 110.853 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.82 154.46 17.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 73.52 111.143 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -163.0 139.88 7.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.209 -0.451 . . . . 74.04 110.908 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.556 ' HB ' ' HA ' ' A' ' 190' ' ' PHE . 1.7 m -134.31 137.29 51.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 61.24 111.14 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -97.26 88.48 4.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 71.02 110.869 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 71.43 -174.84 0.17 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 73.25 110.925 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -79.47 3.04 69.39 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.75 -0.738 . . . . 54.11 112.469 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 30.5 p -106.36 -23.35 12.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.783 0.325 . . . . 71.1 111.162 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -120.9 123.13 41.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.215 -0.448 . . . . 74.33 110.899 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' PHE . . . . . 0.556 ' HA ' ' HB ' ' A' ' 184' ' ' VAL . 0.5 OUTLIER -139.06 124.73 19.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 75.22 110.841 -179.884 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -165.1 -156.18 8.94 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.714 -0.755 . . . . 64.4 112.443 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -171.09 -168.56 32.96 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.742 -0.742 . . . . 63.42 112.487 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 39.0 t -147.78 145.52 28.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.837 0.351 . . . . 64.2 110.869 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 4.5 mp -120.68 133.36 67.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.113 -0.494 . . . . 74.0 111.112 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -117.68 121.18 40.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.192 -0.458 . . . . 74.22 110.932 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -121.03 131.64 54.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.087 -0.506 . . . . 75.44 110.916 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 23.3 ttpt -97.07 127.4 43.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.173 -0.467 . . . . 72.0 110.895 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 17.9 t 65.01 66.47 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 72.42 111.123 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -112.47 -36.03 5.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.176 -0.465 . . . . 73.04 110.932 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 31.0 tttm -119.77 -67.8 0.96 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 72.4 110.909 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.17 -38.08 1.42 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.209 -0.45 . . . . 75.31 110.892 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 15.1 tp -146.1 -74.43 0.22 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.21 -0.45 . . . . 74.42 110.884 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -124.91 142.1 51.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 74.21 110.86 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 1.7 m -146.01 137.56 24.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 73.21 111.198 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -150.33 162.69 40.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.23 -0.441 . . . . 62.53 111.056 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 1.3 m -137.26 149.98 26.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.194 -0.457 . . . . 74.03 111.176 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -113.81 135.74 53.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 73.54 110.89 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -121.38 145.5 47.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.485 . . . . 75.41 110.906 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -153.32 138.18 17.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.203 -0.453 . . . . 72.31 111.112 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 9.4 t-105 -130.78 134.94 47.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.188 -0.46 . . . . 74.43 110.945 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 2.3 m -96.9 105.27 17.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.252 -0.431 . . . . 74.45 111.12 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -51.6 132.68 30.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.155 -0.475 . . . . 75.13 111.091 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 117.85 -74.96 0.29 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.766 -0.731 . . . . 73.3 112.446 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -179.95 106.93 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.831 0.348 . . . . 73.02 110.843 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 2.0 t -173.96 161.14 3.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.466 . . . . 55.04 110.845 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -63.61 154.85 31.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 73.1 110.904 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 3.7 m -80.95 133.91 35.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.164 -0.471 . . . . 74.32 111.151 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 8.1 mmt85 -89.99 118.08 29.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.45 . . . . 73.43 110.844 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -130.18 137.53 50.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.146 -0.479 . . . . 74.11 110.88 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -142.01 140.64 10.22 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.752 -0.737 . . . . 61.12 112.485 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 4.3 mp -120.53 131.39 72.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.825 0.345 . . . . 74.32 111.142 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -137.49 151.22 48.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 75.23 111.076 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -144.98 129.73 18.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 72.32 111.083 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 29.1 mtpt -102.52 125.25 49.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 71.4 110.914 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -124.28 117.76 25.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.254 -0.43 . . . . 73.23 110.91 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -86.67 104.7 16.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.088 -0.506 . . . . 72.35 110.923 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 1.7 tt -82.68 -31.6 9.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 73.03 111.117 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -161.45 161.44 22.85 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.583 0.706 . . . . 75.34 110.867 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -6.96 19.85 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.664 2.242 . . . . 65.02 112.345 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -112.74 -25.38 9.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.246 -0.434 . . . . 63.31 110.861 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -137.62 145.08 42.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 72.13 111.085 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 25.5 m -136.85 143.14 42.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 75.4 110.915 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -117.73 134.24 55.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 71.22 110.861 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 22.8 t -135.47 152.15 51.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.122 -0.49 . . . . 72.14 110.854 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -139.51 146.27 39.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.087 -0.506 . . . . 72.3 111.129 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.52 159.01 32.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.261 -0.427 . . . . 74.14 110.852 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 1.6 m -141.73 163.97 19.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 74.21 111.097 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -112.89 147.81 36.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 74.01 110.864 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -49.15 -22.36 0.96 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.479 . . . . 73.23 110.854 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 32.2 t -80.99 13.59 2.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 73.31 110.87 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 1.2 t 69.65 40.1 1.43 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.118 -0.492 . . . . 74.42 110.895 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 2.1 mp -97.23 137.79 35.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.131 -0.486 . . . . 74.25 110.956 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.15 117.34 52.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 71.41 111.143 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -139.07 148.47 20.02 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.724 -0.75 . . . . 73.12 112.484 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.425 ' CD1' ' N ' ' A' ' 245' ' ' LEU . 0.0 OUTLIER -146.65 160.86 41.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.849 0.356 . . . . 74.32 110.939 -179.929 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -134.62 147.95 19.33 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.765 -0.731 . . . . 75.45 112.508 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -127.77 116.94 20.98 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.988 0.423 . . . . 74.42 110.911 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 7.5 m -101.78 137.36 40.19 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.08 -0.509 . . . . 71.33 111.079 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -137.25 165.94 24.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 73.52 110.903 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' THR . . . . . 0.447 ' O ' ' CB ' ' A' ' 251' ' ' LEU . 23.5 m 65.88 -104.76 0.1 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.45 . . . . 73.2 111.095 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.447 ' CB ' ' O ' ' A' ' 250' ' ' THR . 0.2 OUTLIER 79.17 -9.17 1.53 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 71.43 110.91 -179.993 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' LYS . . . . . 0.527 ' CB ' ' HD2' ' A' ' 253' ' ' PRO . 4.5 mttm -48.01 171.88 0.08 OUTLIER Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.6 0.714 . . . . 74.02 110.899 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' PRO . . . . . 0.527 ' HD2' ' CB ' ' A' ' 252' ' ' LYS . 54.0 Cg_endo -69.79 58.33 1.56 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.66 2.24 . . . . 64.23 112.34 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' A' ' 283' ' ' ALA . . . -165.87 -62.7 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.7 -0.762 . . . . 35.32 112.485 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -140.95 139.28 34.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.908 0.385 . . . . 70.22 111.141 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . 0.509 ' O ' ' HA ' ' A' ' 279' ' ' LEU . 7.0 tttt -110.16 127.01 54.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 74.33 110.857 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 25.0 tp -88.85 122.78 32.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.175 -0.466 . . . . 72.2 110.889 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 4.8 m -126.54 110.14 12.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 71.13 111.148 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -103.4 134.01 47.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.196 -0.456 . . . . 55.12 110.913 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 24.8 p -128.9 140.64 51.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 63.51 110.892 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -147.24 126.09 12.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.484 . . . . 72.34 111.094 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -131.91 122.96 26.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.458 . . . . 74.42 110.887 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -121.56 109.81 15.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.15 -0.477 . . . . 75.53 110.912 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -87.19 109.41 19.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 74.21 110.916 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -56.24 -20.5 29.04 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.743 -0.741 . . . . 71.04 112.488 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.94 -3.54 48.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.799 0.333 . . . . 74.11 110.924 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -123.73 -57.62 1.62 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 74.45 110.886 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 16.7 m -48.11 -28.24 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 74.34 111.112 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -53.26 -45.77 68.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 61.03 110.929 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -106.14 -16.92 14.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 75.13 111.127 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -108.06 -123.35 4.9 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.719 -0.753 . . . . 62.31 112.474 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -146.47 -163.02 10.15 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.693 -0.765 . . . . 64.44 112.466 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 5.6 p80 -105.35 146.26 29.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.83 0.348 . . . . 75.22 110.884 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 12.4 mtpp -104.28 135.68 45.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.228 -0.442 . . . . 74.14 110.887 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 1.3 tp -137.09 148.18 46.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 72.13 110.944 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -144.37 110.56 0.57 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.726 -0.75 . . . . 71.13 112.493 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -117.06 139.3 50.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.82 0.343 . . . . 62.24 110.956 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . 0.43 ' HA2' ' O ' ' A' ' 28' ' ' LYS . . . -162.13 154.16 25.05 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.696 -0.764 . . . . 73.42 112.48 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . 0.509 ' HA ' ' O ' ' A' ' 256' ' ' LYS . 3.1 mm? -106.88 139.93 40.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.777 0.322 . . . . 73.14 110.865 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -89.1 126.23 35.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 73.41 110.879 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . 0.762 ' HA ' ' HA ' ' A' ' 31' ' ' LEU . 15.1 p90 -74.98 71.18 2.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.145 -0.48 . . . . 72.21 110.884 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 67.5 mm-40 -125.07 102.02 7.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.48 . . . . 73.1 110.904 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . 0.401 ' HA ' ' HA2' ' A' ' 254' ' ' GLY . . . -124.67 136.28 53.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 64.33 111.144 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 4.2 mp 60.83 32.91 20.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 64.32 110.933 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.155 -0.475 . . . . 74.24 110.898 179.962 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.858 0.361 . . . . 74.1 111.023 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.1 p -164.3 133.7 2.95 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.662 0.744 . . . . 70.21 111.107 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.7 167.97 22.81 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.671 2.247 . . . . 73.24 112.383 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 117.97 5.4 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.691 2.261 . . . . 75.43 112.344 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.71 -32.75 14.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.203 -0.453 . . . . 74.22 111.136 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -55.55 -29.82 59.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.246 -0.434 . . . . 72.21 110.953 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -72.95 -22.58 60.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.091 -0.504 . . . . 74.21 111.056 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -87.57 7.51 29.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.205 -0.452 . . . . 75.14 110.858 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 50.0 mt -69.22 -31.39 69.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 75.55 110.885 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -172.45 76.23 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.76 -0.733 . . . . 41.55 112.515 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.4 mmtp -69.25 -55.09 11.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.772 0.32 . . . . 73.13 110.87 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.91 -39.64 93.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.452 . . . . 75.54 110.852 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.91 -37.32 76.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.487 . . . . 73.42 111.098 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -59.76 -31.98 70.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 75.12 110.873 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 -57.47 -48.29 79.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 74.33 110.898 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 61.7 t -81.84 -33.07 11.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.461 . . . . 71.31 111.143 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -64.55 -32.43 74.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 75.43 110.83 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 52.4 m -48.6 114.92 1.07 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 74.24 111.163 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.3 mptt -85.03 -168.72 2.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 72.51 110.895 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 99.03 32.15 5.97 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.711 -0.757 . . . . 64.3 112.483 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -119.03 124.78 47.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.927 0.394 . . . . 75.42 110.926 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 62.56 65.85 2.92 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.81 -0.709 . . . . 74.43 112.472 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -102.43 -4.7 25.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.898 0.38 . . . . 74.3 110.911 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.37 13.6 77.14 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.702 -0.761 . . . . 52.4 112.515 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.2 pp -145.02 -178.35 6.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.737 0.303 . . . . 73.23 110.92 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.4 HG13 ' HB3' ' A' ' 277' ' ' LEU . 1.7 mp -119.6 122.41 68.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 75.32 111.137 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.84 117.04 18.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.135 -0.484 . . . . 62.33 110.886 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.573 ' C ' ' CD2' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -114.78 145.33 42.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.211 -0.449 . . . . 75.11 110.942 179.876 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.547 ' C ' ' HB3' ' A' ' 281' ' ' PHE . 1.3 m-20 -148.06 133.35 18.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.184 -0.462 . . . . 72.4 110.852 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.7 ' HA ' ' HA ' ' A' ' 281' ' ' PHE . 0.2 OUTLIER -127.1 127.79 45.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 73.21 110.87 -179.915 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.587 ' N ' ' HB2' ' A' ' 281' ' ' PHE . 33.5 ttpt -136.56 140.85 43.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 75.12 110.883 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.6 t -135.5 121.66 20.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 72.5 111.166 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.7 pttp -105.13 125.85 51.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.25 -0.432 . . . . 71.51 110.904 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.5 t -114.71 142.79 46.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 72.31 110.827 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -77.17 58.25 1.55 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 74.15 110.89 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -152.86 19.89 0.59 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.143 -0.481 . . . . 73.43 110.88 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.455 ' HA2' ' O ' ' A' ' 63' ' ' ARG . . . 81.01 -4.99 67.68 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.715 -0.755 . . . . 71.14 112.487 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.3 mp -98.42 128.23 44.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.769 0.319 . . . . 74.1 110.902 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -140.97 117.56 10.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 75.12 110.894 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -103.24 122.66 45.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 72.15 110.891 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 90.3 m -126.5 126.31 43.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.137 -0.483 . . . . 63.42 111.142 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.3 p -132.46 142.22 49.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 63.21 110.843 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 58.1 m -149.03 135.84 19.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 71.31 110.874 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -148.02 141.65 9.37 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.702 -0.761 . . . . 65.12 112.44 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 9.0 m -126.91 157.56 39.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.858 0.361 . . . . 71.14 110.887 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -157.11 131.14 8.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.152 -0.476 . . . . 71.42 111.09 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -101.53 141.99 33.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.446 . . . . 73.12 110.893 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 22.2 p -51.03 -34.47 29.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 55.35 111.105 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -51.34 168.24 0.07 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.188 -0.46 . . . . 63.24 110.876 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.2 t -73.05 136.26 44.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 75.23 111.162 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 66.9 p 47.06 71.6 0.31 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.259 -0.428 . . . . 73.14 111.112 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 18.6 mmtp -143.54 35.3 1.3 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.2 -0.455 . . . . 73.35 110.91 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 46.3 t -109.19 124.11 65.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 74.1 111.145 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.6 m -136.11 126.94 27.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 73.14 111.137 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -127.39 141.54 12.73 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.747 -0.74 . . . . 73.01 112.524 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 59.5 p -144.1 160.48 40.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.922 0.392 . . . . 74.14 110.882 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -132.55 150.18 52.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.143 -0.48 . . . . 74.11 110.894 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -136.14 136.18 39.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 74.24 110.9 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.9 p -103.07 129.57 49.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.151 -0.477 . . . . 72.23 111.093 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.1 mtpm? -129.9 159.59 36.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 65.5 110.889 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -130.32 139.65 50.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.217 -0.447 . . . . 74.03 110.929 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.455 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 0.5 OUTLIER -134.51 105.17 6.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.134 -0.484 . . . . 75.44 110.881 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -115.06 101.68 9.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.46 . . . . 72.14 110.952 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.7 t -83.37 -31.76 26.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 64.55 111.149 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -48.47 -34.16 10.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.2 -0.454 . . . . 73.21 110.904 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -118.02 -58.34 2.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.18 -0.464 . . . . 73.14 110.936 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 129.34 58.17 0.1 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.778 -0.725 . . . . 63.15 112.516 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -133.65 141.33 47.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.852 0.358 . . . . 72.02 110.891 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 95.6 m -135.57 130.4 34.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 64.23 111.141 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -119.23 134.82 54.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 73.41 110.875 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -126.73 117.41 22.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.463 . . . . 73.21 111.152 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -132.03 131.47 42.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.27 -0.423 . . . . 73.33 110.875 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.1 ptmt -117.66 135.86 53.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 74.33 110.931 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 12.7 t90 -135.48 128.46 31.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.213 -0.449 . . . . 75.12 110.925 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -120.52 159.52 25.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 70.25 110.872 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 10.5 t -66.79 -13.37 61.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.157 -0.474 . . . . 63.34 111.108 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.443 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 94.9 m-20 -74.92 1.23 13.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.254 -0.43 . . . . 74.52 110.894 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.443 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 2.9 m120 78.72 33.19 0.28 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 75.34 110.91 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 33.3 m -114.89 123.4 49.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.145 -0.48 . . . . 63.24 111.119 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -122.05 119.62 31.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 74.42 110.897 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.76 111.72 3.74 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.731 -0.747 . . . . 70.45 112.473 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.0 t -93.03 120.69 33.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.795 0.331 . . . . 63.14 111.119 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -134.06 126.69 30.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.45 . . . . 73.21 110.871 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.4 138.46 45.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.163 -0.472 . . . . 74.44 111.157 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 99.8 m -129.51 137.72 50.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.202 -0.453 . . . . 72.42 111.126 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.8 t -118.14 137.28 52.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.44 . . . . 72.34 111.149 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -113.71 118.32 33.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 75.34 110.901 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 50.88 74.77 0.21 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.462 . . . . 74.04 110.901 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -96.7 -75.59 0.53 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 74.12 110.885 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 40.9 tp -92.24 -72.37 0.6 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.21 -0.45 . . . . 62.44 110.916 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.53 139.7 39.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 60.13 111.122 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 2.6 ptt180 -60.08 125.09 22.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 74.33 110.868 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 78.73 8.94 87.48 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.756 -0.735 . . . . 52.54 112.502 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 13.8 tp -79.32 134.18 36.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.876 0.37 . . . . 74.14 110.928 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.9 ptmt -121.38 127.51 51.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 75.33 110.905 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -115.03 129.2 56.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.223 -0.444 . . . . 73.33 110.9 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 69.0 m -129.55 119.87 24.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 65.23 111.19 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -122.28 128.71 51.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 65.32 110.858 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -127.84 130.48 48.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.128 -0.487 . . . . 42.24 110.831 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.7 t -142.3 125.93 16.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 75.35 110.88 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.1 t -97.87 131.71 44.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 70.12 110.849 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -129.54 119.69 24.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.106 -0.497 . . . . 74.53 110.878 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -128.83 101.9 19.91 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.661 0.743 . . . . 71.45 110.832 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -37.81 8.58 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.703 2.268 . . . . 74.51 112.334 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -61.57 -75.01 0.07 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 73.53 110.865 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -63.85 -39.0 93.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 51.32 111.153 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.14 24.42 14.79 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.739 -0.744 . . . . 74.55 112.473 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 64.2 mmtt -94.07 148.15 22.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.864 0.364 . . . . 72.2 110.863 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -140.61 135.5 31.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 75.34 110.842 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -121.59 140.84 51.73 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.199 -0.455 . . . . 72.21 110.912 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -127.77 118.02 22.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 72.14 111.077 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 21.3 ttmm -138.45 137.5 37.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 73.35 110.895 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 6.0 tp -134.55 126.73 48.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 73.45 111.154 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -127.45 120.39 28.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 74.43 110.868 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 70.2 p -129.06 127.88 42.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.211 -0.45 . . . . 74.54 111.083 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -150.42 162.39 29.26 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.676 -0.773 . . . . 65.12 112.481 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 6.6 p90 -127.44 141.19 51.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.953 0.406 . . . . 74.34 110.898 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.3 mmmt -110.15 122.71 48.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.075 -0.511 . . . . 75.5 110.908 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.1 mmt85 -106.28 145.29 31.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.273 -0.421 . . . . 73.33 110.865 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -49.67 -28.51 6.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 74.03 110.927 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 7.8 m170 -87.11 -45.33 10.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 73.41 110.853 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 11.8 pt -152.34 153.86 8.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 74.0 111.119 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -117.98 116.61 27.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.468 . . . . 74.51 110.907 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -131.46 141.93 49.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 75.54 110.932 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -147.9 149.01 21.03 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.743 -0.741 . . . . 54.02 112.483 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 31.0 p -112.83 134.72 54.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.827 0.346 . . . . 62.41 110.896 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -117.35 150.8 38.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 73.11 110.857 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 43.2 ttm -135.98 135.98 39.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 74.35 110.851 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -122.53 128.09 50.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 72.43 110.842 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -95.55 97.69 9.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.456 . . . . 75.5 110.888 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -92.05 175.75 6.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 72.33 110.877 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 2.5 pp -73.92 -37.51 47.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.262 -0.426 . . . . 74.14 111.089 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -78.39 -20.43 51.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 74.24 111.081 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 155.22 150.7 5.64 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.778 -0.725 . . . . 73.34 112.483 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 107.92 1.97 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.697 2.265 . . . . 73.32 112.349 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.65 152.79 29.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.247 -0.433 . . . . 70.45 110.909 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 5.0 mp -106.16 132.33 53.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.455 . . . . 74.12 111.14 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 12.3 ttm180 -122.58 133.48 54.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 74.5 110.865 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -127.61 133.3 7.81 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.753 -0.737 . . . . 72.23 112.502 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -140.65 116.07 10.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.824 0.345 . . . . 73.41 111.12 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.2 tp -129.1 133.79 47.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 74.2 110.89 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 61.7 t -128.44 120.97 54.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 70.41 111.146 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.4 mp -114.72 139.94 49.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 74.21 110.925 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -129.51 124.62 4.53 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.772 -0.728 . . . . 62.14 112.533 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -144.93 146.62 32.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.817 0.341 . . . . 72.42 110.922 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 50.29 30.75 4.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.475 . . . . 74.21 110.896 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 85.9 -28.71 4.89 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.727 -0.749 . . . . 61.23 112.522 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 29.9 m0 -69.31 134.83 49.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.833 0.349 . . . . 64.33 110.938 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -108.5 137.81 45.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.256 -0.429 . . . . 64.33 110.892 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -135.96 126.12 26.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 74.44 111.073 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -132.15 146.34 18.01 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.743 -0.742 . . . . 44.04 112.477 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -143.49 119.26 10.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.783 0.325 . . . . 74.41 110.914 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -122.53 120.67 34.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 74.31 110.886 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 4.0 ptt? -148.13 143.52 27.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.251 -0.431 . . . . 71.42 110.882 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -113.64 131.54 56.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 74.44 110.87 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.49 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 9.8 m-85 -93.28 138.89 31.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 74.05 110.858 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.512 ' O ' ' CG ' ' A' ' 158' ' ' GLU . 5.2 pt-20 -76.4 117.32 17.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.105 -0.498 . . . . 74.42 110.876 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 9.8 t -67.23 -31.69 72.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.141 -0.482 . . . . 72.24 111.135 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -47.9 -23.92 0.89 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.215 -0.448 . . . . 64.42 111.129 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.99 -157.65 0.36 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.449 . . . . 74.31 110.9 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 54.1 m -99.51 40.82 1.19 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 74.43 110.858 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.45 173.42 7.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 75.2 110.923 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.49 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 2.5 t -105.82 141.04 22.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.444 . . . . 74.31 111.117 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -88.7 -37.26 15.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.131 -0.486 . . . . 62.31 111.149 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -155.8 131.87 10.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 74.45 110.882 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 2.2 p -127.05 109.63 12.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 71.25 110.878 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -130.87 142.33 50.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 73.02 110.88 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -132.39 156.57 46.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.194 -0.457 . . . . 74.43 110.861 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -154.89 129.89 9.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.117 -0.492 . . . . 75.4 111.081 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 41.2 t -126.86 134.12 66.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 74.45 111.136 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -107.93 124.07 7.38 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.741 -0.743 . . . . 75.5 112.464 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -113.97 122.36 46.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.978 0.418 . . . . 73.31 110.869 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -102.89 133.53 47.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.08 -0.509 . . . . 73.44 110.915 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.59 165.22 21.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 71.43 111.13 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -40.27 -75.38 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 63.21 110.898 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -116.66 14.91 15.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.214 -0.448 . . . . 74.33 110.889 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -126.16 149.55 48.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.131 -0.486 . . . . 74.45 110.863 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -133.26 124.44 27.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.115 -0.493 . . . . 73.34 110.922 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -123.55 126.09 46.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 74.34 110.907 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 22.1 m80 -130.59 114.86 15.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.446 . . . . 72.35 110.875 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 2.1 t -106.51 151.05 25.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.269 -0.423 . . . . 72.52 111.167 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -162.38 136.95 6.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 72.41 110.879 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 2.3 t -123.68 127.79 74.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.483 . . . . 72.4 111.129 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -120.69 83.03 2.0 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 75.4 110.887 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -48.25 -20.13 0.35 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 75.13 110.868 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -74.89 -33.08 56.04 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.793 -0.718 . . . . 71.31 112.49 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 69.0 p -123.48 -55.37 1.74 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.718 0.294 . . . . 73.2 111.135 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -165.87 152.98 10.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 72.41 110.901 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -114.45 125.16 53.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 74.33 110.884 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -175.72 -132.36 1.59 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.745 -0.741 . . . . 74.42 112.489 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -176.4 -165.92 32.81 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.77 -0.729 . . . . 73.32 112.491 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -149.33 150.33 32.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.803 0.335 . . . . 64.14 110.9 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 4.2 mp -120.62 143.02 33.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 74.53 111.158 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -127.74 121.3 29.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.178 -0.465 . . . . 73.23 110.942 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 6.1 tm0? -124.57 130.43 52.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 75.11 110.963 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 20.5 tttt -107.12 127.77 53.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 73.53 110.876 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 98.5 t -74.34 -74.62 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 73.35 111.083 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -170.82 65.32 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 75.53 110.909 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? 48.29 33.47 3.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.143 -0.481 . . . . 74.25 110.915 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 6.2 ttmm -140.98 -43.74 0.38 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 74.31 110.881 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 6.1 mp -131.05 128.47 40.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.237 -0.438 . . . . 75.05 110.902 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -114.88 131.2 56.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 74.24 110.908 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 21.7 m -124.06 138.58 54.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.186 -0.461 . . . . 74.4 111.145 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -141.5 137.93 32.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.434 . . . . 71.1 111.139 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 30.3 t -112.93 140.69 31.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 74.2 111.079 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -114.95 134.22 55.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.475 . . . . 74.41 110.881 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -134.16 130.71 37.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 74.54 110.925 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -156.42 132.11 9.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 53.22 111.083 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 3.8 t-105 -110.66 135.01 51.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.208 -0.451 . . . . 71.44 110.964 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 3.3 t -93.39 111.36 23.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.253 -0.43 . . . . 73.34 111.092 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -51.11 136.81 23.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 65.53 111.076 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 117.36 -83.98 0.36 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.765 -0.731 . . . . 71.12 112.541 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -79.37 179.11 7.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.854 0.359 . . . . 65.23 110.864 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 9.7 p -103.36 36.43 2.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 72.12 110.867 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 35.0 m120 -102.09 125.2 48.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 74.4 110.874 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -105.34 137.6 42.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 63.03 111.141 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 -97.62 117.66 32.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.258 -0.428 . . . . 73.15 110.837 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -128.34 132.11 48.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 74.34 110.874 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -145.2 160.99 28.15 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.735 -0.745 . . . . 73.15 112.474 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.89 130.51 35.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.807 0.337 . . . . 74.52 111.104 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -126.84 130.83 50.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 75.42 111.114 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -119.2 130.81 55.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.257 -0.429 . . . . 74.41 111.104 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -106.76 128.47 54.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.436 . . . . 73.52 110.872 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -127.07 117.67 22.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 74.53 110.934 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -84.7 123.91 30.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 71.22 110.942 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 64.6 mt -108.9 -33.56 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.446 . . . . 72.33 111.157 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -143.42 161.22 48.37 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.583 0.706 . . . . 75.44 110.918 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -19.32 36.22 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.738 2.292 . . . . 73.25 112.31 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -109.78 -27.06 9.51 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.224 -0.443 . . . . 74.41 110.893 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -124.6 141.95 51.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.469 . . . . 63.04 111.124 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 57.6 m -139.31 142.58 37.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.196 -0.456 . . . . 74.54 110.862 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -98.79 133.11 43.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.175 -0.466 . . . . 73.53 110.89 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 24.6 p -135.09 128.31 31.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 74.35 110.843 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -128.98 158.45 38.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 54.2 111.093 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.52 164.27 36.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 73.33 110.913 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 10.0 p -154.86 143.19 13.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 74.13 111.148 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -102.52 148.47 25.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 75.43 110.869 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' ASN . . . . . 0.408 ' C ' ' H ' ' A' ' 241' ' ' SER . 14.1 t30 -54.09 -21.68 9.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 74.41 110.901 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 46.4 t -80.84 25.76 0.44 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.45 . . . . 64.34 110.843 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' SER . . . . . 0.408 ' H ' ' C ' ' A' ' 239' ' ' ASN . 1.9 m 59.2 39.29 22.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 74.21 110.926 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 22.6 mt -99.4 118.11 35.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.093 -0.503 . . . . 72.4 110.915 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 5.4 mp -84.62 125.92 40.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.172 -0.467 . . . . 75.43 111.102 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -128.21 132.81 7.49 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.771 -0.728 . . . . 73.21 112.496 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 1.3 pp -146.14 140.88 26.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.882 0.372 . . . . 61.43 110.902 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -153.13 150.32 22.05 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.677 -0.773 . . . . 71.21 112.445 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -128.39 132.19 48.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.943 0.401 . . . . 75.21 110.947 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.02 123.94 50.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 60.44 111.131 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -143.09 129.59 20.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 75.34 110.873 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 3.1 m -80.62 142.31 34.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.222 -0.444 . . . . 74.22 111.174 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 7.6 tp -72.84 -70.74 0.34 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 74.33 110.888 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' LYS . . . . . 0.491 ' N ' ' HD2' ' A' ' 253' ' ' PRO . 16.9 ttpt 178.35 -59.45 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.6 0.714 . . . . 71.4 110.926 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' PRO . . . . . 0.491 ' HD2' ' N ' ' A' ' 252' ' ' LYS . 54.0 Cg_endo -69.74 -86.64 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.705 2.27 . . . . 64.21 112.342 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . 0.407 ' H ' ' HG2' ' A' ' 253' ' ' PRO . . . -145.72 16.58 1.8 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.734 -0.746 . . . . 74.33 112.484 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 3.7 mt -105.32 118.07 52.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.882 0.372 . . . . 75.53 111.094 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . 0.54 ' O ' ' HA ' ' A' ' 279' ' ' LEU . 0.0 OUTLIER -99.09 135.06 41.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 75.11 110.88 179.856 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.08 124.02 37.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.464 . . . . 75.43 110.887 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 27.5 p -128.15 111.68 13.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.448 . . . . 75.21 111.121 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.9 126.24 53.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.242 -0.435 . . . . 73.43 110.928 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 4.1 m -126.49 140.86 52.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 74.25 110.839 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -144.21 128.52 17.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.121 -0.491 . . . . 70.02 111.116 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -121.66 120.77 35.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.446 . . . . 72.12 110.913 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.95 109.77 15.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.446 . . . . 73.31 110.887 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -90.95 115.78 28.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.454 . . . . 74.1 110.853 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -55.45 -18.38 15.04 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.704 -0.76 . . . . 54.23 112.5 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 6.4 ttpp -79.09 -25.99 43.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.836 0.35 . . . . 74.52 110.942 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -109.59 -54.46 2.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 72.13 110.916 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 13.8 m -51.04 -29.03 7.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.48 . . . . 71.32 111.109 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -52.43 -35.12 51.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 73.34 110.901 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -103.67 -17.44 15.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.123 -0.489 . . . . 71.23 111.074 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 125.7 98.58 1.14 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.721 -0.752 . . . . 43.24 112.498 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 168.2 93.13 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.716 -0.754 . . . . 71.52 112.465 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -113.43 144.5 42.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.877 0.37 . . . . 74.41 110.859 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 43.5 mmtm -101.12 136.85 40.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 74.12 110.874 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -135.85 137.71 41.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.476 . . . . 73.52 110.89 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -139.56 136.37 7.81 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.721 -0.752 . . . . 73.22 112.464 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.4 ' HB3' HG13 ' A' ' 27' ' ' ILE . 3.1 tm? -132.52 138.2 47.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.898 0.38 . . . . 74.33 110.9 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -160.67 161.01 32.41 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.761 -0.733 . . . . 75.04 112.455 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . 0.54 ' HA ' ' O ' ' A' ' 256' ' ' LYS . 2.9 mm? -113.93 143.37 44.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.815 0.34 . . . . 75.13 110.937 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -91.37 130.1 37.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 75.3 110.87 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . 0.7 ' HA ' ' HA ' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -76.33 60.26 1.52 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 72.45 110.89 -179.941 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -109.38 97.74 7.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.133 -0.485 . . . . 72.25 110.875 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -128.65 110.93 12.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.212 -0.449 . . . . 65.53 111.117 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 94.6 mt -152.15 178.38 9.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 71.21 110.923 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 42.2 tp10 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 71.15 110.864 179.941 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.097 0 CA-C-O 120.845 0.355 . . . . 61.52 111.07 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.87 158.46 74.93 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.633 0.73 . . . . 75.51 111.124 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.85 170.25 17.11 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.688 2.259 . . . . 74.12 112.321 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 77.74 1.06 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.643 2.229 . . . . 74.33 112.36 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.6 p -70.37 -45.75 65.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 74.44 111.132 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 91.2 t80 -52.46 -32.38 39.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 75.05 110.901 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -82.18 -26.53 33.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 72.35 111.116 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -74.21 -12.86 60.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 73.04 110.843 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.42 -34.42 66.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 73.21 110.896 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 142.45 64.77 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.762 -0.732 . . . . 63.55 112.529 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.6 ttpp -69.35 -42.12 75.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.801 0.334 . . . . 74.24 110.873 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.6 t -63.65 -39.35 94.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.207 -0.451 . . . . 71.43 110.901 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.8 -37.93 74.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.074 -0.512 . . . . 74.11 111.112 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 3.1 tmt_? -60.77 -33.12 72.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.444 . . . . 74.41 110.858 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -58.46 -40.0 81.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.45 . . . . 70.45 110.834 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.6 t -58.91 -39.42 77.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 73.32 111.113 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -60.54 -41.07 93.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.481 . . . . 52.04 110.866 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.1 p 46.75 69.2 0.51 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 73.22 111.191 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 16.0 tptm -69.24 112.48 5.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 75.35 110.921 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 63.5 99.44 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.737 -0.744 . . . . 62.35 112.476 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -172.9 129.36 0.49 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.945 0.402 . . . . 74.15 110.908 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.52 40.84 3.09 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.784 -0.722 . . . . 73.12 112.501 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -103.18 13.01 34.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.911 0.386 . . . . 73.41 110.892 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 80.79 15.44 77.66 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.773 -0.727 . . . . 65.04 112.46 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.89 168.74 8.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.799 0.333 . . . . 72.11 110.917 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 2.8 mm -120.2 123.42 70.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.234 -0.439 . . . . 72.43 111.089 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.6 ttmt -115.2 118.15 32.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.465 . . . . 75.23 110.921 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -114.68 142.99 45.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 72.11 110.915 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -147.82 128.62 14.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 71.21 110.851 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.7 tp -127.2 128.78 46.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 74.44 110.908 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.0 pttm -124.83 125.48 44.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 73.2 110.887 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.6 p -135.2 120.8 19.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.199 -0.455 . . . . 72.04 111.158 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 53.1 mttm -118.75 129.99 55.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 74.25 110.91 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.2 t -116.14 138.29 51.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 75.23 110.87 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -77.41 59.25 1.83 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.157 -0.474 . . . . 74.02 110.889 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -160.51 25.27 0.15 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 73.35 110.805 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.51 ' HA2' ' O ' ' A' ' 63' ' ' ARG . . . 79.7 -4.11 66.31 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.737 -0.744 . . . . 62.35 112.526 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.5 mp -98.23 126.11 43.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.782 0.325 . . . . 74.52 110.897 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.4 ' HB3' ' HB3' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -142.1 118.39 10.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.172 -0.467 . . . . 73.21 110.861 179.962 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -103.71 124.15 48.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.152 -0.476 . . . . 73.42 110.883 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.11 115.5 19.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 73.54 111.124 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.42 138.12 53.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 63.35 110.863 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 27.0 m -150.6 126.96 10.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 71.34 110.905 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -164.53 166.43 37.89 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.726 -0.749 . . . . 62.12 112.489 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 60.3 m -138.03 168.62 19.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.877 0.37 . . . . 73.51 110.878 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -134.13 139.52 45.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.126 -0.488 . . . . 74.41 111.096 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -113.41 141.43 47.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 74.22 110.919 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 64.07 169.53 0.17 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 64.15 111.109 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.28 94.52 2.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.462 . . . . 72.44 110.863 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 61.5 p 45.98 84.01 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.127 -0.488 . . . . 75.43 111.134 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.7 m -151.5 -59.66 0.17 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.237 -0.438 . . . . 73.44 111.196 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 18.0 mmtp -142.33 113.69 7.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 75.21 110.897 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -125.55 147.54 30.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 75.33 111.142 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.2 p -110.32 126.57 54.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 72.23 111.13 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -118.76 143.63 17.55 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.72 -0.753 . . . . 60.53 112.503 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.85 142.51 50.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.968 0.413 . . . . 61.44 110.851 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -120.86 132.85 55.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 73.13 110.948 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -134.0 124.65 26.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 71.51 110.889 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 27.0 m -104.77 130.35 52.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 72.32 111.146 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.4 ' HB3' ' HB3' ' A' ' 40' ' ' GLU . 8.5 ttpt -132.48 156.93 45.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.239 -0.437 . . . . 71.13 110.919 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.433 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 26.0 m-85 -129.06 140.68 51.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.282 -0.417 . . . . 73.53 110.939 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.51 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 27.9 ttp85 -127.99 105.37 8.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 73.53 110.894 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 5.6 m-90 -113.19 134.33 54.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 63.11 110.935 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 30.3 p -69.82 -27.17 64.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.275 -0.42 . . . . 75.21 111.122 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -52.51 102.53 0.05 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.211 -0.45 . . . . 75.43 110.889 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 7.3 t80 65.33 9.77 5.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.149 -0.478 . . . . 75.03 110.902 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 57.33 70.27 1.03 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.77 -0.729 . . . . 74.1 112.491 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.451 HD23 ' HA ' ' A' ' 87' ' ' VAL . 5.7 mt -119.15 137.21 53.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.859 0.361 . . . . 65.3 110.9 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 27.7 m -136.24 127.84 28.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 72.51 111.163 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -121.79 121.62 37.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 71.45 110.86 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 14.4 t -119.87 136.22 54.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 70.11 111.133 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -131.06 122.82 27.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 70.22 110.88 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.9 ptmt -95.51 135.99 36.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 75.3 110.91 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 8.7 t90 -134.81 128.84 33.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.246 -0.434 . . . . 74.2 110.926 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -117.85 154.93 31.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 65.43 110.878 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 7.3 t -62.48 -16.47 55.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.127 -0.488 . . . . 74.31 111.142 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.423 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 2.4 m-20 -74.61 0.78 13.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.258 -0.428 . . . . 70.43 110.89 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.423 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 3.7 m120 78.53 37.19 0.18 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.465 . . . . 73.34 110.877 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.6 p -113.58 121.54 44.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 74.32 111.144 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -111.23 132.96 53.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 70.13 110.966 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -123.61 92.84 0.46 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.803 -0.713 . . . . 73.32 112.517 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -79.34 106.1 11.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.821 0.343 . . . . 74.42 111.13 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -124.47 107.37 11.01 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.211 -0.449 . . . . 71.41 110.86 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.4 pp -111.51 130.84 64.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 74.13 111.13 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 88.5 m -122.2 123.16 40.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 60.12 111.161 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.451 ' HA ' HD23 ' A' ' 69' ' ' LEU . 1.6 m -115.17 139.79 39.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.223 -0.444 . . . . 75.42 111.145 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -90.55 128.32 36.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 70.24 110.85 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.64 179.17 1.43 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.173 -0.467 . . . . 73.41 110.863 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -126.76 -65.9 0.93 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 75.53 110.883 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 20.1 tp -50.55 -75.47 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 75.25 110.931 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -73.26 76.35 1.32 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 73.31 111.091 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 7.7 tpp85 -48.78 133.69 17.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.435 . . . . 74.11 110.851 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 100.97 8.38 48.13 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.727 -0.749 . . . . 74.34 112.524 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.4 tp -112.68 124.67 53.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.861 0.362 . . . . 74.34 110.956 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 13.5 ttmt -124.62 125.05 43.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 72.05 110.929 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.64 127.13 48.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.222 -0.444 . . . . 73.13 110.939 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.4 p -127.89 119.91 26.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 64.42 111.158 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.1 119.96 41.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.44 . . . . 71.25 110.917 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -109.9 142.12 41.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.474 . . . . 73.33 110.846 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.1 m -143.14 127.78 18.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 74.21 110.86 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -95.36 125.74 40.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 74.32 110.865 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -129.17 126.86 40.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 75.11 110.895 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.409 ' HA ' ' HD2' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -128.82 102.4 19.6 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.7 0.762 . . . . 73.0 110.827 -179.758 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 104' ' ' SER . 53.6 Cg_endo -69.76 -32.63 18.2 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.709 2.273 . . . . 71.33 112.349 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -70.12 -72.58 0.19 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.186 -0.461 . . . . 73.13 110.891 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.5 p -64.26 -40.09 95.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.129 -0.487 . . . . 73.35 111.131 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.52 24.45 13.92 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.726 -0.749 . . . . 75.11 112.495 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.11 148.09 22.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.82 0.343 . . . . 72.34 110.874 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -142.06 131.63 23.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 75.45 110.866 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -130.08 152.56 49.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.245 -0.434 . . . . 62.33 110.923 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -130.24 125.26 34.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 71.45 111.132 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.03 137.99 36.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 73.44 110.861 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -125.84 138.35 54.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 74.22 111.149 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 128' ' ' ASP . 14.9 mtmt -130.17 130.11 44.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 75.43 110.925 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.2 p -119.22 119.2 33.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.446 . . . . 73.14 111.155 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -107.64 125.33 7.92 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.689 -0.767 . . . . 72.51 112.471 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -131.09 115.52 16.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.941 0.401 . . . . 63.54 110.886 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 13.7 mtpp -106.58 125.34 50.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.147 -0.479 . . . . 72.33 110.93 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 13.9 ttt85 -104.95 144.96 31.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.281 -0.418 . . . . 74.33 110.867 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -50.41 -26.57 5.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 71.24 110.9 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 33.9 m170 -86.98 -45.51 10.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 75.12 110.886 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 49.4 pt -151.38 156.6 6.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 64.31 111.143 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -104.21 129.7 51.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 62.02 110.897 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -127.77 143.42 51.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 74.01 110.924 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -146.51 117.18 0.92 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.762 -0.732 . . . . 74.15 112.547 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 36.8 t -113.89 132.09 56.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.847 0.356 . . . . 72.2 110.85 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.415 ' HA ' ' HA ' ' A' ' 115' ' ' LYS . 0.2 OUTLIER -128.38 117.32 21.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 73.54 110.821 -179.963 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 19.4 mtm -103.97 136.25 43.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 72.34 110.92 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -128.41 120.25 26.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 73.31 110.834 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -94.74 119.9 34.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 75.3 110.886 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -128.71 131.83 47.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.164 -0.471 . . . . 73.51 110.827 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -55.9 -29.86 27.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 73.3 111.125 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -80.01 -20.26 45.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 70.22 111.07 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 157.61 100.26 0.17 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.754 -0.736 . . . . 72.54 112.465 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.76 129.48 17.68 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.679 2.253 . . . . 72.41 112.399 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 12.5 t -129.08 161.79 29.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 74.32 110.887 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 1.7 mp -120.72 117.12 52.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.111 -0.495 . . . . 72.41 111.14 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 15.2 mtm180 -121.81 125.29 46.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 72.34 110.883 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -147.16 152.18 24.36 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.72 -0.753 . . . . 75.33 112.519 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -120.72 139.55 52.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.855 0.359 . . . . 72.14 111.099 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -141.33 143.41 34.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 74.13 110.939 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.439 ' HA ' ' HA3' ' A' ' 152' ' ' GLY . 1.0 OUTLIER -133.58 143.74 37.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 72.12 111.153 179.817 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -125.99 138.31 53.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.172 -0.467 . . . . 75.3 110.925 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -113.29 119.32 4.8 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.764 -0.732 . . . . 64.11 112.499 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -144.84 148.27 33.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.862 0.363 . . . . 74.24 110.89 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 50.06 26.36 2.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.139 -0.482 . . . . 75.43 110.897 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 88.78 -31.82 4.8 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.749 -0.739 . . . . 55.32 112.523 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 52.9 p-90 -80.72 146.21 31.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.814 0.34 . . . . 73.04 110.936 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 2.7 mt -114.5 145.52 41.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.451 . . . . 72.43 110.93 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.445 ' HA ' ' HA ' ' A' ' 171' ' ' VAL . . . -141.74 113.9 8.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 75.13 111.099 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.439 ' HA3' ' HA ' ' A' ' 143' ' ' VAL . . . -166.04 162.57 36.08 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.722 -0.751 . . . . 63.34 112.444 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.771 ' HB3' ' O ' ' A' ' 168' ' ' ASN . 0.0 OUTLIER -174.68 -168.45 0.36 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.858 0.361 . . . . 73.51 110.925 -179.862 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -99.99 146.21 26.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.072 -0.513 . . . . 71.44 110.867 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 3.1 ppp? -145.21 127.54 15.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 73.22 110.9 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -111.46 119.95 40.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 74.22 110.843 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -108.51 138.99 43.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 75.11 110.867 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -77.65 98.38 5.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 75.11 110.918 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 7.2 t -66.24 -40.84 90.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 52.24 111.149 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -48.67 -25.1 1.61 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 65.32 111.108 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 35.4 mmtm -141.47 -159.89 1.02 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 75.41 110.88 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 17.1 m -109.59 40.06 1.96 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 62.3 110.879 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -131.27 171.58 13.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.134 -0.485 . . . . 72.42 110.889 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -106.91 141.05 23.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 54.53 111.125 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 62.6 m -90.29 -35.26 15.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 72.42 111.153 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -154.92 137.64 15.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 73.41 110.917 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 2.8 t -128.2 102.14 6.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 74.14 110.85 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.771 ' O ' ' HB3' ' A' ' 153' ' ' TYR . 0.1 OUTLIER -116.27 122.65 45.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 71.24 110.92 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.536 ' HA ' ' HB2' ' A' ' 153' ' ' TYR . 42.3 m-85 -133.96 138.6 45.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 62.11 110.887 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.424 ' H ' ' HB2' ' A' ' 153' ' ' TYR . . . -151.3 152.04 32.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 73.33 111.118 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' A' ' 151' ' ' ALA . 0.9 OUTLIER -140.9 148.3 21.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.22 -0.446 . . . . 62.34 111.088 179.988 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -121.99 129.16 7.51 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.725 -0.75 . . . . 54.11 112.513 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -113.67 131.45 56.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.912 0.386 . . . . 74.0 110.954 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 20.9 mmtp -102.67 128.2 49.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.105 -0.498 . . . . 75.11 110.882 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.456 ' O ' ' C ' ' A' ' 176' ' ' ASP . 0.2 OUTLIER -119.64 167.05 12.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.451 . . . . 73.32 111.153 179.979 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.456 ' C ' ' O ' ' A' ' 175' ' ' THR . 0.8 OUTLIER -34.13 -77.74 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 74.22 110.87 179.937 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -117.64 14.66 14.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 75.1 110.907 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -128.14 147.49 50.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 65.12 110.897 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -136.32 126.64 26.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 73.33 110.902 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -124.29 137.28 54.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 71.4 110.894 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 5.8 t-80 -130.98 113.45 14.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 74.03 110.859 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -96.16 146.97 24.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 74.51 111.154 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -159.52 140.7 12.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.248 -0.433 . . . . 72.44 110.898 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.519 ' HB ' ' HA ' ' A' ' 190' ' ' PHE . 1.4 m -135.07 135.71 52.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.125 -0.489 . . . . 73.14 111.104 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -100.52 88.3 3.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 74.32 110.916 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 73.58 176.57 0.25 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.196 -0.456 . . . . 73.41 110.862 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -72.44 1.67 34.35 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.743 -0.741 . . . . 64.23 112.463 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 33.3 p -105.12 -24.34 12.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.715 0.293 . . . . 63.35 111.103 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -119.16 120.08 36.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.24 -0.436 . . . . 75.34 110.9 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' PHE . . . . . 0.519 ' HA ' ' HB ' ' A' ' 184' ' ' VAL . 0.5 OUTLIER -140.13 124.57 17.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.456 . . . . 75.31 110.947 -179.954 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -171.39 -150.33 7.04 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.72 -0.752 . . . . 53.45 112.463 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 172.37 -166.68 39.49 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.751 -0.737 . . . . 52.5 112.519 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 1.4 t -148.84 151.8 35.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.849 0.357 . . . . 72.23 110.857 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.433 HG12 HG21 ' A' ' 206' ' ' VAL . 0.0 OUTLIER -136.76 135.02 48.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 74.22 111.159 179.934 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -131.75 137.12 48.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 65.31 110.929 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 46.4 tp60 -124.35 131.9 53.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.123 -0.49 . . . . 75.24 110.963 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 11.2 ttpt -81.92 126.22 31.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 73.23 110.921 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 18.1 t -91.15 139.95 16.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 65.45 111.151 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -81.86 59.7 4.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 74.45 110.883 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 22.1 ttmt -165.9 39.87 0.06 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.198 -0.455 . . . . 72.41 110.889 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 4.8 mptt 57.32 44.06 22.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 75.0 110.87 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 58.7 tp -152.92 145.98 24.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.249 -0.432 . . . . 75.31 110.906 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -127.32 149.24 50.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 75.41 110.911 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 71.2 p -123.29 138.24 54.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 74.25 111.115 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -145.81 135.73 23.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.214 -0.448 . . . . 74.44 111.134 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.433 HG21 HG12 ' A' ' 194' ' ' ILE . 0.9 OUTLIER -132.16 144.02 38.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 73.34 111.119 179.993 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -130.92 127.32 38.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.474 . . . . 72.1 110.852 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -143.24 150.23 39.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.125 -0.489 . . . . 75.13 110.929 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -138.63 149.56 45.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 73.44 111.099 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 3.9 t-105 -120.63 135.19 55.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.447 . . . . 71.42 110.918 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 3.1 m -95.68 104.32 16.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 73.11 111.16 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -53.05 150.16 5.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 74.05 111.123 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 97.01 -34.16 5.26 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.729 -0.748 . . . . 63.31 112.498 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -122.58 -171.14 2.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.803 0.335 . . . . 75.35 110.919 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 22.7 t -119.03 38.06 3.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 74.15 110.857 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -101.96 111.88 24.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 72.42 110.917 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 14.6 t -115.18 138.18 51.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 74.44 111.173 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 63.3 mmt-85 -128.46 127.64 42.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 73.11 110.84 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -134.44 158.0 45.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.452 . . . . 74.4 110.861 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -147.44 147.46 18.23 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.718 -0.754 . . . . 75.14 112.516 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 3.8 mp -118.32 133.24 65.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.836 0.35 . . . . 73.41 111.12 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -131.77 143.73 50.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.462 . . . . 65.44 111.102 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -112.45 134.48 53.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.454 . . . . 61.05 111.071 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 1.1 ttpp -109.37 114.84 28.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 73.24 110.895 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 36.9 t80 -131.21 117.61 19.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.276 -0.42 . . . . 74.31 110.908 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -111.7 109.07 18.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.128 -0.487 . . . . 75.4 110.927 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 2.3 tt -80.93 -32.34 12.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 75.42 111.11 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -150.54 160.25 33.11 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.626 0.727 . . . . 72.41 110.882 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -7.61 21.48 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.671 2.248 . . . . 74.14 112.314 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -106.78 -29.52 9.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.247 -0.433 . . . . 75.03 110.9 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -124.54 133.56 53.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 72.32 111.09 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 42.1 m -134.81 141.76 46.5 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.235 -0.439 . . . . 74.44 110.849 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -127.13 133.48 50.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.474 . . . . 72.35 110.895 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 11.8 p -142.73 139.68 31.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.102 -0.499 . . . . 72.45 110.855 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -111.09 161.01 16.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.117 -0.492 . . . . 73.12 111.089 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 6.7 ptpp? -151.71 142.03 22.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 72.45 110.877 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 1.1 p -139.7 143.99 29.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 74.13 111.154 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -112.86 147.98 35.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.465 . . . . 73.32 110.927 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 40.1 t30 -59.43 -16.35 22.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 73.2 110.89 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 3.5 m -81.96 25.44 0.57 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 63.22 110.829 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 65.41 32.34 9.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.107 -0.497 . . . . 72.13 110.871 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 5.1 mp -100.28 118.07 35.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.122 -0.49 . . . . 73.51 110.923 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -118.1 116.79 52.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.223 -0.444 . . . . 74.44 111.115 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -147.88 163.39 28.84 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.723 -0.751 . . . . 74.41 112.452 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.418 ' CD1' ' N ' ' A' ' 245' ' ' LEU . 0.0 OUTLIER -146.5 160.43 42.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.88 0.371 . . . . 73.54 110.949 -179.972 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -141.41 137.84 8.35 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.715 -0.755 . . . . 74.24 112.507 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -129.38 131.06 46.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.919 0.39 . . . . 72.44 110.942 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 1.8 t -118.68 118.79 32.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.121 -0.49 . . . . 73.54 111.178 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -115.21 122.45 46.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.247 -0.433 . . . . 74.2 110.927 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 7.6 m -95.73 122.88 38.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 75.51 111.13 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 17.9 tp -98.84 92.57 5.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.179 -0.464 . . . . 72.54 110.919 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 3.7 mtpp 63.75 161.41 0.12 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.563 0.697 . . . . 74.3 110.894 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 76.76 1.11 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.687 2.258 . . . . 73.44 112.337 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 178.32 -48.61 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.8 -0.715 . . . . 73.25 112.527 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.72 135.42 62.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.925 0.393 . . . . 74.34 111.133 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -133.37 133.14 42.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.125 -0.488 . . . . 73.31 110.853 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.13 133.9 51.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 74.24 110.895 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 30.9 p -132.62 122.04 24.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 74.53 111.16 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.96 150.1 41.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 73.31 110.911 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 1.5 m -142.64 140.5 31.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 73.12 110.815 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -141.66 129.2 21.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 72.1 111.094 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 1.3 tt -131.18 137.63 49.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 74.42 110.946 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.9 108.59 14.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.173 -0.467 . . . . 72.52 110.918 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . 0.403 ' HB2' ' HB2' ' A' ' 267' ' ' ASN . 0.5 OUTLIER -84.66 108.95 17.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 63.31 110.904 179.823 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -53.94 -18.85 9.37 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.788 -0.72 . . . . 75.24 112.48 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -91.05 -26.1 19.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.823 0.344 . . . . 74.31 110.876 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . 0.403 ' HB2' ' HB2' ' A' ' 264' ' ' ASP . 3.5 m120 -100.1 -56.62 2.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 72.23 110.888 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 12.9 m -49.87 -27.36 3.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 73.42 111.117 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -53.74 -45.69 70.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 71.15 110.863 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -105.69 -17.16 14.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.473 . . . . 73.22 111.109 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -111.01 -120.18 4.01 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.778 -0.725 . . . . 75.15 112.501 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -150.39 -164.82 12.15 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.821 -0.704 . . . . 54.42 112.499 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -89.62 145.93 24.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.851 0.358 . . . . 75.22 110.866 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 24.0 mttp -97.15 135.85 38.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 75.14 110.916 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -134.94 138.93 44.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.256 -0.429 . . . . 75.25 110.913 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -132.75 140.04 11.47 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.752 -0.737 . . . . 73.11 112.523 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -113.94 136.7 52.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.792 0.329 . . . . 74.43 110.955 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -141.94 127.86 3.4 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.771 -0.728 . . . . 74.44 112.495 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -108.35 131.66 54.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.794 0.33 . . . . 72.31 110.882 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -123.36 112.03 17.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 74.0 110.928 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -112.87 133.34 54.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 73.53 110.906 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -135.34 130.5 35.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 71.24 110.91 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -99.16 135.78 40.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 74.42 111.106 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 41.7 37.14 0.68 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.253 -0.43 . . . . 72.53 110.91 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.47 . . . . 72.24 110.859 179.938 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.798 0.332 . . . . 65.11 111.089 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 60.2 t -114.42 78.75 4.92 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.642 0.734 . . . . 73.11 111.122 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 166.01 29.07 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.688 2.259 . . . . 74.52 112.316 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 101.66 0.94 Allowed 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.702 2.268 . . . . 72.43 112.296 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.7 -46.36 9.07 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.218 -0.446 . . . . 75.44 111.178 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -54.39 -33.84 60.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 72.33 110.906 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -82.98 -19.16 37.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 74.12 111.129 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -88.85 10.09 22.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 63.23 110.903 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 89.5 mt -67.19 -34.25 77.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 64.43 110.911 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -139.57 68.45 0.49 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.738 -0.744 . . . . 72.25 112.484 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 12.4 mttp -64.64 -53.9 40.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.843 0.354 . . . . 72.44 110.942 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.9 t -58.77 -48.75 80.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 75.44 110.854 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.58 -37.82 88.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.113 -0.494 . . . . 73.42 111.065 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 16.2 ttm-85 -60.42 -34.32 73.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.26 -0.427 . . . . 74.22 110.881 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.08 -39.07 93.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.198 -0.455 . . . . 74.24 110.87 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.6 t -82.2 -33.33 11.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.256 -0.429 . . . . 64.11 111.128 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -72.18 -42.05 66.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 73.13 110.88 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 12.3 t -68.49 -32.0 71.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 75.15 111.112 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -73.89 127.79 33.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 75.21 110.904 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -50.73 136.37 28.44 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.803 -0.713 . . . . 71.24 112.477 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -125.93 33.24 5.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.87 0.367 . . . . 73.32 110.897 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 73.87 88.63 0.19 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.714 -0.755 . . . . 74.12 112.524 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -94.24 -4.36 49.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.93 0.395 . . . . 72.42 110.897 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.58 13.36 80.26 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.754 -0.736 . . . . 54.41 112.49 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.5 pp -150.33 -178.9 6.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.814 0.34 . . . . 75.14 110.926 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 8.9 mm -111.36 145.04 18.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 74.44 111.121 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.7 ttpt -122.65 151.15 41.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 75.23 110.883 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -140.56 128.06 21.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 74.34 110.911 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -139.18 129.42 25.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.466 . . . . 63.51 110.858 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.8 tt -137.53 133.49 34.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 73.33 110.933 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.6 mtpp -135.33 125.51 26.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 72.13 110.928 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 24.4 m -123.2 146.18 48.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.212 -0.449 . . . . 74.21 111.11 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 10.1 tptt -105.24 158.04 16.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 72.14 110.9 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.483 ' O ' ' C ' ' A' ' 36' ' ' GLU . 0.5 OUTLIER -132.14 174.86 9.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 63.12 110.873 -179.915 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.483 ' C ' ' O ' ' A' ' 35' ' ' SER . 46.2 tt0 -31.8 -73.46 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.16 -0.473 . . . . 75.54 110.869 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -164.82 131.77 3.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 73.13 110.925 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.457 ' HA2' ' O ' ' A' ' 63' ' ' ARG . . . 86.28 -14.59 53.75 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.763 -0.732 . . . . 65.23 112.496 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.43 129.17 52.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.816 0.341 . . . . 75.22 110.901 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.97 118.15 10.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 64.14 110.93 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -92.04 122.55 34.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 75.14 110.892 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -125.6 131.12 52.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 74.05 111.111 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.4 t -131.69 139.64 49.1 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.202 -0.454 . . . . 73.31 110.839 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.4 t -145.73 126.59 14.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.144 -0.48 . . . . 72.13 110.829 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -146.31 147.71 18.86 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.739 -0.743 . . . . 73.04 112.518 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.24 135.78 37.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.857 0.36 . . . . 74.33 110.846 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.16 130.56 14.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.129 -0.487 . . . . 71.04 111.11 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 64.3 t-20 -96.63 126.0 41.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.242 -0.436 . . . . 73.22 110.872 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 91.9 m -75.59 -50.1 16.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 71.35 111.104 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -56.7 -49.23 75.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 71.22 110.851 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -108.84 124.53 50.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 74.42 111.182 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.9 t -54.37 104.63 0.11 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.209 -0.451 . . . . 74.43 111.168 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 30.9 tttp -174.03 99.32 0.1 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 75.33 110.896 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 31.7 t -120.51 124.75 73.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.195 -0.457 . . . . 75.32 111.117 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.4 p -135.57 129.72 33.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 73.52 111.122 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -129.37 137.93 9.91 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.761 -0.733 . . . . 63.41 112.532 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.3 p -141.49 160.32 40.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.892 0.377 . . . . 73.24 110.868 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.3 tp -128.38 149.97 50.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.101 -0.5 . . . . 74.55 110.877 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -135.73 131.19 35.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 71.13 110.893 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.07 118.38 36.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 64.4 111.12 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 5.2 ttmt -112.18 147.91 35.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 74.43 110.855 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -131.75 133.41 44.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 74.1 110.948 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.457 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 25.5 ttm180 -135.23 106.71 6.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.13 -0.487 . . . . 72.01 110.903 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 58.0 t-105 -114.56 138.74 50.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.202 -0.453 . . . . 73.14 110.9 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.3 m 66.19 119.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.281 -0.418 . . . . 73.45 111.17 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -50.59 105.38 0.1 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.438 . . . . 74.25 110.919 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 64.61 48.85 2.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.148 -0.478 . . . . 72.24 110.913 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -122.29 -74.41 0.32 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.741 -0.742 . . . . 74.31 112.52 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -134.23 129.43 35.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.872 0.367 . . . . 73.2 110.935 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.2 m -138.6 112.61 8.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 75.34 111.169 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -123.59 124.36 42.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 75.32 110.88 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 61' ' ' LYS . 5.1 t -129.38 137.68 51.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 74.04 111.14 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -124.02 123.23 39.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 74.51 110.843 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 22.3 mtpp -89.82 142.17 27.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.105 -0.498 . . . . 74.4 110.913 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 7.3 t90 -134.58 128.82 33.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.227 -0.442 . . . . 73.41 110.894 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -117.72 155.13 30.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 71.44 110.875 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 9.4 t -61.37 -17.53 54.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 61.05 111.16 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.415 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 48.5 m-20 -74.11 0.35 14.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 71.3 110.87 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.415 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 3.5 m120 77.34 35.67 0.33 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 73.4 110.9 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.8 m -114.45 128.57 56.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 71.42 111.167 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -120.19 139.59 52.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.227 -0.442 . . . . 73.11 110.904 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -137.92 98.6 0.27 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.75 -0.738 . . . . 73.22 112.495 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.1 m -84.76 142.02 30.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.768 0.318 . . . . 63.03 111.161 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -146.47 115.25 6.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 73.21 110.853 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -112.7 136.48 48.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 73.1 111.147 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 20.5 p -128.99 124.09 34.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 74.24 111.177 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.5 p -114.91 137.24 49.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 75.14 111.132 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -103.83 119.81 39.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 73.52 110.887 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -60.51 130.32 45.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 74.32 110.878 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -83.14 -57.8 3.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 71.13 110.885 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 36.0 mt -63.28 -54.28 39.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 71.23 110.876 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -85.58 75.35 10.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.453 . . . . 65.3 111.092 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 12.2 tpp85 -51.37 134.59 28.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 75.11 110.885 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 100.61 -23.41 35.87 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.718 -0.753 . . . . 72.11 112.475 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -79.62 114.94 18.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.915 0.388 . . . . 72.25 110.946 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.8 ttpm? -121.29 130.0 53.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 74.54 110.934 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -121.71 127.06 50.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.259 -0.428 . . . . 75.02 110.89 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 17.4 p -129.92 121.09 25.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.201 -0.454 . . . . 64.53 111.151 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -110.22 129.24 55.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 73.14 110.825 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -112.25 142.16 45.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.099 -0.5 . . . . 72.21 110.883 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.3 t -142.06 124.54 15.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 74.11 110.819 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.8 t -96.09 123.82 39.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 71.15 110.854 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -118.78 132.9 56.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.157 -0.474 . . . . 75.11 110.909 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -128.69 101.83 20.38 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.718 0.77 . . . . 75.21 110.817 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -33.16 17.1 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.685 2.257 . . . . 74.41 112.373 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -79.87 -69.73 0.57 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 61.33 110.911 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.4 -45.07 92.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.456 . . . . 74.43 111.14 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.37 24.34 14.51 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.757 -0.735 . . . . 52.43 112.49 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.92 148.05 22.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.871 0.367 . . . . 74.54 110.86 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -134.47 126.69 29.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 71.23 110.884 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -121.35 136.31 54.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 75.3 110.931 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -125.56 120.19 30.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.445 . . . . 74.03 111.125 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -138.39 138.62 38.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 75.32 110.899 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 5.4 tp -122.57 137.43 56.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.235 -0.439 . . . . 73.21 111.151 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.9 mtpp -128.58 121.38 28.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.172 -0.467 . . . . 73.23 110.911 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 62.6 p -128.26 121.47 29.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 65.4 111.109 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -150.03 163.31 29.41 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.702 -0.761 . . . . 54.13 112.47 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -133.05 143.81 49.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.942 0.401 . . . . 70.34 110.926 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 9.0 mtmt -111.86 120.83 43.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 72.3 110.902 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 28.2 ttm180 -108.37 144.46 35.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 74.3 110.881 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -51.18 -29.28 13.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.219 -0.446 . . . . 74.44 110.851 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 37.1 m80 -86.54 -42.54 13.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 74.24 110.862 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 2.2 pp -150.09 153.62 10.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.238 -0.437 . . . . 75.34 111.137 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -124.68 116.25 22.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.466 . . . . 61.33 110.867 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.506 ' HB2' ' HG ' ' A' ' 142' ' ' LEU . 0.4 OUTLIER -133.51 145.17 49.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.197 -0.456 . . . . 74.33 110.913 179.96 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -146.33 136.0 6.08 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.739 -0.744 . . . . 74.0 112.476 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 44.8 t -103.91 133.97 47.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.837 0.351 . . . . 74.44 110.882 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -125.67 142.13 51.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.474 . . . . 75.32 110.872 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 47.7 ttm -137.89 134.44 35.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 75.45 110.898 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -124.9 122.58 37.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 75.12 110.876 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -94.45 123.15 37.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 75.15 110.881 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -115.12 179.68 3.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 73.54 110.857 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 3.1 mp -93.29 -42.23 13.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.181 -0.463 . . . . 75.11 111.114 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -80.98 -20.09 42.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 65.2 111.125 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 164.23 114.12 0.3 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.751 -0.738 . . . . 74.04 112.509 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 144.75 54.9 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.704 2.269 . . . . 75.23 112.322 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.6 m -126.54 151.62 47.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 74.3 110.868 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 4.6 mp -121.36 126.41 74.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 71.41 111.116 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -121.71 121.95 38.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 74.04 110.855 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -121.86 141.59 14.52 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.779 -0.724 . . . . 73.32 112.52 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -126.75 116.21 20.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.819 0.343 . . . . 61.3 111.107 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.506 ' HG ' ' HB2' ' A' ' 125' ' ' LEU . 0.3 OUTLIER -119.76 122.1 40.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 75.11 110.895 -179.963 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.403 ' HA ' ' HA2' ' A' ' 152' ' ' GLY . 1.5 m -132.61 140.84 46.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 63.14 111.172 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 6.3 mp -116.42 138.84 51.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.22 -0.445 . . . . 73.33 110.93 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -91.71 133.23 11.66 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.745 -0.741 . . . . 75.12 112.48 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.402 ' O ' ' N ' ' A' ' 148' ' ' GLY . 3.2 m-85 -128.74 146.8 50.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.823 0.344 . . . . 74.2 110.96 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -49.4 93.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.111 -0.495 . . . . 73.23 110.889 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 146' ' ' TYR . . . 87.26 -23.59 11.37 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.776 -0.726 . . . . 73.43 112.448 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 7.8 m0 -105.67 145.95 30.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.801 0.334 . . . . 72.24 110.942 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.77 137.13 53.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.243 -0.435 . . . . 74.23 110.919 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -129.26 134.07 47.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.455 . . . . 75.03 111.054 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.403 ' HA2' ' HA ' ' A' ' 143' ' ' VAL . . . -152.92 133.03 3.87 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.701 -0.762 . . . . 73.45 112.514 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 8.4 p90 -144.16 119.34 10.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.909 0.385 . . . . 75.23 110.921 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -110.58 123.62 50.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.075 -0.511 . . . . 73.12 110.935 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 2.4 ttt -120.39 128.72 53.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.44 . . . . 73.54 110.878 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.494 ' O ' ' HB ' ' A' ' 164' ' ' VAL . 20.0 m-20 -112.82 116.79 30.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.444 . . . . 75.01 110.867 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.529 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 60.4 m-85 -89.88 131.98 35.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.165 -0.471 . . . . 74.35 110.87 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -91.3 104.31 16.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 71.23 110.901 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.77 -47.9 73.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.134 -0.485 . . . . 75.11 111.118 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -49.65 -26.14 3.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 73.34 111.126 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.2 -166.85 1.36 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 73.45 110.853 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 68.1 m -112.97 39.18 2.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 75.33 110.829 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -165.06 177.19 7.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.116 -0.493 . . . . 70.51 110.832 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.529 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 1.0 OUTLIER -75.46 144.11 12.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.181 -0.463 . . . . 74.42 111.101 179.993 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 12.9 t -88.74 -32.64 17.82 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.149 -0.478 . . . . 75.33 111.165 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 3.9 tp60 -151.45 134.69 16.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 75.13 110.93 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 11.3 p -124.1 107.07 10.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 75.43 110.868 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 28.9 m-20 -110.74 148.47 32.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.115 -0.493 . . . . 64.24 110.897 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -154.8 140.57 18.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 71.34 110.914 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -154.38 135.01 13.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.13 -0.487 . . . . 74.5 111.094 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 48.5 t -144.15 133.42 19.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 72.04 111.159 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -111.6 122.25 6.0 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.775 -0.726 . . . . 70.12 112.496 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.65 131.06 56.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.934 0.397 . . . . 73.41 110.953 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 2.6 mtpm? -102.95 127.2 50.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.476 . . . . 65.35 110.888 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.406 ' O ' ' C ' ' A' ' 176' ' ' ASP . 0.2 OUTLIER -111.78 166.39 11.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.219 -0.446 . . . . 75.42 111.111 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.406 ' C ' ' O ' ' A' ' 175' ' ' THR . 2.8 m-20 -37.89 -76.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 75.01 110.896 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -117.32 16.51 14.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.179 -0.464 . . . . 72.45 110.932 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -130.79 150.68 51.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.132 -0.485 . . . . 64.13 110.862 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 37.2 mm-40 -116.09 123.1 47.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.124 -0.489 . . . . 73.15 110.895 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -107.15 125.58 51.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.164 -0.471 . . . . 73.4 110.89 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 22.6 m80 -130.63 130.41 43.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 75.2 110.836 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 1.2 t -128.9 111.49 13.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 74.53 111.172 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -120.55 139.65 52.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.236 -0.438 . . . . 63.11 110.908 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 2.5 t -133.33 110.29 14.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 72.14 111.111 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -100.79 89.51 3.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 74.11 110.872 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 67.47 -179.75 0.22 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 73.21 110.882 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -75.19 -2.95 68.12 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.775 -0.726 . . . . 65.22 112.477 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 15.6 p -97.53 -25.49 15.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.769 0.319 . . . . 74.22 111.126 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.27 113.48 20.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 75.41 110.905 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -139.76 123.03 17.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 72.24 110.857 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 171.46 -141.43 6.41 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.747 -0.74 . . . . 63.11 112.519 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 167.24 -167.4 39.83 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.699 -0.763 . . . . 62.42 112.445 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' SER . . . . . 0.479 ' HA ' ' O ' ' A' ' 206' ' ' VAL . 70.3 m -127.5 144.42 51.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.813 0.339 . . . . 72.32 110.875 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -142.03 118.33 6.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.168 -0.469 . . . . 72.53 111.121 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . 0.791 ' CB ' ' HA ' ' A' ' 205' ' ' ALA . 0.1 OUTLIER 178.66 -175.21 0.19 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 64.12 110.892 -179.989 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 16.8 tm0? -123.51 128.54 49.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.091 -0.504 . . . . 75.41 110.894 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 3.4 pttp -114.65 113.97 25.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 73.41 110.903 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 5.2 t -86.47 143.85 10.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.237 -0.438 . . . . 75.32 111.133 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -93.06 32.53 1.28 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 72.3 110.894 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 10.3 mmtt -127.59 35.03 4.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 73.22 110.917 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 2.2 mttp 72.7 51.11 0.16 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 75.31 110.904 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -177.47 82.49 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 73.24 110.938 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -128.17 133.2 48.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.461 . . . . 74.43 110.866 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' THR . . . . . 0.608 ' O ' ' HB3' ' A' ' 195' ' ' TYR . 11.0 t -132.45 136.91 47.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.467 . . . . 75.12 111.158 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . 0.791 ' HA ' ' CB ' ' A' ' 195' ' ' TYR . . . -141.47 136.68 31.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 71.44 111.083 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.49 ' CG1' ' CD2' ' A' ' 195' ' ' TYR . 1.1 m -103.9 139.51 24.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.44 . . . . 63.25 111.074 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -114.35 132.7 56.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.46 . . . . 71.33 110.897 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 4.6 mp -126.11 138.17 53.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.167 -0.47 . . . . 74.25 110.935 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -129.61 139.96 51.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 62.53 111.129 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 2.4 t-105 -130.27 130.32 44.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 71.41 110.944 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.07 109.44 22.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.253 -0.43 . . . . 71.53 111.116 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -51.62 134.81 29.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.448 . . . . 64.34 111.156 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 120.4 33.91 0.99 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.705 -0.76 . . . . 73.21 112.447 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 49.5 t30 59.66 43.34 15.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.822 0.344 . . . . 71.14 110.898 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 14.0 m -90.99 -169.72 2.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 72.32 110.872 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -102.55 137.1 41.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.462 . . . . 74.3 110.913 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 3.9 t -79.12 139.5 38.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.47 . . . . 65.44 111.153 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 17.3 ptp180 -110.84 133.29 53.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 71.43 110.886 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -114.37 138.35 50.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.25 -0.432 . . . . 75.44 110.859 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -140.65 144.52 14.87 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.713 -0.755 . . . . 74.44 112.467 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.93 130.73 64.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.841 0.353 . . . . 75.05 111.129 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -133.74 131.64 39.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 72.52 111.104 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -125.22 146.06 49.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.254 -0.43 . . . . 75.32 111.093 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 3.5 mtmp? -129.1 123.55 32.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 74.44 110.908 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -132.29 133.16 43.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.212 -0.449 . . . . 74.42 110.963 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -85.6 128.78 34.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.475 . . . . 72.24 110.901 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 44.5 mm -74.16 -55.55 11.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 74.24 111.111 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . 0.536 ' N ' ' HD2' ' A' ' 229' ' ' PRO . 0.1 OUTLIER 175.13 -57.35 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.599 0.714 . . . . 74.24 110.826 179.867 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 228' ' ' ASP . 53.4 Cg_endo -69.75 -156.6 0.04 OUTLIER 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.655 2.237 . . . . 73.4 112.368 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.6 15.69 4.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 64.33 110.839 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -120.63 121.92 39.38 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.22 -0.445 . . . . 71.22 111.118 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 36.7 m -108.7 143.99 37.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 52.0 110.889 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -105.3 127.88 53.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 74.53 110.877 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 15.2 m -127.09 137.49 53.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.134 -0.484 . . . . 64.24 110.842 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -121.3 143.17 49.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.158 -0.474 . . . . 63.13 111.083 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.76 141.87 31.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 75.13 110.894 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 5.3 p -140.25 144.73 27.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 63.33 111.117 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -108.16 148.31 30.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 73.42 110.896 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' ASN . . . . . 0.411 ' C ' ' H ' ' A' ' 241' ' ' SER . 7.6 t30 -56.11 -19.52 13.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 75.23 110.869 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 37.3 t -81.15 25.48 0.48 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.474 . . . . 64.05 110.856 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' SER . . . . . 0.411 ' H ' ' C ' ' A' ' 239' ' ' ASN . 2.3 t 61.89 35.73 16.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 72.41 110.851 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 4.6 mp -99.03 117.89 34.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.138 -0.483 . . . . 73.53 110.963 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -104.84 119.0 53.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.207 -0.451 . . . . 75.15 111.181 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -138.04 160.67 25.43 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.749 -0.739 . . . . 72.23 112.498 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.428 ' CD1' ' N ' ' A' ' 245' ' ' LEU . 0.0 OUTLIER -145.16 160.04 42.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.858 0.361 . . . . 71.33 110.872 -179.917 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -149.09 121.77 1.36 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.77 -0.729 . . . . 74.43 112.508 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -109.3 115.89 30.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.976 0.417 . . . . 73.0 110.931 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 3.5 t -101.8 115.05 29.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.131 -0.486 . . . . 75.24 111.153 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -119.71 130.01 54.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 73.5 110.87 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 7.3 p -121.39 117.92 28.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.136 -0.483 . . . . 75.22 111.115 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 11.0 mt -113.42 101.2 9.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 75.32 110.974 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' LYS . . . . . 0.411 ' HB3' ' HD2' ' A' ' 253' ' ' PRO . 17.6 mttp 64.19 155.36 0.12 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.632 0.73 . . . . 73.25 110.835 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' PRO . . . . . 0.411 ' HD2' ' HB3' ' A' ' 252' ' ' LYS . 53.8 Cg_endo -69.74 73.68 1.34 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.706 2.271 . . . . 61.4 112.341 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 171.92 -29.7 0.11 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.727 -0.749 . . . . 71.52 112.442 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 55.5 mt -116.13 121.37 67.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.854 0.359 . . . . 74.5 111.131 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 32.3 ttmt -133.39 132.81 41.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 73.32 110.86 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -118.44 125.06 49.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.175 -0.466 . . . . 73.51 110.931 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 93.6 m -115.72 111.74 21.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 73.22 111.167 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.6 132.65 53.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.45 . . . . 74.22 110.923 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 16.5 t -145.95 153.37 40.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 74.24 110.889 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -158.12 130.87 7.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 64.05 111.102 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -125.8 124.45 40.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.459 . . . . 74.32 110.911 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.01 110.31 16.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 74.23 110.907 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -79.11 113.88 17.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.198 -0.456 . . . . 74.45 110.871 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -58.9 -17.0 34.07 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.785 -0.722 . . . . 52.34 112.457 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 45.4 tttt -90.84 -3.2 57.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.822 0.344 . . . . 75.12 110.913 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -127.55 -52.82 1.36 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 64.12 110.919 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 17.1 m -51.19 -29.37 8.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 73.3 111.123 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -52.24 -40.39 61.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 74.2 110.918 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -104.91 -17.45 14.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.131 -0.486 . . . . 75.22 111.108 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 129.71 94.8 0.74 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.712 -0.756 . . . . 74.22 112.515 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -179.74 74.94 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.73 -0.748 . . . . 74.43 112.474 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 32.6 p-80 -108.14 145.96 33.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.851 0.357 . . . . 65.22 110.855 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -127.12 138.73 53.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.185 -0.461 . . . . 73.54 110.925 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 1.5 tp -121.75 145.6 47.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.447 . . . . 74.13 110.879 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -123.63 108.25 1.16 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.724 -0.751 . . . . 70.24 112.459 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -114.43 141.4 47.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.858 0.361 . . . . 74.13 110.921 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -148.84 132.59 4.17 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.772 -0.727 . . . . 75.11 112.482 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -109.36 133.63 52.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.766 0.317 . . . . 74.41 110.881 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -124.06 112.62 17.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 72.24 110.88 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -117.93 134.1 55.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.1 -0.5 . . . . 74.42 110.85 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -135.85 112.47 10.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.127 -0.488 . . . . 74.25 110.913 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -96.05 113.36 24.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 74.24 111.071 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 6.1 mp -140.52 177.05 8.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.257 -0.429 . . . . 74.42 110.919 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 75.44 110.864 179.917 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.865 0.364 . . . . 73.31 111.127 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.419 ' HB ' ' HA ' ' A' ' 121' ' ' GLU . 0.2 OUTLIER -145.16 108.86 4.6 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.637 0.732 . . . . 72.3 111.155 179.955 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 170.73 15.85 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.648 2.232 . . . . 71.24 112.377 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 83.54 0.7 Allowed 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.695 2.263 . . . . 62.4 112.334 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 46.2 p -70.27 -48.94 54.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.212 -0.449 . . . . 75.12 111.157 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -51.13 -33.81 28.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.237 -0.438 . . . . 71.11 110.896 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -83.44 -28.32 28.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 73.43 111.132 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -90.32 11.61 20.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.211 -0.45 . . . . 75.33 110.823 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 25.1 mt -59.88 -29.76 68.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 75.3 110.928 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 159.4 59.01 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.703 -0.76 . . . . 65.14 112.469 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 12.7 mmtm -67.16 -53.84 26.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.751 0.31 . . . . 73.44 110.874 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.4 t -56.87 -48.06 78.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.27 -0.423 . . . . 70.42 110.906 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.23 -36.77 76.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.092 -0.504 . . . . 72.52 111.104 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.89 -30.57 67.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 74.4 110.864 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -56.44 -48.94 75.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 64.32 110.857 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 79.5 t -62.53 -26.59 40.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 74.23 111.135 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -59.63 -41.11 89.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 74.54 110.865 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.08 -66.64 0.7 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 74.42 111.138 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.1 tppm? -47.28 104.73 0.06 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 74.13 110.902 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 158.93 38.83 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.755 -0.736 . . . . 72.41 112.492 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 18.5 p90 -165.56 140.08 4.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.955 0.407 . . . . 72.14 110.897 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -62.65 129.83 42.48 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.734 -0.746 . . . . 73.45 112.489 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -103.1 -3.51 25.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.879 0.371 . . . . 74.43 110.849 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.78 14.02 78.32 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.721 -0.752 . . . . 64.43 112.509 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -127.77 171.94 11.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.804 0.335 . . . . 63.03 110.899 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.411 HG13 ' HB3' ' A' ' 277' ' ' LEU . 1.3 mp -118.35 121.49 67.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 73.23 111.108 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 37.0 tttp -111.42 117.37 32.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 75.33 110.902 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.1 tt -115.16 141.06 48.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 72.22 110.951 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -147.88 129.98 15.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.178 -0.465 . . . . 74.15 110.838 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.3 tt -126.93 133.38 50.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 73.13 110.876 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mtmp? -127.23 127.02 43.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 75.4 110.892 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.7 m -130.1 141.03 50.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.24 -0.436 . . . . 75.23 111.169 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.88 156.27 20.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.464 . . . . 73.53 110.882 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.517 ' O ' ' C ' ' A' ' 36' ' ' GLU . 0.6 OUTLIER -133.89 174.35 10.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 72.14 110.847 -179.904 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.517 ' C ' ' O ' ' A' ' 35' ' ' SER . 39.9 mm-40 -27.46 -75.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.095 -0.502 . . . . 72.55 110.876 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -166.82 140.39 3.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.115 -0.493 . . . . 74.44 110.879 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.485 ' HA2' ' O ' ' A' ' 63' ' ' ARG . . . 83.54 -12.69 50.71 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.798 -0.715 . . . . 65.12 112.518 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -105.02 130.07 53.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.787 0.327 . . . . 75.31 110.923 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -140.33 118.48 11.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.23 -0.441 . . . . 75.23 110.882 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -98.34 121.55 40.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 74.34 110.869 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 27.6 m -126.06 123.82 39.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.163 -0.471 . . . . 74.41 111.166 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.4 t -125.1 132.39 53.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.264 -0.425 . . . . 54.44 110.875 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 6.0 p -150.04 126.57 10.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.115 -0.493 . . . . 54.12 110.853 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -155.05 167.36 32.78 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.735 -0.745 . . . . 74.53 112.461 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 17.9 m -127.66 156.45 42.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.9 0.381 . . . . 71.25 110.878 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.41 ' HA ' ' HA ' ' A' ' 54' ' ' VAL . . . -142.84 131.33 22.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 71.25 111.103 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 61.5 t-20 -101.65 123.54 45.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 72.43 110.865 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 60.4 m -88.51 -55.35 3.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.169 -0.469 . . . . 75.43 111.122 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -51.12 -36.4 40.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 72.14 110.875 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.14 155.54 50.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 54.32 111.125 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.0 m -71.09 86.99 0.76 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 73.55 111.167 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.2 tptp -152.68 80.91 1.22 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.233 -0.439 . . . . 63.31 110.901 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.41 ' HA ' ' HA ' ' A' ' 47' ' ' ALA . 1.3 p -127.96 123.21 60.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 75.41 111.159 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.0 p -136.6 132.85 35.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 73.44 111.158 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -107.18 136.56 13.46 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.756 -0.735 . . . . 52.23 112.475 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -114.26 144.97 42.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.895 0.379 . . . . 64.15 110.874 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -121.48 132.82 54.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 75.53 110.927 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -133.46 136.96 45.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 75.2 110.904 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 4.9 m -114.79 140.15 49.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 64.4 111.131 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -135.71 157.44 46.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 74.41 110.885 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.434 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 16.2 m-85 -129.26 140.86 51.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.218 -0.447 . . . . 70.34 110.939 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.485 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 43.6 ttm-85 -127.12 104.51 8.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.11 -0.495 . . . . 74.51 110.863 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 66.0 m95 -114.2 123.84 50.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 72.34 110.9 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.5 m 67.3 125.39 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.216 -0.447 . . . . 74.32 111.126 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -51.3 103.95 0.07 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.46 . . . . 63.31 110.911 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 63.64 58.51 1.29 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.459 . . . . 74.1 110.935 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -133.64 -77.81 0.12 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.762 -0.732 . . . . 72.11 112.455 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -133.99 130.35 37.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.881 0.372 . . . . 72.12 110.936 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.57 137.42 38.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 74.22 111.141 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -95.79 133.84 39.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 73.23 110.92 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.5 m -112.67 117.23 31.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.167 -0.469 . . . . 74.12 111.136 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -134.49 134.06 41.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.455 . . . . 75.51 110.9 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 53.5 tttt -145.26 132.85 20.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 72.31 110.893 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 9.6 t90 -135.48 128.91 32.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.439 . . . . 74.35 110.928 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 10.5 m-20 -117.14 150.99 37.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 73.12 110.904 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.7 m -68.21 -12.29 60.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 74.41 111.122 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.489 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 38.8 t70 -74.65 0.17 15.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.227 -0.442 . . . . 63.0 110.893 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.489 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 5.7 t-20 83.55 34.47 0.05 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 75.32 110.865 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 12.7 p -114.77 123.04 48.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 65.21 111.162 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -109.38 136.98 47.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.449 . . . . 71.01 110.908 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -149.33 89.34 0.14 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.666 -0.778 . . . . 61.41 112.452 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.405 ' O ' ' HB2' ' A' ' 84' ' ' GLU . 3.8 m -127.45 160.95 29.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.741 0.305 . . . . 74.13 111.167 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.624 ' HB3' ' O ' ' A' ' 99' ' ' PHE . 0.6 OUTLIER 169.22 -163.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 61.1 110.882 -179.99 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.33 142.96 38.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 74.22 111.111 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 33.7 p -128.88 126.34 39.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.146 -0.479 . . . . 74.21 111.157 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 9.0 p -110.67 137.13 44.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 74.54 111.127 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -125.26 118.51 26.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 65.33 110.937 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 52.14 90.39 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 74.14 110.857 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -138.66 -75.13 0.38 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 73.35 110.932 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 30.1 tp -62.39 -36.12 81.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 73.35 110.938 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -143.29 125.72 15.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 63.24 111.069 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.11 124.8 13.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 73.41 110.872 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 97.64 -23.98 33.59 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.76 -0.733 . . . . 70.53 112.548 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.99 124.28 28.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.834 0.349 . . . . 74.22 110.884 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.2 pttp -121.86 123.31 41.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.219 -0.446 . . . . 75.25 110.932 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -125.53 124.85 42.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.23 -0.441 . . . . 64.12 110.967 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 12.2 p -124.84 119.6 29.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 75.53 111.143 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.624 ' O ' ' HB3' ' A' ' 84' ' ' GLU . 0.3 OUTLIER -109.83 117.73 34.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 72.44 110.86 -179.968 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.544 ' HA ' ' CB ' ' A' ' 84' ' ' GLU . 6.7 t70 -115.71 144.6 43.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 74.12 110.88 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 10.5 t -140.1 133.2 29.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 72.15 110.866 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -120.67 149.51 42.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.484 . . . . 72.53 110.861 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -127.95 137.96 52.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 73.52 110.888 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 99.6 p -128.63 101.52 20.8 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.707 0.765 . . . . 64.22 110.841 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.66 -31.22 21.38 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.705 2.27 . . . . 74.41 112.4 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -50.27 -68.24 0.19 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 73.43 110.885 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.1 p -86.05 -33.45 21.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.481 . . . . 71.21 111.175 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.39 23.57 16.28 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.723 -0.751 . . . . 64.31 112.485 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 46.3 mtpt -94.31 148.09 22.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.821 0.343 . . . . 73.31 110.926 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.15 144.42 31.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 75.45 110.914 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -120.7 128.59 53.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.269 -0.423 . . . . 74.54 110.851 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -133.35 124.82 27.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 52.24 111.088 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -134.77 138.37 44.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.223 -0.444 . . . . 75.12 110.864 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -134.43 136.53 52.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.248 -0.433 . . . . 72.41 111.111 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 10.9 mtmt -126.29 121.59 33.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 75.32 110.883 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 99.6 m -125.22 121.44 34.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 74.4 111.103 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -152.69 163.06 30.26 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.738 -0.744 . . . . 72.33 112.511 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -132.49 145.22 51.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.982 0.42 . . . . 74.53 110.915 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.06 123.47 49.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.094 -0.503 . . . . 74.41 110.905 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.466 ' N ' ' O ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -104.54 147.36 27.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.245 -0.434 . . . . 74.25 110.892 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.419 ' HA ' ' HB ' ' A' ' 3' ' ' VAL . 85.0 tt0 -54.64 -30.95 56.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 75.33 110.873 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 54.2 p-80 -125.95 11.13 7.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 74.23 110.864 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.466 ' O ' ' N ' ' A' ' 120' ' ' ARG . 1.0 OUTLIER -147.63 150.19 14.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.24 -0.437 . . . . 75.44 111.169 179.974 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.401 ' HB3' HG12 ' A' ' 143' ' ' VAL . 5.9 t-20 -128.96 113.69 15.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 60.02 110.9 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -121.89 130.76 53.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 62.14 110.873 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -146.94 115.81 0.81 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.689 -0.767 . . . . 73.12 112.442 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -113.3 135.51 53.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.771 0.32 . . . . 71.21 110.876 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -132.91 117.22 17.43 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.184 -0.462 . . . . 70.52 110.852 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 3.3 tmm? -109.36 138.74 45.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 75.43 110.918 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -117.75 119.23 34.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.248 -0.433 . . . . 63.11 110.854 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -96.43 114.98 26.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 75.45 110.885 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -120.39 153.16 36.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 65.43 110.881 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.02 -29.5 14.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.216 -0.447 . . . . 74.51 111.117 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -84.48 -20.32 31.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 75.44 111.068 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 164.05 97.38 0.12 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.745 -0.74 . . . . 65.51 112.483 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 137.27 35.09 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.648 2.232 . . . . 73.04 112.348 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.07 153.65 46.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.189 -0.459 . . . . 75.35 110.832 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 5.2 mp -110.52 132.29 59.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 75.43 111.135 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 9.2 mtt-85 -119.79 138.72 53.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 75.21 110.862 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -131.95 145.18 16.95 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.761 -0.733 . . . . 74.42 112.508 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -139.23 116.47 11.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.842 0.353 . . . . 72.32 111.076 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -125.34 124.02 40.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 71.25 110.928 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.406 ' HA ' ' HA2' ' A' ' 152' ' ' GLY . 0.1 OUTLIER -132.85 145.0 34.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 74.32 111.126 179.857 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -131.78 140.91 49.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.446 . . . . 74.11 110.921 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -123.4 117.79 3.32 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.722 -0.751 . . . . 75.15 112.463 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.435 ' O ' ' CD1' ' A' ' 149' ' ' TRP . 7.0 t80 -145.52 153.86 41.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.864 0.364 . . . . 73.14 110.921 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 52.58 23.72 2.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 74.54 110.861 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 89.93 -31.2 5.42 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.736 -0.745 . . . . 72.34 112.504 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.435 ' CD1' ' O ' ' A' ' 146' ' ' TYR . 50.5 p-90 -78.0 145.0 36.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.754 0.311 . . . . 73.34 110.923 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.4 mt -124.21 144.4 49.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.249 -0.432 . . . . 65.05 110.906 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -142.97 125.89 16.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.15 -0.477 . . . . 73.54 111.086 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.734 ' O ' ' HB3' ' A' ' 169' ' ' PHE . . . -126.94 131.5 7.29 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.717 -0.754 . . . . 64.15 112.488 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.415 ' C ' ' HD1' ' A' ' 169' ' ' PHE . 5.5 t80 -133.2 120.28 20.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.841 0.353 . . . . 74.03 110.949 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.626 ' H ' ' HB2' ' A' ' 169' ' ' PHE . 0.5 OUTLIER -104.24 138.54 40.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.484 . . . . 70.3 110.915 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -122.73 146.76 47.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 72.13 110.849 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -108.88 120.48 42.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.182 -0.463 . . . . 75.15 110.883 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -91.04 123.18 34.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 75.13 110.86 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.742 ' O ' ' O ' ' A' ' 161' ' ' LYS . 0.1 OUTLIER -78.19 137.64 38.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 71.34 110.881 -179.963 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 5.4 t -69.05 -46.99 66.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.15 -0.477 . . . . 64.4 111.17 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -50.77 -25.87 4.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 75.41 111.111 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.742 ' O ' ' O ' ' A' ' 158' ' ' GLU . 33.2 mmtt -147.29 139.62 24.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 75.24 110.909 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 12.6 m -71.56 49.63 0.16 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 73.41 110.868 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -138.58 170.69 15.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.487 . . . . 75.12 110.889 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 90.8 t -91.15 138.66 19.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.442 . . . . 75.4 111.107 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 96.1 m -94.65 -42.23 8.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.474 . . . . 72.04 111.125 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -160.1 142.2 13.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 72.02 110.922 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 6.8 p -127.12 125.94 42.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 72.21 110.865 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.429 ' CB ' ' HA ' ' A' ' 185' ' ' ASN . 5.8 p30 -139.7 152.3 46.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.102 -0.499 . . . . 73.24 110.906 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.734 ' HB3' ' O ' ' A' ' 152' ' ' GLY . 0.1 OUTLIER -178.55 -159.18 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 74.33 110.893 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -132.92 150.56 52.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 61.24 111.106 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 71.0 t -145.72 127.15 7.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.218 -0.446 . . . . 75.55 111.097 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -163.37 167.19 37.51 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.714 -0.755 . . . . 64.41 112.482 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 27.1 p90 -125.55 154.67 41.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.989 0.424 . . . . 51.12 110.9 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 38.8 mtpt -106.8 130.93 54.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.119 -0.491 . . . . 74.02 110.892 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.15 165.53 16.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 70.13 111.13 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -42.53 -71.74 0.08 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 72.24 110.915 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 26.5 mp0 -115.48 14.46 16.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 74.11 110.92 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -127.83 143.57 51.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.11 -0.496 . . . . 70.41 110.854 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -136.81 130.96 32.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 72.34 110.882 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -124.21 117.5 24.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.14 -0.482 . . . . 71.45 110.891 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 18.2 t-80 -135.07 118.43 16.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 74.54 110.892 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -130.74 127.83 39.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 75.53 111.162 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -119.36 141.01 49.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 72.23 110.922 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.527 ' HB ' ' HA ' ' A' ' 190' ' ' PHE . 1.3 m -133.07 141.19 45.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.457 . . . . 73.1 111.141 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.429 ' HA ' ' CB ' ' A' ' 168' ' ' ASN . 0.8 OUTLIER -105.13 89.2 3.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 72.5 110.884 179.999 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 74.41 -175.93 0.15 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.222 -0.444 . . . . 72.33 110.859 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -80.09 4.84 64.84 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.708 -0.758 . . . . 62.31 112.463 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 22.3 p -110.42 -22.19 11.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.755 0.312 . . . . 74.22 111.142 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -118.12 125.96 51.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 74.4 110.907 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' PHE . . . . . 0.527 ' HA ' ' HB ' ' A' ' 184' ' ' VAL . 32.2 t80 -137.4 125.1 22.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 75.1 110.822 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -136.46 141.95 13.06 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.724 -0.751 . . . . 64.33 112.473 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -133.46 145.19 17.25 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.696 -0.764 . . . . 74.21 112.442 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 3.3 t -139.31 152.63 47.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.893 0.378 . . . . 71.22 110.833 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 3.1 mp -127.43 130.56 70.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 75.43 111.106 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -108.66 123.11 48.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.171 -0.468 . . . . 74.5 110.897 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -124.78 112.45 16.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.122 -0.49 . . . . 72.34 110.877 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 33.6 mtpt -107.69 127.94 54.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 72.14 110.936 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.2 t 66.45 22.21 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.253 -0.431 . . . . 71.13 111.164 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -92.54 -32.74 14.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 72.21 110.87 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 22.6 mtpp -154.28 66.13 0.7 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 74.34 110.924 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 24.8 mttm 68.55 112.92 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.44 . . . . 75.24 110.941 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 63.25 -163.25 0.27 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.211 -0.45 . . . . 75.3 110.946 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 5.6 pm0 -115.04 129.68 56.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.436 . . . . 71.23 110.875 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 17.4 p -142.07 156.76 45.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 73.44 111.152 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -149.44 148.44 29.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.248 -0.433 . . . . 73.41 111.099 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -112.89 148.54 15.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.224 -0.444 . . . . 75.04 111.149 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -126.71 136.92 53.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 65.45 110.917 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 5.6 mp -130.72 142.3 50.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.167 -0.47 . . . . 70.33 110.928 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -131.59 131.64 43.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.466 . . . . 64.43 111.071 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 18.9 t90 -130.69 126.21 35.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 73.03 110.946 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 2.0 t -113.43 105.92 13.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.27 -0.423 . . . . 73.2 111.169 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -51.98 149.09 5.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 74.31 111.114 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 114.2 43.92 0.76 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.752 -0.737 . . . . 65.31 112.497 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 55.73 62.66 2.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.867 0.365 . . . . 72.45 110.901 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 7.1 t -121.85 -178.04 3.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 60.51 110.826 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 29.7 m120 -101.74 150.29 23.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.128 -0.487 . . . . 65.25 110.873 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 2.9 p -79.24 138.69 37.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 75.42 111.181 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 75.6 mtt180 -105.97 126.99 52.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 73.24 110.857 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -122.77 139.43 54.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 75.02 110.887 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -149.68 149.01 20.88 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.745 -0.741 . . . . 73.53 112.521 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.421 HG12 HG13 ' A' ' 237' ' ' VAL . 0.0 OUTLIER -138.7 130.85 37.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.775 0.321 . . . . 74.44 111.142 -179.954 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -120.81 133.12 55.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 72.32 111.107 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -111.91 125.85 54.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 75.5 111.105 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 18.3 ttpp -115.58 114.66 25.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 75.14 110.863 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -109.59 118.6 37.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 74.44 110.903 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.93 114.11 27.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 73.44 110.887 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 44.2 mt -109.06 -35.35 2.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 75.51 111.102 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -149.17 157.47 39.65 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.637 0.732 . . . . 61.2 110.862 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -17.0 37.89 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.694 2.263 . . . . 75.34 112.366 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -103.35 -28.04 12.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 74.31 110.855 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -124.32 129.9 51.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.463 . . . . 64.21 111.087 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 19.1 m -139.65 141.18 37.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.272 -0.422 . . . . 72.33 110.89 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -106.6 133.16 51.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.447 . . . . 75.05 110.895 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 2.8 t -138.27 143.22 39.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.471 . . . . 64.0 110.852 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -146.7 159.03 43.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.128 -0.487 . . . . 73.22 111.098 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.98 148.71 19.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 73.53 110.86 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . 0.421 HG13 HG12 ' A' ' 221' ' ' ILE . 0.9 OUTLIER -140.65 149.1 21.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 74.23 111.115 179.896 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -117.56 147.95 42.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 73.15 110.886 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' ASN . . . . . 0.404 ' C ' ' H ' ' A' ' 241' ' ' SER . 8.3 t30 -58.16 -18.16 23.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 74.44 110.858 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 11.2 t -81.46 26.67 0.46 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 71.2 110.884 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' SER . . . . . 0.404 ' H ' ' C ' ' A' ' 239' ' ' ASN . 1.7 m 62.78 32.94 15.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 75.03 110.841 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 4.5 mp -100.13 117.69 34.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.136 -0.483 . . . . 74.52 110.892 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -109.56 117.75 55.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.131 -0.486 . . . . 75.35 111.178 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . 0.426 ' HA2' ' HA ' ' A' ' 262' ' ' LEU . . . -122.31 148.29 17.02 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.723 -0.751 . . . . 72.24 112.479 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -145.57 130.08 17.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.882 0.373 . . . . 75.45 110.914 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -129.67 138.78 10.47 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.759 -0.734 . . . . 51.44 112.499 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -128.95 131.81 47.54 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.965 0.412 . . . . 75.0 110.919 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 16.8 p -111.41 129.19 56.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 72.45 111.126 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -142.78 123.12 13.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 62.33 110.951 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 20.8 p -106.77 153.13 22.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 72.15 111.129 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 6.2 mt -85.74 -77.11 0.31 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.216 -0.447 . . . . 72.53 110.927 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' LYS . . . . . 0.462 ' CB ' ' CD ' ' A' ' 253' ' ' PRO . 1.6 mttm 177.88 -60.71 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.598 0.714 . . . . 75.24 110.858 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' PRO . . . . . 0.462 ' CD ' ' CB ' ' A' ' 252' ' ' LYS . 53.5 Cg_endo -69.81 69.31 1.68 Allowed 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.725 2.283 . . . . 71.15 112.314 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 50.47 32.46 23.24 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.785 -0.722 . . . . 70.22 112.445 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 58.6 mt -114.45 122.54 68.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.864 0.364 . . . . 75.44 111.113 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 17.4 mtpp -130.71 120.52 23.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.14 -0.482 . . . . 71.15 110.889 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.75 128.71 46.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.455 . . . . 74.34 110.909 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 1.5 m -115.5 115.24 26.17 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.177 -0.465 . . . . 74.52 111.164 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.39 126.09 54.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.239 -0.437 . . . . 75.34 110.919 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 23.6 p -133.67 144.98 49.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 61.03 110.876 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -155.08 128.25 8.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.129 -0.487 . . . . 74.24 111.06 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.426 ' HA ' ' HA2' ' A' ' 244' ' ' GLY . 1.5 tt -132.75 139.89 47.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.453 . . . . 74.34 110.937 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . 0.432 ' CD2' ' N ' ' A' ' 263' ' ' LEU . 0.0 OUTLIER -123.93 110.13 14.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.202 -0.454 . . . . 75.14 110.937 179.884 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -79.92 106.15 11.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.209 -0.451 . . . . 74.2 110.836 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -53.69 -19.67 10.47 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.767 -0.73 . . . . 72.44 112.461 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.8 -25.95 18.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.785 0.326 . . . . 72.32 110.889 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -99.04 -55.91 2.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 72.2 110.871 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 13.1 m -49.47 -28.23 3.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 72.4 111.124 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -53.25 -44.78 68.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 70.22 110.879 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -105.28 -17.38 14.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.445 . . . . 63.14 111.094 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -111.73 -119.82 3.85 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.743 -0.741 . . . . 65.41 112.488 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -148.72 -170.55 16.61 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.762 -0.733 . . . . 55.35 112.549 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -87.96 146.04 25.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.9 0.381 . . . . 71.54 110.815 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -96.96 135.81 38.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 72.14 110.925 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -132.1 123.26 26.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 71.23 110.922 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -119.38 130.4 8.5 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.737 -0.744 . . . . 55.05 112.509 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.411 ' HB3' HG13 ' A' ' 27' ' ' ILE . 3.3 tm? -119.31 141.03 49.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.874 0.369 . . . . 73.0 110.921 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -145.36 132.46 4.65 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.797 -0.716 . . . . 74.21 112.512 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -108.7 132.12 54.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.805 0.336 . . . . 62.22 110.899 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 50.3 tt0 -127.57 117.67 22.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.185 -0.461 . . . . 73.13 110.871 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -122.7 134.5 54.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.483 . . . . 71.44 110.898 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -135.12 124.3 24.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 73.1 110.938 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -100.06 130.88 46.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.445 . . . . 74.13 111.085 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 41.21 38.31 0.74 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.446 . . . . 74.41 110.92 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.46 . . . . 75.13 110.861 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.857 0.361 . . . . 73.34 111.145 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 19.5 t -136.7 75.42 50.04 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 121.674 0.75 . . . . 64.55 111.133 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.7 167.91 23.01 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.74 2.293 . . . . 72.52 112.377 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 102.55 1.05 Allowed 'Trans proline' 0 N--CA 1.465 -0.172 0 C-N-CA 122.684 2.256 . . . . 73.42 112.362 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -86.45 -37.68 18.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 73.42 111.161 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -52.16 -39.9 60.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 71.41 110.886 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -76.24 -24.13 54.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 53.52 111.118 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -74.07 -21.11 60.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 52.24 110.917 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 20.7 mt -56.88 -34.1 67.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.157 -0.474 . . . . 72.14 110.92 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -132.18 29.2 3.37 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.742 -0.742 . . . . 74.11 112.481 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 12.5 ttpp -69.59 -45.79 67.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.801 0.334 . . . . 72.4 110.877 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.4 m -64.37 -39.34 93.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.458 . . . . 74.24 110.883 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.26 -50.58 73.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 54.55 111.109 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -67.44 -33.8 75.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 75.23 110.879 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -60.31 -47.91 84.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 74.43 110.833 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 85.8 t -75.77 -33.46 26.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 73.45 111.135 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -59.8 -41.36 91.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 75.15 110.881 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.3 p 46.74 85.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.139 -0.482 . . . . 74.2 111.152 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.0 mtmt -50.64 -34.44 26.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 65.43 110.933 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -98.79 79.14 0.55 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.72 -0.752 . . . . 72.35 112.442 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -129.66 108.31 10.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.952 0.406 . . . . 74.5 110.965 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 51.71 77.14 0.14 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.741 -0.742 . . . . 65.12 112.503 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -103.35 -3.43 25.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.887 0.375 . . . . 71.2 110.833 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.56 13.7 80.04 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.785 -0.722 . . . . 63.24 112.46 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.0 tp -138.88 -178.93 5.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.78 0.324 . . . . 64.45 110.91 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 14.7 mm -104.7 141.38 20.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.182 -0.463 . . . . 63.54 111.151 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.7 tttt -122.42 139.39 53.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 74.43 110.928 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -131.81 128.73 39.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 73.24 110.884 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -140.73 127.14 19.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.141 -0.481 . . . . 74.45 110.882 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.2 tt -138.37 138.89 38.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 73.44 110.93 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -121.47 125.61 47.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 72.54 110.922 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 96.6 m -121.01 129.12 53.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.229 -0.441 . . . . 73.53 111.108 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.4 tttt -143.33 126.97 16.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.214 -0.448 . . . . 70.1 110.926 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.5 ' O ' ' C ' ' A' ' 36' ' ' GLU . 0.2 OUTLIER -88.22 174.95 7.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.24 -0.436 . . . . 73.21 110.843 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.5 ' C ' ' O ' ' A' ' 35' ' ' SER . 43.8 mm-40 -29.38 -56.61 0.15 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.112 -0.495 . . . . 71.31 110.904 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 -173.77 149.37 1.57 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 73.24 110.899 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 86.54 -11.16 64.56 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.757 -0.735 . . . . 54.1 112.488 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -104.2 132.49 50.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.791 0.329 . . . . 75.44 110.922 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.0 tm-20 -137.78 114.47 10.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.224 -0.444 . . . . 72.34 110.899 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -134.94 118.32 16.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.094 -0.503 . . . . 63.34 110.868 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.58 130.82 46.17 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.125 -0.489 . . . . 75.22 111.107 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.3 p -127.04 131.99 50.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.196 -0.457 . . . . 65.53 110.825 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.9 m -148.72 126.82 12.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.092 -0.504 . . . . 54.41 110.813 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -167.92 179.41 41.21 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.757 -0.735 . . . . 71.42 112.517 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.0 m -137.33 161.5 36.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.899 0.38 . . . . 75.13 110.819 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.7 150.49 36.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.093 -0.503 . . . . 70.2 111.108 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -73.77 142.65 46.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 74.11 110.832 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -55.14 -39.27 69.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.123 -0.489 . . . . 73.24 111.127 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -95.17 25.24 4.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.454 . . . . 73.13 110.874 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 20.5 p 48.09 30.75 2.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 75.1 111.093 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 22.7 m -71.1 -30.8 66.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 71.14 111.124 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 10.5 tptm -165.84 130.72 2.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.247 -0.433 . . . . 75.2 110.885 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.9 t -125.18 125.71 69.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 73.21 111.095 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.7 t -136.68 129.04 30.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 62.22 111.165 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -151.03 150.46 22.43 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.705 -0.759 . . . . 72.1 112.474 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -104.48 146.39 28.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.874 0.369 . . . . 74.15 110.875 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -125.67 132.41 52.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.12 -0.491 . . . . 73.21 110.94 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -125.39 120.08 30.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.441 . . . . 75.4 110.85 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 96.9 m -124.76 137.68 54.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 73.43 111.12 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.646 ' CB ' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -172.39 -178.6 2.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 74.54 110.882 179.901 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -115.22 141.65 47.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.233 -0.44 . . . . 75.42 110.897 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -134.41 111.65 10.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.097 -0.501 . . . . 74.44 110.906 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 2.4 m-90 -106.12 110.59 22.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 73.21 110.952 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 10.3 t -81.29 -33.26 32.75 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.257 -0.429 . . . . 65.05 111.136 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -49.97 -54.82 17.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.245 -0.434 . . . . 72.23 110.888 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -73.76 -51.11 17.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.463 . . . . 61.42 110.91 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 123.78 32.01 0.91 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.785 -0.721 . . . . 75.01 112.462 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -135.09 132.87 38.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.917 0.389 . . . . 75.23 110.866 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 55.5 p -132.42 111.09 11.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 75.51 111.119 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.634 ' O ' ' HB3' ' A' ' 61' ' ' LYS . 0.2 OUTLIER -105.56 132.69 51.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.438 . . . . 73.32 110.888 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.646 ' HA ' ' CB ' ' A' ' 61' ' ' LYS . 17.8 p -129.88 136.14 49.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.484 . . . . 70.23 111.143 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.567 ' H ' ' HB2' ' A' ' 61' ' ' LYS . 25.6 tt0 -126.5 122.01 33.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 73.41 110.877 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.49 139.69 44.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 75.1 110.892 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 8.1 t90 -135.44 129.54 33.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 75.42 110.924 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -116.85 149.29 40.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.263 -0.426 . . . . 73.14 110.891 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 8.8 t -65.12 -14.22 59.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.184 -0.462 . . . . 73.04 111.172 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.456 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 5.6 m-20 -75.25 2.03 12.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 74.35 110.865 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.456 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 2.9 m120 80.09 36.83 0.12 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 75.23 110.932 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.2 m -116.55 121.39 41.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 74.5 111.168 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -101.67 149.22 24.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.249 -0.432 . . . . 75.2 110.933 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -148.81 143.15 10.6 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.696 -0.764 . . . . 72.3 112.493 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.53 96.97 2.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.763 0.316 . . . . 61.04 111.11 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.423 ' HA ' ' HA ' ' A' ' 100' ' ' ASP . 15.8 tt0 -106.14 122.7 46.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.207 -0.451 . . . . 74.24 110.886 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -121.63 138.26 52.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 74.5 111.146 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.62 141.28 47.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.148 -0.478 . . . . 72.33 111.122 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -121.58 120.07 60.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 61.23 111.148 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -93.77 118.26 31.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 71.51 110.943 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 49.68 70.37 0.5 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.203 -0.453 . . . . 73.22 110.876 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 -76.37 86.69 3.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.205 -0.452 . . . . 74.32 110.9 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 11.7 tp 66.19 30.38 9.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 72.15 110.933 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -179.48 100.68 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 73.14 111.126 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 5.9 mpt_? -51.13 134.41 26.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 70.51 110.86 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 96.41 -20.27 51.06 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.721 -0.752 . . . . 61.24 112.542 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 14.5 tp -85.0 134.78 34.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.902 0.382 . . . . 75.22 110.896 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 10.9 ptmt -121.94 128.02 51.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 74.11 110.898 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -122.98 130.58 52.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 74.11 110.925 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -130.53 117.17 19.19 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.176 -0.465 . . . . 75.43 111.138 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -125.47 115.1 19.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 74.32 110.849 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.423 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 2.9 p30 -130.5 142.25 50.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.137 -0.483 . . . . 63.13 110.865 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.541 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 3.1 p -141.77 122.79 14.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 72.41 110.881 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 71.3 p -140.7 141.65 34.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 65.21 110.883 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.485 ' HB2' ' H ' ' A' ' 111' ' ' ASN . 0.1 OUTLIER -176.7 157.79 1.6 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.48 . . . . 74.32 110.885 -179.902 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -78.92 113.13 32.9 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.629 0.728 . . . . 73.54 110.888 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 -4.02 13.19 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.71 2.273 . . . . 71.11 112.325 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -45.13 -35.0 2.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 75.52 110.86 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.8 p -129.2 23.12 5.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.455 . . . . 74.52 111.177 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 75.69 27.33 63.23 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.678 -0.772 . . . . 74.24 112.511 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.431 ' O ' ' HB3' ' A' ' 103' ' ' PHE . 15.4 mtpt -77.61 140.74 39.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.835 0.35 . . . . 74.14 110.902 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.403 ' C ' ' HD1' ' A' ' 103' ' ' PHE . 23.4 mttt -156.61 113.38 3.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 62.54 110.895 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.541 ' O ' ' HA ' ' A' ' 101' ' ' SER . 44.2 t-20 -115.33 118.68 33.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.444 . . . . 64.44 110.914 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.424 ' HA ' ' HA ' ' A' ' 101' ' ' SER . . . -116.1 150.23 37.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.221 -0.445 . . . . 72.12 111.107 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 4.0 tttp -135.19 136.78 42.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 74.21 110.874 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 6.2 tp -112.07 125.01 69.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 72.43 111.096 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 28.5 tttt -122.02 120.0 33.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 72.51 110.915 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 7.1 t -125.35 125.98 44.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 73.53 111.168 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -153.46 176.9 31.3 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.7 -0.762 . . . . 54.12 112.487 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -128.27 144.6 51.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.907 0.384 . . . . 74.22 110.965 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 17.8 mtpt -110.42 117.97 35.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.106 -0.497 . . . . 75.42 110.893 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.447 ' HB2' HG22 ' A' ' 123' ' ' ILE . 1.4 mmm180 -110.65 146.55 35.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 75.15 110.899 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -56.6 -31.01 63.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 74.32 110.875 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 13.9 m80 -124.23 9.37 8.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.455 . . . . 74.32 110.884 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.447 HG22 ' HB2' ' A' ' 120' ' ' ARG . 1.0 OUTLIER -145.58 147.37 18.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 75.01 111.104 -179.999 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -127.62 113.62 16.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 75.33 110.877 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -117.44 127.43 54.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 74.44 110.94 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -146.7 114.71 0.74 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.726 -0.749 . . . . 74.4 112.476 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -113.29 134.62 54.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.847 0.356 . . . . 64.45 110.872 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -124.94 143.58 50.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 64.31 110.834 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 3.2 mmt -138.98 119.04 13.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 74.23 110.88 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -86.17 123.64 31.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.24 -0.436 . . . . 70.13 110.881 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -92.1 98.97 11.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 73.55 110.882 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -115.92 117.05 29.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.141 -0.481 . . . . 74.51 110.882 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 2.5 pp -53.83 -32.54 22.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 72.25 111.172 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -84.36 -20.01 32.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 65.13 111.115 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 162.01 101.66 0.17 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.741 -0.742 . . . . 74.21 112.503 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 161.31 46.42 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.703 2.269 . . . . 75.42 112.369 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.0 m -127.97 151.68 48.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.231 -0.44 . . . . 74.31 110.894 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 3.0 mp -109.06 125.65 66.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 70.21 111.093 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 15.5 ttt180 -122.85 129.25 51.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.119 -0.492 . . . . 74.4 110.882 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -124.18 133.71 8.85 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.712 -0.756 . . . . 72.42 112.509 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -133.16 126.64 32.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.855 0.36 . . . . 62.02 111.093 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -139.93 121.65 15.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.435 . . . . 75.11 110.882 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 1.5 m -133.8 139.55 48.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 74.25 111.139 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.6 mp -109.67 138.66 45.72 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.205 -0.452 . . . . 75.2 110.937 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -100.38 136.94 12.97 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.701 -0.761 . . . . 61.44 112.473 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -141.68 147.13 37.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.851 0.357 . . . . 75.44 110.932 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -49.85 94.3 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.135 -0.484 . . . . 63.22 110.842 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 89.66 -25.27 11.64 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.74 -0.743 . . . . 23.42 112.509 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 37.2 m95 -104.92 142.01 35.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.816 0.341 . . . . 73.03 110.909 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 43.7 tp -140.15 140.16 35.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.236 -0.438 . . . . 73.55 110.868 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -136.01 141.52 44.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 71.23 111.102 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -148.71 134.27 4.92 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.726 -0.749 . . . . 54.2 112.465 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -133.3 124.08 26.63 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.866 0.365 . . . . 73.21 110.976 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -121.0 121.57 38.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.116 -0.493 . . . . 75.11 110.908 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 2.7 ptp -128.1 128.41 44.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.451 . . . . 74.53 110.891 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 -113.62 121.58 44.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 71.53 110.901 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.422 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 38.9 m-85 -94.84 126.78 40.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 75.51 110.883 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.412 ' HG2' ' HB ' ' A' ' 165' ' ' THR . 0.0 OUTLIER -79.04 100.86 7.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 64.32 110.883 -179.909 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.56 -48.11 76.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.461 . . . . 74.41 111.11 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -48.19 -26.09 1.77 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.225 -0.443 . . . . 62.44 111.11 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 25.4 mmtt -127.24 -167.76 1.78 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 74.31 110.87 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 6.1 t -110.59 40.12 2.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.26 -0.427 . . . . 72.11 110.874 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 9.4 mmt180 -154.19 176.74 11.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.108 -0.496 . . . . 73.51 110.83 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.422 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 0.9 OUTLIER -73.61 142.69 14.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.14 -0.482 . . . . 72.22 111.122 179.97 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' THR . . . . . 0.412 ' HB ' ' HG2' ' A' ' 158' ' ' GLU . 8.6 t -90.51 -36.13 14.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.47 . . . . 74.25 111.117 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -156.24 142.88 18.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 64.43 110.871 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 2.5 p -124.99 129.66 50.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.177 -0.465 . . . . 72.3 110.845 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -136.2 148.31 48.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.103 -0.499 . . . . 74.52 110.889 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -152.09 140.17 20.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.192 -0.458 . . . . 74.32 110.892 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -154.63 142.77 20.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.465 . . . . 64.03 111.112 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -145.97 127.48 7.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 71.25 111.111 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -98.97 117.43 5.87 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.728 -0.749 . . . . 72.43 112.445 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.76 119.01 35.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.956 0.408 . . . . 74.24 110.92 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 3.3 mtpm? -116.16 127.28 54.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.085 -0.507 . . . . 71.12 110.878 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.14 166.99 10.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.226 -0.443 . . . . 74.54 111.151 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -73.34 -6.39 45.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.186 -0.461 . . . . 74.2 110.866 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -119.49 -37.99 3.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 74.43 110.867 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -148.96 150.81 33.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 71.22 110.904 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -125.55 122.05 35.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.136 -0.484 . . . . 72.32 110.917 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.524 ' C ' ' CD1' ' A' ' 180' ' ' LEU . 0.3 OUTLIER -126.35 146.15 50.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.22 -0.445 . . . . 73.2 110.97 179.982 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 66.1 m-70 -119.74 116.71 26.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 71.54 110.821 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.24 143.82 28.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 73.41 111.163 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 18.2 t30 -145.18 137.86 26.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 73.44 110.875 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 2.4 t -134.62 114.3 17.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.253 -0.43 . . . . 71.45 111.146 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -101.96 92.58 4.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 75.41 110.883 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 2.6 t70 66.13 171.36 0.23 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 75.23 110.879 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -69.53 -4.71 46.85 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.738 -0.744 . . . . 71.33 112.487 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 33.9 p -95.06 -26.34 16.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.808 0.337 . . . . 75.42 111.162 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -123.65 114.9 20.6 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.186 -0.461 . . . . 74.04 110.906 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -140.75 124.9 17.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 72.51 110.859 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -175.46 -149.17 7.19 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.744 -0.741 . . . . 62.41 112.509 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -173.51 -165.96 31.09 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.731 -0.747 . . . . 64.44 112.472 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 70.9 m -149.51 148.01 28.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.886 0.374 . . . . 75.13 110.858 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 5.4 mp -119.91 140.98 42.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.099 -0.5 . . . . 73.22 111.131 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -132.34 120.7 22.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 74.24 110.941 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 8.7 tm0? -126.2 131.26 52.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.168 -0.469 . . . . 72.23 110.946 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 6.1 mtmp? -97.65 124.81 42.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 73.15 110.851 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 84.1 t -94.39 -33.7 5.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.445 . . . . 74.24 111.107 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -174.66 170.41 3.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.47 . . . . 61.24 110.906 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 19.1 mtpt -50.93 -33.66 25.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 75.33 110.878 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 4.0 mptt -120.43 53.44 1.1 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.245 -0.434 . . . . 72.23 110.944 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -175.14 92.92 0.06 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 74.12 110.911 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -111.95 134.51 53.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 74.32 110.899 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 4.8 t -130.8 138.1 49.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 64.54 111.109 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -150.3 163.42 38.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.242 -0.435 . . . . 72.51 111.112 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -137.14 147.95 26.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.44 . . . . 70.12 111.124 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -120.87 126.61 50.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.47 . . . . 74.44 110.911 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 1.3 mp -128.41 142.77 51.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.161 -0.472 . . . . 74.43 110.908 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -157.47 130.77 7.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 73.24 111.126 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 1.8 t-105 -103.6 123.63 47.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.199 -0.455 . . . . 74.42 110.955 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 61.8 p -107.47 104.74 14.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.257 -0.429 . . . . 72.34 111.161 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -51.11 138.69 19.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.262 -0.426 . . . . 73.41 111.074 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 154.73 -46.79 0.53 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.689 -0.767 . . . . 73.31 112.482 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -151.62 35.02 0.55 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.804 0.335 . . . . 73.42 110.866 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 47.7 t 50.98 44.76 28.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 73.41 110.892 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -101.87 131.79 48.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.147 -0.479 . . . . 74.03 110.922 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 5.2 t -115.36 139.0 50.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 75.21 111.179 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -105.94 131.57 53.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.209 -0.45 . . . . 74.04 110.879 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -131.41 136.21 47.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.466 . . . . 73.21 110.919 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -145.45 153.12 25.08 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.73 -0.748 . . . . 74.21 112.446 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.67 130.68 42.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.85 0.357 . . . . 75.51 111.169 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -135.81 149.0 48.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.16 -0.473 . . . . 63.31 111.119 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -145.02 143.43 30.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.248 -0.433 . . . . 71.23 111.113 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 21.3 ttpp -117.74 132.89 56.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.237 -0.438 . . . . 73.34 110.865 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -132.99 132.38 41.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 73.35 110.908 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -93.67 130.45 39.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.107 -0.497 . . . . 74.43 110.922 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 71.5 mt -78.26 -56.0 8.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.214 -0.448 . . . . 74.34 111.129 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . 0.547 ' N ' ' HD2' ' A' ' 229' ' ' PRO . 0.1 OUTLIER 173.33 -56.94 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.61 0.719 . . . . 73.4 110.881 179.843 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 228' ' ' ASP . 53.2 Cg_endo -69.79 -156.73 0.04 OUTLIER 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.743 2.295 . . . . 64.45 112.332 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -85.55 15.79 4.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.266 -0.424 . . . . 64.11 110.871 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -120.43 122.28 40.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 65.22 111.059 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 31.7 m -115.71 144.39 44.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 74.03 110.837 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -111.44 131.23 55.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 75.11 110.823 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 3.5 p -127.67 141.75 51.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 70.12 110.867 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -119.76 141.65 49.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.122 -0.49 . . . . 74.24 111.096 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 18.2 mttp -145.74 142.54 29.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 74.01 110.858 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 6.7 p -136.35 142.74 37.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 72.12 111.129 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -104.51 148.38 26.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 72.32 110.866 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -57.15 -18.76 16.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 75.23 110.891 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 2.1 m -82.02 25.37 0.58 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.476 . . . . 64.01 110.874 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 63.6 34.46 12.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.121 -0.49 . . . . 74.44 110.829 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 2.7 mp -99.93 117.24 33.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 72.31 110.882 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -111.19 116.5 52.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.142 -0.481 . . . . 75.31 111.128 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -145.93 164.98 28.16 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.721 -0.752 . . . . 72.33 112.487 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.423 ' N ' ' CD1' ' A' ' 245' ' ' LEU . 0.0 OUTLIER -145.36 160.68 41.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.812 0.339 . . . . 75.03 110.926 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -129.52 139.62 11.1 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.718 -0.753 . . . . 64.13 112.464 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -116.69 115.86 26.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.996 0.427 . . . . 70.32 110.905 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 56.1 p -111.76 115.51 29.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.119 -0.492 . . . . 72.42 111.128 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -129.07 137.89 51.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 75.42 110.897 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 95.4 m -119.05 116.81 27.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.45 . . . . 73.54 111.157 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -106.02 103.71 13.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.236 -0.438 . . . . 75.04 110.921 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 20.1 mmmt 64.34 154.6 0.12 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.588 0.709 . . . . 73.12 110.886 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 75.42 1.23 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.699 2.266 . . . . 74.03 112.312 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 167.02 -32.17 0.2 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.782 -0.723 . . . . 74.43 112.477 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 7.3 mt -117.68 122.58 70.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.965 0.412 . . . . 74.15 111.099 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 20.9 mtpt -130.81 127.35 38.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.484 . . . . 71.01 110.935 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -100.68 128.78 46.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.242 -0.435 . . . . 73.21 110.886 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 23.3 m -126.46 113.01 16.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 74.11 111.125 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -121.45 150.55 41.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.207 -0.452 . . . . 75.32 110.915 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 40.8 p -151.16 140.96 21.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 71.22 110.874 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -141.37 133.49 27.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.142 -0.481 . . . . 74.32 111.087 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -131.85 138.2 48.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.221 -0.445 . . . . 75.13 110.917 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -121.81 109.28 14.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.155 -0.475 . . . . 73.33 110.923 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.73 103.95 14.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 71.31 110.86 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -59.21 -11.04 11.31 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.685 -0.769 . . . . 71.13 112.508 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 47.3 mtpt -78.29 -3.31 42.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.826 0.346 . . . . 75.33 110.914 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 -156.19 -53.28 0.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 63.15 110.884 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 1.8 m -57.71 -18.85 10.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 73.34 111.126 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -50.94 -28.35 9.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 73.33 110.88 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -102.95 -17.61 15.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.457 . . . . 71.03 111.085 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 142.43 122.66 1.77 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.758 -0.734 . . . . 73.22 112.496 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 134.78 62.12 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.707 -0.759 . . . . 73.13 112.521 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 18.2 p-80 -76.33 146.13 39.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.855 0.359 . . . . 72.24 110.843 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 13.9 mttp -95.46 135.37 37.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 72.15 110.933 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -135.59 139.25 43.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 75.14 110.927 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -134.03 129.26 5.22 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.738 -0.744 . . . . 51.45 112.526 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -115.54 135.35 54.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.901 0.382 . . . . 75.2 110.889 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -147.45 141.49 9.35 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.746 -0.74 . . . . 75.02 112.481 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -119.57 140.13 51.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.798 0.333 . . . . 63.12 110.894 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 15.3 mp0 -128.53 118.21 22.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.148 -0.478 . . . . 74.3 110.868 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -114.24 128.83 56.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.479 . . . . 73.51 110.877 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -113.42 112.99 24.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 72.12 110.92 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -115.72 113.34 23.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 63.44 111.066 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -130.75 -74.52 0.53 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 74.42 110.941 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 74.13 110.929 179.92 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.3 mmt . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.791 0.329 . . . . 65.44 110.88 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -124.64 137.92 54.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 52.03 111.12 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.1 t 60.47 82.58 0.22 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.649 0.737 . . . . 74.34 111.148 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 167.76 23.49 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.684 2.256 . . . . 75.31 112.323 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 116.48 4.59 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.653 2.236 . . . . 75.3 112.324 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.8 t -107.85 -39.44 5.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 74.44 111.172 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -67.96 -35.17 77.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 74.45 110.896 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -73.17 -23.32 60.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.113 -0.494 . . . . 74.35 111.103 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -90.02 13.95 13.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 72.51 110.855 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 45.2 mt -73.77 -34.27 64.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.2 -0.455 . . . . 74.43 110.954 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 172.62 40.94 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.699 -0.762 . . . . 71.41 112.437 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 44.4 tptt -68.6 -46.02 70.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.823 0.344 . . . . 74.13 110.917 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.1 t -64.79 -39.44 93.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 72.21 110.865 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.14 -49.97 52.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 55.14 111.083 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -66.72 -32.79 74.32 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.223 -0.444 . . . . 75.52 110.87 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -58.89 -48.17 82.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.147 -0.478 . . . . 73.45 110.837 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.8 p -81.54 -31.44 11.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 73.24 111.148 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -65.92 -41.35 91.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 74.32 110.905 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 69.0 p -73.81 76.92 1.6 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 73.55 111.187 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.95 124.68 18.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 72.33 110.882 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -53.49 120.11 12.76 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.761 -0.733 . . . . 73.21 112.456 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -59.89 97.96 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.936 0.398 . . . . 74.2 110.914 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -77.74 88.78 1.05 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.749 -0.739 . . . . 74.11 112.529 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -101.12 13.39 35.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.914 0.388 . . . . 73.53 110.888 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.85 13.31 80.77 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.709 -0.758 . . . . 71.42 112.481 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.7 pp -101.91 174.81 5.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.836 0.351 . . . . 74.53 110.881 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 1.7 mp -116.94 123.89 72.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 74.42 111.142 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 71.6 mttt -101.69 154.56 18.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 73.45 110.909 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -146.05 136.34 23.85 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.23 -0.441 . . . . 73.25 110.88 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -153.81 124.64 7.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.456 . . . . 73.13 110.93 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -137.2 128.12 27.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.196 -0.456 . . . . 74.4 110.919 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 10.8 pttp -120.7 134.67 55.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 74.04 110.936 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -137.95 120.65 16.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 65.31 111.147 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -126.12 146.99 49.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.234 -0.439 . . . . 75.12 110.892 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -139.06 166.99 23.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 64.41 110.878 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -89.42 49.46 1.76 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.118 -0.492 . . . . 62.32 110.878 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -136.37 4.84 2.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.476 . . . . 73.22 110.875 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.513 ' HA2' ' O ' ' A' ' 63' ' ' ARG . . . 89.13 -7.16 82.76 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.741 -0.742 . . . . 74.33 112.482 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.415 ' O ' HD21 ' A' ' 39' ' ' LEU . 1.6 pt? -98.76 129.83 45.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.779 0.323 . . . . 75.43 110.926 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -142.08 117.86 10.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.444 . . . . 70.12 110.895 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.51 122.29 43.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 71.42 110.872 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.11 115.32 19.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 70.42 111.12 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.7 p -115.68 134.43 55.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.249 -0.432 . . . . 73.15 110.888 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 74.8 m -149.26 126.64 11.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 64.43 110.827 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -173.62 167.53 40.17 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.734 -0.746 . . . . 70.24 112.524 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.4 p -137.58 158.05 45.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.885 0.374 . . . . 73.54 110.865 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.428 ' HA ' ' HA ' ' A' ' 54' ' ' VAL . . . -140.42 129.66 23.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 74.01 111.085 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -98.06 127.34 43.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 74.54 110.874 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 28.6 p -90.68 -52.93 4.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 74.31 111.113 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -51.51 -38.28 53.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 73.12 110.896 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 43.9 p -133.91 161.79 33.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 73.24 111.134 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.2 p -75.7 78.1 2.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.227 -0.442 . . . . 72.2 111.111 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 10.9 ttpt -142.7 78.83 1.63 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 74.45 110.906 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.428 ' HA ' ' HA ' ' A' ' 47' ' ' ALA . 1.3 p -127.79 121.24 56.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 74.14 111.104 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 6.3 m -137.22 126.72 25.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.202 -0.454 . . . . 73.13 111.107 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -111.87 154.28 16.86 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.751 -0.738 . . . . 64.33 112.487 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.5 m -136.98 143.87 43.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.889 0.376 . . . . 61.21 110.865 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -121.08 126.28 49.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 72.21 110.911 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -121.69 126.46 49.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 72.13 110.878 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -104.11 120.12 40.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.143 -0.481 . . . . 73.01 111.119 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -119.76 158.75 25.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.181 -0.463 . . . . 74.42 110.855 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.418 ' HB2' ' HB2' ' A' ' 71' ' ' PHE . 21.7 m-85 -133.16 140.89 47.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.145 -0.479 . . . . 74.04 110.898 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.513 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 21.4 tpp180 -131.25 103.32 6.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.107 -0.497 . . . . 73.14 110.86 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 17.8 m95 -116.15 121.26 41.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.461 . . . . 72.44 110.961 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.7 m 66.34 136.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.251 -0.431 . . . . 73.05 111.148 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -63.82 106.07 0.94 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.241 -0.436 . . . . 74.42 110.858 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 23.2 t80 66.51 59.08 0.63 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.154 -0.475 . . . . 73.53 110.886 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -140.62 -65.78 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.743 -0.741 . . . . 71.42 112.482 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -130.62 129.03 42.18 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.891 0.377 . . . . 74.14 110.907 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 5.1 m -137.92 133.26 33.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.177 -0.465 . . . . 62.34 111.124 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.418 ' HB2' ' HB2' ' A' ' 62' ' ' TYR . 19.9 m-85 -123.27 134.79 54.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.444 . . . . 74.13 110.886 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.8 p -127.28 118.52 24.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.466 . . . . 72.5 111.19 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -121.82 130.06 53.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.259 -0.428 . . . . 74.44 110.849 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -122.24 104.98 9.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.48 . . . . 73.23 110.857 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 8.6 t90 -122.35 125.71 46.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.251 -0.431 . . . . 75.23 110.909 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -102.81 137.11 41.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 70.22 110.926 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 24.0 m -66.85 -34.4 77.72 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.206 -0.452 . . . . 73.32 111.136 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -110.81 -34.08 6.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.258 -0.428 . . . . 64.24 110.891 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -81.25 -160.55 0.34 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 72.25 110.901 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 66.6 p -80.95 154.05 27.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 74.53 111.154 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -111.44 137.31 49.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 74.24 110.896 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -159.77 162.94 33.37 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.73 -0.748 . . . . 54.11 112.466 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.5 t -138.46 163.54 31.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.721 0.296 . . . . 74.22 111.137 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.33 145.48 25.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.456 . . . . 74.21 110.868 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.56 138.08 55.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.475 . . . . 74.52 111.146 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 20.3 m -127.03 129.15 47.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.18 -0.463 . . . . 73.44 111.156 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.4 p -128.61 137.34 57.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 74.14 111.16 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -102.62 118.47 36.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 71.54 110.878 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -50.49 128.07 19.2 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.156 -0.474 . . . . 74.33 110.867 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -79.43 -56.71 4.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.185 -0.461 . . . . 71.43 110.935 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 15.3 mt -72.26 -41.29 66.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 74.42 110.928 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -93.78 71.6 4.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 74.24 111.121 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 11.5 tpt180 -50.98 135.32 24.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 74.31 110.883 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 101.75 -23.61 34.27 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.762 -0.733 . . . . 71.41 112.507 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.8 119.41 22.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.914 0.388 . . . . 75.33 110.905 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -121.42 125.74 47.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 74.44 110.871 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -118.62 126.71 52.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.445 . . . . 75.4 110.943 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 97.2 m -131.33 119.83 22.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 72.12 111.139 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -115.11 121.73 43.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 75.21 110.895 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -119.29 150.0 40.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.163 -0.471 . . . . 73.32 110.851 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 7.1 t -142.22 124.81 15.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 73.42 110.84 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 4.9 m -99.77 146.52 26.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.108 -0.496 . . . . 75.24 110.898 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -143.12 138.55 29.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.458 . . . . 74.41 110.923 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 17.7 m -99.0 137.41 20.48 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.647 0.737 . . . . 72.32 110.882 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.83 125.57 12.26 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.719 2.279 . . . . 62.32 112.332 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 51.01 48.86 22.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 71.14 110.928 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 25.9 m -136.96 -41.53 0.59 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.143 -0.481 . . . . 71.43 111.103 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 92.28 -18.01 55.55 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.763 -0.732 . . . . 72.42 112.525 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 8.5 tttm -65.94 116.61 7.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.855 0.36 . . . . 75.41 110.931 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 15.0 ptmt -115.81 131.0 57.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 74.13 110.912 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -120.98 123.87 43.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.208 -0.451 . . . . 73.23 110.907 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -110.55 136.2 50.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.454 . . . . 72.43 111.113 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 11.2 mttt -138.25 137.78 37.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 74.51 110.888 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 5.7 tp -120.34 130.73 74.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.437 . . . . 65.33 111.127 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.6 tptp -120.35 119.69 33.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 74.03 110.879 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 58.7 m -129.61 121.48 27.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 74.33 111.145 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -150.56 170.68 30.43 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.769 -0.729 . . . . 74.24 112.497 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -127.98 135.84 50.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.973 0.416 . . . . 75.02 110.934 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.9 tttt -110.86 118.02 34.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.12 -0.491 . . . . 75.51 110.87 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 23.1 ttm-85 -111.42 143.73 41.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 71.44 110.883 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -52.35 -29.36 23.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 74.42 110.899 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -86.31 -41.16 14.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 74.54 110.883 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.3 pp -148.25 153.53 11.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.224 -0.444 . . . . 74.51 111.111 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -127.24 115.06 18.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 75.5 110.905 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.616 ' CD2' ' C ' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -133.39 142.79 48.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 72.42 110.927 179.959 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -148.02 141.97 9.67 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.723 -0.751 . . . . 71.2 112.47 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 2.0 t -113.32 131.0 56.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.81 0.338 . . . . 74.42 110.883 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -119.68 150.41 40.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.232 -0.44 . . . . 75.34 110.888 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 8.1 ttt -138.03 119.76 15.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.446 . . . . 75.21 110.886 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -102.33 120.95 41.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.202 -0.454 . . . . 73.31 110.871 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -95.34 116.34 28.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 75.04 110.868 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -109.94 173.66 6.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 62.21 110.87 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 2.8 mp -93.34 -33.59 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 72.44 111.154 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -92.69 -19.77 21.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 75.42 111.075 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 168.9 106.63 0.19 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.76 -0.733 . . . . 71.45 112.484 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 144.56 54.25 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.639 2.226 . . . . 75.14 112.328 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 9.4 t -128.77 152.35 48.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.444 . . . . 73.24 110.841 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 1.7 mp -112.34 135.48 51.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.131 -0.486 . . . . 73.14 111.09 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 8.5 ttm180 -121.48 112.32 18.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.458 . . . . 73.4 110.871 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -111.65 136.38 13.51 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.775 -0.726 . . . . 70.21 112.525 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -138.54 116.26 11.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.799 0.333 . . . . 74.43 111.125 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.1 tp -123.86 124.51 42.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.252 -0.431 . . . . 74.41 110.901 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 44.5 t -114.25 129.85 69.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 74.2 111.081 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -106.14 138.85 41.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 74.51 110.899 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -116.27 136.6 13.0 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.781 -0.723 . . . . 73.1 112.487 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -140.46 146.43 38.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.876 0.37 . . . . 75.01 110.909 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 74.5 mt-10 -50.31 96.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.136 -0.483 . . . . 75.42 110.907 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 90.16 -26.08 10.89 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.745 -0.741 . . . . 55.55 112.541 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 7.1 m0 -105.15 135.64 46.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.803 0.335 . . . . 75.54 110.886 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -126.53 140.07 52.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.265 -0.425 . . . . 75.44 110.876 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -139.76 145.2 37.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 73.24 111.083 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -146.97 132.97 4.58 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.71 -0.757 . . . . 62.21 112.516 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -135.43 120.17 18.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.842 0.354 . . . . 75.54 110.899 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -134.05 122.45 23.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.137 -0.483 . . . . 72.23 110.95 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 4.3 ptt? -145.96 155.39 42.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 73.33 110.892 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -112.72 129.92 56.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 74.24 110.846 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.405 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 62.1 t80 -90.44 133.16 35.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.48 . . . . 75.13 110.861 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -77.82 101.94 6.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.473 . . . . 74.4 110.914 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.97 -47.4 77.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.127 -0.488 . . . . 74.12 111.117 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -48.6 -26.07 2.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 71.3 111.097 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 4.1 tptt -126.11 -167.51 1.72 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 65.11 110.919 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 11.7 t -112.03 40.83 2.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.446 . . . . 75.42 110.814 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -154.47 176.09 12.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 75.34 110.869 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 2.0 t -82.55 141.51 14.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.446 . . . . 74.15 111.125 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 15.2 t -91.01 -34.19 15.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.192 -0.458 . . . . 73.24 111.154 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -152.45 138.18 17.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 74.24 110.897 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 3.5 m -124.7 131.14 53.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 72.41 110.879 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -132.09 135.16 46.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 71.53 110.843 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -130.06 148.51 51.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.103 -0.499 . . . . 72.32 110.887 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -153.42 138.13 16.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 74.14 111.117 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 61.8 t -120.64 134.7 63.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.252 -0.431 . . . . 72.11 111.09 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -116.01 131.29 9.53 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.737 -0.744 . . . . 65.03 112.497 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -130.03 120.66 25.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.961 0.41 . . . . 74.22 110.926 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.14 132.28 54.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.079 -0.509 . . . . 73.3 110.888 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.47 166.49 21.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 74.42 111.136 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -39.79 -73.82 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.22 -0.446 . . . . 61.03 110.885 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -117.05 14.81 15.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.459 . . . . 55.34 110.951 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -126.15 142.3 51.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.115 -0.493 . . . . 70.01 110.897 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 53.8 mm-40 -136.6 125.29 23.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.111 -0.495 . . . . 71.23 110.9 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -123.31 129.01 50.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.462 . . . . 72.45 110.929 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 25.7 m80 -129.85 117.78 20.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 73.13 110.89 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 9.2 m -109.31 155.77 20.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 73.4 111.175 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -162.47 139.42 7.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.24 -0.436 . . . . 73.25 110.909 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.546 ' HB ' ' HA ' ' A' ' 190' ' ' PHE . 2.0 m -133.62 138.61 50.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 70.41 111.139 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -97.7 88.77 4.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 75.35 110.891 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 72.4 -176.4 0.18 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.195 -0.457 . . . . 74.33 110.888 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -79.45 3.08 69.12 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.73 -0.748 . . . . 71.21 112.479 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 3.9 t -107.54 -22.29 12.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.801 0.334 . . . . 73.41 111.172 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -120.83 124.32 44.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.47 . . . . 74.42 110.894 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' PHE . . . . . 0.546 ' HA ' ' HB ' ' A' ' 184' ' ' VAL . 0.4 OUTLIER -137.76 125.38 22.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.183 -0.462 . . . . 74.21 110.882 -179.906 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -146.3 170.91 27.31 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.752 -0.737 . . . . 73.05 112.467 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -150.5 164.14 29.74 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.73 -0.748 . . . . 54.02 112.458 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -139.56 141.98 37.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.863 0.363 . . . . 71.44 110.836 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 5.3 mp -131.65 116.89 32.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 75.41 111.107 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -108.83 122.31 46.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.134 -0.485 . . . . 71.32 110.915 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 22.4 tp60 -124.3 122.6 38.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.089 -0.505 . . . . 72.55 110.922 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.94 127.29 47.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 75.15 110.925 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 9.3 t -82.64 155.99 3.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.228 -0.442 . . . . 75.15 111.089 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -50.45 -50.2 52.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 73.31 110.919 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 13.7 mmtp -69.63 -170.42 0.3 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 74.11 110.885 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 23.3 mtpp -81.45 55.58 2.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 73.23 110.912 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -135.61 116.25 13.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 75.41 110.922 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -107.25 139.35 41.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 75.04 110.913 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 6.1 m -124.0 138.83 54.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 74.43 111.106 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -137.6 143.34 41.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 74.41 111.087 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 10.6 t -132.43 137.94 53.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.46 . . . . 74.32 111.124 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -149.22 125.89 11.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 74.0 110.902 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -147.08 150.58 35.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.162 -0.472 . . . . 74.02 110.929 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -134.44 149.28 50.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 75.44 111.075 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 17.3 t90 -130.42 132.02 45.53 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.214 -0.448 . . . . 75.51 110.926 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 1.7 m -95.69 107.89 20.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 75.42 111.153 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -51.88 146.76 7.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 64.31 111.075 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 104.35 -38.54 3.21 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.732 -0.747 . . . . 71.11 112.442 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 31.8 m120 -121.23 166.94 13.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.877 0.37 . . . . 74.5 110.86 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 39.3 m -97.38 36.93 1.4 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 72.22 110.833 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 16.9 t30 -101.83 111.52 23.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.107 -0.497 . . . . 74.11 110.937 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 35.0 p -115.33 138.66 50.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.45 . . . . 71.31 111.139 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -126.77 123.97 38.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 71.03 110.896 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -132.69 156.11 47.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 74.22 110.842 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -149.33 147.88 18.68 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.729 -0.748 . . . . 60.12 112.482 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 3.7 mp -120.67 132.15 70.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.87 0.367 . . . . 75.31 111.106 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -138.06 130.81 29.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 63.21 111.101 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -123.97 158.41 32.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 73.44 111.098 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 19.4 ttmm -124.09 137.48 54.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.431 . . . . 73.25 110.936 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -132.34 117.61 18.36 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.206 -0.452 . . . . 75.01 110.944 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -89.95 130.48 36.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.131 -0.486 . . . . 73.32 110.915 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 62.7 mt -81.83 -57.67 4.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 74.41 111.085 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . 0.546 ' N ' ' HD2' ' A' ' 229' ' ' PRO . 0.6 OUTLIER 170.7 -56.89 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.673 0.749 . . . . 73.04 110.877 179.938 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 228' ' ' ASP . 53.4 Cg_endo -69.81 -156.42 0.04 OUTLIER 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.68 2.253 . . . . 73.43 112.359 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -85.49 17.27 3.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.225 -0.443 . . . . 74.02 110.862 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -119.52 122.12 40.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 44.41 111.097 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 32.5 t -120.6 142.68 49.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.451 . . . . 73.22 110.886 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -108.88 128.18 54.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 75.11 110.855 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -122.12 154.07 37.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 72.24 110.853 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -133.03 149.78 52.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.122 -0.49 . . . . 72.5 111.169 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 34.0 mttp -145.74 164.06 33.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.23 -0.441 . . . . 73.25 110.94 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 6.0 p -156.19 143.17 10.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.266 -0.424 . . . . 73.23 111.171 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -106.2 147.97 28.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 73.54 110.879 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' ASN . . . . . 0.412 ' C ' ' H ' ' A' ' 241' ' ' SER . 4.3 t30 -52.55 -22.77 5.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 73.05 110.854 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 32.2 t -81.2 26.15 0.46 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.46 . . . . 72.1 110.84 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' SER . . . . . 0.412 ' H ' ' C ' ' A' ' 239' ' ' ASN . 5.0 t 58.08 38.98 26.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.475 . . . . 73.21 110.902 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 3.6 mp -98.7 129.54 45.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.093 -0.503 . . . . 75.3 110.888 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 4.0 mp -93.02 117.78 37.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.458 . . . . 74.52 111.12 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -117.53 144.3 18.22 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.766 -0.731 . . . . 55.25 112.468 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.3 128.56 16.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.828 0.347 . . . . 75.15 110.953 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -130.35 122.06 3.51 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.733 -0.746 . . . . 74.51 112.466 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -110.27 115.97 30.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.907 0.384 . . . . 75.24 110.949 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.58 114.88 28.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 74.34 111.143 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -143.4 138.64 29.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 74.13 110.924 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' THR . . . . . 0.445 ' HA ' ' HA ' ' A' ' 256' ' ' LYS . 16.3 p -77.95 147.51 34.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 74.25 111.137 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 13.8 tp -111.36 -74.71 0.63 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 75.43 110.954 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' LYS . . . . . 0.562 ' HB3' ' HD2' ' A' ' 253' ' ' PRO . 12.7 mmmt -97.43 163.15 20.36 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.564 0.697 . . . . 74.45 110.918 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . 0.562 ' HD2' ' HB3' ' A' ' 252' ' ' LYS . 53.7 Cg_endo -69.75 67.08 1.75 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.718 2.278 . . . . 73.22 112.335 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . 0.617 ' O ' ' HB3' ' A' ' 281' ' ' PHE . . . 157.67 -17.94 0.35 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.767 -0.73 . . . . 74.14 112.495 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.435 ' HA ' ' CB ' ' A' ' 281' ' ' PHE . 15.9 pt -129.36 141.5 46.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.928 0.394 . . . . 75.22 111.121 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 250' ' ' THR . 48.7 tttt -117.69 138.33 52.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 75.02 110.895 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.09 128.56 43.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 74.35 110.92 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 4.4 m -119.81 122.62 41.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.465 . . . . 75.12 111.16 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -110.29 138.94 45.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.218 -0.446 . . . . 75.51 110.912 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 70.6 m -136.67 140.55 42.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 71.13 110.857 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -146.57 129.07 15.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.099 -0.5 . . . . 55.54 111.14 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -121.94 130.05 53.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.27 -0.423 . . . . 72.11 110.924 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -124.24 110.55 14.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.469 . . . . 72.32 110.919 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . 0.554 ' O ' ' HB ' ' A' ' 268' ' ' VAL . 0.7 OUTLIER -86.8 98.33 11.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.155 -0.475 . . . . 75.4 110.846 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -53.02 -11.95 1.62 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.762 -0.732 . . . . 74.2 112.454 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -64.41 -25.46 68.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.78 0.324 . . . . 74.02 110.896 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -168.44 19.91 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 72.04 110.873 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . 0.554 ' HB ' ' O ' ' A' ' 264' ' ' ASP . 1.7 p -68.52 -27.0 34.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 71.32 111.16 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -77.8 -44.83 26.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 75.13 110.922 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -95.93 12.41 30.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 64.43 111.11 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -129.62 -104.22 1.1 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.708 -0.758 . . . . 71.13 112.47 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -164.67 172.26 40.35 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.708 -0.758 . . . . 73.4 112.489 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 2.4 p-80 -105.25 146.66 29.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.839 0.352 . . . . 74.21 110.909 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -95.66 136.34 36.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 74.21 110.884 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -134.36 139.07 45.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.243 -0.435 . . . . 74.23 110.917 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -140.04 130.29 4.61 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.685 -0.769 . . . . 63.02 112.462 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -115.93 138.67 50.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.859 0.361 . . . . 73.22 110.904 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -162.04 129.06 2.0 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.74 -0.743 . . . . 73.52 112.474 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.69 127.99 54.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.784 0.326 . . . . 73.53 110.896 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . 0.436 ' O ' ' HB2' ' A' ' 281' ' ' PHE . 1.8 pm0 -140.92 147.06 38.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.162 -0.472 . . . . 71.11 110.888 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . 0.617 ' HB3' ' O ' ' A' ' 254' ' ' GLY . 0.0 OUTLIER 168.73 -157.99 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.134 -0.484 . . . . 73.13 110.842 -179.945 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -136.22 143.15 44.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.145 -0.48 . . . . 63.12 110.984 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -91.17 112.43 24.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 74.02 111.131 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -136.99 179.18 6.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.23 -0.441 . . . . 71.05 110.944 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.214 -0.448 . . . . 74.11 110.898 179.962 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' NAI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.2 mtm . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.813 0.339 . . . . 74.13 110.884 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -159.1 133.5 7.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 72.15 111.1 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 24.8 t -139.7 82.16 18.52 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.601 0.715 . . . . 73.21 111.127 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 168.28 21.98 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.712 2.275 . . . . 74.11 112.319 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 95.55 0.56 Allowed 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.636 2.224 . . . . 72.22 112.349 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -79.64 -48.6 13.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.247 -0.433 . . . . 72.11 111.088 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -52.79 -40.52 63.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.21 -0.45 . . . . 73.14 110.931 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.99 -19.86 58.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.134 -0.485 . . . . 71.12 111.109 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -88.62 10.47 20.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.168 -0.469 . . . . 75.3 110.833 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.59 -34.15 77.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.456 . . . . 72.32 110.935 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -152.09 63.57 0.38 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.748 -0.739 . . . . 74.33 112.499 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.34 -54.51 14.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.833 0.349 . . . . 75.41 110.879 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 m -64.02 -39.49 94.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 64.15 110.83 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.51 -37.7 73.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 73.13 111.11 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 63.2 mtt-85 -61.85 -36.85 82.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.451 . . . . 74.3 110.874 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.91 -37.97 82.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.218 -0.446 . . . . 71.44 110.855 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 97.6 t -75.24 -35.88 35.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.143 -0.48 . . . . 74.33 111.139 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -60.92 -41.0 95.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 73.31 110.853 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.0 m 51.9 78.34 0.12 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 73.42 111.137 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.84 119.74 11.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.44 . . . . 75.41 110.862 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.46 96.74 1.28 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.733 -0.746 . . . . 73.3 112.507 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -86.55 -175.83 5.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.928 0.394 . . . . 74.51 110.932 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.84 114.5 5.34 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.728 -0.748 . . . . 64.2 112.478 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -103.9 12.85 33.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.956 0.408 . . . . 75.22 110.924 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.61 14.18 77.79 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.685 -0.769 . . . . 73.35 112.498 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.2 pp -114.81 179.81 3.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.794 0.331 . . . . 74.05 110.932 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 32.6 mm -109.87 125.84 67.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 75.01 111.125 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.9 mttt -102.84 149.85 24.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.182 -0.463 . . . . 73.24 110.878 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -147.1 130.3 16.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 62.3 110.911 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -146.71 126.3 13.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.207 -0.452 . . . . 74.14 110.897 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -134.78 125.54 27.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 74.31 110.922 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.86 147.23 45.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.218 -0.446 . . . . 75.15 110.898 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.9 p -137.2 120.48 16.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.44 . . . . 74.01 111.15 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 40.1 mtpt -115.32 129.99 56.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.245 -0.434 . . . . 74.14 110.917 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -125.44 138.13 54.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 74.32 110.822 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -76.85 60.29 1.73 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.476 . . . . 73.32 110.868 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -159.28 23.12 0.19 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 73.34 110.895 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.578 ' HA2' ' O ' ' A' ' 63' ' ' ARG . . . 79.59 -3.73 67.34 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.781 -0.723 . . . . 51.52 112.437 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -97.39 124.3 41.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.802 0.334 . . . . 74.33 110.899 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -145.26 117.98 8.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.134 -0.484 . . . . 73.2 110.893 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -111.71 123.58 50.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.481 . . . . 72.23 110.902 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.65 120.97 30.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 74.13 111.168 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.9 p -121.37 142.36 50.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 71.04 110.87 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 21.0 m -147.99 136.05 21.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.147 -0.479 . . . . 61.31 110.861 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -172.87 158.85 29.08 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.759 -0.734 . . . . 74.34 112.492 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -138.32 150.69 46.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.911 0.386 . . . . 74.52 110.872 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -121.17 130.74 53.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.475 . . . . 75.51 111.055 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -72.07 118.94 15.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 75.3 110.91 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 33.8 m -58.73 149.68 25.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.47 . . . . 74.43 111.186 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 39.9 40.13 0.67 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 74.13 110.92 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 98.8 m -161.26 126.69 3.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.154 -0.475 . . . . 74.32 111.126 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 71.5 p -76.24 66.8 2.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.251 -0.432 . . . . 75.31 111.153 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.6 ttmt -156.27 104.04 2.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 74.43 110.886 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.2 m -126.47 148.29 31.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.182 -0.463 . . . . 65.03 111.146 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 91.5 m -116.26 126.61 53.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 72.42 111.164 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -127.73 150.8 18.38 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.742 -0.742 . . . . 71.04 112.478 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 78.0 p -146.29 142.23 28.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.918 0.39 . . . . 73.12 110.869 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -121.88 125.27 46.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.124 -0.489 . . . . 74.32 110.935 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -124.77 129.47 50.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 75.42 110.902 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.9 t -99.63 128.85 45.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.135 -0.484 . . . . 54.15 111.129 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.401 ' HA ' ' O ' ' A' ' 71' ' ' PHE . 26.7 ttmt -126.98 154.36 44.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 72.01 110.906 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.429 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 9.4 m-85 -130.38 140.08 50.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.443 . . . . 72.43 110.887 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.578 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 21.7 tpp85 -118.0 103.99 10.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.062 -0.517 . . . . 73.12 110.879 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -106.4 114.66 28.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 74.25 110.895 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 6.0 t -94.41 -167.55 1.68 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.209 -0.45 . . . . 74.1 111.108 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 59.41 30.42 20.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 71.32 110.857 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 179.58 -53.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 65.41 110.949 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 110.51 64.77 0.53 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.732 -0.747 . . . . 65.5 112.505 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.0 mp -134.44 132.33 39.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.88 0.371 . . . . 72.42 110.933 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 44.2 p -136.29 135.1 38.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 63.11 111.167 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.402 ' HB3' ' HB2' ' A' ' 62' ' ' TYR . 23.7 t80 -117.46 131.14 56.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.241 -0.436 . . . . 74.33 110.899 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.8 t -128.56 121.09 27.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 72.22 111.107 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -126.62 130.21 50.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 75.2 110.883 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 5.4 ttpm? -113.0 110.82 21.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.479 . . . . 73.23 110.883 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.421 ' CD1' ' CB ' ' A' ' 81' ' ' LEU . 2.6 t90 -115.67 126.92 54.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 72.43 110.908 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -120.74 136.11 54.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.25 -0.432 . . . . 74.13 110.904 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 9.5 t -70.5 -36.08 73.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 74.24 111.177 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -111.6 -35.37 5.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.207 -0.451 . . . . 72.05 110.886 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -78.88 -154.0 0.07 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 72.51 110.904 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.1 t -78.97 149.39 32.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 74.31 111.135 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.421 ' CB ' ' CD1' ' A' ' 75' ' ' TRP . 0.1 OUTLIER -124.04 117.64 25.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 73.05 110.897 179.962 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.83 170.16 39.03 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.743 -0.742 . . . . 73.43 112.489 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -131.52 159.63 37.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.776 0.322 . . . . 72.44 111.119 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -142.42 144.54 33.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 74.11 110.899 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.5 pp -121.61 138.87 50.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 71.51 111.146 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.46 127.73 43.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 71.35 111.123 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.9 m -128.39 138.36 54.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 75.24 111.099 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -118.47 128.48 54.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.139 -0.482 . . . . 73.22 110.922 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 56.98 39.85 29.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.184 -0.462 . . . . 74.21 110.88 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -66.81 -35.32 79.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.452 . . . . 75.43 110.872 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.3 tt -122.31 -37.12 2.85 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.24 -0.436 . . . . 64.41 110.904 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -146.67 138.4 24.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 72.51 111.112 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -59.73 134.45 57.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.25 -0.432 . . . . 73.01 110.853 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 100.37 -23.45 35.8 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.717 -0.754 . . . . 62.11 112.473 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 4.7 tp -95.62 129.4 42.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.879 0.371 . . . . 63.34 110.898 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 8.8 tttm -122.66 131.48 53.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 72.04 110.904 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.82 127.31 54.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.235 -0.439 . . . . 73.15 110.934 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.8 m -129.76 123.53 31.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.203 -0.453 . . . . 73.43 111.127 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -110.38 121.97 46.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.459 . . . . 75.54 110.874 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -110.36 124.49 51.8 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.163 -0.472 . . . . 74.34 110.877 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.0 t -124.14 121.45 35.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 73.33 110.865 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 75.7 m -114.88 145.86 41.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 75.13 110.852 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -135.12 137.41 42.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.147 -0.479 . . . . 73.35 110.895 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.7 t -128.41 138.94 34.12 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.681 0.753 . . . . 75.42 110.847 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.79 -23.91 30.13 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.646 2.231 . . . . 74.51 112.319 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -56.2 99.06 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.431 . . . . 75.42 110.877 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 53.2 26.92 5.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 75.31 111.171 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 67.15 24.5 73.35 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.71 -0.757 . . . . 62.43 112.515 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 58.3 tttt -65.43 118.02 8.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.881 0.372 . . . . 74.23 110.87 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 17.6 pttm -122.59 151.09 41.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 74.23 110.893 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -127.2 136.59 52.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 74.4 110.862 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -116.04 131.03 57.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 72.42 111.092 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -138.28 138.68 38.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 74.43 110.865 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 5.4 tp -134.07 127.32 51.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 73.31 111.135 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 7.2 mmtp -119.53 118.86 32.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 73.33 110.885 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.1 t -129.74 119.67 23.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.216 -0.447 . . . . 71.3 111.099 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.459 ' HA3' ' HA2' ' A' ' 126' ' ' GLY . . . -153.29 168.76 32.06 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.693 -0.765 . . . . 72.33 112.476 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -133.16 132.05 41.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.971 0.415 . . . . 73.12 110.95 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 18.0 mtmm -108.18 119.47 39.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 72.54 110.95 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 43.3 ttt180 -110.14 143.53 40.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.279 -0.419 . . . . 72.51 110.878 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -51.48 -28.01 12.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 74.44 110.901 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 70.7 m80 -89.17 -40.12 13.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 65.35 110.861 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 2.3 tp -149.23 138.3 15.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 74.12 111.077 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.498 ' HB3' HG22 ' A' ' 143' ' ' VAL . 0.3 OUTLIER -105.03 118.66 37.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 65.12 110.851 179.947 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -116.51 140.52 49.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 75.25 110.91 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.459 ' HA2' ' HA3' ' A' ' 117' ' ' GLY . . . -143.29 121.52 1.71 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.749 -0.739 . . . . 51.11 112.476 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -112.47 107.71 16.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.8 0.333 . . . . 74.34 110.881 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -104.92 145.18 30.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.223 -0.444 . . . . 73.32 110.836 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 96.8 mtp -138.68 136.1 35.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 73.14 110.892 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -128.27 135.69 49.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 75.51 110.854 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -95.8 102.38 14.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 64.42 110.9 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.4 149.87 21.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.134 -0.485 . . . . 72.21 110.847 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.2 tp -52.71 -44.06 45.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 63.31 111.14 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -73.77 -18.93 60.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 54.54 111.084 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 155.24 150.34 5.54 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.797 -0.716 . . . . 72.4 112.504 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 112.37 3.05 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.749 2.3 . . . . 61.3 112.322 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.5 m -81.89 147.55 29.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.442 . . . . 64.51 110.847 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.1 mp -107.28 118.83 55.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 74.51 111.126 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 -106.95 121.85 45.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 72.31 110.83 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -110.99 133.83 11.79 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.778 -0.725 . . . . 74.11 112.503 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -131.38 122.54 26.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.798 0.332 . . . . 74.04 111.082 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -140.39 122.35 15.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.242 -0.436 . . . . 74.2 110.89 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.523 ' HA ' ' HA2' ' A' ' 152' ' ' GLY . 0.7 OUTLIER -133.76 144.93 34.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 62.23 111.1 179.866 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -107.84 139.96 41.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.184 -0.462 . . . . 74.03 110.902 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -110.7 118.7 5.03 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.771 -0.728 . . . . 72.14 112.471 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -122.91 146.38 47.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.901 0.381 . . . . 74.42 110.902 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -50.44 96.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.118 -0.492 . . . . 64.41 110.931 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 93.94 -29.41 8.69 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.783 -0.722 . . . . 73.25 112.475 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 36.6 m95 -102.15 141.7 34.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.833 0.349 . . . . 75.22 110.903 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.98 136.61 42.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.436 . . . . 73.13 110.91 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -142.77 143.88 32.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.448 . . . . 75.43 111.082 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.523 ' HA2' ' HA ' ' A' ' 143' ' ' VAL . . . -153.48 144.09 10.94 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.72 -0.752 . . . . 72.4 112.473 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -145.12 119.21 9.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.849 0.356 . . . . 74.24 110.923 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -118.95 123.79 45.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.145 -0.48 . . . . 74.34 110.89 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.7 134.68 52.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 73.32 110.894 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -112.29 123.07 49.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.253 -0.43 . . . . 71.32 110.876 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.44 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 15.0 t80 -94.4 125.88 39.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 73.33 110.888 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.43 ' HG2' ' HB ' ' A' ' 165' ' ' THR . 0.1 OUTLIER -79.33 103.16 9.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.136 -0.484 . . . . 72.15 110.904 -179.912 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 75.5 m -65.53 -48.18 73.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 65.14 111.171 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -48.35 -26.12 1.9 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 74.21 111.103 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 12.1 mmtp -125.79 -168.76 1.89 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 72.44 110.874 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 2.4 m -110.63 40.2 2.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 75.22 110.875 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 2.4 tpp180 -156.67 175.25 14.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.131 -0.486 . . . . 75.53 110.904 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.44 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 0.9 OUTLIER -74.52 142.5 14.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 73.5 111.124 179.966 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' THR . . . . . 0.43 ' HB ' ' HG2' ' A' ' 158' ' ' GLU . 2.5 t -90.63 -34.6 15.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.459 . . . . 75.24 111.14 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -153.99 136.14 14.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.244 -0.434 . . . . 73.01 110.897 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -123.06 127.34 48.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.446 . . . . 72.32 110.858 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -135.68 142.75 45.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 74.04 110.926 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -149.03 140.13 23.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 75.02 110.878 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -148.49 129.12 14.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 74.23 111.107 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 7.3 t -148.1 139.59 17.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.451 . . . . 71.42 111.112 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -165.25 163.83 36.78 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.723 -0.751 . . . . 75.24 112.504 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -118.95 125.09 48.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.946 0.403 . . . . 74.25 110.919 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 39.9 mtpt -101.84 126.14 48.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.132 -0.485 . . . . 71.23 110.926 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.431 ' HB ' ' H ' ' A' ' 178' ' ' PHE . 1.2 m -131.26 165.02 24.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.444 . . . . 70.25 111.112 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -78.14 -7.76 57.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 52.13 110.86 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -118.13 -31.65 4.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.211 -0.45 . . . . 71.05 110.873 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.431 ' H ' ' HB ' ' A' ' 175' ' ' THR . 18.4 p90 -144.54 150.14 37.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 75.4 110.891 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -136.51 123.05 20.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 71.43 110.913 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -124.15 128.26 49.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.211 -0.45 . . . . 65.12 110.943 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 15.7 m170 -131.36 115.01 15.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 73.32 110.865 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.05 135.55 42.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 64.04 111.144 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -128.0 139.25 52.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.441 . . . . 73.31 110.92 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 2.8 t -134.33 110.04 13.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 73.1 111.147 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -101.08 89.46 3.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 75.04 110.898 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 65.77 179.46 0.2 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 73.03 110.865 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -73.1 -3.49 60.85 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.684 -0.77 . . . . 75.12 112.466 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 5.7 m -95.96 -25.54 15.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.804 0.335 . . . . 72.32 111.174 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -121.95 112.49 18.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.192 -0.458 . . . . 72.42 110.903 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -138.85 123.41 18.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.135 -0.484 . . . . 75.31 110.883 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 174.17 -154.86 20.35 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.715 -0.755 . . . . 43.13 112.456 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -176.56 -163.2 28.55 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.743 -0.741 . . . . 75.04 112.471 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 11.4 p -148.39 155.47 41.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.857 0.361 . . . . 73.42 110.868 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 3.5 mp -131.62 120.27 44.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.122 -0.49 . . . . 63.34 111.104 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -108.87 121.05 44.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.188 -0.46 . . . . 74.2 110.922 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -125.52 131.52 52.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.476 . . . . 62.31 110.891 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 1.8 tppp? -96.04 127.66 42.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 72.21 110.863 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 34.5 t -85.73 117.36 30.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.44 . . . . 74.24 111.135 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -49.82 132.96 22.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 74.43 110.867 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp 51.05 33.82 9.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 75.21 110.893 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 4.8 mmtp -153.83 -167.31 2.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 75.43 110.861 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 1.4 pp -79.19 -168.49 1.51 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.45 . . . . 74.03 110.936 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -115.11 136.15 53.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 64.21 110.884 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 11.5 t -123.96 138.78 54.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.12 -0.491 . . . . 73.41 111.143 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -145.01 163.49 34.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.434 . . . . 75.34 111.117 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 1.7 m -133.58 149.08 30.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.255 -0.429 . . . . 62.41 111.094 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -113.91 131.52 56.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 73.11 110.89 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -119.71 129.93 54.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 63.04 110.955 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -138.42 130.77 28.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.446 . . . . 73.51 111.1 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 11.7 t90 -130.09 123.21 29.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 74.45 110.9 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 94.5 m -112.22 110.51 20.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.264 -0.425 . . . . 73.12 111.173 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -51.4 128.09 21.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.263 -0.426 . . . . 74.1 111.095 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 163.78 -73.66 0.18 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.749 -0.738 . . . . 64.5 112.514 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 65.9 m-80 -125.61 33.79 5.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.804 0.335 . . . . 75.14 110.861 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 43.4 m 51.43 52.77 14.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.452 . . . . 74.43 110.858 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -94.69 112.0 23.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.122 -0.49 . . . . 64.2 110.938 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 2.5 p -94.29 135.63 35.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 74.14 111.121 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 17.7 tpp85 -117.41 119.18 34.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 75.12 110.845 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 21.4 t80 -122.83 137.6 54.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 74.01 110.893 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -145.69 159.17 27.87 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.767 -0.73 . . . . 63.2 112.52 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 4.7 mp -137.29 130.46 43.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.828 0.347 . . . . 71.44 111.133 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -124.89 141.52 52.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 73.21 111.117 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -116.08 134.84 54.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.243 -0.435 . . . . 64.41 111.1 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 11.1 mttt -120.64 115.44 23.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 73.23 110.905 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -130.75 128.66 41.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.232 -0.44 . . . . 73.45 110.899 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -111.92 115.99 29.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.158 -0.474 . . . . 71.42 110.941 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 8.1 tp -103.05 -35.21 3.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 71.42 111.128 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -130.24 160.6 64.82 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.64 0.733 . . . . 74.41 110.857 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.72 -32.58 18.45 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.684 2.256 . . . . 74.1 112.312 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -107.19 10.27 30.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 74.44 110.838 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -141.41 127.18 19.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 73.54 111.123 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 42.4 t -134.47 141.97 46.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.255 -0.429 . . . . 64.45 110.924 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -112.25 130.24 56.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 74.11 110.873 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 84.2 p -129.51 140.62 51.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.464 . . . . 71.24 110.885 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -127.01 159.29 34.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 73.44 111.126 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.77 147.81 21.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.217 -0.447 . . . . 74.0 110.917 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 5.4 p -144.86 142.69 22.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.444 . . . . 55.43 111.15 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -106.54 147.64 29.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 75.44 110.92 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' ASN . . . . . 0.405 ' C ' ' H ' ' A' ' 241' ' ' SER . 7.1 t-20 -54.71 -21.01 9.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.185 -0.461 . . . . 70.21 110.9 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 3.7 m -81.7 26.28 0.5 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.459 . . . . 64.51 110.874 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' SER . . . . . 0.405 ' H ' ' C ' ' A' ' 239' ' ' ASN . 6.8 t 59.98 39.33 20.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.081 -0.509 . . . . 75.35 110.854 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 18.4 mt -98.91 124.9 44.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.12 -0.491 . . . . 71.43 110.903 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 3.0 mp -99.83 118.73 46.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 75.25 111.09 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -129.49 138.75 10.45 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.714 -0.755 . . . . 73.33 112.471 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.424 ' N ' ' CD1' ' A' ' 245' ' ' LEU . 0.0 OUTLIER -145.92 158.93 43.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.865 0.364 . . . . 75.51 110.865 -179.885 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -162.57 144.27 9.49 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.719 -0.753 . . . . 55.14 112.443 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -128.31 131.84 48.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.99 0.424 . . . . 74.12 110.894 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 27.6 p -115.5 117.77 31.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.076 -0.511 . . . . 73.13 111.124 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -129.38 131.48 46.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 74.42 110.899 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 3.7 m -59.74 148.43 34.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 75.23 111.167 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 46.0 tp -78.58 -73.33 0.33 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 75.21 110.904 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' LYS . . . . . 0.462 ' N ' ' HD2' ' A' ' 253' ' ' PRO . 0.1 OUTLIER 179.29 -60.66 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.558 0.694 . . . . 71.51 110.882 179.848 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' A' ' 252' ' ' LYS . 54.0 Cg_endo -69.77 -86.4 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.679 2.253 . . . . 71.54 112.395 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . 0.566 ' O ' ' HB3' ' A' ' 281' ' ' PHE . . . -146.7 33.9 1.38 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.746 -0.74 . . . . 61.1 112.499 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 3.6 mp -131.01 145.3 35.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.893 0.377 . . . . 71.4 111.093 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 279' ' ' LEU . 19.7 ttpp -113.12 135.41 53.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 73.43 110.882 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 5.1 tp -96.74 124.35 40.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 75.45 110.879 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 2.8 p -124.29 122.34 37.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.161 -0.472 . . . . 72.42 111.115 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -116.58 126.53 53.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 74.22 110.92 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 27.7 p -124.92 145.84 49.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 62.1 110.878 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -147.99 135.25 20.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 75.21 111.112 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -125.41 122.22 36.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.453 . . . . 71.11 110.877 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.03 109.86 15.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 74.01 110.929 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -82.72 116.95 22.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.184 -0.462 . . . . 75.44 110.831 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -54.41 -21.15 19.09 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.744 -0.741 . . . . 72.25 112.464 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.77 -26.56 20.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.839 0.352 . . . . 74.43 110.912 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 13.8 m-20 -95.42 -57.86 2.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.194 -0.457 . . . . 74.11 110.926 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 11.7 m -51.6 -29.34 9.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.469 . . . . 73.53 111.104 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -53.02 -36.43 60.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 74.25 110.89 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -103.65 -17.69 15.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 75.24 111.144 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 124.73 100.75 1.34 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.691 -0.766 . . . . 74.23 112.45 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 168.16 92.74 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.722 -0.752 . . . . 73.14 112.493 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 19.2 p80 -111.9 144.64 40.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.899 0.38 . . . . 75.24 110.83 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -102.26 137.34 40.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 74.33 110.935 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -135.94 144.11 45.28 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.253 -0.43 . . . . 74.22 110.927 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -147.52 133.65 4.81 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.694 -0.765 . . . . 74.01 112.492 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -125.81 135.23 51.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.819 0.342 . . . . 75.04 110.913 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -161.59 140.08 6.4 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.694 -0.765 . . . . 45.12 112.488 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.411 ' HA ' ' O ' ' A' ' 256' ' ' LYS . 0.0 OUTLIER -119.59 129.86 54.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.809 0.337 . . . . 73.14 110.899 -179.938 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . 0.502 ' O ' ' HB2' ' A' ' 281' ' ' PHE . 2.5 pp20? -141.94 146.41 35.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.47 . . . . 71.12 110.899 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . 0.566 ' HB3' ' O ' ' A' ' 254' ' ' GLY . 0.3 OUTLIER 172.08 -150.75 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.155 -0.475 . . . . 65.21 110.894 -179.88 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -138.55 144.68 40.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 75.52 110.891 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -113.09 112.6 24.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.45 . . . . 72.41 111.128 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 12.7 mt -130.41 178.63 6.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 74.42 110.878 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 71.41 110.909 179.943 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' NAI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.4 mmt . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.794 0.331 . . . . 73.33 110.886 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -110.21 -171.67 1.88 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 72.01 111.111 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.1 t 61.18 75.62 0.44 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.668 0.747 . . . . 70.01 111.083 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 167.91 23.06 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.667 2.244 . . . . 70.31 112.362 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 108.97 2.2 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.734 2.289 . . . . 75.1 112.326 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 12.3 t -107.15 -28.47 9.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 75.53 111.138 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 32.9 p90 -55.53 -30.59 61.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.25 -0.432 . . . . 74.44 110.92 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -72.26 -19.4 61.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.108 -0.497 . . . . 64.5 111.114 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -95.03 11.9 30.4 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.243 -0.435 . . . . 74.21 110.878 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.56 -33.05 72.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.211 -0.45 . . . . 74.21 110.87 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -136.17 31.28 2.63 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.758 -0.734 . . . . 72.45 112.488 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.3 mmtt -69.58 -54.5 13.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.78 0.324 . . . . 65.14 110.88 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.9 t -60.25 -39.72 87.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.252 -0.431 . . . . 73.15 110.873 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.56 -37.62 76.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 74.0 111.113 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -61.05 -32.66 72.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 75.42 110.859 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -58.38 -48.45 80.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 72.15 110.866 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.5 t -80.43 -36.91 16.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 64.41 111.128 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -63.33 -34.98 78.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 74.03 110.888 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.2 m 65.06 80.51 0.23 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 70.15 111.159 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -57.77 -34.61 69.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.251 -0.431 . . . . 74.24 110.855 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -51.5 106.82 0.34 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.72 -0.753 . . . . 54.31 112.462 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -58.43 151.69 19.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.886 0.374 . . . . 74.25 110.942 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -133.8 69.26 0.53 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.727 -0.749 . . . . 73.24 112.531 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -91.95 13.71 17.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.906 0.384 . . . . 73.42 110.915 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.07 14.6 64.2 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.713 -0.756 . . . . 74.23 112.498 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.2 pp -118.98 -179.1 3.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.762 0.315 . . . . 73.11 110.918 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.446 HG13 ' HB3' ' A' ' 277' ' ' LEU . 1.6 mp -109.99 131.8 59.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 73.12 111.132 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.406 ' HG2' ' HA2' ' A' ' 278' ' ' GLY . 6.4 ptmm? -115.91 138.22 51.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 73.12 110.904 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -123.67 136.45 54.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.235 -0.439 . . . . 72.43 110.891 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -126.76 127.78 45.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.469 . . . . 71.22 110.871 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.75 125.1 52.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 72.34 110.902 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.3 tptp -123.57 125.09 44.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 72.4 110.866 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.9 m -135.42 120.67 18.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 71.12 111.14 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -134.22 125.6 28.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 72.52 110.875 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 38.4 t -127.24 143.7 51.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 71.44 110.859 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -76.59 58.72 1.41 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 73.03 110.885 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -147.67 16.96 1.13 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.146 -0.479 . . . . 73.55 110.865 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.552 ' HA2' ' O ' ' A' ' 63' ' ' ARG . . . 82.94 -5.3 76.55 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.729 -0.748 . . . . 65.31 112.489 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -101.14 126.22 47.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.8 0.333 . . . . 75.1 110.904 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -139.46 117.68 11.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.168 -0.469 . . . . 74.31 110.885 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -107.07 121.48 44.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.122 -0.49 . . . . 70.12 110.887 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 3.9 m -127.96 115.15 18.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.141 -0.481 . . . . 73.34 111.183 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -122.05 141.7 51.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 72.51 110.864 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.4 p -151.01 126.41 10.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.464 . . . . 63.41 110.892 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -166.41 165.5 38.32 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.722 -0.751 . . . . 73.54 112.48 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 82.8 p -137.25 168.96 18.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.896 0.379 . . . . 70.42 110.876 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -158.63 140.57 13.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 60.23 111.118 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 46.0 t-20 -101.26 141.9 33.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.242 -0.435 . . . . 74.12 110.832 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.5 t -92.7 -35.24 13.58 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.168 -0.469 . . . . 73.44 111.165 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.85 -63.48 1.15 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.227 -0.442 . . . . 75.11 110.89 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.18 149.91 33.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.125 -0.489 . . . . 74.33 111.108 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.3 t -59.09 110.69 1.1 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.172 -0.467 . . . . 64.54 111.155 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.6 mtpm? -166.53 99.9 0.59 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.242 -0.436 . . . . 74.24 110.949 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 24.2 t -122.5 133.49 68.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.245 -0.434 . . . . 65.51 111.125 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.0 m -136.04 134.56 38.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.165 -0.47 . . . . 72.13 111.132 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -142.8 140.48 9.84 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.699 -0.762 . . . . 73.35 112.441 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.6 p -133.18 144.52 49.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.903 0.383 . . . . 72.11 110.839 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -120.92 134.51 55.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.108 -0.496 . . . . 73.35 110.903 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -134.33 123.05 23.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 74.21 110.888 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 23.1 p -107.0 134.0 50.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 52.31 111.095 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 47.6 mttt -133.41 159.68 39.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 74.24 110.931 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.512 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 9.2 t80 -121.06 129.67 53.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 74.44 110.892 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.552 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 3.9 ttt85 -112.9 103.43 11.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 74.52 110.865 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -112.73 98.65 7.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.188 -0.46 . . . . 63.05 110.933 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 60.68 163.43 0.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 62.5 111.156 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -78.78 145.16 34.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.248 -0.433 . . . . 73.13 110.877 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 26.0 p90 37.81 43.35 0.49 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.177 -0.465 . . . . 64.42 110.872 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -123.75 -78.93 0.41 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.743 -0.742 . . . . 70.33 112.445 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -134.59 129.06 34.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.914 0.387 . . . . 64.32 110.883 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.8 m -138.61 114.89 10.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.157 -0.474 . . . . 73.41 111.136 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -99.39 132.89 44.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 71.03 110.894 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.73 119.87 31.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.122 -0.49 . . . . 74.41 111.181 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -131.52 122.56 26.36 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.196 -0.456 . . . . 74.33 110.902 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -106.38 137.49 44.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.153 -0.476 . . . . 72.53 110.908 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 9.8 t90 -134.53 128.75 33.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.456 . . . . 73.22 110.887 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 28.9 t30 -117.13 155.41 29.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 63.25 110.908 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 12.3 m -60.36 -18.12 48.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 73.45 111.127 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.417 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 9.0 m-20 -74.63 0.37 15.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 71.43 110.863 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.417 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 4.1 m120 77.16 38.55 0.23 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.198 -0.455 . . . . 63.0 110.885 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 28.3 m -114.83 125.63 53.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.455 . . . . 74.31 111.157 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.6 mp -114.14 127.35 55.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.294 -0.412 . . . . 74.34 110.939 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -113.42 107.71 1.98 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.788 -0.72 . . . . 72.22 112.489 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.1 m -87.52 131.45 34.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.713 0.292 . . . . 73.25 111.16 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -159.99 96.68 1.23 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 74.1 110.893 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.1 pp -111.6 138.65 39.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 74.04 111.172 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.6 m -118.11 139.57 51.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 72.12 111.119 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.2 m -129.39 139.62 51.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 74.25 111.155 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 -97.8 129.18 44.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 73.35 110.926 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -50.56 168.61 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.199 -0.455 . . . . 74.12 110.893 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -123.45 -35.58 2.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 63.31 110.911 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 92.5 mt -96.79 -70.12 0.73 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.245 -0.434 . . . . 75.1 110.945 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.86 78.03 1.15 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 72.25 111.07 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 9.2 ptp85 -49.29 135.32 17.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.467 . . . . 73.32 110.889 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 101.59 9.29 44.11 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.715 -0.755 . . . . 65.52 112.531 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.7 tp -114.93 129.15 56.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.898 0.38 . . . . 75.24 110.891 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 31.5 pttt -124.56 136.19 53.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 75.21 110.897 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -124.8 126.72 46.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 74.21 110.877 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.6 m -125.61 139.41 53.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.462 . . . . 74.32 111.131 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -116.02 123.01 46.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.252 -0.431 . . . . 64.21 110.841 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -113.97 130.29 56.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.112 -0.494 . . . . 73.1 110.855 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.5 m -142.41 134.07 26.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.475 . . . . 72.54 110.851 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.6 t -95.81 126.17 40.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.115 -0.493 . . . . 74.52 110.857 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -118.34 119.65 35.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.097 -0.502 . . . . 75.22 110.869 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.409 ' HA ' ' HD2' ' A' ' 105' ' ' PRO . 1.7 t -128.83 101.39 20.28 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.61 0.719 . . . . 72.5 110.919 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 104' ' ' SER . 53.4 Cg_endo -69.79 -32.89 17.56 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.681 2.254 . . . . 75.24 112.301 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 16.9 t30 -51.56 -74.25 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.269 -0.423 . . . . 73.0 110.916 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 6.0 m -77.02 -33.57 57.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 74.32 111.139 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.61 23.92 14.94 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.773 -0.727 . . . . 61.11 112.51 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -94.48 147.02 23.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.853 0.359 . . . . 74.41 110.907 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 27.6 ttpt -133.42 140.88 47.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.218 -0.446 . . . . 73.34 110.938 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -120.94 136.22 55.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 75.21 110.938 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -110.57 125.28 53.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 70.41 111.094 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 17.4 mtmt -138.87 138.23 37.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 73.12 110.888 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 5.7 tp -121.99 139.86 47.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.212 -0.449 . . . . 74.3 111.092 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 19.8 ttpt -130.06 118.87 22.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.166 -0.47 . . . . 73.23 110.899 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 4.8 t -130.9 118.6 20.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.446 . . . . 73.11 111.13 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.432 ' HA3' ' HA2' ' A' ' 126' ' ' GLY . . . -152.99 159.14 28.32 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.695 -0.764 . . . . 41.41 112.476 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -129.34 138.34 51.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.982 0.42 . . . . 74.53 110.912 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 36.2 pttt -109.82 121.15 44.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.115 -0.493 . . . . 74.43 110.891 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 6.8 tpt180 -109.53 143.88 38.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 74.52 110.885 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -50.73 -28.31 8.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 72.25 110.881 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 59.2 m-70 -88.45 -41.97 12.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 75.34 110.897 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 2.2 tt -151.67 145.03 16.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 73.11 111.198 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -113.73 116.02 28.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 74.53 110.822 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.418 ' HG ' HD22 ' A' ' 142' ' ' LEU . 2.0 mt -119.24 141.45 48.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.472 . . . . 75.14 110.895 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.432 ' HA2' ' HA3' ' A' ' 117' ' ' GLY . . . -145.96 125.91 2.4 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.721 -0.752 . . . . 74.35 112.457 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 8.3 t -114.51 119.46 36.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.816 0.341 . . . . 64.31 110.883 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -118.9 146.58 44.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.466 . . . . 72.12 110.867 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 7.8 ttt -136.62 136.27 39.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.203 -0.453 . . . . 75.44 110.869 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -110.86 124.99 53.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.173 -0.467 . . . . 71.12 110.883 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -95.53 98.2 10.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 74.22 110.886 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -103.92 169.65 8.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.139 -0.482 . . . . 65.24 110.898 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 2.5 pp -74.91 -35.61 36.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 75.24 111.121 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -77.06 -20.27 56.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 74.12 111.07 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 154.16 149.64 5.28 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.705 -0.759 . . . . 62.13 112.467 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 114.5 3.73 Favored 'Trans proline' 0 C--O 1.231 0.146 0 C-N-CA 122.69 2.26 . . . . 74.52 112.315 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.64 148.76 30.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.211 -0.449 . . . . 75.03 110.915 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 5.3 mp -106.3 122.84 60.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.19 -0.459 . . . . 72.24 111.145 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 3.9 ttm105 -121.56 114.55 21.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 74.51 110.874 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -110.63 133.96 11.89 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.732 -0.747 . . . . 74.34 112.478 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -132.91 116.31 16.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.815 0.341 . . . . 62.04 111.109 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.421 HD23 HD21 ' A' ' 144' ' ' LEU . 0.2 OUTLIER -121.97 125.23 45.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.161 -0.472 . . . . 61.32 110.878 -179.939 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 40.7 t -131.19 123.17 52.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 73.31 111.151 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.421 HD21 HD23 ' A' ' 142' ' ' LEU . 0.3 OUTLIER -116.85 156.32 27.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 75.21 110.934 179.996 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -106.71 133.05 11.44 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.746 -0.74 . . . . 72.24 112.465 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.413 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 0.2 OUTLIER -128.58 147.88 50.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.823 0.344 . . . . 74.54 110.874 -179.765 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 48.7 tt0 -57.35 97.99 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.077 -0.511 . . . . 74.51 110.826 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.527 ' O ' ' HB3' ' A' ' 173' ' ' TYR . . . 86.04 -15.9 45.93 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.74 -0.743 . . . . 73.23 112.505 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.413 ' O ' ' CB ' ' A' ' 146' ' ' TYR . 5.1 m95 -123.61 146.68 47.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.78 0.324 . . . . 71.13 110.929 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.69 ' N ' ' HB2' ' A' ' 173' ' ' TYR . 13.0 tp -108.75 156.45 19.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.264 -0.426 . . . . 72.13 110.899 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.406 ' HB1' ' HG ' ' A' ' 144' ' ' LEU . . . -127.64 131.31 49.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.191 -0.459 . . . . 73.15 111.127 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -155.64 133.24 3.66 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.748 -0.739 . . . . 41.22 112.474 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -145.81 118.81 8.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.81 0.338 . . . . 73.11 110.941 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -122.43 123.13 40.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.096 -0.502 . . . . 74.04 110.883 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 97.8 mtp -133.57 134.89 43.89 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.172 -0.467 . . . . 75.33 110.873 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.473 ' O ' ' HB ' ' A' ' 164' ' ' VAL . 4.9 m120 -112.36 117.48 32.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 71.31 110.899 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.474 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 0.2 OUTLIER -87.23 125.69 34.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 74.23 110.882 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.39 108.15 15.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.13 -0.486 . . . . 75.22 110.943 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 6.0 t -66.14 -47.14 75.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.476 . . . . 74.24 111.152 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -50.71 -26.17 5.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 74.22 111.063 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 10.6 mmtt -120.93 -167.72 1.54 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.244 -0.434 . . . . 74.51 110.889 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 50.1 m -112.92 39.29 2.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 74.54 110.885 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.66 174.88 9.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 74.33 110.853 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.474 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 1.0 OUTLIER -78.63 146.0 8.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 75.25 111.167 179.925 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 15.3 t -88.32 -34.11 17.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 74.13 111.109 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -152.7 132.74 13.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 73.12 110.945 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 3.8 m -126.06 125.78 43.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 74.42 110.858 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 15.1 p-10 -135.72 137.02 41.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 74.35 110.891 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -131.64 150.26 52.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.459 . . . . 75.05 110.88 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -150.33 129.46 12.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.485 . . . . 61.15 111.068 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -145.69 138.5 20.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.157 -0.474 . . . . 74.32 111.123 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.432 ' O ' ' HB3' ' A' ' 150' ' ' LEU . . . 136.69 146.25 5.14 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.747 -0.74 . . . . 52.45 112.478 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . 0.69 ' HB2' ' N ' ' A' ' 150' ' ' LEU . 5.0 t80 -151.04 177.56 10.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.008 0.433 . . . . 75.44 110.88 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -97.1 136.08 38.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.105 -0.498 . . . . 71.33 110.895 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.651 ' O ' ' C ' ' A' ' 176' ' ' ASP . 0.2 OUTLIER -122.86 165.54 16.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.224 -0.443 . . . . 73.33 111.156 179.979 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.651 ' C ' ' O ' ' A' ' 175' ' ' THR . 2.0 m-20 -9.5 -86.72 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.25 -0.432 . . . . 73.3 110.869 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -120.35 12.95 11.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 64.3 110.884 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -130.2 116.58 18.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 74.12 110.889 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -114.13 124.2 51.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.135 -0.484 . . . . 73.13 110.91 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -122.07 120.99 35.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 74.42 110.936 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -123.71 145.75 48.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 73.41 110.869 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.89 136.72 23.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 74.32 111.102 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 22.1 m120 -132.65 140.04 48.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 73.24 110.853 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 2.5 t -132.74 110.38 15.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 75.53 111.117 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -99.0 90.07 4.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 75.22 110.893 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 66.2 176.86 0.22 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.177 -0.465 . . . . 64.34 110.86 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -73.22 -2.2 58.44 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.737 -0.744 . . . . 63.53 112.52 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 7.7 t -98.4 -25.35 14.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.742 0.306 . . . . 71.44 111.12 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -121.94 115.27 22.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 74.53 110.926 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -140.81 124.47 16.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 75.44 110.883 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -175.55 -161.6 25.25 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.756 -0.735 . . . . 33.14 112.503 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -175.33 -172.05 39.87 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.767 -0.73 . . . . 74.22 112.529 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 34.3 m -147.63 148.42 31.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.796 0.331 . . . . 75.21 110.877 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 4.7 mp -119.63 130.96 73.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.12 -0.491 . . . . 75.04 111.168 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -119.24 126.05 50.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.198 -0.455 . . . . 75.41 110.942 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 3.7 tm0? -124.75 131.13 53.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.095 -0.502 . . . . 72.14 110.881 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 36.0 mttt -100.64 127.23 47.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 72.11 110.873 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 16.4 t -80.33 152.63 4.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.27 -0.423 . . . . 75.42 111.174 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -51.15 -37.9 48.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 75.44 110.908 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.75 -170.4 2.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 63.3 110.92 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 1.6 ptmt -76.71 64.67 2.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 75.04 110.926 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 6.3 mp -145.62 128.45 16.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.236 -0.438 . . . . 64.11 110.915 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -120.61 130.07 54.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.15 -0.477 . . . . 72.21 110.889 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 2.3 t -132.23 138.31 47.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 74.53 111.091 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -149.69 156.7 42.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 74.24 111.111 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 1.3 m -126.08 147.21 30.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 75.34 111.173 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -117.92 127.96 54.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.454 . . . . 72.3 110.923 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 2.2 mp -125.7 147.03 49.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 73.02 110.877 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -157.24 131.55 8.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 72.13 111.105 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 21.5 t90 -129.91 133.56 46.93 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.26 -0.427 . . . . 74.3 110.927 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -101.09 103.68 14.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.25 -0.432 . . . . 61.14 111.152 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -53.26 140.88 25.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.26 -0.427 . . . . 73.23 111.111 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 134.74 -72.76 0.46 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.689 -0.767 . . . . 63.44 112.481 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -171.79 36.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.793 0.33 . . . . 51.44 110.882 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 32.8 t -111.85 165.33 12.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 63.33 110.852 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -88.16 162.59 16.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 74.43 110.866 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 2.9 m -78.11 137.96 38.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 74.42 111.172 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 33.4 ttp180 -102.95 129.06 49.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 75.35 110.872 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -134.0 133.25 41.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 65.21 110.86 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -143.53 145.46 15.26 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.72 -0.752 . . . . 50.2 112.5 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.14 138.32 52.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.863 0.363 . . . . 73.51 111.173 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -138.12 153.22 49.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.451 . . . . 73.11 111.13 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -145.49 157.72 43.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.239 -0.437 . . . . 73.34 111.097 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 3.1 tttm -142.94 124.41 14.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.441 . . . . 73.42 110.861 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -133.6 133.93 42.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 63.41 110.938 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 7.9 mm-40 -79.15 130.71 35.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.139 -0.482 . . . . 72.02 110.894 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . 0.416 ' CG2' ' HD2' ' A' ' 229' ' ' PRO . 1.3 tp -77.41 -38.34 26.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.469 . . . . 74.14 111.108 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . 0.469 ' N ' ' HD2' ' A' ' 229' ' ' PRO . 0.3 OUTLIER 172.12 -60.91 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.6 0.714 . . . . 72.4 110.863 179.884 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' A' ' 228' ' ' ASP . 53.8 Cg_endo -69.76 -157.52 0.04 OUTLIER 'Trans proline' 0 C--O 1.231 0.148 0 C-N-CA 122.722 2.281 . . . . 72.24 112.315 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -85.37 15.23 4.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 72.44 110.906 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -120.59 122.0 39.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 75.54 111.078 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 13.0 p -112.79 144.56 42.12 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.444 . . . . 73.21 110.864 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -97.2 127.64 43.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 74.23 110.888 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 1.2 t -117.54 137.15 52.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.126 -0.488 . . . . 64.51 110.807 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -130.67 141.27 50.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 60.5 111.094 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 7.7 pttm -144.45 165.06 29.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 73.4 110.884 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 8.7 p -154.93 146.23 13.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 73.25 111.124 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -104.82 147.69 27.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 70.44 110.848 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -53.46 -22.83 8.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.111 -0.495 . . . . 64.51 110.851 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 2.6 t -82.03 26.86 0.5 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 73.11 110.901 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 59.14 37.77 23.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.078 -0.51 . . . . 54.15 110.881 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -98.39 121.14 39.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.103 -0.499 . . . . 74.32 110.901 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 5.4 mp -86.82 123.06 39.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 70.12 111.128 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -115.81 133.8 11.09 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.74 -0.743 . . . . 74.44 112.492 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 11.0 mp -130.58 129.81 43.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.878 0.37 . . . . 75.2 110.942 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -140.29 121.74 2.04 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.729 -0.748 . . . . 70.0 112.465 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -111.76 121.68 45.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.936 0.398 . . . . 75.43 110.964 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -109.75 120.8 43.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.476 . . . . 62.13 111.112 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -128.32 122.68 32.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 72.24 110.931 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 96.0 m -110.31 111.51 22.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 71.53 111.137 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -106.37 88.57 2.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 73.34 110.904 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 6.2 mtmt 62.44 161.46 0.12 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.549 0.69 . . . . 73.22 110.925 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 76.84 1.13 Allowed 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.679 2.253 . . . . 75.3 112.306 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 169.34 -32.16 0.17 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.751 -0.738 . . . . 62.44 112.467 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 4.4 mp -118.19 122.47 69.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.831 0.348 . . . . 73.51 111.119 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 25.7 mmtt -131.6 132.83 44.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.229 -0.442 . . . . 72.14 110.877 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 1.5 tt -114.11 127.05 55.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.223 -0.444 . . . . 74.25 110.878 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 13.9 p -126.45 117.11 22.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 72.24 111.12 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.98 130.6 55.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 70.31 110.91 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 15.8 p -127.25 140.6 52.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 70.31 110.87 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -151.99 128.79 10.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.127 -0.488 . . . . 61.53 111.105 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -125.21 115.8 20.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 75.54 110.868 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.63 109.62 19.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 74.42 110.928 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.01 116.45 22.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.204 -0.453 . . . . 72.53 110.853 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -57.19 -16.58 20.24 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.716 -0.754 . . . . 64.14 112.513 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -86.11 -22.15 27.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.844 0.354 . . . . 75.55 110.945 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -108.57 -53.6 2.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 73.34 110.889 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 17.4 m -50.88 -30.29 8.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 74.4 111.138 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -52.98 -41.02 64.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 70.21 110.864 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -103.73 -17.62 15.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.14 -0.482 . . . . 73.1 111.124 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 128.49 94.39 0.79 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.762 -0.732 . . . . 71.3 112.482 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 175.53 78.67 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.762 -0.732 . . . . 72.41 112.491 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 13.0 p80 -104.91 144.19 32.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.853 0.359 . . . . 70.2 110.871 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 1.6 mtpt -99.43 136.19 39.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.268 -0.424 . . . . 74.12 110.887 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -136.58 144.91 44.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 73.11 110.88 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -154.19 130.63 2.96 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.729 -0.748 . . . . 55.52 112.487 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.446 ' HB3' HG13 ' A' ' 27' ' ' ILE . 0.1 OUTLIER -113.7 140.21 48.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.824 0.345 . . . . 74.32 110.928 -179.923 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . 0.406 ' HA2' ' HG2' ' A' ' 28' ' ' LYS . . . -147.16 126.79 2.5 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.781 -0.723 . . . . 73.43 112.502 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -121.67 133.25 54.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.762 0.315 . . . . 64.04 110.952 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -114.98 133.35 56.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 73.44 110.925 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -126.29 120.2 29.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 75.44 110.867 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -113.74 117.34 31.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.133 -0.485 . . . . 75.14 110.9 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -99.59 112.41 24.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 74.24 111.09 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 10.9 mt -144.87 -170.4 3.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.203 -0.453 . . . . 71.15 110.863 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 74.44 110.946 179.917 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' NAI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.7 mtt . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.796 0.331 . . . . 74.01 110.913 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 61.5 43.52 10.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.263 -0.426 . . . . 75.04 111.112 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 17.8 t -141.1 75.33 23.9 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.675 0.75 . . . . 73.23 111.13 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 168.01 22.76 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.678 2.252 . . . . 73.4 112.372 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 101.23 0.88 Allowed 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.638 2.226 . . . . 71.54 112.374 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -80.0 -34.49 38.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.456 . . . . 71.43 111.157 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -53.7 -30.98 46.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 62.32 110.929 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -80.55 -26.02 38.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.147 -0.479 . . . . 75.35 111.057 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -74.31 -9.94 59.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.227 -0.442 . . . . 73.51 110.888 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.4 mp -56.72 -34.25 67.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 62.41 110.953 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 152.24 64.38 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.759 -0.734 . . . . 75.15 112.517 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 24.5 ttpp -62.81 -52.44 63.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.771 0.319 . . . . 74.23 110.913 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 75.5 m -62.87 -49.39 75.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.448 . . . . 54.31 110.855 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.94 -37.38 79.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 75.14 111.13 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 45.7 ttt180 -66.01 -34.03 77.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 71.55 110.909 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -60.29 -46.28 90.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 72.11 110.857 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.3 p -80.98 -33.74 13.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 74.14 111.133 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -66.9 -41.18 87.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.485 . . . . 54.3 110.89 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.26 -173.93 2.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 71.11 111.16 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.8 mtmt -95.56 -168.48 1.79 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 75.33 110.915 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.56 48.95 1.46 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.741 -0.742 . . . . 53.44 112.493 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 12.9 p90 -122.63 -35.77 3.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.937 0.399 . . . . 74.12 110.933 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -144.98 139.29 8.31 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.754 -0.736 . . . . 73.0 112.528 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -104.24 -6.35 21.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.926 0.393 . . . . 71.34 110.899 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.27 12.42 57.39 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.772 -0.728 . . . . 73.52 112.488 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.518 ' CD1' ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -150.88 -173.48 4.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.819 0.343 . . . . 65.41 110.937 -179.934 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.404 ' HA ' ' O ' ' A' ' 277' ' ' LEU . 21.2 mm -92.34 133.46 33.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 74.45 111.124 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.5 mtpp -113.06 154.66 26.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 75.42 110.885 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -147.79 136.84 22.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.229 -0.442 . . . . 72.54 110.944 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -152.22 124.21 8.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 74.5 110.863 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -125.5 129.13 49.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 72.31 110.907 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.17 128.24 56.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 70.54 110.88 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 93.8 m -137.21 121.12 17.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.44 . . . . 75.14 111.154 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.9 ptmm? -140.89 141.93 34.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 72.44 110.888 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 17.9 t -139.23 152.49 47.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.207 -0.451 . . . . 71.22 110.864 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -75.97 61.45 1.51 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 71.24 110.907 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -153.27 20.67 0.56 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.132 -0.486 . . . . 73.2 110.876 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.538 ' HA2' ' O ' ' A' ' 63' ' ' ARG . . . 75.72 -3.53 49.23 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.721 -0.752 . . . . 72.23 112.524 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.2 mp -98.94 124.16 43.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.771 0.319 . . . . 74.1 110.897 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.82 118.28 10.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.162 -0.472 . . . . 72.2 110.825 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -110.1 123.58 49.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 73.02 110.905 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 83.9 m -127.39 116.62 20.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.47 . . . . 73.53 111.18 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.5 t -115.44 135.81 53.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.435 . . . . 74.23 110.861 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.27 143.91 25.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 61.42 110.871 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 164.95 168.49 27.18 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.712 -0.756 . . . . 70.21 112.463 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -137.3 169.45 17.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.866 0.365 . . . . 75.24 110.872 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -147.11 127.43 13.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 75.04 111.089 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.423 ' HA ' ' HB2' ' A' ' 26' ' ' LEU . 2.5 m120 -95.45 142.55 27.68 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.198 -0.456 . . . . 74.53 110.852 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 61.1 p -94.12 56.45 2.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 75.01 111.174 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -126.19 -74.89 0.59 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 64.1 110.889 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.4 ' O ' ' C ' ' A' ' 52' ' ' THR . 2.2 m -130.33 65.65 1.52 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 65.24 111.133 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.4 ' C ' ' O ' ' A' ' 51' ' ' THR . 10.1 t 37.05 43.88 0.34 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 65.41 111.16 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -105.2 95.02 5.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 75.41 110.885 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -126.81 148.23 31.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 74.22 111.144 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.7 p -113.27 126.59 55.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 75.22 111.138 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -118.94 147.27 18.43 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.797 -0.716 . . . . 60.13 112.52 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.4 p -146.06 133.55 20.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.918 0.389 . . . . 75.15 110.871 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.458 ' O ' ' HB3' ' A' ' 74' ' ' LYS . 0.3 OUTLIER -123.09 130.08 52.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.465 . . . . 71.11 110.892 -179.968 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.513 ' HA ' ' CB ' ' A' ' 74' ' ' LYS . 0.9 OUTLIER -134.84 120.82 19.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.21 -0.45 . . . . 62.02 110.86 179.923 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.479 ' H ' ' HB2' ' A' ' 74' ' ' LYS . 20.3 m -105.43 117.81 34.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.126 -0.488 . . . . 72.44 111.149 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 71' ' ' PHE . 8.2 mttp -106.58 157.95 17.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 75.13 110.867 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.509 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 10.3 t80 -122.16 121.16 36.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 62.23 110.899 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.538 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -88.45 101.31 13.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.082 -0.508 . . . . 75.42 110.908 179.963 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 42.5 t-105 -116.21 136.35 53.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.209 -0.451 . . . . 73.51 110.895 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 24.0 p -80.98 -169.85 2.42 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.211 -0.45 . . . . 75.31 111.182 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 66.29 101.89 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.235 -0.438 . . . . 74.14 110.859 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 65.04 13.98 9.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.158 -0.474 . . . . 74.12 110.946 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 49.95 91.19 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.717 -0.754 . . . . 73.22 112.51 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -118.05 141.04 48.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.834 0.349 . . . . 71.13 110.941 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 62' ' ' TYR . 83.4 m -135.68 121.74 20.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 73.3 111.161 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.409 ' O ' ' HA ' ' A' ' 61' ' ' LYS . 14.2 t80 -100.26 119.73 38.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 73.43 110.902 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.403 ' O ' ' HA ' ' A' ' 83' ' ' THR . 3.1 t -111.37 116.06 30.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 74.31 111.154 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.59 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 8.5 tt0 -139.66 126.94 21.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 73.44 110.895 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.59 ' HB2' ' O ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER 165.63 -156.78 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 74.22 110.934 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.414 ' CD1' ' HB3' ' A' ' 81' ' ' LEU . 12.2 t90 -133.93 136.38 44.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.268 -0.424 . . . . 75.0 110.896 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -107.88 155.64 20.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.281 -0.418 . . . . 71.33 110.909 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 15.2 t -68.79 -8.42 43.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.172 -0.467 . . . . 72.21 111.128 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.472 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 5.1 m-20 -73.8 3.43 6.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.237 -0.438 . . . . 74.53 110.839 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.472 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 3.9 m-20 81.03 15.33 0.6 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 73.32 110.842 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -116.0 116.25 27.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 65.24 111.126 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.414 ' HB3' ' CD1' ' A' ' 75' ' ' TRP . 0.1 OUTLIER -122.97 128.21 49.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 74.25 110.914 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 177.58 -133.19 2.15 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.776 -0.726 . . . . 72.22 112.536 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.445 ' OG1' ' N ' ' A' ' 84' ' ' GLU . 4.3 t -178.92 -178.35 0.54 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.812 0.339 . . . . 74.34 111.109 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.65 ' HB3' ' O ' ' A' ' 99' ' ' PHE . 0.6 OUTLIER 170.93 -166.58 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.202 -0.454 . . . . 73.51 110.932 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.8 pp -136.78 145.69 29.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.203 -0.453 . . . . 73.35 111.135 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 98.6 m -128.96 123.27 32.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.465 . . . . 72.51 111.196 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.2 p -112.54 138.66 40.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 73.43 111.157 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -123.86 118.69 27.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 70.34 110.887 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 43.1 t0 64.42 76.88 0.33 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.143 -0.48 . . . . 63.34 110.878 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -109.01 -68.87 0.89 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 73.32 110.882 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -65.33 -74.28 0.11 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 73.23 110.86 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -121.41 142.38 50.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.174 -0.466 . . . . 63.23 111.117 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 19.5 ttm180 -50.64 133.99 24.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 70.45 110.9 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 100.88 -22.31 40.08 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.732 -0.747 . . . . 72.25 112.49 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.98 125.04 34.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.923 0.392 . . . . 73.2 110.917 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 28.8 tttp -124.02 129.83 51.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.466 . . . . 74.2 110.903 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -122.2 123.04 40.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.45 . . . . 73.42 110.92 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 87.6 m -123.79 118.68 27.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.209 -0.451 . . . . 72.04 111.108 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.65 ' O ' ' HB3' ' A' ' 84' ' ' GLU . 0.7 OUTLIER -115.3 117.33 30.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.455 . . . . 74.32 110.857 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.558 ' HA ' ' CB ' ' A' ' 84' ' ' GLU . 8.4 t70 -121.62 139.47 53.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.103 -0.499 . . . . 72.23 110.901 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 37.7 t -130.55 121.26 25.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 72.11 110.87 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 15.8 m -116.6 153.41 32.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.096 -0.502 . . . . 71.52 110.878 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -123.72 138.41 54.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 75.42 110.895 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 4.2 t -116.83 106.69 47.47 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.634 0.73 . . . . 71.12 110.881 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.68 -32.61 18.55 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.683 2.255 . . . . 75.2 112.389 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -57.3 -35.9 70.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.469 . . . . 73.03 110.903 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 10.0 m -99.09 -32.4 11.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 61.1 111.12 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.66 -18.58 57.24 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.762 -0.732 . . . . 71.52 112.532 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 29.6 tptt -94.44 147.47 23.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.817 0.342 . . . . 74.23 110.915 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -92.95 150.84 20.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.279 -0.419 . . . . 74.22 110.924 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.1 m120 -121.08 126.32 49.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.436 . . . . 60.34 110.913 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -113.68 139.3 49.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 65.44 111.066 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 27.9 mttm -138.3 137.91 37.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 64.11 110.889 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 4.1 tp -134.66 133.68 54.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 64.42 111.152 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 40.0 mttp -125.42 120.83 32.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 72.33 110.894 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.7 p -127.81 118.33 23.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 74.42 111.167 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -152.19 156.08 26.5 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.753 -0.737 . . . . 74.22 112.495 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -132.41 130.49 40.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.973 0.416 . . . . 73.52 110.896 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 37.7 mttp -107.05 118.5 36.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.103 -0.499 . . . . 75.54 110.893 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.26 142.94 42.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 74.43 110.851 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -52.42 -27.32 15.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.134 -0.485 . . . . 75.35 110.887 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 27.9 m80 -90.38 -38.3 13.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 75.14 110.895 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 9.3 tp -147.67 140.65 19.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.445 . . . . 74.53 111.098 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -111.25 115.94 30.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 72.34 110.87 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -122.96 139.91 53.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.175 -0.466 . . . . 75.21 110.935 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -146.74 121.5 1.44 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.741 -0.743 . . . . 64.22 112.437 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 18.5 m -113.19 134.02 54.78 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.791 0.329 . . . . 72.1 110.916 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -126.62 146.97 49.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 71.11 110.905 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 8.7 mtm -139.04 127.23 22.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 72.24 110.869 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -117.81 121.3 40.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 75.22 110.88 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -95.26 119.71 34.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.465 . . . . 75.33 110.887 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -128.2 121.15 28.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 75.11 110.855 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.1 tp -52.41 -43.75 41.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 73.41 111.166 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -74.39 -18.29 60.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.481 . . . . 65.53 111.121 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.402 ' HA2' ' HD2' ' A' ' 136' ' ' PRO . . . 161.47 103.59 0.18 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.725 -0.75 . . . . 72.42 112.454 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.402 ' HD2' ' HA2' ' A' ' 135' ' ' GLY . 53.8 Cg_endo -69.72 147.99 64.34 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.656 2.237 . . . . 74.13 112.382 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 28.4 t -128.73 150.49 50.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 75.14 110.875 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 1.4 mp -107.89 132.99 54.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.12 -0.491 . . . . 73.35 111.136 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 18.9 mtp180 -112.37 131.25 55.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 73.43 110.869 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -126.72 134.01 8.3 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.705 -0.76 . . . . 70.41 112.485 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -139.17 116.94 11.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.832 0.349 . . . . 72.01 111.125 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.3 tp -127.01 124.59 39.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.242 -0.436 . . . . 62.45 110.954 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 46.6 t -123.34 134.8 65.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 64.44 111.092 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -109.38 143.36 39.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.106 -0.497 . . . . 75.12 110.889 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -121.36 120.25 4.37 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.774 -0.727 . . . . 74.02 112.513 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.417 ' HB3' ' HB2' ' A' ' 149' ' ' TRP . 38.5 t80 -128.85 145.5 51.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.825 0.345 . . . . 73.45 110.893 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -50.95 96.89 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.126 -0.488 . . . . 64.32 110.876 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 92.88 -30.7 6.78 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.707 -0.759 . . . . 63.35 112.464 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.417 ' HB2' ' HB3' ' A' ' 146' ' ' TYR . 25.0 m95 -104.77 141.09 37.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.828 0.347 . . . . 74.33 110.863 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -130.71 140.6 50.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.446 . . . . 74.04 110.943 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -131.44 148.12 52.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 73.54 111.086 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -150.95 137.06 5.86 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.752 -0.737 . . . . 74.42 112.484 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -144.11 119.78 10.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.877 0.37 . . . . 74.31 110.923 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -126.94 122.44 34.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.117 -0.492 . . . . 74.3 110.892 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 15.6 ptt? -146.82 150.17 34.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 71.33 110.846 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 48.9 m-20 -112.12 138.56 48.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 73.12 110.891 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -92.24 132.49 36.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 63.43 110.868 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -77.86 99.64 6.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.141 -0.482 . . . . 71.43 110.865 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.21 -47.0 78.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.139 -0.482 . . . . 75.32 111.165 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -48.29 -26.11 1.85 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 75.55 111.119 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 43.9 mttt -127.33 -166.64 1.63 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.459 . . . . 63.11 110.935 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 39.6 m -111.18 40.29 2.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.44 . . . . 73.33 110.795 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 11.0 mmm180 -153.3 176.21 12.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 73.25 110.889 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 1.5 t -78.01 141.42 15.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 74.11 111.119 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 15.2 t -90.61 -33.73 15.74 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.158 -0.474 . . . . 62.15 111.131 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -150.97 134.84 16.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.445 . . . . 74.42 110.9 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 89.5 p -124.81 119.01 27.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 73.31 110.893 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -130.47 142.56 50.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 75.23 110.89 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -138.2 158.14 44.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.126 -0.488 . . . . 71.32 110.866 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -154.07 138.96 17.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 64.21 111.114 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 46.2 t -120.63 134.87 62.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 74.12 111.113 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -117.59 112.56 2.48 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.706 -0.759 . . . . 73.11 112.491 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -114.18 121.58 44.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.994 0.426 . . . . 73.32 110.901 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 26.0 ttmt -104.36 134.77 47.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.113 -0.494 . . . . 75.1 110.916 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.97 165.11 22.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 74.35 111.128 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -40.93 -74.82 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.175 -0.466 . . . . 54.22 110.892 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -116.07 15.15 16.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 72.21 110.913 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -127.09 149.57 49.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 75.41 110.868 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 6.6 mm-40 -135.22 123.87 23.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.123 -0.49 . . . . 74.23 110.881 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -124.23 122.32 37.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.132 -0.485 . . . . 75.4 110.873 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -130.47 115.94 17.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 72.23 110.9 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.77 153.12 17.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.217 -0.447 . . . . 75.34 111.1 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -146.76 138.56 24.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 73.31 110.896 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 2.3 t -134.72 111.3 13.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.473 . . . . 71.52 111.143 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -100.09 89.28 3.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 72.3 110.9 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 65.28 179.14 0.19 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.179 -0.464 . . . . 71.22 110.821 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -73.47 -4.17 64.2 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.69 -0.767 . . . . 75.4 112.506 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 29.3 p -95.38 -25.87 16.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.765 0.317 . . . . 62.14 111.15 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -122.83 114.17 20.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 75.43 110.915 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -139.72 124.13 18.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 73.11 110.813 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 178.8 -150.88 9.87 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.678 -0.772 . . . . 44.43 112.47 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -176.42 170.43 43.24 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.726 -0.749 . . . . 74.35 112.485 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 65.3 m -121.21 147.19 45.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.872 0.368 . . . . 63.22 110.798 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 4.0 mp -119.79 123.45 70.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.104 -0.498 . . . . 73.22 111.073 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -108.48 121.91 45.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 75.45 110.929 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 53.9 tp60 -124.47 130.2 52.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 74.52 110.914 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 21.2 mtpp -106.25 127.19 53.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 74.53 110.874 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 14.7 t -79.21 153.33 4.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 73.51 111.159 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . 0.406 ' O ' ' C ' ' A' ' 200' ' ' LYS . 47.0 t30 -59.62 97.94 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 73.35 110.9 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . 0.406 ' C ' ' O ' ' A' ' 199' ' ' ASN . 16.6 ptpt 37.3 63.12 0.76 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 75.11 110.897 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 25.3 mttm -145.46 -56.46 0.31 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 75.53 110.917 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -173.76 172.42 3.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 74.01 110.936 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -116.58 144.9 43.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 72.24 110.876 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 7.3 m -146.53 138.77 24.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 74.02 111.105 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -145.3 136.64 25.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.441 . . . . 72.14 111.141 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 1.1 m -113.79 149.97 15.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 73.23 111.095 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -113.58 137.19 51.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.485 . . . . 72.43 110.865 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -120.61 129.72 53.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.17 -0.468 . . . . 73.51 110.897 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -129.77 130.07 44.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.119 -0.492 . . . . 73.24 111.08 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 2.9 t-105 -129.67 128.1 41.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 71.4 110.941 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 2.7 p -99.14 109.02 21.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.225 -0.443 . . . . 75.33 111.159 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -54.91 149.84 10.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 72.14 111.063 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 95.59 -36.49 3.8 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.71 -0.757 . . . . 72.41 112.474 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -121.54 -179.46 4.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.782 0.325 . . . . 74.12 110.879 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 3.0 t -112.11 38.37 2.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 71.12 110.882 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -102.17 112.21 24.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 75.55 110.905 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 18.6 m -114.65 138.45 50.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.459 . . . . 74.33 111.132 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 18.4 ttt85 -108.55 131.99 54.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.441 . . . . 75.43 110.848 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -117.45 136.7 53.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 74.41 110.89 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -137.46 140.63 11.48 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.737 -0.744 . . . . 71.32 112.511 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 4.8 mp -123.85 130.73 73.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.854 0.359 . . . . 70.45 111.104 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -127.61 152.21 47.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 65.41 111.1 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -137.37 129.34 29.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.246 -0.434 . . . . 75.22 111.084 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 7.3 ttmt -115.21 128.48 56.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 73.32 110.894 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -132.25 131.54 42.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.252 -0.431 . . . . 73.24 110.913 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 58.7 mm-40 -102.71 112.28 24.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 75.35 110.875 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 71.4 mt -102.68 -40.1 6.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 73.33 111.109 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -124.17 160.7 51.19 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.579 0.704 . . . . 62.32 110.882 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -32.34 18.82 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.725 2.283 . . . . 73.44 112.317 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -109.2 10.49 25.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.435 . . . . 72.43 110.882 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -136.1 140.42 43.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.179 -0.464 . . . . 64.12 111.086 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 21.8 m -138.74 136.49 35.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.213 -0.449 . . . . 62.25 110.903 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -110.42 132.77 53.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 73.3 110.924 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 58.2 p -137.08 149.71 47.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 72.44 110.826 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -136.47 155.59 49.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.096 -0.502 . . . . 73.44 111.089 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.51 145.91 29.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 74.41 110.861 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 1.7 p -143.04 143.88 24.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 73.32 111.143 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -112.31 148.08 34.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 73.03 110.886 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' ASN . . . . . 0.415 ' C ' ' H ' ' A' ' 241' ' ' SER . 2.4 t-20 -57.1 -18.53 15.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 63.55 110.89 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 29.9 t -80.93 25.89 0.44 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 73.31 110.814 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' SER . . . . . 0.415 ' H ' ' C ' ' A' ' 239' ' ' ASN . 0.8 OUTLIER 62.22 35.19 15.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.123 -0.49 . . . . 73.32 110.875 -179.838 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 4.9 mp -99.25 118.5 36.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.132 -0.486 . . . . 74.01 110.916 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -107.42 117.88 54.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 74.35 111.154 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -137.12 149.62 20.33 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.701 -0.762 . . . . 71.3 112.467 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.425 ' CD1' ' N ' ' A' ' 245' ' ' LEU . 0.0 OUTLIER -145.83 158.48 43.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.869 0.366 . . . . 64.44 110.887 -179.895 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -163.01 136.83 4.48 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.687 -0.768 . . . . 71.42 112.465 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -128.42 132.59 48.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.902 0.382 . . . . 75.4 110.932 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 7.8 t -111.99 125.83 54.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.487 . . . . 62.41 111.177 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -143.43 148.82 36.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.235 -0.438 . . . . 75.11 110.961 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 5.5 m -88.93 145.24 25.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.262 -0.426 . . . . 72.03 111.127 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 47.4 mt -93.94 -176.05 3.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 71.45 110.889 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' LYS . . . . . 0.472 ' CB ' ' CD ' ' A' ' 253' ' ' PRO . 0.1 OUTLIER -51.16 -61.07 4.46 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.545 0.688 . . . . 73.4 110.87 179.845 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . 0.472 ' CD ' ' CB ' ' A' ' 252' ' ' LYS . 53.8 Cg_endo -69.73 -170.26 0.38 Allowed 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.687 2.258 . . . . 64.35 112.306 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . 0.538 ' O ' ' HB3' ' A' ' 281' ' ' PHE . . . -85.1 51.55 4.56 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.737 -0.744 . . . . 73.42 112.465 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.435 ' HA ' ' CB ' ' A' ' 281' ' ' PHE . 6.2 pt -129.27 135.1 62.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.893 0.377 . . . . 65.31 111.152 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . 0.425 ' H ' ' HB2' ' A' ' 281' ' ' PHE . 0.1 OUTLIER -98.39 132.1 44.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.447 . . . . 74.1 110.888 179.858 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 5.2 tp -100.07 125.45 46.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 75.22 110.921 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 21.9 m -116.39 111.75 20.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 73.11 111.152 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.33 130.02 55.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.253 -0.431 . . . . 75.41 110.868 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 1.7 t -144.16 155.8 44.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.167 -0.469 . . . . 73.25 110.898 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -158.88 128.38 5.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 62.24 111.06 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -118.48 122.98 44.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 71.32 110.921 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -118.93 110.56 17.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.159 -0.473 . . . . 73.4 110.88 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . 0.55 ' O ' ' HB ' ' A' ' 268' ' ' VAL . 1.7 m-20 -88.62 99.87 12.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 73.31 110.844 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -52.86 -11.48 1.35 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.737 -0.744 . . . . 74.45 112.464 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.407 ' H ' ' C ' ' A' ' 264' ' ' ASP . 7.4 ttmm -63.86 -25.66 68.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.825 0.345 . . . . 70.13 110.915 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -166.82 16.91 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 72.05 110.881 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . 0.55 ' HB ' ' O ' ' A' ' 264' ' ' ASP . 1.4 p -68.05 -28.51 41.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 64.54 111.119 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -74.48 -37.44 63.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 74.25 110.914 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -85.83 -17.64 35.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.142 -0.481 . . . . 62.41 111.103 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 131.21 95.26 0.68 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.768 -0.729 . . . . 72.51 112.515 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 178.86 53.74 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.774 -0.727 . . . . 74.14 112.537 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 14.8 p80 -112.17 144.21 41.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.887 0.375 . . . . 72.3 110.84 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -123.71 149.32 45.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 72.11 110.889 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 2.4 tp -128.41 148.55 50.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 72.3 110.898 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -131.34 97.53 0.36 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.784 -0.722 . . . . 75.45 112.501 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.404 ' O ' ' HA ' ' A' ' 27' ' ' ILE . 3.2 tm? -119.28 129.65 55.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.845 0.355 . . . . 74.45 110.886 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -164.48 145.61 10.51 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.752 -0.737 . . . . 72.53 112.533 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.415 ' CD2' ' N ' ' A' ' 279' ' ' LEU . 0.0 OUTLIER -118.47 130.03 55.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.745 0.307 . . . . 72.44 110.971 -179.969 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . 0.526 ' O ' ' HB2' ' A' ' 281' ' ' PHE . 0.0 OUTLIER -140.37 143.58 35.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.449 . . . . 73.2 110.924 179.961 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . 0.538 ' HB3' ' O ' ' A' ' 254' ' ' GLY . 0.2 OUTLIER 172.63 -144.39 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 73.34 110.856 -179.949 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -137.47 148.82 46.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 72.04 110.933 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -101.11 111.45 23.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 71.31 111.106 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -151.31 178.44 9.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.235 -0.439 . . . . 75.11 110.904 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 73.15 110.893 179.919 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' NAI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 33.2 mtt . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.774 0.321 . . . . 70.41 110.9 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -140.46 107.71 5.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.279 -0.419 . . . . 75.52 111.104 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.1 t -114.43 78.48 4.8 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.668 0.746 . . . . 71.11 111.14 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 167.7 23.68 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.681 2.254 . . . . 72.14 112.351 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 119.57 6.49 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.654 2.236 . . . . 61.03 112.335 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 34.7 p -106.99 -49.61 3.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 70.21 111.154 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -56.39 -30.69 63.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.26 -0.427 . . . . 74.54 110.924 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -79.75 -23.08 42.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.082 -0.508 . . . . 74.03 111.117 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -90.66 13.28 16.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 74.33 110.846 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.39 -33.83 71.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.21 -0.45 . . . . 64.44 110.907 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 161.31 49.8 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.764 -0.731 . . . . 72.12 112.511 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.29 -48.51 81.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.775 0.321 . . . . 74.43 110.921 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.6 m -61.25 -49.14 78.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 71.11 110.839 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.22 -38.21 88.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 75.32 111.083 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.0 ttt-85 -60.73 -33.51 73.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 75.22 110.873 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -58.05 -46.02 86.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 74.23 110.893 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 92.8 t -65.19 -41.92 92.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 73.04 111.127 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -62.67 -41.01 98.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 71.44 110.911 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.0 t -94.11 43.13 1.1 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.145 -0.48 . . . . 64.21 111.165 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -129.5 174.1 9.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 75.41 110.866 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 77.55 -72.53 2.17 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.764 -0.732 . . . . 61.14 112.459 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -68.1 87.76 0.28 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.966 0.412 . . . . 73.21 110.942 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -61.29 -176.05 1.83 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.751 -0.738 . . . . 74.11 112.445 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -97.68 -4.49 37.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.944 0.402 . . . . 74.31 110.894 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.61 13.15 77.97 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.738 -0.744 . . . . 72.54 112.457 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.2 pp -149.54 -176.7 5.5 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.749 0.309 . . . . 74.33 110.952 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 1.6 mp -118.33 120.91 65.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.206 -0.452 . . . . 72.24 111.171 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.43 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 0.0 OUTLIER -125.81 117.13 22.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 74.44 110.915 179.844 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.69 137.91 50.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.44 . . . . 75.52 110.926 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.548 ' C ' ' HB3' ' A' ' 281' ' ' PHE . 0.7 OUTLIER -147.51 132.54 18.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.238 -0.437 . . . . 74.33 110.864 179.88 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.762 ' HA ' ' HA ' ' A' ' 281' ' ' PHE . 4.2 tt -129.55 124.58 34.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.196 -0.456 . . . . 75.43 110.952 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.595 ' N ' ' HB2' ' A' ' 281' ' ' PHE . 0.3 OUTLIER -120.36 125.29 47.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 72.23 110.891 179.873 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 46.2 m -122.2 121.11 36.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 74.14 111.124 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 5.9 ptmt -121.01 148.03 44.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 71.35 110.89 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 75.6 m -139.07 169.3 18.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 65.33 110.873 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -83.17 52.49 2.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.105 -0.498 . . . . 74.22 110.874 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -140.65 8.59 2.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.139 -0.482 . . . . 74.32 110.908 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' A' ' 63' ' ' ARG . . . 79.27 -5.09 60.71 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.727 -0.749 . . . . 72.02 112.511 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -99.08 128.53 45.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.726 0.298 . . . . 61.02 110.94 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.401 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -139.82 118.49 12.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 72.32 110.86 179.934 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -102.97 126.59 50.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 74.3 110.872 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 54.3 m -127.08 117.42 22.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.108 -0.496 . . . . 75.52 111.173 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 36.5 p -104.31 134.27 47.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 73.25 110.9 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 35.6 t -127.0 127.15 44.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 71.52 110.835 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -141.86 129.79 4.09 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.7 -0.762 . . . . 51.53 112.453 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 48.6 m -128.97 135.74 49.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.87 0.367 . . . . 72.21 110.866 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.401 ' HA ' ' HA ' ' A' ' 54' ' ' VAL . . . -134.66 129.7 35.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.128 -0.487 . . . . 74.11 111.106 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -92.18 136.42 33.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 75.21 110.866 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -96.23 -55.89 2.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 72.12 111.168 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -50.49 -34.91 26.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.221 -0.445 . . . . 73.51 110.9 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -139.3 165.21 27.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 72.41 111.117 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 22.0 p -78.72 84.6 4.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.462 . . . . 73.35 111.112 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 10.9 tptp -145.61 82.27 1.63 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 74.41 110.885 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.401 ' HA ' ' HA ' ' A' ' 47' ' ' ALA . 0.7 OUTLIER -126.68 120.07 55.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 75.22 111.128 179.845 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 82.7 p -137.93 160.82 38.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.198 -0.455 . . . . 72.34 111.117 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -129.74 158.57 22.28 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.733 -0.746 . . . . 71.41 112.502 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.2 p -146.51 161.21 40.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.913 0.387 . . . . 73.22 110.869 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -119.95 131.04 55.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.115 -0.493 . . . . 75.31 110.929 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -115.84 124.41 50.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 73.43 110.88 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.57 125.8 51.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 72.41 111.161 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.401 ' HB2' ' HB3' ' A' ' 40' ' ' GLU . 3.6 mttp -134.57 159.16 42.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 75.41 110.905 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -131.92 140.77 49.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 74.51 110.936 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.492 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 2.9 tmm_? -130.33 103.27 6.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 75.43 110.855 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 16.9 m95 -116.06 120.21 38.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 74.43 110.917 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.6 m 64.74 118.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 64.23 111.146 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -51.02 115.07 1.36 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.441 . . . . 75.35 110.85 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 65.59 56.93 0.9 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.113 -0.494 . . . . 75.15 110.948 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -144.35 -70.52 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.711 -0.757 . . . . 72.14 112.493 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -125.12 128.88 49.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.869 0.366 . . . . 60.31 110.928 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -137.67 128.82 27.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.26 -0.427 . . . . 71.54 111.156 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -114.47 133.35 55.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 75.52 110.848 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 49.8 p -126.32 115.0 19.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.127 -0.488 . . . . 73.41 111.171 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -132.06 136.16 47.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.231 -0.44 . . . . 64.43 110.857 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 13.6 pttp -123.15 94.72 4.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.47 . . . . 74.03 110.903 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.479 ' CD1' ' HB3' ' A' ' 81' ' ' LEU . 5.8 t90 -95.37 125.88 40.29 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.232 -0.44 . . . . 72.33 110.896 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -94.25 137.12 33.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.267 -0.424 . . . . 75.23 110.873 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 8.0 t -65.57 -36.66 84.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.153 -0.476 . . . . 75.35 111.162 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -112.1 -37.19 5.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.182 -0.463 . . . . 63.23 110.931 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -77.71 -162.19 0.3 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 74.52 110.898 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 20.7 p -81.09 157.35 25.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.161 -0.472 . . . . 74.02 111.156 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.479 ' HB3' ' CD1' ' A' ' 75' ' ' TRP . 0.2 OUTLIER -96.38 119.15 34.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 71.53 110.909 179.961 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.19 144.11 15.74 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.752 -0.737 . . . . 54.51 112.51 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.9 t -144.98 124.9 13.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.73 0.3 . . . . 75.44 111.169 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 50.9 tt0 -134.73 151.4 50.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 73.44 110.89 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.1 tt -129.12 139.02 52.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 72.55 111.117 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 7.6 p -129.11 121.24 27.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.16 -0.473 . . . . 73.55 111.155 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.0 p -118.62 134.39 62.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 75.02 111.168 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -106.75 128.12 53.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 64.43 110.874 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 61.34 56.03 2.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.185 -0.461 . . . . 74.35 110.849 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -64.34 -67.52 0.43 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 73.4 110.892 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 56.5 tp -106.6 -53.99 2.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.18 -0.464 . . . . 64.03 110.919 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -106.44 124.44 49.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 74.02 111.109 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 -51.71 133.64 30.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.242 -0.435 . . . . 74.4 110.923 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 99.97 -23.59 35.42 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.734 -0.746 . . . . 74.24 112.479 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.24 134.6 34.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.844 0.354 . . . . 75.2 110.937 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.7 tttp -122.29 131.15 53.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 74.2 110.883 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -116.75 130.72 56.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.205 -0.452 . . . . 75.22 110.924 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 51.6 m -129.64 125.0 35.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 64.33 111.106 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -115.42 116.47 28.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.232 -0.44 . . . . 73.53 110.875 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -109.33 133.15 53.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.17 -0.468 . . . . 72.24 110.844 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.4 t -142.87 128.38 19.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 71.21 110.857 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.1 m -108.11 151.02 26.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.131 -0.486 . . . . 72.12 110.866 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -133.23 132.44 41.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 70.54 110.868 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 9.6 t -128.18 109.67 19.73 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.627 0.727 . . . . 74.52 110.9 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 -16.35 37.67 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.623 2.216 . . . . 73.41 112.36 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -48.97 -70.7 0.08 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 63.32 110.839 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.6 m -129.13 31.47 4.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 73.03 111.145 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 67.76 24.22 74.14 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.726 -0.75 . . . . 75.12 112.472 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.55 116.53 13.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.837 0.351 . . . . 74.53 110.891 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 37.0 mtmt -116.01 147.98 40.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.172 -0.467 . . . . 73.34 110.911 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -120.5 132.54 55.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 73.43 110.889 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -114.65 121.48 43.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 64.42 111.129 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 16.5 ttmt -138.03 138.21 38.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.253 -0.431 . . . . 75.35 110.926 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 6.1 tp -134.11 123.23 43.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.434 . . . . 71.41 111.144 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 68.7 tttt -119.13 121.0 38.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 74.42 110.922 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.0 t -128.23 125.4 38.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.44 . . . . 73.11 111.136 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -150.7 157.47 27.21 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.78 -0.724 . . . . 71.42 112.494 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 16.3 p90 -132.21 130.78 41.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.939 0.399 . . . . 75.55 110.953 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 29.7 tttp -107.64 118.23 36.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.481 . . . . 75.34 110.884 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 12.4 mmt85 -110.85 142.91 42.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.247 -0.433 . . . . 74.42 110.857 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -52.79 -27.41 17.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 64.11 110.88 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 74.6 t60 -88.08 -39.61 14.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 75.24 110.859 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 8.6 tp -148.41 144.65 18.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 72.42 111.149 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -109.47 119.11 38.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 75.51 110.913 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -123.62 139.59 53.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 74.32 110.952 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -145.34 121.77 1.58 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.711 -0.757 . . . . 73.01 112.462 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -112.41 134.44 53.94 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.808 0.337 . . . . 75.32 110.857 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -129.67 133.82 47.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.164 -0.471 . . . . 72.32 110.898 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 2.1 mmt -127.99 129.17 46.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.457 . . . . 72.4 110.855 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -123.23 120.2 32.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 73.53 110.866 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -94.98 127.92 41.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 74.31 110.901 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -134.77 122.71 22.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.112 -0.494 . . . . 64.32 110.858 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -55.31 -25.25 16.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 74.12 111.133 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -91.79 -20.03 21.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 70.53 111.095 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 164.04 98.97 0.13 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.711 -0.757 . . . . 62.22 112.452 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.82 138.44 37.63 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.692 2.261 . . . . 65.21 112.328 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.1 m -127.77 159.52 34.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 71.42 110.844 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.4 mp -123.63 140.83 45.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.105 -0.498 . . . . 75.21 111.121 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 43.7 ttt180 -121.36 120.44 35.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 74.22 110.819 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -112.08 134.0 11.78 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.757 -0.735 . . . . 41.3 112.431 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -134.28 120.71 20.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.762 0.315 . . . . 75.52 111.135 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.0 tp -131.62 125.74 32.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.229 -0.441 . . . . 73.24 110.92 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 78.5 t -127.93 133.92 66.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.45 . . . . 75.24 111.134 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.6 mp -110.04 138.68 46.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 75.45 110.898 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -111.96 124.72 6.89 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.751 -0.738 . . . . 72.0 112.498 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -134.2 145.07 48.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.825 0.345 . . . . 73.24 110.968 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -50.45 96.47 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.125 -0.489 . . . . 62.41 110.903 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 90.02 -26.77 9.18 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.724 -0.75 . . . . 74.5 112.462 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 8.4 m0 -104.91 135.89 45.41 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.819 0.342 . . . . 72.42 110.913 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -129.91 137.56 50.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 74.24 110.903 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -129.98 137.4 50.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 62.12 111.136 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -138.72 136.08 7.8 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.739 -0.743 . . . . 72.53 112.48 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -139.33 119.38 13.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.831 0.348 . . . . 74.24 110.911 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 38.0 tt0 -132.59 122.44 24.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.484 . . . . 70.24 110.895 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 10.7 ptt? -146.12 157.76 43.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 75.5 110.843 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.42 ' O ' ' HB ' ' A' ' 164' ' ' VAL . 5.0 m120 -112.86 121.5 44.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.435 . . . . 74.03 110.868 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.515 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 49.0 t80 -84.29 128.63 34.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.121 -0.49 . . . . 70.05 110.854 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.416 ' H ' ' HA ' ' A' ' 164' ' ' VAL . 5.0 tp10 -85.51 107.88 17.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.491 . . . . 71.14 110.899 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.92 -48.31 71.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.137 -0.483 . . . . 74.2 111.156 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -50.24 -26.25 4.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.453 . . . . 75.11 111.066 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 43.6 mttm -117.02 -166.59 1.19 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 74.14 110.872 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 18.8 t -114.26 37.28 3.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 75.12 110.891 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 7.5 ptp85 -168.32 175.01 6.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.112 -0.494 . . . . 73.11 110.867 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.515 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 1.7 m -80.45 142.18 14.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 72.41 111.131 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 7.9 t -91.13 -25.81 19.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.196 -0.456 . . . . 75.55 111.156 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 5.3 tp60 -139.31 133.25 30.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 72.23 110.968 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -125.23 130.54 52.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.178 -0.465 . . . . 71.15 110.878 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -136.07 138.2 41.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 73.15 110.891 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -133.26 144.58 49.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 72.14 110.857 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -149.97 137.04 19.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 73.35 111.119 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 21.7 t -121.11 140.53 44.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 72.12 111.127 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -115.24 126.36 7.14 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.736 -0.745 . . . . 71.02 112.51 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -128.43 121.59 29.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.924 0.392 . . . . 73.32 110.928 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 22.3 mtmm -103.39 133.33 48.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.112 -0.494 . . . . 62.23 110.917 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -127.05 165.26 19.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 73.43 111.121 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -38.96 -76.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 70.5 110.828 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -117.13 14.22 14.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 74.43 110.879 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -125.39 150.14 47.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.48 . . . . 74.43 110.889 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 46.2 mm-40 -129.34 124.88 35.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 74.35 110.863 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -122.71 124.49 43.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 75.21 110.893 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 76.4 m-70 -130.72 116.35 17.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.21 -0.45 . . . . 73.12 110.853 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.82 154.46 17.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 73.52 111.143 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -163.0 139.88 7.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.209 -0.451 . . . . 74.04 110.908 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.556 ' HB ' ' HA ' ' A' ' 190' ' ' PHE . 1.7 m -134.31 137.29 51.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 61.24 111.14 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -97.26 88.48 4.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 71.02 110.869 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 71.43 -174.84 0.17 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 73.25 110.925 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -79.47 3.04 69.39 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.75 -0.738 . . . . 54.11 112.469 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 30.5 p -106.36 -23.35 12.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.783 0.325 . . . . 71.1 111.162 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -120.9 123.13 41.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.215 -0.448 . . . . 74.33 110.899 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' PHE . . . . . 0.556 ' HA ' ' HB ' ' A' ' 184' ' ' VAL . 0.5 OUTLIER -139.06 124.73 19.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 75.22 110.841 -179.884 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -165.1 -156.18 8.94 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.714 -0.755 . . . . 64.4 112.443 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -171.09 -168.56 32.96 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.742 -0.742 . . . . 63.42 112.487 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 39.0 t -147.78 145.52 28.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.837 0.351 . . . . 64.2 110.869 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 4.5 mp -120.68 133.36 67.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.113 -0.494 . . . . 74.0 111.112 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -117.68 121.18 40.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.192 -0.458 . . . . 74.22 110.932 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -121.03 131.64 54.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.087 -0.506 . . . . 75.44 110.916 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 23.3 ttpt -97.07 127.4 43.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.173 -0.467 . . . . 72.0 110.895 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 17.9 t 65.01 66.47 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 72.42 111.123 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -112.47 -36.03 5.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.176 -0.465 . . . . 73.04 110.932 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 31.0 tttm -119.77 -67.8 0.96 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 72.4 110.909 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.17 -38.08 1.42 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.209 -0.45 . . . . 75.31 110.892 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 15.1 tp -146.1 -74.43 0.22 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.21 -0.45 . . . . 74.42 110.884 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -124.91 142.1 51.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 74.21 110.86 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 1.7 m -146.01 137.56 24.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 73.21 111.198 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -150.33 162.69 40.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.23 -0.441 . . . . 62.53 111.056 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 1.3 m -137.26 149.98 26.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.194 -0.457 . . . . 74.03 111.176 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -113.81 135.74 53.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 73.54 110.89 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -121.38 145.5 47.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.485 . . . . 75.41 110.906 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -153.32 138.18 17.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.203 -0.453 . . . . 72.31 111.112 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 9.4 t-105 -130.78 134.94 47.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.188 -0.46 . . . . 74.43 110.945 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 2.3 m -96.9 105.27 17.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.252 -0.431 . . . . 74.45 111.12 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -51.6 132.68 30.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.155 -0.475 . . . . 75.13 111.091 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 117.85 -74.96 0.29 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.766 -0.731 . . . . 73.3 112.446 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -179.95 106.93 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.831 0.348 . . . . 73.02 110.843 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 2.0 t -173.96 161.14 3.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.466 . . . . 55.04 110.845 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -63.61 154.85 31.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 73.1 110.904 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 3.7 m -80.95 133.91 35.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.164 -0.471 . . . . 74.32 111.151 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 8.1 mmt85 -89.99 118.08 29.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.45 . . . . 73.43 110.844 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -130.18 137.53 50.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.146 -0.479 . . . . 74.11 110.88 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -142.01 140.64 10.22 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.752 -0.737 . . . . 61.12 112.485 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 4.3 mp -120.53 131.39 72.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.825 0.345 . . . . 74.32 111.142 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -137.49 151.22 48.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 75.23 111.076 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -144.98 129.73 18.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 72.32 111.083 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 29.1 mtpt -102.52 125.25 49.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 71.4 110.914 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -124.28 117.76 25.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.254 -0.43 . . . . 73.23 110.91 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -86.67 104.7 16.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.088 -0.506 . . . . 72.35 110.923 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 1.7 tt -82.68 -31.6 9.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 73.03 111.117 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -161.45 161.44 22.85 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.583 0.706 . . . . 75.34 110.867 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -6.96 19.85 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.664 2.242 . . . . 65.02 112.345 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -112.74 -25.38 9.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.246 -0.434 . . . . 63.31 110.861 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -137.62 145.08 42.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 72.13 111.085 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 25.5 m -136.85 143.14 42.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 75.4 110.915 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -117.73 134.24 55.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 71.22 110.861 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 22.8 t -135.47 152.15 51.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.122 -0.49 . . . . 72.14 110.854 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -139.51 146.27 39.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.087 -0.506 . . . . 72.3 111.129 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.52 159.01 32.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.261 -0.427 . . . . 74.14 110.852 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 1.6 m -141.73 163.97 19.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 74.21 111.097 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -112.89 147.81 36.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 74.01 110.864 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -49.15 -22.36 0.96 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.479 . . . . 73.23 110.854 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 32.2 t -80.99 13.59 2.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 73.31 110.87 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 1.2 t 69.65 40.1 1.43 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.118 -0.492 . . . . 74.42 110.895 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 2.1 mp -97.23 137.79 35.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.131 -0.486 . . . . 74.25 110.956 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.15 117.34 52.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 71.41 111.143 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -139.07 148.47 20.02 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.724 -0.75 . . . . 73.12 112.484 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.425 ' CD1' ' N ' ' A' ' 245' ' ' LEU . 0.0 OUTLIER -146.65 160.86 41.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.849 0.356 . . . . 74.32 110.939 -179.929 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -134.62 147.95 19.33 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.765 -0.731 . . . . 75.45 112.508 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -127.77 116.94 20.98 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.988 0.423 . . . . 74.42 110.911 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 7.5 m -101.78 137.36 40.19 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.08 -0.509 . . . . 71.33 111.079 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -137.25 165.94 24.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 73.52 110.903 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' THR . . . . . 0.447 ' O ' ' CB ' ' A' ' 251' ' ' LEU . 23.5 m 65.88 -104.76 0.1 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.45 . . . . 73.2 111.095 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.447 ' CB ' ' O ' ' A' ' 250' ' ' THR . 0.2 OUTLIER 79.17 -9.17 1.53 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 71.43 110.91 -179.993 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' LYS . . . . . 0.527 ' CB ' ' HD2' ' A' ' 253' ' ' PRO . 4.5 mttm -48.01 171.88 0.08 OUTLIER Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.6 0.714 . . . . 74.02 110.899 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . 0.527 ' HD2' ' CB ' ' A' ' 252' ' ' LYS . 54.0 Cg_endo -69.79 58.33 1.56 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.66 2.24 . . . . 64.23 112.34 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' A' ' 283' ' ' ALA . . . -165.87 -62.7 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.7 -0.762 . . . . 35.32 112.485 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -140.95 139.28 34.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.908 0.385 . . . . 70.22 111.141 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . 0.509 ' O ' ' HA ' ' A' ' 279' ' ' LEU . 7.0 tttt -110.16 127.01 54.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 74.33 110.857 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 25.0 tp -88.85 122.78 32.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.175 -0.466 . . . . 72.2 110.889 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 4.8 m -126.54 110.14 12.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 71.13 111.148 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -103.4 134.01 47.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.196 -0.456 . . . . 55.12 110.913 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 24.8 p -128.9 140.64 51.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 63.51 110.892 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -147.24 126.09 12.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.484 . . . . 72.34 111.094 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -131.91 122.96 26.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.458 . . . . 74.42 110.887 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -121.56 109.81 15.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.15 -0.477 . . . . 75.53 110.912 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -87.19 109.41 19.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 74.21 110.916 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -56.24 -20.5 29.04 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.743 -0.741 . . . . 71.04 112.488 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.94 -3.54 48.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.799 0.333 . . . . 74.11 110.924 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -123.73 -57.62 1.62 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 74.45 110.886 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 16.7 m -48.11 -28.24 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 74.34 111.112 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -53.26 -45.77 68.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 61.03 110.929 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -106.14 -16.92 14.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 75.13 111.127 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -108.06 -123.35 4.9 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.719 -0.753 . . . . 62.31 112.474 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -146.47 -163.02 10.15 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.693 -0.765 . . . . 64.44 112.466 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 5.6 p80 -105.35 146.26 29.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.83 0.348 . . . . 75.22 110.884 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 12.4 mtpp -104.28 135.68 45.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.228 -0.442 . . . . 74.14 110.887 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 1.3 tp -137.09 148.18 46.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 72.13 110.944 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -144.37 110.56 0.57 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.726 -0.75 . . . . 71.13 112.493 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -117.06 139.3 50.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.82 0.343 . . . . 62.24 110.956 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . 0.43 ' HA2' ' O ' ' A' ' 28' ' ' LYS . . . -162.13 154.16 25.05 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.696 -0.764 . . . . 73.42 112.48 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.509 ' HA ' ' O ' ' A' ' 256' ' ' LYS . 3.1 mm? -106.88 139.93 40.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.777 0.322 . . . . 73.14 110.865 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -89.1 126.23 35.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 73.41 110.879 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . 0.762 ' HA ' ' HA ' ' A' ' 31' ' ' LEU . 15.1 p90 -74.98 71.18 2.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.145 -0.48 . . . . 72.21 110.884 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 67.5 mm-40 -125.07 102.02 7.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.48 . . . . 73.1 110.904 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . 0.401 ' HA ' ' HA2' ' A' ' 254' ' ' GLY . . . -124.67 136.28 53.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 64.33 111.144 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 4.2 mp 60.83 32.91 20.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 64.32 110.933 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.155 -0.475 . . . . 74.24 110.898 179.962 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' NAI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.782 0.325 . . . . 62.33 110.875 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -113.37 -174.03 2.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 74.1 111.023 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.1 p -164.3 133.7 2.95 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.662 0.744 . . . . 70.21 111.107 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.7 167.97 22.81 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.671 2.247 . . . . 73.24 112.383 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 117.97 5.4 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.691 2.261 . . . . 75.43 112.344 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.71 -32.75 14.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.203 -0.453 . . . . 74.22 111.136 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -55.55 -29.82 59.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.246 -0.434 . . . . 72.21 110.953 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -72.95 -22.58 60.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.091 -0.504 . . . . 74.21 111.056 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -87.57 7.51 29.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.205 -0.452 . . . . 75.14 110.858 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 50.0 mt -69.22 -31.39 69.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 75.55 110.885 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -172.45 76.23 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.76 -0.733 . . . . 41.55 112.515 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.4 mmtp -69.25 -55.09 11.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.772 0.32 . . . . 73.13 110.87 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.91 -39.64 93.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.452 . . . . 75.54 110.852 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.91 -37.32 76.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.487 . . . . 73.42 111.098 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -59.76 -31.98 70.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 75.12 110.873 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 -57.47 -48.29 79.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 74.33 110.898 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 61.7 t -81.84 -33.07 11.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.461 . . . . 71.31 111.143 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -64.55 -32.43 74.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 75.43 110.83 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 52.4 m -48.6 114.92 1.07 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 74.24 111.163 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.3 mptt -85.03 -168.72 2.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 72.51 110.895 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 99.03 32.15 5.97 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.711 -0.757 . . . . 64.3 112.483 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -119.03 124.78 47.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.927 0.394 . . . . 75.42 110.926 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 62.56 65.85 2.92 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.81 -0.709 . . . . 74.43 112.472 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -102.43 -4.7 25.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.898 0.38 . . . . 74.3 110.911 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.37 13.6 77.14 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.702 -0.761 . . . . 52.4 112.515 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.2 pp -145.02 -178.35 6.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.737 0.303 . . . . 73.23 110.92 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.4 HG13 ' HB3' ' A' ' 277' ' ' LEU . 1.7 mp -119.6 122.41 68.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 75.32 111.137 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.84 117.04 18.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.135 -0.484 . . . . 62.33 110.886 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.573 ' C ' ' CD2' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -114.78 145.33 42.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.211 -0.449 . . . . 75.11 110.942 179.876 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.547 ' C ' ' HB3' ' A' ' 281' ' ' PHE . 1.3 m-20 -148.06 133.35 18.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.184 -0.462 . . . . 72.4 110.852 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.7 ' HA ' ' HA ' ' A' ' 281' ' ' PHE . 0.2 OUTLIER -127.1 127.79 45.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 73.21 110.87 -179.915 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.587 ' N ' ' HB2' ' A' ' 281' ' ' PHE . 33.5 ttpt -136.56 140.85 43.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 75.12 110.883 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.6 t -135.5 121.66 20.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 72.5 111.166 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.7 pttp -105.13 125.85 51.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.25 -0.432 . . . . 71.51 110.904 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.5 t -114.71 142.79 46.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 72.31 110.827 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -77.17 58.25 1.55 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 74.15 110.89 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -152.86 19.89 0.59 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.143 -0.481 . . . . 73.43 110.88 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.455 ' HA2' ' O ' ' A' ' 63' ' ' ARG . . . 81.01 -4.99 67.68 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.715 -0.755 . . . . 71.14 112.487 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.3 mp -98.42 128.23 44.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.769 0.319 . . . . 74.1 110.902 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -140.97 117.56 10.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 75.12 110.894 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -103.24 122.66 45.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 72.15 110.891 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 90.3 m -126.5 126.31 43.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.137 -0.483 . . . . 63.42 111.142 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.3 p -132.46 142.22 49.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 63.21 110.843 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 58.1 m -149.03 135.84 19.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 71.31 110.874 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -148.02 141.65 9.37 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.702 -0.761 . . . . 65.12 112.44 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 9.0 m -126.91 157.56 39.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.858 0.361 . . . . 71.14 110.887 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -157.11 131.14 8.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.152 -0.476 . . . . 71.42 111.09 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -101.53 141.99 33.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.446 . . . . 73.12 110.893 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 22.2 p -51.03 -34.47 29.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 55.35 111.105 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -51.34 168.24 0.07 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.188 -0.46 . . . . 63.24 110.876 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.2 t -73.05 136.26 44.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 75.23 111.162 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 66.9 p 47.06 71.6 0.31 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.259 -0.428 . . . . 73.14 111.112 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 18.6 mmtp -143.54 35.3 1.3 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.2 -0.455 . . . . 73.35 110.91 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 46.3 t -109.19 124.11 65.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 74.1 111.145 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.6 m -136.11 126.94 27.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 73.14 111.137 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -127.39 141.54 12.73 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.747 -0.74 . . . . 73.01 112.524 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 59.5 p -144.1 160.48 40.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.922 0.392 . . . . 74.14 110.882 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -132.55 150.18 52.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.143 -0.48 . . . . 74.11 110.894 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -136.14 136.18 39.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 74.24 110.9 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.9 p -103.07 129.57 49.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.151 -0.477 . . . . 72.23 111.093 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.1 mtpm? -129.9 159.59 36.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 65.5 110.889 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -130.32 139.65 50.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.217 -0.447 . . . . 74.03 110.929 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.455 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 0.5 OUTLIER -134.51 105.17 6.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.134 -0.484 . . . . 75.44 110.881 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -115.06 101.68 9.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.46 . . . . 72.14 110.952 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.7 t -83.37 -31.76 26.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 64.55 111.149 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -48.47 -34.16 10.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.2 -0.454 . . . . 73.21 110.904 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -118.02 -58.34 2.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.18 -0.464 . . . . 73.14 110.936 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 129.34 58.17 0.1 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.778 -0.725 . . . . 63.15 112.516 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -133.65 141.33 47.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.852 0.358 . . . . 72.02 110.891 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 95.6 m -135.57 130.4 34.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 64.23 111.141 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -119.23 134.82 54.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 73.41 110.875 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -126.73 117.41 22.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.463 . . . . 73.21 111.152 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -132.03 131.47 42.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.27 -0.423 . . . . 73.33 110.875 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.1 ptmt -117.66 135.86 53.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 74.33 110.931 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 12.7 t90 -135.48 128.46 31.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.213 -0.449 . . . . 75.12 110.925 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -120.52 159.52 25.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 70.25 110.872 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 10.5 t -66.79 -13.37 61.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.157 -0.474 . . . . 63.34 111.108 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.443 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 94.9 m-20 -74.92 1.23 13.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.254 -0.43 . . . . 74.52 110.894 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.443 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 2.9 m120 78.72 33.19 0.28 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 75.34 110.91 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 33.3 m -114.89 123.4 49.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.145 -0.48 . . . . 63.24 111.119 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -122.05 119.62 31.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 74.42 110.897 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.76 111.72 3.74 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.731 -0.747 . . . . 70.45 112.473 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.0 t -93.03 120.69 33.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.795 0.331 . . . . 63.14 111.119 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -134.06 126.69 30.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.45 . . . . 73.21 110.871 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.4 138.46 45.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.163 -0.472 . . . . 74.44 111.157 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 99.8 m -129.51 137.72 50.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.202 -0.453 . . . . 72.42 111.126 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.8 t -118.14 137.28 52.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.44 . . . . 72.34 111.149 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -113.71 118.32 33.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 75.34 110.901 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 50.88 74.77 0.21 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.462 . . . . 74.04 110.901 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -96.7 -75.59 0.53 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 74.12 110.885 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 40.9 tp -92.24 -72.37 0.6 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.21 -0.45 . . . . 62.44 110.916 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.53 139.7 39.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 60.13 111.122 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 2.6 ptt180 -60.08 125.09 22.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 74.33 110.868 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 78.73 8.94 87.48 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.756 -0.735 . . . . 52.54 112.502 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 13.8 tp -79.32 134.18 36.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.876 0.37 . . . . 74.14 110.928 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.9 ptmt -121.38 127.51 51.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 75.33 110.905 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -115.03 129.2 56.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.223 -0.444 . . . . 73.33 110.9 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 69.0 m -129.55 119.87 24.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 65.23 111.19 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -122.28 128.71 51.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 65.32 110.858 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -127.84 130.48 48.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.128 -0.487 . . . . 42.24 110.831 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.7 t -142.3 125.93 16.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 75.35 110.88 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.1 t -97.87 131.71 44.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 70.12 110.849 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -129.54 119.69 24.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.106 -0.497 . . . . 74.53 110.878 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -128.83 101.9 19.91 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.661 0.743 . . . . 71.45 110.832 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -37.81 8.58 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.703 2.268 . . . . 74.51 112.334 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -61.57 -75.01 0.07 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 73.53 110.865 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -63.85 -39.0 93.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 51.32 111.153 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.14 24.42 14.79 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.739 -0.744 . . . . 74.55 112.473 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 64.2 mmtt -94.07 148.15 22.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.864 0.364 . . . . 72.2 110.863 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -140.61 135.5 31.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 75.34 110.842 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -121.59 140.84 51.73 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.199 -0.455 . . . . 72.21 110.912 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -127.77 118.02 22.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 72.14 111.077 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 21.3 ttmm -138.45 137.5 37.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 73.35 110.895 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 6.0 tp -134.55 126.73 48.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 73.45 111.154 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -127.45 120.39 28.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 74.43 110.868 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 70.2 p -129.06 127.88 42.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.211 -0.45 . . . . 74.54 111.083 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -150.42 162.39 29.26 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.676 -0.773 . . . . 65.12 112.481 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 6.6 p90 -127.44 141.19 51.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.953 0.406 . . . . 74.34 110.898 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.3 mmmt -110.15 122.71 48.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.075 -0.511 . . . . 75.5 110.908 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.1 mmt85 -106.28 145.29 31.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.273 -0.421 . . . . 73.33 110.865 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -49.67 -28.51 6.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 74.03 110.927 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 7.8 m170 -87.11 -45.33 10.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 73.41 110.853 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 11.8 pt -152.34 153.86 8.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 74.0 111.119 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -117.98 116.61 27.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.468 . . . . 74.51 110.907 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -131.46 141.93 49.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 75.54 110.932 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -147.9 149.01 21.03 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.743 -0.741 . . . . 54.02 112.483 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 31.0 p -112.83 134.72 54.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.827 0.346 . . . . 62.41 110.896 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -117.35 150.8 38.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 73.11 110.857 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 43.2 ttm -135.98 135.98 39.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 74.35 110.851 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -122.53 128.09 50.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 72.43 110.842 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -95.55 97.69 9.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.456 . . . . 75.5 110.888 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -92.05 175.75 6.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 72.33 110.877 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 2.5 pp -73.92 -37.51 47.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.262 -0.426 . . . . 74.14 111.089 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -78.39 -20.43 51.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 74.24 111.081 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 155.22 150.7 5.64 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.778 -0.725 . . . . 73.34 112.483 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 107.92 1.97 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.697 2.265 . . . . 73.32 112.349 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.65 152.79 29.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.247 -0.433 . . . . 70.45 110.909 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 5.0 mp -106.16 132.33 53.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.455 . . . . 74.12 111.14 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 12.3 ttm180 -122.58 133.48 54.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 74.5 110.865 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -127.61 133.3 7.81 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.753 -0.737 . . . . 72.23 112.502 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -140.65 116.07 10.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.824 0.345 . . . . 73.41 111.12 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.2 tp -129.1 133.79 47.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 74.2 110.89 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 61.7 t -128.44 120.97 54.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 70.41 111.146 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.4 mp -114.72 139.94 49.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 74.21 110.925 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -129.51 124.62 4.53 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.772 -0.728 . . . . 62.14 112.533 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -144.93 146.62 32.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.817 0.341 . . . . 72.42 110.922 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 50.29 30.75 4.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.475 . . . . 74.21 110.896 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 85.9 -28.71 4.89 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.727 -0.749 . . . . 61.23 112.522 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 29.9 m0 -69.31 134.83 49.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.833 0.349 . . . . 64.33 110.938 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -108.5 137.81 45.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.256 -0.429 . . . . 64.33 110.892 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -135.96 126.12 26.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 74.44 111.073 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -132.15 146.34 18.01 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.743 -0.742 . . . . 44.04 112.477 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -143.49 119.26 10.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.783 0.325 . . . . 74.41 110.914 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -122.53 120.67 34.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 74.31 110.886 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 4.0 ptt? -148.13 143.52 27.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.251 -0.431 . . . . 71.42 110.882 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -113.64 131.54 56.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 74.44 110.87 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.49 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 9.8 m-85 -93.28 138.89 31.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 74.05 110.858 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.512 ' O ' ' CG ' ' A' ' 158' ' ' GLU . 5.2 pt-20 -76.4 117.32 17.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.105 -0.498 . . . . 74.42 110.876 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 9.8 t -67.23 -31.69 72.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.141 -0.482 . . . . 72.24 111.135 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -47.9 -23.92 0.89 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.215 -0.448 . . . . 64.42 111.129 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.99 -157.65 0.36 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.449 . . . . 74.31 110.9 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 54.1 m -99.51 40.82 1.19 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 74.43 110.858 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.45 173.42 7.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 75.2 110.923 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.49 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 2.5 t -105.82 141.04 22.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.444 . . . . 74.31 111.117 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -88.7 -37.26 15.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.131 -0.486 . . . . 62.31 111.149 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -155.8 131.87 10.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 74.45 110.882 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 2.2 p -127.05 109.63 12.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 71.25 110.878 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -130.87 142.33 50.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 73.02 110.88 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -132.39 156.57 46.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.194 -0.457 . . . . 74.43 110.861 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -154.89 129.89 9.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.117 -0.492 . . . . 75.4 111.081 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 41.2 t -126.86 134.12 66.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 74.45 111.136 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -107.93 124.07 7.38 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.741 -0.743 . . . . 75.5 112.464 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -113.97 122.36 46.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.978 0.418 . . . . 73.31 110.869 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -102.89 133.53 47.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.08 -0.509 . . . . 73.44 110.915 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.59 165.22 21.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 71.43 111.13 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -40.27 -75.38 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 63.21 110.898 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -116.66 14.91 15.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.214 -0.448 . . . . 74.33 110.889 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -126.16 149.55 48.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.131 -0.486 . . . . 74.45 110.863 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -133.26 124.44 27.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.115 -0.493 . . . . 73.34 110.922 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -123.55 126.09 46.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 74.34 110.907 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 22.1 m80 -130.59 114.86 15.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.446 . . . . 72.35 110.875 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 2.1 t -106.51 151.05 25.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.269 -0.423 . . . . 72.52 111.167 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -162.38 136.95 6.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 72.41 110.879 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 2.3 t -123.68 127.79 74.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.483 . . . . 72.4 111.129 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -120.69 83.03 2.0 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 75.4 110.887 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -48.25 -20.13 0.35 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 75.13 110.868 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -74.89 -33.08 56.04 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.793 -0.718 . . . . 71.31 112.49 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 69.0 p -123.48 -55.37 1.74 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.718 0.294 . . . . 73.2 111.135 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -165.87 152.98 10.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 72.41 110.901 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -114.45 125.16 53.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 74.33 110.884 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -175.72 -132.36 1.59 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.745 -0.741 . . . . 74.42 112.489 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -176.4 -165.92 32.81 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.77 -0.729 . . . . 73.32 112.491 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -149.33 150.33 32.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.803 0.335 . . . . 64.14 110.9 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 4.2 mp -120.62 143.02 33.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 74.53 111.158 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -127.74 121.3 29.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.178 -0.465 . . . . 73.23 110.942 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 6.1 tm0? -124.57 130.43 52.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 75.11 110.963 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 20.5 tttt -107.12 127.77 53.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 73.53 110.876 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 98.5 t -74.34 -74.62 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 73.35 111.083 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -170.82 65.32 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 75.53 110.909 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? 48.29 33.47 3.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.143 -0.481 . . . . 74.25 110.915 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 6.2 ttmm -140.98 -43.74 0.38 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 74.31 110.881 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 6.1 mp -131.05 128.47 40.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.237 -0.438 . . . . 75.05 110.902 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -114.88 131.2 56.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 74.24 110.908 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 21.7 m -124.06 138.58 54.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.186 -0.461 . . . . 74.4 111.145 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -141.5 137.93 32.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.434 . . . . 71.1 111.139 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 30.3 t -112.93 140.69 31.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 74.2 111.079 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -114.95 134.22 55.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.475 . . . . 74.41 110.881 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -134.16 130.71 37.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 74.54 110.925 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -156.42 132.11 9.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 53.22 111.083 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 3.8 t-105 -110.66 135.01 51.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.208 -0.451 . . . . 71.44 110.964 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 3.3 t -93.39 111.36 23.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.253 -0.43 . . . . 73.34 111.092 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -51.11 136.81 23.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 65.53 111.076 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 117.36 -83.98 0.36 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.765 -0.731 . . . . 71.12 112.541 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -79.37 179.11 7.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.854 0.359 . . . . 65.23 110.864 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 9.7 p -103.36 36.43 2.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 72.12 110.867 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 35.0 m120 -102.09 125.2 48.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 74.4 110.874 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -105.34 137.6 42.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 63.03 111.141 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 -97.62 117.66 32.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.258 -0.428 . . . . 73.15 110.837 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -128.34 132.11 48.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 74.34 110.874 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -145.2 160.99 28.15 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.735 -0.745 . . . . 73.15 112.474 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.89 130.51 35.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.807 0.337 . . . . 74.52 111.104 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -126.84 130.83 50.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 75.42 111.114 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -119.2 130.81 55.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.257 -0.429 . . . . 74.41 111.104 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -106.76 128.47 54.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.436 . . . . 73.52 110.872 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -127.07 117.67 22.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 74.53 110.934 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -84.7 123.91 30.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 71.22 110.942 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 64.6 mt -108.9 -33.56 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.446 . . . . 72.33 111.157 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -143.42 161.22 48.37 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.583 0.706 . . . . 75.44 110.918 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -19.32 36.22 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.738 2.292 . . . . 73.25 112.31 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -109.78 -27.06 9.51 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.224 -0.443 . . . . 74.41 110.893 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -124.6 141.95 51.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.469 . . . . 63.04 111.124 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 57.6 m -139.31 142.58 37.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.196 -0.456 . . . . 74.54 110.862 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -98.79 133.11 43.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.175 -0.466 . . . . 73.53 110.89 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 24.6 p -135.09 128.31 31.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 74.35 110.843 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -128.98 158.45 38.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 54.2 111.093 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.52 164.27 36.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 73.33 110.913 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 10.0 p -154.86 143.19 13.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 74.13 111.148 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -102.52 148.47 25.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 75.43 110.869 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' ASN . . . . . 0.408 ' C ' ' H ' ' A' ' 241' ' ' SER . 14.1 t30 -54.09 -21.68 9.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 74.41 110.901 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 46.4 t -80.84 25.76 0.44 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.45 . . . . 64.34 110.843 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' SER . . . . . 0.408 ' H ' ' C ' ' A' ' 239' ' ' ASN . 1.9 m 59.2 39.29 22.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 74.21 110.926 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 22.6 mt -99.4 118.11 35.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.093 -0.503 . . . . 72.4 110.915 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 5.4 mp -84.62 125.92 40.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.172 -0.467 . . . . 75.43 111.102 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -128.21 132.81 7.49 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.771 -0.728 . . . . 73.21 112.496 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 1.3 pp -146.14 140.88 26.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.882 0.372 . . . . 61.43 110.902 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -153.13 150.32 22.05 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.677 -0.773 . . . . 71.21 112.445 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -128.39 132.19 48.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.943 0.401 . . . . 75.21 110.947 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.02 123.94 50.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 60.44 111.131 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -143.09 129.59 20.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 75.34 110.873 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 3.1 m -80.62 142.31 34.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.222 -0.444 . . . . 74.22 111.174 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 7.6 tp -72.84 -70.74 0.34 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 74.33 110.888 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' LYS . . . . . 0.491 ' N ' ' HD2' ' A' ' 253' ' ' PRO . 16.9 ttpt 178.35 -59.45 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.6 0.714 . . . . 71.4 110.926 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . 0.491 ' HD2' ' N ' ' A' ' 252' ' ' LYS . 54.0 Cg_endo -69.74 -86.64 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.705 2.27 . . . . 64.21 112.342 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . 0.407 ' H ' ' HG2' ' A' ' 253' ' ' PRO . . . -145.72 16.58 1.8 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.734 -0.746 . . . . 74.33 112.484 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 3.7 mt -105.32 118.07 52.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.882 0.372 . . . . 75.53 111.094 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . 0.54 ' O ' ' HA ' ' A' ' 279' ' ' LEU . 0.0 OUTLIER -99.09 135.06 41.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 75.11 110.88 179.856 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.08 124.02 37.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.464 . . . . 75.43 110.887 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 27.5 p -128.15 111.68 13.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.448 . . . . 75.21 111.121 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.9 126.24 53.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.242 -0.435 . . . . 73.43 110.928 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 4.1 m -126.49 140.86 52.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 74.25 110.839 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -144.21 128.52 17.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.121 -0.491 . . . . 70.02 111.116 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -121.66 120.77 35.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.446 . . . . 72.12 110.913 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.95 109.77 15.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.446 . . . . 73.31 110.887 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -90.95 115.78 28.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.454 . . . . 74.1 110.853 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -55.45 -18.38 15.04 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.704 -0.76 . . . . 54.23 112.5 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 6.4 ttpp -79.09 -25.99 43.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.836 0.35 . . . . 74.52 110.942 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -109.59 -54.46 2.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 72.13 110.916 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 13.8 m -51.04 -29.03 7.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.48 . . . . 71.32 111.109 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -52.43 -35.12 51.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 73.34 110.901 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -103.67 -17.44 15.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.123 -0.489 . . . . 71.23 111.074 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 125.7 98.58 1.14 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.721 -0.752 . . . . 43.24 112.498 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 168.2 93.13 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.716 -0.754 . . . . 71.52 112.465 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -113.43 144.5 42.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.877 0.37 . . . . 74.41 110.859 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 43.5 mmtm -101.12 136.85 40.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 74.12 110.874 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -135.85 137.71 41.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.476 . . . . 73.52 110.89 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -139.56 136.37 7.81 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.721 -0.752 . . . . 73.22 112.464 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.4 ' HB3' HG13 ' A' ' 27' ' ' ILE . 3.1 tm? -132.52 138.2 47.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.898 0.38 . . . . 74.33 110.9 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -160.67 161.01 32.41 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.761 -0.733 . . . . 75.04 112.455 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.54 ' HA ' ' O ' ' A' ' 256' ' ' LYS . 2.9 mm? -113.93 143.37 44.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.815 0.34 . . . . 75.13 110.937 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -91.37 130.1 37.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 75.3 110.87 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . 0.7 ' HA ' ' HA ' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -76.33 60.26 1.52 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 72.45 110.89 -179.941 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -109.38 97.74 7.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.133 -0.485 . . . . 72.25 110.875 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -128.65 110.93 12.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.212 -0.449 . . . . 65.53 111.117 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 94.6 mt -152.15 178.38 9.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 71.21 110.923 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 42.2 tp10 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 71.15 110.864 179.941 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' NAI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.7 mmt . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.791 0.329 . . . . 63.44 110.862 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.91 -63.23 1.27 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.258 -0.428 . . . . 61.52 111.07 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.87 158.46 74.93 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.633 0.73 . . . . 75.51 111.124 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.85 170.25 17.11 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.688 2.259 . . . . 74.12 112.321 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 77.74 1.06 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.643 2.229 . . . . 74.33 112.36 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.6 p -70.37 -45.75 65.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 74.44 111.132 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 91.2 t80 -52.46 -32.38 39.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 75.05 110.901 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -82.18 -26.53 33.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 72.35 111.116 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -74.21 -12.86 60.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 73.04 110.843 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.42 -34.42 66.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 73.21 110.896 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 142.45 64.77 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.762 -0.732 . . . . 63.55 112.529 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.6 ttpp -69.35 -42.12 75.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.801 0.334 . . . . 74.24 110.873 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.6 t -63.65 -39.35 94.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.207 -0.451 . . . . 71.43 110.901 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.8 -37.93 74.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.074 -0.512 . . . . 74.11 111.112 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 3.1 tmt_? -60.77 -33.12 72.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.444 . . . . 74.41 110.858 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -58.46 -40.0 81.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.45 . . . . 70.45 110.834 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.6 t -58.91 -39.42 77.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 73.32 111.113 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -60.54 -41.07 93.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.481 . . . . 52.04 110.866 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.1 p 46.75 69.2 0.51 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 73.22 111.191 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 16.0 tptm -69.24 112.48 5.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 75.35 110.921 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 63.5 99.44 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.737 -0.744 . . . . 62.35 112.476 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -172.9 129.36 0.49 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.945 0.402 . . . . 74.15 110.908 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.52 40.84 3.09 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.784 -0.722 . . . . 73.12 112.501 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -103.18 13.01 34.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.911 0.386 . . . . 73.41 110.892 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 80.79 15.44 77.66 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.773 -0.727 . . . . 65.04 112.46 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.89 168.74 8.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.799 0.333 . . . . 72.11 110.917 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 2.8 mm -120.2 123.42 70.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.234 -0.439 . . . . 72.43 111.089 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.6 ttmt -115.2 118.15 32.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.465 . . . . 75.23 110.921 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -114.68 142.99 45.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 72.11 110.915 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -147.82 128.62 14.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 71.21 110.851 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.7 tp -127.2 128.78 46.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 74.44 110.908 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.0 pttm -124.83 125.48 44.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 73.2 110.887 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.6 p -135.2 120.8 19.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.199 -0.455 . . . . 72.04 111.158 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 53.1 mttm -118.75 129.99 55.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 74.25 110.91 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.2 t -116.14 138.29 51.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 75.23 110.87 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -77.41 59.25 1.83 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.157 -0.474 . . . . 74.02 110.889 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -160.51 25.27 0.15 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 73.35 110.805 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.51 ' HA2' ' O ' ' A' ' 63' ' ' ARG . . . 79.7 -4.11 66.31 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.737 -0.744 . . . . 62.35 112.526 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.5 mp -98.23 126.11 43.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.782 0.325 . . . . 74.52 110.897 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.4 ' HB3' ' HB3' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -142.1 118.39 10.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.172 -0.467 . . . . 73.21 110.861 179.962 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -103.71 124.15 48.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.152 -0.476 . . . . 73.42 110.883 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.11 115.5 19.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 73.54 111.124 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.42 138.12 53.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 63.35 110.863 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 27.0 m -150.6 126.96 10.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 71.34 110.905 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -164.53 166.43 37.89 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.726 -0.749 . . . . 62.12 112.489 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 60.3 m -138.03 168.62 19.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.877 0.37 . . . . 73.51 110.878 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -134.13 139.52 45.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.126 -0.488 . . . . 74.41 111.096 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -113.41 141.43 47.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 74.22 110.919 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 64.07 169.53 0.17 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 64.15 111.109 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.28 94.52 2.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.462 . . . . 72.44 110.863 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 61.5 p 45.98 84.01 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.127 -0.488 . . . . 75.43 111.134 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.7 m -151.5 -59.66 0.17 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.237 -0.438 . . . . 73.44 111.196 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 18.0 mmtp -142.33 113.69 7.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 75.21 110.897 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -125.55 147.54 30.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 75.33 111.142 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.2 p -110.32 126.57 54.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 72.23 111.13 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -118.76 143.63 17.55 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.72 -0.753 . . . . 60.53 112.503 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.85 142.51 50.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.968 0.413 . . . . 61.44 110.851 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -120.86 132.85 55.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 73.13 110.948 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -134.0 124.65 26.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 71.51 110.889 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 27.0 m -104.77 130.35 52.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 72.32 111.146 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.4 ' HB3' ' HB3' ' A' ' 40' ' ' GLU . 8.5 ttpt -132.48 156.93 45.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.239 -0.437 . . . . 71.13 110.919 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.433 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 26.0 m-85 -129.06 140.68 51.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.282 -0.417 . . . . 73.53 110.939 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.51 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 27.9 ttp85 -127.99 105.37 8.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 73.53 110.894 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 5.6 m-90 -113.19 134.33 54.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 63.11 110.935 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 30.3 p -69.82 -27.17 64.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.275 -0.42 . . . . 75.21 111.122 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -52.51 102.53 0.05 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.211 -0.45 . . . . 75.43 110.889 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 7.3 t80 65.33 9.77 5.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.149 -0.478 . . . . 75.03 110.902 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 57.33 70.27 1.03 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.77 -0.729 . . . . 74.1 112.491 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.451 HD23 ' HA ' ' A' ' 87' ' ' VAL . 5.7 mt -119.15 137.21 53.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.859 0.361 . . . . 65.3 110.9 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 27.7 m -136.24 127.84 28.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 72.51 111.163 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -121.79 121.62 37.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 71.45 110.86 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 14.4 t -119.87 136.22 54.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 70.11 111.133 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -131.06 122.82 27.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 70.22 110.88 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.9 ptmt -95.51 135.99 36.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 75.3 110.91 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 8.7 t90 -134.81 128.84 33.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.246 -0.434 . . . . 74.2 110.926 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -117.85 154.93 31.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 65.43 110.878 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 7.3 t -62.48 -16.47 55.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.127 -0.488 . . . . 74.31 111.142 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.423 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 2.4 m-20 -74.61 0.78 13.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.258 -0.428 . . . . 70.43 110.89 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.423 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 3.7 m120 78.53 37.19 0.18 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.465 . . . . 73.34 110.877 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.6 p -113.58 121.54 44.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 74.32 111.144 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -111.23 132.96 53.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 70.13 110.966 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -123.61 92.84 0.46 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.803 -0.713 . . . . 73.32 112.517 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -79.34 106.1 11.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.821 0.343 . . . . 74.42 111.13 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -124.47 107.37 11.01 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.211 -0.449 . . . . 71.41 110.86 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.4 pp -111.51 130.84 64.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 74.13 111.13 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 88.5 m -122.2 123.16 40.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 60.12 111.161 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.451 ' HA ' HD23 ' A' ' 69' ' ' LEU . 1.6 m -115.17 139.79 39.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.223 -0.444 . . . . 75.42 111.145 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -90.55 128.32 36.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 70.24 110.85 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.64 179.17 1.43 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.173 -0.467 . . . . 73.41 110.863 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -126.76 -65.9 0.93 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 75.53 110.883 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 20.1 tp -50.55 -75.47 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 75.25 110.931 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -73.26 76.35 1.32 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 73.31 111.091 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 7.7 tpp85 -48.78 133.69 17.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.435 . . . . 74.11 110.851 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 100.97 8.38 48.13 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.727 -0.749 . . . . 74.34 112.524 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.4 tp -112.68 124.67 53.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.861 0.362 . . . . 74.34 110.956 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 13.5 ttmt -124.62 125.05 43.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 72.05 110.929 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.64 127.13 48.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.222 -0.444 . . . . 73.13 110.939 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.4 p -127.89 119.91 26.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 64.42 111.158 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.1 119.96 41.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.44 . . . . 71.25 110.917 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -109.9 142.12 41.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.474 . . . . 73.33 110.846 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.1 m -143.14 127.78 18.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 74.21 110.86 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -95.36 125.74 40.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 74.32 110.865 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -129.17 126.86 40.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 75.11 110.895 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.409 ' HA ' ' HD2' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -128.82 102.4 19.6 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.7 0.762 . . . . 73.0 110.827 -179.758 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 104' ' ' SER . 53.6 Cg_endo -69.76 -32.63 18.2 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.709 2.273 . . . . 71.33 112.349 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -70.12 -72.58 0.19 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.186 -0.461 . . . . 73.13 110.891 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.5 p -64.26 -40.09 95.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.129 -0.487 . . . . 73.35 111.131 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.52 24.45 13.92 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.726 -0.749 . . . . 75.11 112.495 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.11 148.09 22.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.82 0.343 . . . . 72.34 110.874 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -142.06 131.63 23.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 75.45 110.866 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -130.08 152.56 49.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.245 -0.434 . . . . 62.33 110.923 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -130.24 125.26 34.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 71.45 111.132 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.03 137.99 36.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 73.44 110.861 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -125.84 138.35 54.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 74.22 111.149 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 128' ' ' ASP . 14.9 mtmt -130.17 130.11 44.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 75.43 110.925 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.2 p -119.22 119.2 33.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.446 . . . . 73.14 111.155 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -107.64 125.33 7.92 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.689 -0.767 . . . . 72.51 112.471 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -131.09 115.52 16.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.941 0.401 . . . . 63.54 110.886 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 13.7 mtpp -106.58 125.34 50.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.147 -0.479 . . . . 72.33 110.93 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 13.9 ttt85 -104.95 144.96 31.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.281 -0.418 . . . . 74.33 110.867 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -50.41 -26.57 5.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 71.24 110.9 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 33.9 m170 -86.98 -45.51 10.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 75.12 110.886 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 49.4 pt -151.38 156.6 6.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 64.31 111.143 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -104.21 129.7 51.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 62.02 110.897 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -127.77 143.42 51.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 74.01 110.924 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -146.51 117.18 0.92 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.762 -0.732 . . . . 74.15 112.547 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 36.8 t -113.89 132.09 56.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.847 0.356 . . . . 72.2 110.85 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.415 ' HA ' ' HA ' ' A' ' 115' ' ' LYS . 0.2 OUTLIER -128.38 117.32 21.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 73.54 110.821 -179.963 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 19.4 mtm -103.97 136.25 43.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 72.34 110.92 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -128.41 120.25 26.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 73.31 110.834 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -94.74 119.9 34.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 75.3 110.886 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -128.71 131.83 47.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.164 -0.471 . . . . 73.51 110.827 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -55.9 -29.86 27.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 73.3 111.125 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -80.01 -20.26 45.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 70.22 111.07 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 157.61 100.26 0.17 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.754 -0.736 . . . . 72.54 112.465 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.76 129.48 17.68 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.679 2.253 . . . . 72.41 112.399 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 12.5 t -129.08 161.79 29.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 74.32 110.887 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 1.7 mp -120.72 117.12 52.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.111 -0.495 . . . . 72.41 111.14 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 15.2 mtm180 -121.81 125.29 46.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 72.34 110.883 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -147.16 152.18 24.36 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.72 -0.753 . . . . 75.33 112.519 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -120.72 139.55 52.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.855 0.359 . . . . 72.14 111.099 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -141.33 143.41 34.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 74.13 110.939 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.439 ' HA ' ' HA3' ' A' ' 152' ' ' GLY . 1.0 OUTLIER -133.58 143.74 37.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 72.12 111.153 179.817 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -125.99 138.31 53.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.172 -0.467 . . . . 75.3 110.925 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -113.29 119.32 4.8 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.764 -0.732 . . . . 64.11 112.499 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -144.84 148.27 33.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.862 0.363 . . . . 74.24 110.89 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 50.06 26.36 2.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.139 -0.482 . . . . 75.43 110.897 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 88.78 -31.82 4.8 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.749 -0.739 . . . . 55.32 112.523 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 52.9 p-90 -80.72 146.21 31.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.814 0.34 . . . . 73.04 110.936 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 2.7 mt -114.5 145.52 41.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.451 . . . . 72.43 110.93 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.445 ' HA ' ' HA ' ' A' ' 171' ' ' VAL . . . -141.74 113.9 8.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 75.13 111.099 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.439 ' HA3' ' HA ' ' A' ' 143' ' ' VAL . . . -166.04 162.57 36.08 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.722 -0.751 . . . . 63.34 112.444 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.771 ' HB3' ' O ' ' A' ' 168' ' ' ASN . 0.0 OUTLIER -174.68 -168.45 0.36 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.858 0.361 . . . . 73.51 110.925 -179.862 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -99.99 146.21 26.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.072 -0.513 . . . . 71.44 110.867 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 3.1 ppp? -145.21 127.54 15.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 73.22 110.9 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -111.46 119.95 40.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 74.22 110.843 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -108.51 138.99 43.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 75.11 110.867 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -77.65 98.38 5.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 75.11 110.918 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 7.2 t -66.24 -40.84 90.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 52.24 111.149 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -48.67 -25.1 1.61 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 65.32 111.108 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 35.4 mmtm -141.47 -159.89 1.02 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 75.41 110.88 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 17.1 m -109.59 40.06 1.96 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 62.3 110.879 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -131.27 171.58 13.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.134 -0.485 . . . . 72.42 110.889 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -106.91 141.05 23.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 54.53 111.125 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 62.6 m -90.29 -35.26 15.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 72.42 111.153 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -154.92 137.64 15.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 73.41 110.917 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 2.8 t -128.2 102.14 6.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 74.14 110.85 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.771 ' O ' ' HB3' ' A' ' 153' ' ' TYR . 0.1 OUTLIER -116.27 122.65 45.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 71.24 110.92 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.536 ' HA ' ' HB2' ' A' ' 153' ' ' TYR . 42.3 m-85 -133.96 138.6 45.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 62.11 110.887 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.424 ' H ' ' HB2' ' A' ' 153' ' ' TYR . . . -151.3 152.04 32.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 73.33 111.118 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' A' ' 151' ' ' ALA . 0.9 OUTLIER -140.9 148.3 21.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.22 -0.446 . . . . 62.34 111.088 179.988 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -121.99 129.16 7.51 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.725 -0.75 . . . . 54.11 112.513 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -113.67 131.45 56.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.912 0.386 . . . . 74.0 110.954 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 20.9 mmtp -102.67 128.2 49.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.105 -0.498 . . . . 75.11 110.882 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.456 ' O ' ' C ' ' A' ' 176' ' ' ASP . 0.2 OUTLIER -119.64 167.05 12.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.451 . . . . 73.32 111.153 179.979 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.456 ' C ' ' O ' ' A' ' 175' ' ' THR . 0.8 OUTLIER -34.13 -77.74 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 74.22 110.87 179.937 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -117.64 14.66 14.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 75.1 110.907 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -128.14 147.49 50.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 65.12 110.897 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -136.32 126.64 26.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 73.33 110.902 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -124.29 137.28 54.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 71.4 110.894 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 5.8 t-80 -130.98 113.45 14.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 74.03 110.859 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -96.16 146.97 24.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 74.51 111.154 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -159.52 140.7 12.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.248 -0.433 . . . . 72.44 110.898 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.519 ' HB ' ' HA ' ' A' ' 190' ' ' PHE . 1.4 m -135.07 135.71 52.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.125 -0.489 . . . . 73.14 111.104 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -100.52 88.3 3.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 74.32 110.916 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 73.58 176.57 0.25 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.196 -0.456 . . . . 73.41 110.862 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -72.44 1.67 34.35 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.743 -0.741 . . . . 64.23 112.463 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 33.3 p -105.12 -24.34 12.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.715 0.293 . . . . 63.35 111.103 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -119.16 120.08 36.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.24 -0.436 . . . . 75.34 110.9 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' PHE . . . . . 0.519 ' HA ' ' HB ' ' A' ' 184' ' ' VAL . 0.5 OUTLIER -140.13 124.57 17.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.456 . . . . 75.31 110.947 -179.954 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -171.39 -150.33 7.04 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.72 -0.752 . . . . 53.45 112.463 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 172.37 -166.68 39.49 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.751 -0.737 . . . . 52.5 112.519 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 1.4 t -148.84 151.8 35.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.849 0.357 . . . . 72.23 110.857 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.433 HG12 HG21 ' A' ' 206' ' ' VAL . 0.0 OUTLIER -136.76 135.02 48.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 74.22 111.159 179.934 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -131.75 137.12 48.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 65.31 110.929 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 46.4 tp60 -124.35 131.9 53.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.123 -0.49 . . . . 75.24 110.963 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 11.2 ttpt -81.92 126.22 31.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 73.23 110.921 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 18.1 t -91.15 139.95 16.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 65.45 111.151 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -81.86 59.7 4.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 74.45 110.883 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 22.1 ttmt -165.9 39.87 0.06 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.198 -0.455 . . . . 72.41 110.889 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 4.8 mptt 57.32 44.06 22.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 75.0 110.87 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 58.7 tp -152.92 145.98 24.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.249 -0.432 . . . . 75.31 110.906 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -127.32 149.24 50.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 75.41 110.911 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 71.2 p -123.29 138.24 54.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 74.25 111.115 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -145.81 135.73 23.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.214 -0.448 . . . . 74.44 111.134 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.433 HG21 HG12 ' A' ' 194' ' ' ILE . 0.9 OUTLIER -132.16 144.02 38.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 73.34 111.119 179.993 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -130.92 127.32 38.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.474 . . . . 72.1 110.852 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -143.24 150.23 39.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.125 -0.489 . . . . 75.13 110.929 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -138.63 149.56 45.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 73.44 111.099 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 3.9 t-105 -120.63 135.19 55.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.447 . . . . 71.42 110.918 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 3.1 m -95.68 104.32 16.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 73.11 111.16 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -53.05 150.16 5.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 74.05 111.123 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 97.01 -34.16 5.26 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.729 -0.748 . . . . 63.31 112.498 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -122.58 -171.14 2.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.803 0.335 . . . . 75.35 110.919 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 22.7 t -119.03 38.06 3.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 74.15 110.857 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -101.96 111.88 24.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 72.42 110.917 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 14.6 t -115.18 138.18 51.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 74.44 111.173 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 63.3 mmt-85 -128.46 127.64 42.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 73.11 110.84 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -134.44 158.0 45.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.452 . . . . 74.4 110.861 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -147.44 147.46 18.23 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.718 -0.754 . . . . 75.14 112.516 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 3.8 mp -118.32 133.24 65.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.836 0.35 . . . . 73.41 111.12 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -131.77 143.73 50.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.462 . . . . 65.44 111.102 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -112.45 134.48 53.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.454 . . . . 61.05 111.071 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 1.1 ttpp -109.37 114.84 28.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 73.24 110.895 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 36.9 t80 -131.21 117.61 19.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.276 -0.42 . . . . 74.31 110.908 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -111.7 109.07 18.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.128 -0.487 . . . . 75.4 110.927 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 2.3 tt -80.93 -32.34 12.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 75.42 111.11 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -150.54 160.25 33.11 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.626 0.727 . . . . 72.41 110.882 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -7.61 21.48 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.671 2.248 . . . . 74.14 112.314 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -106.78 -29.52 9.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.247 -0.433 . . . . 75.03 110.9 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -124.54 133.56 53.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 72.32 111.09 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 42.1 m -134.81 141.76 46.5 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.235 -0.439 . . . . 74.44 110.849 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -127.13 133.48 50.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.474 . . . . 72.35 110.895 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 11.8 p -142.73 139.68 31.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.102 -0.499 . . . . 72.45 110.855 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -111.09 161.01 16.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.117 -0.492 . . . . 73.12 111.089 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 6.7 ptpp? -151.71 142.03 22.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 72.45 110.877 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 1.1 p -139.7 143.99 29.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 74.13 111.154 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -112.86 147.98 35.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.465 . . . . 73.32 110.927 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 40.1 t30 -59.43 -16.35 22.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 73.2 110.89 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 3.5 m -81.96 25.44 0.57 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 63.22 110.829 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 65.41 32.34 9.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.107 -0.497 . . . . 72.13 110.871 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 5.1 mp -100.28 118.07 35.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.122 -0.49 . . . . 73.51 110.923 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -118.1 116.79 52.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.223 -0.444 . . . . 74.44 111.115 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -147.88 163.39 28.84 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.723 -0.751 . . . . 74.41 112.452 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.418 ' CD1' ' N ' ' A' ' 245' ' ' LEU . 0.0 OUTLIER -146.5 160.43 42.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.88 0.371 . . . . 73.54 110.949 -179.972 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -141.41 137.84 8.35 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.715 -0.755 . . . . 74.24 112.507 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -129.38 131.06 46.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.919 0.39 . . . . 72.44 110.942 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 1.8 t -118.68 118.79 32.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.121 -0.49 . . . . 73.54 111.178 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -115.21 122.45 46.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.247 -0.433 . . . . 74.2 110.927 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 7.6 m -95.73 122.88 38.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 75.51 111.13 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 17.9 tp -98.84 92.57 5.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.179 -0.464 . . . . 72.54 110.919 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 3.7 mtpp 63.75 161.41 0.12 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.563 0.697 . . . . 74.3 110.894 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 76.76 1.11 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.687 2.258 . . . . 73.44 112.337 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 178.32 -48.61 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.8 -0.715 . . . . 73.25 112.527 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.72 135.42 62.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.925 0.393 . . . . 74.34 111.133 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -133.37 133.14 42.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.125 -0.488 . . . . 73.31 110.853 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.13 133.9 51.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 74.24 110.895 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 30.9 p -132.62 122.04 24.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 74.53 111.16 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.96 150.1 41.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 73.31 110.911 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 1.5 m -142.64 140.5 31.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 73.12 110.815 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -141.66 129.2 21.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 72.1 111.094 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 1.3 tt -131.18 137.63 49.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 74.42 110.946 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.9 108.59 14.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.173 -0.467 . . . . 72.52 110.918 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . 0.403 ' HB2' ' HB2' ' A' ' 267' ' ' ASN . 0.5 OUTLIER -84.66 108.95 17.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 63.31 110.904 179.823 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -53.94 -18.85 9.37 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.788 -0.72 . . . . 75.24 112.48 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -91.05 -26.1 19.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.823 0.344 . . . . 74.31 110.876 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . 0.403 ' HB2' ' HB2' ' A' ' 264' ' ' ASP . 3.5 m120 -100.1 -56.62 2.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 72.23 110.888 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 12.9 m -49.87 -27.36 3.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 73.42 111.117 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -53.74 -45.69 70.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 71.15 110.863 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -105.69 -17.16 14.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.473 . . . . 73.22 111.109 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -111.01 -120.18 4.01 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.778 -0.725 . . . . 75.15 112.501 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -150.39 -164.82 12.15 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.821 -0.704 . . . . 54.42 112.499 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -89.62 145.93 24.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.851 0.358 . . . . 75.22 110.866 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 24.0 mttp -97.15 135.85 38.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 75.14 110.916 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -134.94 138.93 44.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.256 -0.429 . . . . 75.25 110.913 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -132.75 140.04 11.47 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.752 -0.737 . . . . 73.11 112.523 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -113.94 136.7 52.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.792 0.329 . . . . 74.43 110.955 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -141.94 127.86 3.4 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.771 -0.728 . . . . 74.44 112.495 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -108.35 131.66 54.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.794 0.33 . . . . 72.31 110.882 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -123.36 112.03 17.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 74.0 110.928 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -112.87 133.34 54.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 73.53 110.906 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -135.34 130.5 35.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 71.24 110.91 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -99.16 135.78 40.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 74.42 111.106 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 41.7 37.14 0.68 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.253 -0.43 . . . . 72.53 110.91 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.47 . . . . 72.24 110.859 179.938 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' NAI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.9 mmm . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.735 0.302 . . . . 75.1 110.872 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.88 88.06 1.03 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 65.11 111.089 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 60.2 t -114.42 78.75 4.92 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.642 0.734 . . . . 73.11 111.122 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 166.01 29.07 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.688 2.259 . . . . 74.52 112.316 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 101.66 0.94 Allowed 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.702 2.268 . . . . 72.43 112.296 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.7 -46.36 9.07 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.218 -0.446 . . . . 75.44 111.178 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -54.39 -33.84 60.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 72.33 110.906 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -82.98 -19.16 37.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 74.12 111.129 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -88.85 10.09 22.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 63.23 110.903 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 89.5 mt -67.19 -34.25 77.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 64.43 110.911 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -139.57 68.45 0.49 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.738 -0.744 . . . . 72.25 112.484 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 12.4 mttp -64.64 -53.9 40.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.843 0.354 . . . . 72.44 110.942 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.9 t -58.77 -48.75 80.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 75.44 110.854 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.58 -37.82 88.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.113 -0.494 . . . . 73.42 111.065 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 16.2 ttm-85 -60.42 -34.32 73.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.26 -0.427 . . . . 74.22 110.881 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.08 -39.07 93.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.198 -0.455 . . . . 74.24 110.87 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.6 t -82.2 -33.33 11.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.256 -0.429 . . . . 64.11 111.128 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -72.18 -42.05 66.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 73.13 110.88 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 12.3 t -68.49 -32.0 71.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 75.15 111.112 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -73.89 127.79 33.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 75.21 110.904 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -50.73 136.37 28.44 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.803 -0.713 . . . . 71.24 112.477 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -125.93 33.24 5.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.87 0.367 . . . . 73.32 110.897 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 73.87 88.63 0.19 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.714 -0.755 . . . . 74.12 112.524 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -94.24 -4.36 49.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.93 0.395 . . . . 72.42 110.897 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.58 13.36 80.26 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.754 -0.736 . . . . 54.41 112.49 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.5 pp -150.33 -178.9 6.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.814 0.34 . . . . 75.14 110.926 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 8.9 mm -111.36 145.04 18.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 74.44 111.121 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.7 ttpt -122.65 151.15 41.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 75.23 110.883 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -140.56 128.06 21.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 74.34 110.911 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -139.18 129.42 25.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.466 . . . . 63.51 110.858 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.8 tt -137.53 133.49 34.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 73.33 110.933 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.6 mtpp -135.33 125.51 26.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 72.13 110.928 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 24.4 m -123.2 146.18 48.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.212 -0.449 . . . . 74.21 111.11 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 10.1 tptt -105.24 158.04 16.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 72.14 110.9 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.483 ' O ' ' C ' ' A' ' 36' ' ' GLU . 0.5 OUTLIER -132.14 174.86 9.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 63.12 110.873 -179.915 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.483 ' C ' ' O ' ' A' ' 35' ' ' SER . 46.2 tt0 -31.8 -73.46 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.16 -0.473 . . . . 75.54 110.869 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -164.82 131.77 3.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 73.13 110.925 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.457 ' HA2' ' O ' ' A' ' 63' ' ' ARG . . . 86.28 -14.59 53.75 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.763 -0.732 . . . . 65.23 112.496 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.43 129.17 52.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.816 0.341 . . . . 75.22 110.901 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.97 118.15 10.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 64.14 110.93 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -92.04 122.55 34.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 75.14 110.892 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -125.6 131.12 52.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 74.05 111.111 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.4 t -131.69 139.64 49.1 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.202 -0.454 . . . . 73.31 110.839 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.4 t -145.73 126.59 14.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.144 -0.48 . . . . 72.13 110.829 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -146.31 147.71 18.86 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.739 -0.743 . . . . 73.04 112.518 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.24 135.78 37.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.857 0.36 . . . . 74.33 110.846 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.16 130.56 14.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.129 -0.487 . . . . 71.04 111.11 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 64.3 t-20 -96.63 126.0 41.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.242 -0.436 . . . . 73.22 110.872 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 91.9 m -75.59 -50.1 16.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 71.35 111.104 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -56.7 -49.23 75.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 71.22 110.851 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -108.84 124.53 50.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 74.42 111.182 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.9 t -54.37 104.63 0.11 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.209 -0.451 . . . . 74.43 111.168 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 30.9 tttp -174.03 99.32 0.1 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 75.33 110.896 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 31.7 t -120.51 124.75 73.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.195 -0.457 . . . . 75.32 111.117 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.4 p -135.57 129.72 33.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 73.52 111.122 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -129.37 137.93 9.91 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.761 -0.733 . . . . 63.41 112.532 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.3 p -141.49 160.32 40.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.892 0.377 . . . . 73.24 110.868 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.3 tp -128.38 149.97 50.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.101 -0.5 . . . . 74.55 110.877 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -135.73 131.19 35.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 71.13 110.893 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.07 118.38 36.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 64.4 111.12 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 5.2 ttmt -112.18 147.91 35.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 74.43 110.855 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -131.75 133.41 44.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 74.1 110.948 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.457 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 25.5 ttm180 -135.23 106.71 6.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.13 -0.487 . . . . 72.01 110.903 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 58.0 t-105 -114.56 138.74 50.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.202 -0.453 . . . . 73.14 110.9 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.3 m 66.19 119.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.281 -0.418 . . . . 73.45 111.17 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -50.59 105.38 0.1 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.438 . . . . 74.25 110.919 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 64.61 48.85 2.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.148 -0.478 . . . . 72.24 110.913 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -122.29 -74.41 0.32 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.741 -0.742 . . . . 74.31 112.52 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -134.23 129.43 35.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.872 0.367 . . . . 73.2 110.935 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.2 m -138.6 112.61 8.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 75.34 111.169 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -123.59 124.36 42.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 75.32 110.88 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 61' ' ' LYS . 5.1 t -129.38 137.68 51.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 74.04 111.14 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -124.02 123.23 39.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 74.51 110.843 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 22.3 mtpp -89.82 142.17 27.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.105 -0.498 . . . . 74.4 110.913 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 7.3 t90 -134.58 128.82 33.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.227 -0.442 . . . . 73.41 110.894 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -117.72 155.13 30.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 71.44 110.875 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 9.4 t -61.37 -17.53 54.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 61.05 111.16 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.415 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 48.5 m-20 -74.11 0.35 14.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 71.3 110.87 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.415 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 3.5 m120 77.34 35.67 0.33 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 73.4 110.9 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.8 m -114.45 128.57 56.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 71.42 111.167 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -120.19 139.59 52.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.227 -0.442 . . . . 73.11 110.904 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -137.92 98.6 0.27 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.75 -0.738 . . . . 73.22 112.495 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.1 m -84.76 142.02 30.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.768 0.318 . . . . 63.03 111.161 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -146.47 115.25 6.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 73.21 110.853 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -112.7 136.48 48.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 73.1 111.147 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 20.5 p -128.99 124.09 34.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 74.24 111.177 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.5 p -114.91 137.24 49.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 75.14 111.132 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -103.83 119.81 39.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 73.52 110.887 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -60.51 130.32 45.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 74.32 110.878 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -83.14 -57.8 3.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 71.13 110.885 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 36.0 mt -63.28 -54.28 39.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 71.23 110.876 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -85.58 75.35 10.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.453 . . . . 65.3 111.092 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 12.2 tpp85 -51.37 134.59 28.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 75.11 110.885 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 100.61 -23.41 35.87 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.718 -0.753 . . . . 72.11 112.475 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -79.62 114.94 18.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.915 0.388 . . . . 72.25 110.946 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.8 ttpm? -121.29 130.0 53.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 74.54 110.934 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -121.71 127.06 50.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.259 -0.428 . . . . 75.02 110.89 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 17.4 p -129.92 121.09 25.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.201 -0.454 . . . . 64.53 111.151 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -110.22 129.24 55.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 73.14 110.825 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -112.25 142.16 45.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.099 -0.5 . . . . 72.21 110.883 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.3 t -142.06 124.54 15.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 74.11 110.819 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.8 t -96.09 123.82 39.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 71.15 110.854 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -118.78 132.9 56.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.157 -0.474 . . . . 75.11 110.909 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -128.69 101.83 20.38 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.718 0.77 . . . . 75.21 110.817 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -33.16 17.1 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.685 2.257 . . . . 74.41 112.373 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -79.87 -69.73 0.57 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 61.33 110.911 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.4 -45.07 92.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.456 . . . . 74.43 111.14 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.37 24.34 14.51 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.757 -0.735 . . . . 52.43 112.49 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.92 148.05 22.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.871 0.367 . . . . 74.54 110.86 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -134.47 126.69 29.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 71.23 110.884 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -121.35 136.31 54.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 75.3 110.931 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -125.56 120.19 30.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.445 . . . . 74.03 111.125 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -138.39 138.62 38.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 75.32 110.899 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 5.4 tp -122.57 137.43 56.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.235 -0.439 . . . . 73.21 111.151 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.9 mtpp -128.58 121.38 28.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.172 -0.467 . . . . 73.23 110.911 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 62.6 p -128.26 121.47 29.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 65.4 111.109 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -150.03 163.31 29.41 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.702 -0.761 . . . . 54.13 112.47 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -133.05 143.81 49.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.942 0.401 . . . . 70.34 110.926 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 9.0 mtmt -111.86 120.83 43.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 72.3 110.902 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 28.2 ttm180 -108.37 144.46 35.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 74.3 110.881 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -51.18 -29.28 13.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.219 -0.446 . . . . 74.44 110.851 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 37.1 m80 -86.54 -42.54 13.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 74.24 110.862 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 2.2 pp -150.09 153.62 10.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.238 -0.437 . . . . 75.34 111.137 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -124.68 116.25 22.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.466 . . . . 61.33 110.867 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.506 ' HB2' ' HG ' ' A' ' 142' ' ' LEU . 0.4 OUTLIER -133.51 145.17 49.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.197 -0.456 . . . . 74.33 110.913 179.96 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -146.33 136.0 6.08 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.739 -0.744 . . . . 74.0 112.476 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 44.8 t -103.91 133.97 47.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.837 0.351 . . . . 74.44 110.882 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -125.67 142.13 51.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.474 . . . . 75.32 110.872 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 47.7 ttm -137.89 134.44 35.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 75.45 110.898 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -124.9 122.58 37.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 75.12 110.876 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -94.45 123.15 37.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 75.15 110.881 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -115.12 179.68 3.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 73.54 110.857 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 3.1 mp -93.29 -42.23 13.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.181 -0.463 . . . . 75.11 111.114 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -80.98 -20.09 42.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 65.2 111.125 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 164.23 114.12 0.3 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.751 -0.738 . . . . 74.04 112.509 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 144.75 54.9 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.704 2.269 . . . . 75.23 112.322 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.6 m -126.54 151.62 47.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 74.3 110.868 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 4.6 mp -121.36 126.41 74.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 71.41 111.116 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -121.71 121.95 38.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 74.04 110.855 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -121.86 141.59 14.52 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.779 -0.724 . . . . 73.32 112.52 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -126.75 116.21 20.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.819 0.343 . . . . 61.3 111.107 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.506 ' HG ' ' HB2' ' A' ' 125' ' ' LEU . 0.3 OUTLIER -119.76 122.1 40.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 75.11 110.895 -179.963 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.403 ' HA ' ' HA2' ' A' ' 152' ' ' GLY . 1.5 m -132.61 140.84 46.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 63.14 111.172 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 6.3 mp -116.42 138.84 51.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.22 -0.445 . . . . 73.33 110.93 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -91.71 133.23 11.66 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.745 -0.741 . . . . 75.12 112.48 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.402 ' O ' ' N ' ' A' ' 148' ' ' GLY . 3.2 m-85 -128.74 146.8 50.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.823 0.344 . . . . 74.2 110.96 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -49.4 93.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.111 -0.495 . . . . 73.23 110.889 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 146' ' ' TYR . . . 87.26 -23.59 11.37 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.776 -0.726 . . . . 73.43 112.448 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 7.8 m0 -105.67 145.95 30.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.801 0.334 . . . . 72.24 110.942 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.77 137.13 53.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.243 -0.435 . . . . 74.23 110.919 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -129.26 134.07 47.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.455 . . . . 75.03 111.054 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.403 ' HA2' ' HA ' ' A' ' 143' ' ' VAL . . . -152.92 133.03 3.87 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.701 -0.762 . . . . 73.45 112.514 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 8.4 p90 -144.16 119.34 10.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.909 0.385 . . . . 75.23 110.921 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -110.58 123.62 50.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.075 -0.511 . . . . 73.12 110.935 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 2.4 ttt -120.39 128.72 53.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.44 . . . . 73.54 110.878 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.494 ' O ' ' HB ' ' A' ' 164' ' ' VAL . 20.0 m-20 -112.82 116.79 30.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.444 . . . . 75.01 110.867 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.529 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 60.4 m-85 -89.88 131.98 35.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.165 -0.471 . . . . 74.35 110.87 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -91.3 104.31 16.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 71.23 110.901 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.77 -47.9 73.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.134 -0.485 . . . . 75.11 111.118 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -49.65 -26.14 3.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 73.34 111.126 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.2 -166.85 1.36 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 73.45 110.853 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 68.1 m -112.97 39.18 2.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 75.33 110.829 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -165.06 177.19 7.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.116 -0.493 . . . . 70.51 110.832 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.529 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 1.0 OUTLIER -75.46 144.11 12.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.181 -0.463 . . . . 74.42 111.101 179.993 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 12.9 t -88.74 -32.64 17.82 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.149 -0.478 . . . . 75.33 111.165 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 3.9 tp60 -151.45 134.69 16.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 75.13 110.93 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 11.3 p -124.1 107.07 10.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 75.43 110.868 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 28.9 m-20 -110.74 148.47 32.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.115 -0.493 . . . . 64.24 110.897 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -154.8 140.57 18.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 71.34 110.914 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -154.38 135.01 13.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.13 -0.487 . . . . 74.5 111.094 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 48.5 t -144.15 133.42 19.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 72.04 111.159 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -111.6 122.25 6.0 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.775 -0.726 . . . . 70.12 112.496 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.65 131.06 56.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.934 0.397 . . . . 73.41 110.953 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 2.6 mtpm? -102.95 127.2 50.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.476 . . . . 65.35 110.888 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.406 ' O ' ' C ' ' A' ' 176' ' ' ASP . 0.2 OUTLIER -111.78 166.39 11.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.219 -0.446 . . . . 75.42 111.111 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.406 ' C ' ' O ' ' A' ' 175' ' ' THR . 2.8 m-20 -37.89 -76.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 75.01 110.896 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -117.32 16.51 14.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.179 -0.464 . . . . 72.45 110.932 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -130.79 150.68 51.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.132 -0.485 . . . . 64.13 110.862 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 37.2 mm-40 -116.09 123.1 47.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.124 -0.489 . . . . 73.15 110.895 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -107.15 125.58 51.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.164 -0.471 . . . . 73.4 110.89 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 22.6 m80 -130.63 130.41 43.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 75.2 110.836 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 1.2 t -128.9 111.49 13.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 74.53 111.172 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -120.55 139.65 52.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.236 -0.438 . . . . 63.11 110.908 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 2.5 t -133.33 110.29 14.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 72.14 111.111 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -100.79 89.51 3.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 74.11 110.872 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 67.47 -179.75 0.22 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 73.21 110.882 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -75.19 -2.95 68.12 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.775 -0.726 . . . . 65.22 112.477 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 15.6 p -97.53 -25.49 15.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.769 0.319 . . . . 74.22 111.126 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.27 113.48 20.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 75.41 110.905 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -139.76 123.03 17.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 72.24 110.857 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 171.46 -141.43 6.41 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.747 -0.74 . . . . 63.11 112.519 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 167.24 -167.4 39.83 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.699 -0.763 . . . . 62.42 112.445 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' SER . . . . . 0.479 ' HA ' ' O ' ' A' ' 206' ' ' VAL . 70.3 m -127.5 144.42 51.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.813 0.339 . . . . 72.32 110.875 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -142.03 118.33 6.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.168 -0.469 . . . . 72.53 111.121 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . 0.791 ' CB ' ' HA ' ' A' ' 205' ' ' ALA . 0.1 OUTLIER 178.66 -175.21 0.19 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 64.12 110.892 -179.989 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 16.8 tm0? -123.51 128.54 49.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.091 -0.504 . . . . 75.41 110.894 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 3.4 pttp -114.65 113.97 25.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 73.41 110.903 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 5.2 t -86.47 143.85 10.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.237 -0.438 . . . . 75.32 111.133 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -93.06 32.53 1.28 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 72.3 110.894 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 10.3 mmtt -127.59 35.03 4.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 73.22 110.917 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 2.2 mttp 72.7 51.11 0.16 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 75.31 110.904 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -177.47 82.49 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 73.24 110.938 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -128.17 133.2 48.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.461 . . . . 74.43 110.866 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' THR . . . . . 0.608 ' O ' ' HB3' ' A' ' 195' ' ' TYR . 11.0 t -132.45 136.91 47.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.467 . . . . 75.12 111.158 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . 0.791 ' HA ' ' CB ' ' A' ' 195' ' ' TYR . . . -141.47 136.68 31.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 71.44 111.083 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.49 ' CG1' ' CD2' ' A' ' 195' ' ' TYR . 1.1 m -103.9 139.51 24.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.44 . . . . 63.25 111.074 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -114.35 132.7 56.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.46 . . . . 71.33 110.897 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 4.6 mp -126.11 138.17 53.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.167 -0.47 . . . . 74.25 110.935 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -129.61 139.96 51.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 62.53 111.129 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 2.4 t-105 -130.27 130.32 44.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 71.41 110.944 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.07 109.44 22.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.253 -0.43 . . . . 71.53 111.116 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -51.62 134.81 29.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.448 . . . . 64.34 111.156 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 120.4 33.91 0.99 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.705 -0.76 . . . . 73.21 112.447 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 49.5 t30 59.66 43.34 15.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.822 0.344 . . . . 71.14 110.898 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 14.0 m -90.99 -169.72 2.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 72.32 110.872 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -102.55 137.1 41.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.462 . . . . 74.3 110.913 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 3.9 t -79.12 139.5 38.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.47 . . . . 65.44 111.153 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 17.3 ptp180 -110.84 133.29 53.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 71.43 110.886 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -114.37 138.35 50.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.25 -0.432 . . . . 75.44 110.859 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -140.65 144.52 14.87 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.713 -0.755 . . . . 74.44 112.467 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.93 130.73 64.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.841 0.353 . . . . 75.05 111.129 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -133.74 131.64 39.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 72.52 111.104 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -125.22 146.06 49.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.254 -0.43 . . . . 75.32 111.093 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 3.5 mtmp? -129.1 123.55 32.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 74.44 110.908 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -132.29 133.16 43.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.212 -0.449 . . . . 74.42 110.963 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -85.6 128.78 34.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.475 . . . . 72.24 110.901 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 44.5 mm -74.16 -55.55 11.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 74.24 111.111 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . 0.536 ' N ' ' HD2' ' A' ' 229' ' ' PRO . 0.1 OUTLIER 175.13 -57.35 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.599 0.714 . . . . 74.24 110.826 179.867 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 228' ' ' ASP . 53.4 Cg_endo -69.75 -156.6 0.04 OUTLIER 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.655 2.237 . . . . 73.4 112.368 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.6 15.69 4.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 64.33 110.839 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -120.63 121.92 39.38 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.22 -0.445 . . . . 71.22 111.118 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 36.7 m -108.7 143.99 37.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 52.0 110.889 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -105.3 127.88 53.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 74.53 110.877 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 15.2 m -127.09 137.49 53.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.134 -0.484 . . . . 64.24 110.842 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -121.3 143.17 49.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.158 -0.474 . . . . 63.13 111.083 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.76 141.87 31.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 75.13 110.894 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 5.3 p -140.25 144.73 27.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 63.33 111.117 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -108.16 148.31 30.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 73.42 110.896 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' ASN . . . . . 0.411 ' C ' ' H ' ' A' ' 241' ' ' SER . 7.6 t30 -56.11 -19.52 13.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 75.23 110.869 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 37.3 t -81.15 25.48 0.48 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.474 . . . . 64.05 110.856 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' SER . . . . . 0.411 ' H ' ' C ' ' A' ' 239' ' ' ASN . 2.3 t 61.89 35.73 16.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 72.41 110.851 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 4.6 mp -99.03 117.89 34.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.138 -0.483 . . . . 73.53 110.963 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -104.84 119.0 53.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.207 -0.451 . . . . 75.15 111.181 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -138.04 160.67 25.43 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.749 -0.739 . . . . 72.23 112.498 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.428 ' CD1' ' N ' ' A' ' 245' ' ' LEU . 0.0 OUTLIER -145.16 160.04 42.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.858 0.361 . . . . 71.33 110.872 -179.917 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -149.09 121.77 1.36 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.77 -0.729 . . . . 74.43 112.508 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -109.3 115.89 30.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.976 0.417 . . . . 73.0 110.931 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 3.5 t -101.8 115.05 29.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.131 -0.486 . . . . 75.24 111.153 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -119.71 130.01 54.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 73.5 110.87 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 7.3 p -121.39 117.92 28.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.136 -0.483 . . . . 75.22 111.115 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 11.0 mt -113.42 101.2 9.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 75.32 110.974 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' LYS . . . . . 0.411 ' HB3' ' HD2' ' A' ' 253' ' ' PRO . 17.6 mttp 64.19 155.36 0.12 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.632 0.73 . . . . 73.25 110.835 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . 0.411 ' HD2' ' HB3' ' A' ' 252' ' ' LYS . 53.8 Cg_endo -69.74 73.68 1.34 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.706 2.271 . . . . 61.4 112.341 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 171.92 -29.7 0.11 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.727 -0.749 . . . . 71.52 112.442 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 55.5 mt -116.13 121.37 67.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.854 0.359 . . . . 74.5 111.131 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 32.3 ttmt -133.39 132.81 41.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 73.32 110.86 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -118.44 125.06 49.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.175 -0.466 . . . . 73.51 110.931 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 93.6 m -115.72 111.74 21.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 73.22 111.167 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.6 132.65 53.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.45 . . . . 74.22 110.923 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 16.5 t -145.95 153.37 40.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 74.24 110.889 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -158.12 130.87 7.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 64.05 111.102 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -125.8 124.45 40.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.459 . . . . 74.32 110.911 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.01 110.31 16.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 74.23 110.907 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -79.11 113.88 17.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.198 -0.456 . . . . 74.45 110.871 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -58.9 -17.0 34.07 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.785 -0.722 . . . . 52.34 112.457 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 45.4 tttt -90.84 -3.2 57.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.822 0.344 . . . . 75.12 110.913 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -127.55 -52.82 1.36 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 64.12 110.919 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 17.1 m -51.19 -29.37 8.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 73.3 111.123 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -52.24 -40.39 61.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 74.2 110.918 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -104.91 -17.45 14.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.131 -0.486 . . . . 75.22 111.108 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 129.71 94.8 0.74 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.712 -0.756 . . . . 74.22 112.515 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -179.74 74.94 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.73 -0.748 . . . . 74.43 112.474 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 32.6 p-80 -108.14 145.96 33.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.851 0.357 . . . . 65.22 110.855 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -127.12 138.73 53.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.185 -0.461 . . . . 73.54 110.925 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 1.5 tp -121.75 145.6 47.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.447 . . . . 74.13 110.879 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -123.63 108.25 1.16 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.724 -0.751 . . . . 70.24 112.459 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -114.43 141.4 47.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.858 0.361 . . . . 74.13 110.921 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -148.84 132.59 4.17 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.772 -0.727 . . . . 75.11 112.482 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -109.36 133.63 52.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.766 0.317 . . . . 74.41 110.881 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -124.06 112.62 17.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 72.24 110.88 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -117.93 134.1 55.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.1 -0.5 . . . . 74.42 110.85 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -135.85 112.47 10.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.127 -0.488 . . . . 74.25 110.913 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -96.05 113.36 24.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 74.24 111.071 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 6.1 mp -140.52 177.05 8.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.257 -0.429 . . . . 74.42 110.919 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 75.44 110.864 179.917 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' NAI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.831 0.348 . . . . 64.03 110.87 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.4 -38.18 74.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 73.31 111.127 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.419 ' HB ' ' HA ' ' A' ' 121' ' ' GLU . 0.2 OUTLIER -145.16 108.86 4.6 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.637 0.732 . . . . 72.3 111.155 179.955 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 170.73 15.85 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.648 2.232 . . . . 71.24 112.377 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 83.54 0.7 Allowed 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.695 2.263 . . . . 62.4 112.334 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 46.2 p -70.27 -48.94 54.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.212 -0.449 . . . . 75.12 111.157 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -51.13 -33.81 28.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.237 -0.438 . . . . 71.11 110.896 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -83.44 -28.32 28.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 73.43 111.132 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -90.32 11.61 20.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.211 -0.45 . . . . 75.33 110.823 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 25.1 mt -59.88 -29.76 68.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 75.3 110.928 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 159.4 59.01 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.703 -0.76 . . . . 65.14 112.469 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 12.7 mmtm -67.16 -53.84 26.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.751 0.31 . . . . 73.44 110.874 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.4 t -56.87 -48.06 78.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.27 -0.423 . . . . 70.42 110.906 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.23 -36.77 76.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.092 -0.504 . . . . 72.52 111.104 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.89 -30.57 67.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 74.4 110.864 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -56.44 -48.94 75.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 64.32 110.857 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 79.5 t -62.53 -26.59 40.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 74.23 111.135 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -59.63 -41.11 89.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 74.54 110.865 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.08 -66.64 0.7 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 74.42 111.138 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.1 tppm? -47.28 104.73 0.06 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 74.13 110.902 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 158.93 38.83 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.755 -0.736 . . . . 72.41 112.492 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 18.5 p90 -165.56 140.08 4.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.955 0.407 . . . . 72.14 110.897 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -62.65 129.83 42.48 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.734 -0.746 . . . . 73.45 112.489 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -103.1 -3.51 25.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.879 0.371 . . . . 74.43 110.849 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.78 14.02 78.32 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.721 -0.752 . . . . 64.43 112.509 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -127.77 171.94 11.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.804 0.335 . . . . 63.03 110.899 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.411 HG13 ' HB3' ' A' ' 277' ' ' LEU . 1.3 mp -118.35 121.49 67.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 73.23 111.108 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 37.0 tttp -111.42 117.37 32.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 75.33 110.902 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.1 tt -115.16 141.06 48.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 72.22 110.951 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -147.88 129.98 15.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.178 -0.465 . . . . 74.15 110.838 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.3 tt -126.93 133.38 50.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 73.13 110.876 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mtmp? -127.23 127.02 43.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 75.4 110.892 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.7 m -130.1 141.03 50.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.24 -0.436 . . . . 75.23 111.169 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.88 156.27 20.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.464 . . . . 73.53 110.882 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.517 ' O ' ' C ' ' A' ' 36' ' ' GLU . 0.6 OUTLIER -133.89 174.35 10.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 72.14 110.847 -179.904 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.517 ' C ' ' O ' ' A' ' 35' ' ' SER . 39.9 mm-40 -27.46 -75.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.095 -0.502 . . . . 72.55 110.876 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -166.82 140.39 3.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.115 -0.493 . . . . 74.44 110.879 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.485 ' HA2' ' O ' ' A' ' 63' ' ' ARG . . . 83.54 -12.69 50.71 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.798 -0.715 . . . . 65.12 112.518 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -105.02 130.07 53.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.787 0.327 . . . . 75.31 110.923 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -140.33 118.48 11.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.23 -0.441 . . . . 75.23 110.882 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -98.34 121.55 40.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 74.34 110.869 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 27.6 m -126.06 123.82 39.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.163 -0.471 . . . . 74.41 111.166 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.4 t -125.1 132.39 53.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.264 -0.425 . . . . 54.44 110.875 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 6.0 p -150.04 126.57 10.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.115 -0.493 . . . . 54.12 110.853 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -155.05 167.36 32.78 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.735 -0.745 . . . . 74.53 112.461 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 17.9 m -127.66 156.45 42.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.9 0.381 . . . . 71.25 110.878 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.41 ' HA ' ' HA ' ' A' ' 54' ' ' VAL . . . -142.84 131.33 22.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 71.25 111.103 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 61.5 t-20 -101.65 123.54 45.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 72.43 110.865 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 60.4 m -88.51 -55.35 3.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.169 -0.469 . . . . 75.43 111.122 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -51.12 -36.4 40.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 72.14 110.875 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.14 155.54 50.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 54.32 111.125 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.0 m -71.09 86.99 0.76 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 73.55 111.167 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.2 tptp -152.68 80.91 1.22 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.233 -0.439 . . . . 63.31 110.901 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.41 ' HA ' ' HA ' ' A' ' 47' ' ' ALA . 1.3 p -127.96 123.21 60.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 75.41 111.159 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.0 p -136.6 132.85 35.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 73.44 111.158 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -107.18 136.56 13.46 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.756 -0.735 . . . . 52.23 112.475 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -114.26 144.97 42.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.895 0.379 . . . . 64.15 110.874 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -121.48 132.82 54.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 75.53 110.927 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -133.46 136.96 45.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 75.2 110.904 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 4.9 m -114.79 140.15 49.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 64.4 111.131 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -135.71 157.44 46.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 74.41 110.885 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.434 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 16.2 m-85 -129.26 140.86 51.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.218 -0.447 . . . . 70.34 110.939 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.485 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 43.6 ttm-85 -127.12 104.51 8.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.11 -0.495 . . . . 74.51 110.863 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 66.0 m95 -114.2 123.84 50.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 72.34 110.9 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.5 m 67.3 125.39 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.216 -0.447 . . . . 74.32 111.126 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -51.3 103.95 0.07 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.46 . . . . 63.31 110.911 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 63.64 58.51 1.29 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.459 . . . . 74.1 110.935 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -133.64 -77.81 0.12 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.762 -0.732 . . . . 72.11 112.455 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -133.99 130.35 37.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.881 0.372 . . . . 72.12 110.936 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.57 137.42 38.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 74.22 111.141 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -95.79 133.84 39.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 73.23 110.92 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.5 m -112.67 117.23 31.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.167 -0.469 . . . . 74.12 111.136 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -134.49 134.06 41.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.455 . . . . 75.51 110.9 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 53.5 tttt -145.26 132.85 20.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 72.31 110.893 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 9.6 t90 -135.48 128.91 32.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.439 . . . . 74.35 110.928 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 10.5 m-20 -117.14 150.99 37.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 73.12 110.904 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.7 m -68.21 -12.29 60.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 74.41 111.122 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.489 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 38.8 t70 -74.65 0.17 15.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.227 -0.442 . . . . 63.0 110.893 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.489 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 5.7 t-20 83.55 34.47 0.05 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 75.32 110.865 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 12.7 p -114.77 123.04 48.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 65.21 111.162 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -109.38 136.98 47.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.449 . . . . 71.01 110.908 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -149.33 89.34 0.14 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.666 -0.778 . . . . 61.41 112.452 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.405 ' O ' ' HB2' ' A' ' 84' ' ' GLU . 3.8 m -127.45 160.95 29.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.741 0.305 . . . . 74.13 111.167 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.624 ' HB3' ' O ' ' A' ' 99' ' ' PHE . 0.6 OUTLIER 169.22 -163.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 61.1 110.882 -179.99 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.33 142.96 38.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 74.22 111.111 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 33.7 p -128.88 126.34 39.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.146 -0.479 . . . . 74.21 111.157 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 9.0 p -110.67 137.13 44.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 74.54 111.127 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -125.26 118.51 26.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 65.33 110.937 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 52.14 90.39 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 74.14 110.857 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -138.66 -75.13 0.38 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 73.35 110.932 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 30.1 tp -62.39 -36.12 81.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 73.35 110.938 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -143.29 125.72 15.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 63.24 111.069 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.11 124.8 13.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 73.41 110.872 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 97.64 -23.98 33.59 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.76 -0.733 . . . . 70.53 112.548 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.99 124.28 28.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.834 0.349 . . . . 74.22 110.884 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.2 pttp -121.86 123.31 41.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.219 -0.446 . . . . 75.25 110.932 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -125.53 124.85 42.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.23 -0.441 . . . . 64.12 110.967 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 12.2 p -124.84 119.6 29.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 75.53 111.143 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.624 ' O ' ' HB3' ' A' ' 84' ' ' GLU . 0.3 OUTLIER -109.83 117.73 34.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 72.44 110.86 -179.968 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.544 ' HA ' ' CB ' ' A' ' 84' ' ' GLU . 6.7 t70 -115.71 144.6 43.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 74.12 110.88 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 10.5 t -140.1 133.2 29.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 72.15 110.866 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -120.67 149.51 42.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.484 . . . . 72.53 110.861 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -127.95 137.96 52.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 73.52 110.888 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 99.6 p -128.63 101.52 20.8 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.707 0.765 . . . . 64.22 110.841 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.66 -31.22 21.38 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.705 2.27 . . . . 74.41 112.4 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -50.27 -68.24 0.19 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 73.43 110.885 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.1 p -86.05 -33.45 21.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.481 . . . . 71.21 111.175 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.39 23.57 16.28 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.723 -0.751 . . . . 64.31 112.485 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 46.3 mtpt -94.31 148.09 22.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.821 0.343 . . . . 73.31 110.926 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.15 144.42 31.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 75.45 110.914 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -120.7 128.59 53.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.269 -0.423 . . . . 74.54 110.851 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -133.35 124.82 27.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 52.24 111.088 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -134.77 138.37 44.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.223 -0.444 . . . . 75.12 110.864 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -134.43 136.53 52.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.248 -0.433 . . . . 72.41 111.111 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 10.9 mtmt -126.29 121.59 33.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 75.32 110.883 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 99.6 m -125.22 121.44 34.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 74.4 111.103 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -152.69 163.06 30.26 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.738 -0.744 . . . . 72.33 112.511 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -132.49 145.22 51.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.982 0.42 . . . . 74.53 110.915 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.06 123.47 49.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.094 -0.503 . . . . 74.41 110.905 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.466 ' N ' ' O ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -104.54 147.36 27.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.245 -0.434 . . . . 74.25 110.892 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.419 ' HA ' ' HB ' ' A' ' 3' ' ' VAL . 85.0 tt0 -54.64 -30.95 56.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 75.33 110.873 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 54.2 p-80 -125.95 11.13 7.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 74.23 110.864 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.466 ' O ' ' N ' ' A' ' 120' ' ' ARG . 1.0 OUTLIER -147.63 150.19 14.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.24 -0.437 . . . . 75.44 111.169 179.974 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.401 ' HB3' HG12 ' A' ' 143' ' ' VAL . 5.9 t-20 -128.96 113.69 15.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 60.02 110.9 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -121.89 130.76 53.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 62.14 110.873 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -146.94 115.81 0.81 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.689 -0.767 . . . . 73.12 112.442 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -113.3 135.51 53.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.771 0.32 . . . . 71.21 110.876 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -132.91 117.22 17.43 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.184 -0.462 . . . . 70.52 110.852 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 3.3 tmm? -109.36 138.74 45.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 75.43 110.918 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -117.75 119.23 34.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.248 -0.433 . . . . 63.11 110.854 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -96.43 114.98 26.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 75.45 110.885 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -120.39 153.16 36.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 65.43 110.881 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.02 -29.5 14.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.216 -0.447 . . . . 74.51 111.117 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -84.48 -20.32 31.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 75.44 111.068 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 164.05 97.38 0.12 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.745 -0.74 . . . . 65.51 112.483 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 137.27 35.09 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.648 2.232 . . . . 73.04 112.348 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.07 153.65 46.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.189 -0.459 . . . . 75.35 110.832 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 5.2 mp -110.52 132.29 59.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 75.43 111.135 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 9.2 mtt-85 -119.79 138.72 53.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 75.21 110.862 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -131.95 145.18 16.95 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.761 -0.733 . . . . 74.42 112.508 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -139.23 116.47 11.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.842 0.353 . . . . 72.32 111.076 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -125.34 124.02 40.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 71.25 110.928 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.406 ' HA ' ' HA2' ' A' ' 152' ' ' GLY . 0.1 OUTLIER -132.85 145.0 34.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 74.32 111.126 179.857 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -131.78 140.91 49.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.446 . . . . 74.11 110.921 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -123.4 117.79 3.32 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.722 -0.751 . . . . 75.15 112.463 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.435 ' O ' ' CD1' ' A' ' 149' ' ' TRP . 7.0 t80 -145.52 153.86 41.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.864 0.364 . . . . 73.14 110.921 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 52.58 23.72 2.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 74.54 110.861 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 89.93 -31.2 5.42 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.736 -0.745 . . . . 72.34 112.504 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.435 ' CD1' ' O ' ' A' ' 146' ' ' TYR . 50.5 p-90 -78.0 145.0 36.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.754 0.311 . . . . 73.34 110.923 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.4 mt -124.21 144.4 49.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.249 -0.432 . . . . 65.05 110.906 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -142.97 125.89 16.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.15 -0.477 . . . . 73.54 111.086 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.734 ' O ' ' HB3' ' A' ' 169' ' ' PHE . . . -126.94 131.5 7.29 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.717 -0.754 . . . . 64.15 112.488 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.415 ' C ' ' HD1' ' A' ' 169' ' ' PHE . 5.5 t80 -133.2 120.28 20.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.841 0.353 . . . . 74.03 110.949 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.626 ' H ' ' HB2' ' A' ' 169' ' ' PHE . 0.5 OUTLIER -104.24 138.54 40.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.484 . . . . 70.3 110.915 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -122.73 146.76 47.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 72.13 110.849 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -108.88 120.48 42.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.182 -0.463 . . . . 75.15 110.883 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -91.04 123.18 34.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 75.13 110.86 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.742 ' O ' ' O ' ' A' ' 161' ' ' LYS . 0.1 OUTLIER -78.19 137.64 38.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 71.34 110.881 -179.963 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 5.4 t -69.05 -46.99 66.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.15 -0.477 . . . . 64.4 111.17 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -50.77 -25.87 4.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 75.41 111.111 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.742 ' O ' ' O ' ' A' ' 158' ' ' GLU . 33.2 mmtt -147.29 139.62 24.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 75.24 110.909 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 12.6 m -71.56 49.63 0.16 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 73.41 110.868 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -138.58 170.69 15.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.487 . . . . 75.12 110.889 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 90.8 t -91.15 138.66 19.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.442 . . . . 75.4 111.107 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 96.1 m -94.65 -42.23 8.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.474 . . . . 72.04 111.125 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -160.1 142.2 13.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 72.02 110.922 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 6.8 p -127.12 125.94 42.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 72.21 110.865 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.429 ' CB ' ' HA ' ' A' ' 185' ' ' ASN . 5.8 p30 -139.7 152.3 46.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.102 -0.499 . . . . 73.24 110.906 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.734 ' HB3' ' O ' ' A' ' 152' ' ' GLY . 0.1 OUTLIER -178.55 -159.18 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 74.33 110.893 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -132.92 150.56 52.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 61.24 111.106 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 71.0 t -145.72 127.15 7.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.218 -0.446 . . . . 75.55 111.097 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -163.37 167.19 37.51 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.714 -0.755 . . . . 64.41 112.482 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 27.1 p90 -125.55 154.67 41.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.989 0.424 . . . . 51.12 110.9 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 38.8 mtpt -106.8 130.93 54.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.119 -0.491 . . . . 74.02 110.892 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.15 165.53 16.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 70.13 111.13 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -42.53 -71.74 0.08 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 72.24 110.915 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 26.5 mp0 -115.48 14.46 16.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 74.11 110.92 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -127.83 143.57 51.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.11 -0.496 . . . . 70.41 110.854 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -136.81 130.96 32.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 72.34 110.882 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -124.21 117.5 24.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.14 -0.482 . . . . 71.45 110.891 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 18.2 t-80 -135.07 118.43 16.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 74.54 110.892 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -130.74 127.83 39.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 75.53 111.162 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -119.36 141.01 49.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 72.23 110.922 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.527 ' HB ' ' HA ' ' A' ' 190' ' ' PHE . 1.3 m -133.07 141.19 45.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.457 . . . . 73.1 111.141 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.429 ' HA ' ' CB ' ' A' ' 168' ' ' ASN . 0.8 OUTLIER -105.13 89.2 3.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 72.5 110.884 179.999 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 74.41 -175.93 0.15 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.222 -0.444 . . . . 72.33 110.859 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -80.09 4.84 64.84 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.708 -0.758 . . . . 62.31 112.463 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 22.3 p -110.42 -22.19 11.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.755 0.312 . . . . 74.22 111.142 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -118.12 125.96 51.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 74.4 110.907 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' PHE . . . . . 0.527 ' HA ' ' HB ' ' A' ' 184' ' ' VAL . 32.2 t80 -137.4 125.1 22.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 75.1 110.822 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -136.46 141.95 13.06 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.724 -0.751 . . . . 64.33 112.473 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -133.46 145.19 17.25 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.696 -0.764 . . . . 74.21 112.442 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 3.3 t -139.31 152.63 47.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.893 0.378 . . . . 71.22 110.833 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 3.1 mp -127.43 130.56 70.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 75.43 111.106 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -108.66 123.11 48.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.171 -0.468 . . . . 74.5 110.897 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -124.78 112.45 16.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.122 -0.49 . . . . 72.34 110.877 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 33.6 mtpt -107.69 127.94 54.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 72.14 110.936 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.2 t 66.45 22.21 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.253 -0.431 . . . . 71.13 111.164 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -92.54 -32.74 14.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 72.21 110.87 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 22.6 mtpp -154.28 66.13 0.7 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 74.34 110.924 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 24.8 mttm 68.55 112.92 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.44 . . . . 75.24 110.941 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 63.25 -163.25 0.27 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.211 -0.45 . . . . 75.3 110.946 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 5.6 pm0 -115.04 129.68 56.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.436 . . . . 71.23 110.875 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 17.4 p -142.07 156.76 45.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 73.44 111.152 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -149.44 148.44 29.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.248 -0.433 . . . . 73.41 111.099 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -112.89 148.54 15.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.224 -0.444 . . . . 75.04 111.149 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -126.71 136.92 53.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 65.45 110.917 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 5.6 mp -130.72 142.3 50.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.167 -0.47 . . . . 70.33 110.928 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -131.59 131.64 43.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.466 . . . . 64.43 111.071 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 18.9 t90 -130.69 126.21 35.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 73.03 110.946 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 2.0 t -113.43 105.92 13.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.27 -0.423 . . . . 73.2 111.169 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -51.98 149.09 5.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 74.31 111.114 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 114.2 43.92 0.76 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.752 -0.737 . . . . 65.31 112.497 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 55.73 62.66 2.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.867 0.365 . . . . 72.45 110.901 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 7.1 t -121.85 -178.04 3.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 60.51 110.826 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 29.7 m120 -101.74 150.29 23.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.128 -0.487 . . . . 65.25 110.873 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 2.9 p -79.24 138.69 37.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 75.42 111.181 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 75.6 mtt180 -105.97 126.99 52.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 73.24 110.857 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -122.77 139.43 54.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 75.02 110.887 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -149.68 149.01 20.88 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.745 -0.741 . . . . 73.53 112.521 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.421 HG12 HG13 ' A' ' 237' ' ' VAL . 0.0 OUTLIER -138.7 130.85 37.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.775 0.321 . . . . 74.44 111.142 -179.954 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -120.81 133.12 55.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 72.32 111.107 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -111.91 125.85 54.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 75.5 111.105 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 18.3 ttpp -115.58 114.66 25.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 75.14 110.863 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -109.59 118.6 37.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 74.44 110.903 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.93 114.11 27.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 73.44 110.887 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 44.2 mt -109.06 -35.35 2.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 75.51 111.102 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -149.17 157.47 39.65 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.637 0.732 . . . . 61.2 110.862 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -17.0 37.89 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.694 2.263 . . . . 75.34 112.366 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -103.35 -28.04 12.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 74.31 110.855 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -124.32 129.9 51.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.463 . . . . 64.21 111.087 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 19.1 m -139.65 141.18 37.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.272 -0.422 . . . . 72.33 110.89 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -106.6 133.16 51.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.447 . . . . 75.05 110.895 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 2.8 t -138.27 143.22 39.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.471 . . . . 64.0 110.852 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -146.7 159.03 43.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.128 -0.487 . . . . 73.22 111.098 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.98 148.71 19.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 73.53 110.86 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . 0.421 HG13 HG12 ' A' ' 221' ' ' ILE . 0.9 OUTLIER -140.65 149.1 21.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 74.23 111.115 179.896 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -117.56 147.95 42.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 73.15 110.886 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' ASN . . . . . 0.404 ' C ' ' H ' ' A' ' 241' ' ' SER . 8.3 t30 -58.16 -18.16 23.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 74.44 110.858 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 11.2 t -81.46 26.67 0.46 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 71.2 110.884 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' SER . . . . . 0.404 ' H ' ' C ' ' A' ' 239' ' ' ASN . 1.7 m 62.78 32.94 15.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 75.03 110.841 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 4.5 mp -100.13 117.69 34.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.136 -0.483 . . . . 74.52 110.892 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -109.56 117.75 55.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.131 -0.486 . . . . 75.35 111.178 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . 0.426 ' HA2' ' HA ' ' A' ' 262' ' ' LEU . . . -122.31 148.29 17.02 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.723 -0.751 . . . . 72.24 112.479 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -145.57 130.08 17.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.882 0.373 . . . . 75.45 110.914 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -129.67 138.78 10.47 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.759 -0.734 . . . . 51.44 112.499 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -128.95 131.81 47.54 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.965 0.412 . . . . 75.0 110.919 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 16.8 p -111.41 129.19 56.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 72.45 111.126 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -142.78 123.12 13.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 62.33 110.951 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 20.8 p -106.77 153.13 22.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 72.15 111.129 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 6.2 mt -85.74 -77.11 0.31 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.216 -0.447 . . . . 72.53 110.927 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' LYS . . . . . 0.462 ' CB ' ' CD ' ' A' ' 253' ' ' PRO . 1.6 mttm 177.88 -60.71 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.598 0.714 . . . . 75.24 110.858 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . 0.462 ' CD ' ' CB ' ' A' ' 252' ' ' LYS . 53.5 Cg_endo -69.81 69.31 1.68 Allowed 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.725 2.283 . . . . 71.15 112.314 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 50.47 32.46 23.24 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.785 -0.722 . . . . 70.22 112.445 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 58.6 mt -114.45 122.54 68.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.864 0.364 . . . . 75.44 111.113 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 17.4 mtpp -130.71 120.52 23.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.14 -0.482 . . . . 71.15 110.889 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.75 128.71 46.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.455 . . . . 74.34 110.909 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 1.5 m -115.5 115.24 26.17 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.177 -0.465 . . . . 74.52 111.164 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.39 126.09 54.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.239 -0.437 . . . . 75.34 110.919 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 23.6 p -133.67 144.98 49.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 61.03 110.876 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -155.08 128.25 8.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.129 -0.487 . . . . 74.24 111.06 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.426 ' HA ' ' HA2' ' A' ' 244' ' ' GLY . 1.5 tt -132.75 139.89 47.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.453 . . . . 74.34 110.937 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . 0.432 ' CD2' ' N ' ' A' ' 263' ' ' LEU . 0.0 OUTLIER -123.93 110.13 14.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.202 -0.454 . . . . 75.14 110.937 179.884 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -79.92 106.15 11.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.209 -0.451 . . . . 74.2 110.836 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -53.69 -19.67 10.47 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.767 -0.73 . . . . 72.44 112.461 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.8 -25.95 18.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.785 0.326 . . . . 72.32 110.889 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -99.04 -55.91 2.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 72.2 110.871 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 13.1 m -49.47 -28.23 3.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 72.4 111.124 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -53.25 -44.78 68.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 70.22 110.879 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -105.28 -17.38 14.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.445 . . . . 63.14 111.094 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -111.73 -119.82 3.85 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.743 -0.741 . . . . 65.41 112.488 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -148.72 -170.55 16.61 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.762 -0.733 . . . . 55.35 112.549 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -87.96 146.04 25.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.9 0.381 . . . . 71.54 110.815 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -96.96 135.81 38.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 72.14 110.925 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -132.1 123.26 26.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 71.23 110.922 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -119.38 130.4 8.5 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.737 -0.744 . . . . 55.05 112.509 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.411 ' HB3' HG13 ' A' ' 27' ' ' ILE . 3.3 tm? -119.31 141.03 49.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.874 0.369 . . . . 73.0 110.921 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -145.36 132.46 4.65 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.797 -0.716 . . . . 74.21 112.512 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -108.7 132.12 54.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.805 0.336 . . . . 62.22 110.899 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 50.3 tt0 -127.57 117.67 22.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.185 -0.461 . . . . 73.13 110.871 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -122.7 134.5 54.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.483 . . . . 71.44 110.898 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -135.12 124.3 24.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 73.1 110.938 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -100.06 130.88 46.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.445 . . . . 74.13 111.085 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 41.21 38.31 0.74 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.446 . . . . 74.41 110.92 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.46 . . . . 75.13 110.861 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' NAI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.4 mtt . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.808 0.337 . . . . 73.44 110.898 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.24 90.9 0.36 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 73.34 111.145 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 19.5 t -136.7 75.42 50.04 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 121.674 0.75 . . . . 64.55 111.133 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.7 167.91 23.01 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.74 2.293 . . . . 72.52 112.377 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 102.55 1.05 Allowed 'Trans proline' 0 N--CA 1.465 -0.172 0 C-N-CA 122.684 2.256 . . . . 73.42 112.362 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -86.45 -37.68 18.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 73.42 111.161 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -52.16 -39.9 60.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 71.41 110.886 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -76.24 -24.13 54.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 53.52 111.118 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -74.07 -21.11 60.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 52.24 110.917 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 20.7 mt -56.88 -34.1 67.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.157 -0.474 . . . . 72.14 110.92 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -132.18 29.2 3.37 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.742 -0.742 . . . . 74.11 112.481 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 12.5 ttpp -69.59 -45.79 67.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.801 0.334 . . . . 72.4 110.877 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.4 m -64.37 -39.34 93.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.458 . . . . 74.24 110.883 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.26 -50.58 73.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 54.55 111.109 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -67.44 -33.8 75.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 75.23 110.879 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -60.31 -47.91 84.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 74.43 110.833 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 85.8 t -75.77 -33.46 26.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 73.45 111.135 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -59.8 -41.36 91.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 75.15 110.881 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.3 p 46.74 85.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.139 -0.482 . . . . 74.2 111.152 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.0 mtmt -50.64 -34.44 26.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 65.43 110.933 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -98.79 79.14 0.55 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.72 -0.752 . . . . 72.35 112.442 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -129.66 108.31 10.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.952 0.406 . . . . 74.5 110.965 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 51.71 77.14 0.14 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.741 -0.742 . . . . 65.12 112.503 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -103.35 -3.43 25.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.887 0.375 . . . . 71.2 110.833 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.56 13.7 80.04 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.785 -0.722 . . . . 63.24 112.46 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.0 tp -138.88 -178.93 5.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.78 0.324 . . . . 64.45 110.91 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 14.7 mm -104.7 141.38 20.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.182 -0.463 . . . . 63.54 111.151 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.7 tttt -122.42 139.39 53.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 74.43 110.928 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -131.81 128.73 39.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 73.24 110.884 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -140.73 127.14 19.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.141 -0.481 . . . . 74.45 110.882 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.2 tt -138.37 138.89 38.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 73.44 110.93 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -121.47 125.61 47.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 72.54 110.922 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 96.6 m -121.01 129.12 53.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.229 -0.441 . . . . 73.53 111.108 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.4 tttt -143.33 126.97 16.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.214 -0.448 . . . . 70.1 110.926 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.5 ' O ' ' C ' ' A' ' 36' ' ' GLU . 0.2 OUTLIER -88.22 174.95 7.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.24 -0.436 . . . . 73.21 110.843 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.5 ' C ' ' O ' ' A' ' 35' ' ' SER . 43.8 mm-40 -29.38 -56.61 0.15 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.112 -0.495 . . . . 71.31 110.904 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 -173.77 149.37 1.57 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 73.24 110.899 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 86.54 -11.16 64.56 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.757 -0.735 . . . . 54.1 112.488 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -104.2 132.49 50.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.791 0.329 . . . . 75.44 110.922 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.0 tm-20 -137.78 114.47 10.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.224 -0.444 . . . . 72.34 110.899 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -134.94 118.32 16.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.094 -0.503 . . . . 63.34 110.868 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.58 130.82 46.17 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.125 -0.489 . . . . 75.22 111.107 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.3 p -127.04 131.99 50.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.196 -0.457 . . . . 65.53 110.825 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.9 m -148.72 126.82 12.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.092 -0.504 . . . . 54.41 110.813 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -167.92 179.41 41.21 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.757 -0.735 . . . . 71.42 112.517 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.0 m -137.33 161.5 36.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.899 0.38 . . . . 75.13 110.819 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.7 150.49 36.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.093 -0.503 . . . . 70.2 111.108 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -73.77 142.65 46.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 74.11 110.832 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -55.14 -39.27 69.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.123 -0.489 . . . . 73.24 111.127 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -95.17 25.24 4.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.454 . . . . 73.13 110.874 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 20.5 p 48.09 30.75 2.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 75.1 111.093 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 22.7 m -71.1 -30.8 66.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 71.14 111.124 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 10.5 tptm -165.84 130.72 2.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.247 -0.433 . . . . 75.2 110.885 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.9 t -125.18 125.71 69.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 73.21 111.095 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.7 t -136.68 129.04 30.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 62.22 111.165 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -151.03 150.46 22.43 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.705 -0.759 . . . . 72.1 112.474 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -104.48 146.39 28.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.874 0.369 . . . . 74.15 110.875 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -125.67 132.41 52.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.12 -0.491 . . . . 73.21 110.94 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -125.39 120.08 30.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.441 . . . . 75.4 110.85 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 96.9 m -124.76 137.68 54.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 73.43 111.12 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.646 ' CB ' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -172.39 -178.6 2.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 74.54 110.882 179.901 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -115.22 141.65 47.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.233 -0.44 . . . . 75.42 110.897 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -134.41 111.65 10.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.097 -0.501 . . . . 74.44 110.906 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 2.4 m-90 -106.12 110.59 22.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 73.21 110.952 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 10.3 t -81.29 -33.26 32.75 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.257 -0.429 . . . . 65.05 111.136 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -49.97 -54.82 17.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.245 -0.434 . . . . 72.23 110.888 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -73.76 -51.11 17.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.463 . . . . 61.42 110.91 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 123.78 32.01 0.91 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.785 -0.721 . . . . 75.01 112.462 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -135.09 132.87 38.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.917 0.389 . . . . 75.23 110.866 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 55.5 p -132.42 111.09 11.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 75.51 111.119 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.634 ' O ' ' HB3' ' A' ' 61' ' ' LYS . 0.2 OUTLIER -105.56 132.69 51.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.438 . . . . 73.32 110.888 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.646 ' HA ' ' CB ' ' A' ' 61' ' ' LYS . 17.8 p -129.88 136.14 49.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.484 . . . . 70.23 111.143 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.567 ' H ' ' HB2' ' A' ' 61' ' ' LYS . 25.6 tt0 -126.5 122.01 33.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 73.41 110.877 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.49 139.69 44.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 75.1 110.892 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 8.1 t90 -135.44 129.54 33.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 75.42 110.924 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -116.85 149.29 40.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.263 -0.426 . . . . 73.14 110.891 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 8.8 t -65.12 -14.22 59.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.184 -0.462 . . . . 73.04 111.172 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.456 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 5.6 m-20 -75.25 2.03 12.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 74.35 110.865 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.456 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 2.9 m120 80.09 36.83 0.12 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 75.23 110.932 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.2 m -116.55 121.39 41.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 74.5 111.168 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -101.67 149.22 24.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.249 -0.432 . . . . 75.2 110.933 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -148.81 143.15 10.6 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.696 -0.764 . . . . 72.3 112.493 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.53 96.97 2.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.763 0.316 . . . . 61.04 111.11 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.423 ' HA ' ' HA ' ' A' ' 100' ' ' ASP . 15.8 tt0 -106.14 122.7 46.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.207 -0.451 . . . . 74.24 110.886 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -121.63 138.26 52.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 74.5 111.146 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.62 141.28 47.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.148 -0.478 . . . . 72.33 111.122 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -121.58 120.07 60.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 61.23 111.148 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -93.77 118.26 31.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 71.51 110.943 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 49.68 70.37 0.5 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.203 -0.453 . . . . 73.22 110.876 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 -76.37 86.69 3.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.205 -0.452 . . . . 74.32 110.9 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 11.7 tp 66.19 30.38 9.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 72.15 110.933 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -179.48 100.68 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 73.14 111.126 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 5.9 mpt_? -51.13 134.41 26.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 70.51 110.86 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 96.41 -20.27 51.06 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.721 -0.752 . . . . 61.24 112.542 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 14.5 tp -85.0 134.78 34.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.902 0.382 . . . . 75.22 110.896 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 10.9 ptmt -121.94 128.02 51.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 74.11 110.898 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -122.98 130.58 52.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 74.11 110.925 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -130.53 117.17 19.19 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.176 -0.465 . . . . 75.43 111.138 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -125.47 115.1 19.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 74.32 110.849 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.423 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 2.9 p30 -130.5 142.25 50.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.137 -0.483 . . . . 63.13 110.865 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.541 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 3.1 p -141.77 122.79 14.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 72.41 110.881 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 71.3 p -140.7 141.65 34.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 65.21 110.883 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.485 ' HB2' ' H ' ' A' ' 111' ' ' ASN . 0.1 OUTLIER -176.7 157.79 1.6 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.48 . . . . 74.32 110.885 -179.902 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -78.92 113.13 32.9 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.629 0.728 . . . . 73.54 110.888 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 -4.02 13.19 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.71 2.273 . . . . 71.11 112.325 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -45.13 -35.0 2.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 75.52 110.86 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.8 p -129.2 23.12 5.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.455 . . . . 74.52 111.177 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 75.69 27.33 63.23 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.678 -0.772 . . . . 74.24 112.511 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.431 ' O ' ' HB3' ' A' ' 103' ' ' PHE . 15.4 mtpt -77.61 140.74 39.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.835 0.35 . . . . 74.14 110.902 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.403 ' C ' ' HD1' ' A' ' 103' ' ' PHE . 23.4 mttt -156.61 113.38 3.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 62.54 110.895 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.541 ' O ' ' HA ' ' A' ' 101' ' ' SER . 44.2 t-20 -115.33 118.68 33.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.444 . . . . 64.44 110.914 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.424 ' HA ' ' HA ' ' A' ' 101' ' ' SER . . . -116.1 150.23 37.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.221 -0.445 . . . . 72.12 111.107 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 4.0 tttp -135.19 136.78 42.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 74.21 110.874 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 6.2 tp -112.07 125.01 69.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 72.43 111.096 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 28.5 tttt -122.02 120.0 33.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 72.51 110.915 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 7.1 t -125.35 125.98 44.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 73.53 111.168 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -153.46 176.9 31.3 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.7 -0.762 . . . . 54.12 112.487 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -128.27 144.6 51.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.907 0.384 . . . . 74.22 110.965 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 17.8 mtpt -110.42 117.97 35.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.106 -0.497 . . . . 75.42 110.893 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.447 ' HB2' HG22 ' A' ' 123' ' ' ILE . 1.4 mmm180 -110.65 146.55 35.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 75.15 110.899 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -56.6 -31.01 63.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 74.32 110.875 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 13.9 m80 -124.23 9.37 8.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.455 . . . . 74.32 110.884 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.447 HG22 ' HB2' ' A' ' 120' ' ' ARG . 1.0 OUTLIER -145.58 147.37 18.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 75.01 111.104 -179.999 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -127.62 113.62 16.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 75.33 110.877 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -117.44 127.43 54.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 74.44 110.94 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -146.7 114.71 0.74 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.726 -0.749 . . . . 74.4 112.476 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -113.29 134.62 54.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.847 0.356 . . . . 64.45 110.872 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -124.94 143.58 50.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 64.31 110.834 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 3.2 mmt -138.98 119.04 13.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 74.23 110.88 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -86.17 123.64 31.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.24 -0.436 . . . . 70.13 110.881 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -92.1 98.97 11.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 73.55 110.882 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -115.92 117.05 29.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.141 -0.481 . . . . 74.51 110.882 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 2.5 pp -53.83 -32.54 22.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 72.25 111.172 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -84.36 -20.01 32.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 65.13 111.115 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 162.01 101.66 0.17 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.741 -0.742 . . . . 74.21 112.503 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 161.31 46.42 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.703 2.269 . . . . 75.42 112.369 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.0 m -127.97 151.68 48.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.231 -0.44 . . . . 74.31 110.894 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 3.0 mp -109.06 125.65 66.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 70.21 111.093 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 15.5 ttt180 -122.85 129.25 51.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.119 -0.492 . . . . 74.4 110.882 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -124.18 133.71 8.85 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.712 -0.756 . . . . 72.42 112.509 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -133.16 126.64 32.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.855 0.36 . . . . 62.02 111.093 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -139.93 121.65 15.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.435 . . . . 75.11 110.882 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 1.5 m -133.8 139.55 48.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 74.25 111.139 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.6 mp -109.67 138.66 45.72 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.205 -0.452 . . . . 75.2 110.937 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -100.38 136.94 12.97 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.701 -0.761 . . . . 61.44 112.473 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -141.68 147.13 37.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.851 0.357 . . . . 75.44 110.932 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -49.85 94.3 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.135 -0.484 . . . . 63.22 110.842 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 89.66 -25.27 11.64 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.74 -0.743 . . . . 23.42 112.509 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 37.2 m95 -104.92 142.01 35.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.816 0.341 . . . . 73.03 110.909 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 43.7 tp -140.15 140.16 35.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.236 -0.438 . . . . 73.55 110.868 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -136.01 141.52 44.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 71.23 111.102 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -148.71 134.27 4.92 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.726 -0.749 . . . . 54.2 112.465 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -133.3 124.08 26.63 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.866 0.365 . . . . 73.21 110.976 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -121.0 121.57 38.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.116 -0.493 . . . . 75.11 110.908 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 2.7 ptp -128.1 128.41 44.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.451 . . . . 74.53 110.891 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 -113.62 121.58 44.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 71.53 110.901 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.422 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 38.9 m-85 -94.84 126.78 40.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 75.51 110.883 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.412 ' HG2' ' HB ' ' A' ' 165' ' ' THR . 0.0 OUTLIER -79.04 100.86 7.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 64.32 110.883 -179.909 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.56 -48.11 76.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.461 . . . . 74.41 111.11 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -48.19 -26.09 1.77 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.225 -0.443 . . . . 62.44 111.11 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 25.4 mmtt -127.24 -167.76 1.78 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 74.31 110.87 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 6.1 t -110.59 40.12 2.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.26 -0.427 . . . . 72.11 110.874 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 9.4 mmt180 -154.19 176.74 11.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.108 -0.496 . . . . 73.51 110.83 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.422 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 0.9 OUTLIER -73.61 142.69 14.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.14 -0.482 . . . . 72.22 111.122 179.97 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' THR . . . . . 0.412 ' HB ' ' HG2' ' A' ' 158' ' ' GLU . 8.6 t -90.51 -36.13 14.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.47 . . . . 74.25 111.117 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -156.24 142.88 18.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 64.43 110.871 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 2.5 p -124.99 129.66 50.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.177 -0.465 . . . . 72.3 110.845 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -136.2 148.31 48.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.103 -0.499 . . . . 74.52 110.889 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -152.09 140.17 20.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.192 -0.458 . . . . 74.32 110.892 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -154.63 142.77 20.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.465 . . . . 64.03 111.112 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -145.97 127.48 7.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 71.25 111.111 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -98.97 117.43 5.87 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.728 -0.749 . . . . 72.43 112.445 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.76 119.01 35.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.956 0.408 . . . . 74.24 110.92 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 3.3 mtpm? -116.16 127.28 54.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.085 -0.507 . . . . 71.12 110.878 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.14 166.99 10.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.226 -0.443 . . . . 74.54 111.151 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -73.34 -6.39 45.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.186 -0.461 . . . . 74.2 110.866 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -119.49 -37.99 3.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 74.43 110.867 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -148.96 150.81 33.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 71.22 110.904 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -125.55 122.05 35.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.136 -0.484 . . . . 72.32 110.917 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.524 ' C ' ' CD1' ' A' ' 180' ' ' LEU . 0.3 OUTLIER -126.35 146.15 50.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.22 -0.445 . . . . 73.2 110.97 179.982 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 66.1 m-70 -119.74 116.71 26.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 71.54 110.821 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.24 143.82 28.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 73.41 111.163 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 18.2 t30 -145.18 137.86 26.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 73.44 110.875 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 2.4 t -134.62 114.3 17.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.253 -0.43 . . . . 71.45 111.146 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -101.96 92.58 4.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 75.41 110.883 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 2.6 t70 66.13 171.36 0.23 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 75.23 110.879 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -69.53 -4.71 46.85 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.738 -0.744 . . . . 71.33 112.487 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 33.9 p -95.06 -26.34 16.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.808 0.337 . . . . 75.42 111.162 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -123.65 114.9 20.6 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.186 -0.461 . . . . 74.04 110.906 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -140.75 124.9 17.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 72.51 110.859 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -175.46 -149.17 7.19 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.744 -0.741 . . . . 62.41 112.509 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -173.51 -165.96 31.09 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.731 -0.747 . . . . 64.44 112.472 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 70.9 m -149.51 148.01 28.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.886 0.374 . . . . 75.13 110.858 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 5.4 mp -119.91 140.98 42.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.099 -0.5 . . . . 73.22 111.131 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -132.34 120.7 22.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 74.24 110.941 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 8.7 tm0? -126.2 131.26 52.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.168 -0.469 . . . . 72.23 110.946 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 6.1 mtmp? -97.65 124.81 42.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 73.15 110.851 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 84.1 t -94.39 -33.7 5.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.445 . . . . 74.24 111.107 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -174.66 170.41 3.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.47 . . . . 61.24 110.906 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 19.1 mtpt -50.93 -33.66 25.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 75.33 110.878 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 4.0 mptt -120.43 53.44 1.1 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.245 -0.434 . . . . 72.23 110.944 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -175.14 92.92 0.06 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 74.12 110.911 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -111.95 134.51 53.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 74.32 110.899 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 4.8 t -130.8 138.1 49.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 64.54 111.109 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -150.3 163.42 38.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.242 -0.435 . . . . 72.51 111.112 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -137.14 147.95 26.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.44 . . . . 70.12 111.124 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -120.87 126.61 50.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.47 . . . . 74.44 110.911 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 1.3 mp -128.41 142.77 51.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.161 -0.472 . . . . 74.43 110.908 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -157.47 130.77 7.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 73.24 111.126 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 1.8 t-105 -103.6 123.63 47.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.199 -0.455 . . . . 74.42 110.955 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 61.8 p -107.47 104.74 14.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.257 -0.429 . . . . 72.34 111.161 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -51.11 138.69 19.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.262 -0.426 . . . . 73.41 111.074 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 154.73 -46.79 0.53 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.689 -0.767 . . . . 73.31 112.482 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -151.62 35.02 0.55 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.804 0.335 . . . . 73.42 110.866 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 47.7 t 50.98 44.76 28.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 73.41 110.892 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -101.87 131.79 48.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.147 -0.479 . . . . 74.03 110.922 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 5.2 t -115.36 139.0 50.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 75.21 111.179 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -105.94 131.57 53.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.209 -0.45 . . . . 74.04 110.879 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -131.41 136.21 47.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.466 . . . . 73.21 110.919 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -145.45 153.12 25.08 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.73 -0.748 . . . . 74.21 112.446 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.67 130.68 42.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.85 0.357 . . . . 75.51 111.169 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -135.81 149.0 48.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.16 -0.473 . . . . 63.31 111.119 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -145.02 143.43 30.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.248 -0.433 . . . . 71.23 111.113 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 21.3 ttpp -117.74 132.89 56.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.237 -0.438 . . . . 73.34 110.865 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -132.99 132.38 41.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 73.35 110.908 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -93.67 130.45 39.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.107 -0.497 . . . . 74.43 110.922 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 71.5 mt -78.26 -56.0 8.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.214 -0.448 . . . . 74.34 111.129 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . 0.547 ' N ' ' HD2' ' A' ' 229' ' ' PRO . 0.1 OUTLIER 173.33 -56.94 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.61 0.719 . . . . 73.4 110.881 179.843 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 228' ' ' ASP . 53.2 Cg_endo -69.79 -156.73 0.04 OUTLIER 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.743 2.295 . . . . 64.45 112.332 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -85.55 15.79 4.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.266 -0.424 . . . . 64.11 110.871 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -120.43 122.28 40.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 65.22 111.059 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 31.7 m -115.71 144.39 44.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 74.03 110.837 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -111.44 131.23 55.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 75.11 110.823 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 3.5 p -127.67 141.75 51.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 70.12 110.867 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -119.76 141.65 49.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.122 -0.49 . . . . 74.24 111.096 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 18.2 mttp -145.74 142.54 29.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 74.01 110.858 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 6.7 p -136.35 142.74 37.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 72.12 111.129 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -104.51 148.38 26.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 72.32 110.866 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -57.15 -18.76 16.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 75.23 110.891 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 2.1 m -82.02 25.37 0.58 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.476 . . . . 64.01 110.874 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 63.6 34.46 12.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.121 -0.49 . . . . 74.44 110.829 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 2.7 mp -99.93 117.24 33.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 72.31 110.882 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -111.19 116.5 52.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.142 -0.481 . . . . 75.31 111.128 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -145.93 164.98 28.16 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.721 -0.752 . . . . 72.33 112.487 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.423 ' N ' ' CD1' ' A' ' 245' ' ' LEU . 0.0 OUTLIER -145.36 160.68 41.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.812 0.339 . . . . 75.03 110.926 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -129.52 139.62 11.1 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.718 -0.753 . . . . 64.13 112.464 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -116.69 115.86 26.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.996 0.427 . . . . 70.32 110.905 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 56.1 p -111.76 115.51 29.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.119 -0.492 . . . . 72.42 111.128 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -129.07 137.89 51.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 75.42 110.897 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 95.4 m -119.05 116.81 27.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.45 . . . . 73.54 111.157 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -106.02 103.71 13.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.236 -0.438 . . . . 75.04 110.921 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 20.1 mmmt 64.34 154.6 0.12 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.588 0.709 . . . . 73.12 110.886 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 75.42 1.23 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.699 2.266 . . . . 74.03 112.312 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 167.02 -32.17 0.2 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.782 -0.723 . . . . 74.43 112.477 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 7.3 mt -117.68 122.58 70.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.965 0.412 . . . . 74.15 111.099 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 20.9 mtpt -130.81 127.35 38.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.484 . . . . 71.01 110.935 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -100.68 128.78 46.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.242 -0.435 . . . . 73.21 110.886 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 23.3 m -126.46 113.01 16.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 74.11 111.125 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -121.45 150.55 41.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.207 -0.452 . . . . 75.32 110.915 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 40.8 p -151.16 140.96 21.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 71.22 110.874 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -141.37 133.49 27.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.142 -0.481 . . . . 74.32 111.087 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -131.85 138.2 48.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.221 -0.445 . . . . 75.13 110.917 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -121.81 109.28 14.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.155 -0.475 . . . . 73.33 110.923 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.73 103.95 14.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 71.31 110.86 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -59.21 -11.04 11.31 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.685 -0.769 . . . . 71.13 112.508 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 47.3 mtpt -78.29 -3.31 42.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.826 0.346 . . . . 75.33 110.914 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 -156.19 -53.28 0.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 63.15 110.884 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 1.8 m -57.71 -18.85 10.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 73.34 111.126 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -50.94 -28.35 9.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 73.33 110.88 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -102.95 -17.61 15.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.457 . . . . 71.03 111.085 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 142.43 122.66 1.77 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.758 -0.734 . . . . 73.22 112.496 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 134.78 62.12 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.707 -0.759 . . . . 73.13 112.521 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 18.2 p-80 -76.33 146.13 39.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.855 0.359 . . . . 72.24 110.843 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 13.9 mttp -95.46 135.37 37.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 72.15 110.933 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -135.59 139.25 43.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 75.14 110.927 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -134.03 129.26 5.22 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.738 -0.744 . . . . 51.45 112.526 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -115.54 135.35 54.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.901 0.382 . . . . 75.2 110.889 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -147.45 141.49 9.35 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.746 -0.74 . . . . 75.02 112.481 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -119.57 140.13 51.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.798 0.333 . . . . 63.12 110.894 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 15.3 mp0 -128.53 118.21 22.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.148 -0.478 . . . . 74.3 110.868 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -114.24 128.83 56.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.479 . . . . 73.51 110.877 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -113.42 112.99 24.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 72.12 110.92 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -115.72 113.34 23.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 63.44 111.066 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -130.75 -74.52 0.53 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 74.42 110.941 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 74.13 110.929 179.92 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' NAI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.824 0.345 . . . . 52.03 111.12 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.683 HG22 ' CA ' ' A' ' 121' ' ' GLU . 3.1 t 60.47 82.58 0.22 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.649 0.737 . . . . 74.14 111.148 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 167.76 23.49 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.684 2.256 . . . . 75.31 112.323 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 116.48 4.59 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.653 2.236 . . . . 75.3 112.324 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.612 ' OG1' HD21 ' A' ' 150' ' ' LEU . 1.8 t -107.85 -39.44 5.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 72.44 111.172 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.717 ' CB ' HG21 ' A' ' 143' ' ' VAL . 41.5 p90 -67.96 -35.17 77.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 72.04 110.896 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -73.17 -23.32 60.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.113 -0.494 . . . . 74.13 111.103 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -90.02 13.95 13.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 70.3 110.855 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.607 HD23 HD22 ' A' ' 150' ' ' LEU . 45.2 mt -73.77 -34.27 64.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.2 -0.455 . . . . 73.54 110.954 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 172.62 40.94 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.699 -0.762 . . . . 71.12 112.437 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 44.4 tptt -68.6 -46.02 70.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.823 0.344 . . . . 51.41 110.917 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.1 t -64.79 -39.44 93.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 63.24 110.865 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.14 -49.97 52.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 55.14 111.083 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.499 ' O ' HG23 ' A' ' 19' ' ' THR . 9.7 ptp180 -66.72 -32.79 74.32 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.223 -0.444 . . . . 75.52 110.87 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -58.89 -48.17 82.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.147 -0.478 . . . . 73.45 110.837 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.8 p -81.54 -31.44 11.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 73.24 111.148 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -65.92 -41.35 91.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 73.44 110.905 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.499 HG23 ' O ' ' A' ' 15' ' ' ARG . 69.0 p -73.81 76.92 1.6 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 73.55 111.187 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.95 124.68 18.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 72.33 110.882 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -53.49 120.11 12.76 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.761 -0.733 . . . . 73.21 112.456 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -59.89 97.96 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.936 0.398 . . . . 73.15 110.914 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -77.74 88.78 1.05 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.749 -0.739 . . . . 74.11 112.529 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.438 ' HB2' HD23 ' A' ' 26' ' ' LEU . 20.0 m-85 -101.12 13.39 35.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.914 0.388 . . . . 73.53 110.888 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.85 13.31 80.77 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.709 -0.758 . . . . 71.42 112.481 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.594 HD12 ' N ' ' A' ' 27' ' ' ILE . 1.7 pp -101.91 174.81 5.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.836 0.351 . . . . 74.33 110.881 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.702 HG13 HD12 ' A' ' 277' ' ' LEU . 1.7 mp -116.94 123.89 72.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 73.13 111.142 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.494 ' O ' HD22 ' A' ' 279' ' ' LEU . 71.6 mttt -101.69 154.56 18.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 73.45 110.909 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.659 HD13 ' N ' ' A' ' 30' ' ' ASP . 3.0 tm? -146.05 136.34 23.85 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.23 -0.441 . . . . 73.25 110.88 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.659 ' N ' HD13 ' A' ' 29' ' ' LEU . 13.8 m-20 -153.81 124.64 7.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.456 . . . . 73.13 110.93 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.736 HD11 ' CB ' ' A' ' 283' ' ' ALA . 3.2 tm? -137.2 128.12 27.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.196 -0.456 . . . . 74.14 110.919 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.474 ' N ' HD13 ' A' ' 31' ' ' LEU . 10.8 pttp -120.7 134.67 55.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 65.31 110.936 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -137.95 120.65 16.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 65.31 111.147 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -126.12 146.99 49.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.234 -0.439 . . . . 75.12 110.892 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -139.06 166.99 23.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 64.41 110.878 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -89.42 49.46 1.76 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.118 -0.492 . . . . 52.15 110.878 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -136.37 4.84 2.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.476 . . . . 72.04 110.875 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' A' ' 63' ' ' ARG . . . 89.13 -7.16 82.76 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.741 -0.742 . . . . 74.33 112.482 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.418 HD23 ' O ' ' A' ' 39' ' ' LEU . 1.6 pt? -98.76 129.83 45.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.779 0.323 . . . . 61.1 110.926 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -142.08 117.86 10.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.444 . . . . 64.3 110.895 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.51 122.29 43.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 71.42 110.872 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.11 115.32 19.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 62.12 111.12 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.7 p -115.68 134.43 55.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.249 -0.432 . . . . 52.12 110.888 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 74.8 m -149.26 126.64 11.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 64.43 110.827 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -173.62 167.53 40.17 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.734 -0.746 . . . . 70.24 112.524 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.4 p -137.58 158.05 45.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.885 0.374 . . . . 73.54 110.865 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.435 ' HA ' ' HA ' ' A' ' 54' ' ' VAL . . . -140.42 129.66 23.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 74.01 111.085 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -98.06 127.34 43.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 74.01 110.874 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 28.6 p -90.68 -52.93 4.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 72.4 111.113 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -51.51 -38.28 53.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 73.12 110.896 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 43.9 p -133.91 161.79 33.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 73.24 111.134 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.2 p -75.7 78.1 2.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.227 -0.442 . . . . 72.2 111.111 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 10.9 ttpt -142.7 78.83 1.63 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 72.31 110.906 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' A' ' 47' ' ' ALA . 1.3 p -127.79 121.24 56.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 71.44 111.104 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 6.3 m -137.22 126.72 25.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.202 -0.454 . . . . 73.13 111.107 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -111.87 154.28 16.86 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.751 -0.738 . . . . 54.33 112.487 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.5 m -136.98 143.87 43.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.889 0.376 . . . . 51.54 110.865 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.564 HD13 ' N ' ' A' ' 59' ' ' GLU . 0.8 OUTLIER -121.08 126.28 49.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 52.21 110.911 179.99 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.564 ' N ' HD13 ' A' ' 58' ' ' LEU . 8.2 mp0 -121.69 126.46 49.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 65.22 110.878 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -104.11 120.12 40.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.143 -0.481 . . . . 51.11 111.119 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -119.76 158.75 25.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.181 -0.463 . . . . 74.42 110.855 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -133.16 140.89 47.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.145 -0.479 . . . . 74.04 110.898 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.512 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 21.4 tpp180 -131.25 103.32 6.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.107 -0.497 . . . . 71.43 110.86 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 17.8 m95 -116.15 121.26 41.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.461 . . . . 72.44 110.961 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.7 m 66.34 136.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.251 -0.431 . . . . 73.05 111.148 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -63.82 106.07 0.94 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.241 -0.436 . . . . 63.42 110.858 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 23.2 t80 66.51 59.08 0.63 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.154 -0.475 . . . . 73.53 110.886 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -140.62 -65.78 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.743 -0.741 . . . . 54.32 112.482 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.487 HD13 ' HA ' ' A' ' 87' ' ' VAL . 0.7 OUTLIER -130.62 129.03 42.18 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.891 0.377 . . . . 63.53 110.907 -179.91 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 5.1 m -137.92 133.26 33.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.177 -0.465 . . . . 62.34 111.124 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -123.27 134.79 54.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.444 . . . . 71.42 110.886 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.8 p -127.28 118.52 24.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.466 . . . . 72.5 111.19 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -121.82 130.06 53.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.259 -0.428 . . . . 74.44 110.849 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -122.24 104.98 9.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.48 . . . . 73.23 110.857 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 8.6 t90 -122.35 125.71 46.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.251 -0.431 . . . . 74.53 110.909 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -102.81 137.11 41.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 70.22 110.926 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 24.0 m -66.85 -34.4 77.72 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.206 -0.452 . . . . 73.32 111.136 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -110.81 -34.08 6.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.258 -0.428 . . . . 64.24 110.891 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -81.25 -160.55 0.34 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 54.41 110.901 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 66.6 p -80.95 154.05 27.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 74.53 111.154 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.618 ' H ' HD23 ' A' ' 81' ' ' LEU . 2.1 pt? -111.44 137.31 49.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 73.13 110.896 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -159.77 162.94 33.37 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.73 -0.748 . . . . 41.21 112.466 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.5 t -138.46 163.54 31.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.721 0.296 . . . . 53.12 111.137 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.33 145.48 25.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.456 . . . . 43.34 110.868 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.56 138.08 55.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.475 . . . . 71.11 111.146 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.542 HG23 ' OG1' ' A' ' 98' ' ' THR . 20.3 m -127.03 129.15 47.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.18 -0.463 . . . . 54.35 111.156 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.487 ' HA ' HD13 ' A' ' 69' ' ' LEU . 3.4 p -128.61 137.34 57.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 61.25 111.16 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -102.62 118.47 36.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 71.54 110.878 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -50.49 128.07 19.2 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.156 -0.474 . . . . 74.33 110.867 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -79.43 -56.71 4.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.185 -0.461 . . . . 64.33 110.935 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 15.3 mt -72.26 -41.29 66.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 74.22 110.928 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -93.78 71.6 4.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 74.24 111.121 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 11.5 tpt180 -50.98 135.32 24.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 74.31 110.883 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 101.75 -23.61 34.27 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.762 -0.733 . . . . 71.41 112.507 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.604 HD12 HD11 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -79.8 119.41 22.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.914 0.388 . . . . 73.21 110.905 -179.937 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.563 ' C ' HD13 ' A' ' 97' ' ' LEU . 26.7 ttpp -121.42 125.74 47.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 72.12 110.871 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.604 HD11 HD12 ' A' ' 95' ' ' LEU . 0.6 OUTLIER -118.62 126.71 52.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.445 . . . . 75.4 110.943 179.913 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.542 ' OG1' HG23 ' A' ' 86' ' ' THR . 97.2 m -131.33 119.83 22.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 64.32 111.139 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -115.11 121.73 43.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 75.21 110.895 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -119.29 150.0 40.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.163 -0.471 . . . . 73.32 110.851 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 7.1 t -142.22 124.81 15.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 71.14 110.84 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 4.9 m -99.77 146.52 26.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.108 -0.496 . . . . 75.24 110.898 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.414 ' O ' HD23 ' A' ' 81' ' ' LEU . 11.1 m-85 -143.12 138.55 29.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.458 . . . . 74.41 110.923 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 17.7 m -99.0 137.41 20.48 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.647 0.737 . . . . 72.32 110.882 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.83 125.57 12.26 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.719 2.279 . . . . 62.32 112.332 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 51.01 48.86 22.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 53.41 110.928 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 25.9 m -136.96 -41.53 0.59 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.143 -0.481 . . . . 71.43 111.103 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 92.28 -18.01 55.55 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.763 -0.732 . . . . 43.31 112.525 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 8.5 tttm -65.94 116.61 7.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.855 0.36 . . . . 75.41 110.931 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 15.0 ptmt -115.81 131.0 57.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 74.13 110.912 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -120.98 123.87 43.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.208 -0.451 . . . . 73.23 110.907 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -110.55 136.2 50.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.454 . . . . 63.03 111.113 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 11.2 mttt -138.25 137.78 37.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 73.21 110.888 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 5.7 tp -120.34 130.73 74.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.437 . . . . 65.33 111.127 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.6 tptp -120.35 119.69 33.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 73.31 110.879 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.59 HG23 HD12 ' A' ' 97' ' ' LEU . 58.7 m -129.61 121.48 27.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 71.24 111.145 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.435 ' HA3' ' HA2' ' A' ' 126' ' ' GLY . . . -150.56 170.68 30.43 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.769 -0.729 . . . . 74.24 112.497 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.428 ' CD2' HD22 ' A' ' 95' ' ' LEU . 0.2 OUTLIER -127.98 135.84 50.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.973 0.416 . . . . 71.3 110.934 -179.836 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.662 ' HG2' HG11 ' A' ' 3' ' ' VAL . 2.9 tttt -110.86 118.02 34.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.12 -0.491 . . . . 75.51 110.87 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.455 ' O ' HG13 ' A' ' 3' ' ' VAL . 23.1 ttm-85 -111.42 143.73 41.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 70.44 110.883 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.683 ' CA ' HG22 ' A' ' 3' ' ' VAL . 17.8 pt-20 -52.35 -29.36 23.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 73.41 110.899 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -86.31 -41.16 14.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 54.44 110.883 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.435 ' HB ' HD13 ' A' ' 144' ' ' LEU . 1.3 pp -148.25 153.53 11.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.224 -0.444 . . . . 74.51 111.111 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -127.24 115.06 18.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 75.5 110.905 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.899 HD22 ' C ' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -133.39 142.79 48.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 72.42 110.927 179.959 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.667 ' N ' HD22 ' A' ' 125' ' ' LEU . . . -148.02 141.97 9.67 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.723 -0.751 . . . . 61.32 112.47 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 2.0 t -113.32 131.0 56.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.81 0.338 . . . . 74.42 110.883 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -119.68 150.41 40.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.232 -0.44 . . . . 75.1 110.888 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 8.1 ttt -138.03 119.76 15.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.446 . . . . 75.21 110.886 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -102.33 120.95 41.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.202 -0.454 . . . . 72.45 110.871 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -95.34 116.34 28.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 75.04 110.868 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.431 ' OD1' HD12 ' A' ' 133' ' ' ILE . 15.8 t0 -109.94 173.66 6.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 62.21 110.87 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.545 ' H ' HD12 ' A' ' 133' ' ' ILE . 2.8 mp -93.34 -33.59 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 71.21 111.154 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -92.69 -19.77 21.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 72.52 111.075 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 168.9 106.63 0.19 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.76 -0.733 . . . . 45.34 112.484 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 144.56 54.25 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.639 2.226 . . . . 72.0 112.328 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 9.4 t -128.77 152.35 48.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.444 . . . . 71.52 110.841 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.716 HD12 ' OG1' ' A' ' 159' ' ' THR . 1.7 mp -112.34 135.48 51.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.131 -0.486 . . . . 73.14 111.09 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 8.5 ttm180 -121.48 112.32 18.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.458 . . . . 72.41 110.871 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -111.65 136.38 13.51 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.775 -0.726 . . . . 61.02 112.525 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -138.54 116.26 11.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.799 0.333 . . . . 74.43 111.125 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.759 HD13 ' CB ' ' A' ' 125' ' ' LEU . 1.1 tp -123.86 124.51 42.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.252 -0.431 . . . . 41.42 110.901 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.754 ' N ' HD12 ' A' ' 142' ' ' LEU . 44.5 t -114.25 129.85 69.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 71.31 111.081 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.454 HD13 ' HA ' ' A' ' 144' ' ' LEU . 2.6 mm? -106.14 138.85 41.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 52.35 110.899 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -116.27 136.6 13.0 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.781 -0.723 . . . . 72.42 112.487 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -140.46 146.43 38.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.876 0.37 . . . . 75.01 110.909 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 74.5 mt-10 -50.31 96.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.136 -0.483 . . . . 44.21 110.907 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 90.16 -26.08 10.89 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.745 -0.741 . . . . 54.32 112.541 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 7.1 m0 -105.15 135.64 46.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.803 0.335 . . . . 75.54 110.886 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.612 HD21 ' OG1' ' A' ' 6' ' ' THR . 0.6 OUTLIER -126.53 140.07 52.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.265 -0.425 . . . . 75.44 110.876 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.468 ' H ' HD23 ' A' ' 150' ' ' LEU . . . -139.76 145.2 37.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 73.24 111.083 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -146.97 132.97 4.58 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.71 -0.757 . . . . 51.35 112.516 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -135.43 120.17 18.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.842 0.354 . . . . 70.13 110.899 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -134.05 122.45 23.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.137 -0.483 . . . . 72.23 110.95 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 4.3 ptt? -145.96 155.39 42.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 53.12 110.892 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -112.72 129.92 56.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 63.25 110.846 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.424 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 62.1 t80 -90.44 133.16 35.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.48 . . . . 73.11 110.861 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -77.82 101.94 6.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.473 . . . . 71.42 110.914 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.716 ' OG1' HD12 ' A' ' 138' ' ' ILE . 0.2 OUTLIER -64.97 -47.4 77.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.127 -0.488 . . . . 74.12 111.117 -179.9 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -48.6 -26.07 2.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 71.3 111.097 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 4.1 tptt -126.11 -167.51 1.72 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 64.32 110.919 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 11.7 t -112.03 40.83 2.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.446 . . . . 75.42 110.814 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -154.47 176.09 12.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 65.31 110.869 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.424 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 2.0 t -82.55 141.51 14.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.446 . . . . 63.31 111.125 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 15.2 t -91.01 -34.19 15.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.192 -0.458 . . . . 73.24 111.154 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -152.45 138.18 17.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 74.24 110.897 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 3.5 m -124.7 131.14 53.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 72.41 110.879 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -132.09 135.16 46.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 71.53 110.843 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.628 ' HB3' HG22 ' A' ' 184' ' ' VAL . 11.3 t80 -130.06 148.51 51.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.103 -0.499 . . . . 72.32 110.887 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -153.42 138.13 16.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 52.32 111.117 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 61.8 t -120.64 134.7 63.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.252 -0.431 . . . . 72.11 111.09 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -116.01 131.29 9.53 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.737 -0.744 . . . . 65.03 112.497 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -130.03 120.66 25.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.961 0.41 . . . . 74.22 110.926 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.14 132.28 54.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.079 -0.509 . . . . 73.3 110.888 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.47 166.49 21.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 74.32 111.136 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -39.79 -73.82 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.22 -0.446 . . . . 61.03 110.885 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -117.05 14.81 15.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.459 . . . . 55.34 110.951 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.64 ' CZ ' HG23 ' A' ' 194' ' ' ILE . 88.8 t80 -126.15 142.3 51.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.115 -0.493 . . . . 70.01 110.897 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 53.8 mm-40 -136.6 125.29 23.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.111 -0.495 . . . . 52.11 110.9 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.688 HD12 HG13 ' A' ' 194' ' ' ILE . 1.0 OUTLIER -123.31 129.01 50.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.462 . . . . 71.33 110.929 179.991 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 25.7 m80 -129.85 117.78 20.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 62.13 110.89 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 9.2 m -109.31 155.77 20.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 72.32 111.175 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -162.47 139.42 7.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.24 -0.436 . . . . 64.22 110.909 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.628 HG22 ' HB3' ' A' ' 169' ' ' PHE . 2.0 m -133.62 138.61 50.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 70.41 111.139 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -97.7 88.77 4.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 75.35 110.891 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 186' ' ' ASP . . . . . 0.4 ' HB2' HG22 ' A' ' 188' ' ' THR . 2.0 m-20 72.4 -176.4 0.18 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.195 -0.457 . . . . 74.33 110.888 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -79.45 3.08 69.12 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.73 -0.748 . . . . 71.21 112.479 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 188' ' ' THR . . . . . 0.4 HG22 ' HB2' ' A' ' 186' ' ' ASP . 3.9 t -107.54 -22.29 12.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.801 0.334 . . . . 71.51 111.172 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -120.83 124.32 44.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.47 . . . . 74.42 110.894 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' PHE . . . . . 0.552 ' HA ' ' HB ' ' A' ' 184' ' ' VAL . 0.4 OUTLIER -137.76 125.38 22.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.183 -0.462 . . . . 74.13 110.882 -179.906 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -146.3 170.91 27.31 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.752 -0.737 . . . . 63.23 112.467 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.539 ' O ' HD23 ' A' ' 208' ' ' LEU . . . -150.5 164.14 29.74 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.73 -0.748 . . . . 54.02 112.458 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -139.56 141.98 37.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.863 0.363 . . . . 71.33 110.836 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.688 HG13 HD12 ' A' ' 180' ' ' LEU . 5.3 mp -131.65 116.89 32.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 74.31 111.107 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 195' ' ' TYR . . . . . 0.593 ' CE2' ' HB2' ' A' ' 205' ' ' ALA . 2.6 t80 -108.83 122.31 46.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.134 -0.485 . . . . 71.32 110.915 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 22.4 tp60 -124.3 122.6 38.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.089 -0.505 . . . . 72.04 110.922 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.94 127.29 47.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 74.2 110.925 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 9.3 t -82.64 155.99 3.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.228 -0.442 . . . . 75.15 111.089 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -50.45 -50.2 52.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 54.01 110.919 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 13.7 mmtp -69.63 -170.42 0.3 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 63.25 110.885 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' LYS . . . . . 0.75 ' O ' HD22 ' A' ' 202' ' ' LEU . 23.3 mtpp -81.45 55.58 2.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 73.23 110.912 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.75 HD22 ' O ' ' A' ' 201' ' ' LYS . 3.9 mm? -135.61 116.25 13.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 75.41 110.922 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -107.25 139.35 41.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 75.04 110.913 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 6.1 m -124.0 138.83 54.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 74.43 111.106 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.593 ' HB2' ' CE2' ' A' ' 195' ' ' TYR . . . -137.6 143.34 41.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 74.41 111.087 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 10.6 t -132.43 137.94 53.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.46 . . . . 55.04 111.124 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -149.22 125.89 11.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 74.0 110.902 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.539 HD23 ' O ' ' A' ' 192' ' ' GLY . 2.6 pt? -147.08 150.58 35.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.162 -0.472 . . . . 72.25 110.929 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -134.44 149.28 50.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 75.44 111.075 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 17.3 t90 -130.42 132.02 45.53 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.214 -0.448 . . . . 75.51 110.926 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 1.7 m -95.69 107.89 20.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 73.24 111.153 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -51.88 146.76 7.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 54.11 111.075 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 104.35 -38.54 3.21 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.732 -0.747 . . . . 71.11 112.442 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 31.8 m120 -121.23 166.94 13.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.877 0.37 . . . . 74.5 110.86 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 39.3 m -97.38 36.93 1.4 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 72.22 110.833 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 16.9 t30 -101.83 111.52 23.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.107 -0.497 . . . . 71.53 110.937 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 35.0 p -115.33 138.66 50.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.45 . . . . 71.31 111.139 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -126.77 123.97 38.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 71.03 110.896 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -132.69 156.11 47.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 72.43 110.842 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -149.33 147.88 18.68 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.729 -0.748 . . . . 51.03 112.482 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 3.7 mp -120.67 132.15 70.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.87 0.367 . . . . 75.31 111.106 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -138.06 130.81 29.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 55.54 111.101 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -123.97 158.41 32.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 71.54 111.098 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 19.4 ttmm -124.09 137.48 54.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.431 . . . . 71.51 110.936 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -132.34 117.61 18.36 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.206 -0.452 . . . . 64.0 110.944 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -89.95 130.48 36.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.131 -0.486 . . . . 73.32 110.915 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 62.7 mt -81.83 -57.67 4.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 74.41 111.085 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 228' ' ' ASP . . . . . 0.559 ' N ' ' HD2' ' A' ' 229' ' ' PRO . 0.6 OUTLIER 170.7 -56.89 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.673 0.749 . . . . 73.04 110.877 179.938 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 228' ' ' ASP . 53.4 Cg_endo -69.81 -156.42 0.04 OUTLIER 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.68 2.253 . . . . 73.2 112.359 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -85.49 17.27 3.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.225 -0.443 . . . . 54.42 110.862 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -119.52 122.12 40.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 44.41 111.097 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 32.5 t -120.6 142.68 49.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.451 . . . . 73.22 110.886 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -108.88 128.18 54.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 75.11 110.855 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -122.12 154.07 37.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 72.24 110.853 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -133.03 149.78 52.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.122 -0.49 . . . . 71.45 111.169 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 34.0 mttp -145.74 164.06 33.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.23 -0.441 . . . . 61.21 110.94 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 242' ' ' LEU . 6.0 p -156.19 143.17 10.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.266 -0.424 . . . . 71.05 111.171 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -106.2 147.97 28.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 73.4 110.879 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -52.55 -22.77 5.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 72.35 110.854 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 32.2 t -81.2 26.15 0.46 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.46 . . . . 72.1 110.84 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 5.0 t 58.08 38.98 26.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.475 . . . . 72.33 110.902 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 242' ' ' LEU . . . . . 0.446 ' O ' HG23 ' A' ' 237' ' ' VAL . 3.6 mp -98.7 129.54 45.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.093 -0.503 . . . . 75.3 110.888 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.491 ' H ' HD12 ' A' ' 243' ' ' ILE . 4.0 mp -93.02 117.78 37.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.458 . . . . 65.32 111.12 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -117.53 144.3 18.22 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.766 -0.731 . . . . 55.25 112.468 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.641 HD21 HD21 ' A' ' 263' ' ' LEU . 0.0 OUTLIER -145.3 128.56 16.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.828 0.347 . . . . 75.15 110.953 -179.943 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -130.35 122.06 3.51 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.733 -0.746 . . . . 74.51 112.466 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -110.27 115.97 30.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.907 0.384 . . . . 75.24 110.949 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.899 HG23 HG23 ' A' ' 258' ' ' THR . 0.2 OUTLIER -110.58 114.88 28.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 51.44 111.143 -179.966 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -143.4 138.64 29.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 74.13 110.924 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 250' ' ' THR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 256' ' ' LYS . 16.3 p -77.95 147.51 34.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 74.25 111.137 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.4 ' HG ' ' HD2' ' A' ' 252' ' ' LYS . 13.8 tp -111.36 -74.71 0.63 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 75.43 110.954 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 252' ' ' LYS . . . . . 0.595 ' HG2' HD11 ' A' ' 255' ' ' ILE . 12.7 mmmt -97.43 163.15 20.36 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.564 0.697 . . . . 64.5 110.918 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 253' ' ' PRO . . . . . 0.593 ' HD2' ' HB3' ' A' ' 252' ' ' LYS . 53.7 Cg_endo -69.75 67.08 1.75 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.718 2.278 . . . . 71.21 112.335 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 254' ' ' GLY . . . . . 0.632 ' O ' ' HB3' ' A' ' 281' ' ' PHE . . . 157.67 -17.94 0.35 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.767 -0.73 . . . . 33.55 112.495 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.595 HD11 ' HG2' ' A' ' 252' ' ' LYS . 15.9 pt -129.36 141.5 46.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.928 0.394 . . . . 75.22 111.121 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 250' ' ' THR . 48.7 tttt -117.69 138.33 52.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 75.02 110.895 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 0.704 ' HA ' HD12 ' A' ' 279' ' ' LEU . 0.2 OUTLIER -96.09 128.56 43.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 74.15 110.92 179.919 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 258' ' ' THR . . . . . 0.899 HG23 HG23 ' A' ' 248' ' ' THR . 4.4 m -119.81 122.62 41.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.465 . . . . 75.12 111.16 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.881 HD22 HD23 ' A' ' 277' ' ' LEU . 0.0 OUTLIER -110.29 138.94 45.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.218 -0.446 . . . . 75.51 110.912 179.971 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.559 ' O ' HD22 ' A' ' 275' ' ' LEU . 70.6 m -136.67 140.55 42.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 63.44 110.857 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -146.57 129.07 15.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.099 -0.5 . . . . 55.54 111.14 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.707 ' C ' HD13 ' A' ' 263' ' ' LEU . 2.8 tm? -121.94 130.05 53.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.27 -0.423 . . . . 72.02 110.924 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 263' ' ' LEU . . . . . 0.889 ' HB3' HG21 ' A' ' 268' ' ' VAL . 0.3 OUTLIER -124.24 110.55 14.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.469 . . . . 72.32 110.919 179.885 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 264' ' ' ASP . . . . . 0.562 ' O ' ' HB ' ' A' ' 268' ' ' VAL . 0.7 OUTLIER -86.8 98.33 11.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.155 -0.475 . . . . 54.01 110.846 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -53.02 -11.95 1.62 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.762 -0.732 . . . . 74.2 112.454 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -64.41 -25.46 68.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.78 0.324 . . . . 72.53 110.896 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -168.44 19.91 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 72.04 110.873 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 268' ' ' VAL . . . . . 0.889 HG21 ' HB3' ' A' ' 263' ' ' LEU . 1.7 p -68.52 -27.0 34.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 70.53 111.16 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -77.8 -44.83 26.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 61.14 110.922 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -95.93 12.41 30.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 64.43 111.11 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -129.62 -104.22 1.1 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.708 -0.758 . . . . 41.33 112.47 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -164.67 172.26 40.35 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.708 -0.758 . . . . 73.4 112.489 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 273' ' ' HIS . . . . . 0.406 ' CB ' HD12 ' A' ' 263' ' ' LEU . 2.4 p-80 -105.25 146.66 29.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.839 0.352 . . . . 74.21 110.909 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -95.66 136.34 36.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 74.21 110.884 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.744 HD13 ' N ' ' A' ' 276' ' ' GLY . 2.5 tm? -134.36 139.07 45.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.243 -0.435 . . . . 62.13 110.917 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 276' ' ' GLY . . . . . 0.744 ' N ' HD13 ' A' ' 275' ' ' LEU . . . -140.04 130.29 4.61 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.685 -0.769 . . . . 63.02 112.462 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.881 HD23 HD22 ' A' ' 259' ' ' LEU . 3.5 tm? -115.93 138.67 50.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.859 0.361 . . . . 72.11 110.904 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 278' ' ' GLY . . . . . 0.656 ' N ' HD13 ' A' ' 277' ' ' LEU . . . -162.04 129.06 2.0 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.74 -0.743 . . . . 51.0 112.474 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.704 HD12 ' HA ' ' A' ' 257' ' ' LEU . 0.1 OUTLIER -108.69 127.99 54.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.784 0.326 . . . . 73.14 110.896 -179.916 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 280' ' ' GLU . . . . . 0.423 ' O ' ' HB2' ' A' ' 281' ' ' PHE . 1.8 pm0 -140.92 147.06 38.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.162 -0.472 . . . . 71.11 110.888 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 281' ' ' PHE . . . . . 0.632 ' HB3' ' O ' ' A' ' 254' ' ' GLY . 0.0 OUTLIER 168.73 -157.99 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.134 -0.484 . . . . 72.42 110.842 -179.945 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -136.22 143.15 44.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.145 -0.48 . . . . 63.12 110.984 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.736 ' CB ' HD11 ' A' ' 31' ' ' LEU . . . -91.17 112.43 24.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 74.02 111.131 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.666 HD22 ' O ' ' A' ' 283' ' ' ALA . 1.5 mm? -136.99 179.18 6.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.23 -0.441 . . . . 71.05 110.944 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.214 -0.448 . . . . 60.31 110.898 179.962 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.097 0 CA-C-O 120.861 0.362 . . . . 34.44 111.1 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.733 HG11 ' O ' ' A' ' 119' ' ' LYS . 24.8 t -139.7 82.16 18.52 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.601 0.715 . . . . 73.21 111.127 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 168.28 21.98 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.712 2.275 . . . . 64.33 112.319 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 95.55 0.56 Allowed 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.636 2.224 . . . . 71.23 112.349 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -79.64 -48.6 13.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.247 -0.433 . . . . 72.11 111.088 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.427 ' HB2' HG11 ' A' ' 143' ' ' VAL . 35.7 t80 -52.79 -40.52 63.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.21 -0.45 . . . . 71.32 110.931 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.99 -19.86 58.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.134 -0.485 . . . . 71.12 111.109 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -88.62 10.47 20.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.168 -0.469 . . . . 74.54 110.833 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.884 HD21 ' HA3' ' A' ' 152' ' ' GLY . 0.6 OUTLIER -64.59 -34.15 77.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.456 . . . . 72.32 110.935 -179.986 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -152.09 63.57 0.38 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.748 -0.739 . . . . 74.33 112.499 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.34 -54.51 14.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.833 0.349 . . . . 75.41 110.879 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 m -64.02 -39.49 94.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 64.15 110.83 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.51 -37.7 73.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 73.13 111.11 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 63.2 mtt-85 -61.85 -36.85 82.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.451 . . . . 74.3 110.874 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.91 -37.97 82.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.218 -0.446 . . . . 71.44 110.855 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 97.6 t -75.24 -35.88 35.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.143 -0.48 . . . . 74.33 111.139 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -60.92 -41.0 95.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 61.34 110.853 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.0 m 51.9 78.34 0.12 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 73.42 111.137 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.84 119.74 11.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.44 . . . . 75.41 110.862 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.46 96.74 1.28 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.733 -0.746 . . . . 73.3 112.507 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -86.55 -175.83 5.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.928 0.394 . . . . 72.43 110.932 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.84 114.5 5.34 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.728 -0.748 . . . . 64.2 112.478 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -103.9 12.85 33.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.956 0.408 . . . . 75.22 110.924 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.61 14.18 77.79 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.685 -0.769 . . . . 73.35 112.498 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.554 HD12 ' N ' ' A' ' 27' ' ' ILE . 2.2 pp -114.81 179.81 3.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.794 0.331 . . . . 74.05 110.932 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.918 HG23 HD12 ' A' ' 277' ' ' LEU . 32.6 mm -109.87 125.84 67.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 65.4 111.125 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.54 ' O ' HD22 ' A' ' 279' ' ' LEU . 8.9 mttt -102.84 149.85 24.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.182 -0.463 . . . . 73.1 110.878 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.617 HD13 ' N ' ' A' ' 30' ' ' ASP . 0.5 OUTLIER -147.1 130.3 16.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 54.35 110.911 179.918 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.617 ' N ' HD13 ' A' ' 29' ' ' LEU . 18.2 m-20 -146.71 126.3 13.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.207 -0.452 . . . . 73.15 110.897 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.794 HD11 ' HB3' ' A' ' 283' ' ' ALA . 2.0 tm? -134.78 125.54 27.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 74.31 110.922 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.522 ' N ' HD13 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -120.86 147.23 45.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.218 -0.446 . . . . 75.13 110.898 179.86 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.9 p -137.2 120.48 16.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.44 . . . . 74.01 111.15 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 40.1 mtpt -115.32 129.99 56.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.245 -0.434 . . . . 74.14 110.917 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -125.44 138.13 54.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 74.32 110.822 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -76.85 60.29 1.73 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.476 . . . . 72.13 110.868 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.446 ' O ' HD22 ' A' ' 39' ' ' LEU . 31.0 m-80 -159.28 23.12 0.19 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 54.03 110.895 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.581 ' HA2' ' O ' ' A' ' 63' ' ' ARG . . . 79.59 -3.73 67.34 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.781 -0.723 . . . . 51.52 112.437 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.446 HD22 ' O ' ' A' ' 37' ' ' ASN . 3.0 mm? -97.39 124.3 41.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.802 0.334 . . . . 73.12 110.899 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -145.26 117.98 8.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.134 -0.484 . . . . 62.21 110.893 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -111.71 123.58 50.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.481 . . . . 70.12 110.902 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.65 120.97 30.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 74.13 111.168 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.9 p -121.37 142.36 50.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 64.03 110.87 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 21.0 m -147.99 136.05 21.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.147 -0.479 . . . . 61.31 110.861 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -172.87 158.85 29.08 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.759 -0.734 . . . . 74.34 112.492 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -138.32 150.69 46.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.911 0.386 . . . . 74.52 110.872 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -121.17 130.74 53.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.475 . . . . 64.1 111.055 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -72.07 118.94 15.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 74.12 110.91 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 33.8 m -58.73 149.68 25.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.47 . . . . 71.21 111.186 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 39.9 40.13 0.67 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 74.13 110.92 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 98.8 m -161.26 126.69 3.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.154 -0.475 . . . . 74.32 111.126 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 71.5 p -76.24 66.8 2.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.251 -0.432 . . . . 75.31 111.153 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.6 ttmt -156.27 104.04 2.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 74.43 110.886 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.2 m -126.47 148.29 31.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.182 -0.463 . . . . 61.55 111.146 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 91.5 m -116.26 126.61 53.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 52.32 111.164 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -127.73 150.8 18.38 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.742 -0.742 . . . . 71.04 112.478 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 78.0 p -146.29 142.23 28.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.918 0.39 . . . . 72.34 110.869 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.516 HD13 ' N ' ' A' ' 59' ' ' GLU . 0.6 OUTLIER -121.88 125.27 46.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.124 -0.489 . . . . 72.31 110.935 179.966 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.516 ' N ' HD13 ' A' ' 58' ' ' LEU . 5.7 pt-20 -124.77 129.47 50.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 73.04 110.902 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.9 t -99.63 128.85 45.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.135 -0.484 . . . . 53.4 111.129 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 71' ' ' PHE . 26.7 ttmt -126.98 154.36 44.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 72.01 110.906 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.434 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 9.4 m-85 -130.38 140.08 50.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.443 . . . . 71.12 110.887 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.581 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 21.7 tpp85 -118.0 103.99 10.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.062 -0.517 . . . . 73.12 110.879 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -106.4 114.66 28.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 74.25 110.895 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 6.0 t -94.41 -167.55 1.68 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.209 -0.45 . . . . 74.1 111.108 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 59.41 30.42 20.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 71.32 110.857 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 179.58 -53.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 65.41 110.949 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 110.51 64.77 0.53 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.732 -0.747 . . . . 65.5 112.505 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.0 mp -134.44 132.33 39.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.88 0.371 . . . . 72.42 110.933 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 44.2 p -136.29 135.1 38.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 63.11 111.167 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.655 ' CD2' HG22 ' A' ' 85' ' ' ILE . 23.7 t80 -117.46 131.14 56.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.241 -0.436 . . . . 74.33 110.899 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.59 HG23 ' HB2' ' A' ' 84' ' ' GLU . 3.8 t -128.56 121.09 27.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 72.22 111.107 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -126.62 130.21 50.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 75.2 110.883 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 5.4 ttpm? -113.0 110.82 21.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.479 . . . . 73.23 110.883 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.421 ' CD1' ' CB ' ' A' ' 81' ' ' LEU . 2.6 t90 -115.67 126.92 54.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 71.5 110.908 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -120.74 136.11 54.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.25 -0.432 . . . . 74.13 110.904 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 9.5 t -70.5 -36.08 73.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 74.24 111.177 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -111.6 -35.37 5.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.207 -0.451 . . . . 72.05 110.886 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -78.88 -154.0 0.07 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 72.51 110.904 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.1 t -78.97 149.39 32.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 64.34 111.135 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.421 ' CB ' ' CD1' ' A' ' 75' ' ' TRP . 0.1 OUTLIER -124.04 117.64 25.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 53.42 110.897 179.962 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.83 170.16 39.03 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.743 -0.742 . . . . 60.22 112.489 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -131.52 159.63 37.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.776 0.322 . . . . 72.44 111.119 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.59 ' HB2' HG23 ' A' ' 72' ' ' THR . 40.4 mt-10 -142.42 144.54 33.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 74.11 110.899 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.655 HG22 ' CD2' ' A' ' 71' ' ' PHE . 1.5 pp -121.61 138.87 50.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 71.51 111.146 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.451 HG22 ' HE2' ' A' ' 96' ' ' LYS . 0.2 OUTLIER -128.46 127.73 43.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 71.35 111.123 179.996 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.424 HG22 ' HB2' ' A' ' 97' ' ' LEU . 3.9 m -128.39 138.36 54.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 75.24 111.099 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -118.47 128.48 54.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.139 -0.482 . . . . 73.22 110.922 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 56.98 39.85 29.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.184 -0.462 . . . . 74.21 110.88 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -66.81 -35.32 79.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.452 . . . . 75.43 110.872 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.3 tt -122.31 -37.12 2.85 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.24 -0.436 . . . . 64.41 110.904 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -146.67 138.4 24.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 72.51 111.112 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -59.73 134.45 57.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.25 -0.432 . . . . 73.01 110.853 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 100.37 -23.45 35.8 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.717 -0.754 . . . . 62.11 112.473 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.472 HD12 ' HB3' ' A' ' 118' ' ' TYR . 4.7 tp -95.62 129.4 42.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.879 0.371 . . . . 51.42 110.898 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.587 ' C ' HD13 ' A' ' 97' ' ' LEU . 8.8 tttm -122.66 131.48 53.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 72.04 110.904 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.587 HD13 ' C ' ' A' ' 96' ' ' LYS . 0.5 OUTLIER -116.82 127.31 54.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.235 -0.439 . . . . 72.55 110.934 179.877 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.446 HG23 HG23 ' A' ' 86' ' ' THR . 2.8 m -129.76 123.53 31.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.203 -0.453 . . . . 73.43 111.127 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.733 ' CD2' HD13 ' A' ' 114' ' ' ILE . 1.1 t80 -110.38 121.97 46.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.459 . . . . 75.54 110.874 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -110.36 124.49 51.8 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.163 -0.472 . . . . 74.34 110.877 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.0 t -124.14 121.45 35.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 73.33 110.865 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 75.7 m -114.88 145.86 41.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 75.13 110.852 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -135.12 137.41 42.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.147 -0.479 . . . . 54.25 110.895 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.7 t -128.41 138.94 34.12 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.681 0.753 . . . . 75.42 110.847 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.79 -23.91 30.13 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.646 2.231 . . . . 73.44 112.319 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -56.2 99.06 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.431 . . . . 75.42 110.877 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 53.2 26.92 5.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 75.31 111.171 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 67.15 24.5 73.35 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.71 -0.757 . . . . 53.25 112.515 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 58.3 tttt -65.43 118.02 8.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.881 0.372 . . . . 72.01 110.87 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 17.6 pttm -122.59 151.09 41.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 73.01 110.893 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -127.2 136.59 52.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 74.4 110.862 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -116.04 131.03 57.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 54.34 111.092 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -138.28 138.68 38.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 62.14 110.865 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.733 HD13 ' CD2' ' A' ' 99' ' ' PHE . 5.4 tp -134.07 127.32 51.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 44.2 111.135 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 7.2 mmtp -119.53 118.86 32.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 73.33 110.885 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.1 t -129.74 119.67 23.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.216 -0.447 . . . . 63.32 111.099 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.483 ' HA3' ' HA2' ' A' ' 126' ' ' GLY . . . -153.29 168.76 32.06 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.693 -0.765 . . . . 72.12 112.476 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.472 ' HB3' HD12 ' A' ' 95' ' ' LEU . 41.7 p90 -133.16 132.05 41.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.971 0.415 . . . . 72.33 110.95 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.733 ' O ' HG11 ' A' ' 3' ' ' VAL . 18.0 mtmm -108.18 119.47 39.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 72.54 110.95 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 43.3 ttt180 -110.14 143.53 40.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.279 -0.419 . . . . 72.51 110.878 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -51.48 -28.01 12.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 74.44 110.901 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 70.7 m80 -89.17 -40.12 13.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 64.43 110.861 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.91 HD13 HD13 ' A' ' 144' ' ' LEU . 2.3 tp -149.23 138.3 15.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 74.12 111.077 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.62 ' H ' HD12 ' A' ' 123' ' ' ILE . 0.3 OUTLIER -105.03 118.66 37.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 65.12 110.851 179.947 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -116.51 140.52 49.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 54.34 110.91 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.483 ' HA2' ' HA3' ' A' ' 117' ' ' GLY . . . -143.29 121.52 1.71 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.749 -0.739 . . . . 40.41 112.476 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -112.47 107.71 16.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.8 0.333 . . . . 74.34 110.881 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -104.92 145.18 30.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.223 -0.444 . . . . 73.32 110.836 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 96.8 mtp -138.68 136.1 35.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 73.14 110.892 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -128.27 135.69 49.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 75.51 110.854 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -95.8 102.38 14.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 64.42 110.9 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.4 149.87 21.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.134 -0.485 . . . . 72.21 110.847 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.538 HD12 ' O ' ' A' ' 133' ' ' ILE . 1.2 tp -52.71 -44.06 45.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 52.4 111.14 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -73.77 -18.93 60.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 54.54 111.084 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 155.24 150.34 5.54 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.797 -0.716 . . . . 72.22 112.504 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 112.37 3.05 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.749 2.3 . . . . 61.22 112.322 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.5 m -81.89 147.55 29.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.442 . . . . 63.42 110.847 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.1 mp -107.28 118.83 55.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 74.51 111.126 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 -106.95 121.85 45.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 72.31 110.83 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -110.99 133.83 11.79 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.778 -0.725 . . . . 63.13 112.503 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -131.38 122.54 26.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.798 0.332 . . . . 72.42 111.082 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.839 HD21 HD11 ' A' ' 123' ' ' ILE . 0.3 OUTLIER -140.39 122.35 15.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.242 -0.436 . . . . 44.21 110.89 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.528 ' HA ' ' HA2' ' A' ' 152' ' ' GLY . 0.7 OUTLIER -133.76 144.93 34.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 62.23 111.1 179.866 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.91 HD13 HD13 ' A' ' 123' ' ' ILE . 3.5 mm? -107.84 139.96 41.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.184 -0.462 . . . . 72.24 110.902 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -110.7 118.7 5.03 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.771 -0.728 . . . . 60.32 112.471 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -122.91 146.38 47.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.901 0.381 . . . . 74.42 110.902 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -50.44 96.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.118 -0.492 . . . . 64.41 110.931 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 93.94 -29.41 8.69 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.783 -0.722 . . . . 73.25 112.475 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 36.6 m95 -102.15 141.7 34.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.833 0.349 . . . . 74.15 110.903 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.444 HD22 HD12 ' A' ' 10' ' ' LEU . 0.4 OUTLIER -134.98 136.61 42.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.436 . . . . 63.31 110.91 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -142.77 143.88 32.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.448 . . . . 75.43 111.082 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.884 ' HA3' HD21 ' A' ' 10' ' ' LEU . . . -153.48 144.09 10.94 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.72 -0.752 . . . . 72.31 112.473 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -145.12 119.21 9.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.849 0.356 . . . . 54.04 110.923 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.402 HE21 ' HB2' ' A' ' 154' ' ' GLN . 0.0 OUTLIER -118.95 123.79 45.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.145 -0.48 . . . . 74.34 110.89 -179.977 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.7 134.68 52.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 44.04 110.894 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.62 ' O ' HG22 ' A' ' 164' ' ' VAL . 27.6 t-20 -112.29 123.07 49.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.253 -0.43 . . . . 71.32 110.876 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.456 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 15.0 t80 -94.4 125.88 39.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 71.44 110.888 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.691 ' OE2' ' HB3' ' A' ' 160' ' ' ALA . 0.1 OUTLIER -79.33 103.16 9.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.136 -0.484 . . . . 72.15 110.904 -179.912 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 75.5 m -65.53 -48.18 73.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 65.14 111.171 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.691 ' HB3' ' OE2' ' A' ' 158' ' ' GLU . . . -48.35 -26.12 1.9 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 74.21 111.103 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 12.1 mmtp -125.79 -168.76 1.89 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 72.11 110.874 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 2.4 m -110.63 40.2 2.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 75.22 110.875 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 2.4 tpp180 -156.67 175.25 14.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.131 -0.486 . . . . 73.42 110.904 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.62 HG22 ' O ' ' A' ' 156' ' ' ASN . 0.9 OUTLIER -74.52 142.5 14.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 64.31 111.124 179.966 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.429 ' HB ' ' HG2' ' A' ' 158' ' ' GLU . 2.5 t -90.63 -34.6 15.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.459 . . . . 75.24 111.14 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -153.99 136.14 14.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.244 -0.434 . . . . 72.33 110.897 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -123.06 127.34 48.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.446 . . . . 70.43 110.858 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -135.68 142.75 45.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 63.23 110.926 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -149.03 140.13 23.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 75.02 110.878 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.546 ' HB3' HD23 ' A' ' 10' ' ' LEU . . . -148.49 129.12 14.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 74.23 111.107 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 7.3 t -148.1 139.59 17.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.451 . . . . 62.13 111.112 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' GLY . . . . . 0.432 ' HA2' HD23 ' A' ' 180' ' ' LEU . . . -165.25 163.83 36.78 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.723 -0.751 . . . . 75.24 112.504 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -118.95 125.09 48.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.946 0.403 . . . . 74.25 110.919 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 39.9 mtpt -101.84 126.14 48.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.132 -0.485 . . . . 65.44 110.926 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.511 ' HB ' ' H ' ' A' ' 178' ' ' PHE . 1.2 m -131.26 165.02 24.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.444 . . . . 70.25 111.112 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.406 ' H ' HG22 ' A' ' 175' ' ' THR . 34.4 t70 -78.14 -7.76 57.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 52.12 110.86 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -118.13 -31.65 4.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.211 -0.45 . . . . 71.05 110.873 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.511 ' H ' ' HB ' ' A' ' 175' ' ' THR . 18.4 p90 -144.54 150.14 37.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 75.4 110.891 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -136.51 123.05 20.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 71.43 110.913 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.466 HD12 HG13 ' A' ' 194' ' ' ILE . 0.3 OUTLIER -124.15 128.26 49.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.211 -0.45 . . . . 65.12 110.943 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 15.7 m170 -131.36 115.01 15.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 73.32 110.865 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' THR . . . . . 0.481 HG22 ' O ' ' A' ' 191' ' ' GLY . 0.2 OUTLIER -101.05 135.55 42.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 54.01 111.144 -179.909 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -128.0 139.25 52.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.441 . . . . 73.31 110.92 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.426 ' O ' HG12 ' A' ' 184' ' ' VAL . 2.8 t -134.33 110.04 13.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 53.21 111.147 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -101.08 89.46 3.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 72.11 110.898 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 65.77 179.46 0.2 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 63.24 110.865 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -73.1 -3.49 60.85 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.684 -0.77 . . . . 71.31 112.466 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 5.7 m -95.96 -25.54 15.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.804 0.335 . . . . 61.43 111.174 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -121.95 112.49 18.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.192 -0.458 . . . . 72.42 110.903 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -138.85 123.41 18.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.135 -0.484 . . . . 75.31 110.883 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' GLY . . . . . 0.481 ' O ' HG22 ' A' ' 182' ' ' THR . . . 174.17 -154.86 20.35 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.715 -0.755 . . . . 43.13 112.456 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -176.56 -163.2 28.55 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.743 -0.741 . . . . 75.04 112.471 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' SER . . . . . 0.595 ' C ' HD12 ' A' ' 194' ' ' ILE . 11.4 p -148.39 155.47 41.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.857 0.361 . . . . 64.24 110.868 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.595 HD12 ' C ' ' A' ' 193' ' ' SER . 3.5 mp -131.62 120.27 44.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.122 -0.49 . . . . 43.51 111.104 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -108.87 121.05 44.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.188 -0.46 . . . . 74.2 110.922 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -125.52 131.52 52.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.476 . . . . 61.32 110.891 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 1.8 tppp? -96.04 127.66 42.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 72.21 110.863 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.501 HG12 ' HB2' ' A' ' 201' ' ' LYS . 34.5 t -85.73 117.36 30.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.44 . . . . 74.24 111.135 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -49.82 132.96 22.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 74.43 110.867 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp 51.05 33.82 9.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 61.44 110.893 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' LYS . . . . . 0.501 ' HB2' HG12 ' A' ' 198' ' ' VAL . 4.8 mmtp -153.83 -167.31 2.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 75.43 110.861 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.509 HD12 ' O ' ' A' ' 203' ' ' GLU . 1.4 pp -79.19 -168.49 1.51 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.45 . . . . 72.24 110.936 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.509 ' O ' HD12 ' A' ' 202' ' ' LEU . 12.0 mt-10 -115.11 136.15 53.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 64.21 110.884 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 11.5 t -123.96 138.78 54.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.12 -0.491 . . . . 45.15 111.143 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -145.01 163.49 34.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.434 . . . . 72.01 111.117 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 1.7 m -133.58 149.08 30.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.255 -0.429 . . . . 54.32 111.094 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -113.91 131.52 56.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 73.11 110.89 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -119.71 129.93 54.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 62.2 110.955 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.603 ' HB3' ' HB3' ' A' ' 218' ' ' ARG . . . -138.42 130.77 28.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.446 . . . . 73.51 111.1 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 11.7 t90 -130.09 123.21 29.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 72.14 110.9 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 94.5 m -112.22 110.51 20.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.264 -0.425 . . . . 73.12 111.173 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -51.4 128.09 21.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.263 -0.426 . . . . 64.34 111.095 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 163.78 -73.66 0.18 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.749 -0.738 . . . . 64.5 112.514 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 65.9 m-80 -125.61 33.79 5.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.804 0.335 . . . . 75.14 110.861 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 43.4 m 51.43 52.77 14.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.452 . . . . 50.03 110.858 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -94.69 112.0 23.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.122 -0.49 . . . . 64.2 110.938 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 2.5 p -94.29 135.63 35.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 74.14 111.121 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 218' ' ' ARG . . . . . 0.603 ' HB3' ' HB3' ' A' ' 209' ' ' ALA . 17.7 tpp85 -117.41 119.18 34.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 74.3 110.845 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 219' ' ' PHE . . . . . 0.504 ' CE2' HD11 ' A' ' 221' ' ' ILE . 21.4 t80 -122.83 137.6 54.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 74.01 110.893 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -145.69 159.17 27.87 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.767 -0.73 . . . . 22.01 112.52 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.504 HD11 ' CE2' ' A' ' 219' ' ' PHE . 4.7 mp -137.29 130.46 43.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.828 0.347 . . . . 71.44 111.133 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -124.89 141.52 52.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 73.21 111.117 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.481 ' HB3' ' HB3' ' A' ' 235' ' ' ALA . . . -116.08 134.84 54.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.243 -0.435 . . . . 64.41 111.1 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 11.1 mttt -120.64 115.44 23.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 73.23 110.905 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -130.75 128.66 41.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.232 -0.44 . . . . 73.45 110.899 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -111.92 115.99 29.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.158 -0.474 . . . . 71.42 110.941 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 8.1 tp -103.05 -35.21 3.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 71.42 111.128 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 228' ' ' ASP . . . . . 0.684 ' HB2' ' HB3' ' A' ' 231' ' ' ALA . 2.7 m-20 -130.24 160.6 64.82 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.64 0.733 . . . . 74.41 110.857 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.72 -32.58 18.45 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.684 2.256 . . . . 74.1 112.312 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -107.19 10.27 30.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 74.44 110.838 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.684 ' HB3' ' HB2' ' A' ' 228' ' ' ASP . . . -141.41 127.18 19.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 61.3 111.123 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 42.4 t -134.47 141.97 46.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.255 -0.429 . . . . 63.54 110.924 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -112.25 130.24 56.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 74.11 110.873 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 84.2 p -129.51 140.62 51.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.464 . . . . 54.33 110.885 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 235' ' ' ALA . . . . . 0.481 ' HB3' ' HB3' ' A' ' 223' ' ' ALA . . . -127.01 159.29 34.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 73.3 111.126 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.77 147.81 21.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.217 -0.447 . . . . 72.34 110.917 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 242' ' ' LEU . 5.4 p -144.86 142.69 22.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.444 . . . . 55.43 111.15 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -106.54 147.64 29.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 75.44 110.92 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -54.71 -21.01 9.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.185 -0.461 . . . . 70.21 110.9 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 3.7 m -81.7 26.28 0.5 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.459 . . . . 64.51 110.874 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 6.8 t 59.98 39.33 20.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.081 -0.509 . . . . 53.12 110.854 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 242' ' ' LEU . . . . . 0.458 ' O ' HG23 ' A' ' 237' ' ' VAL . 18.4 mt -98.91 124.9 44.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.12 -0.491 . . . . 71.43 110.903 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.467 ' H ' HD12 ' A' ' 243' ' ' ILE . 3.0 mp -99.83 118.73 46.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 71.42 111.09 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 244' ' ' GLY . . . . . 0.519 ' C ' HD13 ' A' ' 245' ' ' LEU . . . -129.49 138.75 10.45 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.714 -0.755 . . . . 73.33 112.471 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.665 ' N ' HD13 ' A' ' 245' ' ' LEU . 0.0 OUTLIER -145.92 158.93 43.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.865 0.364 . . . . 75.51 110.865 -179.885 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -162.57 144.27 9.49 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.719 -0.753 . . . . 55.14 112.443 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -128.31 131.84 48.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.99 0.424 . . . . 65.2 110.894 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 27.6 p -115.5 117.77 31.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.076 -0.511 . . . . 62.25 111.124 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -129.38 131.48 46.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 74.42 110.899 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 3.7 m -59.74 148.43 34.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 75.23 111.167 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 46.0 tp -78.58 -73.33 0.33 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 72.01 110.904 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 252' ' ' LYS . . . . . 0.47 ' N ' ' HD2' ' A' ' 253' ' ' PRO . 0.1 OUTLIER 179.29 -60.66 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.558 0.694 . . . . 65.13 110.882 179.848 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 253' ' ' PRO . . . . . 0.574 ' HG2' HD12 ' A' ' 255' ' ' ILE . 54.0 Cg_endo -69.77 -86.4 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.679 2.253 . . . . 71.52 112.395 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 254' ' ' GLY . . . . . 0.573 ' O ' ' HB3' ' A' ' 281' ' ' PHE . . . -146.7 33.9 1.38 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.746 -0.74 . . . . 55.3 112.499 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.574 HD12 ' HG2' ' A' ' 253' ' ' PRO . 3.6 mp -131.01 145.3 35.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.893 0.377 . . . . 63.22 111.093 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 279' ' ' LEU . 19.7 ttpp -113.12 135.41 53.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 71.51 110.882 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 0.773 ' HA ' HD12 ' A' ' 279' ' ' LEU . 5.1 tp -96.74 124.35 40.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 74.51 110.879 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 258' ' ' THR . . . . . 0.417 ' N ' HD12 ' A' ' 257' ' ' LEU . 2.8 p -124.29 122.34 37.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.161 -0.472 . . . . 72.14 111.115 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.789 HD22 HD23 ' A' ' 277' ' ' LEU . 0.1 OUTLIER -116.58 126.53 53.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 74.02 110.92 179.938 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.436 ' O ' HD22 ' A' ' 275' ' ' LEU . 27.7 p -124.92 145.84 49.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 62.1 110.878 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 261' ' ' ALA . . . . . 0.426 ' HB3' ' CD2' ' A' ' 245' ' ' LEU . . . -147.99 135.25 20.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 70.11 111.112 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.691 ' C ' HD13 ' A' ' 263' ' ' LEU . 2.4 tm? -125.41 122.22 36.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.453 . . . . 71.11 110.877 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 263' ' ' LEU . . . . . 0.829 ' HB3' HG11 ' A' ' 268' ' ' VAL . 0.2 OUTLIER -120.03 109.86 15.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 73.3 110.929 179.855 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 264' ' ' ASP . . . . . 0.639 ' O ' HG22 ' A' ' 268' ' ' VAL . 0.8 OUTLIER -82.72 116.95 22.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.184 -0.462 . . . . 74.25 110.831 179.844 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -54.41 -21.15 19.09 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.744 -0.741 . . . . 72.25 112.464 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.77 -26.56 20.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.839 0.352 . . . . 74.43 110.912 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 13.8 m-20 -95.42 -57.86 2.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.194 -0.457 . . . . 62.11 110.926 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 268' ' ' VAL . . . . . 0.829 HG11 ' HB3' ' A' ' 263' ' ' LEU . 11.7 m -51.6 -29.34 9.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.469 . . . . 62.45 111.104 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -53.02 -36.43 60.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 62.31 110.89 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -103.65 -17.69 15.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 75.24 111.144 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 124.73 100.75 1.34 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.691 -0.766 . . . . 74.23 112.45 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 168.16 92.74 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.722 -0.752 . . . . 73.14 112.493 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 19.2 p80 -111.9 144.64 40.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.899 0.38 . . . . 75.24 110.83 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -102.26 137.34 40.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 65.13 110.935 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.745 HD13 ' N ' ' A' ' 276' ' ' GLY . 2.9 tm? -135.94 144.11 45.28 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.253 -0.43 . . . . 74.22 110.927 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 276' ' ' GLY . . . . . 0.745 ' N ' HD13 ' A' ' 275' ' ' LEU . . . -147.52 133.65 4.81 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.694 -0.765 . . . . 31.44 112.492 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.918 HD12 HG23 ' A' ' 27' ' ' ILE . 2.8 tm? -125.81 135.23 51.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.819 0.342 . . . . 70.14 110.913 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 278' ' ' GLY . . . . . 0.73 ' C ' HD13 ' A' ' 279' ' ' LEU . . . -161.59 140.08 6.4 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.694 -0.765 . . . . 45.12 112.488 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.773 HD12 ' HA ' ' A' ' 257' ' ' LEU . 0.0 OUTLIER -119.59 129.86 54.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.809 0.337 . . . . 72.43 110.899 -179.938 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 280' ' ' GLU . . . . . 0.494 ' O ' ' HB2' ' A' ' 281' ' ' PHE . 2.5 pp20? -141.94 146.41 35.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.47 . . . . 71.12 110.899 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 281' ' ' PHE . . . . . 0.573 ' HB3' ' O ' ' A' ' 254' ' ' GLY . 0.3 OUTLIER 172.08 -150.75 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.155 -0.475 . . . . 65.21 110.894 -179.88 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -138.55 144.68 40.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 73.32 110.891 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.794 ' HB3' HD11 ' A' ' 31' ' ' LEU . . . -113.09 112.6 24.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.45 . . . . 72.41 111.128 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 12.7 mt -130.41 178.63 6.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 61.34 110.878 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 71.41 110.909 179.943 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.834 0.35 . . . . 72.01 111.111 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.1 t 61.18 75.62 0.44 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.668 0.747 . . . . 63.04 111.083 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 167.91 23.06 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.667 2.244 . . . . 63.32 112.362 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 108.97 2.2 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.734 2.289 . . . . 73.12 112.326 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.483 HG23 HG11 ' A' ' 143' ' ' VAL . 12.3 t -107.15 -28.47 9.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 74.05 111.138 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.755 ' CB ' HG21 ' A' ' 143' ' ' VAL . 32.9 p90 -55.53 -30.59 61.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.25 -0.432 . . . . 73.42 110.92 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -72.26 -19.4 61.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.108 -0.497 . . . . 64.5 111.114 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -95.03 11.9 30.4 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.243 -0.435 . . . . 74.21 110.878 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.677 HD21 ' HA3' ' A' ' 152' ' ' GLY . 0.8 OUTLIER -60.56 -33.05 72.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.211 -0.45 . . . . 70.25 110.87 -179.929 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -136.17 31.28 2.63 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.758 -0.734 . . . . 72.25 112.488 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.3 mmtt -69.58 -54.5 13.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.78 0.324 . . . . 62.5 110.88 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.9 t -60.25 -39.72 87.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.252 -0.431 . . . . 60.43 110.873 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.56 -37.62 76.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 74.0 111.113 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -61.05 -32.66 72.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 72.43 110.859 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -58.38 -48.45 80.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 60.54 110.866 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.5 t -80.43 -36.91 16.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 64.41 111.128 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -63.33 -34.98 78.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 74.03 110.888 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.2 m 65.06 80.51 0.23 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 70.15 111.159 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -57.77 -34.61 69.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.251 -0.431 . . . . 74.24 110.855 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -51.5 106.82 0.34 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.72 -0.753 . . . . 23.51 112.462 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -58.43 151.69 19.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.886 0.374 . . . . 74.25 110.942 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -133.8 69.26 0.53 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.727 -0.749 . . . . 43.53 112.531 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -91.95 13.71 17.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.906 0.384 . . . . 63.45 110.915 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.07 14.6 64.2 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.713 -0.756 . . . . 74.23 112.498 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.591 ' C ' HD12 ' A' ' 27' ' ' ILE . 1.2 pp -118.98 -179.1 3.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.762 0.315 . . . . 53.52 110.918 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.591 HD12 ' C ' ' A' ' 26' ' ' LEU . 1.6 mp -109.99 131.8 59.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 70.43 111.132 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.447 ' HG2' ' HA2' ' A' ' 278' ' ' GLY . 6.4 ptmm? -115.91 138.22 51.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 72.35 110.904 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.679 HD13 ' N ' ' A' ' 30' ' ' ASP . 3.2 tm? -123.67 136.45 54.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.235 -0.439 . . . . 70.4 110.891 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.679 ' N ' HD13 ' A' ' 29' ' ' LEU . 0.8 OUTLIER -126.76 127.78 45.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.469 . . . . 71.22 110.871 179.856 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.743 HD22 ' HB3' ' A' ' 281' ' ' PHE . 0.2 OUTLIER -115.75 125.1 52.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 65.31 110.902 -179.967 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.472 ' HD2' HG23 ' A' ' 42' ' ' THR . 5.3 tptp -123.57 125.09 44.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 63.34 110.866 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.9 m -135.42 120.67 18.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 71.12 111.14 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -134.22 125.6 28.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 61.54 110.875 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 38.4 t -127.24 143.7 51.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 71.44 110.859 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -76.59 58.72 1.41 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 73.03 110.885 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -147.67 16.96 1.13 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.146 -0.479 . . . . 73.55 110.865 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.555 ' HA2' ' O ' ' A' ' 63' ' ' ARG . . . 82.94 -5.3 76.55 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.729 -0.748 . . . . 62.21 112.489 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -101.14 126.22 47.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.8 0.333 . . . . 42.04 110.904 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.407 ' HB2' ' O ' ' A' ' 61' ' ' LYS . 0.8 OUTLIER -139.46 117.68 11.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.168 -0.469 . . . . 74.31 110.885 179.934 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.415 ' CZ ' HD21 ' A' ' 58' ' ' LEU . 5.4 t80 -107.07 121.48 44.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.122 -0.49 . . . . 61.4 110.887 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.472 HG23 ' HD2' ' A' ' 32' ' ' LYS . 3.9 m -127.96 115.15 18.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.141 -0.481 . . . . 73.34 111.183 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -122.05 141.7 51.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 72.51 110.864 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.4 p -151.01 126.41 10.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.464 . . . . 62.02 110.892 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -166.41 165.5 38.32 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.722 -0.751 . . . . 71.53 112.48 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 82.8 p -137.25 168.96 18.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.896 0.379 . . . . 53.12 110.876 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -158.63 140.57 13.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 51.14 111.118 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 46.0 t-20 -101.26 141.9 33.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.242 -0.435 . . . . 73.25 110.832 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.5 t -92.7 -35.24 13.58 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.168 -0.469 . . . . 64.31 111.165 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.85 -63.48 1.15 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.227 -0.442 . . . . 75.11 110.89 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.18 149.91 33.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.125 -0.489 . . . . 73.23 111.108 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.3 t -59.09 110.69 1.1 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.172 -0.467 . . . . 64.54 111.155 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.6 mtpm? -166.53 99.9 0.59 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.242 -0.436 . . . . 74.24 110.949 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 24.2 t -122.5 133.49 68.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.245 -0.434 . . . . 53.21 111.125 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.0 m -136.04 134.56 38.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.165 -0.47 . . . . 63.3 111.132 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -142.8 140.48 9.84 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.699 -0.762 . . . . 73.35 112.441 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.6 p -133.18 144.52 49.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.903 0.383 . . . . 72.11 110.839 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.606 HD13 ' N ' ' A' ' 59' ' ' GLU . 0.3 OUTLIER -120.92 134.51 55.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.108 -0.496 . . . . 72.05 110.903 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.606 ' N ' HD13 ' A' ' 58' ' ' LEU . 2.0 tt0 -134.33 123.05 23.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 74.21 110.888 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 23.1 p -107.0 134.0 50.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 41.45 111.095 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.407 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 47.6 mttt -133.41 159.68 39.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 52.23 110.931 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.521 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 9.2 t80 -121.06 129.67 53.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 73.42 110.892 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.555 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 3.9 ttt85 -112.9 103.43 11.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 74.52 110.865 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -112.73 98.65 7.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.188 -0.46 . . . . 62.21 110.933 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 60.68 163.43 0.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 62.31 111.156 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -78.78 145.16 34.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.248 -0.433 . . . . 73.13 110.877 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 26.0 p90 37.81 43.35 0.49 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.177 -0.465 . . . . 64.42 110.872 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.644 ' O ' HD22 ' A' ' 69' ' ' LEU . . . -123.75 -78.93 0.41 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.743 -0.742 . . . . 70.33 112.445 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.644 HD22 ' O ' ' A' ' 68' ' ' GLY . 3.4 mm? -134.59 129.06 34.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.914 0.387 . . . . 53.43 110.883 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.8 m -138.61 114.89 10.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.157 -0.474 . . . . 73.41 111.136 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.475 ' HA ' HG22 ' A' ' 85' ' ' ILE . 12.8 m-85 -99.39 132.89 44.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 71.03 110.894 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.73 119.87 31.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.122 -0.49 . . . . 53.4 111.181 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -131.52 122.56 26.36 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.196 -0.456 . . . . 34.55 110.902 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -106.38 137.49 44.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.153 -0.476 . . . . 71.13 110.908 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 9.8 t90 -134.53 128.75 33.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.456 . . . . 71.15 110.887 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 28.9 t30 -117.13 155.41 29.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 63.25 110.908 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 12.3 m -60.36 -18.12 48.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 73.42 111.127 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.417 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 9.0 m-20 -74.63 0.37 15.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 71.43 110.863 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.417 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 4.1 m120 77.16 38.55 0.23 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.198 -0.455 . . . . 60.24 110.885 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 28.3 m -114.83 125.63 53.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.455 . . . . 74.31 111.157 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.6 mp -114.14 127.35 55.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.294 -0.412 . . . . 74.34 110.939 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -113.42 107.71 1.98 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.788 -0.72 . . . . 72.22 112.489 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.1 m -87.52 131.45 34.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.713 0.292 . . . . 73.25 111.16 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -159.99 96.68 1.23 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 73.35 110.893 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.475 HG22 ' HA ' ' A' ' 71' ' ' PHE . 1.1 pp -111.6 138.65 39.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 61.13 111.172 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.687 HG23 ' OG1' ' A' ' 98' ' ' THR . 1.6 m -118.11 139.57 51.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 53.24 111.119 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.57 HG12 ' CD1' ' A' ' 69' ' ' LEU . 2.2 m -129.39 139.62 51.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 74.25 111.155 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 -97.8 129.18 44.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 73.35 110.926 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -50.56 168.61 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.199 -0.455 . . . . 74.12 110.893 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -123.45 -35.58 2.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 63.31 110.911 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 92.5 mt -96.79 -70.12 0.73 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.245 -0.434 . . . . 71.54 110.945 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.86 78.03 1.15 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 65.41 111.07 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 9.2 ptp85 -49.29 135.32 17.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.467 . . . . 73.32 110.889 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 101.59 9.29 44.11 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.715 -0.755 . . . . 65.52 112.531 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.605 HD12 ' N ' ' A' ' 96' ' ' LYS . 8.7 tp -114.93 129.15 56.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.898 0.38 . . . . 75.24 110.891 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.605 ' N ' HD12 ' A' ' 95' ' ' LEU . 31.5 pttt -124.56 136.19 53.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 74.54 110.897 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.582 HD13 ' O ' ' A' ' 96' ' ' LYS . 1.9 mm? -124.8 126.72 46.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 74.21 110.877 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.687 ' OG1' HG23 ' A' ' 86' ' ' THR . 7.6 m -125.61 139.41 53.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.462 . . . . 73.21 111.131 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.459 ' CE2' HD13 ' A' ' 114' ' ' ILE . 24.6 m-85 -116.02 123.01 46.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.252 -0.431 . . . . 64.12 110.841 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -113.97 130.29 56.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.112 -0.494 . . . . 73.1 110.855 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.5 m -142.41 134.07 26.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.475 . . . . 72.54 110.851 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.6 t -95.81 126.17 40.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.115 -0.493 . . . . 74.14 110.857 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -118.34 119.65 35.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.097 -0.502 . . . . 75.22 110.869 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.433 ' HA ' ' HD2' ' A' ' 105' ' ' PRO . 1.7 t -128.83 101.39 20.28 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.61 0.719 . . . . 72.5 110.919 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 104' ' ' SER . 53.4 Cg_endo -69.79 -32.89 17.56 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.681 2.254 . . . . 65.21 112.301 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 16.9 t30 -51.56 -74.25 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.269 -0.423 . . . . 54.11 110.916 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 6.0 m -77.02 -33.57 57.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 74.32 111.139 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.61 23.92 14.94 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.773 -0.727 . . . . 54.21 112.51 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -94.48 147.02 23.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.853 0.359 . . . . 74.41 110.907 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 27.6 ttpt -133.42 140.88 47.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.218 -0.446 . . . . 71.24 110.938 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -120.94 136.22 55.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 70.24 110.938 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -110.57 125.28 53.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 70.41 111.094 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 17.4 mtmt -138.87 138.23 37.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 73.12 110.888 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.459 HD13 ' CE2' ' A' ' 99' ' ' PHE . 5.7 tp -121.99 139.86 47.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.212 -0.449 . . . . 64.12 111.092 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.45 ' H ' HD12 ' A' ' 114' ' ' ILE . 19.8 ttpt -130.06 118.87 22.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.166 -0.47 . . . . 73.23 110.899 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.415 HG23 ' O ' ' A' ' 116' ' ' THR . 4.8 t -130.9 118.6 20.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.446 . . . . 73.11 111.13 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.472 ' HA3' ' HA2' ' A' ' 126' ' ' GLY . . . -152.99 159.14 28.32 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.695 -0.764 . . . . 24.11 112.476 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -129.34 138.34 51.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.982 0.42 . . . . 73.24 110.912 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 36.2 pttt -109.82 121.15 44.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.115 -0.493 . . . . 74.43 110.891 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 6.8 tpt180 -109.53 143.88 38.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 74.52 110.885 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -50.73 -28.31 8.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 72.25 110.881 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 59.2 m-70 -88.45 -41.97 12.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 75.34 110.897 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.687 ' CD1' HD22 ' A' ' 144' ' ' LEU . 2.2 tt -151.67 145.03 16.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 73.11 111.198 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -113.73 116.02 28.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 74.53 110.822 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.559 HD23 ' HG ' ' A' ' 142' ' ' LEU . 2.0 mt -119.24 141.45 48.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.472 . . . . 75.14 110.895 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.472 ' HA2' ' HA3' ' A' ' 117' ' ' GLY . . . -145.96 125.91 2.4 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.721 -0.752 . . . . 74.35 112.457 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 8.3 t -114.51 119.46 36.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.816 0.341 . . . . 53.31 110.883 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -118.9 146.58 44.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.466 . . . . 72.12 110.867 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 7.8 ttt -136.62 136.27 39.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.203 -0.453 . . . . 75.44 110.869 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -110.86 124.99 53.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.173 -0.467 . . . . 71.12 110.883 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -95.53 98.2 10.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 74.22 110.886 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -103.92 169.65 8.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.139 -0.482 . . . . 65.24 110.898 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 2.5 pp -74.91 -35.61 36.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 75.24 111.121 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -77.06 -20.27 56.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 74.12 111.07 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 154.16 149.64 5.28 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.705 -0.759 . . . . 62.13 112.467 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 114.5 3.73 Favored 'Trans proline' 0 C--O 1.231 0.146 0 C-N-CA 122.69 2.26 . . . . 73.35 112.315 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.64 148.76 30.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.211 -0.449 . . . . 75.03 110.915 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 5.3 mp -106.3 122.84 60.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.19 -0.459 . . . . 62.0 111.145 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 3.9 ttm105 -121.56 114.55 21.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 71.14 110.874 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -110.63 133.96 11.89 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.732 -0.747 . . . . 74.34 112.478 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -132.91 116.31 16.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.815 0.341 . . . . 54.52 111.109 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.74 HD22 HD21 ' A' ' 144' ' ' LEU . 0.2 OUTLIER -121.97 125.23 45.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.161 -0.472 . . . . 61.32 110.878 -179.939 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.798 ' C ' HD23 ' A' ' 144' ' ' LEU . 40.7 t -131.19 123.17 52.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 73.31 111.151 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.798 HD23 ' C ' ' A' ' 143' ' ' VAL . 0.3 OUTLIER -116.85 156.32 27.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 73.12 110.934 179.996 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -106.71 133.05 11.44 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.746 -0.74 . . . . 72.24 112.465 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.413 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 0.2 OUTLIER -128.58 147.88 50.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.823 0.344 . . . . 74.3 110.874 -179.765 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 48.7 tt0 -57.35 97.99 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.077 -0.511 . . . . 74.51 110.826 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.535 ' O ' ' HB3' ' A' ' 173' ' ' TYR . . . 86.04 -15.9 45.93 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.74 -0.743 . . . . 73.23 112.505 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.413 ' O ' ' CB ' ' A' ' 146' ' ' TYR . 5.1 m95 -123.61 146.68 47.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.78 0.324 . . . . 71.13 110.929 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.712 ' N ' ' HB2' ' A' ' 173' ' ' TYR . 13.0 tp -108.75 156.45 19.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.264 -0.426 . . . . 70.5 110.899 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.465 ' HB3' ' HB2' ' A' ' 144' ' ' LEU . . . -127.64 131.31 49.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.191 -0.459 . . . . 73.15 111.127 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.677 ' HA3' HD21 ' A' ' 10' ' ' LEU . . . -155.64 133.24 3.66 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.748 -0.739 . . . . 41.22 112.474 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -145.81 118.81 8.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.81 0.338 . . . . 73.11 110.941 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -122.43 123.13 40.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.096 -0.502 . . . . 74.04 110.883 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 97.8 mtp -133.57 134.89 43.89 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.172 -0.467 . . . . 61.22 110.873 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.478 ' O ' ' HB ' ' A' ' 164' ' ' VAL . 4.9 m120 -112.36 117.48 32.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 55.42 110.899 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.493 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 0.2 OUTLIER -87.23 125.69 34.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 74.11 110.882 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.719 ' OE1' ' HB3' ' A' ' 160' ' ' ALA . 0.2 OUTLIER -82.39 108.15 15.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.13 -0.486 . . . . 75.22 110.943 -179.951 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.488 HG23 ' N ' ' A' ' 160' ' ' ALA . 6.0 t -66.14 -47.14 75.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.476 . . . . 74.24 111.152 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.719 ' HB3' ' OE1' ' A' ' 158' ' ' GLU . . . -50.71 -26.17 5.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 71.01 111.063 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 10.6 mmtt -120.93 -167.72 1.54 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.244 -0.434 . . . . 54.44 110.889 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 50.1 m -112.92 39.29 2.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 62.45 110.885 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.66 174.88 9.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 73.12 110.853 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.493 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 1.0 OUTLIER -78.63 146.0 8.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 75.25 111.167 179.925 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.464 HG23 ' HG2' ' A' ' 166' ' ' GLN . 15.3 t -88.32 -34.11 17.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 74.13 111.109 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' GLN . . . . . 0.464 ' HG2' HG23 ' A' ' 165' ' ' THR . 30.1 pt20 -152.7 132.74 13.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 73.12 110.945 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 3.8 m -126.06 125.78 43.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 74.42 110.858 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 15.1 p-10 -135.72 137.02 41.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 54.24 110.891 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -131.64 150.26 52.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.459 . . . . 61.35 110.88 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -150.33 129.46 12.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.485 . . . . 55.24 111.068 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -145.69 138.5 20.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.157 -0.474 . . . . 73.54 111.123 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' GLY . . . . . 0.454 ' O ' ' HB3' ' A' ' 150' ' ' LEU . . . 136.69 146.25 5.14 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.747 -0.74 . . . . 52.45 112.478 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' TYR . . . . . 0.712 ' HB2' ' N ' ' A' ' 150' ' ' LEU . 5.0 t80 -151.04 177.56 10.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.008 0.433 . . . . 75.44 110.88 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -97.1 136.08 38.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.105 -0.498 . . . . 71.33 110.895 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.651 ' O ' ' C ' ' A' ' 176' ' ' ASP . 0.2 OUTLIER -122.86 165.54 16.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.224 -0.443 . . . . 73.33 111.156 179.979 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.651 ' C ' ' O ' ' A' ' 175' ' ' THR . 2.0 m-20 -9.5 -86.72 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.25 -0.432 . . . . 73.22 110.869 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -120.35 12.95 11.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 53.3 110.884 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -130.2 116.58 18.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 74.12 110.889 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -114.13 124.2 51.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.135 -0.484 . . . . 62.03 110.91 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.525 HD13 ' C ' ' A' ' 180' ' ' LEU . 3.3 tm? -122.07 120.99 35.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 73.44 110.936 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 181' ' ' HIS . . . . . 0.415 ' HA ' ' HA3' ' A' ' 172' ' ' GLY . 0.1 OUTLIER -123.71 145.75 48.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 72.34 110.869 179.901 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.89 136.72 23.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 73.15 111.102 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 22.1 m120 -132.65 140.04 48.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 72.43 110.853 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.458 ' O ' HG12 ' A' ' 184' ' ' VAL . 2.5 t -132.74 110.38 15.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 71.42 111.117 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -99.0 90.07 4.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 72.13 110.893 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 186' ' ' ASP . . . . . 0.542 ' HB2' HG22 ' A' ' 188' ' ' THR . 1.0 OUTLIER 66.2 176.86 0.22 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.177 -0.465 . . . . 43.24 110.86 179.911 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -73.22 -2.2 58.44 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.737 -0.744 . . . . 63.53 112.52 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 188' ' ' THR . . . . . 0.542 HG22 ' HB2' ' A' ' 186' ' ' ASP . 7.7 t -98.4 -25.35 14.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.742 0.306 . . . . 53.12 111.12 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -121.94 115.27 22.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 72.54 110.926 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -140.81 124.47 16.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 75.44 110.883 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -175.55 -161.6 25.25 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.756 -0.735 . . . . 33.14 112.503 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -175.33 -172.05 39.87 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.767 -0.73 . . . . 52.11 112.529 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 34.3 m -147.63 148.42 31.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.796 0.331 . . . . 75.21 110.877 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.404 ' N ' HD12 ' A' ' 194' ' ' ILE . 4.7 mp -119.63 130.96 73.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.12 -0.491 . . . . 75.04 111.168 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 195' ' ' TYR . . . . . 0.464 ' CD1' ' HB2' ' A' ' 205' ' ' ALA . 5.4 t80 -119.24 126.05 50.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.198 -0.455 . . . . 75.41 110.942 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 3.7 tm0? -124.75 131.13 53.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.095 -0.502 . . . . 54.43 110.881 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 36.0 mttt -100.64 127.23 47.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 63.5 110.873 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 16.4 t -80.33 152.63 4.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.27 -0.423 . . . . 75.42 111.174 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -51.15 -37.9 48.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 75.44 110.908 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.75 -170.4 2.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 51.25 110.92 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 201' ' ' LYS . . . . . 0.65 ' C ' HD12 ' A' ' 202' ' ' LEU . 1.6 ptmt -76.71 64.67 2.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 72.4 110.926 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.65 HD12 ' C ' ' A' ' 201' ' ' LYS . 6.3 mp -145.62 128.45 16.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.236 -0.438 . . . . 62.32 110.915 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -120.61 130.07 54.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.15 -0.477 . . . . 72.21 110.889 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 2.3 t -132.23 138.31 47.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 70.41 111.091 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.464 ' HB2' ' CD1' ' A' ' 195' ' ' TYR . . . -149.69 156.7 42.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 74.24 111.111 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.761 HG12 HG22 ' A' ' 221' ' ' ILE . 1.3 m -126.08 147.21 30.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 41.12 111.173 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -117.92 127.96 54.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.454 . . . . 72.3 110.923 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 2.2 mp -125.7 147.03 49.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 64.41 110.877 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -157.24 131.55 8.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 63.22 111.105 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 21.5 t90 -129.91 133.56 46.93 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.26 -0.427 . . . . 70.42 110.927 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -101.09 103.68 14.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.25 -0.432 . . . . 61.14 111.152 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -53.26 140.88 25.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.26 -0.427 . . . . 73.23 111.111 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 134.74 -72.76 0.46 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.689 -0.767 . . . . 42.44 112.481 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -171.79 36.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.793 0.33 . . . . 51.44 110.882 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 32.8 t -111.85 165.33 12.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 44.5 110.852 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -88.16 162.59 16.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 64.22 110.866 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 2.9 m -78.11 137.96 38.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 64.45 111.172 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 33.4 ttp180 -102.95 129.06 49.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 74.23 110.872 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -134.0 133.25 41.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 65.21 110.86 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -143.53 145.46 15.26 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.72 -0.752 . . . . 50.2 112.5 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.761 HG22 HG12 ' A' ' 206' ' ' VAL . 0.0 OUTLIER -122.14 138.32 52.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.863 0.363 . . . . 54.05 111.173 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -138.12 153.22 49.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.451 . . . . 73.11 111.13 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.457 ' HB1' ' CZ ' ' A' ' 225' ' ' TYR . . . -145.49 157.72 43.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.239 -0.437 . . . . 71.22 111.097 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 3.1 tttm -142.94 124.41 14.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.441 . . . . 73.32 110.861 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 225' ' ' TYR . . . . . 0.609 ' CE1' HD23 ' A' ' 202' ' ' LEU . 8.7 m-85 -133.6 133.93 42.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 62.42 110.938 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 7.9 mm-40 -79.15 130.71 35.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.139 -0.482 . . . . 72.02 110.894 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 227' ' ' ILE . . . . . 0.937 HG23 ' HD2' ' A' ' 229' ' ' PRO . 1.3 tp -77.41 -38.34 26.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.469 . . . . 43.4 111.108 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 228' ' ' ASP . . . . . 0.48 ' N ' ' HD2' ' A' ' 229' ' ' PRO . 0.3 OUTLIER 172.12 -60.91 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.6 0.714 . . . . 72.4 110.863 179.884 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.937 ' HD2' HG23 ' A' ' 227' ' ' ILE . 53.8 Cg_endo -69.76 -157.52 0.04 OUTLIER 'Trans proline' 0 C--O 1.231 0.148 0 C-N-CA 122.722 2.281 . . . . 72.24 112.315 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -85.37 15.23 4.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 72.44 110.906 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.66 ' HB2' ' HG3' ' A' ' 249' ' ' GLN . . . -120.59 122.0 39.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 75.54 111.078 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 13.0 p -112.79 144.56 42.12 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.444 . . . . 71.41 110.864 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -97.2 127.64 43.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 74.23 110.888 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 1.2 t -117.54 137.15 52.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.126 -0.488 . . . . 52.2 110.807 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -130.67 141.27 50.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 53.33 111.094 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 7.7 pttm -144.45 165.06 29.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 61.14 110.884 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 242' ' ' LEU . 8.7 p -154.93 146.23 13.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 73.25 111.124 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -104.82 147.69 27.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 64.34 110.848 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -53.46 -22.83 8.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.111 -0.495 . . . . 42.43 110.851 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 2.6 t -82.03 26.86 0.5 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 52.14 110.901 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 59.14 37.77 23.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.078 -0.51 . . . . 52.14 110.881 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 242' ' ' LEU . . . . . 0.625 ' HG ' HD11 ' A' ' 262' ' ' LEU . 1.0 OUTLIER -98.39 121.14 39.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.103 -0.499 . . . . 73.25 110.901 -179.972 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.542 ' O ' HD22 ' A' ' 262' ' ' LEU . 5.4 mp -86.82 123.06 39.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 70.12 111.128 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 244' ' ' GLY . . . . . 0.654 ' C ' HD12 ' A' ' 245' ' ' LEU . . . -115.81 133.8 11.09 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.74 -0.743 . . . . 74.44 112.492 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.654 HD12 ' C ' ' A' ' 244' ' ' GLY . 11.0 mp -130.58 129.81 43.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.878 0.37 . . . . 73.15 110.942 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -140.29 121.74 2.04 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.729 -0.748 . . . . 54.31 112.465 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -111.76 121.68 45.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.936 0.398 . . . . 75.43 110.964 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -109.75 120.8 43.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.476 . . . . 62.13 111.112 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 249' ' ' GLN . . . . . 0.66 ' HG3' ' HB2' ' A' ' 231' ' ' ALA . 25.9 tt0 -128.32 122.68 32.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 65.23 110.931 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 250' ' ' THR . . . . . 0.494 HG23 ' HD3' ' A' ' 256' ' ' LYS . 96.0 m -110.31 111.51 22.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 71.53 111.137 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -106.37 88.57 2.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 73.34 110.904 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 6.2 mtmt 62.44 161.46 0.12 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.549 0.69 . . . . 73.22 110.925 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 76.84 1.13 Allowed 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.679 2.253 . . . . 70.11 112.306 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 169.34 -32.16 0.17 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.751 -0.738 . . . . 62.44 112.467 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 4.4 mp -118.19 122.47 69.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.831 0.348 . . . . 73.14 111.119 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 0.494 ' HD3' HG23 ' A' ' 250' ' ' THR . 25.7 mmtt -131.6 132.83 44.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.229 -0.442 . . . . 65.02 110.877 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 0.53 HD23 ' N ' ' A' ' 258' ' ' THR . 1.5 tt -114.11 127.05 55.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.223 -0.444 . . . . 73.3 110.878 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 258' ' ' THR . . . . . 0.53 ' N ' HD23 ' A' ' 257' ' ' LEU . 13.9 p -126.45 117.11 22.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 54.24 111.12 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.5 HD13 ' N ' ' A' ' 260' ' ' SER . 0.2 OUTLIER -111.98 130.6 55.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 62.14 110.91 179.934 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.5 ' N ' HD13 ' A' ' 259' ' ' LEU . 15.8 p -127.25 140.6 52.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 70.31 110.87 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -151.99 128.79 10.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.127 -0.488 . . . . 61.53 111.105 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.625 HD11 ' HG ' ' A' ' 242' ' ' LEU . 1.5 tm? -125.21 115.8 20.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 75.54 110.868 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 263' ' ' LEU . . . . . 0.82 ' HB3' HG11 ' A' ' 268' ' ' VAL . 0.2 OUTLIER -112.63 109.62 19.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 74.42 110.928 179.884 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 264' ' ' ASP . . . . . 0.653 ' O ' HG22 ' A' ' 268' ' ' VAL . 0.8 OUTLIER -84.01 116.45 22.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.204 -0.453 . . . . 71.03 110.853 179.848 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -57.19 -16.58 20.24 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.716 -0.754 . . . . 64.14 112.513 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -86.11 -22.15 27.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.844 0.354 . . . . 72.22 110.945 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -108.57 -53.6 2.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 62.33 110.889 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 268' ' ' VAL . . . . . 0.82 HG11 ' HB3' ' A' ' 263' ' ' LEU . 17.4 m -50.88 -30.29 8.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 55.12 111.138 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -52.98 -41.02 64.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 65.23 110.864 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -103.73 -17.62 15.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.14 -0.482 . . . . 72.33 111.124 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 128.49 94.39 0.79 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.762 -0.732 . . . . 71.3 112.482 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 175.53 78.67 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.762 -0.732 . . . . 72.41 112.491 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 273' ' ' HIS . . . . . 0.661 ' HB2' HD12 ' A' ' 263' ' ' LEU . 13.0 p80 -104.91 144.19 32.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.853 0.359 . . . . 62.01 110.871 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 1.6 mtpt -99.43 136.19 39.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.268 -0.424 . . . . 65.12 110.887 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.763 HD13 ' N ' ' A' ' 276' ' ' GLY . 2.6 tm? -136.58 144.91 44.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 73.11 110.88 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 276' ' ' GLY . . . . . 0.763 ' N ' HD13 ' A' ' 275' ' ' LEU . . . -154.19 130.63 2.96 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.729 -0.748 . . . . 52.43 112.487 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.471 ' HB3' HG13 ' A' ' 27' ' ' ILE . 0.1 OUTLIER -113.7 140.21 48.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.824 0.345 . . . . 74.32 110.928 -179.923 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 278' ' ' GLY . . . . . 0.612 ' O ' HD13 ' A' ' 279' ' ' LEU . . . -147.16 126.79 2.5 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.781 -0.723 . . . . 54.42 112.502 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.612 HD13 ' O ' ' A' ' 278' ' ' GLY . 1.1 mm? -121.67 133.25 54.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.762 0.315 . . . . 64.04 110.952 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -114.98 133.35 56.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 73.44 110.925 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 281' ' ' PHE . . . . . 0.743 ' HB3' HD22 ' A' ' 31' ' ' LEU . 26.8 t80 -126.29 120.2 29.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 75.44 110.867 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -113.74 117.34 31.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.133 -0.485 . . . . 75.14 110.9 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.424 ' O ' HD23 ' A' ' 284' ' ' LEU . . . -99.59 112.41 24.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 54.04 111.09 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.424 HD23 ' O ' ' A' ' 283' ' ' ALA . 10.9 mt -144.87 -170.4 3.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.203 -0.453 . . . . 70.43 110.863 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 74.44 110.946 179.917 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.864 0.364 . . . . 75.04 111.112 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.52 HG11 ' C ' ' A' ' 119' ' ' LYS . 17.8 t -141.1 75.33 23.9 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.675 0.75 . . . . 71.25 111.13 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 168.01 22.76 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.678 2.252 . . . . 73.4 112.372 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 101.23 0.88 Allowed 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.638 2.226 . . . . 71.15 112.374 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.654 ' HB ' HD21 ' A' ' 150' ' ' LEU . 0.6 OUTLIER -80.0 -34.49 38.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.456 . . . . 71.15 111.157 -179.969 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.518 ' HB2' HG21 ' A' ' 143' ' ' VAL . 72.7 t80 -53.7 -30.98 46.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 62.32 110.929 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -80.55 -26.02 38.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.147 -0.479 . . . . 63.43 111.057 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -74.31 -9.94 59.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.227 -0.442 . . . . 73.51 110.888 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.811 HD21 ' HA3' ' A' ' 152' ' ' GLY . 1.4 mp -56.72 -34.25 67.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 61.43 110.953 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 152.24 64.38 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.759 -0.734 . . . . 75.15 112.517 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 24.5 ttpp -62.81 -52.44 63.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.771 0.319 . . . . 72.31 110.913 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 75.5 m -62.87 -49.39 75.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.448 . . . . 54.31 110.855 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.475 ' HB1' ' CB ' ' A' ' 193' ' ' SER . . . -59.94 -37.38 79.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 70.43 111.13 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 45.7 ttt180 -66.01 -34.03 77.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 71.55 110.909 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -60.29 -46.28 90.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 64.12 110.857 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.719 HG21 ' HB2' ' A' ' 222' ' ' ALA . 9.3 p -80.98 -33.74 13.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 73.42 111.133 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.489 ' HE1' ' HB2' ' A' ' 209' ' ' ALA . 11.6 t80 -66.9 -41.18 87.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.485 . . . . 54.3 110.89 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.26 -173.93 2.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 71.11 111.16 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.8 mtmt -95.56 -168.48 1.79 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 71.42 110.915 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.56 48.95 1.46 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.741 -0.742 . . . . 51.5 112.493 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 12.9 p90 -122.63 -35.77 3.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.937 0.399 . . . . 74.12 110.933 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -144.98 139.29 8.31 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.754 -0.736 . . . . 73.0 112.528 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.522 ' HB3' HD11 ' A' ' 26' ' ' LEU . 48.8 m-85 -104.24 -6.35 21.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.926 0.393 . . . . 71.32 110.899 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.27 12.42 57.39 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.772 -0.728 . . . . 73.52 112.488 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.749 ' N ' HD13 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -150.88 -173.48 4.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.819 0.343 . . . . 65.41 110.937 -179.934 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.971 HG23 HD12 ' A' ' 277' ' ' LEU . 21.2 mm -92.34 133.46 33.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 74.45 111.124 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.529 ' O ' HD22 ' A' ' 279' ' ' LEU . 4.5 mtpp -113.06 154.66 26.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 75.42 110.885 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.617 HD13 ' N ' ' A' ' 30' ' ' ASP . 3.3 tm? -147.79 136.84 22.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.229 -0.442 . . . . 72.54 110.944 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.617 ' N ' HD13 ' A' ' 29' ' ' LEU . 1.2 t70 -152.22 124.21 8.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 61.34 110.863 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.711 HD11 ' CB ' ' A' ' 283' ' ' ALA . 2.7 tm? -125.5 129.13 49.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 72.23 110.907 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.54 ' N ' HD13 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -112.17 128.24 56.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 70.54 110.88 179.814 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 93.8 m -137.21 121.12 17.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.44 . . . . 75.14 111.154 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.9 ptmm? -140.89 141.93 34.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 72.44 110.888 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 17.9 t -139.23 152.49 47.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.207 -0.451 . . . . 71.22 110.864 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -75.97 61.45 1.51 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 71.24 110.907 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -153.27 20.67 0.56 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.132 -0.486 . . . . 73.2 110.876 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.545 ' HA2' ' O ' ' A' ' 63' ' ' ARG . . . 75.72 -3.53 49.23 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.721 -0.752 . . . . 72.23 112.524 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.2 mp -98.94 124.16 43.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.771 0.319 . . . . 74.1 110.897 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.82 118.28 10.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.162 -0.472 . . . . 45.15 110.825 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -110.1 123.58 49.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 71.12 110.905 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 83.9 m -127.39 116.62 20.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.47 . . . . 73.34 111.18 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.5 t -115.44 135.81 53.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.435 . . . . 74.23 110.861 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.27 143.91 25.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 54.01 110.871 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 164.95 168.49 27.18 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.712 -0.756 . . . . 70.21 112.463 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -137.3 169.45 17.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.866 0.365 . . . . 75.24 110.872 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -147.11 127.43 13.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 72.23 111.089 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.469 ' ND2' HD12 ' A' ' 26' ' ' LEU . 2.5 m120 -95.45 142.55 27.68 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.198 -0.456 . . . . 74.53 110.852 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 61.1 p -94.12 56.45 2.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 75.01 111.174 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -126.19 -74.89 0.59 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 64.1 110.889 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.4 ' O ' ' C ' ' A' ' 52' ' ' THR . 2.2 m -130.33 65.65 1.52 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 51.13 111.133 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.4 ' C ' ' O ' ' A' ' 51' ' ' THR . 10.1 t 37.05 43.88 0.34 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 65.41 111.16 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -105.2 95.02 5.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 75.02 110.885 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -126.81 148.23 31.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 72.24 111.144 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.7 p -113.27 126.59 55.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 74.05 111.138 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -118.94 147.27 18.43 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.797 -0.716 . . . . 60.13 112.52 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.4 p -146.06 133.55 20.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.918 0.389 . . . . 75.15 110.871 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.455 ' O ' ' HB3' ' A' ' 74' ' ' LYS . 0.3 OUTLIER -123.09 130.08 52.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.465 . . . . 63.44 110.892 -179.968 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.524 ' HA ' ' CB ' ' A' ' 74' ' ' LYS . 0.9 OUTLIER -134.84 120.82 19.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.21 -0.45 . . . . 62.02 110.86 179.923 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.477 ' H ' ' HB2' ' A' ' 74' ' ' LYS . 20.3 m -105.43 117.81 34.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.126 -0.488 . . . . 54.01 111.149 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 71' ' ' PHE . 8.2 mttp -106.58 157.95 17.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 74.33 110.867 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.518 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 10.3 t80 -122.16 121.16 36.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 62.23 110.899 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.545 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -88.45 101.31 13.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.082 -0.508 . . . . 73.44 110.908 179.963 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 42.5 t-105 -116.21 136.35 53.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.209 -0.451 . . . . 73.51 110.895 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 24.0 p -80.98 -169.85 2.42 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.211 -0.45 . . . . 75.31 111.182 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.587 ' O ' HD23 ' A' ' 69' ' ' LEU . 33.6 mm-40 66.29 101.89 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.235 -0.438 . . . . 74.14 110.859 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 65.04 13.98 9.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.158 -0.474 . . . . 73.23 110.946 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 49.95 91.19 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.717 -0.754 . . . . 73.22 112.51 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.587 HD23 ' O ' ' A' ' 66' ' ' GLU . 4.3 mm? -118.05 141.04 48.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.834 0.349 . . . . 71.13 110.941 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.436 ' HA ' ' O ' ' A' ' 62' ' ' TYR . 83.4 m -135.68 121.74 20.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 73.3 111.161 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.68 ' CD1' HG22 ' A' ' 85' ' ' ILE . 14.2 t80 -100.26 119.73 38.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 73.43 110.902 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.1 t -111.37 116.06 30.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 74.31 111.154 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.578 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 8.5 tt0 -139.66 126.94 21.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 71.54 110.895 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.578 ' HB2' ' O ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER 165.63 -156.78 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 55.13 110.934 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.49 ' CD1' HD22 ' A' ' 81' ' ' LEU . 12.2 t90 -133.93 136.38 44.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.268 -0.424 . . . . 71.03 110.896 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -107.88 155.64 20.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.281 -0.418 . . . . 71.33 110.909 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 15.2 t -68.79 -8.42 43.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.172 -0.467 . . . . 72.21 111.128 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.472 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 5.1 m-20 -73.8 3.43 6.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.237 -0.438 . . . . 71.42 110.839 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.472 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 3.9 m-20 81.03 15.33 0.6 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 73.32 110.842 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -116.0 116.25 27.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 64.22 111.126 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.49 HD22 ' CD1' ' A' ' 75' ' ' TRP . 0.1 OUTLIER -122.97 128.21 49.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 74.25 110.914 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 177.58 -133.19 2.15 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.776 -0.726 . . . . 43.44 112.536 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.445 ' OG1' ' N ' ' A' ' 84' ' ' GLU . 4.3 t -178.92 -178.35 0.54 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.812 0.339 . . . . 74.34 111.109 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.65 ' HB3' ' O ' ' A' ' 99' ' ' PHE . 0.6 OUTLIER 170.93 -166.58 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.202 -0.454 . . . . 55.55 110.932 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.68 HG22 ' CD1' ' A' ' 71' ' ' PHE . 1.8 pp -136.78 145.69 29.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.203 -0.453 . . . . 52.33 111.135 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.712 ' OG1' HG23 ' A' ' 98' ' ' THR . 98.6 m -128.96 123.27 32.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.465 . . . . 72.51 111.196 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.2 p -112.54 138.66 40.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 64.13 111.157 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -123.86 118.69 27.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 70.34 110.887 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 43.1 t0 64.42 76.88 0.33 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.143 -0.48 . . . . 63.34 110.878 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -109.01 -68.87 0.89 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 73.11 110.882 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -65.33 -74.28 0.11 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 73.23 110.86 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -121.41 142.38 50.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.174 -0.466 . . . . 63.23 111.117 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 19.5 ttm180 -50.64 133.99 24.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 62.22 110.9 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 100.88 -22.31 40.08 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.732 -0.747 . . . . 61.42 112.49 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.98 125.04 34.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.923 0.392 . . . . 73.2 110.917 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.622 ' O ' HD13 ' A' ' 97' ' ' LEU . 28.8 tttp -124.02 129.83 51.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.466 . . . . 74.2 110.903 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.622 HD13 ' O ' ' A' ' 96' ' ' LYS . 1.2 mm? -122.2 123.04 40.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.45 . . . . 64.13 110.92 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.712 HG23 ' OG1' ' A' ' 86' ' ' THR . 87.6 m -123.79 118.68 27.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.209 -0.451 . . . . 72.04 111.108 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.754 ' CD1' HD13 ' A' ' 114' ' ' ILE . 0.7 OUTLIER -115.3 117.33 30.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.455 . . . . 71.11 110.857 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.568 ' HA ' ' CB ' ' A' ' 84' ' ' GLU . 8.4 t70 -121.62 139.47 53.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.103 -0.499 . . . . 64.11 110.901 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 37.7 t -130.55 121.26 25.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 65.44 110.87 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 15.8 m -116.6 153.41 32.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.096 -0.502 . . . . 54.44 110.878 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -123.72 138.41 54.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 71.24 110.895 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.424 ' HA ' ' HD2' ' A' ' 105' ' ' PRO . 4.2 t -116.83 106.69 47.47 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.634 0.73 . . . . 71.12 110.881 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 104' ' ' SER . 54.1 Cg_endo -69.68 -32.61 18.55 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.683 2.255 . . . . 75.2 112.389 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -57.3 -35.9 70.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.469 . . . . 71.01 110.903 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 10.0 m -99.09 -32.4 11.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 61.1 111.12 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.66 -18.58 57.24 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.762 -0.732 . . . . 71.52 112.532 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 29.6 tptt -94.44 147.47 23.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.817 0.342 . . . . 42.51 110.915 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -92.95 150.84 20.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.279 -0.419 . . . . 74.22 110.924 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.1 m120 -121.08 126.32 49.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.436 . . . . 60.34 110.913 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -113.68 139.3 49.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 65.44 111.066 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 27.9 mttm -138.3 137.91 37.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 64.11 110.889 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.754 HD13 ' CD1' ' A' ' 99' ' ' PHE . 4.1 tp -134.66 133.68 54.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 61.24 111.152 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.464 ' H ' HD12 ' A' ' 114' ' ' ILE . 40.0 mttp -125.42 120.83 32.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 72.33 110.894 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.563 HG22 HD12 ' A' ' 97' ' ' LEU . 59.7 p -127.81 118.33 23.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 55.21 111.167 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.4 ' HA3' ' HA2' ' A' ' 126' ' ' GLY . . . -152.19 156.08 26.5 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.753 -0.737 . . . . 74.22 112.495 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -132.41 130.49 40.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.973 0.416 . . . . 73.52 110.896 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.52 ' C ' HG11 ' A' ' 3' ' ' VAL . 37.7 mttp -107.05 118.5 36.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.103 -0.499 . . . . 75.34 110.893 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.26 142.94 42.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 74.43 110.851 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -52.42 -27.32 15.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.134 -0.485 . . . . 64.23 110.887 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 27.9 m80 -90.38 -38.3 13.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 75.14 110.895 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.443 HD11 HD22 ' A' ' 144' ' ' LEU . 9.3 tp -147.67 140.65 19.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.445 . . . . 74.53 111.098 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -111.25 115.94 30.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 72.34 110.87 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.511 ' CD2' HD13 ' A' ' 142' ' ' LEU . 2.9 mm? -122.96 139.91 53.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.175 -0.466 . . . . 73.13 110.935 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.4 ' HA2' ' HA3' ' A' ' 117' ' ' GLY . . . -146.74 121.5 1.44 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.741 -0.743 . . . . 63.3 112.437 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 18.5 m -113.19 134.02 54.78 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.791 0.329 . . . . 72.1 110.916 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -126.62 146.97 49.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 61.45 110.905 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 8.7 mtm -139.04 127.23 22.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 72.24 110.869 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -117.81 121.3 40.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 75.22 110.88 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -95.26 119.71 34.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.465 . . . . 74.05 110.887 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -128.2 121.15 28.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 72.2 110.855 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.546 HD12 ' O ' ' A' ' 133' ' ' ILE . 1.1 tp -52.41 -43.75 41.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 54.31 111.166 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -74.39 -18.29 60.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.481 . . . . 65.53 111.121 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 161.47 103.59 0.18 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.725 -0.75 . . . . 72.42 112.454 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 147.99 64.34 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.656 2.237 . . . . 74.13 112.382 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 28.4 t -128.73 150.49 50.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 75.14 110.875 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.703 HD12 ' OG1' ' A' ' 159' ' ' THR . 1.4 mp -107.89 132.99 54.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.12 -0.491 . . . . 61.24 111.136 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 18.9 mtp180 -112.37 131.25 55.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 72.34 110.869 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -126.72 134.01 8.3 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.705 -0.76 . . . . 51.45 112.485 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -139.17 116.94 11.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.832 0.349 . . . . 71.41 111.125 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.595 HD12 ' N ' ' A' ' 143' ' ' VAL . 5.3 tp -127.01 124.59 39.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.242 -0.436 . . . . 62.45 110.954 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.595 ' N ' HD12 ' A' ' 142' ' ' LEU . 46.6 t -123.34 134.8 65.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 64.44 111.092 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.545 HD23 ' C ' ' A' ' 143' ' ' VAL . 0.5 OUTLIER -109.38 143.36 39.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.106 -0.497 . . . . 75.12 110.889 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -121.36 120.25 4.37 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.774 -0.727 . . . . 31.12 112.513 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.428 ' HB3' ' HB2' ' A' ' 149' ' ' TRP . 38.5 t80 -128.85 145.5 51.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.825 0.345 . . . . 72.34 110.893 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -50.95 96.89 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.126 -0.488 . . . . 62.43 110.876 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 92.88 -30.7 6.78 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.707 -0.759 . . . . 63.35 112.464 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.428 ' HB2' ' HB3' ' A' ' 146' ' ' TYR . 25.0 m95 -104.77 141.09 37.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.828 0.347 . . . . 74.11 110.863 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.654 HD21 ' HB ' ' A' ' 6' ' ' THR . 0.5 OUTLIER -130.71 140.6 50.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.446 . . . . 71.53 110.943 179.955 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.516 ' HB3' ' HB2' ' A' ' 144' ' ' LEU . . . -131.44 148.12 52.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 73.54 111.086 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.811 ' HA3' HD21 ' A' ' 10' ' ' LEU . . . -150.95 137.06 5.86 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.752 -0.737 . . . . 74.42 112.484 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -144.11 119.78 10.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.877 0.37 . . . . 74.31 110.923 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -126.94 122.44 34.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.117 -0.492 . . . . 60.21 110.892 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 15.6 ptt? -146.82 150.17 34.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 62.54 110.846 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 48.9 m-20 -112.12 138.56 48.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 73.12 110.891 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -92.24 132.49 36.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 63.31 110.868 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -77.86 99.64 6.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.141 -0.482 . . . . 71.43 110.865 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.703 ' OG1' HD12 ' A' ' 138' ' ' ILE . 0.2 OUTLIER -65.21 -47.0 78.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.139 -0.482 . . . . 64.33 111.165 -179.937 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -48.29 -26.11 1.85 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 54.43 111.119 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 43.9 mttt -127.33 -166.64 1.63 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.459 . . . . 62.23 110.935 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 39.6 m -111.18 40.29 2.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.44 . . . . 73.3 110.795 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 11.0 mmm180 -153.3 176.21 12.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 71.43 110.889 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 1.5 t -78.01 141.42 15.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 74.11 111.119 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 15.2 t -90.61 -33.73 15.74 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.158 -0.474 . . . . 53.44 111.131 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -150.97 134.84 16.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.445 . . . . 73.44 110.9 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 89.5 p -124.81 119.01 27.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 53.34 110.893 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -130.47 142.56 50.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 63.25 110.89 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -138.2 158.14 44.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.126 -0.488 . . . . 71.32 110.866 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -154.07 138.96 17.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 53.01 111.114 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 46.2 t -120.63 134.87 62.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 72.23 111.113 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -117.59 112.56 2.48 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.706 -0.759 . . . . 44.32 112.491 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -114.18 121.58 44.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.994 0.426 . . . . 73.13 110.901 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 26.0 ttmt -104.36 134.77 47.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.113 -0.494 . . . . 72.11 110.916 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.97 165.11 22.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 64.12 111.128 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -40.93 -74.82 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.175 -0.466 . . . . 54.22 110.892 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -116.07 15.15 16.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 64.12 110.913 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -127.09 149.57 49.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 74.13 110.868 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 6.6 mm-40 -135.22 123.87 23.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.123 -0.49 . . . . 55.24 110.881 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.656 HD23 HG13 ' A' ' 194' ' ' ILE . 2.6 tm? -124.23 122.32 37.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.132 -0.485 . . . . 74.45 110.873 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' HIS . . . . . 0.452 ' N ' HD22 ' A' ' 180' ' ' LEU . 91.6 m-70 -130.47 115.94 17.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 71.53 110.9 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 182' ' ' THR . . . . . 0.494 HG22 ' O ' ' A' ' 191' ' ' GLY . 0.2 OUTLIER -94.77 153.12 17.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.217 -0.447 . . . . 71.22 111.1 -179.856 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -146.76 138.56 24.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 73.31 110.896 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.454 ' O ' HG12 ' A' ' 184' ' ' VAL . 2.3 t -134.72 111.3 13.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.473 . . . . 71.14 111.143 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -100.09 89.28 3.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 72.3 110.9 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 65.28 179.14 0.19 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.179 -0.464 . . . . 71.22 110.821 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -73.47 -4.17 64.2 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.69 -0.767 . . . . 75.4 112.506 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 29.3 p -95.38 -25.87 16.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.765 0.317 . . . . 62.14 111.15 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -122.83 114.17 20.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 75.43 110.915 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -139.72 124.13 18.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 70.22 110.813 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 191' ' ' GLY . . . . . 0.494 ' O ' HG22 ' A' ' 182' ' ' THR . . . 178.8 -150.88 9.87 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.678 -0.772 . . . . 44.43 112.47 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -176.42 170.43 43.24 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.726 -0.749 . . . . 74.35 112.485 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' SER . . . . . 0.475 ' CB ' ' HB1' ' A' ' 14' ' ' ALA . 65.3 m -121.21 147.19 45.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.872 0.368 . . . . 53.32 110.798 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.656 HG13 HD23 ' A' ' 180' ' ' LEU . 4.0 mp -119.79 123.45 70.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.104 -0.498 . . . . 73.22 111.073 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 195' ' ' TYR . . . . . 0.64 ' HD1' ' HB2' ' A' ' 205' ' ' ALA . 12.6 t80 -108.48 121.91 45.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 73.2 110.929 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -124.47 130.2 52.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 74.52 110.914 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 21.2 mtpp -106.25 127.19 53.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 73.32 110.874 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 14.7 t -79.21 153.33 4.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 73.51 111.159 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' ASN . . . . . 0.406 ' O ' ' C ' ' A' ' 200' ' ' LYS . 47.0 t30 -59.62 97.94 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 73.35 110.9 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 200' ' ' LYS . . . . . 0.406 ' C ' ' O ' ' A' ' 199' ' ' ASN . 16.6 ptpt 37.3 63.12 0.76 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 75.11 110.897 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 201' ' ' LYS . . . . . 0.428 ' HB3' HD23 ' A' ' 202' ' ' LEU . 25.3 mttm -145.46 -56.46 0.31 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 75.53 110.917 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.428 HD23 ' HB3' ' A' ' 201' ' ' LYS . 2.1 pt? -173.76 172.42 3.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 73.44 110.936 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -116.58 144.9 43.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 72.24 110.876 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 204' ' ' THR . . . . . 0.438 HG23 ' O ' ' A' ' 222' ' ' ALA . 7.3 m -146.53 138.77 24.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 74.02 111.105 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.64 ' HB2' ' HD1' ' A' ' 195' ' ' TYR . . . -145.3 136.64 25.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.441 . . . . 72.14 111.141 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 1.1 m -113.79 149.97 15.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 73.23 111.095 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -113.58 137.19 51.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.485 . . . . 72.34 110.865 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.579 HD11 ' CE1' ' A' ' 219' ' ' PHE . 3.8 mm? -120.61 129.72 53.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.17 -0.468 . . . . 73.51 110.897 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.489 ' HB2' ' HE1' ' A' ' 18' ' ' PHE . . . -129.77 130.07 44.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.119 -0.492 . . . . 64.31 111.08 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 2.9 t-105 -129.67 128.1 41.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 71.4 110.941 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 2.7 p -99.14 109.02 21.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.225 -0.443 . . . . 75.33 111.159 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -54.91 149.84 10.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 65.51 111.063 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 95.59 -36.49 3.8 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.71 -0.757 . . . . 51.04 112.474 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -121.54 -179.46 4.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.782 0.325 . . . . 74.12 110.879 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 3.0 t -112.11 38.37 2.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 71.12 110.882 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -102.17 112.21 24.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 75.55 110.905 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 18.6 m -114.65 138.45 50.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.459 . . . . 74.33 111.132 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 218' ' ' ARG . . . . . 0.446 ' HB3' ' HB3' ' A' ' 209' ' ' ALA . 18.4 ttt85 -108.55 131.99 54.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.441 . . . . 60.44 110.848 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 219' ' ' PHE . . . . . 0.579 ' CE1' HD11 ' A' ' 208' ' ' LEU . 17.9 m-85 -117.45 136.7 53.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 65.33 110.89 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -137.46 140.63 11.48 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.737 -0.744 . . . . 63.14 112.511 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.514 ' HB ' HG12 ' A' ' 237' ' ' VAL . 4.8 mp -123.85 130.73 73.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.854 0.359 . . . . 61.54 111.104 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.719 ' HB2' HG21 ' A' ' 17' ' ' VAL . . . -127.61 152.21 47.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 65.41 111.1 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -137.37 129.34 29.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.246 -0.434 . . . . 75.22 111.084 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 7.3 ttmt -115.21 128.48 56.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 72.42 110.894 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -132.25 131.54 42.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.252 -0.431 . . . . 71.51 110.913 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 58.7 mm-40 -102.71 112.28 24.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 75.35 110.875 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 71.4 mt -102.68 -40.1 6.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 73.33 111.109 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 228' ' ' ASP . . . . . 0.757 ' HB2' ' HB3' ' A' ' 231' ' ' ALA . 0.4 OUTLIER -124.17 160.7 51.19 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.579 0.704 . . . . 62.32 110.882 179.88 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -32.34 18.82 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.725 2.283 . . . . 73.44 112.317 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -109.2 10.49 25.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.435 . . . . 72.43 110.882 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.757 ' HB3' ' HB2' ' A' ' 228' ' ' ASP . . . -136.1 140.42 43.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.179 -0.464 . . . . 64.12 111.086 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 21.8 m -138.74 136.49 35.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.213 -0.449 . . . . 52.01 110.903 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -110.42 132.77 53.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 73.3 110.924 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 58.2 p -137.08 149.71 47.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 63.24 110.826 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -136.47 155.59 49.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.096 -0.502 . . . . 63.32 111.089 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.51 145.91 29.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 71.24 110.861 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.514 HG12 ' HB ' ' A' ' 221' ' ' ILE . 1.7 p -143.04 143.88 24.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 73.32 111.143 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 238' ' ' ASN . . . . . 0.404 ' HB3' ' HB2' ' A' ' 242' ' ' LEU . 0.9 OUTLIER -112.31 148.08 34.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 73.03 110.886 179.986 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -57.1 -18.53 15.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 63.32 110.89 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 29.9 t -80.93 25.89 0.44 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 73.31 110.814 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 62.22 35.19 15.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.123 -0.49 . . . . 72.14 110.875 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 242' ' ' LEU . . . . . 0.444 HD11 ' HB3' ' A' ' 264' ' ' ASP . 4.9 mp -99.25 118.5 36.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.132 -0.486 . . . . 74.01 110.916 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.508 ' H ' HD12 ' A' ' 243' ' ' ILE . 0.8 OUTLIER -107.42 117.88 54.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 74.35 111.154 179.852 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 244' ' ' GLY . . . . . 0.533 ' C ' HD13 ' A' ' 245' ' ' LEU . . . -137.12 149.62 20.33 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.701 -0.762 . . . . 63.21 112.467 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.669 ' N ' HD13 ' A' ' 245' ' ' LEU . 0.0 OUTLIER -145.83 158.48 43.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.869 0.366 . . . . 54.02 110.887 -179.895 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -163.01 136.83 4.48 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.687 -0.768 . . . . 44.2 112.465 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -128.42 132.59 48.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.902 0.382 . . . . 75.4 110.932 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 7.8 t -111.99 125.83 54.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.487 . . . . 62.41 111.177 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -143.43 148.82 36.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.235 -0.438 . . . . 51.32 110.961 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 5.5 m -88.93 145.24 25.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.262 -0.426 . . . . 72.03 111.127 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.613 HD12 HD11 ' A' ' 255' ' ' ILE . 47.4 mt -93.94 -176.05 3.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 71.45 110.889 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 252' ' ' LYS . . . . . 0.472 ' CB ' ' CD ' ' A' ' 253' ' ' PRO . 0.1 OUTLIER -51.16 -61.07 4.46 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.545 0.688 . . . . 61.3 110.87 179.845 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 253' ' ' PRO . . . . . 0.472 ' CD ' ' CB ' ' A' ' 252' ' ' LYS . 53.8 Cg_endo -69.73 -170.26 0.38 Allowed 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.687 2.258 . . . . 64.35 112.306 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 254' ' ' GLY . . . . . 0.536 ' O ' ' HB3' ' A' ' 281' ' ' PHE . . . -85.1 51.55 4.56 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.737 -0.744 . . . . 73.42 112.465 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.613 HD11 HD12 ' A' ' 251' ' ' LEU . 6.2 pt -129.27 135.1 62.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.893 0.377 . . . . 65.11 111.152 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 0.441 ' H ' ' HB2' ' A' ' 281' ' ' PHE . 0.1 OUTLIER -98.39 132.1 44.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.447 . . . . 70.13 110.888 179.858 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 0.721 ' HA ' HD12 ' A' ' 279' ' ' LEU . 5.2 tp -100.07 125.45 46.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 75.22 110.921 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 258' ' ' THR . . . . . 0.434 ' O ' HD22 ' A' ' 277' ' ' LEU . 21.9 m -116.39 111.75 20.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 73.11 111.152 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 1.015 HD22 HD23 ' A' ' 277' ' ' LEU . 0.2 OUTLIER -109.33 130.02 55.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.253 -0.431 . . . . 74.01 110.868 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.504 ' N ' HD13 ' A' ' 259' ' ' LEU . 1.7 t -144.16 155.8 44.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.167 -0.469 . . . . 73.25 110.898 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 261' ' ' ALA . . . . . 0.438 ' HB3' ' CD2' ' A' ' 245' ' ' LEU . . . -158.88 128.38 5.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 62.24 111.06 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.655 ' C ' HD13 ' A' ' 263' ' ' LEU . 3.2 tm? -118.48 122.98 44.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 62.52 110.921 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 263' ' ' LEU . . . . . 0.892 ' HB3' HG21 ' A' ' 268' ' ' VAL . 0.4 OUTLIER -118.93 110.56 17.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.159 -0.473 . . . . 73.4 110.88 179.896 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 264' ' ' ASP . . . . . 0.555 ' O ' ' HB ' ' A' ' 268' ' ' VAL . 1.7 m-20 -88.62 99.87 12.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 70.21 110.844 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -52.86 -11.48 1.35 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.737 -0.744 . . . . 72.32 112.464 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 7.4 ttmm -63.86 -25.66 68.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.825 0.345 . . . . 70.13 110.915 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -166.82 16.91 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 64.01 110.881 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 268' ' ' VAL . . . . . 0.892 HG21 ' HB3' ' A' ' 263' ' ' LEU . 1.4 p -68.05 -28.51 41.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 62.44 111.119 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -74.48 -37.44 63.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 73.21 110.914 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -85.83 -17.64 35.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.142 -0.481 . . . . 53.14 111.103 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 131.21 95.26 0.68 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.768 -0.729 . . . . 53.31 112.515 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 178.86 53.74 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.774 -0.727 . . . . 53.32 112.537 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 273' ' ' HIS . . . . . 0.492 ' HB2' HD12 ' A' ' 263' ' ' LEU . 14.8 p80 -112.17 144.21 41.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.887 0.375 . . . . 72.3 110.84 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -123.71 149.32 45.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 64.42 110.889 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.422 HD12 ' HB2' ' A' ' 261' ' ' ALA . 2.4 tp -128.41 148.55 50.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 71.15 110.898 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -131.34 97.53 0.36 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.784 -0.722 . . . . 75.45 112.501 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 1.015 HD23 HD22 ' A' ' 259' ' ' LEU . 3.2 tm? -119.28 129.65 55.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.845 0.355 . . . . 74.45 110.886 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 278' ' ' GLY . . . . . 0.711 ' C ' HD13 ' A' ' 279' ' ' LEU . . . -164.48 145.61 10.51 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.752 -0.737 . . . . 72.53 112.533 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.721 HD12 ' HA ' ' A' ' 257' ' ' LEU . 0.0 OUTLIER -118.47 130.03 55.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.745 0.307 . . . . 72.44 110.971 -179.969 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 280' ' ' GLU . . . . . 0.522 ' O ' ' HB2' ' A' ' 281' ' ' PHE . 0.0 OUTLIER -140.37 143.58 35.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.449 . . . . 73.2 110.924 179.961 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 281' ' ' PHE . . . . . 0.536 ' HB3' ' O ' ' A' ' 254' ' ' GLY . 0.2 OUTLIER 172.63 -144.39 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 73.34 110.856 -179.949 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -137.47 148.82 46.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 71.31 110.933 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.711 ' CB ' HD11 ' A' ' 31' ' ' LEU . . . -101.11 111.45 23.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 71.31 111.106 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.66 HD12 ' O ' ' A' ' 283' ' ' ALA . 0.8 OUTLIER -151.31 178.44 9.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.235 -0.439 . . . . 75.11 110.904 -179.959 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 71.43 110.893 179.919 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.845 0.355 . . . . 63.1 111.104 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.491 HG22 ' N ' ' A' ' 121' ' ' GLU . 9.1 t -114.43 78.48 4.8 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.668 0.746 . . . . 71.11 111.14 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 167.7 23.68 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.681 2.254 . . . . 72.14 112.351 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 119.57 6.49 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.654 2.236 . . . . 55.04 112.335 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.488 ' HB ' HD21 ' A' ' 150' ' ' LEU . 34.7 p -106.99 -49.61 3.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 62.31 111.154 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.716 ' HB2' HG21 ' A' ' 143' ' ' VAL . 72.3 t80 -56.39 -30.69 63.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.26 -0.427 . . . . 74.54 110.924 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -79.75 -23.08 42.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.082 -0.508 . . . . 74.03 111.117 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -90.66 13.28 16.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 74.33 110.846 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.777 HD21 ' HA3' ' A' ' 152' ' ' GLY . 0.5 OUTLIER -70.39 -33.83 71.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.21 -0.45 . . . . 64.44 110.907 -179.971 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 161.31 49.8 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.764 -0.731 . . . . 72.12 112.511 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.29 -48.51 81.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.775 0.321 . . . . 61.32 110.921 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.6 m -61.25 -49.14 78.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 61.05 110.839 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.537 ' HB1' ' CB ' ' A' ' 193' ' ' SER . . . -62.22 -38.21 88.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 75.32 111.083 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.725 ' O ' HG22 ' A' ' 19' ' ' THR . 17.0 ttt-85 -60.73 -33.51 73.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 75.14 110.873 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -58.05 -46.02 86.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 74.23 110.893 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.514 HG21 ' HB3' ' A' ' 205' ' ' ALA . 92.8 t -65.19 -41.92 92.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 73.04 111.127 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -62.67 -41.01 98.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 71.44 110.911 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.725 HG22 ' O ' ' A' ' 15' ' ' ARG . 9.0 t -94.11 43.13 1.1 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.145 -0.48 . . . . 40.22 111.165 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -129.5 174.1 9.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 74.11 110.866 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 77.55 -72.53 2.17 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.764 -0.732 . . . . 53.32 112.459 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -68.1 87.76 0.28 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.966 0.412 . . . . 73.21 110.942 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -61.29 -176.05 1.83 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.751 -0.738 . . . . 73.42 112.445 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -97.68 -4.49 37.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.944 0.402 . . . . 64.11 110.894 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.61 13.15 77.97 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.738 -0.744 . . . . 72.54 112.457 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.593 HD12 ' N ' ' A' ' 27' ' ' ILE . 2.2 pp -149.54 -176.7 5.5 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.749 0.309 . . . . 63.41 110.952 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.593 ' N ' HD12 ' A' ' 26' ' ' LEU . 1.6 mp -118.33 120.91 65.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.206 -0.452 . . . . 72.24 111.171 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.446 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 0.0 OUTLIER -125.81 117.13 22.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 74.44 110.915 179.844 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.82 ' HB2' HD23 ' A' ' 279' ' ' LEU . 0.6 OUTLIER -112.69 137.91 50.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.44 . . . . 74.2 110.926 179.939 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.562 ' C ' ' HB3' ' A' ' 281' ' ' PHE . 0.7 OUTLIER -147.51 132.54 18.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.238 -0.437 . . . . 74.33 110.864 179.88 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.781 ' HA ' ' HA ' ' A' ' 281' ' ' PHE . 4.2 tt -129.55 124.58 34.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.196 -0.456 . . . . 72.55 110.952 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.617 ' N ' ' HB2' ' A' ' 281' ' ' PHE . 0.3 OUTLIER -120.36 125.29 47.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 61.2 110.891 179.873 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.914 HG23 HD13 ' A' ' 284' ' ' LEU . 46.2 m -122.2 121.11 36.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 71.42 111.124 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 5.9 ptmt -121.01 148.03 44.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 71.35 110.89 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 75.6 m -139.07 169.3 18.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 65.33 110.873 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -83.17 52.49 2.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.105 -0.498 . . . . 72.43 110.874 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -140.65 8.59 2.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.139 -0.482 . . . . 74.32 110.908 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.489 ' HA2' ' O ' ' A' ' 63' ' ' ARG . . . 79.27 -5.09 60.71 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.727 -0.749 . . . . 72.02 112.511 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -99.08 128.53 45.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.726 0.298 . . . . 43.24 110.94 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.412 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -139.82 118.49 12.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 64.25 110.86 179.934 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -102.97 126.59 50.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 73.4 110.872 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 54.3 m -127.08 117.42 22.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.108 -0.496 . . . . 73.32 111.173 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 36.5 p -104.31 134.27 47.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 73.25 110.9 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 35.6 t -127.0 127.15 44.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 71.52 110.835 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -141.86 129.79 4.09 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.7 -0.762 . . . . 51.53 112.453 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 48.6 m -128.97 135.74 49.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.87 0.367 . . . . 72.21 110.866 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.408 ' HA ' ' HA ' ' A' ' 54' ' ' VAL . . . -134.66 129.7 35.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.128 -0.487 . . . . 74.11 111.106 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -92.18 136.42 33.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 75.21 110.866 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -96.23 -55.89 2.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 72.12 111.168 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -50.49 -34.91 26.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.221 -0.445 . . . . 71.42 110.9 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -139.3 165.21 27.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 72.41 111.117 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 22.0 p -78.72 84.6 4.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.462 . . . . 73.35 111.112 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 10.9 tptp -145.61 82.27 1.63 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 73.15 110.885 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.408 ' HA ' ' HA ' ' A' ' 47' ' ' ALA . 0.7 OUTLIER -126.68 120.07 55.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 64.31 111.128 179.845 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 82.7 p -137.93 160.82 38.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.198 -0.455 . . . . 72.34 111.117 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.414 ' O ' HG22 ' A' ' 77' ' ' THR . . . -129.74 158.57 22.28 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.733 -0.746 . . . . 71.23 112.502 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.2 p -146.51 161.21 40.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.913 0.387 . . . . 54.13 110.869 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.607 HD13 ' N ' ' A' ' 59' ' ' GLU . 0.5 OUTLIER -119.95 131.04 55.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.115 -0.493 . . . . 75.31 110.929 179.969 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.607 ' N ' HD13 ' A' ' 58' ' ' LEU . 3.8 mt-10 -115.84 124.41 50.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 63.4 110.88 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.57 125.8 51.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 72.31 111.161 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.412 ' HB2' ' HB3' ' A' ' 40' ' ' GLU . 3.6 mttp -134.57 159.16 42.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 44.42 110.905 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -131.92 140.77 49.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 74.51 110.936 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.489 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 2.9 tmm_? -130.33 103.27 6.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 54.33 110.855 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 16.9 m95 -116.06 120.21 38.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 74.23 110.917 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.6 m 64.74 118.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 64.23 111.146 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -51.02 115.07 1.36 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.441 . . . . 64.3 110.85 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 65.59 56.93 0.9 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.113 -0.494 . . . . 72.51 110.948 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -144.35 -70.52 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.711 -0.757 . . . . 72.14 112.493 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.425 HD13 ' HA ' ' A' ' 69' ' ' LEU . 0.6 OUTLIER -125.12 128.88 49.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.869 0.366 . . . . 60.31 110.928 -179.93 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -137.67 128.82 27.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.26 -0.427 . . . . 55.11 111.156 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -114.47 133.35 55.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 75.52 110.848 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 49.8 p -126.32 115.0 19.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.127 -0.488 . . . . 73.41 111.171 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -132.06 136.16 47.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.231 -0.44 . . . . 64.43 110.857 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 13.6 pttp -123.15 94.72 4.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.47 . . . . 72.24 110.903 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.491 ' CD1' ' HB3' ' A' ' 81' ' ' LEU . 5.8 t90 -95.37 125.88 40.29 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.232 -0.44 . . . . 72.33 110.896 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -94.25 137.12 33.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.267 -0.424 . . . . 75.23 110.873 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.414 HG22 ' O ' ' A' ' 56' ' ' GLY . 8.0 t -65.57 -36.66 84.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.153 -0.476 . . . . 62.41 111.162 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -112.1 -37.19 5.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.182 -0.463 . . . . 51.43 110.931 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -77.71 -162.19 0.3 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 53.34 110.898 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 20.7 p -81.09 157.35 25.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.161 -0.472 . . . . 74.02 111.156 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.491 ' HB3' ' CD1' ' A' ' 75' ' ' TRP . 0.2 OUTLIER -96.38 119.15 34.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 63.21 110.909 179.961 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.19 144.11 15.74 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.752 -0.737 . . . . 41.11 112.51 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.9 t -144.98 124.9 13.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.73 0.3 . . . . 75.44 111.169 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 50.9 tt0 -134.73 151.4 50.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 73.44 110.89 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.1 tt -129.12 139.02 52.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 72.55 111.117 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.627 HG22 HG23 ' A' ' 98' ' ' THR . 7.6 p -129.11 121.24 27.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.16 -0.473 . . . . 73.55 111.155 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.452 HG12 ' O ' ' A' ' 97' ' ' LEU . 3.0 p -118.62 134.39 62.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 71.34 111.168 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -106.75 128.12 53.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 61.42 110.874 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 61.34 56.03 2.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.185 -0.461 . . . . 71.33 110.849 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.486 ' HB2' HD23 ' A' ' 97' ' ' LEU . 5.3 tt0 -64.34 -67.52 0.43 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 73.32 110.892 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 56.5 tp -106.6 -53.99 2.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.18 -0.464 . . . . 64.03 110.919 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -106.44 124.44 49.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 74.02 111.109 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 -51.71 133.64 30.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.242 -0.435 . . . . 74.4 110.923 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 99.97 -23.59 35.42 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.734 -0.746 . . . . 60.34 112.479 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.24 134.6 34.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.844 0.354 . . . . 75.2 110.937 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.7 tttp -122.29 131.15 53.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 73.14 110.883 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.486 HD23 ' HB2' ' A' ' 90' ' ' GLN . 1.7 mm? -116.75 130.72 56.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.205 -0.452 . . . . 75.22 110.924 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.627 HG23 HG22 ' A' ' 86' ' ' THR . 51.6 m -129.64 125.0 35.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 64.33 111.106 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -115.42 116.47 28.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.232 -0.44 . . . . 73.53 110.875 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -109.33 133.15 53.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.17 -0.468 . . . . 64.11 110.844 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.4 t -142.87 128.38 19.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 71.21 110.857 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.1 m -108.11 151.02 26.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.131 -0.486 . . . . 62.2 110.866 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -133.23 132.44 41.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 70.54 110.868 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 9.6 t -128.18 109.67 19.73 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.627 0.727 . . . . 55.45 110.9 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.491 ' HD3' HD21 ' A' ' 81' ' ' LEU . 54.0 Cg_endo -69.72 -16.35 37.67 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.623 2.216 . . . . 73.41 112.36 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -48.97 -70.7 0.08 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 63.32 110.839 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.6 m -129.13 31.47 4.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 73.03 111.145 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 67.76 24.22 74.14 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.726 -0.75 . . . . 75.12 112.472 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.55 116.53 13.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.837 0.351 . . . . 74.53 110.891 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 37.0 mtmt -116.01 147.98 40.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.172 -0.467 . . . . 73.33 110.911 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -120.5 132.54 55.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 73.43 110.889 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -114.65 121.48 43.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 64.42 111.129 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 16.5 ttmt -138.03 138.21 38.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.253 -0.431 . . . . 71.13 110.926 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.402 HG23 ' O ' ' A' ' 114' ' ' ILE . 6.1 tp -134.11 123.23 43.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.434 . . . . 50.23 111.144 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 68.7 tttt -119.13 121.0 38.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 74.42 110.922 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.0 t -128.23 125.4 38.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.44 . . . . 63.51 111.136 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -150.7 157.47 27.21 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.78 -0.724 . . . . 71.42 112.494 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 16.3 p90 -132.21 130.78 41.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.939 0.399 . . . . 75.55 110.953 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 29.7 tttp -107.64 118.23 36.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.481 . . . . 75.34 110.884 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 12.4 mmt85 -110.85 142.91 42.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.247 -0.433 . . . . 74.33 110.857 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.491 ' N ' HG22 ' A' ' 3' ' ' VAL . 7.6 pt-20 -52.79 -27.41 17.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 64.11 110.88 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 74.6 t60 -88.08 -39.61 14.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 65.04 110.859 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.581 HD12 ' HA ' ' A' ' 144' ' ' LEU . 8.6 tp -148.41 144.65 18.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 62.42 111.149 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -109.47 119.11 38.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 75.51 110.913 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.62 ' CD2' HD13 ' A' ' 142' ' ' LEU . 2.9 mm? -123.62 139.59 53.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 74.32 110.952 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -145.34 121.77 1.58 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.711 -0.757 . . . . 73.01 112.462 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -112.41 134.44 53.94 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.808 0.337 . . . . 64.53 110.857 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -129.67 133.82 47.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.164 -0.471 . . . . 72.32 110.898 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.416 ' SD ' HG23 ' A' ' 138' ' ' ILE . 2.1 mmt -127.99 129.17 46.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.457 . . . . 64.33 110.855 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -123.23 120.2 32.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 73.53 110.866 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -94.98 127.92 41.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 74.31 110.901 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -134.77 122.71 22.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.112 -0.494 . . . . 64.32 110.858 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.463 ' N ' HD13 ' A' ' 133' ' ' ILE . 0.2 OUTLIER -55.31 -25.25 16.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 74.12 111.133 179.998 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -91.79 -20.03 21.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 63.52 111.095 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 164.04 98.97 0.13 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.711 -0.757 . . . . 62.22 112.452 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.82 138.44 37.63 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.692 2.261 . . . . 65.21 112.328 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.1 m -127.77 159.52 34.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 71.42 110.844 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.564 HD12 ' OG1' ' A' ' 159' ' ' THR . 2.4 mp -123.63 140.83 45.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.105 -0.498 . . . . 63.12 111.121 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 43.7 ttt180 -121.36 120.44 35.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 74.22 110.819 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -112.08 134.0 11.78 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.757 -0.735 . . . . 22.42 112.431 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -134.28 120.71 20.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.762 0.315 . . . . 74.21 111.135 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.637 HD12 ' N ' ' A' ' 143' ' ' VAL . 4.0 tp -131.62 125.74 32.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.229 -0.441 . . . . 73.24 110.92 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.716 HG21 ' HB2' ' A' ' 7' ' ' TYR . 78.5 t -127.93 133.92 66.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.45 . . . . 42.41 111.134 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.581 ' HA ' HD12 ' A' ' 123' ' ' ILE . 1.6 mp -110.04 138.68 46.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 65.23 110.898 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -111.96 124.72 6.89 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.751 -0.738 . . . . 43.3 112.498 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -134.2 145.07 48.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.825 0.345 . . . . 73.24 110.968 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -50.45 96.47 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.125 -0.489 . . . . 62.32 110.903 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 90.02 -26.77 9.18 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.724 -0.75 . . . . 72.3 112.462 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 8.4 m0 -104.91 135.89 45.41 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.819 0.342 . . . . 71.13 110.913 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.488 HD21 ' HB ' ' A' ' 6' ' ' THR . 0.5 OUTLIER -129.91 137.56 50.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 74.24 110.903 179.967 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.492 ' HB3' HD13 ' A' ' 144' ' ' LEU . . . -129.98 137.4 50.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 54.44 111.136 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.777 ' HA3' HD21 ' A' ' 10' ' ' LEU . . . -138.72 136.08 7.8 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.739 -0.743 . . . . 72.53 112.48 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -139.33 119.38 13.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.831 0.348 . . . . 74.24 110.911 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 38.0 tt0 -132.59 122.44 24.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.484 . . . . 64.31 110.895 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 10.7 ptt? -146.12 157.76 43.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 62.41 110.843 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.424 ' O ' ' HB ' ' A' ' 164' ' ' VAL . 5.0 m120 -112.86 121.5 44.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.435 . . . . 74.03 110.868 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.534 ' HD1' HD13 ' A' ' 138' ' ' ILE . 49.0 t80 -84.29 128.63 34.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.121 -0.49 . . . . 70.05 110.854 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.416 ' H ' ' HA ' ' A' ' 164' ' ' VAL . 5.0 tp10 -85.51 107.88 17.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.491 . . . . 71.14 110.899 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.564 ' OG1' HD12 ' A' ' 138' ' ' ILE . 0.2 OUTLIER -65.92 -48.31 71.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.137 -0.483 . . . . 74.2 111.156 -179.919 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -50.24 -26.25 4.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.453 . . . . 72.03 111.066 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 43.6 mttm -117.02 -166.59 1.19 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 73.01 110.872 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 18.8 t -114.26 37.28 3.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 75.12 110.891 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 7.5 ptp85 -168.32 175.01 6.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.112 -0.494 . . . . 73.11 110.867 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.527 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 1.7 m -80.45 142.18 14.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 53.11 111.131 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 7.9 t -91.13 -25.81 19.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.196 -0.456 . . . . 75.55 111.156 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 5.3 tp60 -139.31 133.25 30.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 61.3 110.968 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -125.23 130.54 52.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.178 -0.465 . . . . 71.15 110.878 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -136.07 138.2 41.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 73.15 110.891 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.7 ' HB3' HG22 ' A' ' 184' ' ' VAL . 6.5 t80 -133.26 144.58 49.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 72.14 110.857 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -149.97 137.04 19.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 73.35 111.119 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 21.7 t -121.11 140.53 44.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 72.12 111.127 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -115.24 126.36 7.14 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.736 -0.745 . . . . 71.02 112.51 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -128.43 121.59 29.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.924 0.392 . . . . 73.32 110.928 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 22.3 mtmm -103.39 133.33 48.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.112 -0.494 . . . . 62.23 110.917 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -127.05 165.26 19.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 73.43 111.121 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -38.96 -76.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 70.5 110.828 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -117.13 14.22 14.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 54.14 110.879 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -125.39 150.14 47.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.48 . . . . 74.04 110.889 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 46.2 mm-40 -129.34 124.88 35.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 74.35 110.863 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.601 HD23 HG13 ' A' ' 194' ' ' ILE . 3.0 tm? -122.71 124.49 43.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 61.14 110.893 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 76.4 m-70 -130.72 116.35 17.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.21 -0.45 . . . . 73.05 110.853 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.82 154.46 17.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 65.3 111.143 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -163.0 139.88 7.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.209 -0.451 . . . . 73.02 110.908 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.7 HG22 ' HB3' ' A' ' 169' ' ' PHE . 1.7 m -134.31 137.29 51.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 61.24 111.14 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -97.26 88.48 4.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 71.02 110.869 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 71.43 -174.84 0.17 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 72.41 110.925 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -79.47 3.04 69.39 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.75 -0.738 . . . . 51.13 112.469 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 30.5 p -106.36 -23.35 12.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.783 0.325 . . . . 71.1 111.162 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 189' ' ' GLU . . . . . 0.401 ' O ' ' HB ' ' A' ' 184' ' ' VAL . 1.2 tp10 -120.9 123.13 41.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.215 -0.448 . . . . 70.41 110.899 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 190' ' ' PHE . . . . . 0.568 ' HA ' ' HB ' ' A' ' 184' ' ' VAL . 0.5 OUTLIER -139.06 124.73 19.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 74.21 110.841 -179.884 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -165.1 -156.18 8.94 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.714 -0.755 . . . . 61.25 112.443 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -171.09 -168.56 32.96 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.742 -0.742 . . . . 42.03 112.487 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' SER . . . . . 0.537 ' CB ' ' HB1' ' A' ' 14' ' ' ALA . 39.0 t -147.78 145.52 28.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.837 0.351 . . . . 50.25 110.869 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.601 HG13 HD23 ' A' ' 180' ' ' LEU . 4.5 mp -120.68 133.36 67.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.113 -0.494 . . . . 73.32 111.112 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -117.68 121.18 40.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.192 -0.458 . . . . 74.22 110.932 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 46.0 mm-40 -121.03 131.64 54.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.087 -0.506 . . . . 64.42 110.916 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.413 ' HG2' HG23 ' A' ' 198' ' ' VAL . 23.3 ttpt -97.07 127.4 43.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.173 -0.467 . . . . 60.34 110.895 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.413 HG23 ' HG2' ' A' ' 197' ' ' LYS . 17.9 t 65.01 66.47 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 62.01 111.123 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -112.47 -36.03 5.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.176 -0.465 . . . . 72.3 110.932 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 31.0 tttm -119.77 -67.8 0.96 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 63.12 110.909 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.17 -38.08 1.42 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.209 -0.45 . . . . 74.0 110.892 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.584 HD22 ' H ' ' A' ' 226' ' ' GLN . 15.1 tp -146.1 -74.43 0.22 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.21 -0.45 . . . . 65.43 110.884 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -124.91 142.1 51.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 74.21 110.86 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 1.7 m -146.01 137.56 24.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 73.21 111.198 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.514 ' HB3' HG21 ' A' ' 17' ' ' VAL . . . -150.33 162.69 40.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.23 -0.441 . . . . 41.42 111.056 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 1.3 m -137.26 149.98 26.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.194 -0.457 . . . . 71.41 111.176 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -113.81 135.74 53.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 73.54 110.89 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.429 HD13 ' HA ' ' A' ' 208' ' ' LEU . 3.7 mm? -121.38 145.5 47.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.485 . . . . 75.41 110.906 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.631 ' HB3' ' HB2' ' A' ' 218' ' ' ARG . . . -153.32 138.18 17.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.203 -0.453 . . . . 72.31 111.112 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 9.4 t-105 -130.78 134.94 47.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.188 -0.46 . . . . 74.43 110.945 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 2.3 m -96.9 105.27 17.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.252 -0.431 . . . . 70.55 111.12 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -51.6 132.68 30.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.155 -0.475 . . . . 52.43 111.091 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 117.85 -74.96 0.29 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.766 -0.731 . . . . 73.3 112.446 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -179.95 106.93 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.831 0.348 . . . . 71.11 110.843 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 2.0 t -173.96 161.14 3.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.466 . . . . 55.04 110.845 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -63.61 154.85 31.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 73.1 110.904 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 3.7 m -80.95 133.91 35.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.164 -0.471 . . . . 62.53 111.151 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 218' ' ' ARG . . . . . 0.631 ' HB2' ' HB3' ' A' ' 209' ' ' ALA . 8.1 mmt85 -89.99 118.08 29.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.45 . . . . 73.43 110.844 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 219' ' ' PHE . . . . . 0.706 ' CE1' HD11 ' A' ' 221' ' ' ILE . 18.1 t80 -130.18 137.53 50.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.146 -0.479 . . . . 74.11 110.88 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -142.01 140.64 10.22 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.752 -0.737 . . . . 54.42 112.485 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.706 HD11 ' CE1' ' A' ' 219' ' ' PHE . 4.3 mp -120.53 131.39 72.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.825 0.345 . . . . 74.32 111.142 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.494 ' CB ' HG13 ' A' ' 17' ' ' VAL . . . -137.49 151.22 48.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 74.03 111.076 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -144.98 129.73 18.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 72.32 111.083 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 29.1 mtpt -102.52 125.25 49.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 52.02 110.914 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -124.28 117.76 25.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.254 -0.43 . . . . 73.23 110.91 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 226' ' ' GLN . . . . . 0.584 ' H ' HD22 ' A' ' 202' ' ' LEU . 23.1 tt0 -86.67 104.7 16.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.088 -0.506 . . . . 72.35 110.923 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 1.7 tt -82.68 -31.6 9.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 60.34 111.117 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -161.45 161.44 22.85 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.583 0.706 . . . . 72.34 110.867 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -6.96 19.85 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.664 2.242 . . . . 32.13 112.345 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -112.74 -25.38 9.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.246 -0.434 . . . . 63.31 110.861 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -137.62 145.08 42.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 72.13 111.085 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 25.5 m -136.85 143.14 42.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 75.4 110.915 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -117.73 134.24 55.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 65.45 110.861 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 22.8 t -135.47 152.15 51.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.122 -0.49 . . . . 72.14 110.854 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -139.51 146.27 39.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.087 -0.506 . . . . 71.53 111.129 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.52 159.01 32.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.261 -0.427 . . . . 73.32 110.852 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.624 HG12 ' HA ' ' A' ' 243' ' ' ILE . 1.6 m -141.73 163.97 19.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 53.22 111.097 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -112.89 147.81 36.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 70.44 110.864 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -49.15 -22.36 0.96 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.479 . . . . 73.23 110.854 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 32.2 t -80.99 13.59 2.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 73.21 110.87 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 1.2 t 69.65 40.1 1.43 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.118 -0.492 . . . . 51.34 110.895 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 242' ' ' LEU . . . . . 0.616 ' O ' HG12 ' A' ' 237' ' ' VAL . 2.1 mp -97.23 137.79 35.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.131 -0.486 . . . . 73.31 110.956 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.624 ' HA ' HG12 ' A' ' 237' ' ' VAL . 0.0 OUTLIER -107.15 117.34 52.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 71.1 111.143 179.85 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 244' ' ' GLY . . . . . 0.54 ' C ' HD13 ' A' ' 245' ' ' LEU . . . -139.07 148.47 20.02 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.724 -0.75 . . . . 63.33 112.484 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.732 ' CD2' ' HB3' ' A' ' 261' ' ' ALA . 0.0 OUTLIER -146.65 160.86 41.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.849 0.356 . . . . 74.32 110.939 -179.929 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -134.62 147.95 19.33 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.765 -0.731 . . . . 55.41 112.508 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -127.77 116.94 20.98 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.988 0.423 . . . . 74.42 110.911 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.459 HG23 ' O ' ' A' ' 257' ' ' LEU . 7.5 m -101.78 137.36 40.19 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.08 -0.509 . . . . 71.33 111.079 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 249' ' ' GLN . . . . . 0.7 ' CB ' HD23 ' A' ' 257' ' ' LEU . 1.0 OUTLIER -137.25 165.94 24.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 73.52 110.903 179.971 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 250' ' ' THR . . . . . 0.447 ' O ' ' CB ' ' A' ' 251' ' ' LEU . 23.5 m 65.88 -104.76 0.1 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.45 . . . . 72.22 111.095 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.676 ' O ' HD12 ' A' ' 251' ' ' LEU . 0.2 OUTLIER 79.17 -9.17 1.53 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 53.43 110.91 -179.993 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 252' ' ' LYS . . . . . 0.54 ' CB ' ' HD2' ' A' ' 253' ' ' PRO . 4.5 mttm -48.01 171.88 0.08 OUTLIER Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.6 0.714 . . . . 74.02 110.899 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 253' ' ' PRO . . . . . 0.54 ' HD2' ' CB ' ' A' ' 252' ' ' LYS . 54.0 Cg_endo -69.79 58.33 1.56 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.66 2.24 . . . . 64.13 112.34 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -165.87 -62.7 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.7 -0.762 . . . . 35.32 112.485 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -140.95 139.28 34.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.908 0.385 . . . . 64.21 111.141 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 0.521 ' O ' ' HA ' ' A' ' 279' ' ' LEU . 7.0 tttt -110.16 127.01 54.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 72.52 110.857 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 0.715 ' CD1' HD21 ' A' ' 277' ' ' LEU . 25.0 tp -88.85 122.78 32.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.175 -0.466 . . . . 64.02 110.889 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 258' ' ' THR . . . . . 0.405 ' O ' HD22 ' A' ' 277' ' ' LEU . 4.8 m -126.54 110.14 12.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 71.13 111.148 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 1.088 HD22 HD23 ' A' ' 277' ' ' LEU . 0.0 OUTLIER -103.4 134.01 47.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.196 -0.456 . . . . 55.12 110.913 179.957 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 24.8 p -128.9 140.64 51.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 63.51 110.892 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 261' ' ' ALA . . . . . 0.732 ' HB3' ' CD2' ' A' ' 245' ' ' LEU . . . -147.24 126.09 12.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.484 . . . . 72.34 111.094 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.786 ' C ' HD13 ' A' ' 263' ' ' LEU . 3.2 tm? -131.91 122.96 26.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.458 . . . . 74.42 110.887 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 263' ' ' LEU . . . . . 0.786 HD13 ' C ' ' A' ' 262' ' ' LEU . 0.1 OUTLIER -121.56 109.81 15.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.15 -0.477 . . . . 75.53 110.912 179.867 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 264' ' ' ASP . . . . . 0.673 ' O ' HG22 ' A' ' 268' ' ' VAL . 0.1 OUTLIER -87.19 109.41 19.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 71.4 110.916 179.809 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -56.24 -20.5 29.04 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.743 -0.741 . . . . 71.04 112.488 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.94 -3.54 48.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.799 0.333 . . . . 73.41 110.924 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -123.73 -57.62 1.62 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 73.21 110.886 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 268' ' ' VAL . . . . . 0.71 HG12 ' O ' ' A' ' 272' ' ' GLY . 16.7 m -48.11 -28.24 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 71.01 111.112 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -53.26 -45.77 68.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 60.01 110.929 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -106.14 -16.92 14.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 64.11 111.127 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -108.06 -123.35 4.9 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.719 -0.753 . . . . 43.05 112.474 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 272' ' ' GLY . . . . . 0.71 ' O ' HG12 ' A' ' 268' ' ' VAL . . . -146.47 -163.02 10.15 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.693 -0.765 . . . . 64.44 112.466 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 273' ' ' HIS . . . . . 0.61 ' CB ' HD12 ' A' ' 263' ' ' LEU . 5.6 p80 -105.35 146.26 29.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.83 0.348 . . . . 75.22 110.884 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 12.4 mtpp -104.28 135.68 45.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.228 -0.442 . . . . 73.01 110.887 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.462 HD12 ' HB2' ' A' ' 261' ' ' ALA . 1.3 tp -137.09 148.18 46.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 72.13 110.944 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -144.37 110.56 0.57 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.726 -0.75 . . . . 71.13 112.493 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 1.088 HD23 HD22 ' A' ' 259' ' ' LEU . 3.2 tm? -117.06 139.3 50.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.82 0.343 . . . . 62.21 110.956 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 278' ' ' GLY . . . . . 0.597 ' H ' HD22 ' A' ' 277' ' ' LEU . . . -162.13 154.16 25.05 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.696 -0.764 . . . . 62.15 112.48 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.82 HD23 ' HB2' ' A' ' 29' ' ' LEU . 3.1 mm? -106.88 139.93 40.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.777 0.322 . . . . 71.11 110.865 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -89.1 126.23 35.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 73.41 110.879 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 281' ' ' PHE . . . . . 0.781 ' HA ' ' HA ' ' A' ' 31' ' ' LEU . 15.1 p90 -74.98 71.18 2.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.145 -0.48 . . . . 70.25 110.884 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 67.5 mm-40 -125.07 102.02 7.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.48 . . . . 73.1 110.904 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.62 ' HB1' HD12 ' A' ' 284' ' ' LEU . . . -124.67 136.28 53.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 60.13 111.144 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.914 HD13 HG23 ' A' ' 33' ' ' THR . 4.2 mp 60.83 32.91 20.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 63.13 110.933 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.155 -0.475 . . . . 74.24 110.898 179.962 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.858 0.361 . . . . 64.15 111.023 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.45 HG23 ' HD2' ' A' ' 4' ' ' PRO . 7.1 p -164.3 133.7 2.95 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.662 0.744 . . . . 70.21 111.107 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.45 ' HD2' HG23 ' A' ' 3' ' ' VAL . 53.6 Cg_endo -69.7 167.97 22.81 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.671 2.247 . . . . 71.44 112.383 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 117.97 5.4 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.691 2.261 . . . . 75.43 112.344 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' THR . . . . . 1.066 HG22 HD21 ' A' ' 150' ' ' LEU . 0.2 OUTLIER -92.71 -32.75 14.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.203 -0.453 . . . . 74.22 111.136 -179.946 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.663 ' HB2' HG21 ' A' ' 143' ' ' VAL . 18.0 t80 -55.55 -29.82 59.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.246 -0.434 . . . . 70.33 110.953 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -72.95 -22.58 60.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.091 -0.504 . . . . 44.53 111.056 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -87.57 7.51 29.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.205 -0.452 . . . . 75.14 110.858 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.72 HD21 HG13 ' A' ' 143' ' ' VAL . 50.0 mt -69.22 -31.39 69.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 64.2 110.885 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -172.45 76.23 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.76 -0.733 . . . . 41.55 112.515 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.4 mmtp -69.25 -55.09 11.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.772 0.32 . . . . 54.15 110.87 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.91 -39.64 93.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.452 . . . . 74.34 110.852 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.403 ' HB2' ' HB2' ' A' ' 181' ' ' HIS . . . -58.91 -37.32 76.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.487 . . . . 71.32 111.098 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -59.76 -31.98 70.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 75.12 110.873 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 -57.47 -48.29 79.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 74.02 110.898 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 61.7 t -81.84 -33.07 11.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.461 . . . . 64.53 111.143 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -64.55 -32.43 74.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 75.43 110.83 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 52.4 m -48.6 114.92 1.07 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 73.25 111.163 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.3 mptt -85.03 -168.72 2.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 65.44 110.895 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 99.03 32.15 5.97 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.711 -0.757 . . . . 60.21 112.483 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -119.03 124.78 47.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.927 0.394 . . . . 75.42 110.926 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 62.56 65.85 2.92 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.81 -0.709 . . . . 74.43 112.472 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -102.43 -4.7 25.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.898 0.38 . . . . 74.3 110.911 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.37 13.6 77.14 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.702 -0.761 . . . . 31.03 112.515 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.591 ' C ' HD12 ' A' ' 27' ' ' ILE . 2.2 pp -145.02 -178.35 6.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.737 0.303 . . . . 64.31 110.92 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.591 HD12 ' C ' ' A' ' 26' ' ' LEU . 1.7 mp -119.6 122.41 68.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 75.32 111.137 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.84 117.04 18.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.135 -0.484 . . . . 62.33 110.886 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 1.01 HD13 ' O ' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -114.78 145.33 42.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.211 -0.449 . . . . 75.11 110.942 179.876 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.772 ' N ' HD22 ' A' ' 29' ' ' LEU . 1.3 m-20 -148.06 133.35 18.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.184 -0.462 . . . . 72.4 110.852 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.717 ' HA ' ' HA ' ' A' ' 281' ' ' PHE . 0.2 OUTLIER -127.1 127.79 45.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 73.21 110.87 -179.915 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.613 ' N ' ' HB2' ' A' ' 281' ' ' PHE . 33.5 ttpt -136.56 140.85 43.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 73.21 110.883 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.437 ' O ' HG23 ' A' ' 33' ' ' THR . 8.6 t -135.5 121.66 20.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 72.5 111.166 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.793 ' HG2' HD21 ' A' ' 284' ' ' LEU . 1.7 pttp -105.13 125.85 51.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.25 -0.432 . . . . 71.51 110.904 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.5 t -114.71 142.79 46.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 72.31 110.827 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -77.17 58.25 1.55 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 74.15 110.89 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -152.86 19.89 0.59 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.143 -0.481 . . . . 73.43 110.88 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.453 ' HA2' ' C ' ' A' ' 63' ' ' ARG . . . 81.01 -4.99 67.68 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.715 -0.755 . . . . 71.14 112.487 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.3 mp -98.42 128.23 44.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.769 0.319 . . . . 74.1 110.902 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -140.97 117.56 10.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 73.53 110.894 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -103.24 122.66 45.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 64.33 110.891 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 90.3 m -126.5 126.31 43.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.137 -0.483 . . . . 63.42 111.142 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.3 p -132.46 142.22 49.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 63.21 110.843 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 58.1 m -149.03 135.84 19.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 71.31 110.874 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -148.02 141.65 9.37 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.702 -0.761 . . . . 65.12 112.44 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 9.0 m -126.91 157.56 39.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.858 0.361 . . . . 70.41 110.887 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.595 ' HB1' HG22 ' A' ' 54' ' ' VAL . . . -157.11 131.14 8.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.152 -0.476 . . . . 71.42 111.09 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -101.53 141.99 33.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.446 . . . . 73.12 110.893 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 22.2 p -51.03 -34.47 29.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 55.35 111.105 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -51.34 168.24 0.07 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.188 -0.46 . . . . 63.24 110.876 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.2 t -73.05 136.26 44.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 74.12 111.162 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 66.9 p 47.06 71.6 0.31 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.259 -0.428 . . . . 60.31 111.112 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 18.6 mmtp -143.54 35.3 1.3 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.2 -0.455 . . . . 72.32 110.91 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.595 HG22 ' HB1' ' A' ' 47' ' ' ALA . 46.3 t -109.19 124.11 65.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 52.22 111.145 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.6 m -136.11 126.94 27.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 53.12 111.137 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -127.39 141.54 12.73 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.747 -0.74 . . . . 73.01 112.524 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 59.5 p -144.1 160.48 40.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.922 0.392 . . . . 74.14 110.882 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -132.55 150.18 52.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.143 -0.48 . . . . 74.11 110.894 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.408 ' HB3' ' HA ' ' A' ' 74' ' ' LYS . 1.1 pm0 -136.14 136.18 39.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 74.24 110.9 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.9 p -103.07 129.57 49.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.151 -0.477 . . . . 72.23 111.093 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.1 mtpm? -129.9 159.59 36.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 65.5 110.889 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -130.32 139.65 50.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.217 -0.447 . . . . 74.03 110.929 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.453 ' C ' ' HA2' ' A' ' 38' ' ' GLY . 0.5 OUTLIER -134.51 105.17 6.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.134 -0.484 . . . . 75.44 110.881 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -115.06 101.68 9.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.46 . . . . 72.14 110.952 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.7 t -83.37 -31.76 26.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 64.55 111.149 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -48.47 -34.16 10.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.2 -0.454 . . . . 73.21 110.904 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.557 ' CD1' HD23 ' A' ' 69' ' ' LEU . 29.7 t80 -118.02 -58.34 2.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.18 -0.464 . . . . 71.33 110.936 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.651 ' O ' HD22 ' A' ' 69' ' ' LEU . . . 129.34 58.17 0.1 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.778 -0.725 . . . . 63.15 112.516 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.651 HD22 ' O ' ' A' ' 68' ' ' GLY . 2.4 mm? -133.65 141.33 47.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.852 0.358 . . . . 62.44 110.891 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 95.6 m -135.57 130.4 34.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 64.01 111.141 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -119.23 134.82 54.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 73.41 110.875 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.534 HG23 ' HB2' ' A' ' 84' ' ' GLU . 0.6 OUTLIER -126.73 117.41 22.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.463 . . . . 73.21 111.152 -179.897 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -132.03 131.47 42.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.27 -0.423 . . . . 73.33 110.875 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.408 ' HA ' ' HB3' ' A' ' 59' ' ' GLU . 17.1 ptmt -117.66 135.86 53.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 74.33 110.931 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 12.7 t90 -135.48 128.46 31.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.213 -0.449 . . . . 75.12 110.925 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -120.52 159.52 25.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 70.25 110.872 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 10.5 t -66.79 -13.37 61.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.157 -0.474 . . . . 63.34 111.108 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.443 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 94.9 m-20 -74.92 1.23 13.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.254 -0.43 . . . . 71.41 110.894 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.443 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 2.9 m120 78.72 33.19 0.28 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 75.34 110.91 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 33.3 m -114.89 123.4 49.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.145 -0.48 . . . . 63.24 111.119 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -122.05 119.62 31.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 73.31 110.897 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.76 111.72 3.74 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.731 -0.747 . . . . 60.24 112.473 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.0 t -93.03 120.69 33.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.795 0.331 . . . . 43.11 111.119 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.534 ' HB2' HG23 ' A' ' 72' ' ' THR . 26.8 mt-10 -134.06 126.69 30.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.45 . . . . 65.03 110.871 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.406 HG22 ' HB3' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -115.4 138.46 45.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.163 -0.472 . . . . 53.4 111.157 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 99.8 m -129.51 137.72 50.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.202 -0.453 . . . . 70.32 111.126 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.456 ' HB ' HD23 ' A' ' 97' ' ' LEU . 1.8 t -118.14 137.28 52.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.44 . . . . 72.34 111.149 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -113.71 118.32 33.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 75.34 110.901 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 50.88 74.77 0.21 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.462 . . . . 73.13 110.901 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -96.7 -75.59 0.53 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 74.12 110.885 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 40.9 tp -92.24 -72.37 0.6 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.21 -0.45 . . . . 62.44 110.916 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.571 ' HB3' ' HB2' ' A' ' 95' ' ' LEU . . . -77.53 139.7 39.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 51.34 111.122 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 2.6 ptt180 -60.08 125.09 22.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 74.33 110.868 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 78.73 8.94 87.48 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.756 -0.735 . . . . 44.35 112.502 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.571 ' HB2' ' HB3' ' A' ' 92' ' ' ALA . 13.8 tp -79.32 134.18 36.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.876 0.37 . . . . 62.21 110.928 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.9 ptmt -121.38 127.51 51.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 64.34 110.905 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.458 HD22 ' N ' ' A' ' 97' ' ' LEU . 1.7 mm? -115.03 129.2 56.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.223 -0.444 . . . . 65.05 110.9 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 69.0 m -129.55 119.87 24.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 65.23 111.19 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.406 ' HB3' HG22 ' A' ' 85' ' ' ILE . 3.1 t80 -122.28 128.71 51.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 65.32 110.858 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -127.84 130.48 48.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.128 -0.487 . . . . 40.11 110.831 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.7 t -142.3 125.93 16.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 73.2 110.88 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.1 t -97.87 131.71 44.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 70.12 110.849 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -129.54 119.69 24.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.106 -0.497 . . . . 74.53 110.878 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -128.83 101.9 19.91 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.661 0.743 . . . . 65.04 110.832 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -37.81 8.58 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.703 2.268 . . . . 74.51 112.334 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -61.57 -75.01 0.07 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 73.53 110.865 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -63.85 -39.0 93.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 51.32 111.153 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.14 24.42 14.79 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.739 -0.744 . . . . 74.55 112.473 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 64.2 mmtt -94.07 148.15 22.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.864 0.364 . . . . 71.03 110.863 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -140.61 135.5 31.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 75.34 110.842 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -121.59 140.84 51.73 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.199 -0.455 . . . . 72.21 110.912 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -127.77 118.02 22.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 72.14 111.077 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 21.3 ttmm -138.45 137.5 37.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 64.44 110.895 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 6.0 tp -134.55 126.73 48.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 73.15 111.154 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -127.45 120.39 28.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 74.43 110.868 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 70.2 p -129.06 127.88 42.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.211 -0.45 . . . . 62.54 111.083 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -150.42 162.39 29.26 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.676 -0.773 . . . . 63.5 112.481 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 6.6 p90 -127.44 141.19 51.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.953 0.406 . . . . 74.34 110.898 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.43 ' NZ ' HD22 ' A' ' 124' ' ' ASN . 5.3 mmmt -110.15 122.71 48.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.075 -0.511 . . . . 72.41 110.908 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.1 mmt85 -106.28 145.29 31.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.273 -0.421 . . . . 71.42 110.865 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -49.67 -28.51 6.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 74.03 110.927 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 7.8 m170 -87.11 -45.33 10.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 73.41 110.853 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.429 HG21 HD23 ' A' ' 144' ' ' LEU . 11.8 pt -152.34 153.86 8.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 42.11 111.119 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.43 HD22 ' NZ ' ' A' ' 119' ' ' LYS . 17.6 p-10 -117.98 116.61 27.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.468 . . . . 44.41 110.907 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.671 ' HB3' HD13 ' A' ' 142' ' ' LEU . 0.4 OUTLIER -131.46 141.93 49.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 73.55 110.932 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -147.9 149.01 21.03 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.743 -0.741 . . . . 54.02 112.483 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 31.0 p -112.83 134.72 54.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.827 0.346 . . . . 62.41 110.896 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -117.35 150.8 38.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 73.11 110.857 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 43.2 ttm -135.98 135.98 39.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 74.35 110.851 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -122.53 128.09 50.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 72.43 110.842 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -95.55 97.69 9.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.456 . . . . 71.14 110.888 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -92.05 175.75 6.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 72.33 110.877 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.42 HD12 ' N ' ' A' ' 134' ' ' ALA . 2.5 pp -73.92 -37.51 47.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.262 -0.426 . . . . 63.4 111.089 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.42 ' N ' HD12 ' A' ' 133' ' ' ILE . . . -78.39 -20.43 51.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 74.24 111.081 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 155.22 150.7 5.64 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.778 -0.725 . . . . 65.44 112.483 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 107.92 1.97 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.697 2.265 . . . . 62.31 112.349 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.65 152.79 29.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.247 -0.433 . . . . 63.43 110.909 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.416 HD12 ' N ' ' A' ' 138' ' ' ILE . 5.0 mp -106.16 132.33 53.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.455 . . . . 74.12 111.14 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 12.3 ttm180 -122.58 133.48 54.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 61.11 110.865 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -127.61 133.3 7.81 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.753 -0.737 . . . . 65.01 112.502 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -140.65 116.07 10.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.824 0.345 . . . . 45.3 111.12 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.697 HD12 ' N ' ' A' ' 143' ' ' VAL . 3.2 tp -129.1 133.79 47.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 64.3 110.89 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.72 HG13 HD21 ' A' ' 10' ' ' LEU . 61.7 t -128.44 120.97 54.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 70.41 111.146 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.558 HD11 HD21 ' A' ' 142' ' ' LEU . 4.4 mp -114.72 139.94 49.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 72.44 110.925 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -129.51 124.62 4.53 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.772 -0.728 . . . . 62.14 112.533 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -144.93 146.62 32.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.817 0.341 . . . . 53.23 110.922 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 50.29 30.75 4.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.475 . . . . 71.25 110.896 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 85.9 -28.71 4.89 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.727 -0.749 . . . . 61.23 112.522 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 29.9 m0 -69.31 134.83 49.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.833 0.349 . . . . 64.33 110.938 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 1.066 HD21 HG22 ' A' ' 6' ' ' THR . 0.0 OUTLIER -108.5 137.81 45.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.256 -0.429 . . . . 43.34 110.892 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -135.96 126.12 26.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 73.43 111.073 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -132.15 146.34 18.01 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.743 -0.742 . . . . 21.53 112.477 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -143.49 119.26 10.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.783 0.325 . . . . 70.52 110.914 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -122.53 120.67 34.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 74.31 110.886 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 4.0 ptt? -148.13 143.52 27.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.251 -0.431 . . . . 71.42 110.882 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -113.64 131.54 56.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 74.44 110.87 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.505 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 9.8 m-85 -93.28 138.89 31.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 61.04 110.858 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.512 ' CG ' ' O ' ' A' ' 158' ' ' GLU . 5.2 pt-20 -76.4 117.32 17.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.105 -0.498 . . . . 74.42 110.876 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 9.8 t -67.23 -31.69 72.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.141 -0.482 . . . . 72.24 111.135 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -47.9 -23.92 0.89 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.215 -0.448 . . . . 64.42 111.129 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.99 -157.65 0.36 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.449 . . . . 74.31 110.9 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 54.1 m -99.51 40.82 1.19 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 42.21 110.858 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.45 173.42 7.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 75.2 110.923 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.505 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 2.5 t -105.82 141.04 22.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.444 . . . . 74.31 111.117 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -88.7 -37.26 15.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.131 -0.486 . . . . 62.31 111.149 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -155.8 131.87 10.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 64.43 110.882 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 2.2 p -127.05 109.63 12.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 71.25 110.878 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -130.87 142.33 50.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 65.23 110.88 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -132.39 156.57 46.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.194 -0.457 . . . . 74.23 110.861 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -154.89 129.89 9.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.117 -0.492 . . . . 75.4 111.081 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 41.2 t -126.86 134.12 66.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 74.45 111.136 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -107.93 124.07 7.38 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.741 -0.743 . . . . 75.5 112.464 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -113.97 122.36 46.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.978 0.418 . . . . 63.22 110.869 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -102.89 133.53 47.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.08 -0.509 . . . . 73.3 110.915 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.59 165.22 21.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 41.31 111.13 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -40.27 -75.38 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 63.21 110.898 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -116.66 14.91 15.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.214 -0.448 . . . . 74.33 110.889 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -126.16 149.55 48.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.131 -0.486 . . . . 63.42 110.863 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -133.26 124.44 27.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.115 -0.493 . . . . 73.34 110.922 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.594 HD23 HG13 ' A' ' 194' ' ' ILE . 2.6 tm? -123.55 126.09 46.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 73.33 110.907 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 181' ' ' HIS . . . . . 0.52 ' N ' HD22 ' A' ' 180' ' ' LEU . 51.1 m-70 -130.59 114.86 15.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.446 . . . . 71.05 110.875 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 2.1 t -106.51 151.05 25.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.269 -0.423 . . . . 72.34 111.167 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -162.38 136.95 6.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 62.11 110.879 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.764 HG13 ' HB3' ' A' ' 190' ' ' PHE . 2.3 t -123.68 127.79 74.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.483 . . . . 72.4 111.129 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -120.69 83.03 2.0 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 75.4 110.887 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -48.25 -20.13 0.35 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 75.13 110.868 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -74.89 -33.08 56.04 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.793 -0.718 . . . . 70.03 112.49 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 69.0 p -123.48 -55.37 1.74 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.718 0.294 . . . . 53.13 111.135 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 189' ' ' GLU . . . . . 0.689 ' HG3' ' HB1' ' A' ' 209' ' ' ALA . 0.9 OUTLIER -165.87 152.98 10.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 72.3 110.901 179.998 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 190' ' ' PHE . . . . . 0.764 ' HB3' HG13 ' A' ' 184' ' ' VAL . 10.0 p90 -114.45 125.16 53.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 70.42 110.884 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -175.72 -132.36 1.59 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.745 -0.741 . . . . 74.42 112.489 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -176.4 -165.92 32.81 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.77 -0.729 . . . . 72.13 112.491 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -149.33 150.33 32.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.803 0.335 . . . . 52.53 110.9 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.594 HG13 HD23 ' A' ' 180' ' ' LEU . 4.2 mp -120.62 143.02 33.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 74.5 111.158 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -127.74 121.3 29.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.178 -0.465 . . . . 72.42 110.942 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 6.1 tm0? -124.57 130.43 52.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 75.11 110.963 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 20.5 tttt -107.12 127.77 53.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 72.54 110.876 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 98.5 t -74.34 -74.62 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 72.22 111.083 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -170.82 65.32 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 73.23 110.909 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? 48.29 33.47 3.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.143 -0.481 . . . . 61.11 110.915 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 6.2 ttmm -140.98 -43.74 0.38 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 74.11 110.881 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 6.1 mp -131.05 128.47 40.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.237 -0.438 . . . . 75.05 110.902 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -114.88 131.2 56.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 74.24 110.908 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 21.7 m -124.06 138.58 54.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.186 -0.461 . . . . 72.12 111.145 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -141.5 137.93 32.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.434 . . . . 71.1 111.139 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.91 HG22 HG22 ' A' ' 221' ' ' ILE . 30.3 t -112.93 140.69 31.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 63.01 111.079 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 207' ' ' ASN . . . . . 0.621 ' O ' HD22 ' A' ' 208' ' ' LEU . 3.5 m120 -114.95 134.22 55.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.475 . . . . 60.52 110.881 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.621 HD22 ' O ' ' A' ' 207' ' ' ASN . 2.8 mm? -134.16 130.71 37.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 72.33 110.925 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.689 ' HB1' ' HG3' ' A' ' 189' ' ' GLU . . . -156.42 132.11 9.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 53.12 111.083 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 210' ' ' TRP . . . . . 0.563 ' CE3' HG23 ' A' ' 217' ' ' THR . 3.8 t-105 -110.66 135.01 51.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.208 -0.451 . . . . 64.21 110.964 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 211' ' ' THR . . . . . 0.436 HG23 ' O ' ' A' ' 211' ' ' THR . 3.3 t -93.39 111.36 23.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.253 -0.43 . . . . 53.44 111.092 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -51.11 136.81 23.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 60.24 111.076 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 117.36 -83.98 0.36 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.765 -0.731 . . . . 71.12 112.541 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -79.37 179.11 7.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.854 0.359 . . . . 65.23 110.864 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 9.7 p -103.36 36.43 2.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 72.12 110.867 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 35.0 m120 -102.09 125.2 48.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 70.33 110.874 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 217' ' ' THR . . . . . 0.563 HG23 ' CE3' ' A' ' 210' ' ' TRP . 0.6 OUTLIER -105.34 137.6 42.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 60.11 111.141 -179.955 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 -97.62 117.66 32.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.258 -0.428 . . . . 72.31 110.837 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -128.34 132.11 48.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 73.22 110.874 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -145.2 160.99 28.15 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.735 -0.745 . . . . 73.15 112.474 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.91 HG22 HG22 ' A' ' 206' ' ' VAL . 0.0 OUTLIER -138.89 130.51 35.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.807 0.337 . . . . 74.52 111.104 -179.947 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -126.84 130.83 50.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 74.0 111.114 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -119.2 130.81 55.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.257 -0.429 . . . . 73.41 111.104 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -106.76 128.47 54.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.436 . . . . 73.52 110.872 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -127.07 117.67 22.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 74.53 110.934 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -84.7 123.91 30.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 71.14 110.942 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 227' ' ' ILE . . . . . 0.517 HD12 ' CD2' ' A' ' 233' ' ' PHE . 64.6 mt -108.9 -33.56 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.446 . . . . 72.33 111.157 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -143.42 161.22 48.37 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.583 0.706 . . . . 71.15 110.918 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -19.32 36.22 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.738 2.292 . . . . 73.25 112.31 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -109.78 -27.06 9.51 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.224 -0.443 . . . . 53.3 110.893 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -124.6 141.95 51.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.469 . . . . 63.04 111.124 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 57.6 m -139.31 142.58 37.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.196 -0.456 . . . . 73.1 110.862 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 233' ' ' PHE . . . . . 0.517 ' CD2' HD12 ' A' ' 227' ' ' ILE . 2.5 m-85 -98.79 133.11 43.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.175 -0.466 . . . . 73.53 110.89 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 24.6 p -135.09 128.31 31.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 71.1 110.843 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -128.98 158.45 38.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 54.2 111.093 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.52 164.27 36.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 64.34 110.913 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 242' ' ' LEU . 10.0 p -154.86 143.19 13.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 74.13 111.148 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -102.52 148.47 25.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 75.43 110.869 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 14.1 t30 -54.09 -21.68 9.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 74.41 110.901 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 46.4 t -80.84 25.76 0.44 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.45 . . . . 64.34 110.843 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 1.9 m 59.2 39.29 22.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 62.54 110.926 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 242' ' ' LEU . . . . . 0.692 HD22 ' HB3' ' A' ' 264' ' ' ASP . 22.6 mt -99.4 118.11 35.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.093 -0.503 . . . . 63.32 110.915 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.437 ' H ' HD12 ' A' ' 243' ' ' ILE . 5.4 mp -84.62 125.92 40.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.172 -0.467 . . . . 75.43 111.102 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -128.21 132.81 7.49 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.771 -0.728 . . . . 73.21 112.496 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.422 ' CD1' ' HB3' ' A' ' 261' ' ' ALA . 1.3 pp -146.14 140.88 26.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.882 0.372 . . . . 61.43 110.902 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -153.13 150.32 22.05 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.677 -0.773 . . . . 71.21 112.445 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -128.39 132.19 48.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.943 0.401 . . . . 74.11 110.947 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.02 123.94 50.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 60.44 111.131 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -143.09 129.59 20.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 75.34 110.873 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 250' ' ' THR . . . . . 0.41 HG23 ' HG2' ' A' ' 256' ' ' LYS . 3.1 m -80.62 142.31 34.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.222 -0.444 . . . . 65.24 111.174 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.662 HD23 ' HD2' ' A' ' 253' ' ' PRO . 7.6 tp -72.84 -70.74 0.34 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 74.33 110.888 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 252' ' ' LYS . . . . . 0.5 ' N ' ' HD2' ' A' ' 253' ' ' PRO . 16.9 ttpt 178.35 -59.45 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.6 0.714 . . . . 71.4 110.926 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 253' ' ' PRO . . . . . 0.662 ' HD2' HD23 ' A' ' 251' ' ' LEU . 54.0 Cg_endo -69.74 -86.64 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.705 2.27 . . . . 64.21 112.342 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -145.72 16.58 1.8 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.734 -0.746 . . . . 71.01 112.484 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.414 HG12 HD23 ' A' ' 31' ' ' LEU . 3.7 mt -105.32 118.07 52.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.882 0.372 . . . . 75.53 111.094 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 0.55 ' O ' ' HA ' ' A' ' 279' ' ' LEU . 0.0 OUTLIER -99.09 135.06 41.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 75.11 110.88 179.856 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 0.527 ' CD2' HD21 ' A' ' 277' ' ' LEU . 0.3 OUTLIER -94.08 124.02 37.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.464 . . . . 74.13 110.887 179.949 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 27.5 p -128.15 111.68 13.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.448 . . . . 75.21 111.121 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.907 HD22 HD23 ' A' ' 277' ' ' LEU . 0.1 OUTLIER -109.9 126.24 53.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.242 -0.435 . . . . 72.04 110.928 179.901 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.452 ' N ' HD13 ' A' ' 259' ' ' LEU . 4.1 m -126.49 140.86 52.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 74.25 110.839 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 261' ' ' ALA . . . . . 0.422 ' HB3' ' CD1' ' A' ' 245' ' ' LEU . . . -144.21 128.52 17.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.121 -0.491 . . . . 61.31 111.116 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.693 ' C ' HD13 ' A' ' 263' ' ' LEU . 0.7 OUTLIER -121.66 120.77 35.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.446 . . . . 63.43 110.913 -179.939 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 263' ' ' LEU . . . . . 0.693 HD13 ' C ' ' A' ' 262' ' ' LEU . 0.2 OUTLIER -119.95 109.77 15.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.446 . . . . 73.31 110.887 179.913 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 264' ' ' ASP . . . . . 0.692 ' HB3' HD22 ' A' ' 242' ' ' LEU . 3.0 p30 -90.95 115.78 28.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.454 . . . . 64.22 110.853 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 265' ' ' GLY . . . . . 0.425 ' HA2' HG22 ' A' ' 268' ' ' VAL . . . -55.45 -18.38 15.04 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.704 -0.76 . . . . 43.22 112.5 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 6.4 ttpp -79.09 -25.99 43.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.836 0.35 . . . . 73.2 110.942 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -109.59 -54.46 2.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 72.13 110.916 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 268' ' ' VAL . . . . . 0.644 HG22 ' O ' ' A' ' 264' ' ' ASP . 13.8 m -51.04 -29.03 7.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.48 . . . . 64.52 111.109 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -52.43 -35.12 51.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 73.34 110.901 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -103.67 -17.44 15.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.123 -0.489 . . . . 71.23 111.074 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 125.7 98.58 1.14 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.721 -0.752 . . . . 43.24 112.498 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 272' ' ' GLY . . . . . 0.405 ' O ' HG12 ' A' ' 268' ' ' VAL . . . 168.2 93.13 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.716 -0.754 . . . . 71.52 112.465 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 273' ' ' HIS . . . . . 0.499 ' CB ' HD12 ' A' ' 263' ' ' LEU . 9.6 p80 -113.43 144.5 42.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.877 0.37 . . . . 74.24 110.859 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 43.5 mmtm -101.12 136.85 40.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 73.22 110.874 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.729 HD13 ' N ' ' A' ' 276' ' ' GLY . 2.2 tm? -135.85 137.71 41.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.476 . . . . 73.52 110.89 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 276' ' ' GLY . . . . . 0.729 ' N ' HD13 ' A' ' 275' ' ' LEU . . . -139.56 136.37 7.81 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.721 -0.752 . . . . 73.22 112.464 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.907 HD23 HD22 ' A' ' 259' ' ' LEU . 3.1 tm? -132.52 138.2 47.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.898 0.38 . . . . 74.33 110.9 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 278' ' ' GLY . . . . . 0.588 ' H ' HD22 ' A' ' 277' ' ' LEU . . . -160.67 161.01 32.41 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.761 -0.733 . . . . 75.04 112.455 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.74 HD23 ' HB2' ' A' ' 29' ' ' LEU . 2.9 mm? -113.93 143.37 44.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.815 0.34 . . . . 75.13 110.937 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 280' ' ' GLU . . . . . 0.421 ' HB2' ' HB3' ' A' ' 256' ' ' LYS . 0.9 OUTLIER -91.37 130.1 37.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 75.3 110.87 179.994 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 281' ' ' PHE . . . . . 0.717 ' HA ' ' HA ' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -76.33 60.26 1.52 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 71.32 110.89 -179.941 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -109.38 97.74 7.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.133 -0.485 . . . . 72.25 110.875 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.478 ' HB2' HD11 ' A' ' 31' ' ' LEU . . . -128.65 110.93 12.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.212 -0.449 . . . . 65.53 111.117 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.793 HD21 ' HG2' ' A' ' 34' ' ' LYS . 94.6 mt -152.15 178.38 9.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 63.44 110.923 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 42.2 tp10 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 71.15 110.864 179.941 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.097 0 CA-C-O 120.845 0.355 . . . . 61.52 111.07 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.724 HG13 ' HA ' ' A' ' 121' ' ' GLU . 0.0 OUTLIER -134.87 158.46 74.93 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.633 0.73 . . . . 75.51 111.124 179.997 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.85 170.25 17.11 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.688 2.259 . . . . 74.12 112.321 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 77.74 1.06 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.643 2.229 . . . . 64.32 112.36 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.561 HG22 HD11 ' A' ' 150' ' ' LEU . 2.6 p -70.37 -45.75 65.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 74.44 111.132 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 91.2 t80 -52.46 -32.38 39.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 75.05 110.901 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -82.18 -26.53 33.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 72.15 111.116 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -74.21 -12.86 60.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 72.23 110.843 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.427 HD21 ' O ' ' A' ' 152' ' ' GLY . 0.7 OUTLIER -56.42 -34.42 66.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 73.21 110.896 -179.961 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 142.45 64.77 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.762 -0.732 . . . . 52.32 112.529 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.6 ttpp -69.35 -42.12 75.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.801 0.334 . . . . 74.24 110.873 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.6 t -63.65 -39.35 94.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.207 -0.451 . . . . 64.15 110.901 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.8 -37.93 74.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.074 -0.512 . . . . 74.11 111.112 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 3.1 tmt_? -60.77 -33.12 72.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.444 . . . . 73.13 110.858 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.638 ' O ' HG23 ' A' ' 19' ' ' THR . 4.7 t0 -58.46 -40.0 81.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.45 . . . . 70.22 110.834 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.6 t -58.91 -39.42 77.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 73.32 111.113 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -60.54 -41.07 93.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.481 . . . . 45.11 110.866 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.638 HG23 ' O ' ' A' ' 16' ' ' ASP . 1.1 p 46.75 69.2 0.51 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 64.3 111.191 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 16.0 tptm -69.24 112.48 5.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 61.1 110.921 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 63.5 99.44 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.737 -0.744 . . . . 62.35 112.476 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -172.9 129.36 0.49 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.945 0.402 . . . . 74.15 110.908 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.52 40.84 3.09 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.784 -0.722 . . . . 73.12 112.501 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -103.18 13.01 34.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.911 0.386 . . . . 65.42 110.892 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 80.79 15.44 77.66 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.773 -0.727 . . . . 65.04 112.46 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.507 ' C ' HD13 ' A' ' 27' ' ' ILE . 0.1 OUTLIER -105.89 168.74 8.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.799 0.333 . . . . 61.11 110.917 -179.93 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.734 HG23 HD12 ' A' ' 277' ' ' LEU . 2.8 mm -120.2 123.42 70.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.234 -0.439 . . . . 72.43 111.089 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.6 ttmt -115.2 118.15 32.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.465 . . . . 75.23 110.921 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.617 HD12 ' CB ' ' A' ' 279' ' ' LEU . 1.0 OUTLIER -114.68 142.99 45.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 63.41 110.915 179.955 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -147.82 128.62 14.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 71.21 110.851 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.686 HD13 ' HB3' ' A' ' 281' ' ' PHE . 5.7 tp -127.2 128.78 46.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 71.14 110.908 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.673 ' N ' HD12 ' A' ' 31' ' ' LEU . 2.0 pttm -124.83 125.48 44.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 71.23 110.887 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.479 HG22 ' HB2' ' A' ' 283' ' ' ALA . 6.6 p -135.2 120.8 19.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.199 -0.455 . . . . 60.34 111.158 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.581 ' O ' HD21 ' A' ' 284' ' ' LEU . 53.1 mttm -118.75 129.99 55.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 74.25 110.91 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.2 t -116.14 138.29 51.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 73.23 110.87 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -77.41 59.25 1.83 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.157 -0.474 . . . . 74.02 110.889 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -160.51 25.27 0.15 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 73.35 110.805 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.51 ' HA2' ' O ' ' A' ' 63' ' ' ARG . . . 79.7 -4.11 66.31 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.737 -0.744 . . . . 43.14 112.526 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.5 mp -98.23 126.11 43.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.782 0.325 . . . . 64.21 110.897 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.1 118.39 10.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.172 -0.467 . . . . 62.11 110.861 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -103.71 124.15 48.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.152 -0.476 . . . . 73.42 110.883 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.11 115.5 19.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 73.43 111.124 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.42 138.12 53.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 63.35 110.863 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 27.0 m -150.6 126.96 10.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 71.34 110.905 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -164.53 166.43 37.89 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.726 -0.749 . . . . 60.0 112.489 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 60.3 m -138.03 168.62 19.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.877 0.37 . . . . 71.22 110.878 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.426 ' HB1' HG12 ' A' ' 54' ' ' VAL . . . -134.13 139.52 45.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.126 -0.488 . . . . 74.41 111.096 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -113.41 141.43 47.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 65.41 110.919 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.421 HG22 ' H ' ' A' ' 50' ' ' GLU . 0.2 OUTLIER 64.07 169.53 0.17 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 64.15 111.109 -179.986 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.421 ' H ' HG22 ' A' ' 49' ' ' THR . 0.0 OUTLIER -74.28 94.52 2.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.462 . . . . 70.13 110.863 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 61.5 p 45.98 84.01 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.127 -0.488 . . . . 65.32 111.134 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.7 m -151.5 -59.66 0.17 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.237 -0.438 . . . . 73.44 111.196 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 18.0 mmtp -142.33 113.69 7.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 75.21 110.897 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.426 HG12 ' HB1' ' A' ' 47' ' ' ALA . 1.0 OUTLIER -125.55 147.54 30.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 75.33 111.142 179.836 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.2 p -110.32 126.57 54.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 51.54 111.13 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -118.76 143.63 17.55 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.72 -0.753 . . . . 60.53 112.503 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.85 142.51 50.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.968 0.413 . . . . 61.44 110.851 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.661 HD13 ' N ' ' A' ' 59' ' ' GLU . 0.8 OUTLIER -120.86 132.85 55.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 70.35 110.948 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.661 ' N ' HD13 ' A' ' 58' ' ' LEU . 3.4 tt0 -134.0 124.65 26.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 71.51 110.889 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 27.0 m -104.77 130.35 52.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 62.22 111.146 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 8.5 ttpt -132.48 156.93 45.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.239 -0.437 . . . . 71.13 110.919 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.564 ' O ' HG23 ' A' ' 70' ' ' THR . 26.0 m-85 -129.06 140.68 51.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.282 -0.417 . . . . 73.53 110.939 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.51 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 27.9 ttp85 -127.99 105.37 8.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 71.15 110.894 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.414 ' HB3' ' HG2' ' A' ' 66' ' ' GLU . 5.6 m-90 -113.19 134.33 54.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 63.11 110.935 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 30.3 p -69.82 -27.17 64.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.275 -0.42 . . . . 75.21 111.122 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.414 ' HG2' ' HB3' ' A' ' 64' ' ' TRP . 1.9 pt-20 -52.51 102.53 0.05 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.211 -0.45 . . . . 74.33 110.889 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.447 ' CD2' HD21 ' A' ' 69' ' ' LEU . 7.3 t80 65.33 9.77 5.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.149 -0.478 . . . . 75.03 110.902 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.597 ' O ' HD23 ' A' ' 69' ' ' LEU . . . 57.33 70.27 1.03 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.77 -0.729 . . . . 74.1 112.491 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.597 HD23 ' O ' ' A' ' 68' ' ' GLY . 5.7 mt -119.15 137.21 53.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.859 0.361 . . . . 65.3 110.9 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.564 HG23 ' O ' ' A' ' 62' ' ' TYR . 27.7 m -136.24 127.84 28.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 72.51 111.163 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.569 ' HB3' HG22 ' A' ' 85' ' ' ILE . 4.3 m-85 -121.79 121.62 37.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 71.32 110.86 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 61' ' ' LYS . 14.4 t -119.87 136.22 54.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 62.15 111.133 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -131.06 122.82 27.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 70.22 110.88 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.9 ptmt -95.51 135.99 36.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 74.42 110.91 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 8.7 t90 -134.81 128.84 33.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.246 -0.434 . . . . 74.2 110.926 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -117.85 154.93 31.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 62.14 110.878 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 7.3 t -62.48 -16.47 55.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.127 -0.488 . . . . 74.31 111.142 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.423 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 2.4 m-20 -74.61 0.78 13.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.258 -0.428 . . . . 70.43 110.89 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.423 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 3.7 m120 78.53 37.19 0.18 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.465 . . . . 63.44 110.877 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.6 p -113.58 121.54 44.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 74.32 111.144 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.402 HD13 ' HA ' ' A' ' 81' ' ' LEU . 4.3 mm? -111.23 132.96 53.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 70.13 110.966 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -123.61 92.84 0.46 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.803 -0.713 . . . . 73.32 112.517 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -79.34 106.1 11.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.821 0.343 . . . . 74.42 111.13 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -124.47 107.37 11.01 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.211 -0.449 . . . . 71.21 110.86 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.569 HG22 ' HB3' ' A' ' 71' ' ' PHE . 2.4 pp -111.51 130.84 64.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 73.41 111.13 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.863 HG23 HG22 ' A' ' 98' ' ' THR . 88.5 m -122.2 123.16 40.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 55.11 111.161 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.561 ' HB ' HD22 ' A' ' 69' ' ' LEU . 1.6 m -115.17 139.79 39.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.223 -0.444 . . . . 73.14 111.145 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -90.55 128.32 36.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 70.24 110.85 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.64 179.17 1.43 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.173 -0.467 . . . . 73.41 110.863 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -126.76 -65.9 0.93 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 73.11 110.883 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 20.1 tp -50.55 -75.47 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 75.25 110.931 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -73.26 76.35 1.32 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 72.31 111.091 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 7.7 tpp85 -48.78 133.69 17.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.435 . . . . 72.12 110.851 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 100.97 8.38 48.13 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.727 -0.749 . . . . 74.34 112.524 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.4 tp -112.68 124.67 53.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.861 0.362 . . . . 64.45 110.956 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 13.5 ttmt -124.62 125.05 43.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 72.05 110.929 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.566 HD12 HG22 ' A' ' 116' ' ' THR . 0.3 OUTLIER -101.64 127.13 48.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.222 -0.444 . . . . 73.13 110.939 179.914 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.863 HG22 HG23 ' A' ' 86' ' ' THR . 4.4 p -127.89 119.91 26.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 64.42 111.158 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.1 119.96 41.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.44 . . . . 71.25 110.917 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -109.9 142.12 41.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.474 . . . . 73.33 110.846 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.1 m -143.14 127.78 18.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 74.12 110.86 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -95.36 125.74 40.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 74.32 110.865 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -129.17 126.86 40.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 54.41 110.895 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.433 ' HA ' ' HD2' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -128.82 102.4 19.6 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.7 0.762 . . . . 73.0 110.827 -179.758 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 104' ' ' SER . 53.6 Cg_endo -69.76 -32.63 18.2 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.709 2.273 . . . . 54.1 112.349 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -70.12 -72.58 0.19 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.186 -0.461 . . . . 71.45 110.891 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.5 p -64.26 -40.09 95.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.129 -0.487 . . . . 65.42 111.131 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.52 24.45 13.92 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.726 -0.749 . . . . 75.11 112.495 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.11 148.09 22.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.82 0.343 . . . . 64.52 110.874 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -142.06 131.63 23.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 71.31 110.866 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -130.08 152.56 49.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.245 -0.434 . . . . 62.33 110.923 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -130.24 125.26 34.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 71.45 111.132 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.405 ' HB3' ' HA ' ' A' ' 130' ' ' ASP . 0.0 OUTLIER -139.03 137.99 36.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 35.13 110.861 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.536 HD13 ' H ' ' A' ' 115' ' ' LYS . 0.4 OUTLIER -125.84 138.35 54.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 74.22 111.149 179.835 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.536 ' H ' HD13 ' A' ' 114' ' ' ILE . 14.9 mtmt -130.17 130.11 44.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 75.43 110.925 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.566 HG22 HD12 ' A' ' 97' ' ' LEU . 1.2 p -119.22 119.2 33.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.446 . . . . 73.14 111.155 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -107.64 125.33 7.92 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.689 -0.767 . . . . 72.51 112.471 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -131.09 115.52 16.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.941 0.401 . . . . 60.05 110.886 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 13.7 mtpp -106.58 125.34 50.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.147 -0.479 . . . . 72.33 110.93 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 13.9 ttt85 -104.95 144.96 31.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.281 -0.418 . . . . 74.33 110.867 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.724 ' HA ' HG13 ' A' ' 3' ' ' VAL . 9.8 pt-20 -50.41 -26.57 5.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 71.24 110.9 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 33.9 m170 -86.98 -45.51 10.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 75.12 110.886 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 49.4 pt -151.38 156.6 6.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 61.23 111.143 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.404 ' HB2' HG22 ' A' ' 143' ' ' VAL . 2.6 m120 -104.21 129.7 51.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 62.02 110.897 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.543 ' CD2' HD22 ' A' ' 142' ' ' LEU . 1.0 OUTLIER -127.77 143.42 51.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 73.33 110.924 179.926 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -146.51 117.18 0.92 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.762 -0.732 . . . . 74.15 112.547 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 36.8 t -113.89 132.09 56.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.847 0.356 . . . . 72.2 110.85 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.432 ' HA ' ' HA ' ' A' ' 115' ' ' LYS . 0.2 OUTLIER -128.38 117.32 21.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 55.02 110.821 -179.963 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 19.4 mtm -103.97 136.25 43.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 52.24 110.92 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.405 ' HA ' ' HB3' ' A' ' 113' ' ' LYS . 4.3 t0 -128.41 120.25 26.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 73.31 110.834 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -94.74 119.9 34.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 75.3 110.886 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -128.71 131.83 47.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.164 -0.471 . . . . 63.34 110.827 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -55.9 -29.86 27.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 53.1 111.125 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -80.01 -20.26 45.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 63.21 111.07 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 157.61 100.26 0.17 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.754 -0.736 . . . . 54.04 112.465 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.76 129.48 17.68 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.679 2.253 . . . . 61.34 112.399 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.571 ' C ' HD12 ' A' ' 138' ' ' ILE . 12.5 t -129.08 161.79 29.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 64.42 110.887 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.753 HD13 ' HB ' ' A' ' 159' ' ' THR . 1.7 mp -120.72 117.12 52.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.111 -0.495 . . . . 72.41 111.14 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 15.2 mtm180 -121.81 125.29 46.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 72.34 110.883 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -147.16 152.18 24.36 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.72 -0.753 . . . . 75.33 112.519 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -120.72 139.55 52.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.855 0.359 . . . . 53.33 111.099 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.64 HD12 ' N ' ' A' ' 143' ' ' VAL . 0.1 OUTLIER -141.33 143.41 34.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 61.23 110.939 -179.961 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.64 ' N ' HD12 ' A' ' 142' ' ' LEU . 1.0 OUTLIER -133.58 143.74 37.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 61.15 111.153 179.817 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.521 HD12 ' O ' ' A' ' 151' ' ' ALA . 0.5 OUTLIER -125.99 138.31 53.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.172 -0.467 . . . . 75.3 110.925 179.968 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -113.29 119.32 4.8 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.764 -0.732 . . . . 64.11 112.499 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -144.84 148.27 33.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.862 0.363 . . . . 74.24 110.89 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 50.06 26.36 2.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.139 -0.482 . . . . 71.12 110.897 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 88.78 -31.82 4.8 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.749 -0.739 . . . . 53.14 112.523 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 52.9 p-90 -80.72 146.21 31.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.814 0.34 . . . . 71.53 110.936 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.561 HD11 HG22 ' A' ' 6' ' ' THR . 2.7 mt -114.5 145.52 41.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.451 . . . . 51.31 110.93 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.521 ' O ' HD12 ' A' ' 144' ' ' LEU . . . -141.74 113.9 8.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 62.03 111.099 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.459 ' HA3' ' HA ' ' A' ' 143' ' ' VAL . . . -166.04 162.57 36.08 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.722 -0.751 . . . . 63.34 112.444 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.786 ' HB3' ' O ' ' A' ' 168' ' ' ASN . 0.0 OUTLIER -174.68 -168.45 0.36 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.858 0.361 . . . . 73.51 110.925 -179.862 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -99.99 146.21 26.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.072 -0.513 . . . . 64.43 110.867 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 3.1 ppp? -145.21 127.54 15.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 73.22 110.9 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -111.46 119.95 40.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 74.22 110.843 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -108.51 138.99 43.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 75.11 110.867 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -77.65 98.38 5.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 73.34 110.918 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.753 ' HB ' HD13 ' A' ' 138' ' ' ILE . 7.2 t -66.24 -40.84 90.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 52.24 111.149 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -48.67 -25.1 1.61 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 65.32 111.108 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 35.4 mmtm -141.47 -159.89 1.02 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 45.34 110.88 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 17.1 m -109.59 40.06 1.96 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 62.3 110.879 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -131.27 171.58 13.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.134 -0.485 . . . . 70.45 110.889 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -106.91 141.05 23.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 52.51 111.125 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 62.6 m -90.29 -35.26 15.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 72.42 111.153 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -154.92 137.64 15.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 73.41 110.917 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 2.8 t -128.2 102.14 6.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 74.14 110.85 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.786 ' O ' ' HB3' ' A' ' 153' ' ' TYR . 0.1 OUTLIER -116.27 122.65 45.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 71.24 110.92 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.566 ' HA ' ' HB2' ' A' ' 153' ' ' TYR . 42.3 m-85 -133.96 138.6 45.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 62.11 110.887 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.735 ' HB3' ' CD1' ' A' ' 153' ' ' TYR . . . -151.3 152.04 32.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 73.33 111.118 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.469 HG12 ' HB1' ' A' ' 151' ' ' ALA . 0.9 OUTLIER -140.9 148.3 21.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.22 -0.446 . . . . 62.34 111.088 179.988 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -121.99 129.16 7.51 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.725 -0.75 . . . . 54.11 112.513 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -113.67 131.45 56.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.912 0.386 . . . . 74.0 110.954 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 20.9 mmtp -102.67 128.2 49.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.105 -0.498 . . . . 70.15 110.882 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.456 ' O ' ' C ' ' A' ' 176' ' ' ASP . 0.2 OUTLIER -119.64 167.05 12.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.451 . . . . 54.31 111.153 179.979 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.456 ' C ' ' O ' ' A' ' 175' ' ' THR . 0.8 OUTLIER -34.13 -77.74 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 74.22 110.87 179.937 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -117.64 14.66 14.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 75.1 110.907 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -128.14 147.49 50.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 61.11 110.897 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -136.32 126.64 26.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 61.4 110.902 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.751 HD12 ' CG2' ' A' ' 194' ' ' ILE . 0.4 OUTLIER -124.29 137.28 54.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 64.53 110.894 -179.949 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 5.8 t-80 -130.98 113.45 14.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 74.03 110.859 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -96.16 146.97 24.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 54.23 111.154 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' ASN . . . . . 0.413 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 7.0 p30 -159.52 140.7 12.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.248 -0.433 . . . . 72.44 110.898 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.526 ' HB ' ' HA ' ' A' ' 190' ' ' PHE . 1.4 m -135.07 135.71 52.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.125 -0.489 . . . . 62.12 111.104 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -100.52 88.3 3.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 74.32 110.916 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 73.58 176.57 0.25 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.196 -0.456 . . . . 73.41 110.862 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -72.44 1.67 34.35 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.743 -0.741 . . . . 64.23 112.463 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 33.3 p -105.12 -24.34 12.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.715 0.293 . . . . 63.35 111.103 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -119.16 120.08 36.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.24 -0.436 . . . . 75.12 110.9 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' PHE . . . . . 0.526 ' HA ' ' HB ' ' A' ' 184' ' ' VAL . 0.5 OUTLIER -140.13 124.57 17.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.456 . . . . 75.01 110.947 -179.954 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -171.39 -150.33 7.04 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.72 -0.752 . . . . 53.45 112.463 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 172.37 -166.68 39.49 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.751 -0.737 . . . . 30.43 112.519 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' SER . . . . . 0.467 ' C ' HD13 ' A' ' 194' ' ' ILE . 1.4 t -148.84 151.8 35.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.849 0.357 . . . . 72.23 110.857 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.751 ' CG2' HD12 ' A' ' 180' ' ' LEU . 0.0 OUTLIER -136.76 135.02 48.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 74.22 111.159 179.934 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -131.75 137.12 48.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 65.31 110.929 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 46.4 tp60 -124.35 131.9 53.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.123 -0.49 . . . . 64.13 110.963 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 11.2 ttpt -81.92 126.22 31.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 71.44 110.921 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 18.1 t -91.15 139.95 16.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 63.02 111.151 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -81.86 59.7 4.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 74.45 110.883 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 22.1 ttmt -165.9 39.87 0.06 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.198 -0.455 . . . . 71.43 110.889 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 4.8 mptt 57.32 44.06 22.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 75.0 110.87 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.665 HD12 ' O ' ' A' ' 224' ' ' LYS . 58.7 tp -152.92 145.98 24.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.249 -0.432 . . . . 73.15 110.906 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -127.32 149.24 50.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 75.41 110.911 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 71.2 p -123.29 138.24 54.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 74.25 111.115 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -145.81 135.73 23.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.214 -0.448 . . . . 74.44 111.134 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.562 HG22 HG12 ' A' ' 194' ' ' ILE . 0.9 OUTLIER -132.16 144.02 38.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 73.34 111.119 179.993 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -130.92 127.32 38.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.474 . . . . 71.41 110.852 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.446 ' H ' HD23 ' A' ' 208' ' ' LEU . 2.7 pt? -143.24 150.23 39.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.125 -0.489 . . . . 75.13 110.929 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -138.63 149.56 45.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 73.44 111.099 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 3.9 t-105 -120.63 135.19 55.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.447 . . . . 63.24 110.918 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 3.1 m -95.68 104.32 16.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 73.11 111.16 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -53.05 150.16 5.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 74.05 111.123 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 97.01 -34.16 5.26 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.729 -0.748 . . . . 42.21 112.498 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -122.58 -171.14 2.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.803 0.335 . . . . 75.35 110.919 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 22.7 t -119.03 38.06 3.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 53.01 110.857 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -101.96 111.88 24.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 72.42 110.917 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 14.6 t -115.18 138.18 51.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 61.22 111.173 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 63.3 mmt-85 -128.46 127.64 42.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 73.11 110.84 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -134.44 158.0 45.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.452 . . . . 72.54 110.861 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -147.44 147.46 18.23 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.718 -0.754 . . . . 54.5 112.516 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 3.8 mp -118.32 133.24 65.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.836 0.35 . . . . 73.41 111.12 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -131.77 143.73 50.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.462 . . . . 63.12 111.102 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -112.45 134.48 53.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.454 . . . . 43.1 111.071 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 224' ' ' LYS . . . . . 0.665 ' O ' HD12 ' A' ' 202' ' ' LEU . 1.1 ttpp -109.37 114.84 28.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 72.35 110.895 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 36.9 t80 -131.21 117.61 19.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.276 -0.42 . . . . 71.04 110.908 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -111.7 109.07 18.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.128 -0.487 . . . . 72.1 110.927 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 2.3 tt -80.93 -32.34 12.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 75.42 111.11 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -150.54 160.25 33.11 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.626 0.727 . . . . 72.41 110.882 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -7.61 21.48 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.671 2.248 . . . . 74.14 112.314 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -106.78 -29.52 9.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.247 -0.433 . . . . 75.03 110.9 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -124.54 133.56 53.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 72.32 111.09 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 42.1 m -134.81 141.76 46.5 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.235 -0.439 . . . . 42.44 110.849 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -127.13 133.48 50.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.474 . . . . 64.12 110.895 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 11.8 p -142.73 139.68 31.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.102 -0.499 . . . . 55.21 110.855 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -111.09 161.01 16.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.117 -0.492 . . . . 73.12 111.089 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 6.7 ptpp? -151.71 142.03 22.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 63.14 110.877 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 1.1 p -139.7 143.99 29.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 74.13 111.154 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -112.86 147.98 35.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.465 . . . . 63.45 110.927 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 40.1 t30 -59.43 -16.35 22.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 73.2 110.89 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 3.5 m -81.96 25.44 0.57 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 53.13 110.829 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 65.41 32.34 9.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.107 -0.497 . . . . 72.13 110.871 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 5.1 mp -100.28 118.07 35.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.122 -0.49 . . . . 52.31 110.923 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.437 ' H ' HD12 ' A' ' 243' ' ' ILE . 0.3 OUTLIER -118.1 116.79 52.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.223 -0.444 . . . . 74.44 111.115 179.835 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 244' ' ' GLY . . . . . 0.54 ' C ' HD13 ' A' ' 245' ' ' LEU . . . -147.88 163.39 28.84 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.723 -0.751 . . . . 70.32 112.452 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.661 ' N ' HD13 ' A' ' 245' ' ' LEU . 0.0 OUTLIER -146.5 160.43 42.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.88 0.371 . . . . 71.44 110.949 -179.972 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -141.41 137.84 8.35 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.715 -0.755 . . . . 73.22 112.507 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -129.38 131.06 46.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.919 0.39 . . . . 72.44 110.942 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.511 ' OG1' HG22 ' A' ' 258' ' ' THR . 1.8 t -118.68 118.79 32.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.121 -0.49 . . . . 71.15 111.178 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -115.21 122.45 46.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.247 -0.433 . . . . 71.25 110.927 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 250' ' ' THR . . . . . 0.598 HG23 ' HB2' ' A' ' 256' ' ' LYS . 7.6 m -95.73 122.88 38.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 43.2 111.13 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 17.9 tp -98.84 92.57 5.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.179 -0.464 . . . . 64.51 110.919 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 3.7 mtpp 63.75 161.41 0.12 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.563 0.697 . . . . 71.21 110.894 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 76.76 1.11 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.687 2.258 . . . . 73.14 112.337 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 178.32 -48.61 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.8 -0.715 . . . . 73.25 112.527 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.72 135.42 62.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.925 0.393 . . . . 64.13 111.133 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 0.598 ' HB2' HG23 ' A' ' 250' ' ' THR . 36.3 ttpt -133.37 133.14 42.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.125 -0.488 . . . . 73.31 110.853 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 0.406 HD23 ' H ' ' A' ' 258' ' ' THR . 0.4 OUTLIER -108.13 133.9 51.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 74.24 110.895 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 258' ' ' THR . . . . . 0.511 HG22 ' OG1' ' A' ' 248' ' ' THR . 30.9 p -132.62 122.04 24.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 74.34 111.16 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.663 HD21 HD11 ' A' ' 275' ' ' LEU . 0.1 OUTLIER -120.96 150.1 41.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 63.22 110.911 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.508 ' O ' HD22 ' A' ' 275' ' ' LEU . 1.5 m -142.64 140.5 31.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 51.54 110.815 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 261' ' ' ALA . . . . . 0.52 ' HB2' ' CD2' ' A' ' 275' ' ' LEU . . . -141.66 129.2 21.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 72.1 111.094 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.786 ' C ' HD13 ' A' ' 263' ' ' LEU . 1.3 tt -131.18 137.63 49.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 74.42 110.946 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 263' ' ' LEU . . . . . 0.786 HD13 ' C ' ' A' ' 262' ' ' LEU . 0.0 OUTLIER -120.9 108.59 14.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.173 -0.467 . . . . 72.21 110.918 179.915 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 264' ' ' ASP . . . . . 0.694 ' O ' HG22 ' A' ' 268' ' ' VAL . 0.5 OUTLIER -84.66 108.95 17.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 63.31 110.904 179.823 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -53.94 -18.85 9.37 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.788 -0.72 . . . . 44.22 112.48 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -91.05 -26.1 19.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.823 0.344 . . . . 74.31 110.876 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -100.1 -56.62 2.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 71.11 110.888 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 268' ' ' VAL . . . . . 0.717 HG12 ' O ' ' A' ' 272' ' ' GLY . 12.9 m -49.87 -27.36 3.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 71.2 111.117 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -53.74 -45.69 70.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 71.15 110.863 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -105.69 -17.16 14.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.473 . . . . 71.31 111.109 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -111.01 -120.18 4.01 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.778 -0.725 . . . . 75.15 112.501 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 272' ' ' GLY . . . . . 0.717 ' O ' HG12 ' A' ' 268' ' ' VAL . . . -150.39 -164.82 12.15 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.821 -0.704 . . . . 30.32 112.499 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 273' ' ' HIS . . . . . 0.621 ' CB ' HD12 ' A' ' 263' ' ' LEU . 8.9 p80 -89.62 145.93 24.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.851 0.358 . . . . 74.25 110.866 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 24.0 mttp -97.15 135.85 38.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 73.31 110.916 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.748 HD13 ' N ' ' A' ' 276' ' ' GLY . 2.7 tm? -134.94 138.93 44.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.256 -0.429 . . . . 65.51 110.913 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 276' ' ' GLY . . . . . 0.748 ' N ' HD13 ' A' ' 275' ' ' LEU . . . -132.75 140.04 11.47 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.752 -0.737 . . . . 73.11 112.523 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.734 HD12 HG23 ' A' ' 27' ' ' ILE . 2.1 tm? -113.94 136.7 52.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.792 0.329 . . . . 74.43 110.955 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 278' ' ' GLY . . . . . 0.697 ' N ' HD13 ' A' ' 277' ' ' LEU . . . -141.94 127.86 3.4 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.771 -0.728 . . . . 74.44 112.495 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.654 HD11 HD11 ' A' ' 277' ' ' LEU . 1.3 mm? -108.35 131.66 54.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.794 0.33 . . . . 61.12 110.882 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -123.36 112.03 17.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 64.21 110.928 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 281' ' ' PHE . . . . . 0.686 ' HB3' HD13 ' A' ' 31' ' ' LEU . 17.7 m-85 -112.87 133.34 54.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 73.53 110.906 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -135.34 130.5 35.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 71.01 110.91 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.588 ' C ' HD23 ' A' ' 284' ' ' LEU . . . -99.16 135.78 40.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 74.42 111.106 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.588 HD23 ' C ' ' A' ' 283' ' ' ALA . 0.8 OUTLIER 41.7 37.14 0.68 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.253 -0.43 . . . . 53.54 110.91 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.47 . . . . 72.24 110.859 179.938 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.798 0.332 . . . . 43.31 111.089 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.641 HG22 ' N ' ' A' ' 121' ' ' GLU . 60.2 t -114.42 78.75 4.92 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.642 0.734 . . . . 71.51 111.122 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 166.01 29.07 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.688 2.259 . . . . 61.34 112.316 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 101.66 0.94 Allowed 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.702 2.268 . . . . 72.43 112.296 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.649 HG22 HD21 ' A' ' 150' ' ' LEU . 0.0 OUTLIER -88.7 -46.36 9.07 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.218 -0.446 . . . . 70.22 111.178 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -54.39 -33.84 60.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 71.11 110.906 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -82.98 -19.16 37.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 74.12 111.129 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -88.85 10.09 22.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 55.42 110.903 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.567 HD23 HD12 ' A' ' 150' ' ' LEU . 89.5 mt -67.19 -34.25 77.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 61.43 110.911 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -139.57 68.45 0.49 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.738 -0.744 . . . . 72.25 112.484 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 12.4 mttp -64.64 -53.9 40.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.843 0.354 . . . . 72.44 110.942 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.9 t -58.77 -48.75 80.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 75.44 110.854 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.58 -37.82 88.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.113 -0.494 . . . . 70.05 111.065 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.451 ' O ' HG22 ' A' ' 19' ' ' THR . 16.2 ttm-85 -60.42 -34.32 73.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.26 -0.427 . . . . 70.52 110.881 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.08 -39.07 93.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.198 -0.455 . . . . 74.24 110.87 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.6 t -82.2 -33.33 11.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.256 -0.429 . . . . 64.11 111.128 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -72.18 -42.05 66.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 64.11 110.88 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.451 HG22 ' O ' ' A' ' 15' ' ' ARG . 12.3 t -68.49 -32.0 71.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 64.42 111.112 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -73.89 127.79 33.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 65.02 110.904 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -50.73 136.37 28.44 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.803 -0.713 . . . . 71.24 112.477 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -125.93 33.24 5.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.87 0.367 . . . . 71.03 110.897 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 73.87 88.63 0.19 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.714 -0.755 . . . . 72.15 112.524 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -94.24 -4.36 49.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.93 0.395 . . . . 72.42 110.897 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.58 13.36 80.26 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.754 -0.736 . . . . 32.21 112.49 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.461 HD12 ' O ' ' A' ' 27' ' ' ILE . 2.5 pp -150.33 -178.9 6.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.814 0.34 . . . . 75.14 110.926 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.73 HG23 HD12 ' A' ' 277' ' ' LEU . 8.9 mm -111.36 145.04 18.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 74.44 111.121 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.7 ttpt -122.65 151.15 41.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 64.41 110.883 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.514 HD13 ' C ' ' A' ' 29' ' ' LEU . 3.4 tm? -140.56 128.06 21.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 62.24 110.911 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -139.18 129.42 25.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.466 . . . . 63.51 110.858 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.8 tt -137.53 133.49 34.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 73.23 110.933 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.6 mtpp -135.33 125.51 26.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 71.13 110.928 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.641 HG23 ' HB3' ' A' ' 283' ' ' ALA . 24.4 m -123.2 146.18 48.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.212 -0.449 . . . . 52.51 111.11 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 10.1 tptt -105.24 158.04 16.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 62.41 110.9 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.483 ' O ' ' C ' ' A' ' 36' ' ' GLU . 0.5 OUTLIER -132.14 174.86 9.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 62.01 110.873 -179.915 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.483 ' C ' ' O ' ' A' ' 35' ' ' SER . 46.2 tt0 -31.8 -73.46 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.16 -0.473 . . . . 73.2 110.869 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -164.82 131.77 3.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 73.13 110.925 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.453 ' HA2' ' O ' ' A' ' 63' ' ' ARG . . . 86.28 -14.59 53.75 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.763 -0.732 . . . . 65.23 112.496 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.402 ' HB2' ' HB3' ' A' ' 35' ' ' SER . 0.2 OUTLIER -104.43 129.17 52.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.816 0.341 . . . . 74.44 110.901 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.97 118.15 10.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 60.54 110.93 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -92.04 122.55 34.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 73.05 110.892 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -125.6 131.12 52.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 74.05 111.111 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.4 t -131.69 139.64 49.1 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.202 -0.454 . . . . 73.31 110.839 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.4 t -145.73 126.59 14.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.144 -0.48 . . . . 72.13 110.829 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -146.31 147.71 18.86 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.739 -0.743 . . . . 73.04 112.518 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.24 135.78 37.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.857 0.36 . . . . 44.22 110.846 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.874 ' HB2' HG13 ' A' ' 54' ' ' VAL . . . -149.16 130.56 14.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.129 -0.487 . . . . 71.04 111.11 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 64.3 t-20 -96.63 126.0 41.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.242 -0.436 . . . . 54.44 110.872 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 91.9 m -75.59 -50.1 16.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 54.35 111.104 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -56.7 -49.23 75.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 71.22 110.851 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -108.84 124.53 50.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 71.52 111.182 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.41 ' O ' HG23 ' A' ' 52' ' ' THR . 1.9 t -54.37 104.63 0.11 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.209 -0.451 . . . . 74.43 111.168 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 30.9 tttp -174.03 99.32 0.1 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 63.32 110.896 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.874 HG13 ' HB2' ' A' ' 47' ' ' ALA . 31.7 t -120.51 124.75 73.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.195 -0.457 . . . . 61.34 111.117 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.4 p -135.57 129.72 33.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 71.02 111.122 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -129.37 137.93 9.91 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.761 -0.733 . . . . 54.14 112.532 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.3 p -141.49 160.32 40.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.892 0.377 . . . . 64.34 110.868 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.3 tp -128.38 149.97 50.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.101 -0.5 . . . . 71.52 110.877 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -135.73 131.19 35.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 71.13 110.893 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.07 118.38 36.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 64.4 111.12 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 5.2 ttmt -112.18 147.91 35.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 74.43 110.855 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -131.75 133.41 44.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 74.1 110.948 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.453 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 25.5 ttm180 -135.23 106.71 6.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.13 -0.487 . . . . 64.31 110.903 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 58.0 t-105 -114.56 138.74 50.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.202 -0.453 . . . . 73.14 110.9 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.3 m 66.19 119.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.281 -0.418 . . . . 64.43 111.17 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -50.59 105.38 0.1 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.438 . . . . 73.13 110.919 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 64.61 48.85 2.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.148 -0.478 . . . . 72.24 110.913 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.659 ' O ' HD22 ' A' ' 69' ' ' LEU . . . -122.29 -74.41 0.32 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.741 -0.742 . . . . 62.02 112.52 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.659 HD22 ' O ' ' A' ' 68' ' ' GLY . 4.1 mm? -134.23 129.43 35.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.872 0.367 . . . . 73.13 110.935 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.2 m -138.6 112.61 8.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 72.21 111.169 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -123.59 124.36 42.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 75.32 110.88 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.44 ' HA ' ' HA ' ' A' ' 61' ' ' LYS . 5.1 t -129.38 137.68 51.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 74.04 111.14 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.555 ' CD ' HD23 ' A' ' 81' ' ' LEU . 37.8 tt0 -124.02 123.23 39.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 74.51 110.843 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 22.3 mtpp -89.82 142.17 27.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.105 -0.498 . . . . 72.44 110.913 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 7.3 t90 -134.58 128.82 33.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.227 -0.442 . . . . 73.41 110.894 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -117.72 155.13 30.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 71.44 110.875 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 9.4 t -61.37 -17.53 54.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 61.05 111.16 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.415 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 48.5 m-20 -74.11 0.35 14.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 61.21 110.87 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.415 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 3.5 m120 77.34 35.67 0.33 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 73.4 110.9 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.8 m -114.45 128.57 56.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 55.51 111.167 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.555 HD23 ' CD ' ' A' ' 73' ' ' GLU . 0.3 OUTLIER -120.19 139.59 52.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.227 -0.442 . . . . 73.11 110.904 179.98 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -137.92 98.6 0.27 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.75 -0.738 . . . . 73.22 112.495 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.1 m -84.76 142.02 30.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.768 0.318 . . . . 61.14 111.161 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -146.47 115.25 6.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 71.31 110.853 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -112.7 136.48 48.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 70.34 111.147 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.61 HG22 ' HB ' ' A' ' 98' ' ' THR . 20.5 p -128.99 124.09 34.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 44.42 111.177 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.5 p -114.91 137.24 49.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 52.14 111.132 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -103.83 119.81 39.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 73.52 110.887 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -60.51 130.32 45.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 72.55 110.878 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -83.14 -57.8 3.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 61.13 110.885 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 36.0 mt -63.28 -54.28 39.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 71.2 110.876 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -85.58 75.35 10.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.453 . . . . 44.12 111.092 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 12.2 tpp85 -51.37 134.59 28.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 71.44 110.885 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 100.61 -23.41 35.87 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.718 -0.753 . . . . 52.12 112.475 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.805 HD22 ' HB3' ' A' ' 118' ' ' TYR . 0.1 OUTLIER -79.62 114.94 18.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.915 0.388 . . . . 72.25 110.946 -179.95 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.62 ' O ' HD13 ' A' ' 97' ' ' LEU . 3.8 ttpm? -121.29 130.0 53.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 74.54 110.934 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.62 HD13 ' O ' ' A' ' 96' ' ' LYS . 0.9 OUTLIER -121.71 127.06 50.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.259 -0.428 . . . . 75.02 110.89 179.951 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.61 ' HB ' HG22 ' A' ' 86' ' ' THR . 17.4 p -129.92 121.09 25.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.201 -0.454 . . . . 64.53 111.151 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -110.22 129.24 55.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 73.14 110.825 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -112.25 142.16 45.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.099 -0.5 . . . . 72.21 110.883 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.3 t -142.06 124.54 15.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 74.11 110.819 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.8 t -96.09 123.82 39.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 71.15 110.854 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -118.78 132.9 56.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.157 -0.474 . . . . 75.11 110.909 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -128.69 101.83 20.38 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.718 0.77 . . . . 75.21 110.817 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -33.16 17.1 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.685 2.257 . . . . 74.33 112.373 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -79.87 -69.73 0.57 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 55.12 110.911 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.4 -45.07 92.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.456 . . . . 70.51 111.14 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.37 24.34 14.51 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.757 -0.735 . . . . 52.43 112.49 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.92 148.05 22.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.871 0.367 . . . . 74.54 110.86 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -134.47 126.69 29.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 62.51 110.884 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -121.35 136.31 54.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 75.3 110.931 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -125.56 120.19 30.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.445 . . . . 65.22 111.125 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -138.39 138.62 38.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 75.32 110.899 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.433 HD12 ' H ' ' A' ' 115' ' ' LYS . 5.4 tp -122.57 137.43 56.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.235 -0.439 . . . . 61.22 111.151 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.433 ' H ' HD12 ' A' ' 114' ' ' ILE . 1.9 mtpp -128.58 121.38 28.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.172 -0.467 . . . . 73.23 110.911 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.408 HG22 HD12 ' A' ' 97' ' ' LEU . 62.6 p -128.26 121.47 29.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 65.4 111.109 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -150.03 163.31 29.41 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.702 -0.761 . . . . 54.13 112.47 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.805 ' HB3' HD22 ' A' ' 95' ' ' LEU . 7.6 p90 -133.05 143.81 49.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.942 0.401 . . . . 63.44 110.926 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.492 ' O ' HG11 ' A' ' 3' ' ' VAL . 9.0 mtmt -111.86 120.83 43.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 72.3 110.902 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 28.2 ttm180 -108.37 144.46 35.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 72.12 110.881 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.641 ' N ' HG22 ' A' ' 3' ' ' VAL . 36.8 tt0 -51.18 -29.28 13.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.219 -0.446 . . . . 74.44 110.851 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 37.1 m80 -86.54 -42.54 13.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 74.24 110.862 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 2.2 pp -150.09 153.62 10.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.238 -0.437 . . . . 44.33 111.137 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -124.68 116.25 22.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.466 . . . . 61.33 110.867 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.535 ' HB2' ' HG ' ' A' ' 142' ' ' LEU . 0.4 OUTLIER -133.51 145.17 49.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.197 -0.456 . . . . 74.33 110.913 179.96 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -146.33 136.0 6.08 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.739 -0.744 . . . . 72.43 112.476 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 44.8 t -103.91 133.97 47.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.837 0.351 . . . . 54.02 110.882 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -125.67 142.13 51.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.474 . . . . 75.32 110.872 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 47.7 ttm -137.89 134.44 35.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 73.12 110.898 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -124.9 122.58 37.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 75.12 110.876 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -94.45 123.15 37.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 65.35 110.881 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -115.12 179.68 3.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 52.43 110.857 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.53 ' H ' HD12 ' A' ' 133' ' ' ILE . 3.1 mp -93.29 -42.23 13.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.181 -0.463 . . . . 75.11 111.114 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -80.98 -20.09 42.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 44.42 111.125 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.641 ' HA3' ' HB2' ' A' ' 160' ' ' ALA . . . 164.23 114.12 0.3 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.751 -0.738 . . . . 53.1 112.509 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 144.75 54.9 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.704 2.269 . . . . 75.23 112.322 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.6 m -126.54 151.62 47.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 74.3 110.868 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 4.6 mp -121.36 126.41 74.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 71.41 111.116 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -121.71 121.95 38.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 72.13 110.855 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -121.86 141.59 14.52 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.779 -0.724 . . . . 65.44 112.52 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -126.75 116.21 20.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.819 0.343 . . . . 61.3 111.107 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.738 HD13 ' OH ' ' A' ' 153' ' ' TYR . 0.3 OUTLIER -119.76 122.1 40.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 75.11 110.895 -179.963 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.448 ' N ' HD23 ' A' ' 142' ' ' LEU . 1.5 m -132.61 140.84 46.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 63.14 111.172 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 6.3 mp -116.42 138.84 51.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.22 -0.445 . . . . 73.33 110.93 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -91.71 133.23 11.66 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.745 -0.741 . . . . 75.12 112.48 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.402 ' O ' ' N ' ' A' ' 148' ' ' GLY . 3.2 m-85 -128.74 146.8 50.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.823 0.344 . . . . 70.53 110.96 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -49.4 93.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.111 -0.495 . . . . 73.01 110.889 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 146' ' ' TYR . . . 87.26 -23.59 11.37 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.776 -0.726 . . . . 72.53 112.448 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 7.8 m0 -105.67 145.95 30.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.801 0.334 . . . . 71.43 110.942 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.649 HD21 HG22 ' A' ' 6' ' ' THR . 0.0 OUTLIER -126.77 137.13 53.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.243 -0.435 . . . . 74.23 110.919 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -129.26 134.07 47.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.455 . . . . 75.03 111.054 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.412 ' HA2' ' HA ' ' A' ' 143' ' ' VAL . . . -152.92 133.03 3.87 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.701 -0.762 . . . . 32.11 112.514 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.738 ' OH ' HD13 ' A' ' 142' ' ' LEU . 8.4 p90 -144.16 119.34 10.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.909 0.385 . . . . 75.23 110.921 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -110.58 123.62 50.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.075 -0.511 . . . . 64.22 110.935 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 2.4 ttt -120.39 128.72 53.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.44 . . . . 73.54 110.878 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.499 ' O ' ' HB ' ' A' ' 164' ' ' VAL . 20.0 m-20 -112.82 116.79 30.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.444 . . . . 72.53 110.867 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.544 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 60.4 m-85 -89.88 131.98 35.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.165 -0.471 . . . . 65.24 110.87 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -91.3 104.31 16.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 71.23 110.901 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.77 -47.9 73.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.134 -0.485 . . . . 61.14 111.118 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.641 ' HB2' ' HA3' ' A' ' 135' ' ' GLY . . . -49.65 -26.14 3.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 73.34 111.126 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.2 -166.85 1.36 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 65.32 110.853 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 68.1 m -112.97 39.18 2.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 63.33 110.829 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -165.06 177.19 7.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.116 -0.493 . . . . 55.31 110.832 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.544 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 1.0 OUTLIER -75.46 144.11 12.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.181 -0.463 . . . . 61.24 111.101 179.993 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 12.9 t -88.74 -32.64 17.82 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.149 -0.478 . . . . 72.12 111.165 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 3.9 tp60 -151.45 134.69 16.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 75.13 110.93 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 11.3 p -124.1 107.07 10.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 42.43 110.868 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 28.9 m-20 -110.74 148.47 32.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.115 -0.493 . . . . 64.24 110.897 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.438 ' CE1' HG23 ' A' ' 171' ' ' VAL . 8.0 t80 -154.8 140.57 18.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 71.15 110.914 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -154.38 135.01 13.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.13 -0.487 . . . . 74.41 111.094 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.438 HG23 ' CE1' ' A' ' 169' ' ' PHE . 48.5 t -144.15 133.42 19.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 72.04 111.159 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -111.6 122.25 6.0 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.775 -0.726 . . . . 70.12 112.496 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' TYR . . . . . 0.604 ' HB2' HD12 ' A' ' 180' ' ' LEU . 0.1 OUTLIER -113.65 131.06 56.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.934 0.397 . . . . 61.43 110.953 -179.829 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 2.6 mtpm? -102.95 127.2 50.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.476 . . . . 65.35 110.888 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.406 ' O ' ' C ' ' A' ' 176' ' ' ASP . 0.2 OUTLIER -111.78 166.39 11.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.219 -0.446 . . . . 75.42 111.111 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.406 ' C ' ' O ' ' A' ' 175' ' ' THR . 2.8 m-20 -37.89 -76.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 75.01 110.896 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -117.32 16.51 14.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.179 -0.464 . . . . 72.45 110.932 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -130.79 150.68 51.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.132 -0.485 . . . . 64.13 110.862 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 37.2 mm-40 -116.09 123.1 47.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.124 -0.489 . . . . 73.15 110.895 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.604 HD12 ' HB2' ' A' ' 173' ' ' TYR . 3.4 tm? -107.15 125.58 51.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.164 -0.471 . . . . 63.31 110.89 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 22.6 m80 -130.63 130.41 43.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 75.2 110.836 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 1.2 t -128.9 111.49 13.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 74.53 111.172 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -120.55 139.65 52.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.236 -0.438 . . . . 63.11 110.908 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.443 HG12 ' O ' ' A' ' 184' ' ' VAL . 2.5 t -133.33 110.29 14.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 72.14 111.111 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -100.79 89.51 3.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 74.11 110.872 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 67.47 -179.75 0.22 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 71.52 110.882 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -75.19 -2.95 68.12 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.775 -0.726 . . . . 65.22 112.477 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 15.6 p -97.53 -25.49 15.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.769 0.319 . . . . 70.22 111.126 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.27 113.48 20.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 75.41 110.905 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 190' ' ' PHE . . . . . 0.412 ' HA ' HG22 ' A' ' 184' ' ' VAL . 0.4 OUTLIER -139.76 123.03 17.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 70.2 110.857 -179.909 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 171.46 -141.43 6.41 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.747 -0.74 . . . . 63.11 112.519 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 167.24 -167.4 39.83 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.699 -0.763 . . . . 62.42 112.445 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' SER . . . . . 0.486 ' HA ' ' O ' ' A' ' 206' ' ' VAL . 70.3 m -127.5 144.42 51.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.813 0.339 . . . . 72.32 110.875 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.423 ' O ' HG22 ' A' ' 206' ' ' VAL . 0.0 OUTLIER -142.03 118.33 6.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.168 -0.469 . . . . 65.24 111.121 179.986 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 195' ' ' TYR . . . . . 0.802 ' CB ' ' HA ' ' A' ' 205' ' ' ALA . 0.1 OUTLIER 178.66 -175.21 0.19 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 62.44 110.892 -179.989 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 16.8 tm0? -123.51 128.54 49.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.091 -0.504 . . . . 64.53 110.894 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 3.4 pttp -114.65 113.97 25.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 71.23 110.903 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.662 HG21 HD12 ' A' ' 202' ' ' LEU . 5.2 t -86.47 143.85 10.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.237 -0.438 . . . . 73.23 111.133 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -93.06 32.53 1.28 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 70.44 110.894 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 10.3 mmtt -127.59 35.03 4.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 73.22 110.917 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 2.2 mttp 72.7 51.11 0.16 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 75.12 110.904 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.662 HD12 HG21 ' A' ' 198' ' ' VAL . 0.3 OUTLIER -177.47 82.49 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 73.22 110.938 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -128.17 133.2 48.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.461 . . . . 74.43 110.866 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' THR . . . . . 0.598 ' O ' ' HB3' ' A' ' 195' ' ' TYR . 11.0 t -132.45 136.91 47.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.467 . . . . 75.12 111.158 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.802 ' HA ' ' CB ' ' A' ' 195' ' ' TYR . . . -141.47 136.68 31.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 70.32 111.083 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.907 HG12 HG22 ' A' ' 221' ' ' ILE . 1.1 m -103.9 139.51 24.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.44 . . . . 63.25 111.074 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -114.35 132.7 56.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.46 . . . . 71.33 110.897 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.529 HD21 ' CD2' ' A' ' 219' ' ' PHE . 4.6 mp -126.11 138.17 53.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.167 -0.47 . . . . 74.25 110.935 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.716 ' HB3' ' CD ' ' A' ' 218' ' ' ARG . . . -129.61 139.96 51.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 62.53 111.129 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 2.4 t-105 -130.27 130.32 44.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 71.41 110.944 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.07 109.44 22.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.253 -0.43 . . . . 71.53 111.116 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -51.62 134.81 29.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.448 . . . . 61.55 111.156 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 120.4 33.91 0.99 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.705 -0.76 . . . . 63.13 112.447 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 49.5 t30 59.66 43.34 15.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.822 0.344 . . . . 71.14 110.898 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 14.0 m -90.99 -169.72 2.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 72.32 110.872 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -102.55 137.1 41.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.462 . . . . 41.45 110.913 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 217' ' ' THR . . . . . 0.426 HG23 ' CE1' ' A' ' 219' ' ' PHE . 3.9 t -79.12 139.5 38.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.47 . . . . 65.44 111.153 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 218' ' ' ARG . . . . . 0.716 ' CD ' ' HB3' ' A' ' 209' ' ' ALA . 17.3 ptp180 -110.84 133.29 53.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 64.35 110.886 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 219' ' ' PHE . . . . . 0.529 ' CD2' HD21 ' A' ' 208' ' ' LEU . 11.1 m-85 -114.37 138.35 50.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.25 -0.432 . . . . 75.44 110.859 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -140.65 144.52 14.87 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.713 -0.755 . . . . 65.42 112.467 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.907 HG22 HG12 ' A' ' 206' ' ' VAL . 0.0 OUTLIER -130.93 130.73 64.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.841 0.353 . . . . 62.2 111.129 -179.998 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -133.74 131.64 39.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 41.55 111.104 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -125.22 146.06 49.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.254 -0.43 . . . . 75.32 111.093 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 3.5 mtmp? -129.1 123.55 32.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 71.01 110.908 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -132.29 133.16 43.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.212 -0.449 . . . . 74.42 110.963 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -85.6 128.78 34.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.475 . . . . 70.3 110.901 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 44.5 mm -74.16 -55.55 11.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 74.24 111.111 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 228' ' ' ASP . . . . . 0.545 ' N ' ' HD2' ' A' ' 229' ' ' PRO . 0.1 OUTLIER 175.13 -57.35 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.599 0.714 . . . . 74.24 110.826 179.867 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.545 ' HD2' ' N ' ' A' ' 228' ' ' ASP . 53.4 Cg_endo -69.75 -156.6 0.04 OUTLIER 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.655 2.237 . . . . 72.43 112.368 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.6 15.69 4.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 64.33 110.839 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.454 ' HB2' ' HG3' ' A' ' 249' ' ' GLN . . . -120.63 121.92 39.38 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.22 -0.445 . . . . 62.14 111.118 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 36.7 m -108.7 143.99 37.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 41.55 110.889 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -105.3 127.88 53.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 71.41 110.877 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 15.2 m -127.09 137.49 53.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.134 -0.484 . . . . 64.15 110.842 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -121.3 143.17 49.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.158 -0.474 . . . . 62.11 111.083 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.76 141.87 31.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 64.31 110.894 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 242' ' ' LEU . 5.3 p -140.25 144.73 27.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 55.13 111.117 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -108.16 148.31 30.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 73.42 110.896 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -56.11 -19.52 13.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 74.01 110.869 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 37.3 t -81.15 25.48 0.48 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.474 . . . . 64.05 110.856 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 2.3 t 61.89 35.73 16.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 72.41 110.851 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 242' ' ' LEU . . . . . 0.447 ' O ' HG23 ' A' ' 237' ' ' VAL . 4.6 mp -99.03 117.89 34.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.138 -0.483 . . . . 63.2 110.963 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.458 HD13 ' H ' ' A' ' 243' ' ' ILE . 0.1 OUTLIER -104.84 119.0 53.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.207 -0.451 . . . . 75.15 111.181 179.831 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 244' ' ' GLY . . . . . 0.519 ' C ' HD13 ' A' ' 245' ' ' LEU . . . -138.04 160.67 25.43 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.749 -0.739 . . . . 72.23 112.498 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.85 HD21 ' HB3' ' A' ' 261' ' ' ALA . 0.0 OUTLIER -145.16 160.04 42.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.858 0.361 . . . . 64.52 110.872 -179.917 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -149.09 121.77 1.36 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.77 -0.729 . . . . 72.42 112.508 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -109.3 115.89 30.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.976 0.417 . . . . 72.34 110.931 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.413 HG23 ' O ' ' A' ' 248' ' ' THR . 3.5 t -101.8 115.05 29.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.131 -0.486 . . . . 71.53 111.153 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 249' ' ' GLN . . . . . 0.454 ' HG3' ' HB2' ' A' ' 231' ' ' ALA . 59.1 tt0 -119.71 130.01 54.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 73.5 110.87 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 7.3 p -121.39 117.92 28.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.136 -0.483 . . . . 65.51 111.115 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 11.0 mt -113.42 101.2 9.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 73.2 110.974 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 252' ' ' LYS . . . . . 0.426 ' HB3' ' HD2' ' A' ' 253' ' ' PRO . 17.6 mttp 64.19 155.36 0.12 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.632 0.73 . . . . 73.25 110.835 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 253' ' ' PRO . . . . . 0.426 ' HD2' ' HB3' ' A' ' 252' ' ' LYS . 53.8 Cg_endo -69.74 73.68 1.34 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.706 2.271 . . . . 44.42 112.341 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 171.92 -29.7 0.11 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.727 -0.749 . . . . 71.52 112.442 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 55.5 mt -116.13 121.37 67.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.854 0.359 . . . . 74.5 111.131 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 32.3 ttmt -133.39 132.81 41.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 73.32 110.86 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 0.504 HD13 ' C ' ' A' ' 257' ' ' LEU . 3.3 tm? -118.44 125.06 49.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.175 -0.466 . . . . 73.22 110.931 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 258' ' ' THR . . . . . 0.514 ' O ' HD22 ' A' ' 277' ' ' LEU . 93.6 m -115.72 111.74 21.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 73.22 111.167 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 1.029 HD22 HD23 ' A' ' 277' ' ' LEU . 0.1 OUTLIER -109.6 132.65 53.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.45 . . . . 70.43 110.923 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.415 ' H ' HD13 ' A' ' 259' ' ' LEU . 16.5 t -145.95 153.37 40.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 74.24 110.889 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 261' ' ' ALA . . . . . 0.85 ' HB3' HD21 ' A' ' 245' ' ' LEU . . . -158.12 130.87 7.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 64.05 111.102 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.73 ' C ' HD13 ' A' ' 263' ' ' LEU . 3.3 tm? -125.8 124.45 40.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.459 . . . . 74.32 110.911 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 263' ' ' LEU . . . . . 0.835 ' HB3' HG11 ' A' ' 268' ' ' VAL . 0.2 OUTLIER -121.01 110.31 16.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 74.23 110.907 179.905 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 264' ' ' ASP . . . . . 0.527 ' O ' HG22 ' A' ' 268' ' ' VAL . 1.8 m-20 -79.11 113.88 17.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.198 -0.456 . . . . 74.45 110.871 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -58.9 -17.0 34.07 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.785 -0.722 . . . . 40.41 112.457 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 45.4 tttt -90.84 -3.2 57.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.822 0.344 . . . . 63.3 110.913 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -127.55 -52.82 1.36 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 64.12 110.919 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 268' ' ' VAL . . . . . 0.835 HG11 ' HB3' ' A' ' 263' ' ' LEU . 17.1 m -51.19 -29.37 8.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 64.41 111.123 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 -52.24 -40.39 61.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 74.2 110.918 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -104.91 -17.45 14.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.131 -0.486 . . . . 75.22 111.108 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 129.71 94.8 0.74 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.712 -0.756 . . . . 74.22 112.515 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -179.74 74.94 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.73 -0.748 . . . . 62.15 112.474 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 273' ' ' HIS . . . . . 0.419 ' HB2' HD12 ' A' ' 263' ' ' LEU . 32.6 p-80 -108.14 145.96 33.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.851 0.357 . . . . 62.43 110.855 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -127.12 138.73 53.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.185 -0.461 . . . . 73.54 110.925 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.65 HD12 ' HB2' ' A' ' 261' ' ' ALA . 1.5 tp -121.75 145.6 47.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.447 . . . . 74.02 110.879 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -123.63 108.25 1.16 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.724 -0.751 . . . . 70.24 112.459 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 1.029 HD23 HD22 ' A' ' 259' ' ' LEU . 3.2 tm? -114.43 141.4 47.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.858 0.361 . . . . 63.23 110.921 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 278' ' ' GLY . . . . . 0.659 ' N ' HD13 ' A' ' 277' ' ' LEU . . . -148.84 132.59 4.17 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.772 -0.727 . . . . 75.11 112.482 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.505 HD11 HD11 ' A' ' 277' ' ' LEU . 1.2 mm? -109.36 133.63 52.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.766 0.317 . . . . 74.41 110.881 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -124.06 112.62 17.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 71.21 110.88 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -117.93 134.1 55.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.1 -0.5 . . . . 74.42 110.85 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 282' ' ' GLN . . . . . 0.676 ' HG2' HD13 ' A' ' 284' ' ' LEU . 11.0 tt0 -135.85 112.47 10.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.127 -0.488 . . . . 73.12 110.913 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.732 ' O ' HD12 ' A' ' 284' ' ' LEU . . . -96.05 113.36 24.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 74.24 111.071 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.732 HD12 ' O ' ' A' ' 283' ' ' ALA . 6.1 mp -140.52 177.05 8.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.257 -0.429 . . . . 74.12 110.919 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 75.44 110.864 179.917 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.865 0.364 . . . . 73.31 111.127 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.478 HG13 ' HG3' ' A' ' 119' ' ' LYS . 0.2 OUTLIER -145.16 108.86 4.6 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.637 0.732 . . . . 72.3 111.155 179.955 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 170.73 15.85 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.648 2.232 . . . . 71.24 112.377 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 83.54 0.7 Allowed 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.695 2.263 . . . . 62.13 112.334 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 46.2 p -70.27 -48.94 54.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.212 -0.449 . . . . 75.12 111.157 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.486 ' CB ' HG11 ' A' ' 143' ' ' VAL . 7.7 p90 -51.13 -33.81 28.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.237 -0.438 . . . . 71.11 110.896 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -83.44 -28.32 28.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 73.43 111.132 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -90.32 11.61 20.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.211 -0.45 . . . . 74.11 110.823 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 25.1 mt -59.88 -29.76 68.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 71.24 110.928 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 159.4 59.01 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.703 -0.76 . . . . 65.14 112.469 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 12.7 mmtm -67.16 -53.84 26.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.751 0.31 . . . . 73.44 110.874 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.4 t -56.87 -48.06 78.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.27 -0.423 . . . . 65.42 110.906 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.23 -36.77 76.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.092 -0.504 . . . . 43.23 111.104 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.89 -30.57 67.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 74.24 110.864 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -56.44 -48.94 75.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 63.32 110.857 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 79.5 t -62.53 -26.59 40.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 74.23 111.135 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -59.63 -41.11 89.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 64.41 110.865 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.08 -66.64 0.7 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 53.25 111.138 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.1 tppm? -47.28 104.73 0.06 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 74.02 110.902 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 158.93 38.83 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.755 -0.736 . . . . 72.41 112.492 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.431 ' HB3' HD13 ' A' ' 262' ' ' LEU . 18.5 p90 -165.56 140.08 4.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.955 0.407 . . . . 72.14 110.897 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -62.65 129.83 42.48 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.734 -0.746 . . . . 73.45 112.489 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -103.1 -3.51 25.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.879 0.371 . . . . 74.14 110.849 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.78 14.02 78.32 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.721 -0.752 . . . . 45.35 112.509 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.514 ' O ' HD12 ' A' ' 27' ' ' ILE . 0.6 OUTLIER -127.77 171.94 11.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.804 0.335 . . . . 62.15 110.899 -179.924 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.538 HG13 HD12 ' A' ' 277' ' ' LEU . 1.3 mp -118.35 121.49 67.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 73.23 111.108 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 37.0 tttp -111.42 117.37 32.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 75.33 110.902 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.488 HD12 ' HB2' ' A' ' 279' ' ' LEU . 1.1 tt -115.16 141.06 48.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 52.11 110.951 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -147.88 129.98 15.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.178 -0.465 . . . . 71.45 110.838 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.514 HD23 ' N ' ' A' ' 32' ' ' LYS . 7.3 tt -126.93 133.38 50.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 73.13 110.876 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.514 ' N ' HD23 ' A' ' 31' ' ' LEU . 7.4 mtmp? -127.23 127.02 43.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 73.22 110.892 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.771 HG23 ' HB3' ' A' ' 283' ' ' ALA . 6.7 m -130.1 141.03 50.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.24 -0.436 . . . . 74.31 111.169 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.88 156.27 20.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.464 . . . . 73.53 110.882 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.517 ' O ' ' C ' ' A' ' 36' ' ' GLU . 0.6 OUTLIER -133.89 174.35 10.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 72.14 110.847 -179.904 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.517 ' C ' ' O ' ' A' ' 35' ' ' SER . 39.9 mm-40 -27.46 -75.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.095 -0.502 . . . . 72.55 110.876 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -166.82 140.39 3.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.115 -0.493 . . . . 74.44 110.879 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.487 ' HA2' ' O ' ' A' ' 63' ' ' ARG . . . 83.54 -12.69 50.71 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.798 -0.715 . . . . 65.12 112.518 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -105.02 130.07 53.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.787 0.327 . . . . 75.31 110.923 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -140.33 118.48 11.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.23 -0.441 . . . . 55.25 110.882 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -98.34 121.55 40.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 73.14 110.869 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 27.6 m -126.06 123.82 39.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.163 -0.471 . . . . 74.41 111.166 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.4 t -125.1 132.39 53.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.264 -0.425 . . . . 54.44 110.875 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 6.0 p -150.04 126.57 10.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.115 -0.493 . . . . 54.12 110.853 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -155.05 167.36 32.78 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.735 -0.745 . . . . 71.13 112.461 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 17.9 m -127.66 156.45 42.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.9 0.381 . . . . 54.33 110.878 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.495 ' O ' HD13 ' A' ' 26' ' ' LEU . . . -142.84 131.33 22.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 71.25 111.103 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 61.5 t-20 -101.65 123.54 45.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 72.43 110.865 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 60.4 m -88.51 -55.35 3.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.169 -0.469 . . . . 75.43 111.122 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -51.12 -36.4 40.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 72.14 110.875 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.14 155.54 50.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 34.22 111.125 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.0 m -71.09 86.99 0.76 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 70.45 111.167 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.2 tptp -152.68 80.91 1.22 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.233 -0.439 . . . . 63.31 110.901 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.415 ' HA ' ' HA ' ' A' ' 47' ' ' ALA . 1.3 p -127.96 123.21 60.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 75.41 111.159 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.0 p -136.6 132.85 35.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 73.41 111.158 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -107.18 136.56 13.46 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.756 -0.735 . . . . 52.23 112.475 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -114.26 144.97 42.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.895 0.379 . . . . 50.21 110.874 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.652 HD13 ' N ' ' A' ' 59' ' ' GLU . 0.8 OUTLIER -121.48 132.82 54.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 75.53 110.927 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.652 ' N ' HD13 ' A' ' 58' ' ' LEU . 1.4 pt-20 -133.46 136.96 45.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 75.15 110.904 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 4.9 m -114.79 140.15 49.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 64.4 111.131 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -135.71 157.44 46.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 71.31 110.885 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.439 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 16.2 m-85 -129.26 140.86 51.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.218 -0.447 . . . . 63.14 110.939 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.487 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 43.6 ttm-85 -127.12 104.51 8.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.11 -0.495 . . . . 74.51 110.863 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 66.0 m95 -114.2 123.84 50.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 63.51 110.9 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.5 m 67.3 125.39 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.216 -0.447 . . . . 74.32 111.126 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -51.3 103.95 0.07 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.46 . . . . 63.31 110.911 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 63.64 58.51 1.29 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.459 . . . . 71.42 110.935 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.631 ' O ' HD22 ' A' ' 69' ' ' LEU . . . -133.64 -77.81 0.12 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.762 -0.732 . . . . 64.51 112.455 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.631 HD22 ' O ' ' A' ' 68' ' ' GLY . 4.0 mm? -133.99 130.35 37.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.881 0.372 . . . . 72.12 110.936 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.639 HG23 ' OG1' ' A' ' 86' ' ' THR . 0.0 OUTLIER -137.57 137.42 38.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 61.53 111.141 179.93 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -95.79 133.84 39.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 64.45 110.92 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.5 m -112.67 117.23 31.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.167 -0.469 . . . . 74.12 111.136 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.417 ' CB ' HG23 ' A' ' 83' ' ' THR . 0.1 OUTLIER -134.49 134.06 41.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.455 . . . . 62.5 110.9 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 53.5 tttt -145.26 132.85 20.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 72.31 110.893 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 9.6 t90 -135.48 128.91 32.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.439 . . . . 72.54 110.928 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 10.5 m-20 -117.14 150.99 37.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 53.54 110.904 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.7 m -68.21 -12.29 60.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 73.01 111.122 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.489 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 38.8 t70 -74.65 0.17 15.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.227 -0.442 . . . . 63.0 110.893 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.489 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 5.7 t-20 83.55 34.47 0.05 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 75.32 110.865 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 12.7 p -114.77 123.04 48.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 62.22 111.162 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -109.38 136.98 47.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.449 . . . . 51.24 110.908 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -149.33 89.34 0.14 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.666 -0.778 . . . . 41.53 112.452 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.417 HG23 ' CB ' ' A' ' 73' ' ' GLU . 3.8 m -127.45 160.95 29.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.741 0.305 . . . . 74.04 111.167 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.622 ' HB3' ' O ' ' A' ' 99' ' ' PHE . 0.6 OUTLIER 169.22 -163.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 61.1 110.882 -179.99 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.532 HD11 HD12 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -135.33 142.96 38.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 63.04 111.111 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.639 ' OG1' HG23 ' A' ' 70' ' ' THR . 33.7 p -128.88 126.34 39.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.146 -0.479 . . . . 74.21 111.157 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 9.0 p -110.67 137.13 44.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 74.54 111.127 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -125.26 118.51 26.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 64.31 110.937 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 52.14 90.39 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 73.52 110.857 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.425 ' HG3' HD21 ' A' ' 69' ' ' LEU . 2.3 mm-40 -138.66 -75.13 0.38 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 73.35 110.932 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 30.1 tp -62.39 -36.12 81.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 73.35 110.938 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -143.29 125.72 15.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 63.24 111.069 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.11 124.8 13.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 73.41 110.872 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 97.64 -23.98 33.59 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.76 -0.733 . . . . 65.02 112.548 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.685 HD22 ' HB3' ' A' ' 118' ' ' TYR . 0.2 OUTLIER -79.99 124.28 28.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.834 0.349 . . . . 73.23 110.884 -179.91 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.739 ' O ' HD13 ' A' ' 97' ' ' LEU . 3.2 pttp -121.86 123.31 41.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.219 -0.446 . . . . 73.34 110.932 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.739 HD13 ' O ' ' A' ' 96' ' ' LYS . 0.7 OUTLIER -125.53 124.85 42.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.23 -0.441 . . . . 64.12 110.967 179.899 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 12.2 p -124.84 119.6 29.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 73.22 111.143 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.622 ' O ' ' HB3' ' A' ' 84' ' ' GLU . 0.3 OUTLIER -109.83 117.73 34.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 72.44 110.86 -179.968 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.556 ' HA ' ' CB ' ' A' ' 84' ' ' GLU . 6.7 t70 -115.71 144.6 43.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 74.12 110.88 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.404 ' CB ' ' HG2' ' A' ' 84' ' ' GLU . 10.5 t -140.1 133.2 29.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 72.15 110.866 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -120.67 149.51 42.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.484 . . . . 61.43 110.861 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -127.95 137.96 52.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 73.52 110.888 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.404 ' HA ' ' HD2' ' A' ' 105' ' ' PRO . 99.6 p -128.63 101.52 20.8 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.707 0.765 . . . . 64.22 110.841 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 104' ' ' SER . 54.3 Cg_endo -69.66 -31.22 21.38 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.705 2.27 . . . . 74.41 112.4 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -50.27 -68.24 0.19 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 45.3 110.885 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.1 p -86.05 -33.45 21.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.481 . . . . 64.13 111.175 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.39 23.57 16.28 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.723 -0.751 . . . . 62.51 112.485 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 46.3 mtpt -94.31 148.09 22.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.821 0.343 . . . . 60.41 110.926 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.15 144.42 31.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 75.45 110.914 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -120.7 128.59 53.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.269 -0.423 . . . . 74.54 110.851 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -133.35 124.82 27.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 52.24 111.088 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -134.77 138.37 44.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.223 -0.444 . . . . 72.41 110.864 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.579 HD13 ' H ' ' A' ' 115' ' ' LYS . 0.4 OUTLIER -134.43 136.53 52.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.248 -0.433 . . . . 71.35 111.111 179.893 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.579 ' H ' HD13 ' A' ' 114' ' ' ILE . 10.9 mtmt -126.29 121.59 33.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 75.32 110.883 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.681 HG23 ' CD1' ' A' ' 97' ' ' LEU . 99.6 m -125.22 121.44 34.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 74.4 111.103 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -152.69 163.06 30.26 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.738 -0.744 . . . . 72.33 112.511 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.685 ' HB3' HD22 ' A' ' 95' ' ' LEU . 0.3 OUTLIER -132.49 145.22 51.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.982 0.42 . . . . 74.53 110.915 -179.838 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.478 ' HG3' HG13 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -109.06 123.47 49.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.094 -0.503 . . . . 43.34 110.905 179.93 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.417 ' HB2' HG22 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -104.54 147.36 27.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.245 -0.434 . . . . 73.1 110.892 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.434 ' HA ' ' HB ' ' A' ' 3' ' ' VAL . 85.0 tt0 -54.64 -30.95 56.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 75.33 110.873 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 54.2 p-80 -125.95 11.13 7.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 74.23 110.864 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.817 HD11 HD23 ' A' ' 144' ' ' LEU . 1.0 OUTLIER -147.63 150.19 14.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.24 -0.437 . . . . 64.33 111.169 179.974 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.636 ' HB3' HG13 ' A' ' 143' ' ' VAL . 5.9 t-20 -128.96 113.69 15.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 60.02 110.9 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.661 HD22 HD23 ' A' ' 142' ' ' LEU . 1.4 mm? -121.89 130.76 53.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 61.11 110.873 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -146.94 115.81 0.81 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.689 -0.767 . . . . 73.12 112.442 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -113.3 135.51 53.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.771 0.32 . . . . 65.22 110.876 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -132.91 117.22 17.43 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.184 -0.462 . . . . 61.02 110.852 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 3.3 tmm? -109.36 138.74 45.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 75.43 110.918 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -117.75 119.23 34.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.248 -0.433 . . . . 61.35 110.854 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -96.43 114.98 26.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 62.5 110.885 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -120.39 153.16 36.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 61.12 110.881 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.02 -29.5 14.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.216 -0.447 . . . . 71.33 111.117 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -84.48 -20.32 31.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 75.44 111.068 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 164.05 97.38 0.12 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.745 -0.74 . . . . 52.35 112.483 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 137.27 35.09 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.648 2.232 . . . . 73.04 112.348 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.07 153.65 46.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.189 -0.459 . . . . 70.25 110.832 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 5.2 mp -110.52 132.29 59.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 60.11 111.135 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 9.2 mtt-85 -119.79 138.72 53.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 75.1 110.862 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -131.95 145.18 16.95 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.761 -0.733 . . . . 74.42 112.508 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -139.23 116.47 11.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.842 0.353 . . . . 72.32 111.076 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.733 HD22 ' N ' ' A' ' 143' ' ' VAL . 0.6 OUTLIER -125.34 124.02 40.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 60.11 110.928 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.733 ' N ' HD22 ' A' ' 142' ' ' LEU . 0.1 OUTLIER -132.85 145.0 34.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 74.32 111.126 179.857 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.817 HD23 HD11 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -131.78 140.91 49.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.446 . . . . 44.25 110.921 179.947 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -123.4 117.79 3.32 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.722 -0.751 . . . . 75.15 112.463 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.435 ' O ' ' CD1' ' A' ' 149' ' ' TRP . 7.0 t80 -145.52 153.86 41.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.864 0.364 . . . . 73.14 110.921 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 52.58 23.72 2.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 74.54 110.861 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 89.93 -31.2 5.42 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.736 -0.745 . . . . 71.12 112.504 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.435 ' CD1' ' O ' ' A' ' 146' ' ' TYR . 50.5 p-90 -78.0 145.0 36.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.754 0.311 . . . . 73.34 110.923 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.533 HD23 ' O ' ' A' ' 144' ' ' LEU . 1.4 mt -124.21 144.4 49.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.249 -0.432 . . . . 54.03 110.906 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.504 ' HA ' HG13 ' A' ' 171' ' ' VAL . . . -142.97 125.89 16.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.15 -0.477 . . . . 72.51 111.086 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.737 ' O ' ' HB3' ' A' ' 169' ' ' PHE . . . -126.94 131.5 7.29 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.717 -0.754 . . . . 64.15 112.488 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.414 ' C ' ' HD1' ' A' ' 169' ' ' PHE . 5.5 t80 -133.2 120.28 20.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.841 0.353 . . . . 74.03 110.949 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.645 ' H ' ' HB2' ' A' ' 169' ' ' PHE . 0.5 OUTLIER -104.24 138.54 40.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.484 . . . . 70.3 110.915 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 155' ' ' MET . . . . . 0.534 ' HB3' HG11 ' A' ' 164' ' ' VAL . 0.4 OUTLIER -122.73 146.76 47.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 52.14 110.849 179.955 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.41 ' O ' HG13 ' A' ' 164' ' ' VAL . 3.6 t30 -108.88 120.48 42.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.182 -0.463 . . . . 75.15 110.883 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -91.04 123.18 34.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 73.15 110.86 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.742 ' O ' ' O ' ' A' ' 161' ' ' LYS . 0.1 OUTLIER -78.19 137.64 38.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 70.31 110.881 -179.963 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.479 HG23 ' N ' ' A' ' 160' ' ' ALA . 5.4 t -69.05 -46.99 66.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.15 -0.477 . . . . 62.42 111.17 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.479 ' N ' HG23 ' A' ' 159' ' ' THR . . . -50.77 -25.87 4.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 75.41 111.111 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.742 ' O ' ' O ' ' A' ' 158' ' ' GLU . 33.2 mmtt -147.29 139.62 24.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 73.33 110.909 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 12.6 m -71.56 49.63 0.16 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 73.24 110.868 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -138.58 170.69 15.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.487 . . . . 75.11 110.889 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.534 HG11 ' HB3' ' A' ' 155' ' ' MET . 90.8 t -91.15 138.66 19.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.442 . . . . 62.13 111.107 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 96.1 m -94.65 -42.23 8.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.474 . . . . 65.31 111.125 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -160.1 142.2 13.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 61.01 110.922 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 6.8 p -127.12 125.94 42.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 72.21 110.865 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.441 ' CB ' ' HA ' ' A' ' 185' ' ' ASN . 5.8 p30 -139.7 152.3 46.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.102 -0.499 . . . . 53.03 110.906 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.737 ' HB3' ' O ' ' A' ' 152' ' ' GLY . 0.1 OUTLIER -178.55 -159.18 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 74.33 110.893 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -132.92 150.56 52.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 50.1 111.106 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.504 HG13 ' HA ' ' A' ' 151' ' ' ALA . 71.0 t -145.72 127.15 7.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.218 -0.446 . . . . 43.35 111.097 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -163.37 167.19 37.51 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.714 -0.755 . . . . 64.41 112.482 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 27.1 p90 -125.55 154.67 41.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.989 0.424 . . . . 44.13 110.9 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 38.8 mtpt -106.8 130.93 54.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.119 -0.491 . . . . 74.02 110.892 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.15 165.53 16.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 70.13 111.13 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -42.53 -71.74 0.08 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 72.24 110.915 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 26.5 mp0 -115.48 14.46 16.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 70.41 110.92 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -127.83 143.57 51.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.11 -0.496 . . . . 70.41 110.854 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' GLN . . . . . 0.401 ' HB3' ' HB2' ' A' ' 195' ' ' TYR . 5.7 mm-40 -136.81 130.96 32.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 72.34 110.882 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.507 HD13 ' C ' ' A' ' 180' ' ' LEU . 2.5 tm? -124.21 117.5 24.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.14 -0.482 . . . . 63.02 110.891 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 18.2 t-80 -135.07 118.43 16.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 74.54 110.892 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -130.74 127.83 39.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 75.53 111.162 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -119.36 141.01 49.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 72.23 110.922 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.538 ' HB ' ' HA ' ' A' ' 190' ' ' PHE . 1.3 m -133.07 141.19 45.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.457 . . . . 73.1 111.141 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.441 ' HA ' ' CB ' ' A' ' 168' ' ' ASN . 0.8 OUTLIER -105.13 89.2 3.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 71.32 110.884 179.999 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 74.41 -175.93 0.15 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.222 -0.444 . . . . 72.33 110.859 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -80.09 4.84 64.84 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.708 -0.758 . . . . 52.02 112.463 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 22.3 p -110.42 -22.19 11.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.755 0.312 . . . . 62.03 111.142 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 189' ' ' GLU . . . . . 0.401 ' HB3' ' CB ' ' A' ' 185' ' ' ASN . 1.9 tt0 -118.12 125.96 51.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 74.4 110.907 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 190' ' ' PHE . . . . . 0.538 ' HA ' ' HB ' ' A' ' 184' ' ' VAL . 32.2 t80 -137.4 125.1 22.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 75.1 110.822 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -136.46 141.95 13.06 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.724 -0.751 . . . . 60.32 112.473 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -133.46 145.19 17.25 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.696 -0.764 . . . . 71.34 112.442 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' SER . . . . . 0.576 ' C ' HD12 ' A' ' 194' ' ' ILE . 3.3 t -139.31 152.63 47.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.893 0.378 . . . . 71.22 110.833 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.576 HD12 ' C ' ' A' ' 193' ' ' SER . 3.1 mp -127.43 130.56 70.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 75.43 111.106 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 195' ' ' TYR . . . . . 0.401 ' HB2' ' HB3' ' A' ' 179' ' ' GLN . 2.4 m-85 -108.66 123.11 48.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.171 -0.468 . . . . 74.5 110.897 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 51.3 mm-40 -124.78 112.45 16.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.122 -0.49 . . . . 64.42 110.877 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 33.6 mtpt -107.69 127.94 54.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 71.3 110.936 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.435 HG12 ' O ' ' A' ' 198' ' ' VAL . 3.2 t 66.45 22.21 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.253 -0.431 . . . . 44.13 111.164 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -92.54 -32.74 14.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 72.2 110.87 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 22.6 mtpp -154.28 66.13 0.7 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 63.0 110.924 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 201' ' ' LYS . . . . . 0.611 ' C ' HD22 ' A' ' 202' ' ' LEU . 24.8 mttm 68.55 112.92 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.44 . . . . 50.24 110.941 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.611 HD22 ' C ' ' A' ' 201' ' ' LYS . 0.8 OUTLIER 63.25 -163.25 0.27 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.211 -0.45 . . . . 75.23 110.946 179.979 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 5.6 pm0 -115.04 129.68 56.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.436 . . . . 55.12 110.875 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 204' ' ' THR . . . . . 0.501 HG22 ' HA ' ' A' ' 223' ' ' ALA . 17.4 p -142.07 156.76 45.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 72.0 111.152 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -149.44 148.44 29.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.248 -0.433 . . . . 72.3 111.099 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.584 HG12 HG22 ' A' ' 221' ' ' ILE . 0.8 OUTLIER -112.89 148.54 15.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.224 -0.444 . . . . 75.04 111.149 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -126.71 136.92 53.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 65.45 110.917 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 5.6 mp -130.72 142.3 50.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.167 -0.47 . . . . 64.22 110.928 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.417 ' HB3' ' HD2' ' A' ' 218' ' ' ARG . . . -131.59 131.64 43.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.466 . . . . 64.43 111.071 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 18.9 t90 -130.69 126.21 35.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 73.03 110.946 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 211' ' ' THR . . . . . 0.62 HG23 ' CB ' ' A' ' 215' ' ' SER . 2.0 t -113.43 105.92 13.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.27 -0.423 . . . . 73.03 111.169 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -51.98 149.09 5.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 74.31 111.114 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 114.2 43.92 0.76 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.752 -0.737 . . . . 62.04 112.497 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 55.73 62.66 2.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.867 0.365 . . . . 72.45 110.901 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 215' ' ' SER . . . . . 0.62 ' CB ' HG23 ' A' ' 211' ' ' THR . 7.1 t -121.85 -178.04 3.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 60.51 110.826 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 29.7 m120 -101.74 150.29 23.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.128 -0.487 . . . . 64.33 110.873 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 2.9 p -79.24 138.69 37.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 75.42 111.181 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 218' ' ' ARG . . . . . 0.417 ' HD2' ' HB3' ' A' ' 209' ' ' ALA . 75.6 mtt180 -105.97 126.99 52.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 71.42 110.857 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -122.77 139.43 54.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 75.02 110.887 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -149.68 149.01 20.88 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.745 -0.741 . . . . 73.53 112.521 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.619 HG12 HG12 ' A' ' 237' ' ' VAL . 0.0 OUTLIER -138.7 130.85 37.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.775 0.321 . . . . 74.44 111.142 -179.954 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -120.81 133.12 55.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 72.32 111.107 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.501 ' HA ' HG22 ' A' ' 204' ' ' THR . . . -111.91 125.85 54.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 75.5 111.105 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 18.3 ttpp -115.58 114.66 25.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 75.11 110.863 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -109.59 118.6 37.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 74.44 110.903 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.93 114.11 27.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 54.32 110.887 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 44.2 mt -109.06 -35.35 2.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 73.24 111.102 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -149.17 157.47 39.65 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.637 0.732 . . . . 50.11 110.862 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -17.0 37.89 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.694 2.263 . . . . 72.34 112.366 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -103.35 -28.04 12.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 74.31 110.855 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -124.32 129.9 51.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.463 . . . . 54.54 111.087 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 19.1 m -139.65 141.18 37.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.272 -0.422 . . . . 64.02 110.89 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -106.6 133.16 51.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.447 . . . . 74.34 110.895 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 2.8 t -138.27 143.22 39.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.471 . . . . 64.0 110.852 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -146.7 159.03 43.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.128 -0.487 . . . . 73.22 111.098 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.98 148.71 19.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 64.44 110.86 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.619 HG12 HG12 ' A' ' 221' ' ' ILE . 0.9 OUTLIER -140.65 149.1 21.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 74.23 111.115 179.896 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -117.56 147.95 42.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 72.31 110.886 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -58.16 -18.16 23.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 74.44 110.858 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 11.2 t -81.46 26.67 0.46 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 53.22 110.884 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 1.7 m 62.78 32.94 15.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 75.03 110.841 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 242' ' ' LEU . . . . . 0.473 HD11 ' HB3' ' A' ' 264' ' ' ASP . 4.5 mp -100.13 117.69 34.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.136 -0.483 . . . . 74.52 110.892 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.43 ' HA ' HG23 ' A' ' 237' ' ' VAL . 0.0 OUTLIER -109.56 117.75 55.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.131 -0.486 . . . . 72.02 111.178 179.782 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 244' ' ' GLY . . . . . 0.443 ' HA2' ' HA ' ' A' ' 262' ' ' LEU . . . -122.31 148.29 17.02 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.723 -0.751 . . . . 72.24 112.479 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -145.57 130.08 17.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.882 0.373 . . . . 75.45 110.914 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -129.67 138.78 10.47 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.759 -0.734 . . . . 51.33 112.499 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -128.95 131.81 47.54 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.965 0.412 . . . . 75.0 110.919 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 16.8 p -111.41 129.19 56.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 61.54 111.126 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -142.78 123.12 13.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 62.33 110.951 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 20.8 p -106.77 153.13 22.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 72.15 111.129 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.794 HD12 HG21 ' A' ' 255' ' ' ILE . 6.2 mt -85.74 -77.11 0.31 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.216 -0.447 . . . . 51.24 110.927 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 252' ' ' LYS . . . . . 0.469 ' N ' ' HD2' ' A' ' 253' ' ' PRO . 1.6 mttm 177.88 -60.71 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.598 0.714 . . . . 73.21 110.858 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 253' ' ' PRO . . . . . 0.735 ' HG2' HD12 ' A' ' 255' ' ' ILE . 53.5 Cg_endo -69.81 69.31 1.68 Allowed 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.725 2.283 . . . . 64.44 112.314 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 50.47 32.46 23.24 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.785 -0.722 . . . . 70.22 112.445 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.794 HG21 HD12 ' A' ' 251' ' ' LEU . 58.6 mt -114.45 122.54 68.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.864 0.364 . . . . 61.31 111.113 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 17.4 mtpp -130.71 120.52 23.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.14 -0.482 . . . . 63.02 110.889 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 0.525 HD21 HD21 ' A' ' 277' ' ' LEU . 0.4 OUTLIER -100.75 128.71 46.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.455 . . . . 74.34 110.909 179.927 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 1.5 m -115.5 115.24 26.17 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.177 -0.465 . . . . 74.52 111.164 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.948 HD22 HD23 ' A' ' 277' ' ' LEU . 0.1 OUTLIER -112.39 126.09 54.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.239 -0.437 . . . . 75.34 110.919 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.404 ' N ' HD13 ' A' ' 259' ' ' LEU . 23.6 p -133.67 144.98 49.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 54.32 110.876 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 261' ' ' ALA . . . . . 0.612 ' HB2' ' CD2' ' A' ' 275' ' ' LEU . . . -155.08 128.25 8.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.129 -0.487 . . . . 53.14 111.06 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.811 ' C ' HD13 ' A' ' 263' ' ' LEU . 1.5 tt -132.75 139.89 47.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.453 . . . . 65.22 110.937 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 263' ' ' LEU . . . . . 0.811 HD13 ' C ' ' A' ' 262' ' ' LEU . 0.0 OUTLIER -123.93 110.13 14.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.202 -0.454 . . . . 65.53 110.937 179.884 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 264' ' ' ASP . . . . . 0.691 ' O ' HG22 ' A' ' 268' ' ' VAL . 1.8 m-20 -79.92 106.15 11.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.209 -0.451 . . . . 71.3 110.836 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -53.69 -19.67 10.47 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.767 -0.73 . . . . 72.44 112.461 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.8 -25.95 18.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.785 0.326 . . . . 72.32 110.889 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -99.04 -55.91 2.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 72.2 110.871 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 268' ' ' VAL . . . . . 0.698 HG12 ' O ' ' A' ' 272' ' ' GLY . 13.1 m -49.47 -28.23 3.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 64.33 111.124 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -53.25 -44.78 68.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 62.31 110.879 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -105.28 -17.38 14.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.445 . . . . 42.15 111.094 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -111.73 -119.82 3.85 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.743 -0.741 . . . . 45.13 112.488 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 272' ' ' GLY . . . . . 0.698 ' O ' HG12 ' A' ' 268' ' ' VAL . . . -148.72 -170.55 16.61 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.762 -0.733 . . . . 55.35 112.549 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 273' ' ' HIS . . . . . 0.669 ' CG ' HD12 ' A' ' 263' ' ' LEU . 0.9 OUTLIER -87.96 146.04 25.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.9 0.381 . . . . 71.54 110.815 -179.914 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -96.96 135.81 38.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 61.24 110.925 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.612 ' CD2' ' HB2' ' A' ' 261' ' ' ALA . 2.1 tm? -132.1 123.26 26.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 54.11 110.922 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 276' ' ' GLY . . . . . 0.506 ' N ' HD13 ' A' ' 275' ' ' LEU . . . -119.38 130.4 8.5 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.737 -0.744 . . . . 55.05 112.509 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.948 HD23 HD22 ' A' ' 259' ' ' LEU . 3.3 tm? -119.31 141.03 49.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.874 0.369 . . . . 73.0 110.921 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 278' ' ' GLY . . . . . 0.685 ' N ' HD13 ' A' ' 277' ' ' LEU . . . -145.36 132.46 4.65 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.797 -0.716 . . . . 74.11 112.512 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.636 HD11 HD11 ' A' ' 277' ' ' LEU . 1.1 mm? -108.7 132.12 54.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.805 0.336 . . . . 44.52 110.899 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 50.3 tt0 -127.57 117.67 22.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.185 -0.461 . . . . 64.41 110.871 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -122.7 134.5 54.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.483 . . . . 71.44 110.898 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -135.12 124.3 24.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 65.21 110.938 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.771 ' HB3' HG23 ' A' ' 33' ' ' THR . . . -100.06 130.88 46.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.445 . . . . 74.13 111.085 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.604 HD23 ' C ' ' A' ' 283' ' ' ALA . 0.9 OUTLIER 41.21 38.31 0.74 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.446 . . . . 74.41 110.92 -179.975 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.46 . . . . 75.13 110.861 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.857 0.361 . . . . 72.25 111.145 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.765 HG22 ' HA ' ' A' ' 121' ' ' GLU . 19.5 t -136.7 75.42 50.04 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 121.674 0.75 . . . . 64.55 111.133 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.7 167.91 23.01 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.74 2.293 . . . . 72.52 112.377 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 102.55 1.05 Allowed 'Trans proline' 0 N--CA 1.465 -0.172 0 C-N-CA 122.684 2.256 . . . . 73.42 112.362 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -86.45 -37.68 18.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 62.12 111.161 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -52.16 -39.9 60.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 71.41 110.886 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -76.24 -24.13 54.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 53.52 111.118 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -74.07 -21.11 60.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 52.24 110.917 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.594 HD23 ' CD2' ' A' ' 150' ' ' LEU . 20.7 mt -56.88 -34.1 67.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.157 -0.474 . . . . 63.04 110.92 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -132.18 29.2 3.37 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.742 -0.742 . . . . 74.11 112.481 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 12.5 ttpp -69.59 -45.79 67.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.801 0.334 . . . . 62.41 110.877 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.4 m -64.37 -39.34 93.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.458 . . . . 62.0 110.883 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.26 -50.58 73.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 31.33 111.109 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -67.44 -33.8 75.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 75.23 110.879 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -60.31 -47.91 84.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 74.43 110.833 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 85.8 t -75.77 -33.46 26.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 70.42 111.135 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -59.8 -41.36 91.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 75.15 110.881 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.3 p 46.74 85.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.139 -0.482 . . . . 73.13 111.152 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.0 mtmt -50.64 -34.44 26.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 65.43 110.933 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -98.79 79.14 0.55 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.72 -0.752 . . . . 72.35 112.442 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -129.66 108.31 10.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.952 0.406 . . . . 74.5 110.965 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 51.71 77.14 0.14 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.741 -0.742 . . . . 44.04 112.503 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -103.35 -3.43 25.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.887 0.375 . . . . 54.52 110.833 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.56 13.7 80.04 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.785 -0.722 . . . . 44.14 112.46 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.628 HD11 HD22 ' A' ' 48' ' ' ASN . 2.0 tp -138.88 -178.93 5.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.78 0.324 . . . . 33.12 110.91 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 1.028 HG23 HD12 ' A' ' 277' ' ' LEU . 14.7 mm -104.7 141.38 20.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.182 -0.463 . . . . 42.0 111.151 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.7 tttt -122.42 139.39 53.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 74.11 110.928 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.504 HD13 ' C ' ' A' ' 29' ' ' LEU . 2.8 tm? -131.81 128.73 39.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 70.2 110.884 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.488 ' N ' HD22 ' A' ' 29' ' ' LEU . 8.2 m-20 -140.73 127.14 19.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.141 -0.481 . . . . 74.45 110.882 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.57 HD23 ' N ' ' A' ' 32' ' ' LYS . 8.2 tt -138.37 138.89 38.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 73.44 110.93 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.57 ' N ' HD23 ' A' ' 31' ' ' LEU . 0.4 OUTLIER -121.47 125.61 47.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 42.52 110.922 179.832 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 96.6 m -121.01 129.12 53.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.229 -0.441 . . . . 73.53 111.108 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.4 tttt -143.33 126.97 16.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.214 -0.448 . . . . 70.1 110.926 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.663 ' HB3' HD23 ' A' ' 39' ' ' LEU . 0.2 OUTLIER -88.22 174.95 7.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.24 -0.436 . . . . 73.21 110.843 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.5 ' C ' ' O ' ' A' ' 35' ' ' SER . 43.8 mm-40 -29.38 -56.61 0.15 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.112 -0.495 . . . . 71.31 110.904 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 -173.77 149.37 1.57 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 73.24 110.899 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 86.54 -11.16 64.56 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.757 -0.735 . . . . 54.1 112.488 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.663 HD23 ' HB3' ' A' ' 35' ' ' SER . 3.2 mm? -104.2 132.49 50.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.791 0.329 . . . . 75.44 110.922 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.0 tm-20 -137.78 114.47 10.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.224 -0.444 . . . . 63.25 110.899 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.423 ' CZ ' HG23 ' A' ' 60' ' ' THR . 25.1 m-85 -134.94 118.32 16.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.094 -0.503 . . . . 63.34 110.868 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.58 130.82 46.17 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.125 -0.489 . . . . 62.24 111.107 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.3 p -127.04 131.99 50.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.196 -0.457 . . . . 65.53 110.825 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.9 m -148.72 126.82 12.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.092 -0.504 . . . . 44.42 110.813 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -167.92 179.41 41.21 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.757 -0.735 . . . . 71.42 112.517 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.0 m -137.33 161.5 36.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.899 0.38 . . . . 75.13 110.819 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.957 ' HB2' HG13 ' A' ' 54' ' ' VAL . . . -145.7 150.49 36.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.093 -0.503 . . . . 63.53 111.108 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.628 HD22 HD11 ' A' ' 26' ' ' LEU . 25.4 t-20 -73.77 142.65 46.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 74.11 110.832 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -55.14 -39.27 69.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.123 -0.489 . . . . 73.24 111.127 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -95.17 25.24 4.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.454 . . . . 73.13 110.874 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 20.5 p 48.09 30.75 2.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 74.23 111.093 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 22.7 m -71.1 -30.8 66.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 64.25 111.124 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 10.5 tptm -165.84 130.72 2.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.247 -0.433 . . . . 52.54 110.885 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.957 HG13 ' HB2' ' A' ' 47' ' ' ALA . 7.9 t -125.18 125.71 69.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 73.15 111.095 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.7 t -136.68 129.04 30.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 61.01 111.165 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -151.03 150.46 22.43 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.705 -0.759 . . . . 72.1 112.474 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -104.48 146.39 28.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.874 0.369 . . . . 74.02 110.875 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.658 HD13 ' N ' ' A' ' 59' ' ' GLU . 0.9 OUTLIER -125.67 132.41 52.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.12 -0.491 . . . . 73.21 110.94 179.985 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.658 ' N ' HD13 ' A' ' 58' ' ' LEU . 6.7 pt-20 -125.39 120.08 30.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.441 . . . . 74.24 110.85 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.423 HG23 ' CZ ' ' A' ' 41' ' ' PHE . 96.9 m -124.76 137.68 54.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 73.43 111.12 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.658 ' CB ' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -172.39 -178.6 2.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 74.54 110.882 179.901 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -115.22 141.65 47.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.233 -0.44 . . . . 75.42 110.897 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -134.41 111.65 10.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.097 -0.501 . . . . 74.44 110.906 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 2.4 m-90 -106.12 110.59 22.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 53.12 110.952 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 10.3 t -81.29 -33.26 32.75 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.257 -0.429 . . . . 62.03 111.136 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -49.97 -54.82 17.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.245 -0.434 . . . . 65.35 110.888 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -73.76 -51.11 17.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.463 . . . . 61.42 110.91 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.742 ' O ' HD22 ' A' ' 69' ' ' LEU . . . 123.78 32.01 0.91 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.785 -0.721 . . . . 75.01 112.462 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.742 HD22 ' O ' ' A' ' 68' ' ' GLY . 3.9 mm? -135.09 132.87 38.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.917 0.389 . . . . 75.23 110.866 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 55.5 p -132.42 111.09 11.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 75.51 111.119 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.632 ' O ' ' HB3' ' A' ' 61' ' ' LYS . 0.2 OUTLIER -105.56 132.69 51.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.438 . . . . 73.03 110.888 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.658 ' HA ' ' CB ' ' A' ' 61' ' ' LYS . 17.8 p -129.88 136.14 49.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.484 . . . . 70.23 111.143 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.631 ' HG3' HG23 ' A' ' 83' ' ' THR . 25.6 tt0 -126.5 122.01 33.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 52.14 110.877 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.49 139.69 44.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 73.14 110.892 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 8.1 t90 -135.44 129.54 33.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 74.21 110.924 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -116.85 149.29 40.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.263 -0.426 . . . . 71.42 110.891 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 8.8 t -65.12 -14.22 59.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.184 -0.462 . . . . 73.04 111.172 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.456 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 5.6 m-20 -75.25 2.03 12.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 74.35 110.865 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.456 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 2.9 m120 80.09 36.83 0.12 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 63.45 110.932 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.2 m -116.55 121.39 41.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 63.44 111.168 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.592 HD23 ' CD ' ' A' ' 105' ' ' PRO . 4.4 mm? -101.67 149.22 24.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.249 -0.432 . . . . 75.2 110.933 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -148.81 143.15 10.6 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.696 -0.764 . . . . 62.31 112.493 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.631 HG23 ' HG3' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -146.53 96.97 2.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.763 0.316 . . . . 61.04 111.11 -179.835 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.435 ' HA ' ' HA ' ' A' ' 100' ' ' ASP . 15.8 tt0 -106.14 122.7 46.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.207 -0.451 . . . . 74.24 110.886 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.481 HG22 ' O ' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -121.63 138.26 52.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 74.5 111.146 179.945 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.477 HG23 HG23 ' A' ' 98' ' ' THR . 0.2 OUTLIER -113.62 141.28 47.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.148 -0.478 . . . . 72.33 111.122 179.976 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.695 HG13 HD11 ' A' ' 69' ' ' LEU . 0.3 OUTLIER -121.58 120.07 60.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 40.13 111.148 179.893 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -93.77 118.26 31.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 71.51 110.943 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 49.68 70.37 0.5 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.203 -0.453 . . . . 73.22 110.876 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.536 ' CB ' HD23 ' A' ' 97' ' ' LEU . 6.4 tp60 -76.37 86.69 3.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.205 -0.452 . . . . 73.42 110.9 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 11.7 tp 66.19 30.38 9.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 71.31 110.933 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -179.48 100.68 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 73.14 111.126 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 5.9 mpt_? -51.13 134.41 26.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 64.42 110.86 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 96.41 -20.27 51.06 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.721 -0.752 . . . . 61.24 112.542 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.487 HD23 HD21 ' A' ' 97' ' ' LEU . 14.5 tp -85.0 134.78 34.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.902 0.382 . . . . 62.34 110.896 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.467 ' O ' HD13 ' A' ' 97' ' ' LEU . 10.9 ptmt -121.94 128.02 51.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 73.1 110.898 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.536 HD23 ' CB ' ' A' ' 90' ' ' GLN . 2.4 mm? -122.98 130.58 52.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 73.24 110.925 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.477 HG23 HG23 ' A' ' 86' ' ' THR . 0.3 OUTLIER -130.53 117.17 19.19 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.176 -0.465 . . . . 74.03 111.138 179.932 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.481 ' O ' HG22 ' A' ' 85' ' ' ILE . 75.0 t80 -125.47 115.1 19.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 72.35 110.849 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.435 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 2.9 p30 -130.5 142.25 50.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.137 -0.483 . . . . 63.13 110.865 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.552 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 3.1 p -141.77 122.79 14.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 64.42 110.881 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 71.3 p -140.7 141.65 34.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 52.33 110.883 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.477 ' HB2' ' H ' ' A' ' 111' ' ' ASN . 0.1 OUTLIER -176.7 157.79 1.6 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.48 . . . . 74.32 110.885 -179.902 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -78.92 113.13 32.9 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.629 0.728 . . . . 73.54 110.888 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.592 ' CD ' HD23 ' A' ' 81' ' ' LEU . 54.2 Cg_endo -69.75 -4.02 13.19 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.71 2.273 . . . . 50.44 112.325 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -45.13 -35.0 2.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 75.52 110.86 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.8 p -129.2 23.12 5.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.455 . . . . 71.42 111.177 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 75.69 27.33 63.23 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.678 -0.772 . . . . 74.24 112.511 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.446 ' O ' ' HB3' ' A' ' 103' ' ' PHE . 15.4 mtpt -77.61 140.74 39.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.835 0.35 . . . . 74.14 110.902 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.401 ' C ' ' HD1' ' A' ' 103' ' ' PHE . 23.4 mttt -156.61 113.38 3.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 62.54 110.895 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.552 ' O ' ' HA ' ' A' ' 101' ' ' SER . 44.2 t-20 -115.33 118.68 33.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.444 . . . . 62.4 110.914 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.466 ' HB1' ' CZ ' ' A' ' 99' ' ' PHE . . . -116.1 150.23 37.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.221 -0.445 . . . . 72.12 111.107 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 4.0 tttp -135.19 136.78 42.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 73.34 110.874 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 6.2 tp -112.07 125.01 69.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 63.34 111.096 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 28.5 tttt -122.02 120.0 33.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 63.11 110.915 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 7.1 t -125.35 125.98 44.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 73.53 111.168 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -153.46 176.9 31.3 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.7 -0.762 . . . . 54.12 112.487 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -128.27 144.6 51.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.907 0.384 . . . . 74.22 110.965 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 17.8 mtpt -110.42 117.97 35.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.106 -0.497 . . . . 73.4 110.893 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.43 ' HB2' HG22 ' A' ' 123' ' ' ILE . 1.4 mmm180 -110.65 146.55 35.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 75.15 110.899 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.765 ' HA ' HG22 ' A' ' 3' ' ' VAL . 15.7 pt-20 -56.6 -31.01 63.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 74.32 110.875 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 13.9 m80 -124.23 9.37 8.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.455 . . . . 74.32 110.884 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.604 ' CG2' HD23 ' A' ' 125' ' ' LEU . 1.0 OUTLIER -145.58 147.37 18.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 73.4 111.104 -179.999 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -127.62 113.62 16.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 75.33 110.877 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.604 HD23 ' CG2' ' A' ' 123' ' ' ILE . 3.4 mm? -117.44 127.43 54.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 72.4 110.94 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -146.7 114.71 0.74 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.726 -0.749 . . . . 63.21 112.476 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -113.29 134.62 54.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.847 0.356 . . . . 64.45 110.872 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -124.94 143.58 50.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 64.31 110.834 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 3.2 mmt -138.98 119.04 13.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 74.23 110.88 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -86.17 123.64 31.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.24 -0.436 . . . . 70.13 110.881 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -92.1 98.97 11.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 73.55 110.882 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -115.92 117.05 29.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.141 -0.481 . . . . 74.51 110.882 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 2.5 pp -53.83 -32.54 22.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 72.25 111.172 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -84.36 -20.01 32.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 65.13 111.115 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 162.01 101.66 0.17 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.741 -0.742 . . . . 74.21 112.503 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 161.31 46.42 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.703 2.269 . . . . 71.52 112.369 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.0 m -127.97 151.68 48.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.231 -0.44 . . . . 74.14 110.894 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.631 HD12 ' OG1' ' A' ' 159' ' ' THR . 3.0 mp -109.06 125.65 66.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 63.35 111.093 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 15.5 ttt180 -122.85 129.25 51.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.119 -0.492 . . . . 71.1 110.882 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -124.18 133.71 8.85 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.712 -0.756 . . . . 72.42 112.509 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -133.16 126.64 32.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.855 0.36 . . . . 61.25 111.093 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.507 HD23 ' N ' ' A' ' 143' ' ' VAL . 0.7 OUTLIER -139.93 121.65 15.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.435 . . . . 55.21 110.882 -179.987 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.507 ' N ' HD23 ' A' ' 142' ' ' LEU . 1.5 m -133.8 139.55 48.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 73.41 111.139 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.41 HD12 ' N ' ' A' ' 144' ' ' LEU . 4.6 mp -109.67 138.66 45.72 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.205 -0.452 . . . . 75.2 110.937 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -100.38 136.94 12.97 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.701 -0.761 . . . . 23.43 112.473 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -141.68 147.13 37.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.851 0.357 . . . . 73.03 110.932 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -49.85 94.3 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.135 -0.484 . . . . 63.11 110.842 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 89.66 -25.27 11.64 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.74 -0.743 . . . . 23.42 112.509 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 37.2 m95 -104.92 142.01 35.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.816 0.341 . . . . 63.23 110.909 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.594 ' CD2' HD23 ' A' ' 10' ' ' LEU . 43.7 tp -140.15 140.16 35.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.236 -0.438 . . . . 73.55 110.868 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -136.01 141.52 44.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 63.12 111.102 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -148.71 134.27 4.92 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.726 -0.749 . . . . 32.44 112.465 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -133.3 124.08 26.63 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.866 0.365 . . . . 73.21 110.976 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -121.0 121.57 38.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.116 -0.493 . . . . 75.11 110.908 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 2.7 ptp -128.1 128.41 44.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.451 . . . . 61.34 110.891 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.487 ' O ' HG22 ' A' ' 164' ' ' VAL . 14.6 m-20 -113.62 121.58 44.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 63.41 110.901 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.435 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 38.9 m-85 -94.84 126.78 40.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 75.51 110.883 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.693 ' OE2' ' HB3' ' A' ' 160' ' ' ALA . 0.0 OUTLIER -79.04 100.86 7.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 64.32 110.883 -179.909 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.631 ' OG1' HD12 ' A' ' 138' ' ' ILE . 0.2 OUTLIER -64.56 -48.11 76.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.461 . . . . 74.41 111.11 -179.909 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.693 ' HB3' ' OE2' ' A' ' 158' ' ' GLU . . . -48.19 -26.09 1.77 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.225 -0.443 . . . . 60.01 111.11 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 25.4 mmtt -127.24 -167.76 1.78 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 74.31 110.87 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 6.1 t -110.59 40.12 2.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.26 -0.427 . . . . 72.11 110.874 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 9.4 mmt180 -154.19 176.74 11.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.108 -0.496 . . . . 73.51 110.83 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.487 HG22 ' O ' ' A' ' 156' ' ' ASN . 0.9 OUTLIER -73.61 142.69 14.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.14 -0.482 . . . . 72.11 111.122 179.97 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.408 ' HB ' ' HG2' ' A' ' 158' ' ' GLU . 8.6 t -90.51 -36.13 14.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.47 . . . . 74.25 111.117 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -156.24 142.88 18.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 64.43 110.871 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 2.5 p -124.99 129.66 50.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.177 -0.465 . . . . 54.44 110.845 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -136.2 148.31 48.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.103 -0.499 . . . . 74.52 110.889 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -152.09 140.17 20.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.192 -0.458 . . . . 74.32 110.892 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -154.63 142.77 20.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.465 . . . . 64.03 111.112 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -145.97 127.48 7.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 71.25 111.111 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -98.97 117.43 5.87 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.728 -0.749 . . . . 72.43 112.445 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.76 119.01 35.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.956 0.408 . . . . 74.24 110.92 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 3.3 mtpm? -116.16 127.28 54.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.085 -0.507 . . . . 60.1 110.878 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.421 ' HB ' ' H ' ' A' ' 178' ' ' PHE . 0.2 OUTLIER -110.14 166.99 10.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.226 -0.443 . . . . 74.54 111.151 -179.991 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -73.34 -6.39 45.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.186 -0.461 . . . . 73.13 110.866 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -119.49 -37.99 3.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 74.43 110.867 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.421 ' H ' ' HB ' ' A' ' 175' ' ' THR . 34.5 p90 -148.96 150.81 33.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 71.22 110.904 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -125.55 122.05 35.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.136 -0.484 . . . . 72.32 110.917 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.757 ' C ' HD12 ' A' ' 180' ' ' LEU . 0.3 OUTLIER -126.35 146.15 50.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.22 -0.445 . . . . 72.13 110.97 179.982 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 181' ' ' HIS . . . . . 0.703 ' N ' HD12 ' A' ' 180' ' ' LEU . 66.1 m-70 -119.74 116.71 26.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 65.53 110.821 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.24 143.82 28.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 60.31 111.163 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 18.2 t30 -145.18 137.86 26.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 62.24 110.875 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.532 HG22 ' HA ' ' A' ' 190' ' ' PHE . 2.4 t -134.62 114.3 17.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.253 -0.43 . . . . 71.45 111.146 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -101.96 92.58 4.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 75.41 110.883 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 2.6 t70 66.13 171.36 0.23 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 60.2 110.879 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -69.53 -4.71 46.85 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.738 -0.744 . . . . 51.52 112.487 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 33.9 p -95.06 -26.34 16.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.808 0.337 . . . . 73.34 111.162 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -123.65 114.9 20.6 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.186 -0.461 . . . . 61.33 110.906 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' PHE . . . . . 0.532 ' HA ' HG22 ' A' ' 184' ' ' VAL . 26.2 p90 -140.75 124.9 17.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 62.13 110.859 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -175.46 -149.17 7.19 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.744 -0.741 . . . . 62.41 112.509 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -173.51 -165.96 31.09 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.731 -0.747 . . . . 64.44 112.472 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 70.9 m -149.51 148.01 28.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.886 0.374 . . . . 61.41 110.858 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.483 ' HB ' HG22 ' A' ' 206' ' ' VAL . 5.4 mp -119.91 140.98 42.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.099 -0.5 . . . . 73.22 111.131 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 195' ' ' TYR . . . . . 0.618 ' HD2' ' HB2' ' A' ' 205' ' ' ALA . 14.8 t80 -132.34 120.7 22.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 74.24 110.941 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 8.7 tm0? -126.2 131.26 52.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.168 -0.469 . . . . 53.44 110.946 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 6.1 mtmp? -97.65 124.81 42.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 73.15 110.851 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.445 ' HB ' HD12 ' A' ' 202' ' ' LEU . 84.1 t -94.39 -33.7 5.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.445 . . . . 71.15 111.107 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -174.66 170.41 3.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.47 . . . . 53.3 110.906 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 19.1 mtpt -50.93 -33.66 25.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 75.33 110.878 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 4.0 mptt -120.43 53.44 1.1 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.245 -0.434 . . . . 72.23 110.944 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.445 HD12 ' HB ' ' A' ' 198' ' ' VAL . 0.2 OUTLIER -175.14 92.92 0.06 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 74.12 110.911 179.934 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -111.95 134.51 53.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 74.32 110.899 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 4.8 t -130.8 138.1 49.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 64.54 111.109 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.618 ' HB2' ' HD2' ' A' ' 195' ' ' TYR . . . -150.3 163.42 38.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.242 -0.435 . . . . 53.33 111.112 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.896 HG12 HG22 ' A' ' 221' ' ' ILE . 1.0 OUTLIER -137.14 147.95 26.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.44 . . . . 60.41 111.124 179.96 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -120.87 126.61 50.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.47 . . . . 54.44 110.911 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.409 HD12 HG23 ' A' ' 206' ' ' VAL . 1.3 mp -128.41 142.77 51.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.161 -0.472 . . . . 65.44 110.908 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -157.47 130.77 7.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 73.24 111.126 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 1.8 t-105 -103.6 123.63 47.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.199 -0.455 . . . . 73.42 110.955 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 61.8 p -107.47 104.74 14.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.257 -0.429 . . . . 62.23 111.161 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -51.11 138.69 19.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.262 -0.426 . . . . 72.35 111.074 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 154.73 -46.79 0.53 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.689 -0.767 . . . . 64.02 112.482 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -151.62 35.02 0.55 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.804 0.335 . . . . 73.42 110.866 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 47.7 t 50.98 44.76 28.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 63.03 110.892 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -101.87 131.79 48.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.147 -0.479 . . . . 73.01 110.922 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 5.2 t -115.36 139.0 50.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 75.21 111.179 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -105.94 131.57 53.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.209 -0.45 . . . . 74.04 110.879 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 219' ' ' PHE . . . . . 0.522 ' CZ ' HD12 ' A' ' 221' ' ' ILE . 13.4 t80 -131.41 136.21 47.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.466 . . . . 73.21 110.919 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -145.45 153.12 25.08 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.73 -0.748 . . . . 74.21 112.446 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.896 HG22 HG12 ' A' ' 206' ' ' VAL . 0.0 OUTLIER -137.67 130.68 42.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.85 0.357 . . . . 63.53 111.169 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -135.81 149.0 48.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.16 -0.473 . . . . 63.31 111.119 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -145.02 143.43 30.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.248 -0.433 . . . . 71.23 111.113 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 21.3 ttpp -117.74 132.89 56.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.237 -0.438 . . . . 60.34 110.865 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -132.99 132.38 41.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 64.24 110.908 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -93.67 130.45 39.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.107 -0.497 . . . . 61.22 110.922 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 71.5 mt -78.26 -56.0 8.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.214 -0.448 . . . . 51.44 111.129 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 228' ' ' ASP . . . . . 0.56 ' N ' ' HD2' ' A' ' 229' ' ' PRO . 0.1 OUTLIER 173.33 -56.94 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.61 0.719 . . . . 73.4 110.881 179.843 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 228' ' ' ASP . 53.2 Cg_endo -69.79 -156.73 0.04 OUTLIER 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.743 2.295 . . . . 53.53 112.332 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -85.55 15.79 4.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.266 -0.424 . . . . 62.34 110.871 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.665 ' HB2' ' HG3' ' A' ' 249' ' ' GLN . . . -120.43 122.28 40.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 65.22 111.059 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 31.7 m -115.71 144.39 44.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 73.04 110.837 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -111.44 131.23 55.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 70.14 110.823 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 3.5 p -127.67 141.75 51.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 63.43 110.867 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -119.76 141.65 49.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.122 -0.49 . . . . 65.51 111.096 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 18.2 mttp -145.74 142.54 29.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 74.01 110.858 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 242' ' ' LEU . 6.7 p -136.35 142.74 37.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 62.03 111.129 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -104.51 148.38 26.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 72.32 110.866 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -57.15 -18.76 16.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 72.35 110.891 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 2.1 m -82.02 25.37 0.58 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.476 . . . . 60.21 110.874 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 63.6 34.46 12.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.121 -0.49 . . . . 71.23 110.829 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 242' ' ' LEU . . . . . 0.457 HD11 ' HB3' ' A' ' 264' ' ' ASP . 2.7 mp -99.93 117.24 33.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 64.53 110.882 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.516 ' H ' HD12 ' A' ' 243' ' ' ILE . 0.2 OUTLIER -111.19 116.5 52.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.142 -0.481 . . . . 75.31 111.128 179.836 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 244' ' ' GLY . . . . . 0.522 ' C ' HD13 ' A' ' 245' ' ' LEU . . . -145.93 164.98 28.16 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.721 -0.752 . . . . 72.33 112.487 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.667 ' N ' HD13 ' A' ' 245' ' ' LEU . 0.0 OUTLIER -145.36 160.68 41.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.812 0.339 . . . . 75.03 110.926 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -129.52 139.62 11.1 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.718 -0.753 . . . . 64.13 112.464 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -116.69 115.86 26.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.996 0.427 . . . . 70.23 110.905 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 56.1 p -111.76 115.51 29.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.119 -0.492 . . . . 72.42 111.128 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 249' ' ' GLN . . . . . 0.665 ' HG3' ' HB2' ' A' ' 231' ' ' ALA . 49.5 tt0 -129.07 137.89 51.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 71.24 110.897 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 250' ' ' THR . . . . . 0.653 HG23 ' HG2' ' A' ' 256' ' ' LYS . 95.4 m -119.05 116.81 27.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.45 . . . . 72.2 111.157 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -106.02 103.71 13.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.236 -0.438 . . . . 75.04 110.921 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 252' ' ' LYS . . . . . 0.409 ' HB3' ' HD2' ' A' ' 253' ' ' PRO . 20.1 mmmt 64.34 154.6 0.12 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.588 0.709 . . . . 73.12 110.886 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 253' ' ' PRO . . . . . 0.409 ' HD2' ' HB3' ' A' ' 252' ' ' LYS . 53.6 Cg_endo -69.8 75.42 1.23 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.699 2.266 . . . . 74.03 112.312 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 167.02 -32.17 0.2 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.782 -0.723 . . . . 74.43 112.477 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 7.3 mt -117.68 122.58 70.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.965 0.412 . . . . 73.01 111.099 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 0.653 ' HG2' HG23 ' A' ' 250' ' ' THR . 20.9 mtpt -130.81 127.35 38.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.484 . . . . 63.41 110.935 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -100.68 128.78 46.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.242 -0.435 . . . . 65.03 110.886 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 23.3 m -126.46 113.01 16.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 72.53 111.125 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.594 ' CD1' HD23 ' A' ' 277' ' ' LEU . 0.1 OUTLIER -121.45 150.55 41.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.207 -0.452 . . . . 75.32 110.915 179.91 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 40.8 p -151.16 140.96 21.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 62.4 110.874 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 261' ' ' ALA . . . . . 0.613 ' HB2' ' CD2' ' A' ' 275' ' ' LEU . . . -141.37 133.49 27.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.142 -0.481 . . . . 53.02 111.087 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.787 ' C ' HD13 ' A' ' 263' ' ' LEU . 0.7 OUTLIER -131.85 138.2 48.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.221 -0.445 . . . . 75.13 110.917 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 263' ' ' LEU . . . . . 0.787 HD13 ' C ' ' A' ' 262' ' ' LEU . 0.1 OUTLIER -121.81 109.28 14.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.155 -0.475 . . . . 71.41 110.923 179.881 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 264' ' ' ASP . . . . . 0.605 ' O ' HG22 ' A' ' 268' ' ' VAL . 1.0 OUTLIER -84.73 103.95 14.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 63.44 110.86 179.903 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -59.21 -11.04 11.31 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.685 -0.769 . . . . 54.34 112.508 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 47.3 mtpt -78.29 -3.31 42.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.826 0.346 . . . . 73.04 110.914 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 -156.19 -53.28 0.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 61.42 110.884 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 268' ' ' VAL . . . . . 0.62 HG12 ' O ' ' A' ' 272' ' ' GLY . 1.8 m -57.71 -18.85 10.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 73.22 111.126 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -50.94 -28.35 9.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 73.33 110.88 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -102.95 -17.61 15.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.457 . . . . 64.35 111.085 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 142.43 122.66 1.77 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.758 -0.734 . . . . 52.21 112.496 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 272' ' ' GLY . . . . . 0.62 ' O ' HG12 ' A' ' 268' ' ' VAL . . . 134.78 62.12 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.707 -0.759 . . . . 55.54 112.521 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 273' ' ' HIS . . . . . 0.589 ' HB2' HD12 ' A' ' 263' ' ' LEU . 18.2 p-80 -76.33 146.13 39.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.855 0.359 . . . . 72.24 110.843 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 13.9 mttp -95.46 135.37 37.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 65.31 110.933 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.747 HD13 ' N ' ' A' ' 276' ' ' GLY . 2.4 tm? -135.59 139.25 43.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 72.44 110.927 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 276' ' ' GLY . . . . . 0.747 ' N ' HD13 ' A' ' 275' ' ' LEU . . . -134.03 129.26 5.22 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.738 -0.744 . . . . 42.24 112.526 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 1.028 HD12 HG23 ' A' ' 27' ' ' ILE . 3.3 tm? -115.54 135.35 54.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.901 0.382 . . . . 72.23 110.889 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 278' ' ' GLY . . . . . 0.548 ' O ' HD13 ' A' ' 279' ' ' LEU . . . -147.45 141.49 9.35 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.746 -0.74 . . . . 75.02 112.481 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.548 HD13 ' O ' ' A' ' 278' ' ' GLY . 1.1 mm? -119.57 140.13 51.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.798 0.333 . . . . 63.12 110.894 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 15.3 mp0 -128.53 118.21 22.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.148 -0.478 . . . . 74.3 110.868 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -114.24 128.83 56.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.479 . . . . 73.51 110.877 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -113.42 112.99 24.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 65.24 110.92 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.636 ' C ' HD22 ' A' ' 284' ' ' LEU . . . -115.72 113.34 23.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 63.44 111.066 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.636 HD22 ' C ' ' A' ' 283' ' ' ALA . 3.2 mm? -130.75 -74.52 0.53 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 74.42 110.941 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 63.44 110.929 179.92 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.3 mmt . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.791 0.329 . . . . 53.12 110.88 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -124.64 137.92 54.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 52.03 111.12 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.683 HG22 ' CA ' ' A' ' 121' ' ' GLU . 3.1 t 60.47 82.58 0.22 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.649 0.737 . . . . 74.14 111.148 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 167.76 23.49 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.684 2.256 . . . . 75.31 112.323 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 116.48 4.59 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.653 2.236 . . . . 75.3 112.324 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.612 ' OG1' HD21 ' A' ' 150' ' ' LEU . 1.8 t -107.85 -39.44 5.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 72.44 111.172 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.717 ' CB ' HG21 ' A' ' 143' ' ' VAL . 41.5 p90 -67.96 -35.17 77.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 72.04 110.896 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -73.17 -23.32 60.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.113 -0.494 . . . . 74.13 111.103 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -90.02 13.95 13.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 70.3 110.855 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.607 HD23 HD22 ' A' ' 150' ' ' LEU . 45.2 mt -73.77 -34.27 64.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.2 -0.455 . . . . 73.54 110.954 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 172.62 40.94 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.699 -0.762 . . . . 71.12 112.437 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 44.4 tptt -68.6 -46.02 70.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.823 0.344 . . . . 51.41 110.917 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.1 t -64.79 -39.44 93.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 63.24 110.865 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.14 -49.97 52.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 55.14 111.083 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.499 ' O ' HG23 ' A' ' 19' ' ' THR . 9.7 ptp180 -66.72 -32.79 74.32 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.223 -0.444 . . . . 75.52 110.87 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -58.89 -48.17 82.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.147 -0.478 . . . . 73.45 110.837 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.8 p -81.54 -31.44 11.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 73.24 111.148 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -65.92 -41.35 91.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 73.44 110.905 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.499 HG23 ' O ' ' A' ' 15' ' ' ARG . 69.0 p -73.81 76.92 1.6 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 73.55 111.187 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.95 124.68 18.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 72.33 110.882 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -53.49 120.11 12.76 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.761 -0.733 . . . . 73.21 112.456 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -59.89 97.96 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.936 0.398 . . . . 73.15 110.914 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -77.74 88.78 1.05 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.749 -0.739 . . . . 74.11 112.529 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.438 ' HB2' HD23 ' A' ' 26' ' ' LEU . 20.0 m-85 -101.12 13.39 35.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.914 0.388 . . . . 73.53 110.888 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.85 13.31 80.77 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.709 -0.758 . . . . 71.42 112.481 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.594 HD12 ' N ' ' A' ' 27' ' ' ILE . 1.7 pp -101.91 174.81 5.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.836 0.351 . . . . 74.33 110.881 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.702 HG13 HD12 ' A' ' 277' ' ' LEU . 1.7 mp -116.94 123.89 72.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 73.13 111.142 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.494 ' O ' HD22 ' A' ' 279' ' ' LEU . 71.6 mttt -101.69 154.56 18.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 73.45 110.909 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.659 HD13 ' N ' ' A' ' 30' ' ' ASP . 3.0 tm? -146.05 136.34 23.85 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.23 -0.441 . . . . 73.25 110.88 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.659 ' N ' HD13 ' A' ' 29' ' ' LEU . 13.8 m-20 -153.81 124.64 7.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.456 . . . . 73.13 110.93 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.736 HD11 ' CB ' ' A' ' 283' ' ' ALA . 3.2 tm? -137.2 128.12 27.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.196 -0.456 . . . . 74.14 110.919 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.474 ' N ' HD13 ' A' ' 31' ' ' LEU . 10.8 pttp -120.7 134.67 55.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 65.31 110.936 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -137.95 120.65 16.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 65.31 111.147 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -126.12 146.99 49.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.234 -0.439 . . . . 75.12 110.892 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -139.06 166.99 23.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 64.41 110.878 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -89.42 49.46 1.76 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.118 -0.492 . . . . 52.15 110.878 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -136.37 4.84 2.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.476 . . . . 72.04 110.875 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' A' ' 63' ' ' ARG . . . 89.13 -7.16 82.76 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.741 -0.742 . . . . 74.33 112.482 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.418 HD23 ' O ' ' A' ' 39' ' ' LEU . 1.6 pt? -98.76 129.83 45.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.779 0.323 . . . . 61.1 110.926 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -142.08 117.86 10.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.444 . . . . 64.3 110.895 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.51 122.29 43.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 71.42 110.872 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.11 115.32 19.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 62.12 111.12 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.7 p -115.68 134.43 55.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.249 -0.432 . . . . 52.12 110.888 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 74.8 m -149.26 126.64 11.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 64.43 110.827 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -173.62 167.53 40.17 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.734 -0.746 . . . . 70.24 112.524 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.4 p -137.58 158.05 45.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.885 0.374 . . . . 73.54 110.865 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.435 ' HA ' ' HA ' ' A' ' 54' ' ' VAL . . . -140.42 129.66 23.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 74.01 111.085 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -98.06 127.34 43.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 74.01 110.874 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 28.6 p -90.68 -52.93 4.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 72.4 111.113 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -51.51 -38.28 53.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 73.12 110.896 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 43.9 p -133.91 161.79 33.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 73.24 111.134 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.2 p -75.7 78.1 2.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.227 -0.442 . . . . 72.2 111.111 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 10.9 ttpt -142.7 78.83 1.63 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 72.31 110.906 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' A' ' 47' ' ' ALA . 1.3 p -127.79 121.24 56.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 71.44 111.104 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 6.3 m -137.22 126.72 25.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.202 -0.454 . . . . 73.13 111.107 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -111.87 154.28 16.86 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.751 -0.738 . . . . 54.33 112.487 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.5 m -136.98 143.87 43.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.889 0.376 . . . . 51.54 110.865 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.564 HD13 ' N ' ' A' ' 59' ' ' GLU . 0.8 OUTLIER -121.08 126.28 49.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 52.21 110.911 179.99 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.564 ' N ' HD13 ' A' ' 58' ' ' LEU . 8.2 mp0 -121.69 126.46 49.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 65.22 110.878 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -104.11 120.12 40.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.143 -0.481 . . . . 51.11 111.119 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -119.76 158.75 25.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.181 -0.463 . . . . 74.42 110.855 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -133.16 140.89 47.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.145 -0.479 . . . . 74.04 110.898 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.512 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 21.4 tpp180 -131.25 103.32 6.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.107 -0.497 . . . . 71.43 110.86 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 17.8 m95 -116.15 121.26 41.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.461 . . . . 72.44 110.961 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.7 m 66.34 136.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.251 -0.431 . . . . 73.05 111.148 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -63.82 106.07 0.94 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.241 -0.436 . . . . 63.42 110.858 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 23.2 t80 66.51 59.08 0.63 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.154 -0.475 . . . . 73.53 110.886 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -140.62 -65.78 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.743 -0.741 . . . . 54.32 112.482 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.487 HD13 ' HA ' ' A' ' 87' ' ' VAL . 0.7 OUTLIER -130.62 129.03 42.18 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.891 0.377 . . . . 63.53 110.907 -179.91 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 5.1 m -137.92 133.26 33.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.177 -0.465 . . . . 62.34 111.124 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -123.27 134.79 54.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.444 . . . . 71.42 110.886 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.8 p -127.28 118.52 24.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.466 . . . . 72.5 111.19 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -121.82 130.06 53.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.259 -0.428 . . . . 74.44 110.849 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -122.24 104.98 9.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.48 . . . . 73.23 110.857 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 8.6 t90 -122.35 125.71 46.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.251 -0.431 . . . . 74.53 110.909 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -102.81 137.11 41.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 70.22 110.926 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 24.0 m -66.85 -34.4 77.72 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.206 -0.452 . . . . 73.32 111.136 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -110.81 -34.08 6.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.258 -0.428 . . . . 64.24 110.891 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -81.25 -160.55 0.34 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 54.41 110.901 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 66.6 p -80.95 154.05 27.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 74.53 111.154 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.618 ' H ' HD23 ' A' ' 81' ' ' LEU . 2.1 pt? -111.44 137.31 49.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 73.13 110.896 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -159.77 162.94 33.37 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.73 -0.748 . . . . 41.21 112.466 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.5 t -138.46 163.54 31.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.721 0.296 . . . . 53.12 111.137 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.33 145.48 25.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.456 . . . . 43.34 110.868 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.56 138.08 55.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.475 . . . . 71.11 111.146 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.542 HG23 ' OG1' ' A' ' 98' ' ' THR . 20.3 m -127.03 129.15 47.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.18 -0.463 . . . . 54.35 111.156 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.487 ' HA ' HD13 ' A' ' 69' ' ' LEU . 3.4 p -128.61 137.34 57.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 61.25 111.16 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -102.62 118.47 36.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 71.54 110.878 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -50.49 128.07 19.2 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.156 -0.474 . . . . 74.33 110.867 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -79.43 -56.71 4.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.185 -0.461 . . . . 64.33 110.935 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 15.3 mt -72.26 -41.29 66.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 74.22 110.928 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -93.78 71.6 4.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 74.24 111.121 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 11.5 tpt180 -50.98 135.32 24.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 74.31 110.883 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 101.75 -23.61 34.27 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.762 -0.733 . . . . 71.41 112.507 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.604 HD12 HD11 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -79.8 119.41 22.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.914 0.388 . . . . 73.21 110.905 -179.937 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.563 ' C ' HD13 ' A' ' 97' ' ' LEU . 26.7 ttpp -121.42 125.74 47.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 72.12 110.871 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.604 HD11 HD12 ' A' ' 95' ' ' LEU . 0.6 OUTLIER -118.62 126.71 52.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.445 . . . . 75.4 110.943 179.913 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.542 ' OG1' HG23 ' A' ' 86' ' ' THR . 97.2 m -131.33 119.83 22.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 64.32 111.139 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -115.11 121.73 43.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 75.21 110.895 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -119.29 150.0 40.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.163 -0.471 . . . . 73.32 110.851 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 7.1 t -142.22 124.81 15.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 71.14 110.84 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 4.9 m -99.77 146.52 26.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.108 -0.496 . . . . 75.24 110.898 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.414 ' O ' HD23 ' A' ' 81' ' ' LEU . 11.1 m-85 -143.12 138.55 29.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.458 . . . . 74.41 110.923 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 17.7 m -99.0 137.41 20.48 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.647 0.737 . . . . 72.32 110.882 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.83 125.57 12.26 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.719 2.279 . . . . 62.32 112.332 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 51.01 48.86 22.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 53.41 110.928 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 25.9 m -136.96 -41.53 0.59 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.143 -0.481 . . . . 71.43 111.103 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 92.28 -18.01 55.55 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.763 -0.732 . . . . 43.31 112.525 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 8.5 tttm -65.94 116.61 7.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.855 0.36 . . . . 75.41 110.931 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 15.0 ptmt -115.81 131.0 57.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 74.13 110.912 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -120.98 123.87 43.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.208 -0.451 . . . . 73.23 110.907 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -110.55 136.2 50.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.454 . . . . 63.03 111.113 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 11.2 mttt -138.25 137.78 37.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 73.21 110.888 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 5.7 tp -120.34 130.73 74.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.437 . . . . 65.33 111.127 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.6 tptp -120.35 119.69 33.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 73.31 110.879 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.59 HG23 HD12 ' A' ' 97' ' ' LEU . 58.7 m -129.61 121.48 27.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 71.24 111.145 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.435 ' HA3' ' HA2' ' A' ' 126' ' ' GLY . . . -150.56 170.68 30.43 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.769 -0.729 . . . . 74.24 112.497 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.428 ' CD2' HD22 ' A' ' 95' ' ' LEU . 0.2 OUTLIER -127.98 135.84 50.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.973 0.416 . . . . 71.3 110.934 -179.836 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.662 ' HG2' HG11 ' A' ' 3' ' ' VAL . 2.9 tttt -110.86 118.02 34.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.12 -0.491 . . . . 75.51 110.87 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.455 ' O ' HG13 ' A' ' 3' ' ' VAL . 23.1 ttm-85 -111.42 143.73 41.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 70.44 110.883 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.683 ' CA ' HG22 ' A' ' 3' ' ' VAL . 17.8 pt-20 -52.35 -29.36 23.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 73.41 110.899 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -86.31 -41.16 14.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 54.44 110.883 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.435 ' HB ' HD13 ' A' ' 144' ' ' LEU . 1.3 pp -148.25 153.53 11.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.224 -0.444 . . . . 74.51 111.111 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -127.24 115.06 18.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 75.5 110.905 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.899 HD22 ' C ' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -133.39 142.79 48.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 72.42 110.927 179.959 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.667 ' N ' HD22 ' A' ' 125' ' ' LEU . . . -148.02 141.97 9.67 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.723 -0.751 . . . . 61.32 112.47 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 2.0 t -113.32 131.0 56.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.81 0.338 . . . . 74.42 110.883 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -119.68 150.41 40.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.232 -0.44 . . . . 75.1 110.888 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 8.1 ttt -138.03 119.76 15.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.446 . . . . 75.21 110.886 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -102.33 120.95 41.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.202 -0.454 . . . . 72.45 110.871 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -95.34 116.34 28.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 75.04 110.868 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.431 ' OD1' HD12 ' A' ' 133' ' ' ILE . 15.8 t0 -109.94 173.66 6.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 62.21 110.87 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.545 ' H ' HD12 ' A' ' 133' ' ' ILE . 2.8 mp -93.34 -33.59 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 71.21 111.154 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -92.69 -19.77 21.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 72.52 111.075 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 168.9 106.63 0.19 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.76 -0.733 . . . . 45.34 112.484 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 144.56 54.25 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.639 2.226 . . . . 72.0 112.328 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 9.4 t -128.77 152.35 48.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.444 . . . . 71.52 110.841 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.716 HD12 ' OG1' ' A' ' 159' ' ' THR . 1.7 mp -112.34 135.48 51.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.131 -0.486 . . . . 73.14 111.09 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 8.5 ttm180 -121.48 112.32 18.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.458 . . . . 72.41 110.871 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -111.65 136.38 13.51 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.775 -0.726 . . . . 61.02 112.525 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -138.54 116.26 11.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.799 0.333 . . . . 74.43 111.125 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.759 HD13 ' CB ' ' A' ' 125' ' ' LEU . 1.1 tp -123.86 124.51 42.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.252 -0.431 . . . . 41.42 110.901 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.754 ' N ' HD12 ' A' ' 142' ' ' LEU . 44.5 t -114.25 129.85 69.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 71.31 111.081 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.454 HD13 ' HA ' ' A' ' 144' ' ' LEU . 2.6 mm? -106.14 138.85 41.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 52.35 110.899 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -116.27 136.6 13.0 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.781 -0.723 . . . . 72.42 112.487 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -140.46 146.43 38.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.876 0.37 . . . . 75.01 110.909 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 74.5 mt-10 -50.31 96.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.136 -0.483 . . . . 44.21 110.907 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 90.16 -26.08 10.89 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.745 -0.741 . . . . 54.32 112.541 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 7.1 m0 -105.15 135.64 46.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.803 0.335 . . . . 75.54 110.886 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.612 HD21 ' OG1' ' A' ' 6' ' ' THR . 0.6 OUTLIER -126.53 140.07 52.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.265 -0.425 . . . . 75.44 110.876 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.468 ' H ' HD23 ' A' ' 150' ' ' LEU . . . -139.76 145.2 37.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 73.24 111.083 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -146.97 132.97 4.58 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.71 -0.757 . . . . 51.35 112.516 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -135.43 120.17 18.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.842 0.354 . . . . 70.13 110.899 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -134.05 122.45 23.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.137 -0.483 . . . . 72.23 110.95 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 4.3 ptt? -145.96 155.39 42.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 53.12 110.892 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -112.72 129.92 56.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 63.25 110.846 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.424 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 62.1 t80 -90.44 133.16 35.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.48 . . . . 73.11 110.861 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -77.82 101.94 6.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.473 . . . . 71.42 110.914 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.716 ' OG1' HD12 ' A' ' 138' ' ' ILE . 0.2 OUTLIER -64.97 -47.4 77.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.127 -0.488 . . . . 74.12 111.117 -179.9 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -48.6 -26.07 2.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 71.3 111.097 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 4.1 tptt -126.11 -167.51 1.72 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 64.32 110.919 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 11.7 t -112.03 40.83 2.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.446 . . . . 75.42 110.814 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -154.47 176.09 12.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 65.31 110.869 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.424 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 2.0 t -82.55 141.51 14.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.446 . . . . 63.31 111.125 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 15.2 t -91.01 -34.19 15.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.192 -0.458 . . . . 73.24 111.154 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -152.45 138.18 17.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 74.24 110.897 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 3.5 m -124.7 131.14 53.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 72.41 110.879 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -132.09 135.16 46.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 71.53 110.843 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.628 ' HB3' HG22 ' A' ' 184' ' ' VAL . 11.3 t80 -130.06 148.51 51.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.103 -0.499 . . . . 72.32 110.887 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -153.42 138.13 16.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 52.32 111.117 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 61.8 t -120.64 134.7 63.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.252 -0.431 . . . . 72.11 111.09 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -116.01 131.29 9.53 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.737 -0.744 . . . . 65.03 112.497 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -130.03 120.66 25.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.961 0.41 . . . . 74.22 110.926 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.14 132.28 54.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.079 -0.509 . . . . 73.3 110.888 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.47 166.49 21.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 74.32 111.136 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -39.79 -73.82 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.22 -0.446 . . . . 61.03 110.885 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -117.05 14.81 15.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.459 . . . . 55.34 110.951 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.64 ' CZ ' HG23 ' A' ' 194' ' ' ILE . 88.8 t80 -126.15 142.3 51.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.115 -0.493 . . . . 70.01 110.897 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 53.8 mm-40 -136.6 125.29 23.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.111 -0.495 . . . . 52.11 110.9 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.688 HD12 HG13 ' A' ' 194' ' ' ILE . 1.0 OUTLIER -123.31 129.01 50.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.462 . . . . 71.33 110.929 179.991 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 25.7 m80 -129.85 117.78 20.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 62.13 110.89 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 9.2 m -109.31 155.77 20.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 72.32 111.175 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -162.47 139.42 7.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.24 -0.436 . . . . 64.22 110.909 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.628 HG22 ' HB3' ' A' ' 169' ' ' PHE . 2.0 m -133.62 138.61 50.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 70.41 111.139 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -97.7 88.77 4.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 75.35 110.891 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' ASP . . . . . 0.4 ' HB2' HG22 ' A' ' 188' ' ' THR . 2.0 m-20 72.4 -176.4 0.18 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.195 -0.457 . . . . 74.33 110.888 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -79.45 3.08 69.12 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.73 -0.748 . . . . 71.21 112.479 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' THR . . . . . 0.4 HG22 ' HB2' ' A' ' 186' ' ' ASP . 3.9 t -107.54 -22.29 12.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.801 0.334 . . . . 71.51 111.172 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -120.83 124.32 44.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.47 . . . . 74.42 110.894 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' PHE . . . . . 0.552 ' HA ' ' HB ' ' A' ' 184' ' ' VAL . 0.4 OUTLIER -137.76 125.38 22.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.183 -0.462 . . . . 74.13 110.882 -179.906 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -146.3 170.91 27.31 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.752 -0.737 . . . . 63.23 112.467 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.539 ' O ' HD23 ' A' ' 208' ' ' LEU . . . -150.5 164.14 29.74 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.73 -0.748 . . . . 54.02 112.458 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -139.56 141.98 37.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.863 0.363 . . . . 71.33 110.836 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.688 HG13 HD12 ' A' ' 180' ' ' LEU . 5.3 mp -131.65 116.89 32.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 74.31 111.107 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' TYR . . . . . 0.593 ' CE2' ' HB2' ' A' ' 205' ' ' ALA . 2.6 t80 -108.83 122.31 46.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.134 -0.485 . . . . 71.32 110.915 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 22.4 tp60 -124.3 122.6 38.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.089 -0.505 . . . . 72.04 110.922 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.94 127.29 47.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 74.2 110.925 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 9.3 t -82.64 155.99 3.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.228 -0.442 . . . . 75.15 111.089 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -50.45 -50.2 52.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 54.01 110.919 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 13.7 mmtp -69.63 -170.42 0.3 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 63.25 110.885 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' LYS . . . . . 0.75 ' O ' HD22 ' A' ' 202' ' ' LEU . 23.3 mtpp -81.45 55.58 2.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 73.23 110.912 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.75 HD22 ' O ' ' A' ' 201' ' ' LYS . 3.9 mm? -135.61 116.25 13.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 75.41 110.922 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -107.25 139.35 41.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 75.04 110.913 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 6.1 m -124.0 138.83 54.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 74.43 111.106 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.593 ' HB2' ' CE2' ' A' ' 195' ' ' TYR . . . -137.6 143.34 41.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 74.41 111.087 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 10.6 t -132.43 137.94 53.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.46 . . . . 55.04 111.124 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -149.22 125.89 11.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 74.0 110.902 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.539 HD23 ' O ' ' A' ' 192' ' ' GLY . 2.6 pt? -147.08 150.58 35.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.162 -0.472 . . . . 72.25 110.929 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -134.44 149.28 50.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 75.44 111.075 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 17.3 t90 -130.42 132.02 45.53 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.214 -0.448 . . . . 75.51 110.926 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 1.7 m -95.69 107.89 20.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 73.24 111.153 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -51.88 146.76 7.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 54.11 111.075 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 104.35 -38.54 3.21 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.732 -0.747 . . . . 71.11 112.442 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 31.8 m120 -121.23 166.94 13.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.877 0.37 . . . . 74.5 110.86 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 39.3 m -97.38 36.93 1.4 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 72.22 110.833 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 16.9 t30 -101.83 111.52 23.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.107 -0.497 . . . . 71.53 110.937 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 35.0 p -115.33 138.66 50.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.45 . . . . 71.31 111.139 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -126.77 123.97 38.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 71.03 110.896 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -132.69 156.11 47.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 72.43 110.842 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -149.33 147.88 18.68 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.729 -0.748 . . . . 51.03 112.482 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 3.7 mp -120.67 132.15 70.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.87 0.367 . . . . 75.31 111.106 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -138.06 130.81 29.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 55.54 111.101 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -123.97 158.41 32.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 71.54 111.098 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 19.4 ttmm -124.09 137.48 54.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.431 . . . . 71.51 110.936 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -132.34 117.61 18.36 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.206 -0.452 . . . . 64.0 110.944 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -89.95 130.48 36.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.131 -0.486 . . . . 73.32 110.915 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 62.7 mt -81.83 -57.67 4.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 74.41 111.085 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.559 ' N ' ' HD2' ' A' ' 229' ' ' PRO . 0.6 OUTLIER 170.7 -56.89 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.673 0.749 . . . . 73.04 110.877 179.938 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 228' ' ' ASP . 53.4 Cg_endo -69.81 -156.42 0.04 OUTLIER 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.68 2.253 . . . . 73.2 112.359 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -85.49 17.27 3.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.225 -0.443 . . . . 54.42 110.862 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -119.52 122.12 40.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 44.41 111.097 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 32.5 t -120.6 142.68 49.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.451 . . . . 73.22 110.886 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -108.88 128.18 54.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 75.11 110.855 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -122.12 154.07 37.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 72.24 110.853 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -133.03 149.78 52.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.122 -0.49 . . . . 71.45 111.169 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 34.0 mttp -145.74 164.06 33.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.23 -0.441 . . . . 61.21 110.94 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 242' ' ' LEU . 6.0 p -156.19 143.17 10.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.266 -0.424 . . . . 71.05 111.171 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -106.2 147.97 28.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 73.4 110.879 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -52.55 -22.77 5.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 72.35 110.854 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 32.2 t -81.2 26.15 0.46 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.46 . . . . 72.1 110.84 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 5.0 t 58.08 38.98 26.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.475 . . . . 72.33 110.902 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' LEU . . . . . 0.446 ' O ' HG23 ' A' ' 237' ' ' VAL . 3.6 mp -98.7 129.54 45.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.093 -0.503 . . . . 75.3 110.888 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.491 ' H ' HD12 ' A' ' 243' ' ' ILE . 4.0 mp -93.02 117.78 37.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.458 . . . . 65.32 111.12 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -117.53 144.3 18.22 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.766 -0.731 . . . . 55.25 112.468 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.641 HD21 HD21 ' A' ' 263' ' ' LEU . 0.0 OUTLIER -145.3 128.56 16.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.828 0.347 . . . . 75.15 110.953 -179.943 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -130.35 122.06 3.51 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.733 -0.746 . . . . 74.51 112.466 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -110.27 115.97 30.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.907 0.384 . . . . 75.24 110.949 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.899 HG23 HG23 ' A' ' 258' ' ' THR . 0.2 OUTLIER -110.58 114.88 28.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 51.44 111.143 -179.966 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -143.4 138.64 29.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 74.13 110.924 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 250' ' ' THR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 256' ' ' LYS . 16.3 p -77.95 147.51 34.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 74.25 111.137 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.4 ' HG ' ' HD2' ' A' ' 252' ' ' LYS . 13.8 tp -111.36 -74.71 0.63 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 75.43 110.954 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 252' ' ' LYS . . . . . 0.595 ' HG2' HD11 ' A' ' 255' ' ' ILE . 12.7 mmmt -97.43 163.15 20.36 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.564 0.697 . . . . 64.5 110.918 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 253' ' ' PRO . . . . . 0.593 ' HD2' ' HB3' ' A' ' 252' ' ' LYS . 53.7 Cg_endo -69.75 67.08 1.75 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.718 2.278 . . . . 71.21 112.335 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 254' ' ' GLY . . . . . 0.632 ' O ' ' HB3' ' A' ' 281' ' ' PHE . . . 157.67 -17.94 0.35 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.767 -0.73 . . . . 33.55 112.495 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.595 HD11 ' HG2' ' A' ' 252' ' ' LYS . 15.9 pt -129.36 141.5 46.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.928 0.394 . . . . 75.22 111.121 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 250' ' ' THR . 48.7 tttt -117.69 138.33 52.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 75.02 110.895 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 0.704 ' HA ' HD12 ' A' ' 279' ' ' LEU . 0.2 OUTLIER -96.09 128.56 43.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 74.15 110.92 179.919 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 258' ' ' THR . . . . . 0.899 HG23 HG23 ' A' ' 248' ' ' THR . 4.4 m -119.81 122.62 41.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.465 . . . . 75.12 111.16 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.881 HD22 HD23 ' A' ' 277' ' ' LEU . 0.0 OUTLIER -110.29 138.94 45.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.218 -0.446 . . . . 75.51 110.912 179.971 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.559 ' O ' HD22 ' A' ' 275' ' ' LEU . 70.6 m -136.67 140.55 42.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 63.44 110.857 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -146.57 129.07 15.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.099 -0.5 . . . . 55.54 111.14 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.707 ' C ' HD13 ' A' ' 263' ' ' LEU . 2.8 tm? -121.94 130.05 53.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.27 -0.423 . . . . 72.02 110.924 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 263' ' ' LEU . . . . . 0.889 ' HB3' HG21 ' A' ' 268' ' ' VAL . 0.3 OUTLIER -124.24 110.55 14.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.469 . . . . 72.32 110.919 179.885 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 264' ' ' ASP . . . . . 0.562 ' O ' ' HB ' ' A' ' 268' ' ' VAL . 0.7 OUTLIER -86.8 98.33 11.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.155 -0.475 . . . . 54.01 110.846 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -53.02 -11.95 1.62 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.762 -0.732 . . . . 74.2 112.454 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -64.41 -25.46 68.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.78 0.324 . . . . 72.53 110.896 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -168.44 19.91 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 72.04 110.873 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 268' ' ' VAL . . . . . 0.889 HG21 ' HB3' ' A' ' 263' ' ' LEU . 1.7 p -68.52 -27.0 34.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 70.53 111.16 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -77.8 -44.83 26.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 61.14 110.922 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -95.93 12.41 30.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 64.43 111.11 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -129.62 -104.22 1.1 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.708 -0.758 . . . . 41.33 112.47 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -164.67 172.26 40.35 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.708 -0.758 . . . . 73.4 112.489 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 273' ' ' HIS . . . . . 0.406 ' CB ' HD12 ' A' ' 263' ' ' LEU . 2.4 p-80 -105.25 146.66 29.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.839 0.352 . . . . 74.21 110.909 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -95.66 136.34 36.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 74.21 110.884 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.744 HD13 ' N ' ' A' ' 276' ' ' GLY . 2.5 tm? -134.36 139.07 45.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.243 -0.435 . . . . 62.13 110.917 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 276' ' ' GLY . . . . . 0.744 ' N ' HD13 ' A' ' 275' ' ' LEU . . . -140.04 130.29 4.61 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.685 -0.769 . . . . 63.02 112.462 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.881 HD23 HD22 ' A' ' 259' ' ' LEU . 3.5 tm? -115.93 138.67 50.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.859 0.361 . . . . 72.11 110.904 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 278' ' ' GLY . . . . . 0.656 ' N ' HD13 ' A' ' 277' ' ' LEU . . . -162.04 129.06 2.0 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.74 -0.743 . . . . 51.0 112.474 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.704 HD12 ' HA ' ' A' ' 257' ' ' LEU . 0.1 OUTLIER -108.69 127.99 54.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.784 0.326 . . . . 73.14 110.896 -179.916 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 280' ' ' GLU . . . . . 0.423 ' O ' ' HB2' ' A' ' 281' ' ' PHE . 1.8 pm0 -140.92 147.06 38.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.162 -0.472 . . . . 71.11 110.888 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.632 ' HB3' ' O ' ' A' ' 254' ' ' GLY . 0.0 OUTLIER 168.73 -157.99 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.134 -0.484 . . . . 72.42 110.842 -179.945 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -136.22 143.15 44.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.145 -0.48 . . . . 63.12 110.984 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.736 ' CB ' HD11 ' A' ' 31' ' ' LEU . . . -91.17 112.43 24.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 74.02 111.131 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.666 HD22 ' O ' ' A' ' 283' ' ' ALA . 1.5 mm? -136.99 179.18 6.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.23 -0.441 . . . . 71.05 110.944 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.214 -0.448 . . . . 60.31 110.898 179.962 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 301' ' ' NAI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.2 mtm . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.813 0.339 . . . . 73.31 110.884 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -159.1 133.5 7.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 34.44 111.1 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.733 HG11 ' O ' ' A' ' 119' ' ' LYS . 24.8 t -139.7 82.16 18.52 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.601 0.715 . . . . 73.21 111.127 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 168.28 21.98 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.712 2.275 . . . . 64.33 112.319 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 95.55 0.56 Allowed 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.636 2.224 . . . . 71.23 112.349 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -79.64 -48.6 13.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.247 -0.433 . . . . 72.11 111.088 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.427 ' HB2' HG11 ' A' ' 143' ' ' VAL . 35.7 t80 -52.79 -40.52 63.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.21 -0.45 . . . . 71.32 110.931 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.99 -19.86 58.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.134 -0.485 . . . . 71.12 111.109 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -88.62 10.47 20.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.168 -0.469 . . . . 74.54 110.833 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.884 HD21 ' HA3' ' A' ' 152' ' ' GLY . 0.6 OUTLIER -64.59 -34.15 77.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.456 . . . . 72.32 110.935 -179.986 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -152.09 63.57 0.38 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.748 -0.739 . . . . 74.33 112.499 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.34 -54.51 14.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.833 0.349 . . . . 75.41 110.879 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 m -64.02 -39.49 94.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 64.15 110.83 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.51 -37.7 73.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 73.13 111.11 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 63.2 mtt-85 -61.85 -36.85 82.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.451 . . . . 74.3 110.874 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.91 -37.97 82.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.218 -0.446 . . . . 71.44 110.855 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 97.6 t -75.24 -35.88 35.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.143 -0.48 . . . . 74.33 111.139 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -60.92 -41.0 95.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 61.34 110.853 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.0 m 51.9 78.34 0.12 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 73.42 111.137 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.84 119.74 11.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.44 . . . . 75.41 110.862 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.46 96.74 1.28 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.733 -0.746 . . . . 73.3 112.507 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -86.55 -175.83 5.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.928 0.394 . . . . 72.43 110.932 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.84 114.5 5.34 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.728 -0.748 . . . . 64.2 112.478 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -103.9 12.85 33.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.956 0.408 . . . . 75.22 110.924 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.61 14.18 77.79 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.685 -0.769 . . . . 73.35 112.498 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.554 HD12 ' N ' ' A' ' 27' ' ' ILE . 2.2 pp -114.81 179.81 3.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.794 0.331 . . . . 74.05 110.932 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.918 HG23 HD12 ' A' ' 277' ' ' LEU . 32.6 mm -109.87 125.84 67.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 65.4 111.125 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.54 ' O ' HD22 ' A' ' 279' ' ' LEU . 8.9 mttt -102.84 149.85 24.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.182 -0.463 . . . . 73.1 110.878 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.617 HD13 ' N ' ' A' ' 30' ' ' ASP . 0.5 OUTLIER -147.1 130.3 16.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 54.35 110.911 179.918 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.617 ' N ' HD13 ' A' ' 29' ' ' LEU . 18.2 m-20 -146.71 126.3 13.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.207 -0.452 . . . . 73.15 110.897 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.794 HD11 ' HB3' ' A' ' 283' ' ' ALA . 2.0 tm? -134.78 125.54 27.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 74.31 110.922 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.522 ' N ' HD13 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -120.86 147.23 45.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.218 -0.446 . . . . 75.13 110.898 179.86 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.9 p -137.2 120.48 16.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.44 . . . . 74.01 111.15 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 40.1 mtpt -115.32 129.99 56.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.245 -0.434 . . . . 74.14 110.917 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -125.44 138.13 54.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 74.32 110.822 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -76.85 60.29 1.73 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.476 . . . . 72.13 110.868 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.446 ' O ' HD22 ' A' ' 39' ' ' LEU . 31.0 m-80 -159.28 23.12 0.19 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 54.03 110.895 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.581 ' HA2' ' O ' ' A' ' 63' ' ' ARG . . . 79.59 -3.73 67.34 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.781 -0.723 . . . . 51.52 112.437 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.446 HD22 ' O ' ' A' ' 37' ' ' ASN . 3.0 mm? -97.39 124.3 41.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.802 0.334 . . . . 73.12 110.899 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -145.26 117.98 8.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.134 -0.484 . . . . 62.21 110.893 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -111.71 123.58 50.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.481 . . . . 70.12 110.902 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.65 120.97 30.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 74.13 111.168 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.9 p -121.37 142.36 50.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 64.03 110.87 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 21.0 m -147.99 136.05 21.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.147 -0.479 . . . . 61.31 110.861 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -172.87 158.85 29.08 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.759 -0.734 . . . . 74.34 112.492 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -138.32 150.69 46.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.911 0.386 . . . . 74.52 110.872 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -121.17 130.74 53.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.475 . . . . 64.1 111.055 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -72.07 118.94 15.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 74.12 110.91 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 33.8 m -58.73 149.68 25.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.47 . . . . 71.21 111.186 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 39.9 40.13 0.67 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 74.13 110.92 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 98.8 m -161.26 126.69 3.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.154 -0.475 . . . . 74.32 111.126 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 71.5 p -76.24 66.8 2.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.251 -0.432 . . . . 75.31 111.153 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.6 ttmt -156.27 104.04 2.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 74.43 110.886 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.2 m -126.47 148.29 31.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.182 -0.463 . . . . 61.55 111.146 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 91.5 m -116.26 126.61 53.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 52.32 111.164 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -127.73 150.8 18.38 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.742 -0.742 . . . . 71.04 112.478 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 78.0 p -146.29 142.23 28.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.918 0.39 . . . . 72.34 110.869 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.516 HD13 ' N ' ' A' ' 59' ' ' GLU . 0.6 OUTLIER -121.88 125.27 46.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.124 -0.489 . . . . 72.31 110.935 179.966 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.516 ' N ' HD13 ' A' ' 58' ' ' LEU . 5.7 pt-20 -124.77 129.47 50.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 73.04 110.902 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.9 t -99.63 128.85 45.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.135 -0.484 . . . . 53.4 111.129 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 71' ' ' PHE . 26.7 ttmt -126.98 154.36 44.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 72.01 110.906 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.434 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 9.4 m-85 -130.38 140.08 50.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.443 . . . . 71.12 110.887 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.581 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 21.7 tpp85 -118.0 103.99 10.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.062 -0.517 . . . . 73.12 110.879 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -106.4 114.66 28.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 74.25 110.895 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 6.0 t -94.41 -167.55 1.68 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.209 -0.45 . . . . 74.1 111.108 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 59.41 30.42 20.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 71.32 110.857 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 179.58 -53.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 65.41 110.949 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 110.51 64.77 0.53 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.732 -0.747 . . . . 65.5 112.505 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.0 mp -134.44 132.33 39.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.88 0.371 . . . . 72.42 110.933 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 44.2 p -136.29 135.1 38.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 63.11 111.167 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.655 ' CD2' HG22 ' A' ' 85' ' ' ILE . 23.7 t80 -117.46 131.14 56.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.241 -0.436 . . . . 74.33 110.899 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.59 HG23 ' HB2' ' A' ' 84' ' ' GLU . 3.8 t -128.56 121.09 27.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 72.22 111.107 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -126.62 130.21 50.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 75.2 110.883 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 5.4 ttpm? -113.0 110.82 21.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.479 . . . . 73.23 110.883 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.421 ' CD1' ' CB ' ' A' ' 81' ' ' LEU . 2.6 t90 -115.67 126.92 54.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 71.5 110.908 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -120.74 136.11 54.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.25 -0.432 . . . . 74.13 110.904 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 9.5 t -70.5 -36.08 73.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 74.24 111.177 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -111.6 -35.37 5.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.207 -0.451 . . . . 72.05 110.886 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -78.88 -154.0 0.07 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 72.51 110.904 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.1 t -78.97 149.39 32.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 64.34 111.135 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.421 ' CB ' ' CD1' ' A' ' 75' ' ' TRP . 0.1 OUTLIER -124.04 117.64 25.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 53.42 110.897 179.962 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.83 170.16 39.03 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.743 -0.742 . . . . 60.22 112.489 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -131.52 159.63 37.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.776 0.322 . . . . 72.44 111.119 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.59 ' HB2' HG23 ' A' ' 72' ' ' THR . 40.4 mt-10 -142.42 144.54 33.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 74.11 110.899 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.655 HG22 ' CD2' ' A' ' 71' ' ' PHE . 1.5 pp -121.61 138.87 50.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 71.51 111.146 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.451 HG22 ' HE2' ' A' ' 96' ' ' LYS . 0.2 OUTLIER -128.46 127.73 43.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 71.35 111.123 179.996 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.424 HG22 ' HB2' ' A' ' 97' ' ' LEU . 3.9 m -128.39 138.36 54.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 75.24 111.099 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -118.47 128.48 54.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.139 -0.482 . . . . 73.22 110.922 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 56.98 39.85 29.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.184 -0.462 . . . . 74.21 110.88 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -66.81 -35.32 79.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.452 . . . . 75.43 110.872 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.3 tt -122.31 -37.12 2.85 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.24 -0.436 . . . . 64.41 110.904 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -146.67 138.4 24.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 72.51 111.112 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -59.73 134.45 57.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.25 -0.432 . . . . 73.01 110.853 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 100.37 -23.45 35.8 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.717 -0.754 . . . . 62.11 112.473 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.472 HD12 ' HB3' ' A' ' 118' ' ' TYR . 4.7 tp -95.62 129.4 42.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.879 0.371 . . . . 51.42 110.898 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.587 ' C ' HD13 ' A' ' 97' ' ' LEU . 8.8 tttm -122.66 131.48 53.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 72.04 110.904 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.587 HD13 ' C ' ' A' ' 96' ' ' LYS . 0.5 OUTLIER -116.82 127.31 54.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.235 -0.439 . . . . 72.55 110.934 179.877 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.446 HG23 HG23 ' A' ' 86' ' ' THR . 2.8 m -129.76 123.53 31.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.203 -0.453 . . . . 73.43 111.127 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.733 ' CD2' HD13 ' A' ' 114' ' ' ILE . 1.1 t80 -110.38 121.97 46.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.459 . . . . 75.54 110.874 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -110.36 124.49 51.8 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.163 -0.472 . . . . 74.34 110.877 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.0 t -124.14 121.45 35.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 73.33 110.865 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 75.7 m -114.88 145.86 41.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 75.13 110.852 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -135.12 137.41 42.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.147 -0.479 . . . . 54.25 110.895 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.7 t -128.41 138.94 34.12 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.681 0.753 . . . . 75.42 110.847 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.79 -23.91 30.13 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.646 2.231 . . . . 73.44 112.319 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -56.2 99.06 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.431 . . . . 75.42 110.877 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 53.2 26.92 5.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 75.31 111.171 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 67.15 24.5 73.35 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.71 -0.757 . . . . 53.25 112.515 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 58.3 tttt -65.43 118.02 8.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.881 0.372 . . . . 72.01 110.87 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 17.6 pttm -122.59 151.09 41.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 73.01 110.893 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -127.2 136.59 52.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 74.4 110.862 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -116.04 131.03 57.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 54.34 111.092 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -138.28 138.68 38.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 62.14 110.865 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.733 HD13 ' CD2' ' A' ' 99' ' ' PHE . 5.4 tp -134.07 127.32 51.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 44.2 111.135 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 7.2 mmtp -119.53 118.86 32.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 73.33 110.885 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.1 t -129.74 119.67 23.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.216 -0.447 . . . . 63.32 111.099 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.483 ' HA3' ' HA2' ' A' ' 126' ' ' GLY . . . -153.29 168.76 32.06 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.693 -0.765 . . . . 72.12 112.476 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.472 ' HB3' HD12 ' A' ' 95' ' ' LEU . 41.7 p90 -133.16 132.05 41.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.971 0.415 . . . . 72.33 110.95 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.733 ' O ' HG11 ' A' ' 3' ' ' VAL . 18.0 mtmm -108.18 119.47 39.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 72.54 110.95 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 43.3 ttt180 -110.14 143.53 40.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.279 -0.419 . . . . 72.51 110.878 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -51.48 -28.01 12.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 74.44 110.901 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 70.7 m80 -89.17 -40.12 13.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 64.43 110.861 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.91 HD13 HD13 ' A' ' 144' ' ' LEU . 2.3 tp -149.23 138.3 15.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 74.12 111.077 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.62 ' H ' HD12 ' A' ' 123' ' ' ILE . 0.3 OUTLIER -105.03 118.66 37.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 65.12 110.851 179.947 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -116.51 140.52 49.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 54.34 110.91 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.483 ' HA2' ' HA3' ' A' ' 117' ' ' GLY . . . -143.29 121.52 1.71 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.749 -0.739 . . . . 40.41 112.476 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -112.47 107.71 16.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.8 0.333 . . . . 74.34 110.881 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -104.92 145.18 30.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.223 -0.444 . . . . 73.32 110.836 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 96.8 mtp -138.68 136.1 35.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 73.14 110.892 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -128.27 135.69 49.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 75.51 110.854 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -95.8 102.38 14.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 64.42 110.9 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.4 149.87 21.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.134 -0.485 . . . . 72.21 110.847 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.538 HD12 ' O ' ' A' ' 133' ' ' ILE . 1.2 tp -52.71 -44.06 45.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 52.4 111.14 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -73.77 -18.93 60.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 54.54 111.084 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 155.24 150.34 5.54 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.797 -0.716 . . . . 72.22 112.504 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 112.37 3.05 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.749 2.3 . . . . 61.22 112.322 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.5 m -81.89 147.55 29.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.442 . . . . 63.42 110.847 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.1 mp -107.28 118.83 55.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 74.51 111.126 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 -106.95 121.85 45.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 72.31 110.83 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -110.99 133.83 11.79 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.778 -0.725 . . . . 63.13 112.503 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -131.38 122.54 26.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.798 0.332 . . . . 72.42 111.082 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.839 HD21 HD11 ' A' ' 123' ' ' ILE . 0.3 OUTLIER -140.39 122.35 15.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.242 -0.436 . . . . 44.21 110.89 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.528 ' HA ' ' HA2' ' A' ' 152' ' ' GLY . 0.7 OUTLIER -133.76 144.93 34.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 62.23 111.1 179.866 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.91 HD13 HD13 ' A' ' 123' ' ' ILE . 3.5 mm? -107.84 139.96 41.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.184 -0.462 . . . . 72.24 110.902 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -110.7 118.7 5.03 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.771 -0.728 . . . . 60.32 112.471 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -122.91 146.38 47.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.901 0.381 . . . . 74.42 110.902 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -50.44 96.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.118 -0.492 . . . . 64.41 110.931 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 93.94 -29.41 8.69 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.783 -0.722 . . . . 73.25 112.475 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 36.6 m95 -102.15 141.7 34.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.833 0.349 . . . . 74.15 110.903 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.444 HD22 HD12 ' A' ' 10' ' ' LEU . 0.4 OUTLIER -134.98 136.61 42.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.436 . . . . 63.31 110.91 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -142.77 143.88 32.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.448 . . . . 75.43 111.082 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.884 ' HA3' HD21 ' A' ' 10' ' ' LEU . . . -153.48 144.09 10.94 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.72 -0.752 . . . . 72.31 112.473 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -145.12 119.21 9.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.849 0.356 . . . . 54.04 110.923 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.402 HE21 ' HB2' ' A' ' 154' ' ' GLN . 0.0 OUTLIER -118.95 123.79 45.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.145 -0.48 . . . . 74.34 110.89 -179.977 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.7 134.68 52.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 44.04 110.894 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.62 ' O ' HG22 ' A' ' 164' ' ' VAL . 27.6 t-20 -112.29 123.07 49.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.253 -0.43 . . . . 71.32 110.876 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.456 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 15.0 t80 -94.4 125.88 39.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 71.44 110.888 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.691 ' OE2' ' HB3' ' A' ' 160' ' ' ALA . 0.1 OUTLIER -79.33 103.16 9.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.136 -0.484 . . . . 72.15 110.904 -179.912 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 75.5 m -65.53 -48.18 73.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 65.14 111.171 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.691 ' HB3' ' OE2' ' A' ' 158' ' ' GLU . . . -48.35 -26.12 1.9 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 74.21 111.103 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 12.1 mmtp -125.79 -168.76 1.89 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 72.11 110.874 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 2.4 m -110.63 40.2 2.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 75.22 110.875 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 2.4 tpp180 -156.67 175.25 14.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.131 -0.486 . . . . 73.42 110.904 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.62 HG22 ' O ' ' A' ' 156' ' ' ASN . 0.9 OUTLIER -74.52 142.5 14.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 64.31 111.124 179.966 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.429 ' HB ' ' HG2' ' A' ' 158' ' ' GLU . 2.5 t -90.63 -34.6 15.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.459 . . . . 75.24 111.14 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -153.99 136.14 14.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.244 -0.434 . . . . 72.33 110.897 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -123.06 127.34 48.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.446 . . . . 70.43 110.858 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -135.68 142.75 45.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 63.23 110.926 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -149.03 140.13 23.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 75.02 110.878 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.546 ' HB3' HD23 ' A' ' 10' ' ' LEU . . . -148.49 129.12 14.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 74.23 111.107 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 7.3 t -148.1 139.59 17.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.451 . . . . 62.13 111.112 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.432 ' HA2' HD23 ' A' ' 180' ' ' LEU . . . -165.25 163.83 36.78 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.723 -0.751 . . . . 75.24 112.504 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -118.95 125.09 48.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.946 0.403 . . . . 74.25 110.919 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 39.9 mtpt -101.84 126.14 48.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.132 -0.485 . . . . 65.44 110.926 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.511 ' HB ' ' H ' ' A' ' 178' ' ' PHE . 1.2 m -131.26 165.02 24.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.444 . . . . 70.25 111.112 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.406 ' H ' HG22 ' A' ' 175' ' ' THR . 34.4 t70 -78.14 -7.76 57.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 52.12 110.86 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -118.13 -31.65 4.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.211 -0.45 . . . . 71.05 110.873 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.511 ' H ' ' HB ' ' A' ' 175' ' ' THR . 18.4 p90 -144.54 150.14 37.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 75.4 110.891 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -136.51 123.05 20.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 71.43 110.913 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.466 HD12 HG13 ' A' ' 194' ' ' ILE . 0.3 OUTLIER -124.15 128.26 49.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.211 -0.45 . . . . 65.12 110.943 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 15.7 m170 -131.36 115.01 15.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 73.32 110.865 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' THR . . . . . 0.481 HG22 ' O ' ' A' ' 191' ' ' GLY . 0.2 OUTLIER -101.05 135.55 42.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 54.01 111.144 -179.909 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -128.0 139.25 52.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.441 . . . . 73.31 110.92 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.426 ' O ' HG12 ' A' ' 184' ' ' VAL . 2.8 t -134.33 110.04 13.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 53.21 111.147 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -101.08 89.46 3.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 72.11 110.898 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 65.77 179.46 0.2 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 63.24 110.865 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -73.1 -3.49 60.85 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.684 -0.77 . . . . 71.31 112.466 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 5.7 m -95.96 -25.54 15.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.804 0.335 . . . . 61.43 111.174 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -121.95 112.49 18.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.192 -0.458 . . . . 72.42 110.903 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -138.85 123.41 18.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.135 -0.484 . . . . 75.31 110.883 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.481 ' O ' HG22 ' A' ' 182' ' ' THR . . . 174.17 -154.86 20.35 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.715 -0.755 . . . . 43.13 112.456 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -176.56 -163.2 28.55 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.743 -0.741 . . . . 75.04 112.471 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' SER . . . . . 0.595 ' C ' HD12 ' A' ' 194' ' ' ILE . 11.4 p -148.39 155.47 41.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.857 0.361 . . . . 64.24 110.868 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.595 HD12 ' C ' ' A' ' 193' ' ' SER . 3.5 mp -131.62 120.27 44.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.122 -0.49 . . . . 43.51 111.104 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -108.87 121.05 44.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.188 -0.46 . . . . 74.2 110.922 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -125.52 131.52 52.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.476 . . . . 61.32 110.891 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 1.8 tppp? -96.04 127.66 42.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 72.21 110.863 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.501 HG12 ' HB2' ' A' ' 201' ' ' LYS . 34.5 t -85.73 117.36 30.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.44 . . . . 74.24 111.135 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -49.82 132.96 22.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 74.43 110.867 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp 51.05 33.82 9.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 61.44 110.893 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' LYS . . . . . 0.501 ' HB2' HG12 ' A' ' 198' ' ' VAL . 4.8 mmtp -153.83 -167.31 2.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 75.43 110.861 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.509 HD12 ' O ' ' A' ' 203' ' ' GLU . 1.4 pp -79.19 -168.49 1.51 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.45 . . . . 72.24 110.936 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.509 ' O ' HD12 ' A' ' 202' ' ' LEU . 12.0 mt-10 -115.11 136.15 53.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 64.21 110.884 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 11.5 t -123.96 138.78 54.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.12 -0.491 . . . . 45.15 111.143 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -145.01 163.49 34.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.434 . . . . 72.01 111.117 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 1.7 m -133.58 149.08 30.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.255 -0.429 . . . . 54.32 111.094 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -113.91 131.52 56.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 73.11 110.89 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -119.71 129.93 54.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 62.2 110.955 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.603 ' HB3' ' HB3' ' A' ' 218' ' ' ARG . . . -138.42 130.77 28.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.446 . . . . 73.51 111.1 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 11.7 t90 -130.09 123.21 29.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 72.14 110.9 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 94.5 m -112.22 110.51 20.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.264 -0.425 . . . . 73.12 111.173 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -51.4 128.09 21.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.263 -0.426 . . . . 64.34 111.095 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 163.78 -73.66 0.18 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.749 -0.738 . . . . 64.5 112.514 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 65.9 m-80 -125.61 33.79 5.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.804 0.335 . . . . 75.14 110.861 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 43.4 m 51.43 52.77 14.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.452 . . . . 50.03 110.858 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -94.69 112.0 23.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.122 -0.49 . . . . 64.2 110.938 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 2.5 p -94.29 135.63 35.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 74.14 111.121 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' ARG . . . . . 0.603 ' HB3' ' HB3' ' A' ' 209' ' ' ALA . 17.7 tpp85 -117.41 119.18 34.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 74.3 110.845 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 219' ' ' PHE . . . . . 0.504 ' CE2' HD11 ' A' ' 221' ' ' ILE . 21.4 t80 -122.83 137.6 54.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 74.01 110.893 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -145.69 159.17 27.87 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.767 -0.73 . . . . 22.01 112.52 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.504 HD11 ' CE2' ' A' ' 219' ' ' PHE . 4.7 mp -137.29 130.46 43.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.828 0.347 . . . . 71.44 111.133 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -124.89 141.52 52.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 73.21 111.117 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.481 ' HB3' ' HB3' ' A' ' 235' ' ' ALA . . . -116.08 134.84 54.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.243 -0.435 . . . . 64.41 111.1 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 11.1 mttt -120.64 115.44 23.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 73.23 110.905 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -130.75 128.66 41.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.232 -0.44 . . . . 73.45 110.899 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -111.92 115.99 29.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.158 -0.474 . . . . 71.42 110.941 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 8.1 tp -103.05 -35.21 3.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 71.42 111.128 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.684 ' HB2' ' HB3' ' A' ' 231' ' ' ALA . 2.7 m-20 -130.24 160.6 64.82 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.64 0.733 . . . . 74.41 110.857 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.72 -32.58 18.45 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.684 2.256 . . . . 74.1 112.312 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -107.19 10.27 30.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 74.44 110.838 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.684 ' HB3' ' HB2' ' A' ' 228' ' ' ASP . . . -141.41 127.18 19.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 61.3 111.123 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 42.4 t -134.47 141.97 46.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.255 -0.429 . . . . 63.54 110.924 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -112.25 130.24 56.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 74.11 110.873 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 84.2 p -129.51 140.62 51.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.464 . . . . 54.33 110.885 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 235' ' ' ALA . . . . . 0.481 ' HB3' ' HB3' ' A' ' 223' ' ' ALA . . . -127.01 159.29 34.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 73.3 111.126 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.77 147.81 21.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.217 -0.447 . . . . 72.34 110.917 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 242' ' ' LEU . 5.4 p -144.86 142.69 22.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.444 . . . . 55.43 111.15 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -106.54 147.64 29.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 75.44 110.92 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -54.71 -21.01 9.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.185 -0.461 . . . . 70.21 110.9 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 3.7 m -81.7 26.28 0.5 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.459 . . . . 64.51 110.874 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 6.8 t 59.98 39.33 20.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.081 -0.509 . . . . 53.12 110.854 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 242' ' ' LEU . . . . . 0.458 ' O ' HG23 ' A' ' 237' ' ' VAL . 18.4 mt -98.91 124.9 44.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.12 -0.491 . . . . 71.43 110.903 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.467 ' H ' HD12 ' A' ' 243' ' ' ILE . 3.0 mp -99.83 118.73 46.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 71.42 111.09 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 244' ' ' GLY . . . . . 0.519 ' C ' HD13 ' A' ' 245' ' ' LEU . . . -129.49 138.75 10.45 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.714 -0.755 . . . . 73.33 112.471 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.665 ' N ' HD13 ' A' ' 245' ' ' LEU . 0.0 OUTLIER -145.92 158.93 43.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.865 0.364 . . . . 75.51 110.865 -179.885 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -162.57 144.27 9.49 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.719 -0.753 . . . . 55.14 112.443 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -128.31 131.84 48.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.99 0.424 . . . . 65.2 110.894 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 27.6 p -115.5 117.77 31.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.076 -0.511 . . . . 62.25 111.124 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -129.38 131.48 46.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 74.42 110.899 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 3.7 m -59.74 148.43 34.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 75.23 111.167 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 46.0 tp -78.58 -73.33 0.33 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 72.01 110.904 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 252' ' ' LYS . . . . . 0.47 ' N ' ' HD2' ' A' ' 253' ' ' PRO . 0.1 OUTLIER 179.29 -60.66 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.558 0.694 . . . . 65.13 110.882 179.848 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 253' ' ' PRO . . . . . 0.574 ' HG2' HD12 ' A' ' 255' ' ' ILE . 54.0 Cg_endo -69.77 -86.4 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.679 2.253 . . . . 71.52 112.395 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 254' ' ' GLY . . . . . 0.573 ' O ' ' HB3' ' A' ' 281' ' ' PHE . . . -146.7 33.9 1.38 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.746 -0.74 . . . . 55.3 112.499 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.574 HD12 ' HG2' ' A' ' 253' ' ' PRO . 3.6 mp -131.01 145.3 35.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.893 0.377 . . . . 63.22 111.093 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 279' ' ' LEU . 19.7 ttpp -113.12 135.41 53.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 71.51 110.882 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 0.773 ' HA ' HD12 ' A' ' 279' ' ' LEU . 5.1 tp -96.74 124.35 40.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 74.51 110.879 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 258' ' ' THR . . . . . 0.417 ' N ' HD12 ' A' ' 257' ' ' LEU . 2.8 p -124.29 122.34 37.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.161 -0.472 . . . . 72.14 111.115 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.789 HD22 HD23 ' A' ' 277' ' ' LEU . 0.1 OUTLIER -116.58 126.53 53.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 74.02 110.92 179.938 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.436 ' O ' HD22 ' A' ' 275' ' ' LEU . 27.7 p -124.92 145.84 49.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 62.1 110.878 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 261' ' ' ALA . . . . . 0.426 ' HB3' ' CD2' ' A' ' 245' ' ' LEU . . . -147.99 135.25 20.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 70.11 111.112 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.691 ' C ' HD13 ' A' ' 263' ' ' LEU . 2.4 tm? -125.41 122.22 36.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.453 . . . . 71.11 110.877 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 263' ' ' LEU . . . . . 0.829 ' HB3' HG11 ' A' ' 268' ' ' VAL . 0.2 OUTLIER -120.03 109.86 15.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 73.3 110.929 179.855 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 264' ' ' ASP . . . . . 0.639 ' O ' HG22 ' A' ' 268' ' ' VAL . 0.8 OUTLIER -82.72 116.95 22.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.184 -0.462 . . . . 74.25 110.831 179.844 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -54.41 -21.15 19.09 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.744 -0.741 . . . . 72.25 112.464 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.77 -26.56 20.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.839 0.352 . . . . 74.43 110.912 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 13.8 m-20 -95.42 -57.86 2.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.194 -0.457 . . . . 62.11 110.926 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 268' ' ' VAL . . . . . 0.829 HG11 ' HB3' ' A' ' 263' ' ' LEU . 11.7 m -51.6 -29.34 9.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.469 . . . . 62.45 111.104 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -53.02 -36.43 60.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 62.31 110.89 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -103.65 -17.69 15.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 75.24 111.144 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 124.73 100.75 1.34 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.691 -0.766 . . . . 74.23 112.45 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 168.16 92.74 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.722 -0.752 . . . . 73.14 112.493 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 19.2 p80 -111.9 144.64 40.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.899 0.38 . . . . 75.24 110.83 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -102.26 137.34 40.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 65.13 110.935 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.745 HD13 ' N ' ' A' ' 276' ' ' GLY . 2.9 tm? -135.94 144.11 45.28 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.253 -0.43 . . . . 74.22 110.927 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 276' ' ' GLY . . . . . 0.745 ' N ' HD13 ' A' ' 275' ' ' LEU . . . -147.52 133.65 4.81 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.694 -0.765 . . . . 31.44 112.492 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.918 HD12 HG23 ' A' ' 27' ' ' ILE . 2.8 tm? -125.81 135.23 51.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.819 0.342 . . . . 70.14 110.913 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 278' ' ' GLY . . . . . 0.73 ' C ' HD13 ' A' ' 279' ' ' LEU . . . -161.59 140.08 6.4 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.694 -0.765 . . . . 45.12 112.488 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.773 HD12 ' HA ' ' A' ' 257' ' ' LEU . 0.0 OUTLIER -119.59 129.86 54.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.809 0.337 . . . . 72.43 110.899 -179.938 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 280' ' ' GLU . . . . . 0.494 ' O ' ' HB2' ' A' ' 281' ' ' PHE . 2.5 pp20? -141.94 146.41 35.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.47 . . . . 71.12 110.899 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.573 ' HB3' ' O ' ' A' ' 254' ' ' GLY . 0.3 OUTLIER 172.08 -150.75 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.155 -0.475 . . . . 65.21 110.894 -179.88 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -138.55 144.68 40.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 73.32 110.891 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.794 ' HB3' HD11 ' A' ' 31' ' ' LEU . . . -113.09 112.6 24.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.45 . . . . 72.41 111.128 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 12.7 mt -130.41 178.63 6.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 61.34 110.878 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 71.41 110.909 179.943 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 301' ' ' NAI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.4 mmt . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.794 0.331 . . . . 73.33 110.886 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -110.21 -171.67 1.88 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 72.01 111.111 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.1 t 61.18 75.62 0.44 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.668 0.747 . . . . 63.04 111.083 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 167.91 23.06 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.667 2.244 . . . . 63.32 112.362 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 108.97 2.2 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.734 2.289 . . . . 73.12 112.326 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.483 HG23 HG11 ' A' ' 143' ' ' VAL . 12.3 t -107.15 -28.47 9.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 74.05 111.138 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.755 ' CB ' HG21 ' A' ' 143' ' ' VAL . 32.9 p90 -55.53 -30.59 61.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.25 -0.432 . . . . 73.42 110.92 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -72.26 -19.4 61.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.108 -0.497 . . . . 64.5 111.114 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -95.03 11.9 30.4 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.243 -0.435 . . . . 74.21 110.878 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.677 HD21 ' HA3' ' A' ' 152' ' ' GLY . 0.8 OUTLIER -60.56 -33.05 72.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.211 -0.45 . . . . 70.25 110.87 -179.929 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -136.17 31.28 2.63 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.758 -0.734 . . . . 72.25 112.488 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.3 mmtt -69.58 -54.5 13.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.78 0.324 . . . . 62.5 110.88 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.9 t -60.25 -39.72 87.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.252 -0.431 . . . . 60.43 110.873 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.56 -37.62 76.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 74.0 111.113 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -61.05 -32.66 72.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 72.43 110.859 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -58.38 -48.45 80.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 60.54 110.866 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.5 t -80.43 -36.91 16.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 64.41 111.128 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -63.33 -34.98 78.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 74.03 110.888 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.2 m 65.06 80.51 0.23 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 70.15 111.159 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -57.77 -34.61 69.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.251 -0.431 . . . . 74.24 110.855 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -51.5 106.82 0.34 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.72 -0.753 . . . . 23.51 112.462 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -58.43 151.69 19.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.886 0.374 . . . . 74.25 110.942 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -133.8 69.26 0.53 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.727 -0.749 . . . . 43.53 112.531 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -91.95 13.71 17.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.906 0.384 . . . . 63.45 110.915 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.07 14.6 64.2 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.713 -0.756 . . . . 74.23 112.498 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.591 ' C ' HD12 ' A' ' 27' ' ' ILE . 1.2 pp -118.98 -179.1 3.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.762 0.315 . . . . 53.52 110.918 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.591 HD12 ' C ' ' A' ' 26' ' ' LEU . 1.6 mp -109.99 131.8 59.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 70.43 111.132 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.447 ' HG2' ' HA2' ' A' ' 278' ' ' GLY . 6.4 ptmm? -115.91 138.22 51.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 72.35 110.904 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.679 HD13 ' N ' ' A' ' 30' ' ' ASP . 3.2 tm? -123.67 136.45 54.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.235 -0.439 . . . . 70.4 110.891 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.679 ' N ' HD13 ' A' ' 29' ' ' LEU . 0.8 OUTLIER -126.76 127.78 45.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.469 . . . . 71.22 110.871 179.856 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.743 HD22 ' HB3' ' A' ' 281' ' ' PHE . 0.2 OUTLIER -115.75 125.1 52.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 65.31 110.902 -179.967 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.472 ' HD2' HG23 ' A' ' 42' ' ' THR . 5.3 tptp -123.57 125.09 44.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 63.34 110.866 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.9 m -135.42 120.67 18.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 71.12 111.14 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -134.22 125.6 28.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 61.54 110.875 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 38.4 t -127.24 143.7 51.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 71.44 110.859 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -76.59 58.72 1.41 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 73.03 110.885 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -147.67 16.96 1.13 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.146 -0.479 . . . . 73.55 110.865 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.555 ' HA2' ' O ' ' A' ' 63' ' ' ARG . . . 82.94 -5.3 76.55 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.729 -0.748 . . . . 62.21 112.489 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -101.14 126.22 47.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.8 0.333 . . . . 42.04 110.904 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.407 ' HB2' ' O ' ' A' ' 61' ' ' LYS . 0.8 OUTLIER -139.46 117.68 11.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.168 -0.469 . . . . 74.31 110.885 179.934 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.415 ' CZ ' HD21 ' A' ' 58' ' ' LEU . 5.4 t80 -107.07 121.48 44.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.122 -0.49 . . . . 61.4 110.887 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.472 HG23 ' HD2' ' A' ' 32' ' ' LYS . 3.9 m -127.96 115.15 18.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.141 -0.481 . . . . 73.34 111.183 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -122.05 141.7 51.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 72.51 110.864 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.4 p -151.01 126.41 10.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.464 . . . . 62.02 110.892 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -166.41 165.5 38.32 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.722 -0.751 . . . . 71.53 112.48 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 82.8 p -137.25 168.96 18.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.896 0.379 . . . . 53.12 110.876 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -158.63 140.57 13.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 51.14 111.118 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 46.0 t-20 -101.26 141.9 33.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.242 -0.435 . . . . 73.25 110.832 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.5 t -92.7 -35.24 13.58 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.168 -0.469 . . . . 64.31 111.165 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.85 -63.48 1.15 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.227 -0.442 . . . . 75.11 110.89 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.18 149.91 33.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.125 -0.489 . . . . 73.23 111.108 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.3 t -59.09 110.69 1.1 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.172 -0.467 . . . . 64.54 111.155 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.6 mtpm? -166.53 99.9 0.59 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.242 -0.436 . . . . 74.24 110.949 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 24.2 t -122.5 133.49 68.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.245 -0.434 . . . . 53.21 111.125 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.0 m -136.04 134.56 38.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.165 -0.47 . . . . 63.3 111.132 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -142.8 140.48 9.84 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.699 -0.762 . . . . 73.35 112.441 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.6 p -133.18 144.52 49.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.903 0.383 . . . . 72.11 110.839 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.606 HD13 ' N ' ' A' ' 59' ' ' GLU . 0.3 OUTLIER -120.92 134.51 55.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.108 -0.496 . . . . 72.05 110.903 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.606 ' N ' HD13 ' A' ' 58' ' ' LEU . 2.0 tt0 -134.33 123.05 23.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 74.21 110.888 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 23.1 p -107.0 134.0 50.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 41.45 111.095 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.407 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 47.6 mttt -133.41 159.68 39.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 52.23 110.931 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.521 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 9.2 t80 -121.06 129.67 53.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 73.42 110.892 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.555 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 3.9 ttt85 -112.9 103.43 11.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 74.52 110.865 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -112.73 98.65 7.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.188 -0.46 . . . . 62.21 110.933 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 60.68 163.43 0.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 62.31 111.156 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -78.78 145.16 34.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.248 -0.433 . . . . 73.13 110.877 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 26.0 p90 37.81 43.35 0.49 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.177 -0.465 . . . . 64.42 110.872 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.644 ' O ' HD22 ' A' ' 69' ' ' LEU . . . -123.75 -78.93 0.41 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.743 -0.742 . . . . 70.33 112.445 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.644 HD22 ' O ' ' A' ' 68' ' ' GLY . 3.4 mm? -134.59 129.06 34.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.914 0.387 . . . . 53.43 110.883 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.8 m -138.61 114.89 10.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.157 -0.474 . . . . 73.41 111.136 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.475 ' HA ' HG22 ' A' ' 85' ' ' ILE . 12.8 m-85 -99.39 132.89 44.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 71.03 110.894 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.73 119.87 31.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.122 -0.49 . . . . 53.4 111.181 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -131.52 122.56 26.36 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.196 -0.456 . . . . 34.55 110.902 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -106.38 137.49 44.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.153 -0.476 . . . . 71.13 110.908 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 9.8 t90 -134.53 128.75 33.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.456 . . . . 71.15 110.887 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 28.9 t30 -117.13 155.41 29.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 63.25 110.908 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 12.3 m -60.36 -18.12 48.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 73.42 111.127 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.417 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 9.0 m-20 -74.63 0.37 15.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 71.43 110.863 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.417 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 4.1 m120 77.16 38.55 0.23 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.198 -0.455 . . . . 60.24 110.885 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 28.3 m -114.83 125.63 53.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.455 . . . . 74.31 111.157 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.6 mp -114.14 127.35 55.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.294 -0.412 . . . . 74.34 110.939 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -113.42 107.71 1.98 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.788 -0.72 . . . . 72.22 112.489 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.1 m -87.52 131.45 34.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.713 0.292 . . . . 73.25 111.16 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -159.99 96.68 1.23 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 73.35 110.893 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.475 HG22 ' HA ' ' A' ' 71' ' ' PHE . 1.1 pp -111.6 138.65 39.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 61.13 111.172 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.687 HG23 ' OG1' ' A' ' 98' ' ' THR . 1.6 m -118.11 139.57 51.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 53.24 111.119 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.57 HG12 ' CD1' ' A' ' 69' ' ' LEU . 2.2 m -129.39 139.62 51.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 74.25 111.155 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 -97.8 129.18 44.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 73.35 110.926 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -50.56 168.61 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.199 -0.455 . . . . 74.12 110.893 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -123.45 -35.58 2.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 63.31 110.911 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 92.5 mt -96.79 -70.12 0.73 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.245 -0.434 . . . . 71.54 110.945 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.86 78.03 1.15 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 65.41 111.07 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 9.2 ptp85 -49.29 135.32 17.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.467 . . . . 73.32 110.889 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 101.59 9.29 44.11 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.715 -0.755 . . . . 65.52 112.531 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.605 HD12 ' N ' ' A' ' 96' ' ' LYS . 8.7 tp -114.93 129.15 56.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.898 0.38 . . . . 75.24 110.891 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.605 ' N ' HD12 ' A' ' 95' ' ' LEU . 31.5 pttt -124.56 136.19 53.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 74.54 110.897 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.582 HD13 ' O ' ' A' ' 96' ' ' LYS . 1.9 mm? -124.8 126.72 46.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 74.21 110.877 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.687 ' OG1' HG23 ' A' ' 86' ' ' THR . 7.6 m -125.61 139.41 53.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.462 . . . . 73.21 111.131 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.459 ' CE2' HD13 ' A' ' 114' ' ' ILE . 24.6 m-85 -116.02 123.01 46.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.252 -0.431 . . . . 64.12 110.841 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -113.97 130.29 56.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.112 -0.494 . . . . 73.1 110.855 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.5 m -142.41 134.07 26.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.475 . . . . 72.54 110.851 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.6 t -95.81 126.17 40.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.115 -0.493 . . . . 74.14 110.857 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -118.34 119.65 35.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.097 -0.502 . . . . 75.22 110.869 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.433 ' HA ' ' HD2' ' A' ' 105' ' ' PRO . 1.7 t -128.83 101.39 20.28 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.61 0.719 . . . . 72.5 110.919 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 104' ' ' SER . 53.4 Cg_endo -69.79 -32.89 17.56 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.681 2.254 . . . . 65.21 112.301 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 16.9 t30 -51.56 -74.25 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.269 -0.423 . . . . 54.11 110.916 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 6.0 m -77.02 -33.57 57.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 74.32 111.139 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.61 23.92 14.94 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.773 -0.727 . . . . 54.21 112.51 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -94.48 147.02 23.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.853 0.359 . . . . 74.41 110.907 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 27.6 ttpt -133.42 140.88 47.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.218 -0.446 . . . . 71.24 110.938 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -120.94 136.22 55.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 70.24 110.938 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -110.57 125.28 53.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 70.41 111.094 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 17.4 mtmt -138.87 138.23 37.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 73.12 110.888 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.459 HD13 ' CE2' ' A' ' 99' ' ' PHE . 5.7 tp -121.99 139.86 47.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.212 -0.449 . . . . 64.12 111.092 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.45 ' H ' HD12 ' A' ' 114' ' ' ILE . 19.8 ttpt -130.06 118.87 22.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.166 -0.47 . . . . 73.23 110.899 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.415 HG23 ' O ' ' A' ' 116' ' ' THR . 4.8 t -130.9 118.6 20.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.446 . . . . 73.11 111.13 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.472 ' HA3' ' HA2' ' A' ' 126' ' ' GLY . . . -152.99 159.14 28.32 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.695 -0.764 . . . . 24.11 112.476 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -129.34 138.34 51.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.982 0.42 . . . . 73.24 110.912 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 36.2 pttt -109.82 121.15 44.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.115 -0.493 . . . . 74.43 110.891 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 6.8 tpt180 -109.53 143.88 38.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 74.52 110.885 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -50.73 -28.31 8.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 72.25 110.881 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 59.2 m-70 -88.45 -41.97 12.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 75.34 110.897 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.687 ' CD1' HD22 ' A' ' 144' ' ' LEU . 2.2 tt -151.67 145.03 16.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 73.11 111.198 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -113.73 116.02 28.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 74.53 110.822 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.559 HD23 ' HG ' ' A' ' 142' ' ' LEU . 2.0 mt -119.24 141.45 48.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.472 . . . . 75.14 110.895 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.472 ' HA2' ' HA3' ' A' ' 117' ' ' GLY . . . -145.96 125.91 2.4 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.721 -0.752 . . . . 74.35 112.457 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 8.3 t -114.51 119.46 36.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.816 0.341 . . . . 53.31 110.883 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -118.9 146.58 44.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.466 . . . . 72.12 110.867 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 7.8 ttt -136.62 136.27 39.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.203 -0.453 . . . . 75.44 110.869 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -110.86 124.99 53.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.173 -0.467 . . . . 71.12 110.883 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -95.53 98.2 10.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 74.22 110.886 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -103.92 169.65 8.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.139 -0.482 . . . . 65.24 110.898 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 2.5 pp -74.91 -35.61 36.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 75.24 111.121 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -77.06 -20.27 56.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 74.12 111.07 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 154.16 149.64 5.28 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.705 -0.759 . . . . 62.13 112.467 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 114.5 3.73 Favored 'Trans proline' 0 C--O 1.231 0.146 0 C-N-CA 122.69 2.26 . . . . 73.35 112.315 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.64 148.76 30.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.211 -0.449 . . . . 75.03 110.915 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 5.3 mp -106.3 122.84 60.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.19 -0.459 . . . . 62.0 111.145 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 3.9 ttm105 -121.56 114.55 21.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 71.14 110.874 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -110.63 133.96 11.89 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.732 -0.747 . . . . 74.34 112.478 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -132.91 116.31 16.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.815 0.341 . . . . 54.52 111.109 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.74 HD22 HD21 ' A' ' 144' ' ' LEU . 0.2 OUTLIER -121.97 125.23 45.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.161 -0.472 . . . . 61.32 110.878 -179.939 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.798 ' C ' HD23 ' A' ' 144' ' ' LEU . 40.7 t -131.19 123.17 52.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 73.31 111.151 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.798 HD23 ' C ' ' A' ' 143' ' ' VAL . 0.3 OUTLIER -116.85 156.32 27.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 73.12 110.934 179.996 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -106.71 133.05 11.44 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.746 -0.74 . . . . 72.24 112.465 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.413 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 0.2 OUTLIER -128.58 147.88 50.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.823 0.344 . . . . 74.3 110.874 -179.765 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 48.7 tt0 -57.35 97.99 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.077 -0.511 . . . . 74.51 110.826 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.535 ' O ' ' HB3' ' A' ' 173' ' ' TYR . . . 86.04 -15.9 45.93 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.74 -0.743 . . . . 73.23 112.505 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.413 ' O ' ' CB ' ' A' ' 146' ' ' TYR . 5.1 m95 -123.61 146.68 47.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.78 0.324 . . . . 71.13 110.929 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.712 ' N ' ' HB2' ' A' ' 173' ' ' TYR . 13.0 tp -108.75 156.45 19.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.264 -0.426 . . . . 70.5 110.899 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.465 ' HB3' ' HB2' ' A' ' 144' ' ' LEU . . . -127.64 131.31 49.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.191 -0.459 . . . . 73.15 111.127 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.677 ' HA3' HD21 ' A' ' 10' ' ' LEU . . . -155.64 133.24 3.66 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.748 -0.739 . . . . 41.22 112.474 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -145.81 118.81 8.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.81 0.338 . . . . 73.11 110.941 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -122.43 123.13 40.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.096 -0.502 . . . . 74.04 110.883 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 97.8 mtp -133.57 134.89 43.89 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.172 -0.467 . . . . 61.22 110.873 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.478 ' O ' ' HB ' ' A' ' 164' ' ' VAL . 4.9 m120 -112.36 117.48 32.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 55.42 110.899 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.493 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 0.2 OUTLIER -87.23 125.69 34.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 74.11 110.882 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.719 ' OE1' ' HB3' ' A' ' 160' ' ' ALA . 0.2 OUTLIER -82.39 108.15 15.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.13 -0.486 . . . . 75.22 110.943 -179.951 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.488 HG23 ' N ' ' A' ' 160' ' ' ALA . 6.0 t -66.14 -47.14 75.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.476 . . . . 74.24 111.152 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.719 ' HB3' ' OE1' ' A' ' 158' ' ' GLU . . . -50.71 -26.17 5.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 71.01 111.063 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 10.6 mmtt -120.93 -167.72 1.54 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.244 -0.434 . . . . 54.44 110.889 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 50.1 m -112.92 39.29 2.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 62.45 110.885 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.66 174.88 9.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 73.12 110.853 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.493 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 1.0 OUTLIER -78.63 146.0 8.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 75.25 111.167 179.925 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.464 HG23 ' HG2' ' A' ' 166' ' ' GLN . 15.3 t -88.32 -34.11 17.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 74.13 111.109 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' GLN . . . . . 0.464 ' HG2' HG23 ' A' ' 165' ' ' THR . 30.1 pt20 -152.7 132.74 13.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 73.12 110.945 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 3.8 m -126.06 125.78 43.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 74.42 110.858 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 15.1 p-10 -135.72 137.02 41.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 54.24 110.891 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -131.64 150.26 52.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.459 . . . . 61.35 110.88 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -150.33 129.46 12.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.485 . . . . 55.24 111.068 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -145.69 138.5 20.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.157 -0.474 . . . . 73.54 111.123 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.454 ' O ' ' HB3' ' A' ' 150' ' ' LEU . . . 136.69 146.25 5.14 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.747 -0.74 . . . . 52.45 112.478 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' TYR . . . . . 0.712 ' HB2' ' N ' ' A' ' 150' ' ' LEU . 5.0 t80 -151.04 177.56 10.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.008 0.433 . . . . 75.44 110.88 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -97.1 136.08 38.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.105 -0.498 . . . . 71.33 110.895 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.651 ' O ' ' C ' ' A' ' 176' ' ' ASP . 0.2 OUTLIER -122.86 165.54 16.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.224 -0.443 . . . . 73.33 111.156 179.979 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.651 ' C ' ' O ' ' A' ' 175' ' ' THR . 2.0 m-20 -9.5 -86.72 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.25 -0.432 . . . . 73.22 110.869 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -120.35 12.95 11.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 53.3 110.884 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -130.2 116.58 18.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 74.12 110.889 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -114.13 124.2 51.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.135 -0.484 . . . . 62.03 110.91 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.525 HD13 ' C ' ' A' ' 180' ' ' LEU . 3.3 tm? -122.07 120.99 35.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 73.44 110.936 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' HIS . . . . . 0.415 ' HA ' ' HA3' ' A' ' 172' ' ' GLY . 0.1 OUTLIER -123.71 145.75 48.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 72.34 110.869 179.901 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.89 136.72 23.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 73.15 111.102 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 22.1 m120 -132.65 140.04 48.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 72.43 110.853 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.458 ' O ' HG12 ' A' ' 184' ' ' VAL . 2.5 t -132.74 110.38 15.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 71.42 111.117 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -99.0 90.07 4.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 72.13 110.893 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' ASP . . . . . 0.542 ' HB2' HG22 ' A' ' 188' ' ' THR . 1.0 OUTLIER 66.2 176.86 0.22 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.177 -0.465 . . . . 43.24 110.86 179.911 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -73.22 -2.2 58.44 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.737 -0.744 . . . . 63.53 112.52 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' THR . . . . . 0.542 HG22 ' HB2' ' A' ' 186' ' ' ASP . 7.7 t -98.4 -25.35 14.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.742 0.306 . . . . 53.12 111.12 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -121.94 115.27 22.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 72.54 110.926 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -140.81 124.47 16.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 75.44 110.883 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -175.55 -161.6 25.25 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.756 -0.735 . . . . 33.14 112.503 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -175.33 -172.05 39.87 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.767 -0.73 . . . . 52.11 112.529 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 34.3 m -147.63 148.42 31.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.796 0.331 . . . . 75.21 110.877 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.404 ' N ' HD12 ' A' ' 194' ' ' ILE . 4.7 mp -119.63 130.96 73.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.12 -0.491 . . . . 75.04 111.168 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 195' ' ' TYR . . . . . 0.464 ' CD1' ' HB2' ' A' ' 205' ' ' ALA . 5.4 t80 -119.24 126.05 50.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.198 -0.455 . . . . 75.41 110.942 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 3.7 tm0? -124.75 131.13 53.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.095 -0.502 . . . . 54.43 110.881 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 36.0 mttt -100.64 127.23 47.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 63.5 110.873 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 16.4 t -80.33 152.63 4.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.27 -0.423 . . . . 75.42 111.174 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -51.15 -37.9 48.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 75.44 110.908 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.75 -170.4 2.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 51.25 110.92 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 201' ' ' LYS . . . . . 0.65 ' C ' HD12 ' A' ' 202' ' ' LEU . 1.6 ptmt -76.71 64.67 2.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 72.4 110.926 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.65 HD12 ' C ' ' A' ' 201' ' ' LYS . 6.3 mp -145.62 128.45 16.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.236 -0.438 . . . . 62.32 110.915 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -120.61 130.07 54.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.15 -0.477 . . . . 72.21 110.889 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 2.3 t -132.23 138.31 47.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 70.41 111.091 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.464 ' HB2' ' CD1' ' A' ' 195' ' ' TYR . . . -149.69 156.7 42.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 74.24 111.111 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.761 HG12 HG22 ' A' ' 221' ' ' ILE . 1.3 m -126.08 147.21 30.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 41.12 111.173 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -117.92 127.96 54.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.454 . . . . 72.3 110.923 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 2.2 mp -125.7 147.03 49.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 64.41 110.877 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -157.24 131.55 8.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 63.22 111.105 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 21.5 t90 -129.91 133.56 46.93 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.26 -0.427 . . . . 70.42 110.927 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -101.09 103.68 14.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.25 -0.432 . . . . 61.14 111.152 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -53.26 140.88 25.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.26 -0.427 . . . . 73.23 111.111 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 134.74 -72.76 0.46 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.689 -0.767 . . . . 42.44 112.481 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -171.79 36.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.793 0.33 . . . . 51.44 110.882 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 32.8 t -111.85 165.33 12.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 44.5 110.852 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -88.16 162.59 16.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 64.22 110.866 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 2.9 m -78.11 137.96 38.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 64.45 111.172 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 33.4 ttp180 -102.95 129.06 49.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 74.23 110.872 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -134.0 133.25 41.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 65.21 110.86 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -143.53 145.46 15.26 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.72 -0.752 . . . . 50.2 112.5 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.761 HG22 HG12 ' A' ' 206' ' ' VAL . 0.0 OUTLIER -122.14 138.32 52.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.863 0.363 . . . . 54.05 111.173 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -138.12 153.22 49.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.451 . . . . 73.11 111.13 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.457 ' HB1' ' CZ ' ' A' ' 225' ' ' TYR . . . -145.49 157.72 43.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.239 -0.437 . . . . 71.22 111.097 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 3.1 tttm -142.94 124.41 14.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.441 . . . . 73.32 110.861 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 225' ' ' TYR . . . . . 0.609 ' CE1' HD23 ' A' ' 202' ' ' LEU . 8.7 m-85 -133.6 133.93 42.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 62.42 110.938 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 7.9 mm-40 -79.15 130.71 35.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.139 -0.482 . . . . 72.02 110.894 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.937 HG23 ' HD2' ' A' ' 229' ' ' PRO . 1.3 tp -77.41 -38.34 26.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.469 . . . . 43.4 111.108 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.48 ' N ' ' HD2' ' A' ' 229' ' ' PRO . 0.3 OUTLIER 172.12 -60.91 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.6 0.714 . . . . 72.4 110.863 179.884 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.937 ' HD2' HG23 ' A' ' 227' ' ' ILE . 53.8 Cg_endo -69.76 -157.52 0.04 OUTLIER 'Trans proline' 0 C--O 1.231 0.148 0 C-N-CA 122.722 2.281 . . . . 72.24 112.315 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -85.37 15.23 4.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 72.44 110.906 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.66 ' HB2' ' HG3' ' A' ' 249' ' ' GLN . . . -120.59 122.0 39.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 75.54 111.078 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 13.0 p -112.79 144.56 42.12 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.444 . . . . 71.41 110.864 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -97.2 127.64 43.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 74.23 110.888 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 1.2 t -117.54 137.15 52.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.126 -0.488 . . . . 52.2 110.807 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -130.67 141.27 50.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 53.33 111.094 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 7.7 pttm -144.45 165.06 29.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 61.14 110.884 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 242' ' ' LEU . 8.7 p -154.93 146.23 13.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 73.25 111.124 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -104.82 147.69 27.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 64.34 110.848 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -53.46 -22.83 8.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.111 -0.495 . . . . 42.43 110.851 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 2.6 t -82.03 26.86 0.5 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 52.14 110.901 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 59.14 37.77 23.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.078 -0.51 . . . . 52.14 110.881 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 242' ' ' LEU . . . . . 0.625 ' HG ' HD11 ' A' ' 262' ' ' LEU . 1.0 OUTLIER -98.39 121.14 39.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.103 -0.499 . . . . 73.25 110.901 -179.972 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.542 ' O ' HD22 ' A' ' 262' ' ' LEU . 5.4 mp -86.82 123.06 39.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 70.12 111.128 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 244' ' ' GLY . . . . . 0.654 ' C ' HD12 ' A' ' 245' ' ' LEU . . . -115.81 133.8 11.09 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.74 -0.743 . . . . 74.44 112.492 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.654 HD12 ' C ' ' A' ' 244' ' ' GLY . 11.0 mp -130.58 129.81 43.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.878 0.37 . . . . 73.15 110.942 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -140.29 121.74 2.04 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.729 -0.748 . . . . 54.31 112.465 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -111.76 121.68 45.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.936 0.398 . . . . 75.43 110.964 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -109.75 120.8 43.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.476 . . . . 62.13 111.112 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 249' ' ' GLN . . . . . 0.66 ' HG3' ' HB2' ' A' ' 231' ' ' ALA . 25.9 tt0 -128.32 122.68 32.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 65.23 110.931 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 250' ' ' THR . . . . . 0.494 HG23 ' HD3' ' A' ' 256' ' ' LYS . 96.0 m -110.31 111.51 22.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 71.53 111.137 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -106.37 88.57 2.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 73.34 110.904 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 6.2 mtmt 62.44 161.46 0.12 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.549 0.69 . . . . 73.22 110.925 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 76.84 1.13 Allowed 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.679 2.253 . . . . 70.11 112.306 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 169.34 -32.16 0.17 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.751 -0.738 . . . . 62.44 112.467 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 4.4 mp -118.19 122.47 69.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.831 0.348 . . . . 73.14 111.119 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.494 ' HD3' HG23 ' A' ' 250' ' ' THR . 25.7 mmtt -131.6 132.83 44.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.229 -0.442 . . . . 65.02 110.877 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 0.53 HD23 ' N ' ' A' ' 258' ' ' THR . 1.5 tt -114.11 127.05 55.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.223 -0.444 . . . . 73.3 110.878 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 258' ' ' THR . . . . . 0.53 ' N ' HD23 ' A' ' 257' ' ' LEU . 13.9 p -126.45 117.11 22.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 54.24 111.12 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.5 HD13 ' N ' ' A' ' 260' ' ' SER . 0.2 OUTLIER -111.98 130.6 55.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 62.14 110.91 179.934 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.5 ' N ' HD13 ' A' ' 259' ' ' LEU . 15.8 p -127.25 140.6 52.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 70.31 110.87 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -151.99 128.79 10.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.127 -0.488 . . . . 61.53 111.105 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.625 HD11 ' HG ' ' A' ' 242' ' ' LEU . 1.5 tm? -125.21 115.8 20.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 75.54 110.868 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 263' ' ' LEU . . . . . 0.82 ' HB3' HG11 ' A' ' 268' ' ' VAL . 0.2 OUTLIER -112.63 109.62 19.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 74.42 110.928 179.884 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 264' ' ' ASP . . . . . 0.653 ' O ' HG22 ' A' ' 268' ' ' VAL . 0.8 OUTLIER -84.01 116.45 22.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.204 -0.453 . . . . 71.03 110.853 179.848 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -57.19 -16.58 20.24 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.716 -0.754 . . . . 64.14 112.513 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -86.11 -22.15 27.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.844 0.354 . . . . 72.22 110.945 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -108.57 -53.6 2.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 62.33 110.889 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 268' ' ' VAL . . . . . 0.82 HG11 ' HB3' ' A' ' 263' ' ' LEU . 17.4 m -50.88 -30.29 8.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 55.12 111.138 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -52.98 -41.02 64.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 65.23 110.864 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -103.73 -17.62 15.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.14 -0.482 . . . . 72.33 111.124 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 128.49 94.39 0.79 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.762 -0.732 . . . . 71.3 112.482 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 175.53 78.67 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.762 -0.732 . . . . 72.41 112.491 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 273' ' ' HIS . . . . . 0.661 ' HB2' HD12 ' A' ' 263' ' ' LEU . 13.0 p80 -104.91 144.19 32.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.853 0.359 . . . . 62.01 110.871 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 1.6 mtpt -99.43 136.19 39.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.268 -0.424 . . . . 65.12 110.887 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.763 HD13 ' N ' ' A' ' 276' ' ' GLY . 2.6 tm? -136.58 144.91 44.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 73.11 110.88 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 276' ' ' GLY . . . . . 0.763 ' N ' HD13 ' A' ' 275' ' ' LEU . . . -154.19 130.63 2.96 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.729 -0.748 . . . . 52.43 112.487 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.471 ' HB3' HG13 ' A' ' 27' ' ' ILE . 0.1 OUTLIER -113.7 140.21 48.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.824 0.345 . . . . 74.32 110.928 -179.923 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 278' ' ' GLY . . . . . 0.612 ' O ' HD13 ' A' ' 279' ' ' LEU . . . -147.16 126.79 2.5 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.781 -0.723 . . . . 54.42 112.502 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.612 HD13 ' O ' ' A' ' 278' ' ' GLY . 1.1 mm? -121.67 133.25 54.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.762 0.315 . . . . 64.04 110.952 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -114.98 133.35 56.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 73.44 110.925 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.743 ' HB3' HD22 ' A' ' 31' ' ' LEU . 26.8 t80 -126.29 120.2 29.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 75.44 110.867 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -113.74 117.34 31.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.133 -0.485 . . . . 75.14 110.9 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.424 ' O ' HD23 ' A' ' 284' ' ' LEU . . . -99.59 112.41 24.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 54.04 111.09 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.424 HD23 ' O ' ' A' ' 283' ' ' ALA . 10.9 mt -144.87 -170.4 3.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.203 -0.453 . . . . 70.43 110.863 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 74.44 110.946 179.917 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 301' ' ' NAI . . . . . 0.486 ' H5N' HD21 ' A' ' 262' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.429 ' O ' HG23 ' A' ' 3' ' ' VAL . 21.7 mtt . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.796 0.331 . . . . 71.4 110.913 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 61.5 43.52 10.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.263 -0.426 . . . . 75.04 111.112 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.52 HG11 ' C ' ' A' ' 119' ' ' LYS . 17.8 t -141.1 75.33 23.9 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.675 0.75 . . . . 71.25 111.13 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 168.01 22.76 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.678 2.252 . . . . 73.4 112.372 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 101.23 0.88 Allowed 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.638 2.226 . . . . 71.15 112.374 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.654 ' HB ' HD21 ' A' ' 150' ' ' LEU . 0.6 OUTLIER -80.0 -34.49 38.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.456 . . . . 71.15 111.157 -179.969 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.518 ' HB2' HG21 ' A' ' 143' ' ' VAL . 72.7 t80 -53.7 -30.98 46.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 62.32 110.929 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -80.55 -26.02 38.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.147 -0.479 . . . . 63.43 111.057 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -74.31 -9.94 59.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.227 -0.442 . . . . 73.51 110.888 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.811 HD21 ' HA3' ' A' ' 152' ' ' GLY . 1.4 mp -56.72 -34.25 67.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 61.43 110.953 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 152.24 64.38 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.759 -0.734 . . . . 75.15 112.517 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 24.5 ttpp -62.81 -52.44 63.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.771 0.319 . . . . 72.31 110.913 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 75.5 m -62.87 -49.39 75.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.448 . . . . 54.31 110.855 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.475 ' HB1' ' CB ' ' A' ' 193' ' ' SER . . . -59.94 -37.38 79.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 70.43 111.13 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 45.7 ttt180 -66.01 -34.03 77.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 71.55 110.909 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -60.29 -46.28 90.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 64.12 110.857 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.719 HG21 ' HB2' ' A' ' 222' ' ' ALA . 9.3 p -80.98 -33.74 13.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 73.42 111.133 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.489 ' HE1' ' HB2' ' A' ' 209' ' ' ALA . 11.6 t80 -66.9 -41.18 87.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.485 . . . . 54.3 110.89 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.26 -173.93 2.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 71.11 111.16 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.8 mtmt -95.56 -168.48 1.79 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 71.42 110.915 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.56 48.95 1.46 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.741 -0.742 . . . . 51.5 112.493 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 12.9 p90 -122.63 -35.77 3.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.937 0.399 . . . . 74.12 110.933 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -144.98 139.29 8.31 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.754 -0.736 . . . . 73.0 112.528 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.522 ' HB3' HD11 ' A' ' 26' ' ' LEU . 48.8 m-85 -104.24 -6.35 21.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.926 0.393 . . . . 71.32 110.899 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.27 12.42 57.39 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.772 -0.728 . . . . 73.52 112.488 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.749 ' N ' HD13 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -150.88 -173.48 4.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.819 0.343 . . . . 65.41 110.937 -179.934 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.971 HG23 HD12 ' A' ' 277' ' ' LEU . 21.2 mm -92.34 133.46 33.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 74.45 111.124 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.529 ' O ' HD22 ' A' ' 279' ' ' LEU . 4.5 mtpp -113.06 154.66 26.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 75.42 110.885 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.617 HD13 ' N ' ' A' ' 30' ' ' ASP . 3.3 tm? -147.79 136.84 22.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.229 -0.442 . . . . 72.54 110.944 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.617 ' N ' HD13 ' A' ' 29' ' ' LEU . 1.2 t70 -152.22 124.21 8.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 61.34 110.863 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.711 HD11 ' CB ' ' A' ' 283' ' ' ALA . 2.7 tm? -125.5 129.13 49.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 72.23 110.907 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.54 ' N ' HD13 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -112.17 128.24 56.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 70.54 110.88 179.814 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 93.8 m -137.21 121.12 17.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.44 . . . . 75.14 111.154 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.9 ptmm? -140.89 141.93 34.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 72.44 110.888 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 17.9 t -139.23 152.49 47.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.207 -0.451 . . . . 71.22 110.864 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -75.97 61.45 1.51 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 71.24 110.907 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -153.27 20.67 0.56 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.132 -0.486 . . . . 73.2 110.876 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.545 ' HA2' ' O ' ' A' ' 63' ' ' ARG . . . 75.72 -3.53 49.23 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.721 -0.752 . . . . 72.23 112.524 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.2 mp -98.94 124.16 43.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.771 0.319 . . . . 74.1 110.897 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.82 118.28 10.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.162 -0.472 . . . . 45.15 110.825 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -110.1 123.58 49.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 71.12 110.905 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 83.9 m -127.39 116.62 20.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.47 . . . . 73.34 111.18 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.5 t -115.44 135.81 53.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.435 . . . . 74.23 110.861 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.27 143.91 25.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 54.01 110.871 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 164.95 168.49 27.18 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.712 -0.756 . . . . 70.21 112.463 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -137.3 169.45 17.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.866 0.365 . . . . 75.24 110.872 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -147.11 127.43 13.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 72.23 111.089 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.469 ' ND2' HD12 ' A' ' 26' ' ' LEU . 2.5 m120 -95.45 142.55 27.68 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.198 -0.456 . . . . 74.53 110.852 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 61.1 p -94.12 56.45 2.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 75.01 111.174 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -126.19 -74.89 0.59 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 64.1 110.889 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.4 ' O ' ' C ' ' A' ' 52' ' ' THR . 2.2 m -130.33 65.65 1.52 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 51.13 111.133 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.4 ' C ' ' O ' ' A' ' 51' ' ' THR . 10.1 t 37.05 43.88 0.34 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 65.41 111.16 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -105.2 95.02 5.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 75.02 110.885 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -126.81 148.23 31.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 72.24 111.144 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.7 p -113.27 126.59 55.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 74.05 111.138 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -118.94 147.27 18.43 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.797 -0.716 . . . . 60.13 112.52 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.4 p -146.06 133.55 20.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.918 0.389 . . . . 75.15 110.871 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.455 ' O ' ' HB3' ' A' ' 74' ' ' LYS . 0.3 OUTLIER -123.09 130.08 52.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.465 . . . . 63.44 110.892 -179.968 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.524 ' HA ' ' CB ' ' A' ' 74' ' ' LYS . 0.9 OUTLIER -134.84 120.82 19.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.21 -0.45 . . . . 62.02 110.86 179.923 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.477 ' H ' ' HB2' ' A' ' 74' ' ' LYS . 20.3 m -105.43 117.81 34.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.126 -0.488 . . . . 54.01 111.149 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 71' ' ' PHE . 8.2 mttp -106.58 157.95 17.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 74.33 110.867 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.518 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 10.3 t80 -122.16 121.16 36.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 62.23 110.899 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.545 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -88.45 101.31 13.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.082 -0.508 . . . . 73.44 110.908 179.963 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 42.5 t-105 -116.21 136.35 53.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.209 -0.451 . . . . 73.51 110.895 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 24.0 p -80.98 -169.85 2.42 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.211 -0.45 . . . . 75.31 111.182 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.587 ' O ' HD23 ' A' ' 69' ' ' LEU . 33.6 mm-40 66.29 101.89 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.235 -0.438 . . . . 74.14 110.859 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 65.04 13.98 9.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.158 -0.474 . . . . 73.23 110.946 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 49.95 91.19 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.717 -0.754 . . . . 73.22 112.51 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.587 HD23 ' O ' ' A' ' 66' ' ' GLU . 4.3 mm? -118.05 141.04 48.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.834 0.349 . . . . 71.13 110.941 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.436 ' HA ' ' O ' ' A' ' 62' ' ' TYR . 83.4 m -135.68 121.74 20.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 73.3 111.161 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.68 ' CD1' HG22 ' A' ' 85' ' ' ILE . 14.2 t80 -100.26 119.73 38.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 73.43 110.902 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.1 t -111.37 116.06 30.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 74.31 111.154 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.578 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 8.5 tt0 -139.66 126.94 21.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 71.54 110.895 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.578 ' HB2' ' O ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER 165.63 -156.78 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 55.13 110.934 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.49 ' CD1' HD22 ' A' ' 81' ' ' LEU . 12.2 t90 -133.93 136.38 44.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.268 -0.424 . . . . 71.03 110.896 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -107.88 155.64 20.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.281 -0.418 . . . . 71.33 110.909 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 15.2 t -68.79 -8.42 43.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.172 -0.467 . . . . 72.21 111.128 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.472 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 5.1 m-20 -73.8 3.43 6.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.237 -0.438 . . . . 71.42 110.839 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.472 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 3.9 m-20 81.03 15.33 0.6 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 73.32 110.842 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -116.0 116.25 27.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 64.22 111.126 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.49 HD22 ' CD1' ' A' ' 75' ' ' TRP . 0.1 OUTLIER -122.97 128.21 49.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 74.25 110.914 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 177.58 -133.19 2.15 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.776 -0.726 . . . . 43.44 112.536 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.445 ' OG1' ' N ' ' A' ' 84' ' ' GLU . 4.3 t -178.92 -178.35 0.54 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.812 0.339 . . . . 74.34 111.109 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.65 ' HB3' ' O ' ' A' ' 99' ' ' PHE . 0.6 OUTLIER 170.93 -166.58 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.202 -0.454 . . . . 55.55 110.932 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.68 HG22 ' CD1' ' A' ' 71' ' ' PHE . 1.8 pp -136.78 145.69 29.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.203 -0.453 . . . . 52.33 111.135 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.712 ' OG1' HG23 ' A' ' 98' ' ' THR . 98.6 m -128.96 123.27 32.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.465 . . . . 72.51 111.196 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.2 p -112.54 138.66 40.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 64.13 111.157 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -123.86 118.69 27.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 70.34 110.887 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 43.1 t0 64.42 76.88 0.33 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.143 -0.48 . . . . 63.34 110.878 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -109.01 -68.87 0.89 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 73.11 110.882 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -65.33 -74.28 0.11 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 73.23 110.86 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -121.41 142.38 50.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.174 -0.466 . . . . 63.23 111.117 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 19.5 ttm180 -50.64 133.99 24.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 62.22 110.9 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 100.88 -22.31 40.08 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.732 -0.747 . . . . 61.42 112.49 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.98 125.04 34.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.923 0.392 . . . . 73.2 110.917 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.622 ' O ' HD13 ' A' ' 97' ' ' LEU . 28.8 tttp -124.02 129.83 51.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.466 . . . . 74.2 110.903 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.622 HD13 ' O ' ' A' ' 96' ' ' LYS . 1.2 mm? -122.2 123.04 40.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.45 . . . . 64.13 110.92 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.712 HG23 ' OG1' ' A' ' 86' ' ' THR . 87.6 m -123.79 118.68 27.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.209 -0.451 . . . . 72.04 111.108 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.754 ' CD1' HD13 ' A' ' 114' ' ' ILE . 0.7 OUTLIER -115.3 117.33 30.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.455 . . . . 71.11 110.857 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.568 ' HA ' ' CB ' ' A' ' 84' ' ' GLU . 8.4 t70 -121.62 139.47 53.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.103 -0.499 . . . . 64.11 110.901 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 37.7 t -130.55 121.26 25.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 65.44 110.87 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 15.8 m -116.6 153.41 32.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.096 -0.502 . . . . 54.44 110.878 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -123.72 138.41 54.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 71.24 110.895 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.424 ' HA ' ' HD2' ' A' ' 105' ' ' PRO . 4.2 t -116.83 106.69 47.47 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.634 0.73 . . . . 71.12 110.881 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 104' ' ' SER . 54.1 Cg_endo -69.68 -32.61 18.55 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.683 2.255 . . . . 75.2 112.389 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -57.3 -35.9 70.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.469 . . . . 71.01 110.903 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 10.0 m -99.09 -32.4 11.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 61.1 111.12 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.66 -18.58 57.24 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.762 -0.732 . . . . 71.52 112.532 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 29.6 tptt -94.44 147.47 23.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.817 0.342 . . . . 42.51 110.915 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -92.95 150.84 20.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.279 -0.419 . . . . 74.22 110.924 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.1 m120 -121.08 126.32 49.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.436 . . . . 60.34 110.913 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -113.68 139.3 49.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 65.44 111.066 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 27.9 mttm -138.3 137.91 37.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 64.11 110.889 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.754 HD13 ' CD1' ' A' ' 99' ' ' PHE . 4.1 tp -134.66 133.68 54.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 61.24 111.152 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.464 ' H ' HD12 ' A' ' 114' ' ' ILE . 40.0 mttp -125.42 120.83 32.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 72.33 110.894 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.563 HG22 HD12 ' A' ' 97' ' ' LEU . 59.7 p -127.81 118.33 23.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 55.21 111.167 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.4 ' HA3' ' HA2' ' A' ' 126' ' ' GLY . . . -152.19 156.08 26.5 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.753 -0.737 . . . . 74.22 112.495 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -132.41 130.49 40.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.973 0.416 . . . . 73.52 110.896 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.52 ' C ' HG11 ' A' ' 3' ' ' VAL . 37.7 mttp -107.05 118.5 36.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.103 -0.499 . . . . 75.34 110.893 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.26 142.94 42.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 74.43 110.851 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -52.42 -27.32 15.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.134 -0.485 . . . . 64.23 110.887 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 27.9 m80 -90.38 -38.3 13.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 75.14 110.895 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.443 HD11 HD22 ' A' ' 144' ' ' LEU . 9.3 tp -147.67 140.65 19.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.445 . . . . 74.53 111.098 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -111.25 115.94 30.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 72.34 110.87 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.511 ' CD2' HD13 ' A' ' 142' ' ' LEU . 2.9 mm? -122.96 139.91 53.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.175 -0.466 . . . . 73.13 110.935 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.4 ' HA2' ' HA3' ' A' ' 117' ' ' GLY . . . -146.74 121.5 1.44 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.741 -0.743 . . . . 63.3 112.437 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 18.5 m -113.19 134.02 54.78 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.791 0.329 . . . . 72.1 110.916 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -126.62 146.97 49.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 61.45 110.905 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 8.7 mtm -139.04 127.23 22.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 72.24 110.869 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -117.81 121.3 40.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 75.22 110.88 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -95.26 119.71 34.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.465 . . . . 74.05 110.887 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -128.2 121.15 28.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 72.2 110.855 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.546 HD12 ' O ' ' A' ' 133' ' ' ILE . 1.1 tp -52.41 -43.75 41.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 54.31 111.166 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -74.39 -18.29 60.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.481 . . . . 65.53 111.121 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 161.47 103.59 0.18 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.725 -0.75 . . . . 72.42 112.454 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 147.99 64.34 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.656 2.237 . . . . 74.13 112.382 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 28.4 t -128.73 150.49 50.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 75.14 110.875 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.703 HD12 ' OG1' ' A' ' 159' ' ' THR . 1.4 mp -107.89 132.99 54.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.12 -0.491 . . . . 61.24 111.136 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 18.9 mtp180 -112.37 131.25 55.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 72.34 110.869 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -126.72 134.01 8.3 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.705 -0.76 . . . . 51.45 112.485 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -139.17 116.94 11.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.832 0.349 . . . . 71.41 111.125 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.595 HD12 ' N ' ' A' ' 143' ' ' VAL . 5.3 tp -127.01 124.59 39.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.242 -0.436 . . . . 62.45 110.954 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.595 ' N ' HD12 ' A' ' 142' ' ' LEU . 46.6 t -123.34 134.8 65.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 64.44 111.092 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.545 HD23 ' C ' ' A' ' 143' ' ' VAL . 0.5 OUTLIER -109.38 143.36 39.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.106 -0.497 . . . . 75.12 110.889 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -121.36 120.25 4.37 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.774 -0.727 . . . . 31.12 112.513 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.428 ' HB3' ' HB2' ' A' ' 149' ' ' TRP . 38.5 t80 -128.85 145.5 51.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.825 0.345 . . . . 72.34 110.893 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -50.95 96.89 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.126 -0.488 . . . . 62.43 110.876 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 92.88 -30.7 6.78 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.707 -0.759 . . . . 63.35 112.464 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.428 ' HB2' ' HB3' ' A' ' 146' ' ' TYR . 25.0 m95 -104.77 141.09 37.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.828 0.347 . . . . 74.11 110.863 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.654 HD21 ' HB ' ' A' ' 6' ' ' THR . 0.5 OUTLIER -130.71 140.6 50.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.446 . . . . 71.53 110.943 179.955 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.516 ' HB3' ' HB2' ' A' ' 144' ' ' LEU . . . -131.44 148.12 52.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 73.54 111.086 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.811 ' HA3' HD21 ' A' ' 10' ' ' LEU . . . -150.95 137.06 5.86 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.752 -0.737 . . . . 74.42 112.484 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -144.11 119.78 10.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.877 0.37 . . . . 74.31 110.923 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -126.94 122.44 34.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.117 -0.492 . . . . 60.21 110.892 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 15.6 ptt? -146.82 150.17 34.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 62.54 110.846 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 48.9 m-20 -112.12 138.56 48.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 73.12 110.891 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -92.24 132.49 36.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 63.31 110.868 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -77.86 99.64 6.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.141 -0.482 . . . . 71.43 110.865 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.703 ' OG1' HD12 ' A' ' 138' ' ' ILE . 0.2 OUTLIER -65.21 -47.0 78.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.139 -0.482 . . . . 64.33 111.165 -179.937 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -48.29 -26.11 1.85 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 54.43 111.119 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 43.9 mttt -127.33 -166.64 1.63 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.459 . . . . 62.23 110.935 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 39.6 m -111.18 40.29 2.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.44 . . . . 73.3 110.795 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 11.0 mmm180 -153.3 176.21 12.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 71.43 110.889 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 1.5 t -78.01 141.42 15.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 74.11 111.119 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 15.2 t -90.61 -33.73 15.74 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.158 -0.474 . . . . 53.44 111.131 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -150.97 134.84 16.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.445 . . . . 73.44 110.9 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 89.5 p -124.81 119.01 27.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 53.34 110.893 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -130.47 142.56 50.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 63.25 110.89 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -138.2 158.14 44.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.126 -0.488 . . . . 71.32 110.866 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -154.07 138.96 17.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 53.01 111.114 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 46.2 t -120.63 134.87 62.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 72.23 111.113 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -117.59 112.56 2.48 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.706 -0.759 . . . . 44.32 112.491 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -114.18 121.58 44.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.994 0.426 . . . . 73.13 110.901 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 26.0 ttmt -104.36 134.77 47.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.113 -0.494 . . . . 72.11 110.916 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.97 165.11 22.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 64.12 111.128 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -40.93 -74.82 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.175 -0.466 . . . . 54.22 110.892 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -116.07 15.15 16.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 64.12 110.913 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -127.09 149.57 49.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 74.13 110.868 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 6.6 mm-40 -135.22 123.87 23.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.123 -0.49 . . . . 55.24 110.881 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.656 HD23 HG13 ' A' ' 194' ' ' ILE . 2.6 tm? -124.23 122.32 37.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.132 -0.485 . . . . 74.45 110.873 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' HIS . . . . . 0.452 ' N ' HD22 ' A' ' 180' ' ' LEU . 91.6 m-70 -130.47 115.94 17.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 71.53 110.9 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' THR . . . . . 0.494 HG22 ' O ' ' A' ' 191' ' ' GLY . 0.2 OUTLIER -94.77 153.12 17.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.217 -0.447 . . . . 71.22 111.1 -179.856 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -146.76 138.56 24.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 73.31 110.896 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.454 ' O ' HG12 ' A' ' 184' ' ' VAL . 2.3 t -134.72 111.3 13.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.473 . . . . 71.14 111.143 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -100.09 89.28 3.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 72.3 110.9 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 65.28 179.14 0.19 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.179 -0.464 . . . . 71.22 110.821 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -73.47 -4.17 64.2 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.69 -0.767 . . . . 75.4 112.506 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 29.3 p -95.38 -25.87 16.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.765 0.317 . . . . 62.14 111.15 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -122.83 114.17 20.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 75.43 110.915 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -139.72 124.13 18.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 70.22 110.813 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.494 ' O ' HG22 ' A' ' 182' ' ' THR . . . 178.8 -150.88 9.87 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.678 -0.772 . . . . 44.43 112.47 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -176.42 170.43 43.24 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.726 -0.749 . . . . 74.35 112.485 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' SER . . . . . 0.475 ' CB ' ' HB1' ' A' ' 14' ' ' ALA . 65.3 m -121.21 147.19 45.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.872 0.368 . . . . 53.32 110.798 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.656 HG13 HD23 ' A' ' 180' ' ' LEU . 4.0 mp -119.79 123.45 70.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.104 -0.498 . . . . 73.22 111.073 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 195' ' ' TYR . . . . . 0.64 ' HD1' ' HB2' ' A' ' 205' ' ' ALA . 12.6 t80 -108.48 121.91 45.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 73.2 110.929 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -124.47 130.2 52.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 74.52 110.914 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 21.2 mtpp -106.25 127.19 53.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 73.32 110.874 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 14.7 t -79.21 153.33 4.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 73.51 111.159 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' ASN . . . . . 0.406 ' O ' ' C ' ' A' ' 200' ' ' LYS . 47.0 t30 -59.62 97.94 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 73.35 110.9 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' LYS . . . . . 0.406 ' C ' ' O ' ' A' ' 199' ' ' ASN . 16.6 ptpt 37.3 63.12 0.76 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 75.11 110.897 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 201' ' ' LYS . . . . . 0.428 ' HB3' HD23 ' A' ' 202' ' ' LEU . 25.3 mttm -145.46 -56.46 0.31 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 75.53 110.917 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.428 HD23 ' HB3' ' A' ' 201' ' ' LYS . 2.1 pt? -173.76 172.42 3.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 73.44 110.936 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -116.58 144.9 43.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 72.24 110.876 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.438 HG23 ' O ' ' A' ' 222' ' ' ALA . 7.3 m -146.53 138.77 24.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 74.02 111.105 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.64 ' HB2' ' HD1' ' A' ' 195' ' ' TYR . . . -145.3 136.64 25.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.441 . . . . 72.14 111.141 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 1.1 m -113.79 149.97 15.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 73.23 111.095 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -113.58 137.19 51.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.485 . . . . 72.34 110.865 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.579 HD11 ' CE1' ' A' ' 219' ' ' PHE . 3.8 mm? -120.61 129.72 53.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.17 -0.468 . . . . 73.51 110.897 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.489 ' HB2' ' HE1' ' A' ' 18' ' ' PHE . . . -129.77 130.07 44.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.119 -0.492 . . . . 64.31 111.08 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 2.9 t-105 -129.67 128.1 41.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 71.4 110.941 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 2.7 p -99.14 109.02 21.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.225 -0.443 . . . . 75.33 111.159 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -54.91 149.84 10.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 65.51 111.063 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 95.59 -36.49 3.8 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.71 -0.757 . . . . 51.04 112.474 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -121.54 -179.46 4.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.782 0.325 . . . . 74.12 110.879 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 3.0 t -112.11 38.37 2.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 71.12 110.882 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -102.17 112.21 24.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 75.55 110.905 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 18.6 m -114.65 138.45 50.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.459 . . . . 74.33 111.132 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' ARG . . . . . 0.446 ' HB3' ' HB3' ' A' ' 209' ' ' ALA . 18.4 ttt85 -108.55 131.99 54.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.441 . . . . 60.44 110.848 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 219' ' ' PHE . . . . . 0.579 ' CE1' HD11 ' A' ' 208' ' ' LEU . 17.9 m-85 -117.45 136.7 53.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 65.33 110.89 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -137.46 140.63 11.48 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.737 -0.744 . . . . 63.14 112.511 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.514 ' HB ' HG12 ' A' ' 237' ' ' VAL . 4.8 mp -123.85 130.73 73.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.854 0.359 . . . . 61.54 111.104 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.719 ' HB2' HG21 ' A' ' 17' ' ' VAL . . . -127.61 152.21 47.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 65.41 111.1 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -137.37 129.34 29.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.246 -0.434 . . . . 75.22 111.084 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 7.3 ttmt -115.21 128.48 56.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 72.42 110.894 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -132.25 131.54 42.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.252 -0.431 . . . . 71.51 110.913 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 58.7 mm-40 -102.71 112.28 24.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 75.35 110.875 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 71.4 mt -102.68 -40.1 6.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 73.33 111.109 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.757 ' HB2' ' HB3' ' A' ' 231' ' ' ALA . 0.4 OUTLIER -124.17 160.7 51.19 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.579 0.704 . . . . 62.32 110.882 179.88 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -32.34 18.82 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.725 2.283 . . . . 73.44 112.317 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -109.2 10.49 25.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.435 . . . . 72.43 110.882 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.757 ' HB3' ' HB2' ' A' ' 228' ' ' ASP . . . -136.1 140.42 43.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.179 -0.464 . . . . 64.12 111.086 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 21.8 m -138.74 136.49 35.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.213 -0.449 . . . . 52.01 110.903 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -110.42 132.77 53.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 73.3 110.924 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 58.2 p -137.08 149.71 47.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 63.24 110.826 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -136.47 155.59 49.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.096 -0.502 . . . . 63.32 111.089 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.51 145.91 29.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 71.24 110.861 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.514 HG12 ' HB ' ' A' ' 221' ' ' ILE . 1.7 p -143.04 143.88 24.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 73.32 111.143 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 238' ' ' ASN . . . . . 0.404 ' HB3' ' HB2' ' A' ' 242' ' ' LEU . 0.9 OUTLIER -112.31 148.08 34.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 73.03 110.886 179.986 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -57.1 -18.53 15.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 63.32 110.89 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 29.9 t -80.93 25.89 0.44 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 73.31 110.814 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 62.22 35.19 15.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.123 -0.49 . . . . 72.14 110.875 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 242' ' ' LEU . . . . . 0.444 HD11 ' HB3' ' A' ' 264' ' ' ASP . 4.9 mp -99.25 118.5 36.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.132 -0.486 . . . . 74.01 110.916 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.508 ' H ' HD12 ' A' ' 243' ' ' ILE . 0.8 OUTLIER -107.42 117.88 54.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 74.35 111.154 179.852 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 244' ' ' GLY . . . . . 0.533 ' C ' HD13 ' A' ' 245' ' ' LEU . . . -137.12 149.62 20.33 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.701 -0.762 . . . . 63.21 112.467 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.669 ' N ' HD13 ' A' ' 245' ' ' LEU . 0.0 OUTLIER -145.83 158.48 43.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.869 0.366 . . . . 54.02 110.887 -179.895 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -163.01 136.83 4.48 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.687 -0.768 . . . . 44.2 112.465 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -128.42 132.59 48.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.902 0.382 . . . . 75.4 110.932 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 7.8 t -111.99 125.83 54.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.487 . . . . 62.41 111.177 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -143.43 148.82 36.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.235 -0.438 . . . . 51.32 110.961 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 5.5 m -88.93 145.24 25.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.262 -0.426 . . . . 72.03 111.127 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.613 HD12 HD11 ' A' ' 255' ' ' ILE . 47.4 mt -93.94 -176.05 3.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 71.45 110.889 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 252' ' ' LYS . . . . . 0.472 ' CB ' ' CD ' ' A' ' 253' ' ' PRO . 0.1 OUTLIER -51.16 -61.07 4.46 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.545 0.688 . . . . 61.3 110.87 179.845 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 253' ' ' PRO . . . . . 0.472 ' CD ' ' CB ' ' A' ' 252' ' ' LYS . 53.8 Cg_endo -69.73 -170.26 0.38 Allowed 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.687 2.258 . . . . 64.35 112.306 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 254' ' ' GLY . . . . . 0.536 ' O ' ' HB3' ' A' ' 281' ' ' PHE . . . -85.1 51.55 4.56 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.737 -0.744 . . . . 73.42 112.465 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.613 HD11 HD12 ' A' ' 251' ' ' LEU . 6.2 pt -129.27 135.1 62.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.893 0.377 . . . . 65.11 111.152 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.441 ' H ' ' HB2' ' A' ' 281' ' ' PHE . 0.1 OUTLIER -98.39 132.1 44.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.447 . . . . 70.13 110.888 179.858 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 0.721 ' HA ' HD12 ' A' ' 279' ' ' LEU . 5.2 tp -100.07 125.45 46.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 75.22 110.921 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 258' ' ' THR . . . . . 0.434 ' O ' HD22 ' A' ' 277' ' ' LEU . 21.9 m -116.39 111.75 20.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 73.11 111.152 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 1.015 HD22 HD23 ' A' ' 277' ' ' LEU . 0.2 OUTLIER -109.33 130.02 55.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.253 -0.431 . . . . 74.01 110.868 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.504 ' N ' HD13 ' A' ' 259' ' ' LEU . 1.7 t -144.16 155.8 44.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.167 -0.469 . . . . 73.25 110.898 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 261' ' ' ALA . . . . . 0.438 ' HB3' ' CD2' ' A' ' 245' ' ' LEU . . . -158.88 128.38 5.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 62.24 111.06 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.655 ' C ' HD13 ' A' ' 263' ' ' LEU . 3.2 tm? -118.48 122.98 44.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 62.52 110.921 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 263' ' ' LEU . . . . . 0.892 ' HB3' HG21 ' A' ' 268' ' ' VAL . 0.4 OUTLIER -118.93 110.56 17.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.159 -0.473 . . . . 73.4 110.88 179.896 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 264' ' ' ASP . . . . . 0.555 ' O ' ' HB ' ' A' ' 268' ' ' VAL . 1.7 m-20 -88.62 99.87 12.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 70.21 110.844 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -52.86 -11.48 1.35 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.737 -0.744 . . . . 72.32 112.464 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 7.4 ttmm -63.86 -25.66 68.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.825 0.345 . . . . 70.13 110.915 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -166.82 16.91 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 64.01 110.881 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 268' ' ' VAL . . . . . 0.892 HG21 ' HB3' ' A' ' 263' ' ' LEU . 1.4 p -68.05 -28.51 41.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 62.44 111.119 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -74.48 -37.44 63.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 73.21 110.914 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -85.83 -17.64 35.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.142 -0.481 . . . . 53.14 111.103 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 131.21 95.26 0.68 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.768 -0.729 . . . . 53.31 112.515 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 178.86 53.74 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.774 -0.727 . . . . 53.32 112.537 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 273' ' ' HIS . . . . . 0.492 ' HB2' HD12 ' A' ' 263' ' ' LEU . 14.8 p80 -112.17 144.21 41.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.887 0.375 . . . . 72.3 110.84 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -123.71 149.32 45.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 64.42 110.889 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.422 HD12 ' HB2' ' A' ' 261' ' ' ALA . 2.4 tp -128.41 148.55 50.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 71.15 110.898 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -131.34 97.53 0.36 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.784 -0.722 . . . . 75.45 112.501 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 1.015 HD23 HD22 ' A' ' 259' ' ' LEU . 3.2 tm? -119.28 129.65 55.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.845 0.355 . . . . 74.45 110.886 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 278' ' ' GLY . . . . . 0.711 ' C ' HD13 ' A' ' 279' ' ' LEU . . . -164.48 145.61 10.51 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.752 -0.737 . . . . 72.53 112.533 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.721 HD12 ' HA ' ' A' ' 257' ' ' LEU . 0.0 OUTLIER -118.47 130.03 55.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.745 0.307 . . . . 72.44 110.971 -179.969 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 280' ' ' GLU . . . . . 0.522 ' O ' ' HB2' ' A' ' 281' ' ' PHE . 0.0 OUTLIER -140.37 143.58 35.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.449 . . . . 73.2 110.924 179.961 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.536 ' HB3' ' O ' ' A' ' 254' ' ' GLY . 0.2 OUTLIER 172.63 -144.39 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 73.34 110.856 -179.949 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -137.47 148.82 46.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 71.31 110.933 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.711 ' CB ' HD11 ' A' ' 31' ' ' LEU . . . -101.11 111.45 23.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 71.31 111.106 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.66 HD12 ' O ' ' A' ' 283' ' ' ALA . 0.8 OUTLIER -151.31 178.44 9.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.235 -0.439 . . . . 75.11 110.904 -179.959 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 71.43 110.893 179.919 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 301' ' ' NAI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 33.2 mtt . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.774 0.321 . . . . 70.41 110.9 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -140.46 107.71 5.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.279 -0.419 . . . . 63.1 111.104 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.491 HG22 ' N ' ' A' ' 121' ' ' GLU . 9.1 t -114.43 78.48 4.8 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.668 0.746 . . . . 71.11 111.14 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 167.7 23.68 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.681 2.254 . . . . 72.14 112.351 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 119.57 6.49 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.654 2.236 . . . . 55.04 112.335 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.488 ' HB ' HD21 ' A' ' 150' ' ' LEU . 34.7 p -106.99 -49.61 3.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 62.31 111.154 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.716 ' HB2' HG21 ' A' ' 143' ' ' VAL . 72.3 t80 -56.39 -30.69 63.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.26 -0.427 . . . . 74.54 110.924 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -79.75 -23.08 42.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.082 -0.508 . . . . 74.03 111.117 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -90.66 13.28 16.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 74.33 110.846 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.777 HD21 ' HA3' ' A' ' 152' ' ' GLY . 0.5 OUTLIER -70.39 -33.83 71.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.21 -0.45 . . . . 64.44 110.907 -179.971 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 161.31 49.8 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.764 -0.731 . . . . 72.12 112.511 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.29 -48.51 81.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.775 0.321 . . . . 61.32 110.921 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.6 m -61.25 -49.14 78.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 61.05 110.839 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.537 ' HB1' ' CB ' ' A' ' 193' ' ' SER . . . -62.22 -38.21 88.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 75.32 111.083 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.725 ' O ' HG22 ' A' ' 19' ' ' THR . 17.0 ttt-85 -60.73 -33.51 73.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 75.14 110.873 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -58.05 -46.02 86.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 74.23 110.893 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.514 HG21 ' HB3' ' A' ' 205' ' ' ALA . 92.8 t -65.19 -41.92 92.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 73.04 111.127 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -62.67 -41.01 98.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 71.44 110.911 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.725 HG22 ' O ' ' A' ' 15' ' ' ARG . 9.0 t -94.11 43.13 1.1 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.145 -0.48 . . . . 40.22 111.165 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -129.5 174.1 9.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 74.11 110.866 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 77.55 -72.53 2.17 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.764 -0.732 . . . . 53.32 112.459 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -68.1 87.76 0.28 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.966 0.412 . . . . 73.21 110.942 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -61.29 -176.05 1.83 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.751 -0.738 . . . . 73.42 112.445 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -97.68 -4.49 37.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.944 0.402 . . . . 64.11 110.894 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.61 13.15 77.97 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.738 -0.744 . . . . 72.54 112.457 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.593 HD12 ' N ' ' A' ' 27' ' ' ILE . 2.2 pp -149.54 -176.7 5.5 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.749 0.309 . . . . 63.41 110.952 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.593 ' N ' HD12 ' A' ' 26' ' ' LEU . 1.6 mp -118.33 120.91 65.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.206 -0.452 . . . . 72.24 111.171 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.446 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 0.0 OUTLIER -125.81 117.13 22.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 74.44 110.915 179.844 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.82 ' HB2' HD23 ' A' ' 279' ' ' LEU . 0.6 OUTLIER -112.69 137.91 50.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.44 . . . . 74.2 110.926 179.939 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.562 ' C ' ' HB3' ' A' ' 281' ' ' PHE . 0.7 OUTLIER -147.51 132.54 18.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.238 -0.437 . . . . 74.33 110.864 179.88 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.781 ' HA ' ' HA ' ' A' ' 281' ' ' PHE . 4.2 tt -129.55 124.58 34.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.196 -0.456 . . . . 72.55 110.952 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.617 ' N ' ' HB2' ' A' ' 281' ' ' PHE . 0.3 OUTLIER -120.36 125.29 47.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 61.2 110.891 179.873 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.914 HG23 HD13 ' A' ' 284' ' ' LEU . 46.2 m -122.2 121.11 36.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 71.42 111.124 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 5.9 ptmt -121.01 148.03 44.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 71.35 110.89 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 75.6 m -139.07 169.3 18.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 65.33 110.873 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -83.17 52.49 2.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.105 -0.498 . . . . 72.43 110.874 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -140.65 8.59 2.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.139 -0.482 . . . . 74.32 110.908 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.489 ' HA2' ' O ' ' A' ' 63' ' ' ARG . . . 79.27 -5.09 60.71 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.727 -0.749 . . . . 72.02 112.511 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -99.08 128.53 45.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.726 0.298 . . . . 43.24 110.94 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.412 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -139.82 118.49 12.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 64.25 110.86 179.934 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -102.97 126.59 50.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 73.4 110.872 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 54.3 m -127.08 117.42 22.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.108 -0.496 . . . . 73.32 111.173 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 36.5 p -104.31 134.27 47.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 73.25 110.9 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 35.6 t -127.0 127.15 44.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 71.52 110.835 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -141.86 129.79 4.09 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.7 -0.762 . . . . 51.53 112.453 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 48.6 m -128.97 135.74 49.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.87 0.367 . . . . 72.21 110.866 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.408 ' HA ' ' HA ' ' A' ' 54' ' ' VAL . . . -134.66 129.7 35.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.128 -0.487 . . . . 74.11 111.106 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -92.18 136.42 33.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 75.21 110.866 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -96.23 -55.89 2.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 72.12 111.168 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -50.49 -34.91 26.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.221 -0.445 . . . . 71.42 110.9 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -139.3 165.21 27.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 72.41 111.117 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 22.0 p -78.72 84.6 4.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.462 . . . . 73.35 111.112 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 10.9 tptp -145.61 82.27 1.63 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 73.15 110.885 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.408 ' HA ' ' HA ' ' A' ' 47' ' ' ALA . 0.7 OUTLIER -126.68 120.07 55.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 64.31 111.128 179.845 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 82.7 p -137.93 160.82 38.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.198 -0.455 . . . . 72.34 111.117 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.414 ' O ' HG22 ' A' ' 77' ' ' THR . . . -129.74 158.57 22.28 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.733 -0.746 . . . . 71.23 112.502 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.2 p -146.51 161.21 40.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.913 0.387 . . . . 54.13 110.869 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.607 HD13 ' N ' ' A' ' 59' ' ' GLU . 0.5 OUTLIER -119.95 131.04 55.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.115 -0.493 . . . . 75.31 110.929 179.969 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.607 ' N ' HD13 ' A' ' 58' ' ' LEU . 3.8 mt-10 -115.84 124.41 50.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 63.4 110.88 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.57 125.8 51.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 72.31 111.161 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.412 ' HB2' ' HB3' ' A' ' 40' ' ' GLU . 3.6 mttp -134.57 159.16 42.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 44.42 110.905 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -131.92 140.77 49.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 74.51 110.936 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.489 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 2.9 tmm_? -130.33 103.27 6.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 54.33 110.855 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 16.9 m95 -116.06 120.21 38.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 74.23 110.917 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.6 m 64.74 118.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 64.23 111.146 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -51.02 115.07 1.36 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.441 . . . . 64.3 110.85 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 65.59 56.93 0.9 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.113 -0.494 . . . . 72.51 110.948 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -144.35 -70.52 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.711 -0.757 . . . . 72.14 112.493 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.425 HD13 ' HA ' ' A' ' 69' ' ' LEU . 0.6 OUTLIER -125.12 128.88 49.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.869 0.366 . . . . 60.31 110.928 -179.93 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -137.67 128.82 27.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.26 -0.427 . . . . 55.11 111.156 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -114.47 133.35 55.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 75.52 110.848 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 49.8 p -126.32 115.0 19.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.127 -0.488 . . . . 73.41 111.171 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -132.06 136.16 47.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.231 -0.44 . . . . 64.43 110.857 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 13.6 pttp -123.15 94.72 4.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.47 . . . . 72.24 110.903 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.491 ' CD1' ' HB3' ' A' ' 81' ' ' LEU . 5.8 t90 -95.37 125.88 40.29 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.232 -0.44 . . . . 72.33 110.896 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -94.25 137.12 33.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.267 -0.424 . . . . 75.23 110.873 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.414 HG22 ' O ' ' A' ' 56' ' ' GLY . 8.0 t -65.57 -36.66 84.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.153 -0.476 . . . . 62.41 111.162 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -112.1 -37.19 5.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.182 -0.463 . . . . 51.43 110.931 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -77.71 -162.19 0.3 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 53.34 110.898 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 20.7 p -81.09 157.35 25.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.161 -0.472 . . . . 74.02 111.156 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.491 ' HB3' ' CD1' ' A' ' 75' ' ' TRP . 0.2 OUTLIER -96.38 119.15 34.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 63.21 110.909 179.961 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.19 144.11 15.74 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.752 -0.737 . . . . 41.11 112.51 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.9 t -144.98 124.9 13.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.73 0.3 . . . . 75.44 111.169 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 50.9 tt0 -134.73 151.4 50.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 73.44 110.89 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.1 tt -129.12 139.02 52.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 72.55 111.117 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.627 HG22 HG23 ' A' ' 98' ' ' THR . 7.6 p -129.11 121.24 27.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.16 -0.473 . . . . 73.55 111.155 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.452 HG12 ' O ' ' A' ' 97' ' ' LEU . 3.0 p -118.62 134.39 62.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 71.34 111.168 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -106.75 128.12 53.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 61.42 110.874 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 61.34 56.03 2.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.185 -0.461 . . . . 71.33 110.849 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.486 ' HB2' HD23 ' A' ' 97' ' ' LEU . 5.3 tt0 -64.34 -67.52 0.43 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 73.32 110.892 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 56.5 tp -106.6 -53.99 2.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.18 -0.464 . . . . 64.03 110.919 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -106.44 124.44 49.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 74.02 111.109 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 -51.71 133.64 30.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.242 -0.435 . . . . 74.4 110.923 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 99.97 -23.59 35.42 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.734 -0.746 . . . . 60.34 112.479 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.24 134.6 34.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.844 0.354 . . . . 75.2 110.937 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.7 tttp -122.29 131.15 53.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 73.14 110.883 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.486 HD23 ' HB2' ' A' ' 90' ' ' GLN . 1.7 mm? -116.75 130.72 56.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.205 -0.452 . . . . 75.22 110.924 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.627 HG23 HG22 ' A' ' 86' ' ' THR . 51.6 m -129.64 125.0 35.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 64.33 111.106 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -115.42 116.47 28.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.232 -0.44 . . . . 73.53 110.875 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -109.33 133.15 53.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.17 -0.468 . . . . 64.11 110.844 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.4 t -142.87 128.38 19.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 71.21 110.857 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.1 m -108.11 151.02 26.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.131 -0.486 . . . . 62.2 110.866 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -133.23 132.44 41.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 70.54 110.868 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 9.6 t -128.18 109.67 19.73 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.627 0.727 . . . . 55.45 110.9 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.491 ' HD3' HD21 ' A' ' 81' ' ' LEU . 54.0 Cg_endo -69.72 -16.35 37.67 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.623 2.216 . . . . 73.41 112.36 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -48.97 -70.7 0.08 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 63.32 110.839 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.6 m -129.13 31.47 4.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 73.03 111.145 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 67.76 24.22 74.14 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.726 -0.75 . . . . 75.12 112.472 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.55 116.53 13.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.837 0.351 . . . . 74.53 110.891 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 37.0 mtmt -116.01 147.98 40.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.172 -0.467 . . . . 73.33 110.911 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -120.5 132.54 55.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 73.43 110.889 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -114.65 121.48 43.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 64.42 111.129 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 16.5 ttmt -138.03 138.21 38.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.253 -0.431 . . . . 71.13 110.926 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.402 HG23 ' O ' ' A' ' 114' ' ' ILE . 6.1 tp -134.11 123.23 43.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.434 . . . . 50.23 111.144 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 68.7 tttt -119.13 121.0 38.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 74.42 110.922 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.0 t -128.23 125.4 38.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.44 . . . . 63.51 111.136 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -150.7 157.47 27.21 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.78 -0.724 . . . . 71.42 112.494 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 16.3 p90 -132.21 130.78 41.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.939 0.399 . . . . 75.55 110.953 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 29.7 tttp -107.64 118.23 36.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.481 . . . . 75.34 110.884 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 12.4 mmt85 -110.85 142.91 42.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.247 -0.433 . . . . 74.33 110.857 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.491 ' N ' HG22 ' A' ' 3' ' ' VAL . 7.6 pt-20 -52.79 -27.41 17.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 64.11 110.88 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 74.6 t60 -88.08 -39.61 14.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 65.04 110.859 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.581 HD12 ' HA ' ' A' ' 144' ' ' LEU . 8.6 tp -148.41 144.65 18.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 62.42 111.149 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -109.47 119.11 38.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 75.51 110.913 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.62 ' CD2' HD13 ' A' ' 142' ' ' LEU . 2.9 mm? -123.62 139.59 53.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 74.32 110.952 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -145.34 121.77 1.58 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.711 -0.757 . . . . 73.01 112.462 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -112.41 134.44 53.94 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.808 0.337 . . . . 64.53 110.857 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -129.67 133.82 47.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.164 -0.471 . . . . 72.32 110.898 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.416 ' SD ' HG23 ' A' ' 138' ' ' ILE . 2.1 mmt -127.99 129.17 46.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.457 . . . . 64.33 110.855 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -123.23 120.2 32.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 73.53 110.866 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -94.98 127.92 41.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 74.31 110.901 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -134.77 122.71 22.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.112 -0.494 . . . . 64.32 110.858 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.463 ' N ' HD13 ' A' ' 133' ' ' ILE . 0.2 OUTLIER -55.31 -25.25 16.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 74.12 111.133 179.998 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -91.79 -20.03 21.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 63.52 111.095 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 164.04 98.97 0.13 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.711 -0.757 . . . . 62.22 112.452 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.82 138.44 37.63 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.692 2.261 . . . . 65.21 112.328 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.1 m -127.77 159.52 34.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 71.42 110.844 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.564 HD12 ' OG1' ' A' ' 159' ' ' THR . 2.4 mp -123.63 140.83 45.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.105 -0.498 . . . . 63.12 111.121 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 43.7 ttt180 -121.36 120.44 35.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 74.22 110.819 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -112.08 134.0 11.78 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.757 -0.735 . . . . 22.42 112.431 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -134.28 120.71 20.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.762 0.315 . . . . 74.21 111.135 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.637 HD12 ' N ' ' A' ' 143' ' ' VAL . 4.0 tp -131.62 125.74 32.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.229 -0.441 . . . . 73.24 110.92 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.716 HG21 ' HB2' ' A' ' 7' ' ' TYR . 78.5 t -127.93 133.92 66.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.45 . . . . 42.41 111.134 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.581 ' HA ' HD12 ' A' ' 123' ' ' ILE . 1.6 mp -110.04 138.68 46.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 65.23 110.898 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -111.96 124.72 6.89 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.751 -0.738 . . . . 43.3 112.498 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -134.2 145.07 48.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.825 0.345 . . . . 73.24 110.968 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -50.45 96.47 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.125 -0.489 . . . . 62.32 110.903 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 90.02 -26.77 9.18 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.724 -0.75 . . . . 72.3 112.462 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 8.4 m0 -104.91 135.89 45.41 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.819 0.342 . . . . 71.13 110.913 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.488 HD21 ' HB ' ' A' ' 6' ' ' THR . 0.5 OUTLIER -129.91 137.56 50.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 74.24 110.903 179.967 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.492 ' HB3' HD13 ' A' ' 144' ' ' LEU . . . -129.98 137.4 50.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 54.44 111.136 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.777 ' HA3' HD21 ' A' ' 10' ' ' LEU . . . -138.72 136.08 7.8 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.739 -0.743 . . . . 72.53 112.48 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -139.33 119.38 13.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.831 0.348 . . . . 74.24 110.911 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 38.0 tt0 -132.59 122.44 24.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.484 . . . . 64.31 110.895 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 10.7 ptt? -146.12 157.76 43.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 62.41 110.843 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.424 ' O ' ' HB ' ' A' ' 164' ' ' VAL . 5.0 m120 -112.86 121.5 44.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.435 . . . . 74.03 110.868 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.534 ' HD1' HD13 ' A' ' 138' ' ' ILE . 49.0 t80 -84.29 128.63 34.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.121 -0.49 . . . . 70.05 110.854 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.416 ' H ' ' HA ' ' A' ' 164' ' ' VAL . 5.0 tp10 -85.51 107.88 17.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.491 . . . . 71.14 110.899 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.564 ' OG1' HD12 ' A' ' 138' ' ' ILE . 0.2 OUTLIER -65.92 -48.31 71.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.137 -0.483 . . . . 74.2 111.156 -179.919 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -50.24 -26.25 4.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.453 . . . . 72.03 111.066 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 43.6 mttm -117.02 -166.59 1.19 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 73.01 110.872 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 18.8 t -114.26 37.28 3.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 75.12 110.891 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 7.5 ptp85 -168.32 175.01 6.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.112 -0.494 . . . . 73.11 110.867 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.527 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 1.7 m -80.45 142.18 14.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 53.11 111.131 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 7.9 t -91.13 -25.81 19.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.196 -0.456 . . . . 75.55 111.156 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 5.3 tp60 -139.31 133.25 30.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 61.3 110.968 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -125.23 130.54 52.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.178 -0.465 . . . . 71.15 110.878 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -136.07 138.2 41.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 73.15 110.891 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.7 ' HB3' HG22 ' A' ' 184' ' ' VAL . 6.5 t80 -133.26 144.58 49.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 72.14 110.857 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -149.97 137.04 19.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 73.35 111.119 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 21.7 t -121.11 140.53 44.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 72.12 111.127 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -115.24 126.36 7.14 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.736 -0.745 . . . . 71.02 112.51 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -128.43 121.59 29.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.924 0.392 . . . . 73.32 110.928 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 22.3 mtmm -103.39 133.33 48.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.112 -0.494 . . . . 62.23 110.917 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -127.05 165.26 19.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 73.43 111.121 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -38.96 -76.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 70.5 110.828 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -117.13 14.22 14.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 54.14 110.879 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -125.39 150.14 47.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.48 . . . . 74.04 110.889 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 46.2 mm-40 -129.34 124.88 35.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 74.35 110.863 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.601 HD23 HG13 ' A' ' 194' ' ' ILE . 3.0 tm? -122.71 124.49 43.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 61.14 110.893 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 76.4 m-70 -130.72 116.35 17.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.21 -0.45 . . . . 73.05 110.853 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.82 154.46 17.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 65.3 111.143 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -163.0 139.88 7.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.209 -0.451 . . . . 73.02 110.908 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.7 HG22 ' HB3' ' A' ' 169' ' ' PHE . 1.7 m -134.31 137.29 51.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 61.24 111.14 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -97.26 88.48 4.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 71.02 110.869 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 71.43 -174.84 0.17 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 72.41 110.925 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -79.47 3.04 69.39 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.75 -0.738 . . . . 51.13 112.469 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 30.5 p -106.36 -23.35 12.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.783 0.325 . . . . 71.1 111.162 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' GLU . . . . . 0.401 ' O ' ' HB ' ' A' ' 184' ' ' VAL . 1.2 tp10 -120.9 123.13 41.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.215 -0.448 . . . . 70.41 110.899 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 190' ' ' PHE . . . . . 0.568 ' HA ' ' HB ' ' A' ' 184' ' ' VAL . 0.5 OUTLIER -139.06 124.73 19.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 74.21 110.841 -179.884 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -165.1 -156.18 8.94 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.714 -0.755 . . . . 61.25 112.443 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -171.09 -168.56 32.96 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.742 -0.742 . . . . 42.03 112.487 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' SER . . . . . 0.537 ' CB ' ' HB1' ' A' ' 14' ' ' ALA . 39.0 t -147.78 145.52 28.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.837 0.351 . . . . 50.25 110.869 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.601 HG13 HD23 ' A' ' 180' ' ' LEU . 4.5 mp -120.68 133.36 67.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.113 -0.494 . . . . 73.32 111.112 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -117.68 121.18 40.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.192 -0.458 . . . . 74.22 110.932 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 46.0 mm-40 -121.03 131.64 54.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.087 -0.506 . . . . 64.42 110.916 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.413 ' HG2' HG23 ' A' ' 198' ' ' VAL . 23.3 ttpt -97.07 127.4 43.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.173 -0.467 . . . . 60.34 110.895 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.413 HG23 ' HG2' ' A' ' 197' ' ' LYS . 17.9 t 65.01 66.47 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 62.01 111.123 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -112.47 -36.03 5.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.176 -0.465 . . . . 72.3 110.932 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 31.0 tttm -119.77 -67.8 0.96 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 63.12 110.909 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.17 -38.08 1.42 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.209 -0.45 . . . . 74.0 110.892 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.584 HD22 ' H ' ' A' ' 226' ' ' GLN . 15.1 tp -146.1 -74.43 0.22 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.21 -0.45 . . . . 65.43 110.884 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -124.91 142.1 51.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 74.21 110.86 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 1.7 m -146.01 137.56 24.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 73.21 111.198 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.514 ' HB3' HG21 ' A' ' 17' ' ' VAL . . . -150.33 162.69 40.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.23 -0.441 . . . . 41.42 111.056 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 1.3 m -137.26 149.98 26.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.194 -0.457 . . . . 71.41 111.176 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -113.81 135.74 53.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 73.54 110.89 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.429 HD13 ' HA ' ' A' ' 208' ' ' LEU . 3.7 mm? -121.38 145.5 47.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.485 . . . . 75.41 110.906 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.631 ' HB3' ' HB2' ' A' ' 218' ' ' ARG . . . -153.32 138.18 17.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.203 -0.453 . . . . 72.31 111.112 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 9.4 t-105 -130.78 134.94 47.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.188 -0.46 . . . . 74.43 110.945 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 2.3 m -96.9 105.27 17.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.252 -0.431 . . . . 70.55 111.12 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -51.6 132.68 30.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.155 -0.475 . . . . 52.43 111.091 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 117.85 -74.96 0.29 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.766 -0.731 . . . . 73.3 112.446 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -179.95 106.93 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.831 0.348 . . . . 71.11 110.843 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 2.0 t -173.96 161.14 3.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.466 . . . . 55.04 110.845 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -63.61 154.85 31.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 73.1 110.904 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 3.7 m -80.95 133.91 35.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.164 -0.471 . . . . 62.53 111.151 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' ARG . . . . . 0.631 ' HB2' ' HB3' ' A' ' 209' ' ' ALA . 8.1 mmt85 -89.99 118.08 29.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.45 . . . . 73.43 110.844 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 219' ' ' PHE . . . . . 0.706 ' CE1' HD11 ' A' ' 221' ' ' ILE . 18.1 t80 -130.18 137.53 50.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.146 -0.479 . . . . 74.11 110.88 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -142.01 140.64 10.22 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.752 -0.737 . . . . 54.42 112.485 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.706 HD11 ' CE1' ' A' ' 219' ' ' PHE . 4.3 mp -120.53 131.39 72.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.825 0.345 . . . . 74.32 111.142 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.494 ' CB ' HG13 ' A' ' 17' ' ' VAL . . . -137.49 151.22 48.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 74.03 111.076 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -144.98 129.73 18.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 72.32 111.083 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 29.1 mtpt -102.52 125.25 49.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 52.02 110.914 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -124.28 117.76 25.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.254 -0.43 . . . . 73.23 110.91 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' GLN . . . . . 0.584 ' H ' HD22 ' A' ' 202' ' ' LEU . 23.1 tt0 -86.67 104.7 16.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.088 -0.506 . . . . 72.35 110.923 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 1.7 tt -82.68 -31.6 9.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 60.34 111.117 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -161.45 161.44 22.85 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.583 0.706 . . . . 72.34 110.867 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -6.96 19.85 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.664 2.242 . . . . 32.13 112.345 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -112.74 -25.38 9.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.246 -0.434 . . . . 63.31 110.861 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -137.62 145.08 42.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 72.13 111.085 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 25.5 m -136.85 143.14 42.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 75.4 110.915 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -117.73 134.24 55.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 65.45 110.861 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 22.8 t -135.47 152.15 51.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.122 -0.49 . . . . 72.14 110.854 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -139.51 146.27 39.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.087 -0.506 . . . . 71.53 111.129 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.52 159.01 32.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.261 -0.427 . . . . 73.32 110.852 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.624 HG12 ' HA ' ' A' ' 243' ' ' ILE . 1.6 m -141.73 163.97 19.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 53.22 111.097 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -112.89 147.81 36.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 70.44 110.864 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -49.15 -22.36 0.96 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.479 . . . . 73.23 110.854 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 32.2 t -80.99 13.59 2.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 73.21 110.87 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 1.2 t 69.65 40.1 1.43 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.118 -0.492 . . . . 51.34 110.895 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 242' ' ' LEU . . . . . 0.616 ' O ' HG12 ' A' ' 237' ' ' VAL . 2.1 mp -97.23 137.79 35.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.131 -0.486 . . . . 73.31 110.956 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.624 ' HA ' HG12 ' A' ' 237' ' ' VAL . 0.0 OUTLIER -107.15 117.34 52.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 71.1 111.143 179.85 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 244' ' ' GLY . . . . . 0.54 ' C ' HD13 ' A' ' 245' ' ' LEU . . . -139.07 148.47 20.02 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.724 -0.75 . . . . 63.33 112.484 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.732 ' CD2' ' HB3' ' A' ' 261' ' ' ALA . 0.0 OUTLIER -146.65 160.86 41.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.849 0.356 . . . . 74.32 110.939 -179.929 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -134.62 147.95 19.33 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.765 -0.731 . . . . 55.41 112.508 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -127.77 116.94 20.98 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.988 0.423 . . . . 74.42 110.911 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.459 HG23 ' O ' ' A' ' 257' ' ' LEU . 7.5 m -101.78 137.36 40.19 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.08 -0.509 . . . . 71.33 111.079 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 249' ' ' GLN . . . . . 0.7 ' CB ' HD23 ' A' ' 257' ' ' LEU . 1.0 OUTLIER -137.25 165.94 24.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 73.52 110.903 179.971 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 250' ' ' THR . . . . . 0.447 ' O ' ' CB ' ' A' ' 251' ' ' LEU . 23.5 m 65.88 -104.76 0.1 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.45 . . . . 72.22 111.095 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.676 ' O ' HD12 ' A' ' 251' ' ' LEU . 0.2 OUTLIER 79.17 -9.17 1.53 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 53.43 110.91 -179.993 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 252' ' ' LYS . . . . . 0.54 ' CB ' ' HD2' ' A' ' 253' ' ' PRO . 4.5 mttm -48.01 171.88 0.08 OUTLIER Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.6 0.714 . . . . 74.02 110.899 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 253' ' ' PRO . . . . . 0.54 ' HD2' ' CB ' ' A' ' 252' ' ' LYS . 54.0 Cg_endo -69.79 58.33 1.56 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.66 2.24 . . . . 64.13 112.34 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -165.87 -62.7 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.7 -0.762 . . . . 35.32 112.485 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -140.95 139.28 34.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.908 0.385 . . . . 64.21 111.141 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.521 ' O ' ' HA ' ' A' ' 279' ' ' LEU . 7.0 tttt -110.16 127.01 54.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 72.52 110.857 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 0.715 ' CD1' HD21 ' A' ' 277' ' ' LEU . 25.0 tp -88.85 122.78 32.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.175 -0.466 . . . . 64.02 110.889 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 258' ' ' THR . . . . . 0.405 ' O ' HD22 ' A' ' 277' ' ' LEU . 4.8 m -126.54 110.14 12.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 71.13 111.148 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 1.088 HD22 HD23 ' A' ' 277' ' ' LEU . 0.0 OUTLIER -103.4 134.01 47.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.196 -0.456 . . . . 55.12 110.913 179.957 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 24.8 p -128.9 140.64 51.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 63.51 110.892 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 261' ' ' ALA . . . . . 0.732 ' HB3' ' CD2' ' A' ' 245' ' ' LEU . . . -147.24 126.09 12.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.484 . . . . 72.34 111.094 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.786 ' C ' HD13 ' A' ' 263' ' ' LEU . 3.2 tm? -131.91 122.96 26.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.458 . . . . 74.42 110.887 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 263' ' ' LEU . . . . . 0.786 HD13 ' C ' ' A' ' 262' ' ' LEU . 0.1 OUTLIER -121.56 109.81 15.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.15 -0.477 . . . . 75.53 110.912 179.867 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 264' ' ' ASP . . . . . 0.673 ' O ' HG22 ' A' ' 268' ' ' VAL . 0.1 OUTLIER -87.19 109.41 19.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 71.4 110.916 179.809 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -56.24 -20.5 29.04 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.743 -0.741 . . . . 71.04 112.488 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.94 -3.54 48.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.799 0.333 . . . . 73.41 110.924 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -123.73 -57.62 1.62 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 73.21 110.886 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 268' ' ' VAL . . . . . 0.71 HG12 ' O ' ' A' ' 272' ' ' GLY . 16.7 m -48.11 -28.24 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 71.01 111.112 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -53.26 -45.77 68.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 60.01 110.929 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -106.14 -16.92 14.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 64.11 111.127 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -108.06 -123.35 4.9 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.719 -0.753 . . . . 43.05 112.474 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 272' ' ' GLY . . . . . 0.71 ' O ' HG12 ' A' ' 268' ' ' VAL . . . -146.47 -163.02 10.15 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.693 -0.765 . . . . 64.44 112.466 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 273' ' ' HIS . . . . . 0.61 ' CB ' HD12 ' A' ' 263' ' ' LEU . 5.6 p80 -105.35 146.26 29.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.83 0.348 . . . . 75.22 110.884 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 12.4 mtpp -104.28 135.68 45.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.228 -0.442 . . . . 73.01 110.887 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.462 HD12 ' HB2' ' A' ' 261' ' ' ALA . 1.3 tp -137.09 148.18 46.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 72.13 110.944 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -144.37 110.56 0.57 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.726 -0.75 . . . . 71.13 112.493 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 1.088 HD23 HD22 ' A' ' 259' ' ' LEU . 3.2 tm? -117.06 139.3 50.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.82 0.343 . . . . 62.21 110.956 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 278' ' ' GLY . . . . . 0.597 ' H ' HD22 ' A' ' 277' ' ' LEU . . . -162.13 154.16 25.05 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.696 -0.764 . . . . 62.15 112.48 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.82 HD23 ' HB2' ' A' ' 29' ' ' LEU . 3.1 mm? -106.88 139.93 40.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.777 0.322 . . . . 71.11 110.865 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -89.1 126.23 35.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 73.41 110.879 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.781 ' HA ' ' HA ' ' A' ' 31' ' ' LEU . 15.1 p90 -74.98 71.18 2.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.145 -0.48 . . . . 70.25 110.884 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 67.5 mm-40 -125.07 102.02 7.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.48 . . . . 73.1 110.904 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.62 ' HB1' HD12 ' A' ' 284' ' ' LEU . . . -124.67 136.28 53.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 60.13 111.144 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.914 HD13 HG23 ' A' ' 33' ' ' THR . 4.2 mp 60.83 32.91 20.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 63.13 110.933 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.155 -0.475 . . . . 74.24 110.898 179.962 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 301' ' ' NAI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.782 0.325 . . . . 61.3 110.875 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -113.37 -174.03 2.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 64.15 111.023 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.45 HG23 ' HD2' ' A' ' 4' ' ' PRO . 7.1 p -164.3 133.7 2.95 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.662 0.744 . . . . 70.21 111.107 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.45 ' HD2' HG23 ' A' ' 3' ' ' VAL . 53.6 Cg_endo -69.7 167.97 22.81 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.671 2.247 . . . . 71.44 112.383 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 117.97 5.4 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.691 2.261 . . . . 75.43 112.344 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' THR . . . . . 1.066 HG22 HD21 ' A' ' 150' ' ' LEU . 0.2 OUTLIER -92.71 -32.75 14.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.203 -0.453 . . . . 74.22 111.136 -179.946 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.663 ' HB2' HG21 ' A' ' 143' ' ' VAL . 18.0 t80 -55.55 -29.82 59.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.246 -0.434 . . . . 70.33 110.953 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -72.95 -22.58 60.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.091 -0.504 . . . . 44.53 111.056 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -87.57 7.51 29.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.205 -0.452 . . . . 75.14 110.858 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.72 HD21 HG13 ' A' ' 143' ' ' VAL . 50.0 mt -69.22 -31.39 69.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 64.2 110.885 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -172.45 76.23 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.76 -0.733 . . . . 41.55 112.515 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.4 mmtp -69.25 -55.09 11.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.772 0.32 . . . . 54.15 110.87 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.91 -39.64 93.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.452 . . . . 74.34 110.852 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.403 ' HB2' ' HB2' ' A' ' 181' ' ' HIS . . . -58.91 -37.32 76.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.487 . . . . 71.32 111.098 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -59.76 -31.98 70.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 75.12 110.873 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 -57.47 -48.29 79.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 74.02 110.898 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 61.7 t -81.84 -33.07 11.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.461 . . . . 64.53 111.143 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -64.55 -32.43 74.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 75.43 110.83 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 52.4 m -48.6 114.92 1.07 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 73.25 111.163 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.3 mptt -85.03 -168.72 2.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 65.44 110.895 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 99.03 32.15 5.97 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.711 -0.757 . . . . 60.21 112.483 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -119.03 124.78 47.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.927 0.394 . . . . 75.42 110.926 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 62.56 65.85 2.92 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.81 -0.709 . . . . 74.43 112.472 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -102.43 -4.7 25.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.898 0.38 . . . . 74.3 110.911 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.37 13.6 77.14 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.702 -0.761 . . . . 31.03 112.515 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.591 ' C ' HD12 ' A' ' 27' ' ' ILE . 2.2 pp -145.02 -178.35 6.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.737 0.303 . . . . 64.31 110.92 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.591 HD12 ' C ' ' A' ' 26' ' ' LEU . 1.7 mp -119.6 122.41 68.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 75.32 111.137 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.84 117.04 18.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.135 -0.484 . . . . 62.33 110.886 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 1.01 HD13 ' O ' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -114.78 145.33 42.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.211 -0.449 . . . . 75.11 110.942 179.876 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.772 ' N ' HD22 ' A' ' 29' ' ' LEU . 1.3 m-20 -148.06 133.35 18.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.184 -0.462 . . . . 72.4 110.852 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.717 ' HA ' ' HA ' ' A' ' 281' ' ' PHE . 0.2 OUTLIER -127.1 127.79 45.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 73.21 110.87 -179.915 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.613 ' N ' ' HB2' ' A' ' 281' ' ' PHE . 33.5 ttpt -136.56 140.85 43.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 73.21 110.883 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.437 ' O ' HG23 ' A' ' 33' ' ' THR . 8.6 t -135.5 121.66 20.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 72.5 111.166 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.793 ' HG2' HD21 ' A' ' 284' ' ' LEU . 1.7 pttp -105.13 125.85 51.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.25 -0.432 . . . . 71.51 110.904 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.5 t -114.71 142.79 46.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 72.31 110.827 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -77.17 58.25 1.55 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 74.15 110.89 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -152.86 19.89 0.59 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.143 -0.481 . . . . 73.43 110.88 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.453 ' HA2' ' C ' ' A' ' 63' ' ' ARG . . . 81.01 -4.99 67.68 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.715 -0.755 . . . . 71.14 112.487 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.3 mp -98.42 128.23 44.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.769 0.319 . . . . 74.1 110.902 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -140.97 117.56 10.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 73.53 110.894 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -103.24 122.66 45.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 64.33 110.891 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 90.3 m -126.5 126.31 43.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.137 -0.483 . . . . 63.42 111.142 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.3 p -132.46 142.22 49.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 63.21 110.843 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 58.1 m -149.03 135.84 19.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 71.31 110.874 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -148.02 141.65 9.37 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.702 -0.761 . . . . 65.12 112.44 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 9.0 m -126.91 157.56 39.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.858 0.361 . . . . 70.41 110.887 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.595 ' HB1' HG22 ' A' ' 54' ' ' VAL . . . -157.11 131.14 8.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.152 -0.476 . . . . 71.42 111.09 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -101.53 141.99 33.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.446 . . . . 73.12 110.893 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 22.2 p -51.03 -34.47 29.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 55.35 111.105 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -51.34 168.24 0.07 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.188 -0.46 . . . . 63.24 110.876 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.2 t -73.05 136.26 44.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 74.12 111.162 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 66.9 p 47.06 71.6 0.31 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.259 -0.428 . . . . 60.31 111.112 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 18.6 mmtp -143.54 35.3 1.3 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.2 -0.455 . . . . 72.32 110.91 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.595 HG22 ' HB1' ' A' ' 47' ' ' ALA . 46.3 t -109.19 124.11 65.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 52.22 111.145 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.6 m -136.11 126.94 27.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 53.12 111.137 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -127.39 141.54 12.73 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.747 -0.74 . . . . 73.01 112.524 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 59.5 p -144.1 160.48 40.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.922 0.392 . . . . 74.14 110.882 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -132.55 150.18 52.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.143 -0.48 . . . . 74.11 110.894 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.408 ' HB3' ' HA ' ' A' ' 74' ' ' LYS . 1.1 pm0 -136.14 136.18 39.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 74.24 110.9 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.9 p -103.07 129.57 49.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.151 -0.477 . . . . 72.23 111.093 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.1 mtpm? -129.9 159.59 36.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 65.5 110.889 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -130.32 139.65 50.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.217 -0.447 . . . . 74.03 110.929 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.453 ' C ' ' HA2' ' A' ' 38' ' ' GLY . 0.5 OUTLIER -134.51 105.17 6.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.134 -0.484 . . . . 75.44 110.881 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -115.06 101.68 9.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.46 . . . . 72.14 110.952 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.7 t -83.37 -31.76 26.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 64.55 111.149 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -48.47 -34.16 10.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.2 -0.454 . . . . 73.21 110.904 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.557 ' CD1' HD23 ' A' ' 69' ' ' LEU . 29.7 t80 -118.02 -58.34 2.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.18 -0.464 . . . . 71.33 110.936 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.651 ' O ' HD22 ' A' ' 69' ' ' LEU . . . 129.34 58.17 0.1 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.778 -0.725 . . . . 63.15 112.516 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.651 HD22 ' O ' ' A' ' 68' ' ' GLY . 2.4 mm? -133.65 141.33 47.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.852 0.358 . . . . 62.44 110.891 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 95.6 m -135.57 130.4 34.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 64.01 111.141 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -119.23 134.82 54.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 73.41 110.875 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.534 HG23 ' HB2' ' A' ' 84' ' ' GLU . 0.6 OUTLIER -126.73 117.41 22.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.463 . . . . 73.21 111.152 -179.897 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -132.03 131.47 42.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.27 -0.423 . . . . 73.33 110.875 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.408 ' HA ' ' HB3' ' A' ' 59' ' ' GLU . 17.1 ptmt -117.66 135.86 53.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 74.33 110.931 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 12.7 t90 -135.48 128.46 31.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.213 -0.449 . . . . 75.12 110.925 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -120.52 159.52 25.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 70.25 110.872 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 10.5 t -66.79 -13.37 61.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.157 -0.474 . . . . 63.34 111.108 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.443 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 94.9 m-20 -74.92 1.23 13.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.254 -0.43 . . . . 71.41 110.894 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.443 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 2.9 m120 78.72 33.19 0.28 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 75.34 110.91 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 33.3 m -114.89 123.4 49.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.145 -0.48 . . . . 63.24 111.119 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -122.05 119.62 31.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 73.31 110.897 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.76 111.72 3.74 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.731 -0.747 . . . . 60.24 112.473 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.0 t -93.03 120.69 33.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.795 0.331 . . . . 43.11 111.119 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.534 ' HB2' HG23 ' A' ' 72' ' ' THR . 26.8 mt-10 -134.06 126.69 30.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.45 . . . . 65.03 110.871 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.406 HG22 ' HB3' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -115.4 138.46 45.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.163 -0.472 . . . . 53.4 111.157 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 99.8 m -129.51 137.72 50.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.202 -0.453 . . . . 70.32 111.126 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.456 ' HB ' HD23 ' A' ' 97' ' ' LEU . 1.8 t -118.14 137.28 52.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.44 . . . . 72.34 111.149 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -113.71 118.32 33.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 75.34 110.901 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 50.88 74.77 0.21 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.462 . . . . 73.13 110.901 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -96.7 -75.59 0.53 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 74.12 110.885 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 40.9 tp -92.24 -72.37 0.6 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.21 -0.45 . . . . 62.44 110.916 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.571 ' HB3' ' HB2' ' A' ' 95' ' ' LEU . . . -77.53 139.7 39.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 51.34 111.122 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 2.6 ptt180 -60.08 125.09 22.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 74.33 110.868 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 78.73 8.94 87.48 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.756 -0.735 . . . . 44.35 112.502 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.571 ' HB2' ' HB3' ' A' ' 92' ' ' ALA . 13.8 tp -79.32 134.18 36.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.876 0.37 . . . . 62.21 110.928 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.9 ptmt -121.38 127.51 51.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 64.34 110.905 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.458 HD22 ' N ' ' A' ' 97' ' ' LEU . 1.7 mm? -115.03 129.2 56.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.223 -0.444 . . . . 65.05 110.9 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 69.0 m -129.55 119.87 24.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 65.23 111.19 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.406 ' HB3' HG22 ' A' ' 85' ' ' ILE . 3.1 t80 -122.28 128.71 51.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 65.32 110.858 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -127.84 130.48 48.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.128 -0.487 . . . . 40.11 110.831 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.7 t -142.3 125.93 16.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 73.2 110.88 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.1 t -97.87 131.71 44.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 70.12 110.849 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -129.54 119.69 24.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.106 -0.497 . . . . 74.53 110.878 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -128.83 101.9 19.91 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.661 0.743 . . . . 65.04 110.832 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -37.81 8.58 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.703 2.268 . . . . 74.51 112.334 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -61.57 -75.01 0.07 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 73.53 110.865 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -63.85 -39.0 93.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 51.32 111.153 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.14 24.42 14.79 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.739 -0.744 . . . . 74.55 112.473 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 64.2 mmtt -94.07 148.15 22.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.864 0.364 . . . . 71.03 110.863 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -140.61 135.5 31.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 75.34 110.842 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -121.59 140.84 51.73 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.199 -0.455 . . . . 72.21 110.912 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -127.77 118.02 22.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 72.14 111.077 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 21.3 ttmm -138.45 137.5 37.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 64.44 110.895 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 6.0 tp -134.55 126.73 48.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 73.15 111.154 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -127.45 120.39 28.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 74.43 110.868 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 70.2 p -129.06 127.88 42.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.211 -0.45 . . . . 62.54 111.083 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -150.42 162.39 29.26 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.676 -0.773 . . . . 63.5 112.481 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 6.6 p90 -127.44 141.19 51.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.953 0.406 . . . . 74.34 110.898 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.43 ' NZ ' HD22 ' A' ' 124' ' ' ASN . 5.3 mmmt -110.15 122.71 48.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.075 -0.511 . . . . 72.41 110.908 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.1 mmt85 -106.28 145.29 31.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.273 -0.421 . . . . 71.42 110.865 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -49.67 -28.51 6.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 74.03 110.927 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 7.8 m170 -87.11 -45.33 10.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 73.41 110.853 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.429 HG21 HD23 ' A' ' 144' ' ' LEU . 11.8 pt -152.34 153.86 8.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 42.11 111.119 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.43 HD22 ' NZ ' ' A' ' 119' ' ' LYS . 17.6 p-10 -117.98 116.61 27.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.468 . . . . 44.41 110.907 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.671 ' HB3' HD13 ' A' ' 142' ' ' LEU . 0.4 OUTLIER -131.46 141.93 49.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 73.55 110.932 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -147.9 149.01 21.03 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.743 -0.741 . . . . 54.02 112.483 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 31.0 p -112.83 134.72 54.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.827 0.346 . . . . 62.41 110.896 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -117.35 150.8 38.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 73.11 110.857 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 43.2 ttm -135.98 135.98 39.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 74.35 110.851 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -122.53 128.09 50.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 72.43 110.842 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -95.55 97.69 9.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.456 . . . . 71.14 110.888 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -92.05 175.75 6.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 72.33 110.877 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.42 HD12 ' N ' ' A' ' 134' ' ' ALA . 2.5 pp -73.92 -37.51 47.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.262 -0.426 . . . . 63.4 111.089 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.42 ' N ' HD12 ' A' ' 133' ' ' ILE . . . -78.39 -20.43 51.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 74.24 111.081 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 155.22 150.7 5.64 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.778 -0.725 . . . . 65.44 112.483 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 107.92 1.97 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.697 2.265 . . . . 62.31 112.349 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.65 152.79 29.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.247 -0.433 . . . . 63.43 110.909 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.416 HD12 ' N ' ' A' ' 138' ' ' ILE . 5.0 mp -106.16 132.33 53.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.455 . . . . 74.12 111.14 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 12.3 ttm180 -122.58 133.48 54.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 61.11 110.865 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -127.61 133.3 7.81 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.753 -0.737 . . . . 65.01 112.502 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -140.65 116.07 10.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.824 0.345 . . . . 45.3 111.12 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.697 HD12 ' N ' ' A' ' 143' ' ' VAL . 3.2 tp -129.1 133.79 47.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 64.3 110.89 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.72 HG13 HD21 ' A' ' 10' ' ' LEU . 61.7 t -128.44 120.97 54.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 70.41 111.146 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.558 HD11 HD21 ' A' ' 142' ' ' LEU . 4.4 mp -114.72 139.94 49.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 72.44 110.925 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -129.51 124.62 4.53 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.772 -0.728 . . . . 62.14 112.533 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -144.93 146.62 32.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.817 0.341 . . . . 53.23 110.922 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 50.29 30.75 4.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.475 . . . . 71.25 110.896 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 85.9 -28.71 4.89 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.727 -0.749 . . . . 61.23 112.522 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 29.9 m0 -69.31 134.83 49.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.833 0.349 . . . . 64.33 110.938 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 1.066 HD21 HG22 ' A' ' 6' ' ' THR . 0.0 OUTLIER -108.5 137.81 45.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.256 -0.429 . . . . 43.34 110.892 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -135.96 126.12 26.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 73.43 111.073 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -132.15 146.34 18.01 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.743 -0.742 . . . . 21.53 112.477 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -143.49 119.26 10.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.783 0.325 . . . . 70.52 110.914 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -122.53 120.67 34.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 74.31 110.886 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 4.0 ptt? -148.13 143.52 27.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.251 -0.431 . . . . 71.42 110.882 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -113.64 131.54 56.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 74.44 110.87 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.505 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 9.8 m-85 -93.28 138.89 31.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 61.04 110.858 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.512 ' CG ' ' O ' ' A' ' 158' ' ' GLU . 5.2 pt-20 -76.4 117.32 17.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.105 -0.498 . . . . 74.42 110.876 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 9.8 t -67.23 -31.69 72.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.141 -0.482 . . . . 72.24 111.135 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -47.9 -23.92 0.89 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.215 -0.448 . . . . 64.42 111.129 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.99 -157.65 0.36 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.449 . . . . 74.31 110.9 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 54.1 m -99.51 40.82 1.19 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 42.21 110.858 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.45 173.42 7.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 75.2 110.923 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.505 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 2.5 t -105.82 141.04 22.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.444 . . . . 74.31 111.117 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -88.7 -37.26 15.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.131 -0.486 . . . . 62.31 111.149 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -155.8 131.87 10.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 64.43 110.882 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 2.2 p -127.05 109.63 12.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 71.25 110.878 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -130.87 142.33 50.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 65.23 110.88 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -132.39 156.57 46.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.194 -0.457 . . . . 74.23 110.861 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -154.89 129.89 9.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.117 -0.492 . . . . 75.4 111.081 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 41.2 t -126.86 134.12 66.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 74.45 111.136 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -107.93 124.07 7.38 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.741 -0.743 . . . . 75.5 112.464 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -113.97 122.36 46.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.978 0.418 . . . . 63.22 110.869 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -102.89 133.53 47.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.08 -0.509 . . . . 73.3 110.915 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.59 165.22 21.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 41.31 111.13 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -40.27 -75.38 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 63.21 110.898 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -116.66 14.91 15.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.214 -0.448 . . . . 74.33 110.889 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -126.16 149.55 48.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.131 -0.486 . . . . 63.42 110.863 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -133.26 124.44 27.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.115 -0.493 . . . . 73.34 110.922 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.594 HD23 HG13 ' A' ' 194' ' ' ILE . 2.6 tm? -123.55 126.09 46.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 73.33 110.907 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' HIS . . . . . 0.52 ' N ' HD22 ' A' ' 180' ' ' LEU . 51.1 m-70 -130.59 114.86 15.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.446 . . . . 71.05 110.875 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 2.1 t -106.51 151.05 25.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.269 -0.423 . . . . 72.34 111.167 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -162.38 136.95 6.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 62.11 110.879 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.764 HG13 ' HB3' ' A' ' 190' ' ' PHE . 2.3 t -123.68 127.79 74.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.483 . . . . 72.4 111.129 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -120.69 83.03 2.0 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 75.4 110.887 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -48.25 -20.13 0.35 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 75.13 110.868 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -74.89 -33.08 56.04 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.793 -0.718 . . . . 70.03 112.49 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 69.0 p -123.48 -55.37 1.74 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.718 0.294 . . . . 53.13 111.135 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' GLU . . . . . 0.689 ' HG3' ' HB1' ' A' ' 209' ' ' ALA . 0.9 OUTLIER -165.87 152.98 10.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 72.3 110.901 179.998 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 190' ' ' PHE . . . . . 0.764 ' HB3' HG13 ' A' ' 184' ' ' VAL . 10.0 p90 -114.45 125.16 53.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 70.42 110.884 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -175.72 -132.36 1.59 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.745 -0.741 . . . . 74.42 112.489 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -176.4 -165.92 32.81 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.77 -0.729 . . . . 72.13 112.491 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -149.33 150.33 32.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.803 0.335 . . . . 52.53 110.9 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.594 HG13 HD23 ' A' ' 180' ' ' LEU . 4.2 mp -120.62 143.02 33.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 74.5 111.158 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -127.74 121.3 29.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.178 -0.465 . . . . 72.42 110.942 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 6.1 tm0? -124.57 130.43 52.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 75.11 110.963 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 20.5 tttt -107.12 127.77 53.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 72.54 110.876 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 98.5 t -74.34 -74.62 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 72.22 111.083 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -170.82 65.32 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 73.23 110.909 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? 48.29 33.47 3.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.143 -0.481 . . . . 61.11 110.915 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 6.2 ttmm -140.98 -43.74 0.38 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 74.11 110.881 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 6.1 mp -131.05 128.47 40.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.237 -0.438 . . . . 75.05 110.902 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -114.88 131.2 56.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 74.24 110.908 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 21.7 m -124.06 138.58 54.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.186 -0.461 . . . . 72.12 111.145 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -141.5 137.93 32.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.434 . . . . 71.1 111.139 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.91 HG22 HG22 ' A' ' 221' ' ' ILE . 30.3 t -112.93 140.69 31.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 63.01 111.079 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 207' ' ' ASN . . . . . 0.621 ' O ' HD22 ' A' ' 208' ' ' LEU . 3.5 m120 -114.95 134.22 55.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.475 . . . . 60.52 110.881 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.621 HD22 ' O ' ' A' ' 207' ' ' ASN . 2.8 mm? -134.16 130.71 37.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 72.33 110.925 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.689 ' HB1' ' HG3' ' A' ' 189' ' ' GLU . . . -156.42 132.11 9.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 53.12 111.083 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 210' ' ' TRP . . . . . 0.563 ' CE3' HG23 ' A' ' 217' ' ' THR . 3.8 t-105 -110.66 135.01 51.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.208 -0.451 . . . . 64.21 110.964 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 211' ' ' THR . . . . . 0.436 HG23 ' O ' ' A' ' 211' ' ' THR . 3.3 t -93.39 111.36 23.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.253 -0.43 . . . . 53.44 111.092 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -51.11 136.81 23.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 60.24 111.076 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 117.36 -83.98 0.36 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.765 -0.731 . . . . 71.12 112.541 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -79.37 179.11 7.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.854 0.359 . . . . 65.23 110.864 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 9.7 p -103.36 36.43 2.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 72.12 110.867 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 35.0 m120 -102.09 125.2 48.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 70.33 110.874 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' THR . . . . . 0.563 HG23 ' CE3' ' A' ' 210' ' ' TRP . 0.6 OUTLIER -105.34 137.6 42.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 60.11 111.141 -179.955 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 -97.62 117.66 32.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.258 -0.428 . . . . 72.31 110.837 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -128.34 132.11 48.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 73.22 110.874 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -145.2 160.99 28.15 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.735 -0.745 . . . . 73.15 112.474 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.91 HG22 HG22 ' A' ' 206' ' ' VAL . 0.0 OUTLIER -138.89 130.51 35.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.807 0.337 . . . . 74.52 111.104 -179.947 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -126.84 130.83 50.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 74.0 111.114 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -119.2 130.81 55.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.257 -0.429 . . . . 73.41 111.104 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -106.76 128.47 54.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.436 . . . . 73.52 110.872 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -127.07 117.67 22.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 74.53 110.934 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -84.7 123.91 30.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 71.14 110.942 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.517 HD12 ' CD2' ' A' ' 233' ' ' PHE . 64.6 mt -108.9 -33.56 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.446 . . . . 72.33 111.157 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -143.42 161.22 48.37 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.583 0.706 . . . . 71.15 110.918 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -19.32 36.22 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.738 2.292 . . . . 73.25 112.31 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -109.78 -27.06 9.51 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.224 -0.443 . . . . 53.3 110.893 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -124.6 141.95 51.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.469 . . . . 63.04 111.124 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 57.6 m -139.31 142.58 37.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.196 -0.456 . . . . 73.1 110.862 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 233' ' ' PHE . . . . . 0.517 ' CD2' HD12 ' A' ' 227' ' ' ILE . 2.5 m-85 -98.79 133.11 43.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.175 -0.466 . . . . 73.53 110.89 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 24.6 p -135.09 128.31 31.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 71.1 110.843 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -128.98 158.45 38.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 54.2 111.093 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.52 164.27 36.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 64.34 110.913 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 242' ' ' LEU . 10.0 p -154.86 143.19 13.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 74.13 111.148 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -102.52 148.47 25.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 75.43 110.869 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 14.1 t30 -54.09 -21.68 9.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 74.41 110.901 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 46.4 t -80.84 25.76 0.44 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.45 . . . . 64.34 110.843 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 1.9 m 59.2 39.29 22.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 62.54 110.926 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 242' ' ' LEU . . . . . 0.692 HD22 ' HB3' ' A' ' 264' ' ' ASP . 22.6 mt -99.4 118.11 35.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.093 -0.503 . . . . 63.32 110.915 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.437 ' H ' HD12 ' A' ' 243' ' ' ILE . 5.4 mp -84.62 125.92 40.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.172 -0.467 . . . . 75.43 111.102 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -128.21 132.81 7.49 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.771 -0.728 . . . . 73.21 112.496 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.422 ' CD1' ' HB3' ' A' ' 261' ' ' ALA . 1.3 pp -146.14 140.88 26.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.882 0.372 . . . . 61.43 110.902 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -153.13 150.32 22.05 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.677 -0.773 . . . . 71.21 112.445 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -128.39 132.19 48.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.943 0.401 . . . . 74.11 110.947 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.02 123.94 50.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 60.44 111.131 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -143.09 129.59 20.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 75.34 110.873 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 250' ' ' THR . . . . . 0.41 HG23 ' HG2' ' A' ' 256' ' ' LYS . 3.1 m -80.62 142.31 34.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.222 -0.444 . . . . 65.24 111.174 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.662 HD23 ' HD2' ' A' ' 253' ' ' PRO . 7.6 tp -72.84 -70.74 0.34 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 74.33 110.888 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 252' ' ' LYS . . . . . 0.5 ' N ' ' HD2' ' A' ' 253' ' ' PRO . 16.9 ttpt 178.35 -59.45 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.6 0.714 . . . . 71.4 110.926 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 253' ' ' PRO . . . . . 0.662 ' HD2' HD23 ' A' ' 251' ' ' LEU . 54.0 Cg_endo -69.74 -86.64 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.705 2.27 . . . . 64.21 112.342 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -145.72 16.58 1.8 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.734 -0.746 . . . . 71.01 112.484 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.414 HG12 HD23 ' A' ' 31' ' ' LEU . 3.7 mt -105.32 118.07 52.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.882 0.372 . . . . 75.53 111.094 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.55 ' O ' ' HA ' ' A' ' 279' ' ' LEU . 0.0 OUTLIER -99.09 135.06 41.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 75.11 110.88 179.856 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 0.527 ' CD2' HD21 ' A' ' 277' ' ' LEU . 0.3 OUTLIER -94.08 124.02 37.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.464 . . . . 74.13 110.887 179.949 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 27.5 p -128.15 111.68 13.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.448 . . . . 75.21 111.121 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.907 HD22 HD23 ' A' ' 277' ' ' LEU . 0.1 OUTLIER -109.9 126.24 53.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.242 -0.435 . . . . 72.04 110.928 179.901 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.452 ' N ' HD13 ' A' ' 259' ' ' LEU . 4.1 m -126.49 140.86 52.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 74.25 110.839 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 261' ' ' ALA . . . . . 0.422 ' HB3' ' CD1' ' A' ' 245' ' ' LEU . . . -144.21 128.52 17.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.121 -0.491 . . . . 61.31 111.116 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.731 HD21 ' H6N' ' A' ' 301' ' ' NAI . 0.7 OUTLIER -121.66 120.77 35.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.446 . . . . 63.43 110.913 -179.939 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 263' ' ' LEU . . . . . 0.693 HD13 ' C ' ' A' ' 262' ' ' LEU . 0.2 OUTLIER -119.95 109.77 15.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.446 . . . . 73.31 110.887 179.913 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 264' ' ' ASP . . . . . 0.692 ' HB3' HD22 ' A' ' 242' ' ' LEU . 3.0 p30 -90.95 115.78 28.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.454 . . . . 64.22 110.853 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 265' ' ' GLY . . . . . 0.425 ' HA2' HG22 ' A' ' 268' ' ' VAL . . . -55.45 -18.38 15.04 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.704 -0.76 . . . . 43.22 112.5 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 6.4 ttpp -79.09 -25.99 43.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.836 0.35 . . . . 73.2 110.942 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -109.59 -54.46 2.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 72.13 110.916 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 268' ' ' VAL . . . . . 0.644 HG22 ' O ' ' A' ' 264' ' ' ASP . 13.8 m -51.04 -29.03 7.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.48 . . . . 64.52 111.109 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -52.43 -35.12 51.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 73.34 110.901 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -103.67 -17.44 15.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.123 -0.489 . . . . 71.23 111.074 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 125.7 98.58 1.14 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.721 -0.752 . . . . 43.24 112.498 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 272' ' ' GLY . . . . . 0.405 ' O ' HG12 ' A' ' 268' ' ' VAL . . . 168.2 93.13 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.716 -0.754 . . . . 71.52 112.465 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 273' ' ' HIS . . . . . 0.499 ' CB ' HD12 ' A' ' 263' ' ' LEU . 9.6 p80 -113.43 144.5 42.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.877 0.37 . . . . 74.24 110.859 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 43.5 mmtm -101.12 136.85 40.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 73.22 110.874 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.729 HD13 ' N ' ' A' ' 276' ' ' GLY . 2.2 tm? -135.85 137.71 41.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.476 . . . . 73.52 110.89 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 276' ' ' GLY . . . . . 0.729 ' N ' HD13 ' A' ' 275' ' ' LEU . . . -139.56 136.37 7.81 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.721 -0.752 . . . . 73.22 112.464 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.907 HD23 HD22 ' A' ' 259' ' ' LEU . 3.1 tm? -132.52 138.2 47.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.898 0.38 . . . . 74.33 110.9 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 278' ' ' GLY . . . . . 0.588 ' H ' HD22 ' A' ' 277' ' ' LEU . . . -160.67 161.01 32.41 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.761 -0.733 . . . . 75.04 112.455 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.74 HD23 ' HB2' ' A' ' 29' ' ' LEU . 2.9 mm? -113.93 143.37 44.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.815 0.34 . . . . 75.13 110.937 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 280' ' ' GLU . . . . . 0.421 ' HB2' ' HB3' ' A' ' 256' ' ' LYS . 0.9 OUTLIER -91.37 130.1 37.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 75.3 110.87 179.994 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.717 ' HA ' ' HA ' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -76.33 60.26 1.52 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 71.32 110.89 -179.941 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -109.38 97.74 7.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.133 -0.485 . . . . 72.25 110.875 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.478 ' HB2' HD11 ' A' ' 31' ' ' LEU . . . -128.65 110.93 12.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.212 -0.449 . . . . 65.53 111.117 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.793 HD21 ' HG2' ' A' ' 34' ' ' LYS . 94.6 mt -152.15 178.38 9.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 63.44 110.923 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 42.2 tp10 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 71.15 110.864 179.941 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 301' ' ' NAI . . . . . 0.731 ' H6N' HD21 ' A' ' 262' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.7 mmt . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.791 0.329 . . . . 62.11 110.862 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.91 -63.23 1.27 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.258 -0.428 . . . . 61.52 111.07 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.724 HG13 ' HA ' ' A' ' 121' ' ' GLU . 0.0 OUTLIER -134.87 158.46 74.93 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.633 0.73 . . . . 75.51 111.124 179.997 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.85 170.25 17.11 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.688 2.259 . . . . 74.12 112.321 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 77.74 1.06 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.643 2.229 . . . . 64.32 112.36 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.561 HG22 HD11 ' A' ' 150' ' ' LEU . 2.6 p -70.37 -45.75 65.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 74.44 111.132 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 91.2 t80 -52.46 -32.38 39.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 75.05 110.901 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -82.18 -26.53 33.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 72.15 111.116 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -74.21 -12.86 60.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 72.23 110.843 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.427 HD21 ' O ' ' A' ' 152' ' ' GLY . 0.7 OUTLIER -56.42 -34.42 66.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 73.21 110.896 -179.961 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 142.45 64.77 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.762 -0.732 . . . . 52.32 112.529 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.6 ttpp -69.35 -42.12 75.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.801 0.334 . . . . 74.24 110.873 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.6 t -63.65 -39.35 94.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.207 -0.451 . . . . 64.15 110.901 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.8 -37.93 74.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.074 -0.512 . . . . 74.11 111.112 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 3.1 tmt_? -60.77 -33.12 72.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.444 . . . . 73.13 110.858 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.638 ' O ' HG23 ' A' ' 19' ' ' THR . 4.7 t0 -58.46 -40.0 81.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.45 . . . . 70.22 110.834 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.6 t -58.91 -39.42 77.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 73.32 111.113 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -60.54 -41.07 93.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.481 . . . . 45.11 110.866 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.638 HG23 ' O ' ' A' ' 16' ' ' ASP . 1.1 p 46.75 69.2 0.51 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 64.3 111.191 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 16.0 tptm -69.24 112.48 5.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 61.1 110.921 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 63.5 99.44 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.737 -0.744 . . . . 62.35 112.476 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -172.9 129.36 0.49 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.945 0.402 . . . . 74.15 110.908 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.52 40.84 3.09 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.784 -0.722 . . . . 73.12 112.501 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -103.18 13.01 34.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.911 0.386 . . . . 65.42 110.892 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 80.79 15.44 77.66 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.773 -0.727 . . . . 65.04 112.46 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.507 ' C ' HD13 ' A' ' 27' ' ' ILE . 0.1 OUTLIER -105.89 168.74 8.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.799 0.333 . . . . 61.11 110.917 -179.93 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.734 HG23 HD12 ' A' ' 277' ' ' LEU . 2.8 mm -120.2 123.42 70.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.234 -0.439 . . . . 72.43 111.089 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.6 ttmt -115.2 118.15 32.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.465 . . . . 75.23 110.921 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.617 HD12 ' CB ' ' A' ' 279' ' ' LEU . 1.0 OUTLIER -114.68 142.99 45.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 63.41 110.915 179.955 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -147.82 128.62 14.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 71.21 110.851 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.686 HD13 ' HB3' ' A' ' 281' ' ' PHE . 5.7 tp -127.2 128.78 46.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 71.14 110.908 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.673 ' N ' HD12 ' A' ' 31' ' ' LEU . 2.0 pttm -124.83 125.48 44.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 71.23 110.887 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.479 HG22 ' HB2' ' A' ' 283' ' ' ALA . 6.6 p -135.2 120.8 19.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.199 -0.455 . . . . 60.34 111.158 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.581 ' O ' HD21 ' A' ' 284' ' ' LEU . 53.1 mttm -118.75 129.99 55.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 74.25 110.91 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.2 t -116.14 138.29 51.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 73.23 110.87 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -77.41 59.25 1.83 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.157 -0.474 . . . . 74.02 110.889 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -160.51 25.27 0.15 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 73.35 110.805 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.51 ' HA2' ' O ' ' A' ' 63' ' ' ARG . . . 79.7 -4.11 66.31 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.737 -0.744 . . . . 43.14 112.526 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.5 mp -98.23 126.11 43.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.782 0.325 . . . . 64.21 110.897 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.1 118.39 10.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.172 -0.467 . . . . 62.11 110.861 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -103.71 124.15 48.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.152 -0.476 . . . . 73.42 110.883 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.11 115.5 19.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 73.43 111.124 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.42 138.12 53.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 63.35 110.863 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 27.0 m -150.6 126.96 10.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 71.34 110.905 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -164.53 166.43 37.89 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.726 -0.749 . . . . 60.0 112.489 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 60.3 m -138.03 168.62 19.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.877 0.37 . . . . 71.22 110.878 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.426 ' HB1' HG12 ' A' ' 54' ' ' VAL . . . -134.13 139.52 45.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.126 -0.488 . . . . 74.41 111.096 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -113.41 141.43 47.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 65.41 110.919 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.421 HG22 ' H ' ' A' ' 50' ' ' GLU . 0.2 OUTLIER 64.07 169.53 0.17 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 64.15 111.109 -179.986 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.421 ' H ' HG22 ' A' ' 49' ' ' THR . 0.0 OUTLIER -74.28 94.52 2.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.462 . . . . 70.13 110.863 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 61.5 p 45.98 84.01 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.127 -0.488 . . . . 65.32 111.134 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.7 m -151.5 -59.66 0.17 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.237 -0.438 . . . . 73.44 111.196 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 18.0 mmtp -142.33 113.69 7.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 75.21 110.897 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.426 HG12 ' HB1' ' A' ' 47' ' ' ALA . 1.0 OUTLIER -125.55 147.54 30.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 75.33 111.142 179.836 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.2 p -110.32 126.57 54.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 51.54 111.13 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -118.76 143.63 17.55 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.72 -0.753 . . . . 60.53 112.503 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.85 142.51 50.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.968 0.413 . . . . 61.44 110.851 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.661 HD13 ' N ' ' A' ' 59' ' ' GLU . 0.8 OUTLIER -120.86 132.85 55.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 70.35 110.948 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.661 ' N ' HD13 ' A' ' 58' ' ' LEU . 3.4 tt0 -134.0 124.65 26.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 71.51 110.889 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 27.0 m -104.77 130.35 52.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 62.22 111.146 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 8.5 ttpt -132.48 156.93 45.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.239 -0.437 . . . . 71.13 110.919 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.564 ' O ' HG23 ' A' ' 70' ' ' THR . 26.0 m-85 -129.06 140.68 51.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.282 -0.417 . . . . 73.53 110.939 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.51 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 27.9 ttp85 -127.99 105.37 8.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 71.15 110.894 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.414 ' HB3' ' HG2' ' A' ' 66' ' ' GLU . 5.6 m-90 -113.19 134.33 54.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 63.11 110.935 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 30.3 p -69.82 -27.17 64.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.275 -0.42 . . . . 75.21 111.122 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.414 ' HG2' ' HB3' ' A' ' 64' ' ' TRP . 1.9 pt-20 -52.51 102.53 0.05 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.211 -0.45 . . . . 74.33 110.889 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.447 ' CD2' HD21 ' A' ' 69' ' ' LEU . 7.3 t80 65.33 9.77 5.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.149 -0.478 . . . . 75.03 110.902 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.597 ' O ' HD23 ' A' ' 69' ' ' LEU . . . 57.33 70.27 1.03 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.77 -0.729 . . . . 74.1 112.491 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.597 HD23 ' O ' ' A' ' 68' ' ' GLY . 5.7 mt -119.15 137.21 53.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.859 0.361 . . . . 65.3 110.9 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.564 HG23 ' O ' ' A' ' 62' ' ' TYR . 27.7 m -136.24 127.84 28.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 72.51 111.163 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.569 ' HB3' HG22 ' A' ' 85' ' ' ILE . 4.3 m-85 -121.79 121.62 37.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 71.32 110.86 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 61' ' ' LYS . 14.4 t -119.87 136.22 54.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 62.15 111.133 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -131.06 122.82 27.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 70.22 110.88 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.9 ptmt -95.51 135.99 36.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 74.42 110.91 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 8.7 t90 -134.81 128.84 33.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.246 -0.434 . . . . 74.2 110.926 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -117.85 154.93 31.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 62.14 110.878 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 7.3 t -62.48 -16.47 55.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.127 -0.488 . . . . 74.31 111.142 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.423 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 2.4 m-20 -74.61 0.78 13.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.258 -0.428 . . . . 70.43 110.89 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.423 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 3.7 m120 78.53 37.19 0.18 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.465 . . . . 63.44 110.877 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.6 p -113.58 121.54 44.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 74.32 111.144 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.402 HD13 ' HA ' ' A' ' 81' ' ' LEU . 4.3 mm? -111.23 132.96 53.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 70.13 110.966 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -123.61 92.84 0.46 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.803 -0.713 . . . . 73.32 112.517 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -79.34 106.1 11.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.821 0.343 . . . . 74.42 111.13 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -124.47 107.37 11.01 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.211 -0.449 . . . . 71.21 110.86 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.569 HG22 ' HB3' ' A' ' 71' ' ' PHE . 2.4 pp -111.51 130.84 64.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 73.41 111.13 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.863 HG23 HG22 ' A' ' 98' ' ' THR . 88.5 m -122.2 123.16 40.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 55.11 111.161 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.561 ' HB ' HD22 ' A' ' 69' ' ' LEU . 1.6 m -115.17 139.79 39.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.223 -0.444 . . . . 73.14 111.145 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -90.55 128.32 36.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 70.24 110.85 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.64 179.17 1.43 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.173 -0.467 . . . . 73.41 110.863 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -126.76 -65.9 0.93 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 73.11 110.883 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 20.1 tp -50.55 -75.47 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 75.25 110.931 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -73.26 76.35 1.32 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 72.31 111.091 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 7.7 tpp85 -48.78 133.69 17.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.435 . . . . 72.12 110.851 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 100.97 8.38 48.13 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.727 -0.749 . . . . 74.34 112.524 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.4 tp -112.68 124.67 53.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.861 0.362 . . . . 64.45 110.956 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 13.5 ttmt -124.62 125.05 43.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 72.05 110.929 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.566 HD12 HG22 ' A' ' 116' ' ' THR . 0.3 OUTLIER -101.64 127.13 48.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.222 -0.444 . . . . 73.13 110.939 179.914 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.863 HG22 HG23 ' A' ' 86' ' ' THR . 4.4 p -127.89 119.91 26.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 64.42 111.158 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.1 119.96 41.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.44 . . . . 71.25 110.917 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -109.9 142.12 41.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.474 . . . . 73.33 110.846 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.1 m -143.14 127.78 18.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 74.12 110.86 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -95.36 125.74 40.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 74.32 110.865 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -129.17 126.86 40.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 54.41 110.895 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.433 ' HA ' ' HD2' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -128.82 102.4 19.6 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.7 0.762 . . . . 73.0 110.827 -179.758 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 104' ' ' SER . 53.6 Cg_endo -69.76 -32.63 18.2 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.709 2.273 . . . . 54.1 112.349 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -70.12 -72.58 0.19 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.186 -0.461 . . . . 71.45 110.891 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.5 p -64.26 -40.09 95.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.129 -0.487 . . . . 65.42 111.131 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.52 24.45 13.92 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.726 -0.749 . . . . 75.11 112.495 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.11 148.09 22.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.82 0.343 . . . . 64.52 110.874 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -142.06 131.63 23.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 71.31 110.866 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -130.08 152.56 49.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.245 -0.434 . . . . 62.33 110.923 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -130.24 125.26 34.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 71.45 111.132 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.405 ' HB3' ' HA ' ' A' ' 130' ' ' ASP . 0.0 OUTLIER -139.03 137.99 36.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 35.13 110.861 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.536 HD13 ' H ' ' A' ' 115' ' ' LYS . 0.4 OUTLIER -125.84 138.35 54.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 74.22 111.149 179.835 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.536 ' H ' HD13 ' A' ' 114' ' ' ILE . 14.9 mtmt -130.17 130.11 44.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 75.43 110.925 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.566 HG22 HD12 ' A' ' 97' ' ' LEU . 1.2 p -119.22 119.2 33.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.446 . . . . 73.14 111.155 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -107.64 125.33 7.92 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.689 -0.767 . . . . 72.51 112.471 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -131.09 115.52 16.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.941 0.401 . . . . 60.05 110.886 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 13.7 mtpp -106.58 125.34 50.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.147 -0.479 . . . . 72.33 110.93 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 13.9 ttt85 -104.95 144.96 31.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.281 -0.418 . . . . 74.33 110.867 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.724 ' HA ' HG13 ' A' ' 3' ' ' VAL . 9.8 pt-20 -50.41 -26.57 5.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 71.24 110.9 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 33.9 m170 -86.98 -45.51 10.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 75.12 110.886 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 49.4 pt -151.38 156.6 6.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 61.23 111.143 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.404 ' HB2' HG22 ' A' ' 143' ' ' VAL . 2.6 m120 -104.21 129.7 51.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 62.02 110.897 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.543 ' CD2' HD22 ' A' ' 142' ' ' LEU . 1.0 OUTLIER -127.77 143.42 51.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 73.33 110.924 179.926 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -146.51 117.18 0.92 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.762 -0.732 . . . . 74.15 112.547 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 36.8 t -113.89 132.09 56.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.847 0.356 . . . . 72.2 110.85 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.432 ' HA ' ' HA ' ' A' ' 115' ' ' LYS . 0.2 OUTLIER -128.38 117.32 21.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 55.02 110.821 -179.963 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 19.4 mtm -103.97 136.25 43.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 52.24 110.92 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.405 ' HA ' ' HB3' ' A' ' 113' ' ' LYS . 4.3 t0 -128.41 120.25 26.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 73.31 110.834 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -94.74 119.9 34.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 75.3 110.886 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -128.71 131.83 47.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.164 -0.471 . . . . 63.34 110.827 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -55.9 -29.86 27.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 53.1 111.125 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -80.01 -20.26 45.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 63.21 111.07 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 157.61 100.26 0.17 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.754 -0.736 . . . . 54.04 112.465 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.76 129.48 17.68 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.679 2.253 . . . . 61.34 112.399 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.571 ' C ' HD12 ' A' ' 138' ' ' ILE . 12.5 t -129.08 161.79 29.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 64.42 110.887 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.753 HD13 ' HB ' ' A' ' 159' ' ' THR . 1.7 mp -120.72 117.12 52.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.111 -0.495 . . . . 72.41 111.14 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 15.2 mtm180 -121.81 125.29 46.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 72.34 110.883 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -147.16 152.18 24.36 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.72 -0.753 . . . . 75.33 112.519 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -120.72 139.55 52.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.855 0.359 . . . . 53.33 111.099 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.64 HD12 ' N ' ' A' ' 143' ' ' VAL . 0.1 OUTLIER -141.33 143.41 34.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 61.23 110.939 -179.961 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.64 ' N ' HD12 ' A' ' 142' ' ' LEU . 1.0 OUTLIER -133.58 143.74 37.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 61.15 111.153 179.817 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.521 HD12 ' O ' ' A' ' 151' ' ' ALA . 0.5 OUTLIER -125.99 138.31 53.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.172 -0.467 . . . . 75.3 110.925 179.968 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -113.29 119.32 4.8 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.764 -0.732 . . . . 64.11 112.499 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -144.84 148.27 33.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.862 0.363 . . . . 74.24 110.89 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 50.06 26.36 2.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.139 -0.482 . . . . 71.12 110.897 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 88.78 -31.82 4.8 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.749 -0.739 . . . . 53.14 112.523 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 52.9 p-90 -80.72 146.21 31.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.814 0.34 . . . . 71.53 110.936 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.561 HD11 HG22 ' A' ' 6' ' ' THR . 2.7 mt -114.5 145.52 41.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.451 . . . . 51.31 110.93 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.521 ' O ' HD12 ' A' ' 144' ' ' LEU . . . -141.74 113.9 8.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 62.03 111.099 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.459 ' HA3' ' HA ' ' A' ' 143' ' ' VAL . . . -166.04 162.57 36.08 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.722 -0.751 . . . . 63.34 112.444 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.786 ' HB3' ' O ' ' A' ' 168' ' ' ASN . 0.0 OUTLIER -174.68 -168.45 0.36 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.858 0.361 . . . . 73.51 110.925 -179.862 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -99.99 146.21 26.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.072 -0.513 . . . . 64.43 110.867 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 3.1 ppp? -145.21 127.54 15.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 73.22 110.9 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -111.46 119.95 40.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 74.22 110.843 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -108.51 138.99 43.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 75.11 110.867 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -77.65 98.38 5.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 73.34 110.918 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.753 ' HB ' HD13 ' A' ' 138' ' ' ILE . 7.2 t -66.24 -40.84 90.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 52.24 111.149 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -48.67 -25.1 1.61 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 65.32 111.108 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 35.4 mmtm -141.47 -159.89 1.02 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 45.34 110.88 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 17.1 m -109.59 40.06 1.96 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 62.3 110.879 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -131.27 171.58 13.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.134 -0.485 . . . . 70.45 110.889 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -106.91 141.05 23.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 52.51 111.125 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 62.6 m -90.29 -35.26 15.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 72.42 111.153 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -154.92 137.64 15.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 73.41 110.917 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 2.8 t -128.2 102.14 6.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 74.14 110.85 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.786 ' O ' ' HB3' ' A' ' 153' ' ' TYR . 0.1 OUTLIER -116.27 122.65 45.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 71.24 110.92 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.566 ' HA ' ' HB2' ' A' ' 153' ' ' TYR . 42.3 m-85 -133.96 138.6 45.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 62.11 110.887 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.735 ' HB3' ' CD1' ' A' ' 153' ' ' TYR . . . -151.3 152.04 32.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 73.33 111.118 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.469 HG12 ' HB1' ' A' ' 151' ' ' ALA . 0.9 OUTLIER -140.9 148.3 21.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.22 -0.446 . . . . 62.34 111.088 179.988 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -121.99 129.16 7.51 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.725 -0.75 . . . . 54.11 112.513 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -113.67 131.45 56.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.912 0.386 . . . . 74.0 110.954 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 20.9 mmtp -102.67 128.2 49.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.105 -0.498 . . . . 70.15 110.882 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.456 ' O ' ' C ' ' A' ' 176' ' ' ASP . 0.2 OUTLIER -119.64 167.05 12.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.451 . . . . 54.31 111.153 179.979 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.456 ' C ' ' O ' ' A' ' 175' ' ' THR . 0.8 OUTLIER -34.13 -77.74 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 74.22 110.87 179.937 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -117.64 14.66 14.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 75.1 110.907 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -128.14 147.49 50.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 61.11 110.897 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -136.32 126.64 26.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 61.4 110.902 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.751 HD12 ' CG2' ' A' ' 194' ' ' ILE . 0.4 OUTLIER -124.29 137.28 54.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 64.53 110.894 -179.949 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 5.8 t-80 -130.98 113.45 14.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 74.03 110.859 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -96.16 146.97 24.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 54.23 111.154 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' ASN . . . . . 0.413 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 7.0 p30 -159.52 140.7 12.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.248 -0.433 . . . . 72.44 110.898 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.526 ' HB ' ' HA ' ' A' ' 190' ' ' PHE . 1.4 m -135.07 135.71 52.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.125 -0.489 . . . . 62.12 111.104 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -100.52 88.3 3.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 74.32 110.916 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 73.58 176.57 0.25 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.196 -0.456 . . . . 73.41 110.862 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -72.44 1.67 34.35 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.743 -0.741 . . . . 64.23 112.463 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 33.3 p -105.12 -24.34 12.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.715 0.293 . . . . 63.35 111.103 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -119.16 120.08 36.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.24 -0.436 . . . . 75.12 110.9 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' PHE . . . . . 0.526 ' HA ' ' HB ' ' A' ' 184' ' ' VAL . 0.5 OUTLIER -140.13 124.57 17.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.456 . . . . 75.01 110.947 -179.954 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -171.39 -150.33 7.04 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.72 -0.752 . . . . 53.45 112.463 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 172.37 -166.68 39.49 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.751 -0.737 . . . . 30.43 112.519 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' SER . . . . . 0.467 ' C ' HD13 ' A' ' 194' ' ' ILE . 1.4 t -148.84 151.8 35.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.849 0.357 . . . . 72.23 110.857 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.751 ' CG2' HD12 ' A' ' 180' ' ' LEU . 0.0 OUTLIER -136.76 135.02 48.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 74.22 111.159 179.934 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -131.75 137.12 48.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 65.31 110.929 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 46.4 tp60 -124.35 131.9 53.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.123 -0.49 . . . . 64.13 110.963 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 11.2 ttpt -81.92 126.22 31.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 71.44 110.921 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 18.1 t -91.15 139.95 16.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 63.02 111.151 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -81.86 59.7 4.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 74.45 110.883 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 22.1 ttmt -165.9 39.87 0.06 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.198 -0.455 . . . . 71.43 110.889 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 4.8 mptt 57.32 44.06 22.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 75.0 110.87 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.665 HD12 ' O ' ' A' ' 224' ' ' LYS . 58.7 tp -152.92 145.98 24.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.249 -0.432 . . . . 73.15 110.906 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -127.32 149.24 50.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 75.41 110.911 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 71.2 p -123.29 138.24 54.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 74.25 111.115 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -145.81 135.73 23.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.214 -0.448 . . . . 74.44 111.134 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.562 HG22 HG12 ' A' ' 194' ' ' ILE . 0.9 OUTLIER -132.16 144.02 38.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 73.34 111.119 179.993 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -130.92 127.32 38.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.474 . . . . 71.41 110.852 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.446 ' H ' HD23 ' A' ' 208' ' ' LEU . 2.7 pt? -143.24 150.23 39.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.125 -0.489 . . . . 75.13 110.929 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -138.63 149.56 45.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 73.44 111.099 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 3.9 t-105 -120.63 135.19 55.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.447 . . . . 63.24 110.918 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 3.1 m -95.68 104.32 16.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 73.11 111.16 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -53.05 150.16 5.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 74.05 111.123 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 97.01 -34.16 5.26 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.729 -0.748 . . . . 42.21 112.498 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -122.58 -171.14 2.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.803 0.335 . . . . 75.35 110.919 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 22.7 t -119.03 38.06 3.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 53.01 110.857 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -101.96 111.88 24.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 72.42 110.917 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 14.6 t -115.18 138.18 51.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 61.22 111.173 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 63.3 mmt-85 -128.46 127.64 42.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 73.11 110.84 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -134.44 158.0 45.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.452 . . . . 72.54 110.861 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -147.44 147.46 18.23 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.718 -0.754 . . . . 54.5 112.516 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 3.8 mp -118.32 133.24 65.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.836 0.35 . . . . 73.41 111.12 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -131.77 143.73 50.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.462 . . . . 63.12 111.102 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -112.45 134.48 53.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.454 . . . . 43.1 111.071 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' LYS . . . . . 0.665 ' O ' HD12 ' A' ' 202' ' ' LEU . 1.1 ttpp -109.37 114.84 28.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 72.35 110.895 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 36.9 t80 -131.21 117.61 19.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.276 -0.42 . . . . 71.04 110.908 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -111.7 109.07 18.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.128 -0.487 . . . . 72.1 110.927 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 2.3 tt -80.93 -32.34 12.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 75.42 111.11 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -150.54 160.25 33.11 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.626 0.727 . . . . 72.41 110.882 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -7.61 21.48 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.671 2.248 . . . . 74.14 112.314 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -106.78 -29.52 9.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.247 -0.433 . . . . 75.03 110.9 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -124.54 133.56 53.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 72.32 111.09 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 42.1 m -134.81 141.76 46.5 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.235 -0.439 . . . . 42.44 110.849 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -127.13 133.48 50.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.474 . . . . 64.12 110.895 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 11.8 p -142.73 139.68 31.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.102 -0.499 . . . . 55.21 110.855 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -111.09 161.01 16.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.117 -0.492 . . . . 73.12 111.089 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 6.7 ptpp? -151.71 142.03 22.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 63.14 110.877 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 1.1 p -139.7 143.99 29.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 74.13 111.154 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -112.86 147.98 35.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.465 . . . . 63.45 110.927 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 40.1 t30 -59.43 -16.35 22.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 73.2 110.89 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 3.5 m -81.96 25.44 0.57 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 53.13 110.829 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 65.41 32.34 9.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.107 -0.497 . . . . 72.13 110.871 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 5.1 mp -100.28 118.07 35.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.122 -0.49 . . . . 52.31 110.923 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.437 ' H ' HD12 ' A' ' 243' ' ' ILE . 0.3 OUTLIER -118.1 116.79 52.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.223 -0.444 . . . . 74.44 111.115 179.835 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 244' ' ' GLY . . . . . 0.54 ' C ' HD13 ' A' ' 245' ' ' LEU . . . -147.88 163.39 28.84 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.723 -0.751 . . . . 70.32 112.452 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.661 ' N ' HD13 ' A' ' 245' ' ' LEU . 0.0 OUTLIER -146.5 160.43 42.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.88 0.371 . . . . 71.44 110.949 -179.972 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -141.41 137.84 8.35 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.715 -0.755 . . . . 73.22 112.507 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -129.38 131.06 46.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.919 0.39 . . . . 72.44 110.942 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.511 ' OG1' HG22 ' A' ' 258' ' ' THR . 1.8 t -118.68 118.79 32.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.121 -0.49 . . . . 71.15 111.178 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -115.21 122.45 46.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.247 -0.433 . . . . 71.25 110.927 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 250' ' ' THR . . . . . 0.598 HG23 ' HB2' ' A' ' 256' ' ' LYS . 7.6 m -95.73 122.88 38.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 43.2 111.13 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 17.9 tp -98.84 92.57 5.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.179 -0.464 . . . . 64.51 110.919 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 3.7 mtpp 63.75 161.41 0.12 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.563 0.697 . . . . 71.21 110.894 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 76.76 1.11 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.687 2.258 . . . . 73.14 112.337 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 178.32 -48.61 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.8 -0.715 . . . . 73.25 112.527 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.72 135.42 62.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.925 0.393 . . . . 64.13 111.133 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.598 ' HB2' HG23 ' A' ' 250' ' ' THR . 36.3 ttpt -133.37 133.14 42.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.125 -0.488 . . . . 73.31 110.853 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 0.406 HD23 ' H ' ' A' ' 258' ' ' THR . 0.4 OUTLIER -108.13 133.9 51.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 74.24 110.895 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 258' ' ' THR . . . . . 0.511 HG22 ' OG1' ' A' ' 248' ' ' THR . 30.9 p -132.62 122.04 24.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 74.34 111.16 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.663 HD21 HD11 ' A' ' 275' ' ' LEU . 0.1 OUTLIER -120.96 150.1 41.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 63.22 110.911 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.508 ' O ' HD22 ' A' ' 275' ' ' LEU . 1.5 m -142.64 140.5 31.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 51.54 110.815 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 261' ' ' ALA . . . . . 0.52 ' HB2' ' CD2' ' A' ' 275' ' ' LEU . . . -141.66 129.2 21.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 72.1 111.094 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.786 ' C ' HD13 ' A' ' 263' ' ' LEU . 1.3 tt -131.18 137.63 49.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 74.42 110.946 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 263' ' ' LEU . . . . . 0.786 HD13 ' C ' ' A' ' 262' ' ' LEU . 0.0 OUTLIER -120.9 108.59 14.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.173 -0.467 . . . . 72.21 110.918 179.915 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 264' ' ' ASP . . . . . 0.694 ' O ' HG22 ' A' ' 268' ' ' VAL . 0.5 OUTLIER -84.66 108.95 17.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 63.31 110.904 179.823 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -53.94 -18.85 9.37 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.788 -0.72 . . . . 44.22 112.48 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -91.05 -26.1 19.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.823 0.344 . . . . 74.31 110.876 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -100.1 -56.62 2.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 71.11 110.888 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 268' ' ' VAL . . . . . 0.717 HG12 ' O ' ' A' ' 272' ' ' GLY . 12.9 m -49.87 -27.36 3.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 71.2 111.117 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -53.74 -45.69 70.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 71.15 110.863 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -105.69 -17.16 14.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.473 . . . . 71.31 111.109 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -111.01 -120.18 4.01 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.778 -0.725 . . . . 75.15 112.501 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 272' ' ' GLY . . . . . 0.717 ' O ' HG12 ' A' ' 268' ' ' VAL . . . -150.39 -164.82 12.15 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.821 -0.704 . . . . 30.32 112.499 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 273' ' ' HIS . . . . . 0.621 ' CB ' HD12 ' A' ' 263' ' ' LEU . 8.9 p80 -89.62 145.93 24.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.851 0.358 . . . . 74.25 110.866 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 24.0 mttp -97.15 135.85 38.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 73.31 110.916 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.748 HD13 ' N ' ' A' ' 276' ' ' GLY . 2.7 tm? -134.94 138.93 44.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.256 -0.429 . . . . 65.51 110.913 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 276' ' ' GLY . . . . . 0.748 ' N ' HD13 ' A' ' 275' ' ' LEU . . . -132.75 140.04 11.47 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.752 -0.737 . . . . 73.11 112.523 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.734 HD12 HG23 ' A' ' 27' ' ' ILE . 2.1 tm? -113.94 136.7 52.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.792 0.329 . . . . 74.43 110.955 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 278' ' ' GLY . . . . . 0.697 ' N ' HD13 ' A' ' 277' ' ' LEU . . . -141.94 127.86 3.4 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.771 -0.728 . . . . 74.44 112.495 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.654 HD11 HD11 ' A' ' 277' ' ' LEU . 1.3 mm? -108.35 131.66 54.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.794 0.33 . . . . 61.12 110.882 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -123.36 112.03 17.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 64.21 110.928 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.686 ' HB3' HD13 ' A' ' 31' ' ' LEU . 17.7 m-85 -112.87 133.34 54.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 73.53 110.906 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -135.34 130.5 35.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 71.01 110.91 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.588 ' C ' HD23 ' A' ' 284' ' ' LEU . . . -99.16 135.78 40.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 74.42 111.106 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.588 HD23 ' C ' ' A' ' 283' ' ' ALA . 0.8 OUTLIER 41.7 37.14 0.68 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.253 -0.43 . . . . 53.54 110.91 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.47 . . . . 72.24 110.859 179.938 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 301' ' ' NAI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.9 mmm . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.735 0.302 . . . . 75.1 110.872 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.88 88.06 1.03 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 43.31 111.089 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.641 HG22 ' N ' ' A' ' 121' ' ' GLU . 60.2 t -114.42 78.75 4.92 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.642 0.734 . . . . 71.51 111.122 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 166.01 29.07 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.688 2.259 . . . . 61.34 112.316 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 101.66 0.94 Allowed 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.702 2.268 . . . . 72.43 112.296 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.649 HG22 HD21 ' A' ' 150' ' ' LEU . 0.0 OUTLIER -88.7 -46.36 9.07 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.218 -0.446 . . . . 70.22 111.178 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -54.39 -33.84 60.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 71.11 110.906 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -82.98 -19.16 37.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 74.12 111.129 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -88.85 10.09 22.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 55.42 110.903 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.567 HD23 HD12 ' A' ' 150' ' ' LEU . 89.5 mt -67.19 -34.25 77.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 61.43 110.911 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -139.57 68.45 0.49 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.738 -0.744 . . . . 72.25 112.484 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 12.4 mttp -64.64 -53.9 40.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.843 0.354 . . . . 72.44 110.942 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.9 t -58.77 -48.75 80.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 75.44 110.854 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.58 -37.82 88.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.113 -0.494 . . . . 70.05 111.065 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.451 ' O ' HG22 ' A' ' 19' ' ' THR . 16.2 ttm-85 -60.42 -34.32 73.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.26 -0.427 . . . . 70.52 110.881 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.08 -39.07 93.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.198 -0.455 . . . . 74.24 110.87 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.6 t -82.2 -33.33 11.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.256 -0.429 . . . . 64.11 111.128 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -72.18 -42.05 66.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 64.11 110.88 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.451 HG22 ' O ' ' A' ' 15' ' ' ARG . 12.3 t -68.49 -32.0 71.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 64.42 111.112 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -73.89 127.79 33.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 65.02 110.904 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -50.73 136.37 28.44 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.803 -0.713 . . . . 71.24 112.477 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -125.93 33.24 5.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.87 0.367 . . . . 71.03 110.897 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 73.87 88.63 0.19 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.714 -0.755 . . . . 72.15 112.524 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -94.24 -4.36 49.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.93 0.395 . . . . 72.42 110.897 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.58 13.36 80.26 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.754 -0.736 . . . . 32.21 112.49 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.461 HD12 ' O ' ' A' ' 27' ' ' ILE . 2.5 pp -150.33 -178.9 6.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.814 0.34 . . . . 75.14 110.926 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.73 HG23 HD12 ' A' ' 277' ' ' LEU . 8.9 mm -111.36 145.04 18.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 74.44 111.121 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.7 ttpt -122.65 151.15 41.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 64.41 110.883 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.514 HD13 ' C ' ' A' ' 29' ' ' LEU . 3.4 tm? -140.56 128.06 21.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 62.24 110.911 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -139.18 129.42 25.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.466 . . . . 63.51 110.858 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.8 tt -137.53 133.49 34.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 73.23 110.933 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.6 mtpp -135.33 125.51 26.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 71.13 110.928 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.641 HG23 ' HB3' ' A' ' 283' ' ' ALA . 24.4 m -123.2 146.18 48.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.212 -0.449 . . . . 52.51 111.11 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 10.1 tptt -105.24 158.04 16.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 62.41 110.9 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.483 ' O ' ' C ' ' A' ' 36' ' ' GLU . 0.5 OUTLIER -132.14 174.86 9.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 62.01 110.873 -179.915 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.483 ' C ' ' O ' ' A' ' 35' ' ' SER . 46.2 tt0 -31.8 -73.46 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.16 -0.473 . . . . 73.2 110.869 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -164.82 131.77 3.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 73.13 110.925 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.453 ' HA2' ' O ' ' A' ' 63' ' ' ARG . . . 86.28 -14.59 53.75 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.763 -0.732 . . . . 65.23 112.496 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.402 ' HB2' ' HB3' ' A' ' 35' ' ' SER . 0.2 OUTLIER -104.43 129.17 52.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.816 0.341 . . . . 74.44 110.901 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.97 118.15 10.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 60.54 110.93 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -92.04 122.55 34.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 73.05 110.892 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -125.6 131.12 52.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 74.05 111.111 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.4 t -131.69 139.64 49.1 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.202 -0.454 . . . . 73.31 110.839 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.4 t -145.73 126.59 14.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.144 -0.48 . . . . 72.13 110.829 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -146.31 147.71 18.86 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.739 -0.743 . . . . 73.04 112.518 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.24 135.78 37.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.857 0.36 . . . . 44.22 110.846 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.874 ' HB2' HG13 ' A' ' 54' ' ' VAL . . . -149.16 130.56 14.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.129 -0.487 . . . . 71.04 111.11 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 64.3 t-20 -96.63 126.0 41.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.242 -0.436 . . . . 54.44 110.872 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 91.9 m -75.59 -50.1 16.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 54.35 111.104 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -56.7 -49.23 75.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 71.22 110.851 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -108.84 124.53 50.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 71.52 111.182 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.41 ' O ' HG23 ' A' ' 52' ' ' THR . 1.9 t -54.37 104.63 0.11 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.209 -0.451 . . . . 74.43 111.168 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 30.9 tttp -174.03 99.32 0.1 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 63.32 110.896 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.874 HG13 ' HB2' ' A' ' 47' ' ' ALA . 31.7 t -120.51 124.75 73.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.195 -0.457 . . . . 61.34 111.117 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.4 p -135.57 129.72 33.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 71.02 111.122 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -129.37 137.93 9.91 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.761 -0.733 . . . . 54.14 112.532 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.3 p -141.49 160.32 40.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.892 0.377 . . . . 64.34 110.868 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.3 tp -128.38 149.97 50.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.101 -0.5 . . . . 71.52 110.877 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -135.73 131.19 35.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 71.13 110.893 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.07 118.38 36.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 64.4 111.12 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 5.2 ttmt -112.18 147.91 35.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 74.43 110.855 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -131.75 133.41 44.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 74.1 110.948 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.453 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 25.5 ttm180 -135.23 106.71 6.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.13 -0.487 . . . . 64.31 110.903 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 58.0 t-105 -114.56 138.74 50.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.202 -0.453 . . . . 73.14 110.9 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.3 m 66.19 119.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.281 -0.418 . . . . 64.43 111.17 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -50.59 105.38 0.1 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.438 . . . . 73.13 110.919 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 64.61 48.85 2.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.148 -0.478 . . . . 72.24 110.913 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.659 ' O ' HD22 ' A' ' 69' ' ' LEU . . . -122.29 -74.41 0.32 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.741 -0.742 . . . . 62.02 112.52 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.659 HD22 ' O ' ' A' ' 68' ' ' GLY . 4.1 mm? -134.23 129.43 35.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.872 0.367 . . . . 73.13 110.935 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.2 m -138.6 112.61 8.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 72.21 111.169 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -123.59 124.36 42.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 75.32 110.88 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.44 ' HA ' ' HA ' ' A' ' 61' ' ' LYS . 5.1 t -129.38 137.68 51.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 74.04 111.14 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.555 ' CD ' HD23 ' A' ' 81' ' ' LEU . 37.8 tt0 -124.02 123.23 39.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 74.51 110.843 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 22.3 mtpp -89.82 142.17 27.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.105 -0.498 . . . . 72.44 110.913 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 7.3 t90 -134.58 128.82 33.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.227 -0.442 . . . . 73.41 110.894 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -117.72 155.13 30.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 71.44 110.875 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 9.4 t -61.37 -17.53 54.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 61.05 111.16 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.415 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 48.5 m-20 -74.11 0.35 14.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 61.21 110.87 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.415 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 3.5 m120 77.34 35.67 0.33 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 73.4 110.9 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.8 m -114.45 128.57 56.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 55.51 111.167 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.555 HD23 ' CD ' ' A' ' 73' ' ' GLU . 0.3 OUTLIER -120.19 139.59 52.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.227 -0.442 . . . . 73.11 110.904 179.98 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -137.92 98.6 0.27 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.75 -0.738 . . . . 73.22 112.495 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.1 m -84.76 142.02 30.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.768 0.318 . . . . 61.14 111.161 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -146.47 115.25 6.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 71.31 110.853 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -112.7 136.48 48.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 70.34 111.147 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.61 HG22 ' HB ' ' A' ' 98' ' ' THR . 20.5 p -128.99 124.09 34.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 44.42 111.177 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.5 p -114.91 137.24 49.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 52.14 111.132 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -103.83 119.81 39.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 73.52 110.887 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -60.51 130.32 45.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 72.55 110.878 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -83.14 -57.8 3.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 61.13 110.885 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 36.0 mt -63.28 -54.28 39.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 71.2 110.876 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -85.58 75.35 10.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.453 . . . . 44.12 111.092 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 12.2 tpp85 -51.37 134.59 28.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 71.44 110.885 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 100.61 -23.41 35.87 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.718 -0.753 . . . . 52.12 112.475 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.805 HD22 ' HB3' ' A' ' 118' ' ' TYR . 0.1 OUTLIER -79.62 114.94 18.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.915 0.388 . . . . 72.25 110.946 -179.95 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.62 ' O ' HD13 ' A' ' 97' ' ' LEU . 3.8 ttpm? -121.29 130.0 53.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 74.54 110.934 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.62 HD13 ' O ' ' A' ' 96' ' ' LYS . 0.9 OUTLIER -121.71 127.06 50.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.259 -0.428 . . . . 75.02 110.89 179.951 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.61 ' HB ' HG22 ' A' ' 86' ' ' THR . 17.4 p -129.92 121.09 25.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.201 -0.454 . . . . 64.53 111.151 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -110.22 129.24 55.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 73.14 110.825 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -112.25 142.16 45.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.099 -0.5 . . . . 72.21 110.883 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.3 t -142.06 124.54 15.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 74.11 110.819 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.8 t -96.09 123.82 39.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 71.15 110.854 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -118.78 132.9 56.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.157 -0.474 . . . . 75.11 110.909 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -128.69 101.83 20.38 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.718 0.77 . . . . 75.21 110.817 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -33.16 17.1 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.685 2.257 . . . . 74.33 112.373 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -79.87 -69.73 0.57 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 55.12 110.911 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.4 -45.07 92.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.456 . . . . 70.51 111.14 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.37 24.34 14.51 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.757 -0.735 . . . . 52.43 112.49 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.92 148.05 22.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.871 0.367 . . . . 74.54 110.86 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -134.47 126.69 29.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 62.51 110.884 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -121.35 136.31 54.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 75.3 110.931 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -125.56 120.19 30.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.445 . . . . 65.22 111.125 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -138.39 138.62 38.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 75.32 110.899 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.433 HD12 ' H ' ' A' ' 115' ' ' LYS . 5.4 tp -122.57 137.43 56.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.235 -0.439 . . . . 61.22 111.151 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.433 ' H ' HD12 ' A' ' 114' ' ' ILE . 1.9 mtpp -128.58 121.38 28.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.172 -0.467 . . . . 73.23 110.911 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.408 HG22 HD12 ' A' ' 97' ' ' LEU . 62.6 p -128.26 121.47 29.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 65.4 111.109 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -150.03 163.31 29.41 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.702 -0.761 . . . . 54.13 112.47 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.805 ' HB3' HD22 ' A' ' 95' ' ' LEU . 7.6 p90 -133.05 143.81 49.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.942 0.401 . . . . 63.44 110.926 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.492 ' O ' HG11 ' A' ' 3' ' ' VAL . 9.0 mtmt -111.86 120.83 43.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 72.3 110.902 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 28.2 ttm180 -108.37 144.46 35.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 72.12 110.881 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.641 ' N ' HG22 ' A' ' 3' ' ' VAL . 36.8 tt0 -51.18 -29.28 13.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.219 -0.446 . . . . 74.44 110.851 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 37.1 m80 -86.54 -42.54 13.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 74.24 110.862 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 2.2 pp -150.09 153.62 10.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.238 -0.437 . . . . 44.33 111.137 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -124.68 116.25 22.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.466 . . . . 61.33 110.867 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.535 ' HB2' ' HG ' ' A' ' 142' ' ' LEU . 0.4 OUTLIER -133.51 145.17 49.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.197 -0.456 . . . . 74.33 110.913 179.96 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -146.33 136.0 6.08 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.739 -0.744 . . . . 72.43 112.476 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 44.8 t -103.91 133.97 47.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.837 0.351 . . . . 54.02 110.882 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -125.67 142.13 51.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.474 . . . . 75.32 110.872 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 47.7 ttm -137.89 134.44 35.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 73.12 110.898 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -124.9 122.58 37.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 75.12 110.876 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -94.45 123.15 37.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 65.35 110.881 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -115.12 179.68 3.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 52.43 110.857 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.53 ' H ' HD12 ' A' ' 133' ' ' ILE . 3.1 mp -93.29 -42.23 13.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.181 -0.463 . . . . 75.11 111.114 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -80.98 -20.09 42.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 44.42 111.125 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.641 ' HA3' ' HB2' ' A' ' 160' ' ' ALA . . . 164.23 114.12 0.3 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.751 -0.738 . . . . 53.1 112.509 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 144.75 54.9 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.704 2.269 . . . . 75.23 112.322 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.6 m -126.54 151.62 47.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 74.3 110.868 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 4.6 mp -121.36 126.41 74.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 71.41 111.116 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -121.71 121.95 38.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 72.13 110.855 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -121.86 141.59 14.52 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.779 -0.724 . . . . 65.44 112.52 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -126.75 116.21 20.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.819 0.343 . . . . 61.3 111.107 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.738 HD13 ' OH ' ' A' ' 153' ' ' TYR . 0.3 OUTLIER -119.76 122.1 40.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 75.11 110.895 -179.963 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.448 ' N ' HD23 ' A' ' 142' ' ' LEU . 1.5 m -132.61 140.84 46.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 63.14 111.172 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 6.3 mp -116.42 138.84 51.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.22 -0.445 . . . . 73.33 110.93 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -91.71 133.23 11.66 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.745 -0.741 . . . . 75.12 112.48 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.402 ' O ' ' N ' ' A' ' 148' ' ' GLY . 3.2 m-85 -128.74 146.8 50.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.823 0.344 . . . . 70.53 110.96 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -49.4 93.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.111 -0.495 . . . . 73.01 110.889 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 146' ' ' TYR . . . 87.26 -23.59 11.37 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.776 -0.726 . . . . 72.53 112.448 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 7.8 m0 -105.67 145.95 30.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.801 0.334 . . . . 71.43 110.942 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.649 HD21 HG22 ' A' ' 6' ' ' THR . 0.0 OUTLIER -126.77 137.13 53.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.243 -0.435 . . . . 74.23 110.919 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -129.26 134.07 47.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.455 . . . . 75.03 111.054 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.412 ' HA2' ' HA ' ' A' ' 143' ' ' VAL . . . -152.92 133.03 3.87 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.701 -0.762 . . . . 32.11 112.514 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.738 ' OH ' HD13 ' A' ' 142' ' ' LEU . 8.4 p90 -144.16 119.34 10.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.909 0.385 . . . . 75.23 110.921 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -110.58 123.62 50.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.075 -0.511 . . . . 64.22 110.935 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 2.4 ttt -120.39 128.72 53.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.44 . . . . 73.54 110.878 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.499 ' O ' ' HB ' ' A' ' 164' ' ' VAL . 20.0 m-20 -112.82 116.79 30.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.444 . . . . 72.53 110.867 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.544 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 60.4 m-85 -89.88 131.98 35.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.165 -0.471 . . . . 65.24 110.87 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -91.3 104.31 16.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 71.23 110.901 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.77 -47.9 73.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.134 -0.485 . . . . 61.14 111.118 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.641 ' HB2' ' HA3' ' A' ' 135' ' ' GLY . . . -49.65 -26.14 3.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 73.34 111.126 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.2 -166.85 1.36 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 65.32 110.853 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 68.1 m -112.97 39.18 2.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 63.33 110.829 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -165.06 177.19 7.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.116 -0.493 . . . . 55.31 110.832 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.544 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 1.0 OUTLIER -75.46 144.11 12.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.181 -0.463 . . . . 61.24 111.101 179.993 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 12.9 t -88.74 -32.64 17.82 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.149 -0.478 . . . . 72.12 111.165 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 3.9 tp60 -151.45 134.69 16.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 75.13 110.93 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 11.3 p -124.1 107.07 10.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 42.43 110.868 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 28.9 m-20 -110.74 148.47 32.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.115 -0.493 . . . . 64.24 110.897 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.438 ' CE1' HG23 ' A' ' 171' ' ' VAL . 8.0 t80 -154.8 140.57 18.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 71.15 110.914 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -154.38 135.01 13.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.13 -0.487 . . . . 74.41 111.094 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.438 HG23 ' CE1' ' A' ' 169' ' ' PHE . 48.5 t -144.15 133.42 19.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 72.04 111.159 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -111.6 122.25 6.0 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.775 -0.726 . . . . 70.12 112.496 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' TYR . . . . . 0.604 ' HB2' HD12 ' A' ' 180' ' ' LEU . 0.1 OUTLIER -113.65 131.06 56.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.934 0.397 . . . . 61.43 110.953 -179.829 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 2.6 mtpm? -102.95 127.2 50.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.476 . . . . 65.35 110.888 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.406 ' O ' ' C ' ' A' ' 176' ' ' ASP . 0.2 OUTLIER -111.78 166.39 11.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.219 -0.446 . . . . 75.42 111.111 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.406 ' C ' ' O ' ' A' ' 175' ' ' THR . 2.8 m-20 -37.89 -76.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 75.01 110.896 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -117.32 16.51 14.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.179 -0.464 . . . . 72.45 110.932 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -130.79 150.68 51.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.132 -0.485 . . . . 64.13 110.862 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 37.2 mm-40 -116.09 123.1 47.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.124 -0.489 . . . . 73.15 110.895 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.604 HD12 ' HB2' ' A' ' 173' ' ' TYR . 3.4 tm? -107.15 125.58 51.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.164 -0.471 . . . . 63.31 110.89 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 22.6 m80 -130.63 130.41 43.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 75.2 110.836 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 1.2 t -128.9 111.49 13.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 74.53 111.172 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -120.55 139.65 52.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.236 -0.438 . . . . 63.11 110.908 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.443 HG12 ' O ' ' A' ' 184' ' ' VAL . 2.5 t -133.33 110.29 14.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 72.14 111.111 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -100.79 89.51 3.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 74.11 110.872 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 67.47 -179.75 0.22 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 71.52 110.882 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -75.19 -2.95 68.12 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.775 -0.726 . . . . 65.22 112.477 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 15.6 p -97.53 -25.49 15.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.769 0.319 . . . . 70.22 111.126 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.27 113.48 20.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 75.41 110.905 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 190' ' ' PHE . . . . . 0.412 ' HA ' HG22 ' A' ' 184' ' ' VAL . 0.4 OUTLIER -139.76 123.03 17.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 70.2 110.857 -179.909 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 171.46 -141.43 6.41 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.747 -0.74 . . . . 63.11 112.519 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 167.24 -167.4 39.83 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.699 -0.763 . . . . 62.42 112.445 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' SER . . . . . 0.486 ' HA ' ' O ' ' A' ' 206' ' ' VAL . 70.3 m -127.5 144.42 51.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.813 0.339 . . . . 72.32 110.875 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.423 ' O ' HG22 ' A' ' 206' ' ' VAL . 0.0 OUTLIER -142.03 118.33 6.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.168 -0.469 . . . . 65.24 111.121 179.986 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 195' ' ' TYR . . . . . 0.802 ' CB ' ' HA ' ' A' ' 205' ' ' ALA . 0.1 OUTLIER 178.66 -175.21 0.19 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 62.44 110.892 -179.989 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 16.8 tm0? -123.51 128.54 49.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.091 -0.504 . . . . 64.53 110.894 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 3.4 pttp -114.65 113.97 25.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 71.23 110.903 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.662 HG21 HD12 ' A' ' 202' ' ' LEU . 5.2 t -86.47 143.85 10.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.237 -0.438 . . . . 73.23 111.133 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -93.06 32.53 1.28 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 70.44 110.894 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 10.3 mmtt -127.59 35.03 4.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 73.22 110.917 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 2.2 mttp 72.7 51.11 0.16 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 75.12 110.904 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.662 HD12 HG21 ' A' ' 198' ' ' VAL . 0.3 OUTLIER -177.47 82.49 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 73.22 110.938 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -128.17 133.2 48.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.461 . . . . 74.43 110.866 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.598 ' O ' ' HB3' ' A' ' 195' ' ' TYR . 11.0 t -132.45 136.91 47.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.467 . . . . 75.12 111.158 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.802 ' HA ' ' CB ' ' A' ' 195' ' ' TYR . . . -141.47 136.68 31.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 70.32 111.083 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.907 HG12 HG22 ' A' ' 221' ' ' ILE . 1.1 m -103.9 139.51 24.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.44 . . . . 63.25 111.074 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -114.35 132.7 56.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.46 . . . . 71.33 110.897 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.529 HD21 ' CD2' ' A' ' 219' ' ' PHE . 4.6 mp -126.11 138.17 53.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.167 -0.47 . . . . 74.25 110.935 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.716 ' HB3' ' CD ' ' A' ' 218' ' ' ARG . . . -129.61 139.96 51.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 62.53 111.129 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 2.4 t-105 -130.27 130.32 44.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 71.41 110.944 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.07 109.44 22.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.253 -0.43 . . . . 71.53 111.116 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -51.62 134.81 29.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.448 . . . . 61.55 111.156 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 120.4 33.91 0.99 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.705 -0.76 . . . . 63.13 112.447 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 49.5 t30 59.66 43.34 15.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.822 0.344 . . . . 71.14 110.898 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 14.0 m -90.99 -169.72 2.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 72.32 110.872 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -102.55 137.1 41.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.462 . . . . 41.45 110.913 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' THR . . . . . 0.426 HG23 ' CE1' ' A' ' 219' ' ' PHE . 3.9 t -79.12 139.5 38.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.47 . . . . 65.44 111.153 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 218' ' ' ARG . . . . . 0.716 ' CD ' ' HB3' ' A' ' 209' ' ' ALA . 17.3 ptp180 -110.84 133.29 53.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 64.35 110.886 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 219' ' ' PHE . . . . . 0.529 ' CD2' HD21 ' A' ' 208' ' ' LEU . 11.1 m-85 -114.37 138.35 50.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.25 -0.432 . . . . 75.44 110.859 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -140.65 144.52 14.87 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.713 -0.755 . . . . 65.42 112.467 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.907 HG22 HG12 ' A' ' 206' ' ' VAL . 0.0 OUTLIER -130.93 130.73 64.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.841 0.353 . . . . 62.2 111.129 -179.998 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -133.74 131.64 39.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 41.55 111.104 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -125.22 146.06 49.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.254 -0.43 . . . . 75.32 111.093 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 3.5 mtmp? -129.1 123.55 32.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 71.01 110.908 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -132.29 133.16 43.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.212 -0.449 . . . . 74.42 110.963 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -85.6 128.78 34.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.475 . . . . 70.3 110.901 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 44.5 mm -74.16 -55.55 11.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 74.24 111.111 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.545 ' N ' ' HD2' ' A' ' 229' ' ' PRO . 0.1 OUTLIER 175.13 -57.35 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.599 0.714 . . . . 74.24 110.826 179.867 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.545 ' HD2' ' N ' ' A' ' 228' ' ' ASP . 53.4 Cg_endo -69.75 -156.6 0.04 OUTLIER 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.655 2.237 . . . . 72.43 112.368 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.6 15.69 4.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 64.33 110.839 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.454 ' HB2' ' HG3' ' A' ' 249' ' ' GLN . . . -120.63 121.92 39.38 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.22 -0.445 . . . . 62.14 111.118 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 36.7 m -108.7 143.99 37.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 41.55 110.889 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -105.3 127.88 53.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 71.41 110.877 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 15.2 m -127.09 137.49 53.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.134 -0.484 . . . . 64.15 110.842 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -121.3 143.17 49.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.158 -0.474 . . . . 62.11 111.083 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.76 141.87 31.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 64.31 110.894 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 242' ' ' LEU . 5.3 p -140.25 144.73 27.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 55.13 111.117 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -108.16 148.31 30.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 73.42 110.896 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -56.11 -19.52 13.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 74.01 110.869 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 37.3 t -81.15 25.48 0.48 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.474 . . . . 64.05 110.856 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 2.3 t 61.89 35.73 16.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 72.41 110.851 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 242' ' ' LEU . . . . . 0.447 ' O ' HG23 ' A' ' 237' ' ' VAL . 4.6 mp -99.03 117.89 34.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.138 -0.483 . . . . 63.2 110.963 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.458 HD13 ' H ' ' A' ' 243' ' ' ILE . 0.1 OUTLIER -104.84 119.0 53.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.207 -0.451 . . . . 75.15 111.181 179.831 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 244' ' ' GLY . . . . . 0.519 ' C ' HD13 ' A' ' 245' ' ' LEU . . . -138.04 160.67 25.43 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.749 -0.739 . . . . 72.23 112.498 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.85 HD21 ' HB3' ' A' ' 261' ' ' ALA . 0.0 OUTLIER -145.16 160.04 42.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.858 0.361 . . . . 64.52 110.872 -179.917 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -149.09 121.77 1.36 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.77 -0.729 . . . . 72.42 112.508 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -109.3 115.89 30.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.976 0.417 . . . . 72.34 110.931 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.413 HG23 ' O ' ' A' ' 248' ' ' THR . 3.5 t -101.8 115.05 29.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.131 -0.486 . . . . 71.53 111.153 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 249' ' ' GLN . . . . . 0.454 ' HG3' ' HB2' ' A' ' 231' ' ' ALA . 59.1 tt0 -119.71 130.01 54.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 73.5 110.87 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 7.3 p -121.39 117.92 28.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.136 -0.483 . . . . 65.51 111.115 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 11.0 mt -113.42 101.2 9.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 73.2 110.974 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 252' ' ' LYS . . . . . 0.426 ' HB3' ' HD2' ' A' ' 253' ' ' PRO . 17.6 mttp 64.19 155.36 0.12 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.632 0.73 . . . . 73.25 110.835 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 253' ' ' PRO . . . . . 0.426 ' HD2' ' HB3' ' A' ' 252' ' ' LYS . 53.8 Cg_endo -69.74 73.68 1.34 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.706 2.271 . . . . 44.42 112.341 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 171.92 -29.7 0.11 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.727 -0.749 . . . . 71.52 112.442 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 55.5 mt -116.13 121.37 67.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.854 0.359 . . . . 74.5 111.131 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 32.3 ttmt -133.39 132.81 41.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 73.32 110.86 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 0.504 HD13 ' C ' ' A' ' 257' ' ' LEU . 3.3 tm? -118.44 125.06 49.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.175 -0.466 . . . . 73.22 110.931 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 258' ' ' THR . . . . . 0.514 ' O ' HD22 ' A' ' 277' ' ' LEU . 93.6 m -115.72 111.74 21.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 73.22 111.167 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 1.029 HD22 HD23 ' A' ' 277' ' ' LEU . 0.1 OUTLIER -109.6 132.65 53.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.45 . . . . 70.43 110.923 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.415 ' H ' HD13 ' A' ' 259' ' ' LEU . 16.5 t -145.95 153.37 40.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 74.24 110.889 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 261' ' ' ALA . . . . . 0.85 ' HB3' HD21 ' A' ' 245' ' ' LEU . . . -158.12 130.87 7.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 64.05 111.102 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.73 ' C ' HD13 ' A' ' 263' ' ' LEU . 3.3 tm? -125.8 124.45 40.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.459 . . . . 74.32 110.911 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 263' ' ' LEU . . . . . 0.835 ' HB3' HG11 ' A' ' 268' ' ' VAL . 0.2 OUTLIER -121.01 110.31 16.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 74.23 110.907 179.905 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 264' ' ' ASP . . . . . 0.527 ' O ' HG22 ' A' ' 268' ' ' VAL . 1.8 m-20 -79.11 113.88 17.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.198 -0.456 . . . . 74.45 110.871 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -58.9 -17.0 34.07 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.785 -0.722 . . . . 40.41 112.457 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 45.4 tttt -90.84 -3.2 57.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.822 0.344 . . . . 63.3 110.913 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -127.55 -52.82 1.36 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 64.12 110.919 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 268' ' ' VAL . . . . . 0.835 HG11 ' HB3' ' A' ' 263' ' ' LEU . 17.1 m -51.19 -29.37 8.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 64.41 111.123 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 -52.24 -40.39 61.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 74.2 110.918 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -104.91 -17.45 14.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.131 -0.486 . . . . 75.22 111.108 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 129.71 94.8 0.74 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.712 -0.756 . . . . 74.22 112.515 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -179.74 74.94 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.73 -0.748 . . . . 62.15 112.474 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 273' ' ' HIS . . . . . 0.419 ' HB2' HD12 ' A' ' 263' ' ' LEU . 32.6 p-80 -108.14 145.96 33.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.851 0.357 . . . . 62.43 110.855 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -127.12 138.73 53.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.185 -0.461 . . . . 73.54 110.925 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.65 HD12 ' HB2' ' A' ' 261' ' ' ALA . 1.5 tp -121.75 145.6 47.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.447 . . . . 74.02 110.879 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -123.63 108.25 1.16 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.724 -0.751 . . . . 70.24 112.459 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 1.029 HD23 HD22 ' A' ' 259' ' ' LEU . 3.2 tm? -114.43 141.4 47.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.858 0.361 . . . . 63.23 110.921 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 278' ' ' GLY . . . . . 0.659 ' N ' HD13 ' A' ' 277' ' ' LEU . . . -148.84 132.59 4.17 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.772 -0.727 . . . . 75.11 112.482 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.505 HD11 HD11 ' A' ' 277' ' ' LEU . 1.2 mm? -109.36 133.63 52.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.766 0.317 . . . . 74.41 110.881 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -124.06 112.62 17.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 71.21 110.88 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -117.93 134.1 55.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.1 -0.5 . . . . 74.42 110.85 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 282' ' ' GLN . . . . . 0.676 ' HG2' HD13 ' A' ' 284' ' ' LEU . 11.0 tt0 -135.85 112.47 10.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.127 -0.488 . . . . 73.12 110.913 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.732 ' O ' HD12 ' A' ' 284' ' ' LEU . . . -96.05 113.36 24.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 74.24 111.071 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.732 HD12 ' O ' ' A' ' 283' ' ' ALA . 6.1 mp -140.52 177.05 8.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.257 -0.429 . . . . 74.12 110.919 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 75.44 110.864 179.917 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 301' ' ' NAI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.831 0.348 . . . . 64.03 110.87 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.4 -38.18 74.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 73.31 111.127 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.478 HG13 ' HG3' ' A' ' 119' ' ' LYS . 0.2 OUTLIER -145.16 108.86 4.6 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.637 0.732 . . . . 72.3 111.155 179.955 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 170.73 15.85 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.648 2.232 . . . . 71.24 112.377 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 83.54 0.7 Allowed 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.695 2.263 . . . . 62.13 112.334 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 46.2 p -70.27 -48.94 54.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.212 -0.449 . . . . 75.12 111.157 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.486 ' CB ' HG11 ' A' ' 143' ' ' VAL . 7.7 p90 -51.13 -33.81 28.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.237 -0.438 . . . . 71.11 110.896 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -83.44 -28.32 28.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 73.43 111.132 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -90.32 11.61 20.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.211 -0.45 . . . . 74.11 110.823 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 25.1 mt -59.88 -29.76 68.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 71.24 110.928 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 159.4 59.01 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.703 -0.76 . . . . 65.14 112.469 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 12.7 mmtm -67.16 -53.84 26.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.751 0.31 . . . . 73.44 110.874 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.4 t -56.87 -48.06 78.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.27 -0.423 . . . . 65.42 110.906 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.23 -36.77 76.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.092 -0.504 . . . . 43.23 111.104 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.89 -30.57 67.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 74.24 110.864 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -56.44 -48.94 75.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 63.32 110.857 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 79.5 t -62.53 -26.59 40.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 74.23 111.135 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -59.63 -41.11 89.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 64.41 110.865 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.08 -66.64 0.7 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 53.25 111.138 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.1 tppm? -47.28 104.73 0.06 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 74.02 110.902 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 158.93 38.83 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.755 -0.736 . . . . 72.41 112.492 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.431 ' HB3' HD13 ' A' ' 262' ' ' LEU . 18.5 p90 -165.56 140.08 4.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.955 0.407 . . . . 72.14 110.897 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -62.65 129.83 42.48 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.734 -0.746 . . . . 73.45 112.489 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -103.1 -3.51 25.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.879 0.371 . . . . 74.14 110.849 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.78 14.02 78.32 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.721 -0.752 . . . . 45.35 112.509 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.514 ' O ' HD12 ' A' ' 27' ' ' ILE . 0.6 OUTLIER -127.77 171.94 11.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.804 0.335 . . . . 62.15 110.899 -179.924 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.538 HG13 HD12 ' A' ' 277' ' ' LEU . 1.3 mp -118.35 121.49 67.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 73.23 111.108 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 37.0 tttp -111.42 117.37 32.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 75.33 110.902 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.488 HD12 ' HB2' ' A' ' 279' ' ' LEU . 1.1 tt -115.16 141.06 48.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 52.11 110.951 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -147.88 129.98 15.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.178 -0.465 . . . . 71.45 110.838 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.514 HD23 ' N ' ' A' ' 32' ' ' LYS . 7.3 tt -126.93 133.38 50.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 73.13 110.876 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.514 ' N ' HD23 ' A' ' 31' ' ' LEU . 7.4 mtmp? -127.23 127.02 43.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 73.22 110.892 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.771 HG23 ' HB3' ' A' ' 283' ' ' ALA . 6.7 m -130.1 141.03 50.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.24 -0.436 . . . . 74.31 111.169 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.88 156.27 20.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.464 . . . . 73.53 110.882 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.517 ' O ' ' C ' ' A' ' 36' ' ' GLU . 0.6 OUTLIER -133.89 174.35 10.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 72.14 110.847 -179.904 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.517 ' C ' ' O ' ' A' ' 35' ' ' SER . 39.9 mm-40 -27.46 -75.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.095 -0.502 . . . . 72.55 110.876 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -166.82 140.39 3.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.115 -0.493 . . . . 74.44 110.879 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.487 ' HA2' ' O ' ' A' ' 63' ' ' ARG . . . 83.54 -12.69 50.71 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.798 -0.715 . . . . 65.12 112.518 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -105.02 130.07 53.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.787 0.327 . . . . 75.31 110.923 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -140.33 118.48 11.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.23 -0.441 . . . . 55.25 110.882 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -98.34 121.55 40.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 73.14 110.869 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 27.6 m -126.06 123.82 39.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.163 -0.471 . . . . 74.41 111.166 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.4 t -125.1 132.39 53.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.264 -0.425 . . . . 54.44 110.875 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 6.0 p -150.04 126.57 10.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.115 -0.493 . . . . 54.12 110.853 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -155.05 167.36 32.78 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.735 -0.745 . . . . 71.13 112.461 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 17.9 m -127.66 156.45 42.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.9 0.381 . . . . 54.33 110.878 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.495 ' O ' HD13 ' A' ' 26' ' ' LEU . . . -142.84 131.33 22.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 71.25 111.103 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 61.5 t-20 -101.65 123.54 45.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 72.43 110.865 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 60.4 m -88.51 -55.35 3.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.169 -0.469 . . . . 75.43 111.122 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -51.12 -36.4 40.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 72.14 110.875 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.14 155.54 50.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 34.22 111.125 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.0 m -71.09 86.99 0.76 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 70.45 111.167 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.2 tptp -152.68 80.91 1.22 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.233 -0.439 . . . . 63.31 110.901 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.415 ' HA ' ' HA ' ' A' ' 47' ' ' ALA . 1.3 p -127.96 123.21 60.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 75.41 111.159 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.0 p -136.6 132.85 35.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 73.41 111.158 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -107.18 136.56 13.46 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.756 -0.735 . . . . 52.23 112.475 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -114.26 144.97 42.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.895 0.379 . . . . 50.21 110.874 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.652 HD13 ' N ' ' A' ' 59' ' ' GLU . 0.8 OUTLIER -121.48 132.82 54.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 75.53 110.927 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.652 ' N ' HD13 ' A' ' 58' ' ' LEU . 1.4 pt-20 -133.46 136.96 45.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 75.15 110.904 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 4.9 m -114.79 140.15 49.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 64.4 111.131 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -135.71 157.44 46.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 71.31 110.885 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.439 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 16.2 m-85 -129.26 140.86 51.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.218 -0.447 . . . . 63.14 110.939 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.487 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 43.6 ttm-85 -127.12 104.51 8.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.11 -0.495 . . . . 74.51 110.863 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 66.0 m95 -114.2 123.84 50.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 63.51 110.9 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.5 m 67.3 125.39 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.216 -0.447 . . . . 74.32 111.126 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -51.3 103.95 0.07 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.46 . . . . 63.31 110.911 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 63.64 58.51 1.29 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.459 . . . . 71.42 110.935 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.631 ' O ' HD22 ' A' ' 69' ' ' LEU . . . -133.64 -77.81 0.12 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.762 -0.732 . . . . 64.51 112.455 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.631 HD22 ' O ' ' A' ' 68' ' ' GLY . 4.0 mm? -133.99 130.35 37.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.881 0.372 . . . . 72.12 110.936 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.639 HG23 ' OG1' ' A' ' 86' ' ' THR . 0.0 OUTLIER -137.57 137.42 38.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 61.53 111.141 179.93 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -95.79 133.84 39.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 64.45 110.92 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.5 m -112.67 117.23 31.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.167 -0.469 . . . . 74.12 111.136 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.417 ' CB ' HG23 ' A' ' 83' ' ' THR . 0.1 OUTLIER -134.49 134.06 41.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.455 . . . . 62.5 110.9 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 53.5 tttt -145.26 132.85 20.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 72.31 110.893 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 9.6 t90 -135.48 128.91 32.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.439 . . . . 72.54 110.928 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 10.5 m-20 -117.14 150.99 37.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 53.54 110.904 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.7 m -68.21 -12.29 60.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 73.01 111.122 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.489 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 38.8 t70 -74.65 0.17 15.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.227 -0.442 . . . . 63.0 110.893 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.489 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 5.7 t-20 83.55 34.47 0.05 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 75.32 110.865 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 12.7 p -114.77 123.04 48.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 62.22 111.162 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -109.38 136.98 47.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.449 . . . . 51.24 110.908 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -149.33 89.34 0.14 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.666 -0.778 . . . . 41.53 112.452 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.417 HG23 ' CB ' ' A' ' 73' ' ' GLU . 3.8 m -127.45 160.95 29.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.741 0.305 . . . . 74.04 111.167 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.622 ' HB3' ' O ' ' A' ' 99' ' ' PHE . 0.6 OUTLIER 169.22 -163.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 61.1 110.882 -179.99 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.532 HD11 HD12 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -135.33 142.96 38.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 63.04 111.111 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.639 ' OG1' HG23 ' A' ' 70' ' ' THR . 33.7 p -128.88 126.34 39.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.146 -0.479 . . . . 74.21 111.157 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 9.0 p -110.67 137.13 44.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 74.54 111.127 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -125.26 118.51 26.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 64.31 110.937 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 52.14 90.39 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 73.52 110.857 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.425 ' HG3' HD21 ' A' ' 69' ' ' LEU . 2.3 mm-40 -138.66 -75.13 0.38 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 73.35 110.932 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 30.1 tp -62.39 -36.12 81.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 73.35 110.938 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -143.29 125.72 15.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 63.24 111.069 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.11 124.8 13.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 73.41 110.872 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 97.64 -23.98 33.59 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.76 -0.733 . . . . 65.02 112.548 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.685 HD22 ' HB3' ' A' ' 118' ' ' TYR . 0.2 OUTLIER -79.99 124.28 28.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.834 0.349 . . . . 73.23 110.884 -179.91 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.739 ' O ' HD13 ' A' ' 97' ' ' LEU . 3.2 pttp -121.86 123.31 41.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.219 -0.446 . . . . 73.34 110.932 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.739 HD13 ' O ' ' A' ' 96' ' ' LYS . 0.7 OUTLIER -125.53 124.85 42.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.23 -0.441 . . . . 64.12 110.967 179.899 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 12.2 p -124.84 119.6 29.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 73.22 111.143 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.622 ' O ' ' HB3' ' A' ' 84' ' ' GLU . 0.3 OUTLIER -109.83 117.73 34.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 72.44 110.86 -179.968 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.556 ' HA ' ' CB ' ' A' ' 84' ' ' GLU . 6.7 t70 -115.71 144.6 43.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 74.12 110.88 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.404 ' CB ' ' HG2' ' A' ' 84' ' ' GLU . 10.5 t -140.1 133.2 29.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 72.15 110.866 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -120.67 149.51 42.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.484 . . . . 61.43 110.861 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -127.95 137.96 52.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 73.52 110.888 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.404 ' HA ' ' HD2' ' A' ' 105' ' ' PRO . 99.6 p -128.63 101.52 20.8 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.707 0.765 . . . . 64.22 110.841 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 104' ' ' SER . 54.3 Cg_endo -69.66 -31.22 21.38 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.705 2.27 . . . . 74.41 112.4 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -50.27 -68.24 0.19 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 45.3 110.885 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.1 p -86.05 -33.45 21.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.481 . . . . 64.13 111.175 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.39 23.57 16.28 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.723 -0.751 . . . . 62.51 112.485 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 46.3 mtpt -94.31 148.09 22.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.821 0.343 . . . . 60.41 110.926 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.15 144.42 31.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 75.45 110.914 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -120.7 128.59 53.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.269 -0.423 . . . . 74.54 110.851 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -133.35 124.82 27.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 52.24 111.088 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -134.77 138.37 44.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.223 -0.444 . . . . 72.41 110.864 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.579 HD13 ' H ' ' A' ' 115' ' ' LYS . 0.4 OUTLIER -134.43 136.53 52.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.248 -0.433 . . . . 71.35 111.111 179.893 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.579 ' H ' HD13 ' A' ' 114' ' ' ILE . 10.9 mtmt -126.29 121.59 33.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 75.32 110.883 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.681 HG23 ' CD1' ' A' ' 97' ' ' LEU . 99.6 m -125.22 121.44 34.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 74.4 111.103 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -152.69 163.06 30.26 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.738 -0.744 . . . . 72.33 112.511 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.685 ' HB3' HD22 ' A' ' 95' ' ' LEU . 0.3 OUTLIER -132.49 145.22 51.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.982 0.42 . . . . 74.53 110.915 -179.838 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.478 ' HG3' HG13 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -109.06 123.47 49.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.094 -0.503 . . . . 43.34 110.905 179.93 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.417 ' HB2' HG22 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -104.54 147.36 27.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.245 -0.434 . . . . 73.1 110.892 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.434 ' HA ' ' HB ' ' A' ' 3' ' ' VAL . 85.0 tt0 -54.64 -30.95 56.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 75.33 110.873 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 54.2 p-80 -125.95 11.13 7.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 74.23 110.864 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.817 HD11 HD23 ' A' ' 144' ' ' LEU . 1.0 OUTLIER -147.63 150.19 14.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.24 -0.437 . . . . 64.33 111.169 179.974 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.636 ' HB3' HG13 ' A' ' 143' ' ' VAL . 5.9 t-20 -128.96 113.69 15.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 60.02 110.9 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.661 HD22 HD23 ' A' ' 142' ' ' LEU . 1.4 mm? -121.89 130.76 53.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 61.11 110.873 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -146.94 115.81 0.81 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.689 -0.767 . . . . 73.12 112.442 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -113.3 135.51 53.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.771 0.32 . . . . 65.22 110.876 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -132.91 117.22 17.43 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.184 -0.462 . . . . 61.02 110.852 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 3.3 tmm? -109.36 138.74 45.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 75.43 110.918 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -117.75 119.23 34.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.248 -0.433 . . . . 61.35 110.854 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -96.43 114.98 26.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 62.5 110.885 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -120.39 153.16 36.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 61.12 110.881 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.02 -29.5 14.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.216 -0.447 . . . . 71.33 111.117 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -84.48 -20.32 31.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 75.44 111.068 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 164.05 97.38 0.12 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.745 -0.74 . . . . 52.35 112.483 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 137.27 35.09 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.648 2.232 . . . . 73.04 112.348 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.07 153.65 46.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.189 -0.459 . . . . 70.25 110.832 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 5.2 mp -110.52 132.29 59.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 60.11 111.135 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 9.2 mtt-85 -119.79 138.72 53.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 75.1 110.862 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -131.95 145.18 16.95 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.761 -0.733 . . . . 74.42 112.508 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -139.23 116.47 11.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.842 0.353 . . . . 72.32 111.076 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.733 HD22 ' N ' ' A' ' 143' ' ' VAL . 0.6 OUTLIER -125.34 124.02 40.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 60.11 110.928 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.733 ' N ' HD22 ' A' ' 142' ' ' LEU . 0.1 OUTLIER -132.85 145.0 34.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 74.32 111.126 179.857 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.817 HD23 HD11 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -131.78 140.91 49.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.446 . . . . 44.25 110.921 179.947 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -123.4 117.79 3.32 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.722 -0.751 . . . . 75.15 112.463 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.435 ' O ' ' CD1' ' A' ' 149' ' ' TRP . 7.0 t80 -145.52 153.86 41.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.864 0.364 . . . . 73.14 110.921 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 52.58 23.72 2.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 74.54 110.861 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 89.93 -31.2 5.42 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.736 -0.745 . . . . 71.12 112.504 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.435 ' CD1' ' O ' ' A' ' 146' ' ' TYR . 50.5 p-90 -78.0 145.0 36.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.754 0.311 . . . . 73.34 110.923 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.533 HD23 ' O ' ' A' ' 144' ' ' LEU . 1.4 mt -124.21 144.4 49.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.249 -0.432 . . . . 54.03 110.906 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.504 ' HA ' HG13 ' A' ' 171' ' ' VAL . . . -142.97 125.89 16.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.15 -0.477 . . . . 72.51 111.086 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.737 ' O ' ' HB3' ' A' ' 169' ' ' PHE . . . -126.94 131.5 7.29 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.717 -0.754 . . . . 64.15 112.488 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.414 ' C ' ' HD1' ' A' ' 169' ' ' PHE . 5.5 t80 -133.2 120.28 20.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.841 0.353 . . . . 74.03 110.949 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.645 ' H ' ' HB2' ' A' ' 169' ' ' PHE . 0.5 OUTLIER -104.24 138.54 40.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.484 . . . . 70.3 110.915 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 155' ' ' MET . . . . . 0.534 ' HB3' HG11 ' A' ' 164' ' ' VAL . 0.4 OUTLIER -122.73 146.76 47.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 52.14 110.849 179.955 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.41 ' O ' HG13 ' A' ' 164' ' ' VAL . 3.6 t30 -108.88 120.48 42.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.182 -0.463 . . . . 75.15 110.883 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -91.04 123.18 34.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 73.15 110.86 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.742 ' O ' ' O ' ' A' ' 161' ' ' LYS . 0.1 OUTLIER -78.19 137.64 38.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 70.31 110.881 -179.963 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.479 HG23 ' N ' ' A' ' 160' ' ' ALA . 5.4 t -69.05 -46.99 66.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.15 -0.477 . . . . 62.42 111.17 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.479 ' N ' HG23 ' A' ' 159' ' ' THR . . . -50.77 -25.87 4.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 75.41 111.111 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.742 ' O ' ' O ' ' A' ' 158' ' ' GLU . 33.2 mmtt -147.29 139.62 24.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 73.33 110.909 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 12.6 m -71.56 49.63 0.16 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 73.24 110.868 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -138.58 170.69 15.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.487 . . . . 75.11 110.889 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.534 HG11 ' HB3' ' A' ' 155' ' ' MET . 90.8 t -91.15 138.66 19.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.442 . . . . 62.13 111.107 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 96.1 m -94.65 -42.23 8.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.474 . . . . 65.31 111.125 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -160.1 142.2 13.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 61.01 110.922 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 6.8 p -127.12 125.94 42.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 72.21 110.865 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.441 ' CB ' ' HA ' ' A' ' 185' ' ' ASN . 5.8 p30 -139.7 152.3 46.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.102 -0.499 . . . . 53.03 110.906 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.737 ' HB3' ' O ' ' A' ' 152' ' ' GLY . 0.1 OUTLIER -178.55 -159.18 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 74.33 110.893 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -132.92 150.56 52.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 50.1 111.106 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.504 HG13 ' HA ' ' A' ' 151' ' ' ALA . 71.0 t -145.72 127.15 7.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.218 -0.446 . . . . 43.35 111.097 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -163.37 167.19 37.51 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.714 -0.755 . . . . 64.41 112.482 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 27.1 p90 -125.55 154.67 41.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.989 0.424 . . . . 44.13 110.9 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 38.8 mtpt -106.8 130.93 54.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.119 -0.491 . . . . 74.02 110.892 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.15 165.53 16.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 70.13 111.13 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -42.53 -71.74 0.08 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 72.24 110.915 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 26.5 mp0 -115.48 14.46 16.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 70.41 110.92 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -127.83 143.57 51.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.11 -0.496 . . . . 70.41 110.854 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' GLN . . . . . 0.401 ' HB3' ' HB2' ' A' ' 195' ' ' TYR . 5.7 mm-40 -136.81 130.96 32.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 72.34 110.882 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.507 HD13 ' C ' ' A' ' 180' ' ' LEU . 2.5 tm? -124.21 117.5 24.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.14 -0.482 . . . . 63.02 110.891 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 18.2 t-80 -135.07 118.43 16.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 74.54 110.892 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -130.74 127.83 39.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 75.53 111.162 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -119.36 141.01 49.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 72.23 110.922 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.538 ' HB ' ' HA ' ' A' ' 190' ' ' PHE . 1.3 m -133.07 141.19 45.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.457 . . . . 73.1 111.141 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.441 ' HA ' ' CB ' ' A' ' 168' ' ' ASN . 0.8 OUTLIER -105.13 89.2 3.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 71.32 110.884 179.999 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 74.41 -175.93 0.15 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.222 -0.444 . . . . 72.33 110.859 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -80.09 4.84 64.84 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.708 -0.758 . . . . 52.02 112.463 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 22.3 p -110.42 -22.19 11.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.755 0.312 . . . . 62.03 111.142 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' GLU . . . . . 0.401 ' HB3' ' CB ' ' A' ' 185' ' ' ASN . 1.9 tt0 -118.12 125.96 51.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 74.4 110.907 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 190' ' ' PHE . . . . . 0.538 ' HA ' ' HB ' ' A' ' 184' ' ' VAL . 32.2 t80 -137.4 125.1 22.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 75.1 110.822 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -136.46 141.95 13.06 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.724 -0.751 . . . . 60.32 112.473 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -133.46 145.19 17.25 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.696 -0.764 . . . . 71.34 112.442 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' SER . . . . . 0.576 ' C ' HD12 ' A' ' 194' ' ' ILE . 3.3 t -139.31 152.63 47.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.893 0.378 . . . . 71.22 110.833 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.576 HD12 ' C ' ' A' ' 193' ' ' SER . 3.1 mp -127.43 130.56 70.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 75.43 111.106 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 195' ' ' TYR . . . . . 0.401 ' HB2' ' HB3' ' A' ' 179' ' ' GLN . 2.4 m-85 -108.66 123.11 48.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.171 -0.468 . . . . 74.5 110.897 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 51.3 mm-40 -124.78 112.45 16.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.122 -0.49 . . . . 64.42 110.877 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 33.6 mtpt -107.69 127.94 54.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 71.3 110.936 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.435 HG12 ' O ' ' A' ' 198' ' ' VAL . 3.2 t 66.45 22.21 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.253 -0.431 . . . . 44.13 111.164 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -92.54 -32.74 14.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 72.2 110.87 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 22.6 mtpp -154.28 66.13 0.7 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 63.0 110.924 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' LYS . . . . . 0.611 ' C ' HD22 ' A' ' 202' ' ' LEU . 24.8 mttm 68.55 112.92 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.44 . . . . 50.24 110.941 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.611 HD22 ' C ' ' A' ' 201' ' ' LYS . 0.8 OUTLIER 63.25 -163.25 0.27 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.211 -0.45 . . . . 75.23 110.946 179.979 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 5.6 pm0 -115.04 129.68 56.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.436 . . . . 55.12 110.875 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.501 HG22 ' HA ' ' A' ' 223' ' ' ALA . 17.4 p -142.07 156.76 45.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 72.0 111.152 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -149.44 148.44 29.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.248 -0.433 . . . . 72.3 111.099 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.584 HG12 HG22 ' A' ' 221' ' ' ILE . 0.8 OUTLIER -112.89 148.54 15.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.224 -0.444 . . . . 75.04 111.149 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -126.71 136.92 53.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 65.45 110.917 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 5.6 mp -130.72 142.3 50.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.167 -0.47 . . . . 64.22 110.928 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.417 ' HB3' ' HD2' ' A' ' 218' ' ' ARG . . . -131.59 131.64 43.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.466 . . . . 64.43 111.071 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 18.9 t90 -130.69 126.21 35.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 73.03 110.946 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' THR . . . . . 0.62 HG23 ' CB ' ' A' ' 215' ' ' SER . 2.0 t -113.43 105.92 13.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.27 -0.423 . . . . 73.03 111.169 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -51.98 149.09 5.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 74.31 111.114 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 114.2 43.92 0.76 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.752 -0.737 . . . . 62.04 112.497 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 55.73 62.66 2.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.867 0.365 . . . . 72.45 110.901 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' SER . . . . . 0.62 ' CB ' HG23 ' A' ' 211' ' ' THR . 7.1 t -121.85 -178.04 3.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 60.51 110.826 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 29.7 m120 -101.74 150.29 23.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.128 -0.487 . . . . 64.33 110.873 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 2.9 p -79.24 138.69 37.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 75.42 111.181 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' ARG . . . . . 0.417 ' HD2' ' HB3' ' A' ' 209' ' ' ALA . 75.6 mtt180 -105.97 126.99 52.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 71.42 110.857 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -122.77 139.43 54.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 75.02 110.887 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -149.68 149.01 20.88 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.745 -0.741 . . . . 73.53 112.521 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.619 HG12 HG12 ' A' ' 237' ' ' VAL . 0.0 OUTLIER -138.7 130.85 37.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.775 0.321 . . . . 74.44 111.142 -179.954 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -120.81 133.12 55.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 72.32 111.107 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.501 ' HA ' HG22 ' A' ' 204' ' ' THR . . . -111.91 125.85 54.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 75.5 111.105 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 18.3 ttpp -115.58 114.66 25.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 75.11 110.863 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -109.59 118.6 37.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 74.44 110.903 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.93 114.11 27.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 54.32 110.887 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 44.2 mt -109.06 -35.35 2.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 73.24 111.102 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -149.17 157.47 39.65 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.637 0.732 . . . . 50.11 110.862 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -17.0 37.89 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.694 2.263 . . . . 72.34 112.366 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -103.35 -28.04 12.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 74.31 110.855 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -124.32 129.9 51.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.463 . . . . 54.54 111.087 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 19.1 m -139.65 141.18 37.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.272 -0.422 . . . . 64.02 110.89 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -106.6 133.16 51.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.447 . . . . 74.34 110.895 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 2.8 t -138.27 143.22 39.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.471 . . . . 64.0 110.852 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -146.7 159.03 43.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.128 -0.487 . . . . 73.22 111.098 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.98 148.71 19.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 64.44 110.86 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.619 HG12 HG12 ' A' ' 221' ' ' ILE . 0.9 OUTLIER -140.65 149.1 21.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 74.23 111.115 179.896 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -117.56 147.95 42.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 72.31 110.886 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -58.16 -18.16 23.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 74.44 110.858 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 11.2 t -81.46 26.67 0.46 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 53.22 110.884 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 1.7 m 62.78 32.94 15.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 75.03 110.841 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 242' ' ' LEU . . . . . 0.473 HD11 ' HB3' ' A' ' 264' ' ' ASP . 4.5 mp -100.13 117.69 34.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.136 -0.483 . . . . 74.52 110.892 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.43 ' HA ' HG23 ' A' ' 237' ' ' VAL . 0.0 OUTLIER -109.56 117.75 55.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.131 -0.486 . . . . 72.02 111.178 179.782 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 244' ' ' GLY . . . . . 0.443 ' HA2' ' HA ' ' A' ' 262' ' ' LEU . . . -122.31 148.29 17.02 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.723 -0.751 . . . . 72.24 112.479 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -145.57 130.08 17.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.882 0.373 . . . . 75.45 110.914 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -129.67 138.78 10.47 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.759 -0.734 . . . . 51.33 112.499 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -128.95 131.81 47.54 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.965 0.412 . . . . 75.0 110.919 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 16.8 p -111.41 129.19 56.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 61.54 111.126 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -142.78 123.12 13.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 62.33 110.951 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 20.8 p -106.77 153.13 22.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 72.15 111.129 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.794 HD12 HG21 ' A' ' 255' ' ' ILE . 6.2 mt -85.74 -77.11 0.31 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.216 -0.447 . . . . 51.24 110.927 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 252' ' ' LYS . . . . . 0.469 ' N ' ' HD2' ' A' ' 253' ' ' PRO . 1.6 mttm 177.88 -60.71 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.598 0.714 . . . . 73.21 110.858 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 253' ' ' PRO . . . . . 0.735 ' HG2' HD12 ' A' ' 255' ' ' ILE . 53.5 Cg_endo -69.81 69.31 1.68 Allowed 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.725 2.283 . . . . 64.44 112.314 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 50.47 32.46 23.24 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.785 -0.722 . . . . 70.22 112.445 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.794 HG21 HD12 ' A' ' 251' ' ' LEU . 58.6 mt -114.45 122.54 68.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.864 0.364 . . . . 61.31 111.113 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 17.4 mtpp -130.71 120.52 23.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.14 -0.482 . . . . 63.02 110.889 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 0.525 HD21 HD21 ' A' ' 277' ' ' LEU . 0.4 OUTLIER -100.75 128.71 46.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.455 . . . . 74.34 110.909 179.927 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 1.5 m -115.5 115.24 26.17 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.177 -0.465 . . . . 74.52 111.164 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.948 HD22 HD23 ' A' ' 277' ' ' LEU . 0.1 OUTLIER -112.39 126.09 54.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.239 -0.437 . . . . 75.34 110.919 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.404 ' N ' HD13 ' A' ' 259' ' ' LEU . 23.6 p -133.67 144.98 49.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 54.32 110.876 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 261' ' ' ALA . . . . . 0.612 ' HB2' ' CD2' ' A' ' 275' ' ' LEU . . . -155.08 128.25 8.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.129 -0.487 . . . . 53.14 111.06 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.811 ' C ' HD13 ' A' ' 263' ' ' LEU . 1.5 tt -132.75 139.89 47.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.453 . . . . 65.22 110.937 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 263' ' ' LEU . . . . . 0.811 HD13 ' C ' ' A' ' 262' ' ' LEU . 0.0 OUTLIER -123.93 110.13 14.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.202 -0.454 . . . . 65.53 110.937 179.884 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 264' ' ' ASP . . . . . 0.691 ' O ' HG22 ' A' ' 268' ' ' VAL . 1.8 m-20 -79.92 106.15 11.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.209 -0.451 . . . . 71.3 110.836 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -53.69 -19.67 10.47 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.767 -0.73 . . . . 72.44 112.461 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.8 -25.95 18.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.785 0.326 . . . . 72.32 110.889 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -99.04 -55.91 2.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 72.2 110.871 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 268' ' ' VAL . . . . . 0.698 HG12 ' O ' ' A' ' 272' ' ' GLY . 13.1 m -49.47 -28.23 3.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 64.33 111.124 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -53.25 -44.78 68.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 62.31 110.879 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -105.28 -17.38 14.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.445 . . . . 42.15 111.094 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -111.73 -119.82 3.85 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.743 -0.741 . . . . 45.13 112.488 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 272' ' ' GLY . . . . . 0.698 ' O ' HG12 ' A' ' 268' ' ' VAL . . . -148.72 -170.55 16.61 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.762 -0.733 . . . . 55.35 112.549 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 273' ' ' HIS . . . . . 0.669 ' CG ' HD12 ' A' ' 263' ' ' LEU . 0.9 OUTLIER -87.96 146.04 25.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.9 0.381 . . . . 71.54 110.815 -179.914 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -96.96 135.81 38.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 61.24 110.925 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.612 ' CD2' ' HB2' ' A' ' 261' ' ' ALA . 2.1 tm? -132.1 123.26 26.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 54.11 110.922 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 276' ' ' GLY . . . . . 0.506 ' N ' HD13 ' A' ' 275' ' ' LEU . . . -119.38 130.4 8.5 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.737 -0.744 . . . . 55.05 112.509 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.948 HD23 HD22 ' A' ' 259' ' ' LEU . 3.3 tm? -119.31 141.03 49.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.874 0.369 . . . . 73.0 110.921 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 278' ' ' GLY . . . . . 0.685 ' N ' HD13 ' A' ' 277' ' ' LEU . . . -145.36 132.46 4.65 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.797 -0.716 . . . . 74.11 112.512 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.636 HD11 HD11 ' A' ' 277' ' ' LEU . 1.1 mm? -108.7 132.12 54.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.805 0.336 . . . . 44.52 110.899 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 50.3 tt0 -127.57 117.67 22.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.185 -0.461 . . . . 64.41 110.871 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -122.7 134.5 54.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.483 . . . . 71.44 110.898 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -135.12 124.3 24.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 65.21 110.938 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.771 ' HB3' HG23 ' A' ' 33' ' ' THR . . . -100.06 130.88 46.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.445 . . . . 74.13 111.085 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.604 HD23 ' C ' ' A' ' 283' ' ' ALA . 0.9 OUTLIER 41.21 38.31 0.74 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.446 . . . . 74.41 110.92 -179.975 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.46 . . . . 75.13 110.861 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 301' ' ' NAI . . . . . 0.412 ' H6N' HD11 ' A' ' 262' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.4 mtt . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.808 0.337 . . . . 73.44 110.898 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.24 90.9 0.36 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 72.25 111.145 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.765 HG22 ' HA ' ' A' ' 121' ' ' GLU . 19.5 t -136.7 75.42 50.04 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 121.674 0.75 . . . . 64.55 111.133 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.7 167.91 23.01 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.74 2.293 . . . . 72.52 112.377 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 102.55 1.05 Allowed 'Trans proline' 0 N--CA 1.465 -0.172 0 C-N-CA 122.684 2.256 . . . . 73.42 112.362 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -86.45 -37.68 18.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 62.12 111.161 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -52.16 -39.9 60.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 71.41 110.886 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -76.24 -24.13 54.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 53.52 111.118 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -74.07 -21.11 60.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 52.24 110.917 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.594 HD23 ' CD2' ' A' ' 150' ' ' LEU . 20.7 mt -56.88 -34.1 67.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.157 -0.474 . . . . 63.04 110.92 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -132.18 29.2 3.37 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.742 -0.742 . . . . 74.11 112.481 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 12.5 ttpp -69.59 -45.79 67.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.801 0.334 . . . . 62.41 110.877 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.4 m -64.37 -39.34 93.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.458 . . . . 62.0 110.883 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.26 -50.58 73.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 31.33 111.109 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -67.44 -33.8 75.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 75.23 110.879 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -60.31 -47.91 84.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 74.43 110.833 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 85.8 t -75.77 -33.46 26.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 70.42 111.135 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -59.8 -41.36 91.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 75.15 110.881 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.3 p 46.74 85.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.139 -0.482 . . . . 73.13 111.152 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.0 mtmt -50.64 -34.44 26.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 65.43 110.933 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -98.79 79.14 0.55 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.72 -0.752 . . . . 72.35 112.442 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -129.66 108.31 10.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.952 0.406 . . . . 74.5 110.965 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 51.71 77.14 0.14 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.741 -0.742 . . . . 44.04 112.503 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -103.35 -3.43 25.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.887 0.375 . . . . 54.52 110.833 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.56 13.7 80.04 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.785 -0.722 . . . . 44.14 112.46 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.628 HD11 HD22 ' A' ' 48' ' ' ASN . 2.0 tp -138.88 -178.93 5.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.78 0.324 . . . . 33.12 110.91 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 1.028 HG23 HD12 ' A' ' 277' ' ' LEU . 14.7 mm -104.7 141.38 20.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.182 -0.463 . . . . 42.0 111.151 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.7 tttt -122.42 139.39 53.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 74.11 110.928 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.504 HD13 ' C ' ' A' ' 29' ' ' LEU . 2.8 tm? -131.81 128.73 39.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 70.2 110.884 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.488 ' N ' HD22 ' A' ' 29' ' ' LEU . 8.2 m-20 -140.73 127.14 19.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.141 -0.481 . . . . 74.45 110.882 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.57 HD23 ' N ' ' A' ' 32' ' ' LYS . 8.2 tt -138.37 138.89 38.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 73.44 110.93 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.57 ' N ' HD23 ' A' ' 31' ' ' LEU . 0.4 OUTLIER -121.47 125.61 47.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 42.52 110.922 179.832 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 96.6 m -121.01 129.12 53.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.229 -0.441 . . . . 73.53 111.108 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.4 tttt -143.33 126.97 16.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.214 -0.448 . . . . 70.1 110.926 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.663 ' HB3' HD23 ' A' ' 39' ' ' LEU . 0.2 OUTLIER -88.22 174.95 7.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.24 -0.436 . . . . 73.21 110.843 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.5 ' C ' ' O ' ' A' ' 35' ' ' SER . 43.8 mm-40 -29.38 -56.61 0.15 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.112 -0.495 . . . . 71.31 110.904 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 -173.77 149.37 1.57 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 73.24 110.899 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 86.54 -11.16 64.56 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.757 -0.735 . . . . 54.1 112.488 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.663 HD23 ' HB3' ' A' ' 35' ' ' SER . 3.2 mm? -104.2 132.49 50.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.791 0.329 . . . . 75.44 110.922 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.0 tm-20 -137.78 114.47 10.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.224 -0.444 . . . . 63.25 110.899 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.423 ' CZ ' HG23 ' A' ' 60' ' ' THR . 25.1 m-85 -134.94 118.32 16.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.094 -0.503 . . . . 63.34 110.868 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.58 130.82 46.17 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.125 -0.489 . . . . 62.24 111.107 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.3 p -127.04 131.99 50.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.196 -0.457 . . . . 65.53 110.825 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.9 m -148.72 126.82 12.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.092 -0.504 . . . . 44.42 110.813 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -167.92 179.41 41.21 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.757 -0.735 . . . . 71.42 112.517 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.0 m -137.33 161.5 36.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.899 0.38 . . . . 75.13 110.819 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.957 ' HB2' HG13 ' A' ' 54' ' ' VAL . . . -145.7 150.49 36.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.093 -0.503 . . . . 63.53 111.108 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.628 HD22 HD11 ' A' ' 26' ' ' LEU . 25.4 t-20 -73.77 142.65 46.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 74.11 110.832 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -55.14 -39.27 69.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.123 -0.489 . . . . 73.24 111.127 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -95.17 25.24 4.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.454 . . . . 73.13 110.874 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 20.5 p 48.09 30.75 2.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 74.23 111.093 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 22.7 m -71.1 -30.8 66.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 64.25 111.124 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 10.5 tptm -165.84 130.72 2.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.247 -0.433 . . . . 52.54 110.885 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.957 HG13 ' HB2' ' A' ' 47' ' ' ALA . 7.9 t -125.18 125.71 69.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 73.15 111.095 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.7 t -136.68 129.04 30.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 61.01 111.165 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -151.03 150.46 22.43 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.705 -0.759 . . . . 72.1 112.474 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -104.48 146.39 28.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.874 0.369 . . . . 74.02 110.875 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.658 HD13 ' N ' ' A' ' 59' ' ' GLU . 0.9 OUTLIER -125.67 132.41 52.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.12 -0.491 . . . . 73.21 110.94 179.985 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.658 ' N ' HD13 ' A' ' 58' ' ' LEU . 6.7 pt-20 -125.39 120.08 30.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.441 . . . . 74.24 110.85 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.423 HG23 ' CZ ' ' A' ' 41' ' ' PHE . 96.9 m -124.76 137.68 54.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 73.43 111.12 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.658 ' CB ' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -172.39 -178.6 2.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 74.54 110.882 179.901 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -115.22 141.65 47.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.233 -0.44 . . . . 75.42 110.897 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -134.41 111.65 10.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.097 -0.501 . . . . 74.44 110.906 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 2.4 m-90 -106.12 110.59 22.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 53.12 110.952 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 10.3 t -81.29 -33.26 32.75 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.257 -0.429 . . . . 62.03 111.136 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -49.97 -54.82 17.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.245 -0.434 . . . . 65.35 110.888 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -73.76 -51.11 17.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.463 . . . . 61.42 110.91 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.742 ' O ' HD22 ' A' ' 69' ' ' LEU . . . 123.78 32.01 0.91 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.785 -0.721 . . . . 75.01 112.462 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.742 HD22 ' O ' ' A' ' 68' ' ' GLY . 3.9 mm? -135.09 132.87 38.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.917 0.389 . . . . 75.23 110.866 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 55.5 p -132.42 111.09 11.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 75.51 111.119 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.632 ' O ' ' HB3' ' A' ' 61' ' ' LYS . 0.2 OUTLIER -105.56 132.69 51.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.438 . . . . 73.03 110.888 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.658 ' HA ' ' CB ' ' A' ' 61' ' ' LYS . 17.8 p -129.88 136.14 49.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.484 . . . . 70.23 111.143 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.631 ' HG3' HG23 ' A' ' 83' ' ' THR . 25.6 tt0 -126.5 122.01 33.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 52.14 110.877 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.49 139.69 44.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 73.14 110.892 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 8.1 t90 -135.44 129.54 33.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 74.21 110.924 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -116.85 149.29 40.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.263 -0.426 . . . . 71.42 110.891 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 8.8 t -65.12 -14.22 59.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.184 -0.462 . . . . 73.04 111.172 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.456 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 5.6 m-20 -75.25 2.03 12.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 74.35 110.865 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.456 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 2.9 m120 80.09 36.83 0.12 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 63.45 110.932 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.2 m -116.55 121.39 41.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 63.44 111.168 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.592 HD23 ' CD ' ' A' ' 105' ' ' PRO . 4.4 mm? -101.67 149.22 24.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.249 -0.432 . . . . 75.2 110.933 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -148.81 143.15 10.6 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.696 -0.764 . . . . 62.31 112.493 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.631 HG23 ' HG3' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -146.53 96.97 2.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.763 0.316 . . . . 61.04 111.11 -179.835 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.435 ' HA ' ' HA ' ' A' ' 100' ' ' ASP . 15.8 tt0 -106.14 122.7 46.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.207 -0.451 . . . . 74.24 110.886 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.481 HG22 ' O ' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -121.63 138.26 52.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 74.5 111.146 179.945 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.477 HG23 HG23 ' A' ' 98' ' ' THR . 0.2 OUTLIER -113.62 141.28 47.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.148 -0.478 . . . . 72.33 111.122 179.976 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.695 HG13 HD11 ' A' ' 69' ' ' LEU . 0.3 OUTLIER -121.58 120.07 60.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 40.13 111.148 179.893 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -93.77 118.26 31.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 71.51 110.943 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 49.68 70.37 0.5 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.203 -0.453 . . . . 73.22 110.876 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.536 ' CB ' HD23 ' A' ' 97' ' ' LEU . 6.4 tp60 -76.37 86.69 3.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.205 -0.452 . . . . 73.42 110.9 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 11.7 tp 66.19 30.38 9.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 71.31 110.933 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -179.48 100.68 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 73.14 111.126 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 5.9 mpt_? -51.13 134.41 26.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 64.42 110.86 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 96.41 -20.27 51.06 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.721 -0.752 . . . . 61.24 112.542 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.487 HD23 HD21 ' A' ' 97' ' ' LEU . 14.5 tp -85.0 134.78 34.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.902 0.382 . . . . 62.34 110.896 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.467 ' O ' HD13 ' A' ' 97' ' ' LEU . 10.9 ptmt -121.94 128.02 51.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 73.1 110.898 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.536 HD23 ' CB ' ' A' ' 90' ' ' GLN . 2.4 mm? -122.98 130.58 52.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 73.24 110.925 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.477 HG23 HG23 ' A' ' 86' ' ' THR . 0.3 OUTLIER -130.53 117.17 19.19 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.176 -0.465 . . . . 74.03 111.138 179.932 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.481 ' O ' HG22 ' A' ' 85' ' ' ILE . 75.0 t80 -125.47 115.1 19.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 72.35 110.849 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.435 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 2.9 p30 -130.5 142.25 50.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.137 -0.483 . . . . 63.13 110.865 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.552 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 3.1 p -141.77 122.79 14.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 64.42 110.881 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 71.3 p -140.7 141.65 34.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 52.33 110.883 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.477 ' HB2' ' H ' ' A' ' 111' ' ' ASN . 0.1 OUTLIER -176.7 157.79 1.6 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.48 . . . . 74.32 110.885 -179.902 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -78.92 113.13 32.9 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.629 0.728 . . . . 73.54 110.888 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.592 ' CD ' HD23 ' A' ' 81' ' ' LEU . 54.2 Cg_endo -69.75 -4.02 13.19 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.71 2.273 . . . . 50.44 112.325 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -45.13 -35.0 2.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 75.52 110.86 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.8 p -129.2 23.12 5.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.455 . . . . 71.42 111.177 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 75.69 27.33 63.23 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.678 -0.772 . . . . 74.24 112.511 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.446 ' O ' ' HB3' ' A' ' 103' ' ' PHE . 15.4 mtpt -77.61 140.74 39.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.835 0.35 . . . . 74.14 110.902 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.401 ' C ' ' HD1' ' A' ' 103' ' ' PHE . 23.4 mttt -156.61 113.38 3.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 62.54 110.895 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.552 ' O ' ' HA ' ' A' ' 101' ' ' SER . 44.2 t-20 -115.33 118.68 33.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.444 . . . . 62.4 110.914 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.466 ' HB1' ' CZ ' ' A' ' 99' ' ' PHE . . . -116.1 150.23 37.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.221 -0.445 . . . . 72.12 111.107 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 4.0 tttp -135.19 136.78 42.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 73.34 110.874 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 6.2 tp -112.07 125.01 69.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 63.34 111.096 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 28.5 tttt -122.02 120.0 33.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 63.11 110.915 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 7.1 t -125.35 125.98 44.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 73.53 111.168 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -153.46 176.9 31.3 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.7 -0.762 . . . . 54.12 112.487 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -128.27 144.6 51.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.907 0.384 . . . . 74.22 110.965 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 17.8 mtpt -110.42 117.97 35.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.106 -0.497 . . . . 73.4 110.893 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.43 ' HB2' HG22 ' A' ' 123' ' ' ILE . 1.4 mmm180 -110.65 146.55 35.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 75.15 110.899 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.765 ' HA ' HG22 ' A' ' 3' ' ' VAL . 15.7 pt-20 -56.6 -31.01 63.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 74.32 110.875 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 13.9 m80 -124.23 9.37 8.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.455 . . . . 74.32 110.884 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.604 ' CG2' HD23 ' A' ' 125' ' ' LEU . 1.0 OUTLIER -145.58 147.37 18.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 73.4 111.104 -179.999 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -127.62 113.62 16.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 75.33 110.877 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.604 HD23 ' CG2' ' A' ' 123' ' ' ILE . 3.4 mm? -117.44 127.43 54.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 72.4 110.94 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -146.7 114.71 0.74 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.726 -0.749 . . . . 63.21 112.476 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -113.29 134.62 54.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.847 0.356 . . . . 64.45 110.872 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -124.94 143.58 50.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 64.31 110.834 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 3.2 mmt -138.98 119.04 13.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 74.23 110.88 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -86.17 123.64 31.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.24 -0.436 . . . . 70.13 110.881 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -92.1 98.97 11.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 73.55 110.882 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -115.92 117.05 29.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.141 -0.481 . . . . 74.51 110.882 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 2.5 pp -53.83 -32.54 22.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 72.25 111.172 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -84.36 -20.01 32.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 65.13 111.115 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 162.01 101.66 0.17 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.741 -0.742 . . . . 74.21 112.503 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 161.31 46.42 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.703 2.269 . . . . 71.52 112.369 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.0 m -127.97 151.68 48.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.231 -0.44 . . . . 74.14 110.894 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.631 HD12 ' OG1' ' A' ' 159' ' ' THR . 3.0 mp -109.06 125.65 66.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 63.35 111.093 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 15.5 ttt180 -122.85 129.25 51.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.119 -0.492 . . . . 71.1 110.882 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -124.18 133.71 8.85 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.712 -0.756 . . . . 72.42 112.509 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -133.16 126.64 32.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.855 0.36 . . . . 61.25 111.093 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.507 HD23 ' N ' ' A' ' 143' ' ' VAL . 0.7 OUTLIER -139.93 121.65 15.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.435 . . . . 55.21 110.882 -179.987 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.507 ' N ' HD23 ' A' ' 142' ' ' LEU . 1.5 m -133.8 139.55 48.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 73.41 111.139 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.41 HD12 ' N ' ' A' ' 144' ' ' LEU . 4.6 mp -109.67 138.66 45.72 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.205 -0.452 . . . . 75.2 110.937 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -100.38 136.94 12.97 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.701 -0.761 . . . . 23.43 112.473 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -141.68 147.13 37.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.851 0.357 . . . . 73.03 110.932 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -49.85 94.3 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.135 -0.484 . . . . 63.11 110.842 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 89.66 -25.27 11.64 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.74 -0.743 . . . . 23.42 112.509 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 37.2 m95 -104.92 142.01 35.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.816 0.341 . . . . 63.23 110.909 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.594 ' CD2' HD23 ' A' ' 10' ' ' LEU . 43.7 tp -140.15 140.16 35.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.236 -0.438 . . . . 73.55 110.868 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -136.01 141.52 44.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 63.12 111.102 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -148.71 134.27 4.92 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.726 -0.749 . . . . 32.44 112.465 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -133.3 124.08 26.63 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.866 0.365 . . . . 73.21 110.976 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -121.0 121.57 38.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.116 -0.493 . . . . 75.11 110.908 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 2.7 ptp -128.1 128.41 44.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.451 . . . . 61.34 110.891 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.487 ' O ' HG22 ' A' ' 164' ' ' VAL . 14.6 m-20 -113.62 121.58 44.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 63.41 110.901 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.435 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 38.9 m-85 -94.84 126.78 40.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 75.51 110.883 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.693 ' OE2' ' HB3' ' A' ' 160' ' ' ALA . 0.0 OUTLIER -79.04 100.86 7.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 64.32 110.883 -179.909 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.631 ' OG1' HD12 ' A' ' 138' ' ' ILE . 0.2 OUTLIER -64.56 -48.11 76.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.461 . . . . 74.41 111.11 -179.909 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.693 ' HB3' ' OE2' ' A' ' 158' ' ' GLU . . . -48.19 -26.09 1.77 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.225 -0.443 . . . . 60.01 111.11 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 25.4 mmtt -127.24 -167.76 1.78 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 74.31 110.87 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 6.1 t -110.59 40.12 2.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.26 -0.427 . . . . 72.11 110.874 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 9.4 mmt180 -154.19 176.74 11.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.108 -0.496 . . . . 73.51 110.83 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.487 HG22 ' O ' ' A' ' 156' ' ' ASN . 0.9 OUTLIER -73.61 142.69 14.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.14 -0.482 . . . . 72.11 111.122 179.97 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.408 ' HB ' ' HG2' ' A' ' 158' ' ' GLU . 8.6 t -90.51 -36.13 14.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.47 . . . . 74.25 111.117 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -156.24 142.88 18.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 64.43 110.871 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 2.5 p -124.99 129.66 50.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.177 -0.465 . . . . 54.44 110.845 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -136.2 148.31 48.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.103 -0.499 . . . . 74.52 110.889 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -152.09 140.17 20.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.192 -0.458 . . . . 74.32 110.892 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -154.63 142.77 20.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.465 . . . . 64.03 111.112 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -145.97 127.48 7.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 71.25 111.111 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -98.97 117.43 5.87 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.728 -0.749 . . . . 72.43 112.445 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.76 119.01 35.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.956 0.408 . . . . 74.24 110.92 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 3.3 mtpm? -116.16 127.28 54.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.085 -0.507 . . . . 60.1 110.878 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.421 ' HB ' ' H ' ' A' ' 178' ' ' PHE . 0.2 OUTLIER -110.14 166.99 10.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.226 -0.443 . . . . 74.54 111.151 -179.991 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -73.34 -6.39 45.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.186 -0.461 . . . . 73.13 110.866 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -119.49 -37.99 3.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 74.43 110.867 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.421 ' H ' ' HB ' ' A' ' 175' ' ' THR . 34.5 p90 -148.96 150.81 33.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 71.22 110.904 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -125.55 122.05 35.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.136 -0.484 . . . . 72.32 110.917 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.757 ' C ' HD12 ' A' ' 180' ' ' LEU . 0.3 OUTLIER -126.35 146.15 50.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.22 -0.445 . . . . 72.13 110.97 179.982 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 181' ' ' HIS . . . . . 0.703 ' N ' HD12 ' A' ' 180' ' ' LEU . 66.1 m-70 -119.74 116.71 26.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 65.53 110.821 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.24 143.82 28.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 60.31 111.163 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 18.2 t30 -145.18 137.86 26.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 62.24 110.875 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.532 HG22 ' HA ' ' A' ' 190' ' ' PHE . 2.4 t -134.62 114.3 17.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.253 -0.43 . . . . 71.45 111.146 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -101.96 92.58 4.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 75.41 110.883 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 2.6 t70 66.13 171.36 0.23 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 60.2 110.879 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -69.53 -4.71 46.85 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.738 -0.744 . . . . 51.52 112.487 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 33.9 p -95.06 -26.34 16.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.808 0.337 . . . . 73.34 111.162 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -123.65 114.9 20.6 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.186 -0.461 . . . . 61.33 110.906 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' PHE . . . . . 0.532 ' HA ' HG22 ' A' ' 184' ' ' VAL . 26.2 p90 -140.75 124.9 17.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 62.13 110.859 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -175.46 -149.17 7.19 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.744 -0.741 . . . . 62.41 112.509 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -173.51 -165.96 31.09 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.731 -0.747 . . . . 64.44 112.472 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 70.9 m -149.51 148.01 28.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.886 0.374 . . . . 61.41 110.858 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.483 ' HB ' HG22 ' A' ' 206' ' ' VAL . 5.4 mp -119.91 140.98 42.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.099 -0.5 . . . . 73.22 111.131 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 195' ' ' TYR . . . . . 0.618 ' HD2' ' HB2' ' A' ' 205' ' ' ALA . 14.8 t80 -132.34 120.7 22.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 74.24 110.941 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 8.7 tm0? -126.2 131.26 52.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.168 -0.469 . . . . 53.44 110.946 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 6.1 mtmp? -97.65 124.81 42.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 73.15 110.851 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.445 ' HB ' HD12 ' A' ' 202' ' ' LEU . 84.1 t -94.39 -33.7 5.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.445 . . . . 71.15 111.107 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -174.66 170.41 3.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.47 . . . . 53.3 110.906 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 19.1 mtpt -50.93 -33.66 25.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 75.33 110.878 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 4.0 mptt -120.43 53.44 1.1 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.245 -0.434 . . . . 72.23 110.944 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.445 HD12 ' HB ' ' A' ' 198' ' ' VAL . 0.2 OUTLIER -175.14 92.92 0.06 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 74.12 110.911 179.934 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -111.95 134.51 53.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 74.32 110.899 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 4.8 t -130.8 138.1 49.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 64.54 111.109 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.618 ' HB2' ' HD2' ' A' ' 195' ' ' TYR . . . -150.3 163.42 38.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.242 -0.435 . . . . 53.33 111.112 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.896 HG12 HG22 ' A' ' 221' ' ' ILE . 1.0 OUTLIER -137.14 147.95 26.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.44 . . . . 60.41 111.124 179.96 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -120.87 126.61 50.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.47 . . . . 54.44 110.911 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.409 HD12 HG23 ' A' ' 206' ' ' VAL . 1.3 mp -128.41 142.77 51.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.161 -0.472 . . . . 65.44 110.908 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -157.47 130.77 7.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 73.24 111.126 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 1.8 t-105 -103.6 123.63 47.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.199 -0.455 . . . . 73.42 110.955 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 61.8 p -107.47 104.74 14.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.257 -0.429 . . . . 62.23 111.161 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -51.11 138.69 19.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.262 -0.426 . . . . 72.35 111.074 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 154.73 -46.79 0.53 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.689 -0.767 . . . . 64.02 112.482 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -151.62 35.02 0.55 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.804 0.335 . . . . 73.42 110.866 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 47.7 t 50.98 44.76 28.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 63.03 110.892 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -101.87 131.79 48.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.147 -0.479 . . . . 73.01 110.922 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 5.2 t -115.36 139.0 50.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 75.21 111.179 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -105.94 131.57 53.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.209 -0.45 . . . . 74.04 110.879 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' PHE . . . . . 0.522 ' CZ ' HD12 ' A' ' 221' ' ' ILE . 13.4 t80 -131.41 136.21 47.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.466 . . . . 73.21 110.919 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -145.45 153.12 25.08 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.73 -0.748 . . . . 74.21 112.446 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.896 HG22 HG12 ' A' ' 206' ' ' VAL . 0.0 OUTLIER -137.67 130.68 42.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.85 0.357 . . . . 63.53 111.169 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -135.81 149.0 48.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.16 -0.473 . . . . 63.31 111.119 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -145.02 143.43 30.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.248 -0.433 . . . . 71.23 111.113 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 21.3 ttpp -117.74 132.89 56.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.237 -0.438 . . . . 60.34 110.865 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -132.99 132.38 41.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 64.24 110.908 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -93.67 130.45 39.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.107 -0.497 . . . . 61.22 110.922 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 71.5 mt -78.26 -56.0 8.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.214 -0.448 . . . . 51.44 111.129 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.56 ' N ' ' HD2' ' A' ' 229' ' ' PRO . 0.1 OUTLIER 173.33 -56.94 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.61 0.719 . . . . 73.4 110.881 179.843 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 228' ' ' ASP . 53.2 Cg_endo -69.79 -156.73 0.04 OUTLIER 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.743 2.295 . . . . 53.53 112.332 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -85.55 15.79 4.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.266 -0.424 . . . . 62.34 110.871 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.665 ' HB2' ' HG3' ' A' ' 249' ' ' GLN . . . -120.43 122.28 40.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 65.22 111.059 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 31.7 m -115.71 144.39 44.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 73.04 110.837 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -111.44 131.23 55.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 70.14 110.823 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 3.5 p -127.67 141.75 51.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 63.43 110.867 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -119.76 141.65 49.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.122 -0.49 . . . . 65.51 111.096 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 18.2 mttp -145.74 142.54 29.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 74.01 110.858 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 242' ' ' LEU . 6.7 p -136.35 142.74 37.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 62.03 111.129 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -104.51 148.38 26.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 72.32 110.866 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -57.15 -18.76 16.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 72.35 110.891 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 2.1 m -82.02 25.37 0.58 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.476 . . . . 60.21 110.874 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 63.6 34.46 12.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.121 -0.49 . . . . 71.23 110.829 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 242' ' ' LEU . . . . . 0.457 HD11 ' HB3' ' A' ' 264' ' ' ASP . 2.7 mp -99.93 117.24 33.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 64.53 110.882 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.516 ' H ' HD12 ' A' ' 243' ' ' ILE . 0.2 OUTLIER -111.19 116.5 52.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.142 -0.481 . . . . 75.31 111.128 179.836 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 244' ' ' GLY . . . . . 0.522 ' C ' HD13 ' A' ' 245' ' ' LEU . . . -145.93 164.98 28.16 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.721 -0.752 . . . . 72.33 112.487 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.667 ' N ' HD13 ' A' ' 245' ' ' LEU . 0.0 OUTLIER -145.36 160.68 41.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.812 0.339 . . . . 75.03 110.926 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -129.52 139.62 11.1 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.718 -0.753 . . . . 64.13 112.464 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -116.69 115.86 26.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.996 0.427 . . . . 70.23 110.905 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 56.1 p -111.76 115.51 29.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.119 -0.492 . . . . 72.42 111.128 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 249' ' ' GLN . . . . . 0.665 ' HG3' ' HB2' ' A' ' 231' ' ' ALA . 49.5 tt0 -129.07 137.89 51.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 71.24 110.897 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 250' ' ' THR . . . . . 0.653 HG23 ' HG2' ' A' ' 256' ' ' LYS . 95.4 m -119.05 116.81 27.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.45 . . . . 72.2 111.157 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -106.02 103.71 13.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.236 -0.438 . . . . 75.04 110.921 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 252' ' ' LYS . . . . . 0.409 ' HB3' ' HD2' ' A' ' 253' ' ' PRO . 20.1 mmmt 64.34 154.6 0.12 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.588 0.709 . . . . 73.12 110.886 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 253' ' ' PRO . . . . . 0.409 ' HD2' ' HB3' ' A' ' 252' ' ' LYS . 53.6 Cg_endo -69.8 75.42 1.23 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.699 2.266 . . . . 74.03 112.312 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 167.02 -32.17 0.2 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.782 -0.723 . . . . 74.43 112.477 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 7.3 mt -117.68 122.58 70.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.965 0.412 . . . . 73.01 111.099 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.653 ' HG2' HG23 ' A' ' 250' ' ' THR . 20.9 mtpt -130.81 127.35 38.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.484 . . . . 63.41 110.935 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -100.68 128.78 46.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.242 -0.435 . . . . 65.03 110.886 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 23.3 m -126.46 113.01 16.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 72.53 111.125 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.594 ' CD1' HD23 ' A' ' 277' ' ' LEU . 0.1 OUTLIER -121.45 150.55 41.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.207 -0.452 . . . . 75.32 110.915 179.91 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 40.8 p -151.16 140.96 21.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 62.4 110.874 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 261' ' ' ALA . . . . . 0.613 ' HB2' ' CD2' ' A' ' 275' ' ' LEU . . . -141.37 133.49 27.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.142 -0.481 . . . . 53.02 111.087 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.787 ' C ' HD13 ' A' ' 263' ' ' LEU . 0.7 OUTLIER -131.85 138.2 48.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.221 -0.445 . . . . 75.13 110.917 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 263' ' ' LEU . . . . . 0.787 HD13 ' C ' ' A' ' 262' ' ' LEU . 0.1 OUTLIER -121.81 109.28 14.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.155 -0.475 . . . . 71.41 110.923 179.881 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 264' ' ' ASP . . . . . 0.605 ' O ' HG22 ' A' ' 268' ' ' VAL . 1.0 OUTLIER -84.73 103.95 14.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 63.44 110.86 179.903 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -59.21 -11.04 11.31 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.685 -0.769 . . . . 54.34 112.508 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 47.3 mtpt -78.29 -3.31 42.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.826 0.346 . . . . 73.04 110.914 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 -156.19 -53.28 0.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 61.42 110.884 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 268' ' ' VAL . . . . . 0.62 HG12 ' O ' ' A' ' 272' ' ' GLY . 1.8 m -57.71 -18.85 10.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 73.22 111.126 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -50.94 -28.35 9.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 73.33 110.88 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -102.95 -17.61 15.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.457 . . . . 64.35 111.085 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 142.43 122.66 1.77 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.758 -0.734 . . . . 52.21 112.496 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 272' ' ' GLY . . . . . 0.62 ' O ' HG12 ' A' ' 268' ' ' VAL . . . 134.78 62.12 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.707 -0.759 . . . . 55.54 112.521 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 273' ' ' HIS . . . . . 0.589 ' HB2' HD12 ' A' ' 263' ' ' LEU . 18.2 p-80 -76.33 146.13 39.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.855 0.359 . . . . 72.24 110.843 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 13.9 mttp -95.46 135.37 37.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 65.31 110.933 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.747 HD13 ' N ' ' A' ' 276' ' ' GLY . 2.4 tm? -135.59 139.25 43.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 72.44 110.927 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 276' ' ' GLY . . . . . 0.747 ' N ' HD13 ' A' ' 275' ' ' LEU . . . -134.03 129.26 5.22 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.738 -0.744 . . . . 42.24 112.526 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 1.028 HD12 HG23 ' A' ' 27' ' ' ILE . 3.3 tm? -115.54 135.35 54.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.901 0.382 . . . . 72.23 110.889 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 278' ' ' GLY . . . . . 0.548 ' O ' HD13 ' A' ' 279' ' ' LEU . . . -147.45 141.49 9.35 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.746 -0.74 . . . . 75.02 112.481 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.548 HD13 ' O ' ' A' ' 278' ' ' GLY . 1.1 mm? -119.57 140.13 51.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.798 0.333 . . . . 63.12 110.894 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 15.3 mp0 -128.53 118.21 22.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.148 -0.478 . . . . 74.3 110.868 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -114.24 128.83 56.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.479 . . . . 73.51 110.877 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -113.42 112.99 24.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 65.24 110.92 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.636 ' C ' HD22 ' A' ' 284' ' ' LEU . . . -115.72 113.34 23.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 63.44 111.066 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.636 HD22 ' C ' ' A' ' 283' ' ' ALA . 3.2 mm? -130.75 -74.52 0.53 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 74.42 110.941 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 63.44 110.929 179.92 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 301' ' ' NAI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.824 0.345 . . . . 52.03 111.12 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.683 HG22 ' CA ' ' A' ' 121' ' ' GLU . 3.1 t 60.47 82.58 0.22 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.649 0.737 . . . . 74.14 111.148 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 167.76 23.49 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.684 2.256 . . . . 75.31 112.323 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 116.48 4.59 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.653 2.236 . . . . 75.3 112.324 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.612 ' OG1' HD21 ' A' ' 150' ' ' LEU . 1.8 t -107.85 -39.44 5.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 72.44 111.172 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.717 ' CB ' HG21 ' A' ' 143' ' ' VAL . 41.5 p90 -67.96 -35.17 77.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 72.04 110.896 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -73.17 -23.32 60.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.113 -0.494 . . . . 74.13 111.103 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -90.02 13.95 13.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 70.3 110.855 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.607 HD23 HD22 ' A' ' 150' ' ' LEU . 45.2 mt -73.77 -34.27 64.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.2 -0.455 . . . . 73.54 110.954 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 172.62 40.94 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.699 -0.762 . . . . 71.12 112.437 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 44.4 tptt -68.6 -46.02 70.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.823 0.344 . . . . 51.41 110.917 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.1 t -64.79 -39.44 93.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 63.24 110.865 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.14 -49.97 52.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 55.14 111.083 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.499 ' O ' HG23 ' A' ' 19' ' ' THR . 9.7 ptp180 -66.72 -32.79 74.32 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.223 -0.444 . . . . 75.52 110.87 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -58.89 -48.17 82.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.147 -0.478 . . . . 73.45 110.837 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.8 p -81.54 -31.44 11.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 73.24 111.148 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -65.92 -41.35 91.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 73.44 110.905 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.499 HG23 ' O ' ' A' ' 15' ' ' ARG . 69.0 p -73.81 76.92 1.6 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 73.55 111.187 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.95 124.68 18.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 72.33 110.882 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -53.49 120.11 12.76 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.761 -0.733 . . . . 73.21 112.456 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -59.89 97.96 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.936 0.398 . . . . 73.15 110.914 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -77.74 88.78 1.05 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.749 -0.739 . . . . 74.11 112.529 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.438 ' HB2' HD23 ' A' ' 26' ' ' LEU . 20.0 m-85 -101.12 13.39 35.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.914 0.388 . . . . 73.53 110.888 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.85 13.31 80.77 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.709 -0.758 . . . . 71.42 112.481 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.594 HD12 ' N ' ' A' ' 27' ' ' ILE . 1.7 pp -101.91 174.81 5.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.836 0.351 . . . . 74.33 110.881 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.702 HG13 HD12 ' A' ' 277' ' ' LEU . 1.7 mp -116.94 123.89 72.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 73.13 111.142 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.494 ' O ' HD22 ' A' ' 279' ' ' LEU . 71.6 mttt -101.69 154.56 18.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 73.45 110.909 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.659 HD13 ' N ' ' A' ' 30' ' ' ASP . 3.0 tm? -146.05 136.34 23.85 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.23 -0.441 . . . . 73.25 110.88 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.659 ' N ' HD13 ' A' ' 29' ' ' LEU . 13.8 m-20 -153.81 124.64 7.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.456 . . . . 73.13 110.93 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.736 HD11 ' CB ' ' A' ' 283' ' ' ALA . 3.2 tm? -137.2 128.12 27.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.196 -0.456 . . . . 74.14 110.919 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.474 ' N ' HD13 ' A' ' 31' ' ' LEU . 10.8 pttp -120.7 134.67 55.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 65.31 110.936 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -137.95 120.65 16.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 65.31 111.147 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -126.12 146.99 49.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.234 -0.439 . . . . 75.12 110.892 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -139.06 166.99 23.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 64.41 110.878 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -89.42 49.46 1.76 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.118 -0.492 . . . . 52.15 110.878 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -136.37 4.84 2.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.476 . . . . 72.04 110.875 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' A' ' 63' ' ' ARG . . . 89.13 -7.16 82.76 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.741 -0.742 . . . . 74.33 112.482 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.418 HD23 ' O ' ' A' ' 39' ' ' LEU . 1.6 pt? -98.76 129.83 45.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.779 0.323 . . . . 61.1 110.926 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -142.08 117.86 10.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.444 . . . . 64.3 110.895 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.51 122.29 43.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 71.42 110.872 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.11 115.32 19.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 62.12 111.12 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.7 p -115.68 134.43 55.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.249 -0.432 . . . . 52.12 110.888 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 74.8 m -149.26 126.64 11.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 64.43 110.827 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -173.62 167.53 40.17 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.734 -0.746 . . . . 70.24 112.524 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.4 p -137.58 158.05 45.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.885 0.374 . . . . 73.54 110.865 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.435 ' HA ' ' HA ' ' A' ' 54' ' ' VAL . . . -140.42 129.66 23.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 74.01 111.085 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -98.06 127.34 43.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 74.01 110.874 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 28.6 p -90.68 -52.93 4.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 72.4 111.113 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -51.51 -38.28 53.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 73.12 110.896 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 43.9 p -133.91 161.79 33.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 73.24 111.134 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.2 p -75.7 78.1 2.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.227 -0.442 . . . . 72.2 111.111 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 10.9 ttpt -142.7 78.83 1.63 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 72.31 110.906 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' A' ' 47' ' ' ALA . 1.3 p -127.79 121.24 56.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 71.44 111.104 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 6.3 m -137.22 126.72 25.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.202 -0.454 . . . . 73.13 111.107 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -111.87 154.28 16.86 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.751 -0.738 . . . . 54.33 112.487 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.5 m -136.98 143.87 43.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.889 0.376 . . . . 51.54 110.865 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.564 HD13 ' N ' ' A' ' 59' ' ' GLU . 0.8 OUTLIER -121.08 126.28 49.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 52.21 110.911 179.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.564 ' N ' HD13 ' A' ' 58' ' ' LEU . 8.2 mp0 -121.69 126.46 49.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 65.22 110.878 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -104.11 120.12 40.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.143 -0.481 . . . . 51.11 111.119 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -119.76 158.75 25.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.181 -0.463 . . . . 74.42 110.855 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -133.16 140.89 47.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.145 -0.479 . . . . 74.04 110.898 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.512 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 21.4 tpp180 -131.25 103.32 6.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.107 -0.497 . . . . 71.43 110.86 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 17.8 m95 -116.15 121.26 41.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.461 . . . . 72.44 110.961 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.7 m 66.34 136.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.251 -0.431 . . . . 73.05 111.148 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -63.82 106.07 0.94 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.241 -0.436 . . . . 63.42 110.858 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 23.2 t80 66.51 59.08 0.63 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.154 -0.475 . . . . 73.53 110.886 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -140.62 -65.78 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.743 -0.741 . . . . 54.32 112.482 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.487 HD13 ' HA ' ' A' ' 87' ' ' VAL . 0.7 OUTLIER -130.62 129.03 42.18 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.891 0.377 . . . . 63.53 110.907 -179.91 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 5.1 m -137.92 133.26 33.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.177 -0.465 . . . . 62.34 111.124 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -123.27 134.79 54.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.444 . . . . 71.42 110.886 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.8 p -127.28 118.52 24.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.466 . . . . 72.5 111.19 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -121.82 130.06 53.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.259 -0.428 . . . . 74.44 110.849 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -122.24 104.98 9.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.48 . . . . 73.23 110.857 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 8.6 t90 -122.35 125.71 46.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.251 -0.431 . . . . 74.53 110.909 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -102.81 137.11 41.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 70.22 110.926 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 24.0 m -66.85 -34.4 77.72 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.206 -0.452 . . . . 73.32 111.136 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -110.81 -34.08 6.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.258 -0.428 . . . . 64.24 110.891 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -81.25 -160.55 0.34 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 54.41 110.901 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 66.6 p -80.95 154.05 27.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 74.53 111.154 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.618 ' H ' HD23 ' A' ' 81' ' ' LEU . 2.1 pt? -111.44 137.31 49.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 73.13 110.896 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -159.77 162.94 33.37 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.73 -0.748 . . . . 41.21 112.466 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.5 t -138.46 163.54 31.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.721 0.296 . . . . 53.12 111.137 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.33 145.48 25.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.456 . . . . 43.34 110.868 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.56 138.08 55.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.475 . . . . 71.11 111.146 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.542 HG23 ' OG1' ' A' ' 98' ' ' THR . 20.3 m -127.03 129.15 47.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.18 -0.463 . . . . 54.35 111.156 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.487 ' HA ' HD13 ' A' ' 69' ' ' LEU . 3.4 p -128.61 137.34 57.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 61.25 111.16 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -102.62 118.47 36.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 71.54 110.878 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -50.49 128.07 19.2 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.156 -0.474 . . . . 74.33 110.867 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -79.43 -56.71 4.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.185 -0.461 . . . . 64.33 110.935 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 15.3 mt -72.26 -41.29 66.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 74.22 110.928 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -93.78 71.6 4.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 74.24 111.121 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 11.5 tpt180 -50.98 135.32 24.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 74.31 110.883 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 101.75 -23.61 34.27 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.762 -0.733 . . . . 71.41 112.507 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.604 HD12 HD11 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -79.8 119.41 22.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.914 0.388 . . . . 73.21 110.905 -179.937 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.563 ' C ' HD13 ' A' ' 97' ' ' LEU . 26.7 ttpp -121.42 125.74 47.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 72.12 110.871 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.604 HD11 HD12 ' A' ' 95' ' ' LEU . 0.6 OUTLIER -118.62 126.71 52.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.445 . . . . 75.4 110.943 179.913 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.542 ' OG1' HG23 ' A' ' 86' ' ' THR . 97.2 m -131.33 119.83 22.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 64.32 111.139 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -115.11 121.73 43.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 75.21 110.895 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -119.29 150.0 40.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.163 -0.471 . . . . 73.32 110.851 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 7.1 t -142.22 124.81 15.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 71.14 110.84 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 4.9 m -99.77 146.52 26.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.108 -0.496 . . . . 75.24 110.898 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.414 ' O ' HD23 ' A' ' 81' ' ' LEU . 11.1 m-85 -143.12 138.55 29.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.458 . . . . 74.41 110.923 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 17.7 m -99.0 137.41 20.48 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.647 0.737 . . . . 72.32 110.882 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.83 125.57 12.26 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.719 2.279 . . . . 62.32 112.332 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 51.01 48.86 22.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 53.41 110.928 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 25.9 m -136.96 -41.53 0.59 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.143 -0.481 . . . . 71.43 111.103 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 92.28 -18.01 55.55 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.763 -0.732 . . . . 43.31 112.525 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 8.5 tttm -65.94 116.61 7.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.855 0.36 . . . . 75.41 110.931 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 15.0 ptmt -115.81 131.0 57.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 74.13 110.912 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -120.98 123.87 43.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.208 -0.451 . . . . 73.23 110.907 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -110.55 136.2 50.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.454 . . . . 63.03 111.113 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 11.2 mttt -138.25 137.78 37.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 73.21 110.888 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 5.7 tp -120.34 130.73 74.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.437 . . . . 65.33 111.127 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.6 tptp -120.35 119.69 33.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 73.31 110.879 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.59 HG23 HD12 ' A' ' 97' ' ' LEU . 58.7 m -129.61 121.48 27.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 71.24 111.145 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.435 ' HA3' ' HA2' ' A' ' 126' ' ' GLY . . . -150.56 170.68 30.43 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.769 -0.729 . . . . 74.24 112.497 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.428 ' CD2' HD22 ' A' ' 95' ' ' LEU . 0.2 OUTLIER -127.98 135.84 50.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.973 0.416 . . . . 71.3 110.934 -179.836 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.662 ' HG2' HG11 ' A' ' 3' ' ' VAL . 2.9 tttt -110.86 118.02 34.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.12 -0.491 . . . . 75.51 110.87 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.455 ' O ' HG13 ' A' ' 3' ' ' VAL . 23.1 ttm-85 -111.42 143.73 41.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 70.44 110.883 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.683 ' CA ' HG22 ' A' ' 3' ' ' VAL . 17.8 pt-20 -52.35 -29.36 23.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 73.41 110.899 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -86.31 -41.16 14.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 54.44 110.883 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.435 ' HB ' HD13 ' A' ' 144' ' ' LEU . 1.3 pp -148.25 153.53 11.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.224 -0.444 . . . . 74.51 111.111 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -127.24 115.06 18.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 75.5 110.905 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.899 HD22 ' C ' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -133.39 142.79 48.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 72.42 110.927 179.959 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.667 ' N ' HD22 ' A' ' 125' ' ' LEU . . . -148.02 141.97 9.67 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.723 -0.751 . . . . 61.32 112.47 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 2.0 t -113.32 131.0 56.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.81 0.338 . . . . 74.42 110.883 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -119.68 150.41 40.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.232 -0.44 . . . . 75.1 110.888 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 8.1 ttt -138.03 119.76 15.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.446 . . . . 75.21 110.886 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -102.33 120.95 41.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.202 -0.454 . . . . 72.45 110.871 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -95.34 116.34 28.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 75.04 110.868 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.431 ' OD1' HD12 ' A' ' 133' ' ' ILE . 15.8 t0 -109.94 173.66 6.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 62.21 110.87 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.545 ' H ' HD12 ' A' ' 133' ' ' ILE . 2.8 mp -93.34 -33.59 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 71.21 111.154 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -92.69 -19.77 21.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 72.52 111.075 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 168.9 106.63 0.19 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.76 -0.733 . . . . 45.34 112.484 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 144.56 54.25 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.639 2.226 . . . . 72.0 112.328 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 9.4 t -128.77 152.35 48.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.444 . . . . 71.52 110.841 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.716 HD12 ' OG1' ' A' ' 159' ' ' THR . 1.7 mp -112.34 135.48 51.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.131 -0.486 . . . . 73.14 111.09 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 8.5 ttm180 -121.48 112.32 18.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.458 . . . . 72.41 110.871 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -111.65 136.38 13.51 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.775 -0.726 . . . . 61.02 112.525 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -138.54 116.26 11.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.799 0.333 . . . . 74.43 111.125 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.759 HD13 ' CB ' ' A' ' 125' ' ' LEU . 1.1 tp -123.86 124.51 42.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.252 -0.431 . . . . 41.42 110.901 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.754 ' N ' HD12 ' A' ' 142' ' ' LEU . 44.5 t -114.25 129.85 69.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 71.31 111.081 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.454 HD13 ' HA ' ' A' ' 144' ' ' LEU . 2.6 mm? -106.14 138.85 41.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 52.35 110.899 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -116.27 136.6 13.0 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.781 -0.723 . . . . 72.42 112.487 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -140.46 146.43 38.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.876 0.37 . . . . 75.01 110.909 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 74.5 mt-10 -50.31 96.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.136 -0.483 . . . . 44.21 110.907 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 90.16 -26.08 10.89 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.745 -0.741 . . . . 54.32 112.541 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 7.1 m0 -105.15 135.64 46.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.803 0.335 . . . . 75.54 110.886 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.612 HD21 ' OG1' ' A' ' 6' ' ' THR . 0.6 OUTLIER -126.53 140.07 52.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.265 -0.425 . . . . 75.44 110.876 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.468 ' H ' HD23 ' A' ' 150' ' ' LEU . . . -139.76 145.2 37.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 73.24 111.083 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -146.97 132.97 4.58 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.71 -0.757 . . . . 51.35 112.516 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -135.43 120.17 18.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.842 0.354 . . . . 70.13 110.899 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -134.05 122.45 23.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.137 -0.483 . . . . 72.23 110.95 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 4.3 ptt? -145.96 155.39 42.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 53.12 110.892 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -112.72 129.92 56.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 63.25 110.846 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.424 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 62.1 t80 -90.44 133.16 35.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.48 . . . . 73.11 110.861 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -77.82 101.94 6.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.473 . . . . 71.42 110.914 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.716 ' OG1' HD12 ' A' ' 138' ' ' ILE . 0.2 OUTLIER -64.97 -47.4 77.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.127 -0.488 . . . . 74.12 111.117 -179.9 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -48.6 -26.07 2.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 71.3 111.097 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 4.1 tptt -126.11 -167.51 1.72 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 64.32 110.919 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 11.7 t -112.03 40.83 2.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.446 . . . . 75.42 110.814 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -154.47 176.09 12.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 65.31 110.869 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.424 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 2.0 t -82.55 141.51 14.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.446 . . . . 63.31 111.125 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 15.2 t -91.01 -34.19 15.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.192 -0.458 . . . . 73.24 111.154 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -152.45 138.18 17.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 74.24 110.897 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 3.5 m -124.7 131.14 53.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 72.41 110.879 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -132.09 135.16 46.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 71.53 110.843 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.628 ' HB3' HG22 ' A' ' 184' ' ' VAL . 11.3 t80 -130.06 148.51 51.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.103 -0.499 . . . . 72.32 110.887 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -153.42 138.13 16.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 52.32 111.117 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 61.8 t -120.64 134.7 63.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.252 -0.431 . . . . 72.11 111.09 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -116.01 131.29 9.53 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.737 -0.744 . . . . 65.03 112.497 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -130.03 120.66 25.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.961 0.41 . . . . 74.22 110.926 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.14 132.28 54.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.079 -0.509 . . . . 73.3 110.888 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.47 166.49 21.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 74.32 111.136 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -39.79 -73.82 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.22 -0.446 . . . . 61.03 110.885 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -117.05 14.81 15.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.459 . . . . 55.34 110.951 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.64 ' CZ ' HG23 ' A' ' 194' ' ' ILE . 88.8 t80 -126.15 142.3 51.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.115 -0.493 . . . . 70.01 110.897 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 53.8 mm-40 -136.6 125.29 23.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.111 -0.495 . . . . 52.11 110.9 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.688 HD12 HG13 ' A' ' 194' ' ' ILE . 1.0 OUTLIER -123.31 129.01 50.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.462 . . . . 71.33 110.929 179.991 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 25.7 m80 -129.85 117.78 20.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 62.13 110.89 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 9.2 m -109.31 155.77 20.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 72.32 111.175 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -162.47 139.42 7.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.24 -0.436 . . . . 64.22 110.909 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.628 HG22 ' HB3' ' A' ' 169' ' ' PHE . 2.0 m -133.62 138.61 50.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 70.41 111.139 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -97.7 88.77 4.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 75.35 110.891 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . 0.4 ' HB2' HG22 ' A' ' 188' ' ' THR . 2.0 m-20 72.4 -176.4 0.18 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.195 -0.457 . . . . 74.33 110.888 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -79.45 3.08 69.12 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.73 -0.748 . . . . 71.21 112.479 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . 0.4 HG22 ' HB2' ' A' ' 186' ' ' ASP . 3.9 t -107.54 -22.29 12.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.801 0.334 . . . . 71.51 111.172 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -120.83 124.32 44.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.47 . . . . 74.42 110.894 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' PHE . . . . . 0.552 ' HA ' ' HB ' ' A' ' 184' ' ' VAL . 0.4 OUTLIER -137.76 125.38 22.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.183 -0.462 . . . . 74.13 110.882 -179.906 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -146.3 170.91 27.31 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.752 -0.737 . . . . 63.23 112.467 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.539 ' O ' HD23 ' A' ' 208' ' ' LEU . . . -150.5 164.14 29.74 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.73 -0.748 . . . . 54.02 112.458 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -139.56 141.98 37.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.863 0.363 . . . . 71.33 110.836 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.688 HG13 HD12 ' A' ' 180' ' ' LEU . 5.3 mp -131.65 116.89 32.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 74.31 111.107 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . 0.593 ' CE2' ' HB2' ' A' ' 205' ' ' ALA . 2.6 t80 -108.83 122.31 46.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.134 -0.485 . . . . 71.32 110.915 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 22.4 tp60 -124.3 122.6 38.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.089 -0.505 . . . . 72.04 110.922 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.94 127.29 47.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 74.2 110.925 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 9.3 t -82.64 155.99 3.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.228 -0.442 . . . . 75.15 111.089 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -50.45 -50.2 52.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 54.01 110.919 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 13.7 mmtp -69.63 -170.42 0.3 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 63.25 110.885 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . 0.75 ' O ' HD22 ' A' ' 202' ' ' LEU . 23.3 mtpp -81.45 55.58 2.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 73.23 110.912 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.75 HD22 ' O ' ' A' ' 201' ' ' LYS . 3.9 mm? -135.61 116.25 13.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 75.41 110.922 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -107.25 139.35 41.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 75.04 110.913 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 6.1 m -124.0 138.83 54.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 74.43 111.106 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.593 ' HB2' ' CE2' ' A' ' 195' ' ' TYR . . . -137.6 143.34 41.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 74.41 111.087 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 10.6 t -132.43 137.94 53.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.46 . . . . 55.04 111.124 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -149.22 125.89 11.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 74.0 110.902 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.539 HD23 ' O ' ' A' ' 192' ' ' GLY . 2.6 pt? -147.08 150.58 35.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.162 -0.472 . . . . 72.25 110.929 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -134.44 149.28 50.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 75.44 111.075 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 17.3 t90 -130.42 132.02 45.53 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.214 -0.448 . . . . 75.51 110.926 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 1.7 m -95.69 107.89 20.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 73.24 111.153 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -51.88 146.76 7.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 54.11 111.075 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 104.35 -38.54 3.21 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.732 -0.747 . . . . 71.11 112.442 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 31.8 m120 -121.23 166.94 13.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.877 0.37 . . . . 74.5 110.86 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 39.3 m -97.38 36.93 1.4 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 72.22 110.833 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 16.9 t30 -101.83 111.52 23.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.107 -0.497 . . . . 71.53 110.937 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 35.0 p -115.33 138.66 50.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.45 . . . . 71.31 111.139 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -126.77 123.97 38.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 71.03 110.896 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -132.69 156.11 47.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 72.43 110.842 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -149.33 147.88 18.68 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.729 -0.748 . . . . 51.03 112.482 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 3.7 mp -120.67 132.15 70.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.87 0.367 . . . . 75.31 111.106 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -138.06 130.81 29.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 55.54 111.101 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -123.97 158.41 32.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 71.54 111.098 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 19.4 ttmm -124.09 137.48 54.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.431 . . . . 71.51 110.936 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -132.34 117.61 18.36 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.206 -0.452 . . . . 64.0 110.944 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -89.95 130.48 36.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.131 -0.486 . . . . 73.32 110.915 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 62.7 mt -81.83 -57.67 4.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 74.41 111.085 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . 0.559 ' N ' ' HD2' ' A' ' 229' ' ' PRO . 0.6 OUTLIER 170.7 -56.89 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.673 0.749 . . . . 73.04 110.877 179.938 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 228' ' ' ASP . 53.4 Cg_endo -69.81 -156.42 0.04 OUTLIER 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.68 2.253 . . . . 73.2 112.359 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -85.49 17.27 3.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.225 -0.443 . . . . 54.42 110.862 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -119.52 122.12 40.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 44.41 111.097 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 32.5 t -120.6 142.68 49.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.451 . . . . 73.22 110.886 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -108.88 128.18 54.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 75.11 110.855 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -122.12 154.07 37.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 72.24 110.853 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -133.03 149.78 52.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.122 -0.49 . . . . 71.45 111.169 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 34.0 mttp -145.74 164.06 33.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.23 -0.441 . . . . 61.21 110.94 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 242' ' ' LEU . 6.0 p -156.19 143.17 10.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.266 -0.424 . . . . 71.05 111.171 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -106.2 147.97 28.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 73.4 110.879 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -52.55 -22.77 5.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 72.35 110.854 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 32.2 t -81.2 26.15 0.46 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.46 . . . . 72.1 110.84 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 5.0 t 58.08 38.98 26.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.475 . . . . 72.33 110.902 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . 0.446 ' O ' HG23 ' A' ' 237' ' ' VAL . 3.6 mp -98.7 129.54 45.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.093 -0.503 . . . . 75.3 110.888 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.491 ' H ' HD12 ' A' ' 243' ' ' ILE . 4.0 mp -93.02 117.78 37.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.458 . . . . 65.32 111.12 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -117.53 144.3 18.22 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.766 -0.731 . . . . 55.25 112.468 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.641 HD21 HD21 ' A' ' 263' ' ' LEU . 0.0 OUTLIER -145.3 128.56 16.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.828 0.347 . . . . 75.15 110.953 -179.943 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -130.35 122.06 3.51 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.733 -0.746 . . . . 74.51 112.466 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -110.27 115.97 30.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.907 0.384 . . . . 75.24 110.949 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.899 HG23 HG23 ' A' ' 258' ' ' THR . 0.2 OUTLIER -110.58 114.88 28.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 51.44 111.143 -179.966 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -143.4 138.64 29.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 74.13 110.924 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 256' ' ' LYS . 16.3 p -77.95 147.51 34.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 74.25 111.137 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.4 ' HG ' ' HD2' ' A' ' 252' ' ' LYS . 13.8 tp -111.36 -74.71 0.63 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 75.43 110.954 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' LYS . . . . . 0.595 ' HG2' HD11 ' A' ' 255' ' ' ILE . 12.7 mmmt -97.43 163.15 20.36 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.564 0.697 . . . . 64.5 110.918 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' PRO . . . . . 0.593 ' HD2' ' HB3' ' A' ' 252' ' ' LYS . 53.7 Cg_endo -69.75 67.08 1.75 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.718 2.278 . . . . 71.21 112.335 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . 0.632 ' O ' ' HB3' ' A' ' 281' ' ' PHE . . . 157.67 -17.94 0.35 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.767 -0.73 . . . . 33.55 112.495 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.595 HD11 ' HG2' ' A' ' 252' ' ' LYS . 15.9 pt -129.36 141.5 46.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.928 0.394 . . . . 75.22 111.121 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 250' ' ' THR . 48.7 tttt -117.69 138.33 52.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 75.02 110.895 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 0.704 ' HA ' HD12 ' A' ' 279' ' ' LEU . 0.2 OUTLIER -96.09 128.56 43.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 74.15 110.92 179.919 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . 0.899 HG23 HG23 ' A' ' 248' ' ' THR . 4.4 m -119.81 122.62 41.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.465 . . . . 75.12 111.16 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.881 HD22 HD23 ' A' ' 277' ' ' LEU . 0.0 OUTLIER -110.29 138.94 45.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.218 -0.446 . . . . 75.51 110.912 179.971 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.559 ' O ' HD22 ' A' ' 275' ' ' LEU . 70.6 m -136.67 140.55 42.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 63.44 110.857 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -146.57 129.07 15.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.099 -0.5 . . . . 55.54 111.14 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.707 ' C ' HD13 ' A' ' 263' ' ' LEU . 2.8 tm? -121.94 130.05 53.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.27 -0.423 . . . . 72.02 110.924 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . 0.889 ' HB3' HG21 ' A' ' 268' ' ' VAL . 0.3 OUTLIER -124.24 110.55 14.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.469 . . . . 72.32 110.919 179.885 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . 0.562 ' O ' ' HB ' ' A' ' 268' ' ' VAL . 0.7 OUTLIER -86.8 98.33 11.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.155 -0.475 . . . . 54.01 110.846 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -53.02 -11.95 1.62 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.762 -0.732 . . . . 74.2 112.454 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -64.41 -25.46 68.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.78 0.324 . . . . 72.53 110.896 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -168.44 19.91 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 72.04 110.873 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . 0.889 HG21 ' HB3' ' A' ' 263' ' ' LEU . 1.7 p -68.52 -27.0 34.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 70.53 111.16 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -77.8 -44.83 26.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 61.14 110.922 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -95.93 12.41 30.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 64.43 111.11 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -129.62 -104.22 1.1 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.708 -0.758 . . . . 41.33 112.47 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -164.67 172.26 40.35 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.708 -0.758 . . . . 73.4 112.489 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 273' ' ' HIS . . . . . 0.406 ' CB ' HD12 ' A' ' 263' ' ' LEU . 2.4 p-80 -105.25 146.66 29.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.839 0.352 . . . . 74.21 110.909 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -95.66 136.34 36.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 74.21 110.884 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.744 HD13 ' N ' ' A' ' 276' ' ' GLY . 2.5 tm? -134.36 139.07 45.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.243 -0.435 . . . . 62.13 110.917 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . 0.744 ' N ' HD13 ' A' ' 275' ' ' LEU . . . -140.04 130.29 4.61 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.685 -0.769 . . . . 63.02 112.462 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.881 HD23 HD22 ' A' ' 259' ' ' LEU . 3.5 tm? -115.93 138.67 50.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.859 0.361 . . . . 72.11 110.904 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . 0.656 ' N ' HD13 ' A' ' 277' ' ' LEU . . . -162.04 129.06 2.0 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.74 -0.743 . . . . 51.0 112.474 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.704 HD12 ' HA ' ' A' ' 257' ' ' LEU . 0.1 OUTLIER -108.69 127.99 54.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.784 0.326 . . . . 73.14 110.896 -179.916 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . 0.423 ' O ' ' HB2' ' A' ' 281' ' ' PHE . 1.8 pm0 -140.92 147.06 38.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.162 -0.472 . . . . 71.11 110.888 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . 0.632 ' HB3' ' O ' ' A' ' 254' ' ' GLY . 0.0 OUTLIER 168.73 -157.99 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.134 -0.484 . . . . 72.42 110.842 -179.945 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -136.22 143.15 44.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.145 -0.48 . . . . 63.12 110.984 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.736 ' CB ' HD11 ' A' ' 31' ' ' LEU . . . -91.17 112.43 24.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 74.02 111.131 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.666 HD22 ' O ' ' A' ' 283' ' ' ALA . 1.5 mm? -136.99 179.18 6.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.23 -0.441 . . . . 71.05 110.944 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.214 -0.448 . . . . 60.31 110.898 179.962 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.097 0 CA-C-O 120.861 0.362 . . . . 34.44 111.1 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.733 HG11 ' O ' ' A' ' 119' ' ' LYS . 24.8 t -139.7 82.16 18.52 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.601 0.715 . . . . 73.21 111.127 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 168.28 21.98 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.712 2.275 . . . . 64.33 112.319 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 95.55 0.56 Allowed 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.636 2.224 . . . . 71.23 112.349 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -79.64 -48.6 13.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.247 -0.433 . . . . 72.11 111.088 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.427 ' HB2' HG11 ' A' ' 143' ' ' VAL . 35.7 t80 -52.79 -40.52 63.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.21 -0.45 . . . . 71.32 110.931 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.99 -19.86 58.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.134 -0.485 . . . . 71.12 111.109 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -88.62 10.47 20.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.168 -0.469 . . . . 74.54 110.833 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.884 HD21 ' HA3' ' A' ' 152' ' ' GLY . 0.6 OUTLIER -64.59 -34.15 77.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.456 . . . . 72.32 110.935 -179.986 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -152.09 63.57 0.38 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.748 -0.739 . . . . 74.33 112.499 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.34 -54.51 14.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.833 0.349 . . . . 75.41 110.879 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 m -64.02 -39.49 94.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 64.15 110.83 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.51 -37.7 73.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 73.13 111.11 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 63.2 mtt-85 -61.85 -36.85 82.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.451 . . . . 74.3 110.874 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.91 -37.97 82.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.218 -0.446 . . . . 71.44 110.855 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 97.6 t -75.24 -35.88 35.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.143 -0.48 . . . . 74.33 111.139 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -60.92 -41.0 95.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 61.34 110.853 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.0 m 51.9 78.34 0.12 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 73.42 111.137 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.84 119.74 11.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.44 . . . . 75.41 110.862 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.46 96.74 1.28 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.733 -0.746 . . . . 73.3 112.507 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -86.55 -175.83 5.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.928 0.394 . . . . 72.43 110.932 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.84 114.5 5.34 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.728 -0.748 . . . . 64.2 112.478 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -103.9 12.85 33.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.956 0.408 . . . . 75.22 110.924 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.61 14.18 77.79 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.685 -0.769 . . . . 73.35 112.498 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.554 HD12 ' N ' ' A' ' 27' ' ' ILE . 2.2 pp -114.81 179.81 3.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.794 0.331 . . . . 74.05 110.932 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.918 HG23 HD12 ' A' ' 277' ' ' LEU . 32.6 mm -109.87 125.84 67.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 65.4 111.125 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.54 ' O ' HD22 ' A' ' 279' ' ' LEU . 8.9 mttt -102.84 149.85 24.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.182 -0.463 . . . . 73.1 110.878 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.617 HD13 ' N ' ' A' ' 30' ' ' ASP . 0.5 OUTLIER -147.1 130.3 16.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 54.35 110.911 179.918 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.617 ' N ' HD13 ' A' ' 29' ' ' LEU . 18.2 m-20 -146.71 126.3 13.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.207 -0.452 . . . . 73.15 110.897 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.794 HD11 ' HB3' ' A' ' 283' ' ' ALA . 2.0 tm? -134.78 125.54 27.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 74.31 110.922 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.522 ' N ' HD13 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -120.86 147.23 45.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.218 -0.446 . . . . 75.13 110.898 179.86 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.9 p -137.2 120.48 16.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.44 . . . . 74.01 111.15 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 40.1 mtpt -115.32 129.99 56.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.245 -0.434 . . . . 74.14 110.917 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -125.44 138.13 54.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 74.32 110.822 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -76.85 60.29 1.73 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.476 . . . . 72.13 110.868 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.446 ' O ' HD22 ' A' ' 39' ' ' LEU . 31.0 m-80 -159.28 23.12 0.19 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 54.03 110.895 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.581 ' HA2' ' O ' ' A' ' 63' ' ' ARG . . . 79.59 -3.73 67.34 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.781 -0.723 . . . . 51.52 112.437 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.446 HD22 ' O ' ' A' ' 37' ' ' ASN . 3.0 mm? -97.39 124.3 41.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.802 0.334 . . . . 73.12 110.899 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -145.26 117.98 8.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.134 -0.484 . . . . 62.21 110.893 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -111.71 123.58 50.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.481 . . . . 70.12 110.902 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.65 120.97 30.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 74.13 111.168 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.9 p -121.37 142.36 50.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 64.03 110.87 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 21.0 m -147.99 136.05 21.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.147 -0.479 . . . . 61.31 110.861 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -172.87 158.85 29.08 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.759 -0.734 . . . . 74.34 112.492 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -138.32 150.69 46.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.911 0.386 . . . . 74.52 110.872 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -121.17 130.74 53.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.475 . . . . 64.1 111.055 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -72.07 118.94 15.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 74.12 110.91 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 33.8 m -58.73 149.68 25.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.47 . . . . 71.21 111.186 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 39.9 40.13 0.67 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 74.13 110.92 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 98.8 m -161.26 126.69 3.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.154 -0.475 . . . . 74.32 111.126 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 71.5 p -76.24 66.8 2.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.251 -0.432 . . . . 75.31 111.153 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.6 ttmt -156.27 104.04 2.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 74.43 110.886 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.2 m -126.47 148.29 31.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.182 -0.463 . . . . 61.55 111.146 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 91.5 m -116.26 126.61 53.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 52.32 111.164 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -127.73 150.8 18.38 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.742 -0.742 . . . . 71.04 112.478 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 78.0 p -146.29 142.23 28.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.918 0.39 . . . . 72.34 110.869 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.516 HD13 ' N ' ' A' ' 59' ' ' GLU . 0.6 OUTLIER -121.88 125.27 46.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.124 -0.489 . . . . 72.31 110.935 179.966 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.516 ' N ' HD13 ' A' ' 58' ' ' LEU . 5.7 pt-20 -124.77 129.47 50.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 73.04 110.902 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.9 t -99.63 128.85 45.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.135 -0.484 . . . . 53.4 111.129 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 71' ' ' PHE . 26.7 ttmt -126.98 154.36 44.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 72.01 110.906 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.434 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 9.4 m-85 -130.38 140.08 50.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.443 . . . . 71.12 110.887 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.581 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 21.7 tpp85 -118.0 103.99 10.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.062 -0.517 . . . . 73.12 110.879 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -106.4 114.66 28.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 74.25 110.895 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 6.0 t -94.41 -167.55 1.68 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.209 -0.45 . . . . 74.1 111.108 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 59.41 30.42 20.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 71.32 110.857 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 179.58 -53.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 65.41 110.949 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 110.51 64.77 0.53 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.732 -0.747 . . . . 65.5 112.505 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.0 mp -134.44 132.33 39.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.88 0.371 . . . . 72.42 110.933 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 44.2 p -136.29 135.1 38.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 63.11 111.167 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.655 ' CD2' HG22 ' A' ' 85' ' ' ILE . 23.7 t80 -117.46 131.14 56.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.241 -0.436 . . . . 74.33 110.899 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.59 HG23 ' HB2' ' A' ' 84' ' ' GLU . 3.8 t -128.56 121.09 27.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 72.22 111.107 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -126.62 130.21 50.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 75.2 110.883 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 5.4 ttpm? -113.0 110.82 21.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.479 . . . . 73.23 110.883 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.421 ' CD1' ' CB ' ' A' ' 81' ' ' LEU . 2.6 t90 -115.67 126.92 54.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 71.5 110.908 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -120.74 136.11 54.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.25 -0.432 . . . . 74.13 110.904 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 9.5 t -70.5 -36.08 73.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 74.24 111.177 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -111.6 -35.37 5.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.207 -0.451 . . . . 72.05 110.886 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -78.88 -154.0 0.07 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 72.51 110.904 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.1 t -78.97 149.39 32.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 64.34 111.135 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.421 ' CB ' ' CD1' ' A' ' 75' ' ' TRP . 0.1 OUTLIER -124.04 117.64 25.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 53.42 110.897 179.962 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.83 170.16 39.03 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.743 -0.742 . . . . 60.22 112.489 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -131.52 159.63 37.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.776 0.322 . . . . 72.44 111.119 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.59 ' HB2' HG23 ' A' ' 72' ' ' THR . 40.4 mt-10 -142.42 144.54 33.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 74.11 110.899 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.655 HG22 ' CD2' ' A' ' 71' ' ' PHE . 1.5 pp -121.61 138.87 50.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 71.51 111.146 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.451 HG22 ' HE2' ' A' ' 96' ' ' LYS . 0.2 OUTLIER -128.46 127.73 43.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 71.35 111.123 179.996 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.424 HG22 ' HB2' ' A' ' 97' ' ' LEU . 3.9 m -128.39 138.36 54.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 75.24 111.099 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -118.47 128.48 54.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.139 -0.482 . . . . 73.22 110.922 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 56.98 39.85 29.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.184 -0.462 . . . . 74.21 110.88 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -66.81 -35.32 79.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.452 . . . . 75.43 110.872 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.3 tt -122.31 -37.12 2.85 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.24 -0.436 . . . . 64.41 110.904 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -146.67 138.4 24.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 72.51 111.112 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -59.73 134.45 57.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.25 -0.432 . . . . 73.01 110.853 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 100.37 -23.45 35.8 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.717 -0.754 . . . . 62.11 112.473 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.472 HD12 ' HB3' ' A' ' 118' ' ' TYR . 4.7 tp -95.62 129.4 42.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.879 0.371 . . . . 51.42 110.898 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.587 ' C ' HD13 ' A' ' 97' ' ' LEU . 8.8 tttm -122.66 131.48 53.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 72.04 110.904 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.587 HD13 ' C ' ' A' ' 96' ' ' LYS . 0.5 OUTLIER -116.82 127.31 54.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.235 -0.439 . . . . 72.55 110.934 179.877 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.446 HG23 HG23 ' A' ' 86' ' ' THR . 2.8 m -129.76 123.53 31.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.203 -0.453 . . . . 73.43 111.127 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.733 ' CD2' HD13 ' A' ' 114' ' ' ILE . 1.1 t80 -110.38 121.97 46.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.459 . . . . 75.54 110.874 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -110.36 124.49 51.8 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.163 -0.472 . . . . 74.34 110.877 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.0 t -124.14 121.45 35.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 73.33 110.865 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 75.7 m -114.88 145.86 41.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 75.13 110.852 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -135.12 137.41 42.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.147 -0.479 . . . . 54.25 110.895 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.7 t -128.41 138.94 34.12 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.681 0.753 . . . . 75.42 110.847 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.79 -23.91 30.13 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.646 2.231 . . . . 73.44 112.319 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -56.2 99.06 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.431 . . . . 75.42 110.877 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 53.2 26.92 5.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 75.31 111.171 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 67.15 24.5 73.35 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.71 -0.757 . . . . 53.25 112.515 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 58.3 tttt -65.43 118.02 8.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.881 0.372 . . . . 72.01 110.87 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 17.6 pttm -122.59 151.09 41.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 73.01 110.893 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -127.2 136.59 52.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 74.4 110.862 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -116.04 131.03 57.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 54.34 111.092 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -138.28 138.68 38.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 62.14 110.865 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.733 HD13 ' CD2' ' A' ' 99' ' ' PHE . 5.4 tp -134.07 127.32 51.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 44.2 111.135 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 7.2 mmtp -119.53 118.86 32.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 73.33 110.885 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.1 t -129.74 119.67 23.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.216 -0.447 . . . . 63.32 111.099 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.483 ' HA3' ' HA2' ' A' ' 126' ' ' GLY . . . -153.29 168.76 32.06 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.693 -0.765 . . . . 72.12 112.476 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.472 ' HB3' HD12 ' A' ' 95' ' ' LEU . 41.7 p90 -133.16 132.05 41.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.971 0.415 . . . . 72.33 110.95 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.733 ' O ' HG11 ' A' ' 3' ' ' VAL . 18.0 mtmm -108.18 119.47 39.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 72.54 110.95 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 43.3 ttt180 -110.14 143.53 40.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.279 -0.419 . . . . 72.51 110.878 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -51.48 -28.01 12.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 74.44 110.901 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 70.7 m80 -89.17 -40.12 13.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 64.43 110.861 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.91 HD13 HD13 ' A' ' 144' ' ' LEU . 2.3 tp -149.23 138.3 15.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 74.12 111.077 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.62 ' H ' HD12 ' A' ' 123' ' ' ILE . 0.3 OUTLIER -105.03 118.66 37.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 65.12 110.851 179.947 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -116.51 140.52 49.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 54.34 110.91 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.483 ' HA2' ' HA3' ' A' ' 117' ' ' GLY . . . -143.29 121.52 1.71 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.749 -0.739 . . . . 40.41 112.476 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -112.47 107.71 16.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.8 0.333 . . . . 74.34 110.881 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -104.92 145.18 30.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.223 -0.444 . . . . 73.32 110.836 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 96.8 mtp -138.68 136.1 35.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 73.14 110.892 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -128.27 135.69 49.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 75.51 110.854 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -95.8 102.38 14.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 64.42 110.9 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.4 149.87 21.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.134 -0.485 . . . . 72.21 110.847 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.538 HD12 ' O ' ' A' ' 133' ' ' ILE . 1.2 tp -52.71 -44.06 45.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 52.4 111.14 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -73.77 -18.93 60.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 54.54 111.084 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 155.24 150.34 5.54 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.797 -0.716 . . . . 72.22 112.504 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 112.37 3.05 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.749 2.3 . . . . 61.22 112.322 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.5 m -81.89 147.55 29.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.442 . . . . 63.42 110.847 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.1 mp -107.28 118.83 55.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 74.51 111.126 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 -106.95 121.85 45.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 72.31 110.83 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -110.99 133.83 11.79 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.778 -0.725 . . . . 63.13 112.503 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -131.38 122.54 26.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.798 0.332 . . . . 72.42 111.082 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.839 HD21 HD11 ' A' ' 123' ' ' ILE . 0.3 OUTLIER -140.39 122.35 15.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.242 -0.436 . . . . 44.21 110.89 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.528 ' HA ' ' HA2' ' A' ' 152' ' ' GLY . 0.7 OUTLIER -133.76 144.93 34.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 62.23 111.1 179.866 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.91 HD13 HD13 ' A' ' 123' ' ' ILE . 3.5 mm? -107.84 139.96 41.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.184 -0.462 . . . . 72.24 110.902 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -110.7 118.7 5.03 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.771 -0.728 . . . . 60.32 112.471 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -122.91 146.38 47.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.901 0.381 . . . . 74.42 110.902 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -50.44 96.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.118 -0.492 . . . . 64.41 110.931 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 93.94 -29.41 8.69 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.783 -0.722 . . . . 73.25 112.475 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 36.6 m95 -102.15 141.7 34.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.833 0.349 . . . . 74.15 110.903 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.444 HD22 HD12 ' A' ' 10' ' ' LEU . 0.4 OUTLIER -134.98 136.61 42.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.436 . . . . 63.31 110.91 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -142.77 143.88 32.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.448 . . . . 75.43 111.082 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.884 ' HA3' HD21 ' A' ' 10' ' ' LEU . . . -153.48 144.09 10.94 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.72 -0.752 . . . . 72.31 112.473 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -145.12 119.21 9.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.849 0.356 . . . . 54.04 110.923 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -118.95 123.79 45.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.145 -0.48 . . . . 74.34 110.89 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.7 134.68 52.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 44.04 110.894 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.62 ' O ' HG22 ' A' ' 164' ' ' VAL . 27.6 t-20 -112.29 123.07 49.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.253 -0.43 . . . . 71.32 110.876 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.456 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 15.0 t80 -94.4 125.88 39.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 71.44 110.888 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.691 ' OE2' ' HB3' ' A' ' 160' ' ' ALA . 0.1 OUTLIER -79.33 103.16 9.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.136 -0.484 . . . . 72.15 110.904 -179.912 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 75.5 m -65.53 -48.18 73.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 65.14 111.171 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.691 ' HB3' ' OE2' ' A' ' 158' ' ' GLU . . . -48.35 -26.12 1.9 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 74.21 111.103 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 12.1 mmtp -125.79 -168.76 1.89 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 72.11 110.874 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 2.4 m -110.63 40.2 2.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 75.22 110.875 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 2.4 tpp180 -156.67 175.25 14.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.131 -0.486 . . . . 73.42 110.904 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.62 HG22 ' O ' ' A' ' 156' ' ' ASN . 0.9 OUTLIER -74.52 142.5 14.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 64.31 111.124 179.966 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.429 ' HB ' ' HG2' ' A' ' 158' ' ' GLU . 2.5 t -90.63 -34.6 15.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.459 . . . . 75.24 111.14 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -153.99 136.14 14.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.244 -0.434 . . . . 72.33 110.897 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -123.06 127.34 48.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.446 . . . . 70.43 110.858 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -135.68 142.75 45.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 63.23 110.926 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -149.03 140.13 23.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 75.02 110.878 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.546 ' HB3' HD23 ' A' ' 10' ' ' LEU . . . -148.49 129.12 14.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 74.23 111.107 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 7.3 t -148.1 139.59 17.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.451 . . . . 62.13 111.112 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . 0.432 ' HA2' HD23 ' A' ' 180' ' ' LEU . . . -165.25 163.83 36.78 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.723 -0.751 . . . . 75.24 112.504 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -118.95 125.09 48.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.946 0.403 . . . . 74.25 110.919 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 39.9 mtpt -101.84 126.14 48.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.132 -0.485 . . . . 65.44 110.926 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.511 ' HB ' ' H ' ' A' ' 178' ' ' PHE . 1.2 m -131.26 165.02 24.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.444 . . . . 70.25 111.112 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.406 ' H ' HG22 ' A' ' 175' ' ' THR . 34.4 t70 -78.14 -7.76 57.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 52.12 110.86 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -118.13 -31.65 4.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.211 -0.45 . . . . 71.05 110.873 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.511 ' H ' ' HB ' ' A' ' 175' ' ' THR . 18.4 p90 -144.54 150.14 37.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 75.4 110.891 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -136.51 123.05 20.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 71.43 110.913 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.466 HD12 HG13 ' A' ' 194' ' ' ILE . 0.3 OUTLIER -124.15 128.26 49.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.211 -0.45 . . . . 65.12 110.943 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 15.7 m170 -131.36 115.01 15.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 73.32 110.865 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . 0.481 HG22 ' O ' ' A' ' 191' ' ' GLY . 0.2 OUTLIER -101.05 135.55 42.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 54.01 111.144 -179.909 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -128.0 139.25 52.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.441 . . . . 73.31 110.92 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.426 ' O ' HG12 ' A' ' 184' ' ' VAL . 2.8 t -134.33 110.04 13.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 53.21 111.147 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -101.08 89.46 3.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 72.11 110.898 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 65.77 179.46 0.2 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 63.24 110.865 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -73.1 -3.49 60.85 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.684 -0.77 . . . . 71.31 112.466 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 5.7 m -95.96 -25.54 15.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.804 0.335 . . . . 61.43 111.174 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -121.95 112.49 18.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.192 -0.458 . . . . 72.42 110.903 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -138.85 123.41 18.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.135 -0.484 . . . . 75.31 110.883 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . 0.481 ' O ' HG22 ' A' ' 182' ' ' THR . . . 174.17 -154.86 20.35 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.715 -0.755 . . . . 43.13 112.456 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -176.56 -163.2 28.55 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.743 -0.741 . . . . 75.04 112.471 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . 0.595 ' C ' HD12 ' A' ' 194' ' ' ILE . 11.4 p -148.39 155.47 41.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.857 0.361 . . . . 64.24 110.868 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.595 HD12 ' C ' ' A' ' 193' ' ' SER . 3.5 mp -131.62 120.27 44.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.122 -0.49 . . . . 43.51 111.104 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -108.87 121.05 44.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.188 -0.46 . . . . 74.2 110.922 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -125.52 131.52 52.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.476 . . . . 61.32 110.891 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 1.8 tppp? -96.04 127.66 42.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 72.21 110.863 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.501 HG12 ' HB2' ' A' ' 201' ' ' LYS . 34.5 t -85.73 117.36 30.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.44 . . . . 74.24 111.135 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -49.82 132.96 22.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 74.43 110.867 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp 51.05 33.82 9.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 61.44 110.893 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . 0.501 ' HB2' HG12 ' A' ' 198' ' ' VAL . 4.8 mmtp -153.83 -167.31 2.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 75.43 110.861 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.509 HD12 ' O ' ' A' ' 203' ' ' GLU . 1.4 pp -79.19 -168.49 1.51 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.45 . . . . 72.24 110.936 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.509 ' O ' HD12 ' A' ' 202' ' ' LEU . 12.0 mt-10 -115.11 136.15 53.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 64.21 110.884 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 11.5 t -123.96 138.78 54.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.12 -0.491 . . . . 45.15 111.143 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -145.01 163.49 34.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.434 . . . . 72.01 111.117 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 1.7 m -133.58 149.08 30.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.255 -0.429 . . . . 54.32 111.094 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -113.91 131.52 56.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 73.11 110.89 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -119.71 129.93 54.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 62.2 110.955 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.603 ' HB3' ' HB3' ' A' ' 218' ' ' ARG . . . -138.42 130.77 28.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.446 . . . . 73.51 111.1 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 11.7 t90 -130.09 123.21 29.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 72.14 110.9 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 94.5 m -112.22 110.51 20.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.264 -0.425 . . . . 73.12 111.173 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -51.4 128.09 21.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.263 -0.426 . . . . 64.34 111.095 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 163.78 -73.66 0.18 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.749 -0.738 . . . . 64.5 112.514 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 65.9 m-80 -125.61 33.79 5.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.804 0.335 . . . . 75.14 110.861 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 43.4 m 51.43 52.77 14.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.452 . . . . 50.03 110.858 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -94.69 112.0 23.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.122 -0.49 . . . . 64.2 110.938 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 2.5 p -94.29 135.63 35.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 74.14 111.121 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . 0.603 ' HB3' ' HB3' ' A' ' 209' ' ' ALA . 17.7 tpp85 -117.41 119.18 34.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 74.3 110.845 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . 0.504 ' CE2' HD11 ' A' ' 221' ' ' ILE . 21.4 t80 -122.83 137.6 54.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 74.01 110.893 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -145.69 159.17 27.87 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.767 -0.73 . . . . 22.01 112.52 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.504 HD11 ' CE2' ' A' ' 219' ' ' PHE . 4.7 mp -137.29 130.46 43.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.828 0.347 . . . . 71.44 111.133 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -124.89 141.52 52.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 73.21 111.117 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.481 ' HB3' ' HB3' ' A' ' 235' ' ' ALA . . . -116.08 134.84 54.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.243 -0.435 . . . . 64.41 111.1 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 11.1 mttt -120.64 115.44 23.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 73.23 110.905 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -130.75 128.66 41.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.232 -0.44 . . . . 73.45 110.899 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -111.92 115.99 29.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.158 -0.474 . . . . 71.42 110.941 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 8.1 tp -103.05 -35.21 3.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 71.42 111.128 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . 0.684 ' HB2' ' HB3' ' A' ' 231' ' ' ALA . 2.7 m-20 -130.24 160.6 64.82 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.64 0.733 . . . . 74.41 110.857 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.72 -32.58 18.45 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.684 2.256 . . . . 74.1 112.312 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -107.19 10.27 30.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 74.44 110.838 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.684 ' HB3' ' HB2' ' A' ' 228' ' ' ASP . . . -141.41 127.18 19.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 61.3 111.123 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 42.4 t -134.47 141.97 46.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.255 -0.429 . . . . 63.54 110.924 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -112.25 130.24 56.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 74.11 110.873 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 84.2 p -129.51 140.62 51.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.464 . . . . 54.33 110.885 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' ALA . . . . . 0.481 ' HB3' ' HB3' ' A' ' 223' ' ' ALA . . . -127.01 159.29 34.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 73.3 111.126 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.77 147.81 21.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.217 -0.447 . . . . 72.34 110.917 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 242' ' ' LEU . 5.4 p -144.86 142.69 22.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.444 . . . . 55.43 111.15 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -106.54 147.64 29.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 75.44 110.92 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -54.71 -21.01 9.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.185 -0.461 . . . . 70.21 110.9 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 3.7 m -81.7 26.28 0.5 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.459 . . . . 64.51 110.874 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 6.8 t 59.98 39.33 20.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.081 -0.509 . . . . 53.12 110.854 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . 0.458 ' O ' HG23 ' A' ' 237' ' ' VAL . 18.4 mt -98.91 124.9 44.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.12 -0.491 . . . . 71.43 110.903 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.467 ' H ' HD12 ' A' ' 243' ' ' ILE . 3.0 mp -99.83 118.73 46.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 71.42 111.09 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . 0.519 ' C ' HD13 ' A' ' 245' ' ' LEU . . . -129.49 138.75 10.45 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.714 -0.755 . . . . 73.33 112.471 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.665 ' N ' HD13 ' A' ' 245' ' ' LEU . 0.0 OUTLIER -145.92 158.93 43.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.865 0.364 . . . . 75.51 110.865 -179.885 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -162.57 144.27 9.49 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.719 -0.753 . . . . 55.14 112.443 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -128.31 131.84 48.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.99 0.424 . . . . 65.2 110.894 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 27.6 p -115.5 117.77 31.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.076 -0.511 . . . . 62.25 111.124 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -129.38 131.48 46.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 74.42 110.899 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 3.7 m -59.74 148.43 34.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 75.23 111.167 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 46.0 tp -78.58 -73.33 0.33 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 72.01 110.904 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' LYS . . . . . 0.47 ' N ' ' HD2' ' A' ' 253' ' ' PRO . 0.1 OUTLIER 179.29 -60.66 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.558 0.694 . . . . 65.13 110.882 179.848 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' PRO . . . . . 0.574 ' HG2' HD12 ' A' ' 255' ' ' ILE . 54.0 Cg_endo -69.77 -86.4 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.679 2.253 . . . . 71.52 112.395 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . 0.573 ' O ' ' HB3' ' A' ' 281' ' ' PHE . . . -146.7 33.9 1.38 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.746 -0.74 . . . . 55.3 112.499 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.574 HD12 ' HG2' ' A' ' 253' ' ' PRO . 3.6 mp -131.01 145.3 35.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.893 0.377 . . . . 63.22 111.093 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 279' ' ' LEU . 19.7 ttpp -113.12 135.41 53.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 71.51 110.882 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 0.773 ' HA ' HD12 ' A' ' 279' ' ' LEU . 5.1 tp -96.74 124.35 40.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 74.51 110.879 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . 0.417 ' N ' HD12 ' A' ' 257' ' ' LEU . 2.8 p -124.29 122.34 37.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.161 -0.472 . . . . 72.14 111.115 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.789 HD22 HD23 ' A' ' 277' ' ' LEU . 0.1 OUTLIER -116.58 126.53 53.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 74.02 110.92 179.938 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.436 ' O ' HD22 ' A' ' 275' ' ' LEU . 27.7 p -124.92 145.84 49.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 62.1 110.878 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' ALA . . . . . 0.426 ' HB3' ' CD2' ' A' ' 245' ' ' LEU . . . -147.99 135.25 20.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 70.11 111.112 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.691 ' C ' HD13 ' A' ' 263' ' ' LEU . 2.4 tm? -125.41 122.22 36.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.453 . . . . 71.11 110.877 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . 0.829 ' HB3' HG11 ' A' ' 268' ' ' VAL . 0.2 OUTLIER -120.03 109.86 15.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 73.3 110.929 179.855 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . 0.639 ' O ' HG22 ' A' ' 268' ' ' VAL . 0.8 OUTLIER -82.72 116.95 22.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.184 -0.462 . . . . 74.25 110.831 179.844 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -54.41 -21.15 19.09 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.744 -0.741 . . . . 72.25 112.464 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.77 -26.56 20.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.839 0.352 . . . . 74.43 110.912 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 13.8 m-20 -95.42 -57.86 2.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.194 -0.457 . . . . 62.11 110.926 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . 0.829 HG11 ' HB3' ' A' ' 263' ' ' LEU . 11.7 m -51.6 -29.34 9.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.469 . . . . 62.45 111.104 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -53.02 -36.43 60.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 62.31 110.89 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -103.65 -17.69 15.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 75.24 111.144 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 124.73 100.75 1.34 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.691 -0.766 . . . . 74.23 112.45 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 168.16 92.74 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.722 -0.752 . . . . 73.14 112.493 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 19.2 p80 -111.9 144.64 40.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.899 0.38 . . . . 75.24 110.83 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -102.26 137.34 40.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 65.13 110.935 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.745 HD13 ' N ' ' A' ' 276' ' ' GLY . 2.9 tm? -135.94 144.11 45.28 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.253 -0.43 . . . . 74.22 110.927 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . 0.745 ' N ' HD13 ' A' ' 275' ' ' LEU . . . -147.52 133.65 4.81 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.694 -0.765 . . . . 31.44 112.492 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.918 HD12 HG23 ' A' ' 27' ' ' ILE . 2.8 tm? -125.81 135.23 51.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.819 0.342 . . . . 70.14 110.913 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . 0.73 ' C ' HD13 ' A' ' 279' ' ' LEU . . . -161.59 140.08 6.4 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.694 -0.765 . . . . 45.12 112.488 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.773 HD12 ' HA ' ' A' ' 257' ' ' LEU . 0.0 OUTLIER -119.59 129.86 54.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.809 0.337 . . . . 72.43 110.899 -179.938 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . 0.494 ' O ' ' HB2' ' A' ' 281' ' ' PHE . 2.5 pp20? -141.94 146.41 35.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.47 . . . . 71.12 110.899 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . 0.573 ' HB3' ' O ' ' A' ' 254' ' ' GLY . 0.3 OUTLIER 172.08 -150.75 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.155 -0.475 . . . . 65.21 110.894 -179.88 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -138.55 144.68 40.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 73.32 110.891 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.794 ' HB3' HD11 ' A' ' 31' ' ' LEU . . . -113.09 112.6 24.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.45 . . . . 72.41 111.128 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 12.7 mt -130.41 178.63 6.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 61.34 110.878 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 71.41 110.909 179.943 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.834 0.35 . . . . 72.01 111.111 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.1 t 61.18 75.62 0.44 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.668 0.747 . . . . 63.04 111.083 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 167.91 23.06 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.667 2.244 . . . . 63.32 112.362 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 108.97 2.2 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.734 2.289 . . . . 73.12 112.326 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.483 HG23 HG11 ' A' ' 143' ' ' VAL . 12.3 t -107.15 -28.47 9.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 74.05 111.138 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.755 ' CB ' HG21 ' A' ' 143' ' ' VAL . 32.9 p90 -55.53 -30.59 61.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.25 -0.432 . . . . 73.42 110.92 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -72.26 -19.4 61.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.108 -0.497 . . . . 64.5 111.114 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -95.03 11.9 30.4 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.243 -0.435 . . . . 74.21 110.878 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.677 HD21 ' HA3' ' A' ' 152' ' ' GLY . 0.8 OUTLIER -60.56 -33.05 72.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.211 -0.45 . . . . 70.25 110.87 -179.929 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -136.17 31.28 2.63 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.758 -0.734 . . . . 72.25 112.488 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.3 mmtt -69.58 -54.5 13.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.78 0.324 . . . . 62.5 110.88 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.9 t -60.25 -39.72 87.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.252 -0.431 . . . . 60.43 110.873 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.56 -37.62 76.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 74.0 111.113 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -61.05 -32.66 72.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 72.43 110.859 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -58.38 -48.45 80.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 60.54 110.866 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.5 t -80.43 -36.91 16.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 64.41 111.128 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -63.33 -34.98 78.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 74.03 110.888 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.2 m 65.06 80.51 0.23 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 70.15 111.159 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -57.77 -34.61 69.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.251 -0.431 . . . . 74.24 110.855 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -51.5 106.82 0.34 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.72 -0.753 . . . . 23.51 112.462 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -58.43 151.69 19.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.886 0.374 . . . . 74.25 110.942 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -133.8 69.26 0.53 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.727 -0.749 . . . . 43.53 112.531 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -91.95 13.71 17.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.906 0.384 . . . . 63.45 110.915 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.07 14.6 64.2 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.713 -0.756 . . . . 74.23 112.498 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.591 ' C ' HD12 ' A' ' 27' ' ' ILE . 1.2 pp -118.98 -179.1 3.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.762 0.315 . . . . 53.52 110.918 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.591 HD12 ' C ' ' A' ' 26' ' ' LEU . 1.6 mp -109.99 131.8 59.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 70.43 111.132 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.447 ' HG2' ' HA2' ' A' ' 278' ' ' GLY . 6.4 ptmm? -115.91 138.22 51.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 72.35 110.904 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.679 HD13 ' N ' ' A' ' 30' ' ' ASP . 3.2 tm? -123.67 136.45 54.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.235 -0.439 . . . . 70.4 110.891 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.679 ' N ' HD13 ' A' ' 29' ' ' LEU . 0.8 OUTLIER -126.76 127.78 45.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.469 . . . . 71.22 110.871 179.856 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.743 HD22 ' HB3' ' A' ' 281' ' ' PHE . 0.2 OUTLIER -115.75 125.1 52.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 65.31 110.902 -179.967 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.472 ' HD2' HG23 ' A' ' 42' ' ' THR . 5.3 tptp -123.57 125.09 44.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 63.34 110.866 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.9 m -135.42 120.67 18.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 71.12 111.14 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -134.22 125.6 28.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 61.54 110.875 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 38.4 t -127.24 143.7 51.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 71.44 110.859 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -76.59 58.72 1.41 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 73.03 110.885 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -147.67 16.96 1.13 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.146 -0.479 . . . . 73.55 110.865 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.555 ' HA2' ' O ' ' A' ' 63' ' ' ARG . . . 82.94 -5.3 76.55 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.729 -0.748 . . . . 62.21 112.489 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -101.14 126.22 47.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.8 0.333 . . . . 42.04 110.904 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.407 ' HB2' ' O ' ' A' ' 61' ' ' LYS . 0.8 OUTLIER -139.46 117.68 11.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.168 -0.469 . . . . 74.31 110.885 179.934 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.415 ' CZ ' HD21 ' A' ' 58' ' ' LEU . 5.4 t80 -107.07 121.48 44.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.122 -0.49 . . . . 61.4 110.887 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.472 HG23 ' HD2' ' A' ' 32' ' ' LYS . 3.9 m -127.96 115.15 18.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.141 -0.481 . . . . 73.34 111.183 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -122.05 141.7 51.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 72.51 110.864 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.4 p -151.01 126.41 10.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.464 . . . . 62.02 110.892 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -166.41 165.5 38.32 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.722 -0.751 . . . . 71.53 112.48 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 82.8 p -137.25 168.96 18.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.896 0.379 . . . . 53.12 110.876 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -158.63 140.57 13.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 51.14 111.118 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 46.0 t-20 -101.26 141.9 33.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.242 -0.435 . . . . 73.25 110.832 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.5 t -92.7 -35.24 13.58 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.168 -0.469 . . . . 64.31 111.165 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.85 -63.48 1.15 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.227 -0.442 . . . . 75.11 110.89 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.18 149.91 33.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.125 -0.489 . . . . 73.23 111.108 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.3 t -59.09 110.69 1.1 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.172 -0.467 . . . . 64.54 111.155 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.6 mtpm? -166.53 99.9 0.59 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.242 -0.436 . . . . 74.24 110.949 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 24.2 t -122.5 133.49 68.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.245 -0.434 . . . . 53.21 111.125 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.0 m -136.04 134.56 38.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.165 -0.47 . . . . 63.3 111.132 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -142.8 140.48 9.84 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.699 -0.762 . . . . 73.35 112.441 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.6 p -133.18 144.52 49.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.903 0.383 . . . . 72.11 110.839 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.606 HD13 ' N ' ' A' ' 59' ' ' GLU . 0.3 OUTLIER -120.92 134.51 55.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.108 -0.496 . . . . 72.05 110.903 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.606 ' N ' HD13 ' A' ' 58' ' ' LEU . 2.0 tt0 -134.33 123.05 23.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 74.21 110.888 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 23.1 p -107.0 134.0 50.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 41.45 111.095 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.407 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 47.6 mttt -133.41 159.68 39.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 52.23 110.931 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.521 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 9.2 t80 -121.06 129.67 53.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 73.42 110.892 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.555 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 3.9 ttt85 -112.9 103.43 11.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 74.52 110.865 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -112.73 98.65 7.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.188 -0.46 . . . . 62.21 110.933 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 60.68 163.43 0.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 62.31 111.156 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -78.78 145.16 34.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.248 -0.433 . . . . 73.13 110.877 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 26.0 p90 37.81 43.35 0.49 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.177 -0.465 . . . . 64.42 110.872 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.644 ' O ' HD22 ' A' ' 69' ' ' LEU . . . -123.75 -78.93 0.41 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.743 -0.742 . . . . 70.33 112.445 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.644 HD22 ' O ' ' A' ' 68' ' ' GLY . 3.4 mm? -134.59 129.06 34.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.914 0.387 . . . . 53.43 110.883 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.8 m -138.61 114.89 10.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.157 -0.474 . . . . 73.41 111.136 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.475 ' HA ' HG22 ' A' ' 85' ' ' ILE . 12.8 m-85 -99.39 132.89 44.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 71.03 110.894 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.73 119.87 31.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.122 -0.49 . . . . 53.4 111.181 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -131.52 122.56 26.36 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.196 -0.456 . . . . 34.55 110.902 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -106.38 137.49 44.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.153 -0.476 . . . . 71.13 110.908 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 9.8 t90 -134.53 128.75 33.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.456 . . . . 71.15 110.887 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 28.9 t30 -117.13 155.41 29.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 63.25 110.908 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 12.3 m -60.36 -18.12 48.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 73.42 111.127 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.417 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 9.0 m-20 -74.63 0.37 15.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 71.43 110.863 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.417 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 4.1 m120 77.16 38.55 0.23 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.198 -0.455 . . . . 60.24 110.885 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 28.3 m -114.83 125.63 53.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.455 . . . . 74.31 111.157 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.6 mp -114.14 127.35 55.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.294 -0.412 . . . . 74.34 110.939 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -113.42 107.71 1.98 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.788 -0.72 . . . . 72.22 112.489 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.1 m -87.52 131.45 34.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.713 0.292 . . . . 73.25 111.16 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -159.99 96.68 1.23 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 73.35 110.893 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.475 HG22 ' HA ' ' A' ' 71' ' ' PHE . 1.1 pp -111.6 138.65 39.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 61.13 111.172 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.687 HG23 ' OG1' ' A' ' 98' ' ' THR . 1.6 m -118.11 139.57 51.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 53.24 111.119 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.57 HG12 ' CD1' ' A' ' 69' ' ' LEU . 2.2 m -129.39 139.62 51.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 74.25 111.155 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 -97.8 129.18 44.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 73.35 110.926 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -50.56 168.61 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.199 -0.455 . . . . 74.12 110.893 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -123.45 -35.58 2.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 63.31 110.911 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 92.5 mt -96.79 -70.12 0.73 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.245 -0.434 . . . . 71.54 110.945 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.86 78.03 1.15 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 65.41 111.07 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 9.2 ptp85 -49.29 135.32 17.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.467 . . . . 73.32 110.889 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 101.59 9.29 44.11 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.715 -0.755 . . . . 65.52 112.531 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.605 HD12 ' N ' ' A' ' 96' ' ' LYS . 8.7 tp -114.93 129.15 56.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.898 0.38 . . . . 75.24 110.891 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.605 ' N ' HD12 ' A' ' 95' ' ' LEU . 31.5 pttt -124.56 136.19 53.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 74.54 110.897 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.582 HD13 ' O ' ' A' ' 96' ' ' LYS . 1.9 mm? -124.8 126.72 46.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 74.21 110.877 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.687 ' OG1' HG23 ' A' ' 86' ' ' THR . 7.6 m -125.61 139.41 53.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.462 . . . . 73.21 111.131 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.459 ' CE2' HD13 ' A' ' 114' ' ' ILE . 24.6 m-85 -116.02 123.01 46.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.252 -0.431 . . . . 64.12 110.841 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -113.97 130.29 56.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.112 -0.494 . . . . 73.1 110.855 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.5 m -142.41 134.07 26.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.475 . . . . 72.54 110.851 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.6 t -95.81 126.17 40.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.115 -0.493 . . . . 74.14 110.857 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -118.34 119.65 35.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.097 -0.502 . . . . 75.22 110.869 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.433 ' HA ' ' HD2' ' A' ' 105' ' ' PRO . 1.7 t -128.83 101.39 20.28 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.61 0.719 . . . . 72.5 110.919 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 104' ' ' SER . 53.4 Cg_endo -69.79 -32.89 17.56 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.681 2.254 . . . . 65.21 112.301 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 16.9 t30 -51.56 -74.25 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.269 -0.423 . . . . 54.11 110.916 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 6.0 m -77.02 -33.57 57.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 74.32 111.139 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.61 23.92 14.94 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.773 -0.727 . . . . 54.21 112.51 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -94.48 147.02 23.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.853 0.359 . . . . 74.41 110.907 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 27.6 ttpt -133.42 140.88 47.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.218 -0.446 . . . . 71.24 110.938 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -120.94 136.22 55.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 70.24 110.938 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -110.57 125.28 53.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 70.41 111.094 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 17.4 mtmt -138.87 138.23 37.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 73.12 110.888 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.459 HD13 ' CE2' ' A' ' 99' ' ' PHE . 5.7 tp -121.99 139.86 47.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.212 -0.449 . . . . 64.12 111.092 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.45 ' H ' HD12 ' A' ' 114' ' ' ILE . 19.8 ttpt -130.06 118.87 22.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.166 -0.47 . . . . 73.23 110.899 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.415 HG23 ' O ' ' A' ' 116' ' ' THR . 4.8 t -130.9 118.6 20.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.446 . . . . 73.11 111.13 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.472 ' HA3' ' HA2' ' A' ' 126' ' ' GLY . . . -152.99 159.14 28.32 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.695 -0.764 . . . . 24.11 112.476 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -129.34 138.34 51.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.982 0.42 . . . . 73.24 110.912 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 36.2 pttt -109.82 121.15 44.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.115 -0.493 . . . . 74.43 110.891 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 6.8 tpt180 -109.53 143.88 38.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 74.52 110.885 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -50.73 -28.31 8.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 72.25 110.881 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 59.2 m-70 -88.45 -41.97 12.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 75.34 110.897 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.687 ' CD1' HD22 ' A' ' 144' ' ' LEU . 2.2 tt -151.67 145.03 16.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 73.11 111.198 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -113.73 116.02 28.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 74.53 110.822 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.559 HD23 ' HG ' ' A' ' 142' ' ' LEU . 2.0 mt -119.24 141.45 48.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.472 . . . . 75.14 110.895 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.472 ' HA2' ' HA3' ' A' ' 117' ' ' GLY . . . -145.96 125.91 2.4 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.721 -0.752 . . . . 74.35 112.457 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 8.3 t -114.51 119.46 36.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.816 0.341 . . . . 53.31 110.883 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -118.9 146.58 44.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.466 . . . . 72.12 110.867 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 7.8 ttt -136.62 136.27 39.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.203 -0.453 . . . . 75.44 110.869 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -110.86 124.99 53.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.173 -0.467 . . . . 71.12 110.883 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -95.53 98.2 10.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 74.22 110.886 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -103.92 169.65 8.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.139 -0.482 . . . . 65.24 110.898 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 2.5 pp -74.91 -35.61 36.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 75.24 111.121 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -77.06 -20.27 56.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 74.12 111.07 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 154.16 149.64 5.28 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.705 -0.759 . . . . 62.13 112.467 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 114.5 3.73 Favored 'Trans proline' 0 C--O 1.231 0.146 0 C-N-CA 122.69 2.26 . . . . 73.35 112.315 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.64 148.76 30.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.211 -0.449 . . . . 75.03 110.915 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 5.3 mp -106.3 122.84 60.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.19 -0.459 . . . . 62.0 111.145 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 3.9 ttm105 -121.56 114.55 21.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 71.14 110.874 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -110.63 133.96 11.89 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.732 -0.747 . . . . 74.34 112.478 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -132.91 116.31 16.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.815 0.341 . . . . 54.52 111.109 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.74 HD22 HD21 ' A' ' 144' ' ' LEU . 0.2 OUTLIER -121.97 125.23 45.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.161 -0.472 . . . . 61.32 110.878 -179.939 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.798 ' C ' HD23 ' A' ' 144' ' ' LEU . 40.7 t -131.19 123.17 52.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 73.31 111.151 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.798 HD23 ' C ' ' A' ' 143' ' ' VAL . 0.3 OUTLIER -116.85 156.32 27.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 73.12 110.934 179.996 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -106.71 133.05 11.44 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.746 -0.74 . . . . 72.24 112.465 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.413 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 0.2 OUTLIER -128.58 147.88 50.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.823 0.344 . . . . 74.3 110.874 -179.765 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 48.7 tt0 -57.35 97.99 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.077 -0.511 . . . . 74.51 110.826 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.535 ' O ' ' HB3' ' A' ' 173' ' ' TYR . . . 86.04 -15.9 45.93 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.74 -0.743 . . . . 73.23 112.505 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.413 ' O ' ' CB ' ' A' ' 146' ' ' TYR . 5.1 m95 -123.61 146.68 47.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.78 0.324 . . . . 71.13 110.929 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.712 ' N ' ' HB2' ' A' ' 173' ' ' TYR . 13.0 tp -108.75 156.45 19.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.264 -0.426 . . . . 70.5 110.899 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.465 ' HB3' ' HB2' ' A' ' 144' ' ' LEU . . . -127.64 131.31 49.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.191 -0.459 . . . . 73.15 111.127 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.677 ' HA3' HD21 ' A' ' 10' ' ' LEU . . . -155.64 133.24 3.66 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.748 -0.739 . . . . 41.22 112.474 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -145.81 118.81 8.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.81 0.338 . . . . 73.11 110.941 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -122.43 123.13 40.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.096 -0.502 . . . . 74.04 110.883 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 97.8 mtp -133.57 134.89 43.89 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.172 -0.467 . . . . 61.22 110.873 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.478 ' O ' ' HB ' ' A' ' 164' ' ' VAL . 4.9 m120 -112.36 117.48 32.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 55.42 110.899 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.493 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 0.2 OUTLIER -87.23 125.69 34.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 74.11 110.882 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.719 ' OE1' ' HB3' ' A' ' 160' ' ' ALA . 0.2 OUTLIER -82.39 108.15 15.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.13 -0.486 . . . . 75.22 110.943 -179.951 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.488 HG23 ' N ' ' A' ' 160' ' ' ALA . 6.0 t -66.14 -47.14 75.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.476 . . . . 74.24 111.152 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.719 ' HB3' ' OE1' ' A' ' 158' ' ' GLU . . . -50.71 -26.17 5.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 71.01 111.063 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 10.6 mmtt -120.93 -167.72 1.54 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.244 -0.434 . . . . 54.44 110.889 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 50.1 m -112.92 39.29 2.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 62.45 110.885 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.66 174.88 9.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 73.12 110.853 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.493 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 1.0 OUTLIER -78.63 146.0 8.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 75.25 111.167 179.925 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.464 HG23 ' HG2' ' A' ' 166' ' ' GLN . 15.3 t -88.32 -34.11 17.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 74.13 111.109 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . 0.464 ' HG2' HG23 ' A' ' 165' ' ' THR . 30.1 pt20 -152.7 132.74 13.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 73.12 110.945 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 3.8 m -126.06 125.78 43.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 74.42 110.858 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 15.1 p-10 -135.72 137.02 41.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 54.24 110.891 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -131.64 150.26 52.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.459 . . . . 61.35 110.88 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -150.33 129.46 12.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.485 . . . . 55.24 111.068 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -145.69 138.5 20.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.157 -0.474 . . . . 73.54 111.123 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . 0.454 ' O ' ' HB3' ' A' ' 150' ' ' LEU . . . 136.69 146.25 5.14 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.747 -0.74 . . . . 52.45 112.478 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . 0.712 ' HB2' ' N ' ' A' ' 150' ' ' LEU . 5.0 t80 -151.04 177.56 10.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.008 0.433 . . . . 75.44 110.88 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -97.1 136.08 38.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.105 -0.498 . . . . 71.33 110.895 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.651 ' O ' ' C ' ' A' ' 176' ' ' ASP . 0.2 OUTLIER -122.86 165.54 16.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.224 -0.443 . . . . 73.33 111.156 179.979 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.651 ' C ' ' O ' ' A' ' 175' ' ' THR . 2.0 m-20 -9.5 -86.72 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.25 -0.432 . . . . 73.22 110.869 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -120.35 12.95 11.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 53.3 110.884 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -130.2 116.58 18.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 74.12 110.889 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -114.13 124.2 51.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.135 -0.484 . . . . 62.03 110.91 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.525 HD13 ' C ' ' A' ' 180' ' ' LEU . 3.3 tm? -122.07 120.99 35.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 73.44 110.936 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' HIS . . . . . 0.415 ' HA ' ' HA3' ' A' ' 172' ' ' GLY . 0.1 OUTLIER -123.71 145.75 48.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 72.34 110.869 179.901 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.89 136.72 23.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 73.15 111.102 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 22.1 m120 -132.65 140.04 48.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 72.43 110.853 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.458 ' O ' HG12 ' A' ' 184' ' ' VAL . 2.5 t -132.74 110.38 15.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 71.42 111.117 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -99.0 90.07 4.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 72.13 110.893 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . 0.542 ' HB2' HG22 ' A' ' 188' ' ' THR . 1.0 OUTLIER 66.2 176.86 0.22 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.177 -0.465 . . . . 43.24 110.86 179.911 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -73.22 -2.2 58.44 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.737 -0.744 . . . . 63.53 112.52 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . 0.542 HG22 ' HB2' ' A' ' 186' ' ' ASP . 7.7 t -98.4 -25.35 14.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.742 0.306 . . . . 53.12 111.12 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -121.94 115.27 22.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 72.54 110.926 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -140.81 124.47 16.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 75.44 110.883 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -175.55 -161.6 25.25 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.756 -0.735 . . . . 33.14 112.503 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -175.33 -172.05 39.87 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.767 -0.73 . . . . 52.11 112.529 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 34.3 m -147.63 148.42 31.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.796 0.331 . . . . 75.21 110.877 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.404 ' N ' HD12 ' A' ' 194' ' ' ILE . 4.7 mp -119.63 130.96 73.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.12 -0.491 . . . . 75.04 111.168 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . 0.464 ' CD1' ' HB2' ' A' ' 205' ' ' ALA . 5.4 t80 -119.24 126.05 50.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.198 -0.455 . . . . 75.41 110.942 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 3.7 tm0? -124.75 131.13 53.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.095 -0.502 . . . . 54.43 110.881 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 36.0 mttt -100.64 127.23 47.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 63.5 110.873 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 16.4 t -80.33 152.63 4.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.27 -0.423 . . . . 75.42 111.174 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -51.15 -37.9 48.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 75.44 110.908 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.75 -170.4 2.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 51.25 110.92 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . 0.65 ' C ' HD12 ' A' ' 202' ' ' LEU . 1.6 ptmt -76.71 64.67 2.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 72.4 110.926 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.65 HD12 ' C ' ' A' ' 201' ' ' LYS . 6.3 mp -145.62 128.45 16.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.236 -0.438 . . . . 62.32 110.915 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -120.61 130.07 54.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.15 -0.477 . . . . 72.21 110.889 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 2.3 t -132.23 138.31 47.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 70.41 111.091 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.464 ' HB2' ' CD1' ' A' ' 195' ' ' TYR . . . -149.69 156.7 42.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 74.24 111.111 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.761 HG12 HG22 ' A' ' 221' ' ' ILE . 1.3 m -126.08 147.21 30.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 41.12 111.173 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -117.92 127.96 54.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.454 . . . . 72.3 110.923 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 2.2 mp -125.7 147.03 49.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 64.41 110.877 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -157.24 131.55 8.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 63.22 111.105 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 21.5 t90 -129.91 133.56 46.93 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.26 -0.427 . . . . 70.42 110.927 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -101.09 103.68 14.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.25 -0.432 . . . . 61.14 111.152 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -53.26 140.88 25.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.26 -0.427 . . . . 73.23 111.111 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 134.74 -72.76 0.46 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.689 -0.767 . . . . 42.44 112.481 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -171.79 36.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.793 0.33 . . . . 51.44 110.882 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 32.8 t -111.85 165.33 12.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 44.5 110.852 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -88.16 162.59 16.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 64.22 110.866 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 2.9 m -78.11 137.96 38.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 64.45 111.172 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 33.4 ttp180 -102.95 129.06 49.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 74.23 110.872 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -134.0 133.25 41.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 65.21 110.86 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -143.53 145.46 15.26 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.72 -0.752 . . . . 50.2 112.5 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.761 HG22 HG12 ' A' ' 206' ' ' VAL . 0.0 OUTLIER -122.14 138.32 52.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.863 0.363 . . . . 54.05 111.173 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -138.12 153.22 49.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.451 . . . . 73.11 111.13 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.457 ' HB1' ' CZ ' ' A' ' 225' ' ' TYR . . . -145.49 157.72 43.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.239 -0.437 . . . . 71.22 111.097 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 3.1 tttm -142.94 124.41 14.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.441 . . . . 73.32 110.861 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' TYR . . . . . 0.609 ' CE1' HD23 ' A' ' 202' ' ' LEU . 8.7 m-85 -133.6 133.93 42.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 62.42 110.938 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 7.9 mm-40 -79.15 130.71 35.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.139 -0.482 . . . . 72.02 110.894 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . 0.937 HG23 ' HD2' ' A' ' 229' ' ' PRO . 1.3 tp -77.41 -38.34 26.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.469 . . . . 43.4 111.108 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . 0.48 ' N ' ' HD2' ' A' ' 229' ' ' PRO . 0.3 OUTLIER 172.12 -60.91 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.6 0.714 . . . . 72.4 110.863 179.884 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.937 ' HD2' HG23 ' A' ' 227' ' ' ILE . 53.8 Cg_endo -69.76 -157.52 0.04 OUTLIER 'Trans proline' 0 C--O 1.231 0.148 0 C-N-CA 122.722 2.281 . . . . 72.24 112.315 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -85.37 15.23 4.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 72.44 110.906 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.66 ' HB2' ' HG3' ' A' ' 249' ' ' GLN . . . -120.59 122.0 39.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 75.54 111.078 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 13.0 p -112.79 144.56 42.12 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.444 . . . . 71.41 110.864 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -97.2 127.64 43.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 74.23 110.888 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 1.2 t -117.54 137.15 52.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.126 -0.488 . . . . 52.2 110.807 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -130.67 141.27 50.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 53.33 111.094 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 7.7 pttm -144.45 165.06 29.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 61.14 110.884 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 242' ' ' LEU . 8.7 p -154.93 146.23 13.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 73.25 111.124 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -104.82 147.69 27.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 64.34 110.848 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -53.46 -22.83 8.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.111 -0.495 . . . . 42.43 110.851 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 2.6 t -82.03 26.86 0.5 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 52.14 110.901 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 59.14 37.77 23.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.078 -0.51 . . . . 52.14 110.881 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . 0.625 ' HG ' HD11 ' A' ' 262' ' ' LEU . 1.0 OUTLIER -98.39 121.14 39.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.103 -0.499 . . . . 73.25 110.901 -179.972 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.542 ' O ' HD22 ' A' ' 262' ' ' LEU . 5.4 mp -86.82 123.06 39.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 70.12 111.128 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . 0.654 ' C ' HD12 ' A' ' 245' ' ' LEU . . . -115.81 133.8 11.09 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.74 -0.743 . . . . 74.44 112.492 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.654 HD12 ' C ' ' A' ' 244' ' ' GLY . 11.0 mp -130.58 129.81 43.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.878 0.37 . . . . 73.15 110.942 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -140.29 121.74 2.04 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.729 -0.748 . . . . 54.31 112.465 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -111.76 121.68 45.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.936 0.398 . . . . 75.43 110.964 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -109.75 120.8 43.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.476 . . . . 62.13 111.112 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . 0.66 ' HG3' ' HB2' ' A' ' 231' ' ' ALA . 25.9 tt0 -128.32 122.68 32.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 65.23 110.931 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . 0.494 HG23 ' HD3' ' A' ' 256' ' ' LYS . 96.0 m -110.31 111.51 22.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 71.53 111.137 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -106.37 88.57 2.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 73.34 110.904 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 6.2 mtmt 62.44 161.46 0.12 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.549 0.69 . . . . 73.22 110.925 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 76.84 1.13 Allowed 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.679 2.253 . . . . 70.11 112.306 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 169.34 -32.16 0.17 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.751 -0.738 . . . . 62.44 112.467 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 4.4 mp -118.19 122.47 69.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.831 0.348 . . . . 73.14 111.119 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 0.494 ' HD3' HG23 ' A' ' 250' ' ' THR . 25.7 mmtt -131.6 132.83 44.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.229 -0.442 . . . . 65.02 110.877 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 0.53 HD23 ' N ' ' A' ' 258' ' ' THR . 1.5 tt -114.11 127.05 55.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.223 -0.444 . . . . 73.3 110.878 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . 0.53 ' N ' HD23 ' A' ' 257' ' ' LEU . 13.9 p -126.45 117.11 22.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 54.24 111.12 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.5 HD13 ' N ' ' A' ' 260' ' ' SER . 0.2 OUTLIER -111.98 130.6 55.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 62.14 110.91 179.934 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.5 ' N ' HD13 ' A' ' 259' ' ' LEU . 15.8 p -127.25 140.6 52.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 70.31 110.87 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -151.99 128.79 10.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.127 -0.488 . . . . 61.53 111.105 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.625 HD11 ' HG ' ' A' ' 242' ' ' LEU . 1.5 tm? -125.21 115.8 20.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 75.54 110.868 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . 0.82 ' HB3' HG11 ' A' ' 268' ' ' VAL . 0.2 OUTLIER -112.63 109.62 19.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 74.42 110.928 179.884 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . 0.653 ' O ' HG22 ' A' ' 268' ' ' VAL . 0.8 OUTLIER -84.01 116.45 22.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.204 -0.453 . . . . 71.03 110.853 179.848 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -57.19 -16.58 20.24 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.716 -0.754 . . . . 64.14 112.513 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -86.11 -22.15 27.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.844 0.354 . . . . 72.22 110.945 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -108.57 -53.6 2.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 62.33 110.889 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . 0.82 HG11 ' HB3' ' A' ' 263' ' ' LEU . 17.4 m -50.88 -30.29 8.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 55.12 111.138 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -52.98 -41.02 64.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 65.23 110.864 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -103.73 -17.62 15.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.14 -0.482 . . . . 72.33 111.124 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 128.49 94.39 0.79 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.762 -0.732 . . . . 71.3 112.482 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 175.53 78.67 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.762 -0.732 . . . . 72.41 112.491 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 273' ' ' HIS . . . . . 0.661 ' HB2' HD12 ' A' ' 263' ' ' LEU . 13.0 p80 -104.91 144.19 32.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.853 0.359 . . . . 62.01 110.871 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 1.6 mtpt -99.43 136.19 39.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.268 -0.424 . . . . 65.12 110.887 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.763 HD13 ' N ' ' A' ' 276' ' ' GLY . 2.6 tm? -136.58 144.91 44.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 73.11 110.88 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . 0.763 ' N ' HD13 ' A' ' 275' ' ' LEU . . . -154.19 130.63 2.96 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.729 -0.748 . . . . 52.43 112.487 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.471 ' HB3' HG13 ' A' ' 27' ' ' ILE . 0.1 OUTLIER -113.7 140.21 48.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.824 0.345 . . . . 74.32 110.928 -179.923 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . 0.612 ' O ' HD13 ' A' ' 279' ' ' LEU . . . -147.16 126.79 2.5 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.781 -0.723 . . . . 54.42 112.502 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.612 HD13 ' O ' ' A' ' 278' ' ' GLY . 1.1 mm? -121.67 133.25 54.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.762 0.315 . . . . 64.04 110.952 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -114.98 133.35 56.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 73.44 110.925 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . 0.743 ' HB3' HD22 ' A' ' 31' ' ' LEU . 26.8 t80 -126.29 120.2 29.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 75.44 110.867 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -113.74 117.34 31.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.133 -0.485 . . . . 75.14 110.9 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.424 ' O ' HD23 ' A' ' 284' ' ' LEU . . . -99.59 112.41 24.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 54.04 111.09 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.424 HD23 ' O ' ' A' ' 283' ' ' ALA . 10.9 mt -144.87 -170.4 3.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.203 -0.453 . . . . 70.43 110.863 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 74.44 110.946 179.917 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.864 0.364 . . . . 75.04 111.112 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.52 HG11 ' C ' ' A' ' 119' ' ' LYS . 17.8 t -141.1 75.33 23.9 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.675 0.75 . . . . 71.25 111.13 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 168.01 22.76 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.678 2.252 . . . . 73.4 112.372 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 101.23 0.88 Allowed 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.638 2.226 . . . . 71.15 112.374 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.654 ' HB ' HD21 ' A' ' 150' ' ' LEU . 0.6 OUTLIER -80.0 -34.49 38.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.456 . . . . 71.15 111.157 -179.969 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.518 ' HB2' HG21 ' A' ' 143' ' ' VAL . 72.7 t80 -53.7 -30.98 46.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 62.32 110.929 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -80.55 -26.02 38.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.147 -0.479 . . . . 63.43 111.057 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -74.31 -9.94 59.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.227 -0.442 . . . . 73.51 110.888 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.811 HD21 ' HA3' ' A' ' 152' ' ' GLY . 1.4 mp -56.72 -34.25 67.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 61.43 110.953 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 152.24 64.38 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.759 -0.734 . . . . 75.15 112.517 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 24.5 ttpp -62.81 -52.44 63.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.771 0.319 . . . . 72.31 110.913 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 75.5 m -62.87 -49.39 75.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.448 . . . . 54.31 110.855 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.475 ' HB1' ' CB ' ' A' ' 193' ' ' SER . . . -59.94 -37.38 79.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 70.43 111.13 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 45.7 ttt180 -66.01 -34.03 77.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 71.55 110.909 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -60.29 -46.28 90.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 64.12 110.857 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.719 HG21 ' HB2' ' A' ' 222' ' ' ALA . 9.3 p -80.98 -33.74 13.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 73.42 111.133 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.489 ' HE1' ' HB2' ' A' ' 209' ' ' ALA . 11.6 t80 -66.9 -41.18 87.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.485 . . . . 54.3 110.89 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.26 -173.93 2.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 71.11 111.16 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.8 mtmt -95.56 -168.48 1.79 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 71.42 110.915 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.56 48.95 1.46 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.741 -0.742 . . . . 51.5 112.493 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 12.9 p90 -122.63 -35.77 3.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.937 0.399 . . . . 74.12 110.933 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -144.98 139.29 8.31 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.754 -0.736 . . . . 73.0 112.528 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.522 ' HB3' HD11 ' A' ' 26' ' ' LEU . 48.8 m-85 -104.24 -6.35 21.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.926 0.393 . . . . 71.32 110.899 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.27 12.42 57.39 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.772 -0.728 . . . . 73.52 112.488 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.749 ' N ' HD13 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -150.88 -173.48 4.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.819 0.343 . . . . 65.41 110.937 -179.934 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.971 HG23 HD12 ' A' ' 277' ' ' LEU . 21.2 mm -92.34 133.46 33.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 74.45 111.124 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.529 ' O ' HD22 ' A' ' 279' ' ' LEU . 4.5 mtpp -113.06 154.66 26.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 75.42 110.885 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.617 HD13 ' N ' ' A' ' 30' ' ' ASP . 3.3 tm? -147.79 136.84 22.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.229 -0.442 . . . . 72.54 110.944 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.617 ' N ' HD13 ' A' ' 29' ' ' LEU . 1.2 t70 -152.22 124.21 8.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 61.34 110.863 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.711 HD11 ' CB ' ' A' ' 283' ' ' ALA . 2.7 tm? -125.5 129.13 49.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 72.23 110.907 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.54 ' N ' HD13 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -112.17 128.24 56.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 70.54 110.88 179.814 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 93.8 m -137.21 121.12 17.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.44 . . . . 75.14 111.154 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.9 ptmm? -140.89 141.93 34.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 72.44 110.888 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 17.9 t -139.23 152.49 47.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.207 -0.451 . . . . 71.22 110.864 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -75.97 61.45 1.51 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 71.24 110.907 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -153.27 20.67 0.56 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.132 -0.486 . . . . 73.2 110.876 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.545 ' HA2' ' O ' ' A' ' 63' ' ' ARG . . . 75.72 -3.53 49.23 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.721 -0.752 . . . . 72.23 112.524 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.2 mp -98.94 124.16 43.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.771 0.319 . . . . 74.1 110.897 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.82 118.28 10.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.162 -0.472 . . . . 45.15 110.825 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -110.1 123.58 49.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 71.12 110.905 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 83.9 m -127.39 116.62 20.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.47 . . . . 73.34 111.18 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.5 t -115.44 135.81 53.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.435 . . . . 74.23 110.861 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.27 143.91 25.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 54.01 110.871 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 164.95 168.49 27.18 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.712 -0.756 . . . . 70.21 112.463 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -137.3 169.45 17.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.866 0.365 . . . . 75.24 110.872 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -147.11 127.43 13.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 72.23 111.089 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.469 ' ND2' HD12 ' A' ' 26' ' ' LEU . 2.5 m120 -95.45 142.55 27.68 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.198 -0.456 . . . . 74.53 110.852 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 61.1 p -94.12 56.45 2.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 75.01 111.174 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -126.19 -74.89 0.59 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 64.1 110.889 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.4 ' O ' ' C ' ' A' ' 52' ' ' THR . 2.2 m -130.33 65.65 1.52 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 51.13 111.133 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.4 ' C ' ' O ' ' A' ' 51' ' ' THR . 10.1 t 37.05 43.88 0.34 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 65.41 111.16 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -105.2 95.02 5.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 75.02 110.885 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -126.81 148.23 31.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 72.24 111.144 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.7 p -113.27 126.59 55.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 74.05 111.138 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -118.94 147.27 18.43 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.797 -0.716 . . . . 60.13 112.52 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.4 p -146.06 133.55 20.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.918 0.389 . . . . 75.15 110.871 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.455 ' O ' ' HB3' ' A' ' 74' ' ' LYS . 0.3 OUTLIER -123.09 130.08 52.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.465 . . . . 63.44 110.892 -179.968 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.524 ' HA ' ' CB ' ' A' ' 74' ' ' LYS . 0.9 OUTLIER -134.84 120.82 19.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.21 -0.45 . . . . 62.02 110.86 179.923 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.477 ' H ' ' HB2' ' A' ' 74' ' ' LYS . 20.3 m -105.43 117.81 34.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.126 -0.488 . . . . 54.01 111.149 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 71' ' ' PHE . 8.2 mttp -106.58 157.95 17.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 74.33 110.867 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.518 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 10.3 t80 -122.16 121.16 36.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 62.23 110.899 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.545 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -88.45 101.31 13.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.082 -0.508 . . . . 73.44 110.908 179.963 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 42.5 t-105 -116.21 136.35 53.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.209 -0.451 . . . . 73.51 110.895 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 24.0 p -80.98 -169.85 2.42 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.211 -0.45 . . . . 75.31 111.182 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.587 ' O ' HD23 ' A' ' 69' ' ' LEU . 33.6 mm-40 66.29 101.89 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.235 -0.438 . . . . 74.14 110.859 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 65.04 13.98 9.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.158 -0.474 . . . . 73.23 110.946 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 49.95 91.19 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.717 -0.754 . . . . 73.22 112.51 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.587 HD23 ' O ' ' A' ' 66' ' ' GLU . 4.3 mm? -118.05 141.04 48.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.834 0.349 . . . . 71.13 110.941 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.436 ' HA ' ' O ' ' A' ' 62' ' ' TYR . 83.4 m -135.68 121.74 20.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 73.3 111.161 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.68 ' CD1' HG22 ' A' ' 85' ' ' ILE . 14.2 t80 -100.26 119.73 38.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 73.43 110.902 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.1 t -111.37 116.06 30.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 74.31 111.154 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.578 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 8.5 tt0 -139.66 126.94 21.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 71.54 110.895 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.578 ' HB2' ' O ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER 165.63 -156.78 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 55.13 110.934 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.49 ' CD1' HD22 ' A' ' 81' ' ' LEU . 12.2 t90 -133.93 136.38 44.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.268 -0.424 . . . . 71.03 110.896 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -107.88 155.64 20.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.281 -0.418 . . . . 71.33 110.909 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 15.2 t -68.79 -8.42 43.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.172 -0.467 . . . . 72.21 111.128 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.472 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 5.1 m-20 -73.8 3.43 6.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.237 -0.438 . . . . 71.42 110.839 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.472 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 3.9 m-20 81.03 15.33 0.6 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 73.32 110.842 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -116.0 116.25 27.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 64.22 111.126 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.49 HD22 ' CD1' ' A' ' 75' ' ' TRP . 0.1 OUTLIER -122.97 128.21 49.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 74.25 110.914 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 177.58 -133.19 2.15 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.776 -0.726 . . . . 43.44 112.536 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.445 ' OG1' ' N ' ' A' ' 84' ' ' GLU . 4.3 t -178.92 -178.35 0.54 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.812 0.339 . . . . 74.34 111.109 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.65 ' HB3' ' O ' ' A' ' 99' ' ' PHE . 0.6 OUTLIER 170.93 -166.58 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.202 -0.454 . . . . 55.55 110.932 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.68 HG22 ' CD1' ' A' ' 71' ' ' PHE . 1.8 pp -136.78 145.69 29.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.203 -0.453 . . . . 52.33 111.135 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.712 ' OG1' HG23 ' A' ' 98' ' ' THR . 98.6 m -128.96 123.27 32.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.465 . . . . 72.51 111.196 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.2 p -112.54 138.66 40.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 64.13 111.157 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -123.86 118.69 27.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 70.34 110.887 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 43.1 t0 64.42 76.88 0.33 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.143 -0.48 . . . . 63.34 110.878 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -109.01 -68.87 0.89 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 73.11 110.882 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -65.33 -74.28 0.11 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 73.23 110.86 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -121.41 142.38 50.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.174 -0.466 . . . . 63.23 111.117 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 19.5 ttm180 -50.64 133.99 24.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 62.22 110.9 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 100.88 -22.31 40.08 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.732 -0.747 . . . . 61.42 112.49 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.98 125.04 34.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.923 0.392 . . . . 73.2 110.917 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.622 ' O ' HD13 ' A' ' 97' ' ' LEU . 28.8 tttp -124.02 129.83 51.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.466 . . . . 74.2 110.903 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.622 HD13 ' O ' ' A' ' 96' ' ' LYS . 1.2 mm? -122.2 123.04 40.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.45 . . . . 64.13 110.92 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.712 HG23 ' OG1' ' A' ' 86' ' ' THR . 87.6 m -123.79 118.68 27.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.209 -0.451 . . . . 72.04 111.108 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.754 ' CD1' HD13 ' A' ' 114' ' ' ILE . 0.7 OUTLIER -115.3 117.33 30.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.455 . . . . 71.11 110.857 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.568 ' HA ' ' CB ' ' A' ' 84' ' ' GLU . 8.4 t70 -121.62 139.47 53.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.103 -0.499 . . . . 64.11 110.901 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 37.7 t -130.55 121.26 25.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 65.44 110.87 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 15.8 m -116.6 153.41 32.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.096 -0.502 . . . . 54.44 110.878 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -123.72 138.41 54.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 71.24 110.895 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.424 ' HA ' ' HD2' ' A' ' 105' ' ' PRO . 4.2 t -116.83 106.69 47.47 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.634 0.73 . . . . 71.12 110.881 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 104' ' ' SER . 54.1 Cg_endo -69.68 -32.61 18.55 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.683 2.255 . . . . 75.2 112.389 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -57.3 -35.9 70.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.469 . . . . 71.01 110.903 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 10.0 m -99.09 -32.4 11.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 61.1 111.12 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.66 -18.58 57.24 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.762 -0.732 . . . . 71.52 112.532 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 29.6 tptt -94.44 147.47 23.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.817 0.342 . . . . 42.51 110.915 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -92.95 150.84 20.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.279 -0.419 . . . . 74.22 110.924 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.1 m120 -121.08 126.32 49.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.436 . . . . 60.34 110.913 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -113.68 139.3 49.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 65.44 111.066 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 27.9 mttm -138.3 137.91 37.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 64.11 110.889 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.754 HD13 ' CD1' ' A' ' 99' ' ' PHE . 4.1 tp -134.66 133.68 54.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 61.24 111.152 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.464 ' H ' HD12 ' A' ' 114' ' ' ILE . 40.0 mttp -125.42 120.83 32.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 72.33 110.894 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.563 HG22 HD12 ' A' ' 97' ' ' LEU . 59.7 p -127.81 118.33 23.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 55.21 111.167 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.4 ' HA3' ' HA2' ' A' ' 126' ' ' GLY . . . -152.19 156.08 26.5 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.753 -0.737 . . . . 74.22 112.495 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -132.41 130.49 40.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.973 0.416 . . . . 73.52 110.896 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.52 ' C ' HG11 ' A' ' 3' ' ' VAL . 37.7 mttp -107.05 118.5 36.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.103 -0.499 . . . . 75.34 110.893 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.26 142.94 42.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 74.43 110.851 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -52.42 -27.32 15.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.134 -0.485 . . . . 64.23 110.887 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 27.9 m80 -90.38 -38.3 13.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 75.14 110.895 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.443 HD11 HD22 ' A' ' 144' ' ' LEU . 9.3 tp -147.67 140.65 19.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.445 . . . . 74.53 111.098 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -111.25 115.94 30.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 72.34 110.87 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.511 ' CD2' HD13 ' A' ' 142' ' ' LEU . 2.9 mm? -122.96 139.91 53.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.175 -0.466 . . . . 73.13 110.935 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.4 ' HA2' ' HA3' ' A' ' 117' ' ' GLY . . . -146.74 121.5 1.44 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.741 -0.743 . . . . 63.3 112.437 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 18.5 m -113.19 134.02 54.78 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.791 0.329 . . . . 72.1 110.916 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -126.62 146.97 49.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 61.45 110.905 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 8.7 mtm -139.04 127.23 22.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 72.24 110.869 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -117.81 121.3 40.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 75.22 110.88 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -95.26 119.71 34.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.465 . . . . 74.05 110.887 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -128.2 121.15 28.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 72.2 110.855 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.546 HD12 ' O ' ' A' ' 133' ' ' ILE . 1.1 tp -52.41 -43.75 41.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 54.31 111.166 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -74.39 -18.29 60.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.481 . . . . 65.53 111.121 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 161.47 103.59 0.18 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.725 -0.75 . . . . 72.42 112.454 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 147.99 64.34 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.656 2.237 . . . . 74.13 112.382 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 28.4 t -128.73 150.49 50.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 75.14 110.875 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.703 HD12 ' OG1' ' A' ' 159' ' ' THR . 1.4 mp -107.89 132.99 54.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.12 -0.491 . . . . 61.24 111.136 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 18.9 mtp180 -112.37 131.25 55.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 72.34 110.869 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -126.72 134.01 8.3 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.705 -0.76 . . . . 51.45 112.485 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -139.17 116.94 11.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.832 0.349 . . . . 71.41 111.125 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.595 HD12 ' N ' ' A' ' 143' ' ' VAL . 5.3 tp -127.01 124.59 39.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.242 -0.436 . . . . 62.45 110.954 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.595 ' N ' HD12 ' A' ' 142' ' ' LEU . 46.6 t -123.34 134.8 65.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 64.44 111.092 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.545 HD23 ' C ' ' A' ' 143' ' ' VAL . 0.5 OUTLIER -109.38 143.36 39.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.106 -0.497 . . . . 75.12 110.889 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -121.36 120.25 4.37 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.774 -0.727 . . . . 31.12 112.513 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.428 ' HB3' ' HB2' ' A' ' 149' ' ' TRP . 38.5 t80 -128.85 145.5 51.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.825 0.345 . . . . 72.34 110.893 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -50.95 96.89 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.126 -0.488 . . . . 62.43 110.876 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 92.88 -30.7 6.78 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.707 -0.759 . . . . 63.35 112.464 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.428 ' HB2' ' HB3' ' A' ' 146' ' ' TYR . 25.0 m95 -104.77 141.09 37.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.828 0.347 . . . . 74.11 110.863 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.654 HD21 ' HB ' ' A' ' 6' ' ' THR . 0.5 OUTLIER -130.71 140.6 50.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.446 . . . . 71.53 110.943 179.955 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.516 ' HB3' ' HB2' ' A' ' 144' ' ' LEU . . . -131.44 148.12 52.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 73.54 111.086 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.811 ' HA3' HD21 ' A' ' 10' ' ' LEU . . . -150.95 137.06 5.86 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.752 -0.737 . . . . 74.42 112.484 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -144.11 119.78 10.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.877 0.37 . . . . 74.31 110.923 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -126.94 122.44 34.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.117 -0.492 . . . . 60.21 110.892 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 15.6 ptt? -146.82 150.17 34.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 62.54 110.846 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 48.9 m-20 -112.12 138.56 48.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 73.12 110.891 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -92.24 132.49 36.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 63.31 110.868 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -77.86 99.64 6.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.141 -0.482 . . . . 71.43 110.865 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.703 ' OG1' HD12 ' A' ' 138' ' ' ILE . 0.2 OUTLIER -65.21 -47.0 78.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.139 -0.482 . . . . 64.33 111.165 -179.937 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -48.29 -26.11 1.85 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 54.43 111.119 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 43.9 mttt -127.33 -166.64 1.63 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.459 . . . . 62.23 110.935 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 39.6 m -111.18 40.29 2.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.44 . . . . 73.3 110.795 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 11.0 mmm180 -153.3 176.21 12.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 71.43 110.889 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 1.5 t -78.01 141.42 15.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 74.11 111.119 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 15.2 t -90.61 -33.73 15.74 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.158 -0.474 . . . . 53.44 111.131 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -150.97 134.84 16.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.445 . . . . 73.44 110.9 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 89.5 p -124.81 119.01 27.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 53.34 110.893 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -130.47 142.56 50.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 63.25 110.89 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -138.2 158.14 44.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.126 -0.488 . . . . 71.32 110.866 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -154.07 138.96 17.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 53.01 111.114 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 46.2 t -120.63 134.87 62.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 72.23 111.113 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -117.59 112.56 2.48 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.706 -0.759 . . . . 44.32 112.491 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -114.18 121.58 44.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.994 0.426 . . . . 73.13 110.901 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 26.0 ttmt -104.36 134.77 47.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.113 -0.494 . . . . 72.11 110.916 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.97 165.11 22.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 64.12 111.128 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -40.93 -74.82 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.175 -0.466 . . . . 54.22 110.892 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -116.07 15.15 16.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 64.12 110.913 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -127.09 149.57 49.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 74.13 110.868 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 6.6 mm-40 -135.22 123.87 23.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.123 -0.49 . . . . 55.24 110.881 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.656 HD23 HG13 ' A' ' 194' ' ' ILE . 2.6 tm? -124.23 122.32 37.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.132 -0.485 . . . . 74.45 110.873 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' HIS . . . . . 0.452 ' N ' HD22 ' A' ' 180' ' ' LEU . 91.6 m-70 -130.47 115.94 17.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 71.53 110.9 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . 0.494 HG22 ' O ' ' A' ' 191' ' ' GLY . 0.2 OUTLIER -94.77 153.12 17.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.217 -0.447 . . . . 71.22 111.1 -179.856 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -146.76 138.56 24.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 73.31 110.896 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.454 ' O ' HG12 ' A' ' 184' ' ' VAL . 2.3 t -134.72 111.3 13.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.473 . . . . 71.14 111.143 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -100.09 89.28 3.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 72.3 110.9 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 65.28 179.14 0.19 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.179 -0.464 . . . . 71.22 110.821 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -73.47 -4.17 64.2 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.69 -0.767 . . . . 75.4 112.506 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 29.3 p -95.38 -25.87 16.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.765 0.317 . . . . 62.14 111.15 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -122.83 114.17 20.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 75.43 110.915 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -139.72 124.13 18.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 70.22 110.813 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . 0.494 ' O ' HG22 ' A' ' 182' ' ' THR . . . 178.8 -150.88 9.87 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.678 -0.772 . . . . 44.43 112.47 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -176.42 170.43 43.24 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.726 -0.749 . . . . 74.35 112.485 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . 0.475 ' CB ' ' HB1' ' A' ' 14' ' ' ALA . 65.3 m -121.21 147.19 45.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.872 0.368 . . . . 53.32 110.798 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.656 HG13 HD23 ' A' ' 180' ' ' LEU . 4.0 mp -119.79 123.45 70.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.104 -0.498 . . . . 73.22 111.073 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . 0.64 ' HD1' ' HB2' ' A' ' 205' ' ' ALA . 12.6 t80 -108.48 121.91 45.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 73.2 110.929 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 53.9 tp60 -124.47 130.2 52.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 74.52 110.914 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 21.2 mtpp -106.25 127.19 53.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 73.32 110.874 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 14.7 t -79.21 153.33 4.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 73.51 111.159 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' ASN . . . . . 0.406 ' O ' ' C ' ' A' ' 200' ' ' LYS . 47.0 t30 -59.62 97.94 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 73.35 110.9 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . 0.406 ' C ' ' O ' ' A' ' 199' ' ' ASN . 16.6 ptpt 37.3 63.12 0.76 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 75.11 110.897 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . 0.428 ' HB3' HD23 ' A' ' 202' ' ' LEU . 25.3 mttm -145.46 -56.46 0.31 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 75.53 110.917 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.428 HD23 ' HB3' ' A' ' 201' ' ' LYS . 2.1 pt? -173.76 172.42 3.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 73.44 110.936 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -116.58 144.9 43.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 72.24 110.876 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . 0.438 HG23 ' O ' ' A' ' 222' ' ' ALA . 7.3 m -146.53 138.77 24.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 74.02 111.105 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.64 ' HB2' ' HD1' ' A' ' 195' ' ' TYR . . . -145.3 136.64 25.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.441 . . . . 72.14 111.141 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 1.1 m -113.79 149.97 15.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 73.23 111.095 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -113.58 137.19 51.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.485 . . . . 72.34 110.865 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.579 HD11 ' CE1' ' A' ' 219' ' ' PHE . 3.8 mm? -120.61 129.72 53.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.17 -0.468 . . . . 73.51 110.897 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.489 ' HB2' ' HE1' ' A' ' 18' ' ' PHE . . . -129.77 130.07 44.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.119 -0.492 . . . . 64.31 111.08 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 2.9 t-105 -129.67 128.1 41.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 71.4 110.941 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 2.7 p -99.14 109.02 21.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.225 -0.443 . . . . 75.33 111.159 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -54.91 149.84 10.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 65.51 111.063 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 95.59 -36.49 3.8 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.71 -0.757 . . . . 51.04 112.474 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -121.54 -179.46 4.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.782 0.325 . . . . 74.12 110.879 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 3.0 t -112.11 38.37 2.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 71.12 110.882 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -102.17 112.21 24.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 75.55 110.905 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 18.6 m -114.65 138.45 50.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.459 . . . . 74.33 111.132 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . 0.446 ' HB3' ' HB3' ' A' ' 209' ' ' ALA . 18.4 ttt85 -108.55 131.99 54.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.441 . . . . 60.44 110.848 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . 0.579 ' CE1' HD11 ' A' ' 208' ' ' LEU . 17.9 m-85 -117.45 136.7 53.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 65.33 110.89 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -137.46 140.63 11.48 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.737 -0.744 . . . . 63.14 112.511 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.514 ' HB ' HG12 ' A' ' 237' ' ' VAL . 4.8 mp -123.85 130.73 73.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.854 0.359 . . . . 61.54 111.104 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.719 ' HB2' HG21 ' A' ' 17' ' ' VAL . . . -127.61 152.21 47.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 65.41 111.1 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -137.37 129.34 29.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.246 -0.434 . . . . 75.22 111.084 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 7.3 ttmt -115.21 128.48 56.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 72.42 110.894 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -132.25 131.54 42.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.252 -0.431 . . . . 71.51 110.913 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 58.7 mm-40 -102.71 112.28 24.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 75.35 110.875 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 71.4 mt -102.68 -40.1 6.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 73.33 111.109 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . 0.757 ' HB2' ' HB3' ' A' ' 231' ' ' ALA . 0.4 OUTLIER -124.17 160.7 51.19 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.579 0.704 . . . . 62.32 110.882 179.88 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -32.34 18.82 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.725 2.283 . . . . 73.44 112.317 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -109.2 10.49 25.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.435 . . . . 72.43 110.882 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.757 ' HB3' ' HB2' ' A' ' 228' ' ' ASP . . . -136.1 140.42 43.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.179 -0.464 . . . . 64.12 111.086 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 21.8 m -138.74 136.49 35.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.213 -0.449 . . . . 52.01 110.903 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -110.42 132.77 53.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 73.3 110.924 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 58.2 p -137.08 149.71 47.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 63.24 110.826 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -136.47 155.59 49.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.096 -0.502 . . . . 63.32 111.089 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.51 145.91 29.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 71.24 110.861 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.514 HG12 ' HB ' ' A' ' 221' ' ' ILE . 1.7 p -143.04 143.88 24.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 73.32 111.143 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . 0.404 ' HB3' ' HB2' ' A' ' 242' ' ' LEU . 0.9 OUTLIER -112.31 148.08 34.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 73.03 110.886 179.986 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -57.1 -18.53 15.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 63.32 110.89 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 29.9 t -80.93 25.89 0.44 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 73.31 110.814 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 62.22 35.19 15.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.123 -0.49 . . . . 72.14 110.875 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . 0.444 HD11 ' HB3' ' A' ' 264' ' ' ASP . 4.9 mp -99.25 118.5 36.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.132 -0.486 . . . . 74.01 110.916 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.508 ' H ' HD12 ' A' ' 243' ' ' ILE . 0.8 OUTLIER -107.42 117.88 54.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 74.35 111.154 179.852 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . 0.533 ' C ' HD13 ' A' ' 245' ' ' LEU . . . -137.12 149.62 20.33 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.701 -0.762 . . . . 63.21 112.467 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.669 ' N ' HD13 ' A' ' 245' ' ' LEU . 0.0 OUTLIER -145.83 158.48 43.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.869 0.366 . . . . 54.02 110.887 -179.895 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -163.01 136.83 4.48 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.687 -0.768 . . . . 44.2 112.465 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -128.42 132.59 48.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.902 0.382 . . . . 75.4 110.932 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 7.8 t -111.99 125.83 54.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.487 . . . . 62.41 111.177 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -143.43 148.82 36.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.235 -0.438 . . . . 51.32 110.961 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 5.5 m -88.93 145.24 25.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.262 -0.426 . . . . 72.03 111.127 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.613 HD12 HD11 ' A' ' 255' ' ' ILE . 47.4 mt -93.94 -176.05 3.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 71.45 110.889 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' LYS . . . . . 0.472 ' CB ' ' CD ' ' A' ' 253' ' ' PRO . 0.1 OUTLIER -51.16 -61.07 4.46 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.545 0.688 . . . . 61.3 110.87 179.845 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' PRO . . . . . 0.472 ' CD ' ' CB ' ' A' ' 252' ' ' LYS . 53.8 Cg_endo -69.73 -170.26 0.38 Allowed 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.687 2.258 . . . . 64.35 112.306 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . 0.536 ' O ' ' HB3' ' A' ' 281' ' ' PHE . . . -85.1 51.55 4.56 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.737 -0.744 . . . . 73.42 112.465 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.613 HD11 HD12 ' A' ' 251' ' ' LEU . 6.2 pt -129.27 135.1 62.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.893 0.377 . . . . 65.11 111.152 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 0.441 ' H ' ' HB2' ' A' ' 281' ' ' PHE . 0.1 OUTLIER -98.39 132.1 44.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.447 . . . . 70.13 110.888 179.858 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 0.721 ' HA ' HD12 ' A' ' 279' ' ' LEU . 5.2 tp -100.07 125.45 46.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 75.22 110.921 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . 0.434 ' O ' HD22 ' A' ' 277' ' ' LEU . 21.9 m -116.39 111.75 20.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 73.11 111.152 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 1.015 HD22 HD23 ' A' ' 277' ' ' LEU . 0.2 OUTLIER -109.33 130.02 55.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.253 -0.431 . . . . 74.01 110.868 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.504 ' N ' HD13 ' A' ' 259' ' ' LEU . 1.7 t -144.16 155.8 44.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.167 -0.469 . . . . 73.25 110.898 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' ALA . . . . . 0.438 ' HB3' ' CD2' ' A' ' 245' ' ' LEU . . . -158.88 128.38 5.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 62.24 111.06 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.655 ' C ' HD13 ' A' ' 263' ' ' LEU . 3.2 tm? -118.48 122.98 44.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 62.52 110.921 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . 0.892 ' HB3' HG21 ' A' ' 268' ' ' VAL . 0.4 OUTLIER -118.93 110.56 17.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.159 -0.473 . . . . 73.4 110.88 179.896 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . 0.555 ' O ' ' HB ' ' A' ' 268' ' ' VAL . 1.7 m-20 -88.62 99.87 12.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 70.21 110.844 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -52.86 -11.48 1.35 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.737 -0.744 . . . . 72.32 112.464 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 7.4 ttmm -63.86 -25.66 68.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.825 0.345 . . . . 70.13 110.915 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -166.82 16.91 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 64.01 110.881 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . 0.892 HG21 ' HB3' ' A' ' 263' ' ' LEU . 1.4 p -68.05 -28.51 41.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 62.44 111.119 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -74.48 -37.44 63.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 73.21 110.914 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -85.83 -17.64 35.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.142 -0.481 . . . . 53.14 111.103 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 131.21 95.26 0.68 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.768 -0.729 . . . . 53.31 112.515 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 178.86 53.74 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.774 -0.727 . . . . 53.32 112.537 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 273' ' ' HIS . . . . . 0.492 ' HB2' HD12 ' A' ' 263' ' ' LEU . 14.8 p80 -112.17 144.21 41.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.887 0.375 . . . . 72.3 110.84 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -123.71 149.32 45.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 64.42 110.889 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.422 HD12 ' HB2' ' A' ' 261' ' ' ALA . 2.4 tp -128.41 148.55 50.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 71.15 110.898 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -131.34 97.53 0.36 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.784 -0.722 . . . . 75.45 112.501 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 1.015 HD23 HD22 ' A' ' 259' ' ' LEU . 3.2 tm? -119.28 129.65 55.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.845 0.355 . . . . 74.45 110.886 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . 0.711 ' C ' HD13 ' A' ' 279' ' ' LEU . . . -164.48 145.61 10.51 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.752 -0.737 . . . . 72.53 112.533 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.721 HD12 ' HA ' ' A' ' 257' ' ' LEU . 0.0 OUTLIER -118.47 130.03 55.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.745 0.307 . . . . 72.44 110.971 -179.969 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . 0.522 ' O ' ' HB2' ' A' ' 281' ' ' PHE . 0.0 OUTLIER -140.37 143.58 35.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.449 . . . . 73.2 110.924 179.961 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . 0.536 ' HB3' ' O ' ' A' ' 254' ' ' GLY . 0.2 OUTLIER 172.63 -144.39 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 73.34 110.856 -179.949 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -137.47 148.82 46.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 71.31 110.933 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.711 ' CB ' HD11 ' A' ' 31' ' ' LEU . . . -101.11 111.45 23.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 71.31 111.106 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.66 HD12 ' O ' ' A' ' 283' ' ' ALA . 0.8 OUTLIER -151.31 178.44 9.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.235 -0.439 . . . . 75.11 110.904 -179.959 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 71.43 110.893 179.919 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.845 0.355 . . . . 63.1 111.104 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.491 HG22 ' N ' ' A' ' 121' ' ' GLU . 9.1 t -114.43 78.48 4.8 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.668 0.746 . . . . 71.11 111.14 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 167.7 23.68 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.681 2.254 . . . . 72.14 112.351 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 119.57 6.49 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.654 2.236 . . . . 55.04 112.335 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.488 ' HB ' HD21 ' A' ' 150' ' ' LEU . 34.7 p -106.99 -49.61 3.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 62.31 111.154 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.716 ' HB2' HG21 ' A' ' 143' ' ' VAL . 72.3 t80 -56.39 -30.69 63.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.26 -0.427 . . . . 74.54 110.924 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -79.75 -23.08 42.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.082 -0.508 . . . . 74.03 111.117 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -90.66 13.28 16.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 74.33 110.846 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.777 HD21 ' HA3' ' A' ' 152' ' ' GLY . 0.5 OUTLIER -70.39 -33.83 71.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.21 -0.45 . . . . 64.44 110.907 -179.971 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 161.31 49.8 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.764 -0.731 . . . . 72.12 112.511 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.29 -48.51 81.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.775 0.321 . . . . 61.32 110.921 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.6 m -61.25 -49.14 78.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 61.05 110.839 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.537 ' HB1' ' CB ' ' A' ' 193' ' ' SER . . . -62.22 -38.21 88.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 75.32 111.083 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.725 ' O ' HG22 ' A' ' 19' ' ' THR . 17.0 ttt-85 -60.73 -33.51 73.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 75.14 110.873 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -58.05 -46.02 86.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 74.23 110.893 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.514 HG21 ' HB3' ' A' ' 205' ' ' ALA . 92.8 t -65.19 -41.92 92.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 73.04 111.127 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -62.67 -41.01 98.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 71.44 110.911 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.725 HG22 ' O ' ' A' ' 15' ' ' ARG . 9.0 t -94.11 43.13 1.1 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.145 -0.48 . . . . 40.22 111.165 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -129.5 174.1 9.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 74.11 110.866 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 77.55 -72.53 2.17 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.764 -0.732 . . . . 53.32 112.459 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -68.1 87.76 0.28 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.966 0.412 . . . . 73.21 110.942 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -61.29 -176.05 1.83 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.751 -0.738 . . . . 73.42 112.445 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -97.68 -4.49 37.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.944 0.402 . . . . 64.11 110.894 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.61 13.15 77.97 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.738 -0.744 . . . . 72.54 112.457 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.593 HD12 ' N ' ' A' ' 27' ' ' ILE . 2.2 pp -149.54 -176.7 5.5 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.749 0.309 . . . . 63.41 110.952 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.593 ' N ' HD12 ' A' ' 26' ' ' LEU . 1.6 mp -118.33 120.91 65.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.206 -0.452 . . . . 72.24 111.171 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.446 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 0.0 OUTLIER -125.81 117.13 22.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 74.44 110.915 179.844 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.82 ' HB2' HD23 ' A' ' 279' ' ' LEU . 0.6 OUTLIER -112.69 137.91 50.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.44 . . . . 74.2 110.926 179.939 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.562 ' C ' ' HB3' ' A' ' 281' ' ' PHE . 0.7 OUTLIER -147.51 132.54 18.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.238 -0.437 . . . . 74.33 110.864 179.88 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.781 ' HA ' ' HA ' ' A' ' 281' ' ' PHE . 4.2 tt -129.55 124.58 34.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.196 -0.456 . . . . 72.55 110.952 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.617 ' N ' ' HB2' ' A' ' 281' ' ' PHE . 0.3 OUTLIER -120.36 125.29 47.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 61.2 110.891 179.873 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.914 HG23 HD13 ' A' ' 284' ' ' LEU . 46.2 m -122.2 121.11 36.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 71.42 111.124 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 5.9 ptmt -121.01 148.03 44.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 71.35 110.89 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 75.6 m -139.07 169.3 18.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 65.33 110.873 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -83.17 52.49 2.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.105 -0.498 . . . . 72.43 110.874 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -140.65 8.59 2.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.139 -0.482 . . . . 74.32 110.908 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.489 ' HA2' ' O ' ' A' ' 63' ' ' ARG . . . 79.27 -5.09 60.71 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.727 -0.749 . . . . 72.02 112.511 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -99.08 128.53 45.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.726 0.298 . . . . 43.24 110.94 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.412 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -139.82 118.49 12.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 64.25 110.86 179.934 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -102.97 126.59 50.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 73.4 110.872 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 54.3 m -127.08 117.42 22.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.108 -0.496 . . . . 73.32 111.173 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 36.5 p -104.31 134.27 47.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 73.25 110.9 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 35.6 t -127.0 127.15 44.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 71.52 110.835 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -141.86 129.79 4.09 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.7 -0.762 . . . . 51.53 112.453 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 48.6 m -128.97 135.74 49.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.87 0.367 . . . . 72.21 110.866 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.408 ' HA ' ' HA ' ' A' ' 54' ' ' VAL . . . -134.66 129.7 35.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.128 -0.487 . . . . 74.11 111.106 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -92.18 136.42 33.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 75.21 110.866 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -96.23 -55.89 2.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 72.12 111.168 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -50.49 -34.91 26.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.221 -0.445 . . . . 71.42 110.9 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -139.3 165.21 27.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 72.41 111.117 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 22.0 p -78.72 84.6 4.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.462 . . . . 73.35 111.112 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 10.9 tptp -145.61 82.27 1.63 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 73.15 110.885 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.408 ' HA ' ' HA ' ' A' ' 47' ' ' ALA . 0.7 OUTLIER -126.68 120.07 55.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 64.31 111.128 179.845 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 82.7 p -137.93 160.82 38.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.198 -0.455 . . . . 72.34 111.117 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.414 ' O ' HG22 ' A' ' 77' ' ' THR . . . -129.74 158.57 22.28 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.733 -0.746 . . . . 71.23 112.502 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.2 p -146.51 161.21 40.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.913 0.387 . . . . 54.13 110.869 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.607 HD13 ' N ' ' A' ' 59' ' ' GLU . 0.5 OUTLIER -119.95 131.04 55.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.115 -0.493 . . . . 75.31 110.929 179.969 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.607 ' N ' HD13 ' A' ' 58' ' ' LEU . 3.8 mt-10 -115.84 124.41 50.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 63.4 110.88 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.57 125.8 51.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 72.31 111.161 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.412 ' HB2' ' HB3' ' A' ' 40' ' ' GLU . 3.6 mttp -134.57 159.16 42.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 44.42 110.905 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -131.92 140.77 49.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 74.51 110.936 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.489 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 2.9 tmm_? -130.33 103.27 6.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 54.33 110.855 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 16.9 m95 -116.06 120.21 38.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 74.23 110.917 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.6 m 64.74 118.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 64.23 111.146 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -51.02 115.07 1.36 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.441 . . . . 64.3 110.85 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 65.59 56.93 0.9 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.113 -0.494 . . . . 72.51 110.948 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -144.35 -70.52 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.711 -0.757 . . . . 72.14 112.493 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.425 HD13 ' HA ' ' A' ' 69' ' ' LEU . 0.6 OUTLIER -125.12 128.88 49.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.869 0.366 . . . . 60.31 110.928 -179.93 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -137.67 128.82 27.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.26 -0.427 . . . . 55.11 111.156 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -114.47 133.35 55.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 75.52 110.848 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 49.8 p -126.32 115.0 19.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.127 -0.488 . . . . 73.41 111.171 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -132.06 136.16 47.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.231 -0.44 . . . . 64.43 110.857 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 13.6 pttp -123.15 94.72 4.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.47 . . . . 72.24 110.903 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.491 ' CD1' ' HB3' ' A' ' 81' ' ' LEU . 5.8 t90 -95.37 125.88 40.29 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.232 -0.44 . . . . 72.33 110.896 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -94.25 137.12 33.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.267 -0.424 . . . . 75.23 110.873 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.414 HG22 ' O ' ' A' ' 56' ' ' GLY . 8.0 t -65.57 -36.66 84.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.153 -0.476 . . . . 62.41 111.162 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -112.1 -37.19 5.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.182 -0.463 . . . . 51.43 110.931 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -77.71 -162.19 0.3 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 53.34 110.898 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 20.7 p -81.09 157.35 25.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.161 -0.472 . . . . 74.02 111.156 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.491 ' HB3' ' CD1' ' A' ' 75' ' ' TRP . 0.2 OUTLIER -96.38 119.15 34.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 63.21 110.909 179.961 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.19 144.11 15.74 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.752 -0.737 . . . . 41.11 112.51 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.9 t -144.98 124.9 13.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.73 0.3 . . . . 75.44 111.169 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 50.9 tt0 -134.73 151.4 50.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 73.44 110.89 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.1 tt -129.12 139.02 52.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 72.55 111.117 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.627 HG22 HG23 ' A' ' 98' ' ' THR . 7.6 p -129.11 121.24 27.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.16 -0.473 . . . . 73.55 111.155 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.452 HG12 ' O ' ' A' ' 97' ' ' LEU . 3.0 p -118.62 134.39 62.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 71.34 111.168 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -106.75 128.12 53.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 61.42 110.874 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 61.34 56.03 2.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.185 -0.461 . . . . 71.33 110.849 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.486 ' HB2' HD23 ' A' ' 97' ' ' LEU . 5.3 tt0 -64.34 -67.52 0.43 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 73.32 110.892 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 56.5 tp -106.6 -53.99 2.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.18 -0.464 . . . . 64.03 110.919 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -106.44 124.44 49.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 74.02 111.109 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 -51.71 133.64 30.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.242 -0.435 . . . . 74.4 110.923 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 99.97 -23.59 35.42 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.734 -0.746 . . . . 60.34 112.479 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.24 134.6 34.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.844 0.354 . . . . 75.2 110.937 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.7 tttp -122.29 131.15 53.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 73.14 110.883 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.486 HD23 ' HB2' ' A' ' 90' ' ' GLN . 1.7 mm? -116.75 130.72 56.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.205 -0.452 . . . . 75.22 110.924 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.627 HG23 HG22 ' A' ' 86' ' ' THR . 51.6 m -129.64 125.0 35.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 64.33 111.106 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -115.42 116.47 28.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.232 -0.44 . . . . 73.53 110.875 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -109.33 133.15 53.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.17 -0.468 . . . . 64.11 110.844 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.4 t -142.87 128.38 19.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 71.21 110.857 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.1 m -108.11 151.02 26.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.131 -0.486 . . . . 62.2 110.866 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -133.23 132.44 41.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 70.54 110.868 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 9.6 t -128.18 109.67 19.73 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.627 0.727 . . . . 55.45 110.9 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.491 ' HD3' HD21 ' A' ' 81' ' ' LEU . 54.0 Cg_endo -69.72 -16.35 37.67 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.623 2.216 . . . . 73.41 112.36 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -48.97 -70.7 0.08 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 63.32 110.839 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.6 m -129.13 31.47 4.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 73.03 111.145 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 67.76 24.22 74.14 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.726 -0.75 . . . . 75.12 112.472 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.55 116.53 13.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.837 0.351 . . . . 74.53 110.891 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 37.0 mtmt -116.01 147.98 40.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.172 -0.467 . . . . 73.33 110.911 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -120.5 132.54 55.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 73.43 110.889 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -114.65 121.48 43.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 64.42 111.129 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 16.5 ttmt -138.03 138.21 38.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.253 -0.431 . . . . 71.13 110.926 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.402 HG23 ' O ' ' A' ' 114' ' ' ILE . 6.1 tp -134.11 123.23 43.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.434 . . . . 50.23 111.144 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 68.7 tttt -119.13 121.0 38.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 74.42 110.922 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.0 t -128.23 125.4 38.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.44 . . . . 63.51 111.136 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -150.7 157.47 27.21 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.78 -0.724 . . . . 71.42 112.494 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 16.3 p90 -132.21 130.78 41.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.939 0.399 . . . . 75.55 110.953 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 29.7 tttp -107.64 118.23 36.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.481 . . . . 75.34 110.884 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 12.4 mmt85 -110.85 142.91 42.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.247 -0.433 . . . . 74.33 110.857 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.491 ' N ' HG22 ' A' ' 3' ' ' VAL . 7.6 pt-20 -52.79 -27.41 17.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 64.11 110.88 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 74.6 t60 -88.08 -39.61 14.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 65.04 110.859 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.581 HD12 ' HA ' ' A' ' 144' ' ' LEU . 8.6 tp -148.41 144.65 18.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 62.42 111.149 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -109.47 119.11 38.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 75.51 110.913 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.62 ' CD2' HD13 ' A' ' 142' ' ' LEU . 2.9 mm? -123.62 139.59 53.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 74.32 110.952 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -145.34 121.77 1.58 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.711 -0.757 . . . . 73.01 112.462 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -112.41 134.44 53.94 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.808 0.337 . . . . 64.53 110.857 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -129.67 133.82 47.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.164 -0.471 . . . . 72.32 110.898 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.416 ' SD ' HG23 ' A' ' 138' ' ' ILE . 2.1 mmt -127.99 129.17 46.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.457 . . . . 64.33 110.855 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -123.23 120.2 32.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 73.53 110.866 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -94.98 127.92 41.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 74.31 110.901 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -134.77 122.71 22.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.112 -0.494 . . . . 64.32 110.858 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.463 ' N ' HD13 ' A' ' 133' ' ' ILE . 0.2 OUTLIER -55.31 -25.25 16.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 74.12 111.133 179.998 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -91.79 -20.03 21.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 63.52 111.095 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 164.04 98.97 0.13 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.711 -0.757 . . . . 62.22 112.452 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.82 138.44 37.63 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.692 2.261 . . . . 65.21 112.328 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.1 m -127.77 159.52 34.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 71.42 110.844 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.564 HD12 ' OG1' ' A' ' 159' ' ' THR . 2.4 mp -123.63 140.83 45.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.105 -0.498 . . . . 63.12 111.121 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 43.7 ttt180 -121.36 120.44 35.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 74.22 110.819 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -112.08 134.0 11.78 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.757 -0.735 . . . . 22.42 112.431 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -134.28 120.71 20.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.762 0.315 . . . . 74.21 111.135 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.637 HD12 ' N ' ' A' ' 143' ' ' VAL . 4.0 tp -131.62 125.74 32.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.229 -0.441 . . . . 73.24 110.92 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.716 HG21 ' HB2' ' A' ' 7' ' ' TYR . 78.5 t -127.93 133.92 66.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.45 . . . . 42.41 111.134 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.581 ' HA ' HD12 ' A' ' 123' ' ' ILE . 1.6 mp -110.04 138.68 46.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 65.23 110.898 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -111.96 124.72 6.89 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.751 -0.738 . . . . 43.3 112.498 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -134.2 145.07 48.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.825 0.345 . . . . 73.24 110.968 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -50.45 96.47 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.125 -0.489 . . . . 62.32 110.903 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 90.02 -26.77 9.18 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.724 -0.75 . . . . 72.3 112.462 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 8.4 m0 -104.91 135.89 45.41 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.819 0.342 . . . . 71.13 110.913 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.488 HD21 ' HB ' ' A' ' 6' ' ' THR . 0.5 OUTLIER -129.91 137.56 50.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 74.24 110.903 179.967 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.492 ' HB3' HD13 ' A' ' 144' ' ' LEU . . . -129.98 137.4 50.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 54.44 111.136 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.777 ' HA3' HD21 ' A' ' 10' ' ' LEU . . . -138.72 136.08 7.8 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.739 -0.743 . . . . 72.53 112.48 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -139.33 119.38 13.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.831 0.348 . . . . 74.24 110.911 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 38.0 tt0 -132.59 122.44 24.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.484 . . . . 64.31 110.895 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 10.7 ptt? -146.12 157.76 43.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 62.41 110.843 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.424 ' O ' ' HB ' ' A' ' 164' ' ' VAL . 5.0 m120 -112.86 121.5 44.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.435 . . . . 74.03 110.868 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.534 ' HD1' HD13 ' A' ' 138' ' ' ILE . 49.0 t80 -84.29 128.63 34.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.121 -0.49 . . . . 70.05 110.854 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.416 ' H ' ' HA ' ' A' ' 164' ' ' VAL . 5.0 tp10 -85.51 107.88 17.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.491 . . . . 71.14 110.899 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.564 ' OG1' HD12 ' A' ' 138' ' ' ILE . 0.2 OUTLIER -65.92 -48.31 71.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.137 -0.483 . . . . 74.2 111.156 -179.919 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -50.24 -26.25 4.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.453 . . . . 72.03 111.066 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 43.6 mttm -117.02 -166.59 1.19 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 73.01 110.872 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 18.8 t -114.26 37.28 3.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 75.12 110.891 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 7.5 ptp85 -168.32 175.01 6.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.112 -0.494 . . . . 73.11 110.867 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.527 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 1.7 m -80.45 142.18 14.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 53.11 111.131 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 7.9 t -91.13 -25.81 19.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.196 -0.456 . . . . 75.55 111.156 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 5.3 tp60 -139.31 133.25 30.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 61.3 110.968 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -125.23 130.54 52.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.178 -0.465 . . . . 71.15 110.878 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -136.07 138.2 41.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 73.15 110.891 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.7 ' HB3' HG22 ' A' ' 184' ' ' VAL . 6.5 t80 -133.26 144.58 49.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 72.14 110.857 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -149.97 137.04 19.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 73.35 111.119 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 21.7 t -121.11 140.53 44.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 72.12 111.127 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -115.24 126.36 7.14 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.736 -0.745 . . . . 71.02 112.51 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -128.43 121.59 29.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.924 0.392 . . . . 73.32 110.928 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 22.3 mtmm -103.39 133.33 48.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.112 -0.494 . . . . 62.23 110.917 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -127.05 165.26 19.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 73.43 111.121 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -38.96 -76.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 70.5 110.828 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -117.13 14.22 14.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 54.14 110.879 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -125.39 150.14 47.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.48 . . . . 74.04 110.889 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 46.2 mm-40 -129.34 124.88 35.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 74.35 110.863 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.601 HD23 HG13 ' A' ' 194' ' ' ILE . 3.0 tm? -122.71 124.49 43.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 61.14 110.893 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 76.4 m-70 -130.72 116.35 17.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.21 -0.45 . . . . 73.05 110.853 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.82 154.46 17.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 65.3 111.143 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -163.0 139.88 7.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.209 -0.451 . . . . 73.02 110.908 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.7 HG22 ' HB3' ' A' ' 169' ' ' PHE . 1.7 m -134.31 137.29 51.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 61.24 111.14 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -97.26 88.48 4.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 71.02 110.869 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 71.43 -174.84 0.17 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 72.41 110.925 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -79.47 3.04 69.39 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.75 -0.738 . . . . 51.13 112.469 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 30.5 p -106.36 -23.35 12.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.783 0.325 . . . . 71.1 111.162 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . 0.401 ' O ' ' HB ' ' A' ' 184' ' ' VAL . 1.2 tp10 -120.9 123.13 41.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.215 -0.448 . . . . 70.41 110.899 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' PHE . . . . . 0.568 ' HA ' ' HB ' ' A' ' 184' ' ' VAL . 0.5 OUTLIER -139.06 124.73 19.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 74.21 110.841 -179.884 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -165.1 -156.18 8.94 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.714 -0.755 . . . . 61.25 112.443 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -171.09 -168.56 32.96 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.742 -0.742 . . . . 42.03 112.487 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . 0.537 ' CB ' ' HB1' ' A' ' 14' ' ' ALA . 39.0 t -147.78 145.52 28.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.837 0.351 . . . . 50.25 110.869 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.601 HG13 HD23 ' A' ' 180' ' ' LEU . 4.5 mp -120.68 133.36 67.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.113 -0.494 . . . . 73.32 111.112 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -117.68 121.18 40.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.192 -0.458 . . . . 74.22 110.932 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -121.03 131.64 54.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.087 -0.506 . . . . 64.42 110.916 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.413 ' HG2' HG23 ' A' ' 198' ' ' VAL . 23.3 ttpt -97.07 127.4 43.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.173 -0.467 . . . . 60.34 110.895 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.413 HG23 ' HG2' ' A' ' 197' ' ' LYS . 17.9 t 65.01 66.47 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 62.01 111.123 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -112.47 -36.03 5.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.176 -0.465 . . . . 72.3 110.932 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 31.0 tttm -119.77 -67.8 0.96 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 63.12 110.909 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.17 -38.08 1.42 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.209 -0.45 . . . . 74.0 110.892 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.584 HD22 ' H ' ' A' ' 226' ' ' GLN . 15.1 tp -146.1 -74.43 0.22 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.21 -0.45 . . . . 65.43 110.884 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -124.91 142.1 51.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 74.21 110.86 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 1.7 m -146.01 137.56 24.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 73.21 111.198 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.514 ' HB3' HG21 ' A' ' 17' ' ' VAL . . . -150.33 162.69 40.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.23 -0.441 . . . . 41.42 111.056 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 1.3 m -137.26 149.98 26.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.194 -0.457 . . . . 71.41 111.176 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -113.81 135.74 53.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 73.54 110.89 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.429 HD13 ' HA ' ' A' ' 208' ' ' LEU . 3.7 mm? -121.38 145.5 47.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.485 . . . . 75.41 110.906 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.631 ' HB3' ' HB2' ' A' ' 218' ' ' ARG . . . -153.32 138.18 17.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.203 -0.453 . . . . 72.31 111.112 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 9.4 t-105 -130.78 134.94 47.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.188 -0.46 . . . . 74.43 110.945 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 2.3 m -96.9 105.27 17.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.252 -0.431 . . . . 70.55 111.12 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -51.6 132.68 30.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.155 -0.475 . . . . 52.43 111.091 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 117.85 -74.96 0.29 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.766 -0.731 . . . . 73.3 112.446 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -179.95 106.93 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.831 0.348 . . . . 71.11 110.843 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 2.0 t -173.96 161.14 3.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.466 . . . . 55.04 110.845 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -63.61 154.85 31.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 73.1 110.904 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 3.7 m -80.95 133.91 35.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.164 -0.471 . . . . 62.53 111.151 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . 0.631 ' HB2' ' HB3' ' A' ' 209' ' ' ALA . 8.1 mmt85 -89.99 118.08 29.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.45 . . . . 73.43 110.844 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . 0.706 ' CE1' HD11 ' A' ' 221' ' ' ILE . 18.1 t80 -130.18 137.53 50.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.146 -0.479 . . . . 74.11 110.88 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -142.01 140.64 10.22 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.752 -0.737 . . . . 54.42 112.485 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.706 HD11 ' CE1' ' A' ' 219' ' ' PHE . 4.3 mp -120.53 131.39 72.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.825 0.345 . . . . 74.32 111.142 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.494 ' CB ' HG13 ' A' ' 17' ' ' VAL . . . -137.49 151.22 48.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 74.03 111.076 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -144.98 129.73 18.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 72.32 111.083 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 29.1 mtpt -102.52 125.25 49.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 52.02 110.914 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -124.28 117.76 25.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.254 -0.43 . . . . 73.23 110.91 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . 0.584 ' H ' HD22 ' A' ' 202' ' ' LEU . 23.1 tt0 -86.67 104.7 16.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.088 -0.506 . . . . 72.35 110.923 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 1.7 tt -82.68 -31.6 9.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 60.34 111.117 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -161.45 161.44 22.85 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.583 0.706 . . . . 72.34 110.867 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -6.96 19.85 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.664 2.242 . . . . 32.13 112.345 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -112.74 -25.38 9.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.246 -0.434 . . . . 63.31 110.861 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -137.62 145.08 42.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 72.13 111.085 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 25.5 m -136.85 143.14 42.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 75.4 110.915 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -117.73 134.24 55.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 65.45 110.861 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 22.8 t -135.47 152.15 51.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.122 -0.49 . . . . 72.14 110.854 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -139.51 146.27 39.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.087 -0.506 . . . . 71.53 111.129 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.52 159.01 32.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.261 -0.427 . . . . 73.32 110.852 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.624 HG12 ' HA ' ' A' ' 243' ' ' ILE . 1.6 m -141.73 163.97 19.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 53.22 111.097 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -112.89 147.81 36.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 70.44 110.864 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -49.15 -22.36 0.96 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.479 . . . . 73.23 110.854 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 32.2 t -80.99 13.59 2.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 73.21 110.87 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 1.2 t 69.65 40.1 1.43 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.118 -0.492 . . . . 51.34 110.895 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . 0.616 ' O ' HG12 ' A' ' 237' ' ' VAL . 2.1 mp -97.23 137.79 35.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.131 -0.486 . . . . 73.31 110.956 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.624 ' HA ' HG12 ' A' ' 237' ' ' VAL . 0.0 OUTLIER -107.15 117.34 52.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 71.1 111.143 179.85 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . 0.54 ' C ' HD13 ' A' ' 245' ' ' LEU . . . -139.07 148.47 20.02 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.724 -0.75 . . . . 63.33 112.484 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.732 ' CD2' ' HB3' ' A' ' 261' ' ' ALA . 0.0 OUTLIER -146.65 160.86 41.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.849 0.356 . . . . 74.32 110.939 -179.929 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -134.62 147.95 19.33 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.765 -0.731 . . . . 55.41 112.508 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -127.77 116.94 20.98 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.988 0.423 . . . . 74.42 110.911 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.459 HG23 ' O ' ' A' ' 257' ' ' LEU . 7.5 m -101.78 137.36 40.19 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.08 -0.509 . . . . 71.33 111.079 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . 0.7 ' CB ' HD23 ' A' ' 257' ' ' LEU . 1.0 OUTLIER -137.25 165.94 24.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 73.52 110.903 179.971 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . 0.447 ' O ' ' CB ' ' A' ' 251' ' ' LEU . 23.5 m 65.88 -104.76 0.1 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.45 . . . . 72.22 111.095 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.676 ' O ' HD12 ' A' ' 251' ' ' LEU . 0.2 OUTLIER 79.17 -9.17 1.53 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 53.43 110.91 -179.993 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' LYS . . . . . 0.54 ' CB ' ' HD2' ' A' ' 253' ' ' PRO . 4.5 mttm -48.01 171.88 0.08 OUTLIER Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.6 0.714 . . . . 74.02 110.899 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' PRO . . . . . 0.54 ' HD2' ' CB ' ' A' ' 252' ' ' LYS . 54.0 Cg_endo -69.79 58.33 1.56 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.66 2.24 . . . . 64.13 112.34 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -165.87 -62.7 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.7 -0.762 . . . . 35.32 112.485 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -140.95 139.28 34.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.908 0.385 . . . . 64.21 111.141 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 0.521 ' O ' ' HA ' ' A' ' 279' ' ' LEU . 7.0 tttt -110.16 127.01 54.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 72.52 110.857 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 0.715 ' CD1' HD21 ' A' ' 277' ' ' LEU . 25.0 tp -88.85 122.78 32.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.175 -0.466 . . . . 64.02 110.889 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . 0.405 ' O ' HD22 ' A' ' 277' ' ' LEU . 4.8 m -126.54 110.14 12.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 71.13 111.148 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 1.088 HD22 HD23 ' A' ' 277' ' ' LEU . 0.0 OUTLIER -103.4 134.01 47.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.196 -0.456 . . . . 55.12 110.913 179.957 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 24.8 p -128.9 140.64 51.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 63.51 110.892 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' ALA . . . . . 0.732 ' HB3' ' CD2' ' A' ' 245' ' ' LEU . . . -147.24 126.09 12.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.484 . . . . 72.34 111.094 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.786 ' C ' HD13 ' A' ' 263' ' ' LEU . 3.2 tm? -131.91 122.96 26.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.458 . . . . 74.42 110.887 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . 0.786 HD13 ' C ' ' A' ' 262' ' ' LEU . 0.1 OUTLIER -121.56 109.81 15.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.15 -0.477 . . . . 75.53 110.912 179.867 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . 0.673 ' O ' HG22 ' A' ' 268' ' ' VAL . 0.1 OUTLIER -87.19 109.41 19.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 71.4 110.916 179.809 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -56.24 -20.5 29.04 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.743 -0.741 . . . . 71.04 112.488 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.94 -3.54 48.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.799 0.333 . . . . 73.41 110.924 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -123.73 -57.62 1.62 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 73.21 110.886 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . 0.71 HG12 ' O ' ' A' ' 272' ' ' GLY . 16.7 m -48.11 -28.24 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 71.01 111.112 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -53.26 -45.77 68.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 60.01 110.929 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -106.14 -16.92 14.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 64.11 111.127 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -108.06 -123.35 4.9 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.719 -0.753 . . . . 43.05 112.474 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 272' ' ' GLY . . . . . 0.71 ' O ' HG12 ' A' ' 268' ' ' VAL . . . -146.47 -163.02 10.15 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.693 -0.765 . . . . 64.44 112.466 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 273' ' ' HIS . . . . . 0.61 ' CB ' HD12 ' A' ' 263' ' ' LEU . 5.6 p80 -105.35 146.26 29.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.83 0.348 . . . . 75.22 110.884 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 12.4 mtpp -104.28 135.68 45.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.228 -0.442 . . . . 73.01 110.887 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.462 HD12 ' HB2' ' A' ' 261' ' ' ALA . 1.3 tp -137.09 148.18 46.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 72.13 110.944 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -144.37 110.56 0.57 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.726 -0.75 . . . . 71.13 112.493 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 1.088 HD23 HD22 ' A' ' 259' ' ' LEU . 3.2 tm? -117.06 139.3 50.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.82 0.343 . . . . 62.21 110.956 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . 0.597 ' H ' HD22 ' A' ' 277' ' ' LEU . . . -162.13 154.16 25.05 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.696 -0.764 . . . . 62.15 112.48 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.82 HD23 ' HB2' ' A' ' 29' ' ' LEU . 3.1 mm? -106.88 139.93 40.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.777 0.322 . . . . 71.11 110.865 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -89.1 126.23 35.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 73.41 110.879 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . 0.781 ' HA ' ' HA ' ' A' ' 31' ' ' LEU . 15.1 p90 -74.98 71.18 2.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.145 -0.48 . . . . 70.25 110.884 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 67.5 mm-40 -125.07 102.02 7.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.48 . . . . 73.1 110.904 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.62 ' HB1' HD12 ' A' ' 284' ' ' LEU . . . -124.67 136.28 53.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 60.13 111.144 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.914 HD13 HG23 ' A' ' 33' ' ' THR . 4.2 mp 60.83 32.91 20.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 63.13 110.933 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.155 -0.475 . . . . 74.24 110.898 179.962 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.858 0.361 . . . . 64.15 111.023 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.45 HG23 ' HD2' ' A' ' 4' ' ' PRO . 7.1 p -164.3 133.7 2.95 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.662 0.744 . . . . 70.21 111.107 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.45 ' HD2' HG23 ' A' ' 3' ' ' VAL . 53.6 Cg_endo -69.7 167.97 22.81 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.671 2.247 . . . . 71.44 112.383 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 117.97 5.4 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.691 2.261 . . . . 75.43 112.344 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 1.066 HG22 HD21 ' A' ' 150' ' ' LEU . 0.2 OUTLIER -92.71 -32.75 14.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.203 -0.453 . . . . 74.22 111.136 -179.946 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.663 ' HB2' HG21 ' A' ' 143' ' ' VAL . 18.0 t80 -55.55 -29.82 59.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.246 -0.434 . . . . 70.33 110.953 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -72.95 -22.58 60.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.091 -0.504 . . . . 44.53 111.056 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -87.57 7.51 29.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.205 -0.452 . . . . 75.14 110.858 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.72 HD21 HG13 ' A' ' 143' ' ' VAL . 50.0 mt -69.22 -31.39 69.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 64.2 110.885 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -172.45 76.23 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.76 -0.733 . . . . 41.55 112.515 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.4 mmtp -69.25 -55.09 11.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.772 0.32 . . . . 54.15 110.87 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.91 -39.64 93.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.452 . . . . 74.34 110.852 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.403 ' HB2' ' HB2' ' A' ' 181' ' ' HIS . . . -58.91 -37.32 76.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.487 . . . . 71.32 111.098 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -59.76 -31.98 70.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 75.12 110.873 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 -57.47 -48.29 79.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 74.02 110.898 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 61.7 t -81.84 -33.07 11.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.461 . . . . 64.53 111.143 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -64.55 -32.43 74.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 75.43 110.83 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 52.4 m -48.6 114.92 1.07 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 73.25 111.163 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.3 mptt -85.03 -168.72 2.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 65.44 110.895 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 99.03 32.15 5.97 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.711 -0.757 . . . . 60.21 112.483 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -119.03 124.78 47.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.927 0.394 . . . . 75.42 110.926 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 62.56 65.85 2.92 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.81 -0.709 . . . . 74.43 112.472 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -102.43 -4.7 25.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.898 0.38 . . . . 74.3 110.911 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.37 13.6 77.14 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.702 -0.761 . . . . 31.03 112.515 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.591 ' C ' HD12 ' A' ' 27' ' ' ILE . 2.2 pp -145.02 -178.35 6.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.737 0.303 . . . . 64.31 110.92 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.591 HD12 ' C ' ' A' ' 26' ' ' LEU . 1.7 mp -119.6 122.41 68.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 75.32 111.137 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.84 117.04 18.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.135 -0.484 . . . . 62.33 110.886 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 1.01 HD13 ' O ' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -114.78 145.33 42.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.211 -0.449 . . . . 75.11 110.942 179.876 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.772 ' N ' HD22 ' A' ' 29' ' ' LEU . 1.3 m-20 -148.06 133.35 18.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.184 -0.462 . . . . 72.4 110.852 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.717 ' HA ' ' HA ' ' A' ' 281' ' ' PHE . 0.2 OUTLIER -127.1 127.79 45.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 73.21 110.87 -179.915 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.613 ' N ' ' HB2' ' A' ' 281' ' ' PHE . 33.5 ttpt -136.56 140.85 43.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 73.21 110.883 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.437 ' O ' HG23 ' A' ' 33' ' ' THR . 8.6 t -135.5 121.66 20.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 72.5 111.166 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.793 ' HG2' HD21 ' A' ' 284' ' ' LEU . 1.7 pttp -105.13 125.85 51.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.25 -0.432 . . . . 71.51 110.904 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.5 t -114.71 142.79 46.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 72.31 110.827 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -77.17 58.25 1.55 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 74.15 110.89 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -152.86 19.89 0.59 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.143 -0.481 . . . . 73.43 110.88 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.453 ' HA2' ' C ' ' A' ' 63' ' ' ARG . . . 81.01 -4.99 67.68 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.715 -0.755 . . . . 71.14 112.487 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.3 mp -98.42 128.23 44.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.769 0.319 . . . . 74.1 110.902 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -140.97 117.56 10.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 73.53 110.894 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -103.24 122.66 45.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 64.33 110.891 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 90.3 m -126.5 126.31 43.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.137 -0.483 . . . . 63.42 111.142 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.3 p -132.46 142.22 49.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 63.21 110.843 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 58.1 m -149.03 135.84 19.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 71.31 110.874 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -148.02 141.65 9.37 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.702 -0.761 . . . . 65.12 112.44 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 9.0 m -126.91 157.56 39.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.858 0.361 . . . . 70.41 110.887 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.595 ' HB1' HG22 ' A' ' 54' ' ' VAL . . . -157.11 131.14 8.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.152 -0.476 . . . . 71.42 111.09 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -101.53 141.99 33.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.446 . . . . 73.12 110.893 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 22.2 p -51.03 -34.47 29.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 55.35 111.105 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -51.34 168.24 0.07 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.188 -0.46 . . . . 63.24 110.876 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.2 t -73.05 136.26 44.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 74.12 111.162 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 66.9 p 47.06 71.6 0.31 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.259 -0.428 . . . . 60.31 111.112 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 18.6 mmtp -143.54 35.3 1.3 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.2 -0.455 . . . . 72.32 110.91 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.595 HG22 ' HB1' ' A' ' 47' ' ' ALA . 46.3 t -109.19 124.11 65.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 52.22 111.145 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.6 m -136.11 126.94 27.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 53.12 111.137 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -127.39 141.54 12.73 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.747 -0.74 . . . . 73.01 112.524 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 59.5 p -144.1 160.48 40.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.922 0.392 . . . . 74.14 110.882 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -132.55 150.18 52.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.143 -0.48 . . . . 74.11 110.894 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.408 ' HB3' ' HA ' ' A' ' 74' ' ' LYS . 1.1 pm0 -136.14 136.18 39.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 74.24 110.9 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.9 p -103.07 129.57 49.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.151 -0.477 . . . . 72.23 111.093 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.1 mtpm? -129.9 159.59 36.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 65.5 110.889 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -130.32 139.65 50.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.217 -0.447 . . . . 74.03 110.929 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.453 ' C ' ' HA2' ' A' ' 38' ' ' GLY . 0.5 OUTLIER -134.51 105.17 6.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.134 -0.484 . . . . 75.44 110.881 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -115.06 101.68 9.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.46 . . . . 72.14 110.952 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.7 t -83.37 -31.76 26.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 64.55 111.149 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -48.47 -34.16 10.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.2 -0.454 . . . . 73.21 110.904 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.557 ' CD1' HD23 ' A' ' 69' ' ' LEU . 29.7 t80 -118.02 -58.34 2.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.18 -0.464 . . . . 71.33 110.936 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.651 ' O ' HD22 ' A' ' 69' ' ' LEU . . . 129.34 58.17 0.1 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.778 -0.725 . . . . 63.15 112.516 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.651 HD22 ' O ' ' A' ' 68' ' ' GLY . 2.4 mm? -133.65 141.33 47.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.852 0.358 . . . . 62.44 110.891 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 95.6 m -135.57 130.4 34.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 64.01 111.141 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -119.23 134.82 54.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 73.41 110.875 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.534 HG23 ' HB2' ' A' ' 84' ' ' GLU . 0.6 OUTLIER -126.73 117.41 22.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.463 . . . . 73.21 111.152 -179.897 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -132.03 131.47 42.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.27 -0.423 . . . . 73.33 110.875 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.408 ' HA ' ' HB3' ' A' ' 59' ' ' GLU . 17.1 ptmt -117.66 135.86 53.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 74.33 110.931 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 12.7 t90 -135.48 128.46 31.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.213 -0.449 . . . . 75.12 110.925 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -120.52 159.52 25.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 70.25 110.872 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 10.5 t -66.79 -13.37 61.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.157 -0.474 . . . . 63.34 111.108 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.443 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 94.9 m-20 -74.92 1.23 13.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.254 -0.43 . . . . 71.41 110.894 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.443 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 2.9 m120 78.72 33.19 0.28 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 75.34 110.91 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 33.3 m -114.89 123.4 49.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.145 -0.48 . . . . 63.24 111.119 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -122.05 119.62 31.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 73.31 110.897 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.76 111.72 3.74 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.731 -0.747 . . . . 60.24 112.473 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.0 t -93.03 120.69 33.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.795 0.331 . . . . 43.11 111.119 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.534 ' HB2' HG23 ' A' ' 72' ' ' THR . 26.8 mt-10 -134.06 126.69 30.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.45 . . . . 65.03 110.871 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.406 HG22 ' HB3' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -115.4 138.46 45.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.163 -0.472 . . . . 53.4 111.157 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 99.8 m -129.51 137.72 50.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.202 -0.453 . . . . 70.32 111.126 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.456 ' HB ' HD23 ' A' ' 97' ' ' LEU . 1.8 t -118.14 137.28 52.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.44 . . . . 72.34 111.149 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -113.71 118.32 33.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 75.34 110.901 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 50.88 74.77 0.21 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.462 . . . . 73.13 110.901 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -96.7 -75.59 0.53 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 74.12 110.885 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 40.9 tp -92.24 -72.37 0.6 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.21 -0.45 . . . . 62.44 110.916 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.571 ' HB3' ' HB2' ' A' ' 95' ' ' LEU . . . -77.53 139.7 39.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 51.34 111.122 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 2.6 ptt180 -60.08 125.09 22.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 74.33 110.868 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 78.73 8.94 87.48 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.756 -0.735 . . . . 44.35 112.502 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.571 ' HB2' ' HB3' ' A' ' 92' ' ' ALA . 13.8 tp -79.32 134.18 36.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.876 0.37 . . . . 62.21 110.928 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.9 ptmt -121.38 127.51 51.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 64.34 110.905 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.458 HD22 ' N ' ' A' ' 97' ' ' LEU . 1.7 mm? -115.03 129.2 56.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.223 -0.444 . . . . 65.05 110.9 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 69.0 m -129.55 119.87 24.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 65.23 111.19 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.406 ' HB3' HG22 ' A' ' 85' ' ' ILE . 3.1 t80 -122.28 128.71 51.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 65.32 110.858 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -127.84 130.48 48.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.128 -0.487 . . . . 40.11 110.831 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.7 t -142.3 125.93 16.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 73.2 110.88 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.1 t -97.87 131.71 44.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 70.12 110.849 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -129.54 119.69 24.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.106 -0.497 . . . . 74.53 110.878 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -128.83 101.9 19.91 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.661 0.743 . . . . 65.04 110.832 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -37.81 8.58 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.703 2.268 . . . . 74.51 112.334 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -61.57 -75.01 0.07 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 73.53 110.865 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -63.85 -39.0 93.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 51.32 111.153 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.14 24.42 14.79 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.739 -0.744 . . . . 74.55 112.473 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 64.2 mmtt -94.07 148.15 22.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.864 0.364 . . . . 71.03 110.863 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -140.61 135.5 31.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 75.34 110.842 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -121.59 140.84 51.73 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.199 -0.455 . . . . 72.21 110.912 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -127.77 118.02 22.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 72.14 111.077 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 21.3 ttmm -138.45 137.5 37.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 64.44 110.895 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 6.0 tp -134.55 126.73 48.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 73.15 111.154 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -127.45 120.39 28.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 74.43 110.868 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 70.2 p -129.06 127.88 42.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.211 -0.45 . . . . 62.54 111.083 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -150.42 162.39 29.26 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.676 -0.773 . . . . 63.5 112.481 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 6.6 p90 -127.44 141.19 51.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.953 0.406 . . . . 74.34 110.898 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.43 ' NZ ' HD22 ' A' ' 124' ' ' ASN . 5.3 mmmt -110.15 122.71 48.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.075 -0.511 . . . . 72.41 110.908 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.1 mmt85 -106.28 145.29 31.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.273 -0.421 . . . . 71.42 110.865 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -49.67 -28.51 6.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 74.03 110.927 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 7.8 m170 -87.11 -45.33 10.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 73.41 110.853 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.429 HG21 HD23 ' A' ' 144' ' ' LEU . 11.8 pt -152.34 153.86 8.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 42.11 111.119 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.43 HD22 ' NZ ' ' A' ' 119' ' ' LYS . 17.6 p-10 -117.98 116.61 27.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.468 . . . . 44.41 110.907 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.671 ' HB3' HD13 ' A' ' 142' ' ' LEU . 0.4 OUTLIER -131.46 141.93 49.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 73.55 110.932 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -147.9 149.01 21.03 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.743 -0.741 . . . . 54.02 112.483 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 31.0 p -112.83 134.72 54.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.827 0.346 . . . . 62.41 110.896 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -117.35 150.8 38.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 73.11 110.857 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 43.2 ttm -135.98 135.98 39.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 74.35 110.851 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -122.53 128.09 50.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 72.43 110.842 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -95.55 97.69 9.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.456 . . . . 71.14 110.888 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -92.05 175.75 6.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 72.33 110.877 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.42 HD12 ' N ' ' A' ' 134' ' ' ALA . 2.5 pp -73.92 -37.51 47.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.262 -0.426 . . . . 63.4 111.089 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.42 ' N ' HD12 ' A' ' 133' ' ' ILE . . . -78.39 -20.43 51.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 74.24 111.081 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 155.22 150.7 5.64 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.778 -0.725 . . . . 65.44 112.483 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 107.92 1.97 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.697 2.265 . . . . 62.31 112.349 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.65 152.79 29.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.247 -0.433 . . . . 63.43 110.909 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.416 HD12 ' N ' ' A' ' 138' ' ' ILE . 5.0 mp -106.16 132.33 53.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.455 . . . . 74.12 111.14 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 12.3 ttm180 -122.58 133.48 54.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 61.11 110.865 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -127.61 133.3 7.81 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.753 -0.737 . . . . 65.01 112.502 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -140.65 116.07 10.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.824 0.345 . . . . 45.3 111.12 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.697 HD12 ' N ' ' A' ' 143' ' ' VAL . 3.2 tp -129.1 133.79 47.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 64.3 110.89 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.72 HG13 HD21 ' A' ' 10' ' ' LEU . 61.7 t -128.44 120.97 54.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 70.41 111.146 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.558 HD11 HD21 ' A' ' 142' ' ' LEU . 4.4 mp -114.72 139.94 49.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 72.44 110.925 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -129.51 124.62 4.53 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.772 -0.728 . . . . 62.14 112.533 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -144.93 146.62 32.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.817 0.341 . . . . 53.23 110.922 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 50.29 30.75 4.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.475 . . . . 71.25 110.896 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 85.9 -28.71 4.89 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.727 -0.749 . . . . 61.23 112.522 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 29.9 m0 -69.31 134.83 49.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.833 0.349 . . . . 64.33 110.938 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 1.066 HD21 HG22 ' A' ' 6' ' ' THR . 0.0 OUTLIER -108.5 137.81 45.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.256 -0.429 . . . . 43.34 110.892 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -135.96 126.12 26.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 73.43 111.073 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -132.15 146.34 18.01 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.743 -0.742 . . . . 21.53 112.477 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -143.49 119.26 10.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.783 0.325 . . . . 70.52 110.914 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -122.53 120.67 34.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 74.31 110.886 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 4.0 ptt? -148.13 143.52 27.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.251 -0.431 . . . . 71.42 110.882 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -113.64 131.54 56.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 74.44 110.87 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.505 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 9.8 m-85 -93.28 138.89 31.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 61.04 110.858 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.512 ' CG ' ' O ' ' A' ' 158' ' ' GLU . 5.2 pt-20 -76.4 117.32 17.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.105 -0.498 . . . . 74.42 110.876 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 9.8 t -67.23 -31.69 72.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.141 -0.482 . . . . 72.24 111.135 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -47.9 -23.92 0.89 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.215 -0.448 . . . . 64.42 111.129 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.99 -157.65 0.36 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.449 . . . . 74.31 110.9 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 54.1 m -99.51 40.82 1.19 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 42.21 110.858 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.45 173.42 7.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 75.2 110.923 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.505 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 2.5 t -105.82 141.04 22.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.444 . . . . 74.31 111.117 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -88.7 -37.26 15.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.131 -0.486 . . . . 62.31 111.149 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -155.8 131.87 10.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 64.43 110.882 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 2.2 p -127.05 109.63 12.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 71.25 110.878 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -130.87 142.33 50.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 65.23 110.88 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -132.39 156.57 46.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.194 -0.457 . . . . 74.23 110.861 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -154.89 129.89 9.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.117 -0.492 . . . . 75.4 111.081 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 41.2 t -126.86 134.12 66.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 74.45 111.136 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -107.93 124.07 7.38 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.741 -0.743 . . . . 75.5 112.464 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -113.97 122.36 46.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.978 0.418 . . . . 63.22 110.869 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -102.89 133.53 47.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.08 -0.509 . . . . 73.3 110.915 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.59 165.22 21.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 41.31 111.13 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -40.27 -75.38 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 63.21 110.898 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -116.66 14.91 15.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.214 -0.448 . . . . 74.33 110.889 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -126.16 149.55 48.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.131 -0.486 . . . . 63.42 110.863 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -133.26 124.44 27.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.115 -0.493 . . . . 73.34 110.922 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.594 HD23 HG13 ' A' ' 194' ' ' ILE . 2.6 tm? -123.55 126.09 46.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 73.33 110.907 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' HIS . . . . . 0.52 ' N ' HD22 ' A' ' 180' ' ' LEU . 22.1 m80 -130.59 114.86 15.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.446 . . . . 71.05 110.875 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 2.1 t -106.51 151.05 25.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.269 -0.423 . . . . 72.34 111.167 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -162.38 136.95 6.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 62.11 110.879 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.764 HG13 ' HB3' ' A' ' 190' ' ' PHE . 2.3 t -123.68 127.79 74.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.483 . . . . 72.4 111.129 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -120.69 83.03 2.0 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 75.4 110.887 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -48.25 -20.13 0.35 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 75.13 110.868 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -74.89 -33.08 56.04 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.793 -0.718 . . . . 70.03 112.49 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 69.0 p -123.48 -55.37 1.74 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.718 0.294 . . . . 53.13 111.135 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . 0.689 ' HG3' ' HB1' ' A' ' 209' ' ' ALA . 0.9 OUTLIER -165.87 152.98 10.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 72.3 110.901 179.998 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' PHE . . . . . 0.764 ' HB3' HG13 ' A' ' 184' ' ' VAL . 10.0 p90 -114.45 125.16 53.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 70.42 110.884 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -175.72 -132.36 1.59 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.745 -0.741 . . . . 74.42 112.489 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -176.4 -165.92 32.81 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.77 -0.729 . . . . 72.13 112.491 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -149.33 150.33 32.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.803 0.335 . . . . 52.53 110.9 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.594 HG13 HD23 ' A' ' 180' ' ' LEU . 4.2 mp -120.62 143.02 33.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 74.5 111.158 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -127.74 121.3 29.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.178 -0.465 . . . . 72.42 110.942 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 6.1 tm0? -124.57 130.43 52.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 75.11 110.963 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 20.5 tttt -107.12 127.77 53.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 72.54 110.876 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 98.5 t -74.34 -74.62 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 72.22 111.083 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -170.82 65.32 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 73.23 110.909 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? 48.29 33.47 3.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.143 -0.481 . . . . 61.11 110.915 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 6.2 ttmm -140.98 -43.74 0.38 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 74.11 110.881 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 6.1 mp -131.05 128.47 40.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.237 -0.438 . . . . 75.05 110.902 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -114.88 131.2 56.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 74.24 110.908 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 21.7 m -124.06 138.58 54.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.186 -0.461 . . . . 72.12 111.145 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -141.5 137.93 32.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.434 . . . . 71.1 111.139 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.91 HG22 HG22 ' A' ' 221' ' ' ILE . 30.3 t -112.93 140.69 31.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 63.01 111.079 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . 0.621 ' O ' HD22 ' A' ' 208' ' ' LEU . 3.5 m120 -114.95 134.22 55.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.475 . . . . 60.52 110.881 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.621 HD22 ' O ' ' A' ' 207' ' ' ASN . 2.8 mm? -134.16 130.71 37.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 72.33 110.925 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.689 ' HB1' ' HG3' ' A' ' 189' ' ' GLU . . . -156.42 132.11 9.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 53.12 111.083 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . 0.563 ' CE3' HG23 ' A' ' 217' ' ' THR . 3.8 t-105 -110.66 135.01 51.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.208 -0.451 . . . . 64.21 110.964 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . 0.436 HG23 ' O ' ' A' ' 211' ' ' THR . 3.3 t -93.39 111.36 23.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.253 -0.43 . . . . 53.44 111.092 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -51.11 136.81 23.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 60.24 111.076 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 117.36 -83.98 0.36 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.765 -0.731 . . . . 71.12 112.541 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -79.37 179.11 7.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.854 0.359 . . . . 65.23 110.864 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 9.7 p -103.36 36.43 2.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 72.12 110.867 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 35.0 m120 -102.09 125.2 48.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 70.33 110.874 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . 0.563 HG23 ' CE3' ' A' ' 210' ' ' TRP . 0.6 OUTLIER -105.34 137.6 42.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 60.11 111.141 -179.955 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 -97.62 117.66 32.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.258 -0.428 . . . . 72.31 110.837 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -128.34 132.11 48.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 73.22 110.874 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -145.2 160.99 28.15 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.735 -0.745 . . . . 73.15 112.474 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.91 HG22 HG22 ' A' ' 206' ' ' VAL . 0.0 OUTLIER -138.89 130.51 35.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.807 0.337 . . . . 74.52 111.104 -179.947 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -126.84 130.83 50.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 74.0 111.114 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -119.2 130.81 55.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.257 -0.429 . . . . 73.41 111.104 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -106.76 128.47 54.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.436 . . . . 73.52 110.872 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -127.07 117.67 22.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 74.53 110.934 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -84.7 123.91 30.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 71.14 110.942 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . 0.517 HD12 ' CD2' ' A' ' 233' ' ' PHE . 64.6 mt -108.9 -33.56 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.446 . . . . 72.33 111.157 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -143.42 161.22 48.37 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.583 0.706 . . . . 71.15 110.918 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -19.32 36.22 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.738 2.292 . . . . 73.25 112.31 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -109.78 -27.06 9.51 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.224 -0.443 . . . . 53.3 110.893 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -124.6 141.95 51.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.469 . . . . 63.04 111.124 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 57.6 m -139.31 142.58 37.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.196 -0.456 . . . . 73.1 110.862 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . 0.517 ' CD2' HD12 ' A' ' 227' ' ' ILE . 2.5 m-85 -98.79 133.11 43.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.175 -0.466 . . . . 73.53 110.89 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 24.6 p -135.09 128.31 31.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 71.1 110.843 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -128.98 158.45 38.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 54.2 111.093 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.52 164.27 36.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 64.34 110.913 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 242' ' ' LEU . 10.0 p -154.86 143.19 13.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 74.13 111.148 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -102.52 148.47 25.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 75.43 110.869 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 14.1 t30 -54.09 -21.68 9.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 74.41 110.901 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 46.4 t -80.84 25.76 0.44 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.45 . . . . 64.34 110.843 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 1.9 m 59.2 39.29 22.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 62.54 110.926 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . 0.692 HD22 ' HB3' ' A' ' 264' ' ' ASP . 22.6 mt -99.4 118.11 35.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.093 -0.503 . . . . 63.32 110.915 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.437 ' H ' HD12 ' A' ' 243' ' ' ILE . 5.4 mp -84.62 125.92 40.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.172 -0.467 . . . . 75.43 111.102 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -128.21 132.81 7.49 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.771 -0.728 . . . . 73.21 112.496 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.422 ' CD1' ' HB3' ' A' ' 261' ' ' ALA . 1.3 pp -146.14 140.88 26.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.882 0.372 . . . . 61.43 110.902 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -153.13 150.32 22.05 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.677 -0.773 . . . . 71.21 112.445 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -128.39 132.19 48.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.943 0.401 . . . . 74.11 110.947 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.02 123.94 50.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 60.44 111.131 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -143.09 129.59 20.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 75.34 110.873 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . 0.41 HG23 ' HG2' ' A' ' 256' ' ' LYS . 3.1 m -80.62 142.31 34.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.222 -0.444 . . . . 65.24 111.174 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.662 HD23 ' HD2' ' A' ' 253' ' ' PRO . 7.6 tp -72.84 -70.74 0.34 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 74.33 110.888 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' LYS . . . . . 0.5 ' N ' ' HD2' ' A' ' 253' ' ' PRO . 16.9 ttpt 178.35 -59.45 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.6 0.714 . . . . 71.4 110.926 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' PRO . . . . . 0.662 ' HD2' HD23 ' A' ' 251' ' ' LEU . 54.0 Cg_endo -69.74 -86.64 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.705 2.27 . . . . 64.21 112.342 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -145.72 16.58 1.8 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.734 -0.746 . . . . 71.01 112.484 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.414 HG12 HD23 ' A' ' 31' ' ' LEU . 3.7 mt -105.32 118.07 52.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.882 0.372 . . . . 75.53 111.094 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 0.55 ' O ' ' HA ' ' A' ' 279' ' ' LEU . 0.0 OUTLIER -99.09 135.06 41.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 75.11 110.88 179.856 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 0.527 ' CD2' HD21 ' A' ' 277' ' ' LEU . 0.3 OUTLIER -94.08 124.02 37.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.464 . . . . 74.13 110.887 179.949 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 27.5 p -128.15 111.68 13.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.448 . . . . 75.21 111.121 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.907 HD22 HD23 ' A' ' 277' ' ' LEU . 0.1 OUTLIER -109.9 126.24 53.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.242 -0.435 . . . . 72.04 110.928 179.901 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.452 ' N ' HD13 ' A' ' 259' ' ' LEU . 4.1 m -126.49 140.86 52.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 74.25 110.839 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 261' ' ' ALA . . . . . 0.422 ' HB3' ' CD1' ' A' ' 245' ' ' LEU . . . -144.21 128.52 17.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.121 -0.491 . . . . 61.31 111.116 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.693 ' C ' HD13 ' A' ' 263' ' ' LEU . 0.7 OUTLIER -121.66 120.77 35.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.446 . . . . 63.43 110.913 -179.939 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . 0.693 HD13 ' C ' ' A' ' 262' ' ' LEU . 0.2 OUTLIER -119.95 109.77 15.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.446 . . . . 73.31 110.887 179.913 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . 0.692 ' HB3' HD22 ' A' ' 242' ' ' LEU . 3.0 p30 -90.95 115.78 28.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.454 . . . . 64.22 110.853 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . 0.425 ' HA2' HG22 ' A' ' 268' ' ' VAL . . . -55.45 -18.38 15.04 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.704 -0.76 . . . . 43.22 112.5 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 6.4 ttpp -79.09 -25.99 43.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.836 0.35 . . . . 73.2 110.942 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -109.59 -54.46 2.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 72.13 110.916 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . 0.644 HG22 ' O ' ' A' ' 264' ' ' ASP . 13.8 m -51.04 -29.03 7.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.48 . . . . 64.52 111.109 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -52.43 -35.12 51.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 73.34 110.901 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -103.67 -17.44 15.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.123 -0.489 . . . . 71.23 111.074 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 125.7 98.58 1.14 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.721 -0.752 . . . . 43.24 112.498 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 272' ' ' GLY . . . . . 0.405 ' O ' HG12 ' A' ' 268' ' ' VAL . . . 168.2 93.13 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.716 -0.754 . . . . 71.52 112.465 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 273' ' ' HIS . . . . . 0.499 ' CB ' HD12 ' A' ' 263' ' ' LEU . 9.6 p80 -113.43 144.5 42.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.877 0.37 . . . . 74.24 110.859 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 43.5 mmtm -101.12 136.85 40.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 73.22 110.874 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.729 HD13 ' N ' ' A' ' 276' ' ' GLY . 2.2 tm? -135.85 137.71 41.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.476 . . . . 73.52 110.89 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . 0.729 ' N ' HD13 ' A' ' 275' ' ' LEU . . . -139.56 136.37 7.81 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.721 -0.752 . . . . 73.22 112.464 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.907 HD23 HD22 ' A' ' 259' ' ' LEU . 3.1 tm? -132.52 138.2 47.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.898 0.38 . . . . 74.33 110.9 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . 0.588 ' H ' HD22 ' A' ' 277' ' ' LEU . . . -160.67 161.01 32.41 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.761 -0.733 . . . . 75.04 112.455 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.74 HD23 ' HB2' ' A' ' 29' ' ' LEU . 2.9 mm? -113.93 143.37 44.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.815 0.34 . . . . 75.13 110.937 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . 0.421 ' HB2' ' HB3' ' A' ' 256' ' ' LYS . 0.9 OUTLIER -91.37 130.1 37.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 75.3 110.87 179.994 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . 0.717 ' HA ' ' HA ' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -76.33 60.26 1.52 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 71.32 110.89 -179.941 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -109.38 97.74 7.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.133 -0.485 . . . . 72.25 110.875 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.478 ' HB2' HD11 ' A' ' 31' ' ' LEU . . . -128.65 110.93 12.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.212 -0.449 . . . . 65.53 111.117 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.793 HD21 ' HG2' ' A' ' 34' ' ' LYS . 94.6 mt -152.15 178.38 9.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 63.44 110.923 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 42.2 tp10 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 71.15 110.864 179.941 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.097 0 CA-C-O 120.845 0.355 . . . . 61.52 111.07 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.724 HG13 ' HA ' ' A' ' 121' ' ' GLU . 0.0 OUTLIER -134.87 158.46 74.93 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.633 0.73 . . . . 75.51 111.124 179.997 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.85 170.25 17.11 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.688 2.259 . . . . 74.12 112.321 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 77.74 1.06 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.643 2.229 . . . . 64.32 112.36 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.561 HG22 HD11 ' A' ' 150' ' ' LEU . 2.6 p -70.37 -45.75 65.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 74.44 111.132 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 91.2 t80 -52.46 -32.38 39.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 75.05 110.901 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -82.18 -26.53 33.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 72.15 111.116 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -74.21 -12.86 60.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 72.23 110.843 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.427 HD21 ' O ' ' A' ' 152' ' ' GLY . 0.7 OUTLIER -56.42 -34.42 66.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 73.21 110.896 -179.961 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 142.45 64.77 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.762 -0.732 . . . . 52.32 112.529 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.6 ttpp -69.35 -42.12 75.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.801 0.334 . . . . 74.24 110.873 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.6 t -63.65 -39.35 94.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.207 -0.451 . . . . 64.15 110.901 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.8 -37.93 74.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.074 -0.512 . . . . 74.11 111.112 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 3.1 tmt_? -60.77 -33.12 72.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.444 . . . . 73.13 110.858 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.638 ' O ' HG23 ' A' ' 19' ' ' THR . 4.7 t0 -58.46 -40.0 81.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.45 . . . . 70.22 110.834 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.6 t -58.91 -39.42 77.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 73.32 111.113 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -60.54 -41.07 93.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.481 . . . . 45.11 110.866 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.638 HG23 ' O ' ' A' ' 16' ' ' ASP . 1.1 p 46.75 69.2 0.51 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 64.3 111.191 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 16.0 tptm -69.24 112.48 5.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 61.1 110.921 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 63.5 99.44 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.737 -0.744 . . . . 62.35 112.476 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -172.9 129.36 0.49 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.945 0.402 . . . . 74.15 110.908 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.52 40.84 3.09 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.784 -0.722 . . . . 73.12 112.501 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -103.18 13.01 34.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.911 0.386 . . . . 65.42 110.892 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 80.79 15.44 77.66 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.773 -0.727 . . . . 65.04 112.46 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.507 ' C ' HD13 ' A' ' 27' ' ' ILE . 0.1 OUTLIER -105.89 168.74 8.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.799 0.333 . . . . 61.11 110.917 -179.93 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.734 HG23 HD12 ' A' ' 277' ' ' LEU . 2.8 mm -120.2 123.42 70.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.234 -0.439 . . . . 72.43 111.089 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.6 ttmt -115.2 118.15 32.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.465 . . . . 75.23 110.921 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.617 HD12 ' CB ' ' A' ' 279' ' ' LEU . 1.0 OUTLIER -114.68 142.99 45.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 63.41 110.915 179.955 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -147.82 128.62 14.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 71.21 110.851 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.686 HD13 ' HB3' ' A' ' 281' ' ' PHE . 5.7 tp -127.2 128.78 46.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 71.14 110.908 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.673 ' N ' HD12 ' A' ' 31' ' ' LEU . 2.0 pttm -124.83 125.48 44.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 71.23 110.887 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.479 HG22 ' HB2' ' A' ' 283' ' ' ALA . 6.6 p -135.2 120.8 19.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.199 -0.455 . . . . 60.34 111.158 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.581 ' O ' HD21 ' A' ' 284' ' ' LEU . 53.1 mttm -118.75 129.99 55.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 74.25 110.91 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.2 t -116.14 138.29 51.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 73.23 110.87 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -77.41 59.25 1.83 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.157 -0.474 . . . . 74.02 110.889 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -160.51 25.27 0.15 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 73.35 110.805 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.51 ' HA2' ' O ' ' A' ' 63' ' ' ARG . . . 79.7 -4.11 66.31 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.737 -0.744 . . . . 43.14 112.526 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.5 mp -98.23 126.11 43.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.782 0.325 . . . . 64.21 110.897 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.1 118.39 10.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.172 -0.467 . . . . 62.11 110.861 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -103.71 124.15 48.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.152 -0.476 . . . . 73.42 110.883 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.11 115.5 19.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 73.43 111.124 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.42 138.12 53.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 63.35 110.863 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 27.0 m -150.6 126.96 10.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 71.34 110.905 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -164.53 166.43 37.89 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.726 -0.749 . . . . 60.0 112.489 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 60.3 m -138.03 168.62 19.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.877 0.37 . . . . 71.22 110.878 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.426 ' HB1' HG12 ' A' ' 54' ' ' VAL . . . -134.13 139.52 45.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.126 -0.488 . . . . 74.41 111.096 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -113.41 141.43 47.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 65.41 110.919 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.421 HG22 ' H ' ' A' ' 50' ' ' GLU . 0.2 OUTLIER 64.07 169.53 0.17 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 64.15 111.109 -179.986 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.421 ' H ' HG22 ' A' ' 49' ' ' THR . 0.0 OUTLIER -74.28 94.52 2.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.462 . . . . 70.13 110.863 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 61.5 p 45.98 84.01 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.127 -0.488 . . . . 65.32 111.134 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.7 m -151.5 -59.66 0.17 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.237 -0.438 . . . . 73.44 111.196 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 18.0 mmtp -142.33 113.69 7.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 75.21 110.897 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.426 HG12 ' HB1' ' A' ' 47' ' ' ALA . 1.0 OUTLIER -125.55 147.54 30.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 75.33 111.142 179.836 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.2 p -110.32 126.57 54.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 51.54 111.13 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -118.76 143.63 17.55 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.72 -0.753 . . . . 60.53 112.503 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.85 142.51 50.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.968 0.413 . . . . 61.44 110.851 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.661 HD13 ' N ' ' A' ' 59' ' ' GLU . 0.8 OUTLIER -120.86 132.85 55.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 70.35 110.948 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.661 ' N ' HD13 ' A' ' 58' ' ' LEU . 3.4 tt0 -134.0 124.65 26.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 71.51 110.889 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 27.0 m -104.77 130.35 52.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 62.22 111.146 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 8.5 ttpt -132.48 156.93 45.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.239 -0.437 . . . . 71.13 110.919 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.564 ' O ' HG23 ' A' ' 70' ' ' THR . 26.0 m-85 -129.06 140.68 51.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.282 -0.417 . . . . 73.53 110.939 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.51 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 27.9 ttp85 -127.99 105.37 8.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 71.15 110.894 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.414 ' HB3' ' HG2' ' A' ' 66' ' ' GLU . 5.6 m-90 -113.19 134.33 54.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 63.11 110.935 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 30.3 p -69.82 -27.17 64.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.275 -0.42 . . . . 75.21 111.122 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.414 ' HG2' ' HB3' ' A' ' 64' ' ' TRP . 1.9 pt-20 -52.51 102.53 0.05 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.211 -0.45 . . . . 74.33 110.889 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.447 ' CD2' HD21 ' A' ' 69' ' ' LEU . 7.3 t80 65.33 9.77 5.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.149 -0.478 . . . . 75.03 110.902 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.597 ' O ' HD23 ' A' ' 69' ' ' LEU . . . 57.33 70.27 1.03 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.77 -0.729 . . . . 74.1 112.491 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.597 HD23 ' O ' ' A' ' 68' ' ' GLY . 5.7 mt -119.15 137.21 53.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.859 0.361 . . . . 65.3 110.9 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.564 HG23 ' O ' ' A' ' 62' ' ' TYR . 27.7 m -136.24 127.84 28.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 72.51 111.163 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.569 ' HB3' HG22 ' A' ' 85' ' ' ILE . 4.3 m-85 -121.79 121.62 37.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 71.32 110.86 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 61' ' ' LYS . 14.4 t -119.87 136.22 54.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 62.15 111.133 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -131.06 122.82 27.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 70.22 110.88 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.9 ptmt -95.51 135.99 36.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 74.42 110.91 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 8.7 t90 -134.81 128.84 33.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.246 -0.434 . . . . 74.2 110.926 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -117.85 154.93 31.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 62.14 110.878 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 7.3 t -62.48 -16.47 55.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.127 -0.488 . . . . 74.31 111.142 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.423 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 2.4 m-20 -74.61 0.78 13.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.258 -0.428 . . . . 70.43 110.89 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.423 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 3.7 m120 78.53 37.19 0.18 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.465 . . . . 63.44 110.877 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.6 p -113.58 121.54 44.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 74.32 111.144 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.402 HD13 ' HA ' ' A' ' 81' ' ' LEU . 4.3 mm? -111.23 132.96 53.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 70.13 110.966 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -123.61 92.84 0.46 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.803 -0.713 . . . . 73.32 112.517 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -79.34 106.1 11.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.821 0.343 . . . . 74.42 111.13 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -124.47 107.37 11.01 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.211 -0.449 . . . . 71.21 110.86 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.569 HG22 ' HB3' ' A' ' 71' ' ' PHE . 2.4 pp -111.51 130.84 64.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 73.41 111.13 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.863 HG23 HG22 ' A' ' 98' ' ' THR . 88.5 m -122.2 123.16 40.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 55.11 111.161 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.561 ' HB ' HD22 ' A' ' 69' ' ' LEU . 1.6 m -115.17 139.79 39.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.223 -0.444 . . . . 73.14 111.145 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -90.55 128.32 36.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 70.24 110.85 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.64 179.17 1.43 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.173 -0.467 . . . . 73.41 110.863 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -126.76 -65.9 0.93 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 73.11 110.883 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 20.1 tp -50.55 -75.47 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 75.25 110.931 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -73.26 76.35 1.32 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 72.31 111.091 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 7.7 tpp85 -48.78 133.69 17.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.435 . . . . 72.12 110.851 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 100.97 8.38 48.13 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.727 -0.749 . . . . 74.34 112.524 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.4 tp -112.68 124.67 53.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.861 0.362 . . . . 64.45 110.956 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 13.5 ttmt -124.62 125.05 43.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 72.05 110.929 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.566 HD12 HG22 ' A' ' 116' ' ' THR . 0.3 OUTLIER -101.64 127.13 48.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.222 -0.444 . . . . 73.13 110.939 179.914 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.863 HG22 HG23 ' A' ' 86' ' ' THR . 4.4 p -127.89 119.91 26.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 64.42 111.158 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.1 119.96 41.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.44 . . . . 71.25 110.917 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -109.9 142.12 41.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.474 . . . . 73.33 110.846 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.1 m -143.14 127.78 18.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 74.12 110.86 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -95.36 125.74 40.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 74.32 110.865 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -129.17 126.86 40.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 54.41 110.895 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.433 ' HA ' ' HD2' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -128.82 102.4 19.6 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.7 0.762 . . . . 73.0 110.827 -179.758 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 104' ' ' SER . 53.6 Cg_endo -69.76 -32.63 18.2 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.709 2.273 . . . . 54.1 112.349 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -70.12 -72.58 0.19 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.186 -0.461 . . . . 71.45 110.891 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.5 p -64.26 -40.09 95.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.129 -0.487 . . . . 65.42 111.131 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.52 24.45 13.92 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.726 -0.749 . . . . 75.11 112.495 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.11 148.09 22.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.82 0.343 . . . . 64.52 110.874 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -142.06 131.63 23.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 71.31 110.866 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -130.08 152.56 49.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.245 -0.434 . . . . 62.33 110.923 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -130.24 125.26 34.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 71.45 111.132 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.405 ' HB3' ' HA ' ' A' ' 130' ' ' ASP . 0.0 OUTLIER -139.03 137.99 36.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 35.13 110.861 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.536 HD13 ' H ' ' A' ' 115' ' ' LYS . 0.4 OUTLIER -125.84 138.35 54.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 74.22 111.149 179.835 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.536 ' H ' HD13 ' A' ' 114' ' ' ILE . 14.9 mtmt -130.17 130.11 44.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 75.43 110.925 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.566 HG22 HD12 ' A' ' 97' ' ' LEU . 1.2 p -119.22 119.2 33.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.446 . . . . 73.14 111.155 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -107.64 125.33 7.92 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.689 -0.767 . . . . 72.51 112.471 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -131.09 115.52 16.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.941 0.401 . . . . 60.05 110.886 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 13.7 mtpp -106.58 125.34 50.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.147 -0.479 . . . . 72.33 110.93 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 13.9 ttt85 -104.95 144.96 31.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.281 -0.418 . . . . 74.33 110.867 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.724 ' HA ' HG13 ' A' ' 3' ' ' VAL . 9.8 pt-20 -50.41 -26.57 5.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 71.24 110.9 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 33.9 m170 -86.98 -45.51 10.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 75.12 110.886 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 49.4 pt -151.38 156.6 6.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 61.23 111.143 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.404 ' HB2' HG22 ' A' ' 143' ' ' VAL . 2.6 m120 -104.21 129.7 51.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 62.02 110.897 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.543 ' CD2' HD22 ' A' ' 142' ' ' LEU . 1.0 OUTLIER -127.77 143.42 51.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 73.33 110.924 179.926 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -146.51 117.18 0.92 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.762 -0.732 . . . . 74.15 112.547 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 36.8 t -113.89 132.09 56.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.847 0.356 . . . . 72.2 110.85 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.432 ' HA ' ' HA ' ' A' ' 115' ' ' LYS . 0.2 OUTLIER -128.38 117.32 21.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 55.02 110.821 -179.963 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 19.4 mtm -103.97 136.25 43.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 52.24 110.92 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.405 ' HA ' ' HB3' ' A' ' 113' ' ' LYS . 4.3 t0 -128.41 120.25 26.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 73.31 110.834 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -94.74 119.9 34.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 75.3 110.886 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -128.71 131.83 47.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.164 -0.471 . . . . 63.34 110.827 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -55.9 -29.86 27.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 53.1 111.125 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -80.01 -20.26 45.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 63.21 111.07 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 157.61 100.26 0.17 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.754 -0.736 . . . . 54.04 112.465 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.76 129.48 17.68 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.679 2.253 . . . . 61.34 112.399 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.571 ' C ' HD12 ' A' ' 138' ' ' ILE . 12.5 t -129.08 161.79 29.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 64.42 110.887 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.753 HD13 ' HB ' ' A' ' 159' ' ' THR . 1.7 mp -120.72 117.12 52.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.111 -0.495 . . . . 72.41 111.14 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 15.2 mtm180 -121.81 125.29 46.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 72.34 110.883 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -147.16 152.18 24.36 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.72 -0.753 . . . . 75.33 112.519 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -120.72 139.55 52.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.855 0.359 . . . . 53.33 111.099 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.64 HD12 ' N ' ' A' ' 143' ' ' VAL . 0.1 OUTLIER -141.33 143.41 34.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 61.23 110.939 -179.961 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.64 ' N ' HD12 ' A' ' 142' ' ' LEU . 1.0 OUTLIER -133.58 143.74 37.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 61.15 111.153 179.817 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.521 HD12 ' O ' ' A' ' 151' ' ' ALA . 0.5 OUTLIER -125.99 138.31 53.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.172 -0.467 . . . . 75.3 110.925 179.968 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -113.29 119.32 4.8 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.764 -0.732 . . . . 64.11 112.499 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -144.84 148.27 33.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.862 0.363 . . . . 74.24 110.89 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 50.06 26.36 2.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.139 -0.482 . . . . 71.12 110.897 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 88.78 -31.82 4.8 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.749 -0.739 . . . . 53.14 112.523 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 52.9 p-90 -80.72 146.21 31.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.814 0.34 . . . . 71.53 110.936 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.561 HD11 HG22 ' A' ' 6' ' ' THR . 2.7 mt -114.5 145.52 41.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.451 . . . . 51.31 110.93 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.521 ' O ' HD12 ' A' ' 144' ' ' LEU . . . -141.74 113.9 8.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 62.03 111.099 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.459 ' HA3' ' HA ' ' A' ' 143' ' ' VAL . . . -166.04 162.57 36.08 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.722 -0.751 . . . . 63.34 112.444 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.786 ' HB3' ' O ' ' A' ' 168' ' ' ASN . 0.0 OUTLIER -174.68 -168.45 0.36 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.858 0.361 . . . . 73.51 110.925 -179.862 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -99.99 146.21 26.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.072 -0.513 . . . . 64.43 110.867 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 3.1 ppp? -145.21 127.54 15.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 73.22 110.9 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -111.46 119.95 40.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 74.22 110.843 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -108.51 138.99 43.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 75.11 110.867 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -77.65 98.38 5.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 73.34 110.918 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.753 ' HB ' HD13 ' A' ' 138' ' ' ILE . 7.2 t -66.24 -40.84 90.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 52.24 111.149 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -48.67 -25.1 1.61 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 65.32 111.108 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 35.4 mmtm -141.47 -159.89 1.02 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 45.34 110.88 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 17.1 m -109.59 40.06 1.96 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 62.3 110.879 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -131.27 171.58 13.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.134 -0.485 . . . . 70.45 110.889 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -106.91 141.05 23.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 52.51 111.125 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 62.6 m -90.29 -35.26 15.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 72.42 111.153 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -154.92 137.64 15.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 73.41 110.917 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 2.8 t -128.2 102.14 6.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 74.14 110.85 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.786 ' O ' ' HB3' ' A' ' 153' ' ' TYR . 0.1 OUTLIER -116.27 122.65 45.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 71.24 110.92 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.566 ' HA ' ' HB2' ' A' ' 153' ' ' TYR . 42.3 m-85 -133.96 138.6 45.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 62.11 110.887 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.735 ' HB3' ' CD1' ' A' ' 153' ' ' TYR . . . -151.3 152.04 32.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 73.33 111.118 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.469 HG12 ' HB1' ' A' ' 151' ' ' ALA . 0.9 OUTLIER -140.9 148.3 21.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.22 -0.446 . . . . 62.34 111.088 179.988 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -121.99 129.16 7.51 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.725 -0.75 . . . . 54.11 112.513 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -113.67 131.45 56.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.912 0.386 . . . . 74.0 110.954 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 20.9 mmtp -102.67 128.2 49.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.105 -0.498 . . . . 70.15 110.882 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.456 ' O ' ' C ' ' A' ' 176' ' ' ASP . 0.2 OUTLIER -119.64 167.05 12.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.451 . . . . 54.31 111.153 179.979 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.456 ' C ' ' O ' ' A' ' 175' ' ' THR . 0.8 OUTLIER -34.13 -77.74 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 74.22 110.87 179.937 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -117.64 14.66 14.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 75.1 110.907 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -128.14 147.49 50.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 61.11 110.897 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -136.32 126.64 26.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 61.4 110.902 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.751 HD12 ' CG2' ' A' ' 194' ' ' ILE . 0.4 OUTLIER -124.29 137.28 54.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 64.53 110.894 -179.949 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 5.8 t-80 -130.98 113.45 14.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 74.03 110.859 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -96.16 146.97 24.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 54.23 111.154 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . 0.413 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 7.0 p30 -159.52 140.7 12.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.248 -0.433 . . . . 72.44 110.898 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.526 ' HB ' ' HA ' ' A' ' 190' ' ' PHE . 1.4 m -135.07 135.71 52.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.125 -0.489 . . . . 62.12 111.104 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -100.52 88.3 3.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 74.32 110.916 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 73.58 176.57 0.25 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.196 -0.456 . . . . 73.41 110.862 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -72.44 1.67 34.35 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.743 -0.741 . . . . 64.23 112.463 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 33.3 p -105.12 -24.34 12.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.715 0.293 . . . . 63.35 111.103 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -119.16 120.08 36.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.24 -0.436 . . . . 75.12 110.9 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' PHE . . . . . 0.526 ' HA ' ' HB ' ' A' ' 184' ' ' VAL . 0.5 OUTLIER -140.13 124.57 17.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.456 . . . . 75.01 110.947 -179.954 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -171.39 -150.33 7.04 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.72 -0.752 . . . . 53.45 112.463 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 172.37 -166.68 39.49 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.751 -0.737 . . . . 30.43 112.519 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . 0.467 ' C ' HD13 ' A' ' 194' ' ' ILE . 1.4 t -148.84 151.8 35.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.849 0.357 . . . . 72.23 110.857 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.751 ' CG2' HD12 ' A' ' 180' ' ' LEU . 0.0 OUTLIER -136.76 135.02 48.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 74.22 111.159 179.934 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -131.75 137.12 48.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 65.31 110.929 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 46.4 tp60 -124.35 131.9 53.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.123 -0.49 . . . . 64.13 110.963 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 11.2 ttpt -81.92 126.22 31.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 71.44 110.921 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 18.1 t -91.15 139.95 16.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 63.02 111.151 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -81.86 59.7 4.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 74.45 110.883 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 22.1 ttmt -165.9 39.87 0.06 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.198 -0.455 . . . . 71.43 110.889 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 4.8 mptt 57.32 44.06 22.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 75.0 110.87 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.665 HD12 ' O ' ' A' ' 224' ' ' LYS . 58.7 tp -152.92 145.98 24.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.249 -0.432 . . . . 73.15 110.906 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -127.32 149.24 50.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 75.41 110.911 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 71.2 p -123.29 138.24 54.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 74.25 111.115 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -145.81 135.73 23.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.214 -0.448 . . . . 74.44 111.134 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.562 HG22 HG12 ' A' ' 194' ' ' ILE . 0.9 OUTLIER -132.16 144.02 38.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 73.34 111.119 179.993 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -130.92 127.32 38.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.474 . . . . 71.41 110.852 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.446 ' H ' HD23 ' A' ' 208' ' ' LEU . 2.7 pt? -143.24 150.23 39.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.125 -0.489 . . . . 75.13 110.929 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -138.63 149.56 45.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 73.44 111.099 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 3.9 t-105 -120.63 135.19 55.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.447 . . . . 63.24 110.918 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 3.1 m -95.68 104.32 16.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 73.11 111.16 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -53.05 150.16 5.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 74.05 111.123 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 97.01 -34.16 5.26 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.729 -0.748 . . . . 42.21 112.498 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -122.58 -171.14 2.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.803 0.335 . . . . 75.35 110.919 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 22.7 t -119.03 38.06 3.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 53.01 110.857 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -101.96 111.88 24.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 72.42 110.917 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 14.6 t -115.18 138.18 51.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 61.22 111.173 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 63.3 mmt-85 -128.46 127.64 42.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 73.11 110.84 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -134.44 158.0 45.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.452 . . . . 72.54 110.861 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -147.44 147.46 18.23 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.718 -0.754 . . . . 54.5 112.516 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 3.8 mp -118.32 133.24 65.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.836 0.35 . . . . 73.41 111.12 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -131.77 143.73 50.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.462 . . . . 63.12 111.102 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -112.45 134.48 53.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.454 . . . . 43.1 111.071 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . 0.665 ' O ' HD12 ' A' ' 202' ' ' LEU . 1.1 ttpp -109.37 114.84 28.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 72.35 110.895 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 36.9 t80 -131.21 117.61 19.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.276 -0.42 . . . . 71.04 110.908 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -111.7 109.07 18.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.128 -0.487 . . . . 72.1 110.927 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 2.3 tt -80.93 -32.34 12.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 75.42 111.11 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -150.54 160.25 33.11 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.626 0.727 . . . . 72.41 110.882 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -7.61 21.48 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.671 2.248 . . . . 74.14 112.314 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -106.78 -29.52 9.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.247 -0.433 . . . . 75.03 110.9 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -124.54 133.56 53.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 72.32 111.09 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 42.1 m -134.81 141.76 46.5 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.235 -0.439 . . . . 42.44 110.849 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -127.13 133.48 50.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.474 . . . . 64.12 110.895 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 11.8 p -142.73 139.68 31.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.102 -0.499 . . . . 55.21 110.855 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -111.09 161.01 16.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.117 -0.492 . . . . 73.12 111.089 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 6.7 ptpp? -151.71 142.03 22.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 63.14 110.877 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 1.1 p -139.7 143.99 29.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 74.13 111.154 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -112.86 147.98 35.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.465 . . . . 63.45 110.927 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 40.1 t30 -59.43 -16.35 22.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 73.2 110.89 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 3.5 m -81.96 25.44 0.57 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 53.13 110.829 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 65.41 32.34 9.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.107 -0.497 . . . . 72.13 110.871 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 5.1 mp -100.28 118.07 35.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.122 -0.49 . . . . 52.31 110.923 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.437 ' H ' HD12 ' A' ' 243' ' ' ILE . 0.3 OUTLIER -118.1 116.79 52.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.223 -0.444 . . . . 74.44 111.115 179.835 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . 0.54 ' C ' HD13 ' A' ' 245' ' ' LEU . . . -147.88 163.39 28.84 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.723 -0.751 . . . . 70.32 112.452 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.661 ' N ' HD13 ' A' ' 245' ' ' LEU . 0.0 OUTLIER -146.5 160.43 42.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.88 0.371 . . . . 71.44 110.949 -179.972 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -141.41 137.84 8.35 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.715 -0.755 . . . . 73.22 112.507 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -129.38 131.06 46.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.919 0.39 . . . . 72.44 110.942 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.511 ' OG1' HG22 ' A' ' 258' ' ' THR . 1.8 t -118.68 118.79 32.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.121 -0.49 . . . . 71.15 111.178 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -115.21 122.45 46.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.247 -0.433 . . . . 71.25 110.927 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . 0.598 HG23 ' HB2' ' A' ' 256' ' ' LYS . 7.6 m -95.73 122.88 38.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 43.2 111.13 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 17.9 tp -98.84 92.57 5.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.179 -0.464 . . . . 64.51 110.919 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 3.7 mtpp 63.75 161.41 0.12 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.563 0.697 . . . . 71.21 110.894 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 76.76 1.11 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.687 2.258 . . . . 73.14 112.337 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 178.32 -48.61 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.8 -0.715 . . . . 73.25 112.527 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.72 135.42 62.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.925 0.393 . . . . 64.13 111.133 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 0.598 ' HB2' HG23 ' A' ' 250' ' ' THR . 36.3 ttpt -133.37 133.14 42.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.125 -0.488 . . . . 73.31 110.853 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 0.406 HD23 ' H ' ' A' ' 258' ' ' THR . 0.4 OUTLIER -108.13 133.9 51.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 74.24 110.895 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . 0.511 HG22 ' OG1' ' A' ' 248' ' ' THR . 30.9 p -132.62 122.04 24.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 74.34 111.16 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.663 HD21 HD11 ' A' ' 275' ' ' LEU . 0.1 OUTLIER -120.96 150.1 41.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 63.22 110.911 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.508 ' O ' HD22 ' A' ' 275' ' ' LEU . 1.5 m -142.64 140.5 31.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 51.54 110.815 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 261' ' ' ALA . . . . . 0.52 ' HB2' ' CD2' ' A' ' 275' ' ' LEU . . . -141.66 129.2 21.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 72.1 111.094 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.786 ' C ' HD13 ' A' ' 263' ' ' LEU . 1.3 tt -131.18 137.63 49.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 74.42 110.946 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . 0.786 HD13 ' C ' ' A' ' 262' ' ' LEU . 0.0 OUTLIER -120.9 108.59 14.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.173 -0.467 . . . . 72.21 110.918 179.915 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . 0.694 ' O ' HG22 ' A' ' 268' ' ' VAL . 0.5 OUTLIER -84.66 108.95 17.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 63.31 110.904 179.823 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -53.94 -18.85 9.37 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.788 -0.72 . . . . 44.22 112.48 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -91.05 -26.1 19.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.823 0.344 . . . . 74.31 110.876 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -100.1 -56.62 2.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 71.11 110.888 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . 0.717 HG12 ' O ' ' A' ' 272' ' ' GLY . 12.9 m -49.87 -27.36 3.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 71.2 111.117 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -53.74 -45.69 70.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 71.15 110.863 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -105.69 -17.16 14.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.473 . . . . 71.31 111.109 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -111.01 -120.18 4.01 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.778 -0.725 . . . . 75.15 112.501 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 272' ' ' GLY . . . . . 0.717 ' O ' HG12 ' A' ' 268' ' ' VAL . . . -150.39 -164.82 12.15 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.821 -0.704 . . . . 30.32 112.499 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 273' ' ' HIS . . . . . 0.621 ' CB ' HD12 ' A' ' 263' ' ' LEU . 8.9 p80 -89.62 145.93 24.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.851 0.358 . . . . 74.25 110.866 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 24.0 mttp -97.15 135.85 38.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 73.31 110.916 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.748 HD13 ' N ' ' A' ' 276' ' ' GLY . 2.7 tm? -134.94 138.93 44.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.256 -0.429 . . . . 65.51 110.913 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . 0.748 ' N ' HD13 ' A' ' 275' ' ' LEU . . . -132.75 140.04 11.47 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.752 -0.737 . . . . 73.11 112.523 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.734 HD12 HG23 ' A' ' 27' ' ' ILE . 2.1 tm? -113.94 136.7 52.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.792 0.329 . . . . 74.43 110.955 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . 0.697 ' N ' HD13 ' A' ' 277' ' ' LEU . . . -141.94 127.86 3.4 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.771 -0.728 . . . . 74.44 112.495 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.654 HD11 HD11 ' A' ' 277' ' ' LEU . 1.3 mm? -108.35 131.66 54.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.794 0.33 . . . . 61.12 110.882 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -123.36 112.03 17.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 64.21 110.928 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . 0.686 ' HB3' HD13 ' A' ' 31' ' ' LEU . 17.7 m-85 -112.87 133.34 54.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 73.53 110.906 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -135.34 130.5 35.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 71.01 110.91 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.588 ' C ' HD23 ' A' ' 284' ' ' LEU . . . -99.16 135.78 40.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 74.42 111.106 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.588 HD23 ' C ' ' A' ' 283' ' ' ALA . 0.8 OUTLIER 41.7 37.14 0.68 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.253 -0.43 . . . . 53.54 110.91 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.47 . . . . 72.24 110.859 179.938 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.798 0.332 . . . . 43.31 111.089 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.641 HG22 ' N ' ' A' ' 121' ' ' GLU . 60.2 t -114.42 78.75 4.92 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.642 0.734 . . . . 71.51 111.122 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 166.01 29.07 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.688 2.259 . . . . 61.34 112.316 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 101.66 0.94 Allowed 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.702 2.268 . . . . 72.43 112.296 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.649 HG22 HD21 ' A' ' 150' ' ' LEU . 0.0 OUTLIER -88.7 -46.36 9.07 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.218 -0.446 . . . . 70.22 111.178 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -54.39 -33.84 60.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 71.11 110.906 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -82.98 -19.16 37.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 74.12 111.129 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -88.85 10.09 22.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 55.42 110.903 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.567 HD23 HD12 ' A' ' 150' ' ' LEU . 89.5 mt -67.19 -34.25 77.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 61.43 110.911 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -139.57 68.45 0.49 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.738 -0.744 . . . . 72.25 112.484 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 12.4 mttp -64.64 -53.9 40.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.843 0.354 . . . . 72.44 110.942 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.9 t -58.77 -48.75 80.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 75.44 110.854 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.58 -37.82 88.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.113 -0.494 . . . . 70.05 111.065 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.451 ' O ' HG22 ' A' ' 19' ' ' THR . 16.2 ttm-85 -60.42 -34.32 73.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.26 -0.427 . . . . 70.52 110.881 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.08 -39.07 93.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.198 -0.455 . . . . 74.24 110.87 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.6 t -82.2 -33.33 11.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.256 -0.429 . . . . 64.11 111.128 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -72.18 -42.05 66.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 64.11 110.88 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.451 HG22 ' O ' ' A' ' 15' ' ' ARG . 12.3 t -68.49 -32.0 71.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 64.42 111.112 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -73.89 127.79 33.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 65.02 110.904 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -50.73 136.37 28.44 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.803 -0.713 . . . . 71.24 112.477 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -125.93 33.24 5.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.87 0.367 . . . . 71.03 110.897 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 73.87 88.63 0.19 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.714 -0.755 . . . . 72.15 112.524 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -94.24 -4.36 49.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.93 0.395 . . . . 72.42 110.897 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.58 13.36 80.26 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.754 -0.736 . . . . 32.21 112.49 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.461 HD12 ' O ' ' A' ' 27' ' ' ILE . 2.5 pp -150.33 -178.9 6.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.814 0.34 . . . . 75.14 110.926 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.73 HG23 HD12 ' A' ' 277' ' ' LEU . 8.9 mm -111.36 145.04 18.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 74.44 111.121 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.7 ttpt -122.65 151.15 41.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 64.41 110.883 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.514 HD13 ' C ' ' A' ' 29' ' ' LEU . 3.4 tm? -140.56 128.06 21.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 62.24 110.911 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -139.18 129.42 25.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.466 . . . . 63.51 110.858 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.8 tt -137.53 133.49 34.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 73.23 110.933 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.6 mtpp -135.33 125.51 26.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 71.13 110.928 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.641 HG23 ' HB3' ' A' ' 283' ' ' ALA . 24.4 m -123.2 146.18 48.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.212 -0.449 . . . . 52.51 111.11 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 10.1 tptt -105.24 158.04 16.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 62.41 110.9 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.483 ' O ' ' C ' ' A' ' 36' ' ' GLU . 0.5 OUTLIER -132.14 174.86 9.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 62.01 110.873 -179.915 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.483 ' C ' ' O ' ' A' ' 35' ' ' SER . 46.2 tt0 -31.8 -73.46 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.16 -0.473 . . . . 73.2 110.869 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -164.82 131.77 3.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 73.13 110.925 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.453 ' HA2' ' O ' ' A' ' 63' ' ' ARG . . . 86.28 -14.59 53.75 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.763 -0.732 . . . . 65.23 112.496 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.402 ' HB2' ' HB3' ' A' ' 35' ' ' SER . 0.2 OUTLIER -104.43 129.17 52.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.816 0.341 . . . . 74.44 110.901 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.97 118.15 10.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 60.54 110.93 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -92.04 122.55 34.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 73.05 110.892 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -125.6 131.12 52.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 74.05 111.111 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.4 t -131.69 139.64 49.1 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.202 -0.454 . . . . 73.31 110.839 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.4 t -145.73 126.59 14.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.144 -0.48 . . . . 72.13 110.829 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -146.31 147.71 18.86 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.739 -0.743 . . . . 73.04 112.518 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.24 135.78 37.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.857 0.36 . . . . 44.22 110.846 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.874 ' HB2' HG13 ' A' ' 54' ' ' VAL . . . -149.16 130.56 14.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.129 -0.487 . . . . 71.04 111.11 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 64.3 t-20 -96.63 126.0 41.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.242 -0.436 . . . . 54.44 110.872 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 91.9 m -75.59 -50.1 16.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 54.35 111.104 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -56.7 -49.23 75.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 71.22 110.851 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -108.84 124.53 50.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 71.52 111.182 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.41 ' O ' HG23 ' A' ' 52' ' ' THR . 1.9 t -54.37 104.63 0.11 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.209 -0.451 . . . . 74.43 111.168 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 30.9 tttp -174.03 99.32 0.1 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 63.32 110.896 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.874 HG13 ' HB2' ' A' ' 47' ' ' ALA . 31.7 t -120.51 124.75 73.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.195 -0.457 . . . . 61.34 111.117 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.4 p -135.57 129.72 33.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 71.02 111.122 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -129.37 137.93 9.91 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.761 -0.733 . . . . 54.14 112.532 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.3 p -141.49 160.32 40.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.892 0.377 . . . . 64.34 110.868 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.3 tp -128.38 149.97 50.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.101 -0.5 . . . . 71.52 110.877 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -135.73 131.19 35.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 71.13 110.893 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.07 118.38 36.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 64.4 111.12 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 5.2 ttmt -112.18 147.91 35.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 74.43 110.855 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -131.75 133.41 44.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 74.1 110.948 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.453 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 25.5 ttm180 -135.23 106.71 6.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.13 -0.487 . . . . 64.31 110.903 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 58.0 t-105 -114.56 138.74 50.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.202 -0.453 . . . . 73.14 110.9 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.3 m 66.19 119.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.281 -0.418 . . . . 64.43 111.17 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -50.59 105.38 0.1 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.438 . . . . 73.13 110.919 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 64.61 48.85 2.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.148 -0.478 . . . . 72.24 110.913 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.659 ' O ' HD22 ' A' ' 69' ' ' LEU . . . -122.29 -74.41 0.32 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.741 -0.742 . . . . 62.02 112.52 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.659 HD22 ' O ' ' A' ' 68' ' ' GLY . 4.1 mm? -134.23 129.43 35.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.872 0.367 . . . . 73.13 110.935 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.2 m -138.6 112.61 8.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 72.21 111.169 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -123.59 124.36 42.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 75.32 110.88 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.44 ' HA ' ' HA ' ' A' ' 61' ' ' LYS . 5.1 t -129.38 137.68 51.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 74.04 111.14 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.555 ' CD ' HD23 ' A' ' 81' ' ' LEU . 37.8 tt0 -124.02 123.23 39.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 74.51 110.843 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 22.3 mtpp -89.82 142.17 27.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.105 -0.498 . . . . 72.44 110.913 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 7.3 t90 -134.58 128.82 33.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.227 -0.442 . . . . 73.41 110.894 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -117.72 155.13 30.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 71.44 110.875 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 9.4 t -61.37 -17.53 54.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 61.05 111.16 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.415 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 48.5 m-20 -74.11 0.35 14.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 61.21 110.87 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.415 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 3.5 m120 77.34 35.67 0.33 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 73.4 110.9 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.8 m -114.45 128.57 56.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 55.51 111.167 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.555 HD23 ' CD ' ' A' ' 73' ' ' GLU . 0.3 OUTLIER -120.19 139.59 52.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.227 -0.442 . . . . 73.11 110.904 179.98 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -137.92 98.6 0.27 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.75 -0.738 . . . . 73.22 112.495 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.1 m -84.76 142.02 30.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.768 0.318 . . . . 61.14 111.161 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -146.47 115.25 6.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 71.31 110.853 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -112.7 136.48 48.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 70.34 111.147 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.61 HG22 ' HB ' ' A' ' 98' ' ' THR . 20.5 p -128.99 124.09 34.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 44.42 111.177 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.5 p -114.91 137.24 49.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 52.14 111.132 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -103.83 119.81 39.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 73.52 110.887 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -60.51 130.32 45.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 72.55 110.878 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -83.14 -57.8 3.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 61.13 110.885 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 36.0 mt -63.28 -54.28 39.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 71.2 110.876 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -85.58 75.35 10.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.453 . . . . 44.12 111.092 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 12.2 tpp85 -51.37 134.59 28.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 71.44 110.885 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 100.61 -23.41 35.87 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.718 -0.753 . . . . 52.12 112.475 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.805 HD22 ' HB3' ' A' ' 118' ' ' TYR . 0.1 OUTLIER -79.62 114.94 18.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.915 0.388 . . . . 72.25 110.946 -179.95 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.62 ' O ' HD13 ' A' ' 97' ' ' LEU . 3.8 ttpm? -121.29 130.0 53.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 74.54 110.934 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.62 HD13 ' O ' ' A' ' 96' ' ' LYS . 0.9 OUTLIER -121.71 127.06 50.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.259 -0.428 . . . . 75.02 110.89 179.951 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.61 ' HB ' HG22 ' A' ' 86' ' ' THR . 17.4 p -129.92 121.09 25.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.201 -0.454 . . . . 64.53 111.151 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -110.22 129.24 55.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 73.14 110.825 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -112.25 142.16 45.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.099 -0.5 . . . . 72.21 110.883 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.3 t -142.06 124.54 15.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 74.11 110.819 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.8 t -96.09 123.82 39.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 71.15 110.854 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -118.78 132.9 56.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.157 -0.474 . . . . 75.11 110.909 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -128.69 101.83 20.38 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.718 0.77 . . . . 75.21 110.817 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -33.16 17.1 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.685 2.257 . . . . 74.33 112.373 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -79.87 -69.73 0.57 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 55.12 110.911 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.4 -45.07 92.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.456 . . . . 70.51 111.14 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.37 24.34 14.51 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.757 -0.735 . . . . 52.43 112.49 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.92 148.05 22.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.871 0.367 . . . . 74.54 110.86 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -134.47 126.69 29.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 62.51 110.884 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -121.35 136.31 54.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 75.3 110.931 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -125.56 120.19 30.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.445 . . . . 65.22 111.125 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -138.39 138.62 38.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 75.32 110.899 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.433 HD12 ' H ' ' A' ' 115' ' ' LYS . 5.4 tp -122.57 137.43 56.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.235 -0.439 . . . . 61.22 111.151 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.433 ' H ' HD12 ' A' ' 114' ' ' ILE . 1.9 mtpp -128.58 121.38 28.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.172 -0.467 . . . . 73.23 110.911 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.408 HG22 HD12 ' A' ' 97' ' ' LEU . 62.6 p -128.26 121.47 29.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 65.4 111.109 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -150.03 163.31 29.41 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.702 -0.761 . . . . 54.13 112.47 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.805 ' HB3' HD22 ' A' ' 95' ' ' LEU . 7.6 p90 -133.05 143.81 49.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.942 0.401 . . . . 63.44 110.926 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.492 ' O ' HG11 ' A' ' 3' ' ' VAL . 9.0 mtmt -111.86 120.83 43.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 72.3 110.902 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 28.2 ttm180 -108.37 144.46 35.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 72.12 110.881 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.641 ' N ' HG22 ' A' ' 3' ' ' VAL . 36.8 tt0 -51.18 -29.28 13.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.219 -0.446 . . . . 74.44 110.851 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 37.1 m80 -86.54 -42.54 13.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 74.24 110.862 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 2.2 pp -150.09 153.62 10.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.238 -0.437 . . . . 44.33 111.137 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -124.68 116.25 22.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.466 . . . . 61.33 110.867 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.535 ' HB2' ' HG ' ' A' ' 142' ' ' LEU . 0.4 OUTLIER -133.51 145.17 49.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.197 -0.456 . . . . 74.33 110.913 179.96 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -146.33 136.0 6.08 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.739 -0.744 . . . . 72.43 112.476 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 44.8 t -103.91 133.97 47.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.837 0.351 . . . . 54.02 110.882 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -125.67 142.13 51.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.474 . . . . 75.32 110.872 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 47.7 ttm -137.89 134.44 35.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 73.12 110.898 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -124.9 122.58 37.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 75.12 110.876 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -94.45 123.15 37.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 65.35 110.881 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -115.12 179.68 3.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 52.43 110.857 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.53 ' H ' HD12 ' A' ' 133' ' ' ILE . 3.1 mp -93.29 -42.23 13.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.181 -0.463 . . . . 75.11 111.114 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -80.98 -20.09 42.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 44.42 111.125 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.641 ' HA3' ' HB2' ' A' ' 160' ' ' ALA . . . 164.23 114.12 0.3 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.751 -0.738 . . . . 53.1 112.509 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 144.75 54.9 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.704 2.269 . . . . 75.23 112.322 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.6 m -126.54 151.62 47.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 74.3 110.868 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 4.6 mp -121.36 126.41 74.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 71.41 111.116 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -121.71 121.95 38.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 72.13 110.855 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -121.86 141.59 14.52 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.779 -0.724 . . . . 65.44 112.52 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -126.75 116.21 20.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.819 0.343 . . . . 61.3 111.107 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.738 HD13 ' OH ' ' A' ' 153' ' ' TYR . 0.3 OUTLIER -119.76 122.1 40.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 75.11 110.895 -179.963 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.448 ' N ' HD23 ' A' ' 142' ' ' LEU . 1.5 m -132.61 140.84 46.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 63.14 111.172 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 6.3 mp -116.42 138.84 51.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.22 -0.445 . . . . 73.33 110.93 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -91.71 133.23 11.66 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.745 -0.741 . . . . 75.12 112.48 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.402 ' O ' ' N ' ' A' ' 148' ' ' GLY . 3.2 m-85 -128.74 146.8 50.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.823 0.344 . . . . 70.53 110.96 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -49.4 93.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.111 -0.495 . . . . 73.01 110.889 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 146' ' ' TYR . . . 87.26 -23.59 11.37 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.776 -0.726 . . . . 72.53 112.448 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 7.8 m0 -105.67 145.95 30.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.801 0.334 . . . . 71.43 110.942 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.649 HD21 HG22 ' A' ' 6' ' ' THR . 0.0 OUTLIER -126.77 137.13 53.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.243 -0.435 . . . . 74.23 110.919 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -129.26 134.07 47.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.455 . . . . 75.03 111.054 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.412 ' HA2' ' HA ' ' A' ' 143' ' ' VAL . . . -152.92 133.03 3.87 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.701 -0.762 . . . . 32.11 112.514 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.738 ' OH ' HD13 ' A' ' 142' ' ' LEU . 8.4 p90 -144.16 119.34 10.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.909 0.385 . . . . 75.23 110.921 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -110.58 123.62 50.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.075 -0.511 . . . . 64.22 110.935 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 2.4 ttt -120.39 128.72 53.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.44 . . . . 73.54 110.878 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.499 ' O ' ' HB ' ' A' ' 164' ' ' VAL . 20.0 m-20 -112.82 116.79 30.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.444 . . . . 72.53 110.867 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.544 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 60.4 m-85 -89.88 131.98 35.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.165 -0.471 . . . . 65.24 110.87 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -91.3 104.31 16.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 71.23 110.901 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.77 -47.9 73.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.134 -0.485 . . . . 61.14 111.118 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.641 ' HB2' ' HA3' ' A' ' 135' ' ' GLY . . . -49.65 -26.14 3.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 73.34 111.126 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.2 -166.85 1.36 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 65.32 110.853 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 68.1 m -112.97 39.18 2.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 63.33 110.829 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -165.06 177.19 7.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.116 -0.493 . . . . 55.31 110.832 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.544 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 1.0 OUTLIER -75.46 144.11 12.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.181 -0.463 . . . . 61.24 111.101 179.993 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 12.9 t -88.74 -32.64 17.82 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.149 -0.478 . . . . 72.12 111.165 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 3.9 tp60 -151.45 134.69 16.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 75.13 110.93 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 11.3 p -124.1 107.07 10.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 42.43 110.868 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 28.9 m-20 -110.74 148.47 32.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.115 -0.493 . . . . 64.24 110.897 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.438 ' CE1' HG23 ' A' ' 171' ' ' VAL . 8.0 t80 -154.8 140.57 18.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 71.15 110.914 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -154.38 135.01 13.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.13 -0.487 . . . . 74.41 111.094 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.438 HG23 ' CE1' ' A' ' 169' ' ' PHE . 48.5 t -144.15 133.42 19.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 72.04 111.159 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -111.6 122.25 6.0 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.775 -0.726 . . . . 70.12 112.496 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . 0.604 ' HB2' HD12 ' A' ' 180' ' ' LEU . 0.1 OUTLIER -113.65 131.06 56.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.934 0.397 . . . . 61.43 110.953 -179.829 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 2.6 mtpm? -102.95 127.2 50.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.476 . . . . 65.35 110.888 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.406 ' O ' ' C ' ' A' ' 176' ' ' ASP . 0.2 OUTLIER -111.78 166.39 11.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.219 -0.446 . . . . 75.42 111.111 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.406 ' C ' ' O ' ' A' ' 175' ' ' THR . 2.8 m-20 -37.89 -76.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 75.01 110.896 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -117.32 16.51 14.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.179 -0.464 . . . . 72.45 110.932 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -130.79 150.68 51.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.132 -0.485 . . . . 64.13 110.862 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 37.2 mm-40 -116.09 123.1 47.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.124 -0.489 . . . . 73.15 110.895 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.604 HD12 ' HB2' ' A' ' 173' ' ' TYR . 3.4 tm? -107.15 125.58 51.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.164 -0.471 . . . . 63.31 110.89 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 22.6 m80 -130.63 130.41 43.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 75.2 110.836 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 1.2 t -128.9 111.49 13.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 74.53 111.172 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -120.55 139.65 52.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.236 -0.438 . . . . 63.11 110.908 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.443 HG12 ' O ' ' A' ' 184' ' ' VAL . 2.5 t -133.33 110.29 14.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 72.14 111.111 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -100.79 89.51 3.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 74.11 110.872 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 67.47 -179.75 0.22 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 71.52 110.882 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -75.19 -2.95 68.12 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.775 -0.726 . . . . 65.22 112.477 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 15.6 p -97.53 -25.49 15.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.769 0.319 . . . . 70.22 111.126 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.27 113.48 20.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 75.41 110.905 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' PHE . . . . . 0.412 ' HA ' HG22 ' A' ' 184' ' ' VAL . 0.4 OUTLIER -139.76 123.03 17.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 70.2 110.857 -179.909 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 171.46 -141.43 6.41 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.747 -0.74 . . . . 63.11 112.519 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 167.24 -167.4 39.83 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.699 -0.763 . . . . 62.42 112.445 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . 0.486 ' HA ' ' O ' ' A' ' 206' ' ' VAL . 70.3 m -127.5 144.42 51.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.813 0.339 . . . . 72.32 110.875 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.423 ' O ' HG22 ' A' ' 206' ' ' VAL . 0.0 OUTLIER -142.03 118.33 6.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.168 -0.469 . . . . 65.24 111.121 179.986 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . 0.802 ' CB ' ' HA ' ' A' ' 205' ' ' ALA . 0.1 OUTLIER 178.66 -175.21 0.19 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 62.44 110.892 -179.989 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 16.8 tm0? -123.51 128.54 49.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.091 -0.504 . . . . 64.53 110.894 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 3.4 pttp -114.65 113.97 25.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 71.23 110.903 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.662 HG21 HD12 ' A' ' 202' ' ' LEU . 5.2 t -86.47 143.85 10.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.237 -0.438 . . . . 73.23 111.133 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -93.06 32.53 1.28 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 70.44 110.894 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 10.3 mmtt -127.59 35.03 4.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 73.22 110.917 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 2.2 mttp 72.7 51.11 0.16 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 75.12 110.904 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.662 HD12 HG21 ' A' ' 198' ' ' VAL . 0.3 OUTLIER -177.47 82.49 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 73.22 110.938 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -128.17 133.2 48.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.461 . . . . 74.43 110.866 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . 0.598 ' O ' ' HB3' ' A' ' 195' ' ' TYR . 11.0 t -132.45 136.91 47.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.467 . . . . 75.12 111.158 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.802 ' HA ' ' CB ' ' A' ' 195' ' ' TYR . . . -141.47 136.68 31.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 70.32 111.083 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.907 HG12 HG22 ' A' ' 221' ' ' ILE . 1.1 m -103.9 139.51 24.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.44 . . . . 63.25 111.074 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -114.35 132.7 56.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.46 . . . . 71.33 110.897 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.529 HD21 ' CD2' ' A' ' 219' ' ' PHE . 4.6 mp -126.11 138.17 53.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.167 -0.47 . . . . 74.25 110.935 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.716 ' HB3' ' CD ' ' A' ' 218' ' ' ARG . . . -129.61 139.96 51.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 62.53 111.129 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 2.4 t-105 -130.27 130.32 44.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 71.41 110.944 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.07 109.44 22.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.253 -0.43 . . . . 71.53 111.116 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -51.62 134.81 29.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.448 . . . . 61.55 111.156 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 120.4 33.91 0.99 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.705 -0.76 . . . . 63.13 112.447 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 49.5 t30 59.66 43.34 15.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.822 0.344 . . . . 71.14 110.898 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 14.0 m -90.99 -169.72 2.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 72.32 110.872 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -102.55 137.1 41.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.462 . . . . 41.45 110.913 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . 0.426 HG23 ' CE1' ' A' ' 219' ' ' PHE . 3.9 t -79.12 139.5 38.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.47 . . . . 65.44 111.153 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . 0.716 ' CD ' ' HB3' ' A' ' 209' ' ' ALA . 17.3 ptp180 -110.84 133.29 53.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 64.35 110.886 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . 0.529 ' CD2' HD21 ' A' ' 208' ' ' LEU . 11.1 m-85 -114.37 138.35 50.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.25 -0.432 . . . . 75.44 110.859 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -140.65 144.52 14.87 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.713 -0.755 . . . . 65.42 112.467 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.907 HG22 HG12 ' A' ' 206' ' ' VAL . 0.0 OUTLIER -130.93 130.73 64.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.841 0.353 . . . . 62.2 111.129 -179.998 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -133.74 131.64 39.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 41.55 111.104 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -125.22 146.06 49.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.254 -0.43 . . . . 75.32 111.093 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 3.5 mtmp? -129.1 123.55 32.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 71.01 110.908 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -132.29 133.16 43.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.212 -0.449 . . . . 74.42 110.963 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -85.6 128.78 34.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.475 . . . . 70.3 110.901 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 44.5 mm -74.16 -55.55 11.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 74.24 111.111 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . 0.545 ' N ' ' HD2' ' A' ' 229' ' ' PRO . 0.1 OUTLIER 175.13 -57.35 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.599 0.714 . . . . 74.24 110.826 179.867 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.545 ' HD2' ' N ' ' A' ' 228' ' ' ASP . 53.4 Cg_endo -69.75 -156.6 0.04 OUTLIER 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.655 2.237 . . . . 72.43 112.368 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.6 15.69 4.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 64.33 110.839 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.454 ' HB2' ' HG3' ' A' ' 249' ' ' GLN . . . -120.63 121.92 39.38 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.22 -0.445 . . . . 62.14 111.118 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 36.7 m -108.7 143.99 37.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 41.55 110.889 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -105.3 127.88 53.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 71.41 110.877 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 15.2 m -127.09 137.49 53.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.134 -0.484 . . . . 64.15 110.842 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -121.3 143.17 49.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.158 -0.474 . . . . 62.11 111.083 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.76 141.87 31.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 64.31 110.894 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 242' ' ' LEU . 5.3 p -140.25 144.73 27.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 55.13 111.117 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -108.16 148.31 30.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 73.42 110.896 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -56.11 -19.52 13.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 74.01 110.869 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 37.3 t -81.15 25.48 0.48 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.474 . . . . 64.05 110.856 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 2.3 t 61.89 35.73 16.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 72.41 110.851 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . 0.447 ' O ' HG23 ' A' ' 237' ' ' VAL . 4.6 mp -99.03 117.89 34.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.138 -0.483 . . . . 63.2 110.963 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.458 HD13 ' H ' ' A' ' 243' ' ' ILE . 0.1 OUTLIER -104.84 119.0 53.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.207 -0.451 . . . . 75.15 111.181 179.831 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . 0.519 ' C ' HD13 ' A' ' 245' ' ' LEU . . . -138.04 160.67 25.43 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.749 -0.739 . . . . 72.23 112.498 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.85 HD21 ' HB3' ' A' ' 261' ' ' ALA . 0.0 OUTLIER -145.16 160.04 42.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.858 0.361 . . . . 64.52 110.872 -179.917 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -149.09 121.77 1.36 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.77 -0.729 . . . . 72.42 112.508 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -109.3 115.89 30.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.976 0.417 . . . . 72.34 110.931 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.413 HG23 ' O ' ' A' ' 248' ' ' THR . 3.5 t -101.8 115.05 29.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.131 -0.486 . . . . 71.53 111.153 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . 0.454 ' HG3' ' HB2' ' A' ' 231' ' ' ALA . 59.1 tt0 -119.71 130.01 54.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 73.5 110.87 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 7.3 p -121.39 117.92 28.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.136 -0.483 . . . . 65.51 111.115 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 11.0 mt -113.42 101.2 9.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 73.2 110.974 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' LYS . . . . . 0.426 ' HB3' ' HD2' ' A' ' 253' ' ' PRO . 17.6 mttp 64.19 155.36 0.12 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.632 0.73 . . . . 73.25 110.835 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' PRO . . . . . 0.426 ' HD2' ' HB3' ' A' ' 252' ' ' LYS . 53.8 Cg_endo -69.74 73.68 1.34 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.706 2.271 . . . . 44.42 112.341 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 171.92 -29.7 0.11 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.727 -0.749 . . . . 71.52 112.442 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 55.5 mt -116.13 121.37 67.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.854 0.359 . . . . 74.5 111.131 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 32.3 ttmt -133.39 132.81 41.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 73.32 110.86 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 0.504 HD13 ' C ' ' A' ' 257' ' ' LEU . 3.3 tm? -118.44 125.06 49.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.175 -0.466 . . . . 73.22 110.931 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . 0.514 ' O ' HD22 ' A' ' 277' ' ' LEU . 93.6 m -115.72 111.74 21.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 73.22 111.167 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 1.029 HD22 HD23 ' A' ' 277' ' ' LEU . 0.1 OUTLIER -109.6 132.65 53.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.45 . . . . 70.43 110.923 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.415 ' H ' HD13 ' A' ' 259' ' ' LEU . 16.5 t -145.95 153.37 40.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 74.24 110.889 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 261' ' ' ALA . . . . . 0.85 ' HB3' HD21 ' A' ' 245' ' ' LEU . . . -158.12 130.87 7.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 64.05 111.102 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.73 ' C ' HD13 ' A' ' 263' ' ' LEU . 3.3 tm? -125.8 124.45 40.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.459 . . . . 74.32 110.911 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . 0.835 ' HB3' HG11 ' A' ' 268' ' ' VAL . 0.2 OUTLIER -121.01 110.31 16.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 74.23 110.907 179.905 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . 0.527 ' O ' HG22 ' A' ' 268' ' ' VAL . 1.8 m-20 -79.11 113.88 17.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.198 -0.456 . . . . 74.45 110.871 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -58.9 -17.0 34.07 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.785 -0.722 . . . . 40.41 112.457 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 45.4 tttt -90.84 -3.2 57.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.822 0.344 . . . . 63.3 110.913 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -127.55 -52.82 1.36 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 64.12 110.919 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . 0.835 HG11 ' HB3' ' A' ' 263' ' ' LEU . 17.1 m -51.19 -29.37 8.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 64.41 111.123 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -52.24 -40.39 61.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 74.2 110.918 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -104.91 -17.45 14.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.131 -0.486 . . . . 75.22 111.108 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 129.71 94.8 0.74 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.712 -0.756 . . . . 74.22 112.515 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -179.74 74.94 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.73 -0.748 . . . . 62.15 112.474 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 273' ' ' HIS . . . . . 0.419 ' HB2' HD12 ' A' ' 263' ' ' LEU . 32.6 p-80 -108.14 145.96 33.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.851 0.357 . . . . 62.43 110.855 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -127.12 138.73 53.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.185 -0.461 . . . . 73.54 110.925 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.65 HD12 ' HB2' ' A' ' 261' ' ' ALA . 1.5 tp -121.75 145.6 47.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.447 . . . . 74.02 110.879 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -123.63 108.25 1.16 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.724 -0.751 . . . . 70.24 112.459 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 1.029 HD23 HD22 ' A' ' 259' ' ' LEU . 3.2 tm? -114.43 141.4 47.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.858 0.361 . . . . 63.23 110.921 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . 0.659 ' N ' HD13 ' A' ' 277' ' ' LEU . . . -148.84 132.59 4.17 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.772 -0.727 . . . . 75.11 112.482 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.505 HD11 HD11 ' A' ' 277' ' ' LEU . 1.2 mm? -109.36 133.63 52.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.766 0.317 . . . . 74.41 110.881 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -124.06 112.62 17.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 71.21 110.88 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -117.93 134.1 55.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.1 -0.5 . . . . 74.42 110.85 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . 0.676 ' HG2' HD13 ' A' ' 284' ' ' LEU . 11.0 tt0 -135.85 112.47 10.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.127 -0.488 . . . . 73.12 110.913 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.732 ' O ' HD12 ' A' ' 284' ' ' LEU . . . -96.05 113.36 24.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 74.24 111.071 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.732 HD12 ' O ' ' A' ' 283' ' ' ALA . 6.1 mp -140.52 177.05 8.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.257 -0.429 . . . . 74.12 110.919 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 75.44 110.864 179.917 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.865 0.364 . . . . 73.31 111.127 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.478 HG13 ' HG3' ' A' ' 119' ' ' LYS . 0.2 OUTLIER -145.16 108.86 4.6 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.637 0.732 . . . . 72.3 111.155 179.955 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 170.73 15.85 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.648 2.232 . . . . 71.24 112.377 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 83.54 0.7 Allowed 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.695 2.263 . . . . 62.13 112.334 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 46.2 p -70.27 -48.94 54.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.212 -0.449 . . . . 75.12 111.157 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.486 ' CB ' HG11 ' A' ' 143' ' ' VAL . 7.7 p90 -51.13 -33.81 28.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.237 -0.438 . . . . 71.11 110.896 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -83.44 -28.32 28.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 73.43 111.132 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -90.32 11.61 20.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.211 -0.45 . . . . 74.11 110.823 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 25.1 mt -59.88 -29.76 68.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 71.24 110.928 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 159.4 59.01 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.703 -0.76 . . . . 65.14 112.469 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 12.7 mmtm -67.16 -53.84 26.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.751 0.31 . . . . 73.44 110.874 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.4 t -56.87 -48.06 78.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.27 -0.423 . . . . 65.42 110.906 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.23 -36.77 76.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.092 -0.504 . . . . 43.23 111.104 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.89 -30.57 67.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 74.24 110.864 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -56.44 -48.94 75.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 63.32 110.857 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 79.5 t -62.53 -26.59 40.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 74.23 111.135 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -59.63 -41.11 89.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 64.41 110.865 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.08 -66.64 0.7 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 53.25 111.138 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.1 tppm? -47.28 104.73 0.06 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 74.02 110.902 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 158.93 38.83 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.755 -0.736 . . . . 72.41 112.492 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.431 ' HB3' HD13 ' A' ' 262' ' ' LEU . 18.5 p90 -165.56 140.08 4.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.955 0.407 . . . . 72.14 110.897 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -62.65 129.83 42.48 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.734 -0.746 . . . . 73.45 112.489 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -103.1 -3.51 25.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.879 0.371 . . . . 74.14 110.849 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.78 14.02 78.32 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.721 -0.752 . . . . 45.35 112.509 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.514 ' O ' HD12 ' A' ' 27' ' ' ILE . 0.6 OUTLIER -127.77 171.94 11.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.804 0.335 . . . . 62.15 110.899 -179.924 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.538 HG13 HD12 ' A' ' 277' ' ' LEU . 1.3 mp -118.35 121.49 67.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 73.23 111.108 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 37.0 tttp -111.42 117.37 32.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 75.33 110.902 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.488 HD12 ' HB2' ' A' ' 279' ' ' LEU . 1.1 tt -115.16 141.06 48.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 52.11 110.951 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -147.88 129.98 15.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.178 -0.465 . . . . 71.45 110.838 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.514 HD23 ' N ' ' A' ' 32' ' ' LYS . 7.3 tt -126.93 133.38 50.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 73.13 110.876 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.514 ' N ' HD23 ' A' ' 31' ' ' LEU . 7.4 mtmp? -127.23 127.02 43.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 73.22 110.892 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.771 HG23 ' HB3' ' A' ' 283' ' ' ALA . 6.7 m -130.1 141.03 50.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.24 -0.436 . . . . 74.31 111.169 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.88 156.27 20.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.464 . . . . 73.53 110.882 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.517 ' O ' ' C ' ' A' ' 36' ' ' GLU . 0.6 OUTLIER -133.89 174.35 10.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 72.14 110.847 -179.904 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.517 ' C ' ' O ' ' A' ' 35' ' ' SER . 39.9 mm-40 -27.46 -75.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.095 -0.502 . . . . 72.55 110.876 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -166.82 140.39 3.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.115 -0.493 . . . . 74.44 110.879 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.487 ' HA2' ' O ' ' A' ' 63' ' ' ARG . . . 83.54 -12.69 50.71 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.798 -0.715 . . . . 65.12 112.518 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -105.02 130.07 53.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.787 0.327 . . . . 75.31 110.923 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -140.33 118.48 11.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.23 -0.441 . . . . 55.25 110.882 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -98.34 121.55 40.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 73.14 110.869 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 27.6 m -126.06 123.82 39.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.163 -0.471 . . . . 74.41 111.166 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.4 t -125.1 132.39 53.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.264 -0.425 . . . . 54.44 110.875 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 6.0 p -150.04 126.57 10.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.115 -0.493 . . . . 54.12 110.853 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -155.05 167.36 32.78 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.735 -0.745 . . . . 71.13 112.461 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 17.9 m -127.66 156.45 42.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.9 0.381 . . . . 54.33 110.878 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.495 ' O ' HD13 ' A' ' 26' ' ' LEU . . . -142.84 131.33 22.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 71.25 111.103 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 61.5 t-20 -101.65 123.54 45.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 72.43 110.865 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 60.4 m -88.51 -55.35 3.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.169 -0.469 . . . . 75.43 111.122 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -51.12 -36.4 40.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 72.14 110.875 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.14 155.54 50.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 34.22 111.125 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.0 m -71.09 86.99 0.76 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 70.45 111.167 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.2 tptp -152.68 80.91 1.22 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.233 -0.439 . . . . 63.31 110.901 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.415 ' HA ' ' HA ' ' A' ' 47' ' ' ALA . 1.3 p -127.96 123.21 60.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 75.41 111.159 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.0 p -136.6 132.85 35.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 73.41 111.158 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -107.18 136.56 13.46 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.756 -0.735 . . . . 52.23 112.475 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -114.26 144.97 42.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.895 0.379 . . . . 50.21 110.874 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.652 HD13 ' N ' ' A' ' 59' ' ' GLU . 0.8 OUTLIER -121.48 132.82 54.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 75.53 110.927 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.652 ' N ' HD13 ' A' ' 58' ' ' LEU . 1.4 pt-20 -133.46 136.96 45.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 75.15 110.904 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 4.9 m -114.79 140.15 49.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 64.4 111.131 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -135.71 157.44 46.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 71.31 110.885 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.439 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 16.2 m-85 -129.26 140.86 51.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.218 -0.447 . . . . 63.14 110.939 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.487 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 43.6 ttm-85 -127.12 104.51 8.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.11 -0.495 . . . . 74.51 110.863 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 66.0 m95 -114.2 123.84 50.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 63.51 110.9 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.5 m 67.3 125.39 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.216 -0.447 . . . . 74.32 111.126 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -51.3 103.95 0.07 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.46 . . . . 63.31 110.911 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 63.64 58.51 1.29 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.459 . . . . 71.42 110.935 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.631 ' O ' HD22 ' A' ' 69' ' ' LEU . . . -133.64 -77.81 0.12 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.762 -0.732 . . . . 64.51 112.455 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.631 HD22 ' O ' ' A' ' 68' ' ' GLY . 4.0 mm? -133.99 130.35 37.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.881 0.372 . . . . 72.12 110.936 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.639 HG23 ' OG1' ' A' ' 86' ' ' THR . 0.0 OUTLIER -137.57 137.42 38.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 61.53 111.141 179.93 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -95.79 133.84 39.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 64.45 110.92 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.5 m -112.67 117.23 31.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.167 -0.469 . . . . 74.12 111.136 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.417 ' CB ' HG23 ' A' ' 83' ' ' THR . 0.1 OUTLIER -134.49 134.06 41.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.455 . . . . 62.5 110.9 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 53.5 tttt -145.26 132.85 20.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 72.31 110.893 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 9.6 t90 -135.48 128.91 32.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.439 . . . . 72.54 110.928 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 10.5 m-20 -117.14 150.99 37.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 53.54 110.904 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.7 m -68.21 -12.29 60.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 73.01 111.122 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.489 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 38.8 t70 -74.65 0.17 15.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.227 -0.442 . . . . 63.0 110.893 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.489 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 5.7 t-20 83.55 34.47 0.05 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 75.32 110.865 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 12.7 p -114.77 123.04 48.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 62.22 111.162 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -109.38 136.98 47.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.449 . . . . 51.24 110.908 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -149.33 89.34 0.14 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.666 -0.778 . . . . 41.53 112.452 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.417 HG23 ' CB ' ' A' ' 73' ' ' GLU . 3.8 m -127.45 160.95 29.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.741 0.305 . . . . 74.04 111.167 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.622 ' HB3' ' O ' ' A' ' 99' ' ' PHE . 0.6 OUTLIER 169.22 -163.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 61.1 110.882 -179.99 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.532 HD11 HD12 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -135.33 142.96 38.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 63.04 111.111 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.639 ' OG1' HG23 ' A' ' 70' ' ' THR . 33.7 p -128.88 126.34 39.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.146 -0.479 . . . . 74.21 111.157 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 9.0 p -110.67 137.13 44.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 74.54 111.127 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -125.26 118.51 26.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 64.31 110.937 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 52.14 90.39 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 73.52 110.857 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.425 ' HG3' HD21 ' A' ' 69' ' ' LEU . 2.3 mm-40 -138.66 -75.13 0.38 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 73.35 110.932 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 30.1 tp -62.39 -36.12 81.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 73.35 110.938 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -143.29 125.72 15.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 63.24 111.069 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.11 124.8 13.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 73.41 110.872 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 97.64 -23.98 33.59 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.76 -0.733 . . . . 65.02 112.548 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.685 HD22 ' HB3' ' A' ' 118' ' ' TYR . 0.2 OUTLIER -79.99 124.28 28.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.834 0.349 . . . . 73.23 110.884 -179.91 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.739 ' O ' HD13 ' A' ' 97' ' ' LEU . 3.2 pttp -121.86 123.31 41.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.219 -0.446 . . . . 73.34 110.932 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.739 HD13 ' O ' ' A' ' 96' ' ' LYS . 0.7 OUTLIER -125.53 124.85 42.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.23 -0.441 . . . . 64.12 110.967 179.899 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 12.2 p -124.84 119.6 29.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 73.22 111.143 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.622 ' O ' ' HB3' ' A' ' 84' ' ' GLU . 0.3 OUTLIER -109.83 117.73 34.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 72.44 110.86 -179.968 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.556 ' HA ' ' CB ' ' A' ' 84' ' ' GLU . 6.7 t70 -115.71 144.6 43.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 74.12 110.88 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.404 ' CB ' ' HG2' ' A' ' 84' ' ' GLU . 10.5 t -140.1 133.2 29.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 72.15 110.866 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -120.67 149.51 42.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.484 . . . . 61.43 110.861 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -127.95 137.96 52.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 73.52 110.888 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.404 ' HA ' ' HD2' ' A' ' 105' ' ' PRO . 99.6 p -128.63 101.52 20.8 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.707 0.765 . . . . 64.22 110.841 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 104' ' ' SER . 54.3 Cg_endo -69.66 -31.22 21.38 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.705 2.27 . . . . 74.41 112.4 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -50.27 -68.24 0.19 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 45.3 110.885 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.1 p -86.05 -33.45 21.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.481 . . . . 64.13 111.175 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.39 23.57 16.28 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.723 -0.751 . . . . 62.51 112.485 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 46.3 mtpt -94.31 148.09 22.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.821 0.343 . . . . 60.41 110.926 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.15 144.42 31.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 75.45 110.914 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -120.7 128.59 53.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.269 -0.423 . . . . 74.54 110.851 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -133.35 124.82 27.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 52.24 111.088 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -134.77 138.37 44.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.223 -0.444 . . . . 72.41 110.864 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.579 HD13 ' H ' ' A' ' 115' ' ' LYS . 0.4 OUTLIER -134.43 136.53 52.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.248 -0.433 . . . . 71.35 111.111 179.893 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.579 ' H ' HD13 ' A' ' 114' ' ' ILE . 10.9 mtmt -126.29 121.59 33.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 75.32 110.883 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.681 HG23 ' CD1' ' A' ' 97' ' ' LEU . 99.6 m -125.22 121.44 34.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 74.4 111.103 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -152.69 163.06 30.26 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.738 -0.744 . . . . 72.33 112.511 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.685 ' HB3' HD22 ' A' ' 95' ' ' LEU . 0.3 OUTLIER -132.49 145.22 51.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.982 0.42 . . . . 74.53 110.915 -179.838 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.478 ' HG3' HG13 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -109.06 123.47 49.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.094 -0.503 . . . . 43.34 110.905 179.93 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.417 ' HB2' HG22 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -104.54 147.36 27.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.245 -0.434 . . . . 73.1 110.892 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.434 ' HA ' ' HB ' ' A' ' 3' ' ' VAL . 85.0 tt0 -54.64 -30.95 56.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 75.33 110.873 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 54.2 p-80 -125.95 11.13 7.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 74.23 110.864 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.817 HD11 HD23 ' A' ' 144' ' ' LEU . 1.0 OUTLIER -147.63 150.19 14.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.24 -0.437 . . . . 64.33 111.169 179.974 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.636 ' HB3' HG13 ' A' ' 143' ' ' VAL . 5.9 t-20 -128.96 113.69 15.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 60.02 110.9 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.661 HD22 HD23 ' A' ' 142' ' ' LEU . 1.4 mm? -121.89 130.76 53.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 61.11 110.873 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -146.94 115.81 0.81 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.689 -0.767 . . . . 73.12 112.442 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -113.3 135.51 53.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.771 0.32 . . . . 65.22 110.876 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -132.91 117.22 17.43 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.184 -0.462 . . . . 61.02 110.852 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 3.3 tmm? -109.36 138.74 45.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 75.43 110.918 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -117.75 119.23 34.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.248 -0.433 . . . . 61.35 110.854 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -96.43 114.98 26.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 62.5 110.885 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -120.39 153.16 36.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 61.12 110.881 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.02 -29.5 14.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.216 -0.447 . . . . 71.33 111.117 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -84.48 -20.32 31.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 75.44 111.068 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 164.05 97.38 0.12 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.745 -0.74 . . . . 52.35 112.483 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 137.27 35.09 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.648 2.232 . . . . 73.04 112.348 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.07 153.65 46.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.189 -0.459 . . . . 70.25 110.832 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 5.2 mp -110.52 132.29 59.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 60.11 111.135 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 9.2 mtt-85 -119.79 138.72 53.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 75.1 110.862 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -131.95 145.18 16.95 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.761 -0.733 . . . . 74.42 112.508 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -139.23 116.47 11.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.842 0.353 . . . . 72.32 111.076 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.733 HD22 ' N ' ' A' ' 143' ' ' VAL . 0.6 OUTLIER -125.34 124.02 40.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 60.11 110.928 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.733 ' N ' HD22 ' A' ' 142' ' ' LEU . 0.1 OUTLIER -132.85 145.0 34.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 74.32 111.126 179.857 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.817 HD23 HD11 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -131.78 140.91 49.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.446 . . . . 44.25 110.921 179.947 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -123.4 117.79 3.32 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.722 -0.751 . . . . 75.15 112.463 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.435 ' O ' ' CD1' ' A' ' 149' ' ' TRP . 7.0 t80 -145.52 153.86 41.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.864 0.364 . . . . 73.14 110.921 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 52.58 23.72 2.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 74.54 110.861 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 89.93 -31.2 5.42 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.736 -0.745 . . . . 71.12 112.504 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.435 ' CD1' ' O ' ' A' ' 146' ' ' TYR . 50.5 p-90 -78.0 145.0 36.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.754 0.311 . . . . 73.34 110.923 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.533 HD23 ' O ' ' A' ' 144' ' ' LEU . 1.4 mt -124.21 144.4 49.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.249 -0.432 . . . . 54.03 110.906 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.504 ' HA ' HG13 ' A' ' 171' ' ' VAL . . . -142.97 125.89 16.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.15 -0.477 . . . . 72.51 111.086 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.737 ' O ' ' HB3' ' A' ' 169' ' ' PHE . . . -126.94 131.5 7.29 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.717 -0.754 . . . . 64.15 112.488 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.414 ' C ' ' HD1' ' A' ' 169' ' ' PHE . 5.5 t80 -133.2 120.28 20.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.841 0.353 . . . . 74.03 110.949 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.645 ' H ' ' HB2' ' A' ' 169' ' ' PHE . 0.5 OUTLIER -104.24 138.54 40.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.484 . . . . 70.3 110.915 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . 0.534 ' HB3' HG11 ' A' ' 164' ' ' VAL . 0.4 OUTLIER -122.73 146.76 47.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 52.14 110.849 179.955 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.41 ' O ' HG13 ' A' ' 164' ' ' VAL . 3.6 t30 -108.88 120.48 42.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.182 -0.463 . . . . 75.15 110.883 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -91.04 123.18 34.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 73.15 110.86 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.742 ' O ' ' O ' ' A' ' 161' ' ' LYS . 0.1 OUTLIER -78.19 137.64 38.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 70.31 110.881 -179.963 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.479 HG23 ' N ' ' A' ' 160' ' ' ALA . 5.4 t -69.05 -46.99 66.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.15 -0.477 . . . . 62.42 111.17 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.479 ' N ' HG23 ' A' ' 159' ' ' THR . . . -50.77 -25.87 4.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 75.41 111.111 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.742 ' O ' ' O ' ' A' ' 158' ' ' GLU . 33.2 mmtt -147.29 139.62 24.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 73.33 110.909 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 12.6 m -71.56 49.63 0.16 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 73.24 110.868 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -138.58 170.69 15.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.487 . . . . 75.11 110.889 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.534 HG11 ' HB3' ' A' ' 155' ' ' MET . 90.8 t -91.15 138.66 19.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.442 . . . . 62.13 111.107 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 96.1 m -94.65 -42.23 8.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.474 . . . . 65.31 111.125 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -160.1 142.2 13.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 61.01 110.922 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 6.8 p -127.12 125.94 42.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 72.21 110.865 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.441 ' CB ' ' HA ' ' A' ' 185' ' ' ASN . 5.8 p30 -139.7 152.3 46.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.102 -0.499 . . . . 53.03 110.906 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.737 ' HB3' ' O ' ' A' ' 152' ' ' GLY . 0.1 OUTLIER -178.55 -159.18 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 74.33 110.893 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -132.92 150.56 52.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 50.1 111.106 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.504 HG13 ' HA ' ' A' ' 151' ' ' ALA . 71.0 t -145.72 127.15 7.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.218 -0.446 . . . . 43.35 111.097 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -163.37 167.19 37.51 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.714 -0.755 . . . . 64.41 112.482 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 27.1 p90 -125.55 154.67 41.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.989 0.424 . . . . 44.13 110.9 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 38.8 mtpt -106.8 130.93 54.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.119 -0.491 . . . . 74.02 110.892 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.15 165.53 16.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 70.13 111.13 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -42.53 -71.74 0.08 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 72.24 110.915 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 26.5 mp0 -115.48 14.46 16.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 70.41 110.92 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -127.83 143.57 51.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.11 -0.496 . . . . 70.41 110.854 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . 0.401 ' HB3' ' HB2' ' A' ' 195' ' ' TYR . 5.7 mm-40 -136.81 130.96 32.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 72.34 110.882 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.507 HD13 ' C ' ' A' ' 180' ' ' LEU . 2.5 tm? -124.21 117.5 24.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.14 -0.482 . . . . 63.02 110.891 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 18.2 t-80 -135.07 118.43 16.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 74.54 110.892 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -130.74 127.83 39.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 75.53 111.162 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -119.36 141.01 49.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 72.23 110.922 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.538 ' HB ' ' HA ' ' A' ' 190' ' ' PHE . 1.3 m -133.07 141.19 45.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.457 . . . . 73.1 111.141 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.441 ' HA ' ' CB ' ' A' ' 168' ' ' ASN . 0.8 OUTLIER -105.13 89.2 3.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 71.32 110.884 179.999 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 74.41 -175.93 0.15 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.222 -0.444 . . . . 72.33 110.859 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -80.09 4.84 64.84 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.708 -0.758 . . . . 52.02 112.463 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 22.3 p -110.42 -22.19 11.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.755 0.312 . . . . 62.03 111.142 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . 0.401 ' HB3' ' CB ' ' A' ' 185' ' ' ASN . 1.9 tt0 -118.12 125.96 51.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 74.4 110.907 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' PHE . . . . . 0.538 ' HA ' ' HB ' ' A' ' 184' ' ' VAL . 32.2 t80 -137.4 125.1 22.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 75.1 110.822 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -136.46 141.95 13.06 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.724 -0.751 . . . . 60.32 112.473 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -133.46 145.19 17.25 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.696 -0.764 . . . . 71.34 112.442 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . 0.576 ' C ' HD12 ' A' ' 194' ' ' ILE . 3.3 t -139.31 152.63 47.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.893 0.378 . . . . 71.22 110.833 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.576 HD12 ' C ' ' A' ' 193' ' ' SER . 3.1 mp -127.43 130.56 70.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 75.43 111.106 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . 0.401 ' HB2' ' HB3' ' A' ' 179' ' ' GLN . 2.4 m-85 -108.66 123.11 48.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.171 -0.468 . . . . 74.5 110.897 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -124.78 112.45 16.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.122 -0.49 . . . . 64.42 110.877 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 33.6 mtpt -107.69 127.94 54.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 71.3 110.936 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.435 HG12 ' O ' ' A' ' 198' ' ' VAL . 3.2 t 66.45 22.21 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.253 -0.431 . . . . 44.13 111.164 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -92.54 -32.74 14.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 72.2 110.87 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 22.6 mtpp -154.28 66.13 0.7 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 63.0 110.924 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . 0.611 ' C ' HD22 ' A' ' 202' ' ' LEU . 24.8 mttm 68.55 112.92 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.44 . . . . 50.24 110.941 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.611 HD22 ' C ' ' A' ' 201' ' ' LYS . 0.8 OUTLIER 63.25 -163.25 0.27 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.211 -0.45 . . . . 75.23 110.946 179.979 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 5.6 pm0 -115.04 129.68 56.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.436 . . . . 55.12 110.875 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . 0.501 HG22 ' HA ' ' A' ' 223' ' ' ALA . 17.4 p -142.07 156.76 45.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 72.0 111.152 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -149.44 148.44 29.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.248 -0.433 . . . . 72.3 111.099 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.584 HG12 HG22 ' A' ' 221' ' ' ILE . 0.8 OUTLIER -112.89 148.54 15.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.224 -0.444 . . . . 75.04 111.149 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -126.71 136.92 53.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 65.45 110.917 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 5.6 mp -130.72 142.3 50.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.167 -0.47 . . . . 64.22 110.928 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.417 ' HB3' ' HD2' ' A' ' 218' ' ' ARG . . . -131.59 131.64 43.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.466 . . . . 64.43 111.071 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 18.9 t90 -130.69 126.21 35.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 73.03 110.946 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . 0.62 HG23 ' CB ' ' A' ' 215' ' ' SER . 2.0 t -113.43 105.92 13.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.27 -0.423 . . . . 73.03 111.169 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -51.98 149.09 5.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 74.31 111.114 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 114.2 43.92 0.76 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.752 -0.737 . . . . 62.04 112.497 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 55.73 62.66 2.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.867 0.365 . . . . 72.45 110.901 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . 0.62 ' CB ' HG23 ' A' ' 211' ' ' THR . 7.1 t -121.85 -178.04 3.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 60.51 110.826 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 29.7 m120 -101.74 150.29 23.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.128 -0.487 . . . . 64.33 110.873 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 2.9 p -79.24 138.69 37.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 75.42 111.181 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . 0.417 ' HD2' ' HB3' ' A' ' 209' ' ' ALA . 75.6 mtt180 -105.97 126.99 52.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 71.42 110.857 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -122.77 139.43 54.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 75.02 110.887 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -149.68 149.01 20.88 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.745 -0.741 . . . . 73.53 112.521 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.619 HG12 HG12 ' A' ' 237' ' ' VAL . 0.0 OUTLIER -138.7 130.85 37.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.775 0.321 . . . . 74.44 111.142 -179.954 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -120.81 133.12 55.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 72.32 111.107 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.501 ' HA ' HG22 ' A' ' 204' ' ' THR . . . -111.91 125.85 54.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 75.5 111.105 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 18.3 ttpp -115.58 114.66 25.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 75.11 110.863 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -109.59 118.6 37.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 74.44 110.903 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.93 114.11 27.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 54.32 110.887 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 44.2 mt -109.06 -35.35 2.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 73.24 111.102 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -149.17 157.47 39.65 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.637 0.732 . . . . 50.11 110.862 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -17.0 37.89 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.694 2.263 . . . . 72.34 112.366 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -103.35 -28.04 12.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 74.31 110.855 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -124.32 129.9 51.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.463 . . . . 54.54 111.087 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 19.1 m -139.65 141.18 37.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.272 -0.422 . . . . 64.02 110.89 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -106.6 133.16 51.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.447 . . . . 74.34 110.895 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 2.8 t -138.27 143.22 39.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.471 . . . . 64.0 110.852 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -146.7 159.03 43.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.128 -0.487 . . . . 73.22 111.098 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.98 148.71 19.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 64.44 110.86 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.619 HG12 HG12 ' A' ' 221' ' ' ILE . 0.9 OUTLIER -140.65 149.1 21.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 74.23 111.115 179.896 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -117.56 147.95 42.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 72.31 110.886 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -58.16 -18.16 23.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 74.44 110.858 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 11.2 t -81.46 26.67 0.46 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 53.22 110.884 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 1.7 m 62.78 32.94 15.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 75.03 110.841 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . 0.473 HD11 ' HB3' ' A' ' 264' ' ' ASP . 4.5 mp -100.13 117.69 34.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.136 -0.483 . . . . 74.52 110.892 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.43 ' HA ' HG23 ' A' ' 237' ' ' VAL . 0.0 OUTLIER -109.56 117.75 55.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.131 -0.486 . . . . 72.02 111.178 179.782 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . 0.443 ' HA2' ' HA ' ' A' ' 262' ' ' LEU . . . -122.31 148.29 17.02 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.723 -0.751 . . . . 72.24 112.479 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -145.57 130.08 17.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.882 0.373 . . . . 75.45 110.914 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -129.67 138.78 10.47 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.759 -0.734 . . . . 51.33 112.499 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -128.95 131.81 47.54 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.965 0.412 . . . . 75.0 110.919 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 16.8 p -111.41 129.19 56.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 61.54 111.126 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -142.78 123.12 13.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 62.33 110.951 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 20.8 p -106.77 153.13 22.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 72.15 111.129 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.794 HD12 HG21 ' A' ' 255' ' ' ILE . 6.2 mt -85.74 -77.11 0.31 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.216 -0.447 . . . . 51.24 110.927 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' LYS . . . . . 0.469 ' N ' ' HD2' ' A' ' 253' ' ' PRO . 1.6 mttm 177.88 -60.71 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.598 0.714 . . . . 73.21 110.858 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' PRO . . . . . 0.735 ' HG2' HD12 ' A' ' 255' ' ' ILE . 53.5 Cg_endo -69.81 69.31 1.68 Allowed 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.725 2.283 . . . . 64.44 112.314 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 50.47 32.46 23.24 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.785 -0.722 . . . . 70.22 112.445 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.794 HG21 HD12 ' A' ' 251' ' ' LEU . 58.6 mt -114.45 122.54 68.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.864 0.364 . . . . 61.31 111.113 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 17.4 mtpp -130.71 120.52 23.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.14 -0.482 . . . . 63.02 110.889 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 0.525 HD21 HD21 ' A' ' 277' ' ' LEU . 0.4 OUTLIER -100.75 128.71 46.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.455 . . . . 74.34 110.909 179.927 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 1.5 m -115.5 115.24 26.17 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.177 -0.465 . . . . 74.52 111.164 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.948 HD22 HD23 ' A' ' 277' ' ' LEU . 0.1 OUTLIER -112.39 126.09 54.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.239 -0.437 . . . . 75.34 110.919 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.404 ' N ' HD13 ' A' ' 259' ' ' LEU . 23.6 p -133.67 144.98 49.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 54.32 110.876 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 261' ' ' ALA . . . . . 0.612 ' HB2' ' CD2' ' A' ' 275' ' ' LEU . . . -155.08 128.25 8.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.129 -0.487 . . . . 53.14 111.06 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.811 ' C ' HD13 ' A' ' 263' ' ' LEU . 1.5 tt -132.75 139.89 47.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.453 . . . . 65.22 110.937 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . 0.811 HD13 ' C ' ' A' ' 262' ' ' LEU . 0.0 OUTLIER -123.93 110.13 14.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.202 -0.454 . . . . 65.53 110.937 179.884 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . 0.691 ' O ' HG22 ' A' ' 268' ' ' VAL . 1.8 m-20 -79.92 106.15 11.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.209 -0.451 . . . . 71.3 110.836 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -53.69 -19.67 10.47 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.767 -0.73 . . . . 72.44 112.461 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.8 -25.95 18.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.785 0.326 . . . . 72.32 110.889 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -99.04 -55.91 2.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 72.2 110.871 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . 0.698 HG12 ' O ' ' A' ' 272' ' ' GLY . 13.1 m -49.47 -28.23 3.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 64.33 111.124 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -53.25 -44.78 68.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 62.31 110.879 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -105.28 -17.38 14.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.445 . . . . 42.15 111.094 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -111.73 -119.82 3.85 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.743 -0.741 . . . . 45.13 112.488 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 272' ' ' GLY . . . . . 0.698 ' O ' HG12 ' A' ' 268' ' ' VAL . . . -148.72 -170.55 16.61 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.762 -0.733 . . . . 55.35 112.549 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 273' ' ' HIS . . . . . 0.669 ' CG ' HD12 ' A' ' 263' ' ' LEU . 0.9 OUTLIER -87.96 146.04 25.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.9 0.381 . . . . 71.54 110.815 -179.914 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -96.96 135.81 38.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 61.24 110.925 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.612 ' CD2' ' HB2' ' A' ' 261' ' ' ALA . 2.1 tm? -132.1 123.26 26.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 54.11 110.922 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . 0.506 ' N ' HD13 ' A' ' 275' ' ' LEU . . . -119.38 130.4 8.5 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.737 -0.744 . . . . 55.05 112.509 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.948 HD23 HD22 ' A' ' 259' ' ' LEU . 3.3 tm? -119.31 141.03 49.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.874 0.369 . . . . 73.0 110.921 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . 0.685 ' N ' HD13 ' A' ' 277' ' ' LEU . . . -145.36 132.46 4.65 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.797 -0.716 . . . . 74.11 112.512 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.636 HD11 HD11 ' A' ' 277' ' ' LEU . 1.1 mm? -108.7 132.12 54.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.805 0.336 . . . . 44.52 110.899 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 50.3 tt0 -127.57 117.67 22.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.185 -0.461 . . . . 64.41 110.871 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -122.7 134.5 54.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.483 . . . . 71.44 110.898 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -135.12 124.3 24.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 65.21 110.938 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.771 ' HB3' HG23 ' A' ' 33' ' ' THR . . . -100.06 130.88 46.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.445 . . . . 74.13 111.085 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.604 HD23 ' C ' ' A' ' 283' ' ' ALA . 0.9 OUTLIER 41.21 38.31 0.74 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.446 . . . . 74.41 110.92 -179.975 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.46 . . . . 75.13 110.861 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.857 0.361 . . . . 72.25 111.145 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.765 HG22 ' HA ' ' A' ' 121' ' ' GLU . 19.5 t -136.7 75.42 50.04 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 121.674 0.75 . . . . 64.55 111.133 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.7 167.91 23.01 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.74 2.293 . . . . 72.52 112.377 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 102.55 1.05 Allowed 'Trans proline' 0 N--CA 1.465 -0.172 0 C-N-CA 122.684 2.256 . . . . 73.42 112.362 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -86.45 -37.68 18.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 62.12 111.161 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -52.16 -39.9 60.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 71.41 110.886 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -76.24 -24.13 54.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 53.52 111.118 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -74.07 -21.11 60.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 52.24 110.917 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.594 HD23 ' CD2' ' A' ' 150' ' ' LEU . 20.7 mt -56.88 -34.1 67.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.157 -0.474 . . . . 63.04 110.92 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -132.18 29.2 3.37 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.742 -0.742 . . . . 74.11 112.481 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 12.5 ttpp -69.59 -45.79 67.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.801 0.334 . . . . 62.41 110.877 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.4 m -64.37 -39.34 93.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.458 . . . . 62.0 110.883 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.26 -50.58 73.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 31.33 111.109 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -67.44 -33.8 75.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 75.23 110.879 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -60.31 -47.91 84.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 74.43 110.833 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 85.8 t -75.77 -33.46 26.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 70.42 111.135 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -59.8 -41.36 91.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 75.15 110.881 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.3 p 46.74 85.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.139 -0.482 . . . . 73.13 111.152 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.0 mtmt -50.64 -34.44 26.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 65.43 110.933 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -98.79 79.14 0.55 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.72 -0.752 . . . . 72.35 112.442 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -129.66 108.31 10.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.952 0.406 . . . . 74.5 110.965 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 51.71 77.14 0.14 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.741 -0.742 . . . . 44.04 112.503 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -103.35 -3.43 25.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.887 0.375 . . . . 54.52 110.833 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.56 13.7 80.04 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.785 -0.722 . . . . 44.14 112.46 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.628 HD11 HD22 ' A' ' 48' ' ' ASN . 2.0 tp -138.88 -178.93 5.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.78 0.324 . . . . 33.12 110.91 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 1.028 HG23 HD12 ' A' ' 277' ' ' LEU . 14.7 mm -104.7 141.38 20.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.182 -0.463 . . . . 42.0 111.151 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.7 tttt -122.42 139.39 53.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 74.11 110.928 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.504 HD13 ' C ' ' A' ' 29' ' ' LEU . 2.8 tm? -131.81 128.73 39.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 70.2 110.884 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.488 ' N ' HD22 ' A' ' 29' ' ' LEU . 8.2 m-20 -140.73 127.14 19.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.141 -0.481 . . . . 74.45 110.882 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.57 HD23 ' N ' ' A' ' 32' ' ' LYS . 8.2 tt -138.37 138.89 38.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 73.44 110.93 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.57 ' N ' HD23 ' A' ' 31' ' ' LEU . 0.4 OUTLIER -121.47 125.61 47.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 42.52 110.922 179.832 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 96.6 m -121.01 129.12 53.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.229 -0.441 . . . . 73.53 111.108 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.4 tttt -143.33 126.97 16.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.214 -0.448 . . . . 70.1 110.926 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.663 ' HB3' HD23 ' A' ' 39' ' ' LEU . 0.2 OUTLIER -88.22 174.95 7.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.24 -0.436 . . . . 73.21 110.843 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.5 ' C ' ' O ' ' A' ' 35' ' ' SER . 43.8 mm-40 -29.38 -56.61 0.15 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.112 -0.495 . . . . 71.31 110.904 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 -173.77 149.37 1.57 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 73.24 110.899 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 86.54 -11.16 64.56 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.757 -0.735 . . . . 54.1 112.488 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.663 HD23 ' HB3' ' A' ' 35' ' ' SER . 3.2 mm? -104.2 132.49 50.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.791 0.329 . . . . 75.44 110.922 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.0 tm-20 -137.78 114.47 10.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.224 -0.444 . . . . 63.25 110.899 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.423 ' CZ ' HG23 ' A' ' 60' ' ' THR . 25.1 m-85 -134.94 118.32 16.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.094 -0.503 . . . . 63.34 110.868 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.58 130.82 46.17 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.125 -0.489 . . . . 62.24 111.107 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.3 p -127.04 131.99 50.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.196 -0.457 . . . . 65.53 110.825 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.9 m -148.72 126.82 12.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.092 -0.504 . . . . 44.42 110.813 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -167.92 179.41 41.21 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.757 -0.735 . . . . 71.42 112.517 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.0 m -137.33 161.5 36.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.899 0.38 . . . . 75.13 110.819 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.957 ' HB2' HG13 ' A' ' 54' ' ' VAL . . . -145.7 150.49 36.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.093 -0.503 . . . . 63.53 111.108 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.628 HD22 HD11 ' A' ' 26' ' ' LEU . 25.4 t-20 -73.77 142.65 46.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 74.11 110.832 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -55.14 -39.27 69.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.123 -0.489 . . . . 73.24 111.127 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -95.17 25.24 4.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.454 . . . . 73.13 110.874 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 20.5 p 48.09 30.75 2.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 74.23 111.093 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 22.7 m -71.1 -30.8 66.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 64.25 111.124 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 10.5 tptm -165.84 130.72 2.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.247 -0.433 . . . . 52.54 110.885 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.957 HG13 ' HB2' ' A' ' 47' ' ' ALA . 7.9 t -125.18 125.71 69.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 73.15 111.095 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.7 t -136.68 129.04 30.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 61.01 111.165 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -151.03 150.46 22.43 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.705 -0.759 . . . . 72.1 112.474 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -104.48 146.39 28.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.874 0.369 . . . . 74.02 110.875 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.658 HD13 ' N ' ' A' ' 59' ' ' GLU . 0.9 OUTLIER -125.67 132.41 52.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.12 -0.491 . . . . 73.21 110.94 179.985 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.658 ' N ' HD13 ' A' ' 58' ' ' LEU . 6.7 pt-20 -125.39 120.08 30.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.441 . . . . 74.24 110.85 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.423 HG23 ' CZ ' ' A' ' 41' ' ' PHE . 96.9 m -124.76 137.68 54.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 73.43 111.12 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.658 ' CB ' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -172.39 -178.6 2.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 74.54 110.882 179.901 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -115.22 141.65 47.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.233 -0.44 . . . . 75.42 110.897 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -134.41 111.65 10.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.097 -0.501 . . . . 74.44 110.906 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 2.4 m-90 -106.12 110.59 22.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 53.12 110.952 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 10.3 t -81.29 -33.26 32.75 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.257 -0.429 . . . . 62.03 111.136 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -49.97 -54.82 17.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.245 -0.434 . . . . 65.35 110.888 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -73.76 -51.11 17.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.463 . . . . 61.42 110.91 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.742 ' O ' HD22 ' A' ' 69' ' ' LEU . . . 123.78 32.01 0.91 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.785 -0.721 . . . . 75.01 112.462 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.742 HD22 ' O ' ' A' ' 68' ' ' GLY . 3.9 mm? -135.09 132.87 38.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.917 0.389 . . . . 75.23 110.866 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 55.5 p -132.42 111.09 11.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 75.51 111.119 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.632 ' O ' ' HB3' ' A' ' 61' ' ' LYS . 0.2 OUTLIER -105.56 132.69 51.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.438 . . . . 73.03 110.888 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.658 ' HA ' ' CB ' ' A' ' 61' ' ' LYS . 17.8 p -129.88 136.14 49.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.484 . . . . 70.23 111.143 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.631 ' HG3' HG23 ' A' ' 83' ' ' THR . 25.6 tt0 -126.5 122.01 33.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 52.14 110.877 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.49 139.69 44.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 73.14 110.892 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 8.1 t90 -135.44 129.54 33.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 74.21 110.924 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -116.85 149.29 40.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.263 -0.426 . . . . 71.42 110.891 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 8.8 t -65.12 -14.22 59.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.184 -0.462 . . . . 73.04 111.172 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.456 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 5.6 m-20 -75.25 2.03 12.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 74.35 110.865 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.456 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 2.9 m120 80.09 36.83 0.12 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 63.45 110.932 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.2 m -116.55 121.39 41.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 63.44 111.168 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.592 HD23 ' CD ' ' A' ' 105' ' ' PRO . 4.4 mm? -101.67 149.22 24.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.249 -0.432 . . . . 75.2 110.933 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -148.81 143.15 10.6 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.696 -0.764 . . . . 62.31 112.493 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.631 HG23 ' HG3' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -146.53 96.97 2.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.763 0.316 . . . . 61.04 111.11 -179.835 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.435 ' HA ' ' HA ' ' A' ' 100' ' ' ASP . 15.8 tt0 -106.14 122.7 46.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.207 -0.451 . . . . 74.24 110.886 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.481 HG22 ' O ' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -121.63 138.26 52.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 74.5 111.146 179.945 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.477 HG23 HG23 ' A' ' 98' ' ' THR . 0.2 OUTLIER -113.62 141.28 47.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.148 -0.478 . . . . 72.33 111.122 179.976 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.695 HG13 HD11 ' A' ' 69' ' ' LEU . 0.3 OUTLIER -121.58 120.07 60.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 40.13 111.148 179.893 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -93.77 118.26 31.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 71.51 110.943 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 49.68 70.37 0.5 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.203 -0.453 . . . . 73.22 110.876 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.536 ' CB ' HD23 ' A' ' 97' ' ' LEU . 6.4 tp60 -76.37 86.69 3.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.205 -0.452 . . . . 73.42 110.9 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 11.7 tp 66.19 30.38 9.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 71.31 110.933 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -179.48 100.68 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 73.14 111.126 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 5.9 mpt_? -51.13 134.41 26.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 64.42 110.86 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 96.41 -20.27 51.06 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.721 -0.752 . . . . 61.24 112.542 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.487 HD23 HD21 ' A' ' 97' ' ' LEU . 14.5 tp -85.0 134.78 34.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.902 0.382 . . . . 62.34 110.896 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.467 ' O ' HD13 ' A' ' 97' ' ' LEU . 10.9 ptmt -121.94 128.02 51.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 73.1 110.898 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.536 HD23 ' CB ' ' A' ' 90' ' ' GLN . 2.4 mm? -122.98 130.58 52.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 73.24 110.925 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.477 HG23 HG23 ' A' ' 86' ' ' THR . 0.3 OUTLIER -130.53 117.17 19.19 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.176 -0.465 . . . . 74.03 111.138 179.932 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.481 ' O ' HG22 ' A' ' 85' ' ' ILE . 75.0 t80 -125.47 115.1 19.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 72.35 110.849 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.435 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 2.9 p30 -130.5 142.25 50.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.137 -0.483 . . . . 63.13 110.865 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.552 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 3.1 p -141.77 122.79 14.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 64.42 110.881 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 71.3 p -140.7 141.65 34.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 52.33 110.883 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.477 ' HB2' ' H ' ' A' ' 111' ' ' ASN . 0.1 OUTLIER -176.7 157.79 1.6 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.48 . . . . 74.32 110.885 -179.902 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -78.92 113.13 32.9 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.629 0.728 . . . . 73.54 110.888 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.592 ' CD ' HD23 ' A' ' 81' ' ' LEU . 54.2 Cg_endo -69.75 -4.02 13.19 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.71 2.273 . . . . 50.44 112.325 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -45.13 -35.0 2.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 75.52 110.86 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.8 p -129.2 23.12 5.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.455 . . . . 71.42 111.177 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 75.69 27.33 63.23 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.678 -0.772 . . . . 74.24 112.511 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.446 ' O ' ' HB3' ' A' ' 103' ' ' PHE . 15.4 mtpt -77.61 140.74 39.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.835 0.35 . . . . 74.14 110.902 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.401 ' C ' ' HD1' ' A' ' 103' ' ' PHE . 23.4 mttt -156.61 113.38 3.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 62.54 110.895 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.552 ' O ' ' HA ' ' A' ' 101' ' ' SER . 44.2 t-20 -115.33 118.68 33.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.444 . . . . 62.4 110.914 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.466 ' HB1' ' CZ ' ' A' ' 99' ' ' PHE . . . -116.1 150.23 37.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.221 -0.445 . . . . 72.12 111.107 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 4.0 tttp -135.19 136.78 42.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 73.34 110.874 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 6.2 tp -112.07 125.01 69.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 63.34 111.096 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 28.5 tttt -122.02 120.0 33.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 63.11 110.915 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 7.1 t -125.35 125.98 44.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 73.53 111.168 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -153.46 176.9 31.3 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.7 -0.762 . . . . 54.12 112.487 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -128.27 144.6 51.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.907 0.384 . . . . 74.22 110.965 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 17.8 mtpt -110.42 117.97 35.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.106 -0.497 . . . . 73.4 110.893 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.43 ' HB2' HG22 ' A' ' 123' ' ' ILE . 1.4 mmm180 -110.65 146.55 35.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 75.15 110.899 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.765 ' HA ' HG22 ' A' ' 3' ' ' VAL . 15.7 pt-20 -56.6 -31.01 63.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 74.32 110.875 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 13.9 m80 -124.23 9.37 8.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.455 . . . . 74.32 110.884 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.604 ' CG2' HD23 ' A' ' 125' ' ' LEU . 1.0 OUTLIER -145.58 147.37 18.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 73.4 111.104 -179.999 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -127.62 113.62 16.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 75.33 110.877 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.604 HD23 ' CG2' ' A' ' 123' ' ' ILE . 3.4 mm? -117.44 127.43 54.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 72.4 110.94 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -146.7 114.71 0.74 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.726 -0.749 . . . . 63.21 112.476 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -113.29 134.62 54.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.847 0.356 . . . . 64.45 110.872 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -124.94 143.58 50.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 64.31 110.834 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 3.2 mmt -138.98 119.04 13.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 74.23 110.88 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -86.17 123.64 31.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.24 -0.436 . . . . 70.13 110.881 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -92.1 98.97 11.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 73.55 110.882 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -115.92 117.05 29.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.141 -0.481 . . . . 74.51 110.882 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 2.5 pp -53.83 -32.54 22.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 72.25 111.172 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -84.36 -20.01 32.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 65.13 111.115 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 162.01 101.66 0.17 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.741 -0.742 . . . . 74.21 112.503 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 161.31 46.42 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.703 2.269 . . . . 71.52 112.369 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.0 m -127.97 151.68 48.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.231 -0.44 . . . . 74.14 110.894 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.631 HD12 ' OG1' ' A' ' 159' ' ' THR . 3.0 mp -109.06 125.65 66.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 63.35 111.093 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 15.5 ttt180 -122.85 129.25 51.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.119 -0.492 . . . . 71.1 110.882 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -124.18 133.71 8.85 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.712 -0.756 . . . . 72.42 112.509 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -133.16 126.64 32.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.855 0.36 . . . . 61.25 111.093 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.507 HD23 ' N ' ' A' ' 143' ' ' VAL . 0.7 OUTLIER -139.93 121.65 15.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.435 . . . . 55.21 110.882 -179.987 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.507 ' N ' HD23 ' A' ' 142' ' ' LEU . 1.5 m -133.8 139.55 48.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 73.41 111.139 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.41 HD12 ' N ' ' A' ' 144' ' ' LEU . 4.6 mp -109.67 138.66 45.72 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.205 -0.452 . . . . 75.2 110.937 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -100.38 136.94 12.97 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.701 -0.761 . . . . 23.43 112.473 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -141.68 147.13 37.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.851 0.357 . . . . 73.03 110.932 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -49.85 94.3 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.135 -0.484 . . . . 63.11 110.842 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 89.66 -25.27 11.64 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.74 -0.743 . . . . 23.42 112.509 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 37.2 m95 -104.92 142.01 35.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.816 0.341 . . . . 63.23 110.909 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.594 ' CD2' HD23 ' A' ' 10' ' ' LEU . 43.7 tp -140.15 140.16 35.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.236 -0.438 . . . . 73.55 110.868 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -136.01 141.52 44.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 63.12 111.102 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -148.71 134.27 4.92 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.726 -0.749 . . . . 32.44 112.465 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -133.3 124.08 26.63 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.866 0.365 . . . . 73.21 110.976 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -121.0 121.57 38.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.116 -0.493 . . . . 75.11 110.908 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 2.7 ptp -128.1 128.41 44.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.451 . . . . 61.34 110.891 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.487 ' O ' HG22 ' A' ' 164' ' ' VAL . 14.6 m-20 -113.62 121.58 44.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 63.41 110.901 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.435 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 38.9 m-85 -94.84 126.78 40.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 75.51 110.883 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.693 ' OE2' ' HB3' ' A' ' 160' ' ' ALA . 0.0 OUTLIER -79.04 100.86 7.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 64.32 110.883 -179.909 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.631 ' OG1' HD12 ' A' ' 138' ' ' ILE . 0.2 OUTLIER -64.56 -48.11 76.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.461 . . . . 74.41 111.11 -179.909 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.693 ' HB3' ' OE2' ' A' ' 158' ' ' GLU . . . -48.19 -26.09 1.77 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.225 -0.443 . . . . 60.01 111.11 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 25.4 mmtt -127.24 -167.76 1.78 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 74.31 110.87 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 6.1 t -110.59 40.12 2.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.26 -0.427 . . . . 72.11 110.874 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 9.4 mmt180 -154.19 176.74 11.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.108 -0.496 . . . . 73.51 110.83 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.487 HG22 ' O ' ' A' ' 156' ' ' ASN . 0.9 OUTLIER -73.61 142.69 14.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.14 -0.482 . . . . 72.11 111.122 179.97 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.408 ' HB ' ' HG2' ' A' ' 158' ' ' GLU . 8.6 t -90.51 -36.13 14.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.47 . . . . 74.25 111.117 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -156.24 142.88 18.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 64.43 110.871 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 2.5 p -124.99 129.66 50.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.177 -0.465 . . . . 54.44 110.845 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -136.2 148.31 48.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.103 -0.499 . . . . 74.52 110.889 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -152.09 140.17 20.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.192 -0.458 . . . . 74.32 110.892 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -154.63 142.77 20.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.465 . . . . 64.03 111.112 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -145.97 127.48 7.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 71.25 111.111 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -98.97 117.43 5.87 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.728 -0.749 . . . . 72.43 112.445 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.76 119.01 35.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.956 0.408 . . . . 74.24 110.92 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 3.3 mtpm? -116.16 127.28 54.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.085 -0.507 . . . . 60.1 110.878 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.421 ' HB ' ' H ' ' A' ' 178' ' ' PHE . 0.2 OUTLIER -110.14 166.99 10.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.226 -0.443 . . . . 74.54 111.151 -179.991 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -73.34 -6.39 45.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.186 -0.461 . . . . 73.13 110.866 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -119.49 -37.99 3.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 74.43 110.867 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.421 ' H ' ' HB ' ' A' ' 175' ' ' THR . 34.5 p90 -148.96 150.81 33.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 71.22 110.904 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -125.55 122.05 35.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.136 -0.484 . . . . 72.32 110.917 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.757 ' C ' HD12 ' A' ' 180' ' ' LEU . 0.3 OUTLIER -126.35 146.15 50.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.22 -0.445 . . . . 72.13 110.97 179.982 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' HIS . . . . . 0.703 ' N ' HD12 ' A' ' 180' ' ' LEU . 66.1 m-70 -119.74 116.71 26.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 65.53 110.821 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.24 143.82 28.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 60.31 111.163 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 18.2 t30 -145.18 137.86 26.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 62.24 110.875 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.532 HG22 ' HA ' ' A' ' 190' ' ' PHE . 2.4 t -134.62 114.3 17.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.253 -0.43 . . . . 71.45 111.146 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -101.96 92.58 4.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 75.41 110.883 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 2.6 t70 66.13 171.36 0.23 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 60.2 110.879 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -69.53 -4.71 46.85 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.738 -0.744 . . . . 51.52 112.487 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 33.9 p -95.06 -26.34 16.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.808 0.337 . . . . 73.34 111.162 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -123.65 114.9 20.6 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.186 -0.461 . . . . 61.33 110.906 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' PHE . . . . . 0.532 ' HA ' HG22 ' A' ' 184' ' ' VAL . 26.2 p90 -140.75 124.9 17.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 62.13 110.859 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -175.46 -149.17 7.19 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.744 -0.741 . . . . 62.41 112.509 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -173.51 -165.96 31.09 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.731 -0.747 . . . . 64.44 112.472 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 70.9 m -149.51 148.01 28.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.886 0.374 . . . . 61.41 110.858 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.483 ' HB ' HG22 ' A' ' 206' ' ' VAL . 5.4 mp -119.91 140.98 42.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.099 -0.5 . . . . 73.22 111.131 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . 0.618 ' HD2' ' HB2' ' A' ' 205' ' ' ALA . 14.8 t80 -132.34 120.7 22.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 74.24 110.941 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 8.7 tm0? -126.2 131.26 52.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.168 -0.469 . . . . 53.44 110.946 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 6.1 mtmp? -97.65 124.81 42.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 73.15 110.851 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.445 ' HB ' HD12 ' A' ' 202' ' ' LEU . 84.1 t -94.39 -33.7 5.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.445 . . . . 71.15 111.107 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -174.66 170.41 3.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.47 . . . . 53.3 110.906 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 19.1 mtpt -50.93 -33.66 25.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 75.33 110.878 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 4.0 mptt -120.43 53.44 1.1 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.245 -0.434 . . . . 72.23 110.944 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.445 HD12 ' HB ' ' A' ' 198' ' ' VAL . 0.2 OUTLIER -175.14 92.92 0.06 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 74.12 110.911 179.934 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -111.95 134.51 53.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 74.32 110.899 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 4.8 t -130.8 138.1 49.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 64.54 111.109 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.618 ' HB2' ' HD2' ' A' ' 195' ' ' TYR . . . -150.3 163.42 38.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.242 -0.435 . . . . 53.33 111.112 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.896 HG12 HG22 ' A' ' 221' ' ' ILE . 1.0 OUTLIER -137.14 147.95 26.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.44 . . . . 60.41 111.124 179.96 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -120.87 126.61 50.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.47 . . . . 54.44 110.911 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.409 HD12 HG23 ' A' ' 206' ' ' VAL . 1.3 mp -128.41 142.77 51.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.161 -0.472 . . . . 65.44 110.908 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -157.47 130.77 7.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 73.24 111.126 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 1.8 t-105 -103.6 123.63 47.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.199 -0.455 . . . . 73.42 110.955 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 61.8 p -107.47 104.74 14.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.257 -0.429 . . . . 62.23 111.161 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -51.11 138.69 19.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.262 -0.426 . . . . 72.35 111.074 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 154.73 -46.79 0.53 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.689 -0.767 . . . . 64.02 112.482 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -151.62 35.02 0.55 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.804 0.335 . . . . 73.42 110.866 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 47.7 t 50.98 44.76 28.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 63.03 110.892 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -101.87 131.79 48.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.147 -0.479 . . . . 73.01 110.922 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 5.2 t -115.36 139.0 50.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 75.21 111.179 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -105.94 131.57 53.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.209 -0.45 . . . . 74.04 110.879 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . 0.522 ' CZ ' HD12 ' A' ' 221' ' ' ILE . 13.4 t80 -131.41 136.21 47.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.466 . . . . 73.21 110.919 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -145.45 153.12 25.08 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.73 -0.748 . . . . 74.21 112.446 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.896 HG22 HG12 ' A' ' 206' ' ' VAL . 0.0 OUTLIER -137.67 130.68 42.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.85 0.357 . . . . 63.53 111.169 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -135.81 149.0 48.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.16 -0.473 . . . . 63.31 111.119 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -145.02 143.43 30.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.248 -0.433 . . . . 71.23 111.113 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 21.3 ttpp -117.74 132.89 56.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.237 -0.438 . . . . 60.34 110.865 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -132.99 132.38 41.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 64.24 110.908 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -93.67 130.45 39.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.107 -0.497 . . . . 61.22 110.922 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 71.5 mt -78.26 -56.0 8.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.214 -0.448 . . . . 51.44 111.129 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . 0.56 ' N ' ' HD2' ' A' ' 229' ' ' PRO . 0.1 OUTLIER 173.33 -56.94 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.61 0.719 . . . . 73.4 110.881 179.843 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 228' ' ' ASP . 53.2 Cg_endo -69.79 -156.73 0.04 OUTLIER 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.743 2.295 . . . . 53.53 112.332 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -85.55 15.79 4.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.266 -0.424 . . . . 62.34 110.871 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.665 ' HB2' ' HG3' ' A' ' 249' ' ' GLN . . . -120.43 122.28 40.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 65.22 111.059 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 31.7 m -115.71 144.39 44.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 73.04 110.837 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -111.44 131.23 55.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 70.14 110.823 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 3.5 p -127.67 141.75 51.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 63.43 110.867 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -119.76 141.65 49.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.122 -0.49 . . . . 65.51 111.096 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 18.2 mttp -145.74 142.54 29.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 74.01 110.858 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 242' ' ' LEU . 6.7 p -136.35 142.74 37.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 62.03 111.129 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -104.51 148.38 26.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 72.32 110.866 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -57.15 -18.76 16.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 72.35 110.891 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 2.1 m -82.02 25.37 0.58 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.476 . . . . 60.21 110.874 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 63.6 34.46 12.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.121 -0.49 . . . . 71.23 110.829 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . 0.457 HD11 ' HB3' ' A' ' 264' ' ' ASP . 2.7 mp -99.93 117.24 33.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 64.53 110.882 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.516 ' H ' HD12 ' A' ' 243' ' ' ILE . 0.2 OUTLIER -111.19 116.5 52.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.142 -0.481 . . . . 75.31 111.128 179.836 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . 0.522 ' C ' HD13 ' A' ' 245' ' ' LEU . . . -145.93 164.98 28.16 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.721 -0.752 . . . . 72.33 112.487 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.667 ' N ' HD13 ' A' ' 245' ' ' LEU . 0.0 OUTLIER -145.36 160.68 41.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.812 0.339 . . . . 75.03 110.926 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -129.52 139.62 11.1 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.718 -0.753 . . . . 64.13 112.464 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -116.69 115.86 26.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.996 0.427 . . . . 70.23 110.905 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 56.1 p -111.76 115.51 29.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.119 -0.492 . . . . 72.42 111.128 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . 0.665 ' HG3' ' HB2' ' A' ' 231' ' ' ALA . 49.5 tt0 -129.07 137.89 51.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 71.24 110.897 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . 0.653 HG23 ' HG2' ' A' ' 256' ' ' LYS . 95.4 m -119.05 116.81 27.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.45 . . . . 72.2 111.157 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -106.02 103.71 13.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.236 -0.438 . . . . 75.04 110.921 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' LYS . . . . . 0.409 ' HB3' ' HD2' ' A' ' 253' ' ' PRO . 20.1 mmmt 64.34 154.6 0.12 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.588 0.709 . . . . 73.12 110.886 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' PRO . . . . . 0.409 ' HD2' ' HB3' ' A' ' 252' ' ' LYS . 53.6 Cg_endo -69.8 75.42 1.23 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.699 2.266 . . . . 74.03 112.312 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 167.02 -32.17 0.2 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.782 -0.723 . . . . 74.43 112.477 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 7.3 mt -117.68 122.58 70.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.965 0.412 . . . . 73.01 111.099 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 0.653 ' HG2' HG23 ' A' ' 250' ' ' THR . 20.9 mtpt -130.81 127.35 38.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.484 . . . . 63.41 110.935 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -100.68 128.78 46.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.242 -0.435 . . . . 65.03 110.886 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 23.3 m -126.46 113.01 16.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 72.53 111.125 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.594 ' CD1' HD23 ' A' ' 277' ' ' LEU . 0.1 OUTLIER -121.45 150.55 41.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.207 -0.452 . . . . 75.32 110.915 179.91 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 40.8 p -151.16 140.96 21.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 62.4 110.874 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 261' ' ' ALA . . . . . 0.613 ' HB2' ' CD2' ' A' ' 275' ' ' LEU . . . -141.37 133.49 27.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.142 -0.481 . . . . 53.02 111.087 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.787 ' C ' HD13 ' A' ' 263' ' ' LEU . 0.7 OUTLIER -131.85 138.2 48.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.221 -0.445 . . . . 75.13 110.917 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . 0.787 HD13 ' C ' ' A' ' 262' ' ' LEU . 0.1 OUTLIER -121.81 109.28 14.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.155 -0.475 . . . . 71.41 110.923 179.881 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . 0.605 ' O ' HG22 ' A' ' 268' ' ' VAL . 1.0 OUTLIER -84.73 103.95 14.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 63.44 110.86 179.903 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -59.21 -11.04 11.31 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.685 -0.769 . . . . 54.34 112.508 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 47.3 mtpt -78.29 -3.31 42.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.826 0.346 . . . . 73.04 110.914 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 -156.19 -53.28 0.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 61.42 110.884 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . 0.62 HG12 ' O ' ' A' ' 272' ' ' GLY . 1.8 m -57.71 -18.85 10.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 73.22 111.126 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -50.94 -28.35 9.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 73.33 110.88 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -102.95 -17.61 15.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.457 . . . . 64.35 111.085 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 142.43 122.66 1.77 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.758 -0.734 . . . . 52.21 112.496 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 272' ' ' GLY . . . . . 0.62 ' O ' HG12 ' A' ' 268' ' ' VAL . . . 134.78 62.12 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.707 -0.759 . . . . 55.54 112.521 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 273' ' ' HIS . . . . . 0.589 ' HB2' HD12 ' A' ' 263' ' ' LEU . 18.2 p-80 -76.33 146.13 39.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.855 0.359 . . . . 72.24 110.843 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 13.9 mttp -95.46 135.37 37.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 65.31 110.933 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.747 HD13 ' N ' ' A' ' 276' ' ' GLY . 2.4 tm? -135.59 139.25 43.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 72.44 110.927 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . 0.747 ' N ' HD13 ' A' ' 275' ' ' LEU . . . -134.03 129.26 5.22 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.738 -0.744 . . . . 42.24 112.526 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 1.028 HD12 HG23 ' A' ' 27' ' ' ILE . 3.3 tm? -115.54 135.35 54.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.901 0.382 . . . . 72.23 110.889 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . 0.548 ' O ' HD13 ' A' ' 279' ' ' LEU . . . -147.45 141.49 9.35 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.746 -0.74 . . . . 75.02 112.481 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.548 HD13 ' O ' ' A' ' 278' ' ' GLY . 1.1 mm? -119.57 140.13 51.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.798 0.333 . . . . 63.12 110.894 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 15.3 mp0 -128.53 118.21 22.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.148 -0.478 . . . . 74.3 110.868 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -114.24 128.83 56.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.479 . . . . 73.51 110.877 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -113.42 112.99 24.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 65.24 110.92 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.636 ' C ' HD22 ' A' ' 284' ' ' LEU . . . -115.72 113.34 23.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 63.44 111.066 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.636 HD22 ' C ' ' A' ' 283' ' ' ALA . 3.2 mm? -130.75 -74.52 0.53 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 74.42 110.941 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 63.44 110.929 179.92 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.3 mmt . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.791 0.329 . . . . 53.12 110.88 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -124.64 137.92 54.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 52.03 111.12 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.683 HG22 ' CA ' ' A' ' 121' ' ' GLU . 3.1 t 60.47 82.58 0.22 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.649 0.737 . . . . 74.14 111.148 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 167.76 23.49 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.684 2.256 . . . . 75.31 112.323 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 116.48 4.59 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.653 2.236 . . . . 75.3 112.324 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.612 ' OG1' HD21 ' A' ' 150' ' ' LEU . 1.8 t -107.85 -39.44 5.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 72.44 111.172 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.717 ' CB ' HG21 ' A' ' 143' ' ' VAL . 41.5 p90 -67.96 -35.17 77.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 72.04 110.896 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -73.17 -23.32 60.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.113 -0.494 . . . . 74.13 111.103 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -90.02 13.95 13.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 70.3 110.855 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.607 HD23 HD22 ' A' ' 150' ' ' LEU . 45.2 mt -73.77 -34.27 64.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.2 -0.455 . . . . 73.54 110.954 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 172.62 40.94 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.699 -0.762 . . . . 71.12 112.437 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 44.4 tptt -68.6 -46.02 70.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.823 0.344 . . . . 51.41 110.917 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.1 t -64.79 -39.44 93.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 63.24 110.865 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.14 -49.97 52.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 55.14 111.083 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.499 ' O ' HG23 ' A' ' 19' ' ' THR . 9.7 ptp180 -66.72 -32.79 74.32 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.223 -0.444 . . . . 75.52 110.87 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -58.89 -48.17 82.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.147 -0.478 . . . . 73.45 110.837 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.8 p -81.54 -31.44 11.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 73.24 111.148 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -65.92 -41.35 91.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 73.44 110.905 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.499 HG23 ' O ' ' A' ' 15' ' ' ARG . 69.0 p -73.81 76.92 1.6 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 73.55 111.187 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.95 124.68 18.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 72.33 110.882 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -53.49 120.11 12.76 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.761 -0.733 . . . . 73.21 112.456 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -59.89 97.96 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.936 0.398 . . . . 73.15 110.914 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -77.74 88.78 1.05 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.749 -0.739 . . . . 74.11 112.529 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.438 ' HB2' HD23 ' A' ' 26' ' ' LEU . 20.0 m-85 -101.12 13.39 35.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.914 0.388 . . . . 73.53 110.888 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.85 13.31 80.77 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.709 -0.758 . . . . 71.42 112.481 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.594 HD12 ' N ' ' A' ' 27' ' ' ILE . 1.7 pp -101.91 174.81 5.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.836 0.351 . . . . 74.33 110.881 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.702 HG13 HD12 ' A' ' 277' ' ' LEU . 1.7 mp -116.94 123.89 72.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 73.13 111.142 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.494 ' O ' HD22 ' A' ' 279' ' ' LEU . 71.6 mttt -101.69 154.56 18.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 73.45 110.909 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.659 HD13 ' N ' ' A' ' 30' ' ' ASP . 3.0 tm? -146.05 136.34 23.85 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.23 -0.441 . . . . 73.25 110.88 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.659 ' N ' HD13 ' A' ' 29' ' ' LEU . 13.8 m-20 -153.81 124.64 7.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.456 . . . . 73.13 110.93 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.736 HD11 ' CB ' ' A' ' 283' ' ' ALA . 3.2 tm? -137.2 128.12 27.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.196 -0.456 . . . . 74.14 110.919 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.474 ' N ' HD13 ' A' ' 31' ' ' LEU . 10.8 pttp -120.7 134.67 55.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 65.31 110.936 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -137.95 120.65 16.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 65.31 111.147 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -126.12 146.99 49.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.234 -0.439 . . . . 75.12 110.892 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -139.06 166.99 23.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 64.41 110.878 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -89.42 49.46 1.76 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.118 -0.492 . . . . 52.15 110.878 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -136.37 4.84 2.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.476 . . . . 72.04 110.875 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' A' ' 63' ' ' ARG . . . 89.13 -7.16 82.76 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.741 -0.742 . . . . 74.33 112.482 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.418 HD23 ' O ' ' A' ' 39' ' ' LEU . 1.6 pt? -98.76 129.83 45.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.779 0.323 . . . . 61.1 110.926 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -142.08 117.86 10.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.444 . . . . 64.3 110.895 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.51 122.29 43.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 71.42 110.872 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.11 115.32 19.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 62.12 111.12 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.7 p -115.68 134.43 55.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.249 -0.432 . . . . 52.12 110.888 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 74.8 m -149.26 126.64 11.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 64.43 110.827 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -173.62 167.53 40.17 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.734 -0.746 . . . . 70.24 112.524 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.4 p -137.58 158.05 45.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.885 0.374 . . . . 73.54 110.865 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.435 ' HA ' ' HA ' ' A' ' 54' ' ' VAL . . . -140.42 129.66 23.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 74.01 111.085 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -98.06 127.34 43.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 74.01 110.874 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 28.6 p -90.68 -52.93 4.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 72.4 111.113 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -51.51 -38.28 53.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 73.12 110.896 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 43.9 p -133.91 161.79 33.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 73.24 111.134 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.2 p -75.7 78.1 2.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.227 -0.442 . . . . 72.2 111.111 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 10.9 ttpt -142.7 78.83 1.63 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 72.31 110.906 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' A' ' 47' ' ' ALA . 1.3 p -127.79 121.24 56.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 71.44 111.104 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 6.3 m -137.22 126.72 25.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.202 -0.454 . . . . 73.13 111.107 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -111.87 154.28 16.86 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.751 -0.738 . . . . 54.33 112.487 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.5 m -136.98 143.87 43.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.889 0.376 . . . . 51.54 110.865 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.564 HD13 ' N ' ' A' ' 59' ' ' GLU . 0.8 OUTLIER -121.08 126.28 49.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 52.21 110.911 179.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.564 ' N ' HD13 ' A' ' 58' ' ' LEU . 8.2 mp0 -121.69 126.46 49.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 65.22 110.878 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -104.11 120.12 40.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.143 -0.481 . . . . 51.11 111.119 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -119.76 158.75 25.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.181 -0.463 . . . . 74.42 110.855 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -133.16 140.89 47.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.145 -0.479 . . . . 74.04 110.898 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.512 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 21.4 tpp180 -131.25 103.32 6.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.107 -0.497 . . . . 71.43 110.86 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 17.8 m95 -116.15 121.26 41.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.461 . . . . 72.44 110.961 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.7 m 66.34 136.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.251 -0.431 . . . . 73.05 111.148 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -63.82 106.07 0.94 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.241 -0.436 . . . . 63.42 110.858 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 23.2 t80 66.51 59.08 0.63 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.154 -0.475 . . . . 73.53 110.886 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -140.62 -65.78 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.743 -0.741 . . . . 54.32 112.482 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.487 HD13 ' HA ' ' A' ' 87' ' ' VAL . 0.7 OUTLIER -130.62 129.03 42.18 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.891 0.377 . . . . 63.53 110.907 -179.91 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 5.1 m -137.92 133.26 33.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.177 -0.465 . . . . 62.34 111.124 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -123.27 134.79 54.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.444 . . . . 71.42 110.886 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.8 p -127.28 118.52 24.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.466 . . . . 72.5 111.19 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -121.82 130.06 53.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.259 -0.428 . . . . 74.44 110.849 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -122.24 104.98 9.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.48 . . . . 73.23 110.857 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 8.6 t90 -122.35 125.71 46.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.251 -0.431 . . . . 74.53 110.909 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -102.81 137.11 41.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 70.22 110.926 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 24.0 m -66.85 -34.4 77.72 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.206 -0.452 . . . . 73.32 111.136 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -110.81 -34.08 6.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.258 -0.428 . . . . 64.24 110.891 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -81.25 -160.55 0.34 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 54.41 110.901 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 66.6 p -80.95 154.05 27.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 74.53 111.154 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.618 ' H ' HD23 ' A' ' 81' ' ' LEU . 2.1 pt? -111.44 137.31 49.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 73.13 110.896 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -159.77 162.94 33.37 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.73 -0.748 . . . . 41.21 112.466 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.5 t -138.46 163.54 31.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.721 0.296 . . . . 53.12 111.137 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.33 145.48 25.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.456 . . . . 43.34 110.868 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.56 138.08 55.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.475 . . . . 71.11 111.146 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.542 HG23 ' OG1' ' A' ' 98' ' ' THR . 20.3 m -127.03 129.15 47.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.18 -0.463 . . . . 54.35 111.156 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.487 ' HA ' HD13 ' A' ' 69' ' ' LEU . 3.4 p -128.61 137.34 57.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 61.25 111.16 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -102.62 118.47 36.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 71.54 110.878 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -50.49 128.07 19.2 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.156 -0.474 . . . . 74.33 110.867 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -79.43 -56.71 4.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.185 -0.461 . . . . 64.33 110.935 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 15.3 mt -72.26 -41.29 66.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 74.22 110.928 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -93.78 71.6 4.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 74.24 111.121 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 11.5 tpt180 -50.98 135.32 24.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 74.31 110.883 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 101.75 -23.61 34.27 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.762 -0.733 . . . . 71.41 112.507 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.604 HD12 HD11 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -79.8 119.41 22.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.914 0.388 . . . . 73.21 110.905 -179.937 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.563 ' C ' HD13 ' A' ' 97' ' ' LEU . 26.7 ttpp -121.42 125.74 47.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 72.12 110.871 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.604 HD11 HD12 ' A' ' 95' ' ' LEU . 0.6 OUTLIER -118.62 126.71 52.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.445 . . . . 75.4 110.943 179.913 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.542 ' OG1' HG23 ' A' ' 86' ' ' THR . 97.2 m -131.33 119.83 22.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 64.32 111.139 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -115.11 121.73 43.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 75.21 110.895 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -119.29 150.0 40.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.163 -0.471 . . . . 73.32 110.851 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 7.1 t -142.22 124.81 15.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 71.14 110.84 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 4.9 m -99.77 146.52 26.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.108 -0.496 . . . . 75.24 110.898 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.414 ' O ' HD23 ' A' ' 81' ' ' LEU . 11.1 m-85 -143.12 138.55 29.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.458 . . . . 74.41 110.923 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 17.7 m -99.0 137.41 20.48 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.647 0.737 . . . . 72.32 110.882 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.83 125.57 12.26 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.719 2.279 . . . . 62.32 112.332 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 51.01 48.86 22.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 53.41 110.928 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 25.9 m -136.96 -41.53 0.59 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.143 -0.481 . . . . 71.43 111.103 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 92.28 -18.01 55.55 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.763 -0.732 . . . . 43.31 112.525 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 8.5 tttm -65.94 116.61 7.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.855 0.36 . . . . 75.41 110.931 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 15.0 ptmt -115.81 131.0 57.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 74.13 110.912 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -120.98 123.87 43.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.208 -0.451 . . . . 73.23 110.907 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -110.55 136.2 50.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.454 . . . . 63.03 111.113 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 11.2 mttt -138.25 137.78 37.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 73.21 110.888 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 5.7 tp -120.34 130.73 74.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.437 . . . . 65.33 111.127 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.6 tptp -120.35 119.69 33.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 73.31 110.879 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.59 HG23 HD12 ' A' ' 97' ' ' LEU . 58.7 m -129.61 121.48 27.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 71.24 111.145 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.435 ' HA3' ' HA2' ' A' ' 126' ' ' GLY . . . -150.56 170.68 30.43 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.769 -0.729 . . . . 74.24 112.497 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.428 ' CD2' HD22 ' A' ' 95' ' ' LEU . 0.2 OUTLIER -127.98 135.84 50.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.973 0.416 . . . . 71.3 110.934 -179.836 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.662 ' HG2' HG11 ' A' ' 3' ' ' VAL . 2.9 tttt -110.86 118.02 34.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.12 -0.491 . . . . 75.51 110.87 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.455 ' O ' HG13 ' A' ' 3' ' ' VAL . 23.1 ttm-85 -111.42 143.73 41.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 70.44 110.883 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.683 ' CA ' HG22 ' A' ' 3' ' ' VAL . 17.8 pt-20 -52.35 -29.36 23.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 73.41 110.899 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -86.31 -41.16 14.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 54.44 110.883 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.435 ' HB ' HD13 ' A' ' 144' ' ' LEU . 1.3 pp -148.25 153.53 11.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.224 -0.444 . . . . 74.51 111.111 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -127.24 115.06 18.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 75.5 110.905 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.899 HD22 ' C ' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -133.39 142.79 48.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 72.42 110.927 179.959 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.667 ' N ' HD22 ' A' ' 125' ' ' LEU . . . -148.02 141.97 9.67 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.723 -0.751 . . . . 61.32 112.47 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 2.0 t -113.32 131.0 56.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.81 0.338 . . . . 74.42 110.883 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -119.68 150.41 40.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.232 -0.44 . . . . 75.1 110.888 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 8.1 ttt -138.03 119.76 15.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.446 . . . . 75.21 110.886 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -102.33 120.95 41.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.202 -0.454 . . . . 72.45 110.871 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -95.34 116.34 28.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 75.04 110.868 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.431 ' OD1' HD12 ' A' ' 133' ' ' ILE . 15.8 t0 -109.94 173.66 6.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 62.21 110.87 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.545 ' H ' HD12 ' A' ' 133' ' ' ILE . 2.8 mp -93.34 -33.59 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 71.21 111.154 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -92.69 -19.77 21.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 72.52 111.075 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 168.9 106.63 0.19 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.76 -0.733 . . . . 45.34 112.484 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 144.56 54.25 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.639 2.226 . . . . 72.0 112.328 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 9.4 t -128.77 152.35 48.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.444 . . . . 71.52 110.841 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.716 HD12 ' OG1' ' A' ' 159' ' ' THR . 1.7 mp -112.34 135.48 51.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.131 -0.486 . . . . 73.14 111.09 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 8.5 ttm180 -121.48 112.32 18.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.458 . . . . 72.41 110.871 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -111.65 136.38 13.51 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.775 -0.726 . . . . 61.02 112.525 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -138.54 116.26 11.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.799 0.333 . . . . 74.43 111.125 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.759 HD13 ' CB ' ' A' ' 125' ' ' LEU . 1.1 tp -123.86 124.51 42.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.252 -0.431 . . . . 41.42 110.901 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.754 ' N ' HD12 ' A' ' 142' ' ' LEU . 44.5 t -114.25 129.85 69.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 71.31 111.081 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.454 HD13 ' HA ' ' A' ' 144' ' ' LEU . 2.6 mm? -106.14 138.85 41.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 52.35 110.899 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -116.27 136.6 13.0 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.781 -0.723 . . . . 72.42 112.487 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -140.46 146.43 38.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.876 0.37 . . . . 75.01 110.909 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 74.5 mt-10 -50.31 96.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.136 -0.483 . . . . 44.21 110.907 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 90.16 -26.08 10.89 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.745 -0.741 . . . . 54.32 112.541 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 7.1 m0 -105.15 135.64 46.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.803 0.335 . . . . 75.54 110.886 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.612 HD21 ' OG1' ' A' ' 6' ' ' THR . 0.6 OUTLIER -126.53 140.07 52.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.265 -0.425 . . . . 75.44 110.876 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.468 ' H ' HD23 ' A' ' 150' ' ' LEU . . . -139.76 145.2 37.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 73.24 111.083 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -146.97 132.97 4.58 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.71 -0.757 . . . . 51.35 112.516 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -135.43 120.17 18.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.842 0.354 . . . . 70.13 110.899 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -134.05 122.45 23.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.137 -0.483 . . . . 72.23 110.95 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 4.3 ptt? -145.96 155.39 42.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 53.12 110.892 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -112.72 129.92 56.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 63.25 110.846 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.424 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 62.1 t80 -90.44 133.16 35.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.48 . . . . 73.11 110.861 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -77.82 101.94 6.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.473 . . . . 71.42 110.914 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.716 ' OG1' HD12 ' A' ' 138' ' ' ILE . 0.2 OUTLIER -64.97 -47.4 77.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.127 -0.488 . . . . 74.12 111.117 -179.9 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -48.6 -26.07 2.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 71.3 111.097 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 4.1 tptt -126.11 -167.51 1.72 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 64.32 110.919 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 11.7 t -112.03 40.83 2.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.446 . . . . 75.42 110.814 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -154.47 176.09 12.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 65.31 110.869 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.424 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 2.0 t -82.55 141.51 14.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.446 . . . . 63.31 111.125 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 15.2 t -91.01 -34.19 15.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.192 -0.458 . . . . 73.24 111.154 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -152.45 138.18 17.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 74.24 110.897 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 3.5 m -124.7 131.14 53.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 72.41 110.879 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -132.09 135.16 46.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 71.53 110.843 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.628 ' HB3' HG22 ' A' ' 184' ' ' VAL . 11.3 t80 -130.06 148.51 51.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.103 -0.499 . . . . 72.32 110.887 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -153.42 138.13 16.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 52.32 111.117 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 61.8 t -120.64 134.7 63.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.252 -0.431 . . . . 72.11 111.09 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -116.01 131.29 9.53 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.737 -0.744 . . . . 65.03 112.497 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -130.03 120.66 25.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.961 0.41 . . . . 74.22 110.926 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.14 132.28 54.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.079 -0.509 . . . . 73.3 110.888 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.47 166.49 21.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 74.32 111.136 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -39.79 -73.82 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.22 -0.446 . . . . 61.03 110.885 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -117.05 14.81 15.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.459 . . . . 55.34 110.951 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.64 ' CZ ' HG23 ' A' ' 194' ' ' ILE . 88.8 t80 -126.15 142.3 51.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.115 -0.493 . . . . 70.01 110.897 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 53.8 mm-40 -136.6 125.29 23.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.111 -0.495 . . . . 52.11 110.9 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.688 HD12 HG13 ' A' ' 194' ' ' ILE . 1.0 OUTLIER -123.31 129.01 50.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.462 . . . . 71.33 110.929 179.991 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 25.7 m80 -129.85 117.78 20.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 62.13 110.89 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 9.2 m -109.31 155.77 20.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 72.32 111.175 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -162.47 139.42 7.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.24 -0.436 . . . . 64.22 110.909 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.628 HG22 ' HB3' ' A' ' 169' ' ' PHE . 2.0 m -133.62 138.61 50.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 70.41 111.139 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -97.7 88.77 4.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 75.35 110.891 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . 0.4 ' HB2' HG22 ' A' ' 188' ' ' THR . 2.0 m-20 72.4 -176.4 0.18 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.195 -0.457 . . . . 74.33 110.888 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -79.45 3.08 69.12 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.73 -0.748 . . . . 71.21 112.479 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . 0.4 HG22 ' HB2' ' A' ' 186' ' ' ASP . 3.9 t -107.54 -22.29 12.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.801 0.334 . . . . 71.51 111.172 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -120.83 124.32 44.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.47 . . . . 74.42 110.894 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' PHE . . . . . 0.552 ' HA ' ' HB ' ' A' ' 184' ' ' VAL . 0.4 OUTLIER -137.76 125.38 22.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.183 -0.462 . . . . 74.13 110.882 -179.906 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -146.3 170.91 27.31 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.752 -0.737 . . . . 63.23 112.467 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.539 ' O ' HD23 ' A' ' 208' ' ' LEU . . . -150.5 164.14 29.74 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.73 -0.748 . . . . 54.02 112.458 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -139.56 141.98 37.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.863 0.363 . . . . 71.33 110.836 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.688 HG13 HD12 ' A' ' 180' ' ' LEU . 5.3 mp -131.65 116.89 32.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 74.31 111.107 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . 0.593 ' CE2' ' HB2' ' A' ' 205' ' ' ALA . 2.6 t80 -108.83 122.31 46.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.134 -0.485 . . . . 71.32 110.915 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 22.4 tp60 -124.3 122.6 38.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.089 -0.505 . . . . 72.04 110.922 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.94 127.29 47.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 74.2 110.925 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 9.3 t -82.64 155.99 3.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.228 -0.442 . . . . 75.15 111.089 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -50.45 -50.2 52.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 54.01 110.919 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 13.7 mmtp -69.63 -170.42 0.3 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 63.25 110.885 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . 0.75 ' O ' HD22 ' A' ' 202' ' ' LEU . 23.3 mtpp -81.45 55.58 2.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 73.23 110.912 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.75 HD22 ' O ' ' A' ' 201' ' ' LYS . 3.9 mm? -135.61 116.25 13.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 75.41 110.922 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -107.25 139.35 41.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 75.04 110.913 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 6.1 m -124.0 138.83 54.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 74.43 111.106 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.593 ' HB2' ' CE2' ' A' ' 195' ' ' TYR . . . -137.6 143.34 41.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 74.41 111.087 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 10.6 t -132.43 137.94 53.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.46 . . . . 55.04 111.124 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -149.22 125.89 11.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 74.0 110.902 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.539 HD23 ' O ' ' A' ' 192' ' ' GLY . 2.6 pt? -147.08 150.58 35.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.162 -0.472 . . . . 72.25 110.929 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -134.44 149.28 50.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 75.44 111.075 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 17.3 t90 -130.42 132.02 45.53 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.214 -0.448 . . . . 75.51 110.926 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 1.7 m -95.69 107.89 20.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 73.24 111.153 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -51.88 146.76 7.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 54.11 111.075 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 104.35 -38.54 3.21 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.732 -0.747 . . . . 71.11 112.442 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 31.8 m120 -121.23 166.94 13.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.877 0.37 . . . . 74.5 110.86 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 39.3 m -97.38 36.93 1.4 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 72.22 110.833 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 16.9 t30 -101.83 111.52 23.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.107 -0.497 . . . . 71.53 110.937 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 35.0 p -115.33 138.66 50.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.45 . . . . 71.31 111.139 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -126.77 123.97 38.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 71.03 110.896 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -132.69 156.11 47.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 72.43 110.842 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -149.33 147.88 18.68 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.729 -0.748 . . . . 51.03 112.482 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 3.7 mp -120.67 132.15 70.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.87 0.367 . . . . 75.31 111.106 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -138.06 130.81 29.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 55.54 111.101 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -123.97 158.41 32.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 71.54 111.098 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 19.4 ttmm -124.09 137.48 54.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.431 . . . . 71.51 110.936 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -132.34 117.61 18.36 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.206 -0.452 . . . . 64.0 110.944 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -89.95 130.48 36.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.131 -0.486 . . . . 73.32 110.915 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 62.7 mt -81.83 -57.67 4.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 74.41 111.085 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.559 ' N ' ' HD2' ' A' ' 229' ' ' PRO . 0.6 OUTLIER 170.7 -56.89 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.673 0.749 . . . . 73.04 110.877 179.938 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 228' ' ' ASP . 53.4 Cg_endo -69.81 -156.42 0.04 OUTLIER 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.68 2.253 . . . . 73.2 112.359 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -85.49 17.27 3.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.225 -0.443 . . . . 54.42 110.862 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -119.52 122.12 40.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 44.41 111.097 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 32.5 t -120.6 142.68 49.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.451 . . . . 73.22 110.886 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -108.88 128.18 54.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 75.11 110.855 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -122.12 154.07 37.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 72.24 110.853 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -133.03 149.78 52.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.122 -0.49 . . . . 71.45 111.169 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 34.0 mttp -145.74 164.06 33.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.23 -0.441 . . . . 61.21 110.94 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 242' ' ' LEU . 6.0 p -156.19 143.17 10.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.266 -0.424 . . . . 71.05 111.171 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -106.2 147.97 28.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 73.4 110.879 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -52.55 -22.77 5.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 72.35 110.854 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 32.2 t -81.2 26.15 0.46 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.46 . . . . 72.1 110.84 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 5.0 t 58.08 38.98 26.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.475 . . . . 72.33 110.902 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . 0.446 ' O ' HG23 ' A' ' 237' ' ' VAL . 3.6 mp -98.7 129.54 45.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.093 -0.503 . . . . 75.3 110.888 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.491 ' H ' HD12 ' A' ' 243' ' ' ILE . 4.0 mp -93.02 117.78 37.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.458 . . . . 65.32 111.12 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -117.53 144.3 18.22 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.766 -0.731 . . . . 55.25 112.468 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.641 HD21 HD21 ' A' ' 263' ' ' LEU . 0.0 OUTLIER -145.3 128.56 16.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.828 0.347 . . . . 75.15 110.953 -179.943 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -130.35 122.06 3.51 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.733 -0.746 . . . . 74.51 112.466 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -110.27 115.97 30.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.907 0.384 . . . . 75.24 110.949 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.899 HG23 HG23 ' A' ' 258' ' ' THR . 0.2 OUTLIER -110.58 114.88 28.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 51.44 111.143 -179.966 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -143.4 138.64 29.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 74.13 110.924 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 256' ' ' LYS . 16.3 p -77.95 147.51 34.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 74.25 111.137 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.4 ' HG ' ' HD2' ' A' ' 252' ' ' LYS . 13.8 tp -111.36 -74.71 0.63 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 75.43 110.954 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' LYS . . . . . 0.595 ' HG2' HD11 ' A' ' 255' ' ' ILE . 12.7 mmmt -97.43 163.15 20.36 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.564 0.697 . . . . 64.5 110.918 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . 0.593 ' HD2' ' HB3' ' A' ' 252' ' ' LYS . 53.7 Cg_endo -69.75 67.08 1.75 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.718 2.278 . . . . 71.21 112.335 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . 0.632 ' O ' ' HB3' ' A' ' 281' ' ' PHE . . . 157.67 -17.94 0.35 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.767 -0.73 . . . . 33.55 112.495 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.595 HD11 ' HG2' ' A' ' 252' ' ' LYS . 15.9 pt -129.36 141.5 46.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.928 0.394 . . . . 75.22 111.121 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 250' ' ' THR . 48.7 tttt -117.69 138.33 52.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 75.02 110.895 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 0.704 ' HA ' HD12 ' A' ' 279' ' ' LEU . 0.2 OUTLIER -96.09 128.56 43.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 74.15 110.92 179.919 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . 0.899 HG23 HG23 ' A' ' 248' ' ' THR . 4.4 m -119.81 122.62 41.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.465 . . . . 75.12 111.16 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.881 HD22 HD23 ' A' ' 277' ' ' LEU . 0.0 OUTLIER -110.29 138.94 45.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.218 -0.446 . . . . 75.51 110.912 179.971 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.559 ' O ' HD22 ' A' ' 275' ' ' LEU . 70.6 m -136.67 140.55 42.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 63.44 110.857 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -146.57 129.07 15.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.099 -0.5 . . . . 55.54 111.14 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.707 ' C ' HD13 ' A' ' 263' ' ' LEU . 2.8 tm? -121.94 130.05 53.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.27 -0.423 . . . . 72.02 110.924 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . 0.889 ' HB3' HG21 ' A' ' 268' ' ' VAL . 0.3 OUTLIER -124.24 110.55 14.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.469 . . . . 72.32 110.919 179.885 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . 0.562 ' O ' ' HB ' ' A' ' 268' ' ' VAL . 0.7 OUTLIER -86.8 98.33 11.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.155 -0.475 . . . . 54.01 110.846 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -53.02 -11.95 1.62 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.762 -0.732 . . . . 74.2 112.454 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -64.41 -25.46 68.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.78 0.324 . . . . 72.53 110.896 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -168.44 19.91 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 72.04 110.873 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . 0.889 HG21 ' HB3' ' A' ' 263' ' ' LEU . 1.7 p -68.52 -27.0 34.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 70.53 111.16 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -77.8 -44.83 26.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 61.14 110.922 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -95.93 12.41 30.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 64.43 111.11 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -129.62 -104.22 1.1 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.708 -0.758 . . . . 41.33 112.47 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -164.67 172.26 40.35 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.708 -0.758 . . . . 73.4 112.489 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' HIS . . . . . 0.406 ' CB ' HD12 ' A' ' 263' ' ' LEU . 2.4 p-80 -105.25 146.66 29.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.839 0.352 . . . . 74.21 110.909 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -95.66 136.34 36.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 74.21 110.884 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.744 HD13 ' N ' ' A' ' 276' ' ' GLY . 2.5 tm? -134.36 139.07 45.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.243 -0.435 . . . . 62.13 110.917 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . 0.744 ' N ' HD13 ' A' ' 275' ' ' LEU . . . -140.04 130.29 4.61 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.685 -0.769 . . . . 63.02 112.462 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.881 HD23 HD22 ' A' ' 259' ' ' LEU . 3.5 tm? -115.93 138.67 50.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.859 0.361 . . . . 72.11 110.904 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . 0.656 ' N ' HD13 ' A' ' 277' ' ' LEU . . . -162.04 129.06 2.0 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.74 -0.743 . . . . 51.0 112.474 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.704 HD12 ' HA ' ' A' ' 257' ' ' LEU . 0.1 OUTLIER -108.69 127.99 54.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.784 0.326 . . . . 73.14 110.896 -179.916 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . 0.423 ' O ' ' HB2' ' A' ' 281' ' ' PHE . 1.8 pm0 -140.92 147.06 38.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.162 -0.472 . . . . 71.11 110.888 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.632 ' HB3' ' O ' ' A' ' 254' ' ' GLY . 0.0 OUTLIER 168.73 -157.99 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.134 -0.484 . . . . 72.42 110.842 -179.945 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -136.22 143.15 44.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.145 -0.48 . . . . 63.12 110.984 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.736 ' CB ' HD11 ' A' ' 31' ' ' LEU . . . -91.17 112.43 24.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 74.02 111.131 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.666 HD22 ' O ' ' A' ' 283' ' ' ALA . 1.5 mm? -136.99 179.18 6.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.23 -0.441 . . . . 71.05 110.944 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.214 -0.448 . . . . 60.31 110.898 179.962 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' NAI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.2 mtm . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.813 0.339 . . . . 73.31 110.884 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -159.1 133.5 7.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 34.44 111.1 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.733 HG11 ' O ' ' A' ' 119' ' ' LYS . 24.8 t -139.7 82.16 18.52 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.601 0.715 . . . . 73.21 111.127 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 168.28 21.98 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.712 2.275 . . . . 64.33 112.319 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 95.55 0.56 Allowed 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.636 2.224 . . . . 71.23 112.349 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -79.64 -48.6 13.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.247 -0.433 . . . . 72.11 111.088 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.427 ' HB2' HG11 ' A' ' 143' ' ' VAL . 35.7 t80 -52.79 -40.52 63.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.21 -0.45 . . . . 71.32 110.931 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.99 -19.86 58.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.134 -0.485 . . . . 71.12 111.109 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -88.62 10.47 20.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.168 -0.469 . . . . 74.54 110.833 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.884 HD21 ' HA3' ' A' ' 152' ' ' GLY . 0.6 OUTLIER -64.59 -34.15 77.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.456 . . . . 72.32 110.935 -179.986 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -152.09 63.57 0.38 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.748 -0.739 . . . . 74.33 112.499 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.34 -54.51 14.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.833 0.349 . . . . 75.41 110.879 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 m -64.02 -39.49 94.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 64.15 110.83 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.51 -37.7 73.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 73.13 111.11 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 63.2 mtt-85 -61.85 -36.85 82.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.451 . . . . 74.3 110.874 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.91 -37.97 82.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.218 -0.446 . . . . 71.44 110.855 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 97.6 t -75.24 -35.88 35.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.143 -0.48 . . . . 74.33 111.139 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -60.92 -41.0 95.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 61.34 110.853 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.0 m 51.9 78.34 0.12 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 73.42 111.137 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.84 119.74 11.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.44 . . . . 75.41 110.862 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.46 96.74 1.28 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.733 -0.746 . . . . 73.3 112.507 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -86.55 -175.83 5.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.928 0.394 . . . . 72.43 110.932 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.84 114.5 5.34 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.728 -0.748 . . . . 64.2 112.478 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -103.9 12.85 33.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.956 0.408 . . . . 75.22 110.924 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.61 14.18 77.79 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.685 -0.769 . . . . 73.35 112.498 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.554 HD12 ' N ' ' A' ' 27' ' ' ILE . 2.2 pp -114.81 179.81 3.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.794 0.331 . . . . 74.05 110.932 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.918 HG23 HD12 ' A' ' 277' ' ' LEU . 32.6 mm -109.87 125.84 67.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 65.4 111.125 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.54 ' O ' HD22 ' A' ' 279' ' ' LEU . 8.9 mttt -102.84 149.85 24.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.182 -0.463 . . . . 73.1 110.878 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.617 HD13 ' N ' ' A' ' 30' ' ' ASP . 0.5 OUTLIER -147.1 130.3 16.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 54.35 110.911 179.918 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.617 ' N ' HD13 ' A' ' 29' ' ' LEU . 18.2 m-20 -146.71 126.3 13.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.207 -0.452 . . . . 73.15 110.897 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.794 HD11 ' HB3' ' A' ' 283' ' ' ALA . 2.0 tm? -134.78 125.54 27.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 74.31 110.922 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.522 ' N ' HD13 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -120.86 147.23 45.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.218 -0.446 . . . . 75.13 110.898 179.86 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.9 p -137.2 120.48 16.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.44 . . . . 74.01 111.15 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 40.1 mtpt -115.32 129.99 56.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.245 -0.434 . . . . 74.14 110.917 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -125.44 138.13 54.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 74.32 110.822 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -76.85 60.29 1.73 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.476 . . . . 72.13 110.868 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.446 ' O ' HD22 ' A' ' 39' ' ' LEU . 31.0 m-80 -159.28 23.12 0.19 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 54.03 110.895 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.581 ' HA2' ' O ' ' A' ' 63' ' ' ARG . . . 79.59 -3.73 67.34 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.781 -0.723 . . . . 51.52 112.437 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.446 HD22 ' O ' ' A' ' 37' ' ' ASN . 3.0 mm? -97.39 124.3 41.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.802 0.334 . . . . 73.12 110.899 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -145.26 117.98 8.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.134 -0.484 . . . . 62.21 110.893 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -111.71 123.58 50.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.481 . . . . 70.12 110.902 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.65 120.97 30.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 74.13 111.168 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.9 p -121.37 142.36 50.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 64.03 110.87 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 21.0 m -147.99 136.05 21.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.147 -0.479 . . . . 61.31 110.861 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -172.87 158.85 29.08 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.759 -0.734 . . . . 74.34 112.492 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -138.32 150.69 46.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.911 0.386 . . . . 74.52 110.872 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -121.17 130.74 53.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.475 . . . . 64.1 111.055 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -72.07 118.94 15.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 74.12 110.91 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 33.8 m -58.73 149.68 25.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.47 . . . . 71.21 111.186 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 39.9 40.13 0.67 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 74.13 110.92 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 98.8 m -161.26 126.69 3.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.154 -0.475 . . . . 74.32 111.126 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 71.5 p -76.24 66.8 2.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.251 -0.432 . . . . 75.31 111.153 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.6 ttmt -156.27 104.04 2.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 74.43 110.886 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.2 m -126.47 148.29 31.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.182 -0.463 . . . . 61.55 111.146 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 91.5 m -116.26 126.61 53.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 52.32 111.164 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -127.73 150.8 18.38 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.742 -0.742 . . . . 71.04 112.478 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 78.0 p -146.29 142.23 28.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.918 0.39 . . . . 72.34 110.869 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.516 HD13 ' N ' ' A' ' 59' ' ' GLU . 0.6 OUTLIER -121.88 125.27 46.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.124 -0.489 . . . . 72.31 110.935 179.966 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.516 ' N ' HD13 ' A' ' 58' ' ' LEU . 5.7 pt-20 -124.77 129.47 50.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 73.04 110.902 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.9 t -99.63 128.85 45.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.135 -0.484 . . . . 53.4 111.129 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 71' ' ' PHE . 26.7 ttmt -126.98 154.36 44.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 72.01 110.906 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.434 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 9.4 m-85 -130.38 140.08 50.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.443 . . . . 71.12 110.887 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.581 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 21.7 tpp85 -118.0 103.99 10.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.062 -0.517 . . . . 73.12 110.879 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -106.4 114.66 28.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 74.25 110.895 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 6.0 t -94.41 -167.55 1.68 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.209 -0.45 . . . . 74.1 111.108 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 59.41 30.42 20.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 71.32 110.857 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 179.58 -53.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 65.41 110.949 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 110.51 64.77 0.53 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.732 -0.747 . . . . 65.5 112.505 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.0 mp -134.44 132.33 39.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.88 0.371 . . . . 72.42 110.933 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 44.2 p -136.29 135.1 38.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 63.11 111.167 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.655 ' CD2' HG22 ' A' ' 85' ' ' ILE . 23.7 t80 -117.46 131.14 56.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.241 -0.436 . . . . 74.33 110.899 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.59 HG23 ' HB2' ' A' ' 84' ' ' GLU . 3.8 t -128.56 121.09 27.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 72.22 111.107 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -126.62 130.21 50.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 75.2 110.883 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 5.4 ttpm? -113.0 110.82 21.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.479 . . . . 73.23 110.883 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.421 ' CD1' ' CB ' ' A' ' 81' ' ' LEU . 2.6 t90 -115.67 126.92 54.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 71.5 110.908 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -120.74 136.11 54.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.25 -0.432 . . . . 74.13 110.904 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 9.5 t -70.5 -36.08 73.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 74.24 111.177 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -111.6 -35.37 5.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.207 -0.451 . . . . 72.05 110.886 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -78.88 -154.0 0.07 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 72.51 110.904 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.1 t -78.97 149.39 32.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 64.34 111.135 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.421 ' CB ' ' CD1' ' A' ' 75' ' ' TRP . 0.1 OUTLIER -124.04 117.64 25.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 53.42 110.897 179.962 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.83 170.16 39.03 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.743 -0.742 . . . . 60.22 112.489 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -131.52 159.63 37.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.776 0.322 . . . . 72.44 111.119 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.59 ' HB2' HG23 ' A' ' 72' ' ' THR . 40.4 mt-10 -142.42 144.54 33.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 74.11 110.899 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.655 HG22 ' CD2' ' A' ' 71' ' ' PHE . 1.5 pp -121.61 138.87 50.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 71.51 111.146 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.451 HG22 ' HE2' ' A' ' 96' ' ' LYS . 0.2 OUTLIER -128.46 127.73 43.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 71.35 111.123 179.996 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.424 HG22 ' HB2' ' A' ' 97' ' ' LEU . 3.9 m -128.39 138.36 54.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 75.24 111.099 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -118.47 128.48 54.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.139 -0.482 . . . . 73.22 110.922 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 56.98 39.85 29.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.184 -0.462 . . . . 74.21 110.88 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -66.81 -35.32 79.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.452 . . . . 75.43 110.872 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.3 tt -122.31 -37.12 2.85 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.24 -0.436 . . . . 64.41 110.904 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -146.67 138.4 24.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 72.51 111.112 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -59.73 134.45 57.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.25 -0.432 . . . . 73.01 110.853 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 100.37 -23.45 35.8 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.717 -0.754 . . . . 62.11 112.473 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.472 HD12 ' HB3' ' A' ' 118' ' ' TYR . 4.7 tp -95.62 129.4 42.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.879 0.371 . . . . 51.42 110.898 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.587 ' C ' HD13 ' A' ' 97' ' ' LEU . 8.8 tttm -122.66 131.48 53.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 72.04 110.904 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.587 HD13 ' C ' ' A' ' 96' ' ' LYS . 0.5 OUTLIER -116.82 127.31 54.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.235 -0.439 . . . . 72.55 110.934 179.877 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.446 HG23 HG23 ' A' ' 86' ' ' THR . 2.8 m -129.76 123.53 31.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.203 -0.453 . . . . 73.43 111.127 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.733 ' CD2' HD13 ' A' ' 114' ' ' ILE . 1.1 t80 -110.38 121.97 46.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.459 . . . . 75.54 110.874 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -110.36 124.49 51.8 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.163 -0.472 . . . . 74.34 110.877 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.0 t -124.14 121.45 35.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 73.33 110.865 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 75.7 m -114.88 145.86 41.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 75.13 110.852 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -135.12 137.41 42.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.147 -0.479 . . . . 54.25 110.895 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.7 t -128.41 138.94 34.12 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.681 0.753 . . . . 75.42 110.847 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.79 -23.91 30.13 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.646 2.231 . . . . 73.44 112.319 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -56.2 99.06 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.431 . . . . 75.42 110.877 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 53.2 26.92 5.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 75.31 111.171 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 67.15 24.5 73.35 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.71 -0.757 . . . . 53.25 112.515 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 58.3 tttt -65.43 118.02 8.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.881 0.372 . . . . 72.01 110.87 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 17.6 pttm -122.59 151.09 41.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 73.01 110.893 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -127.2 136.59 52.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 74.4 110.862 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -116.04 131.03 57.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 54.34 111.092 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -138.28 138.68 38.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 62.14 110.865 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.733 HD13 ' CD2' ' A' ' 99' ' ' PHE . 5.4 tp -134.07 127.32 51.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 44.2 111.135 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 7.2 mmtp -119.53 118.86 32.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 73.33 110.885 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.1 t -129.74 119.67 23.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.216 -0.447 . . . . 63.32 111.099 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.483 ' HA3' ' HA2' ' A' ' 126' ' ' GLY . . . -153.29 168.76 32.06 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.693 -0.765 . . . . 72.12 112.476 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.472 ' HB3' HD12 ' A' ' 95' ' ' LEU . 41.7 p90 -133.16 132.05 41.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.971 0.415 . . . . 72.33 110.95 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.733 ' O ' HG11 ' A' ' 3' ' ' VAL . 18.0 mtmm -108.18 119.47 39.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 72.54 110.95 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 43.3 ttt180 -110.14 143.53 40.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.279 -0.419 . . . . 72.51 110.878 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -51.48 -28.01 12.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 74.44 110.901 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 70.7 m80 -89.17 -40.12 13.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 64.43 110.861 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.91 HD13 HD13 ' A' ' 144' ' ' LEU . 2.3 tp -149.23 138.3 15.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 74.12 111.077 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.62 ' H ' HD12 ' A' ' 123' ' ' ILE . 0.3 OUTLIER -105.03 118.66 37.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 65.12 110.851 179.947 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -116.51 140.52 49.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 54.34 110.91 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.483 ' HA2' ' HA3' ' A' ' 117' ' ' GLY . . . -143.29 121.52 1.71 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.749 -0.739 . . . . 40.41 112.476 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -112.47 107.71 16.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.8 0.333 . . . . 74.34 110.881 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -104.92 145.18 30.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.223 -0.444 . . . . 73.32 110.836 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 96.8 mtp -138.68 136.1 35.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 73.14 110.892 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -128.27 135.69 49.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 75.51 110.854 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -95.8 102.38 14.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 64.42 110.9 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.4 149.87 21.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.134 -0.485 . . . . 72.21 110.847 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.538 HD12 ' O ' ' A' ' 133' ' ' ILE . 1.2 tp -52.71 -44.06 45.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 52.4 111.14 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -73.77 -18.93 60.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 54.54 111.084 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 155.24 150.34 5.54 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.797 -0.716 . . . . 72.22 112.504 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 112.37 3.05 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.749 2.3 . . . . 61.22 112.322 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.5 m -81.89 147.55 29.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.442 . . . . 63.42 110.847 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.1 mp -107.28 118.83 55.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 74.51 111.126 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 -106.95 121.85 45.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 72.31 110.83 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -110.99 133.83 11.79 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.778 -0.725 . . . . 63.13 112.503 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -131.38 122.54 26.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.798 0.332 . . . . 72.42 111.082 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.839 HD21 HD11 ' A' ' 123' ' ' ILE . 0.3 OUTLIER -140.39 122.35 15.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.242 -0.436 . . . . 44.21 110.89 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.528 ' HA ' ' HA2' ' A' ' 152' ' ' GLY . 0.7 OUTLIER -133.76 144.93 34.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 62.23 111.1 179.866 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.91 HD13 HD13 ' A' ' 123' ' ' ILE . 3.5 mm? -107.84 139.96 41.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.184 -0.462 . . . . 72.24 110.902 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -110.7 118.7 5.03 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.771 -0.728 . . . . 60.32 112.471 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -122.91 146.38 47.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.901 0.381 . . . . 74.42 110.902 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -50.44 96.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.118 -0.492 . . . . 64.41 110.931 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 93.94 -29.41 8.69 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.783 -0.722 . . . . 73.25 112.475 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 36.6 m95 -102.15 141.7 34.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.833 0.349 . . . . 74.15 110.903 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.444 HD22 HD12 ' A' ' 10' ' ' LEU . 0.4 OUTLIER -134.98 136.61 42.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.436 . . . . 63.31 110.91 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -142.77 143.88 32.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.448 . . . . 75.43 111.082 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.884 ' HA3' HD21 ' A' ' 10' ' ' LEU . . . -153.48 144.09 10.94 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.72 -0.752 . . . . 72.31 112.473 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -145.12 119.21 9.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.849 0.356 . . . . 54.04 110.923 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -118.95 123.79 45.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.145 -0.48 . . . . 74.34 110.89 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.7 134.68 52.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 44.04 110.894 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.62 ' O ' HG22 ' A' ' 164' ' ' VAL . 27.6 t-20 -112.29 123.07 49.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.253 -0.43 . . . . 71.32 110.876 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.456 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 15.0 t80 -94.4 125.88 39.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 71.44 110.888 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.691 ' OE2' ' HB3' ' A' ' 160' ' ' ALA . 0.1 OUTLIER -79.33 103.16 9.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.136 -0.484 . . . . 72.15 110.904 -179.912 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 75.5 m -65.53 -48.18 73.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 65.14 111.171 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.691 ' HB3' ' OE2' ' A' ' 158' ' ' GLU . . . -48.35 -26.12 1.9 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 74.21 111.103 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 12.1 mmtp -125.79 -168.76 1.89 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 72.11 110.874 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 2.4 m -110.63 40.2 2.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 75.22 110.875 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 2.4 tpp180 -156.67 175.25 14.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.131 -0.486 . . . . 73.42 110.904 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.62 HG22 ' O ' ' A' ' 156' ' ' ASN . 0.9 OUTLIER -74.52 142.5 14.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 64.31 111.124 179.966 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.429 ' HB ' ' HG2' ' A' ' 158' ' ' GLU . 2.5 t -90.63 -34.6 15.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.459 . . . . 75.24 111.14 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -153.99 136.14 14.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.244 -0.434 . . . . 72.33 110.897 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -123.06 127.34 48.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.446 . . . . 70.43 110.858 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -135.68 142.75 45.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 63.23 110.926 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -149.03 140.13 23.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 75.02 110.878 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.546 ' HB3' HD23 ' A' ' 10' ' ' LEU . . . -148.49 129.12 14.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 74.23 111.107 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 7.3 t -148.1 139.59 17.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.451 . . . . 62.13 111.112 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.432 ' HA2' HD23 ' A' ' 180' ' ' LEU . . . -165.25 163.83 36.78 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.723 -0.751 . . . . 75.24 112.504 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -118.95 125.09 48.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.946 0.403 . . . . 74.25 110.919 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 39.9 mtpt -101.84 126.14 48.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.132 -0.485 . . . . 65.44 110.926 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.511 ' HB ' ' H ' ' A' ' 178' ' ' PHE . 1.2 m -131.26 165.02 24.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.444 . . . . 70.25 111.112 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.406 ' H ' HG22 ' A' ' 175' ' ' THR . 34.4 t70 -78.14 -7.76 57.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 52.12 110.86 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -118.13 -31.65 4.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.211 -0.45 . . . . 71.05 110.873 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.511 ' H ' ' HB ' ' A' ' 175' ' ' THR . 18.4 p90 -144.54 150.14 37.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 75.4 110.891 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -136.51 123.05 20.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 71.43 110.913 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.466 HD12 HG13 ' A' ' 194' ' ' ILE . 0.3 OUTLIER -124.15 128.26 49.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.211 -0.45 . . . . 65.12 110.943 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 15.7 m170 -131.36 115.01 15.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 73.32 110.865 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . 0.481 HG22 ' O ' ' A' ' 191' ' ' GLY . 0.2 OUTLIER -101.05 135.55 42.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 54.01 111.144 -179.909 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -128.0 139.25 52.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.441 . . . . 73.31 110.92 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.426 ' O ' HG12 ' A' ' 184' ' ' VAL . 2.8 t -134.33 110.04 13.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 53.21 111.147 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -101.08 89.46 3.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 72.11 110.898 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 65.77 179.46 0.2 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 63.24 110.865 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -73.1 -3.49 60.85 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.684 -0.77 . . . . 71.31 112.466 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 5.7 m -95.96 -25.54 15.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.804 0.335 . . . . 61.43 111.174 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -121.95 112.49 18.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.192 -0.458 . . . . 72.42 110.903 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -138.85 123.41 18.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.135 -0.484 . . . . 75.31 110.883 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.481 ' O ' HG22 ' A' ' 182' ' ' THR . . . 174.17 -154.86 20.35 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.715 -0.755 . . . . 43.13 112.456 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -176.56 -163.2 28.55 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.743 -0.741 . . . . 75.04 112.471 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . 0.595 ' C ' HD12 ' A' ' 194' ' ' ILE . 11.4 p -148.39 155.47 41.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.857 0.361 . . . . 64.24 110.868 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.595 HD12 ' C ' ' A' ' 193' ' ' SER . 3.5 mp -131.62 120.27 44.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.122 -0.49 . . . . 43.51 111.104 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -108.87 121.05 44.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.188 -0.46 . . . . 74.2 110.922 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -125.52 131.52 52.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.476 . . . . 61.32 110.891 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 1.8 tppp? -96.04 127.66 42.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 72.21 110.863 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.501 HG12 ' HB2' ' A' ' 201' ' ' LYS . 34.5 t -85.73 117.36 30.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.44 . . . . 74.24 111.135 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -49.82 132.96 22.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 74.43 110.867 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp 51.05 33.82 9.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 61.44 110.893 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . 0.501 ' HB2' HG12 ' A' ' 198' ' ' VAL . 4.8 mmtp -153.83 -167.31 2.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 75.43 110.861 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.509 HD12 ' O ' ' A' ' 203' ' ' GLU . 1.4 pp -79.19 -168.49 1.51 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.45 . . . . 72.24 110.936 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.509 ' O ' HD12 ' A' ' 202' ' ' LEU . 12.0 mt-10 -115.11 136.15 53.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 64.21 110.884 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 11.5 t -123.96 138.78 54.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.12 -0.491 . . . . 45.15 111.143 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -145.01 163.49 34.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.434 . . . . 72.01 111.117 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 1.7 m -133.58 149.08 30.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.255 -0.429 . . . . 54.32 111.094 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -113.91 131.52 56.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 73.11 110.89 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -119.71 129.93 54.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 62.2 110.955 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.603 ' HB3' ' HB3' ' A' ' 218' ' ' ARG . . . -138.42 130.77 28.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.446 . . . . 73.51 111.1 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 11.7 t90 -130.09 123.21 29.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 72.14 110.9 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 94.5 m -112.22 110.51 20.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.264 -0.425 . . . . 73.12 111.173 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -51.4 128.09 21.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.263 -0.426 . . . . 64.34 111.095 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 163.78 -73.66 0.18 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.749 -0.738 . . . . 64.5 112.514 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 65.9 m-80 -125.61 33.79 5.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.804 0.335 . . . . 75.14 110.861 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 43.4 m 51.43 52.77 14.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.452 . . . . 50.03 110.858 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -94.69 112.0 23.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.122 -0.49 . . . . 64.2 110.938 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 2.5 p -94.29 135.63 35.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 74.14 111.121 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . 0.603 ' HB3' ' HB3' ' A' ' 209' ' ' ALA . 17.7 tpp85 -117.41 119.18 34.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 74.3 110.845 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . 0.504 ' CE2' HD11 ' A' ' 221' ' ' ILE . 21.4 t80 -122.83 137.6 54.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 74.01 110.893 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -145.69 159.17 27.87 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.767 -0.73 . . . . 22.01 112.52 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.504 HD11 ' CE2' ' A' ' 219' ' ' PHE . 4.7 mp -137.29 130.46 43.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.828 0.347 . . . . 71.44 111.133 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -124.89 141.52 52.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 73.21 111.117 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.481 ' HB3' ' HB3' ' A' ' 235' ' ' ALA . . . -116.08 134.84 54.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.243 -0.435 . . . . 64.41 111.1 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 11.1 mttt -120.64 115.44 23.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 73.23 110.905 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -130.75 128.66 41.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.232 -0.44 . . . . 73.45 110.899 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -111.92 115.99 29.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.158 -0.474 . . . . 71.42 110.941 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 8.1 tp -103.05 -35.21 3.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 71.42 111.128 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.684 ' HB2' ' HB3' ' A' ' 231' ' ' ALA . 2.7 m-20 -130.24 160.6 64.82 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.64 0.733 . . . . 74.41 110.857 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.72 -32.58 18.45 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.684 2.256 . . . . 74.1 112.312 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -107.19 10.27 30.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 74.44 110.838 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.684 ' HB3' ' HB2' ' A' ' 228' ' ' ASP . . . -141.41 127.18 19.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 61.3 111.123 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 42.4 t -134.47 141.97 46.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.255 -0.429 . . . . 63.54 110.924 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -112.25 130.24 56.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 74.11 110.873 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 84.2 p -129.51 140.62 51.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.464 . . . . 54.33 110.885 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . 0.481 ' HB3' ' HB3' ' A' ' 223' ' ' ALA . . . -127.01 159.29 34.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 73.3 111.126 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.77 147.81 21.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.217 -0.447 . . . . 72.34 110.917 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 242' ' ' LEU . 5.4 p -144.86 142.69 22.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.444 . . . . 55.43 111.15 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -106.54 147.64 29.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 75.44 110.92 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -54.71 -21.01 9.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.185 -0.461 . . . . 70.21 110.9 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 3.7 m -81.7 26.28 0.5 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.459 . . . . 64.51 110.874 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 6.8 t 59.98 39.33 20.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.081 -0.509 . . . . 53.12 110.854 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . 0.458 ' O ' HG23 ' A' ' 237' ' ' VAL . 18.4 mt -98.91 124.9 44.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.12 -0.491 . . . . 71.43 110.903 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.467 ' H ' HD12 ' A' ' 243' ' ' ILE . 3.0 mp -99.83 118.73 46.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 71.42 111.09 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . 0.519 ' C ' HD13 ' A' ' 245' ' ' LEU . . . -129.49 138.75 10.45 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.714 -0.755 . . . . 73.33 112.471 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.665 ' N ' HD13 ' A' ' 245' ' ' LEU . 0.0 OUTLIER -145.92 158.93 43.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.865 0.364 . . . . 75.51 110.865 -179.885 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -162.57 144.27 9.49 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.719 -0.753 . . . . 55.14 112.443 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -128.31 131.84 48.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.99 0.424 . . . . 65.2 110.894 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 27.6 p -115.5 117.77 31.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.076 -0.511 . . . . 62.25 111.124 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -129.38 131.48 46.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 74.42 110.899 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 3.7 m -59.74 148.43 34.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 75.23 111.167 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 46.0 tp -78.58 -73.33 0.33 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 72.01 110.904 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' LYS . . . . . 0.47 ' N ' ' HD2' ' A' ' 253' ' ' PRO . 0.1 OUTLIER 179.29 -60.66 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.558 0.694 . . . . 65.13 110.882 179.848 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . 0.574 ' HG2' HD12 ' A' ' 255' ' ' ILE . 54.0 Cg_endo -69.77 -86.4 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.679 2.253 . . . . 71.52 112.395 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . 0.573 ' O ' ' HB3' ' A' ' 281' ' ' PHE . . . -146.7 33.9 1.38 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.746 -0.74 . . . . 55.3 112.499 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.574 HD12 ' HG2' ' A' ' 253' ' ' PRO . 3.6 mp -131.01 145.3 35.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.893 0.377 . . . . 63.22 111.093 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 279' ' ' LEU . 19.7 ttpp -113.12 135.41 53.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 71.51 110.882 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 0.773 ' HA ' HD12 ' A' ' 279' ' ' LEU . 5.1 tp -96.74 124.35 40.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 74.51 110.879 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . 0.417 ' N ' HD12 ' A' ' 257' ' ' LEU . 2.8 p -124.29 122.34 37.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.161 -0.472 . . . . 72.14 111.115 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.789 HD22 HD23 ' A' ' 277' ' ' LEU . 0.1 OUTLIER -116.58 126.53 53.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 74.02 110.92 179.938 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.436 ' O ' HD22 ' A' ' 275' ' ' LEU . 27.7 p -124.92 145.84 49.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 62.1 110.878 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' ALA . . . . . 0.426 ' HB3' ' CD2' ' A' ' 245' ' ' LEU . . . -147.99 135.25 20.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 70.11 111.112 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.691 ' C ' HD13 ' A' ' 263' ' ' LEU . 2.4 tm? -125.41 122.22 36.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.453 . . . . 71.11 110.877 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . 0.829 ' HB3' HG11 ' A' ' 268' ' ' VAL . 0.2 OUTLIER -120.03 109.86 15.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 73.3 110.929 179.855 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . 0.639 ' O ' HG22 ' A' ' 268' ' ' VAL . 0.8 OUTLIER -82.72 116.95 22.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.184 -0.462 . . . . 74.25 110.831 179.844 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -54.41 -21.15 19.09 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.744 -0.741 . . . . 72.25 112.464 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.77 -26.56 20.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.839 0.352 . . . . 74.43 110.912 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 13.8 m-20 -95.42 -57.86 2.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.194 -0.457 . . . . 62.11 110.926 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . 0.829 HG11 ' HB3' ' A' ' 263' ' ' LEU . 11.7 m -51.6 -29.34 9.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.469 . . . . 62.45 111.104 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -53.02 -36.43 60.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 62.31 110.89 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -103.65 -17.69 15.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 75.24 111.144 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 124.73 100.75 1.34 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.691 -0.766 . . . . 74.23 112.45 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 168.16 92.74 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.722 -0.752 . . . . 73.14 112.493 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 19.2 p80 -111.9 144.64 40.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.899 0.38 . . . . 75.24 110.83 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -102.26 137.34 40.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 65.13 110.935 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.745 HD13 ' N ' ' A' ' 276' ' ' GLY . 2.9 tm? -135.94 144.11 45.28 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.253 -0.43 . . . . 74.22 110.927 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . 0.745 ' N ' HD13 ' A' ' 275' ' ' LEU . . . -147.52 133.65 4.81 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.694 -0.765 . . . . 31.44 112.492 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.918 HD12 HG23 ' A' ' 27' ' ' ILE . 2.8 tm? -125.81 135.23 51.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.819 0.342 . . . . 70.14 110.913 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . 0.73 ' C ' HD13 ' A' ' 279' ' ' LEU . . . -161.59 140.08 6.4 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.694 -0.765 . . . . 45.12 112.488 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.773 HD12 ' HA ' ' A' ' 257' ' ' LEU . 0.0 OUTLIER -119.59 129.86 54.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.809 0.337 . . . . 72.43 110.899 -179.938 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . 0.494 ' O ' ' HB2' ' A' ' 281' ' ' PHE . 2.5 pp20? -141.94 146.41 35.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.47 . . . . 71.12 110.899 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.573 ' HB3' ' O ' ' A' ' 254' ' ' GLY . 0.3 OUTLIER 172.08 -150.75 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.155 -0.475 . . . . 65.21 110.894 -179.88 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -138.55 144.68 40.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 73.32 110.891 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.794 ' HB3' HD11 ' A' ' 31' ' ' LEU . . . -113.09 112.6 24.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.45 . . . . 72.41 111.128 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 12.7 mt -130.41 178.63 6.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 61.34 110.878 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 71.41 110.909 179.943 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' NAI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.4 mmt . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.794 0.331 . . . . 73.33 110.886 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -110.21 -171.67 1.88 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 72.01 111.111 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.1 t 61.18 75.62 0.44 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.668 0.747 . . . . 63.04 111.083 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 167.91 23.06 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.667 2.244 . . . . 63.32 112.362 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 108.97 2.2 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.734 2.289 . . . . 73.12 112.326 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.483 HG23 HG11 ' A' ' 143' ' ' VAL . 12.3 t -107.15 -28.47 9.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 74.05 111.138 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.755 ' CB ' HG21 ' A' ' 143' ' ' VAL . 32.9 p90 -55.53 -30.59 61.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.25 -0.432 . . . . 73.42 110.92 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -72.26 -19.4 61.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.108 -0.497 . . . . 64.5 111.114 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -95.03 11.9 30.4 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.243 -0.435 . . . . 74.21 110.878 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.677 HD21 ' HA3' ' A' ' 152' ' ' GLY . 0.8 OUTLIER -60.56 -33.05 72.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.211 -0.45 . . . . 70.25 110.87 -179.929 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -136.17 31.28 2.63 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.758 -0.734 . . . . 72.25 112.488 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.3 mmtt -69.58 -54.5 13.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.78 0.324 . . . . 62.5 110.88 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.9 t -60.25 -39.72 87.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.252 -0.431 . . . . 60.43 110.873 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.56 -37.62 76.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 74.0 111.113 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -61.05 -32.66 72.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 72.43 110.859 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -58.38 -48.45 80.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 60.54 110.866 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.5 t -80.43 -36.91 16.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 64.41 111.128 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -63.33 -34.98 78.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 74.03 110.888 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.2 m 65.06 80.51 0.23 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 70.15 111.159 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -57.77 -34.61 69.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.251 -0.431 . . . . 74.24 110.855 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -51.5 106.82 0.34 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.72 -0.753 . . . . 23.51 112.462 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -58.43 151.69 19.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.886 0.374 . . . . 74.25 110.942 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -133.8 69.26 0.53 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.727 -0.749 . . . . 43.53 112.531 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -91.95 13.71 17.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.906 0.384 . . . . 63.45 110.915 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.07 14.6 64.2 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.713 -0.756 . . . . 74.23 112.498 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.591 ' C ' HD12 ' A' ' 27' ' ' ILE . 1.2 pp -118.98 -179.1 3.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.762 0.315 . . . . 53.52 110.918 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.591 HD12 ' C ' ' A' ' 26' ' ' LEU . 1.6 mp -109.99 131.8 59.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 70.43 111.132 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.447 ' HG2' ' HA2' ' A' ' 278' ' ' GLY . 6.4 ptmm? -115.91 138.22 51.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 72.35 110.904 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.679 HD13 ' N ' ' A' ' 30' ' ' ASP . 3.2 tm? -123.67 136.45 54.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.235 -0.439 . . . . 70.4 110.891 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.679 ' N ' HD13 ' A' ' 29' ' ' LEU . 0.8 OUTLIER -126.76 127.78 45.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.469 . . . . 71.22 110.871 179.856 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.743 HD22 ' HB3' ' A' ' 281' ' ' PHE . 0.2 OUTLIER -115.75 125.1 52.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 65.31 110.902 -179.967 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.472 ' HD2' HG23 ' A' ' 42' ' ' THR . 5.3 tptp -123.57 125.09 44.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 63.34 110.866 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.9 m -135.42 120.67 18.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 71.12 111.14 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -134.22 125.6 28.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 61.54 110.875 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 38.4 t -127.24 143.7 51.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 71.44 110.859 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -76.59 58.72 1.41 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 73.03 110.885 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -147.67 16.96 1.13 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.146 -0.479 . . . . 73.55 110.865 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.555 ' HA2' ' O ' ' A' ' 63' ' ' ARG . . . 82.94 -5.3 76.55 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.729 -0.748 . . . . 62.21 112.489 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -101.14 126.22 47.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.8 0.333 . . . . 42.04 110.904 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.407 ' HB2' ' O ' ' A' ' 61' ' ' LYS . 0.8 OUTLIER -139.46 117.68 11.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.168 -0.469 . . . . 74.31 110.885 179.934 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.415 ' CZ ' HD21 ' A' ' 58' ' ' LEU . 5.4 t80 -107.07 121.48 44.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.122 -0.49 . . . . 61.4 110.887 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.472 HG23 ' HD2' ' A' ' 32' ' ' LYS . 3.9 m -127.96 115.15 18.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.141 -0.481 . . . . 73.34 111.183 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -122.05 141.7 51.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 72.51 110.864 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.4 p -151.01 126.41 10.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.464 . . . . 62.02 110.892 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -166.41 165.5 38.32 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.722 -0.751 . . . . 71.53 112.48 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 82.8 p -137.25 168.96 18.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.896 0.379 . . . . 53.12 110.876 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -158.63 140.57 13.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 51.14 111.118 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 46.0 t-20 -101.26 141.9 33.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.242 -0.435 . . . . 73.25 110.832 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.5 t -92.7 -35.24 13.58 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.168 -0.469 . . . . 64.31 111.165 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.85 -63.48 1.15 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.227 -0.442 . . . . 75.11 110.89 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.18 149.91 33.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.125 -0.489 . . . . 73.23 111.108 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.3 t -59.09 110.69 1.1 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.172 -0.467 . . . . 64.54 111.155 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.6 mtpm? -166.53 99.9 0.59 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.242 -0.436 . . . . 74.24 110.949 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 24.2 t -122.5 133.49 68.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.245 -0.434 . . . . 53.21 111.125 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.0 m -136.04 134.56 38.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.165 -0.47 . . . . 63.3 111.132 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -142.8 140.48 9.84 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.699 -0.762 . . . . 73.35 112.441 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.6 p -133.18 144.52 49.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.903 0.383 . . . . 72.11 110.839 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.606 HD13 ' N ' ' A' ' 59' ' ' GLU . 0.3 OUTLIER -120.92 134.51 55.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.108 -0.496 . . . . 72.05 110.903 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.606 ' N ' HD13 ' A' ' 58' ' ' LEU . 2.0 tt0 -134.33 123.05 23.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 74.21 110.888 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 23.1 p -107.0 134.0 50.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 41.45 111.095 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.407 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 47.6 mttt -133.41 159.68 39.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 52.23 110.931 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.521 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 9.2 t80 -121.06 129.67 53.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 73.42 110.892 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.555 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 3.9 ttt85 -112.9 103.43 11.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 74.52 110.865 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -112.73 98.65 7.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.188 -0.46 . . . . 62.21 110.933 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 60.68 163.43 0.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 62.31 111.156 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -78.78 145.16 34.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.248 -0.433 . . . . 73.13 110.877 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 26.0 p90 37.81 43.35 0.49 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.177 -0.465 . . . . 64.42 110.872 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.644 ' O ' HD22 ' A' ' 69' ' ' LEU . . . -123.75 -78.93 0.41 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.743 -0.742 . . . . 70.33 112.445 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.644 HD22 ' O ' ' A' ' 68' ' ' GLY . 3.4 mm? -134.59 129.06 34.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.914 0.387 . . . . 53.43 110.883 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.8 m -138.61 114.89 10.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.157 -0.474 . . . . 73.41 111.136 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.475 ' HA ' HG22 ' A' ' 85' ' ' ILE . 12.8 m-85 -99.39 132.89 44.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 71.03 110.894 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.73 119.87 31.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.122 -0.49 . . . . 53.4 111.181 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -131.52 122.56 26.36 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.196 -0.456 . . . . 34.55 110.902 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -106.38 137.49 44.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.153 -0.476 . . . . 71.13 110.908 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 9.8 t90 -134.53 128.75 33.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.456 . . . . 71.15 110.887 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 28.9 t30 -117.13 155.41 29.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 63.25 110.908 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 12.3 m -60.36 -18.12 48.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 73.42 111.127 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.417 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 9.0 m-20 -74.63 0.37 15.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 71.43 110.863 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.417 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 4.1 m120 77.16 38.55 0.23 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.198 -0.455 . . . . 60.24 110.885 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 28.3 m -114.83 125.63 53.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.455 . . . . 74.31 111.157 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.6 mp -114.14 127.35 55.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.294 -0.412 . . . . 74.34 110.939 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -113.42 107.71 1.98 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.788 -0.72 . . . . 72.22 112.489 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.1 m -87.52 131.45 34.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.713 0.292 . . . . 73.25 111.16 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -159.99 96.68 1.23 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 73.35 110.893 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.475 HG22 ' HA ' ' A' ' 71' ' ' PHE . 1.1 pp -111.6 138.65 39.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 61.13 111.172 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.687 HG23 ' OG1' ' A' ' 98' ' ' THR . 1.6 m -118.11 139.57 51.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 53.24 111.119 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.57 HG12 ' CD1' ' A' ' 69' ' ' LEU . 2.2 m -129.39 139.62 51.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 74.25 111.155 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 -97.8 129.18 44.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 73.35 110.926 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -50.56 168.61 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.199 -0.455 . . . . 74.12 110.893 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -123.45 -35.58 2.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 63.31 110.911 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 92.5 mt -96.79 -70.12 0.73 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.245 -0.434 . . . . 71.54 110.945 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.86 78.03 1.15 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 65.41 111.07 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 9.2 ptp85 -49.29 135.32 17.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.467 . . . . 73.32 110.889 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 101.59 9.29 44.11 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.715 -0.755 . . . . 65.52 112.531 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.605 HD12 ' N ' ' A' ' 96' ' ' LYS . 8.7 tp -114.93 129.15 56.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.898 0.38 . . . . 75.24 110.891 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.605 ' N ' HD12 ' A' ' 95' ' ' LEU . 31.5 pttt -124.56 136.19 53.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 74.54 110.897 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.582 HD13 ' O ' ' A' ' 96' ' ' LYS . 1.9 mm? -124.8 126.72 46.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 74.21 110.877 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.687 ' OG1' HG23 ' A' ' 86' ' ' THR . 7.6 m -125.61 139.41 53.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.462 . . . . 73.21 111.131 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.459 ' CE2' HD13 ' A' ' 114' ' ' ILE . 24.6 m-85 -116.02 123.01 46.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.252 -0.431 . . . . 64.12 110.841 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -113.97 130.29 56.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.112 -0.494 . . . . 73.1 110.855 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.5 m -142.41 134.07 26.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.475 . . . . 72.54 110.851 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.6 t -95.81 126.17 40.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.115 -0.493 . . . . 74.14 110.857 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -118.34 119.65 35.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.097 -0.502 . . . . 75.22 110.869 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.433 ' HA ' ' HD2' ' A' ' 105' ' ' PRO . 1.7 t -128.83 101.39 20.28 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.61 0.719 . . . . 72.5 110.919 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 104' ' ' SER . 53.4 Cg_endo -69.79 -32.89 17.56 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.681 2.254 . . . . 65.21 112.301 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 16.9 t30 -51.56 -74.25 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.269 -0.423 . . . . 54.11 110.916 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 6.0 m -77.02 -33.57 57.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 74.32 111.139 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.61 23.92 14.94 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.773 -0.727 . . . . 54.21 112.51 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -94.48 147.02 23.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.853 0.359 . . . . 74.41 110.907 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 27.6 ttpt -133.42 140.88 47.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.218 -0.446 . . . . 71.24 110.938 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -120.94 136.22 55.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 70.24 110.938 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -110.57 125.28 53.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 70.41 111.094 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 17.4 mtmt -138.87 138.23 37.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 73.12 110.888 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.459 HD13 ' CE2' ' A' ' 99' ' ' PHE . 5.7 tp -121.99 139.86 47.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.212 -0.449 . . . . 64.12 111.092 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.45 ' H ' HD12 ' A' ' 114' ' ' ILE . 19.8 ttpt -130.06 118.87 22.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.166 -0.47 . . . . 73.23 110.899 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.415 HG23 ' O ' ' A' ' 116' ' ' THR . 4.8 t -130.9 118.6 20.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.446 . . . . 73.11 111.13 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.472 ' HA3' ' HA2' ' A' ' 126' ' ' GLY . . . -152.99 159.14 28.32 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.695 -0.764 . . . . 24.11 112.476 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -129.34 138.34 51.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.982 0.42 . . . . 73.24 110.912 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 36.2 pttt -109.82 121.15 44.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.115 -0.493 . . . . 74.43 110.891 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 6.8 tpt180 -109.53 143.88 38.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 74.52 110.885 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -50.73 -28.31 8.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 72.25 110.881 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 59.2 m-70 -88.45 -41.97 12.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 75.34 110.897 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.687 ' CD1' HD22 ' A' ' 144' ' ' LEU . 2.2 tt -151.67 145.03 16.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 73.11 111.198 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -113.73 116.02 28.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 74.53 110.822 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.559 HD23 ' HG ' ' A' ' 142' ' ' LEU . 2.0 mt -119.24 141.45 48.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.472 . . . . 75.14 110.895 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.472 ' HA2' ' HA3' ' A' ' 117' ' ' GLY . . . -145.96 125.91 2.4 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.721 -0.752 . . . . 74.35 112.457 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 8.3 t -114.51 119.46 36.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.816 0.341 . . . . 53.31 110.883 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -118.9 146.58 44.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.466 . . . . 72.12 110.867 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 7.8 ttt -136.62 136.27 39.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.203 -0.453 . . . . 75.44 110.869 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -110.86 124.99 53.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.173 -0.467 . . . . 71.12 110.883 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -95.53 98.2 10.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 74.22 110.886 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -103.92 169.65 8.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.139 -0.482 . . . . 65.24 110.898 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 2.5 pp -74.91 -35.61 36.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 75.24 111.121 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -77.06 -20.27 56.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 74.12 111.07 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 154.16 149.64 5.28 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.705 -0.759 . . . . 62.13 112.467 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 114.5 3.73 Favored 'Trans proline' 0 C--O 1.231 0.146 0 C-N-CA 122.69 2.26 . . . . 73.35 112.315 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.64 148.76 30.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.211 -0.449 . . . . 75.03 110.915 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 5.3 mp -106.3 122.84 60.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.19 -0.459 . . . . 62.0 111.145 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 3.9 ttm105 -121.56 114.55 21.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 71.14 110.874 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -110.63 133.96 11.89 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.732 -0.747 . . . . 74.34 112.478 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -132.91 116.31 16.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.815 0.341 . . . . 54.52 111.109 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.74 HD22 HD21 ' A' ' 144' ' ' LEU . 0.2 OUTLIER -121.97 125.23 45.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.161 -0.472 . . . . 61.32 110.878 -179.939 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.798 ' C ' HD23 ' A' ' 144' ' ' LEU . 40.7 t -131.19 123.17 52.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 73.31 111.151 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.798 HD23 ' C ' ' A' ' 143' ' ' VAL . 0.3 OUTLIER -116.85 156.32 27.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 73.12 110.934 179.996 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -106.71 133.05 11.44 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.746 -0.74 . . . . 72.24 112.465 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.413 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 0.2 OUTLIER -128.58 147.88 50.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.823 0.344 . . . . 74.3 110.874 -179.765 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 48.7 tt0 -57.35 97.99 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.077 -0.511 . . . . 74.51 110.826 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.535 ' O ' ' HB3' ' A' ' 173' ' ' TYR . . . 86.04 -15.9 45.93 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.74 -0.743 . . . . 73.23 112.505 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.413 ' O ' ' CB ' ' A' ' 146' ' ' TYR . 5.1 m95 -123.61 146.68 47.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.78 0.324 . . . . 71.13 110.929 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.712 ' N ' ' HB2' ' A' ' 173' ' ' TYR . 13.0 tp -108.75 156.45 19.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.264 -0.426 . . . . 70.5 110.899 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.465 ' HB3' ' HB2' ' A' ' 144' ' ' LEU . . . -127.64 131.31 49.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.191 -0.459 . . . . 73.15 111.127 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.677 ' HA3' HD21 ' A' ' 10' ' ' LEU . . . -155.64 133.24 3.66 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.748 -0.739 . . . . 41.22 112.474 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -145.81 118.81 8.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.81 0.338 . . . . 73.11 110.941 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -122.43 123.13 40.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.096 -0.502 . . . . 74.04 110.883 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 97.8 mtp -133.57 134.89 43.89 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.172 -0.467 . . . . 61.22 110.873 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.478 ' O ' ' HB ' ' A' ' 164' ' ' VAL . 4.9 m120 -112.36 117.48 32.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 55.42 110.899 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.493 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 0.2 OUTLIER -87.23 125.69 34.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 74.11 110.882 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.719 ' OE1' ' HB3' ' A' ' 160' ' ' ALA . 0.2 OUTLIER -82.39 108.15 15.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.13 -0.486 . . . . 75.22 110.943 -179.951 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.488 HG23 ' N ' ' A' ' 160' ' ' ALA . 6.0 t -66.14 -47.14 75.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.476 . . . . 74.24 111.152 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.719 ' HB3' ' OE1' ' A' ' 158' ' ' GLU . . . -50.71 -26.17 5.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 71.01 111.063 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 10.6 mmtt -120.93 -167.72 1.54 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.244 -0.434 . . . . 54.44 110.889 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 50.1 m -112.92 39.29 2.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 62.45 110.885 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.66 174.88 9.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 73.12 110.853 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.493 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 1.0 OUTLIER -78.63 146.0 8.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 75.25 111.167 179.925 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.464 HG23 ' HG2' ' A' ' 166' ' ' GLN . 15.3 t -88.32 -34.11 17.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 74.13 111.109 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . 0.464 ' HG2' HG23 ' A' ' 165' ' ' THR . 30.1 pt20 -152.7 132.74 13.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 73.12 110.945 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 3.8 m -126.06 125.78 43.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 74.42 110.858 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 15.1 p-10 -135.72 137.02 41.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 54.24 110.891 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -131.64 150.26 52.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.459 . . . . 61.35 110.88 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -150.33 129.46 12.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.485 . . . . 55.24 111.068 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -145.69 138.5 20.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.157 -0.474 . . . . 73.54 111.123 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.454 ' O ' ' HB3' ' A' ' 150' ' ' LEU . . . 136.69 146.25 5.14 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.747 -0.74 . . . . 52.45 112.478 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . 0.712 ' HB2' ' N ' ' A' ' 150' ' ' LEU . 5.0 t80 -151.04 177.56 10.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.008 0.433 . . . . 75.44 110.88 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -97.1 136.08 38.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.105 -0.498 . . . . 71.33 110.895 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.651 ' O ' ' C ' ' A' ' 176' ' ' ASP . 0.2 OUTLIER -122.86 165.54 16.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.224 -0.443 . . . . 73.33 111.156 179.979 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.651 ' C ' ' O ' ' A' ' 175' ' ' THR . 2.0 m-20 -9.5 -86.72 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.25 -0.432 . . . . 73.22 110.869 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -120.35 12.95 11.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 53.3 110.884 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -130.2 116.58 18.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 74.12 110.889 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -114.13 124.2 51.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.135 -0.484 . . . . 62.03 110.91 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.525 HD13 ' C ' ' A' ' 180' ' ' LEU . 3.3 tm? -122.07 120.99 35.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 73.44 110.936 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . 0.415 ' HA ' ' HA3' ' A' ' 172' ' ' GLY . 0.1 OUTLIER -123.71 145.75 48.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 72.34 110.869 179.901 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.89 136.72 23.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 73.15 111.102 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 22.1 m120 -132.65 140.04 48.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 72.43 110.853 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.458 ' O ' HG12 ' A' ' 184' ' ' VAL . 2.5 t -132.74 110.38 15.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 71.42 111.117 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -99.0 90.07 4.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 72.13 110.893 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . 0.542 ' HB2' HG22 ' A' ' 188' ' ' THR . 1.0 OUTLIER 66.2 176.86 0.22 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.177 -0.465 . . . . 43.24 110.86 179.911 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -73.22 -2.2 58.44 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.737 -0.744 . . . . 63.53 112.52 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . 0.542 HG22 ' HB2' ' A' ' 186' ' ' ASP . 7.7 t -98.4 -25.35 14.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.742 0.306 . . . . 53.12 111.12 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -121.94 115.27 22.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 72.54 110.926 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -140.81 124.47 16.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 75.44 110.883 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -175.55 -161.6 25.25 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.756 -0.735 . . . . 33.14 112.503 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -175.33 -172.05 39.87 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.767 -0.73 . . . . 52.11 112.529 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 34.3 m -147.63 148.42 31.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.796 0.331 . . . . 75.21 110.877 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.404 ' N ' HD12 ' A' ' 194' ' ' ILE . 4.7 mp -119.63 130.96 73.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.12 -0.491 . . . . 75.04 111.168 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . 0.464 ' CD1' ' HB2' ' A' ' 205' ' ' ALA . 5.4 t80 -119.24 126.05 50.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.198 -0.455 . . . . 75.41 110.942 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 3.7 tm0? -124.75 131.13 53.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.095 -0.502 . . . . 54.43 110.881 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 36.0 mttt -100.64 127.23 47.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 63.5 110.873 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 16.4 t -80.33 152.63 4.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.27 -0.423 . . . . 75.42 111.174 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -51.15 -37.9 48.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 75.44 110.908 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.75 -170.4 2.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 51.25 110.92 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . 0.65 ' C ' HD12 ' A' ' 202' ' ' LEU . 1.6 ptmt -76.71 64.67 2.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 72.4 110.926 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.65 HD12 ' C ' ' A' ' 201' ' ' LYS . 6.3 mp -145.62 128.45 16.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.236 -0.438 . . . . 62.32 110.915 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -120.61 130.07 54.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.15 -0.477 . . . . 72.21 110.889 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 2.3 t -132.23 138.31 47.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 70.41 111.091 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.464 ' HB2' ' CD1' ' A' ' 195' ' ' TYR . . . -149.69 156.7 42.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 74.24 111.111 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.761 HG12 HG22 ' A' ' 221' ' ' ILE . 1.3 m -126.08 147.21 30.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 41.12 111.173 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -117.92 127.96 54.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.454 . . . . 72.3 110.923 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 2.2 mp -125.7 147.03 49.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 64.41 110.877 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -157.24 131.55 8.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 63.22 111.105 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 21.5 t90 -129.91 133.56 46.93 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.26 -0.427 . . . . 70.42 110.927 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -101.09 103.68 14.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.25 -0.432 . . . . 61.14 111.152 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -53.26 140.88 25.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.26 -0.427 . . . . 73.23 111.111 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 134.74 -72.76 0.46 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.689 -0.767 . . . . 42.44 112.481 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -171.79 36.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.793 0.33 . . . . 51.44 110.882 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 32.8 t -111.85 165.33 12.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 44.5 110.852 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -88.16 162.59 16.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 64.22 110.866 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 2.9 m -78.11 137.96 38.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 64.45 111.172 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 33.4 ttp180 -102.95 129.06 49.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 74.23 110.872 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -134.0 133.25 41.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 65.21 110.86 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -143.53 145.46 15.26 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.72 -0.752 . . . . 50.2 112.5 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.761 HG22 HG12 ' A' ' 206' ' ' VAL . 0.0 OUTLIER -122.14 138.32 52.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.863 0.363 . . . . 54.05 111.173 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -138.12 153.22 49.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.451 . . . . 73.11 111.13 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.457 ' HB1' ' CZ ' ' A' ' 225' ' ' TYR . . . -145.49 157.72 43.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.239 -0.437 . . . . 71.22 111.097 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 3.1 tttm -142.94 124.41 14.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.441 . . . . 73.32 110.861 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' TYR . . . . . 0.609 ' CE1' HD23 ' A' ' 202' ' ' LEU . 8.7 m-85 -133.6 133.93 42.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 62.42 110.938 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 7.9 mm-40 -79.15 130.71 35.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.139 -0.482 . . . . 72.02 110.894 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.937 HG23 ' HD2' ' A' ' 229' ' ' PRO . 1.3 tp -77.41 -38.34 26.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.469 . . . . 43.4 111.108 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.48 ' N ' ' HD2' ' A' ' 229' ' ' PRO . 0.3 OUTLIER 172.12 -60.91 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.6 0.714 . . . . 72.4 110.863 179.884 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.937 ' HD2' HG23 ' A' ' 227' ' ' ILE . 53.8 Cg_endo -69.76 -157.52 0.04 OUTLIER 'Trans proline' 0 C--O 1.231 0.148 0 C-N-CA 122.722 2.281 . . . . 72.24 112.315 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -85.37 15.23 4.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 72.44 110.906 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.66 ' HB2' ' HG3' ' A' ' 249' ' ' GLN . . . -120.59 122.0 39.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 75.54 111.078 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 13.0 p -112.79 144.56 42.12 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.444 . . . . 71.41 110.864 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -97.2 127.64 43.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 74.23 110.888 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 1.2 t -117.54 137.15 52.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.126 -0.488 . . . . 52.2 110.807 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -130.67 141.27 50.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 53.33 111.094 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 7.7 pttm -144.45 165.06 29.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 61.14 110.884 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 242' ' ' LEU . 8.7 p -154.93 146.23 13.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 73.25 111.124 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -104.82 147.69 27.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 64.34 110.848 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -53.46 -22.83 8.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.111 -0.495 . . . . 42.43 110.851 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 2.6 t -82.03 26.86 0.5 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 52.14 110.901 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 59.14 37.77 23.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.078 -0.51 . . . . 52.14 110.881 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . 0.625 ' HG ' HD11 ' A' ' 262' ' ' LEU . 1.0 OUTLIER -98.39 121.14 39.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.103 -0.499 . . . . 73.25 110.901 -179.972 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.542 ' O ' HD22 ' A' ' 262' ' ' LEU . 5.4 mp -86.82 123.06 39.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 70.12 111.128 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . 0.654 ' C ' HD12 ' A' ' 245' ' ' LEU . . . -115.81 133.8 11.09 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.74 -0.743 . . . . 74.44 112.492 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.654 HD12 ' C ' ' A' ' 244' ' ' GLY . 11.0 mp -130.58 129.81 43.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.878 0.37 . . . . 73.15 110.942 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -140.29 121.74 2.04 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.729 -0.748 . . . . 54.31 112.465 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -111.76 121.68 45.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.936 0.398 . . . . 75.43 110.964 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -109.75 120.8 43.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.476 . . . . 62.13 111.112 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . 0.66 ' HG3' ' HB2' ' A' ' 231' ' ' ALA . 25.9 tt0 -128.32 122.68 32.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 65.23 110.931 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . 0.494 HG23 ' HD3' ' A' ' 256' ' ' LYS . 96.0 m -110.31 111.51 22.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 71.53 111.137 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -106.37 88.57 2.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 73.34 110.904 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 6.2 mtmt 62.44 161.46 0.12 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.549 0.69 . . . . 73.22 110.925 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 76.84 1.13 Allowed 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.679 2.253 . . . . 70.11 112.306 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 169.34 -32.16 0.17 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.751 -0.738 . . . . 62.44 112.467 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 4.4 mp -118.19 122.47 69.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.831 0.348 . . . . 73.14 111.119 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.494 ' HD3' HG23 ' A' ' 250' ' ' THR . 25.7 mmtt -131.6 132.83 44.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.229 -0.442 . . . . 65.02 110.877 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 0.53 HD23 ' N ' ' A' ' 258' ' ' THR . 1.5 tt -114.11 127.05 55.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.223 -0.444 . . . . 73.3 110.878 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . 0.53 ' N ' HD23 ' A' ' 257' ' ' LEU . 13.9 p -126.45 117.11 22.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 54.24 111.12 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.5 HD13 ' N ' ' A' ' 260' ' ' SER . 0.2 OUTLIER -111.98 130.6 55.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 62.14 110.91 179.934 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.5 ' N ' HD13 ' A' ' 259' ' ' LEU . 15.8 p -127.25 140.6 52.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 70.31 110.87 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -151.99 128.79 10.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.127 -0.488 . . . . 61.53 111.105 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.625 HD11 ' HG ' ' A' ' 242' ' ' LEU . 1.5 tm? -125.21 115.8 20.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 75.54 110.868 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . 0.82 ' HB3' HG11 ' A' ' 268' ' ' VAL . 0.2 OUTLIER -112.63 109.62 19.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 74.42 110.928 179.884 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . 0.653 ' O ' HG22 ' A' ' 268' ' ' VAL . 0.8 OUTLIER -84.01 116.45 22.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.204 -0.453 . . . . 71.03 110.853 179.848 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -57.19 -16.58 20.24 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.716 -0.754 . . . . 64.14 112.513 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -86.11 -22.15 27.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.844 0.354 . . . . 72.22 110.945 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -108.57 -53.6 2.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 62.33 110.889 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . 0.82 HG11 ' HB3' ' A' ' 263' ' ' LEU . 17.4 m -50.88 -30.29 8.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 55.12 111.138 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -52.98 -41.02 64.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 65.23 110.864 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -103.73 -17.62 15.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.14 -0.482 . . . . 72.33 111.124 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 128.49 94.39 0.79 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.762 -0.732 . . . . 71.3 112.482 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 175.53 78.67 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.762 -0.732 . . . . 72.41 112.491 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' HIS . . . . . 0.661 ' HB2' HD12 ' A' ' 263' ' ' LEU . 13.0 p80 -104.91 144.19 32.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.853 0.359 . . . . 62.01 110.871 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 1.6 mtpt -99.43 136.19 39.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.268 -0.424 . . . . 65.12 110.887 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.763 HD13 ' N ' ' A' ' 276' ' ' GLY . 2.6 tm? -136.58 144.91 44.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 73.11 110.88 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . 0.763 ' N ' HD13 ' A' ' 275' ' ' LEU . . . -154.19 130.63 2.96 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.729 -0.748 . . . . 52.43 112.487 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.471 ' HB3' HG13 ' A' ' 27' ' ' ILE . 0.1 OUTLIER -113.7 140.21 48.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.824 0.345 . . . . 74.32 110.928 -179.923 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . 0.612 ' O ' HD13 ' A' ' 279' ' ' LEU . . . -147.16 126.79 2.5 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.781 -0.723 . . . . 54.42 112.502 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.612 HD13 ' O ' ' A' ' 278' ' ' GLY . 1.1 mm? -121.67 133.25 54.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.762 0.315 . . . . 64.04 110.952 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -114.98 133.35 56.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 73.44 110.925 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.743 ' HB3' HD22 ' A' ' 31' ' ' LEU . 26.8 t80 -126.29 120.2 29.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 75.44 110.867 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -113.74 117.34 31.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.133 -0.485 . . . . 75.14 110.9 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.424 ' O ' HD23 ' A' ' 284' ' ' LEU . . . -99.59 112.41 24.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 54.04 111.09 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.424 HD23 ' O ' ' A' ' 283' ' ' ALA . 10.9 mt -144.87 -170.4 3.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.203 -0.453 . . . . 70.43 110.863 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 74.44 110.946 179.917 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' NAI . . . . . 0.486 ' H5N' HD21 ' A' ' 262' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.429 ' O ' HG23 ' A' ' 3' ' ' VAL . 21.7 mtt . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.796 0.331 . . . . 71.4 110.913 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 61.5 43.52 10.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.263 -0.426 . . . . 75.04 111.112 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.52 HG11 ' C ' ' A' ' 119' ' ' LYS . 17.8 t -141.1 75.33 23.9 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.675 0.75 . . . . 71.25 111.13 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 168.01 22.76 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.678 2.252 . . . . 73.4 112.372 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 101.23 0.88 Allowed 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.638 2.226 . . . . 71.15 112.374 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.654 ' HB ' HD21 ' A' ' 150' ' ' LEU . 0.6 OUTLIER -80.0 -34.49 38.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.456 . . . . 71.15 111.157 -179.969 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.518 ' HB2' HG21 ' A' ' 143' ' ' VAL . 72.7 t80 -53.7 -30.98 46.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 62.32 110.929 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -80.55 -26.02 38.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.147 -0.479 . . . . 63.43 111.057 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -74.31 -9.94 59.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.227 -0.442 . . . . 73.51 110.888 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.811 HD21 ' HA3' ' A' ' 152' ' ' GLY . 1.4 mp -56.72 -34.25 67.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 61.43 110.953 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 152.24 64.38 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.759 -0.734 . . . . 75.15 112.517 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 24.5 ttpp -62.81 -52.44 63.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.771 0.319 . . . . 72.31 110.913 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 75.5 m -62.87 -49.39 75.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.448 . . . . 54.31 110.855 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.475 ' HB1' ' CB ' ' A' ' 193' ' ' SER . . . -59.94 -37.38 79.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 70.43 111.13 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 45.7 ttt180 -66.01 -34.03 77.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 71.55 110.909 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -60.29 -46.28 90.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 64.12 110.857 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.719 HG21 ' HB2' ' A' ' 222' ' ' ALA . 9.3 p -80.98 -33.74 13.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 73.42 111.133 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.489 ' HE1' ' HB2' ' A' ' 209' ' ' ALA . 11.6 t80 -66.9 -41.18 87.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.485 . . . . 54.3 110.89 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.26 -173.93 2.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 71.11 111.16 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.8 mtmt -95.56 -168.48 1.79 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 71.42 110.915 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.56 48.95 1.46 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.741 -0.742 . . . . 51.5 112.493 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 12.9 p90 -122.63 -35.77 3.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.937 0.399 . . . . 74.12 110.933 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -144.98 139.29 8.31 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.754 -0.736 . . . . 73.0 112.528 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.522 ' HB3' HD11 ' A' ' 26' ' ' LEU . 48.8 m-85 -104.24 -6.35 21.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.926 0.393 . . . . 71.32 110.899 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.27 12.42 57.39 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.772 -0.728 . . . . 73.52 112.488 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.749 ' N ' HD13 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -150.88 -173.48 4.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.819 0.343 . . . . 65.41 110.937 -179.934 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.971 HG23 HD12 ' A' ' 277' ' ' LEU . 21.2 mm -92.34 133.46 33.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 74.45 111.124 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.529 ' O ' HD22 ' A' ' 279' ' ' LEU . 4.5 mtpp -113.06 154.66 26.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 75.42 110.885 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.617 HD13 ' N ' ' A' ' 30' ' ' ASP . 3.3 tm? -147.79 136.84 22.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.229 -0.442 . . . . 72.54 110.944 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.617 ' N ' HD13 ' A' ' 29' ' ' LEU . 1.2 t70 -152.22 124.21 8.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 61.34 110.863 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.711 HD11 ' CB ' ' A' ' 283' ' ' ALA . 2.7 tm? -125.5 129.13 49.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 72.23 110.907 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.54 ' N ' HD13 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -112.17 128.24 56.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 70.54 110.88 179.814 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 93.8 m -137.21 121.12 17.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.44 . . . . 75.14 111.154 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.9 ptmm? -140.89 141.93 34.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 72.44 110.888 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 17.9 t -139.23 152.49 47.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.207 -0.451 . . . . 71.22 110.864 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -75.97 61.45 1.51 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 71.24 110.907 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -153.27 20.67 0.56 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.132 -0.486 . . . . 73.2 110.876 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.545 ' HA2' ' O ' ' A' ' 63' ' ' ARG . . . 75.72 -3.53 49.23 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.721 -0.752 . . . . 72.23 112.524 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.2 mp -98.94 124.16 43.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.771 0.319 . . . . 74.1 110.897 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.82 118.28 10.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.162 -0.472 . . . . 45.15 110.825 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -110.1 123.58 49.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 71.12 110.905 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 83.9 m -127.39 116.62 20.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.47 . . . . 73.34 111.18 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.5 t -115.44 135.81 53.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.435 . . . . 74.23 110.861 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.27 143.91 25.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 54.01 110.871 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 164.95 168.49 27.18 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.712 -0.756 . . . . 70.21 112.463 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -137.3 169.45 17.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.866 0.365 . . . . 75.24 110.872 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -147.11 127.43 13.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 72.23 111.089 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.469 ' ND2' HD12 ' A' ' 26' ' ' LEU . 2.5 m120 -95.45 142.55 27.68 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.198 -0.456 . . . . 74.53 110.852 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 61.1 p -94.12 56.45 2.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 75.01 111.174 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -126.19 -74.89 0.59 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 64.1 110.889 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.4 ' O ' ' C ' ' A' ' 52' ' ' THR . 2.2 m -130.33 65.65 1.52 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 51.13 111.133 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.4 ' C ' ' O ' ' A' ' 51' ' ' THR . 10.1 t 37.05 43.88 0.34 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 65.41 111.16 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -105.2 95.02 5.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 75.02 110.885 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -126.81 148.23 31.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 72.24 111.144 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.7 p -113.27 126.59 55.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 74.05 111.138 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -118.94 147.27 18.43 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.797 -0.716 . . . . 60.13 112.52 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.4 p -146.06 133.55 20.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.918 0.389 . . . . 75.15 110.871 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.455 ' O ' ' HB3' ' A' ' 74' ' ' LYS . 0.3 OUTLIER -123.09 130.08 52.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.465 . . . . 63.44 110.892 -179.968 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.524 ' HA ' ' CB ' ' A' ' 74' ' ' LYS . 0.9 OUTLIER -134.84 120.82 19.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.21 -0.45 . . . . 62.02 110.86 179.923 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.477 ' H ' ' HB2' ' A' ' 74' ' ' LYS . 20.3 m -105.43 117.81 34.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.126 -0.488 . . . . 54.01 111.149 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 71' ' ' PHE . 8.2 mttp -106.58 157.95 17.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 74.33 110.867 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.518 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 10.3 t80 -122.16 121.16 36.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 62.23 110.899 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.545 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -88.45 101.31 13.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.082 -0.508 . . . . 73.44 110.908 179.963 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 42.5 t-105 -116.21 136.35 53.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.209 -0.451 . . . . 73.51 110.895 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 24.0 p -80.98 -169.85 2.42 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.211 -0.45 . . . . 75.31 111.182 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.587 ' O ' HD23 ' A' ' 69' ' ' LEU . 33.6 mm-40 66.29 101.89 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.235 -0.438 . . . . 74.14 110.859 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 65.04 13.98 9.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.158 -0.474 . . . . 73.23 110.946 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 49.95 91.19 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.717 -0.754 . . . . 73.22 112.51 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.587 HD23 ' O ' ' A' ' 66' ' ' GLU . 4.3 mm? -118.05 141.04 48.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.834 0.349 . . . . 71.13 110.941 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.436 ' HA ' ' O ' ' A' ' 62' ' ' TYR . 83.4 m -135.68 121.74 20.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 73.3 111.161 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.68 ' CD1' HG22 ' A' ' 85' ' ' ILE . 14.2 t80 -100.26 119.73 38.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 73.43 110.902 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.1 t -111.37 116.06 30.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 74.31 111.154 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.578 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 8.5 tt0 -139.66 126.94 21.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 71.54 110.895 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.578 ' HB2' ' O ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER 165.63 -156.78 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 55.13 110.934 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.49 ' CD1' HD22 ' A' ' 81' ' ' LEU . 12.2 t90 -133.93 136.38 44.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.268 -0.424 . . . . 71.03 110.896 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -107.88 155.64 20.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.281 -0.418 . . . . 71.33 110.909 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 15.2 t -68.79 -8.42 43.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.172 -0.467 . . . . 72.21 111.128 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.472 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 5.1 m-20 -73.8 3.43 6.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.237 -0.438 . . . . 71.42 110.839 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.472 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 3.9 m-20 81.03 15.33 0.6 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 73.32 110.842 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -116.0 116.25 27.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 64.22 111.126 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.49 HD22 ' CD1' ' A' ' 75' ' ' TRP . 0.1 OUTLIER -122.97 128.21 49.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 74.25 110.914 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 177.58 -133.19 2.15 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.776 -0.726 . . . . 43.44 112.536 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.445 ' OG1' ' N ' ' A' ' 84' ' ' GLU . 4.3 t -178.92 -178.35 0.54 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.812 0.339 . . . . 74.34 111.109 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.65 ' HB3' ' O ' ' A' ' 99' ' ' PHE . 0.6 OUTLIER 170.93 -166.58 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.202 -0.454 . . . . 55.55 110.932 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.68 HG22 ' CD1' ' A' ' 71' ' ' PHE . 1.8 pp -136.78 145.69 29.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.203 -0.453 . . . . 52.33 111.135 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.712 ' OG1' HG23 ' A' ' 98' ' ' THR . 98.6 m -128.96 123.27 32.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.465 . . . . 72.51 111.196 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.2 p -112.54 138.66 40.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 64.13 111.157 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -123.86 118.69 27.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 70.34 110.887 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 43.1 t0 64.42 76.88 0.33 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.143 -0.48 . . . . 63.34 110.878 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -109.01 -68.87 0.89 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 73.11 110.882 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -65.33 -74.28 0.11 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 73.23 110.86 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -121.41 142.38 50.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.174 -0.466 . . . . 63.23 111.117 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 19.5 ttm180 -50.64 133.99 24.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 62.22 110.9 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 100.88 -22.31 40.08 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.732 -0.747 . . . . 61.42 112.49 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.98 125.04 34.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.923 0.392 . . . . 73.2 110.917 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.622 ' O ' HD13 ' A' ' 97' ' ' LEU . 28.8 tttp -124.02 129.83 51.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.466 . . . . 74.2 110.903 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.622 HD13 ' O ' ' A' ' 96' ' ' LYS . 1.2 mm? -122.2 123.04 40.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.45 . . . . 64.13 110.92 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.712 HG23 ' OG1' ' A' ' 86' ' ' THR . 87.6 m -123.79 118.68 27.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.209 -0.451 . . . . 72.04 111.108 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.754 ' CD1' HD13 ' A' ' 114' ' ' ILE . 0.7 OUTLIER -115.3 117.33 30.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.455 . . . . 71.11 110.857 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.568 ' HA ' ' CB ' ' A' ' 84' ' ' GLU . 8.4 t70 -121.62 139.47 53.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.103 -0.499 . . . . 64.11 110.901 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 37.7 t -130.55 121.26 25.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 65.44 110.87 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 15.8 m -116.6 153.41 32.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.096 -0.502 . . . . 54.44 110.878 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -123.72 138.41 54.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 71.24 110.895 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.424 ' HA ' ' HD2' ' A' ' 105' ' ' PRO . 4.2 t -116.83 106.69 47.47 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.634 0.73 . . . . 71.12 110.881 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 104' ' ' SER . 54.1 Cg_endo -69.68 -32.61 18.55 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.683 2.255 . . . . 75.2 112.389 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -57.3 -35.9 70.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.469 . . . . 71.01 110.903 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 10.0 m -99.09 -32.4 11.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 61.1 111.12 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.66 -18.58 57.24 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.762 -0.732 . . . . 71.52 112.532 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 29.6 tptt -94.44 147.47 23.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.817 0.342 . . . . 42.51 110.915 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -92.95 150.84 20.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.279 -0.419 . . . . 74.22 110.924 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.1 m120 -121.08 126.32 49.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.436 . . . . 60.34 110.913 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -113.68 139.3 49.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 65.44 111.066 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 27.9 mttm -138.3 137.91 37.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 64.11 110.889 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.754 HD13 ' CD1' ' A' ' 99' ' ' PHE . 4.1 tp -134.66 133.68 54.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 61.24 111.152 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.464 ' H ' HD12 ' A' ' 114' ' ' ILE . 40.0 mttp -125.42 120.83 32.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 72.33 110.894 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.563 HG22 HD12 ' A' ' 97' ' ' LEU . 59.7 p -127.81 118.33 23.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 55.21 111.167 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.4 ' HA3' ' HA2' ' A' ' 126' ' ' GLY . . . -152.19 156.08 26.5 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.753 -0.737 . . . . 74.22 112.495 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -132.41 130.49 40.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.973 0.416 . . . . 73.52 110.896 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.52 ' C ' HG11 ' A' ' 3' ' ' VAL . 37.7 mttp -107.05 118.5 36.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.103 -0.499 . . . . 75.34 110.893 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.26 142.94 42.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 74.43 110.851 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -52.42 -27.32 15.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.134 -0.485 . . . . 64.23 110.887 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 27.9 m80 -90.38 -38.3 13.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 75.14 110.895 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.443 HD11 HD22 ' A' ' 144' ' ' LEU . 9.3 tp -147.67 140.65 19.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.445 . . . . 74.53 111.098 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -111.25 115.94 30.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 72.34 110.87 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.511 ' CD2' HD13 ' A' ' 142' ' ' LEU . 2.9 mm? -122.96 139.91 53.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.175 -0.466 . . . . 73.13 110.935 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.4 ' HA2' ' HA3' ' A' ' 117' ' ' GLY . . . -146.74 121.5 1.44 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.741 -0.743 . . . . 63.3 112.437 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 18.5 m -113.19 134.02 54.78 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.791 0.329 . . . . 72.1 110.916 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -126.62 146.97 49.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 61.45 110.905 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 8.7 mtm -139.04 127.23 22.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 72.24 110.869 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -117.81 121.3 40.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 75.22 110.88 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -95.26 119.71 34.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.465 . . . . 74.05 110.887 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -128.2 121.15 28.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 72.2 110.855 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.546 HD12 ' O ' ' A' ' 133' ' ' ILE . 1.1 tp -52.41 -43.75 41.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 54.31 111.166 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -74.39 -18.29 60.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.481 . . . . 65.53 111.121 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 161.47 103.59 0.18 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.725 -0.75 . . . . 72.42 112.454 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 147.99 64.34 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.656 2.237 . . . . 74.13 112.382 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 28.4 t -128.73 150.49 50.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 75.14 110.875 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.703 HD12 ' OG1' ' A' ' 159' ' ' THR . 1.4 mp -107.89 132.99 54.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.12 -0.491 . . . . 61.24 111.136 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 18.9 mtp180 -112.37 131.25 55.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 72.34 110.869 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -126.72 134.01 8.3 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.705 -0.76 . . . . 51.45 112.485 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -139.17 116.94 11.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.832 0.349 . . . . 71.41 111.125 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.595 HD12 ' N ' ' A' ' 143' ' ' VAL . 5.3 tp -127.01 124.59 39.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.242 -0.436 . . . . 62.45 110.954 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.595 ' N ' HD12 ' A' ' 142' ' ' LEU . 46.6 t -123.34 134.8 65.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 64.44 111.092 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.545 HD23 ' C ' ' A' ' 143' ' ' VAL . 0.5 OUTLIER -109.38 143.36 39.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.106 -0.497 . . . . 75.12 110.889 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -121.36 120.25 4.37 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.774 -0.727 . . . . 31.12 112.513 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.428 ' HB3' ' HB2' ' A' ' 149' ' ' TRP . 38.5 t80 -128.85 145.5 51.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.825 0.345 . . . . 72.34 110.893 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -50.95 96.89 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.126 -0.488 . . . . 62.43 110.876 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 92.88 -30.7 6.78 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.707 -0.759 . . . . 63.35 112.464 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.428 ' HB2' ' HB3' ' A' ' 146' ' ' TYR . 25.0 m95 -104.77 141.09 37.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.828 0.347 . . . . 74.11 110.863 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.654 HD21 ' HB ' ' A' ' 6' ' ' THR . 0.5 OUTLIER -130.71 140.6 50.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.446 . . . . 71.53 110.943 179.955 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.516 ' HB3' ' HB2' ' A' ' 144' ' ' LEU . . . -131.44 148.12 52.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 73.54 111.086 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.811 ' HA3' HD21 ' A' ' 10' ' ' LEU . . . -150.95 137.06 5.86 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.752 -0.737 . . . . 74.42 112.484 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -144.11 119.78 10.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.877 0.37 . . . . 74.31 110.923 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -126.94 122.44 34.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.117 -0.492 . . . . 60.21 110.892 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 15.6 ptt? -146.82 150.17 34.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 62.54 110.846 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 48.9 m-20 -112.12 138.56 48.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 73.12 110.891 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -92.24 132.49 36.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 63.31 110.868 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -77.86 99.64 6.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.141 -0.482 . . . . 71.43 110.865 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.703 ' OG1' HD12 ' A' ' 138' ' ' ILE . 0.2 OUTLIER -65.21 -47.0 78.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.139 -0.482 . . . . 64.33 111.165 -179.937 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -48.29 -26.11 1.85 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 54.43 111.119 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 43.9 mttt -127.33 -166.64 1.63 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.459 . . . . 62.23 110.935 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 39.6 m -111.18 40.29 2.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.44 . . . . 73.3 110.795 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 11.0 mmm180 -153.3 176.21 12.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 71.43 110.889 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 1.5 t -78.01 141.42 15.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 74.11 111.119 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 15.2 t -90.61 -33.73 15.74 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.158 -0.474 . . . . 53.44 111.131 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -150.97 134.84 16.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.445 . . . . 73.44 110.9 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 89.5 p -124.81 119.01 27.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 53.34 110.893 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -130.47 142.56 50.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 63.25 110.89 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -138.2 158.14 44.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.126 -0.488 . . . . 71.32 110.866 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -154.07 138.96 17.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 53.01 111.114 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 46.2 t -120.63 134.87 62.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 72.23 111.113 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -117.59 112.56 2.48 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.706 -0.759 . . . . 44.32 112.491 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -114.18 121.58 44.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.994 0.426 . . . . 73.13 110.901 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 26.0 ttmt -104.36 134.77 47.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.113 -0.494 . . . . 72.11 110.916 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.97 165.11 22.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 64.12 111.128 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -40.93 -74.82 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.175 -0.466 . . . . 54.22 110.892 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -116.07 15.15 16.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 64.12 110.913 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -127.09 149.57 49.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 74.13 110.868 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 6.6 mm-40 -135.22 123.87 23.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.123 -0.49 . . . . 55.24 110.881 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.656 HD23 HG13 ' A' ' 194' ' ' ILE . 2.6 tm? -124.23 122.32 37.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.132 -0.485 . . . . 74.45 110.873 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . 0.452 ' N ' HD22 ' A' ' 180' ' ' LEU . 91.6 m-70 -130.47 115.94 17.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 71.53 110.9 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . 0.494 HG22 ' O ' ' A' ' 191' ' ' GLY . 0.2 OUTLIER -94.77 153.12 17.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.217 -0.447 . . . . 71.22 111.1 -179.856 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -146.76 138.56 24.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 73.31 110.896 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.454 ' O ' HG12 ' A' ' 184' ' ' VAL . 2.3 t -134.72 111.3 13.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.473 . . . . 71.14 111.143 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -100.09 89.28 3.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 72.3 110.9 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 65.28 179.14 0.19 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.179 -0.464 . . . . 71.22 110.821 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -73.47 -4.17 64.2 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.69 -0.767 . . . . 75.4 112.506 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 29.3 p -95.38 -25.87 16.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.765 0.317 . . . . 62.14 111.15 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -122.83 114.17 20.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 75.43 110.915 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -139.72 124.13 18.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 70.22 110.813 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.494 ' O ' HG22 ' A' ' 182' ' ' THR . . . 178.8 -150.88 9.87 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.678 -0.772 . . . . 44.43 112.47 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -176.42 170.43 43.24 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.726 -0.749 . . . . 74.35 112.485 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . 0.475 ' CB ' ' HB1' ' A' ' 14' ' ' ALA . 65.3 m -121.21 147.19 45.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.872 0.368 . . . . 53.32 110.798 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.656 HG13 HD23 ' A' ' 180' ' ' LEU . 4.0 mp -119.79 123.45 70.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.104 -0.498 . . . . 73.22 111.073 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . 0.64 ' HD1' ' HB2' ' A' ' 205' ' ' ALA . 12.6 t80 -108.48 121.91 45.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 73.2 110.929 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 53.9 tp60 -124.47 130.2 52.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 74.52 110.914 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 21.2 mtpp -106.25 127.19 53.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 73.32 110.874 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 14.7 t -79.21 153.33 4.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 73.51 111.159 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . 0.406 ' O ' ' C ' ' A' ' 200' ' ' LYS . 47.0 t30 -59.62 97.94 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 73.35 110.9 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . 0.406 ' C ' ' O ' ' A' ' 199' ' ' ASN . 16.6 ptpt 37.3 63.12 0.76 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 75.11 110.897 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . 0.428 ' HB3' HD23 ' A' ' 202' ' ' LEU . 25.3 mttm -145.46 -56.46 0.31 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 75.53 110.917 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.428 HD23 ' HB3' ' A' ' 201' ' ' LYS . 2.1 pt? -173.76 172.42 3.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 73.44 110.936 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -116.58 144.9 43.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 72.24 110.876 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.438 HG23 ' O ' ' A' ' 222' ' ' ALA . 7.3 m -146.53 138.77 24.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 74.02 111.105 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.64 ' HB2' ' HD1' ' A' ' 195' ' ' TYR . . . -145.3 136.64 25.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.441 . . . . 72.14 111.141 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 1.1 m -113.79 149.97 15.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 73.23 111.095 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -113.58 137.19 51.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.485 . . . . 72.34 110.865 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.579 HD11 ' CE1' ' A' ' 219' ' ' PHE . 3.8 mm? -120.61 129.72 53.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.17 -0.468 . . . . 73.51 110.897 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.489 ' HB2' ' HE1' ' A' ' 18' ' ' PHE . . . -129.77 130.07 44.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.119 -0.492 . . . . 64.31 111.08 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 2.9 t-105 -129.67 128.1 41.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 71.4 110.941 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 2.7 p -99.14 109.02 21.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.225 -0.443 . . . . 75.33 111.159 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -54.91 149.84 10.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 65.51 111.063 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 95.59 -36.49 3.8 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.71 -0.757 . . . . 51.04 112.474 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -121.54 -179.46 4.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.782 0.325 . . . . 74.12 110.879 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 3.0 t -112.11 38.37 2.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 71.12 110.882 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -102.17 112.21 24.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 75.55 110.905 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 18.6 m -114.65 138.45 50.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.459 . . . . 74.33 111.132 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . 0.446 ' HB3' ' HB3' ' A' ' 209' ' ' ALA . 18.4 ttt85 -108.55 131.99 54.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.441 . . . . 60.44 110.848 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . 0.579 ' CE1' HD11 ' A' ' 208' ' ' LEU . 17.9 m-85 -117.45 136.7 53.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 65.33 110.89 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -137.46 140.63 11.48 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.737 -0.744 . . . . 63.14 112.511 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.514 ' HB ' HG12 ' A' ' 237' ' ' VAL . 4.8 mp -123.85 130.73 73.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.854 0.359 . . . . 61.54 111.104 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.719 ' HB2' HG21 ' A' ' 17' ' ' VAL . . . -127.61 152.21 47.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 65.41 111.1 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -137.37 129.34 29.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.246 -0.434 . . . . 75.22 111.084 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 7.3 ttmt -115.21 128.48 56.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 72.42 110.894 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -132.25 131.54 42.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.252 -0.431 . . . . 71.51 110.913 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 58.7 mm-40 -102.71 112.28 24.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 75.35 110.875 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 71.4 mt -102.68 -40.1 6.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 73.33 111.109 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.757 ' HB2' ' HB3' ' A' ' 231' ' ' ALA . 0.4 OUTLIER -124.17 160.7 51.19 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.579 0.704 . . . . 62.32 110.882 179.88 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -32.34 18.82 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.725 2.283 . . . . 73.44 112.317 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -109.2 10.49 25.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.435 . . . . 72.43 110.882 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.757 ' HB3' ' HB2' ' A' ' 228' ' ' ASP . . . -136.1 140.42 43.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.179 -0.464 . . . . 64.12 111.086 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 21.8 m -138.74 136.49 35.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.213 -0.449 . . . . 52.01 110.903 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -110.42 132.77 53.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 73.3 110.924 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 58.2 p -137.08 149.71 47.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 63.24 110.826 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -136.47 155.59 49.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.096 -0.502 . . . . 63.32 111.089 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.51 145.91 29.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 71.24 110.861 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.514 HG12 ' HB ' ' A' ' 221' ' ' ILE . 1.7 p -143.04 143.88 24.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 73.32 111.143 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . 0.404 ' HB3' ' HB2' ' A' ' 242' ' ' LEU . 0.9 OUTLIER -112.31 148.08 34.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 73.03 110.886 179.986 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -57.1 -18.53 15.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 63.32 110.89 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 29.9 t -80.93 25.89 0.44 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 73.31 110.814 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 62.22 35.19 15.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.123 -0.49 . . . . 72.14 110.875 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . 0.444 HD11 ' HB3' ' A' ' 264' ' ' ASP . 4.9 mp -99.25 118.5 36.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.132 -0.486 . . . . 74.01 110.916 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.508 ' H ' HD12 ' A' ' 243' ' ' ILE . 0.8 OUTLIER -107.42 117.88 54.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 74.35 111.154 179.852 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . 0.533 ' C ' HD13 ' A' ' 245' ' ' LEU . . . -137.12 149.62 20.33 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.701 -0.762 . . . . 63.21 112.467 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.669 ' N ' HD13 ' A' ' 245' ' ' LEU . 0.0 OUTLIER -145.83 158.48 43.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.869 0.366 . . . . 54.02 110.887 -179.895 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -163.01 136.83 4.48 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.687 -0.768 . . . . 44.2 112.465 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -128.42 132.59 48.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.902 0.382 . . . . 75.4 110.932 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 7.8 t -111.99 125.83 54.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.487 . . . . 62.41 111.177 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -143.43 148.82 36.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.235 -0.438 . . . . 51.32 110.961 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 5.5 m -88.93 145.24 25.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.262 -0.426 . . . . 72.03 111.127 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.613 HD12 HD11 ' A' ' 255' ' ' ILE . 47.4 mt -93.94 -176.05 3.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 71.45 110.889 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' LYS . . . . . 0.472 ' CB ' ' CD ' ' A' ' 253' ' ' PRO . 0.1 OUTLIER -51.16 -61.07 4.46 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.545 0.688 . . . . 61.3 110.87 179.845 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . 0.472 ' CD ' ' CB ' ' A' ' 252' ' ' LYS . 53.8 Cg_endo -69.73 -170.26 0.38 Allowed 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.687 2.258 . . . . 64.35 112.306 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . 0.536 ' O ' ' HB3' ' A' ' 281' ' ' PHE . . . -85.1 51.55 4.56 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.737 -0.744 . . . . 73.42 112.465 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.613 HD11 HD12 ' A' ' 251' ' ' LEU . 6.2 pt -129.27 135.1 62.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.893 0.377 . . . . 65.11 111.152 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.441 ' H ' ' HB2' ' A' ' 281' ' ' PHE . 0.1 OUTLIER -98.39 132.1 44.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.447 . . . . 70.13 110.888 179.858 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 0.721 ' HA ' HD12 ' A' ' 279' ' ' LEU . 5.2 tp -100.07 125.45 46.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 75.22 110.921 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . 0.434 ' O ' HD22 ' A' ' 277' ' ' LEU . 21.9 m -116.39 111.75 20.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 73.11 111.152 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 1.015 HD22 HD23 ' A' ' 277' ' ' LEU . 0.2 OUTLIER -109.33 130.02 55.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.253 -0.431 . . . . 74.01 110.868 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.504 ' N ' HD13 ' A' ' 259' ' ' LEU . 1.7 t -144.16 155.8 44.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.167 -0.469 . . . . 73.25 110.898 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' ALA . . . . . 0.438 ' HB3' ' CD2' ' A' ' 245' ' ' LEU . . . -158.88 128.38 5.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 62.24 111.06 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.655 ' C ' HD13 ' A' ' 263' ' ' LEU . 3.2 tm? -118.48 122.98 44.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 62.52 110.921 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . 0.892 ' HB3' HG21 ' A' ' 268' ' ' VAL . 0.4 OUTLIER -118.93 110.56 17.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.159 -0.473 . . . . 73.4 110.88 179.896 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . 0.555 ' O ' ' HB ' ' A' ' 268' ' ' VAL . 1.7 m-20 -88.62 99.87 12.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 70.21 110.844 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -52.86 -11.48 1.35 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.737 -0.744 . . . . 72.32 112.464 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 7.4 ttmm -63.86 -25.66 68.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.825 0.345 . . . . 70.13 110.915 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -166.82 16.91 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 64.01 110.881 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . 0.892 HG21 ' HB3' ' A' ' 263' ' ' LEU . 1.4 p -68.05 -28.51 41.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 62.44 111.119 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -74.48 -37.44 63.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 73.21 110.914 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -85.83 -17.64 35.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.142 -0.481 . . . . 53.14 111.103 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 131.21 95.26 0.68 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.768 -0.729 . . . . 53.31 112.515 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 178.86 53.74 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.774 -0.727 . . . . 53.32 112.537 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' HIS . . . . . 0.492 ' HB2' HD12 ' A' ' 263' ' ' LEU . 14.8 p80 -112.17 144.21 41.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.887 0.375 . . . . 72.3 110.84 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -123.71 149.32 45.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 64.42 110.889 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.422 HD12 ' HB2' ' A' ' 261' ' ' ALA . 2.4 tp -128.41 148.55 50.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 71.15 110.898 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -131.34 97.53 0.36 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.784 -0.722 . . . . 75.45 112.501 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 1.015 HD23 HD22 ' A' ' 259' ' ' LEU . 3.2 tm? -119.28 129.65 55.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.845 0.355 . . . . 74.45 110.886 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . 0.711 ' C ' HD13 ' A' ' 279' ' ' LEU . . . -164.48 145.61 10.51 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.752 -0.737 . . . . 72.53 112.533 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.721 HD12 ' HA ' ' A' ' 257' ' ' LEU . 0.0 OUTLIER -118.47 130.03 55.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.745 0.307 . . . . 72.44 110.971 -179.969 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . 0.522 ' O ' ' HB2' ' A' ' 281' ' ' PHE . 0.0 OUTLIER -140.37 143.58 35.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.449 . . . . 73.2 110.924 179.961 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.536 ' HB3' ' O ' ' A' ' 254' ' ' GLY . 0.2 OUTLIER 172.63 -144.39 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 73.34 110.856 -179.949 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -137.47 148.82 46.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 71.31 110.933 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.711 ' CB ' HD11 ' A' ' 31' ' ' LEU . . . -101.11 111.45 23.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 71.31 111.106 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.66 HD12 ' O ' ' A' ' 283' ' ' ALA . 0.8 OUTLIER -151.31 178.44 9.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.235 -0.439 . . . . 75.11 110.904 -179.959 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 71.43 110.893 179.919 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' NAI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 33.2 mtt . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.774 0.321 . . . . 70.41 110.9 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -140.46 107.71 5.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.279 -0.419 . . . . 63.1 111.104 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.491 HG22 ' N ' ' A' ' 121' ' ' GLU . 9.1 t -114.43 78.48 4.8 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.668 0.746 . . . . 71.11 111.14 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 167.7 23.68 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.681 2.254 . . . . 72.14 112.351 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 119.57 6.49 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.654 2.236 . . . . 55.04 112.335 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.488 ' HB ' HD21 ' A' ' 150' ' ' LEU . 34.7 p -106.99 -49.61 3.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 62.31 111.154 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.716 ' HB2' HG21 ' A' ' 143' ' ' VAL . 72.3 t80 -56.39 -30.69 63.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.26 -0.427 . . . . 74.54 110.924 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -79.75 -23.08 42.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.082 -0.508 . . . . 74.03 111.117 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -90.66 13.28 16.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 74.33 110.846 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.777 HD21 ' HA3' ' A' ' 152' ' ' GLY . 0.5 OUTLIER -70.39 -33.83 71.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.21 -0.45 . . . . 64.44 110.907 -179.971 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 161.31 49.8 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.764 -0.731 . . . . 72.12 112.511 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.29 -48.51 81.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.775 0.321 . . . . 61.32 110.921 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.6 m -61.25 -49.14 78.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 61.05 110.839 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.537 ' HB1' ' CB ' ' A' ' 193' ' ' SER . . . -62.22 -38.21 88.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 75.32 111.083 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.725 ' O ' HG22 ' A' ' 19' ' ' THR . 17.0 ttt-85 -60.73 -33.51 73.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 75.14 110.873 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -58.05 -46.02 86.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 74.23 110.893 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.514 HG21 ' HB3' ' A' ' 205' ' ' ALA . 92.8 t -65.19 -41.92 92.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 73.04 111.127 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -62.67 -41.01 98.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 71.44 110.911 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.725 HG22 ' O ' ' A' ' 15' ' ' ARG . 9.0 t -94.11 43.13 1.1 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.145 -0.48 . . . . 40.22 111.165 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -129.5 174.1 9.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 74.11 110.866 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 77.55 -72.53 2.17 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.764 -0.732 . . . . 53.32 112.459 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -68.1 87.76 0.28 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.966 0.412 . . . . 73.21 110.942 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -61.29 -176.05 1.83 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.751 -0.738 . . . . 73.42 112.445 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -97.68 -4.49 37.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.944 0.402 . . . . 64.11 110.894 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.61 13.15 77.97 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.738 -0.744 . . . . 72.54 112.457 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.593 HD12 ' N ' ' A' ' 27' ' ' ILE . 2.2 pp -149.54 -176.7 5.5 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.749 0.309 . . . . 63.41 110.952 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.593 ' N ' HD12 ' A' ' 26' ' ' LEU . 1.6 mp -118.33 120.91 65.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.206 -0.452 . . . . 72.24 111.171 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.446 ' O ' ' HA2' ' A' ' 278' ' ' GLY . 0.0 OUTLIER -125.81 117.13 22.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 74.44 110.915 179.844 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.82 ' HB2' HD23 ' A' ' 279' ' ' LEU . 0.6 OUTLIER -112.69 137.91 50.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.44 . . . . 74.2 110.926 179.939 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.562 ' C ' ' HB3' ' A' ' 281' ' ' PHE . 0.7 OUTLIER -147.51 132.54 18.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.238 -0.437 . . . . 74.33 110.864 179.88 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.781 ' HA ' ' HA ' ' A' ' 281' ' ' PHE . 4.2 tt -129.55 124.58 34.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.196 -0.456 . . . . 72.55 110.952 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.617 ' N ' ' HB2' ' A' ' 281' ' ' PHE . 0.3 OUTLIER -120.36 125.29 47.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 61.2 110.891 179.873 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.914 HG23 HD13 ' A' ' 284' ' ' LEU . 46.2 m -122.2 121.11 36.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 71.42 111.124 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 5.9 ptmt -121.01 148.03 44.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 71.35 110.89 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 75.6 m -139.07 169.3 18.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 65.33 110.873 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -83.17 52.49 2.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.105 -0.498 . . . . 72.43 110.874 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -140.65 8.59 2.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.139 -0.482 . . . . 74.32 110.908 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.489 ' HA2' ' O ' ' A' ' 63' ' ' ARG . . . 79.27 -5.09 60.71 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.727 -0.749 . . . . 72.02 112.511 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -99.08 128.53 45.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.726 0.298 . . . . 43.24 110.94 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.412 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -139.82 118.49 12.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 64.25 110.86 179.934 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -102.97 126.59 50.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 73.4 110.872 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 54.3 m -127.08 117.42 22.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.108 -0.496 . . . . 73.32 111.173 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 36.5 p -104.31 134.27 47.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 73.25 110.9 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 35.6 t -127.0 127.15 44.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 71.52 110.835 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -141.86 129.79 4.09 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.7 -0.762 . . . . 51.53 112.453 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 48.6 m -128.97 135.74 49.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.87 0.367 . . . . 72.21 110.866 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.408 ' HA ' ' HA ' ' A' ' 54' ' ' VAL . . . -134.66 129.7 35.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.128 -0.487 . . . . 74.11 111.106 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -92.18 136.42 33.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 75.21 110.866 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -96.23 -55.89 2.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 72.12 111.168 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -50.49 -34.91 26.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.221 -0.445 . . . . 71.42 110.9 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -139.3 165.21 27.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 72.41 111.117 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 22.0 p -78.72 84.6 4.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.462 . . . . 73.35 111.112 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 10.9 tptp -145.61 82.27 1.63 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 73.15 110.885 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.408 ' HA ' ' HA ' ' A' ' 47' ' ' ALA . 0.7 OUTLIER -126.68 120.07 55.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 64.31 111.128 179.845 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 82.7 p -137.93 160.82 38.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.198 -0.455 . . . . 72.34 111.117 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.414 ' O ' HG22 ' A' ' 77' ' ' THR . . . -129.74 158.57 22.28 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.733 -0.746 . . . . 71.23 112.502 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.2 p -146.51 161.21 40.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.913 0.387 . . . . 54.13 110.869 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.607 HD13 ' N ' ' A' ' 59' ' ' GLU . 0.5 OUTLIER -119.95 131.04 55.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.115 -0.493 . . . . 75.31 110.929 179.969 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.607 ' N ' HD13 ' A' ' 58' ' ' LEU . 3.8 mt-10 -115.84 124.41 50.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 63.4 110.88 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.57 125.8 51.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 72.31 111.161 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.412 ' HB2' ' HB3' ' A' ' 40' ' ' GLU . 3.6 mttp -134.57 159.16 42.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 44.42 110.905 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -131.92 140.77 49.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 74.51 110.936 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.489 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 2.9 tmm_? -130.33 103.27 6.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 54.33 110.855 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 16.9 m95 -116.06 120.21 38.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 74.23 110.917 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.6 m 64.74 118.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 64.23 111.146 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -51.02 115.07 1.36 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.441 . . . . 64.3 110.85 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 65.59 56.93 0.9 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.113 -0.494 . . . . 72.51 110.948 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -144.35 -70.52 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.711 -0.757 . . . . 72.14 112.493 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.425 HD13 ' HA ' ' A' ' 69' ' ' LEU . 0.6 OUTLIER -125.12 128.88 49.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.869 0.366 . . . . 60.31 110.928 -179.93 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -137.67 128.82 27.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.26 -0.427 . . . . 55.11 111.156 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -114.47 133.35 55.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 75.52 110.848 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 49.8 p -126.32 115.0 19.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.127 -0.488 . . . . 73.41 111.171 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -132.06 136.16 47.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.231 -0.44 . . . . 64.43 110.857 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 13.6 pttp -123.15 94.72 4.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.47 . . . . 72.24 110.903 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.491 ' CD1' ' HB3' ' A' ' 81' ' ' LEU . 5.8 t90 -95.37 125.88 40.29 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.232 -0.44 . . . . 72.33 110.896 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -94.25 137.12 33.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.267 -0.424 . . . . 75.23 110.873 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.414 HG22 ' O ' ' A' ' 56' ' ' GLY . 8.0 t -65.57 -36.66 84.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.153 -0.476 . . . . 62.41 111.162 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -112.1 -37.19 5.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.182 -0.463 . . . . 51.43 110.931 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -77.71 -162.19 0.3 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 53.34 110.898 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 20.7 p -81.09 157.35 25.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.161 -0.472 . . . . 74.02 111.156 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.491 ' HB3' ' CD1' ' A' ' 75' ' ' TRP . 0.2 OUTLIER -96.38 119.15 34.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 63.21 110.909 179.961 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.19 144.11 15.74 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.752 -0.737 . . . . 41.11 112.51 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.9 t -144.98 124.9 13.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.73 0.3 . . . . 75.44 111.169 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 50.9 tt0 -134.73 151.4 50.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 73.44 110.89 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.1 tt -129.12 139.02 52.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 72.55 111.117 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.627 HG22 HG23 ' A' ' 98' ' ' THR . 7.6 p -129.11 121.24 27.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.16 -0.473 . . . . 73.55 111.155 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.452 HG12 ' O ' ' A' ' 97' ' ' LEU . 3.0 p -118.62 134.39 62.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 71.34 111.168 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -106.75 128.12 53.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 61.42 110.874 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 61.34 56.03 2.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.185 -0.461 . . . . 71.33 110.849 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.486 ' HB2' HD23 ' A' ' 97' ' ' LEU . 5.3 tt0 -64.34 -67.52 0.43 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 73.32 110.892 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 56.5 tp -106.6 -53.99 2.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.18 -0.464 . . . . 64.03 110.919 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -106.44 124.44 49.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 74.02 111.109 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 -51.71 133.64 30.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.242 -0.435 . . . . 74.4 110.923 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 99.97 -23.59 35.42 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.734 -0.746 . . . . 60.34 112.479 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.24 134.6 34.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.844 0.354 . . . . 75.2 110.937 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.7 tttp -122.29 131.15 53.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 73.14 110.883 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.486 HD23 ' HB2' ' A' ' 90' ' ' GLN . 1.7 mm? -116.75 130.72 56.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.205 -0.452 . . . . 75.22 110.924 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.627 HG23 HG22 ' A' ' 86' ' ' THR . 51.6 m -129.64 125.0 35.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 64.33 111.106 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -115.42 116.47 28.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.232 -0.44 . . . . 73.53 110.875 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -109.33 133.15 53.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.17 -0.468 . . . . 64.11 110.844 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.4 t -142.87 128.38 19.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 71.21 110.857 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.1 m -108.11 151.02 26.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.131 -0.486 . . . . 62.2 110.866 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -133.23 132.44 41.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 70.54 110.868 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 9.6 t -128.18 109.67 19.73 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.627 0.727 . . . . 55.45 110.9 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.491 ' HD3' HD21 ' A' ' 81' ' ' LEU . 54.0 Cg_endo -69.72 -16.35 37.67 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.623 2.216 . . . . 73.41 112.36 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -48.97 -70.7 0.08 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 63.32 110.839 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.6 m -129.13 31.47 4.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 73.03 111.145 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 67.76 24.22 74.14 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.726 -0.75 . . . . 75.12 112.472 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.55 116.53 13.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.837 0.351 . . . . 74.53 110.891 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 37.0 mtmt -116.01 147.98 40.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.172 -0.467 . . . . 73.33 110.911 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -120.5 132.54 55.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 73.43 110.889 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -114.65 121.48 43.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 64.42 111.129 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 16.5 ttmt -138.03 138.21 38.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.253 -0.431 . . . . 71.13 110.926 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.402 HG23 ' O ' ' A' ' 114' ' ' ILE . 6.1 tp -134.11 123.23 43.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.434 . . . . 50.23 111.144 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 68.7 tttt -119.13 121.0 38.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 74.42 110.922 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.0 t -128.23 125.4 38.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.44 . . . . 63.51 111.136 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -150.7 157.47 27.21 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.78 -0.724 . . . . 71.42 112.494 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 16.3 p90 -132.21 130.78 41.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.939 0.399 . . . . 75.55 110.953 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 29.7 tttp -107.64 118.23 36.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.481 . . . . 75.34 110.884 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 12.4 mmt85 -110.85 142.91 42.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.247 -0.433 . . . . 74.33 110.857 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.491 ' N ' HG22 ' A' ' 3' ' ' VAL . 7.6 pt-20 -52.79 -27.41 17.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 64.11 110.88 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 74.6 t60 -88.08 -39.61 14.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 65.04 110.859 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.581 HD12 ' HA ' ' A' ' 144' ' ' LEU . 8.6 tp -148.41 144.65 18.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 62.42 111.149 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -109.47 119.11 38.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 75.51 110.913 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.62 ' CD2' HD13 ' A' ' 142' ' ' LEU . 2.9 mm? -123.62 139.59 53.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 74.32 110.952 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -145.34 121.77 1.58 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.711 -0.757 . . . . 73.01 112.462 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -112.41 134.44 53.94 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.808 0.337 . . . . 64.53 110.857 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -129.67 133.82 47.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.164 -0.471 . . . . 72.32 110.898 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.416 ' SD ' HG23 ' A' ' 138' ' ' ILE . 2.1 mmt -127.99 129.17 46.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.457 . . . . 64.33 110.855 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -123.23 120.2 32.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 73.53 110.866 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -94.98 127.92 41.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 74.31 110.901 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -134.77 122.71 22.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.112 -0.494 . . . . 64.32 110.858 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.463 ' N ' HD13 ' A' ' 133' ' ' ILE . 0.2 OUTLIER -55.31 -25.25 16.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 74.12 111.133 179.998 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -91.79 -20.03 21.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 63.52 111.095 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 164.04 98.97 0.13 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.711 -0.757 . . . . 62.22 112.452 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.82 138.44 37.63 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.692 2.261 . . . . 65.21 112.328 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.1 m -127.77 159.52 34.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 71.42 110.844 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.564 HD12 ' OG1' ' A' ' 159' ' ' THR . 2.4 mp -123.63 140.83 45.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.105 -0.498 . . . . 63.12 111.121 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 43.7 ttt180 -121.36 120.44 35.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 74.22 110.819 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -112.08 134.0 11.78 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.757 -0.735 . . . . 22.42 112.431 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -134.28 120.71 20.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.762 0.315 . . . . 74.21 111.135 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.637 HD12 ' N ' ' A' ' 143' ' ' VAL . 4.0 tp -131.62 125.74 32.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.229 -0.441 . . . . 73.24 110.92 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.716 HG21 ' HB2' ' A' ' 7' ' ' TYR . 78.5 t -127.93 133.92 66.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.45 . . . . 42.41 111.134 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.581 ' HA ' HD12 ' A' ' 123' ' ' ILE . 1.6 mp -110.04 138.68 46.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 65.23 110.898 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -111.96 124.72 6.89 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.751 -0.738 . . . . 43.3 112.498 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -134.2 145.07 48.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.825 0.345 . . . . 73.24 110.968 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -50.45 96.47 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.125 -0.489 . . . . 62.32 110.903 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 90.02 -26.77 9.18 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.724 -0.75 . . . . 72.3 112.462 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 8.4 m0 -104.91 135.89 45.41 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.819 0.342 . . . . 71.13 110.913 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.488 HD21 ' HB ' ' A' ' 6' ' ' THR . 0.5 OUTLIER -129.91 137.56 50.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 74.24 110.903 179.967 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.492 ' HB3' HD13 ' A' ' 144' ' ' LEU . . . -129.98 137.4 50.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 54.44 111.136 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.777 ' HA3' HD21 ' A' ' 10' ' ' LEU . . . -138.72 136.08 7.8 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.739 -0.743 . . . . 72.53 112.48 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -139.33 119.38 13.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.831 0.348 . . . . 74.24 110.911 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 38.0 tt0 -132.59 122.44 24.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.484 . . . . 64.31 110.895 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 10.7 ptt? -146.12 157.76 43.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 62.41 110.843 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.424 ' O ' ' HB ' ' A' ' 164' ' ' VAL . 5.0 m120 -112.86 121.5 44.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.435 . . . . 74.03 110.868 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.534 ' HD1' HD13 ' A' ' 138' ' ' ILE . 49.0 t80 -84.29 128.63 34.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.121 -0.49 . . . . 70.05 110.854 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.416 ' H ' ' HA ' ' A' ' 164' ' ' VAL . 5.0 tp10 -85.51 107.88 17.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.491 . . . . 71.14 110.899 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.564 ' OG1' HD12 ' A' ' 138' ' ' ILE . 0.2 OUTLIER -65.92 -48.31 71.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.137 -0.483 . . . . 74.2 111.156 -179.919 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -50.24 -26.25 4.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.453 . . . . 72.03 111.066 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 43.6 mttm -117.02 -166.59 1.19 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 73.01 110.872 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 18.8 t -114.26 37.28 3.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 75.12 110.891 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 7.5 ptp85 -168.32 175.01 6.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.112 -0.494 . . . . 73.11 110.867 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.527 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 1.7 m -80.45 142.18 14.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 53.11 111.131 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 7.9 t -91.13 -25.81 19.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.196 -0.456 . . . . 75.55 111.156 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 5.3 tp60 -139.31 133.25 30.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 61.3 110.968 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -125.23 130.54 52.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.178 -0.465 . . . . 71.15 110.878 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -136.07 138.2 41.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 73.15 110.891 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.7 ' HB3' HG22 ' A' ' 184' ' ' VAL . 6.5 t80 -133.26 144.58 49.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 72.14 110.857 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -149.97 137.04 19.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 73.35 111.119 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 21.7 t -121.11 140.53 44.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 72.12 111.127 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -115.24 126.36 7.14 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.736 -0.745 . . . . 71.02 112.51 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -128.43 121.59 29.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.924 0.392 . . . . 73.32 110.928 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 22.3 mtmm -103.39 133.33 48.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.112 -0.494 . . . . 62.23 110.917 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -127.05 165.26 19.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 73.43 111.121 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -38.96 -76.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 70.5 110.828 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -117.13 14.22 14.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 54.14 110.879 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -125.39 150.14 47.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.48 . . . . 74.04 110.889 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 46.2 mm-40 -129.34 124.88 35.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 74.35 110.863 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.601 HD23 HG13 ' A' ' 194' ' ' ILE . 3.0 tm? -122.71 124.49 43.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 61.14 110.893 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 76.4 m-70 -130.72 116.35 17.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.21 -0.45 . . . . 73.05 110.853 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.82 154.46 17.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 65.3 111.143 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -163.0 139.88 7.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.209 -0.451 . . . . 73.02 110.908 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.7 HG22 ' HB3' ' A' ' 169' ' ' PHE . 1.7 m -134.31 137.29 51.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 61.24 111.14 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -97.26 88.48 4.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 71.02 110.869 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 71.43 -174.84 0.17 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 72.41 110.925 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -79.47 3.04 69.39 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.75 -0.738 . . . . 51.13 112.469 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 30.5 p -106.36 -23.35 12.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.783 0.325 . . . . 71.1 111.162 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . 0.401 ' O ' ' HB ' ' A' ' 184' ' ' VAL . 1.2 tp10 -120.9 123.13 41.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.215 -0.448 . . . . 70.41 110.899 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' PHE . . . . . 0.568 ' HA ' ' HB ' ' A' ' 184' ' ' VAL . 0.5 OUTLIER -139.06 124.73 19.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 74.21 110.841 -179.884 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -165.1 -156.18 8.94 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.714 -0.755 . . . . 61.25 112.443 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -171.09 -168.56 32.96 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.742 -0.742 . . . . 42.03 112.487 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . 0.537 ' CB ' ' HB1' ' A' ' 14' ' ' ALA . 39.0 t -147.78 145.52 28.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.837 0.351 . . . . 50.25 110.869 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.601 HG13 HD23 ' A' ' 180' ' ' LEU . 4.5 mp -120.68 133.36 67.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.113 -0.494 . . . . 73.32 111.112 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -117.68 121.18 40.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.192 -0.458 . . . . 74.22 110.932 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -121.03 131.64 54.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.087 -0.506 . . . . 64.42 110.916 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.413 ' HG2' HG23 ' A' ' 198' ' ' VAL . 23.3 ttpt -97.07 127.4 43.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.173 -0.467 . . . . 60.34 110.895 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.413 HG23 ' HG2' ' A' ' 197' ' ' LYS . 17.9 t 65.01 66.47 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 62.01 111.123 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -112.47 -36.03 5.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.176 -0.465 . . . . 72.3 110.932 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 31.0 tttm -119.77 -67.8 0.96 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 63.12 110.909 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.17 -38.08 1.42 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.209 -0.45 . . . . 74.0 110.892 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.584 HD22 ' H ' ' A' ' 226' ' ' GLN . 15.1 tp -146.1 -74.43 0.22 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.21 -0.45 . . . . 65.43 110.884 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -124.91 142.1 51.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 74.21 110.86 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 1.7 m -146.01 137.56 24.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 73.21 111.198 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.514 ' HB3' HG21 ' A' ' 17' ' ' VAL . . . -150.33 162.69 40.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.23 -0.441 . . . . 41.42 111.056 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 1.3 m -137.26 149.98 26.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.194 -0.457 . . . . 71.41 111.176 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -113.81 135.74 53.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 73.54 110.89 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.429 HD13 ' HA ' ' A' ' 208' ' ' LEU . 3.7 mm? -121.38 145.5 47.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.485 . . . . 75.41 110.906 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.631 ' HB3' ' HB2' ' A' ' 218' ' ' ARG . . . -153.32 138.18 17.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.203 -0.453 . . . . 72.31 111.112 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 9.4 t-105 -130.78 134.94 47.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.188 -0.46 . . . . 74.43 110.945 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 2.3 m -96.9 105.27 17.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.252 -0.431 . . . . 70.55 111.12 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -51.6 132.68 30.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.155 -0.475 . . . . 52.43 111.091 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 117.85 -74.96 0.29 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.766 -0.731 . . . . 73.3 112.446 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -179.95 106.93 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.831 0.348 . . . . 71.11 110.843 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 2.0 t -173.96 161.14 3.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.466 . . . . 55.04 110.845 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -63.61 154.85 31.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 73.1 110.904 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 3.7 m -80.95 133.91 35.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.164 -0.471 . . . . 62.53 111.151 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . 0.631 ' HB2' ' HB3' ' A' ' 209' ' ' ALA . 8.1 mmt85 -89.99 118.08 29.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.45 . . . . 73.43 110.844 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . 0.706 ' CE1' HD11 ' A' ' 221' ' ' ILE . 18.1 t80 -130.18 137.53 50.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.146 -0.479 . . . . 74.11 110.88 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -142.01 140.64 10.22 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.752 -0.737 . . . . 54.42 112.485 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.706 HD11 ' CE1' ' A' ' 219' ' ' PHE . 4.3 mp -120.53 131.39 72.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.825 0.345 . . . . 74.32 111.142 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.494 ' CB ' HG13 ' A' ' 17' ' ' VAL . . . -137.49 151.22 48.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 74.03 111.076 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -144.98 129.73 18.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 72.32 111.083 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 29.1 mtpt -102.52 125.25 49.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 52.02 110.914 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -124.28 117.76 25.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.254 -0.43 . . . . 73.23 110.91 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . 0.584 ' H ' HD22 ' A' ' 202' ' ' LEU . 23.1 tt0 -86.67 104.7 16.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.088 -0.506 . . . . 72.35 110.923 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 1.7 tt -82.68 -31.6 9.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 60.34 111.117 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -161.45 161.44 22.85 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.583 0.706 . . . . 72.34 110.867 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -6.96 19.85 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.664 2.242 . . . . 32.13 112.345 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -112.74 -25.38 9.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.246 -0.434 . . . . 63.31 110.861 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -137.62 145.08 42.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 72.13 111.085 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 25.5 m -136.85 143.14 42.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 75.4 110.915 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -117.73 134.24 55.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 65.45 110.861 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 22.8 t -135.47 152.15 51.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.122 -0.49 . . . . 72.14 110.854 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -139.51 146.27 39.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.087 -0.506 . . . . 71.53 111.129 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.52 159.01 32.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.261 -0.427 . . . . 73.32 110.852 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.624 HG12 ' HA ' ' A' ' 243' ' ' ILE . 1.6 m -141.73 163.97 19.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 53.22 111.097 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -112.89 147.81 36.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 70.44 110.864 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -49.15 -22.36 0.96 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.479 . . . . 73.23 110.854 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 32.2 t -80.99 13.59 2.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 73.21 110.87 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 1.2 t 69.65 40.1 1.43 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.118 -0.492 . . . . 51.34 110.895 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . 0.616 ' O ' HG12 ' A' ' 237' ' ' VAL . 2.1 mp -97.23 137.79 35.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.131 -0.486 . . . . 73.31 110.956 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.624 ' HA ' HG12 ' A' ' 237' ' ' VAL . 0.0 OUTLIER -107.15 117.34 52.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 71.1 111.143 179.85 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . 0.54 ' C ' HD13 ' A' ' 245' ' ' LEU . . . -139.07 148.47 20.02 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.724 -0.75 . . . . 63.33 112.484 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.732 ' CD2' ' HB3' ' A' ' 261' ' ' ALA . 0.0 OUTLIER -146.65 160.86 41.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.849 0.356 . . . . 74.32 110.939 -179.929 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -134.62 147.95 19.33 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.765 -0.731 . . . . 55.41 112.508 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -127.77 116.94 20.98 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.988 0.423 . . . . 74.42 110.911 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.459 HG23 ' O ' ' A' ' 257' ' ' LEU . 7.5 m -101.78 137.36 40.19 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.08 -0.509 . . . . 71.33 111.079 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . 0.7 ' CB ' HD23 ' A' ' 257' ' ' LEU . 1.0 OUTLIER -137.25 165.94 24.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 73.52 110.903 179.971 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . 0.447 ' O ' ' CB ' ' A' ' 251' ' ' LEU . 23.5 m 65.88 -104.76 0.1 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.45 . . . . 72.22 111.095 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.676 ' O ' HD12 ' A' ' 251' ' ' LEU . 0.2 OUTLIER 79.17 -9.17 1.53 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 53.43 110.91 -179.993 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' LYS . . . . . 0.54 ' CB ' ' HD2' ' A' ' 253' ' ' PRO . 4.5 mttm -48.01 171.88 0.08 OUTLIER Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.6 0.714 . . . . 74.02 110.899 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . 0.54 ' HD2' ' CB ' ' A' ' 252' ' ' LYS . 54.0 Cg_endo -69.79 58.33 1.56 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.66 2.24 . . . . 64.13 112.34 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -165.87 -62.7 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.7 -0.762 . . . . 35.32 112.485 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -140.95 139.28 34.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.908 0.385 . . . . 64.21 111.141 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.521 ' O ' ' HA ' ' A' ' 279' ' ' LEU . 7.0 tttt -110.16 127.01 54.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 72.52 110.857 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 0.715 ' CD1' HD21 ' A' ' 277' ' ' LEU . 25.0 tp -88.85 122.78 32.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.175 -0.466 . . . . 64.02 110.889 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . 0.405 ' O ' HD22 ' A' ' 277' ' ' LEU . 4.8 m -126.54 110.14 12.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 71.13 111.148 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 1.088 HD22 HD23 ' A' ' 277' ' ' LEU . 0.0 OUTLIER -103.4 134.01 47.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.196 -0.456 . . . . 55.12 110.913 179.957 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 24.8 p -128.9 140.64 51.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 63.51 110.892 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' ALA . . . . . 0.732 ' HB3' ' CD2' ' A' ' 245' ' ' LEU . . . -147.24 126.09 12.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.484 . . . . 72.34 111.094 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.786 ' C ' HD13 ' A' ' 263' ' ' LEU . 3.2 tm? -131.91 122.96 26.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.458 . . . . 74.42 110.887 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . 0.786 HD13 ' C ' ' A' ' 262' ' ' LEU . 0.1 OUTLIER -121.56 109.81 15.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.15 -0.477 . . . . 75.53 110.912 179.867 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . 0.673 ' O ' HG22 ' A' ' 268' ' ' VAL . 0.1 OUTLIER -87.19 109.41 19.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 71.4 110.916 179.809 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -56.24 -20.5 29.04 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.743 -0.741 . . . . 71.04 112.488 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.94 -3.54 48.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.799 0.333 . . . . 73.41 110.924 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -123.73 -57.62 1.62 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 73.21 110.886 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . 0.71 HG12 ' O ' ' A' ' 272' ' ' GLY . 16.7 m -48.11 -28.24 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 71.01 111.112 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -53.26 -45.77 68.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 60.01 110.929 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -106.14 -16.92 14.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 64.11 111.127 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -108.06 -123.35 4.9 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.719 -0.753 . . . . 43.05 112.474 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . 0.71 ' O ' HG12 ' A' ' 268' ' ' VAL . . . -146.47 -163.02 10.15 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.693 -0.765 . . . . 64.44 112.466 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' HIS . . . . . 0.61 ' CB ' HD12 ' A' ' 263' ' ' LEU . 5.6 p80 -105.35 146.26 29.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.83 0.348 . . . . 75.22 110.884 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 12.4 mtpp -104.28 135.68 45.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.228 -0.442 . . . . 73.01 110.887 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.462 HD12 ' HB2' ' A' ' 261' ' ' ALA . 1.3 tp -137.09 148.18 46.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 72.13 110.944 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -144.37 110.56 0.57 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.726 -0.75 . . . . 71.13 112.493 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 1.088 HD23 HD22 ' A' ' 259' ' ' LEU . 3.2 tm? -117.06 139.3 50.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.82 0.343 . . . . 62.21 110.956 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . 0.597 ' H ' HD22 ' A' ' 277' ' ' LEU . . . -162.13 154.16 25.05 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.696 -0.764 . . . . 62.15 112.48 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.82 HD23 ' HB2' ' A' ' 29' ' ' LEU . 3.1 mm? -106.88 139.93 40.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.777 0.322 . . . . 71.11 110.865 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -89.1 126.23 35.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 73.41 110.879 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.781 ' HA ' ' HA ' ' A' ' 31' ' ' LEU . 15.1 p90 -74.98 71.18 2.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.145 -0.48 . . . . 70.25 110.884 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 67.5 mm-40 -125.07 102.02 7.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.48 . . . . 73.1 110.904 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.62 ' HB1' HD12 ' A' ' 284' ' ' LEU . . . -124.67 136.28 53.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 60.13 111.144 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.914 HD13 HG23 ' A' ' 33' ' ' THR . 4.2 mp 60.83 32.91 20.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 63.13 110.933 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.155 -0.475 . . . . 74.24 110.898 179.962 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' NAI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.782 0.325 . . . . 61.3 110.875 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -113.37 -174.03 2.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 64.15 111.023 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.45 HG23 ' HD2' ' A' ' 4' ' ' PRO . 7.1 p -164.3 133.7 2.95 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.662 0.744 . . . . 70.21 111.107 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.45 ' HD2' HG23 ' A' ' 3' ' ' VAL . 53.6 Cg_endo -69.7 167.97 22.81 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.671 2.247 . . . . 71.44 112.383 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 117.97 5.4 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.691 2.261 . . . . 75.43 112.344 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 1.066 HG22 HD21 ' A' ' 150' ' ' LEU . 0.2 OUTLIER -92.71 -32.75 14.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.203 -0.453 . . . . 74.22 111.136 -179.946 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.663 ' HB2' HG21 ' A' ' 143' ' ' VAL . 18.0 t80 -55.55 -29.82 59.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.246 -0.434 . . . . 70.33 110.953 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -72.95 -22.58 60.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.091 -0.504 . . . . 44.53 111.056 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -87.57 7.51 29.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.205 -0.452 . . . . 75.14 110.858 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.72 HD21 HG13 ' A' ' 143' ' ' VAL . 50.0 mt -69.22 -31.39 69.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 64.2 110.885 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -172.45 76.23 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.76 -0.733 . . . . 41.55 112.515 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.4 mmtp -69.25 -55.09 11.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.772 0.32 . . . . 54.15 110.87 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.91 -39.64 93.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.452 . . . . 74.34 110.852 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.403 ' HB2' ' HB2' ' A' ' 181' ' ' HIS . . . -58.91 -37.32 76.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.487 . . . . 71.32 111.098 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -59.76 -31.98 70.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 75.12 110.873 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 -57.47 -48.29 79.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 74.02 110.898 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 61.7 t -81.84 -33.07 11.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.461 . . . . 64.53 111.143 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -64.55 -32.43 74.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 75.43 110.83 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 52.4 m -48.6 114.92 1.07 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 73.25 111.163 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.3 mptt -85.03 -168.72 2.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 65.44 110.895 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 99.03 32.15 5.97 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.711 -0.757 . . . . 60.21 112.483 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -119.03 124.78 47.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.927 0.394 . . . . 75.42 110.926 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 62.56 65.85 2.92 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.81 -0.709 . . . . 74.43 112.472 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -102.43 -4.7 25.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.898 0.38 . . . . 74.3 110.911 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.37 13.6 77.14 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.702 -0.761 . . . . 31.03 112.515 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.591 ' C ' HD12 ' A' ' 27' ' ' ILE . 2.2 pp -145.02 -178.35 6.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.737 0.303 . . . . 64.31 110.92 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.591 HD12 ' C ' ' A' ' 26' ' ' LEU . 1.7 mp -119.6 122.41 68.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 75.32 111.137 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.84 117.04 18.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.135 -0.484 . . . . 62.33 110.886 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 1.01 HD13 ' O ' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -114.78 145.33 42.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.211 -0.449 . . . . 75.11 110.942 179.876 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.772 ' N ' HD22 ' A' ' 29' ' ' LEU . 1.3 m-20 -148.06 133.35 18.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.184 -0.462 . . . . 72.4 110.852 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.717 ' HA ' ' HA ' ' A' ' 281' ' ' PHE . 0.2 OUTLIER -127.1 127.79 45.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 73.21 110.87 -179.915 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.613 ' N ' ' HB2' ' A' ' 281' ' ' PHE . 33.5 ttpt -136.56 140.85 43.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 73.21 110.883 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.437 ' O ' HG23 ' A' ' 33' ' ' THR . 8.6 t -135.5 121.66 20.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 72.5 111.166 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.793 ' HG2' HD21 ' A' ' 284' ' ' LEU . 1.7 pttp -105.13 125.85 51.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.25 -0.432 . . . . 71.51 110.904 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.5 t -114.71 142.79 46.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 72.31 110.827 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -77.17 58.25 1.55 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 74.15 110.89 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -152.86 19.89 0.59 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.143 -0.481 . . . . 73.43 110.88 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.453 ' HA2' ' C ' ' A' ' 63' ' ' ARG . . . 81.01 -4.99 67.68 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.715 -0.755 . . . . 71.14 112.487 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.3 mp -98.42 128.23 44.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.769 0.319 . . . . 74.1 110.902 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -140.97 117.56 10.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 73.53 110.894 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -103.24 122.66 45.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 64.33 110.891 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 90.3 m -126.5 126.31 43.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.137 -0.483 . . . . 63.42 111.142 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.3 p -132.46 142.22 49.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 63.21 110.843 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 58.1 m -149.03 135.84 19.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 71.31 110.874 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -148.02 141.65 9.37 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.702 -0.761 . . . . 65.12 112.44 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 9.0 m -126.91 157.56 39.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.858 0.361 . . . . 70.41 110.887 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.595 ' HB1' HG22 ' A' ' 54' ' ' VAL . . . -157.11 131.14 8.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.152 -0.476 . . . . 71.42 111.09 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -101.53 141.99 33.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.446 . . . . 73.12 110.893 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 22.2 p -51.03 -34.47 29.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 55.35 111.105 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -51.34 168.24 0.07 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.188 -0.46 . . . . 63.24 110.876 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.2 t -73.05 136.26 44.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 74.12 111.162 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 66.9 p 47.06 71.6 0.31 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.259 -0.428 . . . . 60.31 111.112 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 18.6 mmtp -143.54 35.3 1.3 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.2 -0.455 . . . . 72.32 110.91 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.595 HG22 ' HB1' ' A' ' 47' ' ' ALA . 46.3 t -109.19 124.11 65.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 52.22 111.145 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.6 m -136.11 126.94 27.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 53.12 111.137 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -127.39 141.54 12.73 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.747 -0.74 . . . . 73.01 112.524 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 59.5 p -144.1 160.48 40.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.922 0.392 . . . . 74.14 110.882 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -132.55 150.18 52.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.143 -0.48 . . . . 74.11 110.894 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.408 ' HB3' ' HA ' ' A' ' 74' ' ' LYS . 1.1 pm0 -136.14 136.18 39.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 74.24 110.9 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.9 p -103.07 129.57 49.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.151 -0.477 . . . . 72.23 111.093 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.1 mtpm? -129.9 159.59 36.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 65.5 110.889 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -130.32 139.65 50.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.217 -0.447 . . . . 74.03 110.929 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.453 ' C ' ' HA2' ' A' ' 38' ' ' GLY . 0.5 OUTLIER -134.51 105.17 6.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.134 -0.484 . . . . 75.44 110.881 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -115.06 101.68 9.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.46 . . . . 72.14 110.952 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.7 t -83.37 -31.76 26.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 64.55 111.149 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -48.47 -34.16 10.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.2 -0.454 . . . . 73.21 110.904 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.557 ' CD1' HD23 ' A' ' 69' ' ' LEU . 29.7 t80 -118.02 -58.34 2.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.18 -0.464 . . . . 71.33 110.936 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.651 ' O ' HD22 ' A' ' 69' ' ' LEU . . . 129.34 58.17 0.1 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.778 -0.725 . . . . 63.15 112.516 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.651 HD22 ' O ' ' A' ' 68' ' ' GLY . 2.4 mm? -133.65 141.33 47.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.852 0.358 . . . . 62.44 110.891 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 95.6 m -135.57 130.4 34.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 64.01 111.141 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -119.23 134.82 54.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 73.41 110.875 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.534 HG23 ' HB2' ' A' ' 84' ' ' GLU . 0.6 OUTLIER -126.73 117.41 22.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.463 . . . . 73.21 111.152 -179.897 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -132.03 131.47 42.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.27 -0.423 . . . . 73.33 110.875 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.408 ' HA ' ' HB3' ' A' ' 59' ' ' GLU . 17.1 ptmt -117.66 135.86 53.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 74.33 110.931 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 12.7 t90 -135.48 128.46 31.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.213 -0.449 . . . . 75.12 110.925 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -120.52 159.52 25.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 70.25 110.872 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 10.5 t -66.79 -13.37 61.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.157 -0.474 . . . . 63.34 111.108 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.443 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 94.9 m-20 -74.92 1.23 13.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.254 -0.43 . . . . 71.41 110.894 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.443 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 2.9 m120 78.72 33.19 0.28 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 75.34 110.91 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 33.3 m -114.89 123.4 49.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.145 -0.48 . . . . 63.24 111.119 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -122.05 119.62 31.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 73.31 110.897 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.76 111.72 3.74 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.731 -0.747 . . . . 60.24 112.473 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.0 t -93.03 120.69 33.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.795 0.331 . . . . 43.11 111.119 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.534 ' HB2' HG23 ' A' ' 72' ' ' THR . 26.8 mt-10 -134.06 126.69 30.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.45 . . . . 65.03 110.871 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.406 HG22 ' HB3' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -115.4 138.46 45.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.163 -0.472 . . . . 53.4 111.157 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 99.8 m -129.51 137.72 50.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.202 -0.453 . . . . 70.32 111.126 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.456 ' HB ' HD23 ' A' ' 97' ' ' LEU . 1.8 t -118.14 137.28 52.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.44 . . . . 72.34 111.149 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -113.71 118.32 33.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 75.34 110.901 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 50.88 74.77 0.21 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.462 . . . . 73.13 110.901 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -96.7 -75.59 0.53 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 74.12 110.885 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 40.9 tp -92.24 -72.37 0.6 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.21 -0.45 . . . . 62.44 110.916 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.571 ' HB3' ' HB2' ' A' ' 95' ' ' LEU . . . -77.53 139.7 39.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 51.34 111.122 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 2.6 ptt180 -60.08 125.09 22.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 74.33 110.868 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 78.73 8.94 87.48 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.756 -0.735 . . . . 44.35 112.502 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.571 ' HB2' ' HB3' ' A' ' 92' ' ' ALA . 13.8 tp -79.32 134.18 36.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.876 0.37 . . . . 62.21 110.928 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.9 ptmt -121.38 127.51 51.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 64.34 110.905 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.458 HD22 ' N ' ' A' ' 97' ' ' LEU . 1.7 mm? -115.03 129.2 56.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.223 -0.444 . . . . 65.05 110.9 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 69.0 m -129.55 119.87 24.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 65.23 111.19 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.406 ' HB3' HG22 ' A' ' 85' ' ' ILE . 3.1 t80 -122.28 128.71 51.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 65.32 110.858 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -127.84 130.48 48.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.128 -0.487 . . . . 40.11 110.831 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.7 t -142.3 125.93 16.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 73.2 110.88 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.1 t -97.87 131.71 44.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 70.12 110.849 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -129.54 119.69 24.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.106 -0.497 . . . . 74.53 110.878 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -128.83 101.9 19.91 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.661 0.743 . . . . 65.04 110.832 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -37.81 8.58 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.703 2.268 . . . . 74.51 112.334 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -61.57 -75.01 0.07 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 73.53 110.865 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -63.85 -39.0 93.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 51.32 111.153 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.14 24.42 14.79 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.739 -0.744 . . . . 74.55 112.473 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 64.2 mmtt -94.07 148.15 22.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.864 0.364 . . . . 71.03 110.863 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -140.61 135.5 31.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 75.34 110.842 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -121.59 140.84 51.73 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.199 -0.455 . . . . 72.21 110.912 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -127.77 118.02 22.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 72.14 111.077 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 21.3 ttmm -138.45 137.5 37.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 64.44 110.895 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 6.0 tp -134.55 126.73 48.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 73.15 111.154 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -127.45 120.39 28.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 74.43 110.868 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 70.2 p -129.06 127.88 42.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.211 -0.45 . . . . 62.54 111.083 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -150.42 162.39 29.26 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.676 -0.773 . . . . 63.5 112.481 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 6.6 p90 -127.44 141.19 51.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.953 0.406 . . . . 74.34 110.898 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.43 ' NZ ' HD22 ' A' ' 124' ' ' ASN . 5.3 mmmt -110.15 122.71 48.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.075 -0.511 . . . . 72.41 110.908 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.1 mmt85 -106.28 145.29 31.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.273 -0.421 . . . . 71.42 110.865 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -49.67 -28.51 6.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 74.03 110.927 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 7.8 m170 -87.11 -45.33 10.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 73.41 110.853 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.429 HG21 HD23 ' A' ' 144' ' ' LEU . 11.8 pt -152.34 153.86 8.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 42.11 111.119 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.43 HD22 ' NZ ' ' A' ' 119' ' ' LYS . 17.6 p-10 -117.98 116.61 27.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.468 . . . . 44.41 110.907 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.671 ' HB3' HD13 ' A' ' 142' ' ' LEU . 0.4 OUTLIER -131.46 141.93 49.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 73.55 110.932 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -147.9 149.01 21.03 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.743 -0.741 . . . . 54.02 112.483 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 31.0 p -112.83 134.72 54.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.827 0.346 . . . . 62.41 110.896 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -117.35 150.8 38.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 73.11 110.857 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 43.2 ttm -135.98 135.98 39.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 74.35 110.851 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -122.53 128.09 50.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 72.43 110.842 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -95.55 97.69 9.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.456 . . . . 71.14 110.888 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -92.05 175.75 6.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 72.33 110.877 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.42 HD12 ' N ' ' A' ' 134' ' ' ALA . 2.5 pp -73.92 -37.51 47.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.262 -0.426 . . . . 63.4 111.089 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.42 ' N ' HD12 ' A' ' 133' ' ' ILE . . . -78.39 -20.43 51.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 74.24 111.081 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 155.22 150.7 5.64 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.778 -0.725 . . . . 65.44 112.483 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 107.92 1.97 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.697 2.265 . . . . 62.31 112.349 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.65 152.79 29.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.247 -0.433 . . . . 63.43 110.909 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.416 HD12 ' N ' ' A' ' 138' ' ' ILE . 5.0 mp -106.16 132.33 53.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.455 . . . . 74.12 111.14 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 12.3 ttm180 -122.58 133.48 54.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 61.11 110.865 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -127.61 133.3 7.81 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.753 -0.737 . . . . 65.01 112.502 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -140.65 116.07 10.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.824 0.345 . . . . 45.3 111.12 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.697 HD12 ' N ' ' A' ' 143' ' ' VAL . 3.2 tp -129.1 133.79 47.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 64.3 110.89 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.72 HG13 HD21 ' A' ' 10' ' ' LEU . 61.7 t -128.44 120.97 54.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 70.41 111.146 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.558 HD11 HD21 ' A' ' 142' ' ' LEU . 4.4 mp -114.72 139.94 49.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 72.44 110.925 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -129.51 124.62 4.53 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.772 -0.728 . . . . 62.14 112.533 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -144.93 146.62 32.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.817 0.341 . . . . 53.23 110.922 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 50.29 30.75 4.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.475 . . . . 71.25 110.896 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 85.9 -28.71 4.89 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.727 -0.749 . . . . 61.23 112.522 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 29.9 m0 -69.31 134.83 49.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.833 0.349 . . . . 64.33 110.938 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 1.066 HD21 HG22 ' A' ' 6' ' ' THR . 0.0 OUTLIER -108.5 137.81 45.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.256 -0.429 . . . . 43.34 110.892 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -135.96 126.12 26.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 73.43 111.073 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -132.15 146.34 18.01 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.743 -0.742 . . . . 21.53 112.477 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -143.49 119.26 10.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.783 0.325 . . . . 70.52 110.914 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -122.53 120.67 34.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 74.31 110.886 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 4.0 ptt? -148.13 143.52 27.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.251 -0.431 . . . . 71.42 110.882 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -113.64 131.54 56.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 74.44 110.87 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.505 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 9.8 m-85 -93.28 138.89 31.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 61.04 110.858 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.512 ' CG ' ' O ' ' A' ' 158' ' ' GLU . 5.2 pt-20 -76.4 117.32 17.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.105 -0.498 . . . . 74.42 110.876 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 9.8 t -67.23 -31.69 72.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.141 -0.482 . . . . 72.24 111.135 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -47.9 -23.92 0.89 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.215 -0.448 . . . . 64.42 111.129 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.99 -157.65 0.36 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.449 . . . . 74.31 110.9 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 54.1 m -99.51 40.82 1.19 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 42.21 110.858 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.45 173.42 7.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 75.2 110.923 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.505 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 2.5 t -105.82 141.04 22.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.444 . . . . 74.31 111.117 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -88.7 -37.26 15.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.131 -0.486 . . . . 62.31 111.149 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -155.8 131.87 10.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 64.43 110.882 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 2.2 p -127.05 109.63 12.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 71.25 110.878 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -130.87 142.33 50.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 65.23 110.88 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -132.39 156.57 46.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.194 -0.457 . . . . 74.23 110.861 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -154.89 129.89 9.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.117 -0.492 . . . . 75.4 111.081 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 41.2 t -126.86 134.12 66.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 74.45 111.136 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -107.93 124.07 7.38 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.741 -0.743 . . . . 75.5 112.464 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -113.97 122.36 46.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.978 0.418 . . . . 63.22 110.869 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -102.89 133.53 47.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.08 -0.509 . . . . 73.3 110.915 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.59 165.22 21.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 41.31 111.13 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -40.27 -75.38 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 63.21 110.898 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -116.66 14.91 15.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.214 -0.448 . . . . 74.33 110.889 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -126.16 149.55 48.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.131 -0.486 . . . . 63.42 110.863 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -133.26 124.44 27.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.115 -0.493 . . . . 73.34 110.922 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.594 HD23 HG13 ' A' ' 194' ' ' ILE . 2.6 tm? -123.55 126.09 46.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 73.33 110.907 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . 0.52 ' N ' HD22 ' A' ' 180' ' ' LEU . 22.1 m80 -130.59 114.86 15.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.446 . . . . 71.05 110.875 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 2.1 t -106.51 151.05 25.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.269 -0.423 . . . . 72.34 111.167 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -162.38 136.95 6.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 62.11 110.879 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.764 HG13 ' HB3' ' A' ' 190' ' ' PHE . 2.3 t -123.68 127.79 74.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.483 . . . . 72.4 111.129 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -120.69 83.03 2.0 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 75.4 110.887 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -48.25 -20.13 0.35 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 75.13 110.868 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -74.89 -33.08 56.04 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.793 -0.718 . . . . 70.03 112.49 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 69.0 p -123.48 -55.37 1.74 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.718 0.294 . . . . 53.13 111.135 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . 0.689 ' HG3' ' HB1' ' A' ' 209' ' ' ALA . 0.9 OUTLIER -165.87 152.98 10.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 72.3 110.901 179.998 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' PHE . . . . . 0.764 ' HB3' HG13 ' A' ' 184' ' ' VAL . 10.0 p90 -114.45 125.16 53.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 70.42 110.884 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -175.72 -132.36 1.59 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.745 -0.741 . . . . 74.42 112.489 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -176.4 -165.92 32.81 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.77 -0.729 . . . . 72.13 112.491 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -149.33 150.33 32.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.803 0.335 . . . . 52.53 110.9 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.594 HG13 HD23 ' A' ' 180' ' ' LEU . 4.2 mp -120.62 143.02 33.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 74.5 111.158 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -127.74 121.3 29.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.178 -0.465 . . . . 72.42 110.942 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 6.1 tm0? -124.57 130.43 52.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 75.11 110.963 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 20.5 tttt -107.12 127.77 53.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 72.54 110.876 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 98.5 t -74.34 -74.62 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 72.22 111.083 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -170.82 65.32 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 73.23 110.909 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? 48.29 33.47 3.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.143 -0.481 . . . . 61.11 110.915 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 6.2 ttmm -140.98 -43.74 0.38 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 74.11 110.881 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 6.1 mp -131.05 128.47 40.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.237 -0.438 . . . . 75.05 110.902 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -114.88 131.2 56.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 74.24 110.908 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 21.7 m -124.06 138.58 54.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.186 -0.461 . . . . 72.12 111.145 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -141.5 137.93 32.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.434 . . . . 71.1 111.139 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.91 HG22 HG22 ' A' ' 221' ' ' ILE . 30.3 t -112.93 140.69 31.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 63.01 111.079 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . 0.621 ' O ' HD22 ' A' ' 208' ' ' LEU . 3.5 m120 -114.95 134.22 55.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.475 . . . . 60.52 110.881 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.621 HD22 ' O ' ' A' ' 207' ' ' ASN . 2.8 mm? -134.16 130.71 37.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 72.33 110.925 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.689 ' HB1' ' HG3' ' A' ' 189' ' ' GLU . . . -156.42 132.11 9.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 53.12 111.083 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . 0.563 ' CE3' HG23 ' A' ' 217' ' ' THR . 3.8 t-105 -110.66 135.01 51.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.208 -0.451 . . . . 64.21 110.964 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . 0.436 HG23 ' O ' ' A' ' 211' ' ' THR . 3.3 t -93.39 111.36 23.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.253 -0.43 . . . . 53.44 111.092 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -51.11 136.81 23.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 60.24 111.076 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 117.36 -83.98 0.36 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.765 -0.731 . . . . 71.12 112.541 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -79.37 179.11 7.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.854 0.359 . . . . 65.23 110.864 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 9.7 p -103.36 36.43 2.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 72.12 110.867 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 35.0 m120 -102.09 125.2 48.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 70.33 110.874 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . 0.563 HG23 ' CE3' ' A' ' 210' ' ' TRP . 0.6 OUTLIER -105.34 137.6 42.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 60.11 111.141 -179.955 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 -97.62 117.66 32.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.258 -0.428 . . . . 72.31 110.837 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -128.34 132.11 48.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 73.22 110.874 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -145.2 160.99 28.15 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.735 -0.745 . . . . 73.15 112.474 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.91 HG22 HG22 ' A' ' 206' ' ' VAL . 0.0 OUTLIER -138.89 130.51 35.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.807 0.337 . . . . 74.52 111.104 -179.947 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -126.84 130.83 50.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 74.0 111.114 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -119.2 130.81 55.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.257 -0.429 . . . . 73.41 111.104 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -106.76 128.47 54.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.436 . . . . 73.52 110.872 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -127.07 117.67 22.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 74.53 110.934 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -84.7 123.91 30.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 71.14 110.942 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.517 HD12 ' CD2' ' A' ' 233' ' ' PHE . 64.6 mt -108.9 -33.56 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.446 . . . . 72.33 111.157 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -143.42 161.22 48.37 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.583 0.706 . . . . 71.15 110.918 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -19.32 36.22 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.738 2.292 . . . . 73.25 112.31 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -109.78 -27.06 9.51 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.224 -0.443 . . . . 53.3 110.893 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -124.6 141.95 51.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.469 . . . . 63.04 111.124 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 57.6 m -139.31 142.58 37.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.196 -0.456 . . . . 73.1 110.862 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . 0.517 ' CD2' HD12 ' A' ' 227' ' ' ILE . 2.5 m-85 -98.79 133.11 43.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.175 -0.466 . . . . 73.53 110.89 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 24.6 p -135.09 128.31 31.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 71.1 110.843 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -128.98 158.45 38.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 54.2 111.093 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.52 164.27 36.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 64.34 110.913 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 242' ' ' LEU . 10.0 p -154.86 143.19 13.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 74.13 111.148 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -102.52 148.47 25.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 75.43 110.869 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 14.1 t30 -54.09 -21.68 9.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 74.41 110.901 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 46.4 t -80.84 25.76 0.44 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.45 . . . . 64.34 110.843 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 1.9 m 59.2 39.29 22.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 62.54 110.926 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . 0.692 HD22 ' HB3' ' A' ' 264' ' ' ASP . 22.6 mt -99.4 118.11 35.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.093 -0.503 . . . . 63.32 110.915 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.437 ' H ' HD12 ' A' ' 243' ' ' ILE . 5.4 mp -84.62 125.92 40.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.172 -0.467 . . . . 75.43 111.102 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -128.21 132.81 7.49 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.771 -0.728 . . . . 73.21 112.496 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.422 ' CD1' ' HB3' ' A' ' 261' ' ' ALA . 1.3 pp -146.14 140.88 26.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.882 0.372 . . . . 61.43 110.902 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -153.13 150.32 22.05 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.677 -0.773 . . . . 71.21 112.445 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -128.39 132.19 48.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.943 0.401 . . . . 74.11 110.947 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.02 123.94 50.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 60.44 111.131 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -143.09 129.59 20.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 75.34 110.873 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . 0.41 HG23 ' HG2' ' A' ' 256' ' ' LYS . 3.1 m -80.62 142.31 34.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.222 -0.444 . . . . 65.24 111.174 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.662 HD23 ' HD2' ' A' ' 253' ' ' PRO . 7.6 tp -72.84 -70.74 0.34 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 74.33 110.888 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' LYS . . . . . 0.5 ' N ' ' HD2' ' A' ' 253' ' ' PRO . 16.9 ttpt 178.35 -59.45 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.6 0.714 . . . . 71.4 110.926 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . 0.662 ' HD2' HD23 ' A' ' 251' ' ' LEU . 54.0 Cg_endo -69.74 -86.64 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.705 2.27 . . . . 64.21 112.342 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -145.72 16.58 1.8 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.734 -0.746 . . . . 71.01 112.484 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.414 HG12 HD23 ' A' ' 31' ' ' LEU . 3.7 mt -105.32 118.07 52.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.882 0.372 . . . . 75.53 111.094 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.55 ' O ' ' HA ' ' A' ' 279' ' ' LEU . 0.0 OUTLIER -99.09 135.06 41.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 75.11 110.88 179.856 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 0.527 ' CD2' HD21 ' A' ' 277' ' ' LEU . 0.3 OUTLIER -94.08 124.02 37.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.464 . . . . 74.13 110.887 179.949 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 27.5 p -128.15 111.68 13.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.448 . . . . 75.21 111.121 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.907 HD22 HD23 ' A' ' 277' ' ' LEU . 0.1 OUTLIER -109.9 126.24 53.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.242 -0.435 . . . . 72.04 110.928 179.901 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.452 ' N ' HD13 ' A' ' 259' ' ' LEU . 4.1 m -126.49 140.86 52.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 74.25 110.839 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' ALA . . . . . 0.422 ' HB3' ' CD1' ' A' ' 245' ' ' LEU . . . -144.21 128.52 17.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.121 -0.491 . . . . 61.31 111.116 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.731 HD21 ' H6N' ' A' ' 301' ' ' NAI . 0.7 OUTLIER -121.66 120.77 35.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.446 . . . . 63.43 110.913 -179.939 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . 0.693 HD13 ' C ' ' A' ' 262' ' ' LEU . 0.2 OUTLIER -119.95 109.77 15.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.446 . . . . 73.31 110.887 179.913 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . 0.692 ' HB3' HD22 ' A' ' 242' ' ' LEU . 3.0 p30 -90.95 115.78 28.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.454 . . . . 64.22 110.853 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . 0.425 ' HA2' HG22 ' A' ' 268' ' ' VAL . . . -55.45 -18.38 15.04 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.704 -0.76 . . . . 43.22 112.5 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 6.4 ttpp -79.09 -25.99 43.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.836 0.35 . . . . 73.2 110.942 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -109.59 -54.46 2.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 72.13 110.916 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . 0.644 HG22 ' O ' ' A' ' 264' ' ' ASP . 13.8 m -51.04 -29.03 7.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.48 . . . . 64.52 111.109 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -52.43 -35.12 51.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 73.34 110.901 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -103.67 -17.44 15.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.123 -0.489 . . . . 71.23 111.074 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 125.7 98.58 1.14 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.721 -0.752 . . . . 43.24 112.498 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . 0.405 ' O ' HG12 ' A' ' 268' ' ' VAL . . . 168.2 93.13 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.716 -0.754 . . . . 71.52 112.465 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 273' ' ' HIS . . . . . 0.499 ' CB ' HD12 ' A' ' 263' ' ' LEU . 9.6 p80 -113.43 144.5 42.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.877 0.37 . . . . 74.24 110.859 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 43.5 mmtm -101.12 136.85 40.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 73.22 110.874 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.729 HD13 ' N ' ' A' ' 276' ' ' GLY . 2.2 tm? -135.85 137.71 41.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.476 . . . . 73.52 110.89 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . 0.729 ' N ' HD13 ' A' ' 275' ' ' LEU . . . -139.56 136.37 7.81 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.721 -0.752 . . . . 73.22 112.464 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.907 HD23 HD22 ' A' ' 259' ' ' LEU . 3.1 tm? -132.52 138.2 47.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.898 0.38 . . . . 74.33 110.9 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . 0.588 ' H ' HD22 ' A' ' 277' ' ' LEU . . . -160.67 161.01 32.41 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.761 -0.733 . . . . 75.04 112.455 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.74 HD23 ' HB2' ' A' ' 29' ' ' LEU . 2.9 mm? -113.93 143.37 44.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.815 0.34 . . . . 75.13 110.937 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . 0.421 ' HB2' ' HB3' ' A' ' 256' ' ' LYS . 0.9 OUTLIER -91.37 130.1 37.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 75.3 110.87 179.994 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.717 ' HA ' ' HA ' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -76.33 60.26 1.52 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 71.32 110.89 -179.941 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -109.38 97.74 7.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.133 -0.485 . . . . 72.25 110.875 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.478 ' HB2' HD11 ' A' ' 31' ' ' LEU . . . -128.65 110.93 12.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.212 -0.449 . . . . 65.53 111.117 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.793 HD21 ' HG2' ' A' ' 34' ' ' LYS . 94.6 mt -152.15 178.38 9.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 63.44 110.923 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 42.2 tp10 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 71.15 110.864 179.941 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' NAI . . . . . 0.731 ' H6N' HD21 ' A' ' 262' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.7 mmt . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.791 0.329 . . . . 62.11 110.862 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.91 -63.23 1.27 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.258 -0.428 . . . . 61.52 111.07 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.724 HG13 ' HA ' ' A' ' 121' ' ' GLU . 0.0 OUTLIER -134.87 158.46 74.93 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.633 0.73 . . . . 75.51 111.124 179.997 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.85 170.25 17.11 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.688 2.259 . . . . 74.12 112.321 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 77.74 1.06 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.643 2.229 . . . . 64.32 112.36 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.561 HG22 HD11 ' A' ' 150' ' ' LEU . 2.6 p -70.37 -45.75 65.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 74.44 111.132 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 91.2 t80 -52.46 -32.38 39.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 75.05 110.901 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -82.18 -26.53 33.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 72.15 111.116 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -74.21 -12.86 60.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 72.23 110.843 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.427 HD21 ' O ' ' A' ' 152' ' ' GLY . 0.7 OUTLIER -56.42 -34.42 66.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 73.21 110.896 -179.961 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 142.45 64.77 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.762 -0.732 . . . . 52.32 112.529 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.6 ttpp -69.35 -42.12 75.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.801 0.334 . . . . 74.24 110.873 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.6 t -63.65 -39.35 94.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.207 -0.451 . . . . 64.15 110.901 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.8 -37.93 74.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.074 -0.512 . . . . 74.11 111.112 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 3.1 tmt_? -60.77 -33.12 72.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.444 . . . . 73.13 110.858 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.638 ' O ' HG23 ' A' ' 19' ' ' THR . 4.7 t0 -58.46 -40.0 81.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.45 . . . . 70.22 110.834 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.6 t -58.91 -39.42 77.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 73.32 111.113 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -60.54 -41.07 93.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.481 . . . . 45.11 110.866 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.638 HG23 ' O ' ' A' ' 16' ' ' ASP . 1.1 p 46.75 69.2 0.51 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 64.3 111.191 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 16.0 tptm -69.24 112.48 5.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 61.1 110.921 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 63.5 99.44 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.737 -0.744 . . . . 62.35 112.476 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -172.9 129.36 0.49 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.945 0.402 . . . . 74.15 110.908 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.52 40.84 3.09 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.784 -0.722 . . . . 73.12 112.501 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -103.18 13.01 34.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.911 0.386 . . . . 65.42 110.892 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 80.79 15.44 77.66 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.773 -0.727 . . . . 65.04 112.46 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.507 ' C ' HD13 ' A' ' 27' ' ' ILE . 0.1 OUTLIER -105.89 168.74 8.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.799 0.333 . . . . 61.11 110.917 -179.93 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.734 HG23 HD12 ' A' ' 277' ' ' LEU . 2.8 mm -120.2 123.42 70.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.234 -0.439 . . . . 72.43 111.089 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.6 ttmt -115.2 118.15 32.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.465 . . . . 75.23 110.921 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.617 HD12 ' CB ' ' A' ' 279' ' ' LEU . 1.0 OUTLIER -114.68 142.99 45.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 63.41 110.915 179.955 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -147.82 128.62 14.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 71.21 110.851 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.686 HD13 ' HB3' ' A' ' 281' ' ' PHE . 5.7 tp -127.2 128.78 46.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 71.14 110.908 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.673 ' N ' HD12 ' A' ' 31' ' ' LEU . 2.0 pttm -124.83 125.48 44.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 71.23 110.887 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.479 HG22 ' HB2' ' A' ' 283' ' ' ALA . 6.6 p -135.2 120.8 19.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.199 -0.455 . . . . 60.34 111.158 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.581 ' O ' HD21 ' A' ' 284' ' ' LEU . 53.1 mttm -118.75 129.99 55.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 74.25 110.91 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.2 t -116.14 138.29 51.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 73.23 110.87 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -77.41 59.25 1.83 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.157 -0.474 . . . . 74.02 110.889 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -160.51 25.27 0.15 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 73.35 110.805 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.51 ' HA2' ' O ' ' A' ' 63' ' ' ARG . . . 79.7 -4.11 66.31 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.737 -0.744 . . . . 43.14 112.526 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.5 mp -98.23 126.11 43.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.782 0.325 . . . . 64.21 110.897 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.1 118.39 10.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.172 -0.467 . . . . 62.11 110.861 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -103.71 124.15 48.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.152 -0.476 . . . . 73.42 110.883 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.11 115.5 19.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 73.43 111.124 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.42 138.12 53.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 63.35 110.863 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 27.0 m -150.6 126.96 10.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 71.34 110.905 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -164.53 166.43 37.89 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.726 -0.749 . . . . 60.0 112.489 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 60.3 m -138.03 168.62 19.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.877 0.37 . . . . 71.22 110.878 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.426 ' HB1' HG12 ' A' ' 54' ' ' VAL . . . -134.13 139.52 45.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.126 -0.488 . . . . 74.41 111.096 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -113.41 141.43 47.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 65.41 110.919 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.421 HG22 ' H ' ' A' ' 50' ' ' GLU . 0.2 OUTLIER 64.07 169.53 0.17 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 64.15 111.109 -179.986 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.421 ' H ' HG22 ' A' ' 49' ' ' THR . 0.0 OUTLIER -74.28 94.52 2.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.462 . . . . 70.13 110.863 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 61.5 p 45.98 84.01 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.127 -0.488 . . . . 65.32 111.134 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.7 m -151.5 -59.66 0.17 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.237 -0.438 . . . . 73.44 111.196 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 18.0 mmtp -142.33 113.69 7.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 75.21 110.897 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.426 HG12 ' HB1' ' A' ' 47' ' ' ALA . 1.0 OUTLIER -125.55 147.54 30.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 75.33 111.142 179.836 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.2 p -110.32 126.57 54.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 51.54 111.13 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -118.76 143.63 17.55 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.72 -0.753 . . . . 60.53 112.503 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.85 142.51 50.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.968 0.413 . . . . 61.44 110.851 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.661 HD13 ' N ' ' A' ' 59' ' ' GLU . 0.8 OUTLIER -120.86 132.85 55.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 70.35 110.948 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.661 ' N ' HD13 ' A' ' 58' ' ' LEU . 3.4 tt0 -134.0 124.65 26.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 71.51 110.889 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 27.0 m -104.77 130.35 52.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 62.22 111.146 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 8.5 ttpt -132.48 156.93 45.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.239 -0.437 . . . . 71.13 110.919 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.564 ' O ' HG23 ' A' ' 70' ' ' THR . 26.0 m-85 -129.06 140.68 51.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.282 -0.417 . . . . 73.53 110.939 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.51 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 27.9 ttp85 -127.99 105.37 8.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 71.15 110.894 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.414 ' HB3' ' HG2' ' A' ' 66' ' ' GLU . 5.6 m-90 -113.19 134.33 54.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 63.11 110.935 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 30.3 p -69.82 -27.17 64.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.275 -0.42 . . . . 75.21 111.122 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.414 ' HG2' ' HB3' ' A' ' 64' ' ' TRP . 1.9 pt-20 -52.51 102.53 0.05 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.211 -0.45 . . . . 74.33 110.889 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.447 ' CD2' HD21 ' A' ' 69' ' ' LEU . 7.3 t80 65.33 9.77 5.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.149 -0.478 . . . . 75.03 110.902 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.597 ' O ' HD23 ' A' ' 69' ' ' LEU . . . 57.33 70.27 1.03 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.77 -0.729 . . . . 74.1 112.491 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.597 HD23 ' O ' ' A' ' 68' ' ' GLY . 5.7 mt -119.15 137.21 53.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.859 0.361 . . . . 65.3 110.9 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.564 HG23 ' O ' ' A' ' 62' ' ' TYR . 27.7 m -136.24 127.84 28.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 72.51 111.163 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.569 ' HB3' HG22 ' A' ' 85' ' ' ILE . 4.3 m-85 -121.79 121.62 37.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 71.32 110.86 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 61' ' ' LYS . 14.4 t -119.87 136.22 54.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 62.15 111.133 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -131.06 122.82 27.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 70.22 110.88 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.9 ptmt -95.51 135.99 36.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 74.42 110.91 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 8.7 t90 -134.81 128.84 33.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.246 -0.434 . . . . 74.2 110.926 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -117.85 154.93 31.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 62.14 110.878 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 7.3 t -62.48 -16.47 55.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.127 -0.488 . . . . 74.31 111.142 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.423 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 2.4 m-20 -74.61 0.78 13.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.258 -0.428 . . . . 70.43 110.89 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.423 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 3.7 m120 78.53 37.19 0.18 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.465 . . . . 63.44 110.877 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.6 p -113.58 121.54 44.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 74.32 111.144 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.402 HD13 ' HA ' ' A' ' 81' ' ' LEU . 4.3 mm? -111.23 132.96 53.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 70.13 110.966 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -123.61 92.84 0.46 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.803 -0.713 . . . . 73.32 112.517 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -79.34 106.1 11.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.821 0.343 . . . . 74.42 111.13 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -124.47 107.37 11.01 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.211 -0.449 . . . . 71.21 110.86 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.569 HG22 ' HB3' ' A' ' 71' ' ' PHE . 2.4 pp -111.51 130.84 64.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 73.41 111.13 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.863 HG23 HG22 ' A' ' 98' ' ' THR . 88.5 m -122.2 123.16 40.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 55.11 111.161 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.561 ' HB ' HD22 ' A' ' 69' ' ' LEU . 1.6 m -115.17 139.79 39.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.223 -0.444 . . . . 73.14 111.145 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -90.55 128.32 36.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 70.24 110.85 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.64 179.17 1.43 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.173 -0.467 . . . . 73.41 110.863 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -126.76 -65.9 0.93 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 73.11 110.883 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 20.1 tp -50.55 -75.47 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 75.25 110.931 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -73.26 76.35 1.32 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 72.31 111.091 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 7.7 tpp85 -48.78 133.69 17.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.435 . . . . 72.12 110.851 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 100.97 8.38 48.13 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.727 -0.749 . . . . 74.34 112.524 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.4 tp -112.68 124.67 53.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.861 0.362 . . . . 64.45 110.956 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 13.5 ttmt -124.62 125.05 43.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 72.05 110.929 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.566 HD12 HG22 ' A' ' 116' ' ' THR . 0.3 OUTLIER -101.64 127.13 48.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.222 -0.444 . . . . 73.13 110.939 179.914 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.863 HG22 HG23 ' A' ' 86' ' ' THR . 4.4 p -127.89 119.91 26.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 64.42 111.158 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.1 119.96 41.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.44 . . . . 71.25 110.917 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -109.9 142.12 41.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.474 . . . . 73.33 110.846 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.1 m -143.14 127.78 18.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 74.12 110.86 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -95.36 125.74 40.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 74.32 110.865 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -129.17 126.86 40.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 54.41 110.895 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.433 ' HA ' ' HD2' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -128.82 102.4 19.6 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.7 0.762 . . . . 73.0 110.827 -179.758 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 104' ' ' SER . 53.6 Cg_endo -69.76 -32.63 18.2 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.709 2.273 . . . . 54.1 112.349 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -70.12 -72.58 0.19 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.186 -0.461 . . . . 71.45 110.891 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.5 p -64.26 -40.09 95.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.129 -0.487 . . . . 65.42 111.131 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.52 24.45 13.92 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.726 -0.749 . . . . 75.11 112.495 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.11 148.09 22.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.82 0.343 . . . . 64.52 110.874 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -142.06 131.63 23.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 71.31 110.866 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -130.08 152.56 49.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.245 -0.434 . . . . 62.33 110.923 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -130.24 125.26 34.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 71.45 111.132 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.405 ' HB3' ' HA ' ' A' ' 130' ' ' ASP . 0.0 OUTLIER -139.03 137.99 36.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 35.13 110.861 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.536 HD13 ' H ' ' A' ' 115' ' ' LYS . 0.4 OUTLIER -125.84 138.35 54.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 74.22 111.149 179.835 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.536 ' H ' HD13 ' A' ' 114' ' ' ILE . 14.9 mtmt -130.17 130.11 44.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 75.43 110.925 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.566 HG22 HD12 ' A' ' 97' ' ' LEU . 1.2 p -119.22 119.2 33.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.446 . . . . 73.14 111.155 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -107.64 125.33 7.92 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.689 -0.767 . . . . 72.51 112.471 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -131.09 115.52 16.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.941 0.401 . . . . 60.05 110.886 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 13.7 mtpp -106.58 125.34 50.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.147 -0.479 . . . . 72.33 110.93 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 13.9 ttt85 -104.95 144.96 31.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.281 -0.418 . . . . 74.33 110.867 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.724 ' HA ' HG13 ' A' ' 3' ' ' VAL . 9.8 pt-20 -50.41 -26.57 5.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 71.24 110.9 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 33.9 m170 -86.98 -45.51 10.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 75.12 110.886 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 49.4 pt -151.38 156.6 6.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 61.23 111.143 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.404 ' HB2' HG22 ' A' ' 143' ' ' VAL . 2.6 m120 -104.21 129.7 51.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 62.02 110.897 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.543 ' CD2' HD22 ' A' ' 142' ' ' LEU . 1.0 OUTLIER -127.77 143.42 51.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 73.33 110.924 179.926 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -146.51 117.18 0.92 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.762 -0.732 . . . . 74.15 112.547 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 36.8 t -113.89 132.09 56.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.847 0.356 . . . . 72.2 110.85 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.432 ' HA ' ' HA ' ' A' ' 115' ' ' LYS . 0.2 OUTLIER -128.38 117.32 21.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 55.02 110.821 -179.963 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 19.4 mtm -103.97 136.25 43.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 52.24 110.92 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.405 ' HA ' ' HB3' ' A' ' 113' ' ' LYS . 4.3 t0 -128.41 120.25 26.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 73.31 110.834 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -94.74 119.9 34.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 75.3 110.886 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -128.71 131.83 47.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.164 -0.471 . . . . 63.34 110.827 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -55.9 -29.86 27.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 53.1 111.125 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -80.01 -20.26 45.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 63.21 111.07 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 157.61 100.26 0.17 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.754 -0.736 . . . . 54.04 112.465 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.76 129.48 17.68 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.679 2.253 . . . . 61.34 112.399 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.571 ' C ' HD12 ' A' ' 138' ' ' ILE . 12.5 t -129.08 161.79 29.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 64.42 110.887 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.753 HD13 ' HB ' ' A' ' 159' ' ' THR . 1.7 mp -120.72 117.12 52.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.111 -0.495 . . . . 72.41 111.14 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 15.2 mtm180 -121.81 125.29 46.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 72.34 110.883 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -147.16 152.18 24.36 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.72 -0.753 . . . . 75.33 112.519 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -120.72 139.55 52.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.855 0.359 . . . . 53.33 111.099 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.64 HD12 ' N ' ' A' ' 143' ' ' VAL . 0.1 OUTLIER -141.33 143.41 34.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 61.23 110.939 -179.961 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.64 ' N ' HD12 ' A' ' 142' ' ' LEU . 1.0 OUTLIER -133.58 143.74 37.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 61.15 111.153 179.817 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.521 HD12 ' O ' ' A' ' 151' ' ' ALA . 0.5 OUTLIER -125.99 138.31 53.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.172 -0.467 . . . . 75.3 110.925 179.968 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -113.29 119.32 4.8 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.764 -0.732 . . . . 64.11 112.499 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -144.84 148.27 33.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.862 0.363 . . . . 74.24 110.89 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 50.06 26.36 2.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.139 -0.482 . . . . 71.12 110.897 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 88.78 -31.82 4.8 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.749 -0.739 . . . . 53.14 112.523 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 52.9 p-90 -80.72 146.21 31.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.814 0.34 . . . . 71.53 110.936 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.561 HD11 HG22 ' A' ' 6' ' ' THR . 2.7 mt -114.5 145.52 41.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.451 . . . . 51.31 110.93 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.521 ' O ' HD12 ' A' ' 144' ' ' LEU . . . -141.74 113.9 8.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 62.03 111.099 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.459 ' HA3' ' HA ' ' A' ' 143' ' ' VAL . . . -166.04 162.57 36.08 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.722 -0.751 . . . . 63.34 112.444 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.786 ' HB3' ' O ' ' A' ' 168' ' ' ASN . 0.0 OUTLIER -174.68 -168.45 0.36 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.858 0.361 . . . . 73.51 110.925 -179.862 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -99.99 146.21 26.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.072 -0.513 . . . . 64.43 110.867 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 3.1 ppp? -145.21 127.54 15.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 73.22 110.9 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -111.46 119.95 40.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 74.22 110.843 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -108.51 138.99 43.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 75.11 110.867 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -77.65 98.38 5.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 73.34 110.918 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.753 ' HB ' HD13 ' A' ' 138' ' ' ILE . 7.2 t -66.24 -40.84 90.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 52.24 111.149 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -48.67 -25.1 1.61 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 65.32 111.108 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 35.4 mmtm -141.47 -159.89 1.02 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 45.34 110.88 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 17.1 m -109.59 40.06 1.96 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 62.3 110.879 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -131.27 171.58 13.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.134 -0.485 . . . . 70.45 110.889 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -106.91 141.05 23.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 52.51 111.125 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 62.6 m -90.29 -35.26 15.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 72.42 111.153 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -154.92 137.64 15.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 73.41 110.917 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 2.8 t -128.2 102.14 6.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 74.14 110.85 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.786 ' O ' ' HB3' ' A' ' 153' ' ' TYR . 0.1 OUTLIER -116.27 122.65 45.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 71.24 110.92 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.566 ' HA ' ' HB2' ' A' ' 153' ' ' TYR . 42.3 m-85 -133.96 138.6 45.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 62.11 110.887 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.735 ' HB3' ' CD1' ' A' ' 153' ' ' TYR . . . -151.3 152.04 32.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 73.33 111.118 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.469 HG12 ' HB1' ' A' ' 151' ' ' ALA . 0.9 OUTLIER -140.9 148.3 21.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.22 -0.446 . . . . 62.34 111.088 179.988 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -121.99 129.16 7.51 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.725 -0.75 . . . . 54.11 112.513 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -113.67 131.45 56.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.912 0.386 . . . . 74.0 110.954 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 20.9 mmtp -102.67 128.2 49.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.105 -0.498 . . . . 70.15 110.882 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.456 ' O ' ' C ' ' A' ' 176' ' ' ASP . 0.2 OUTLIER -119.64 167.05 12.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.451 . . . . 54.31 111.153 179.979 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.456 ' C ' ' O ' ' A' ' 175' ' ' THR . 0.8 OUTLIER -34.13 -77.74 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 74.22 110.87 179.937 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -117.64 14.66 14.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 75.1 110.907 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -128.14 147.49 50.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 61.11 110.897 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -136.32 126.64 26.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 61.4 110.902 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.751 HD12 ' CG2' ' A' ' 194' ' ' ILE . 0.4 OUTLIER -124.29 137.28 54.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 64.53 110.894 -179.949 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 5.8 t-80 -130.98 113.45 14.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 74.03 110.859 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -96.16 146.97 24.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 54.23 111.154 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . 0.413 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 7.0 p30 -159.52 140.7 12.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.248 -0.433 . . . . 72.44 110.898 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.526 ' HB ' ' HA ' ' A' ' 190' ' ' PHE . 1.4 m -135.07 135.71 52.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.125 -0.489 . . . . 62.12 111.104 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -100.52 88.3 3.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 74.32 110.916 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 73.58 176.57 0.25 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.196 -0.456 . . . . 73.41 110.862 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -72.44 1.67 34.35 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.743 -0.741 . . . . 64.23 112.463 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 33.3 p -105.12 -24.34 12.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.715 0.293 . . . . 63.35 111.103 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -119.16 120.08 36.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.24 -0.436 . . . . 75.12 110.9 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' PHE . . . . . 0.526 ' HA ' ' HB ' ' A' ' 184' ' ' VAL . 0.5 OUTLIER -140.13 124.57 17.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.456 . . . . 75.01 110.947 -179.954 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -171.39 -150.33 7.04 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.72 -0.752 . . . . 53.45 112.463 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 172.37 -166.68 39.49 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.751 -0.737 . . . . 30.43 112.519 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . 0.467 ' C ' HD13 ' A' ' 194' ' ' ILE . 1.4 t -148.84 151.8 35.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.849 0.357 . . . . 72.23 110.857 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.751 ' CG2' HD12 ' A' ' 180' ' ' LEU . 0.0 OUTLIER -136.76 135.02 48.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 74.22 111.159 179.934 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -131.75 137.12 48.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 65.31 110.929 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 46.4 tp60 -124.35 131.9 53.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.123 -0.49 . . . . 64.13 110.963 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 11.2 ttpt -81.92 126.22 31.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 71.44 110.921 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 18.1 t -91.15 139.95 16.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 63.02 111.151 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -81.86 59.7 4.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 74.45 110.883 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 22.1 ttmt -165.9 39.87 0.06 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.198 -0.455 . . . . 71.43 110.889 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 4.8 mptt 57.32 44.06 22.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 75.0 110.87 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.665 HD12 ' O ' ' A' ' 224' ' ' LYS . 58.7 tp -152.92 145.98 24.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.249 -0.432 . . . . 73.15 110.906 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -127.32 149.24 50.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 75.41 110.911 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 71.2 p -123.29 138.24 54.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 74.25 111.115 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -145.81 135.73 23.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.214 -0.448 . . . . 74.44 111.134 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.562 HG22 HG12 ' A' ' 194' ' ' ILE . 0.9 OUTLIER -132.16 144.02 38.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 73.34 111.119 179.993 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -130.92 127.32 38.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.474 . . . . 71.41 110.852 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.446 ' H ' HD23 ' A' ' 208' ' ' LEU . 2.7 pt? -143.24 150.23 39.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.125 -0.489 . . . . 75.13 110.929 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -138.63 149.56 45.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 73.44 111.099 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 3.9 t-105 -120.63 135.19 55.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.447 . . . . 63.24 110.918 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 3.1 m -95.68 104.32 16.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 73.11 111.16 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -53.05 150.16 5.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 74.05 111.123 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 97.01 -34.16 5.26 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.729 -0.748 . . . . 42.21 112.498 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -122.58 -171.14 2.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.803 0.335 . . . . 75.35 110.919 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 22.7 t -119.03 38.06 3.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 53.01 110.857 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -101.96 111.88 24.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 72.42 110.917 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 14.6 t -115.18 138.18 51.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 61.22 111.173 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 63.3 mmt-85 -128.46 127.64 42.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 73.11 110.84 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -134.44 158.0 45.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.452 . . . . 72.54 110.861 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -147.44 147.46 18.23 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.718 -0.754 . . . . 54.5 112.516 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 3.8 mp -118.32 133.24 65.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.836 0.35 . . . . 73.41 111.12 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -131.77 143.73 50.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.462 . . . . 63.12 111.102 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -112.45 134.48 53.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.454 . . . . 43.1 111.071 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . 0.665 ' O ' HD12 ' A' ' 202' ' ' LEU . 1.1 ttpp -109.37 114.84 28.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 72.35 110.895 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 36.9 t80 -131.21 117.61 19.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.276 -0.42 . . . . 71.04 110.908 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -111.7 109.07 18.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.128 -0.487 . . . . 72.1 110.927 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 2.3 tt -80.93 -32.34 12.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 75.42 111.11 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -150.54 160.25 33.11 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.626 0.727 . . . . 72.41 110.882 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -7.61 21.48 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.671 2.248 . . . . 74.14 112.314 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -106.78 -29.52 9.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.247 -0.433 . . . . 75.03 110.9 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -124.54 133.56 53.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 72.32 111.09 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 42.1 m -134.81 141.76 46.5 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.235 -0.439 . . . . 42.44 110.849 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -127.13 133.48 50.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.474 . . . . 64.12 110.895 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 11.8 p -142.73 139.68 31.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.102 -0.499 . . . . 55.21 110.855 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -111.09 161.01 16.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.117 -0.492 . . . . 73.12 111.089 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 6.7 ptpp? -151.71 142.03 22.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 63.14 110.877 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 1.1 p -139.7 143.99 29.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 74.13 111.154 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -112.86 147.98 35.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.465 . . . . 63.45 110.927 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 40.1 t30 -59.43 -16.35 22.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 73.2 110.89 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 3.5 m -81.96 25.44 0.57 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 53.13 110.829 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 65.41 32.34 9.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.107 -0.497 . . . . 72.13 110.871 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 5.1 mp -100.28 118.07 35.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.122 -0.49 . . . . 52.31 110.923 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.437 ' H ' HD12 ' A' ' 243' ' ' ILE . 0.3 OUTLIER -118.1 116.79 52.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.223 -0.444 . . . . 74.44 111.115 179.835 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . 0.54 ' C ' HD13 ' A' ' 245' ' ' LEU . . . -147.88 163.39 28.84 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.723 -0.751 . . . . 70.32 112.452 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.661 ' N ' HD13 ' A' ' 245' ' ' LEU . 0.0 OUTLIER -146.5 160.43 42.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.88 0.371 . . . . 71.44 110.949 -179.972 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -141.41 137.84 8.35 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.715 -0.755 . . . . 73.22 112.507 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -129.38 131.06 46.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.919 0.39 . . . . 72.44 110.942 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.511 ' OG1' HG22 ' A' ' 258' ' ' THR . 1.8 t -118.68 118.79 32.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.121 -0.49 . . . . 71.15 111.178 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -115.21 122.45 46.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.247 -0.433 . . . . 71.25 110.927 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . 0.598 HG23 ' HB2' ' A' ' 256' ' ' LYS . 7.6 m -95.73 122.88 38.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 43.2 111.13 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 17.9 tp -98.84 92.57 5.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.179 -0.464 . . . . 64.51 110.919 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 3.7 mtpp 63.75 161.41 0.12 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.563 0.697 . . . . 71.21 110.894 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 76.76 1.11 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.687 2.258 . . . . 73.14 112.337 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 178.32 -48.61 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.8 -0.715 . . . . 73.25 112.527 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.72 135.42 62.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.925 0.393 . . . . 64.13 111.133 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.598 ' HB2' HG23 ' A' ' 250' ' ' THR . 36.3 ttpt -133.37 133.14 42.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.125 -0.488 . . . . 73.31 110.853 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 0.406 HD23 ' H ' ' A' ' 258' ' ' THR . 0.4 OUTLIER -108.13 133.9 51.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 74.24 110.895 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . 0.511 HG22 ' OG1' ' A' ' 248' ' ' THR . 30.9 p -132.62 122.04 24.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 74.34 111.16 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.663 HD21 HD11 ' A' ' 275' ' ' LEU . 0.1 OUTLIER -120.96 150.1 41.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 63.22 110.911 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.508 ' O ' HD22 ' A' ' 275' ' ' LEU . 1.5 m -142.64 140.5 31.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 51.54 110.815 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' ALA . . . . . 0.52 ' HB2' ' CD2' ' A' ' 275' ' ' LEU . . . -141.66 129.2 21.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 72.1 111.094 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.786 ' C ' HD13 ' A' ' 263' ' ' LEU . 1.3 tt -131.18 137.63 49.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 74.42 110.946 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . 0.786 HD13 ' C ' ' A' ' 262' ' ' LEU . 0.0 OUTLIER -120.9 108.59 14.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.173 -0.467 . . . . 72.21 110.918 179.915 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . 0.694 ' O ' HG22 ' A' ' 268' ' ' VAL . 0.5 OUTLIER -84.66 108.95 17.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 63.31 110.904 179.823 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -53.94 -18.85 9.37 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.788 -0.72 . . . . 44.22 112.48 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -91.05 -26.1 19.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.823 0.344 . . . . 74.31 110.876 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -100.1 -56.62 2.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 71.11 110.888 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . 0.717 HG12 ' O ' ' A' ' 272' ' ' GLY . 12.9 m -49.87 -27.36 3.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 71.2 111.117 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -53.74 -45.69 70.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 71.15 110.863 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -105.69 -17.16 14.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.473 . . . . 71.31 111.109 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -111.01 -120.18 4.01 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.778 -0.725 . . . . 75.15 112.501 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . 0.717 ' O ' HG12 ' A' ' 268' ' ' VAL . . . -150.39 -164.82 12.15 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.821 -0.704 . . . . 30.32 112.499 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 273' ' ' HIS . . . . . 0.621 ' CB ' HD12 ' A' ' 263' ' ' LEU . 8.9 p80 -89.62 145.93 24.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.851 0.358 . . . . 74.25 110.866 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 24.0 mttp -97.15 135.85 38.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 73.31 110.916 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.748 HD13 ' N ' ' A' ' 276' ' ' GLY . 2.7 tm? -134.94 138.93 44.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.256 -0.429 . . . . 65.51 110.913 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . 0.748 ' N ' HD13 ' A' ' 275' ' ' LEU . . . -132.75 140.04 11.47 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.752 -0.737 . . . . 73.11 112.523 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.734 HD12 HG23 ' A' ' 27' ' ' ILE . 2.1 tm? -113.94 136.7 52.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.792 0.329 . . . . 74.43 110.955 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . 0.697 ' N ' HD13 ' A' ' 277' ' ' LEU . . . -141.94 127.86 3.4 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.771 -0.728 . . . . 74.44 112.495 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.654 HD11 HD11 ' A' ' 277' ' ' LEU . 1.3 mm? -108.35 131.66 54.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.794 0.33 . . . . 61.12 110.882 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -123.36 112.03 17.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 64.21 110.928 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.686 ' HB3' HD13 ' A' ' 31' ' ' LEU . 17.7 m-85 -112.87 133.34 54.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 73.53 110.906 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -135.34 130.5 35.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 71.01 110.91 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.588 ' C ' HD23 ' A' ' 284' ' ' LEU . . . -99.16 135.78 40.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 74.42 111.106 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.588 HD23 ' C ' ' A' ' 283' ' ' ALA . 0.8 OUTLIER 41.7 37.14 0.68 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.253 -0.43 . . . . 53.54 110.91 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.47 . . . . 72.24 110.859 179.938 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' NAI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.9 mmm . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.735 0.302 . . . . 75.1 110.872 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.88 88.06 1.03 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 43.31 111.089 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.641 HG22 ' N ' ' A' ' 121' ' ' GLU . 60.2 t -114.42 78.75 4.92 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.642 0.734 . . . . 71.51 111.122 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 166.01 29.07 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.688 2.259 . . . . 61.34 112.316 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 101.66 0.94 Allowed 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.702 2.268 . . . . 72.43 112.296 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.649 HG22 HD21 ' A' ' 150' ' ' LEU . 0.0 OUTLIER -88.7 -46.36 9.07 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.218 -0.446 . . . . 70.22 111.178 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -54.39 -33.84 60.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 71.11 110.906 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -82.98 -19.16 37.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 74.12 111.129 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -88.85 10.09 22.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 55.42 110.903 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.567 HD23 HD12 ' A' ' 150' ' ' LEU . 89.5 mt -67.19 -34.25 77.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 61.43 110.911 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -139.57 68.45 0.49 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.738 -0.744 . . . . 72.25 112.484 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 12.4 mttp -64.64 -53.9 40.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.843 0.354 . . . . 72.44 110.942 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.9 t -58.77 -48.75 80.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 75.44 110.854 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.58 -37.82 88.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.113 -0.494 . . . . 70.05 111.065 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.451 ' O ' HG22 ' A' ' 19' ' ' THR . 16.2 ttm-85 -60.42 -34.32 73.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.26 -0.427 . . . . 70.52 110.881 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.08 -39.07 93.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.198 -0.455 . . . . 74.24 110.87 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.6 t -82.2 -33.33 11.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.256 -0.429 . . . . 64.11 111.128 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -72.18 -42.05 66.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 64.11 110.88 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.451 HG22 ' O ' ' A' ' 15' ' ' ARG . 12.3 t -68.49 -32.0 71.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 64.42 111.112 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -73.89 127.79 33.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 65.02 110.904 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -50.73 136.37 28.44 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.803 -0.713 . . . . 71.24 112.477 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -125.93 33.24 5.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.87 0.367 . . . . 71.03 110.897 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 73.87 88.63 0.19 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.714 -0.755 . . . . 72.15 112.524 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -94.24 -4.36 49.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.93 0.395 . . . . 72.42 110.897 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.58 13.36 80.26 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.754 -0.736 . . . . 32.21 112.49 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.461 HD12 ' O ' ' A' ' 27' ' ' ILE . 2.5 pp -150.33 -178.9 6.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.814 0.34 . . . . 75.14 110.926 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.73 HG23 HD12 ' A' ' 277' ' ' LEU . 8.9 mm -111.36 145.04 18.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 74.44 111.121 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.7 ttpt -122.65 151.15 41.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 64.41 110.883 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.514 HD13 ' C ' ' A' ' 29' ' ' LEU . 3.4 tm? -140.56 128.06 21.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 62.24 110.911 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -139.18 129.42 25.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.466 . . . . 63.51 110.858 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.8 tt -137.53 133.49 34.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 73.23 110.933 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.6 mtpp -135.33 125.51 26.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 71.13 110.928 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.641 HG23 ' HB3' ' A' ' 283' ' ' ALA . 24.4 m -123.2 146.18 48.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.212 -0.449 . . . . 52.51 111.11 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 10.1 tptt -105.24 158.04 16.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 62.41 110.9 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.483 ' O ' ' C ' ' A' ' 36' ' ' GLU . 0.5 OUTLIER -132.14 174.86 9.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 62.01 110.873 -179.915 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.483 ' C ' ' O ' ' A' ' 35' ' ' SER . 46.2 tt0 -31.8 -73.46 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.16 -0.473 . . . . 73.2 110.869 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -164.82 131.77 3.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 73.13 110.925 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.453 ' HA2' ' O ' ' A' ' 63' ' ' ARG . . . 86.28 -14.59 53.75 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.763 -0.732 . . . . 65.23 112.496 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.402 ' HB2' ' HB3' ' A' ' 35' ' ' SER . 0.2 OUTLIER -104.43 129.17 52.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.816 0.341 . . . . 74.44 110.901 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.97 118.15 10.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 60.54 110.93 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -92.04 122.55 34.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 73.05 110.892 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -125.6 131.12 52.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 74.05 111.111 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.4 t -131.69 139.64 49.1 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.202 -0.454 . . . . 73.31 110.839 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.4 t -145.73 126.59 14.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.144 -0.48 . . . . 72.13 110.829 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -146.31 147.71 18.86 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.739 -0.743 . . . . 73.04 112.518 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.24 135.78 37.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.857 0.36 . . . . 44.22 110.846 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.874 ' HB2' HG13 ' A' ' 54' ' ' VAL . . . -149.16 130.56 14.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.129 -0.487 . . . . 71.04 111.11 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 64.3 t-20 -96.63 126.0 41.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.242 -0.436 . . . . 54.44 110.872 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 91.9 m -75.59 -50.1 16.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 54.35 111.104 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -56.7 -49.23 75.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 71.22 110.851 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -108.84 124.53 50.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 71.52 111.182 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.41 ' O ' HG23 ' A' ' 52' ' ' THR . 1.9 t -54.37 104.63 0.11 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.209 -0.451 . . . . 74.43 111.168 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 30.9 tttp -174.03 99.32 0.1 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 63.32 110.896 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.874 HG13 ' HB2' ' A' ' 47' ' ' ALA . 31.7 t -120.51 124.75 73.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.195 -0.457 . . . . 61.34 111.117 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.4 p -135.57 129.72 33.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 71.02 111.122 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -129.37 137.93 9.91 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.761 -0.733 . . . . 54.14 112.532 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.3 p -141.49 160.32 40.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.892 0.377 . . . . 64.34 110.868 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.3 tp -128.38 149.97 50.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.101 -0.5 . . . . 71.52 110.877 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -135.73 131.19 35.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 71.13 110.893 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.07 118.38 36.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 64.4 111.12 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 5.2 ttmt -112.18 147.91 35.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 74.43 110.855 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -131.75 133.41 44.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 74.1 110.948 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.453 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 25.5 ttm180 -135.23 106.71 6.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.13 -0.487 . . . . 64.31 110.903 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 58.0 t-105 -114.56 138.74 50.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.202 -0.453 . . . . 73.14 110.9 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.3 m 66.19 119.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.281 -0.418 . . . . 64.43 111.17 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -50.59 105.38 0.1 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.438 . . . . 73.13 110.919 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 64.61 48.85 2.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.148 -0.478 . . . . 72.24 110.913 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.659 ' O ' HD22 ' A' ' 69' ' ' LEU . . . -122.29 -74.41 0.32 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.741 -0.742 . . . . 62.02 112.52 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.659 HD22 ' O ' ' A' ' 68' ' ' GLY . 4.1 mm? -134.23 129.43 35.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.872 0.367 . . . . 73.13 110.935 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.2 m -138.6 112.61 8.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 72.21 111.169 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -123.59 124.36 42.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 75.32 110.88 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.44 ' HA ' ' HA ' ' A' ' 61' ' ' LYS . 5.1 t -129.38 137.68 51.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 74.04 111.14 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.555 ' CD ' HD23 ' A' ' 81' ' ' LEU . 37.8 tt0 -124.02 123.23 39.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 74.51 110.843 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 22.3 mtpp -89.82 142.17 27.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.105 -0.498 . . . . 72.44 110.913 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 7.3 t90 -134.58 128.82 33.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.227 -0.442 . . . . 73.41 110.894 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -117.72 155.13 30.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 71.44 110.875 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 9.4 t -61.37 -17.53 54.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 61.05 111.16 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.415 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 48.5 m-20 -74.11 0.35 14.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 61.21 110.87 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.415 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 3.5 m120 77.34 35.67 0.33 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 73.4 110.9 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.8 m -114.45 128.57 56.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 55.51 111.167 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.555 HD23 ' CD ' ' A' ' 73' ' ' GLU . 0.3 OUTLIER -120.19 139.59 52.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.227 -0.442 . . . . 73.11 110.904 179.98 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -137.92 98.6 0.27 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.75 -0.738 . . . . 73.22 112.495 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.1 m -84.76 142.02 30.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.768 0.318 . . . . 61.14 111.161 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -146.47 115.25 6.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 71.31 110.853 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -112.7 136.48 48.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 70.34 111.147 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.61 HG22 ' HB ' ' A' ' 98' ' ' THR . 20.5 p -128.99 124.09 34.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 44.42 111.177 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.5 p -114.91 137.24 49.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 52.14 111.132 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -103.83 119.81 39.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 73.52 110.887 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -60.51 130.32 45.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 72.55 110.878 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -83.14 -57.8 3.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 61.13 110.885 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 36.0 mt -63.28 -54.28 39.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 71.2 110.876 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -85.58 75.35 10.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.453 . . . . 44.12 111.092 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 12.2 tpp85 -51.37 134.59 28.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 71.44 110.885 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 100.61 -23.41 35.87 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.718 -0.753 . . . . 52.12 112.475 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.805 HD22 ' HB3' ' A' ' 118' ' ' TYR . 0.1 OUTLIER -79.62 114.94 18.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.915 0.388 . . . . 72.25 110.946 -179.95 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.62 ' O ' HD13 ' A' ' 97' ' ' LEU . 3.8 ttpm? -121.29 130.0 53.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 74.54 110.934 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.62 HD13 ' O ' ' A' ' 96' ' ' LYS . 0.9 OUTLIER -121.71 127.06 50.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.259 -0.428 . . . . 75.02 110.89 179.951 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.61 ' HB ' HG22 ' A' ' 86' ' ' THR . 17.4 p -129.92 121.09 25.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.201 -0.454 . . . . 64.53 111.151 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -110.22 129.24 55.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 73.14 110.825 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -112.25 142.16 45.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.099 -0.5 . . . . 72.21 110.883 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.3 t -142.06 124.54 15.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 74.11 110.819 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.8 t -96.09 123.82 39.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 71.15 110.854 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -118.78 132.9 56.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.157 -0.474 . . . . 75.11 110.909 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -128.69 101.83 20.38 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.718 0.77 . . . . 75.21 110.817 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -33.16 17.1 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.685 2.257 . . . . 74.33 112.373 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -79.87 -69.73 0.57 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 55.12 110.911 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.4 -45.07 92.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.456 . . . . 70.51 111.14 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.37 24.34 14.51 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.757 -0.735 . . . . 52.43 112.49 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.92 148.05 22.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.871 0.367 . . . . 74.54 110.86 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -134.47 126.69 29.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 62.51 110.884 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -121.35 136.31 54.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 75.3 110.931 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -125.56 120.19 30.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.445 . . . . 65.22 111.125 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -138.39 138.62 38.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 75.32 110.899 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.433 HD12 ' H ' ' A' ' 115' ' ' LYS . 5.4 tp -122.57 137.43 56.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.235 -0.439 . . . . 61.22 111.151 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.433 ' H ' HD12 ' A' ' 114' ' ' ILE . 1.9 mtpp -128.58 121.38 28.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.172 -0.467 . . . . 73.23 110.911 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.408 HG22 HD12 ' A' ' 97' ' ' LEU . 62.6 p -128.26 121.47 29.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 65.4 111.109 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -150.03 163.31 29.41 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.702 -0.761 . . . . 54.13 112.47 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.805 ' HB3' HD22 ' A' ' 95' ' ' LEU . 7.6 p90 -133.05 143.81 49.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.942 0.401 . . . . 63.44 110.926 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.492 ' O ' HG11 ' A' ' 3' ' ' VAL . 9.0 mtmt -111.86 120.83 43.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 72.3 110.902 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 28.2 ttm180 -108.37 144.46 35.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 72.12 110.881 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.641 ' N ' HG22 ' A' ' 3' ' ' VAL . 36.8 tt0 -51.18 -29.28 13.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.219 -0.446 . . . . 74.44 110.851 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 37.1 m80 -86.54 -42.54 13.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 74.24 110.862 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 2.2 pp -150.09 153.62 10.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.238 -0.437 . . . . 44.33 111.137 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -124.68 116.25 22.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.466 . . . . 61.33 110.867 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.535 ' HB2' ' HG ' ' A' ' 142' ' ' LEU . 0.4 OUTLIER -133.51 145.17 49.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.197 -0.456 . . . . 74.33 110.913 179.96 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -146.33 136.0 6.08 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.739 -0.744 . . . . 72.43 112.476 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 44.8 t -103.91 133.97 47.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.837 0.351 . . . . 54.02 110.882 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -125.67 142.13 51.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.474 . . . . 75.32 110.872 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 47.7 ttm -137.89 134.44 35.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 73.12 110.898 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -124.9 122.58 37.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 75.12 110.876 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -94.45 123.15 37.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 65.35 110.881 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -115.12 179.68 3.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 52.43 110.857 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.53 ' H ' HD12 ' A' ' 133' ' ' ILE . 3.1 mp -93.29 -42.23 13.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.181 -0.463 . . . . 75.11 111.114 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -80.98 -20.09 42.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 44.42 111.125 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.641 ' HA3' ' HB2' ' A' ' 160' ' ' ALA . . . 164.23 114.12 0.3 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.751 -0.738 . . . . 53.1 112.509 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 144.75 54.9 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.704 2.269 . . . . 75.23 112.322 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.6 m -126.54 151.62 47.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 74.3 110.868 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 4.6 mp -121.36 126.41 74.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 71.41 111.116 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -121.71 121.95 38.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 72.13 110.855 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -121.86 141.59 14.52 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.779 -0.724 . . . . 65.44 112.52 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -126.75 116.21 20.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.819 0.343 . . . . 61.3 111.107 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.738 HD13 ' OH ' ' A' ' 153' ' ' TYR . 0.3 OUTLIER -119.76 122.1 40.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 75.11 110.895 -179.963 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.448 ' N ' HD23 ' A' ' 142' ' ' LEU . 1.5 m -132.61 140.84 46.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 63.14 111.172 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 6.3 mp -116.42 138.84 51.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.22 -0.445 . . . . 73.33 110.93 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -91.71 133.23 11.66 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.745 -0.741 . . . . 75.12 112.48 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.402 ' O ' ' N ' ' A' ' 148' ' ' GLY . 3.2 m-85 -128.74 146.8 50.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.823 0.344 . . . . 70.53 110.96 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -49.4 93.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.111 -0.495 . . . . 73.01 110.889 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 146' ' ' TYR . . . 87.26 -23.59 11.37 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.776 -0.726 . . . . 72.53 112.448 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 7.8 m0 -105.67 145.95 30.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.801 0.334 . . . . 71.43 110.942 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.649 HD21 HG22 ' A' ' 6' ' ' THR . 0.0 OUTLIER -126.77 137.13 53.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.243 -0.435 . . . . 74.23 110.919 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -129.26 134.07 47.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.455 . . . . 75.03 111.054 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.412 ' HA2' ' HA ' ' A' ' 143' ' ' VAL . . . -152.92 133.03 3.87 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.701 -0.762 . . . . 32.11 112.514 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.738 ' OH ' HD13 ' A' ' 142' ' ' LEU . 8.4 p90 -144.16 119.34 10.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.909 0.385 . . . . 75.23 110.921 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -110.58 123.62 50.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.075 -0.511 . . . . 64.22 110.935 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 2.4 ttt -120.39 128.72 53.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.44 . . . . 73.54 110.878 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.499 ' O ' ' HB ' ' A' ' 164' ' ' VAL . 20.0 m-20 -112.82 116.79 30.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.444 . . . . 72.53 110.867 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.544 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 60.4 m-85 -89.88 131.98 35.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.165 -0.471 . . . . 65.24 110.87 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -91.3 104.31 16.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 71.23 110.901 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.77 -47.9 73.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.134 -0.485 . . . . 61.14 111.118 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.641 ' HB2' ' HA3' ' A' ' 135' ' ' GLY . . . -49.65 -26.14 3.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 73.34 111.126 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.2 -166.85 1.36 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 65.32 110.853 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 68.1 m -112.97 39.18 2.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 63.33 110.829 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -165.06 177.19 7.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.116 -0.493 . . . . 55.31 110.832 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.544 ' HA ' ' HA ' ' A' ' 157' ' ' PHE . 1.0 OUTLIER -75.46 144.11 12.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.181 -0.463 . . . . 61.24 111.101 179.993 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 12.9 t -88.74 -32.64 17.82 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.149 -0.478 . . . . 72.12 111.165 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 3.9 tp60 -151.45 134.69 16.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 75.13 110.93 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 11.3 p -124.1 107.07 10.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 42.43 110.868 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 28.9 m-20 -110.74 148.47 32.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.115 -0.493 . . . . 64.24 110.897 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.438 ' CE1' HG23 ' A' ' 171' ' ' VAL . 8.0 t80 -154.8 140.57 18.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 71.15 110.914 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -154.38 135.01 13.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.13 -0.487 . . . . 74.41 111.094 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.438 HG23 ' CE1' ' A' ' 169' ' ' PHE . 48.5 t -144.15 133.42 19.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 72.04 111.159 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -111.6 122.25 6.0 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.775 -0.726 . . . . 70.12 112.496 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . 0.604 ' HB2' HD12 ' A' ' 180' ' ' LEU . 0.1 OUTLIER -113.65 131.06 56.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.934 0.397 . . . . 61.43 110.953 -179.829 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 2.6 mtpm? -102.95 127.2 50.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.476 . . . . 65.35 110.888 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.406 ' O ' ' C ' ' A' ' 176' ' ' ASP . 0.2 OUTLIER -111.78 166.39 11.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.219 -0.446 . . . . 75.42 111.111 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.406 ' C ' ' O ' ' A' ' 175' ' ' THR . 2.8 m-20 -37.89 -76.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 75.01 110.896 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -117.32 16.51 14.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.179 -0.464 . . . . 72.45 110.932 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -130.79 150.68 51.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.132 -0.485 . . . . 64.13 110.862 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 37.2 mm-40 -116.09 123.1 47.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.124 -0.489 . . . . 73.15 110.895 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.604 HD12 ' HB2' ' A' ' 173' ' ' TYR . 3.4 tm? -107.15 125.58 51.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.164 -0.471 . . . . 63.31 110.89 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 22.6 m80 -130.63 130.41 43.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 75.2 110.836 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 1.2 t -128.9 111.49 13.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 74.53 111.172 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -120.55 139.65 52.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.236 -0.438 . . . . 63.11 110.908 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.443 HG12 ' O ' ' A' ' 184' ' ' VAL . 2.5 t -133.33 110.29 14.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 72.14 111.111 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -100.79 89.51 3.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 74.11 110.872 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 67.47 -179.75 0.22 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 71.52 110.882 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -75.19 -2.95 68.12 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.775 -0.726 . . . . 65.22 112.477 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 15.6 p -97.53 -25.49 15.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.769 0.319 . . . . 70.22 111.126 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.27 113.48 20.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 75.41 110.905 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' PHE . . . . . 0.412 ' HA ' HG22 ' A' ' 184' ' ' VAL . 0.4 OUTLIER -139.76 123.03 17.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 70.2 110.857 -179.909 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 171.46 -141.43 6.41 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.747 -0.74 . . . . 63.11 112.519 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 167.24 -167.4 39.83 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.699 -0.763 . . . . 62.42 112.445 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . 0.486 ' HA ' ' O ' ' A' ' 206' ' ' VAL . 70.3 m -127.5 144.42 51.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.813 0.339 . . . . 72.32 110.875 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.423 ' O ' HG22 ' A' ' 206' ' ' VAL . 0.0 OUTLIER -142.03 118.33 6.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.168 -0.469 . . . . 65.24 111.121 179.986 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . 0.802 ' CB ' ' HA ' ' A' ' 205' ' ' ALA . 0.1 OUTLIER 178.66 -175.21 0.19 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 62.44 110.892 -179.989 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 16.8 tm0? -123.51 128.54 49.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.091 -0.504 . . . . 64.53 110.894 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 3.4 pttp -114.65 113.97 25.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 71.23 110.903 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.662 HG21 HD12 ' A' ' 202' ' ' LEU . 5.2 t -86.47 143.85 10.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.237 -0.438 . . . . 73.23 111.133 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -93.06 32.53 1.28 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 70.44 110.894 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 10.3 mmtt -127.59 35.03 4.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 73.22 110.917 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 2.2 mttp 72.7 51.11 0.16 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 75.12 110.904 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.662 HD12 HG21 ' A' ' 198' ' ' VAL . 0.3 OUTLIER -177.47 82.49 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 73.22 110.938 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -128.17 133.2 48.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.461 . . . . 74.43 110.866 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.598 ' O ' ' HB3' ' A' ' 195' ' ' TYR . 11.0 t -132.45 136.91 47.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.467 . . . . 75.12 111.158 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.802 ' HA ' ' CB ' ' A' ' 195' ' ' TYR . . . -141.47 136.68 31.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 70.32 111.083 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.907 HG12 HG22 ' A' ' 221' ' ' ILE . 1.1 m -103.9 139.51 24.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.44 . . . . 63.25 111.074 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -114.35 132.7 56.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.46 . . . . 71.33 110.897 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.529 HD21 ' CD2' ' A' ' 219' ' ' PHE . 4.6 mp -126.11 138.17 53.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.167 -0.47 . . . . 74.25 110.935 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.716 ' HB3' ' CD ' ' A' ' 218' ' ' ARG . . . -129.61 139.96 51.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 62.53 111.129 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 2.4 t-105 -130.27 130.32 44.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 71.41 110.944 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.07 109.44 22.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.253 -0.43 . . . . 71.53 111.116 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -51.62 134.81 29.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.448 . . . . 61.55 111.156 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 120.4 33.91 0.99 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.705 -0.76 . . . . 63.13 112.447 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 49.5 t30 59.66 43.34 15.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.822 0.344 . . . . 71.14 110.898 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 14.0 m -90.99 -169.72 2.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 72.32 110.872 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -102.55 137.1 41.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.462 . . . . 41.45 110.913 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . 0.426 HG23 ' CE1' ' A' ' 219' ' ' PHE . 3.9 t -79.12 139.5 38.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.47 . . . . 65.44 111.153 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . 0.716 ' CD ' ' HB3' ' A' ' 209' ' ' ALA . 17.3 ptp180 -110.84 133.29 53.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 64.35 110.886 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . 0.529 ' CD2' HD21 ' A' ' 208' ' ' LEU . 11.1 m-85 -114.37 138.35 50.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.25 -0.432 . . . . 75.44 110.859 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -140.65 144.52 14.87 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.713 -0.755 . . . . 65.42 112.467 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.907 HG22 HG12 ' A' ' 206' ' ' VAL . 0.0 OUTLIER -130.93 130.73 64.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.841 0.353 . . . . 62.2 111.129 -179.998 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -133.74 131.64 39.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 41.55 111.104 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -125.22 146.06 49.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.254 -0.43 . . . . 75.32 111.093 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 3.5 mtmp? -129.1 123.55 32.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 71.01 110.908 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -132.29 133.16 43.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.212 -0.449 . . . . 74.42 110.963 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -85.6 128.78 34.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.475 . . . . 70.3 110.901 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 44.5 mm -74.16 -55.55 11.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 74.24 111.111 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.545 ' N ' ' HD2' ' A' ' 229' ' ' PRO . 0.1 OUTLIER 175.13 -57.35 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.599 0.714 . . . . 74.24 110.826 179.867 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.545 ' HD2' ' N ' ' A' ' 228' ' ' ASP . 53.4 Cg_endo -69.75 -156.6 0.04 OUTLIER 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.655 2.237 . . . . 72.43 112.368 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.6 15.69 4.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 64.33 110.839 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.454 ' HB2' ' HG3' ' A' ' 249' ' ' GLN . . . -120.63 121.92 39.38 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.22 -0.445 . . . . 62.14 111.118 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 36.7 m -108.7 143.99 37.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 41.55 110.889 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -105.3 127.88 53.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 71.41 110.877 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 15.2 m -127.09 137.49 53.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.134 -0.484 . . . . 64.15 110.842 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -121.3 143.17 49.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.158 -0.474 . . . . 62.11 111.083 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.76 141.87 31.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 64.31 110.894 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 242' ' ' LEU . 5.3 p -140.25 144.73 27.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 55.13 111.117 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -108.16 148.31 30.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 73.42 110.896 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -56.11 -19.52 13.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 74.01 110.869 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 37.3 t -81.15 25.48 0.48 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.474 . . . . 64.05 110.856 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 2.3 t 61.89 35.73 16.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 72.41 110.851 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . 0.447 ' O ' HG23 ' A' ' 237' ' ' VAL . 4.6 mp -99.03 117.89 34.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.138 -0.483 . . . . 63.2 110.963 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.458 HD13 ' H ' ' A' ' 243' ' ' ILE . 0.1 OUTLIER -104.84 119.0 53.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.207 -0.451 . . . . 75.15 111.181 179.831 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . 0.519 ' C ' HD13 ' A' ' 245' ' ' LEU . . . -138.04 160.67 25.43 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.749 -0.739 . . . . 72.23 112.498 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.85 HD21 ' HB3' ' A' ' 261' ' ' ALA . 0.0 OUTLIER -145.16 160.04 42.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.858 0.361 . . . . 64.52 110.872 -179.917 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -149.09 121.77 1.36 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.77 -0.729 . . . . 72.42 112.508 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -109.3 115.89 30.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.976 0.417 . . . . 72.34 110.931 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.413 HG23 ' O ' ' A' ' 248' ' ' THR . 3.5 t -101.8 115.05 29.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.131 -0.486 . . . . 71.53 111.153 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . 0.454 ' HG3' ' HB2' ' A' ' 231' ' ' ALA . 59.1 tt0 -119.71 130.01 54.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 73.5 110.87 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 7.3 p -121.39 117.92 28.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.136 -0.483 . . . . 65.51 111.115 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 11.0 mt -113.42 101.2 9.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 73.2 110.974 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' LYS . . . . . 0.426 ' HB3' ' HD2' ' A' ' 253' ' ' PRO . 17.6 mttp 64.19 155.36 0.12 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.632 0.73 . . . . 73.25 110.835 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . 0.426 ' HD2' ' HB3' ' A' ' 252' ' ' LYS . 53.8 Cg_endo -69.74 73.68 1.34 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.706 2.271 . . . . 44.42 112.341 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 171.92 -29.7 0.11 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.727 -0.749 . . . . 71.52 112.442 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 55.5 mt -116.13 121.37 67.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.854 0.359 . . . . 74.5 111.131 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 32.3 ttmt -133.39 132.81 41.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 73.32 110.86 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 0.504 HD13 ' C ' ' A' ' 257' ' ' LEU . 3.3 tm? -118.44 125.06 49.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.175 -0.466 . . . . 73.22 110.931 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . 0.514 ' O ' HD22 ' A' ' 277' ' ' LEU . 93.6 m -115.72 111.74 21.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 73.22 111.167 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 1.029 HD22 HD23 ' A' ' 277' ' ' LEU . 0.1 OUTLIER -109.6 132.65 53.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.45 . . . . 70.43 110.923 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.415 ' H ' HD13 ' A' ' 259' ' ' LEU . 16.5 t -145.95 153.37 40.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 74.24 110.889 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' ALA . . . . . 0.85 ' HB3' HD21 ' A' ' 245' ' ' LEU . . . -158.12 130.87 7.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 64.05 111.102 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.73 ' C ' HD13 ' A' ' 263' ' ' LEU . 3.3 tm? -125.8 124.45 40.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.459 . . . . 74.32 110.911 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . 0.835 ' HB3' HG11 ' A' ' 268' ' ' VAL . 0.2 OUTLIER -121.01 110.31 16.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 74.23 110.907 179.905 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . 0.527 ' O ' HG22 ' A' ' 268' ' ' VAL . 1.8 m-20 -79.11 113.88 17.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.198 -0.456 . . . . 74.45 110.871 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -58.9 -17.0 34.07 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.785 -0.722 . . . . 40.41 112.457 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 45.4 tttt -90.84 -3.2 57.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.822 0.344 . . . . 63.3 110.913 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -127.55 -52.82 1.36 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 64.12 110.919 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . 0.835 HG11 ' HB3' ' A' ' 263' ' ' LEU . 17.1 m -51.19 -29.37 8.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 64.41 111.123 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -52.24 -40.39 61.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 74.2 110.918 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -104.91 -17.45 14.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.131 -0.486 . . . . 75.22 111.108 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 129.71 94.8 0.74 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.712 -0.756 . . . . 74.22 112.515 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -179.74 74.94 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.73 -0.748 . . . . 62.15 112.474 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 273' ' ' HIS . . . . . 0.419 ' HB2' HD12 ' A' ' 263' ' ' LEU . 32.6 p-80 -108.14 145.96 33.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.851 0.357 . . . . 62.43 110.855 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -127.12 138.73 53.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.185 -0.461 . . . . 73.54 110.925 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.65 HD12 ' HB2' ' A' ' 261' ' ' ALA . 1.5 tp -121.75 145.6 47.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.447 . . . . 74.02 110.879 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -123.63 108.25 1.16 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.724 -0.751 . . . . 70.24 112.459 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 1.029 HD23 HD22 ' A' ' 259' ' ' LEU . 3.2 tm? -114.43 141.4 47.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.858 0.361 . . . . 63.23 110.921 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . 0.659 ' N ' HD13 ' A' ' 277' ' ' LEU . . . -148.84 132.59 4.17 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.772 -0.727 . . . . 75.11 112.482 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.505 HD11 HD11 ' A' ' 277' ' ' LEU . 1.2 mm? -109.36 133.63 52.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.766 0.317 . . . . 74.41 110.881 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -124.06 112.62 17.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 71.21 110.88 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -117.93 134.1 55.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.1 -0.5 . . . . 74.42 110.85 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . 0.676 ' HG2' HD13 ' A' ' 284' ' ' LEU . 11.0 tt0 -135.85 112.47 10.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.127 -0.488 . . . . 73.12 110.913 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.732 ' O ' HD12 ' A' ' 284' ' ' LEU . . . -96.05 113.36 24.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 74.24 111.071 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.732 HD12 ' O ' ' A' ' 283' ' ' ALA . 6.1 mp -140.52 177.05 8.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.257 -0.429 . . . . 74.12 110.919 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 75.44 110.864 179.917 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' NAI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.831 0.348 . . . . 64.03 110.87 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.4 -38.18 74.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 73.31 111.127 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.478 HG13 ' HG3' ' A' ' 119' ' ' LYS . 0.2 OUTLIER -145.16 108.86 4.6 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.637 0.732 . . . . 72.3 111.155 179.955 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 170.73 15.85 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.648 2.232 . . . . 71.24 112.377 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 83.54 0.7 Allowed 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.695 2.263 . . . . 62.13 112.334 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 46.2 p -70.27 -48.94 54.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.212 -0.449 . . . . 75.12 111.157 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.486 ' CB ' HG11 ' A' ' 143' ' ' VAL . 7.7 p90 -51.13 -33.81 28.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.237 -0.438 . . . . 71.11 110.896 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -83.44 -28.32 28.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 73.43 111.132 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -90.32 11.61 20.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.211 -0.45 . . . . 74.11 110.823 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 25.1 mt -59.88 -29.76 68.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 71.24 110.928 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 159.4 59.01 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.703 -0.76 . . . . 65.14 112.469 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 12.7 mmtm -67.16 -53.84 26.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.751 0.31 . . . . 73.44 110.874 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.4 t -56.87 -48.06 78.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.27 -0.423 . . . . 65.42 110.906 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.23 -36.77 76.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.092 -0.504 . . . . 43.23 111.104 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.89 -30.57 67.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 74.24 110.864 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -56.44 -48.94 75.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 63.32 110.857 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 79.5 t -62.53 -26.59 40.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 74.23 111.135 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -59.63 -41.11 89.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 64.41 110.865 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.08 -66.64 0.7 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 53.25 111.138 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.1 tppm? -47.28 104.73 0.06 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 74.02 110.902 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 158.93 38.83 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.755 -0.736 . . . . 72.41 112.492 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.431 ' HB3' HD13 ' A' ' 262' ' ' LEU . 18.5 p90 -165.56 140.08 4.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.955 0.407 . . . . 72.14 110.897 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -62.65 129.83 42.48 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.734 -0.746 . . . . 73.45 112.489 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -103.1 -3.51 25.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.879 0.371 . . . . 74.14 110.849 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.78 14.02 78.32 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.721 -0.752 . . . . 45.35 112.509 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.514 ' O ' HD12 ' A' ' 27' ' ' ILE . 0.6 OUTLIER -127.77 171.94 11.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.804 0.335 . . . . 62.15 110.899 -179.924 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.538 HG13 HD12 ' A' ' 277' ' ' LEU . 1.3 mp -118.35 121.49 67.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 73.23 111.108 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 37.0 tttp -111.42 117.37 32.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 75.33 110.902 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.488 HD12 ' HB2' ' A' ' 279' ' ' LEU . 1.1 tt -115.16 141.06 48.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 52.11 110.951 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -147.88 129.98 15.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.178 -0.465 . . . . 71.45 110.838 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.514 HD23 ' N ' ' A' ' 32' ' ' LYS . 7.3 tt -126.93 133.38 50.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 73.13 110.876 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.514 ' N ' HD23 ' A' ' 31' ' ' LEU . 7.4 mtmp? -127.23 127.02 43.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 73.22 110.892 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.771 HG23 ' HB3' ' A' ' 283' ' ' ALA . 6.7 m -130.1 141.03 50.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.24 -0.436 . . . . 74.31 111.169 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.88 156.27 20.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.464 . . . . 73.53 110.882 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.517 ' O ' ' C ' ' A' ' 36' ' ' GLU . 0.6 OUTLIER -133.89 174.35 10.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 72.14 110.847 -179.904 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.517 ' C ' ' O ' ' A' ' 35' ' ' SER . 39.9 mm-40 -27.46 -75.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.095 -0.502 . . . . 72.55 110.876 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -166.82 140.39 3.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.115 -0.493 . . . . 74.44 110.879 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.487 ' HA2' ' O ' ' A' ' 63' ' ' ARG . . . 83.54 -12.69 50.71 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.798 -0.715 . . . . 65.12 112.518 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -105.02 130.07 53.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.787 0.327 . . . . 75.31 110.923 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -140.33 118.48 11.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.23 -0.441 . . . . 55.25 110.882 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -98.34 121.55 40.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 73.14 110.869 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 27.6 m -126.06 123.82 39.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.163 -0.471 . . . . 74.41 111.166 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.4 t -125.1 132.39 53.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.264 -0.425 . . . . 54.44 110.875 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 6.0 p -150.04 126.57 10.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.115 -0.493 . . . . 54.12 110.853 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -155.05 167.36 32.78 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.735 -0.745 . . . . 71.13 112.461 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 17.9 m -127.66 156.45 42.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.9 0.381 . . . . 54.33 110.878 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.495 ' O ' HD13 ' A' ' 26' ' ' LEU . . . -142.84 131.33 22.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 71.25 111.103 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 61.5 t-20 -101.65 123.54 45.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 72.43 110.865 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 60.4 m -88.51 -55.35 3.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.169 -0.469 . . . . 75.43 111.122 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -51.12 -36.4 40.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 72.14 110.875 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.14 155.54 50.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 34.22 111.125 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.0 m -71.09 86.99 0.76 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 70.45 111.167 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.2 tptp -152.68 80.91 1.22 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.233 -0.439 . . . . 63.31 110.901 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.415 ' HA ' ' HA ' ' A' ' 47' ' ' ALA . 1.3 p -127.96 123.21 60.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 75.41 111.159 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.0 p -136.6 132.85 35.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 73.41 111.158 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -107.18 136.56 13.46 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.756 -0.735 . . . . 52.23 112.475 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -114.26 144.97 42.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.895 0.379 . . . . 50.21 110.874 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.652 HD13 ' N ' ' A' ' 59' ' ' GLU . 0.8 OUTLIER -121.48 132.82 54.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 75.53 110.927 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.652 ' N ' HD13 ' A' ' 58' ' ' LEU . 1.4 pt-20 -133.46 136.96 45.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 75.15 110.904 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 4.9 m -114.79 140.15 49.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 64.4 111.131 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -135.71 157.44 46.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 71.31 110.885 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.439 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 16.2 m-85 -129.26 140.86 51.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.218 -0.447 . . . . 63.14 110.939 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.487 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 43.6 ttm-85 -127.12 104.51 8.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.11 -0.495 . . . . 74.51 110.863 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 66.0 m95 -114.2 123.84 50.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 63.51 110.9 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.5 m 67.3 125.39 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.216 -0.447 . . . . 74.32 111.126 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -51.3 103.95 0.07 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.46 . . . . 63.31 110.911 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 63.64 58.51 1.29 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.459 . . . . 71.42 110.935 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.631 ' O ' HD22 ' A' ' 69' ' ' LEU . . . -133.64 -77.81 0.12 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.762 -0.732 . . . . 64.51 112.455 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.631 HD22 ' O ' ' A' ' 68' ' ' GLY . 4.0 mm? -133.99 130.35 37.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.881 0.372 . . . . 72.12 110.936 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.639 HG23 ' OG1' ' A' ' 86' ' ' THR . 0.0 OUTLIER -137.57 137.42 38.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 61.53 111.141 179.93 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -95.79 133.84 39.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 64.45 110.92 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.5 m -112.67 117.23 31.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.167 -0.469 . . . . 74.12 111.136 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.417 ' CB ' HG23 ' A' ' 83' ' ' THR . 0.1 OUTLIER -134.49 134.06 41.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.455 . . . . 62.5 110.9 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 53.5 tttt -145.26 132.85 20.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 72.31 110.893 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 9.6 t90 -135.48 128.91 32.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.439 . . . . 72.54 110.928 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 10.5 m-20 -117.14 150.99 37.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 53.54 110.904 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.7 m -68.21 -12.29 60.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 73.01 111.122 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.489 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 38.8 t70 -74.65 0.17 15.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.227 -0.442 . . . . 63.0 110.893 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.489 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 5.7 t-20 83.55 34.47 0.05 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 75.32 110.865 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 12.7 p -114.77 123.04 48.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 62.22 111.162 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -109.38 136.98 47.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.449 . . . . 51.24 110.908 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -149.33 89.34 0.14 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.666 -0.778 . . . . 41.53 112.452 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.417 HG23 ' CB ' ' A' ' 73' ' ' GLU . 3.8 m -127.45 160.95 29.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.741 0.305 . . . . 74.04 111.167 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.622 ' HB3' ' O ' ' A' ' 99' ' ' PHE . 0.6 OUTLIER 169.22 -163.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 61.1 110.882 -179.99 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.532 HD11 HD12 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -135.33 142.96 38.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 63.04 111.111 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.639 ' OG1' HG23 ' A' ' 70' ' ' THR . 33.7 p -128.88 126.34 39.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.146 -0.479 . . . . 74.21 111.157 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 9.0 p -110.67 137.13 44.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 74.54 111.127 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -125.26 118.51 26.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 64.31 110.937 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 52.14 90.39 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 73.52 110.857 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.425 ' HG3' HD21 ' A' ' 69' ' ' LEU . 2.3 mm-40 -138.66 -75.13 0.38 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 73.35 110.932 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 30.1 tp -62.39 -36.12 81.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 73.35 110.938 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -143.29 125.72 15.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 63.24 111.069 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.11 124.8 13.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 73.41 110.872 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 97.64 -23.98 33.59 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.76 -0.733 . . . . 65.02 112.548 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.685 HD22 ' HB3' ' A' ' 118' ' ' TYR . 0.2 OUTLIER -79.99 124.28 28.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.834 0.349 . . . . 73.23 110.884 -179.91 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.739 ' O ' HD13 ' A' ' 97' ' ' LEU . 3.2 pttp -121.86 123.31 41.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.219 -0.446 . . . . 73.34 110.932 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.739 HD13 ' O ' ' A' ' 96' ' ' LYS . 0.7 OUTLIER -125.53 124.85 42.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.23 -0.441 . . . . 64.12 110.967 179.899 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 12.2 p -124.84 119.6 29.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 73.22 111.143 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.622 ' O ' ' HB3' ' A' ' 84' ' ' GLU . 0.3 OUTLIER -109.83 117.73 34.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 72.44 110.86 -179.968 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.556 ' HA ' ' CB ' ' A' ' 84' ' ' GLU . 6.7 t70 -115.71 144.6 43.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 74.12 110.88 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.404 ' CB ' ' HG2' ' A' ' 84' ' ' GLU . 10.5 t -140.1 133.2 29.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 72.15 110.866 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -120.67 149.51 42.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.484 . . . . 61.43 110.861 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -127.95 137.96 52.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 73.52 110.888 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.404 ' HA ' ' HD2' ' A' ' 105' ' ' PRO . 99.6 p -128.63 101.52 20.8 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.707 0.765 . . . . 64.22 110.841 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 104' ' ' SER . 54.3 Cg_endo -69.66 -31.22 21.38 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.705 2.27 . . . . 74.41 112.4 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -50.27 -68.24 0.19 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 45.3 110.885 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.1 p -86.05 -33.45 21.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.481 . . . . 64.13 111.175 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.39 23.57 16.28 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.723 -0.751 . . . . 62.51 112.485 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 46.3 mtpt -94.31 148.09 22.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.821 0.343 . . . . 60.41 110.926 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.15 144.42 31.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 75.45 110.914 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -120.7 128.59 53.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.269 -0.423 . . . . 74.54 110.851 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -133.35 124.82 27.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 52.24 111.088 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -134.77 138.37 44.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.223 -0.444 . . . . 72.41 110.864 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.579 HD13 ' H ' ' A' ' 115' ' ' LYS . 0.4 OUTLIER -134.43 136.53 52.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.248 -0.433 . . . . 71.35 111.111 179.893 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.579 ' H ' HD13 ' A' ' 114' ' ' ILE . 10.9 mtmt -126.29 121.59 33.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 75.32 110.883 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.681 HG23 ' CD1' ' A' ' 97' ' ' LEU . 99.6 m -125.22 121.44 34.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 74.4 111.103 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -152.69 163.06 30.26 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.738 -0.744 . . . . 72.33 112.511 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.685 ' HB3' HD22 ' A' ' 95' ' ' LEU . 0.3 OUTLIER -132.49 145.22 51.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.982 0.42 . . . . 74.53 110.915 -179.838 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.478 ' HG3' HG13 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -109.06 123.47 49.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.094 -0.503 . . . . 43.34 110.905 179.93 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.417 ' HB2' HG22 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -104.54 147.36 27.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.245 -0.434 . . . . 73.1 110.892 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.434 ' HA ' ' HB ' ' A' ' 3' ' ' VAL . 85.0 tt0 -54.64 -30.95 56.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 75.33 110.873 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 54.2 p-80 -125.95 11.13 7.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 74.23 110.864 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.817 HD11 HD23 ' A' ' 144' ' ' LEU . 1.0 OUTLIER -147.63 150.19 14.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.24 -0.437 . . . . 64.33 111.169 179.974 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.636 ' HB3' HG13 ' A' ' 143' ' ' VAL . 5.9 t-20 -128.96 113.69 15.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 60.02 110.9 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.661 HD22 HD23 ' A' ' 142' ' ' LEU . 1.4 mm? -121.89 130.76 53.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 61.11 110.873 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -146.94 115.81 0.81 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.689 -0.767 . . . . 73.12 112.442 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -113.3 135.51 53.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.771 0.32 . . . . 65.22 110.876 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -132.91 117.22 17.43 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.184 -0.462 . . . . 61.02 110.852 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 3.3 tmm? -109.36 138.74 45.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 75.43 110.918 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -117.75 119.23 34.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.248 -0.433 . . . . 61.35 110.854 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -96.43 114.98 26.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 62.5 110.885 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -120.39 153.16 36.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 61.12 110.881 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.02 -29.5 14.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.216 -0.447 . . . . 71.33 111.117 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -84.48 -20.32 31.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 75.44 111.068 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 164.05 97.38 0.12 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.745 -0.74 . . . . 52.35 112.483 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 137.27 35.09 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.648 2.232 . . . . 73.04 112.348 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.07 153.65 46.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.189 -0.459 . . . . 70.25 110.832 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 5.2 mp -110.52 132.29 59.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 60.11 111.135 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 9.2 mtt-85 -119.79 138.72 53.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 75.1 110.862 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -131.95 145.18 16.95 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.761 -0.733 . . . . 74.42 112.508 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -139.23 116.47 11.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.842 0.353 . . . . 72.32 111.076 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.733 HD22 ' N ' ' A' ' 143' ' ' VAL . 0.6 OUTLIER -125.34 124.02 40.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 60.11 110.928 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.733 ' N ' HD22 ' A' ' 142' ' ' LEU . 0.1 OUTLIER -132.85 145.0 34.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 74.32 111.126 179.857 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.817 HD23 HD11 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -131.78 140.91 49.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.446 . . . . 44.25 110.921 179.947 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -123.4 117.79 3.32 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.722 -0.751 . . . . 75.15 112.463 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.435 ' O ' ' CD1' ' A' ' 149' ' ' TRP . 7.0 t80 -145.52 153.86 41.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.864 0.364 . . . . 73.14 110.921 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 52.58 23.72 2.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 74.54 110.861 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 89.93 -31.2 5.42 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.736 -0.745 . . . . 71.12 112.504 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.435 ' CD1' ' O ' ' A' ' 146' ' ' TYR . 50.5 p-90 -78.0 145.0 36.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.754 0.311 . . . . 73.34 110.923 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.533 HD23 ' O ' ' A' ' 144' ' ' LEU . 1.4 mt -124.21 144.4 49.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.249 -0.432 . . . . 54.03 110.906 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.504 ' HA ' HG13 ' A' ' 171' ' ' VAL . . . -142.97 125.89 16.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.15 -0.477 . . . . 72.51 111.086 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.737 ' O ' ' HB3' ' A' ' 169' ' ' PHE . . . -126.94 131.5 7.29 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.717 -0.754 . . . . 64.15 112.488 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.414 ' C ' ' HD1' ' A' ' 169' ' ' PHE . 5.5 t80 -133.2 120.28 20.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.841 0.353 . . . . 74.03 110.949 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.645 ' H ' ' HB2' ' A' ' 169' ' ' PHE . 0.5 OUTLIER -104.24 138.54 40.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.484 . . . . 70.3 110.915 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . 0.534 ' HB3' HG11 ' A' ' 164' ' ' VAL . 0.4 OUTLIER -122.73 146.76 47.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 52.14 110.849 179.955 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.41 ' O ' HG13 ' A' ' 164' ' ' VAL . 3.6 t30 -108.88 120.48 42.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.182 -0.463 . . . . 75.15 110.883 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -91.04 123.18 34.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 73.15 110.86 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.742 ' O ' ' O ' ' A' ' 161' ' ' LYS . 0.1 OUTLIER -78.19 137.64 38.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 70.31 110.881 -179.963 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.479 HG23 ' N ' ' A' ' 160' ' ' ALA . 5.4 t -69.05 -46.99 66.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.15 -0.477 . . . . 62.42 111.17 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.479 ' N ' HG23 ' A' ' 159' ' ' THR . . . -50.77 -25.87 4.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 75.41 111.111 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.742 ' O ' ' O ' ' A' ' 158' ' ' GLU . 33.2 mmtt -147.29 139.62 24.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 73.33 110.909 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 12.6 m -71.56 49.63 0.16 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 73.24 110.868 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -138.58 170.69 15.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.487 . . . . 75.11 110.889 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.534 HG11 ' HB3' ' A' ' 155' ' ' MET . 90.8 t -91.15 138.66 19.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.442 . . . . 62.13 111.107 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 96.1 m -94.65 -42.23 8.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.474 . . . . 65.31 111.125 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -160.1 142.2 13.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 61.01 110.922 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 6.8 p -127.12 125.94 42.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 72.21 110.865 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.441 ' CB ' ' HA ' ' A' ' 185' ' ' ASN . 5.8 p30 -139.7 152.3 46.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.102 -0.499 . . . . 53.03 110.906 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.737 ' HB3' ' O ' ' A' ' 152' ' ' GLY . 0.1 OUTLIER -178.55 -159.18 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 74.33 110.893 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -132.92 150.56 52.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 50.1 111.106 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.504 HG13 ' HA ' ' A' ' 151' ' ' ALA . 71.0 t -145.72 127.15 7.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.218 -0.446 . . . . 43.35 111.097 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -163.37 167.19 37.51 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.714 -0.755 . . . . 64.41 112.482 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 27.1 p90 -125.55 154.67 41.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.989 0.424 . . . . 44.13 110.9 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 38.8 mtpt -106.8 130.93 54.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.119 -0.491 . . . . 74.02 110.892 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.15 165.53 16.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 70.13 111.13 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -42.53 -71.74 0.08 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 72.24 110.915 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 26.5 mp0 -115.48 14.46 16.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 70.41 110.92 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -127.83 143.57 51.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.11 -0.496 . . . . 70.41 110.854 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . 0.401 ' HB3' ' HB2' ' A' ' 195' ' ' TYR . 5.7 mm-40 -136.81 130.96 32.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 72.34 110.882 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.507 HD13 ' C ' ' A' ' 180' ' ' LEU . 2.5 tm? -124.21 117.5 24.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.14 -0.482 . . . . 63.02 110.891 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 18.2 t-80 -135.07 118.43 16.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 74.54 110.892 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -130.74 127.83 39.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 75.53 111.162 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -119.36 141.01 49.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 72.23 110.922 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.538 ' HB ' ' HA ' ' A' ' 190' ' ' PHE . 1.3 m -133.07 141.19 45.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.457 . . . . 73.1 111.141 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.441 ' HA ' ' CB ' ' A' ' 168' ' ' ASN . 0.8 OUTLIER -105.13 89.2 3.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 71.32 110.884 179.999 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 74.41 -175.93 0.15 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.222 -0.444 . . . . 72.33 110.859 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -80.09 4.84 64.84 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.708 -0.758 . . . . 52.02 112.463 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 22.3 p -110.42 -22.19 11.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.755 0.312 . . . . 62.03 111.142 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . 0.401 ' HB3' ' CB ' ' A' ' 185' ' ' ASN . 1.9 tt0 -118.12 125.96 51.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 74.4 110.907 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' PHE . . . . . 0.538 ' HA ' ' HB ' ' A' ' 184' ' ' VAL . 32.2 t80 -137.4 125.1 22.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 75.1 110.822 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -136.46 141.95 13.06 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.724 -0.751 . . . . 60.32 112.473 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -133.46 145.19 17.25 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.696 -0.764 . . . . 71.34 112.442 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . 0.576 ' C ' HD12 ' A' ' 194' ' ' ILE . 3.3 t -139.31 152.63 47.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.893 0.378 . . . . 71.22 110.833 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.576 HD12 ' C ' ' A' ' 193' ' ' SER . 3.1 mp -127.43 130.56 70.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 75.43 111.106 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . 0.401 ' HB2' ' HB3' ' A' ' 179' ' ' GLN . 2.4 m-85 -108.66 123.11 48.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.171 -0.468 . . . . 74.5 110.897 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -124.78 112.45 16.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.122 -0.49 . . . . 64.42 110.877 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 33.6 mtpt -107.69 127.94 54.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 71.3 110.936 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.435 HG12 ' O ' ' A' ' 198' ' ' VAL . 3.2 t 66.45 22.21 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.253 -0.431 . . . . 44.13 111.164 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -92.54 -32.74 14.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 72.2 110.87 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 22.6 mtpp -154.28 66.13 0.7 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 63.0 110.924 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . 0.611 ' C ' HD22 ' A' ' 202' ' ' LEU . 24.8 mttm 68.55 112.92 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.44 . . . . 50.24 110.941 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.611 HD22 ' C ' ' A' ' 201' ' ' LYS . 0.8 OUTLIER 63.25 -163.25 0.27 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.211 -0.45 . . . . 75.23 110.946 179.979 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 5.6 pm0 -115.04 129.68 56.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.436 . . . . 55.12 110.875 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.501 HG22 ' HA ' ' A' ' 223' ' ' ALA . 17.4 p -142.07 156.76 45.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 72.0 111.152 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -149.44 148.44 29.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.248 -0.433 . . . . 72.3 111.099 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.584 HG12 HG22 ' A' ' 221' ' ' ILE . 0.8 OUTLIER -112.89 148.54 15.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.224 -0.444 . . . . 75.04 111.149 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -126.71 136.92 53.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 65.45 110.917 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 5.6 mp -130.72 142.3 50.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.167 -0.47 . . . . 64.22 110.928 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.417 ' HB3' ' HD2' ' A' ' 218' ' ' ARG . . . -131.59 131.64 43.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.466 . . . . 64.43 111.071 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 18.9 t90 -130.69 126.21 35.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 73.03 110.946 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . 0.62 HG23 ' CB ' ' A' ' 215' ' ' SER . 2.0 t -113.43 105.92 13.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.27 -0.423 . . . . 73.03 111.169 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -51.98 149.09 5.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 74.31 111.114 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 114.2 43.92 0.76 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.752 -0.737 . . . . 62.04 112.497 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 55.73 62.66 2.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.867 0.365 . . . . 72.45 110.901 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . 0.62 ' CB ' HG23 ' A' ' 211' ' ' THR . 7.1 t -121.85 -178.04 3.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 60.51 110.826 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 29.7 m120 -101.74 150.29 23.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.128 -0.487 . . . . 64.33 110.873 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 2.9 p -79.24 138.69 37.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 75.42 111.181 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . 0.417 ' HD2' ' HB3' ' A' ' 209' ' ' ALA . 75.6 mtt180 -105.97 126.99 52.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 71.42 110.857 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -122.77 139.43 54.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 75.02 110.887 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -149.68 149.01 20.88 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.745 -0.741 . . . . 73.53 112.521 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.619 HG12 HG12 ' A' ' 237' ' ' VAL . 0.0 OUTLIER -138.7 130.85 37.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.775 0.321 . . . . 74.44 111.142 -179.954 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -120.81 133.12 55.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 72.32 111.107 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.501 ' HA ' HG22 ' A' ' 204' ' ' THR . . . -111.91 125.85 54.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 75.5 111.105 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 18.3 ttpp -115.58 114.66 25.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 75.11 110.863 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -109.59 118.6 37.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 74.44 110.903 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.93 114.11 27.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 54.32 110.887 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 44.2 mt -109.06 -35.35 2.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 73.24 111.102 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -149.17 157.47 39.65 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.637 0.732 . . . . 50.11 110.862 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -17.0 37.89 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.694 2.263 . . . . 72.34 112.366 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -103.35 -28.04 12.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 74.31 110.855 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -124.32 129.9 51.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.463 . . . . 54.54 111.087 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 19.1 m -139.65 141.18 37.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.272 -0.422 . . . . 64.02 110.89 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -106.6 133.16 51.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.447 . . . . 74.34 110.895 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 2.8 t -138.27 143.22 39.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.471 . . . . 64.0 110.852 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -146.7 159.03 43.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.128 -0.487 . . . . 73.22 111.098 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.98 148.71 19.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 64.44 110.86 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.619 HG12 HG12 ' A' ' 221' ' ' ILE . 0.9 OUTLIER -140.65 149.1 21.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 74.23 111.115 179.896 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -117.56 147.95 42.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 72.31 110.886 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -58.16 -18.16 23.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 74.44 110.858 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 11.2 t -81.46 26.67 0.46 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 53.22 110.884 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 1.7 m 62.78 32.94 15.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 75.03 110.841 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . 0.473 HD11 ' HB3' ' A' ' 264' ' ' ASP . 4.5 mp -100.13 117.69 34.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.136 -0.483 . . . . 74.52 110.892 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.43 ' HA ' HG23 ' A' ' 237' ' ' VAL . 0.0 OUTLIER -109.56 117.75 55.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.131 -0.486 . . . . 72.02 111.178 179.782 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . 0.443 ' HA2' ' HA ' ' A' ' 262' ' ' LEU . . . -122.31 148.29 17.02 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.723 -0.751 . . . . 72.24 112.479 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -145.57 130.08 17.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.882 0.373 . . . . 75.45 110.914 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -129.67 138.78 10.47 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.759 -0.734 . . . . 51.33 112.499 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -128.95 131.81 47.54 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.965 0.412 . . . . 75.0 110.919 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 16.8 p -111.41 129.19 56.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 61.54 111.126 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -142.78 123.12 13.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 62.33 110.951 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 20.8 p -106.77 153.13 22.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 72.15 111.129 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.794 HD12 HG21 ' A' ' 255' ' ' ILE . 6.2 mt -85.74 -77.11 0.31 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.216 -0.447 . . . . 51.24 110.927 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' LYS . . . . . 0.469 ' N ' ' HD2' ' A' ' 253' ' ' PRO . 1.6 mttm 177.88 -60.71 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.598 0.714 . . . . 73.21 110.858 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . 0.735 ' HG2' HD12 ' A' ' 255' ' ' ILE . 53.5 Cg_endo -69.81 69.31 1.68 Allowed 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.725 2.283 . . . . 64.44 112.314 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 50.47 32.46 23.24 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.785 -0.722 . . . . 70.22 112.445 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.794 HG21 HD12 ' A' ' 251' ' ' LEU . 58.6 mt -114.45 122.54 68.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.864 0.364 . . . . 61.31 111.113 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 17.4 mtpp -130.71 120.52 23.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.14 -0.482 . . . . 63.02 110.889 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 0.525 HD21 HD21 ' A' ' 277' ' ' LEU . 0.4 OUTLIER -100.75 128.71 46.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.455 . . . . 74.34 110.909 179.927 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 1.5 m -115.5 115.24 26.17 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.177 -0.465 . . . . 74.52 111.164 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.948 HD22 HD23 ' A' ' 277' ' ' LEU . 0.1 OUTLIER -112.39 126.09 54.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.239 -0.437 . . . . 75.34 110.919 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.404 ' N ' HD13 ' A' ' 259' ' ' LEU . 23.6 p -133.67 144.98 49.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 54.32 110.876 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' ALA . . . . . 0.612 ' HB2' ' CD2' ' A' ' 275' ' ' LEU . . . -155.08 128.25 8.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.129 -0.487 . . . . 53.14 111.06 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.811 ' C ' HD13 ' A' ' 263' ' ' LEU . 1.5 tt -132.75 139.89 47.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.453 . . . . 65.22 110.937 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . 0.811 HD13 ' C ' ' A' ' 262' ' ' LEU . 0.0 OUTLIER -123.93 110.13 14.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.202 -0.454 . . . . 65.53 110.937 179.884 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . 0.691 ' O ' HG22 ' A' ' 268' ' ' VAL . 1.8 m-20 -79.92 106.15 11.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.209 -0.451 . . . . 71.3 110.836 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -53.69 -19.67 10.47 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.767 -0.73 . . . . 72.44 112.461 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.8 -25.95 18.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.785 0.326 . . . . 72.32 110.889 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -99.04 -55.91 2.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 72.2 110.871 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . 0.698 HG12 ' O ' ' A' ' 272' ' ' GLY . 13.1 m -49.47 -28.23 3.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 64.33 111.124 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -53.25 -44.78 68.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 62.31 110.879 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -105.28 -17.38 14.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.445 . . . . 42.15 111.094 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -111.73 -119.82 3.85 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.743 -0.741 . . . . 45.13 112.488 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . 0.698 ' O ' HG12 ' A' ' 268' ' ' VAL . . . -148.72 -170.55 16.61 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.762 -0.733 . . . . 55.35 112.549 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 273' ' ' HIS . . . . . 0.669 ' CG ' HD12 ' A' ' 263' ' ' LEU . 0.9 OUTLIER -87.96 146.04 25.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.9 0.381 . . . . 71.54 110.815 -179.914 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -96.96 135.81 38.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 61.24 110.925 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.612 ' CD2' ' HB2' ' A' ' 261' ' ' ALA . 2.1 tm? -132.1 123.26 26.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 54.11 110.922 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . 0.506 ' N ' HD13 ' A' ' 275' ' ' LEU . . . -119.38 130.4 8.5 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.737 -0.744 . . . . 55.05 112.509 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.948 HD23 HD22 ' A' ' 259' ' ' LEU . 3.3 tm? -119.31 141.03 49.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.874 0.369 . . . . 73.0 110.921 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . 0.685 ' N ' HD13 ' A' ' 277' ' ' LEU . . . -145.36 132.46 4.65 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.797 -0.716 . . . . 74.11 112.512 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.636 HD11 HD11 ' A' ' 277' ' ' LEU . 1.1 mm? -108.7 132.12 54.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.805 0.336 . . . . 44.52 110.899 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 50.3 tt0 -127.57 117.67 22.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.185 -0.461 . . . . 64.41 110.871 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -122.7 134.5 54.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.483 . . . . 71.44 110.898 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -135.12 124.3 24.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 65.21 110.938 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.771 ' HB3' HG23 ' A' ' 33' ' ' THR . . . -100.06 130.88 46.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.445 . . . . 74.13 111.085 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.604 HD23 ' C ' ' A' ' 283' ' ' ALA . 0.9 OUTLIER 41.21 38.31 0.74 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.446 . . . . 74.41 110.92 -179.975 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.46 . . . . 75.13 110.861 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' NAI . . . . . 0.412 ' H6N' HD11 ' A' ' 262' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.4 mtt . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.808 0.337 . . . . 73.44 110.898 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.24 90.9 0.36 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 72.25 111.145 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.765 HG22 ' HA ' ' A' ' 121' ' ' GLU . 19.5 t -136.7 75.42 50.04 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 121.674 0.75 . . . . 64.55 111.133 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.7 167.91 23.01 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.74 2.293 . . . . 72.52 112.377 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 102.55 1.05 Allowed 'Trans proline' 0 N--CA 1.465 -0.172 0 C-N-CA 122.684 2.256 . . . . 73.42 112.362 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -86.45 -37.68 18.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 62.12 111.161 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -52.16 -39.9 60.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 71.41 110.886 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -76.24 -24.13 54.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 53.52 111.118 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -74.07 -21.11 60.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 52.24 110.917 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.594 HD23 ' CD2' ' A' ' 150' ' ' LEU . 20.7 mt -56.88 -34.1 67.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.157 -0.474 . . . . 63.04 110.92 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -132.18 29.2 3.37 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.742 -0.742 . . . . 74.11 112.481 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 12.5 ttpp -69.59 -45.79 67.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.801 0.334 . . . . 62.41 110.877 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.4 m -64.37 -39.34 93.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.458 . . . . 62.0 110.883 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.26 -50.58 73.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 31.33 111.109 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -67.44 -33.8 75.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 75.23 110.879 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -60.31 -47.91 84.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 74.43 110.833 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 85.8 t -75.77 -33.46 26.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 70.42 111.135 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -59.8 -41.36 91.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 75.15 110.881 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.3 p 46.74 85.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.139 -0.482 . . . . 73.13 111.152 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.0 mtmt -50.64 -34.44 26.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 65.43 110.933 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -98.79 79.14 0.55 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.72 -0.752 . . . . 72.35 112.442 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -129.66 108.31 10.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.952 0.406 . . . . 74.5 110.965 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 51.71 77.14 0.14 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.741 -0.742 . . . . 44.04 112.503 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -103.35 -3.43 25.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.887 0.375 . . . . 54.52 110.833 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.56 13.7 80.04 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.785 -0.722 . . . . 44.14 112.46 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.628 HD11 HD22 ' A' ' 48' ' ' ASN . 2.0 tp -138.88 -178.93 5.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.78 0.324 . . . . 33.12 110.91 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 1.028 HG23 HD12 ' A' ' 277' ' ' LEU . 14.7 mm -104.7 141.38 20.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.182 -0.463 . . . . 42.0 111.151 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.7 tttt -122.42 139.39 53.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 74.11 110.928 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.504 HD13 ' C ' ' A' ' 29' ' ' LEU . 2.8 tm? -131.81 128.73 39.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 70.2 110.884 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.488 ' N ' HD22 ' A' ' 29' ' ' LEU . 8.2 m-20 -140.73 127.14 19.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.141 -0.481 . . . . 74.45 110.882 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.57 HD23 ' N ' ' A' ' 32' ' ' LYS . 8.2 tt -138.37 138.89 38.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 73.44 110.93 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.57 ' N ' HD23 ' A' ' 31' ' ' LEU . 0.4 OUTLIER -121.47 125.61 47.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 42.52 110.922 179.832 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 96.6 m -121.01 129.12 53.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.229 -0.441 . . . . 73.53 111.108 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.4 tttt -143.33 126.97 16.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.214 -0.448 . . . . 70.1 110.926 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.663 ' HB3' HD23 ' A' ' 39' ' ' LEU . 0.2 OUTLIER -88.22 174.95 7.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.24 -0.436 . . . . 73.21 110.843 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.5 ' C ' ' O ' ' A' ' 35' ' ' SER . 43.8 mm-40 -29.38 -56.61 0.15 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.112 -0.495 . . . . 71.31 110.904 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 -173.77 149.37 1.57 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 73.24 110.899 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 86.54 -11.16 64.56 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.757 -0.735 . . . . 54.1 112.488 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.663 HD23 ' HB3' ' A' ' 35' ' ' SER . 3.2 mm? -104.2 132.49 50.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.791 0.329 . . . . 75.44 110.922 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.0 tm-20 -137.78 114.47 10.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.224 -0.444 . . . . 63.25 110.899 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.423 ' CZ ' HG23 ' A' ' 60' ' ' THR . 25.1 m-85 -134.94 118.32 16.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.094 -0.503 . . . . 63.34 110.868 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.58 130.82 46.17 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.125 -0.489 . . . . 62.24 111.107 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.3 p -127.04 131.99 50.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.196 -0.457 . . . . 65.53 110.825 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.9 m -148.72 126.82 12.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.092 -0.504 . . . . 44.42 110.813 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -167.92 179.41 41.21 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.757 -0.735 . . . . 71.42 112.517 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.0 m -137.33 161.5 36.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.899 0.38 . . . . 75.13 110.819 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.957 ' HB2' HG13 ' A' ' 54' ' ' VAL . . . -145.7 150.49 36.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.093 -0.503 . . . . 63.53 111.108 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.628 HD22 HD11 ' A' ' 26' ' ' LEU . 25.4 t-20 -73.77 142.65 46.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 74.11 110.832 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -55.14 -39.27 69.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.123 -0.489 . . . . 73.24 111.127 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -95.17 25.24 4.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.454 . . . . 73.13 110.874 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 20.5 p 48.09 30.75 2.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 74.23 111.093 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 22.7 m -71.1 -30.8 66.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 64.25 111.124 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 10.5 tptm -165.84 130.72 2.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.247 -0.433 . . . . 52.54 110.885 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.957 HG13 ' HB2' ' A' ' 47' ' ' ALA . 7.9 t -125.18 125.71 69.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 73.15 111.095 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.7 t -136.68 129.04 30.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 61.01 111.165 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -151.03 150.46 22.43 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.705 -0.759 . . . . 72.1 112.474 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -104.48 146.39 28.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.874 0.369 . . . . 74.02 110.875 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.658 HD13 ' N ' ' A' ' 59' ' ' GLU . 0.9 OUTLIER -125.67 132.41 52.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.12 -0.491 . . . . 73.21 110.94 179.985 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.658 ' N ' HD13 ' A' ' 58' ' ' LEU . 6.7 pt-20 -125.39 120.08 30.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.441 . . . . 74.24 110.85 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.423 HG23 ' CZ ' ' A' ' 41' ' ' PHE . 96.9 m -124.76 137.68 54.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 73.43 111.12 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.658 ' CB ' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -172.39 -178.6 2.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 74.54 110.882 179.901 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -115.22 141.65 47.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.233 -0.44 . . . . 75.42 110.897 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -134.41 111.65 10.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.097 -0.501 . . . . 74.44 110.906 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 2.4 m-90 -106.12 110.59 22.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 53.12 110.952 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 10.3 t -81.29 -33.26 32.75 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.257 -0.429 . . . . 62.03 111.136 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -49.97 -54.82 17.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.245 -0.434 . . . . 65.35 110.888 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -73.76 -51.11 17.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.463 . . . . 61.42 110.91 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.742 ' O ' HD22 ' A' ' 69' ' ' LEU . . . 123.78 32.01 0.91 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.785 -0.721 . . . . 75.01 112.462 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.742 HD22 ' O ' ' A' ' 68' ' ' GLY . 3.9 mm? -135.09 132.87 38.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.917 0.389 . . . . 75.23 110.866 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 55.5 p -132.42 111.09 11.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 75.51 111.119 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.632 ' O ' ' HB3' ' A' ' 61' ' ' LYS . 0.2 OUTLIER -105.56 132.69 51.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.438 . . . . 73.03 110.888 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.658 ' HA ' ' CB ' ' A' ' 61' ' ' LYS . 17.8 p -129.88 136.14 49.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.484 . . . . 70.23 111.143 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.631 ' HG3' HG23 ' A' ' 83' ' ' THR . 25.6 tt0 -126.5 122.01 33.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 52.14 110.877 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.49 139.69 44.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 73.14 110.892 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 8.1 t90 -135.44 129.54 33.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 74.21 110.924 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -116.85 149.29 40.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.263 -0.426 . . . . 71.42 110.891 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 8.8 t -65.12 -14.22 59.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.184 -0.462 . . . . 73.04 111.172 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.456 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 5.6 m-20 -75.25 2.03 12.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 74.35 110.865 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.456 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 2.9 m120 80.09 36.83 0.12 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 63.45 110.932 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.2 m -116.55 121.39 41.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 63.44 111.168 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.592 HD23 ' CD ' ' A' ' 105' ' ' PRO . 4.4 mm? -101.67 149.22 24.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.249 -0.432 . . . . 75.2 110.933 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -148.81 143.15 10.6 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.696 -0.764 . . . . 62.31 112.493 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.631 HG23 ' HG3' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -146.53 96.97 2.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.763 0.316 . . . . 61.04 111.11 -179.835 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.435 ' HA ' ' HA ' ' A' ' 100' ' ' ASP . 15.8 tt0 -106.14 122.7 46.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.207 -0.451 . . . . 74.24 110.886 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.481 HG22 ' O ' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -121.63 138.26 52.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 74.5 111.146 179.945 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.477 HG23 HG23 ' A' ' 98' ' ' THR . 0.2 OUTLIER -113.62 141.28 47.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.148 -0.478 . . . . 72.33 111.122 179.976 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.695 HG13 HD11 ' A' ' 69' ' ' LEU . 0.3 OUTLIER -121.58 120.07 60.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 40.13 111.148 179.893 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -93.77 118.26 31.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 71.51 110.943 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 49.68 70.37 0.5 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.203 -0.453 . . . . 73.22 110.876 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.536 ' CB ' HD23 ' A' ' 97' ' ' LEU . 6.4 tp60 -76.37 86.69 3.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.205 -0.452 . . . . 73.42 110.9 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 11.7 tp 66.19 30.38 9.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 71.31 110.933 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -179.48 100.68 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 73.14 111.126 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 5.9 mpt_? -51.13 134.41 26.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 64.42 110.86 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 96.41 -20.27 51.06 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.721 -0.752 . . . . 61.24 112.542 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.487 HD23 HD21 ' A' ' 97' ' ' LEU . 14.5 tp -85.0 134.78 34.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.902 0.382 . . . . 62.34 110.896 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.467 ' O ' HD13 ' A' ' 97' ' ' LEU . 10.9 ptmt -121.94 128.02 51.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 73.1 110.898 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.536 HD23 ' CB ' ' A' ' 90' ' ' GLN . 2.4 mm? -122.98 130.58 52.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 73.24 110.925 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.477 HG23 HG23 ' A' ' 86' ' ' THR . 0.3 OUTLIER -130.53 117.17 19.19 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.176 -0.465 . . . . 74.03 111.138 179.932 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.481 ' O ' HG22 ' A' ' 85' ' ' ILE . 75.0 t80 -125.47 115.1 19.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 72.35 110.849 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.435 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 2.9 p30 -130.5 142.25 50.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.137 -0.483 . . . . 63.13 110.865 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.552 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 3.1 p -141.77 122.79 14.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 64.42 110.881 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 71.3 p -140.7 141.65 34.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 52.33 110.883 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.477 ' HB2' ' H ' ' A' ' 111' ' ' ASN . 0.1 OUTLIER -176.7 157.79 1.6 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.48 . . . . 74.32 110.885 -179.902 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -78.92 113.13 32.9 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.629 0.728 . . . . 73.54 110.888 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.592 ' CD ' HD23 ' A' ' 81' ' ' LEU . 54.2 Cg_endo -69.75 -4.02 13.19 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.71 2.273 . . . . 50.44 112.325 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -45.13 -35.0 2.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 75.52 110.86 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.8 p -129.2 23.12 5.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.455 . . . . 71.42 111.177 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 75.69 27.33 63.23 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.678 -0.772 . . . . 74.24 112.511 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.446 ' O ' ' HB3' ' A' ' 103' ' ' PHE . 15.4 mtpt -77.61 140.74 39.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.835 0.35 . . . . 74.14 110.902 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.401 ' C ' ' HD1' ' A' ' 103' ' ' PHE . 23.4 mttt -156.61 113.38 3.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 62.54 110.895 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.552 ' O ' ' HA ' ' A' ' 101' ' ' SER . 44.2 t-20 -115.33 118.68 33.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.444 . . . . 62.4 110.914 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.466 ' HB1' ' CZ ' ' A' ' 99' ' ' PHE . . . -116.1 150.23 37.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.221 -0.445 . . . . 72.12 111.107 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 4.0 tttp -135.19 136.78 42.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 73.34 110.874 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 6.2 tp -112.07 125.01 69.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 63.34 111.096 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 28.5 tttt -122.02 120.0 33.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 63.11 110.915 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 7.1 t -125.35 125.98 44.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 73.53 111.168 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -153.46 176.9 31.3 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.7 -0.762 . . . . 54.12 112.487 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -128.27 144.6 51.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.907 0.384 . . . . 74.22 110.965 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 17.8 mtpt -110.42 117.97 35.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.106 -0.497 . . . . 73.4 110.893 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.43 ' HB2' HG22 ' A' ' 123' ' ' ILE . 1.4 mmm180 -110.65 146.55 35.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 75.15 110.899 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.765 ' HA ' HG22 ' A' ' 3' ' ' VAL . 15.7 pt-20 -56.6 -31.01 63.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 74.32 110.875 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 13.9 m80 -124.23 9.37 8.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.455 . . . . 74.32 110.884 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.604 ' CG2' HD23 ' A' ' 125' ' ' LEU . 1.0 OUTLIER -145.58 147.37 18.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 73.4 111.104 -179.999 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -127.62 113.62 16.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 75.33 110.877 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.604 HD23 ' CG2' ' A' ' 123' ' ' ILE . 3.4 mm? -117.44 127.43 54.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 72.4 110.94 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -146.7 114.71 0.74 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.726 -0.749 . . . . 63.21 112.476 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -113.29 134.62 54.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.847 0.356 . . . . 64.45 110.872 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -124.94 143.58 50.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 64.31 110.834 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 3.2 mmt -138.98 119.04 13.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 74.23 110.88 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -86.17 123.64 31.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.24 -0.436 . . . . 70.13 110.881 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -92.1 98.97 11.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 73.55 110.882 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -115.92 117.05 29.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.141 -0.481 . . . . 74.51 110.882 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 2.5 pp -53.83 -32.54 22.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 72.25 111.172 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -84.36 -20.01 32.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 65.13 111.115 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 162.01 101.66 0.17 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.741 -0.742 . . . . 74.21 112.503 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 161.31 46.42 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.703 2.269 . . . . 71.52 112.369 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.0 m -127.97 151.68 48.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.231 -0.44 . . . . 74.14 110.894 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.631 HD12 ' OG1' ' A' ' 159' ' ' THR . 3.0 mp -109.06 125.65 66.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 63.35 111.093 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 15.5 ttt180 -122.85 129.25 51.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.119 -0.492 . . . . 71.1 110.882 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -124.18 133.71 8.85 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.712 -0.756 . . . . 72.42 112.509 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -133.16 126.64 32.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.855 0.36 . . . . 61.25 111.093 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.507 HD23 ' N ' ' A' ' 143' ' ' VAL . 0.7 OUTLIER -139.93 121.65 15.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.435 . . . . 55.21 110.882 -179.987 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.507 ' N ' HD23 ' A' ' 142' ' ' LEU . 1.5 m -133.8 139.55 48.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 73.41 111.139 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.41 HD12 ' N ' ' A' ' 144' ' ' LEU . 4.6 mp -109.67 138.66 45.72 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.205 -0.452 . . . . 75.2 110.937 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -100.38 136.94 12.97 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.701 -0.761 . . . . 23.43 112.473 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -141.68 147.13 37.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.851 0.357 . . . . 73.03 110.932 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -49.85 94.3 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.135 -0.484 . . . . 63.11 110.842 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 89.66 -25.27 11.64 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.74 -0.743 . . . . 23.42 112.509 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 37.2 m95 -104.92 142.01 35.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.816 0.341 . . . . 63.23 110.909 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.594 ' CD2' HD23 ' A' ' 10' ' ' LEU . 43.7 tp -140.15 140.16 35.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.236 -0.438 . . . . 73.55 110.868 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -136.01 141.52 44.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 63.12 111.102 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -148.71 134.27 4.92 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.726 -0.749 . . . . 32.44 112.465 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -133.3 124.08 26.63 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.866 0.365 . . . . 73.21 110.976 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -121.0 121.57 38.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.116 -0.493 . . . . 75.11 110.908 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 2.7 ptp -128.1 128.41 44.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.451 . . . . 61.34 110.891 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.487 ' O ' HG22 ' A' ' 164' ' ' VAL . 14.6 m-20 -113.62 121.58 44.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 63.41 110.901 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.435 ' HA ' ' HA ' ' A' ' 164' ' ' VAL . 38.9 m-85 -94.84 126.78 40.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 75.51 110.883 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.693 ' OE2' ' HB3' ' A' ' 160' ' ' ALA . 0.0 OUTLIER -79.04 100.86 7.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 64.32 110.883 -179.909 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.631 ' OG1' HD12 ' A' ' 138' ' ' ILE . 0.2 OUTLIER -64.56 -48.11 76.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.461 . . . . 74.41 111.11 -179.909 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.693 ' HB3' ' OE2' ' A' ' 158' ' ' GLU . . . -48.19 -26.09 1.77 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.225 -0.443 . . . . 60.01 111.11 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 25.4 mmtt -127.24 -167.76 1.78 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 74.31 110.87 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 6.1 t -110.59 40.12 2.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.26 -0.427 . . . . 72.11 110.874 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 9.4 mmt180 -154.19 176.74 11.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.108 -0.496 . . . . 73.51 110.83 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.487 HG22 ' O ' ' A' ' 156' ' ' ASN . 0.9 OUTLIER -73.61 142.69 14.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.14 -0.482 . . . . 72.11 111.122 179.97 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.408 ' HB ' ' HG2' ' A' ' 158' ' ' GLU . 8.6 t -90.51 -36.13 14.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.47 . . . . 74.25 111.117 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -156.24 142.88 18.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 64.43 110.871 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 2.5 p -124.99 129.66 50.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.177 -0.465 . . . . 54.44 110.845 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -136.2 148.31 48.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.103 -0.499 . . . . 74.52 110.889 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -152.09 140.17 20.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.192 -0.458 . . . . 74.32 110.892 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -154.63 142.77 20.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.465 . . . . 64.03 111.112 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -145.97 127.48 7.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 71.25 111.111 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -98.97 117.43 5.87 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.728 -0.749 . . . . 72.43 112.445 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.76 119.01 35.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.956 0.408 . . . . 74.24 110.92 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 3.3 mtpm? -116.16 127.28 54.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.085 -0.507 . . . . 60.1 110.878 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.421 ' HB ' ' H ' ' A' ' 178' ' ' PHE . 0.2 OUTLIER -110.14 166.99 10.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.226 -0.443 . . . . 74.54 111.151 -179.991 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -73.34 -6.39 45.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.186 -0.461 . . . . 73.13 110.866 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -119.49 -37.99 3.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 74.43 110.867 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.421 ' H ' ' HB ' ' A' ' 175' ' ' THR . 34.5 p90 -148.96 150.81 33.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 71.22 110.904 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -125.55 122.05 35.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.136 -0.484 . . . . 72.32 110.917 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.757 ' C ' HD12 ' A' ' 180' ' ' LEU . 0.3 OUTLIER -126.35 146.15 50.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.22 -0.445 . . . . 72.13 110.97 179.982 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . 0.703 ' N ' HD12 ' A' ' 180' ' ' LEU . 66.1 m-70 -119.74 116.71 26.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 65.53 110.821 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.24 143.82 28.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 60.31 111.163 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 18.2 t30 -145.18 137.86 26.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 62.24 110.875 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.532 HG22 ' HA ' ' A' ' 190' ' ' PHE . 2.4 t -134.62 114.3 17.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.253 -0.43 . . . . 71.45 111.146 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -101.96 92.58 4.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 75.41 110.883 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 2.6 t70 66.13 171.36 0.23 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 60.2 110.879 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -69.53 -4.71 46.85 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.738 -0.744 . . . . 51.52 112.487 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 33.9 p -95.06 -26.34 16.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.808 0.337 . . . . 73.34 111.162 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -123.65 114.9 20.6 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.186 -0.461 . . . . 61.33 110.906 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' PHE . . . . . 0.532 ' HA ' HG22 ' A' ' 184' ' ' VAL . 26.2 p90 -140.75 124.9 17.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 62.13 110.859 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -175.46 -149.17 7.19 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.744 -0.741 . . . . 62.41 112.509 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -173.51 -165.96 31.09 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.731 -0.747 . . . . 64.44 112.472 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 70.9 m -149.51 148.01 28.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.886 0.374 . . . . 61.41 110.858 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.483 ' HB ' HG22 ' A' ' 206' ' ' VAL . 5.4 mp -119.91 140.98 42.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.099 -0.5 . . . . 73.22 111.131 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . 0.618 ' HD2' ' HB2' ' A' ' 205' ' ' ALA . 14.8 t80 -132.34 120.7 22.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 74.24 110.941 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 8.7 tm0? -126.2 131.26 52.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.168 -0.469 . . . . 53.44 110.946 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 6.1 mtmp? -97.65 124.81 42.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 73.15 110.851 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.445 ' HB ' HD12 ' A' ' 202' ' ' LEU . 84.1 t -94.39 -33.7 5.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.445 . . . . 71.15 111.107 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -174.66 170.41 3.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.47 . . . . 53.3 110.906 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 19.1 mtpt -50.93 -33.66 25.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 75.33 110.878 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 4.0 mptt -120.43 53.44 1.1 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.245 -0.434 . . . . 72.23 110.944 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.445 HD12 ' HB ' ' A' ' 198' ' ' VAL . 0.2 OUTLIER -175.14 92.92 0.06 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 74.12 110.911 179.934 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -111.95 134.51 53.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 74.32 110.899 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 4.8 t -130.8 138.1 49.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 64.54 111.109 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.618 ' HB2' ' HD2' ' A' ' 195' ' ' TYR . . . -150.3 163.42 38.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.242 -0.435 . . . . 53.33 111.112 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.896 HG12 HG22 ' A' ' 221' ' ' ILE . 1.0 OUTLIER -137.14 147.95 26.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.44 . . . . 60.41 111.124 179.96 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -120.87 126.61 50.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.47 . . . . 54.44 110.911 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.409 HD12 HG23 ' A' ' 206' ' ' VAL . 1.3 mp -128.41 142.77 51.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.161 -0.472 . . . . 65.44 110.908 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -157.47 130.77 7.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 73.24 111.126 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 1.8 t-105 -103.6 123.63 47.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.199 -0.455 . . . . 73.42 110.955 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 61.8 p -107.47 104.74 14.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.257 -0.429 . . . . 62.23 111.161 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -51.11 138.69 19.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.262 -0.426 . . . . 72.35 111.074 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 154.73 -46.79 0.53 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.689 -0.767 . . . . 64.02 112.482 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -151.62 35.02 0.55 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.804 0.335 . . . . 73.42 110.866 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 47.7 t 50.98 44.76 28.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 63.03 110.892 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -101.87 131.79 48.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.147 -0.479 . . . . 73.01 110.922 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 5.2 t -115.36 139.0 50.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 75.21 111.179 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -105.94 131.57 53.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.209 -0.45 . . . . 74.04 110.879 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . 0.522 ' CZ ' HD12 ' A' ' 221' ' ' ILE . 13.4 t80 -131.41 136.21 47.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.466 . . . . 73.21 110.919 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -145.45 153.12 25.08 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.73 -0.748 . . . . 74.21 112.446 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.896 HG22 HG12 ' A' ' 206' ' ' VAL . 0.0 OUTLIER -137.67 130.68 42.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.85 0.357 . . . . 63.53 111.169 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -135.81 149.0 48.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.16 -0.473 . . . . 63.31 111.119 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -145.02 143.43 30.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.248 -0.433 . . . . 71.23 111.113 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 21.3 ttpp -117.74 132.89 56.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.237 -0.438 . . . . 60.34 110.865 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -132.99 132.38 41.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 64.24 110.908 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -93.67 130.45 39.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.107 -0.497 . . . . 61.22 110.922 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 71.5 mt -78.26 -56.0 8.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.214 -0.448 . . . . 51.44 111.129 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.56 ' N ' ' HD2' ' A' ' 229' ' ' PRO . 0.1 OUTLIER 173.33 -56.94 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.61 0.719 . . . . 73.4 110.881 179.843 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 228' ' ' ASP . 53.2 Cg_endo -69.79 -156.73 0.04 OUTLIER 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.743 2.295 . . . . 53.53 112.332 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -85.55 15.79 4.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.266 -0.424 . . . . 62.34 110.871 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.665 ' HB2' ' HG3' ' A' ' 249' ' ' GLN . . . -120.43 122.28 40.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 65.22 111.059 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 31.7 m -115.71 144.39 44.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 73.04 110.837 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -111.44 131.23 55.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 70.14 110.823 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 3.5 p -127.67 141.75 51.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 63.43 110.867 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -119.76 141.65 49.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.122 -0.49 . . . . 65.51 111.096 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 18.2 mttp -145.74 142.54 29.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 74.01 110.858 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 242' ' ' LEU . 6.7 p -136.35 142.74 37.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 62.03 111.129 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -104.51 148.38 26.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 72.32 110.866 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -57.15 -18.76 16.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 72.35 110.891 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 2.1 m -82.02 25.37 0.58 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.476 . . . . 60.21 110.874 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 63.6 34.46 12.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.121 -0.49 . . . . 71.23 110.829 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . 0.457 HD11 ' HB3' ' A' ' 264' ' ' ASP . 2.7 mp -99.93 117.24 33.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 64.53 110.882 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.516 ' H ' HD12 ' A' ' 243' ' ' ILE . 0.2 OUTLIER -111.19 116.5 52.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.142 -0.481 . . . . 75.31 111.128 179.836 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . 0.522 ' C ' HD13 ' A' ' 245' ' ' LEU . . . -145.93 164.98 28.16 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.721 -0.752 . . . . 72.33 112.487 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.667 ' N ' HD13 ' A' ' 245' ' ' LEU . 0.0 OUTLIER -145.36 160.68 41.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.812 0.339 . . . . 75.03 110.926 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -129.52 139.62 11.1 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.718 -0.753 . . . . 64.13 112.464 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -116.69 115.86 26.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.996 0.427 . . . . 70.23 110.905 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 56.1 p -111.76 115.51 29.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.119 -0.492 . . . . 72.42 111.128 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . 0.665 ' HG3' ' HB2' ' A' ' 231' ' ' ALA . 49.5 tt0 -129.07 137.89 51.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 71.24 110.897 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . 0.653 HG23 ' HG2' ' A' ' 256' ' ' LYS . 95.4 m -119.05 116.81 27.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.45 . . . . 72.2 111.157 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -106.02 103.71 13.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.236 -0.438 . . . . 75.04 110.921 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' LYS . . . . . 0.409 ' HB3' ' HD2' ' A' ' 253' ' ' PRO . 20.1 mmmt 64.34 154.6 0.12 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.588 0.709 . . . . 73.12 110.886 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . 0.409 ' HD2' ' HB3' ' A' ' 252' ' ' LYS . 53.6 Cg_endo -69.8 75.42 1.23 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.699 2.266 . . . . 74.03 112.312 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 167.02 -32.17 0.2 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.782 -0.723 . . . . 74.43 112.477 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 7.3 mt -117.68 122.58 70.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.965 0.412 . . . . 73.01 111.099 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.653 ' HG2' HG23 ' A' ' 250' ' ' THR . 20.9 mtpt -130.81 127.35 38.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.484 . . . . 63.41 110.935 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -100.68 128.78 46.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.242 -0.435 . . . . 65.03 110.886 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 23.3 m -126.46 113.01 16.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 72.53 111.125 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.594 ' CD1' HD23 ' A' ' 277' ' ' LEU . 0.1 OUTLIER -121.45 150.55 41.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.207 -0.452 . . . . 75.32 110.915 179.91 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 40.8 p -151.16 140.96 21.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 62.4 110.874 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' ALA . . . . . 0.613 ' HB2' ' CD2' ' A' ' 275' ' ' LEU . . . -141.37 133.49 27.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.142 -0.481 . . . . 53.02 111.087 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.787 ' C ' HD13 ' A' ' 263' ' ' LEU . 0.7 OUTLIER -131.85 138.2 48.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.221 -0.445 . . . . 75.13 110.917 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . 0.787 HD13 ' C ' ' A' ' 262' ' ' LEU . 0.1 OUTLIER -121.81 109.28 14.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.155 -0.475 . . . . 71.41 110.923 179.881 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . 0.605 ' O ' HG22 ' A' ' 268' ' ' VAL . 1.0 OUTLIER -84.73 103.95 14.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 63.44 110.86 179.903 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -59.21 -11.04 11.31 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.685 -0.769 . . . . 54.34 112.508 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 47.3 mtpt -78.29 -3.31 42.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.826 0.346 . . . . 73.04 110.914 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 -156.19 -53.28 0.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 61.42 110.884 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . 0.62 HG12 ' O ' ' A' ' 272' ' ' GLY . 1.8 m -57.71 -18.85 10.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 73.22 111.126 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -50.94 -28.35 9.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 73.33 110.88 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -102.95 -17.61 15.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.457 . . . . 64.35 111.085 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 142.43 122.66 1.77 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.758 -0.734 . . . . 52.21 112.496 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . 0.62 ' O ' HG12 ' A' ' 268' ' ' VAL . . . 134.78 62.12 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.707 -0.759 . . . . 55.54 112.521 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 273' ' ' HIS . . . . . 0.589 ' HB2' HD12 ' A' ' 263' ' ' LEU . 18.2 p-80 -76.33 146.13 39.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.855 0.359 . . . . 72.24 110.843 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 13.9 mttp -95.46 135.37 37.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 65.31 110.933 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.747 HD13 ' N ' ' A' ' 276' ' ' GLY . 2.4 tm? -135.59 139.25 43.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 72.44 110.927 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . 0.747 ' N ' HD13 ' A' ' 275' ' ' LEU . . . -134.03 129.26 5.22 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.738 -0.744 . . . . 42.24 112.526 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 1.028 HD12 HG23 ' A' ' 27' ' ' ILE . 3.3 tm? -115.54 135.35 54.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.901 0.382 . . . . 72.23 110.889 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . 0.548 ' O ' HD13 ' A' ' 279' ' ' LEU . . . -147.45 141.49 9.35 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.746 -0.74 . . . . 75.02 112.481 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.548 HD13 ' O ' ' A' ' 278' ' ' GLY . 1.1 mm? -119.57 140.13 51.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.798 0.333 . . . . 63.12 110.894 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 15.3 mp0 -128.53 118.21 22.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.148 -0.478 . . . . 74.3 110.868 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -114.24 128.83 56.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.479 . . . . 73.51 110.877 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -113.42 112.99 24.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 65.24 110.92 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.636 ' C ' HD22 ' A' ' 284' ' ' LEU . . . -115.72 113.34 23.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 63.44 111.066 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.636 HD22 ' C ' ' A' ' 283' ' ' ALA . 3.2 mm? -130.75 -74.52 0.53 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 74.42 110.941 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 63.44 110.929 179.92 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' NAI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_